Experiment,Cellname,Library,Anchor,Tissue,Conc,CancerType,Gender,Ethnicity,AgeAtSampling,y_trueIC,y_trueEmax,y_predIC,y_predEmax
79088,SIDM00833,BMS-754807,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.0021894,-0.16958249,-0.5110853718330732,-0.03949968070319866
54237,SIDM00833,AZD4547,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.7885383,0.113359,0.36765049647210457,-0.02611915504997247
73320,SIDM00097,Ribociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7924232,-0.087340206,-2.4503417255288054,-0.06445481748281766
45944,SIDM00216,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.2982707,0.07804458,0.8004808705396415,0.06014351707168148
33775,SIDM00148,5-Fluorouracil,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1451046,-0.09773431,-1.1337595122910409,-0.07756987068811999
40357,SIDM00148,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0607082,0.10521686,0.13909188619350504,-0.05747360623307115
54374,SIDM00826,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.006958,-0.04054145,-3.327603729319705,-0.11535744290853091
50077,SIDM00832,LGK974,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.0868237,-0.0943715,1.4831389752708988,0.047845011338995574
80758,SIDM00148,Sorafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.26631916,-0.025210133,-0.37434211207841733,-0.017347224356927097
41369,SIDM00148,Docetaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.47346592,-0.04567943,-0.8699082625522931,-0.04748440176608857
18287,SIDM00455,Dactolisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7053295,-0.087984815,-1.5693990681586316,-0.07653663078212984
37523,SIDM00835,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-1.6327587,-0.13057223,-2.397645900882004,-0.07548371024439707
69926,SIDM00928,Entinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.5208727,0.12702443,1.1202077277178322,0.08722584127609381
92873,SIDM00875,JQ1,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39358014,-0.042581365,0.03220641473850305,0.002867665956582105
11423,SIDM00950,Dasatinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,7.0843997,0.28048983,3.2055458914769686,0.1836640319176159
101181,SIDM00673,AZD6482,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3999227,0.07088779,-0.5681429112305194,-0.031411486569371226
15310,SIDM00933,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.6516705,-0.0700349,-0.050055586670311875,-0.006826101925580939
2638,SIDM00928,KU-55933,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-2.4414823,-0.10165399,0.6128608249645565,0.005267943197560251
40903,SIDM00097,Ribociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3360072,-0.04457313,-0.3337799444052774,-0.0071197615123367265
33992,SIDM00833,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.2483805,0.07964144,-0.7464508610705752,-0.033689653943490716
95386,SIDM00950,Erlotinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3965049,0.2911582,2.0554624730560715,0.1462512595013206
14993,SIDM00216,Olaparib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.63680315,-0.016177349,-0.06839776002241263,0.025283285034565246
74379,SIDM00928,Temozolomide,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.8621099,-0.01921943,0.387034190000783,0.0061839920587356805
27892,SIDM00875,5-Fluorouracil,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4076546,0.1599622,0.6508102759560108,0.10731087123425989
105848,SIDM00933,Doramapimod,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.3069801,0.080446236,2.0927529437392516,0.030862599326769526
14804,SIDM00097,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.608341,-0.14082964,-1.2931227533576848,-0.07698550175069181
56515,SIDM01042,GSK269962A,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1722841,0.21378511,-1.0776201422482488,-0.12584661248803974
73934,SIDM01042,5-Fluorouracil,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6125112,0.094766766,1.3321044886343154,0.0405113851033964
32211,SIDM00148,Axitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.54088897,0.046196073,-0.5628156886937071,-0.011284456956806055
84925,SIDM00872,ZM447439,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4711229,0.14644374,0.3668584629844227,0.04814235750556198
85745,SIDM00872,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7518337,-0.078193106,-0.9373467899007151,-0.08367639390366297
62033,SIDM01197,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.6805928,0.028853612,3.476152230911389,0.1363714196091642
48785,SIDM01042,JQ1,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5482601,0.011408422,1.5507100512391123,0.06166666757587905
76333,SIDM00933,Palbociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.6616244,-0.050784804,-0.42798492712290925,-0.02583022776679469
85997,SIDM00673,Lapatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,2.3450937,0.2308562,2.296078631648443,0.1694138534884909
29974,SIDM00097,OSI-027,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9698708,-0.12348531,1.0726976947342257,0.07939002860369598
104958,SIDM00875,Temozolomide,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9088613,0.02372374,0.4172521231096284,-0.010851033332101473
78122,SIDM00933,Wee1 Inhibitor,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.705259,-0.24488331,-1.4059189910586452,-0.11345879851794448
26559,SIDM01187,Vorinostat,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6024928,0.08468193,1.3327356784480178,0.06148780494234513
69373,SIDM00875,Lapatinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4833357,0.04882436,0.13662548314981277,0.04107223991217387
48895,SIDM01042,Alisertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7707636,-0.22465234,-1.0907260346324321,-0.12391207926135324
49613,SIDM00673,Taselisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.835273,0.0631215,-0.48712626971581524,-0.08095998195399307
29643,SIDM00877,Trametinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.50869906,-0.0143146375,-0.7854815906377255,0.01975154554804403
82275,SIDM00928,Nutlin-3a (-),Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,1.1375391,0.035738528,0.7315055618745604,0.02243950045857046
96012,SIDM00148,Doramapimod,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.67328084,-0.04497036,-1.2696905300610202,-0.021504329474613327
22326,SIDM00872,JQ1,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.91091835,-0.022284158,1.8975930015516078,0.062255487767793036
54046,SIDM00928,MK-2206,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.4504223,0.22667629,3.462688496286842,0.1805309932118867
8842,SIDM00875,Uprosertib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0306187,-0.097157344,-0.7923542328819442,-0.025065368944808167
46922,SIDM01042,Docetaxel,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6388576,0.08001532,-0.8751527399264749,-0.006478763229248851
53849,SIDM00950,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3141584,-0.13592103,-0.7275959881082215,-0.05805299034190152
18736,SIDM00872,Venetoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.64412,-0.08165363,-0.8589627608014273,0.015616139786644915
39059,SIDM00875,Navitoclax,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27218902,-0.030043608,0.29988198991902754,0.0017192094606321932
46594,SIDM00359,AZD4547,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0340695,0.17269446,1.0228320013821608,0.0928569417737341
44127,SIDM00872,Temozolomide,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.15877709,-0.0032486515,0.8148848320249945,0.0024539323658463847
30700,SIDM00673,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.9116808,-0.10781229,-1.6861585424669399,-0.058704267639933985
20040,SIDM00837,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.7585416,0.07524342,-0.14975287390841602,0.04334429389714739
37140,SIDM00097,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5475465,-0.030275844,-0.49048480401827826,0.013801511024077855
30845,SIDM00673,AZD7762,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.21121104,0.01603745,0.5933491332186781,0.05143840825110471
66312,SIDM00833,Oxaliplatin,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.2990663,0.16259742,0.6452324176241749,0.0682551125949309
71829,SIDM00455,Linsitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.082121,-0.17907579,-1.4203427519226768,-0.051577770545716536
64700,SIDM00097,BI-2536,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2748209,0.019946402,0.1035252448223815,0.003395801779410763
53931,SIDM00933,RO-3306,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.015333256,-0.0016356781,-0.3541835451912624,-0.044331392202069164
30051,SIDM00673,Gemcitabine,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.45043248,0.037527397,-0.46973584894301673,0.010751712908674214
47548,SIDM00875,Trametinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5809971,0.06457906,0.9481710210937129,0.06536144774365586
60938,SIDM00950,LGK974,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4265324,-0.040758446,-0.7311555351788919,0.005309360376362098
22726,SIDM00832,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.7683225,0.21618792,1.074136442862963,0.05586634364999074
95791,SIDM00835,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.62429696,0.013833534,0.2336668603402562,0.004458572968622286
34697,SIDM00933,Uprosertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.6251813,0.06714443,-0.2640047430975193,0.071426678008593
18716,SIDM00872,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4666751,-0.046140477,-0.4003697287137033,-0.0648147423051361
4504,SIDM00826,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.3424077,0.12044199,-3.255897427879832,-0.0677276246865221
61014,SIDM00835,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-3.2638185,-0.25119188,-0.062452439391996864,-0.04256653710810768
63920,SIDM00633,ZM447439,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3214658,-0.1172655,-1.3074132608960995,-0.1052250590019996
12623,SIDM00633,Entinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8284227,0.06335173,-0.26003701426632747,0.024491285371007043
82766,SIDM00877,Entinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.47289637,0.03482138,-0.35042684457439316,-0.03702236068873732
9323,SIDM00359,Afatinib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3020507,0.089469105,1.0577229663998846,0.08018684497639725
32692,SIDM00875,Vorinostat,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1860431,0.104698434,1.5851513313203505,0.10744294851560546
22864,SIDM00875,Bortezomib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41497964,0.040663417,0.12775442468768733,-0.02025891705108591
91777,SIDM01042,NU7441,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1429102,0.049015317,1.0643487509800824,0.02447054820551626
86512,SIDM00148,Linsitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33989027,-0.03426187,-0.7201585815551895,-0.009700640526255655
4389,SIDM00833,AZD8055,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.90945,0.13380243,0.4390737567751939,0.02238864003255788
27340,SIDM00950,Cisplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0392997,-0.037433024,0.5408279886709279,0.05280801328565502
13267,SIDM00673,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9974229,0.17148423,-1.2178015389717016,-0.09505806961045854
97664,SIDM00776,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5245338,-0.038559493,-0.36559408802893845,0.008903203645197057
100369,SIDM00928,Bortezomib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.108527,-0.061151925,-0.9972737219069243,-0.04626479971413048
55891,SIDM01042,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3640911,-0.02302214,-0.030274767353006146,-0.028450007348747964
2567,SIDM01042,Ribociclib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.665755,-0.071698695,0.15107526036660782,0.009471593761234048
17452,SIDM01197,Trametinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.48298258,-0.01271857,-1.5979112354085705,-0.0379519803780316
43020,SIDM00673,GSK269962A,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.9237168,-0.12804697,0.477471998225337,0.05726280849364931
14835,SIDM00872,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2056267,-0.04924423,0.37015256457054085,0.06888856928928877
64968,SIDM00359,Navitoclax,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.24256699,0.01124508,1.3411239875167265,0.04429688829823531
94956,SIDM00950,Palbociclib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9187068,-0.08360553,-1.6191004995539662,-0.04684047808376538
40393,SIDM00633,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.07817126,-0.0074627576,-1.748704400148766,-0.10997136292587391
70254,SIDM00146,Alisertib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.84074587,-0.07761779,0.2220959023837693,0.07114456317531509
79209,SIDM00875,Entinostat,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29169807,0.030924354,-0.6079953750230533,-0.017605385610125188
68769,SIDM00826,SB505124,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.7077469,0.03637202,-1.1098931737319737,-0.054712824621276045
49536,SIDM00950,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.361794,0.26430303,2.9800048055792434,0.18402432911993657
76278,SIDM00872,Temozolomide,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.19549114,0.0040473226,0.40732584798584565,0.015579240063691772
96249,SIDM00835,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.1063523,-0.024378248,1.1711993974904644,0.06652313143521232
53138,SIDM01042,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.88596994,-0.093444124,-0.979065658290362,-0.07367003376640054
93998,SIDM00282,BMS-754807,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.9389837,0.055318993,1.478200803519566,0.0847861558026388
15674,SIDM01042,Doramapimod,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87643856,-0.0654839,0.20323521001314912,-0.0005457134642518812
105215,SIDM00928,Navitoclax,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.9037466,0.18561259,2.9207531224438767,0.103236969528649
104779,SIDM00455,Dactolisib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.091269,0.07364251,0.7737785198599365,0.021509144261576567
73865,SIDM00832,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.7911823,-0.06577914,-1.0136249864734825,-0.044506629826662196
91987,SIDM00216,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.9576699,0.016383855,-1.8574968840317074,-0.049520006213816616
44802,SIDM00933,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.48718446,-0.043358024,-0.33812287686926584,-0.011381788910276028
59063,SIDM00359,Afatinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9207066,0.044549767,0.9489775740237606,0.03591163904821893
66650,SIDM00633,AZD8055,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.518916,-0.15409204,-1.137325052556834,-0.08318975503564517
84087,SIDM00875,Venetoclax,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.44201678,0.010892365,0.3156334745698886,0.011962912437963033
103692,SIDM01042,RO-3306,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.28215694,-0.0356746,-1.042537806823357,-0.11119216062481375
43027,SIDM00875,Palbociclib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.89986914,0.031049244,1.6169026674578175,0.03606095464835107
103112,SIDM00877,Taselisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.1988134,-0.06261053,-0.407833326830902,-0.11026482073945527
6511,SIDM00933,PF-4708671,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.3191015,0.1193461,-0.6632124908278001,0.036189492598682614
36688,SIDM00877,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0674335,0.07813565,0.046957850751007196,0.0011204074582131704
8308,SIDM01197,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.6666784,0.28214502,1.2788231348146546,0.11179183427527825
15545,SIDM00957,Navitoclax,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.3826988,-0.045998458,0.0001726265932914125,0.009605460766520574
77929,SIDM00097,Luminespib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9571845,0.06213793,-0.6901434901975733,-0.06033579117795178
44888,SIDM00933,Venetoclax,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-2.596423,-0.08727275,-0.5169965317552224,-0.005371241499020554
59988,SIDM00633,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6277676,0.032975722,-1.1636039600177426,-0.046687712782235165
78512,SIDM00633,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.5457232,-0.11641452,-2.0921783594407373,-0.08806681524538466
59417,SIDM00146,Nilotinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.93144,0.08216717,0.23331206998938092,0.03803094117778303
1042,SIDM00826,Camptothecin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.3616749,0.13109773,2.719597201268014,0.17196699474485708
25926,SIDM01197,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.29619,-0.17190312,0.09165076797935913,0.040113117496535323
33461,SIDM01042,Olaparib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4489028,-0.06435817,-2.1870928258359483,-0.10658916899330749
1260,SIDM00097,NU7441,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0238764,-0.08942363,-0.14795720845093738,0.008573819838661333
16390,SIDM00097,Tozasertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0343946,-0.03596878,0.486727604624764,0.026964645285284822
10227,SIDM00872,Bortezomib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.18314706,-0.014125105,-0.5323183354816539,-0.05490562237729554
49174,SIDM01042,Gemcitabine,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6789922,-0.1974242,-1.0197265715964825,-0.04476411315615808
66781,SIDM01042,Pictilisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1984605,0.055695795,1.3022132728454552,0.06002136050111583
36152,SIDM01042,Alpelisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3063068,0.031136964,1.3514612906073689,0.06819054268319606
53874,SIDM00097,BI-2536,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.873517,0.18536519,3.3004774534968258,0.18638137107634656
4997,SIDM00933,NU7441,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.29355228,0.03095044,-0.38884397039929003,0.005828091134009072
41509,SIDM00146,KU-55933,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.4804344,-0.048638977,-0.6858284254743832,-0.00041768953376105885
7124,SIDM00633,Axitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.590844,0.34203094,2.3607476025665486,0.09482512635493577
77369,SIDM00148,Alisertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.64451385,-0.037754457,1.1465526155045236,0.07728079736074639
81036,SIDM00872,MK-2206,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.16494215,0.017408816,0.33152251916451436,0.002888600344750747
8685,SIDM00776,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.1999702,-0.07442654,0.12222338522295519,0.044992989517313814
14765,SIDM00673,Wee1 Inhibitor,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8823789,0.055875577,-0.4216171707661045,0.004155442228215535
66332,SIDM01197,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.0073426,-0.18104331,-1.0895030512087034,-0.0634261701833127
42285,SIDM00146,Cisplatin,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.7532065,0.029560886,1.5008829790175062,0.09333470698765443
11873,SIDM00835,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-0.52930444,-0.046374507,-1.218374946107144,-0.08194009415564404
36132,SIDM00097,Dabrafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9351394,-0.089851856,-0.18590199243656563,0.02370993799576309
76533,SIDM01042,Alpelisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.478978,0.2637967,2.575502678964833,0.09633443540203773
77601,SIDM00455,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.503063,0.23703839,2.2323288092412423,0.2315783566728026
66400,SIDM00776,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.54350966,-0.047962375,-0.37114766687264616,-0.06409312129795806
25597,SIDM00455,Oxaliplatin,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3776467,-0.072964415,-1.2704699791730516,-0.00273597601046939
24596,SIDM00872,Gemcitabine,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8710773,0.02863698,2.2368141048167915,0.0877894781215349
71874,SIDM00826,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.0127033,0.07284427,-0.7991005849640201,-0.11365235276880781
55127,SIDM00933,Olaparib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.1591411,0.12172564,-1.8895267224241983,-0.03784492577080204
36885,SIDM00928,Navitoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.7495339,-0.14443909,1.36513101745688,0.015507063769681466
57426,SIDM00148,AZD8055,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.785028,-0.12238426,-1.8955410687558654,-0.10932676238967486
26672,SIDM00928,Navitoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.8267422,0.20697658,2.384706286514766,0.05046077191733862
76550,SIDM00837,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-1.7419012,-0.07109373,-2.9056090099025838,-0.08818311791881406
86647,SIDM00042,Crizotinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6873577,-0.05637256,-1.7260210165719856,-0.10272664362534568
89842,SIDM00833,Olaparib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.1996799,0.04638207,0.36911330509213786,0.052984840076466894
79313,SIDM00837,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.5742056,0.012622328,-0.21085050417377982,0.01401593626378474
76063,SIDM01187,Vorinostat,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.57843304,-0.056880552,-0.7056695760682838,-0.030561817068330843
100105,SIDM00950,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.7494239,0.073026314,-1.0071485041830106,-0.048318432341538736
53960,SIDM00146,MK-2206,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.1466078,-0.05838146,0.2372262318327642,0.053975872004881076
90092,SIDM00776,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-0.92857385,-0.0187708,1.0439065576395299,0.06941999315801237
40659,SIDM01042,Ribociclib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9414225,-0.08511862,-1.0887463607667638,-0.025559672834411455
76810,SIDM01042,Alpelisib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5637626,0.051396966,0.4962961938499788,0.025712359138127198
23270,SIDM00633,Cisplatin,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9722872,-0.07077998,-1.1530752656537855,0.0161270327892563
18845,SIDM00933,Palbociclib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-1.2395828,-0.09928548,-1.2511509615345444,-0.0547246016894423
67888,SIDM00928,Gemcitabine,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.3640456,-0.23510516,-2.2845401643364025,-0.17702851492338592
85,SIDM00837,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-1.9272407,-0.019774819,-2.7952681682135836,-0.12981975490252382
42628,SIDM00875,MK-2206,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24861905,0.007592119,0.862644055644623,0.039216484456711206
32827,SIDM00148,Sorafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.07372584,-0.0048037367,-0.9731767744359882,-0.03549531146278838
57858,SIDM00097,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.151899,-0.08898846,-2.319117446180955,-0.07464382408976782
62609,SIDM00928,OSI-027,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.4078134,-0.13054891,-0.6908350087520748,-0.0002387096216365727
15380,SIDM00826,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.92259634,-0.019917972,-1.9829076824059766,-0.05693826160649062
105476,SIDM00673,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.5733912,0.24635163,1.2797249085281208,0.03639949971766
23018,SIDM00833,SCH772984,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.6170228,-0.16233331,-1.2923622258460836,-0.08805385296566053
43132,SIDM00776,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.69740564,0.02125906,0.3601130015677504,0.015089793392008338
98499,SIDM00928,Camptothecin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.4198217,-0.14943369,0.1872347062365969,0.030511633755182132
95629,SIDM00875,Doramapimod,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4831059,0.051274654,1.7785891388158865,0.04201498271543274
88995,SIDM00633,Entinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6921139,0.036759757,3.5450823589509572,0.10317649578653784
35262,SIDM00872,Navitoclax,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5048209,-0.032485403,0.5336449799201904,0.08949611321054271
106018,SIDM00673,JQ1,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2558013,-0.059867904,-0.1745994878906407,0.03759343490021412
15292,SIDM00957,AZD8055,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,4.292126,0.08620882,2.887840474712897,0.1135482746993626
54958,SIDM00928,RO-3306,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-2.0480626,-0.11888444,-0.3318515536251562,-0.0014576888366775425
3403,SIDM00148,Venetoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0862169,0.028098665,1.4871751110877296,0.036397344826965224
85468,SIDM00633,JQ1,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9499815,-0.073973596,-0.42584239742834323,-0.018439611208157666
8871,SIDM00877,Lapatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.9389343,0.16824849,1.8889538955598593,0.1571250586934795
105457,SIDM00146,Uprosertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6719175,0.053227786,0.3336979649562643,0.09288903821334742
41776,SIDM00146,Paclitaxel,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3581636,-0.12008801,-1.17407744574724,-0.1280375154180961
104160,SIDM01197,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,0.96347624,0.013748841,2.671673497234584,0.08023070352015493
77376,SIDM00957,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.076593,0.06821336,1.3388583291393816,0.08624492534746406
64917,SIDM00633,Navitoclax,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.5531697,0.1749445,2.793076676501256,0.16748165191990774
30495,SIDM00042,Irinotecan,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.4660707,-0.1960241,-2.714894762600584,-0.15341173655874113
48901,SIDM00455,OSI-027,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5179626,-0.0896494,0.4821957904331644,-0.02226711848735363
38463,SIDM00097,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.4848672,0.03364821,-0.2411158090588968,-0.05308766017908249
3818,SIDM00148,Bortezomib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.10247305,0.008186108,-0.37132066003590775,-0.03611886444934397
82870,SIDM00826,AZD8055,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.9807781,-0.08658715,-0.16573911988041162,0.014641736524943999
15095,SIDM00673,Taselisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.731375,-0.071936265,-0.7159965368998645,-0.08321972068352115
99839,SIDM01042,Luminespib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9562533,0.065264665,-2.2232910443671794,-0.06217517035405115
1937,SIDM00872,Nutlin-3a (-),PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.37620682,-0.009524947,0.4488065870974421,0.00860381515174648
102262,SIDM00673,AZD8055,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.774566,0.116824694,-0.9608368493543783,-0.07046317102791734
106587,SIDM00950,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4559209,-0.13076304,-1.1564659719412091,-0.06391848946214522
61943,SIDM00833,Crizotinib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,0.35264456,0.026517343,-1.5487123903899453,-0.08572297112838502
47505,SIDM00877,Doramapimod,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.99710613,0.06308105,0.3171527996109675,0.057225917998792196
53550,SIDM00633,Nutlin-3a (-),Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2421892,0.12036016,-0.3946187734181044,0.0010876009520635415
63293,SIDM00950,Navitoclax,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5314542,0.14047539,1.5076474317768291,0.12607916386561366
69892,SIDM00950,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.247617,-0.07766526,-1.2552113334584547,0.0008913588574699056
63953,SIDM01187,Docetaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7848817,0.08017341,-4.274070963483458,-0.22636378362563928
86675,SIDM00835,Vinorelbine,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,2.0472856,0.12707362,1.8146520707525058,0.10453561856116672
81378,SIDM00673,Temozolomide,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3557294,-0.008064126,0.1666367016598399,0.008697563683737274
54268,SIDM00872,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.46395656,-0.049940683,-0.5741814004172062,-0.05311369745674931
47843,SIDM00359,Linsitinib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7840604,0.066177875,0.5526846362273382,0.09506942171140412
69998,SIDM00455,Irinotecan,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0644765,-0.048331507,-1.3087347793584165,0.036361056283155925
1341,SIDM00875,5-Fluorouracil,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1871513,-0.114756614,-1.5718872147519,-0.16296157203073522
72301,SIDM01197,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.70584834,-0.052565865,0.5971703385046433,-0.0009336008624084327
73597,SIDM01042,Alpelisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6628128,-0.12553185,-0.7314116874870286,-0.026510968411318454
38005,SIDM00872,JQ1,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1872007,-0.027608356,2.1632202145030672,0.04766461109078703
58671,SIDM00633,Afatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2637339,-0.035770427,-1.4836753944348564,-0.07471093823616087
106203,SIDM00455,Paclitaxel,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.7644405,-0.17973655,-3.8255689062730456,-0.23716064341918128
76704,SIDM00872,PD173074,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.66130054,-0.030985674,-0.5487948932090676,-0.03446430696189138
12238,SIDM00835,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,1.7262067,0.05241958,1.0704339034600168,0.019611599993774775
69307,SIDM00633,Paclitaxel,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8335289,0.06821188,-0.8046090695370537,0.008247559200088198
14439,SIDM00776,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.8500077,0.027507652,2.7287171498637037,0.07392978521679273
17332,SIDM00148,AZD8055,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3177574,-0.09718589,-1.655895923213447,-0.1119047315847779
18519,SIDM00216,Trametinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8455267,-0.16664082,-2.0490655461568803,-0.10726883372656372
78857,SIDM00673,PD173074,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.9763914,-0.0549588,-0.7632381295278813,0.0003566198494310933
100044,SIDM00146,JQ1,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.5934913,0.043509357,0.3968466497064339,0.020124813775629583
88500,SIDM00148,Uprosertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6356198,0.05269259,0.9844898600277256,0.04854377492295078
34201,SIDM01197,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,0.7876137,0.06287926,-0.9274754871580768,-0.034782565321572284
96437,SIDM00928,Bortezomib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.2986945,-0.080642946,-0.6395292108230829,-0.04611118511256093
75422,SIDM00875,RO-3306,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.67317617,-0.06047936,-0.8871333176630793,-0.06935853041410572
97666,SIDM00097,MK-2206,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.982827,-0.22226734,-1.1187871236543905,-0.06817240770201313
70841,SIDM00282,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,0.85632664,0.036078226,-0.3552380424462711,-0.01902678485008341
80854,SIDM00097,Axitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2514277,-0.17133175,-1.4213546518456543,-0.12001287397531499
37017,SIDM00833,SB505124,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-0.3872345,-0.026036648,-0.21497294791408333,-0.02023108725540263
19218,SIDM00872,Olaparib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.662739,0.10743848,-0.33291693282743673,0.041379489559323517
28098,SIDM00359,LGK974,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.921548,-0.027841028,-0.2216788479329141,-0.0035983325596638505
49745,SIDM00097,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7453292,-0.04967571,-1.3407282798290636,-0.10287130607911318
33965,SIDM00148,Gemcitabine,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0337309,0.045485917,-0.08740101767652766,-0.05597218486740102
59618,SIDM00148,PF-4708671,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.36195,0.19884999,-0.4798327390604884,-0.007098077548704947
51272,SIDM00957,Palbociclib,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,1.0370126,0.027526345,1.7081544505224404,0.07945750252291972
75424,SIDM00097,Tozasertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.435064,-0.0707924,-1.944755120706203,-0.03757453550389992
91655,SIDM00633,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.46155366,-0.040171206,-0.9143220422492109,-0.045656867577663005
62962,SIDM00950,MK-1775,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6081834,0.05194575,-0.5547806010289957,-0.052262709575728115
14761,SIDM01042,Gemcitabine,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.513855,-0.17379363,-1.215303217932853,-0.03575094546529461
60071,SIDM00146,BI-2536,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8772712,0.025799757,0.7152237330140608,-0.014618214285018765
10493,SIDM00633,PF-4708671,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8885415,0.18057643,0.2947546321083907,0.029543927642081424
9880,SIDM00633,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.1409173,-0.14328937,-2.1810737115885486,-0.08524269893557257
79737,SIDM00872,Doramapimod,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.62214005,-0.022336042,0.43643481455359506,0.01434269065997196
74981,SIDM00146,Tozasertib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.6111364,0.13970575,-0.07120723598116797,0.06562443356721737
34050,SIDM00673,Temozolomide,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0530947,0.024207193,0.576392144164265,0.010265682266727612
15637,SIDM00633,Alpelisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6391561,0.06114475,-0.32836719941379416,-0.023426828472413074
39408,SIDM00928,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.9211574,-0.08073897,-0.27869029741123286,0.0039534527789344045
29919,SIDM00832,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-0.7506259,-0.014568514,-0.4609894580575483,0.01732316658592998
46410,SIDM00832,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-2.040146,-0.059698984,-1.4417854763344278,-0.009353027047436688
84002,SIDM00835,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.305674,0.06976093,0.943855895771105,0.01372155494411719
8431,SIDM00455,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.534736,0.13649592,3.025601544846789,0.11913494615754987
25013,SIDM00633,Gemcitabine,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4079144,-0.1256381,-1.7629354466758975,-0.08599997163947726
11717,SIDM00877,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.3759454,-0.02804871,0.3483227302105405,-0.012759724648622576
49156,SIDM01187,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7101367,0.05093512,1.9590723197804374,0.14970079530230845
353,SIDM00837,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.2124736,-0.09080678,-0.7951361525489715,-0.030076597275924034
80719,SIDM00950,Dasatinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8716532,0.18429834,1.2855404799401382,0.0421796533668773
89961,SIDM00950,Irinotecan,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.026969,0.1324095,0.4748229920369737,0.057562380871260095
69437,SIDM00673,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5823942,0.044035763,-0.5474556418765496,-0.04604559286916576
39721,SIDM00673,Luminespib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.238191,-0.21787445,-1.3698756092321347,-0.05078754000575131
98837,SIDM00928,BI-2536,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.8997498,-0.17639478,-2.93635648470035,-0.16268699870083944
55136,SIDM01042,BI-2536,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.574889,-0.031389628,-1.0985950505264654,-0.05920174879897113
35260,SIDM00097,KU-55933,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2278173,-0.073919274,-1.4073765951908168,-0.060513354516804924
72353,SIDM00673,Pictilisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.24957922,0.022968225,-1.4724743672702336,-0.09625221857107916
67987,SIDM01042,Navitoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3138704,-0.035249274,0.996614034210088,0.022081669752273537
33431,SIDM00633,Temozolomide,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7501755,0.090410024,-0.13971602621767854,0.00843088021883866
48042,SIDM00216,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8091284,-0.08613437,-1.8471533886582614,-0.132373433991299
103064,SIDM00928,JQ1,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,3.967793,0.3569434,1.4944313656218573,0.0925697850292307
1529,SIDM00148,Venetoclax,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6127167,0.13287957,1.0874247179486085,0.01611227610675569
73420,SIDM00872,Crizotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7612673,0.14747469,0.7822198682380589,0.060006856959760935
16825,SIDM01197,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2496402,-0.12505004,-2.032359395567606,-0.08409576149355102
91455,SIDM00146,5-Fluorouracil,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.5067338,-0.07290245,-1.028761614416696,-0.0025453992172838977
42605,SIDM01187,Nutlin-3a (-),Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.37405968,0.03285728,-0.30442835413284025,-0.00532175160554048
36678,SIDM00776,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.64115757,-0.03718914,-0.22477497535484633,-0.023682544278700885
76768,SIDM00826,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,3.2074218,0.1738894,0.8366184339106995,0.051743631736076344
61451,SIDM00872,Lapatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0747792,-0.107442215,0.18338114662306745,-0.025318662475351472
21296,SIDM00097,Taselisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2502725,-0.13359934,-0.1787490095238877,-0.03202966841686381
100360,SIDM00928,Uprosertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,2.0020573,0.16958338,0.9518849594714628,0.09764107389196125
53300,SIDM00933,Temozolomide,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.9106194,0.016699677,0.9730717612264452,0.018309120565024407
57291,SIDM00359,LGK974,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8812618,-0.02506485,-1.2109660130704096,-0.009020295753440643
14529,SIDM00832,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.7881765,-0.14342363,-0.708342058225232,-0.0025339217236911484
74926,SIDM00928,Lapatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,1.4017438,0.12780137,-0.43149920136755904,0.004888072097176182
25972,SIDM00097,KU-55933,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.1056223,-0.11699641,-2.861715311169544,-0.10265504153502401
20368,SIDM01187,Lapatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.11290116,-0.009855098,-0.13321306504472544,-0.03550781738964332
86330,SIDM00148,Paclitaxel,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.9320402,-0.20558774,-2.9716335668684284,-0.15439389000467582
67493,SIDM00633,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.3959975,0.12696889,2.280368533795908,0.018836341588633048
106984,SIDM01042,RO-3306,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2337544,0.08250964,-0.7707383610561898,-0.06182049965394994
79231,SIDM00872,Crizotinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.28982893,-0.022300974,0.3537748491444932,0.017706917492712703
19878,SIDM01042,SCH772984,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1683846,0.1767662,-1.0760949943605058,-0.04716421270520649
100037,SIDM00872,Venetoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5753274,-0.074563846,-0.6087322463539162,0.03253159112832083
21735,SIDM00872,JQ1,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1215501,-0.024902623,2.3077138427846764,0.12276541473952995
66777,SIDM00826,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-1.192413,-0.07060226,-1.372435164672301,0.035481122165640394
83480,SIDM00933,BI-2536,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.2812519,0.005250749,-0.7853896602039944,-0.0010506015110359204
70105,SIDM00826,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-1.2195,-0.07499059,-1.7946518471202062,-0.059910098469782
75209,SIDM00776,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.677227,-0.068807214,0.6585479860700856,0.040622724450569324
67789,SIDM00359,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0521771,0.028529154,1.488054213282242,0.05296630556700372
61924,SIDM00146,OSI-027,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8882819,-0.08131357,0.30801497925721805,0.031015940858718602
7907,SIDM00216,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.85428786,-0.078182995,-0.8310948044303367,-0.08646485421251815
79279,SIDM00832,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-2.9394598,-0.11654792,-0.5107342550035803,-0.017808463002118146
48071,SIDM00097,PF-4708671,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55587316,-0.021722555,-1.2075910653291575,-0.05975948797447132
86062,SIDM00673,Afatinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.7796163,0.063769884,0.42445009253842164,0.06954858495504672
98069,SIDM00872,OSI-027,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1182238,-0.09351992,-0.6107586804214113,-0.03553876770669944
101996,SIDM00837,Dabrafenib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-0.8717025,-0.022293424,0.6810114959783404,0.01731329014192781
25804,SIDM00833,Linsitinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.41253,0.15822299,1.740718512712054,0.0664012668243898
13436,SIDM00359,AZD4547,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8135223,-0.05026384,-1.7230673067637559,0.009424798952213851
64925,SIDM00835,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,1.406092,0.067733936,0.6479081322210487,0.03172968173268968
942,SIDM00146,OSI-027,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.054685,0.0718544,0.43775706076257553,0.024695667688173942
64796,SIDM00835,AZD7762,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,5.2157083,0.38289097,-0.8349435506695568,-0.025175033860589904
57461,SIDM00455,Cisplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9046286,-0.03809266,-1.2851420887056304,-0.04130811476335039
52074,SIDM01197,LGK974,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,0.7307608,0.020806579,-0.7805534606326128,-0.03522698636296901
43485,SIDM00835,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.4381661,0.020545553,0.8123481503674208,0.03697311599968135
95252,SIDM00097,MK-1775,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.12666643,-0.008090409,-1.8275504160814549,-0.17796883385955073
5143,SIDM00826,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.29649523,0.00759396,0.0268626657787168,0.03224822240979094
16883,SIDM00216,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.9547234,0.17554887,-0.3316850395862499,0.037814037700219724
96121,SIDM01042,Crizotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.72984475,-0.064649306,-1.2590865736970536,-0.10547681227012377
104882,SIDM00933,AZD6482,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.21083964,0.0073792976,2.5429326751124197,0.1333542919914993
108206,SIDM00833,LGK974,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.61734,-0.020456728,-0.8452267158467359,-0.01616778257274635
58094,SIDM00097,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6792215,0.03240933,0.15854161120784116,-0.034272695568090726
33681,SIDM00837,Taselisib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.8596098,-0.102209605,-0.3894827216992435,-0.021114541721532733
48604,SIDM00148,Alpelisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.41440266,-0.04006728,0.15730363766182642,-0.006183448567994017
93135,SIDM00097,Camptothecin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0098224,-0.037787322,0.41982319979091015,0.09561076684351283
20576,SIDM00872,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.40997955,-0.036305804,0.005952344429020695,0.04445307191633811
41828,SIDM01197,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.0089415,0.010601868,3.682069598400941,0.11312608858055673
49545,SIDM00282,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.82608014,0.035449732,0.3406456948648454,0.061353301629578465
11728,SIDM00872,Linsitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.237138,0.009129347,0.9083712579693246,-0.0011165896676533808
91020,SIDM00776,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5228426,-0.04169746,-0.5576828772959965,-0.022427943136206538
4687,SIDM00957,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.0216436,0.028549736,2.166958857315472,0.03838294288244925
22119,SIDM00872,Vorinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.26807716,0.017172484,1.2162187017147212,0.11685380807244014
36459,SIDM00097,Lapatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.826826,0.15824813,0.7692371233101886,0.06466795624890989
59573,SIDM00877,GSK269962A,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.44107535,-0.052789874,-0.1502348305315597,-0.004282888508803588
79655,SIDM00097,Olaparib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5543015,0.08325274,1.6290059981376874,0.07734907476360738
54999,SIDM01042,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7772069,0.026449524,1.063331585138921,0.04001740523420158
105178,SIDM00826,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.2529065,0.010542476,0.6733493864912466,-0.0029880195624447845
30827,SIDM00146,Taselisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.73855686,0.068243265,-0.4471774415482647,-0.040212715750764294
75221,SIDM00877,Navitoclax,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8020173,-0.085314125,1.5555927644019627,0.0767780784083305
103472,SIDM00097,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45066828,-0.029351098,-0.13254674825218782,-0.005565013034032237
77781,SIDM00872,Gemcitabine,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6257862,0.06666985,4.5458663972533655,0.2020390716194948
106706,SIDM00097,Gemcitabine,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.47543,0.062833,-1.032296081176091,-0.0005107863758940389
95634,SIDM00146,Axitinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.730261,0.30880862,3.311147522050248,0.24001371908648456
7386,SIDM00826,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-3.4519413,-0.1788956,-2.3313380189820556,-0.10515524092786466
23855,SIDM00950,Palbociclib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.7252035,0.45510665,-1.9642932220210014,-0.03578996394163795
97353,SIDM00359,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4321272,0.07646043,2.277158358610684,0.08974282219151415
1441,SIDM00146,Linsitinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,3.6015801,0.11352962,2.989873663060675,0.10715933516886503
16876,SIDM00950,AZD7762,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.055443,-0.18742286,-2.6912958302650156,-0.20509678376438104
30879,SIDM00146,Bortezomib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.8192527,-0.03200914,-0.7824817176331385,-0.028797673995688337
23667,SIDM00877,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9491273,0.08646744,1.6786165786460434,0.10720401994632295
63130,SIDM00928,Dabrafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.26659396,-0.010007759,-0.19214948286779854,-0.01589073855823833
85981,SIDM00933,Alisertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.6485722,0.17682333,0.594915046290853,0.062030127279874794
63374,SIDM00673,5-Fluorouracil,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.6003963,0.08686279,0.40982229296751743,0.10246138924566228
74875,SIDM01197,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.88833165,-0.020607617,0.22743854828658447,0.04285622895443868
38157,SIDM00282,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6069262,-0.026224762,1.3589763894293205,0.09284843525269093
42512,SIDM00950,Cisplatin,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0995934,0.12567113,0.687243730110892,0.08030775948607727
81570,SIDM00097,PF-4708671,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5536809,-0.046869125,1.0328005609806437,0.03422277266996371
1653,SIDM01197,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.4548235,-0.042711724,1.399391185240768,0.04004113012799354
42396,SIDM00872,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2554122,-0.10661107,-0.6492577423277327,0.0043256183148737545
678,SIDM00928,Afatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.7392079,0.20594822,0.15248917406687773,0.025738832470020904
94530,SIDM00148,Gemcitabine,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.055737,0.05397321,-1.3800269217671528,-0.06440487031294075
49597,SIDM00928,Afatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.56732637,-0.05865749,-0.3264817570146602,-0.014684119394534931
29453,SIDM00832,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.3823457,-0.00952042,2.07982599549184,0.0593313872295168
96263,SIDM01042,MK-2206,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.743977,0.033866923,-2.771902914912761,-0.16041793772835042
17965,SIDM00097,Sorafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1817138,0.10637029,0.9952407430438619,0.08458583893930652
8231,SIDM00673,Camptothecin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.7812431,-0.024443135,0.9056964251902307,0.047958753300238376
36945,SIDM00097,BI-2536,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.49561545,-0.03406157,-0.7513705354562166,-0.06304800185482963
75227,SIDM00359,Dabrafenib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7207658,0.090998605,-0.39806331793171873,0.004582091587418212
28747,SIDM00877,Tozasertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9387824,0.09983136,1.5001235588773678,0.08678508393322902
82231,SIDM00097,Cisplatin,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1430507,0.025578886,1.1953588494099068,0.05474333034170295
4508,SIDM01197,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.3496085,0.039622054,2.046060294404732,0.167375875706769
1332,SIDM00282,Linsitinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,0.81647474,0.052875057,0.013081599169086479,-0.0011572252213953745
72240,SIDM00776,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.1386083,-0.03940317,0.11465882491261901,-0.006881363770610179
70540,SIDM01042,Afatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.43193507,-0.05319811,-1.375192753647986,-0.08532085996449768
105159,SIDM00146,Wee1 Inhibitor,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.2232281,-0.08543983,-1.1696638935285955,-0.04967216619175106
99876,SIDM00455,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.682838,-0.105242915,0.44869931171357363,0.024445768076840964
30815,SIDM00957,Afatinib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.6668756,-0.09943934,-0.7072236456321441,-0.048797762438866604
44578,SIDM01187,Vorinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3652574,0.10238298,0.0864777886259933,0.005241893036502205
11246,SIDM00832,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,1.7716411,0.11748106,-0.5766105842083674,-0.02035115486964283
88278,SIDM00928,NU7441,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.3311021,-0.15071557,-1.1671690911829693,-0.10591405471607289
46377,SIDM00835,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.13502386,-0.011961404,-1.3183358535529315,-0.038978655238084504
94294,SIDM00455,Olaparib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.0065229,-0.025524994,0.8055143553348211,0.07518338021056165
1951,SIDM00097,Afatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.51225615,0.032221787,0.7693234867441923,0.06461162571250187
17105,SIDM00148,AZD8055,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8016787,0.12585552,-1.1958938136247863,-0.07073811242297981
26087,SIDM01042,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6149445,0.14706144,2.1878327302642164,0.09171327190095864
102575,SIDM00933,Ribociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.015982363,0.0003108696,0.9119462541298916,0.03832076441750782
19956,SIDM00957,Taselisib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.8879697,-0.07484129,-0.0704888529747873,0.06766528711391395
94136,SIDM01197,AZD4547,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.2094122,0.092355765,-0.051802810255169314,0.04042062840229896
88099,SIDM00835,Linsitinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.4925704,0.1333452,3.3877010250260016,0.12265975213741462
90966,SIDM00832,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.81985915,0.037722953,-0.33540202584251194,0.0009076285796762308
108188,SIDM00928,Ribociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.75269794,0.021928618,0.5036063684706228,0.01030439968393791
99479,SIDM00359,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3361814,0.07660765,-1.1579325672029168,-0.021804529998371222
7687,SIDM00282,SB505124,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.1905482,0.047380578,1.5773967657976273,0.10294342400618495
49280,SIDM00832,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2304873,-0.047316857,0.6586499734188936,0.050768269696045684
14582,SIDM00928,Palbociclib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.8023818,-0.090957396,-1.704306742409475,-0.0569179499390475
19527,SIDM00633,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6032421,-0.05725162,-1.4350674658508316,-0.09148648222834416
97832,SIDM00148,Bortezomib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33989623,-0.02758706,-0.582437940609491,-0.08399016925007773
13897,SIDM00877,Gemcitabine,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.0949616,0.012637689,-3.2175586237686256,-0.12280569887615497
100866,SIDM00097,Vorinostat,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9754936,-0.06873789,-1.151472488121888,-0.08226269863459731
107701,SIDM00633,AZD6482,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8548218,-0.08516174,-0.9424575027335916,-0.04228659184992191
48237,SIDM00097,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6514406,-0.024839535,-1.5533736951395356,-0.02885081166712713
57045,SIDM00148,Camptothecin,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7792994,0.07836502,-1.2565683855584713,-0.06650700206342668
101276,SIDM00633,Venetoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5059896,0.0911242,1.2846060369636738,0.02701602293721636
62749,SIDM00872,Temozolomide,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.17470042,0.0035115473,1.1579420726184266,0.009057426632424948
100987,SIDM00826,AZD8055,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.9965925,0.07281258,-1.1221787233143758,0.012217038609394344
100259,SIDM00875,Pictilisib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3222532,-0.102151275,-1.613046723611418,-0.1080481043263403
29326,SIDM00776,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.49516803,-0.03915778,-1.2164338885093071,-0.1040366795210592
70300,SIDM00042,Gemcitabine,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.5274776,-0.12103863,-2.916814383489493,-0.11447491835465044
57435,SIDM00957,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-2.325838,-0.030974278,0.4427320790989845,0.015286988093001656
81638,SIDM00928,SCH772984,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-0.2948411,-0.03515883,-0.6916896688279995,-0.042358090346801686
83493,SIDM00673,AZD7762,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-5.801981,-0.38468984,-0.8065341738045326,-0.07238442409400746
61601,SIDM00837,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.38554084,-0.01605929,-0.8494855798022419,-0.021496254857432933
80096,SIDM00097,Entinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3878684,-0.13538544,-1.127267635332908,-0.04128201852123511
88655,SIDM00872,BI-2536,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.91407484,0.09579693,1.394677157008396,0.08051985677296686
66346,SIDM00928,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.587144,0.24269824,0.3358479341129044,-0.032913447756072384
80448,SIDM00633,Gemcitabine,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.9455132,-0.24564977,-1.2482334678614173,-0.04728066398026757
74452,SIDM01197,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3415468,-0.18351217,0.7226527787966511,0.08549730434195008
13942,SIDM00872,MK-2206,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2800397,-0.029397415,-0.41881524053829355,-0.04523365878763678
33370,SIDM00216,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,2.1947634,0.1986111,-0.26142510958713266,-0.03781706590525442
65656,SIDM00957,Dabrafenib,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.9817868,-0.025479212,1.0921146287892656,0.055456659110605225
105828,SIDM00216,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-3.020038,-0.022869539,-2.586558162020215,-0.048084888553934536
23778,SIDM00359,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.34849375,-0.020684382,1.3430369419892332,0.028269055026432156
87258,SIDM00877,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.6264812,0.1133842,-0.18571287155788985,-0.025805737707869345
76466,SIDM00957,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.7645278,-0.02432549,0.5609954936424957,0.015249294982680097
22290,SIDM01187,AZD7762,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.46465,0.08996473,0.4261308292767862,0.030370457890972265
96452,SIDM00282,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.7513119,0.024271533,1.002765931469011,0.08203717319255181
98056,SIDM00633,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0024457,0.18493003,-0.7181878957052095,0.005518248253655337
5770,SIDM00872,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6926174,-0.07272366,0.03341747949937053,-0.008222550857441098
86439,SIDM00928,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,6.0765996,0.47170648,3.4556963298937062,0.18822304608108736
61071,SIDM00146,Uprosertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.6930257,-0.11371442,-0.24304480982785043,0.011852526812207172
7659,SIDM00877,Alisertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.96808666,0.08889126,-0.4019874673986815,-0.027530650274065
22820,SIDM00097,PD173074,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0172625,0.12774472,-0.8165779789348815,-0.024956398035403594
46186,SIDM00835,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.5276407,-0.12729941,-1.74798994173492,-0.1219803135591873
74350,SIDM01042,Taselisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.1265867,-0.010330304,0.699083972663782,0.018623291947975823
67004,SIDM00146,BI-2536,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.5784152,-0.12038913,-2.852259966405326,-0.19728559191665967
48569,SIDM01042,AZD8055,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.83159465,0.073277414,1.9294911767991119,0.11159796111023114
28606,SIDM00928,Tozasertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.0851583,0.037815064,0.9983089369603542,0.035720123946724115
14064,SIDM00928,Lapatinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-1.8086803,-0.11950552,0.5943398234558135,0.04701513567567687
86337,SIDM00673,Bortezomib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.5639242,-0.031916592,-1.04114051999088,-0.06687995558024083
106227,SIDM00875,Alisertib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.351681,0.034322288,-1.6632720638170042,-0.10620120951767087
19692,SIDM00455,LGK974,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7422984,0.06556296,-0.2037238931431372,-0.0033640706694870646
23858,SIDM00826,Oxaliplatin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.5102081,-0.14102033,-1.6591080982942754,-0.0971127862254077
83245,SIDM00933,Doramapimod,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.6357188,0.08174906,1.7931090571144088,0.020009896219245312
84247,SIDM00146,Tozasertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8641975,-0.08593728,-1.5875415567949096,-0.0988437806184886
82189,SIDM00950,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6951852,-0.11605844,-0.8170794930901334,-0.07220812175180415
94818,SIDM00282,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9422108,-0.051768735,-1.2438028283734288,-0.042722712672636574
56715,SIDM00837,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.2743474,0.058455013,-0.7269560685620307,-0.049833646100877545
20619,SIDM00282,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.3063743,0.08416969,-0.8497309544858698,-0.0618038836317314
3395,SIDM01042,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9723424,-0.08328414,-2.404695393338326,-0.06834756563501183
57752,SIDM00097,AZD8055,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5398276,-0.1087796,0.7746015505743038,0.04561858036639664
83814,SIDM00872,Lapatinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.28513902,-0.030189741,0.34884304116501863,0.0441665852538976
28260,SIDM00097,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2715647,0.0990968,-0.18271529899462197,0.007547203341783529
79462,SIDM00877,Linsitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.9176661,-0.08300899,-0.5867246440301404,-0.014559454235119862
60712,SIDM00875,Alpelisib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1813868,0.12143064,0.9699715523725597,0.020561109684765457
105375,SIDM00837,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.6812125,-0.0237141,0.1317900011168498,-0.042494209069328104
56971,SIDM00826,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.5143955,0.15992679,2.7409415135417103,0.15762532363855153
62002,SIDM00282,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.57218474,0.043485105,0.8336228215455646,0.07760674858034936
79114,SIDM00837,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-0.4480442,-0.007220914,-3.1007542657603797,-0.11791577893371465
82955,SIDM01187,5-Fluorouracil,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-4.3772006,-0.3168599,-1.2763257470755136,-0.12910223211333519
12533,SIDM00872,KU-55933,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4210372,-0.06576512,0.23223722820336715,-0.020515081276386054
37184,SIDM00928,Docetaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-3.4756434,-0.31086534,-2.5992624146772214,-0.21330121143002226
88813,SIDM00928,Tozasertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.5384938,0.016575094,1.197483667301735,0.014452670259407725
47303,SIDM00875,Linsitinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9163808,0.06861171,1.8477348711068258,0.06293155490452472
8557,SIDM00872,Axitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6687664,-0.046375845,-0.5178607926573402,-0.05397948487969946
58937,SIDM00148,AZD6482,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6565372,0.09629354,-0.8824083892451604,-0.0058078561124724586
60215,SIDM00282,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-0.15980881,-0.010974648,-1.2986660989765337,-0.056764310772055904
29864,SIDM00872,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3251021,0.031061806,0.7319108568058922,0.046837021617135245
93467,SIDM00146,Uprosertib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4386492,-0.089750245,2.1099628514063715,0.22254190011856056
88816,SIDM00832,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.97298944,0.05992863,-0.5732197869885489,0.0050440933941088935
21369,SIDM00633,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.44917488,-0.012372101,-0.8350723485089347,-0.04673732045948191
16404,SIDM00097,AZD6482,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.44164646,0.0299375,-0.20353950949030736,-0.04511017709206265
35251,SIDM00776,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.4598516,-0.09353677,-1.148171917694679,-0.05189741753430641
60368,SIDM00928,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4469216,-0.058214184,-0.4724062084479562,-0.01694501568984553
39034,SIDM00928,RO-3306,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.0551798,-0.11438854,-1.2093021411420926,-0.07590980856580308
96237,SIDM00837,AZD7762,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.6523015,0.09516798,-0.23558373712032943,0.04433321738482869
39696,SIDM00455,Linsitinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7554712,-0.095940664,-1.1414294362977155,-0.05768423189722622
73704,SIDM00872,ZM447439,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4098781,0.04239702,-1.456134202096921,-0.1527946888058946
98315,SIDM00928,PF-4708671,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.673286,-0.12098171,-0.8030208953194998,-0.04460791582380856
84963,SIDM00148,Bortezomib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.23812072,0.019868935,0.2523581205804502,-0.031168499962706195
88615,SIDM00216,Nutlin-3a (-),LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.15658809,-0.014590156,-0.7969397166494063,-0.05760014243009524
1599,SIDM00455,MK-2206,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9072616,0.1272541,1.1641497242512688,0.10979730703307881
77160,SIDM00146,Dabrafenib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.6676831,0.10942771,-0.5714367839936678,0.02174121548493528
84995,SIDM00877,Navitoclax,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.5758964,0.071856976,0.46735216296019355,0.05720426087561166
107885,SIDM00097,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2772946,0.030007979,0.33322082317793644,0.03838958990085533
97826,SIDM00933,AZD8055,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.8771381,0.13425684,-0.16129226593956,0.011639348897383633
104510,SIDM00833,Vinorelbine,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.8383686,-0.054467104,0.7348982003416751,0.005844705423204391
12301,SIDM00216,MK-2206,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.54547626,0.05221279,-0.21868751602942949,-0.0027815878547288856
14797,SIDM00148,Axitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4674894,0.13767943,0.08968590584596,0.03912724967163921
25832,SIDM00097,Docetaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.222438,-0.18364201,-1.9601776201857553,-0.1276319976045978
30223,SIDM00837,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.6856775,0.049263168,-1.620473547847012,-0.04823428982279338
4253,SIDM00148,Axitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3478829,0.09800915,-0.6951792598883882,-0.024009178794153166
98671,SIDM00148,AZD6482,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.90233135,-0.0558106,-0.6235799522492276,0.00492357150320547
74892,SIDM00633,Doramapimod,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.85387415,-0.055234365,1.3497888396689905,0.11896809571870333
30424,SIDM00097,SCH772984,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1252646,-0.0984171,-0.3712602877764135,-0.05893486611466695
107995,SIDM00097,Nutlin-3a (-),Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1839151,-0.038202222,-0.677867771759312,-0.043278351102916904
20755,SIDM00148,Axitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.45803428,0.047256615,0.1458347779840673,-0.05271120524801887
9355,SIDM00097,GSK269962A,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3714062,-0.017852224,-0.6605626619229198,-0.05995940122036973
13947,SIDM00097,Cisplatin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0918934,0.0748219,2.8130794933174625,0.07865150035028462
23353,SIDM00933,Bortezomib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.21120374,0.01833901,-0.2903948540415433,-0.027061093136618516
37201,SIDM00455,OSI-027,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0560217,-0.123606496,0.7827570624096951,-0.021211123389569188
8587,SIDM01042,Crizotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7179357,-0.19325578,-1.8677584162257799,-0.11740254103537903
46334,SIDM00875,RO-3306,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5389371,0.15653934,0.7132715252909193,0.009092532864260788
32734,SIDM01042,NU7441,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.60837966,-0.05693401,-0.08468549277085584,0.031099297257187908
65360,SIDM00826,Palbociclib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.8838882,-0.19025517,-1.6944622772276894,-0.08524081662804008
15315,SIDM00837,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,0.4935101,0.014587636,0.0018497970040849308,-0.009573920129792263
18822,SIDM00146,Luminespib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6805563,0.050332926,-1.0482458447146943,-0.07808571796044593
84623,SIDM00097,Palbociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1963289,0.041113142,0.8656468536114503,0.04734525702134888
95360,SIDM01042,OSI-027,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.44408116,-0.048242763,-1.078377568076406,-0.03627679282996947
85919,SIDM01042,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4683689,-0.18198791,-1.0567458580126912,-0.05649214985353611
30613,SIDM00837,BMS-754807,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-4.338335,-0.05245538,-3.2111898000986283,-0.10817035139304529
18594,SIDM00872,ZM447439,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6073183,0.17322952,-0.7640659311687605,-0.10112754785088976
95234,SIDM00148,Alpelisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6630579,0.07674001,-0.819500284295976,-0.020851500744941336
101997,SIDM00633,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3733459,0.05005707,1.1097556461704918,0.05990735473989523
100426,SIDM00928,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.9634277,0.2078576,-0.03683774435976016,0.024057929616952828
91204,SIDM01042,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5488385,0.01775599,-1.5304064137618552,-0.08644733631271133
7526,SIDM00933,NU7441,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.6822226,0.14493817,0.5245033526930969,0.04182384705366189
37986,SIDM00877,Pictilisib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7411019,-0.06959265,0.39070079246173534,-0.00011556604955012073
77257,SIDM00673,Afatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.14772,0.15394355,1.0488706915227395,0.14873521852447966
36466,SIDM00776,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,1.9272116,0.16122971,2.2474986604579508,0.07638078960767117
30038,SIDM00673,Gemcitabine,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.322006,0.17939559,-0.13864222000471804,0.1017765096555382
58128,SIDM00928,MK-2206,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.950472,0.25407648,1.6325714419243296,0.15204992871507306
34579,SIDM00282,SB505124,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.9256042,0.09138762,1.041637770425657,0.10514817988074512
14760,SIDM00877,Venetoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3473815,0.08435718,1.5825831072677516,0.09006386355578658
64886,SIDM01042,OSI-027,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1290826,0.06998637,-0.43665854669232507,-0.058701723231903646
86385,SIDM01042,Palbociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.86015236,0.03365669,1.3372415531740032,0.07696395740157115
13485,SIDM00146,MK-2206,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,4.8238425,0.27088508,3.8594984222437994,0.24565924313874957
3370,SIDM01042,BI-2536,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5186797,-0.013880876,-2.232058915828427,-0.08082710456661017
103855,SIDM00455,Olaparib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6409044,-0.040184867,0.24487310060186823,0.08315638206784608
70220,SIDM00872,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.651871,-0.05682224,-0.365056941160212,-0.0419957686463235
15931,SIDM00146,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2773979,0.0078597395,0.917393027860224,0.027644870427678145
57814,SIDM00146,Vorinostat,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.51385874,0.043853737,1.65459828990985,0.08698299893182884
34780,SIDM00933,Ribociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.7736695,0.052829728,1.9702198159368431,0.00943205129381335
72117,SIDM01197,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.814385,-0.085774265,-1.4374959658114344,-0.06080746482462626
410,SIDM00928,AZD8055,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.762739,-0.0831033,0.3130972250690113,-0.004322954081394614
62970,SIDM01042,Nutlin-3a (-),Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4228897,0.105152465,1.472924344769282,0.05528035627030258
65378,SIDM00835,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,3.1455219,0.060892146,1.8741272223142487,0.01505954401137422
63966,SIDM01187,Cisplatin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.055466,-0.1307109,-1.2837595518826457,-0.023876745163341578
53532,SIDM00875,GSK269962A,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9550148,-0.089619614,0.26120442487274864,0.008605482518253237
61744,SIDM00933,GSK269962A,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.8870764,0.1937168,0.9190540252594029,0.07818047421708306
24370,SIDM00148,PF-4708671,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.86896485,0.059780754,0.017813203487219074,0.02157764115440903
97991,SIDM00928,Afatinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5976452,0.18267109,0.18539903467455196,-0.017971212908476735
46439,SIDM00928,Nilotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.5290146,0.2569002,0.9988673429919533,0.06848394118326986
25934,SIDM00933,Bortezomib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.26714236,-0.02218146,-0.3451478895910584,-0.010996488899179974
100829,SIDM00928,Navitoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.7635794,0.23574942,2.4852635083012067,0.09166898926441845
80552,SIDM00877,JQ1,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.8082573,0.0623912,0.4967035423814424,0.051542080482958476
31046,SIDM00837,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-1.3980167,-0.06746193,1.1442128463601537,0.08463745310523911
43527,SIDM00872,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0415952,0.041633785,1.7378739833654466,0.08715861495018734
30640,SIDM00837,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.6619338,-0.079870895,-0.5638308751256782,-0.06532236252912352
96690,SIDM00957,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.5033164,-0.06810446,-1.869428122280854,-0.05396584328511023
58618,SIDM00633,Sorafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.38053048,-0.033779256,-0.7806641213380021,-0.054785201941218886
84713,SIDM00933,Crizotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-1.1375201,-0.13367832,-0.5254538178316863,0.001315434452699307
6263,SIDM00148,Lapatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.051908035,-0.004624541,0.6282580628728144,0.00919721328743864
91800,SIDM00950,Dactolisib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.85324377,0.047821775,0.9828150310126587,-0.02695883407261498
8622,SIDM01187,Taselisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6071864,-0.053871077,-1.5179488321319088,-0.11200779071868416
48808,SIDM00359,Dabrafenib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8380736,0.044611864,-1.311935720294735,-0.033028432698126775
53943,SIDM00875,RO-3306,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24949813,0.028430328,0.5605587587152525,-0.012596307236226198
69942,SIDM00835,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-1.8069026,-0.11395954,-1.3485697577919333,-0.09363893016107894
105334,SIDM00673,Axitinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.3045135,-0.091954164,-0.9146540371966004,-0.08143735745800089
72787,SIDM00673,Linsitinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.71496093,0.015734568,2.864748865028529,0.08975150539673771
22146,SIDM00872,GSK269962A,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9795725,0.08232716,0.10584342120049023,0.039424960288034
18897,SIDM00359,Navitoclax,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32394895,-0.01717619,1.2143134102784865,0.043100577553333345
61085,SIDM00872,RO-3306,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1941199,-0.04937759,0.6227045437824428,0.014332541523139638
41036,SIDM00928,AZD6482,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.26949784,0.019143486,-0.35949100466464934,-0.019068083614151844
15957,SIDM00833,Palbociclib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.0908773,0.06858943,2.1337335041487804,0.05680271306787262
7566,SIDM00148,Venetoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4948479,0.06027219,-1.3973910362963944,-0.061062165472137137
60003,SIDM00933,Linsitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.1437362,-0.07716449,-0.292495393301084,0.029873876876102677
22133,SIDM00097,Wee1 Inhibitor,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3356138,-0.075902596,-1.1017551230459424,-0.06090565044722063
4798,SIDM00146,Camptothecin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1766664,-0.06376809,-0.9177893881801008,-0.013369777136109528
71489,SIDM00872,5-Fluorouracil,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4604993,0.029681524,-0.2795830033475404,-0.046730210812012875
80673,SIDM00833,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.0973359,0.04148634,0.3474529530252305,-0.009052375953759226
97986,SIDM00826,Dabrafenib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.9096956,-0.055302676,-1.3267025980366753,-0.08429703905040872
31412,SIDM00148,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1675038,-0.10325469,-0.7663589353865166,-0.06830424794872436
106586,SIDM00673,Olaparib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.777077,-0.10464601,-0.8386740686743344,-0.003251518127277209
75404,SIDM00933,Temozolomide,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.087063976,0.0041337227,0.1788744369421442,0.08224799523840326
78319,SIDM00933,Linsitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.0663028,-0.11011118,-0.21731054855067092,0.0073225822567304566
39630,SIDM00097,ZM447439,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.8942375,0.3113224,3.7069978910139136,0.21525369599637445
29374,SIDM00633,Luminespib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.744242,-0.12020224,-0.9496429643601714,-0.019358841031145706
30689,SIDM00872,KU-55933,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5598395,-0.08165796,0.010385929244752706,-0.015565502243779335
33855,SIDM00957,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-0.8702287,-0.01379427,-0.4311981018920412,0.016299121986374072
65056,SIDM00673,AZD8055,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2001812,0.0863963,-0.8826805654087043,-0.06533546335113535
65628,SIDM00673,JQ1,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7171209,0.047692645,0.30180272970182176,0.05364994067863567
34797,SIDM00826,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.83653873,-0.05600749,-0.2801427684620546,-0.03574339887925096
97287,SIDM01187,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0035403,-0.08811476,-1.476633040209241,-0.12125721982931621
77077,SIDM00877,Gemcitabine,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-3.7426736,-0.08211352,-1.4116388285975447,-0.10801767614760212
46717,SIDM01187,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.43563408,-0.03987645,-0.8509615849058444,-0.07354976049030215
96563,SIDM00833,Olaparib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.5155174,-0.04471131,-1.075192541476424,-0.017744583342462726
42537,SIDM00872,Dabrafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4096154,-0.0081791,0.7448131635783959,0.01847200954559303
49003,SIDM00877,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8650819,-0.04032434,0.7485024968126192,0.022051637252673537
17461,SIDM00148,PF-4708671,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.71336937,0.05540956,-1.1216128562728402,-0.0587977897150272
29352,SIDM00633,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7253937,-0.07709519,-1.414098817831841,-0.04974999124493066
101075,SIDM00282,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.5127158,-0.058955237,1.741348799588084,0.09375829413664376
1589,SIDM00097,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.358205,-0.29982173,-1.5201594037469908,-0.10726056528487163
26819,SIDM01042,Pictilisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2206182,0.036944903,-3.3124462568607584,-0.11316014775500688
606,SIDM01042,Navitoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.37315425,-0.043062985,-1.1311472577416941,-0.055317349924052954
89489,SIDM01042,Tozasertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7323864,0.29067305,-0.3295944434615073,-0.014537109163083275
97270,SIDM00872,Pictilisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8423439,0.077710286,-0.3768347020788008,-0.017980557233666577
96935,SIDM00282,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.5012579,-0.03519921,1.4301525792755387,0.02725652242417472
79564,SIDM00148,PD173074,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5552485,0.04359889,1.0474910911084354,0.023772208866104233
80316,SIDM00957,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.0688118,-0.025853394,-0.7444876101276213,-0.028374624594145467
63483,SIDM01197,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.122441,0.14023343,-2.2132522064183027,-0.0643594564854034
71892,SIDM00872,Entinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9552264,-0.10521947,0.11322196993227443,0.005813392279338062
8590,SIDM00837,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.58812565,-0.011267875,-0.8236057013677016,-0.0395138793094431
102879,SIDM00673,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.249721,-0.16649424,-2.30822877890731,-0.14331607330099555
98404,SIDM00097,Axitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7398872,-0.12826401,-0.9965596899338184,-0.06383351388867575
1685,SIDM00633,GSK269962A,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.19005805,0.017012954,-0.6423229573113669,0.020830354342479044
3852,SIDM00359,Navitoclax,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32234988,0.019054307,1.8124777889298367,0.0368843814280888
76223,SIDM00148,Sorafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.17887455,-0.016359745,0.21002998932978725,-0.0565395488765983
72096,SIDM00872,Paclitaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7238998,-0.16906816,-1.2565478835372164,-0.12791635019745953
92235,SIDM00146,PD173074,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.9096249,-0.120506495,-1.1520141524751126,-0.0765554984271029
14011,SIDM01042,Vorinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3052027,0.033116404,-0.28655214871337903,-0.03365459226607019
46202,SIDM00875,Docetaxel,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3150946,-0.021625053,-0.5200602249947922,-0.022989139496260667
91463,SIDM00933,Axitinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.1938887,-0.027766196,-1.5596565626297185,-0.06331277397846762
103925,SIDM00832,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.4336808,0.0819267,1.8451148373938828,0.06273066771886412
8391,SIDM00875,Nilotinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9401465,0.09858655,-0.4265780884105311,-0.01701554786814179
73072,SIDM01042,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.1499308,-0.018487195,-1.14034774784772,-0.061948163594170436
38976,SIDM00872,Lapatinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0489824,-0.113550365,-0.19374183353477098,-0.005520533848720544
432,SIDM00928,Paclitaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.398521,-0.24327147,-4.074964058701624,-0.3170380534636949
76750,SIDM00455,Dactolisib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.325901,0.0242207,-0.49639321788171425,-0.0007757426071699267
45291,SIDM01042,Vorinostat,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3109528,0.11771239,0.3486917365368919,0.061081311562066254
65138,SIDM00877,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.6746297,0.16455707,1.3684806867805106,0.0784675273213765
66773,SIDM00957,LGK974,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.4591888,-0.019281436,0.29120034871589917,0.06637803698723342
51755,SIDM00833,Olaparib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-2.2896993,-0.056353893,-1.4394623001731393,-0.04857484358628055
40074,SIDM00872,Crizotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5583547,0.13794477,0.9999217303827101,0.07267949416653097
71981,SIDM00042,OSI-027,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3323485,-0.035007305,-0.9401766676369403,-0.03767597568885061
34040,SIDM01042,Sorafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0166539,0.09646861,-0.8307813959051467,-0.00645541837295449
59675,SIDM00835,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.570382,0.19130917,2.0313642048916565,0.09981467926630445
22279,SIDM00875,AZD7762,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24640621,-0.013694651,-1.4680067930210625,-0.11956123651866052
102989,SIDM00877,Axitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.3959876,0.15806143,0.5287435100847997,0.043067072000187764
56925,SIDM00826,Palbociclib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-4.264453,-0.14044602,-1.997173492321345,-0.08172438397895898
49300,SIDM00957,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,3.123395,0.08859772,1.674711795027217,0.09843141499414397
30375,SIDM00148,AZD8055,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2837949,0.09887602,2.4350156778332215,0.12636179131890396
32695,SIDM00673,Nilotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.684592,-0.14869052,-1.311922357476221,-0.037030512626975015
31361,SIDM00282,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.60262847,0.024929997,-1.3016294840849376,-0.08978809305077952
101681,SIDM00146,Linsitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.88980347,0.025524002,2.358203251494761,0.009430129684467103
6176,SIDM00633,Nutlin-3a (-),Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6787694,-0.12808962,-1.2209197284374065,-0.046904598194788406
70158,SIDM00146,5-Fluorouracil,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3547115,0.10590284,0.07438359959978703,0.03020000737642911
61789,SIDM00097,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8678225,0.12185991,-1.212279258387595,-0.034466398359665314
40153,SIDM00872,Navitoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7995725,0.056874767,1.7018943512464555,0.09290540893049434
52887,SIDM00877,Navitoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,2.3700628,0.25266173,0.5795129423545535,0.046428046349377264
51256,SIDM00633,Pictilisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.161017,-0.18128514,-1.1444349290207623,-0.04375696692608069
29339,SIDM00216,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.454656,0.047905948,1.5714337093383224,0.044618586525516465
57637,SIDM00776,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.34841108,-0.028308133,-1.0867101353035988,-0.07770416837587632
11711,SIDM00042,Linsitinib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.14020054,-0.0068425722,0.5440743316208682,0.04659150404152019
33263,SIDM01187,Linsitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9617274,0.02845756,0.33335893031941394,-0.0052082275787057875
22223,SIDM00673,Wee1 Inhibitor,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2664235,-0.073373646,-1.334002389565011,-0.018311205439326322
86546,SIDM00835,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.9863774,0.057555173,1.1571786071418524,0.038493485517825755
66802,SIDM00097,Nilotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1755093,-0.07428097,-1.3645671043535845,-0.1025590921370392
1495,SIDM00872,Afatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.45151788,0.04898019,-0.007872858972084501,-0.03856379097391505
9055,SIDM00673,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2722923,0.11877397,1.2884587778489698,0.04997816676742507
89519,SIDM00872,Cisplatin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.56266123,0.018520907,0.6655565118978053,0.030931810451733432
106609,SIDM00826,Linsitinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.4244987,0.050929464,-2.39132192168989,-0.10055103651139341
39557,SIDM00146,GSK269962A,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.5889257,-0.09402285,0.9062873194025205,0.12196811105122066
95039,SIDM00835,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.7564081,0.052023813,-0.5186646389632239,-0.034905175352055486
80699,SIDM00455,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.666706,0.23563203,2.391433258876972,0.16837649560856643
82155,SIDM00877,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,5.7509246,0.14725877,2.085972560981007,0.06207367746265932
9036,SIDM00835,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.9729246,-0.056401893,1.5219748769936854,0.06268898340461419
47164,SIDM00673,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.13360839,-0.0028533943,0.3090544097234355,0.005337667469834838
51198,SIDM00833,SCH772984,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,0.76188236,0.06253331,-1.3639985442307117,-0.1057542232476927
23328,SIDM00776,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.1924014,0.18386741,0.0045757866891218855,0.004666804822994246
69679,SIDM00826,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-4.1503587,-0.078007616,-4.467677092258567,-0.14712042769157707
97390,SIDM00042,Trametinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-4.24548,-0.20492728,-1.8742362647103699,-0.06834995052032736
74577,SIDM00872,Tozasertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.329945,0.06705759,1.4451819230603502,0.09956748216201593
51843,SIDM00835,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.6529834,0.053958956,0.9437095772515296,0.05219362744235536
77481,SIDM00832,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-3.0848935,-0.110556826,-1.6982147238178875,-0.09568426304309349
78741,SIDM00950,Dactolisib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0948699,-0.09042072,-2.7355314645520825,-0.14365624411850092
74171,SIDM00282,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3664247,-0.06277569,-0.6181334387926748,-0.0004730195201275043
46277,SIDM00359,Palbociclib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4002076,-0.06560741,-0.28883807348776636,0.0361240759974426
23191,SIDM00148,Alisertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4066787,-0.083237246,1.6549607149051164,0.11159622024120755
2657,SIDM00633,Palbociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0938394,0.042588167,0.9041238645981935,0.054286736344381685
31198,SIDM00097,GSK269962A,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8124653,-0.069325,-0.5794244269329575,-0.006968970239074795
52678,SIDM00933,Alpelisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.27595896,-0.024083635,-0.1827288704937219,0.015063298506713292
56119,SIDM00148,Entinostat,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2253622,-0.07701239,-0.2494710584441076,0.05650625690496852
11432,SIDM00146,AZD7762,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.5303521,-0.042331927,0.8368516070440587,0.10160875948301824
76267,SIDM01187,Docetaxel,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.9188247,-0.12714799,-2.0074516292052764,-0.09414572508648478
6648,SIDM00673,SCH772984,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.6261554,-0.17703235,2.481701993824224,0.13731215828315535
25282,SIDM00146,Olaparib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.7386684,-0.06383416,0.5228208210900163,0.036423861723522966
83604,SIDM00872,BI-2536,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4630456,0.13178414,2.1282054235239998,0.10806534724190965
14612,SIDM00146,Wee1 Inhibitor,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.49756312,-0.034489077,-0.6428891560334962,0.036662671576851436
28477,SIDM00455,LGK974,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.1167233,0.10266924,-1.4339912946240363,-0.049887286353870186
97409,SIDM00933,JQ1,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.0430372,0.1841644,-0.12684442284032912,0.020272994373993942
5126,SIDM00933,AZD6482,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,0.17455474,0.0062550837,2.523300298109269,0.07358350776397936
19024,SIDM00146,RO-3306,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0191076,0.09139216,-0.08147272681687139,-0.04277081260844833
11075,SIDM01042,Docetaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.75834316,0.08051044,-1.632299561267869,-0.0698969556846147
57255,SIDM00097,Nutlin-3a (-),Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5406106,-0.052799363,0.47772317645967816,0.0697700441681977
534,SIDM00633,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.6536582,0.21531416,2.5079543068423127,0.1557519140285678
70406,SIDM00776,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9907175,-0.019451829,-1.8742508344610054,-0.041109096381444596
82133,SIDM01187,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7551208,0.06356724,1.4565060391899431,0.15542934954432622
24641,SIDM00877,Vorinostat,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.25271273,0.017468598,0.48085454621550267,0.00015870546819761713
66168,SIDM00957,Olaparib,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,0.75842804,0.011561735,1.9266362622641824,0.018839497320386894
42960,SIDM00872,Trametinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2894093,0.117280126,2.2558203560186336,0.13181503724012905
107668,SIDM00877,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.3942304,-0.050818082,0.12046112426847198,0.07384807918601756
60298,SIDM00877,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,1.4033345,0.11536328,1.3982854144896184,0.19587718384370373
79909,SIDM00957,Linsitinib,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.0477965,-0.01996811,0.8483855529221919,0.02926844340586293
101152,SIDM00146,OSI-027,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.4999484,-0.0494948,-0.3172406348644286,0.00995452785967121
20295,SIDM00928,Uprosertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.88135916,-0.046536278,0.40830148424969714,-0.03197641059265905
99377,SIDM00146,NU7441,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.33300024,-0.033072878,0.125635769240238,0.08922614309465324
40221,SIDM00877,Lapatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.6599202,-0.045971368,0.21847137551856335,-0.019271475588342586
53407,SIDM00933,Alpelisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.64491236,-0.053888213,0.7436300944901311,0.018149579339192704
34575,SIDM00042,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.0080922,0.18826179,2.4054099181090476,0.09611191683312854
93513,SIDM00673,PD173074,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7850902,-0.10797659,-1.3218861522908059,-0.06650817044530023
79323,SIDM00826,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-4.738835,-0.08883346,-4.566086456194954,-0.14601938240101492
50069,SIDM00776,SB505124,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.33150083,-0.02396765,-0.8295386305801591,-0.0480559509951892
2577,SIDM00146,Nutlin-3a (-),AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.5361401,-0.015298827,1.0140329502813452,0.024967131189180338
84134,SIDM00282,Linsitinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2761567,0.07123178,0.4817898395360061,0.05333988567745886
7609,SIDM00957,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,5.308968,0.10876734,0.578577747357919,0.04897689863911546
16974,SIDM00148,AZD8055,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.836993,-0.1707829,-0.08877594814735378,-0.03983644295720039
9473,SIDM01187,AZD7762,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.7817514,0.08981003,2.055765290252364,0.05399657788716103
75093,SIDM01042,SCH772984,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.40959615,-0.019822808,-0.45968754033519643,-0.005246678071899433
105745,SIDM01197,BMS-754807,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.0785565,-0.11609526,-3.1523662044622482,-0.06520216272153133
64648,SIDM00928,Pictilisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.8855105,-0.08591928,-0.6145788983746681,-0.052585878619361745
51726,SIDM00673,OSI-027,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.9504924,0.082052864,-0.9374136984397012,-0.08917366299282123
97439,SIDM00148,OSI-027,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5222211,0.12690341,1.1003228436604746,0.030257735570210324
34253,SIDM00146,AZD8055,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.35202357,-0.027706997,-0.09640079141848476,-0.012407881267082746
69349,SIDM01187,Lapatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5533277,0.041634794,-0.41872183888851733,-0.029054839639566333
95719,SIDM00097,Lapatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1200912,-0.15489474,-0.3988211693592289,-0.043366176776198265
49127,SIDM00146,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.8030814,0.04878958,-1.8219322121745676,-0.022396885749545646
105690,SIDM00282,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.6531415,0.025560431,-0.11606752833157864,0.00848355464226098
16521,SIDM00097,Alpelisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6559922,-0.09892917,1.0071893484601926,0.05755926153942218
21892,SIDM00455,MK-1775,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9426794,-0.14208849,-1.9183513931668266,-0.059709098995197205
17400,SIDM00282,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.0576782,0.07393347,1.6650132784023932,0.04857748598309509
52461,SIDM00146,Lapatinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.3745628,0.033420403,2.2458809668716615,0.14926605579284186
16549,SIDM00872,Dabrafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20930474,-0.004201685,1.4264334798006466,0.047989774660910964
8922,SIDM00832,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.49024263,0.027216526,-0.16922516861348985,-0.028024870294744403
89770,SIDM00928,Venetoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.8395651,-0.025628587,-0.7320946214287515,-0.021295497665342094
35661,SIDM00148,Cisplatin,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.82919264,-0.036970288,-0.04851203000639165,0.013677386562285133
37945,SIDM00826,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.0254022,-0.10154893,0.10104792856680644,0.023645958116452506
1921,SIDM00282,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.3916051,0.006654024,2.2837946692852453,0.06104973790682991
174,SIDM00146,Temozolomide,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.23209347,0.006399362,0.6968909098539571,0.05844657883313126
50234,SIDM00359,AZD7762,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.350028,-0.12175231,-2.158753908871323,-0.059629784485091104
75400,SIDM01197,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-2.4409864,-0.117306486,-2.388565398389951,-0.12822236318015987
76654,SIDM00673,Dabrafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.0873659,0.058040254,1.404238669563728,0.0489171210272904
23367,SIDM00877,Wee1 Inhibitor,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.74552983,0.041815188,-0.8689362575566599,-0.02391392895906275
98824,SIDM00950,Crizotinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0058894,0.066315636,0.08747415674261978,-0.027103258985119384
89076,SIDM00837,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-1.1829967,-0.0557248,-1.0843291566136954,-0.08087890555687502
38757,SIDM00633,Alisertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2737563,-0.068282716,-0.6999390927863851,0.0343517131026882
85777,SIDM00832,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.7652088,-0.05429292,-1.2282954752598647,-0.027899823866926122
50734,SIDM00673,SCH772984,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-4.7908826,-0.2941356,0.545425363141019,0.027636652690763583
62396,SIDM01042,JQ1,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45191962,-0.013981557,0.650475470752539,0.008355774417374014
73818,SIDM01042,PD173074,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5134847,-0.12259187,1.6658778182358442,0.054725460111034754
76796,SIDM00097,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8011068,-0.075892754,-0.9544840061071833,-0.02740250139857805
105447,SIDM01197,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,2.7548428,0.03897362,3.178257164784521,0.0735176473053243
4123,SIDM00673,Lapatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.617754,0.13424219,1.776779703215867,0.11939014871960682
10673,SIDM00673,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9731588,0.016941622,2.875200675658156,0.08144364151274593
31050,SIDM00146,Crizotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.76601005,-0.06495224,-0.9829030448740195,-0.0775555956922889
25605,SIDM00455,Linsitinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.6644824,0.118881,1.3392437766019902,0.1949439135183381
106298,SIDM00673,Wee1 Inhibitor,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.2054622,0.14276509,-0.1925879100266475,0.04046209911747835
9008,SIDM01042,Temozolomide,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9532343,0.019674478,0.7773891430273443,0.003241697208591223
65621,SIDM00928,Trametinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.8096577,0.049867224,-0.9667510044130972,-0.04776379102311812
78705,SIDM00928,PD173074,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.7589252,-0.053155754,1.0032980338193391,0.028090890238837537
23780,SIDM00146,Camptothecin,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.18999232,0.018735472,-0.5566432094933699,-0.031595395176952736
103015,SIDM00146,Alisertib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.693002,-0.064058974,0.9106751470481819,0.09478058139347433
4818,SIDM00673,Luminespib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.3409625,0.10156975,-0.6532689927468855,-0.0013614259329143045
107991,SIDM01187,Docetaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.46897098,-0.042752076,-2.4178044982663516,-0.08806335014346882
86050,SIDM00872,Axitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.060755834,-0.0039031128,1.051904384674416,0.14270856142203506
71062,SIDM00877,Axitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.5644425,0.12020296,0.4736110593701017,0.02047491535533418
41677,SIDM00633,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.35159287,-0.029699514,-0.9952835239956942,-0.012722756420512252
34562,SIDM00359,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9464302,0.07011455,2.9011177057976867,0.10203775906703715
59477,SIDM00832,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.9422102,-0.05764747,-0.7934864562158617,-0.05383874583198002
85944,SIDM01042,AZD7762,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9207451,0.12784438,-0.6714493992006949,-0.08269976000902195
90779,SIDM00673,5-Fluorouracil,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5464205,-0.024128737,0.045125567718096476,0.02220443920957386
22076,SIDM00097,Nilotinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91658795,0.06338843,-0.3949973799946756,-0.05725606601165362
32361,SIDM00097,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6243298,0.16053349,-0.2202793508489385,-0.03182755026257096
37466,SIDM00455,Paclitaxel,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.381417,-0.084240675,-0.6411432373819823,-0.06550839983425907
46741,SIDM00148,Afatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5688659,-0.12144828,0.5605771959648168,0.063171626119093
17475,SIDM01197,BMS-754807,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.9745965,-0.17639682,-0.6186890306437536,-0.04483395418681781
104189,SIDM00837,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-4.4401484,-0.13099234,-5.211099587172126,-0.31091205421257334
106561,SIDM00832,Crizotinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-0.270156,-0.022499373,-0.2537252830388357,-0.05766833643393795
9496,SIDM00950,Oxaliplatin,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2717881,-0.04971321,-1.4160217739270864,-0.04653263292894293
72926,SIDM00957,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,2.4436831,0.051418632,-0.6579692519842089,0.04907849390871131
45178,SIDM00877,Bortezomib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-3.105231,-0.13769963,-0.46487233416255863,-0.014737108463279396
31660,SIDM00146,MK-1775,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.779753,-0.06520392,-0.09951631698604209,-0.03944055125691938
47590,SIDM00832,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.7432455,0.040215176,-2.659040960658418,-0.14400922496361035
92244,SIDM00633,Luminespib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.6446917,-0.19780885,-2.214219187211712,-0.10059899004157073
24461,SIDM00776,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,1.4133878,0.05891522,2.950445732748181,0.09703356388922342
100038,SIDM00633,BI-2536,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.72031254,-0.06993857,-0.44374068743123835,-0.007128551582573587
66979,SIDM00148,Trametinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6023247,-0.047502548,-1.4742204867058484,-0.06345416648396758
74129,SIDM00875,Navitoclax,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0260367,0.08185576,0.8308201456605753,0.057270520436431986
65280,SIDM00933,Olaparib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-1.0217255,-0.1047259,-1.588844625288069,-0.05744005542002385
77394,SIDM00928,Axitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,2.737949,0.2491379,0.4375801492321307,0.04721955954435939
35051,SIDM00455,Linsitinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.3770275,0.29870525,2.2085187623094673,0.19438614650044092
93088,SIDM00216,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4165205,-0.05782677,-1.3532345173731997,-0.02495222646210993
17321,SIDM00872,RO-3306,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6133821,-0.078477204,-0.9455645719089816,-0.06657734762326543
31891,SIDM00148,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8422868,0.079585046,4.059704537699633,0.1632911409201682
11541,SIDM00833,Vinorelbine,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.76712024,0.05979331,0.9724728016879518,0.022121888732177134
22200,SIDM00359,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9494733,0.14526168,0.1256020446826941,0.04497376247908497
75058,SIDM00097,Palbociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2740438,-0.044651013,-0.4019523402569882,0.00610264276487253
11221,SIDM00826,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.66602564,0.021725168,0.4649554248011116,-0.010603574737432888
68415,SIDM00835,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,1.6273326,0.06916547,0.1336702018542471,0.03496892491316213
53189,SIDM00826,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.45510983,-0.029511036,-0.7893772816595586,-0.07198311357620082
30521,SIDM00455,Irinotecan,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4927025,0.060618233,-1.136056496899284,-0.0010137005255657463
100846,SIDM00633,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1546698,-0.079627395,-3.4487024727859854,-0.18397988669782964
8672,SIDM00633,JQ1,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.708044,0.058517084,1.15323967640635,0.0763637137132059
23690,SIDM00146,BI-2536,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6979881,-0.027563572,-1.5536531100458602,-0.09578002625730962
101271,SIDM00875,Uprosertib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0335228,0.168793,2.1180472074304104,0.12835166366480857
89130,SIDM00933,RO-3306,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.4485368,-0.12650286,-0.8622672898303827,-0.06852260523740543
44540,SIDM00928,GSK269962A,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.959788,-0.1353571,0.6507083788574428,0.026634061176128036
53450,SIDM01042,Vorinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.60709,-0.21236967,-1.4340740731031776,-0.07304904848160934
28781,SIDM00875,Docetaxel,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41938028,-0.033586547,0.46380913152015746,0.03844334613543539
37391,SIDM00928,Vorinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-1.2674065,-0.101804465,0.03989055838246815,0.018062629170183392
20617,SIDM00957,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-2.1553798,-0.06242349,-1.6380356985851146,-0.059232665592754606
73359,SIDM00872,RO-3306,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.56163293,0.03879769,-0.08461843056700978,-0.012722078977119937
29697,SIDM00872,KU-55933,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8968725,-0.080233045,-0.4492768632710996,-0.022807585713387975
12959,SIDM00933,Vorinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.57453835,0.07311286,0.05725872624259876,0.030234744939830686
81631,SIDM00875,PF-4708671,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1559702,-0.03975669,0.6802314150775933,0.08263446637834895
34671,SIDM00633,Cisplatin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8350478,-0.072879784,-0.9700981625932755,-0.016655453233255877
74270,SIDM00837,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.64077115,0.036957517,-2.734077331299027,-0.07449105152493808
11702,SIDM00673,JQ1,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.323332,0.08195137,-1.0746440176651866,0.03075399761367267
103832,SIDM00933,PF-4708671,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.45342502,0.039596703,1.01957273141364,0.12611606321305832
64401,SIDM01187,Olaparib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.4036924,-0.010908628,0.11340727565802627,0.054344472350255434
49816,SIDM00950,Erlotinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9536097,0.16299887,-1.0872900246425585,-0.09047069162713532
44911,SIDM00875,Lapatinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.52103114,-0.058465496,1.21188262010856,0.03945105079916234
36316,SIDM00877,Vorinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.9178682,0.060529172,1.3699529264176538,0.01821506684986646
38161,SIDM00872,Taselisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5980349,0.07791007,0.08694927878011355,-0.007752403382621687
79304,SIDM00875,AZD7762,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6786661,0.0384149,0.7579111733818512,0.03149438466873681
17766,SIDM00877,Nutlin-3a (-),Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.0887419,-0.051066443,-0.04002927633670151,0.007732127182585939
3300,SIDM01042,5-Fluorouracil,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.979551,0.0869025,2.220590911127501,0.03083409938384158
69638,SIDM00872,Navitoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5349661,0.036209613,0.18702969706035602,-0.0053588719977254555
44836,SIDM00097,AZD6482,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6191399,0.04444073,0.8831515801274604,-0.021971733319911476
91771,SIDM00928,Nilotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.1752527,-0.07802439,-1.253636909274636,-0.021438346830633708
46791,SIDM00928,Lapatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.9875947,-0.11958199,0.6779227577270699,0.1076657998307914
47895,SIDM00872,ZM447439,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3058248,-0.104260705,1.0477573816281451,0.03539170815595936
105990,SIDM00148,Paclitaxel,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.31179515,-0.0323883,-0.6704258824271715,-0.011715328141301192
19412,SIDM00875,Luminespib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2338225,-0.13884708,0.03572680158711026,-0.051119463817787994
36701,SIDM00875,SCH772984,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3436164,0.03967889,0.34591423005550004,0.045770786431714804
93108,SIDM01197,Trametinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,0.66738313,0.014904816,-1.4497932776700948,-0.08875740111526945
40470,SIDM00933,Linsitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-1.2029002,-0.0722072,1.5499592842344112,0.10709907052051984
41724,SIDM00633,Dabrafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.270364,0.033311106,2.0588499878310547,0.07760613392024615
89471,SIDM00097,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.705824,-0.07478131,-0.9221839277942023,-0.01665575655656811
7550,SIDM00875,MK-2206,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5584808,0.05216424,0.20701366813414432,0.04787857019717687
14571,SIDM01197,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.29991382,-0.021850431,-0.5499520746874846,-0.06337415259459274
18304,SIDM00875,Trametinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9423089,-0.15142848,-1.2633267278914226,-0.1192140293191353
101187,SIDM01042,MK-1775,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7606339,-0.040294092,-0.2643105631403191,-0.04126117655405441
59053,SIDM00872,MK-2206,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1311975,0.22240035,0.40850327259147706,0.0013538088489681898
88026,SIDM00455,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.834399,-0.09826835,-1.0241766896096771,-0.01541790546349123
106101,SIDM00776,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-2.2228057,-0.06865939,-0.05058432136965266,-0.02304921761510833
74907,SIDM00146,Alpelisib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.0570418,-0.033553723,0.053656534503101275,0.04551587168949051
22538,SIDM00957,Trametinib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.897514,-0.12250376,-0.9072615433895326,-0.03592984703592305
107046,SIDM00633,Doramapimod,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.80349195,0.041292112,0.7662279968597946,0.07302126345487318
14928,SIDM01042,Entinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4721112,-0.18185253,0.052753012789591304,0.008212143093976129
75551,SIDM00875,AZD7762,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.10561458,-0.0069158874,-1.067172805009889,-0.07980569901703555
65088,SIDM00877,Alisertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.7602029,0.06541353,0.5364855656134013,0.04278010931310548
34337,SIDM00826,AZD8055,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,0.82856405,0.058369268,-1.3737805810006636,-0.035384378529215665
29191,SIDM00835,SCH772984,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,1.9490906,0.16107322,0.27770502248559187,0.03451469837772569
15378,SIDM00097,Paclitaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0213594,-0.12776506,-0.7898692381415727,-0.11683116036639203
92982,SIDM00877,Afatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.88496554,-0.10918079,-0.7067442196921102,-0.023303238136140433
48399,SIDM00877,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.55851895,-0.06190776,0.16063701604079528,0.0810670127743608
101212,SIDM00097,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2127676,-0.04801331,-0.39899369954679365,-0.008116047792173313
74463,SIDM00950,Crizotinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6455034,0.11262846,0.07496938095092308,0.059914658171920425
106772,SIDM00875,Bortezomib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0819918,0.023629066,-1.7376971555428475,-0.06737002672185359
2151,SIDM00146,SCH772984,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.0210378,-0.09558861,-0.7208833748419099,-0.009250337216222048
60583,SIDM00673,ZM447439,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.11536952,-0.009153447,1.2458950114224672,0.07225960559892651
7059,SIDM00146,Venetoclax,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0132452,0.025822368,0.04023148539339092,0.02146848337402478
20715,SIDM01042,Gemcitabine,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.007483,-0.25511762,-3.3944961014394863,-0.28434206726894984
83880,SIDM00148,Crizotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5345448,-0.015658781,1.1577496877485505,0.03974749565637518
84648,SIDM00042,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.5093694,0.11852186,2.1099699988278853,0.1156220265262001
75897,SIDM00455,Olaparib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3474549,-0.029950991,1.0900604584919324,0.020161841680390622
30448,SIDM00957,MK-2206,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,2.8793802,0.057632122,0.5988831114578237,0.06647833600581471
70051,SIDM00928,Tozasertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,1.8012652,0.074495606,0.4687778926032576,0.030922836126918138
1075,SIDM01187,OSI-027,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.8896456,-0.07225349,-0.9789084222354941,-0.061447818901465216
26753,SIDM01197,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.58205867,-0.044933394,-0.7457014871747807,-0.028519097170529736
100474,SIDM00875,Tozasertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.92852104,-0.035988957,0.12132251510315757,0.03974127669827617
86319,SIDM00837,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.8292105,-0.04763673,-1.547751925273027,-0.07386471542378384
39418,SIDM00148,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.8672743,0.23370701,-1.6153215431406922,-0.015586548833499542
1822,SIDM00872,OSI-027,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6270439,-0.060643468,-1.164470658909832,-0.0481427373648732
92661,SIDM00875,AZD8055,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68016905,0.07612404,0.09093656052891258,0.022810025521788672
81008,SIDM00216,Palbociclib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-4.009918,-0.19190797,-3.196985697906211,-0.12942080787459947
62616,SIDM00872,Alpelisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0769391,0.105443746,0.01327272059137097,-0.020267362885410013
94485,SIDM00776,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.5450275,0.028014494,1.3006751635859346,0.04338197569615368
73976,SIDM01042,Olaparib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.051082,-0.10057912,-1.749687988024603,-0.00022473760922296448
71762,SIDM00097,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0484765,0.054672424,0.45281662318458465,0.01326804028075504
93853,SIDM00875,SCH772984,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97849256,0.10316146,0.7845308203267366,0.08834103972213572
93950,SIDM00928,Olaparib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.365107,-0.09282905,-0.4996265375132379,0.018056775830683266
18608,SIDM00933,Axitinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.3567126,-0.25619778,-1.2883380818977288,-0.07600541930538446
11043,SIDM01042,5-Fluorouracil,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.61981285,0.03170851,0.34382331110967096,0.044355308509371534
76071,SIDM00875,Bortezomib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24843861,-0.024815543,-1.19443301657407,-0.05436468301333016
40633,SIDM00776,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3606915,-0.11908205,0.0972426413008579,0.01548071614876831
56708,SIDM00833,Camptothecin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.3806604,0.0651758,-0.05084732283958058,0.008359253995652485
33388,SIDM01187,OSI-027,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.1922545,0.30861083,0.1016280004780675,0.04882208167929946
90198,SIDM00673,Docetaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-4.1806526,-0.19184414,-1.2274946454877922,0.029910696655232098
54143,SIDM00950,AZD7762,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5721945,-0.044828396,-0.2500552311422324,-0.02146240117185752
34783,SIDM01187,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.0565965,0.1311799,3.0549578042624796,0.14501614033464597
102533,SIDM00877,NU7441,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.8571559,-0.04497316,-0.5662811469236706,0.07655704004985996
22361,SIDM00633,Gemcitabine,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.54022884,-0.045047965,-1.1589693659340778,-0.1023067364019085
45620,SIDM00097,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9001153,-0.084223576,-0.6719656746712389,-0.02581079949818595
84061,SIDM00832,SCH772984,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,2.8431704,0.2283549,-0.40478069923697085,-0.04436853901325618
38079,SIDM00877,NU7441,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.58505106,0.07067627,0.37296680508314767,0.023820580815301372
58205,SIDM00673,Luminespib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.4608986,-0.11528545,-0.5713221143231559,-0.08669132324657701
52169,SIDM00455,MK-1775,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2641342,0.119899645,0.32608244589310487,0.044941897843462066
89222,SIDM00042,Trametinib,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.8806703,0.07537538,-1.1176968803919916,-0.09430260320359957
16424,SIDM00877,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.7857983,-0.075377524,0.5462085745163691,0.05947007121398003
63184,SIDM00282,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3121023,-0.060035873,0.7710607646213217,0.1620316542234095
59193,SIDM00455,MK-2206,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.399644,0.22347637,4.061833973912007,0.2767330040726327
67111,SIDM00928,Olaparib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.06487,-0.07963746,-0.009372392388069391,0.024194703907278854
48127,SIDM01187,OSI-027,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1651598,0.11081109,-0.09980067897294707,0.03421312871496259
39456,SIDM00216,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.56781584,0.01616722,-1.1999540500066135,-0.09166352825732697
53169,SIDM00776,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.7151253,-0.114620455,-0.5047903067036035,-0.02918527485151996
68827,SIDM00928,BI-2536,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.64476675,-0.03433132,0.9041770698009921,0.008876831543156409
69398,SIDM00146,Navitoclax,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.9755206,0.14048456,1.896447640754032,0.06525413795399834
57576,SIDM00832,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.3525294,-0.07749466,-0.8170981353583308,-0.05793215017128029
84131,SIDM00832,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.9322006,0.05535997,1.6071913164799545,0.020353045550380703
99056,SIDM00148,RO-3306,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7667313,0.27199042,-1.3950426435884844,-0.09069331634983653
21995,SIDM00146,Olaparib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.46042454,-0.01953209,-1.106292426701168,-0.024386979617063785
97721,SIDM00877,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9676162,0.009520666,-1.335274563940895,-0.02229717207212558
34778,SIDM00832,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-3.9783707,-0.22302629,0.2177671089582044,0.0029559338048671916
88000,SIDM01042,Gemcitabine,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6693443,0.06820872,-0.6738174483688284,-0.05101855432927349
42767,SIDM00957,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,3.0722475,0.049125217,3.1380077350149387,0.08687270578068876
99248,SIDM00359,AZD8055,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.25579518,0.014193076,1.3453243524985508,0.10056140145815606
103079,SIDM00835,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.6878133,0.111214705,1.6895513257185446,0.021765835390196945
3097,SIDM00877,AZD6482,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.6757397,0.079144344,1.1123850711989556,0.009829068201880661
3781,SIDM00146,Axitinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.4435446,-0.10638463,-0.7711121316828968,0.013541962165814754
65253,SIDM00933,PD173074,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-0.59262526,-0.048513178,-0.1230873994413131,0.00650962699812557
53646,SIDM00833,AZD4547,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.926595,-0.10182848,-0.3999189218118794,-0.0590976333703995
4911,SIDM00833,AZD8055,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.6512237,0.094787486,2.4959364140619855,0.12488427522939866
16933,SIDM00928,Entinostat,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.29903397,-0.027160106,-0.5121925355625833,0.007785796498478784
44049,SIDM00148,Temozolomide,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7270558,-0.020535767,-1.497505962884081,-0.0361785768658118
82276,SIDM00877,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-1.8279265,-0.0770343,-0.18025180024979068,0.03246349440602222
22265,SIDM00146,Temozolomide,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9398304,0.027934918,0.9503627268393262,0.062004000626760834
34313,SIDM00148,Luminespib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6543868,-0.059764903,-0.6659633604608608,-0.0721791935933577
35535,SIDM00957,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.6211874,0.027034337,0.3759366370338316,0.039006844702624575
16142,SIDM00835,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.0896715,0.068804294,0.18425301334007513,-0.026442005766919425
19635,SIDM00877,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.28842577,-0.024120195,0.497955497246571,-0.003727691444023613
38983,SIDM01042,OSI-027,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5179642,-0.050272726,-1.1992608846838833,-0.07326200908938996
62659,SIDM00776,LGK974,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-1.6750513,-0.044244613,-1.7037208868241989,-0.03490258095720919
96137,SIDM00928,AZD7762,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.2129562,-0.1329021,-0.2455816305993228,0.018222147613128684
77256,SIDM00097,SCH772984,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7199298,-0.07641348,-0.19103378520126893,-0.04437324990389054
44701,SIDM00875,Cisplatin,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2260613,0.07110499,1.3133670678123934,0.08328038543787057
51996,SIDM01187,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4232183,-0.03758233,0.6613160173929701,0.1209585253632011
43518,SIDM00146,MK-2206,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1499966,0.0679294,1.0368509859343737,0.17243035536130108
57015,SIDM00877,Pictilisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.14702024,-0.015687449,0.4530755733874483,-0.026614940053923133
16223,SIDM00673,PF-4708671,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9596967,-0.07221799,0.5702609270036577,0.09608646576251488
104818,SIDM00216,AZD7762,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.6424409,0.1444078,-0.3035640001664242,0.038327368799286964
28265,SIDM00282,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.8163993,-0.0805692,-1.6257739925525299,-0.07084333454348765
55796,SIDM00633,Nutlin-3a (-),Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8976487,-0.11459069,-1.570697023676915,-0.08541797406602972
71350,SIDM00877,Linsitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.2112556,-0.1991482,-1.617559004820977,-0.07791726412277311
104205,SIDM00877,ZM447439,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.5305096,-0.044883255,-0.4094377379143778,0.04673363018099108
53635,SIDM00933,Sorafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.3373685,0.15369795,1.712059560912061,0.09938744544079708
28630,SIDM01042,Vorinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2944753,-0.15719205,-0.9242540344143099,-0.060589894864221075
57197,SIDM00835,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.7460624,0.12710512,2.695778222272713,0.1351723317697412
56037,SIDM00633,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0722687,-0.070319965,-1.6827740262772473,-0.07518921722961851
53632,SIDM00633,Paclitaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.92761415,-0.046537094,-2.157978260449117,-0.04831222861532767
101200,SIDM00148,Tozasertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6120637,-0.026039291,-2.5126580437040538,-0.10902305910806655
107806,SIDM00872,Palbociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3789924,0.015578375,0.2876274753801907,0.031560133318982844
76819,SIDM00957,Palbociclib,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.539902,-0.03271364,-0.47740147042357184,0.006143662939629292
30353,SIDM01042,5-Fluorouracil,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41090176,0.01943758,0.0733833517744968,0.03204795535273006
83125,SIDM00833,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.0528922,0.06439241,1.2635554037692383,0.03394996334663058
53688,SIDM01187,Temozolomide,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.67587334,-0.0167219,-0.7434033973692555,0.004290994152108412
2197,SIDM00673,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2513685,0.18507603,1.4124208010212038,0.11798498632931803
32882,SIDM00455,Sorafenib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.280959,-0.07698343,-0.5279194273931883,-0.03156494159477386
39991,SIDM00875,Cisplatin,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7832469,0.11620159,1.1387137067988973,0.03415880081675551
97191,SIDM00097,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2986186,0.042356413,1.014053228726807,0.0545478653380154
85764,SIDM00877,Linsitinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,1.5643443,0.13581468,-0.3405354979610925,0.023493148155097583
17492,SIDM00875,Camptothecin,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3820876,0.14080612,-0.39528776010083433,-0.02211672422069357
107230,SIDM00875,Sorafenib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85161513,0.083188586,-1.072105127028261,0.0012845201855942693
38869,SIDM00097,MK-2206,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3603792,-0.08852929,1.4010559299705312,0.05119683216624424
71731,SIDM00216,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.4399613,-0.021345856,-0.22209129939892955,-0.034036736594404
41947,SIDM00097,AZD6482,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0232728,-0.071547456,-0.2660467140041531,-0.022012506495820105
45082,SIDM00455,5-Fluorouracil,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0589033,0.054418575,-0.37144007149662295,0.05135359907399412
3457,SIDM00872,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0665983,-0.068328634,-1.211540421892962,-0.050849454414916125
4096,SIDM01042,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7644081,0.0033011374,-0.18959112394269087,-0.0025267980527557995
9081,SIDM00837,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.25249475,0.011329697,0.16883474346788138,0.029845153056159483
9031,SIDM00933,NU7441,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.5473361,0.13543358,-0.8100446432081153,-0.06769120384385444
3245,SIDM00928,Camptothecin,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.9784582,-0.14060009,0.5004369428020478,0.0481691480998678
10791,SIDM00928,AZD6482,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,0.7757487,0.05960537,-0.014761100749065899,0.028577289995627753
1920,SIDM00359,Olaparib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5326312,0.09290043,2.0044717351921792,0.059518410495496755
12255,SIDM00928,Alpelisib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.3576083,-0.1424068,0.12706319340209776,-0.020141207714956665
78063,SIDM00673,Cisplatin,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,3.9252543,0.25272307,3.4687854252085764,0.22727100889515386
40676,SIDM00950,LGK974,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6043208,0.06508508,0.10025103726223479,0.010302729969441673
51612,SIDM00146,AZD8055,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.67567396,-0.059993815,-1.0517736561224973,-0.10255535128393779
64971,SIDM00872,Paclitaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.88187706,0.0809754,3.2408251155908334,0.13858111812763046
100940,SIDM01042,Nilotinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48570234,-0.03618749,-0.25222214071701027,-0.026514753852385702
56138,SIDM00872,PF-4708671,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5081733,-0.04309888,-0.06809903355930808,-0.052948816886110556
94008,SIDM01042,Bortezomib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0927829,-0.04744148,-0.5746745810182324,-0.05933327350720802
5556,SIDM00933,RO-3306,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.2160945,-0.12769705,-1.0428646170030271,-0.11142820990532674
94223,SIDM00282,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.27322882,0.010954315,-0.3603109156654507,-0.028908052579128825
48607,SIDM00950,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0329351,-0.01975887,-0.06292576858875662,-0.0019279917338482781
85288,SIDM00776,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,1.6820499,0.14748524,-0.12424831345811573,0.003520089885268023
97139,SIDM00872,AZD8055,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1617485,-0.12875794,-1.364272152335707,-0.14903844079838668
88870,SIDM01042,Cisplatin,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.62064296,-0.024079984,-0.39346544502776987,0.0256560517870587
16496,SIDM00928,MK-1775,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.2454221,-0.19799526,-0.6412392550188764,-0.08907648632869478
55842,SIDM00957,MK-2206,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.2210715,0.059480555,2.283403229910238,0.17659059968514898
101281,SIDM00455,Irinotecan,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5913861,0.07099629,1.381596787876232,0.1562400703804801
66942,SIDM00673,RO-3306,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0524962,-0.11533435,-0.3771924295058323,-0.0010747490008945243
42614,SIDM00148,AZD8055,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.337504,-0.06177847,0.24686627534824832,-0.01975440540232237
43114,SIDM00877,5-Fluorouracil,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.0994316,0.041547444,0.34135563491008203,0.012207589808654608
96305,SIDM00673,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2098212,0.093355,0.20823179344369355,-0.04833857859625403
77751,SIDM00957,Navitoclax,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.7880287,-0.057210892,2.840485044923201,0.07522876225584213
48628,SIDM00950,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.2024088,0.067795105,1.2537001976844333,0.05819152969857587
755,SIDM00832,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.68371475,0.055044822,-0.07995302204170632,-0.05008427176769259
38641,SIDM00216,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3923783,-0.03969577,-3.160905468038715,-0.13894281819716692
36944,SIDM00933,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.66336834,-0.02616788,0.3991395023955846,0.030573839173151096
63566,SIDM01042,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5937732,0.08661227,2.439072879433495,0.02339309937775265
16711,SIDM00877,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.8617932,-0.018920727,-1.1477590921342136,0.0061774953221503505
10158,SIDM01187,Linsitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.175798,0.035353914,-0.13452178735047138,0.0038231723064050026
31220,SIDM00875,MK-1775,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26967257,-0.018079396,-1.3819533600226739,-0.06472015687896523
39946,SIDM00837,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.99795055,-0.022559736,-0.7667106092527455,-0.0568087309493332
66708,SIDM01042,Entinostat,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7939135,-0.09483682,0.43176612670047265,-0.004806262767597107
52973,SIDM00148,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.3320298,0.031551473,-1.1191544007849563,-0.09374936303496212
47677,SIDM00835,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,4.948798,0.1344101,1.8572254324869983,0.05994745166610397
864,SIDM00933,MK-2206,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.7945775,0.11434328,2.108798435459199,0.14771233606040202
22643,SIDM00282,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.5132928,0.08724806,1.5534390079174512,0.08917325208618819
85522,SIDM00875,Uprosertib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74813133,-0.07187206,-0.4325898640524665,0.017227921702184786
93440,SIDM00146,Olaparib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.9291811,-0.05233705,-0.5530235670393163,-0.03317234088677602
75454,SIDM00950,Cisplatin,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3205137,0.15698455,1.852317267988597,0.0884730464797182
50098,SIDM00455,Dasatinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.6313376,-0.08228688,-1.8899967725611495,-0.0899737290564892
36739,SIDM01042,Venetoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1515026,0.113744415,1.1131729091977898,0.03785187120580737
96685,SIDM00146,PD173074,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.89012116,-0.05298498,1.2007371783109286,0.09191219812152375
21702,SIDM00928,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-3.22093,-0.25621507,-2.617292737449605,-0.15310497337035847
36211,SIDM00359,Navitoclax,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.561753,0.034934342,0.39276924710902394,0.003890458116015375
25716,SIDM00776,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.8413444,0.04842754,0.7091320819627525,0.05869819699194026
65337,SIDM00097,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.4276924,0.20013958,1.5371589275503041,0.09755383928239533
54226,SIDM00673,MK-2206,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4021951,-0.05370575,-1.2670957035075918,-0.05883523062976707
56972,SIDM00933,Alpelisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.2243153,0.11023355,0.7161471095020016,0.06541495201147772
46316,SIDM00835,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.023583,-0.099226505,-0.1847187692529175,-0.00785464989106334
87758,SIDM00148,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0083758,-0.02405563,-0.10567441274453922,0.025779070444579083
65739,SIDM00146,Gemcitabine,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5839264,-0.04314555,-2.471524368070168,-0.22266666790602246
20581,SIDM00776,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1963059,-0.1060625,-1.0472097537676186,-0.11314525181676996
8558,SIDM00875,ZM447439,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7201305,0.081859134,-0.2587673243053954,-0.03300808311155004
15370,SIDM00872,Nilotinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0452693,-0.07005942,0.7881929676171597,0.09341466888675531
72809,SIDM00872,Luminespib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5490888,-0.1188722,-0.9693401711442523,-0.048659489067630984
18018,SIDM00835,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.5541517,0.089520074,0.7403920081350484,0.10166486636059645
8493,SIDM00877,Nutlin-3a (-),Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.4189868,-0.063787974,-0.16116280989380133,0.025630577796197953
89197,SIDM00146,Nilotinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3891993,0.12662908,0.8854537620138312,0.05864044542694817
98505,SIDM00776,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,2.9080975,0.14806351,2.0404605969760286,0.053180986550028536
27712,SIDM01042,GSK269962A,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7914584,-0.104021445,-0.03578426037099698,-0.0550041042481566
92971,SIDM00837,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.2984866,-0.009938344,-0.918100407123745,-0.038664087811097855
93447,SIDM00835,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,3.4584029,0.25126418,1.7659176971982016,0.08316580829742141
52214,SIDM00928,Entinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.4792538,-0.16627273,-0.7332195849657475,-0.04891859021791294
27374,SIDM00455,SCH772984,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1674649,0.078637876,0.3577294415035523,0.009491054032782427
60207,SIDM00933,Crizotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.6190133,0.38573277,1.5402511970307657,0.14262480614103795
7787,SIDM00673,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1652031,0.0154704545,3.667236318133888,0.052369154458807826
19717,SIDM00877,Nilotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.0469671,0.10488268,0.584907859903536,0.06791938418711838
9129,SIDM00875,5-Fluorouracil,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7409571,-0.05587171,-2.9101613426017816,-0.16008746451915248
58744,SIDM00097,Alpelisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3514757,-0.0953945,-0.45845390478047193,-0.050107735316070635
79429,SIDM00097,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6448761,0.08632648,1.6649135640521666,0.09341923649885035
25781,SIDM00933,Taselisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.17032994,0.018840762,-0.08074369031141379,-0.03405481030607989
44241,SIDM00633,GSK269962A,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.083308,0.19712865,1.2454815556920642,0.09026465145465619
27431,SIDM00216,Linsitinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,3.139242,0.24696153,1.914742910123123,0.15001960335837392
106048,SIDM00957,AZD8055,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.5271126,-0.028549094,2.499099305242438,0.10869222287704342
81580,SIDM01042,Sorafenib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.53686595,0.055777658,-1.416429660380714,-0.009060624869270933
60487,SIDM00872,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2611135,0.056361884,1.8578250419617375,0.0847236161103627
40249,SIDM00097,Doramapimod,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.973611,0.06509449,1.4283359120357837,0.06568396346311323
37246,SIDM00673,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6566787,-0.030736836,-0.21402659775285415,-0.02428235926035248
19872,SIDM00872,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9239476,-0.058423243,1.072672427198359,0.024040276416571627
107675,SIDM00933,Axitinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,0.21614024,0.03321254,-0.3869251136173133,-0.04099452191618305
9649,SIDM00359,Oxaliplatin,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9634945,-0.095732115,-1.843456538610686,-0.05897489346972507
75808,SIDM00673,Tozasertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0253228,-0.0759399,-1.657133609357873,-0.13026160010558588
43384,SIDM00146,Alisertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.6667492,-0.13951357,-2.7865326172783926,-0.08361900034366669
61409,SIDM00216,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.0407636,-0.17890641,-1.4188846615780466,-0.15818916214713652
85918,SIDM00673,KU-55933,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.0167253,-0.055810045,0.5308033422123041,0.0011500751804611065
72886,SIDM00833,Palbociclib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,2.1267965,0.06635389,1.301360527687051,0.04535269740851398
20598,SIDM00872,Alpelisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.50679255,-0.05025766,-0.19023701187039643,-0.03758169669194945
79440,SIDM00455,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.45856047,-0.027378513,0.4434880077911954,-0.009460350062202702
59913,SIDM00877,Doramapimod,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,1.402609,0.14788206,0.9625227969081295,0.10170688391210225
63219,SIDM01042,PF-4708671,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35298592,-0.031452477,-0.1891623562444996,-0.037137931960435966
54263,SIDM00837,Taselisib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.6202942,0.057272147,-1.2144908393141987,-0.07858430432097793
76785,SIDM00146,AZD7762,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6262305,-0.053567216,0.26414402901555717,0.018423036082153125
68925,SIDM00216,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.99581724,0.040707227,-1.674320228520688,-0.11387492035250399
91422,SIDM00928,AZD7762,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-2.2296371,-0.13352688,-0.31646929679482955,0.020460164835442857
44211,SIDM00933,Pictilisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.35478166,-0.048493918,-0.7478383621803069,-0.06108876497832945
46050,SIDM00928,Uprosertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.97002846,0.06837802,0.4376522847289685,0.034748800538242954
73494,SIDM00455,Dasatinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.1445718,0.13638431,3.618645106037074,0.2314011785740681
88429,SIDM00097,AZD8055,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0410498,-0.064110436,-0.5237563274538488,-0.0019190808470922309
41256,SIDM00832,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.5241332,-0.13754031,-1.485061872544221,-0.07819853497332614
36970,SIDM00148,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8194685,-0.17342249,-1.844860698025405,-0.09286229800029756
82327,SIDM00216,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.25258487,-0.025026433,-0.6241040315759032,-0.07879482439702579
11800,SIDM00146,Docetaxel,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.7260963,0.04302586,-2.1860429661559633,-0.12896828471507712
88991,SIDM00359,Linsitinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9857153,0.14760706,2.197018014566952,0.12068984446132659
74941,SIDM00633,Doramapimod,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9914939,0.13829699,0.4670786054903421,0.0793904749281945
39255,SIDM00146,PF-4708671,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.82070285,0.0253379,1.9121705940236484,0.11167288499203916
64667,SIDM00933,Entinostat,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.0249672,-0.09022099,0.008503466464859343,0.05832221451846367
53239,SIDM00875,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37874508,-0.02651471,-1.6824009496040375,-0.03377834481598758
75057,SIDM00933,PF-4708671,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-2.4181283,-0.15159605,-1.1120869021864443,-0.040987339584537576
9454,SIDM01187,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.8015802,-0.18573079,-1.5774482829631726,-0.09255902558418129
58370,SIDM00633,PF-4708671,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.67689043,-0.045989856,0.5139274839880671,0.005760969692206849
68117,SIDM00877,Nilotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.75683606,0.0824943,0.889973436891822,0.09990029499012713
89392,SIDM00097,Olaparib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.618032,-0.033103492,-0.5502096036690223,-0.014471815661720936
38116,SIDM00455,Olaparib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8863921,0.06940366,1.081002457380491,0.04655709604496879
82718,SIDM00877,Gemcitabine,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-5.6499715,-0.10734209,-3.183353201741937,-0.11059479321164563
24361,SIDM00933,Sorafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.5175975,-0.04706432,-0.6234776996471634,-0.037189727650536096
11951,SIDM00042,Navitoclax,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.5923758,0.10504366,2.1960330358697897,0.045671143155581975
8522,SIDM00928,MK-2206,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,5.153361,0.40396336,0.7817767666558773,0.08451698814337938
105013,SIDM00097,KU-55933,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.404793,-0.05583739,-0.5641461626736749,0.017468804473842556
99124,SIDM00928,Venetoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.821093,-0.022278449,0.49074828475658444,0.014138784194352645
70861,SIDM00872,Pictilisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.60330296,-0.061123528,0.2510285141367239,-0.027103260452663373
37624,SIDM01042,Nilotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.27619767,0.010037494,-0.34019372309010565,-0.06117859222419023
61073,SIDM00933,Alpelisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.6569531,0.15266384,-0.2491785392250698,0.0007490383882711346
107473,SIDM00673,ZM447439,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6301831,0.050960373,0.6245381100423208,0.040388200233411636
60481,SIDM00455,Navitoclax,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.9205246,0.05190874,1.0047118618924937,0.048872623412771356
10009,SIDM00042,OSI-027,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6679574,0.048519075,-0.10224234711411463,0.01916647928692757
5698,SIDM00872,Tozasertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.32347938,0.01398477,0.0647694860347209,-0.011838355093631249
2866,SIDM00832,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,3.5094006,0.13664524,0.3105205502195172,0.018363016069755028
85869,SIDM00837,Linsitinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1558703,0.049678043,-0.7381115788614183,-0.06339561035688017
87586,SIDM00633,Doramapimod,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.37033123,-0.032410108,-0.9206639468887745,0.01962396119670695
37705,SIDM01187,Trametinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.3623867,-0.09041345,-1.5288931918400852,-0.002378611450191735
79139,SIDM00633,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0258102,-0.08330841,-1.035925251624822,-0.05475649893119071
61898,SIDM00146,AZD6482,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0198634,0.076607905,0.12653496969349293,0.018018728603809275
95871,SIDM00148,Temozolomide,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.79863864,-0.022700818,-0.661893494861108,0.006606354527485138
31461,SIDM00148,Luminespib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2075986,-0.07438679,-0.012109693384016323,0.02489646094514226
95334,SIDM00933,Doramapimod,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.249967,0.07439191,2.80957177204013,0.05196570143103921
77699,SIDM01197,BMS-754807,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8293248,-0.06948423,1.2644664155516347,0.027774312145404118
6062,SIDM00877,Vorinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.5501651,0.04195395,-0.3942523826711218,-0.04308722227320188
98842,SIDM00673,Nutlin-3a (-),Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2705005,0.03565251,1.4198753416297718,0.05068733745095121
18882,SIDM00146,NU7441,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.507674,-0.123155944,0.013034810251696886,0.00017247426323948716
4189,SIDM00877,Wee1 Inhibitor,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8741543,-0.044023823,0.5570535757904621,-0.005559854552718727
86877,SIDM00673,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.440649,-0.1907197,-0.07686319082710662,-0.06672229600378453
11447,SIDM00673,Linsitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5955453,0.03634212,2.5638848126103393,0.057471720822033015
30046,SIDM00282,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.32179356,0.021515068,2.353314465169288,0.14519601759757667
45182,SIDM00872,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2915382,-0.011001591,0.7684874592777496,0.024680016569667333
98177,SIDM00146,Doramapimod,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0346757,0.063590065,0.3666771085122375,0.023268175686002493
30002,SIDM00146,Bortezomib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.41716117,-0.019746399,-0.5175291265087678,-0.03182843585698865
78183,SIDM00455,Gemcitabine,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.992945,0.09354102,1.4509094626297465,0.08361030955063856
1397,SIDM00835,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-1.5094398,-0.040496416,-0.8419279267041234,-0.0006215988501908661
38016,SIDM00928,Cisplatin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.960998,0.10601835,2.4823410131171313,0.11045018299326134
104981,SIDM00877,Alpelisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-2.01541,-0.1835644,-0.15456219420526163,-0.017337404833858892
1912,SIDM00837,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,0.42289934,0.009634789,-1.5667893879659238,-0.09655884978838364
58284,SIDM00216,Trametinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,1.2347605,0.11726377,0.5012110759863566,-0.005366613988631994
58672,SIDM00042,SCH772984,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.300704,-0.1396471,-0.6655501578857133,-0.0448407384286207
74922,SIDM00776,Camptothecin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4296381,-0.15593669,-2.6383183747167145,-0.12469668261501518
85007,SIDM00877,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.3338606,-0.027173212,0.3914966507400276,0.060226941258720634
70857,SIDM00835,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,1.7828693,0.09902269,-0.3816158124210906,-0.02097874799576593
104059,SIDM00933,OSI-027,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.177154,-0.15299359,-1.3429714404696933,-0.004111747140179037
82937,SIDM00877,Alisertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.2087113,0.117751606,0.17615220098533466,0.033485336624032684
3831,SIDM00097,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.50707245,-0.0077744476,1.933686476569134,0.050844129247494325
52270,SIDM00877,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.9089259,-0.068069495,-1.9461439670210408,-0.10838784917548318
56720,SIDM01197,AZD4547,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3193455,-0.043498427,-2.2271577099350433,-0.07694087842678764
74430,SIDM00282,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,2.370971,0.09528715,0.15895168118848826,0.024483880089503522
61803,SIDM00148,BI-2536,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6957189,0.05240824,2.1201880809496667,0.09558593358207405
46997,SIDM00835,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.3914292,0.085305,2.556420200888588,0.08723287194855538
11808,SIDM00359,LGK974,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7364531,0.028422147,-1.0267547451481263,0.0318460161115635
91237,SIDM00875,Linsitinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9337244,0.1458206,-0.0005471836441397471,0.00473944632233718
18183,SIDM00146,Taselisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0804055,0.07715071,1.3512956852819136,0.13890158224112523
96226,SIDM00146,Paclitaxel,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-4.163961,-0.31205508,-2.894336093562418,-0.2547529330967096
48477,SIDM00875,Olaparib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.55812144,-0.04363888,-1.5329007388348777,-0.08789002821254194
34743,SIDM00835,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.93211234,-0.07426877,-1.3648712628803423,-0.09729319577996819
99696,SIDM00928,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.3530524,-0.08289684,-0.16633931973149596,-0.01943869948149056
107065,SIDM00282,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.8847495,0.028245982,1.4605762114473175,0.053632996839897445
17898,SIDM00837,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-4.0521183,-0.16820756,-2.9510270355449464,-0.12170220674650489
17240,SIDM00633,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3573078,0.03670006,0.4082208075981292,0.029558094602975364
105206,SIDM00872,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1255372,0.07655591,0.45207131517996535,-0.039392606801512416
86428,SIDM00877,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3776234,-0.14732747,-1.1718095590564142,-0.10221947922172349
104998,SIDM00455,Taselisib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7205983,-0.04865127,-0.9577090077733091,-0.04571141955792358
63494,SIDM00933,MK-2206,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.7150089,0.0805235,0.266250203982529,-0.006887404132185029
97427,SIDM00933,NU7441,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.577188,0.15901858,0.49722016948090003,-0.007629445526086694
75138,SIDM00146,Alisertib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0570282,0.093604594,-0.9472557853535113,0.004038517216235213
17979,SIDM00359,Palbociclib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3662549,-0.06898531,-2.317497147091489,-0.05863445373923963
75499,SIDM00833,Camptothecin,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.47604728,0.030770997,-0.8486330127529109,-0.03252808148659452
13203,SIDM00877,Gemcitabine,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-1.1938261,-0.023122905,-0.627431060605788,-0.0007367675093038424
56140,SIDM00146,Venetoclax,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.9326732,0.056618284,0.3902833223280423,0.026001491051175968
61075,SIDM00673,PF-4708671,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.1120778,-0.06885873,-0.4501869437932041,-0.0019946090906681722
70060,SIDM01187,Bortezomib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6097709,-0.062526636,-0.7205240340672023,-0.05450668919430694
9716,SIDM00872,Afatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,2.190443,0.22173846,1.3349542588387706,0.052243459967125816
81962,SIDM00146,Alpelisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.7352821,0.10473711,2.7830074071108624,0.10201003652651504
18796,SIDM00933,Uprosertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.2666922,0.1281548,0.3836915656360142,0.14147285268418738
2508,SIDM00826,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.8734234,0.010334882,0.7869734251541735,-0.025579930020203777
96106,SIDM00097,Uprosertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0333744,-0.05645679,0.507960424032502,0.04866616628795021
70482,SIDM00933,Nutlin-3a (-),Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.687828,0.21785271,0.3734342772157143,0.04075295593851106
58469,SIDM00216,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.47665736,-0.031544864,-0.7701682280012399,-0.005570285986997311
40181,SIDM00872,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.48982793,-0.050439768,0.05483160063031366,0.0520261417982145
25614,SIDM00097,PF-4708671,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7626823,0.077022135,-0.6816957946636085,-0.010233785739997383
1350,SIDM00216,MK-2206,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9493518,-0.056177028,0.44327077159883815,0.012531801608453078
771,SIDM00455,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7414892,0.096812665,3.1326881133332445,0.2654032833082967
65086,SIDM00282,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.5554575,0.09233463,2.6641664845710515,0.2499894071916181
89925,SIDM00673,Linsitinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5247231,0.0108015835,2.21584142705848,0.006970263082813996
19729,SIDM00833,Afatinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.1790369,0.15894054,-0.016738023219575366,0.002867896553041292
62991,SIDM00928,Dabrafenib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7185221,0.03548718,0.3688170459349651,0.010738478870681358
50797,SIDM00776,Linsitinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6421189,-0.040113725,-0.6496247975163646,-0.035861306086746175
35592,SIDM00097,RO-3306,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2162914,-0.09686747,-1.392739369494863,-0.03132051987762812
35618,SIDM00957,Palbociclib,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,0.79874814,0.018030765,0.41738282777879643,-0.0234159486670567
35778,SIDM00673,Luminespib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.4478538,-0.14515586,-1.475956267305592,-0.06468935089330025
55642,SIDM00875,Pictilisib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2780411,-0.02671712,-2.5809463353589757,-0.045893761687265985
48424,SIDM00877,RO-3306,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.7171074,-0.072537996,0.8174064309757837,0.08841414264735689
8797,SIDM00875,Wee1 Inhibitor,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.22971518,0.014782498,-0.6290459770370888,-0.017515482434246128
18190,SIDM00148,Palbociclib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5450941,0.03140137,-1.9514231424157331,-0.07849914116003212
18052,SIDM00359,Linsitinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4402761,0.10939355,0.8630412190932264,0.057142199519419394
81265,SIDM00872,MK-1775,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6695149,-0.06823358,-0.3153803171777168,-0.02137394126112542
60772,SIDM00673,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.28151217,-0.029061267,-0.6963961766855216,-0.020449618179837793
5282,SIDM00216,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9540925,-0.053052,-1.6193453575258145,-0.1306808023419527
10474,SIDM00826,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.9871588,-0.051947683,-1.1613698486256587,-0.050087815224982395
63181,SIDM00097,BI-2536,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1782475,-0.082188375,-0.8990887221047514,-0.044365791601613566
66354,SIDM00633,5-Fluorouracil,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5009639,0.09947793,-1.3193425395478704,-0.0039883673153378145
104945,SIDM00950,Dasatinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.868012,0.44765872,3.9850698542701966,0.19114305694332892
2142,SIDM00216,Afatinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,6.1232114,0.12382694,-1.0092447795473607,-0.031369139298617475
63278,SIDM01197,LGK974,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-2.2139928,-0.10083205,-1.9638895588015541,-0.08574800529625619
3993,SIDM00933,PD173074,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.7919631,-0.11440382,-1.87830609679483,-0.05893442672169924
46161,SIDM00833,Crizotinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.5131063,-0.051093224,-0.1780990677485957,0.0006288939828045009
93901,SIDM00933,Vorinostat,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.2982132,0.043721914,0.9805384263007638,0.07610322014435288
86073,SIDM00146,GSK269962A,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.4640235,-0.0816769,0.20149925516680223,0.023303828341520012
38821,SIDM00776,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5559152,-0.022483507,0.04375773292607945,0.004505639256100419
68552,SIDM00633,Dabrafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7317197,0.047020543,2.4813657616776466,0.04261309183140912
2653,SIDM00950,Dasatinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.6026018,0.34645164,-1.0227178440519575,-0.047535551975529486
48227,SIDM00875,Taselisib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7758555,-0.08841906,-0.27101452893536754,-0.028901933133440357
70912,SIDM00933,Entinostat,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.5642359,-0.03725954,0.929321333700668,0.07795721778833357
32908,SIDM00877,GSK269962A,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.0260675,-0.18381743,-0.9408658978451948,-0.06168490024565445
806,SIDM00673,MK-2206,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.80824894,-0.054792967,-0.040829010151840726,-0.003817058988029784
74794,SIDM00872,Luminespib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8527443,-0.12698807,0.00471707720675948,-0.020202883594131426
48991,SIDM01197,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.4242691,0.008425562,1.981193997262908,0.04808477942950019
4617,SIDM00633,Lapatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.78376335,-0.019635567,-0.6671795787788805,-0.01814906146759911
55633,SIDM00933,MK-1775,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.33191705,-0.024212228,-0.6210402593720424,-0.03210045174904395
50251,SIDM00455,MK-1775,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.121443,-0.11991646,-1.3524038585903946,-0.0491500842571319
105480,SIDM00877,RO-3306,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.07791362,-0.0074779205,-0.07864398666869839,0.025621826229636383
90807,SIDM00928,RO-3306,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.6285473,-0.09908037,-0.17531314670538917,-0.0001824094889919974
29149,SIDM01197,AZD4547,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,0.9975476,0.056250256,-0.7270657736422215,-0.006554389102517945
55501,SIDM00872,Sorafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.23555069,0.02647892,-0.0913938784046471,-0.043864666758729735
63609,SIDM00146,Doramapimod,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.9532125,0.20827416,2.409086363936673,0.061739768740420406
101068,SIDM01197,Olaparib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,2.072922,0.054294012,2.4787280720992575,0.09684904067897097
83746,SIDM00928,Trametinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.6496245,-0.06908358,0.3389960157740809,-0.033980737892766205
89062,SIDM00455,Linsitinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5483763,-0.13726722,-0.8863619007504364,-0.023595581761083534
3646,SIDM00146,Venetoclax,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6810557,0.052312844,0.4155006393274452,0.07423219748340501
103480,SIDM00877,Sorafenib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.94550985,0.11552953,0.6721905170100944,0.022800651194017096
55594,SIDM00776,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.9745973,-0.0627539,-0.23319878632295762,0.009191392566361178
19227,SIDM00832,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.2467091,-0.08969945,-1.5595765740727978,-0.09830032028178227
45011,SIDM00875,BI-2536,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8260784,-0.09974998,-1.2740341156870623,-0.07777460371861371
40306,SIDM00877,Bortezomib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.9477097,-0.05905356,0.22899473931519349,0.006086409406147875
72282,SIDM00097,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8327606,0.10820155,1.8607711630124095,0.08707095981713904
17348,SIDM00673,Lapatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.43369532,-0.037769012,0.07569944360840836,-0.0431056533577924
47193,SIDM00933,Crizotinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-2.1425986,-0.2280472,-1.1968286899040947,-0.047438197541214006
74449,SIDM01187,Taselisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.3256486,-0.025517464,-1.0881112856422133,-0.007550387109622664
14619,SIDM00877,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.51084715,-0.048132278,-0.32629961403606533,-0.016617224196779225
75731,SIDM00928,BI-2536,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.314434,-0.13892052,0.9136267894339571,0.028814617018024596
82642,SIDM00875,5-Fluorouracil,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8903769,-0.09419355,-1.290672454919437,-0.07286336121450385
104121,SIDM00933,Palbociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.97661716,-0.08158926,-0.05792466630580451,0.029478485995035622
53462,SIDM00950,Trametinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.5116596,0.27430236,1.8622010026967508,0.03326706399920112
62298,SIDM01042,Wee1 Inhibitor,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.27290055,-0.025737358,-0.14695850219986942,-0.0016490621645051306
12865,SIDM00833,Crizotinib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-1.6850407,-0.08764139,-0.6689531510766562,-0.0014215873187256622
95393,SIDM00833,AZD8055,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,0.35495275,0.008042634,1.423592460780333,0.0006293625080807496
73034,SIDM00833,Crizotinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.43742722,-0.0300684,-0.47574600496861424,0.0028493762512469363
66435,SIDM00875,Alisertib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2182708,-0.0913059,-2.583697741319833,-0.09322929843132187
73754,SIDM00877,Entinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.2591801,-0.025499932,-0.3331725826584943,-0.05281486116020902
100820,SIDM00282,Navitoclax,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.1410321,0.08107698,1.5062616026705042,0.06860969794953235
12756,SIDM00042,Trametinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.181502,0.15878619,2.2310338753173626,0.10678230807822159
100707,SIDM00833,SB505124,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-1.185541,-0.08460591,-1.1412999579926473,-0.13865465455875883
15883,SIDM00148,Doramapimod,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5056447,0.09236181,0.14073350568106013,0.020678381535129138
95133,SIDM01042,AZD6482,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9142375,-0.05310093,-0.21136880939375485,-0.03378848909893143
80201,SIDM00832,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.6465096,-0.051297598,-0.3745031747309618,-0.06743905464358549
7751,SIDM00872,GSK269962A,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8731198,0.09013051,0.14598598678503402,0.03346280608036304
8480,SIDM00957,AZD7762,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.6056745,0.07632646,2.0558350202227333,0.06533123284377522
22674,SIDM00837,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,0.3464487,0.007893135,0.7612114941489698,0.006644973018113586
93372,SIDM00146,Palbociclib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-2.3316908,-0.09218682,-2.23431402798473,-0.08355729856460466
22634,SIDM00933,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.2628781,-0.022143072,-0.3327927984776051,-0.050735173139498366
82990,SIDM00455,LGK974,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4285266,-0.06552206,0.07402290108393686,-0.030137227590545334
39822,SIDM01042,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8384084,0.10259659,1.8063131623629265,0.02266891994309169
46003,SIDM00633,5-Fluorouracil,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2216263,-0.09898742,-1.5175516235361644,-0.0786480465064013
6238,SIDM00146,Wee1 Inhibitor,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.43536732,-0.03133069,-0.12661451339685234,-0.02437352463147565
30110,SIDM01042,NU7441,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3742119,-0.033013966,-0.1839562972762624,-0.009629587376998483
66547,SIDM00875,AZD8055,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28975648,0.02532697,0.9069970721223349,0.06747199676501216
70686,SIDM00928,AZD8055,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0629627,-0.11046317,-0.24196326450991332,-0.039821652739551565
12816,SIDM00950,Irinotecan,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7273405,0.13912387,-0.635513309871302,0.08433301143280747
8840,SIDM00933,Trametinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.1329163,0.15601212,1.4526687498625077,0.12641790695207
73844,SIDM00146,Palbociclib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.200107,-0.07487001,-0.7281890747724724,-0.003227644955706525
49378,SIDM00835,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.2814937,0.108903036,2.231640974641891,0.05490358830739489
31910,SIDM01042,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0148394,0.18233511,-0.30203288753443913,-0.00017725883122053404
42663,SIDM00673,Wee1 Inhibitor,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3723629,0.096117705,-0.7847504251842046,-0.0076990181391402256
3607,SIDM00146,Pictilisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.1825588,0.094711535,2.466509913747799,0.1760944675394428
7005,SIDM00826,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.4091413,-0.073407166,0.6056412548591663,0.08096560755565187
44726,SIDM00872,BI-2536,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4919571,0.16341487,0.6349784744107924,0.011152303477005092
14031,SIDM00933,SCH772984,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-1.5505936,-0.09744771,-0.2101637146462775,-0.0047265610007964365
11241,SIDM00875,Alpelisib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9967185,0.16783802,2.522268433040177,0.1170972747236278
26567,SIDM01042,Docetaxel,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.085006,0.12134933,0.06855870858609037,0.031168437210802685
63519,SIDM00097,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5240488,-0.19198604,-3.9900015536351354,-0.2980492028888188
94544,SIDM00282,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0210794,-0.054926805,0.5229391966894545,0.028457843057084247
34511,SIDM00097,Venetoclax,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2175865,-0.054574713,-0.8914719042815578,0.0033829430123839
103122,SIDM00633,ZM447439,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6106179,0.07289006,2.0916127729985794,0.09979908556602496
91617,SIDM00833,SB505124,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.4211184,-0.1184655,-0.8596148224839713,-0.07087255384501086
79331,SIDM00146,KU-55933,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.1216118,0.08681292,0.5996988044602587,0.026023277563882317
106220,SIDM00875,PF-4708671,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0188986,-0.028279725,0.1893245493583903,0.025294523614852602
87786,SIDM00148,PD173074,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.76714003,0.021604141,0.8678311194627836,0.07454350991168542
59930,SIDM00877,Gemcitabine,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-4.249591,-0.07236563,-0.7309534335994854,-0.08250477562986219
25094,SIDM00872,Taselisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5300604,-0.10003657,-1.1152270460351985,-0.10656839060325574
42281,SIDM00148,SCH772984,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9347851,0.12800694,3.3862614417403645,0.11426947567196281
87528,SIDM00837,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,2.491702,0.021821866,2.5432874875193865,0.038512620159314385
15900,SIDM00877,Dabrafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.5756252,0.051941477,1.5582125050503104,0.07290240828937482
85156,SIDM00875,Alpelisib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2009408,0.113913774,0.5702299289087803,0.03238269967814856
101715,SIDM00872,KU-55933,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.535947,-0.07084415,0.24715203906447047,0.007989137467951402
46188,SIDM00832,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,1.1124343,0.026733492,-0.41546500956176646,0.006841341276392033
105337,SIDM00282,Trametinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.36872384,0.026835296,-1.0350892819356978,-0.06603943434833758
35525,SIDM01042,Afatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7190246,-0.08272235,-0.6180461186314675,-0.01818174371119677
10111,SIDM00148,Bortezomib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3929273,0.07114472,-0.6660441694168157,-0.044572454569980206
100127,SIDM00146,PF-4708671,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.3725379,0.17741758,2.061966081213929,0.11871501416237476
52185,SIDM00826,Linsitinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.2012981,-0.0738036,-0.7251305135288448,-0.0408349123222009
93346,SIDM00933,Pictilisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.9958766,0.110365205,1.6189505833865827,0.12859038859740554
57836,SIDM00928,PD173074,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.8413411,0.09055249,1.2329746721336414,0.07662393952468595
34774,SIDM01042,Doramapimod,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6665114,-0.07624884,-1.1044799729550479,-0.06018700936511602
84612,SIDM00877,Wee1 Inhibitor,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.50136,-0.0418704,0.3466958074115883,-0.0017520931549633773
75602,SIDM00146,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35242,-0.03215588,-1.8515961947315924,-0.16442158790151623
98210,SIDM00673,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.22935843,-0.016071586,-0.1834939451063776,0.009450921499438804
32487,SIDM00673,MK-2206,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.75145245,0.048897132,-0.5288324150930689,-0.01878514119664893
29851,SIDM00097,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7407077,-0.011329595,0.9249640600823177,0.042566884175221135
26243,SIDM00146,Gemcitabine,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.4493144,0.13863368,-1.7924163841000786,-0.07094135540872205
2440,SIDM00146,Lapatinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.2192323,0.08979487,0.9650144555662026,0.11050690362123432
56358,SIDM00455,Gemcitabine,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.1314716,-0.085546575,-1.4901009287181037,-0.06346798801642417
61399,SIDM00776,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.5665247,0.03084453,0.8208391224297236,0.029943195288985393
69930,SIDM01042,Venetoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8410059,0.08511137,-0.6699713481822569,-0.008416496236386245
38714,SIDM00148,AZD6482,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4481784,0.1416878,-0.4128142333973577,0.022926048830356465
104427,SIDM00872,PF-4708671,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.634413,0.06397013,1.2964409579651228,0.04530169445396532
29226,SIDM01042,Alpelisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4846404,0.1742768,-1.3286367313713863,-0.06740835872755331
72906,SIDM00928,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.8947316,-0.02805025,-0.9097659781638209,-0.002123590114447133
77030,SIDM00826,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.36623257,-0.01433645,-1.9256027140043268,-0.07176302893196794
77101,SIDM00633,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.9368424,-0.12237041,-2.1225951777973657,-0.10652378015402064
16020,SIDM00877,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.4003973,0.13181871,0.6292666808525429,0.03709535576984105
8702,SIDM01042,ZM447439,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6202087,0.20229062,0.8515154083672399,0.023722725146169812
5960,SIDM00455,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,7.8740745,0.40739927,1.891843638344679,0.15215881932517225
33074,SIDM00833,MK-1775,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-2.6440864,-0.115723275,-2.257057488406039,-0.09346010179421595
108309,SIDM00633,Crizotinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0377872,0.10333394,0.4168975500984154,0.0014393048093393804
60443,SIDM00933,Nilotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.0347574,0.09583143,0.8402235005654776,0.04067463675158439
67186,SIDM00359,Afatinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.81232965,0.05666445,-0.1342695472803287,0.028727365611625023
95324,SIDM00835,MK-1775,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.9465255,0.07561583,0.17109401998897383,0.0475047221322013
31733,SIDM00875,NU7441,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7543594,0.07229317,0.5021126393593157,0.026707277287506024
104625,SIDM00148,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2142094,0.034477804,-0.7404252991090237,0.007009312160746447
56699,SIDM00042,Navitoclax,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.7157269,0.06353026,0.7551375092182009,-0.026399377253376103
95969,SIDM00633,5-Fluorouracil,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6842817,-0.07666031,-1.113643817905491,-0.06756626592319324
83103,SIDM00216,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.2487212,0.10482101,0.05587900301041376,0.018668809994416297
74010,SIDM00933,MK-1775,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.40545622,0.029099064,-0.09811233930039531,-0.019366768626254208
103037,SIDM00875,Navitoclax,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.041207,0.13362092,2.5887459564603916,0.09983220284920756
87256,SIDM00875,Axitinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4545816,0.032042883,-0.5692222276908209,0.0013194877467927087
15265,SIDM00877,Olaparib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.6190923,-0.043910068,-0.8452825404907717,0.03307278204735393
70307,SIDM00216,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6824129,-0.08756418,0.23362740083443642,0.013045503579946658
75500,SIDM00950,MK-2206,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.75359,-0.072204225,-1.4284218333263048,-0.03403379795619399
92228,SIDM01042,AZD6482,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0234876,0.07329062,-1.2136088133915197,-0.07578588064253688
43401,SIDM00359,SCH772984,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.28848594,-0.022419348,-1.8274014958407692,-0.08673791683397764
102109,SIDM00148,RO-3306,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1186877,0.11548605,-0.9049318211770393,-0.058835337302342236
106847,SIDM00875,Nilotinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4820182,-0.011365687,-1.9479880850234748,-0.06215205841255757
34376,SIDM01042,Wee1 Inhibitor,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.91612995,0.07584627,-0.4827616881798779,-0.03396930448224265
66709,SIDM00826,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.0603166,0.016875694,-2.386509234770041,-0.028897669501358744
88974,SIDM00875,Entinostat,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6078718,0.110340774,-0.03582195957731893,-0.011894161320437488
10889,SIDM00928,Temozolomide,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-0.84541196,-0.02023454,0.6432888722767479,0.017818708209597724
52503,SIDM00673,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1108818,0.06995308,0.8857402236759084,0.01935156845326984
87579,SIDM00875,SCH772984,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37412325,-0.039637554,-0.33721762814140055,-0.01226393068731489
32158,SIDM00282,LGK974,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-2.4273136,-0.08516562,0.570624415107569,0.05524424046393913
23773,SIDM00359,MK-2206,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.822469,0.10074145,1.7278593076287094,0.12145255118701788
82287,SIDM00875,Axitinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.61976665,0.04595448,0.18873631393544857,-0.024497569150932468
63779,SIDM00282,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-2.1461446,-0.07803623,0.5752860343692652,0.0695676192484883
38322,SIDM00928,AZD8055,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.4994386,-0.15058033,-1.043739888719978,-0.08789724901669974
28110,SIDM00928,RO-3306,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.3909658,0.1361861,0.31236743657074134,0.001920986105671725
75419,SIDM00832,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-4.5736384,-0.09549555,-5.1015757076260995,-0.10662167329005219
7535,SIDM01197,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.14447582,-0.003781758,1.740746855344211,0.04985085330849076
64353,SIDM01187,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1639682,0.033812724,0.27538352810008515,0.012922173703988134
84773,SIDM00875,Bortezomib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.885333,0.024934229,-1.8087802521867613,-0.0317713442397039
84446,SIDM00877,Docetaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6545963,0.18584502,-0.4292682137478537,-0.014824456563962739
44792,SIDM00957,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.8882425,0.07173139,2.0394821651222586,0.06410646804789438
96985,SIDM00928,SCH772984,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.091301,-0.22235702,-0.8869660101801402,-0.0302205517207105
62886,SIDM00826,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-6.0495954,-0.41176528,-6.115471268555177,-0.33174813376867857
84004,SIDM00875,Doramapimod,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5186568,0.055210672,2.013145665858136,0.052537351045611934
48547,SIDM00875,Sorafenib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.73670065,-0.0664301,-0.19696638721505885,-0.00280168868199367
6086,SIDM00950,Taselisib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.3328725,0.0050118025,-1.6739635285151275,-0.0723473669331721
92049,SIDM00673,Crizotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0312208,-0.094716676,-1.0337236611180949,-0.10756626795874262
27148,SIDM00877,BI-2536,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.28292418,0.000612856,-1.603759015584288,0.006729800393116067
79262,SIDM00148,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2685889,-0.08909934,5.5392247478809954e-05,-0.004005764462976736
207,SIDM00097,Nilotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2561919,0.018606048,-1.5961962977083548,-0.10457395348481616
5646,SIDM00826,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.1513911,-0.003883724,-0.6900758828413178,-0.02938093882702836
64411,SIDM00042,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.40276068,-0.038289826,-0.07086050748014498,-0.002435249304796779
40895,SIDM01042,Linsitinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0790749,-0.07813194,-0.7525859398967194,-0.027263998339143718
99928,SIDM00928,Temozolomide,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.81279415,0.025189495,0.830667712260202,0.016423345665895036
74439,SIDM00042,Linsitinib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.96895456,-0.042850263,-0.8390421352343991,-0.0022060240772308706
3588,SIDM00146,Alpelisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6651055,-0.06945643,1.1466677745223604,0.10448644112727765
74567,SIDM00455,Oxaliplatin,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2221456,0.044367492,-1.6588777330126128,0.0299639911251719
80171,SIDM00359,AZD4547,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1001256,-0.08881539,-1.3095824290759366,-0.05530124133395943
96768,SIDM00872,Taselisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4597138,-0.026287524,-0.6537286396374031,-0.09110379203768579
26149,SIDM00216,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.3498862,-0.114032626,-0.589467078652897,-0.05901375433513962
89153,SIDM01042,Linsitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.765335,-0.09538969,0.4253486743352368,-0.010785194791039315
66377,SIDM01042,SCH772984,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.88440925,0.05374289,3.8074204048447298,0.12775347234136156
45378,SIDM00146,Luminespib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8778984,-0.06755095,-0.7575933450553594,-0.0639919885991018
23869,SIDM00042,Crizotinib,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.650357,0.13063163,-0.22704307584850314,0.02644380770239561
78180,SIDM00933,Luminespib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.46527776,0.016141128,-1.8944623294657625,-0.05013817628489605
99354,SIDM00877,Afatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.08555027,-0.009744967,0.3842910526355491,0.0162112527418798
11760,SIDM00455,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2602756,0.03588044,-0.5256484821788718,-0.00468095353815655
76632,SIDM00673,JQ1,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7039728,-0.14965674,-0.08542750817708478,0.06360605757243457
51202,SIDM00875,Sorafenib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6372909,-0.050614964,-0.15046697794316952,-0.010048080227301052
106712,SIDM01197,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.859928,0.27450493,0.9807948438056332,0.12303191518498771
32579,SIDM00826,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,3.0514624,0.03300514,2.779823149802883,0.0962189612445144
15800,SIDM00877,AZD6482,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.3253301,0.15767749,0.8616974964634027,0.09936810646224492
36811,SIDM01042,AZD7762,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2765024,0.13725378,-1.0478110797860993,-0.07693896010592276
83724,SIDM00673,Taselisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.817944,0.11870541,1.3498277478578504,0.04690364537141224
67669,SIDM00877,AZD6482,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.94895667,0.11587421,0.6450837912741705,0.06240247034635054
15246,SIDM00455,Palbociclib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8013158,0.14596877,0.24765148173650972,0.045812026163104334
13535,SIDM00826,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.186265,-0.08159159,-1.9116853269598102,-0.05388350424766906
24077,SIDM00833,Taselisib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.5835738,0.1917223,2.0601505477108275,0.17276184210702097
14140,SIDM00146,Ribociclib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.9711797,-0.062227026,-0.8185945081065146,0.006437656923044129
58369,SIDM00877,PF-4708671,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.68982625,0.052887373,0.5305894677737483,0.03222537048005296
78722,SIDM00148,Taselisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6878452,-0.051368613,-0.8068835644192334,-0.02876588711513729
42196,SIDM00455,Navitoclax,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.301939,0.27104202,1.309000191818829,0.06752144463281172
16486,SIDM00282,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,1.648092,0.065328985,0.8327481914530657,0.05585310010908402
35440,SIDM00673,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.80453426,0.012205788,1.458476140447221,0.016987333281411405
79518,SIDM00928,Pictilisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.2370925,-0.12686348,-0.5347094887076618,0.02143210499228276
40408,SIDM01042,Pictilisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.26644012,-0.01899595,-1.04801619555147,-0.03886193145183356
49868,SIDM00146,Nilotinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6154624,0.058866262,-0.5036491297711969,-0.019394714003517735
104857,SIDM00042,LGK974,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6315907,-0.017194685,0.4556003425624452,0.015685944416871708
19767,SIDM00875,Temozolomide,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59286654,0.01480925,0.3945936089369142,-0.0033929614823038526
62425,SIDM00097,Pictilisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.68184483,-0.045444056,-0.38590837216663965,-0.09216947971081195
75661,SIDM00097,Cisplatin,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0756967,0.02054571,0.17936234925047698,0.053755277261407
9258,SIDM00875,PD173074,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5524455,0.120513506,2.06364808751984,0.09913906250902069
69639,SIDM00877,BI-2536,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-4.0111146,-0.021376664,-3.665095291967878,-0.05683676044095541
65881,SIDM00633,Axitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4849222,-0.09231199,-0.3337663615093195,-0.016271462494612924
8952,SIDM00097,RO-3306,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3948388,-0.0641653,0.23711969259383256,-0.007334565200884929
60191,SIDM00877,Entinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.7957978,-0.07970951,0.19732389026525998,-0.04493346410568437
19460,SIDM00673,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9567601,-0.045028783,0.8681105443825421,0.09072199286437779
65342,SIDM00216,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9194508,-0.04104209,-1.1921341057278583,-0.12353540220057695
96257,SIDM00933,RO-3306,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.16780789,-0.015204088,0.3627380347889169,0.008026671866713287
15515,SIDM00776,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0953801,-0.09818507,-0.14710294318116549,0.04673470950802558
22294,SIDM00928,MK-2206,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,4.12958,0.3518317,1.8066907469073452,0.16250001692551208
8105,SIDM00833,SCH772984,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.6166775,0.18238978,1.8569728304802602,0.14800335470827766
103440,SIDM01187,Temozolomide,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.598878,-0.013786455,-0.2628363936036546,0.002811271560202529
55513,SIDM00216,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.5351096,0.085553266,-0.7044484789250914,-0.08530265682989918
67142,SIDM01197,BMS-754807,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.617766,-0.023045963,1.2245803024983226,0.015623228251340196
14927,SIDM00872,PF-4708671,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.24346228,-0.021445328,0.24227773272001663,-0.03919342769304722
52709,SIDM01042,AZD8055,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.118036,0.08309214,1.0413542270620357,0.05830361287355198
102139,SIDM00673,Pictilisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.7512506,-0.18349753,-0.7184509156201064,-0.05269358862104975
55098,SIDM01187,Gemcitabine,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5803435,0.055082828,-1.2394314550971448,-0.03563286331426416
25766,SIDM00872,Camptothecin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.76951903,0.018998161,1.5944162091457557,0.025307642859543605
93587,SIDM00455,Erlotinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5655546,0.05007839,2.787842321739262,0.07658942353511375
43173,SIDM00928,Alisertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.76132077,-0.051013656,0.7119617678102819,0.09907332764654851
89606,SIDM00097,Axitinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6997166,-0.069054745,0.9288216151755962,0.052084998968984025
22195,SIDM00776,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.84002,-0.14068855,-1.641705815258029,-0.13331884884262762
12561,SIDM00042,Irinotecan,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.3870733,-0.12926508,0.8215919585535705,0.040154466490172395
107647,SIDM00933,AZD7762,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.6118254,0.07352031,0.32797643685310723,0.0042248440589631835
100124,SIDM00933,Doramapimod,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,2.0311778,0.0736765,2.027290497239815,0.08908107558432818
76342,SIDM00776,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.1179142,-0.09115819,-0.5986175774071708,-0.05966064422996995
83762,SIDM00826,Oxaliplatin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.4454808,-0.09359891,-3.5570816262905836,-0.11076621986067377
58514,SIDM01042,JQ1,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.32433006,0.007585441,1.3300768918780004,0.04004934226482766
58120,SIDM00633,MK-1775,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0764318,-0.081728965,-1.4460166022644114,-0.050337955539386074
36048,SIDM00933,Navitoclax,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.79304206,0.062128246,0.8734385640478728,0.024409827151144044
11456,SIDM00776,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.32690236,-0.025268886,-0.25186679063160017,0.03254994731974296
52452,SIDM00872,Taselisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9865333,0.04405429,-0.19539626900729215,-0.03954832360484075
32895,SIDM00877,Nutlin-3a (-),Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.4937186,-0.060178217,0.7015319487913054,0.07743785715451518
20870,SIDM00875,Alpelisib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7311651,-0.061673034,1.7963812297482555,0.12066456720182894
14223,SIDM01042,Camptothecin,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2354258,-0.107428946,-0.43259725219447076,-0.011869042150993428
79449,SIDM00957,Trametinib,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.3666921,-0.06000902,-0.6063785566138009,-0.009921916480240347
24170,SIDM00216,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0259078,-0.049871285,1.2480298698933172,0.034779254355957905
26407,SIDM00282,Dabrafenib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7177616,-0.026983118,0.8767622135301298,0.012983112591448742
21211,SIDM00776,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.5159395,-0.05459368,0.3077880688141737,0.009342052691858163
53507,SIDM00148,KU-55933,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7328165,0.14637671,-1.3619630039250397,-0.06825531775725537
38034,SIDM01187,Gemcitabine,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5330746,0.05401531,-0.16266203513344243,-0.023050417160232043
83584,SIDM00673,AZD8055,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.58610964,-0.044446878,-0.9271268857944412,-0.044281704849124116
105071,SIDM01187,Vorinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7321997,0.16384175,-0.18095958688731648,-0.014657041958472804
66154,SIDM00928,Ribociclib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,2.6682112,0.12055197,-0.09118750002675143,0.014873762040544481
29018,SIDM00148,ZM447439,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8827475,0.16047281,-0.9604898690197442,-0.05626734812556056
50483,SIDM00837,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-2.1301653,-0.066894904,-0.7305185166125633,-0.0603473408059242
79498,SIDM00835,Vinorelbine,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.28374904,0.014321549,-2.0297681197442934,-0.012126650633079552
79093,SIDM00933,Axitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.5232455,0.079793856,0.028358279261752294,0.05575599932911381
48342,SIDM00875,SCH772984,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.9097273,-0.2138894,-2.2176135533131305,-0.07383160020546545
35345,SIDM00097,AZD7762,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2792592,-0.11006246,-1.9482308410802869,-0.038755671479716425
71196,SIDM00097,Sorafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.289446,0.1264433,1.3628494412083987,0.07241873924012353
103724,SIDM00872,RO-3306,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3775591,-0.065000765,-0.9468226782612117,-0.05338465690904815
18526,SIDM00146,Taselisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6714167,-0.053313125,0.6639534433206125,0.12830265577656783
78596,SIDM00359,Linsitinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5944823,0.048984166,-0.009400620732198738,-0.021971319648212077
62256,SIDM00097,Entinostat,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3014366,0.015322903,1.4872742375674213,0.026017604290438492
41366,SIDM00776,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.13818,-0.086141355,-1.4065881544268404,-0.04867054569213333
67810,SIDM00042,Navitoclax,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.4656633,0.02702508,2.10214261615706,0.08329775816742079
20938,SIDM00957,5-Fluorouracil,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,4.507252,0.09285114,2.4531379588000726,0.06982450181808979
85281,SIDM00673,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22811118,0.023199966,-2.207391416093398,-0.15432547813072423
23779,SIDM00673,Nilotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.51794994,-0.01485566,1.0647254684565746,0.11172270482133558
61508,SIDM01187,Lapatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.18483561,0.016062552,-0.22559252492930873,0.028082070937901462
23545,SIDM00146,MK-2206,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,5.65326,0.3312772,2.9534721467762215,0.1777655653638382
67650,SIDM00950,MK-2206,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9878547,0.14117585,0.46718426824738396,-0.019375444224240628
73116,SIDM00673,PF-4708671,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.240598,-0.112670295,-0.35752766120378887,-0.04525941441212696
70186,SIDM01187,Nutlin-3a (-),Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.5455194,0.32289135,1.655237260190431,0.1191950582702427
30218,SIDM00673,GSK269962A,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.6703188,-0.16727912,-0.2614566070885977,-0.01954881040854996
90593,SIDM00148,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5903468,-0.146397,-0.9084136769635398,-0.06834901752784217
87688,SIDM00097,Wee1 Inhibitor,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0298978,-0.062474947,-0.4933289034327428,-0.04636441637941822
84407,SIDM00216,MK-2206,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,2.0691814,0.19015484,0.6442904870023679,0.012945061460522848
47127,SIDM00950,MK-1775,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75296634,-0.07108268,0.6551303615529155,0.017947215523280734
17166,SIDM01187,Trametinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.8400708,0.13764255,-0.7948890039943921,0.04144070739509455
3183,SIDM00826,Trametinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-1.5853834,-0.012117672,-2.5431043200878456,-0.1040381863936325
66065,SIDM00146,AZD7762,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.398034,-0.11629734,-0.1715129006680115,0.028948147551032193
11574,SIDM00146,Tozasertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.4513948,-0.11257809,-0.8448780050314274,-0.03133525650018578
8184,SIDM01042,AZD8055,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.74508005,-0.07708454,-1.6105142579689924,-0.08241458458824855
98801,SIDM01197,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.0911007,0.118554495,-0.23189943441993344,-0.006130490846196129
80299,SIDM00633,Trametinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4471792,0.07935309,-1.571521140683479,-0.0515827032864665
65074,SIDM01187,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.158766,-0.09931607,0.9777118787937659,0.03681413896578234
47857,SIDM00633,Pictilisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6506541,0.095456235,-0.48436129960829977,-0.06592777039577168
50027,SIDM00216,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7821387,-0.062413935,-1.4689243353909425,-0.12362200511774603
61620,SIDM00833,Camptothecin,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.758829,0.124541506,-0.2733953829054096,0.007939946637734611
60471,SIDM00833,Linsitinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,4.0362697,0.30664617,-0.38279653964746213,0.005817391206296642
49092,SIDM00933,JQ1,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.8460478,0.1757498,2.430443108130468,0.1968096515480535
51126,SIDM00928,AZD8055,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-1.1250968,-0.120945066,-0.0472139864952104,-0.033822556318782074
31959,SIDM00776,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0348593,-0.033233654,-0.031690963846613227,0.021236679453709127
16741,SIDM00633,Cisplatin,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8970416,-0.025848497,0.852527431636866,0.06388900009036504
12287,SIDM00933,Crizotinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6027273,0.09053545,-1.9102925126315322,-0.10853401701555149
56029,SIDM01042,SCH772984,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7740836,0.048456863,0.09263639012326232,-0.014170082457342746
72683,SIDM00455,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.9328165,0.029251855,0.5784210533458349,0.06162262260679432
81746,SIDM00872,Uprosertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.37227973,0.03900844,0.375752926070107,0.02931920421048226
14394,SIDM00097,AZD6482,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5711223,-0.108244024,-1.68074641823607,-0.08864695909096953
85431,SIDM00933,BI-2536,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.7417568,-0.012551001,-5.463631134431445,-0.10291283834475859
101546,SIDM00826,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.74642664,-0.05102171,-0.734958444537221,-0.06751483230512526
18081,SIDM00633,Entinostat,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.4132417,0.028844135,0.4732864961925076,0.010429200611555604
31129,SIDM00835,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-1.1522331,-0.05911068,-1.7433887703524986,-0.06733935842076687
41300,SIDM00633,Luminespib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0205469,-0.07564726,-0.773121482013935,-0.041381794420629794
108285,SIDM00633,Tozasertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1834166,0.024450613,2.5327267177226966,0.08774635220070388
96795,SIDM00097,Docetaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6610651,-0.077281795,0.052358733003919224,0.01620855745770457
71257,SIDM01042,Navitoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2557068,0.028029442,0.4635696329982248,0.03779884116644285
97723,SIDM00933,5-Fluorouracil,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.2418697,-0.10565439,-1.8604955633421205,-0.10711919456897222
1377,SIDM00148,AZD6482,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.15526913,0.01564335,-1.2163607642008971,-0.0477895977290865
102486,SIDM00933,PF-4708671,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.53591686,-0.04170397,-0.6278161235742117,0.01023531576853082
14215,SIDM00872,Dabrafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.36149552,-0.006962164,1.6553641877495824,0.03131767929773446
28369,SIDM01042,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.8387516,-0.26535088,-2.255277842563613,-0.18154550942888575
40906,SIDM00146,Ribociclib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.23314245,-0.011588112,-0.7634824694651546,0.07096157943546567
68214,SIDM00097,Entinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7519417,-0.09894197,-0.05795513851939429,0.0025170165256486322
52584,SIDM00875,Wee1 Inhibitor,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9379256,0.04254891,-0.7568100447959103,-0.06131121766009262
78929,SIDM00633,5-Fluorouracil,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5422312,-0.08302861,-1.7688398926668003,-0.10002639469462211
103090,SIDM00833,Camptothecin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.5562103,-0.1471315,-1.1009312380459246,-0.042547895660237166
44213,SIDM00928,Paclitaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0611453,-0.09385831,-1.6221139427762634,-0.14185008643570393
77605,SIDM00146,Nilotinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2037609,0.10340756,0.3806577419387915,0.041626418517673805
56328,SIDM00097,Venetoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1840086,-0.052839227,-0.6763091882283441,-0.027585372629504643
80992,SIDM00928,PD173074,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.1646676,-0.060491223,-1.2649675405867484,-0.0101288292366525
45411,SIDM00928,Venetoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7059132,0.031781673,-0.522071187358728,-0.0063619172288884715
54000,SIDM00933,Camptothecin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,4.5091248,0.10461171,1.980600317940787,0.11392119233527206
62721,SIDM00950,5-Fluorouracil,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.38253,-0.18285087,-2.573456976237225,-0.15206792568989358
42203,SIDM00633,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1196389,0.032231264,0.7301511647363916,0.034778470682599136
35842,SIDM00933,KU-55933,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.4165663,-0.047065113,-0.3228858781622575,-0.01310660738544327
6505,SIDM00933,NU7441,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.96175194,-0.08963299,0.24473198983024896,0.02581066806490904
37182,SIDM00933,Nilotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.42762485,0.033148386,-0.9745973789131307,-0.04817404042464567
103615,SIDM00633,RO-3306,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5362885,0.13487901,0.8002008086105286,0.06308590458450683
74170,SIDM00877,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5611118,-0.05623488,0.10015081941568935,1.2850368633005193e-05
69911,SIDM01197,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.5620327,0.089932516,0.5034886668798099,0.030618693409903287
79121,SIDM00148,Temozolomide,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9117573,0.03413563,-0.4120794068880634,0.00699276600004635
45913,SIDM00146,KU-55933,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.8565848,-0.035591293,0.9050462420693551,0.07441908360087351
48078,SIDM00359,Afatinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2002803,-0.08744511,-1.4006789721471589,-0.07880901654122727
104903,SIDM00928,Venetoclax,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.0591606,-0.033822022,-1.917988268229116,-0.04208562001500475
30349,SIDM00633,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5443486,0.12979347,-0.6586358556314275,-0.02669921500796993
97650,SIDM00146,KU-55933,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.46167922,-0.020742863,-1.4142564114218612,-0.03858851918589422
22363,SIDM00957,Trametinib,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.630487,-0.06360119,0.4563057478089427,-0.01351957070098803
72995,SIDM01197,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.4599321,0.051299825,1.7481350200560763,0.038274718491882784
106810,SIDM00359,Vinorelbine,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,5.3574862,0.26993445,0.22701090945828864,0.04915775366412567
11313,SIDM00826,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.90239036,0.014975379,0.9348364862913696,0.020738425491981356
49948,SIDM00633,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0550764,-0.16741194,-3.7807896338766334,-0.17153347888586384
97835,SIDM00282,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.252755,0.016648676,-0.9395196924248743,-0.014561616924602692
89394,SIDM01042,Temozolomide,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5183734,0.070559815,-0.2666069274910519,-0.0054589495510444395
38555,SIDM00776,Camptothecin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0632331,-0.07454984,-1.132735024835156,-0.061319340363452775
64443,SIDM00148,Sorafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2985221,-0.10504215,-1.2272712047509644,-0.07775824744086339
32074,SIDM00633,Venetoclax,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0241337,0.118637666,0.34060322273818566,0.0177416627607569
32557,SIDM00455,Cisplatin,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2714515,-0.044900406,-0.6010979819616764,-0.0028138908304974628
85331,SIDM00216,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.26598287,-0.026375365,-1.2920461511928554,-0.13516698010424005
29047,SIDM00877,NU7441,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.0921166,0.21947823,0.00787922696137924,0.07617365209219931
48021,SIDM00833,Linsitinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,6.0563946,0.40827078,1.7900947025523337,0.137528819338633
12885,SIDM00673,Alisertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1417135,-0.06154838,-1.3706567517669,-0.0449497445141637
44849,SIDM00875,Nilotinib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1724794,0.06477658,-1.270163049807128,-0.016071732638244338
46728,SIDM00148,Axitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7512535,-0.15856095,-1.8048348579953546,-0.1346471093644531
50730,SIDM00216,LGK974,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.4322171,0.17223917,0.30145952006163274,0.04684572448707508
47955,SIDM01187,Vorinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1401447,-0.11889076,-0.3622234110322636,-0.0453944489508989
44884,SIDM00832,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.3038409,0.11329565,-1.0509479246683207,-0.06906653623628477
99604,SIDM00872,AZD7762,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.83793324,-0.08803926,-1.0167424719308635,-0.07824460946866521
10592,SIDM00673,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2438216,0.07790686,-1.7151019767913172,-0.0035559213786196843
71215,SIDM00928,Bortezomib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.12736444,-0.011557126,-0.1975977390077079,-0.035411504432945405
15038,SIDM00146,Vorinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.072377,0.094437025,0.6741253361351421,0.026110469013971013
40814,SIDM00097,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.838053,0.03034431,-1.1954383439236524,-0.008648861203124506
21323,SIDM00835,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.7864963,-0.0489816,-0.7578131030151118,0.0015709687483418102
25759,SIDM00933,Nilotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.99794483,0.091514766,0.7118422812800783,0.07290257839182637
21912,SIDM00928,Axitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.4580415,0.11535706,1.2623716291918563,0.09965646617117993
30411,SIDM00875,Luminespib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7852403,0.07208337,0.7732172277008572,0.04477589508510999
71058,SIDM00875,Sorafenib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4255167,0.15583415,0.13045732281697917,0.039580175650361565
77114,SIDM00933,Venetoclax,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-1.7631999,-0.06931699,0.5414644249948573,0.04477218792477768
77680,SIDM00148,Alpelisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0593827,0.1661769,0.10876089331148751,-0.04098705203802261
37211,SIDM00633,RO-3306,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.54843587,-0.05074769,-1.4950319630120081,-0.09585356692877739
27198,SIDM00872,KU-55933,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4286523,0.0249506,1.0848628018123132,0.021516266595453915
71906,SIDM00148,Uprosertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8943408,-0.07062548,-0.6067399882507613,-0.042502717188871934
95171,SIDM00875,Gemcitabine,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.021987,-0.037378892,-5.5745515770307525,-0.20136638756562392
75671,SIDM01187,Linsitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3838996,0.03666516,0.778860965695514,0.03335076194256338
99844,SIDM00633,Afatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6837496,-0.02417762,-0.9732571905380552,-0.038473820178129364
51419,SIDM00776,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.7373683,-0.05663249,-1.145164599953235,-0.08597561069494013
51120,SIDM00097,Gemcitabine,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.9718688,0.21903576,0.3395199719462191,0.06300164781898665
76791,SIDM00928,Linsitinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,5.196168,0.3705424,1.4660533437359342,0.06670499288270698
26481,SIDM01187,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.8400302,0.18412432,-0.7786650086775405,-0.0535695477636998
14997,SIDM01042,Palbociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.19173746,0.008129134,1.0745569018005339,0.057927581660386876
21089,SIDM01187,Navitoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.30961287,-0.02925093,1.227243455422084,0.0566187963725024
29718,SIDM00826,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,1.0313344,0.047734067,0.28144382005710067,-0.07462014453238491
2558,SIDM00673,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7057473,-0.01591661,1.2452057741994764,0.07907344637260215
27040,SIDM00933,Olaparib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.50574887,-0.056787822,-0.03695472975275095,0.013744567109218356
103175,SIDM00148,Tozasertib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.1817233,-0.013687985,-0.4589149947780528,-0.0023498510997413545
51426,SIDM00933,MK-2206,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.83134055,0.101939246,0.8829773919592582,0.10685482490112812
17973,SIDM00216,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.136557,0.07471502,1.6522021839493906,0.05907305255052016
97080,SIDM00875,Trametinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2707279,0.12468964,1.5768775012314362,0.15888975317802084
9846,SIDM01197,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.68053424,0.031450972,-0.20706089697012076,-0.05047510723953262
107563,SIDM00097,Afatinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6643088,-0.10839256,0.07248011755454675,-0.004689740354107025
84204,SIDM00216,Camptothecin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.44919458,-0.03790418,-0.0779566422580898,0.025711969058267434
55645,SIDM00933,Tozasertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.3693509,-0.13560472,-0.9696329947967591,-0.03425445441010689
78333,SIDM00826,Camptothecin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.53364486,0.03302855,0.3502968045854267,0.05840227433596671
97824,SIDM00673,MK-1775,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7738266,0.07852924,-0.19619055143313993,-0.01857377098396344
14782,SIDM00097,Navitoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.90887946,-0.061738946,-0.13050256347736142,-0.04140039826835877
44076,SIDM00957,Afatinib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-2.2673664,-0.08119884,0.5373899958899223,0.05358714249707563
80736,SIDM01197,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5435711,-0.1290804,-0.9758304818065375,-0.06254148779347128
82666,SIDM00282,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3295543,0.09373063,0.9427066724573196,0.1013203376310109
18986,SIDM00146,BI-2536,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.65693355,-0.023652758,-2.309936831991046,-0.11764105921751018
104835,SIDM00833,Vinorelbine,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.8718802,-0.10770807,0.7060588120310762,0.0036914844329573792
53258,SIDM00872,Paclitaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.12813589,-0.012191505,-0.4030554146320574,-0.05754562123992716
90097,SIDM00146,AZD6482,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.4021463,-0.08728384,-0.8137720850672395,-0.050648453493924585
97714,SIDM00097,Olaparib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0255148,0.06165474,0.40041153736785523,0.04076237639139475
3533,SIDM00146,Axitinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.8914843,-0.13277534,-0.9639707875995707,0.030988408838095123
23198,SIDM01197,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.117012,0.07612943,-0.6507970593657602,0.033392769110641415
100485,SIDM00835,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.7967872,0.062628716,-0.8165316353173039,-0.057234828319042544
96978,SIDM01197,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.9475894,-0.21288091,-2.128966966139677,-0.1651622110193236
28531,SIDM00835,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.2242029,-0.027584106,0.5542430114576945,0.01505352577504586
66901,SIDM01042,Venetoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.052105,0.042293217,0.9861538815607469,0.051001279037563144
87268,SIDM00146,NU7441,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.5062114,0.046998475,-0.47857307802580534,-0.0013135012875135595
28395,SIDM00872,SCH772984,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7989261,0.058797874,-0.2505858088243588,-0.023772367669852044
56686,SIDM00832,Camptothecin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.981417,-0.16505215,-0.5326098301544866,-0.051869744075713306
29880,SIDM01042,PD173074,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6152563,-0.09154045,1.0996242274819514,0.06208038609358983
42792,SIDM00837,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.8602691,0.066723384,0.4592145066889202,0.08896945395986074
97258,SIDM00282,Olaparib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.5567813,0.051561043,2.365999203325679,0.02939357569509882
14754,SIDM00148,GSK269962A,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2938081,0.093575746,-0.30800928554401663,-0.05517314014395183
87783,SIDM00872,KU-55933,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.866124,-0.104024485,-0.29434738766459806,-0.02424679545037153
51710,SIDM01042,Venetoclax,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.654816,-0.06758901,-0.5209209371965957,0.015746529268324375
45015,SIDM00875,Tozasertib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7623376,0.10528572,0.48127440686732303,0.05603377585362423
5861,SIDM01197,SCH772984,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,1.1084275,0.026715728,-1.0902268161516633,0.0006390523406461772
14808,SIDM00673,Taselisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.4559574,-0.04324145,-0.9625958387561212,-0.10662350350693496
61081,SIDM00928,Camptothecin,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.7148957,-0.15828781,0.6543682500220411,0.01719839698451739
14590,SIDM00148,Gemcitabine,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9850809,-0.07606562,-1.9257719580215233,-0.14822349277653296
2100,SIDM00146,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.29060853,0.015366359,-0.30090417824145804,-0.00276262638411698
41464,SIDM01042,KU-55933,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.578955,-0.057592038,-0.2928696582255723,-0.04563610320926621
34533,SIDM00097,5-Fluorouracil,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2501897,-0.057739887,-1.0664388401007163,-0.011885101508389801
9204,SIDM01197,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.8576094,-0.01708773,1.732388687380407,0.050854679141188304
30032,SIDM00826,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.61567396,0.020736085,-1.8109321193810446,-0.06356035517021945
13101,SIDM00832,Taselisib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.406996,0.06768674,0.7752807481997531,-0.017312615379431465
5327,SIDM00097,Linsitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.167546,-0.049338445,-0.24687326376011912,0.0029517960534132066
27490,SIDM00837,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,1.0799547,0.07110436,-0.42579830175237093,-0.0022689019630835468
68063,SIDM00097,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.484909,-0.1058399,-3.4885031570478016,-0.13488251968258713
15220,SIDM00042,Trametinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.40824136,-0.03923398,-1.0690152937470494,-0.03995485747860119
106661,SIDM00933,Vorinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.3008394,0.14446415,0.5838846847585014,0.05373476605013965
53733,SIDM00877,OSI-027,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,1.7524188,0.16979094,-0.23824818848237442,0.008431717182798002
106415,SIDM00148,JQ1,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9026136,0.122214295,-0.44086185647015996,-0.041080346437682734
44972,SIDM00673,Alisertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.80017966,-0.044257056,-0.1722267785184637,0.03002849298453625
34736,SIDM00875,Gemcitabine,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9766041,0.0014208702,2.0743296406641805,0.03928601016800562
56521,SIDM00146,KU-55933,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.4162369,-0.04775694,-0.46315173585167413,0.008598816611066915
71226,SIDM00872,Sorafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6778862,-0.14697635,-0.22795070620798705,-0.07588494776267529
73880,SIDM00097,Venetoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0599272,0.08066593,-0.004285174116715835,0.018095686154135333
65852,SIDM01187,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.1612902,-0.16527878,-1.7171352488573344,-0.10242572168889373
50405,SIDM00872,Afatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.61251205,-0.060840327,1.1859957508804462,0.05938732228250291
38200,SIDM00875,Paclitaxel,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1591624,0.010321133,0.11928254640976965,0.008762708792474495
20245,SIDM00673,Taselisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.63221276,-0.056509018,-0.2916196446512829,-0.0547815717999311
6366,SIDM00282,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.8161632,-0.059059493,0.21454284581171076,0.036183174108293276
12653,SIDM01187,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.3942182,-0.15429665,-0.6553495709371953,0.0003079746202510462
27177,SIDM00148,Alpelisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8614,-0.13911471,-1.5239113365508155,-0.042641838886830756
63804,SIDM00216,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.798959,-0.1352235,-2.1673679836978543,-0.14804455892103388
78155,SIDM00673,Wee1 Inhibitor,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.8264699,0.13594411,1.4235602144276553,0.11323751245314558
60431,SIDM00776,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.9244625,0.068791695,-0.8673544609875444,-0.058568216932208546
80022,SIDM00455,OSI-027,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6885028,0.088317975,1.279569166578129,0.04539462949100916
43417,SIDM00875,Pictilisib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5811753,0.06292406,-0.33279431282996325,-0.005444150423990721
13099,SIDM00833,Vinorelbine,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.42649505,-0.03580559,1.6192785501284113,0.11461306485490722
95973,SIDM00146,Alisertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9270874,0.08019219,1.0770842355446917,0.14301392709771488
7481,SIDM00837,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,1.5114759,0.05054131,-0.8227143997529685,-0.04957765262408725
16985,SIDM00146,OSI-027,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.46691942,-0.0464408,-1.1913628228034039,-0.07861229080215168
26213,SIDM01197,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.1247804,0.074810445,0.7948424174214852,0.10719723976975533
57072,SIDM00877,SCH772984,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.6731017,0.07676699,3.4581244891173544,0.20940376307282013
107054,SIDM00872,ZM447439,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.122178,-0.22995754,-1.8203459467583203,-0.12447864016928756
75655,SIDM00776,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5374494,-0.041781332,0.49135992949791996,0.006747532385400468
34810,SIDM00097,Pictilisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2732629,-0.018427435,1.635789138022396,0.1280974746111528
24245,SIDM00875,AZD8055,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6324658,-0.05661621,-0.6507404017421489,-0.024564619159172983
71403,SIDM00875,5-Fluorouracil,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3139908,-0.099585295,-1.0747388805779476,-0.07705218255024184
60319,SIDM00872,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.82937545,0.021249281,1.7837155862538756,0.04951795409173243
82017,SIDM01187,Palbociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3234102,-0.05943988,-1.4144424913800244,-0.046608560438600725
83232,SIDM00097,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3669906,0.12411832,0.2256844469868843,0.052536451977385476
99801,SIDM00832,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-0.77932596,-0.04697292,0.3125880220360482,0.015193408554476094
62634,SIDM00877,Nutlin-3a (-),OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.4688907,-0.06651008,-0.42591832761799375,0.026745271022799978
50779,SIDM00875,Alpelisib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.1640761,-0.015121799,0.46519917857503923,0.011511217040801656
21708,SIDM00875,RO-3306,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3595484,0.04130088,-1.146905196386974,-0.08613935333547006
24595,SIDM00837,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.30197558,-0.008186686,0.910422073200133,0.05299959660714785
51118,SIDM00957,AZD8055,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,0.9193082,0.019126028,2.4381495567075033,0.1356858351416877
78677,SIDM00148,JQ1,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7954923,0.10314911,0.5432982923221009,0.021400996263350732
6869,SIDM00673,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.6213622,0.07382127,2.7047649627695716,0.11921452019618706
102833,SIDM01187,MK-2206,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.9662074,0.13680768,0.014921467299778465,0.019043361662829886
41950,SIDM00950,Irinotecan,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9218916,0.034851182,0.11395607015825028,0.03682745210020904
57445,SIDM00148,Dabrafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4495275,-0.07022185,0.5678074391690524,0.00982193514067465
90330,SIDM00877,Temozolomide,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.3673301,0.049088314,-0.2889252347173716,0.025845783733181433
23354,SIDM00097,Cisplatin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8393806,0.030380366,1.128597001185177,0.04209800233400272
66850,SIDM00633,Olaparib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1720984,0.18175913,-1.1241061129160728,-0.061000825015261974
94146,SIDM01197,LGK974,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4255452,-0.047710143,-1.125804305898525,-0.039862748661404476
45815,SIDM00216,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.383082,-0.055994865,1.3482619529481332,0.09875520330954586
60674,SIDM00673,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.18686067,0.0039309887,0.287653750525305,0.03233053771900422
45367,SIDM00148,Tozasertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5096426,0.23406348,-2.0874499960899358,-0.08789791949586963
78190,SIDM00928,Gemcitabine,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,5.5927367,0.39588517,2.2547388654895335,0.012011973072573089
60264,SIDM00833,Olaparib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-1.4539112,-0.047089722,-0.3149318708739516,0.01585810605166186
59344,SIDM00875,Camptothecin,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.63553077,-0.06737269,-0.34047967650519007,-0.03452997467260379
31114,SIDM00146,RO-3306,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3503071,0.103413485,-0.10872784141555329,0.021907918177217708
56606,SIDM00875,AZD8055,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.19092,0.24046339,1.149374123871617,0.12351136140602684
43435,SIDM00832,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.0814948,-0.031081306,-0.4654710641561888,-0.05896180071219051
106542,SIDM00872,Sorafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4509499,-0.14392453,-0.3859853329365158,-0.07716335804921723
1669,SIDM00633,Alpelisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.666661,0.060308453,-0.5776748502315421,-0.00824247421814564
707,SIDM00877,Vorinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.5700416,0.029522663,0.7869541070765896,0.025511231025357527
47995,SIDM00148,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.48455277,-0.034774218,-1.0455488177292682,-0.04108004609627526
66666,SIDM00928,Paclitaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.3461418,-0.25057116,-3.6039477612531616,-0.26335800775432766
1827,SIDM00933,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.34309918,0.037904546,0.5227355960593244,0.10502896420464668
2375,SIDM00042,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1149122,-0.084002696,1.008016906780854,0.06440146021991172
12546,SIDM00933,AZD6482,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.3902123,0.013364895,1.1549570458387663,0.06588854130429223
86755,SIDM00957,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-3.1061037,-0.10472087,-0.8968137788630013,-0.03219375534562988
32450,SIDM00875,Navitoclax,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97885364,0.090070605,0.14971429964927566,0.03203951916331336
79620,SIDM00875,Sorafenib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0480559,-0.06418478,-1.46827559079549,-0.06986985830807627
28385,SIDM00216,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.2406834,0.042737,0.39916981225226245,0.045796166759468175
25313,SIDM00872,Ribociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.96099937,-0.024490334,0.3751289325577899,0.0015204021186228283
5624,SIDM00359,Taselisib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.791458,0.066164725,-1.4936904193919311,-0.027414454641081696
90146,SIDM00146,AZD7762,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.5830354,-0.040750023,-2.0716537383401366,-0.09075787471868078
41502,SIDM00216,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,6.4024673,0.16999823,-0.1475873558773712,0.03415990010596839
108170,SIDM00148,Palbociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0775577,0.08183378,-1.1869064927342976,-0.01923675323568812
96273,SIDM00146,Crizotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2618804,0.07398943,0.8539063902622295,0.1067913281019122
90484,SIDM01187,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.42046985,-0.034936756,-1.3973907045223277,-0.03213771129744589
39675,SIDM00148,Tozasertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6126237,0.22288789,0.633922074936563,0.047918696652858
75444,SIDM00877,GSK269962A,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.5952047,0.07409633,0.07337600487880254,0.035741258848346995
67666,SIDM01042,Venetoclax,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6850126,-0.07020877,2.1619936167397382,0.02783572605232282
39340,SIDM01042,Axitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.15495665,-0.018889245,-0.7914455673914129,-0.06565237075402018
85748,SIDM00097,PD173074,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9503183,-0.13291207,-0.729096284846915,-0.0901988997294388
55547,SIDM00837,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.9855002,0.027313717,-0.13940901580686765,0.028117654891517668
93672,SIDM00928,Nilotinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-1.5912241,-0.14195734,-1.0709651686985657,-0.04827335032399279
64515,SIDM00837,SCH772984,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.8398856,-0.10922566,-0.8130534389992549,-0.0815158283492051
106605,SIDM00097,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3830895,-0.19387737,-0.8522522637154842,-0.10616746600638638
47989,SIDM01042,Lapatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2890345,0.059607156,-0.41269390299655134,0.00973662246831024
28765,SIDM00146,Afatinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8771948,0.082644746,-0.30073788535015633,0.02286908512994614
91912,SIDM00928,Linsitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,3.4225087,0.32801613,1.3546264800809291,0.09577568569705108
38713,SIDM00875,Crizotinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1231617,-0.10270804,-0.3379706066715671,-0.04724323922783253
59917,SIDM00933,Axitinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6069526,0.08948022,0.2831247352502383,0.01572454279646817
33704,SIDM00359,AZD8055,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.16777,0.09509398,-1.1488327756766583,-0.03472053012693962
13510,SIDM00877,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.9772465,0.13404162,-0.20648068543545317,0.02498140998289025
51947,SIDM01187,Linsitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.9571888,0.1042771,1.5946015266467792,0.03858921371009158
68102,SIDM00875,PD173074,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9981561,0.071475856,0.21383833638487026,-0.0036510718027818246
73414,SIDM00872,MK-2206,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.40018567,-0.041727018,-0.7970431064418761,-0.06852898577616547
97923,SIDM00875,MK-2206,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6303833,0.05885116,0.9379373346628217,0.05524048286806618
61466,SIDM00877,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.771709,0.18674186,1.575583040720286,0.062350621023673655
96677,SIDM01197,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.700371,-0.087190285,-1.7039900045430685,-0.046498443526108414
95783,SIDM00097,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0195894,0.11068703,3.1665849468635687,0.1263222716301208
102308,SIDM00097,SCH772984,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.85708,-0.119743034,-1.5007828302038684,-0.074335812141233
57904,SIDM00875,GSK269962A,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2080605,0.09443608,0.33664419095727377,0.02438555651738377
25850,SIDM00933,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.97213507,-0.08603823,-0.6866695849815088,-0.018963353592880504
6784,SIDM00928,Lapatinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.703917,0.24215539,1.8383073660696805,0.053068576732795095
74251,SIDM00872,KU-55933,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.54565436,-0.028770939,0.06604059991139022,0.013000882029276229
13031,SIDM00928,MK-2206,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.726744,-0.10927962,-0.2140238974642162,-0.040088714176227336
47998,SIDM00673,SCH772984,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.3902764,-0.33793676,-0.8798679427064561,-0.056908653335617086
102422,SIDM00633,GSK269962A,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.36071754,-0.0147698065,0.4489032405131624,0.026556606002040028
74402,SIDM00835,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.1056669,0.08760578,1.0439917469976396,0.08002997132008151
64209,SIDM00933,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-6.5793157,-0.17441796,-5.251926126233051,-0.06333229685783795
107188,SIDM00455,Navitoclax,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.184821,0.22356671,2.23139241076373,0.19431555273470294
11650,SIDM00097,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9029396,-0.14135797,-1.1888157878163363,-0.13663572216313022
100815,SIDM00877,Lapatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.7376145,0.08453369,1.1478809741025622,0.1030561202526542
16207,SIDM00097,AZD8055,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.107934,-0.07393253,-1.6025027231137783,-0.09130767090206547
55365,SIDM01042,SCH772984,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0047795,0.02912842,2.6040702958847883,-0.005190327006013826
72553,SIDM00146,Ribociclib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.5876116,-0.06101517,-1.0651222264809106,-0.01064127064385632
73144,SIDM00042,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.37478057,-0.01704265,1.7425401374092242,0.049276563156397675
13671,SIDM00282,AZD8055,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1935669,-0.057843555,1.1469452570628333,0.09002688783936569
14833,SIDM00835,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.3601425,-0.03465413,-0.6343386766300645,0.0236704645572564
83458,SIDM00148,MK-2206,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3657076,0.2137515,0.6976237840963379,0.010010983470257452
24836,SIDM00877,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.49039188,0.061473493,1.3595462997586438,0.05101580622767052
61343,SIDM00146,AZD6482,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1367887,-0.0748759,-0.8083784341840182,-0.057804989327664
76414,SIDM00146,Palbociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,2.1827922,0.19297796,1.012054394503094,0.03693114256415859
30432,SIDM00673,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.31615153,-0.006984285,-0.052858848022672045,-0.00033740689567701167
97426,SIDM01042,Axitinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.35617158,0.042337414,-2.0334197878054785,-0.134509009374611
107245,SIDM00928,Temozolomide,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.7268052,0.10583039,0.8148429411302551,0.03982832782471514
5592,SIDM00146,Cisplatin,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.044276,0.23327035,3.432592211646637,0.1364914387642882
74055,SIDM00359,MK-1775,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4700123,0.109962255,-0.39211195886915756,-0.046623516942223164
78485,SIDM00826,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-1.0422281,-0.029328184,-2.208905880182275,-0.1335495293733041
5774,SIDM01197,Vinorelbine,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.2258573,0.041293293,0.647351518595951,-0.014253841334639932
8202,SIDM00146,GSK269962A,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.23533,-0.12512197,0.49125567969052913,0.017598669903436514
91135,SIDM00097,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0162001,0.06978902,0.5030951437941554,0.027244133268221324
75,SIDM00826,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-3.249944,-0.06285669,-4.41341477458373,-0.12211035690435318
88375,SIDM00216,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.84320456,0.076486014,1.7519958479695548,0.13177483574150353
11174,SIDM00776,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.9923952,-0.07736922,-0.8092492846349318,-0.08918697095992617
96901,SIDM00933,Alpelisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.6240396,0.2217709,0.280645609058646,0.028820381607757368
44865,SIDM00957,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-0.75180227,-0.010526995,3.142652955147441,0.06809009639644992
53134,SIDM00835,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.5087935,0.011359565,1.3323121179565423,0.011714273912349943
12831,SIDM00957,LGK974,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.499614,-0.02425659,0.26301903774958735,-0.009463667156257448
32842,SIDM00776,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3431556,-0.10432361,-1.737815891983486,-0.11516759598489326
90582,SIDM00633,Alpelisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3019085,0.15871175,-1.3798265847052162,-0.008173993088031736
91910,SIDM00928,GSK269962A,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.9673996,-0.13709216,-0.7345771145223391,-0.02566903939227566
69152,SIDM01042,RO-3306,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1543434,-0.31668192,-1.0426378772189835,-0.10399738840566498
106127,SIDM00282,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1363364,-0.02409919,0.7080578251650428,0.006127609086643746
81509,SIDM00957,AZD4547,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.5680866,-0.06637786,0.5840159746954369,0.009406716538423622
77543,SIDM00928,AZD7762,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-2.496423,-0.1397154,-0.6681857354117037,-0.004686132588659279
33942,SIDM00872,NU7441,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3320858,-0.08063685,0.1967266842428108,0.0003559983622388643
78784,SIDM00950,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3075001,0.14332715,0.7699755812846045,0.11598761000026606
291,SIDM00633,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.540243,0.06654331,0.5683953069254459,0.01807054514051273
1632,SIDM00872,GSK269962A,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.279903,0.1064944,0.3018309002798548,1.4183759967120722e-05
58457,SIDM00673,Taselisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.4695897,0.2047778,-0.6368150877420777,-0.01858638491616524
31249,SIDM00097,Linsitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0360513,-0.108822174,-0.8181438059896127,-0.009308668857367666
89386,SIDM00042,OSI-027,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.8046634,-0.07856104,-0.9078617536377329,-0.013540389280992982
65844,SIDM00359,Nutlin-3a (-),SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5564349,0.068965256,1.958143576266138,0.06133469108698916
77496,SIDM00097,Vorinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7423985,0.053328354,0.09706271398078047,0.02570428951658275
18250,SIDM00832,Navitoclax,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.19175096,-0.007491217,1.068280085716269,0.033016221788103144
17050,SIDM00776,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.043292,-0.07182314,-2.6526641129869803,-0.10871802527209862
78832,SIDM00933,NU7441,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.77197015,0.07155395,0.06715590440739713,0.01027700756015286
9337,SIDM00146,AZD6482,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.7811514,-0.052849326,0.35171346116727137,0.10176218373054054
88564,SIDM00146,BI-2536,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-3.5660393,-0.19047886,-3.064502089833619,-0.1262515779236358
12654,SIDM00042,MK-1775,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.9547321,0.17003913,1.5376121324119318,0.10615901622969674
98568,SIDM00455,Dasatinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0062373,0.06313312,1.9958364824616652,0.1357540750968062
84633,SIDM01042,PD173074,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.4677012,-0.08562212,0.18911420793495878,-0.0032090879231261656
57509,SIDM01187,AZD7762,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.9663702,0.043414332,2.1092254123916745,0.0904129138324404
35209,SIDM00833,Crizotinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.5019039,0.10250203,0.7339348921234148,0.045719946443196595
56808,SIDM00877,Nutlin-3a (-),AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-0.96274126,-0.037274744,0.56379320095184,0.048372081013628686
35291,SIDM00673,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,8.10236,0.45357543,0.20688772022167107,0.05420636809174456
59460,SIDM00097,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9134988,-0.07664655,-1.445955924612624,-0.038917568175986815
41767,SIDM00216,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.506225,-0.118804336,-1.2578421733977758,-0.0972383428054984
44688,SIDM00776,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.86911,-0.15815645,-2.2579320746592093,-0.07083823430334081
11327,SIDM00359,Olaparib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.34434408,0.006130982,1.0063174507169776,0.00899843587369145
48166,SIDM01042,KU-55933,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.49190372,0.0546309,0.05143951108591102,0.031976490155257865
17494,SIDM00835,Dabrafenib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.1484883,0.06025786,0.21028279180241044,0.024734363355439146
14767,SIDM00933,PD173074,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.45889908,0.0472171,-1.073107916893371,-0.00978986684510282
19728,SIDM01042,Navitoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6216103,0.06177335,2.0531818254748444,0.08745024478356073
101299,SIDM00146,Vorinostat,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0681348,0.09546143,-0.3622208609139579,-0.040279905310367466
66676,SIDM00928,Dabrafenib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.98724794,0.05271735,0.3375307968482474,0.03387428136983333
89032,SIDM00097,Lapatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5442803,0.11030228,-0.5463071239440458,-0.03281156462100988
101545,SIDM00837,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-0.59373176,-0.04271514,-0.12546464472796465,-0.016872405107447332
42521,SIDM00875,Axitinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3683518,0.022641953,1.3373753459252138,0.0022222684187678094
99898,SIDM00455,Olaparib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.90459245,0.020255726,1.8832049647343632,0.10384176248120988
20504,SIDM01042,Pictilisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.15847355,-0.011213428,-0.9543164459519672,-0.06434757123611587
50799,SIDM00957,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.3823954,0.020141616,1.2788104155570224,0.05131377167555733
97510,SIDM00933,JQ1,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.433535,-0.13426977,-0.06246212202333084,0.02963757104119651
33122,SIDM00826,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.8715123,-0.08453898,0.8319949281229624,0.0343650510742127
36867,SIDM00875,KU-55933,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3059074,-0.050460864,0.19413288872360374,-0.003968256860448588
71230,SIDM00673,RO-3306,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8747542,0.1139774,-0.14853298110954888,0.0032898159946008866
30896,SIDM00833,Camptothecin,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,4.9428096,0.3932325,3.0748002250638344,0.2533234822008042
74816,SIDM00877,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.91742146,0.09230875,0.5972290188013644,0.001855809401326554
81569,SIDM01042,Crizotinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.38902536,-0.039913453,0.6857357967106898,0.05070342026063884
53854,SIDM00933,GSK269962A,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-1.498677,-0.13839939,-0.3395909091390009,-0.04811499496444613
14374,SIDM00146,Bortezomib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.25157526,-0.01733175,0.05565874132652727,-0.009785068279843984
3217,SIDM01042,Bortezomib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4858444,-0.029997777,-1.3791515567457782,-0.07121259482209298
48318,SIDM00097,Venetoclax,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.38363,-0.06114567,-1.5771372527797645,-0.02490431057786986
92881,SIDM01197,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.7393738,0.110287786,1.1537699008164275,0.09668468473128508
55985,SIDM00877,Lapatinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.006756,-0.057398263,0.22381925858049923,0.05100848941999055
32730,SIDM00933,Pictilisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.50251937,0.07211346,0.7909106663335477,0.05438384616880107
41215,SIDM01187,MK-2206,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.8868362,0.12111178,-0.2140964411016172,0.003598439186457672
60001,SIDM00826,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.2939768,-0.16886018,-1.84289197876862,-0.08807876780231483
2636,SIDM00097,MK-1775,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6111381,0.043649472,-1.1155825696102766,-0.08127794935414834
1737,SIDM00148,Bortezomib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5196892,-0.041652102,-0.2945098091701505,-0.0452097598960182
88438,SIDM00282,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9106401,-0.087655574,0.07457513082660368,-0.003230705626841713
12024,SIDM00832,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.595092,-0.0877281,-0.31577963013303145,-0.017694719098609847
78746,SIDM00957,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-0.4897234,-0.005742027,2.8780884637764377,0.06447693823065412
52000,SIDM00633,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1836395,-0.06157459,-2.3611940807621994,-0.09245128762571053
75833,SIDM00877,Crizotinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.5699687,0.053656176,-0.03369868344894879,-0.024386729407216454
35073,SIDM00933,MK-2206,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.733652,0.23605554,-0.47669965263093494,0.015127750795906546
69141,SIDM01042,Navitoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6963089,0.22169502,1.3360286583518561,0.006324498447704136
92777,SIDM00673,Alpelisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8318055,0.13589881,-0.14539044903701231,-0.023176285334005325
66040,SIDM00146,Bortezomib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5351047,0.03418592,-0.3323118218935977,0.0018856849753548439
4363,SIDM00776,MK-1775,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.44113806,0.029590152,0.6812647221109822,-0.016634017626405054
95582,SIDM00216,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0588748,-0.045717664,2.0485232046199835,0.19148024272221306
104977,SIDM00097,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.72439814,-0.050321016,-0.4938016564840365,-0.07706856236461126
60560,SIDM00928,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.664211,-0.25538513,-1.3351198682436354,-0.12536698637526444
98246,SIDM00877,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.5221335,0.1601443,0.78615567209249,0.07128729053449889
88790,SIDM00872,MK-1775,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5138171,-0.05200239,-0.28380464264674937,-0.04696675694274081
25546,SIDM00875,Entinostat,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.67154485,0.072299145,0.5552715739725012,0.024765803128674536
77339,SIDM00455,LGK974,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0204794,0.09154755,0.35831039872726705,0.02998596130580953
20395,SIDM00835,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.64861727,0.031164672,-0.5150782617853052,-0.02790926921147659
22020,SIDM00633,Paclitaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.511429,0.075334,1.8033276720515303,0.042007667667834196
23942,SIDM00097,5-Fluorouracil,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.87913144,-0.043690756,-1.5661617057515,-0.02621839761114395
4698,SIDM00933,Bortezomib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.74639666,0.06340321,-1.3437551312170029,-0.05731102713981243
102488,SIDM00455,Cisplatin,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0016727,0.051125158,2.097034137159285,0.1956752744263497
37988,SIDM00833,AZD8055,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,3.9249802,0.19583423,1.9977728068718978,0.10413042305065369
58366,SIDM00042,Gemcitabine,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.2270203,-0.1097366,-0.9005658335177662,-0.07450500440889124
30352,SIDM00673,Afatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5222797,0.19816986,0.1702195345561009,0.0007694393414229722
54796,SIDM00148,PD173074,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5497788,0.046917696,1.1056457351928253,0.08696170501228427
78365,SIDM00097,BI-2536,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6853595,0.13005884,1.1723743368451984,0.05949464364751615
5984,SIDM00933,Taselisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.9812323,0.07351618,1.1484991728788077,0.03380453001168444
96027,SIDM00833,AZD8055,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.383811,0.09657568,0.6727043044158544,0.04431319222141023
30711,SIDM00673,Venetoclax,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-1.4348526,-0.03258721,-0.7747164013508636,0.0165788651525131
65184,SIDM00216,MK-2206,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.88164157,-0.07754964,1.4823147774559553,-0.023984717323417937
77840,SIDM00146,ZM447439,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.7493575,0.05254556,1.5375456850307105,0.1265816621922133
63110,SIDM00633,Paclitaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2672596,-0.123602,-3.1515950031815216,-0.1576481909593628
85527,SIDM00776,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.32070723,-0.019082118,1.7673039846375709,0.031874155406887685
18481,SIDM01197,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.838698,-0.12879959,-2.6168155557743984,-0.050319802832024016
79284,SIDM00216,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3554343,0.048949428,0.7515781187200334,0.061427841827829614
91743,SIDM00097,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.107021,-0.0635361,-0.9640961961195403,-0.023553932099730113
36707,SIDM00832,Vinorelbine,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-1.19643,-0.07764272,-0.4141091765942111,-0.02127830199896131
18927,SIDM00933,Camptothecin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,2.063345,0.1415894,-0.823780590866921,-0.07070316806630834
93544,SIDM00148,BI-2536,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2707064,-0.1074733,-3.180132420905543,-0.09674940376192445
74989,SIDM00148,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.68803567,0.0354724,-0.9082135271493019,-0.05741369202653293
88989,SIDM01042,PF-4708671,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5792398,0.0887705,1.473842992895519,0.01845038259602498
102008,SIDM00673,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0420754,0.047141343,-0.7061734238687659,-0.04921938203306397
29615,SIDM00146,MK-1775,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.65335596,-0.042722724,-0.16748546636891307,0.022262945068779322
86646,SIDM00833,Nutlin-3a (-),SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.6473475,0.0756527,0.7984838122859691,0.017791916101539535
4879,SIDM01042,Olaparib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8688065,0.08109267,-0.6425392456887165,-0.016496945559364228
28025,SIDM00933,Alisertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.0875752,0.20178114,-0.1013876559724904,0.013071476290134491
15593,SIDM00097,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8511868,-0.04974089,-1.5180275805404,-0.0385219850275247
58029,SIDM00933,OSI-027,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.1837462,0.16274318,0.9175116982945801,0.1076978865428384
107300,SIDM00097,RO-3306,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.087022,-0.05650305,-0.9305849127413449,-0.04502079970248889
43033,SIDM01042,Ribociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5297443,-0.0653836,-0.93285633296478,0.019129980071227556
79224,SIDM00832,SCH772984,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-3.3683383,-0.26007736,0.821166221849805,-0.006928241773782854
4743,SIDM01187,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3429221,-0.07657991,-0.9751084015877308,-0.046248612677765505
55206,SIDM00872,MK-2206,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7400775,0.1720457,0.18189598698421253,-0.011935545214170184
86611,SIDM00950,Lapatinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5701416,0.13678637,0.9197977035543345,0.033349070277903035
45631,SIDM00455,Cisplatin,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.0767822,-0.040907364,-0.34904155840992207,0.006729018613236907
91252,SIDM00282,Afatinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-2.5407035,-0.11237892,-1.1826358910293013,-0.06285311045556494
13823,SIDM00146,AZD7762,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.5130885,-0.12775569,-0.9376281086404135,-0.04169203859265983
13124,SIDM01187,Trametinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.72636247,0.045496065,-1.039682197329449,-0.026298397323227474
91971,SIDM00042,SCH772984,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1844068,-0.0942936,-2.268381589001365,-0.10480731704374989
70699,SIDM00282,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9565814,-0.05146392,-0.8199748271917644,-0.06488430863637744
5003,SIDM00928,Afatinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.0128372,-0.10691397,-0.30167746693969255,-0.07849037292044411
43623,SIDM00146,MK-1775,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.26262257,0.020231057,0.0446837858903835,0.03865572830611794
75955,SIDM00359,AZD4547,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0369575,-0.07176362,-0.5345403563826729,0.008785857750645597
101140,SIDM00673,Nutlin-3a (-),Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.0269343,0.02897579,0.8268475168460133,0.054329184969906984
104684,SIDM00673,Sorafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.099925,-0.10086125,0.2707134454069989,0.010098085243871126
84079,SIDM00928,PD173074,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.9860165,0.13618273,0.9938185411279106,0.07927528197451045
104142,SIDM00933,PF-4708671,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-2.0776439,-0.15293661,-0.8926857055004462,-0.05571172406255982
17277,SIDM00042,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.4604193,0.07563488,-0.15114851914523708,-0.02107352137684118
42817,SIDM00933,Uprosertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.6666863,0.16221641,0.4626338548428367,0.061649007338886966
44055,SIDM00872,Tozasertib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.57963103,-0.020690164,0.6054482554345371,0.044360262216275655
92290,SIDM00148,KU-55933,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.36690414,-0.008948616,-1.035483682677278,-0.00600639207623241
34772,SIDM00633,AZD8055,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.697624,0.32090923,-1.864697348114003,-0.1052228844083164
3413,SIDM00933,Navitoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.29940334,0.030150775,0.5207862504256726,0.02573815932080904
12715,SIDM00833,MK-1775,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-0.9032731,-0.057561897,-2.7340388273649046,-0.18464789007665855
88336,SIDM00673,Trametinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,8.327597,0.31828126,1.7080033875161558,0.09212491570959122
66828,SIDM00933,OSI-027,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.9651966,0.116748825,-1.4326114092436113,-0.05414490883995628
94448,SIDM00933,AZD6482,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3336072,0.06171218,0.8340760365480338,-0.025785696161167795
86129,SIDM00877,Olaparib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8047237,0.0355195,-0.7745504825610795,0.010472554132026236
106833,SIDM01187,Bortezomib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1974025,-0.11757635,-1.7261382136241334,-0.041250819800890695
6582,SIDM00928,Taselisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.4192917,-0.20094436,-0.865216614619083,-0.059394509481921653
17664,SIDM01042,Alpelisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.241549,-0.10140851,1.5903838767000344,0.10734528282847434
31763,SIDM00097,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0027003,-0.10663142,-0.7034558497277752,-0.03211762335614508
38669,SIDM00835,SB505124,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-0.32178193,-0.027524063,1.4963882870793115,0.0589419485315293
82490,SIDM00282,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.5050261,-0.030924425,-1.3248773798907123,-0.13360912910717831
54035,SIDM00933,Olaparib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.75131774,-0.066251695,-2.0169201491030617,-0.07216674602266834
2752,SIDM00933,Afatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.1529242,0.109902166,1.7726063591387113,0.1325384358872919
93360,SIDM00097,PF-4708671,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9411144,-0.08926443,-1.5035805911880384,-0.06273795461279062
58100,SIDM00928,SCH772984,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.6639209,-0.042573042,-0.2668365924052493,0.010865754731709512
3459,SIDM00928,Uprosertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.7994144,0.1487215,0.260382913192616,0.05244617795125102
78794,SIDM00282,MK-1775,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-0.74402684,-0.052294917,0.4314208276317253,-0.004367978091279152
13078,SIDM00455,5-Fluorouracil,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2028478,0.05933369,-0.5768710665678474,0.0012106449528690947
82058,SIDM00673,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.2365823,-0.12414535,-1.2167263823136298,-0.05905192759168875
72417,SIDM00875,Temozolomide,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8952856,0.024015035,0.10208984859477416,-0.02203589431359244
60246,SIDM00633,NU7441,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2022188,0.06790424,1.1050391538615523,0.01996524487136084
49350,SIDM00875,Axitinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7879617,0.05125809,-0.23686037359918372,-0.009363386484810556
14412,SIDM00957,Trametinib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-0.9670169,-0.04113212,-0.9378875744375281,-0.06105135757527414
71526,SIDM00148,Nutlin-3a (-),AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1678402,-0.10550427,-0.8320288949222522,-0.0885757429083622
59226,SIDM00826,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.751237,-0.09874352,-1.5994634708523467,-0.023653018622412748
4515,SIDM00146,ZM447439,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.256206,0.10163372,1.4431881298599536,0.09651098268364733
12344,SIDM00633,NU7441,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1348289,0.07878665,-0.03247380299632224,0.008125867106507692
19099,SIDM00673,PF-4708671,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.5340674,-0.100968674,-0.1525012757295073,0.03162087042751384
44352,SIDM00928,SCH772984,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.7521129,0.19787832,0.002544516966282207,0.02301119101350142
3828,SIDM00097,BI-2536,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.050658,0.14170137,-0.9734148459074521,-0.08130139440661052
26096,SIDM00776,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.51742893,-0.03457914,-1.2790919219307497,-0.055028400406796865
108110,SIDM00928,Nutlin-3a (-),AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.9048837,0.050072763,0.9617211084277012,0.012789821914354871
24273,SIDM00837,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.3818963,0.11210771,-0.7021841154351156,-0.006047390958499495
66573,SIDM00928,AZD8055,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.0662949,-0.11396856,-0.5518949250984354,-0.034477387101072385
28170,SIDM00148,Doramapimod,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5736213,0.22000328,0.7777717889957745,0.04998632053351717
53972,SIDM00928,Temozolomide,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.8036046,0.046010062,1.2319716321461927,0.02014738932478658
11991,SIDM00097,JQ1,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.440696,-0.1230016,0.39270960314201026,0.0321188809005556
53668,SIDM00042,Erlotinib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.394651,0.08186716,1.2564585183130896,0.08926786415417176
83179,SIDM00216,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.8962512,0.016325679,1.9422537934114235,0.11373926611713318
51712,SIDM01042,Entinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5757717,0.11153004,0.13534219031548045,0.013614845178284353
50637,SIDM00148,5-Fluorouracil,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9163198,-0.084293045,-2.119513122863274,-0.17204394433760947
93003,SIDM00826,Afatinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.5382521,-0.053408943,-0.7551574616557123,0.029465186002358795
4634,SIDM00146,Taselisib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.8067443,-0.13374172,-1.6583154143268044,-0.09599783359376897
15631,SIDM00455,MK-2206,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1454047,0.054518376,-0.36511005587389783,0.03063162561729596
68572,SIDM01042,Palbociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41049123,0.02254483,2.099931183982309,0.06171443985078088
80165,SIDM00776,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.84452647,0.07444152,-0.07575071091389474,-0.008126501188228314
4117,SIDM00633,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.87790495,-0.06530693,-0.6245554724555556,-0.02674401006858686
104081,SIDM00148,Uprosertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5625723,0.03176137,-0.04004961676700306,-0.001511209724171926
69948,SIDM00097,Navitoclax,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.10948315,-0.007465806,1.2331519079739717,0.024495567781482395
62447,SIDM00833,BMS-754807,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,0.47612315,0.037288584,-1.4159236884365853,-0.10128094411418384
81314,SIDM00097,Luminespib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5760068,-0.1005148,-1.658816344544315,-0.11820536606203935
84742,SIDM00928,Pictilisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.375168,-0.15826966,-1.1203830838618158,-0.0614299263233815
48919,SIDM01187,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0009873,-0.1479035,-2.5657311646404213,-0.17466739147626534
1371,SIDM00146,MK-1775,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.00355,-0.05376206,-1.44423661694372,-0.054758197103669005
34181,SIDM00776,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-2.3932536,-0.14549564,-1.6621121884634003,-0.060284474460996454
1861,SIDM00633,ZM447439,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.890341,0.40067023,3.3079227646098817,0.17740125650961597
4006,SIDM00146,OSI-027,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6721841,0.14419673,0.18088214998186847,0.02344271895775318
51754,SIDM00097,BI-2536,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6240884,-0.112933695,-0.7939638089527603,-0.06928411367633013
13980,SIDM00148,Afatinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0747399,0.10070683,-0.5707935904018289,-0.005607824052223089
44641,SIDM00633,Vorinostat,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8271342,-0.017444596,1.9335371087685047,0.09102671590274485
91304,SIDM00673,Navitoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5347993,0.25006962,0.6047274814435647,0.04035669004270776
65075,SIDM00837,Linsitinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.42312694,0.02686704,0.11679784755198416,-0.05211670002086624
5657,SIDM00837,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-0.66920257,-0.03450618,0.11134305949175147,-0.01823709849108727
60745,SIDM00097,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.406756,-0.18171051,-0.9486854148402223,-0.07608456438275002
49197,SIDM00097,Vorinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.62970644,0.042579867,2.130358803957282,0.12219543825550593
51862,SIDM00633,Lapatinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7018111,-0.026121393,-0.5148603310564678,0.011324987877494716
14506,SIDM00957,Olaparib,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.1648257,-0.026667666,0.06879923021439714,0.003989462128787623
70314,SIDM00359,SCH772984,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3349444,0.081969395,0.29347332522513064,0.032791976143627985
3642,SIDM00832,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,3.7829003,0.11945338,0.5785465939244414,-0.001849653498074167
102551,SIDM00359,MK-1775,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.84755814,0.06547723,-1.312072204763056,-0.06866422025867704
50309,SIDM00837,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.7197785,0.09204799,0.24504065448960557,-0.006994560534554117
42759,SIDM00957,LGK974,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,3.2058833,0.068126254,1.773863761207984,0.030559516411441244
73053,SIDM00833,BMS-754807,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.4110308,-0.13643849,-0.3108404006999243,-0.033405884576819325
22545,SIDM00933,Navitoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,3.4735463,0.07236187,1.8523854651500768,0.08654343205691141
53961,SIDM00950,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.52432424,0.030510372,-0.2526612521916224,-0.04535986477694662
20363,SIDM00875,Luminespib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30413842,0.032515846,-1.426526942134196,-0.0689260139807751
85971,SIDM01042,Navitoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.24554676,-0.029848538,0.41482977085447614,-0.00024983215592116803
17024,SIDM01187,Navitoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4979522,0.13888554,0.5545995802951722,0.05027605018034129
104316,SIDM00097,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.86624545,0.017755238,2.0467791964676256,0.08035189321182874
6974,SIDM00957,Vinorelbine,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.27862993,0.005592532,1.0791886729157594,0.08634917326631367
12115,SIDM00832,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.630003,-0.096825115,0.0762315397572628,0.010202593551596967
90429,SIDM01042,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2333362,-0.12673642,-2.0846852125652995,-0.13886445754091126
6315,SIDM00833,AZD7762,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,4.3751874,0.31596527,1.216291849802265,0.1054618111553183
101095,SIDM00928,Docetaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-1.7856488,-0.17243937,-1.0503601284230206,-0.04102400680285602
78039,SIDM00097,Alisertib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1064074,-0.061855398,-1.0247836994432296,-0.014483309449319252
43059,SIDM00957,Afatinib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-2.2984188,-0.0870938,0.24589514036863205,0.03592820322025353
101367,SIDM00633,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.124476,0.10074468,-0.9898725336205534,-0.0028272914163926938
1938,SIDM00837,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.0639756,-0.04649436,-0.22988950600558858,-0.03389145647650858
104337,SIDM00146,KU-55933,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.4973316,-0.05178398,0.6557601618901591,0.053970636449010234
71929,SIDM00776,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2199888,-0.09013319,-1.9291501927919246,-0.1175963893373278
40442,SIDM00282,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.44841048,0.027616419,-1.2168080851295275,-0.06270718588363096
101570,SIDM00359,SCH772984,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8940046,0.11663284,1.8990406992320545,0.09337912418403385
79682,SIDM00146,Gemcitabine,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.0098972,0.107038744,1.475861477977529,0.027375914255817927
15963,SIDM01187,MK-2206,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.8425965,-0.21104641,-0.5655323830319795,-0.04272014833464265
107869,SIDM01187,Luminespib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.74560314,-0.06485019,-1.6016377887660567,-0.027634183601000395
45525,SIDM00875,Navitoclax,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45126337,0.03818225,3.446851516221013,0.13530382856341439
72177,SIDM00455,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8717027,-0.07116953,0.799289836014893,0.04033984210282306
68960,SIDM00872,Wee1 Inhibitor,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.30154714,0.030673003,0.6165612055691119,0.02138308758551723
72539,SIDM00957,AZD8055,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,0.9373935,0.021925274,0.4948475427827265,0.053225223806618205
42250,SIDM00148,Sorafenib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5746423,0.047197223,0.27354523555770777,0.008750290454282921
52284,SIDM00216,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,0.7629309,0.016962446,1.1188936851012194,0.07827014346709203
56214,SIDM00216,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.53581125,-0.010780378,-0.31070108181764794,-0.05256978751087862
77136,SIDM00148,MK-1775,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8980478,0.11188986,-0.30881406674459644,-0.040790140828757225
23436,SIDM00872,Lapatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7644939,0.07695146,-0.08418960390976579,-0.002692440823679885
242,SIDM00042,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.2160048,-0.21291764,-2.8167277684363046,-0.13192326852406477
46707,SIDM00146,Alisertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.25811547,-0.022876756,-0.16615793708771395,0.022485915708301968
48973,SIDM00872,Navitoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9680421,-0.05622148,1.1623415279452354,0.08243685702990122
42754,SIDM00872,Ribociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.97039837,-0.02100285,0.7244337248935437,0.013780383996896437
49337,SIDM00633,Vorinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0112989,0.08616589,2.351852281243201,0.11904907482850922
95921,SIDM00928,OSI-027,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.5437292,-0.14216195,0.3957169583814626,-0.011954267132003347
8440,SIDM00097,ZM447439,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6654231,0.033276692,1.8640214969263846,0.1096667697526987
81589,SIDM00950,Irinotecan,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.7061303,0.32699725,2.408799215818343,0.1531730438328298
32457,SIDM00833,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.6814677,-0.12433142,-1.1779672518044615,-0.11695158286033737
44488,SIDM00950,Palbociclib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.5535544,0.04137101,-0.5022466462109799,-0.02762283456378626
876,SIDM00928,Linsitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.9884775,-0.13893776,-1.050139132546094,-0.03950812489380953
106327,SIDM00872,Dabrafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.39956746,0.0088811675,1.8865033416271164,0.042680090674194315
878,SIDM00933,Luminespib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.025889752,0.00094516017,-0.8132003988809166,-0.06257236453815257
28421,SIDM00928,Olaparib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-3.0697951,-0.13634913,-2.4087405824278476,-0.036357067474861185
79661,SIDM00146,JQ1,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3563439,0.02752792,0.4482318715482469,0.007023126718872156
73622,SIDM01042,Axitinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.723931,-0.28500098,-2.7061812313635807,-0.17309637840656056
16021,SIDM00633,Navitoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9432164,0.15597346,1.0796785431865665,0.04901858214448102
68017,SIDM00455,Linsitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.5985007,0.14270386,0.43817417561723687,0.02903162963337295
39064,SIDM01197,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.265961,-0.048935227,-2.0193417750880975,-0.09825321438737634
29315,SIDM00216,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.5002174,-0.19624557,-0.24022191522534828,-0.0018570151303336435
32546,SIDM00673,Ribociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.7120984,-0.07656349,-0.29309960079365005,0.02601465113778725
21491,SIDM00933,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.0814387,0.11064347,0.5118772349990086,0.05052669463280721
11722,SIDM01187,Olaparib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.46783438,-0.018161342,-1.2987095664405341,0.014834150253899421
57713,SIDM00928,PF-4708671,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.8304282,-0.06840894,-0.027555091087060432,0.04763444360954937
91661,SIDM00837,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,3.2427595,0.034823347,-1.2292162714063892,-0.0575896727719745
101762,SIDM00282,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.6371715,0.070484266,2.5828287102746823,0.14859115855186295
96097,SIDM00872,OSI-027,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5913129,0.063995264,-0.2897134852470572,-0.01878579631940951
92093,SIDM00872,Temozolomide,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3458795,0.007179836,0.2789175964485599,0.017533964514787177
44402,SIDM00146,Doramapimod,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2732159,0.07558602,0.17382541921797862,-0.004788644843189342
92506,SIDM00933,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.8862374,0.05404245,-0.326816478484527,-0.005924998783252061
83865,SIDM00148,Navitoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.87170327,0.058864806,0.7413329394277204,0.005139922760910887
28474,SIDM00216,AZD8055,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,1.7617792,0.1332272,0.038327349301467785,0.006699213638255335
35284,SIDM01042,Uprosertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8286678,-0.033800833,-0.43518605567269364,-0.035555172679694526
35011,SIDM00928,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,0.5829683,0.071386084,0.34847656275166283,0.01209517127210258
102652,SIDM00875,Wee1 Inhibitor,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6706161,-0.02961998,-4.643190664289726,-0.1814439100272314
82184,SIDM00282,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.48357612,-0.027542358,-0.9377418392585427,-0.05678613697139847
46948,SIDM00837,MK-1775,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.78785354,-0.040975437,-2.527844169443791,-0.20971483043779005
47751,SIDM00148,Venetoclax,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.87600476,-0.031398065,0.3891542308784202,0.03144793225806581
33779,SIDM00875,Wee1 Inhibitor,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.14328916,-0.00795272,-0.46612559143521937,-0.003292790303464669
52127,SIDM00282,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.64053446,-0.03651615,-1.3013264213430742,-0.02764327960572228
7718,SIDM00455,MK-1775,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6692654,0.04164011,-0.060307481261856935,0.04366214574612874
14908,SIDM00146,Camptothecin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.8302693,0.2701057,2.5014064733155488,0.21837119156718135
51067,SIDM00633,Ribociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3899345,0.07550498,1.0744083305120986,0.009213607941367082
105759,SIDM00872,MK-1775,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.3636397,-0.038521647,0.12078741504269166,-0.03805988350186322
79448,SIDM00835,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.3644212,0.118720554,-0.2842453062640421,-0.004559785267471435
1227,SIDM00875,SCH772984,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4670365,-0.049376965,0.6162121953899286,0.01725523972716065
47293,SIDM00455,5-Fluorouracil,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3786657,-0.06976323,-2.477382238648029,-0.07303068549695774
44599,SIDM00877,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.4342286,0.045637757,-1.3112162767805535,-0.10120701217261348
74705,SIDM00833,SCH772984,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.6041032,0.1155676,0.6462077621162509,0.0354259182038062
80169,SIDM00148,Nutlin-3a (-),Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.890886,-0.17852618,-1.9311657833414173,-0.1313849631258201
72150,SIDM00950,OSI-027,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7186136,-0.07991456,-2.1055383037262647,-0.05672380578430946
36632,SIDM00928,JQ1,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.6663733,-0.16804628,-1.424889013293672,-0.07191570574168271
16751,SIDM00957,Crizotinib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,0.8840769,0.023521194,2.4616148489824154,0.09520649831392428
10382,SIDM00148,Gemcitabine,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0599904,0.06924809,0.26480858380217787,-0.03276746368552076
7034,SIDM01042,MK-1775,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.00011953114,-5.616429e-06,-1.7674311826499836,-0.05583627656343913
23905,SIDM00877,KU-55933,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8644681,-0.04200193,-0.4594516318645837,0.028494534997378952
63577,SIDM00950,Gemcitabine,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6098485,-0.17361508,-1.5810763375779584,-0.11142557008742075
48328,SIDM00928,Alisertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.1531588,-0.0643639,-1.8693834233323254,-0.0896154758048958
82888,SIDM00633,Olaparib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.93921,0.10342394,-1.2445203638829956,-0.011136329529434046
68038,SIDM00673,PD173074,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.8614295,-0.11623133,-1.3305348029008464,-0.028766672360457792
92498,SIDM00928,GSK269962A,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.3837807,-0.09467152,1.2175959984060643,0.04570659587328027
81860,SIDM00146,Palbociclib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.81688714,0.06335447,-0.061103818571045104,0.007775338929833038
16359,SIDM00933,RO-3306,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-3.6183732,-0.18023369,-0.7751005526599136,-0.09931386578831737
78914,SIDM00455,Dasatinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.0357356,0.114902355,1.7653467847474331,0.22242800172184332
27970,SIDM00673,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.7195992,-0.2736,-3.562940787952975,-0.23119581367351538
65904,SIDM00097,Alpelisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2809248,-0.089348994,0.7741271183701925,-0.009609683218066514
9896,SIDM00282,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.2034507,0.07988157,0.9363492090805405,0.11530084906166448
87297,SIDM00146,SCH772984,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.0514746,-0.13682555,2.791002402190526,0.13654772553489877
59278,SIDM00875,Pictilisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9543467,-0.0284005,-0.774028110948314,-0.039395359454759984
63371,SIDM00673,Cisplatin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4916584,0.07136714,0.47709075573551374,0.0237103726110702
48303,SIDM00933,Afatinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.585105,0.05580947,-0.1304268683630074,-0.0006692811207517789
55857,SIDM00877,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,3.345682,0.14419898,1.7293442738425706,0.07862812145755468
3838,SIDM00097,KU-55933,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0497193,-0.11293181,-2.549804903676313,-0.1063748386320397
25745,SIDM00633,Navitoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0143964,0.077612266,1.22979081213984,0.056578343782554406
7673,SIDM00933,Sorafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.1447418,-0.11374424,-0.5897926111253382,-0.056283201017780796
97590,SIDM00148,ZM447439,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7114134,-0.050573498,-0.630125079455496,-0.037374800677176606
53379,SIDM00146,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5612874,0.10458665,-0.46092743230089556,0.06803883205658307
86271,SIDM00957,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.841963,0.14366007,3.712001529112733,0.19363879356509794
68166,SIDM00837,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.0089762,0.05219443,-1.2102032410235675,-0.081713701523938
40650,SIDM00837,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.0860628,0.03889846,-0.9373687859910605,-0.033950550167664184
92489,SIDM00148,Ribociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0893834,-0.08939787,-1.9250881518794662,-0.0747142857558073
49332,SIDM00282,Taselisib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,1.3541551,0.08963632,2.717737028852731,0.09861683815904433
78487,SIDM00097,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.49658948,0.032695297,1.0120734927985346,0.030026901636385946
35949,SIDM01197,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.3566194,-0.102646284,-1.343977291924492,-0.04307472050629249
104313,SIDM00833,SB505124,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.7365445,-0.1271648,-1.3129460669985094,-0.071570669684799
75256,SIDM00455,Olaparib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.5581482,0.017763259,1.6004108152872893,0.07295200776655376
59109,SIDM00950,5-Fluorouracil,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.83095807,-0.07303238,-0.7233940684109206,-0.05056804241475018
47742,SIDM00633,Gemcitabine,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6761942,-0.08412142,-2.0116337762719083,-0.05000957315047359
56814,SIDM00146,MK-1775,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.43049768,0.026608396,-0.3741826883658489,-0.0350878005304531
36712,SIDM00957,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.1836611,-0.015686795,0.10867703064280207,0.040962673464721405
19314,SIDM00872,Navitoclax,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.08836671,-0.005895295,0.5463618907579194,0.014004820794163533
74860,SIDM00832,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-5.7916555,-0.39863986,-1.338279935693979,-0.10207895306198998
50692,SIDM00877,Luminespib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.575686,-0.067419894,-1.830613755078873,-0.046081097438390624
4697,SIDM00835,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-2.0122025,-0.125691,1.1805057760861613,0.010250577164771844
52218,SIDM00832,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.99976087,-0.03794657,-0.7831319909992203,-0.055284289780004894
23546,SIDM00928,MK-2206,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.7237875,-0.099963896,-0.4583665108714804,-0.0737860013322634
82166,SIDM00673,Dabrafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.7856649,0.045663986,1.4296698036466076,0.0676448088342107
10574,SIDM00928,Palbociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2014716,0.16580404,0.16208335889617156,0.013182416166741505
62130,SIDM00633,Wee1 Inhibitor,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3428578,-0.114064194,-1.1576746011294081,-0.048648525935283876
15465,SIDM00872,AZD6482,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,3.5184462,0.23211339,0.9557414570920336,0.036288992623464
105260,SIDM00950,Linsitinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0549319,0.09989476,-0.5095132833907507,0.00690512327527623
74140,SIDM00146,Venetoclax,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.7763143,0.019242406,1.910123285764253,0.08876962364714079
19701,SIDM00875,RO-3306,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1725949,-0.028769653,-1.6404774768488852,-0.07563865426221626
60765,SIDM01042,Taselisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.33357367,-0.023167768,-0.42081735479109716,-0.0710082860530449
34679,SIDM00832,BMS-754807,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-3.4985445,-0.08734971,-1.6225864743282261,0.011079844943793922
77932,SIDM01042,Tozasertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1573783,0.11758393,-0.5049012693217989,-0.06747799058696888
12640,SIDM00832,AZD7762,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.5790038,0.072759606,-1.0481007854737305,-0.07869205086562121
47946,SIDM00097,Afatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.797868,-0.051569495,-0.9389418006177123,-0.07097926127506893
90859,SIDM00877,AZD8055,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6922953,-0.07717928,0.6303609514573967,0.00714540045681441
20029,SIDM00872,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.595497,0.13111077,2.7517376022577458,0.19712537488922277
2005,SIDM00877,KU-55933,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.6678256,-0.065200396,0.025912641440386054,0.01761644985610561
26747,SIDM00146,Trametinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.8604128,-0.07015649,0.34914298874781297,-0.013894489237581699
78747,SIDM00950,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.902892,-0.2802583,-1.982379684587289,-0.10620940710394626
50793,SIDM00872,MK-1775,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.64274573,0.066555224,0.23995722432375116,-0.02647040195398186
98308,SIDM01042,GSK269962A,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.06780131,0.008577083,-0.6278364899950196,-0.06001811233217253
31894,SIDM00928,PF-4708671,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.4960863,-0.04017792,-0.503692745353406,-0.004100296745290447
20220,SIDM00833,Navitoclax,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.7443966,0.055248633,1.7997010881140212,0.0658782495584485
93880,SIDM01187,Taselisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.57126737,-0.04822434,-0.14267321289108373,-0.036536160335655106
4999,SIDM00872,Ribociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1739274,-0.02898512,0.0969744328002502,0.005920162124765419
88285,SIDM00146,Trametinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.6082926,-0.12509207,-1.0018379010179472,-0.10079852089987847
41295,SIDM01197,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.91034716,0.07277073,0.421554552253388,0.04536841186938117
23537,SIDM01187,PD173074,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.1330602,0.15164922,1.1098502654456062,0.05392743111672759
4661,SIDM00933,Lapatinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.20202534,0.030399391,-0.14177302802709602,0.031138871523216528
27336,SIDM00933,Bortezomib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.3013472,0.024196476,-0.05598671344747359,-0.03112308314572389
43337,SIDM00837,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.7579114,-0.03245535,0.3358035431204048,-0.010292921780873873
13795,SIDM00872,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8061919,0.055942353,1.7976087262637754,0.04970472026276165
4938,SIDM00673,Vorinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0718995,-0.105007336,-0.29989519231844086,-0.032209968701916815
55666,SIDM00455,5-Fluorouracil,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.826941,-0.04566994,-1.107521603177631,0.0013933486950843163
80801,SIDM00933,5-Fluorouracil,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.90461,0.08830889,-0.20883137183683526,-0.010318634340686625
50202,SIDM00933,Palbociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.5933862,0.18992622,1.4536124745713805,0.16606092268102435
52448,SIDM00633,ZM447439,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4947913,-0.13633355,-1.722204239952892,-0.06602662945067178
46154,SIDM00835,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.1753209,-0.058645315,-0.5643177273996968,-0.00456670014049809
102918,SIDM00097,KU-55933,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3776355,-0.074584164,-1.2050405193411469,-0.030181819030661097
45995,SIDM00148,MK-1775,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5647658,0.08061469,1.2013134548309627,-0.02255002323275615
88976,SIDM00835,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,2.0444572,0.15123184,0.2027106696046672,0.007642565495853996
4621,SIDM00872,OSI-027,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.242543,0.11857054,0.7588231338958759,0.06449866124927782
1405,SIDM00146,Doramapimod,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,3.0626764,0.14386667,1.885786245047143,0.08300349505804777
36165,SIDM00633,Trametinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9954681,0.040378004,-0.4210416477661497,-0.014203959153501965
61019,SIDM00282,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.0159392,-0.14080746,-2.5564683417490595,-0.17022003326111412
89801,SIDM00148,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0875409,-0.11820912,-0.8780141152890296,-0.08555303789795402
77690,SIDM00833,AZD8055,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.5000722,0.09534956,1.1776220866082574,-0.005199681739825363
8299,SIDM00042,Taselisib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.7071687,-0.07243173,-1.2074492120798406,-0.008390102711543225
58743,SIDM00633,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.4069097,0.21708499,0.1531757354591163,0.05836886346819103
36393,SIDM01197,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.6341507,0.066042796,-0.0600906035580939,-0.04305698791629409
82209,SIDM00950,AZD7762,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7434887,-0.073123276,-0.2045005043399558,-0.03843916685409315
52301,SIDM00633,Venetoclax,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.676607,0.15296116,0.7354184541162598,0.0148089191237548
307,SIDM00928,Venetoclax,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.019877,-0.03178635,-0.023539116243316113,-0.016372497196363776
90770,SIDM00673,Camptothecin,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0824766,-0.031593252,-0.17811306863106327,0.018816568607386806
23506,SIDM01042,5-Fluorouracil,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9196253,0.04974695,3.183732498625384,0.12600183452856253
57683,SIDM00933,ZM447439,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.3811724,0.22833067,1.5832112003827,0.11446215775787892
35135,SIDM01042,Tozasertib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1020782,0.10877067,-1.8146624581203128,-0.10176730243669936
39763,SIDM00633,RO-3306,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9843084,-0.0906316,-1.2561627577430987,-0.09401822580221068
62132,SIDM00928,Paclitaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.6879254,0.05604019,-0.6236101757175262,-0.06049240949396073
37675,SIDM00146,Axitinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.6833689,0.10006143,0.15739558027570633,0.09374447534445217
84287,SIDM00826,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.0382518,-0.08624495,-2.611088330455218,-0.0865375911974463
92068,SIDM00633,Vorinostat,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.13655312,-0.011685941,0.4528350911053879,0.021669114876396806
79981,SIDM00097,PD173074,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9790173,-0.09090127,-1.1368142747107206,-0.08110744871271568
2754,SIDM00097,Olaparib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7923478,0.041511334,1.6469404826188088,0.03812130351347716
41674,SIDM00146,GSK269962A,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4097552,-0.0877841,1.2757962604711481,0.06834860505632714
6620,SIDM00826,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-1.6885173,-0.08186505,-1.7497305011104622,-0.11075447329736676
64172,SIDM00455,Ruxolitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.5243299,0.009603345,1.7885300683472962,0.0827934622668863
18217,SIDM00872,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.683083,-0.090878986,0.27145452621324556,0.01430894390527374
10922,SIDM00633,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.717975,0.05648379,-0.9319054784856198,-0.08163867417136636
25415,SIDM00455,Sorafenib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6717432,0.042657934,-0.6096720244961013,0.021989382794299614
57079,SIDM00673,MK-2206,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0747395,0.06573579,0.27375361557588274,0.02051685051229249
5952,SIDM00146,Lapatinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.41866574,-0.039571196,-0.2241298346530218,-0.0431602354514827
68626,SIDM01042,OSI-027,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5051945,-0.055057675,-0.5925738857095348,-0.048327022107799204
30397,SIDM00928,BI-2536,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-3.278365,-0.19049327,0.06913226955791371,-0.034078505490020276
66945,SIDM00148,NU7441,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.20761995,-0.018980565,1.2493687950821895,0.04719741815636724
34673,SIDM00282,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.4141214,0.091592394,0.2569096351042244,0.03242412625852068
63638,SIDM00957,Taselisib,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.2608547,-0.03718669,-0.5685348577308654,0.03996429052904521
60725,SIDM01197,Olaparib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.92431164,0.013814251,2.0071792899486893,0.04482552217065839
26676,SIDM00875,Palbociclib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7807773,0.06165422,1.8704555058771077,0.04136432695171211
60152,SIDM00833,Taselisib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-1.2123542,-0.07815896,-0.9858955490601055,-0.05826781418832471
41285,SIDM01197,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.6074655,0.113903634,2.094211255213863,0.07273806373616871
95759,SIDM00633,Wee1 Inhibitor,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6334339,-0.05897605,-1.4005388850104958,-0.08857741379925173
39104,SIDM00673,Venetoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1233256,0.07803594,0.2347462010556027,0.04937041423401984
54840,SIDM00146,BI-2536,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.6969666,0.04791372,0.8143127411891914,-0.00433810277105523
107400,SIDM00673,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24422847,-0.017411973,-0.6091930369951642,-0.019213650829885402
28750,SIDM00928,OSI-027,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.4090383,-0.24661015,-1.0251525945275546,-0.07509383089187265
58025,SIDM00837,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-3.2029777,-0.1071312,-2.7530827855387057,-0.16140648831060353
9954,SIDM00933,Taselisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.5999599,0.041631892,-0.8442471981622935,-0.1313694396048119
72227,SIDM00877,OSI-027,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-2.0399387,-0.16305964,-0.029199349340991627,0.003493132455182831
84355,SIDM00776,Camptothecin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,2.168016,0.1966623,2.578066389665554,0.21387410052296418
53666,SIDM00148,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.430198,-0.14347126,-0.9400838751704073,-0.08348706843208685
19880,SIDM00633,PF-4708671,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7740099,-0.06273542,-1.193846122826321,-0.061502745744753916
93577,SIDM00673,5-Fluorouracil,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.48366475,0.024645975,0.10534893588838387,0.037264424455349505
51748,SIDM01187,Navitoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.35311088,-0.033993572,-0.7783514733620457,-0.03755322462068363
14684,SIDM00148,Lapatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6245332,-0.15477708,0.358562645773514,-0.013294989161167276
12479,SIDM00097,Nilotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55377024,0.036392182,0.3175924810590913,0.0542277931200848
59224,SIDM00933,SCH772984,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.1904838,-0.07462587,0.026333280688237287,-0.03487963877876014
3550,SIDM00875,BI-2536,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.3279834,-0.20519674,-2.788445307087551,-0.20705472912314202
41738,SIDM00776,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3136789,-0.09007399,-0.7204777057894299,-0.04804723470806138
106532,SIDM00097,Nilotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3093707,0.022109177,-0.986587087547324,-0.03746216887794912
82656,SIDM00455,Dactolisib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.7969577,0.058866985,-0.6169804036091847,-0.02974114166206176
43838,SIDM00673,NU7441,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7809456,0.061478555,0.4107834946355994,0.016641329438347695
47466,SIDM00216,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.777913,0.08911952,1.1126273789788315,0.057031578307072554
68694,SIDM00455,MK-1775,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2080603,0.08329553,0.35970704703204626,0.06297787792977395
100350,SIDM00872,Navitoclax,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3312184,0.09769694,3.9546629847273884,0.21955093899184375
4002,SIDM00950,Crizotinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.4278262,0.14589918,-0.49101881953990056,-0.011453145838709529
24200,SIDM00833,5-Fluorouracil,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-1.5894798,-0.12275884,-2.277268867118076,-0.15510840389066138
27655,SIDM00146,5-Fluorouracil,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.22997382,-0.016000362,-1.2092304904400135,-0.005470340767973574
5046,SIDM00282,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-2.239553,-0.05442777,-1.045924740993697,-0.025088085274162453
93036,SIDM00950,MK-1775,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2308638,-0.08332365,-0.5418018419499786,0.006096206410483265
16723,SIDM00872,Axitinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4244089,0.0341274,-0.4046158238191526,-0.019551793174931203
54492,SIDM00832,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.71451575,0.021585513,1.4287185175141637,0.006169972530017924
8069,SIDM00950,Dasatinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6344692,0.060313977,-0.5942144376147391,-0.023576395343331735
66309,SIDM00633,Alisertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8329902,-0.14162198,0.07666603911891398,0.01696241152494163
39299,SIDM00282,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.3270829,-0.09207224,-0.912173492917914,-0.038881598063479385
105708,SIDM01042,NU7441,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.42996344,0.0324776,-0.3469802738892936,-0.029463665433850404
14298,SIDM00776,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.4131615,0.124488145,1.1377311378162946,0.11323124476392175
104324,SIDM00148,Alpelisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.1489012,-0.015211686,0.27709442273177043,-0.0004864359051192391
40157,SIDM00835,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.3726269,0.030401323,1.4318929881409657,-0.0011185045016773
14630,SIDM00832,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.132863,-0.18150048,-0.3217306422441964,-0.04210878552630404
10764,SIDM00872,Gemcitabine,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,6.2133327,0.33649868,6.516476755546724,0.2911940822865282
22762,SIDM00957,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.1020677,0.034455936,0.8730787637235912,0.0527001768123753
1525,SIDM00148,Tozasertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.85005796,0.0717178,-1.0507810424042674,-0.0331561349007539
7578,SIDM00835,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-1.0860413,-0.051145297,1.8938699796295915,0.0744709731892325
99163,SIDM00359,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2417607,-0.06639913,-1.2471161348707558,-0.05038700793899856
2608,SIDM00148,Sorafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7010154,0.06500991,0.20962655316898157,-0.011508710695505618
57120,SIDM00933,Afatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.8585103,0.2535348,1.4494757409730548,0.11132509058249919
79567,SIDM01042,Venetoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0857272,0.12802288,-1.3436596723199776,-0.0259876469959212
59165,SIDM01042,Luminespib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5572432,-0.06667906,-0.8253845546528112,-0.025256917571410235
50829,SIDM00633,AZD7762,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3145752,-0.08775828,-2.50066724078291,-0.07192094702172246
42119,SIDM00928,Cisplatin,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.3450928,0.191771,0.8626783808970777,0.056279022231043495
31237,SIDM00146,AZD6482,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.7580407,-0.10935959,0.04796226262752238,0.041518145712481
5510,SIDM01197,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.5204157,0.037689436,0.014843371568740053,-0.027609359317083422
100231,SIDM00875,JQ1,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4215295,-0.15760754,-1.296274021246869,-0.03790028400508443
86669,SIDM00042,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0766187,0.077849396,-2.5496557540464924,-0.137329951652328
82063,SIDM00877,AZD7762,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.21579899,0.016805092,-0.3148320488564165,-0.008378161285096181
8207,SIDM00633,MK-2206,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3674763,-0.098366186,-1.0627698425350558,-0.06179885483711438
9271,SIDM00455,Crizotinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.88563776,0.058942035,1.6666594795250222,0.15550008024362383
29243,SIDM00833,MK-2206,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,2.1267684,0.14389138,-0.7043451772869226,-0.01226999710983113
48200,SIDM00097,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.85277617,-0.049939983,0.8696091136833086,0.012696745154633132
10859,SIDM00875,Olaparib,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.79524267,0.076633066,1.010038877183262,0.07604840513630888
103732,SIDM01042,NU7441,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6001203,0.09912164,0.5605482773977544,0.009360287308350491
4407,SIDM00146,Docetaxel,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0814779,-0.18869436,-2.947832296974255,-0.16243199158811752
52754,SIDM00633,Pictilisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0507201,0.06793953,-2.988036319757131,-0.0730146295256391
29501,SIDM00633,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7356298,-0.027475048,-0.27691078453018597,-0.017088035270401977
1812,SIDM00776,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.54124963,-0.037104223,-0.7830802433688051,-0.045061702172996494
70237,SIDM00097,GSK269962A,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9967126,0.11819364,-0.6334608038094832,-0.03570060692086557
42930,SIDM00097,MK-2206,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.385991,-0.022741515,0.7933393321366932,0.013537330914664079
100814,SIDM00455,Dactolisib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.7043799,0.049544938,-0.7234323498384027,-0.052402509116457455
94225,SIDM00933,Pictilisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.3011068,0.038807612,-0.019438625313874268,0.05964011903471325
24333,SIDM00833,Taselisib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.5370827,-0.14048092,0.026782756116866292,-0.016734978486827413
8344,SIDM01042,Lapatinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.62817615,-0.07518852,-0.9227290561602863,-0.08417513332442372
71233,SIDM00933,Crizotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.0218967,0.09036951,0.2891902446560814,0.02411497206822568
67705,SIDM00872,GSK269962A,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.151058,0.11806854,0.15219064244804967,0.022650068818961946
14729,SIDM00928,Camptothecin,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.82190186,-0.06615111,-0.030380772244794938,0.014660591521358705
101862,SIDM00148,Dabrafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4099175,0.02909191,-1.3754979623411716,-0.0894930798478302
80315,SIDM00673,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9810885,-0.12015029,-0.35216464612822973,-0.014286650563518084
1843,SIDM00933,NU7441,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.5299482,-0.050909206,8.08490884332872e-05,0.005532933929341665
92161,SIDM00673,MK-2206,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.481392,-0.14507805,-0.35759700660315963,-0.02199313818023712
45302,SIDM00928,Palbociclib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.9062212,-0.11127393,-0.11205394841706712,-0.043858070490809344
7748,SIDM00148,Camptothecin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2156764,0.12074132,-1.1872714451424409,-0.04711776392821307
49290,SIDM00877,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.8839476,0.007968185,1.0313014422458004,0.06145957531343259
42737,SIDM01187,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.6603017,-0.22412564,-3.041543271261332,-0.17547872041006962
19276,SIDM00832,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-1.1801994,-0.10558521,-0.491760377838537,-0.04988810491819133
17454,SIDM01042,JQ1,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3207996,-0.01874212,-0.22605997184592064,0.004530894781396503
59164,SIDM00933,Tozasertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.2200568,-0.18828538,-2.55660791598552,-0.14446407659513316
7272,SIDM00875,RO-3306,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0494556,0.11174249,-0.5875041654955532,-0.04694404454902456
58177,SIDM00673,Alisertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4759717,-0.11781147,-0.9003295857043605,-0.009005427149160996
2462,SIDM00359,Linsitinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3823462,0.17529565,1.561439145154143,0.027805140862756213
43651,SIDM00776,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.5977304,-0.061682932,-0.5870612173225123,0.010691231304094929
10437,SIDM00776,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-2.175229,-0.062021006,0.6405642442774288,0.053446500463241224
93222,SIDM00216,Camptothecin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.0152066,0.066521585,-1.2309014858122063,-0.06058778316279715
39505,SIDM01187,PD173074,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7809751,0.13132833,1.6064454456551296,0.08066309961094562
6643,SIDM00216,Vinorelbine,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.56168854,0.014393958,0.05284134738213781,-0.03692861448312994
62291,SIDM00776,5-Fluorouracil,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.4088572,-0.016639413,-0.429256310157114,0.01933921634990072
57173,SIDM00633,Entinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5299922,0.038869068,-1.1947040217373845,-0.056252799498842966
100506,SIDM01187,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0980756,-0.07431188,-2.1553508492297264,-0.024233170028263865
83351,SIDM00875,Doramapimod,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9560943,0.05330411,0.8544941187998318,-0.017200635263734117
8752,SIDM00148,PF-4708671,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8579547,-0.03129614,0.8370014787301217,0.08693723152700385
62317,SIDM00872,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.70703095,-0.07564769,-0.7786063712197149,-0.10118058597176668
79953,SIDM00673,PF-4708671,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9869101,-0.060058758,-0.7916296941965401,-0.04631713790475874
99728,SIDM00148,OSI-027,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7464459,0.05593409,-0.8947934060306384,-0.02506262779920399
92738,SIDM00875,Paclitaxel,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10590919,0.0074885734,-1.7424759295580023,-0.08384892106830527
96040,SIDM00146,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.9343098,0.14814612,-1.4959621422461429,-0.0865679633232565
95581,SIDM00633,Bortezomib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6891348,-0.11386584,-3.4270323868678028,-0.08711298551820788
29612,SIDM00146,Afatinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.929041,0.13945425,2.4524803570254825,0.13114710769551172
80578,SIDM00837,AZD7762,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,0.7536232,0.045517407,-1.152689682734025,-0.08303840714258226
15828,SIDM00148,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0467684,0.066276625,1.276926924327496,0.0780612418425
40668,SIDM00933,Bortezomib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.47124007,0.046079915,0.08789190289242454,0.029034371428180147
43592,SIDM00673,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.87473166,-0.060274422,-1.6281437991927337,-0.09713944402681488
4673,SIDM00875,Entinostat,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6957104,0.18956396,0.718242280120113,0.027791019115334156
35482,SIDM00359,SCH772984,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4642401,-0.033817064,-1.2165153687688361,-0.037476396784212454
15659,SIDM00673,Navitoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.5560465,0.15498407,2.3153286729570413,0.1132943926210517
91913,SIDM00359,SCH772984,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2138051,0.08926756,-0.33227365728681696,0.0082300406941647
36185,SIDM01042,AZD6482,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.56267107,0.024550578,0.013070667981613028,-0.012820085766661765
64057,SIDM00097,Linsitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9678774,-0.082020424,-1.9951014412954653,-0.04296370449746826
82096,SIDM00148,Uprosertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1408008,0.089007445,-0.007393830257209538,-0.018180271456013947
50983,SIDM01187,Taselisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2023592,0.08361288,-0.055461452626794194,-0.0033144273222175907
61583,SIDM00877,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.2511877,-0.09198768,0.5035113542031066,0.0873651512171266
65615,SIDM00928,5-Fluorouracil,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.9475601,-0.07583014,-1.0252214924047995,-0.023356709112180074
101443,SIDM00097,Vorinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.51617396,0.023401834,1.1819018102741439,0.0980971738800346
54694,SIDM00776,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.3365242,-0.06953998,0.5929569557758672,0.03076332688648663
40266,SIDM00832,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.62629807,-0.045145232,-0.5906206404484509,-0.031850718471354456
104478,SIDM00833,MK-2206,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,2.661299,0.20043756,-0.08220665931978889,0.027807158065313198
53120,SIDM00950,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.4667716,0.22157405,0.8374032286282264,0.06927843781867218
87927,SIDM00455,5-Fluorouracil,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4897945,-0.07855257,-0.2595143297013047,0.037401242753300326
106842,SIDM00928,Linsitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.9379907,0.07955632,-0.2232014814367504,0.005300986897492428
5630,SIDM00148,MK-2206,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5982052,0.1545592,-1.3117350754331882,-0.0832781385641771
30418,SIDM00633,RO-3306,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.60637593,0.062469088,-1.1160032789321028,-0.08130859204733441
10741,SIDM00950,Dactolisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.09092131,0.004089554,-1.4700295430874963,-0.0948496752775448
37160,SIDM01187,Luminespib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.343071,0.03296217,-0.5331263143868799,-0.036064257329737524
4560,SIDM01042,Linsitinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7639601,-0.10303402,-0.29503862574746853,0.005103868631034414
37527,SIDM00633,AZD8055,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7880136,-0.06915435,-0.5608651446131564,-0.04933970737684928
10268,SIDM01197,Crizotinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.054279484,-0.00401861,0.6650550420986354,0.02766770060765779
5755,SIDM00877,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.6014755,0.055596754,-0.9080434534298224,-0.014722332391800895
44767,SIDM01197,Palbociclib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-3.6839979,-0.12081153,-2.3563679716872215,-0.06720189534846795
53249,SIDM00216,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.2165515,-0.040683035,-2.065715124035502,-0.14722896894033413
53695,SIDM00877,5-Fluorouracil,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.8459067,0.14456378,0.24874539360026446,-0.0072699844000574014
15183,SIDM00776,Linsitinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.2318158,-0.052917253,1.5955215944984324,0.11475422135484793
51816,SIDM00146,Pictilisib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.0166861,0.084660575,-0.2924269620220866,0.051705900194118755
47609,SIDM00146,GSK269962A,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5166393,0.035975143,0.4859629137349383,0.06963947388354065
71481,SIDM01197,MK-2206,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.25097674,-0.018039009,0.06067848177951767,-0.015096549457005023
49818,SIDM00835,AZD7762,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,5.8146944,0.35535926,0.9342180260182816,0.05467300875213011
6856,SIDM00146,Axitinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6574753,-0.04951122,1.2551196751490137,0.18188402691012984
26242,SIDM00872,PF-4708671,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1080014,-0.092719205,-1.053025481678064,-0.09611232050559002
19998,SIDM00097,Bortezomib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.54271555,-0.03777867,-0.6604771063645006,-0.07060457879517842
103233,SIDM00673,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.42605236,-0.021526935,-0.9189708886236024,-0.03609931450237187
74677,SIDM00950,Dasatinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.9666467,0.16089147,2.609044163466286,0.15366771765943246
78667,SIDM00833,Olaparib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.85691166,0.030176774,0.693958510876279,0.006514925999907334
22341,SIDM00776,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3890859,-0.11331834,0.02121852515305052,-0.008401777951679745
44778,SIDM01042,Bortezomib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5901352,-0.03954605,-0.7143384870243555,-0.06020889383514094
89133,SIDM00216,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.54899347,-0.05218911,-0.4705528287014741,-0.042685219618931805
61493,SIDM00455,Crizotinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7844884,-0.061294846,-0.08801417232446246,-0.006720707506215084
92233,SIDM00837,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.9549648,0.04040642,1.15981528506286,0.057811610872242854
89236,SIDM00832,AZD8055,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.7767903,0.05321423,1.1872327977349502,0.06751885466937281
27551,SIDM00282,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.21166977,0.014002206,1.6776537220420087,0.1822283221746334
107381,SIDM00933,Palbociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.63051254,0.06296669,0.873707327033983,0.06610092563380393
37281,SIDM00673,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.1845936,0.0030422325,0.8885200018531734,-0.004719679992289477
91051,SIDM00832,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-2.5249243,-0.20873906,-2.0791676226383893,-0.10645584835014933
95151,SIDM00928,Temozolomide,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-0.9441829,-0.022955416,0.6409821408475384,0.007906479210561763
69946,SIDM00933,Ribociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.5906206,0.013193141,1.240300880819564,0.020316722425434777
99343,SIDM00097,Tozasertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0288758,-0.0560598,-0.5725088141142757,-0.02292568933165424
4362,SIDM00835,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,0.6246078,0.03609301,2.7561528939880446,0.11606273779876812
80585,SIDM00097,OSI-027,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.516676,-0.14565891,-0.35296038073141295,0.0024328825414533083
28878,SIDM00933,PD173074,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.75821704,-0.055664767,-1.0389056565996169,-0.03663178041697322
95267,SIDM00216,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.13241756,-0.011080817,-1.0400722525001835,-0.12410921030638632
75430,SIDM00359,5-Fluorouracil,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.58674866,0.030467274,1.003862311380765,0.0836139735871678
63878,SIDM00875,Linsitinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9272444,0.2442158,0.9782103880398941,0.08425168127330394
4093,SIDM00282,Olaparib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,0.64992803,0.017393166,1.4008771715665809,0.06720600880782028
2595,SIDM00833,MK-1775,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.21002641,-0.009507082,-0.42357694288192205,-0.0512379363731696
34951,SIDM00875,RO-3306,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3235371,0.03759619,-0.93504991126595,-0.05403446635290542
29816,SIDM00146,GSK269962A,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.96112186,0.08396485,0.562952428500278,0.03645421424492017
70753,SIDM00146,5-Fluorouracil,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0998678,-0.061981596,0.0469144813999768,0.02290295893281476
52309,SIDM00933,Linsitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.7488635,-0.0779646,-0.6954435144319415,-0.001378893424441413
92605,SIDM00877,JQ1,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.755768,0.13562424,-0.7926677404224103,-0.033440682166793065
80790,SIDM00875,Paclitaxel,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3042855,-0.09747372,-2.0783287696187096,-0.12815373776267058
8036,SIDM00875,Vorinostat,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68170345,0.07408888,0.2505058393296957,0.012677719812111509
47137,SIDM00950,LGK974,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6062946,0.06697083,0.4869272676996457,0.03858659786004972
5983,SIDM00933,Linsitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.6993324,-0.0071372967,1.7065564961595105,0.10978438245404011
5404,SIDM00928,Axitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.516357,-0.12741801,-0.7746022038261721,-0.03462858568161411
31940,SIDM00833,Trametinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,0.71470827,0.029138898,-0.43532620311001996,-0.0073909608783696845
23333,SIDM00097,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.649328,0.10709207,-0.806970386906689,0.006862629969965811
8378,SIDM00097,Pictilisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4162316,-0.22598739,0.10574332055233454,0.011859872802503058
77711,SIDM00633,Venetoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.73719573,0.018978108,0.98478496166442,0.006753511295888234
89129,SIDM01042,Wee1 Inhibitor,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.84153926,-0.045224987,-0.5444631922855765,-0.05561758779173983
5054,SIDM00148,NU7441,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0104086,-0.09774586,-1.066329591364876,-0.0758282801833154
69954,SIDM00875,KU-55933,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8438352,-0.031010477,0.2509462317166316,0.000609531786808683
16410,SIDM00872,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4808918,-0.06978795,-0.5001195884566754,-0.009012002684164033
94876,SIDM00146,AZD6482,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9454125,0.07622496,0.7041519619065438,0.11253094275405072
53344,SIDM00633,Wee1 Inhibitor,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.09549474,-0.008432916,-1.7208823929136823,-0.09015113107598689
58260,SIDM00097,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1918721,-0.15502216,-0.9033465652544017,-0.07824255790238394
98092,SIDM00928,NU7441,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.7079779,0.08233535,-0.14943177557569817,-0.01945154815237148
34708,SIDM00148,MK-1775,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.02623,0.12336449,0.904070520217739,0.034825611020075746
52045,SIDM00957,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.498955,-0.056781415,-0.08045239863536693,-0.0075236516042485255
39918,SIDM00097,Entinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7140038,-0.08236583,-0.9726257123161877,-0.041010764020956866
59595,SIDM00950,AZD7762,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8474003,-0.17675222,-1.957985267017644,-0.13712026284631623
93779,SIDM00835,5-Fluorouracil,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-2.5528378,-0.09620425,-1.6526536493168265,-0.030756943031409873
9127,SIDM01042,Pictilisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.52862555,0.027676359,-2.2741941748538173,-0.05690013761930928
99529,SIDM01187,Vorinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.16793047,0.011539656,0.595612861388236,0.027587038374647183
60696,SIDM00872,Nutlin-3a (-),Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.30504847,-0.007068196,1.060581175210269,0.015530088163300117
35738,SIDM00933,Temozolomide,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.73829275,-0.029780049,-0.11241346522393711,0.0553435460329922
67871,SIDM00957,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,3.5465653,0.09890554,0.8202811314832343,0.042031546667352884
67832,SIDM00950,Taselisib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9632824,0.06156767,-0.7913891593076057,-0.06909288615157964
71276,SIDM00832,Afatinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,2.4511876,0.17771348,-0.11183471609234148,-0.026402912406187213
32397,SIDM00097,Paclitaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6584888,-0.20497784,-2.7990596084915373,-0.22610528926728102
32792,SIDM00359,Camptothecin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.85699,-0.16388252,-2.411498874864517,-0.04903116404076332
5697,SIDM01042,Bortezomib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6239801,0.028291432,-0.8423698937589015,-0.06241090909513207
29667,SIDM00933,Pictilisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.8005171,0.21066453,-0.33691455011233673,0.04900935903239031
6667,SIDM00633,Paclitaxel,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.894095,-0.10470216,-1.2259883892149854,-0.06608794647390831
90436,SIDM00216,Taselisib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.2887576,-0.020721257,-0.3693455742723338,-0.04722097536651057
95952,SIDM00216,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.4800735,0.006842416,2.947718279149731,0.10527277330867245
27640,SIDM00837,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.5492027,0.030741429,-1.0425481110680932,-0.08133948997062687
4438,SIDM00933,Docetaxel,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.5799787,-0.22289594,-2.743794765751827,-0.19971392390269976
60581,SIDM00872,BI-2536,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7858808,0.17704846,1.806796961684054,0.12531814528730997
77027,SIDM00042,Linsitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6088971,-0.05511117,-0.9479988172773717,-0.017982042498048557
37451,SIDM00837,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.2870902,-0.011619149,0.5395939525872414,0.012058805369041161
57977,SIDM00875,AZD6482,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5207747,0.08294445,1.312818092116983,0.0584235613943154
90947,SIDM00835,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,3.7025425,0.20341744,0.8786532290308704,0.1009378879514733
90353,SIDM00097,Alisertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.706163,0.04373606,4.376629260562936,0.29427626057416323
38270,SIDM00146,Cisplatin,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0321224,0.03922121,1.743169493023875,0.0623665778689843
102977,SIDM00146,Nilotinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.6208586,-0.1285047,-2.1102797419838724,-0.10429104777499965
93391,SIDM00673,Afatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.374188,-0.027869774,0.859563738979176,0.07720424714339712
44860,SIDM00928,MK-2206,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.7254975,0.29424107,1.5139206168414838,0.11583828445266872
23205,SIDM00875,Paclitaxel,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.9382634,-0.11118332,-5.086708545409052,-0.31420668178298433
86027,SIDM00042,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1549373,-0.08469139,-1.519962902481619,-0.07450880433881754
20616,SIDM00776,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0310613,0.08701949,1.3586959087515023,0.06592890867132739
90515,SIDM00673,ZM447439,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.14983507,-0.012260998,0.7906565897539238,0.003241434760643432
17206,SIDM01187,5-Fluorouracil,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0302497,-0.09966226,-0.8934114167848827,-0.09484450172972579
7674,SIDM00872,MK-1775,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7249106,-0.106738865,-0.011952966485210516,-0.0390500617948847
96461,SIDM00877,Nutlin-3a (-),Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.518685,-0.06548877,0.8378815837297178,0.05794016518715062
16342,SIDM01042,PD173074,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.09162,-0.06894047,1.3624466210554036,0.03764541778128668
103667,SIDM00928,Luminespib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.7292565,0.1491471,-0.5990019664151112,-0.036850354209170606
16408,SIDM00097,MK-1775,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.44183874,-0.029992979,-1.2299830352395194,-0.07437167614114226
85380,SIDM00933,Bortezomib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.68141854,0.043196917,0.10583445669066499,-0.03251263016628563
11896,SIDM00835,Crizotinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.1345181,-0.16216768,0.8082386250982787,0.02359575993993322
9383,SIDM00833,Taselisib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.90608674,-0.0582073,0.10871174181358335,0.02551280544287738
95236,SIDM00933,Entinostat,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.48387468,-0.03321901,0.3662615226318251,0.019892143455848627
56365,SIDM00146,Trametinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.9377604,-0.16226801,-1.2454966362129407,-0.0660996332497186
86655,SIDM00872,Nutlin-3a (-),Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1702204,0.037620477,1.5633953838442933,0.04890050697582737
45007,SIDM01197,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-2.34095,-0.0491418,-1.7422387254256992,-0.06673367347257193
14458,SIDM00776,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.5722814,-0.037796024,0.742295831607568,0.05342861809036605
26446,SIDM00877,Entinostat,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.76010036,0.04879103,-0.4962029783883699,-0.016379655634782643
87100,SIDM00877,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,3.2062223,0.24346821,1.2435312405428707,0.10206007875447248
14122,SIDM00359,Navitoclax,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.31062886,-0.019494288,0.6888081788517402,0.01822741167161941
88523,SIDM00933,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.14999227,-0.022069387,-0.30549199736907084,-0.033105304744473894
65030,SIDM00282,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4328763,0.089525074,0.3228337899960335,-0.009034885827708988
34658,SIDM01187,Trametinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7006416,-0.07895624,-1.6725146514636458,-0.050124438243303315
84367,SIDM00928,PF-4708671,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.52443784,0.0439774,0.3990137934528214,0.03861552466668465
99706,SIDM00826,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.7355826,-0.015184839,-3.004499854803586,-0.05113476851748428
3883,SIDM00776,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.1426109,-0.10002904,-1.4139603327010513,-0.1125346658457434
61660,SIDM00359,AZD7762,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6153393,-0.1387716,-0.49138762318997575,-0.03446513479599795
105713,SIDM00633,AZD7762,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.7586606,-0.19062623,-3.383635759013165,-0.1997146130452931
78351,SIDM00633,AZD6482,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9150006,0.09071346,0.6396591603836888,0.04425649997835821
39563,SIDM00097,Bortezomib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0528167,0.061991636,0.9348370519386506,0.06300760207142272
26395,SIDM00826,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-0.7785456,-0.06276027,-4.934238624605847,-0.17427328017806917
104292,SIDM00673,BI-2536,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.039293706,-0.0030239206,-1.1064089439428557,-0.08181653196902702
97277,SIDM00950,Dactolisib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.691228,-0.04149901,-1.5762438763288604,-0.11086080288617557
29675,SIDM00042,Linsitinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.8483604,-0.063948035,-0.36119955332570763,0.0015481200529999324
68521,SIDM01042,AZD7762,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3530282,-0.18002833,-2.0404691793264704,-0.22058036349412186
29449,SIDM00282,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.357811,0.095455416,-1.2999019228480082,-0.07266327172995503
51717,SIDM00633,Linsitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.1491337,0.15034597,3.1015401752506473,0.07571657769857174
87125,SIDM00146,KU-55933,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8585982,-0.061943702,-0.049094213297706094,0.037753525543334596
45387,SIDM00148,Luminespib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33388627,-0.026948214,0.0018815617950852478,-0.041580455664055854
80238,SIDM00633,SCH772984,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,8.443317,0.3447276,1.7484169997250545,0.0752255138932028
12135,SIDM00282,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2056168,-0.04499357,-0.11014162649161909,0.004685242265360586
37382,SIDM00146,AZD7762,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.9360735,0.28138074,1.4247788866287505,0.15220983320831558
100657,SIDM00282,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.9980668,0.034251012,-0.42423090088748217,-0.08505901086258286
74749,SIDM00837,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.4090062,-0.043284524,-2.1357793372733105,-0.11243617792680285
11172,SIDM01042,Cisplatin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6042654,-0.024888447,-0.04076489523971351,0.018701998683257615
37433,SIDM00455,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3844357,0.04737658,4.0934161851427655,0.13211269354289965
100309,SIDM00933,Sorafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.4124057,-0.038333256,-0.857160702370223,-0.08350372570028976
5988,SIDM00877,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.8265743,0.17950359,0.9625593657327443,0.08279619372606915
87600,SIDM00146,PF-4708671,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.6447554,0.11274297,1.0991912218801139,0.07300311190421636
33456,SIDM00633,ZM447439,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.88126767,-0.078128494,-1.087491827245045,-0.0669491720874271
99237,SIDM00673,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.59297705,-0.04453303,-0.26069594326816165,-0.045655900797513874
83653,SIDM00950,Paclitaxel,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.249542,-0.09311455,-0.29040773048605445,-0.01418332647143026
105122,SIDM00455,SCH772984,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.6959996,0.3006024,2.988356414932719,0.2240798989011357
24075,SIDM01042,Temozolomide,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2252307,0.10804501,0.2062315053664189,0.04359507337755111
15759,SIDM00826,Olaparib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-1.043823,-0.06339267,-0.21083317214576613,-0.04087113225975986
66094,SIDM00837,LGK974,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,4.601847,0.17636408,2.1324673220038584,0.08251824737321478
39182,SIDM00826,Olaparib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.2688392,0.11160208,-0.04608692982628174,0.05389476923269093
26283,SIDM01042,AZD6482,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8023927,0.027451081,-1.6642285385969235,-0.06447341609229375
33719,SIDM00872,Gemcitabine,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1183884,0.08834961,3.4190196577823553,0.21365690859042735
102152,SIDM00455,Crizotinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3373786,0.07577901,1.2218796105649856,0.052735459395581434
59437,SIDM00875,Palbociclib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3301537,0.05185355,1.0960446238030968,0.04958395800604874
67864,SIDM00216,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.3095875,0.032956894,-0.38637347660323773,-0.019578863176509267
66772,SIDM00875,Palbociclib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.79568,0.023994332,1.5610931531629415,0.04481172821879569
86323,SIDM00957,Olaparib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,0.23225422,0.00233755,2.8652378221468116,0.04095878398008706
54483,SIDM00826,AZD4547,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.4303895,-0.09516637,-2.613936945082895,-0.12487102657359075
61890,SIDM00146,Ribociclib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-2.2329059,-0.07413698,-0.8139051983517528,0.0025557171456899188
2362,SIDM00877,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.3139364,-0.047024615,0.663937662694602,0.03316372193914527
83668,SIDM00673,Lapatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.25314352,-0.022475518,0.14506379614905904,-0.005915778210516153
2342,SIDM00359,Afatinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4649947,-0.11874547,-0.2677046096900564,-0.01899164134181746
59244,SIDM00146,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5736281,-0.051953383,0.39147645333428494,0.04893077685099935
70289,SIDM00146,Venetoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.8835008,0.025837775,1.3100547293347125,0.05909555286960227
58915,SIDM00633,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.1755514,-0.09371677,-0.8111815303366291,0.013312313866139855
32396,SIDM00933,Tozasertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-3.305667,-0.29649398,-2.446099319989823,-0.157837197306833
9166,SIDM00875,Bortezomib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5939694,0.06131886,-0.5192278919297764,-0.02414091381374178
39065,SIDM00097,PD173074,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5790606,-0.04540398,1.4552571427921563,0.08098199205232705
59987,SIDM00833,Oxaliplatin,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-2.819097,-0.09436813,-2.090196313653944,-0.09618591967338054
24012,SIDM00933,Taselisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.7637618,0.12783672,0.43589622076307877,0.0454891946474565
77050,SIDM00875,Tozasertib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.19938284,0.010181296,-0.5931732534922518,0.004387568970074432
20536,SIDM00957,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.5365558,0.05129744,3.3905377982901834,0.09801861590595011
49447,SIDM00776,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.5802126,-0.07939687,-1.903153127492155,-0.05350799615736334
82122,SIDM01187,Vorinostat,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4198947,0.117905825,1.6745402932930218,0.0982093803269718
25423,SIDM00633,JQ1,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.32233244,0.023099782,1.1326486815202388,0.09957698260157656
7697,SIDM00097,Gemcitabine,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.42906505,0.013899363,-0.4383836217145165,0.03955377098823879
98563,SIDM00146,KU-55933,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8743915,0.05007133,0.48356650829646763,0.030758875561213456
31573,SIDM00832,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-3.574503,-0.15848166,-0.8477826841358356,-0.021400261179563625
102689,SIDM00359,5-Fluorouracil,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1666722,-0.123693265,-0.5763210237666393,0.03467573736909843
93704,SIDM00148,Entinostat,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9259075,0.07126263,-0.4737720455586783,-0.04550060302425693
71159,SIDM00097,NU7441,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7438166,-0.035455614,1.5359053450621458,0.06934341662196161
63203,SIDM00146,Doramapimod,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.7597711,0.11053178,1.1635331091557564,0.047126521664978764
61663,SIDM01197,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2079206,-0.06697545,-0.44355466634632246,-0.01703643024744313
67584,SIDM00877,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.0650036,-0.09676618,-0.050522400648587804,-0.012672234355611172
35657,SIDM00875,OSI-027,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7662168,0.08442484,-0.2593260271124388,-0.014144897853945067
49086,SIDM00042,SCH772984,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.765714,0.06890578,1.7183084206736023,0.05389296673737552
55303,SIDM00455,OSI-027,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.15997168,-0.010583105,0.9938223320076031,0.03531434464515855
28907,SIDM00875,Navitoclax,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5803545,-0.06284974,0.8874196210670291,0.061754452726056876
37554,SIDM01042,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.2779245,-0.30208725,-4.935044714441895,-0.32566032741950995
76896,SIDM00673,PD173074,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.2852309,0.25109288,-0.7165495859755875,0.03212107561665845
104980,SIDM00146,Paclitaxel,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.5542116,-0.14118487,-0.8956937258755249,-0.06403379966869073
29467,SIDM01042,Luminespib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.80140615,-0.09736951,-0.9583463758324008,-0.05395956097340692
52182,SIDM00282,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-3.1359763,-0.1881903,-0.06197481589340953,0.002900513088190271
95132,SIDM00633,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.544865,-0.31498626,-4.380870316872386,-0.30773280409310355
98096,SIDM00877,SCH772984,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,2.0665982,0.097641334,1.660247616299749,0.11480174742796641
22147,SIDM00928,KU-55933,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.5881946,-0.06278687,-1.1782531590987997,-0.030005426230816496
11919,SIDM00835,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.2829784,-0.029625017,0.13978064516233868,0.0017436026858833012
31091,SIDM00673,Doramapimod,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0125319,0.02254781,1.173423579173826,0.022620833473974096
73670,SIDM00877,Olaparib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.0368181,-0.010960732,-0.24601541302876992,0.013902624515724469
77776,SIDM01042,Temozolomide,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8755051,0.035066918,-0.8787474322122447,-0.02490580850502662
72801,SIDM00673,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9358774,-0.1560091,-0.08404512499385688,-0.0742591636902082
64127,SIDM00633,SCH772984,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.46675503,-0.046472505,-1.3273407088513702,-0.03784061423844977
52613,SIDM00148,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.866108,-0.06523402,-2.4926946034371125,-0.10480277511694758
100010,SIDM00832,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-4.928556,-0.29371014,-1.6382739656469438,-0.0841896677857734
88561,SIDM00872,JQ1,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9828908,-0.022939904,2.099157587306339,0.10975460090245658
25692,SIDM00928,NU7441,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.3920019,0.16537698,-0.21709050503197808,-0.029429019866669764
44588,SIDM00872,BI-2536,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0827057,0.1924454,0.4325821397719409,0.025647725286355064
102813,SIDM00872,Alpelisib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.36094034,-0.03900089,0.009070318719088507,0.012168310555443767
22479,SIDM00933,OSI-027,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3701702,0.17970191,0.5560772544575019,0.04126042020126314
35742,SIDM00875,Docetaxel,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4193152,0.030967018,-0.4989560176086965,-0.0063941811294720005
64141,SIDM00835,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.6649705,0.13907099,0.8801336574428237,0.0477349100584916
12126,SIDM00875,Trametinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.683049,0.16307342,2.246036580559341,0.18270045248485178
78384,SIDM01187,OSI-027,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.19271,0.17640497,2.1819139655071917,0.1301684259201436
101817,SIDM00146,Olaparib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.1796745,-0.05553675,-0.26412087911756044,0.004134469961539227
18974,SIDM00826,MK-1775,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.773785,0.03675679,-2.1398982357185523,-0.04851769572860389
44187,SIDM00633,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.6641734,0.27343315,1.9625927554352316,0.14825983231853043
59585,SIDM00455,MK-1775,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4160829,0.1507837,1.8862409511127385,0.15394521598548758
46455,SIDM00097,Ribociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2540497,-0.0423834,-1.7270321512090405,-0.03015010114166348
43245,SIDM00833,Vinorelbine,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-3.6630201,-0.26451632,-1.664770158205248,-0.1569749993529486
44559,SIDM00673,Luminespib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.5825105,-0.15688622,-1.934507673561218,-0.10216464235111251
23860,SIDM00957,Trametinib,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.4149866,-0.12055464,0.7119954473973241,0.03388161002688808
53833,SIDM00872,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5022041,-0.08373013,0.05189655869734335,-0.030219555618502973
56602,SIDM00837,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.6242707,-0.025972083,-1.1651564674491692,-0.047238035880659904
69044,SIDM00146,Taselisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.84447426,-0.06041741,0.7752854706864344,0.11788270189676325
16702,SIDM00673,KU-55933,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8958414,-0.050125245,-0.3229168841257955,-0.05395951749325971
36956,SIDM00877,Ribociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.1728692,0.077319324,1.0777906864756017,0.019041906136255355
76713,SIDM00282,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.44422534,0.029867651,-0.01732327444328363,-0.047686821363784326
98459,SIDM00957,Afatinib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.686636,-0.08914951,1.3972390061492326,0.12724293458136746
45662,SIDM00216,Olaparib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,4.7923136,0.37328148,0.3332978631399682,0.05924359256407444
78777,SIDM00877,BI-2536,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-5.4923134,-0.068917096,-5.075154393359998,-0.07103972140454518
74061,SIDM00148,JQ1,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6323128,0.13863039,2.5145768279562564,0.12453749766842562
60601,SIDM00146,Camptothecin,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.36106727,-0.03448902,-0.7043572036043627,-0.04330844676369507
52447,SIDM00148,Afatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3490322,0.21902373,1.330263344156251,0.0936967609130561
31635,SIDM00872,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8394583,0.08444531,1.044821227404861,0.07532265615628549
104563,SIDM00146,Entinostat,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.39287907,-0.028731156,-0.07121825691886821,0.03669280343068554
62577,SIDM00148,Gemcitabine,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6218401,0.04133908,-0.08690049012126363,-0.05396202537263763
9308,SIDM00673,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.784386,-0.10919165,-2.176174529240881,-0.10396360907019447
19462,SIDM00872,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3416297,-0.11599071,-0.9999516734088931,-0.10742475123192717
100655,SIDM00833,Vinorelbine,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.57676125,0.038386993,1.3630398032882662,0.09219759556806932
25398,SIDM00148,JQ1,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.133246,-0.08293591,0.8416489315272689,0.035670458602888026
26396,SIDM00835,Crizotinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.33993372,0.027124569,-0.7367606300027624,-0.031757626653252
72693,SIDM00928,SCH772984,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.7426837,-0.086431816,-0.48715497846894446,-0.010966779099228876
58164,SIDM00673,Lapatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1090544,0.06864245,0.659690645569635,0.02811823650260835
82553,SIDM00148,Nutlin-3a (-),Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5846914,-0.058887582,-0.15956472279124356,-0.007189380657055141
69491,SIDM00216,Crizotinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,0.43171424,0.03859919,-0.9476062303931482,-0.0331080252891183
37809,SIDM01042,Camptothecin,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4873892,-0.10203846,-0.731046600315066,-0.008499981361734112
37946,SIDM00826,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,2.118446,0.044536702,0.8996328360667631,0.00397867117695619
48599,SIDM00928,Olaparib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.4353347,-0.08696407,0.2162891098522856,0.02187812888728438
28418,SIDM00957,Linsitinib,AZD7762,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,2.6989417,0.077523276,0.2939965922191845,-0.004458762210146537
13889,SIDM00455,Taselisib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7132843,0.09364687,2.4148973473115602,0.1183403305825125
68041,SIDM01187,Lapatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.49389464,0.037577208,-0.11761359618657591,-0.019844713803195864
80962,SIDM00835,MK-2206,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,4.3597145,0.293038,2.243101988785898,0.10567172841547334
66596,SIDM00673,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.8573928,0.28022584,1.210315836882036,0.06457214491002339
12700,SIDM00359,Afatinib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4313757,0.11826901,0.37056963557594813,-0.004926177129011747
28330,SIDM00097,Cisplatin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0091262,0.023143722,0.8761502163746809,0.03379265042060031
70078,SIDM00933,Paclitaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.423441,0.14607029,0.296650021030344,0.046216597436185516
62920,SIDM00835,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,0.1821639,0.012642122,1.0790287577605873,0.03118423523581898
83871,SIDM00957,Taselisib,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,5.5942516,0.21286489,0.44926861269457496,0.09543503206991191
44315,SIDM00146,Dabrafenib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.55551124,-0.021312337,-1.179205712626888,-0.020402949749783798
69436,SIDM00455,Olaparib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0899756,0.031969815,1.9495867652491672,0.07046679988918172
85664,SIDM00928,Vorinostat,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.93570566,0.09960576,1.369026152059419,0.10625372358644705
24119,SIDM00928,Nilotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.80563295,0.08148644,0.44929451954888183,0.023417491609786213
88357,SIDM00872,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8229965,0.024215922,1.3513415607283683,0.001445066417575323
64203,SIDM00837,Linsitinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,0.910299,0.0580129,0.37385994968905767,-0.04278060310306346
51286,SIDM00875,BI-2536,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.3333373,-0.25299045,-2.441228648455321,-0.10665260778436936
100190,SIDM01187,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0511664,-0.07913539,-2.4893900544999177,-0.14689345184454783
68460,SIDM01042,PF-4708671,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2268181,-0.09202732,-1.7772384613565904,-0.08112595276972405
98458,SIDM00872,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.59402215,-0.06408685,-0.30874240819232873,-0.07914698410596198
9101,SIDM00835,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.5861218,-0.049618,-2.11255646170743,-0.08021738378945335
94255,SIDM00877,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.3925068,0.007913618,-0.07650782005332214,0.03723494412843289
28000,SIDM00832,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,1.465225,0.062780604,-0.4281754047823722,0.03385924741129065
58700,SIDM00832,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.6632972,-0.07757324,-1.392153980967492,-0.06117911694805489
58868,SIDM00928,5-Fluorouracil,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.3018037,-0.052272677,0.8676299609280188,0.020811353236986404
36809,SIDM00872,Entinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.335567,-0.078083955,-0.48928477024329364,-0.03452877761467931
25101,SIDM00633,BI-2536,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.61705744,-0.06029936,-1.6451747221041646,-0.12845931190298115
35533,SIDM00359,Afatinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.98264766,0.063414976,0.3514839155976492,0.028029739797104627
72940,SIDM00877,AZD6482,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.47418743,0.045510665,-0.5183397198789941,-0.04271613102408436
86475,SIDM00877,Vorinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.16443521,-0.013051763,-0.07136717233111872,-0.03377940565773113
89526,SIDM00933,Linsitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.6682792,-0.070855506,0.035114843327815747,-0.03672240433823472
59739,SIDM00833,Dabrafenib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.1403117,0.025139257,0.7291759621683103,-0.00940506911873771
18193,SIDM00872,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9766031,0.031344216,1.829415724107948,0.07929053868361643
94186,SIDM00928,Bortezomib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.7184164,-0.050398108,-0.9938658976250443,-0.01634810384538511
102541,SIDM00928,Crizotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.930431,-0.094974674,0.04174636102834562,-0.014722372033471664
30197,SIDM00872,Trametinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5614876,-0.050950114,0.18508860289608575,-0.030398183442752927
67350,SIDM00146,Entinostat,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.379028,0.12064988,-0.3947869726240571,-0.010796459693957169
89755,SIDM00933,Sorafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8385135,0.014522779,-0.8060005309769364,-0.0427514568259738
80225,SIDM01187,Docetaxel,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6658378,-0.06206327,-1.2350214682143537,-0.08613777808701684
13198,SIDM00875,Pictilisib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7190823,0.07905726,-0.2690525280675085,0.023935509046335932
95250,SIDM00875,Entinostat,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7626668,0.077327736,-0.6219612567295372,-0.020166707965764193
99620,SIDM00832,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-1.2169288,-0.10545507,-0.9254048530496725,-0.09592715431090787
4588,SIDM00950,5-Fluorouracil,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8512137,-0.16841334,-2.067221218331312,-0.12814485093610137
7416,SIDM00633,Gemcitabine,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4059924,-0.11333449,-0.340081917849546,-0.02221373975803544
95054,SIDM00837,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,4.513531,0.09430083,0.6790499352066443,0.01767537559087752
72027,SIDM00833,AZD8055,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,3.2676675,0.13874397,2.0385761563210156,0.06592083083167688
103488,SIDM00097,AZD7762,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.292523,-0.049195357,-2.3768275177412974,-0.10108101696963301
37648,SIDM00455,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.2995455,0.09804329,4.995314400279491,0.16764674437835117
96242,SIDM01042,JQ1,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6044881,-0.02038443,0.02106615681920202,-0.023540254366836506
1301,SIDM00872,Dabrafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.37068006,-0.0071641807,0.8264413645193084,0.0229570182432697
18258,SIDM00148,Temozolomide,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.42938417,0.012689363,-0.3779033731725421,-0.0025718603339829004
12955,SIDM00933,Palbociclib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.5328859,0.20004207,0.9909155476174197,0.12166554131684046
101394,SIDM00872,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9586982,0.072566964,-0.11670453187431276,-0.036552173262856556
102512,SIDM00928,Temozolomide,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.015029,0.06211284,1.640585631921135,0.03161032648359085
50958,SIDM00633,AZD6482,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4456232,-0.11399119,-0.7380874344448272,-0.035455435154890816
33984,SIDM00928,AZD8055,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.7360845,-0.1874222,-1.2996636525789969,-0.10448477626205208
86683,SIDM00835,LGK974,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.1851839,-0.03387194,-0.5941044641064236,-0.018623274552184946
16508,SIDM00957,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,-1.2094097,-0.016603159,1.562287087153919,0.06189848344261563
19816,SIDM00837,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-4.3322043,-0.0607099,-4.396967224758763,-0.15974226119701276
7956,SIDM00875,Tozasertib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6474458,-0.062415957,0.5778037888390964,0.032580751987152726
26031,SIDM00872,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5387938,-0.029785447,-0.36582681981303505,-0.01737732625620076
22660,SIDM00950,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4022055,0.06906989,1.3612022974230467,0.09104723674371074
50888,SIDM00928,PD173074,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.1595776,-0.06014275,-0.08805984148504968,0.017263281327128097
103299,SIDM00633,KU-55933,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0886438,0.18635383,0.8911186051767367,0.055011141495151454
19087,SIDM00835,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-1.0276865,-0.02304555,1.1621620794409764,0.0363416831909304
85060,SIDM00826,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.23247115,-0.020646168,-1.6424722043425655,-0.07829931804494429
10206,SIDM00928,Ribociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.0592744,0.08610004,-0.7462140317640527,-0.019720703645742587
60107,SIDM00950,Linsitinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1934994,0.1161597,0.295963488274929,0.04219523072758894
80878,SIDM00673,AZD6482,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.26313314,0.02040291,0.5662462992744238,-0.00657845821356442
55752,SIDM00282,Olaparib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.30735132,0.007602659,1.324485260388024,0.024706350505751356
20563,SIDM01187,Cisplatin,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3504074,-0.08837416,-0.6486815310482384,0.011586329201671757
5578,SIDM00673,BI-2536,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.31683192,-0.025513554,-1.031554981238616,-0.07793294657990237
100803,SIDM00673,Luminespib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.4101743,-0.04103691,0.563477991444689,0.05081213615105769
99689,SIDM00042,MK-1775,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0552698,0.11183911,-0.903886262901872,0.013653408391419503
96523,SIDM00835,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.072102934,-0.004967026,-1.2278268019546497,-0.10586491004943444
47627,SIDM00928,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2093426,0.08986008,3.18615796220968,0.22581102728061028
22610,SIDM01197,AZD7762,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.4948454,0.19843066,1.574833157137445,0.11108313673770512
6521,SIDM00673,PF-4708671,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5824479,-0.09511585,-0.12494148273663636,0.0001768602145562232
3396,SIDM00455,Paclitaxel,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.52753246,0.037820693,-1.0100569968727287,-0.0236969947542461
23647,SIDM00097,MK-2206,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.1761193,-0.21284354,-1.2800322681561767,-0.01973751133356568
21967,SIDM00097,AZD6482,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5877903,-0.21759428,-0.7734488471550139,-0.11624867663932613
70161,SIDM00950,Sorafenib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.97043914,0.081430115,0.01846349116337324,0.029123260995744315
42780,SIDM00875,Ribociclib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1183281,-0.032686975,-1.2278238012860037,-0.01792293374763087
21499,SIDM00216,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.1857098,0.07246439,-2.0128297856228636,-0.09746488371391591
75078,SIDM01042,Linsitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2379743,0.08803569,1.0856730593251152,0.05747228307289236
74440,SIDM00928,Uprosertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.5235989,0.12174256,0.3116221841296027,0.0010129835003995869
41996,SIDM00146,Dabrafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.0081484,0.116271324,0.5570799459771587,0.008081229906293352
103128,SIDM00097,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2246268,0.026629074,-0.2422852648523039,0.022017548600201952
35628,SIDM00928,Alpelisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2063471,0.13530754,1.1084913539665966,0.0691554850212855
90849,SIDM00673,Luminespib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.5462353,0.047018655,0.6080252382215883,0.059544079779137775
79142,SIDM00877,Alpelisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.8911713,-0.0732438,-1.3547482506230069,-0.0742290937373526
48274,SIDM00837,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.2420318,-0.036518514,-2.002033486010188,-0.10096990581474093
20900,SIDM00950,Olaparib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7469693,-0.027588781,0.28886396848099577,0.042125831709727626
36430,SIDM00832,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.0652747,-0.047819737,0.047385691876135796,-0.0046530467498697835
14671,SIDM00097,Ribociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5064012,-0.049970016,-1.9053603175532166,-0.03691029302895029
14086,SIDM00359,SCH772984,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6891345,-0.05386289,-2.168905611981318,-0.10314170641165854
58957,SIDM00933,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.3413265,0.1161898,3.386808792151533,0.13590148724453577
86848,SIDM00359,Navitoclax,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.15016435,0.010573189,0.46305452984610185,-0.0016215366580311242
71848,SIDM00837,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.3306379,0.057764355,-1.4354106561460755,-0.03831844386219849
27574,SIDM00097,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.435737,0.0967041,-0.17432456573109023,-0.03175620581173473
92557,SIDM00835,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,0.9825343,0.033111773,0.015471343047057282,-0.012579006108124336
58911,SIDM00148,Temozolomide,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.30236733,0.010277143,-0.26624273153190975,0.01739265379905014
60831,SIDM00933,RO-3306,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.21510628,-0.02385364,-0.3836906866946052,-0.0540746804007051
52036,SIDM01187,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.8524357,0.09222568,0.3700932869564466,0.05349226868155998
15705,SIDM00146,Trametinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.0132709,-0.071527116,-0.15837503200247804,-0.03899766273060687
15770,SIDM00875,Nutlin-3a (-),MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8312624,0.023809567,1.5415791778047339,0.05302432705695356
62059,SIDM00837,AZD8055,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-1.0776497,-0.059079044,-1.2865100766524615,-0.07987625916612319
76578,SIDM00148,Crizotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2174479,0.049880963,1.4000910376038933,0.07128540325092037
68468,SIDM00359,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.344333,-0.13206668,-1.8226219339510394,-0.023482003913443714
82237,SIDM00833,Linsitinib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.5159733,0.19044001,0.2003053089212782,0.03588351073997233
44889,SIDM00928,AZD6482,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.011559,-0.10192184,-0.5921935436036103,-0.04647420349868343
54859,SIDM00633,AZD6482,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.75476325,0.06490134,0.26209543195088264,0.01350314314170066
87381,SIDM00877,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0550632,-0.057444066,-1.1735652800821668,-0.027607898455200498
55287,SIDM00877,Temozolomide,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.23920077,-0.006467208,-0.4120353813707915,0.03736390491826122
1976,SIDM00875,Dabrafenib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2559716,0.03674299,-0.19240960198888502,-0.029882366021331843
44029,SIDM00928,ZM447439,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.30560797,0.035865523,-1.2265796354435903,-0.08676981547304587
30791,SIDM00097,Cisplatin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0542669,0.021495536,0.3060439657177079,0.04936307367622111
30910,SIDM00146,AZD6482,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.7043678,0.12950478,0.7403390265748139,0.1038069710389298
102751,SIDM00097,Trametinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9161301,0.067120224,-0.0480571744086434,-0.00849599549639904
38518,SIDM00832,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,1.6963599,0.09124597,0.5929154914419126,0.0028483744250312948
14446,SIDM00146,Taselisib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0132158,-0.08458069,-1.1209328872358983,0.005127115574424474
42323,SIDM00148,MK-1775,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7920638,0.106253,0.6093204146140966,0.034246613952980245
28384,SIDM01042,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.67335105,-0.027724834,-0.18483015572448813,-0.011001356879633502
76677,SIDM00146,Bortezomib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.4234398,0.02572434,0.3434167780815459,0.052248889475132704
31544,SIDM00832,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.134353,-0.11985165,-2.0394897310485014,-0.05575555711717047
62762,SIDM00933,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6150517,0.045094345,1.5929921243982077,0.19438024846399293
95194,SIDM01042,Ribociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2536496,-0.044403642,0.6393444584537109,0.015514865223884598
50741,SIDM00216,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.7053963,0.026314653,-1.9913534483117739,-0.04934366576218426
60671,SIDM01187,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3681852,0.09806051,-1.4328519722456254,-0.09488897865923548
23070,SIDM00933,Olaparib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.2613976,0.03310996,-0.8147465927789806,0.005250718579086858
21641,SIDM01187,Axitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4767555,-0.09158028,-0.7814465822609669,-0.019385808282312195
72868,SIDM00148,GSK269962A,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5085044,0.13446791,-0.6786347123715792,-0.07315585465377497
89195,SIDM00928,NU7441,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.0189166,0.22965805,1.0852110234993741,0.027520595666670398
69894,SIDM00950,SCH772984,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4215624,0.10706311,1.0980041305655925,0.09573022812384237
34755,SIDM00673,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0858312,-0.09651153,-0.05872078578916452,0.0005853913346474044
8664,SIDM00146,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.3749294,-0.030337349,-1.0474087569469515,-0.0804352736513148
359,SIDM01042,Entinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.82475305,-0.100166544,-0.1601085661540048,-0.008605193697943459
78501,SIDM00673,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.7045798,-0.1163242,-0.3969564042409777,-0.02037470736446999
13501,SIDM00928,RO-3306,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.3986145,0.11832193,1.0021123825716207,0.024100253549812146
22081,SIDM00877,Trametinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.66966015,0.022132926,-0.13225124908461183,0.0536993538594938
90404,SIDM00933,Tozasertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.779934,0.14570671,-0.8153839433930223,-0.048321571157314815
79621,SIDM00148,Olaparib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4862673,0.16045897,-1.1808182044940738,-0.04600686323218042
15855,SIDM00875,SCH772984,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0239598,-0.09280629,-1.7635138474251844,-0.05683309382983449
11008,SIDM00359,AZD7762,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.423534,-0.20545894,-1.8662188542196543,-0.07627193995794027
84374,SIDM00928,Vorinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.6780195,-0.10645335,-0.32104192269977766,0.0024435297201336184
77535,SIDM00148,Bortezomib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.19627829,-0.017029168,-1.447023234008799,-0.06180574710742574
98772,SIDM00933,Temozolomide,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.80905974,-0.03407474,-0.26084053874486207,0.02213256384460912
90725,SIDM00146,AZD7762,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.044655308,0.0036569615,0.6520286441865523,0.046937210306164094
45559,SIDM00216,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.63768774,-0.059228353,-1.0486397581824196,-0.07144639514861903
22713,SIDM01197,SCH772984,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.329068,-0.05057223,-1.4291456091079624,-0.033382928253431705
50421,SIDM00837,Afatinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,1.4461114,0.06452456,0.6465436101237346,-0.004733142641305999
107653,SIDM00928,Tozasertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.29846314,-0.008443554,0.6241195974781204,0.0005176760026485307
53336,SIDM00833,AZD4547,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-2.3930256,-0.06807797,-0.6193383158490815,-0.04871249416728235
20351,SIDM00148,Nilotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.78749907,0.074070424,1.1457073817176617,0.04234988596932986
4442,SIDM00875,PD173074,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3860126,0.10400735,0.6314542045212873,0.06095074788301117
31914,SIDM01187,Lapatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.68389815,-0.05882416,-0.5768457244878604,-0.08796900754223713
26810,SIDM00282,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.3565447,-0.1083156,-0.9115543405789932,-0.04991073172172618
17906,SIDM00832,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.5543965,0.016882293,1.3997259918733365,0.05790605775817362
59211,SIDM00872,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.88056594,-0.023169518,0.7576517699738606,0.025805656832826193
31598,SIDM00933,Temozolomide,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.37696132,-0.012171338,0.3779816547965081,0.020631346739422605
72535,SIDM00359,Oxaliplatin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6314303,-0.090821505,-1.569697038810789,-0.05119686625868998
15710,SIDM00097,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0914083,-0.11911036,-1.578531485285553,-0.06710536019420306
10276,SIDM00633,Uprosertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1696422,-0.063220374,-2.5753154707754016,-0.10236753288489582
71212,SIDM00633,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1887228,0.08832153,-0.8479533098555893,0.0073661071172052405
30264,SIDM00097,5-Fluorouracil,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5992432,-0.09274403,-1.1820418532017067,-0.022948650504105158
70427,SIDM00928,Uprosertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.098731,0.16983983,1.2229969375846284,0.09663245037011146
94719,SIDM00673,Entinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.11734591,-0.009795312,-0.0013834267677676404,-0.022333417152387087
104048,SIDM00928,Entinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.4492194,0.039890565,0.35187218461870845,0.028927587369646436
20949,SIDM00097,Temozolomide,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2568037,-0.0038251162,-0.0702767989636789,0.002753760116996074
44062,SIDM00950,Oxaliplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3184549,0.107183725,-1.3300169717118977,-0.043018408452077134
78299,SIDM01042,OSI-027,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.57522273,0.05537432,0.3547075371626876,-0.00485160681494424
75245,SIDM00933,MK-1775,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.5118181,0.024182769,0.11156740296949016,0.011927125107660573
52931,SIDM00146,OSI-027,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9790945,-0.1757756,-0.6726982531109698,-0.08263098677257877
67449,SIDM00097,AZD6482,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0607467,-0.07109653,0.10200457814055881,-0.020327418111740877
59286,SIDM00957,LGK974,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.7262745,-0.026699243,-0.48902561462559835,-0.0030511768587453783
11515,SIDM00957,SCH772984,AZD7762,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-2.0650012,-0.08848763,-0.25891701635718617,-0.01018984039366759
43652,SIDM00633,Palbociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.113678,-0.04807352,-1.7559129269216456,-0.08686332360490207
99538,SIDM00216,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-0.77031434,-0.007794753,-2.6902994884181615,-0.1054961960509656
54234,SIDM00673,Paclitaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.8282721,0.11853248,0.6240852215321718,0.006746422440478754
95909,SIDM00097,NU7441,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.968995,-0.07850583,0.23762853189219113,0.0404248443114137
38421,SIDM00877,Docetaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.5853371,0.06502301,-0.7035477094532039,-0.017085530810771132
42099,SIDM00872,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7949071,0.019576728,2.492151997244764,0.04001066119672305
103990,SIDM00216,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.2829909,0.05407759,0.3975701004358056,0.06520002378506676
23969,SIDM00148,Cisplatin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8348463,0.025274735,0.548767989141529,0.023577302883794463
41600,SIDM00928,GSK269962A,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.5112495,-0.15569916,-0.8526154287043924,-0.0468433439918418
84739,SIDM00673,GSK269962A,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.0421948,-0.12457708,-0.6422666100612506,0.0005249133773253566
89035,SIDM01187,Pictilisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8027079,-0.13051642,-0.8921417322666125,-0.07452663706260083
914,SIDM00933,Afatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.9258473,0.17302477,-0.3345201003630348,0.02965813637668563
91712,SIDM01042,BI-2536,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9175843,-0.0035579733,0.2044507060963658,0.015299043051213742
59186,SIDM00933,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.34219417,0.033189856,-1.7013965940127909,-0.08143930228371803
53303,SIDM00148,Nilotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.010150787,-0.0009766989,-0.6873887612061909,-0.04839873233212032
64050,SIDM00282,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.6902373,-0.15637542,-0.8898340554553887,-0.07760168462195054
97485,SIDM01187,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9232854,-0.039462063,-1.5268714913434482,-0.03189399979894597
84121,SIDM00148,Nilotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0032663,0.09503248,-0.043873748396374514,-0.011318442370066772
95185,SIDM00148,Paclitaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2008212,-0.16570252,-1.5500511616213561,-0.11187424669039976
47568,SIDM00042,Crizotinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.035321,0.08302711,-0.813033706405159,-0.054184062072307346
49605,SIDM00146,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.104193,0.062937334,1.4840617577109558,0.0966354634943003
37329,SIDM00877,JQ1,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.0909872,0.10851844,1.750931903997444,0.11958630653234165
92341,SIDM00826,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.6708994,-0.03428941,-2.001468500795706,-0.07673907544667244
80988,SIDM00875,Tozasertib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8056568,-0.068374835,-0.65021170011934,-0.003268130233426412
22868,SIDM00833,AZD4547,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.1469964,0.07392605,0.24132315295016643,-0.037640731303253065
24492,SIDM00928,AZD8055,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.905521,0.31410348,0.716397862287669,0.05766749921225656
23706,SIDM00673,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.5515479,0.033756513,0.4784738415975908,0.01634389326108017
63596,SIDM00097,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8246939,-0.046922665,-1.4097937679437151,-0.0462719330430154
59412,SIDM00826,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.003189015,-0.000259208,-0.08857387350992853,-0.05205857559718028
12482,SIDM01042,Entinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.315951,-0.15559612,-0.2594533079612739,-0.007122667898030218
30862,SIDM00633,GSK269962A,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.3870696,0.036316395,-0.7130907935460518,0.014546712215430718
48780,SIDM00097,Nilotinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5717626,0.104926325,-0.4090231961720582,-0.0494030327674745
83333,SIDM00837,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.79585105,-0.06571059,-1.046660976025993,-0.0626909771643707
84043,SIDM00957,LGK974,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,0.93372357,0.012708238,2.106858659053905,0.06502715927471793
31911,SIDM00146,Olaparib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.6551147,0.336827,1.4629461472354663,0.09918562181032696
15775,SIDM00282,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.5192255,0.109878935,0.675069804988909,0.057201744264912514
107292,SIDM00633,Ribociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2053587,0.05027476,-1.059634828061439,-0.004073433759054959
29128,SIDM00875,Temozolomide,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.855026,0.022105264,0.4336961612739445,0.021421197041154576
46478,SIDM00877,Doramapimod,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.3392734,0.030040415,-0.9697727184065092,0.015165678458047373
91095,SIDM00633,Pictilisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.69893,-0.123344935,-2.325317214771684,-0.11546791951600975
36770,SIDM01042,Lapatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4289885,-0.052474726,-0.2921973951147957,-0.04950640623136086
82299,SIDM00282,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.6653838,0.07003388,0.5202903419632456,0.03618707463881941
105466,SIDM01197,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.4335991,0.10679601,0.4846038049219538,0.027567993205009706
27407,SIDM00833,Trametinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.8235719,-0.08464357,-0.9464152174510985,-0.05632068585440574
57997,SIDM00928,Trametinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,4.105772,0.25389764,1.8948243445924757,0.07892796031080371
56726,SIDM00146,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.6114432,-0.048239317,-0.5710264925129211,-0.02754793249031372
35342,SIDM00673,Venetoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2060102,-0.02379295,-0.11056398731697041,0.015473746856835663
86312,SIDM00933,Alisertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.7657163,0.28680173,1.0950279804795695,0.06199538338060907
12594,SIDM00216,MK-1775,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.5224967,0.015849791,-0.44797770991994335,5.026108066154722e-05
67681,SIDM00282,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.87283915,-0.05983512,-0.44038135488324887,0.012965084817136971
29314,SIDM01197,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7180727,-0.084407784,-2.4104719645572925,-0.05651658502024268
107875,SIDM01042,SCH772984,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6346855,0.039528113,-0.5927070658315247,-0.002236617519108024
60726,SIDM00282,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1566228,-0.066734225,-0.6432159623377022,-0.014699301179477927
45808,SIDM00148,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.30631086,0.03132573,-0.09592847002542346,-0.014687161227692994
67122,SIDM01042,Axitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1135949,-0.10848365,-2.144788762405133,-0.07546766936052798
90612,SIDM00832,Afatinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.2867174,-0.1231463,1.260906913502726,0.045781691730700416
21513,SIDM00877,Paclitaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.2446163,0.123649046,1.6703650847108578,0.13272490896512204
87567,SIDM00673,ZM447439,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2852281,0.09955716,2.807249293910701,0.1534751906161742
59875,SIDM00359,AZD8055,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1745507,0.07577732,-1.589965471653968,-0.06678773501698053
48400,SIDM00875,AZD6482,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94042677,-0.060958542,-0.7709568202836742,-0.0005960146823854695
45478,SIDM00097,Nilotinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.73611695,0.03806791,0.8529869369666929,0.02008987744384768
4235,SIDM00097,Uprosertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.66469914,-0.042855907,0.6968677003787832,-0.0034351104853313614
82925,SIDM00875,Wee1 Inhibitor,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.15006545,0.009745789,1.2399517379541876,0.057284197216103096
72554,SIDM01187,Crizotinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.082626,0.095135406,0.6779304641141158,0.071192612577723
78589,SIDM01042,Tozasertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2391567,0.19773583,-0.19293977422424735,-0.0027277474700171675
3552,SIDM00933,GSK269962A,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.2909431,-0.087109424,-1.48778639470168,-0.1315901876672735
43430,SIDM00633,Entinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.83082783,0.0641607,0.4939555408892806,0.07946888746111319
80694,SIDM00950,Erlotinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.6596062,0.092526026,0.9409122105757532,0.0221114190180279
57196,SIDM00148,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9038968,0.22478329,0.21839588334319932,0.047733222365910155
82790,SIDM00875,Crizotinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.32918748,-0.03517197,0.15663437351054527,0.004761403155710543
73444,SIDM01197,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6732184,-0.13173252,-0.9210476946441594,-0.10804249297060294
18517,SIDM00148,Uprosertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.56072783,0.036084253,0.5280090621257219,0.0206209888901793
32932,SIDM00673,Uprosertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.4549909,-0.13520786,-1.8418573225301802,-0.07374162868764714
98832,SIDM00877,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.54352,0.051757395,1.376204963521416,0.11448668858900804
24031,SIDM00146,Axitinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.9418004,-0.16268629,-1.1606884471949888,-0.0037062861435284886
97017,SIDM00673,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.156714,-0.35718188,-2.5534885578909523,-0.12152954082385037
57807,SIDM00928,RO-3306,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.3161061,-0.08473373,-0.45789372418996804,-0.05546224347100867
51610,SIDM00875,Ribociclib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1999435,0.044763464,0.9195706793069319,0.021661007152569165
13589,SIDM00872,GSK269962A,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.45401296,-0.042844746,-0.689054366562412,-0.037359047415562764
52715,SIDM00633,Navitoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8922676,0.122027606,2.2936659839067537,0.1458460835577744
486,SIDM00097,Lapatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.3307734,0.2897625,0.7083127454892665,0.020565832619683116
78026,SIDM00933,Docetaxel,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.6622381,0.08803983,-0.39212419878673055,0.027353022774669555
13083,SIDM00042,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.55507,0.1757719,1.511184213781711,0.08765102646672518
34739,SIDM00877,MK-1775,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,0.21750592,0.005030214,-1.0548887161552996,-0.008476211165195348
61801,SIDM01042,Venetoclax,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5265975,-0.065810986,-1.7586021878932656,-0.006821344913451049
8210,SIDM00957,AZD8055,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.0399712,-0.019170457,0.6616601699340796,0.0893677145426304
46763,SIDM00933,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.58748335,0.008154994,-0.7892184449415343,-0.06127434451701022
54867,SIDM00216,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,-2.008542,-0.053419765,-1.638687029360649,-0.04135563334707551
77245,SIDM00097,Docetaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.675239,-0.16746303,-3.5199800278857367,-0.2640519757868242
45937,SIDM00633,Docetaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0514419,-0.085383184,-2.6367145457389762,-0.12658383607628118
56999,SIDM00928,KU-55933,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.0733918,-0.053138014,-0.6682035909958313,-0.013943549278812375
60849,SIDM00146,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.062643,0.07126061,1.2558817767193293,0.04008631186369077
50697,SIDM00148,MK-2206,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6003865,0.093632735,-1.0385096784038457,-0.03980084818688017
104809,SIDM00146,Navitoclax,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.8004034,0.05564493,-0.08947690227287589,0.022570148094908975
19487,SIDM00042,MK-1775,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.34380394,0.03753143,-1.6713043412105018,-0.11812556987116488
43061,SIDM00148,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.952303,0.19143215,2.203018947296934,0.1549004870288904
73349,SIDM00042,Taselisib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.65140355,0.048050214,0.26269158577193563,0.0038834135792528094
74872,SIDM00877,Entinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.454527,0.055964444,0.13050627352257554,-0.06056567970589775
61462,SIDM00455,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.60042,-0.073799446,-2.280909446040503,-0.08446562285796816
23171,SIDM00826,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.8710531,-0.07014429,-0.9632235654536127,-0.09468948553736463
98205,SIDM01042,Cisplatin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.31729546,0.015339376,1.4340621969710297,0.057055476073872353
52153,SIDM00042,LGK974,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2679139,0.055890117,-0.580653511780326,0.004552523548447476
98479,SIDM00875,GSK269962A,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71999323,0.014250766,-0.5677885064826147,-0.052197717226172245
31451,SIDM00933,Olaparib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.5153143,-0.14719047,-1.181451492432208,-0.014150250437401085
49754,SIDM00776,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,0.6014881,0.018276459,1.2242517147432286,0.032044295167481945
9755,SIDM01197,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.1568375,0.09416031,-0.8774014900056725,-0.014122338474676834
73136,SIDM00875,OSI-027,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5413798,-0.052367907,-0.9098378738850447,-0.03990999628889124
60008,SIDM00833,Dabrafenib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.7282808,0.0358842,1.6102555942579182,0.04675001210132711
85433,SIDM00875,Sorafenib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46677536,0.037868835,0.648152996579994,0.10300817689121787
58492,SIDM00146,AZD8055,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4526669,0.11877332,1.4607780137003086,0.10689615795844541
74106,SIDM00148,MK-2206,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5863836,0.05935699,-0.7175284500098323,-0.012907477340560542
77152,SIDM00282,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7675071,-0.059280995,2.8256024111411273,0.08777855957903913
30972,SIDM00928,AZD7762,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-3.7463934,-0.34775737,-1.7481342118994814,-0.21300323202178217
107394,SIDM00872,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5548736,-0.07392153,-1.230536938399176,-0.0873546123016169
58912,SIDM00455,Olaparib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.122692,0.052792914,1.6586376300520966,0.0958939132051881
16272,SIDM00928,OSI-027,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.6093709,-0.06351925,0.61384742769643,0.052445848363343484
47094,SIDM01042,Lapatinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0277293,0.14770018,-0.6650195258583245,-0.04393081967767019
354,SIDM00146,BI-2536,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.9207381,-0.08348784,-2.4802028604379704,-0.062476661638871674
45285,SIDM01197,BMS-754807,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7012383,-0.025328225,-0.712473714540197,-0.06322813484890613
17076,SIDM00837,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.2541215,-0.011672449,-0.3640847578233266,-0.0730429355882528
95935,SIDM01042,BI-2536,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.5012345,-0.024001723,-1.9132738774192108,-0.08681709561191657
29804,SIDM00877,Luminespib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6733588,-0.1259857,-0.17686265689523553,-0.008441748724856145
66311,SIDM00877,JQ1,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.3049794,-0.1464299,-0.8073491652013609,-0.0012598678014930495
61798,SIDM00872,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.6070526,-0.26185533,-3.4319928476241364,-0.2328667530038877
50327,SIDM00148,Lapatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.48183367,-0.049304947,-0.12128783194826591,-0.031864772820942536
8612,SIDM01042,NU7441,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0564454,0.0653508,0.13093142593062707,0.05181759153806519
17172,SIDM00833,Vinorelbine,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-0.5360038,-0.040802736,1.02359128461813,0.022301175499347264
78632,SIDM00833,Crizotinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.4539043,0.019874357,0.8813734700872796,0.07518507150038871
103556,SIDM00282,5-Fluorouracil,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.5618736,0.043228805,-1.3921138257853793,-0.07405470284192318
62902,SIDM01042,AZD7762,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8215185,0.18157415,-0.7843131939497968,-0.04552353308530625
27243,SIDM00776,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.9221282,-0.12103088,-2.9302019690250996,-0.1789085965478599
50290,SIDM00933,Cisplatin,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.70751387,-0.07455691,-1.0552973893628834,0.003840417001683352
62722,SIDM00957,SB505124,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-5.055961,-0.077059075,-0.1859837267175271,-0.020099612314769765
72500,SIDM00933,Paclitaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.3701279,-0.11003212,-0.0872853967685524,0.0583597486325037
15428,SIDM01042,Ribociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3354657,-0.047474835,-0.3741448020402396,0.022975781824627093
80261,SIDM00148,Palbociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.5861456,0.26356146,0.17059275940021487,0.009551745568257348
54105,SIDM00826,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-1.3130476,-0.104738794,-0.6702585812383635,0.004208741875113359
71654,SIDM01042,SCH772984,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7062411,0.18780804,0.2799114916949122,-0.019435389268332423
85396,SIDM00148,Luminespib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.07119754,-0.0055305487,-0.7459693682861415,-0.06790174738901421
50490,SIDM00673,Olaparib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.078402,-0.074167445,-1.4015869586120837,-0.03125116630983405
57874,SIDM00146,Cisplatin,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1203871,0.04837451,0.7516627183897386,0.07138785014187711
43935,SIDM00148,Alisertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6883801,-0.091389745,-1.0714947556536887,-0.01856251133555801
26371,SIDM00928,Crizotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.1720102,-0.19620964,-0.8893987571723417,-0.05581109067462631
86776,SIDM00933,Trametinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.63936555,-0.08710999,-0.33554291112489165,-0.006918774498795522
17697,SIDM00928,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.817537,0.24787743,-0.25071480560158227,0.022075499547976208
54873,SIDM00835,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.541754,0.12023293,1.5647354861043814,0.02802242307739263
16877,SIDM01197,SCH772984,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-2.936089,-0.073409624,-0.9434733282190336,0.017940988942262547
31064,SIDM00933,AZD6482,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.0555563,0.043448742,2.439184106938157,0.10237890095445795
7567,SIDM00282,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9124612,-0.047819097,0.34840123306068227,0.01083460271869012
103728,SIDM00633,Lapatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7009196,-0.063918985,-2.0907656994744213,-0.08388977307532873
63608,SIDM00928,PD173074,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,4.9474545,0.3835903,1.7567972787333128,0.037013088312082006
15161,SIDM00826,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.7632176,-0.15518527,-1.8017485329000849,-0.1334889108311039
71310,SIDM00097,BI-2536,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2709374,-0.14880921,0.0025391090200824846,-0.01951433784202578
94247,SIDM00455,MK-1775,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.8171955,-0.040095463,-0.2740777995077898,0.01682133835134392
4239,SIDM00872,Uprosertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9313576,0.097934335,0.14424913013879787,0.015999244954595693
43429,SIDM00826,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.7446957,0.056086242,0.8169413240490215,-0.03355614457390367
104798,SIDM00877,SCH772984,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,2.2471073,0.10447122,2.3435361101151373,0.08866581649615704
15282,SIDM01042,JQ1,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0791306,0.025205474,-1.38384718760972,0.020104111565818088
2893,SIDM00633,Nutlin-3a (-),Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5264641,-0.04110166,-0.500757848964323,-0.0437335548231273
5938,SIDM00359,AZD4547,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1669111,-0.07020203,-2.1076711516784816,-0.05931264311061362
46028,SIDM00633,Navitoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4379944,0.12019758,0.41353940877282913,-0.005802310483034037
77550,SIDM00146,Navitoclax,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.22321056,0.01729548,0.7446714069391177,-0.02784854079500125
89643,SIDM00875,Nutlin-3a (-),Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6693631,-0.019624148,0.6112299316038745,0.027196312022047094
89374,SIDM00928,Taselisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.231076,0.14808618,0.2502519411103516,0.019626291559004663
77447,SIDM00875,NU7441,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.6513326,0.05342783,0.37660940299337936,0.013923371650669805
107142,SIDM00833,SCH772984,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.2299169,0.019555604,-0.23094825892384288,-0.00647557306859152
7285,SIDM00776,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,2.8577716,0.17153099,0.2487579141176182,-0.017456925743918113
5684,SIDM00673,Trametinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7606614,0.07118745,-0.09313426520143053,0.008113371059822759
40671,SIDM01197,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3514652,-0.06065536,-0.5921702592886476,-0.03738247311085124
75087,SIDM00833,MK-2206,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,2.0468476,0.13479194,0.02509361752739433,-0.003774530999028409
59914,SIDM00146,Crizotinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.77526474,-0.07057467,-0.2561680691732091,0.029837250345147025
31373,SIDM00455,SCH772984,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.1908627,0.117359735,2.0584628427398513,0.08759003708075365
3444,SIDM00455,Ruxolitinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.1269906,0.09195047,2.1616132696828454,0.06371908227643254
18806,SIDM00633,Ribociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9425789,-0.028021777,-1.2425005534854534,-0.029468456257547956
3018,SIDM00673,Alisertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2153983,-0.10893765,-2.5677918393475645,-0.09520060701244072
91106,SIDM00673,Paclitaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.704121,0.041950967,0.741877827871459,0.04533895489353076
47913,SIDM00673,BI-2536,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.21281464,0.01687419,-0.5932085409295889,-0.044120257815137884
99400,SIDM00146,Wee1 Inhibitor,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.52744424,-0.042831425,-0.37795611099871523,-0.01933517706919871
88981,SIDM00148,Tozasertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3398062,0.095716305,-1.8407194914493703,-0.09278056968816792
22109,SIDM00872,AZD6482,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20672175,-0.020846287,-0.7155389005017289,-0.04980379189581035
30359,SIDM00146,Sorafenib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5030461,-0.04593685,1.1066928325678724,-0.00662337477583547
82252,SIDM00673,Uprosertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.3966193,-0.096367866,-1.5054409963686612,-0.07178409338533917
73879,SIDM01197,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.7145965,0.10342572,-0.8123195859869483,-0.00400223805936056
86493,SIDM00673,Alpelisib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1753243,-0.06605395,-0.22669697008382947,0.005216689586707816
73982,SIDM00146,Trametinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.20647037,-0.015771573,0.23969136542879607,-0.008885900360453697
40296,SIDM00148,AZD7762,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.527092,-0.19080578,-1.0612319363063167,-0.053936138158754206
46144,SIDM00146,AZD8055,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7202045,0.06525639,-0.8032744321025957,-0.06056726868605101
13714,SIDM00872,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2546948,0.072908476,-0.2668362824576116,0.02093066662979749
98655,SIDM00097,SCH772984,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4731553,-0.07048757,0.05500370437480006,-0.025021370901489755
36494,SIDM01042,Afatinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0935576,-0.13702479,-0.46884949932247927,-0.04461898472997685
64951,SIDM00833,Linsitinib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.13715427,-0.009245177,-0.1422096517640043,-0.005015711471110461
86562,SIDM00097,Trametinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9102665,-0.051531356,-1.3146355674046453,0.011093712532538836
1386,SIDM00933,Ribociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.0871255,0.06887317,1.5673069630964749,0.016770311687507537
91941,SIDM00097,Wee1 Inhibitor,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4359856,-0.07354617,-0.7659009286367021,-0.025501862862973963
18976,SIDM00673,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1272172,0.015457175,1.917156857131171,0.010137537518139696
61720,SIDM00148,Temozolomide,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4471308,0.0593428,-0.4992916812012454,0.009780766055226719
95379,SIDM00282,SB505124,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.8207922,0.12022732,0.8769164659730936,0.08548308702358699
69161,SIDM00933,Lapatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.5372338,0.07443816,0.8373998016753469,0.08212259734188819
59188,SIDM00837,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-3.0240133,-0.085109025,-2.9146201898623705,-0.2032928615408638
22685,SIDM00875,Doramapimod,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1872807,0.08961114,1.3414777211073645,0.019034183793110657
3701,SIDM00776,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.0770487,-0.093443654,-0.42723876232348296,-0.055486889394693525
15886,SIDM00875,Trametinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0985667,-0.10871862,2.705546977331695,0.1405978298618159
40389,SIDM00097,Venetoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2151933,0.03744585,0.3846359805950736,-0.0031626632774187278
16964,SIDM00835,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.1417162,-0.085899845,-0.4716774821461104,0.01336656426124507
31515,SIDM00835,Palbociclib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-0.97597,-0.0224405,0.13324025193720038,0.00467501793080159
92621,SIDM00359,MK-2206,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6880195,0.11032664,1.6250350288810416,0.09983382782868584
40537,SIDM00833,Taselisib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,2.5548341,0.20162256,-0.5190772850724641,-0.015716583360222008
97926,SIDM00875,Camptothecin,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6160725,-0.014718255,-2.0214239513322445,-0.15651720851016332
8940,SIDM00097,PF-4708671,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.908262,0.1479458,0.8851977609327575,0.058789910502439334
32070,SIDM00673,Ribociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.5377035,-0.076388486,-2.0735551170212085,-0.08880211395789256
55961,SIDM00957,SB505124,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-2.7080083,-0.04039207,1.8067034097161787,0.08191569734513472
12143,SIDM00097,MK-2206,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.45267442,0.03391675,-0.014396504052916126,-0.02419218615875062
50068,SIDM00837,AZD8055,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-1.4325233,-0.05842128,-1.3698811773926882,-0.012463332680858358
44976,SIDM00832,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.2796764,0.057463344,3.115367685738402,0.10795356736502523
56070,SIDM00633,Linsitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.332393,0.13444409,0.801161735187634,0.022199873644856614
70270,SIDM00872,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4990938,-0.05043139,-0.42050654883316735,-0.08128740429729947
80418,SIDM00216,Olaparib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-0.74137855,-0.004960886,-0.3980135957773735,0.03646044141226714
87001,SIDM00950,Erlotinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8944339,0.19823237,0.8076867770478369,0.05895334969773141
93744,SIDM00877,BI-2536,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-6.8047523,-0.044145156,-6.141893892879191,-0.07165025906245859
3000,SIDM00832,Trametinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.006783,-0.024035547,0.16264165712085302,0.00030435023663298664
11035,SIDM00928,MK-1775,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.7992486,-0.12782621,-0.4735312625853979,-0.02876164862232919
21157,SIDM00216,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.1221707,0.032487277,-0.41324246567493483,-0.019941435659362683
102251,SIDM00835,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.135448,-0.08443551,-0.8366781159076279,-0.046699856294519386
30503,SIDM00833,Afatinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.4779158,0.03819174,-0.33795028692943324,-0.055735105384779854
71071,SIDM00875,Nilotinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1315626,0.10873745,-0.018482293634769092,0.05438639429547358
8213,SIDM00097,Axitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1114464,-0.11079579,-0.8954594887503217,-0.04681669953480221
44764,SIDM00148,Cisplatin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7902566,0.08115522,-0.16577106608833717,0.018098354636182656
66688,SIDM00872,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,3.0907118,0.3046373,1.4725712742520167,0.07972400709358049
74931,SIDM00633,Nutlin-3a (-),OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.9148338,-0.11455324,-1.5176620138951045,-0.043366975468670715
20288,SIDM00875,Axitinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3128755,-0.020107953,-0.47137696716627914,0.024555012161748362
56156,SIDM00832,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-2.010152,-0.13574493,-0.716922865885512,-0.07999471517911555
68928,SIDM00097,Lapatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9122934,0.05161755,1.3981387388935185,0.09521836748164884
33599,SIDM01042,Cisplatin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5384097,-0.019844586,-0.08247914834718453,0.013757273276378322
14084,SIDM00633,SCH772984,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2307582,-0.09229354,-2.016864166387771,-0.08388163176224622
36579,SIDM00148,Cisplatin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.15794095,-0.0070620333,1.2134261224224425,0.12393115664225655
57983,SIDM00148,Pictilisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6174714,0.039617922,0.6896562551853239,-0.005344245951994656
18665,SIDM00097,Sorafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.110695,0.31355894,2.2136888040706624,0.12909380399909876
64112,SIDM00216,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,2.9676015,0.029072478,2.6377684990109054,0.12779109529425384
99381,SIDM00282,Afatinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.34575474,-0.017945465,-0.15638796808739366,-0.0026157796641988543
6133,SIDM00633,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8046612,0.040913276,-0.20132446449800978,-0.0012337322581052073
48174,SIDM00933,Bortezomib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.34197304,0.034031987,-0.29258510322905623,-0.006426715453245014
46561,SIDM01042,Venetoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.276574,-0.053026684,-0.020819254803886356,0.032936268775736105
52430,SIDM00933,Nutlin-3a (-),PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.6489744,0.084136374,-0.4431573787564718,-0.028745451413193575
47889,SIDM01197,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.0275837,0.07883722,1.6468564981472193,0.07085040367438311
22764,SIDM01197,MK-2206,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.8153782,0.111679316,-0.4682527804730977,0.016661522326116576
92973,SIDM00957,Olaparib,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.8108538,-0.02154123,1.0981565036779515,0.02206525577664048
24087,SIDM00957,Olaparib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.97463924,-0.013657325,0.21634419645548378,-0.004325378605211633
42709,SIDM00097,Sorafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4123752,0.13697146,0.3231544086759238,-0.008799634235087726
25356,SIDM00877,Olaparib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.5661558,-0.065868534,-0.7047283889958846,-0.00450700211567661
85927,SIDM00282,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.754072,-0.03928316,-0.43771057500939464,-0.04129152976792441
79961,SIDM00877,Gemcitabine,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-2.6432676,-0.04713475,-0.5093583570660024,-0.03506194428502595
69707,SIDM00282,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.1437213,0.055708542,3.8031441290899983,0.18549477982060125
106835,SIDM00776,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,4.5088835,0.2518901,3.1610153722558603,0.1527187127089236
92066,SIDM00928,Pictilisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.9152358,0.18807235,0.40113589753144646,0.08746856621061838
40120,SIDM00933,Lapatinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.28625855,0.03865738,1.1454054629287165,0.10222867494174932
58077,SIDM00148,NU7441,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.75864756,-0.07572834,0.195264333030529,-0.007473303864424645
16800,SIDM00833,AZD7762,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-0.7508155,-0.024098247,-0.8230123942597398,-0.05123987894675925
50373,SIDM00875,5-Fluorouracil,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.68747747,0.07868673,-0.7849715560285102,-0.0822426943851553
106663,SIDM00957,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,1.1809458,0.03721044,0.1903944347621944,0.004932396710311343
26227,SIDM01197,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3695478,-0.1666199,-0.810750074993133,-0.06496567617304286
55641,SIDM01187,Taselisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7010411,0.050583743,-0.8541684403474591,-0.024241425740219324
53392,SIDM00633,Axitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2536699,-0.070508264,-1.7516267623963035,-0.10177815417215208
49873,SIDM01197,Dabrafenib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5466685,-0.050579224,-1.3248935374805246,-0.04305437882431312
58558,SIDM00148,Wee1 Inhibitor,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6885313,0.061216213,-0.8078323798429546,-0.03995684289893456
39581,SIDM00148,MK-1775,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7933424,0.041082803,1.448935396314128,0.09839252143420173
75230,SIDM00042,Cisplatin,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.4672787,-0.13815837,-1.252726282937311,-0.0751587063114898
66545,SIDM00833,MK-1775,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.0835772,-0.039902773,-1.0364867814435141,-0.028307380786465223
6708,SIDM00950,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2305146,0.08951997,0.6371021566836406,0.07333743129033844
68311,SIDM00359,AZD8055,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0292215,0.2013032,-0.8349498351003842,-0.01889565200696286
93084,SIDM00833,Palbociclib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.9930092,0.023127053,1.739916012064432,0.11823462113711448
38316,SIDM00776,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.9864616,0.061405856,0.45830431446731096,0.020831618236649065
37667,SIDM00282,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.34719676,0.024404189,-1.7870876271035618,-0.1449376303155189
13646,SIDM00933,Dabrafenib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.4219277,-0.09656922,0.459662912814944,0.0849992021997655
102764,SIDM00216,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.18386437,0.006963538,-0.10123841074480605,0.012655321866557743
99727,SIDM00282,Oxaliplatin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6738052,-0.10677426,-1.3528396203606956,-0.07966882144355458
96473,SIDM00950,Ruxolitinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.8309977,0.09725692,1.4185996695284775,0.03444752588876547
10041,SIDM01187,Taselisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.0865664,-0.19856392,-2.686584785029025,-0.1162369684723923
66562,SIDM00282,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2075627,-0.041067474,1.2398133557369821,0.060664682003364306
38985,SIDM00933,Taselisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.3828308,-0.045898017,0.006051279972441353,0.030874771471806114
102281,SIDM00837,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.95670694,-0.022907201,-2.939633431828772,-0.12488399668529199
32795,SIDM00832,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.7991906,-0.07374726,-0.09431277130929978,-0.034564249006012834
82617,SIDM00877,Cisplatin,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.5717954,0.052065693,1.4722554762657993,0.2387542234709161
64157,SIDM00673,ZM447439,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7618722,-0.13512784,-1.9890066857138837,-0.15013831885906875
103596,SIDM00877,Nilotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.8962706,0.077365816,0.6962743426609853,0.1070725607052373
38868,SIDM00835,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.365,0.06938363,2.617227937532438,0.058264470206610484
9692,SIDM00776,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.6146767,-0.11344331,-1.7315056387460637,-0.07574695779452366
54223,SIDM00928,MK-2206,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,3.9776535,0.35194886,2.6344669111510854,0.21364657468529485
71048,SIDM00933,AZD6482,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.47716033,-0.015336231,1.2782553361206317,0.06658156591127329
48170,SIDM01187,Crizotinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8049683,0.06257126,0.4382515176335366,0.026318060164715936
86962,SIDM00673,OSI-027,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4757466,0.20800194,0.331022120087704,0.013807853804889005
35070,SIDM01197,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.0014036,-0.06793322,-0.49409113949996986,-0.05086172920716308
97547,SIDM00097,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0151318,0.058205392,-0.05972900193845614,0.0048477680672067685
70240,SIDM00673,Vorinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.93846136,0.097946174,1.8686232275526267,0.07269547283971975
106826,SIDM01042,Paclitaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.6043334,-0.31204608,-4.117502530380098,-0.29587064157858217
46855,SIDM00872,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.63319594,0.05932731,-0.7154919382307571,-0.028137938571953576
56710,SIDM00673,AZD7762,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.49875507,-0.039579913,-0.8203758652771592,-0.06218586976642508
32324,SIDM00957,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.9767346,-0.025354521,-0.16315600108298067,-0.00016975622641534824
65925,SIDM00097,RO-3306,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1717833,0.060093507,1.1527667718350587,0.04667179993536717
103388,SIDM00633,NU7441,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.4207547,0.29464597,2.930303216910583,0.13680231950651836
49151,SIDM00097,MK-2206,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5654334,0.11512396,-0.8930218434643569,-0.04571101185832197
38406,SIDM01042,Doramapimod,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.28930652,0.03052864,-0.5467943340848299,0.02274212531574093
88050,SIDM00875,NU7441,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3054987,-0.024180189,0.39606537391456714,0.0030879643266820177
101867,SIDM00877,Axitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.1828836,-0.051337734,-0.5285607865345069,-0.011052400722712305
69348,SIDM01042,Nilotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.36623546,0.005511571,-1.5646066500637508,-0.0852000856606314
14197,SIDM00872,GSK269962A,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,3.144087,0.24470685,1.1605222784926217,0.08576849893559194
101526,SIDM00933,PD173074,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.15765764,0.018413166,1.3528955143367918,0.12819038612050881
86476,SIDM00933,PD173074,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.79845774,-0.07529342,0.8143388974770785,0.0638896686118173
5533,SIDM01042,Olaparib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5466303,0.15008762,-0.2952214156793636,0.023518653827844675
82645,SIDM00877,PD173074,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.8458529,0.09845271,0.6853361180868307,0.14040358375972173
78498,SIDM00872,MK-2206,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2043072,-0.021293735,-0.452185455219858,0.00615244370234038
47288,SIDM00950,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5298722,-0.10387526,-0.7088872581998352,-0.0024837991792951686
42972,SIDM00097,PF-4708671,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.56946665,0.02441544,1.2154500470931515,0.08267856871500603
89024,SIDM00146,Dabrafenib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2338315,0.06093516,0.5548131895709413,-0.0038386363539522415
36568,SIDM00097,RO-3306,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4017665,-0.095927864,-0.8367332022005796,-0.03645030183236643
15953,SIDM00875,RO-3306,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.10249757,-0.011106428,0.5578739657711439,0.02151384640281038
71551,SIDM00042,Linsitinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.4912713,-0.042681567,0.5082975081463242,0.019765777731801406
87324,SIDM00146,Camptothecin,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.97140074,0.09789743,-0.2827693831985893,-0.039572110475506364
62948,SIDM00633,KU-55933,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6137162,0.085286476,-0.23643375121675814,0.017394844175276824
98571,SIDM01197,AZD8055,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,2.4608917,0.20066942,-0.26706544853824626,-0.014485220501625092
47960,SIDM00146,Taselisib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7579942,-0.062551826,-0.2765373331923939,0.07554983504479597
13765,SIDM00633,Linsitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.66749436,0.02529767,-0.37101932366798746,-0.04508165410841949
50052,SIDM01042,Ribociclib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5603641,-0.07366694,-1.3151602956974497,-0.026126421984518082
24166,SIDM00673,Vorinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.71461487,0.06855405,1.5045781927525423,0.11794886390198583
89564,SIDM00928,Trametinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.6907693,-0.07379598,-0.5593921441077838,-0.03268854009081255
56244,SIDM00832,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-1.5978433,-0.1171825,-0.9654148449748785,-0.057523658175179744
102132,SIDM00928,Uprosertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.5488982,-0.05861884,0.32927322374832335,-0.030097836452704963
98084,SIDM00872,MK-2206,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6357465,0.06769498,-0.5758500235208708,-0.04827986522010511
81058,SIDM00148,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.88791007,-0.051633596,-1.03627501931881,-0.02922578961920417
94053,SIDM00875,Linsitinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0113862,0.14664637,2.18342599173502,0.11902481842554939
72205,SIDM00872,AZD8055,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.16335301,-0.017197521,0.06507117943452409,-0.045635508248994344
33243,SIDM00933,Olaparib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.7331125,-0.07834443,-1.5587224372822797,-0.05875335235411719
10591,SIDM00455,Palbociclib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3035809,0.046790108,0.9871313581512212,0.07841101257892726
99029,SIDM00928,Crizotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.3195865,0.14014132,0.5244080434539728,0.019310385682124828
32169,SIDM00633,Alpelisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.10876067,-0.009849816,-0.7355311282820447,-0.03662468470262877
83229,SIDM00872,Venetoclax,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9758009,-0.069911346,-1.2223028647610623,-0.03511986501550387
58161,SIDM00146,Trametinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.7073453,0.05420569,1.823070160641826,0.09509542088352062
15567,SIDM00837,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.5971021,0.02132457,-0.6231755480034583,-0.00929764390948017
63985,SIDM00216,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7246323,-0.020494314,-0.1556984812870443,0.015198827232563397
41811,SIDM00832,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.62218815,-0.03422178,1.0517292856105414,0.07943650571997214
22542,SIDM00950,Ruxolitinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6081392,0.031028396,1.544023387941288,0.007571260717903643
52196,SIDM00826,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.8771222,-0.009960265,-4.9689609435071755,-0.07004201862848108
71436,SIDM00933,Wee1 Inhibitor,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.125429,0.07475879,0.7957136575974234,0.07428378239891213
78089,SIDM00673,Docetaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4255123,-0.10111348,-0.7539926581617374,-0.031360057008959004
17709,SIDM00877,Lapatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,1.0625429,0.09763241,0.37593620402358785,0.055928661023804074
95249,SIDM00282,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.356074,0.10863647,1.4210298707016455,0.09428441998565011
23280,SIDM00673,Sorafenib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.86731017,-0.041503638,-0.5889499514580825,0.010919701738850545
71103,SIDM00633,Afatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.60120875,-0.006864078,-3.0439390754998317,-0.11195932695381168
30536,SIDM00776,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.44646508,-0.020536842,-0.9090670265740213,-0.056093700099653386
70908,SIDM00872,Nutlin-3a (-),Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5476615,-0.013782409,0.5485632556769471,-0.012257178939448866
85300,SIDM00933,Tozasertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.7579501,0.101845376,-0.3374411390760857,0.02284283426380727
57114,SIDM00673,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.044904,0.08852404,1.3920723950945508,0.05792052178879264
50832,SIDM00146,Afatinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.1338915,-0.10455135,-1.330769580205162,-0.06951010905823593
18242,SIDM00950,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.796369,0.10173548,1.2846999127194094,0.05967555460033055
3863,SIDM00957,Trametinib,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.1891992,-0.08202764,1.9285193754950052,0.1075705553695072
54914,SIDM00928,BI-2536,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.6575723,-0.1926325,-3.365661930791847,-0.14949485140451202
28723,SIDM00148,Doramapimod,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6088692,0.080311015,0.8699428156829908,0.03610594965917174
510,SIDM00146,GSK269962A,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.4943057,0.12166012,0.5564143050635267,0.046832350710956074
37801,SIDM01197,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,6.4545193,0.31809828,1.17376867309899,0.07872567314810248
102126,SIDM00673,Temozolomide,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.3070118,-0.006741521,0.416826922221079,-4.034405195066124e-05
65018,SIDM01197,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.4192488,-0.14268225,-1.6628191035547444,-0.09356640017677953
70191,SIDM00833,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-2.7804465,-0.13967827,-2.1135257940424204,-0.131636399180505
31916,SIDM01042,Lapatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.229757,-0.026266612,-0.2802317380414284,-0.021158297887856285
64151,SIDM01042,Olaparib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.95607984,0.06215115,-1.9634139403269726,-0.043326726674719825
79813,SIDM00877,KU-55933,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.5709748,0.21852486,-0.5944848915841762,0.028580051932560174
19380,SIDM00832,MK-1775,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.5538352,-0.079879306,-1.9732560076246028,-0.048785028602927286
96716,SIDM00872,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5668409,0.029929392,-1.3461226744295922,-0.013682386880968561
3357,SIDM00146,Trametinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,3.529155,0.16172796,1.6043557525991605,0.09831585398675151
59130,SIDM01197,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8954275,0.12305502,1.938488911179125,0.04998958718532917
77485,SIDM00833,SB505124,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-1.2872196,-0.06799384,-0.9423382014316595,-0.02834640462487782
1578,SIDM01042,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4862161,-0.11514347,0.1935316499549618,0.008695412827088207
89276,SIDM00633,Afatinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7854355,-0.008163446,-1.1018787082546382,-0.01982024884582216
26368,SIDM00833,SB505124,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-2.3964887,-0.07990398,-1.5249038976802847,-0.056792884165483316
52722,SIDM00097,NU7441,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.76946515,0.037303507,1.2299240529432618,0.07892058034602767
3514,SIDM00933,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.3985889,0.04872145,-0.7282810849933594,-0.05010501376655337
79599,SIDM01042,Linsitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.977749,-0.07031682,0.267863405186575,-0.008028419021128866
9160,SIDM00933,Trametinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.45690557,0.05228481,-0.8181406061523483,0.0020014215966838427
99970,SIDM00933,Olaparib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.585553,0.28513163,0.7595387966383216,0.11894610850091625
88978,SIDM00832,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.27127424,-0.009911132,-0.1211586021431548,-0.01156616863253724
247,SIDM01042,Venetoclax,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6616573,-0.068773694,-0.7081416795733267,-0.010373617059931171
62786,SIDM00148,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3605864,0.20320997,0.9387524422504786,0.09936574616319305
71840,SIDM00877,MK-1775,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.52339274,-0.032871183,1.3235097184736433,0.05016843661761991
43537,SIDM00877,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.3855318,-0.043895476,-0.21414403727061262,-0.0017964466661187558
45135,SIDM00872,NU7441,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.8838131,0.25808576,1.7411537831934105,0.12758362947883137
62260,SIDM00097,Dabrafenib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.52592844,-0.023983328,-0.7565128619002836,-0.025331459673333032
31685,SIDM00097,Nutlin-3a (-),Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.457887,-0.05360081,-0.8176993175281103,0.0001839335814952506
91955,SIDM00933,Venetoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.0693996,-0.05564295,-0.46632073421997955,-0.008807865225902134
39444,SIDM00146,SCH772984,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.628843,0.210331,3.4255805403599395,0.16157323119383107
46273,SIDM00875,Linsitinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.554572,0.036939416,-0.18601055259452212,-0.0073550299419155515
61213,SIDM01197,Olaparib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.73622453,-0.018573536,0.9207478826310806,0.055106911640258355
70754,SIDM01197,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7782114,-0.091135964,-2.2105915622070906,-0.07074697030666262
99468,SIDM01197,LGK974,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-0.39619446,-0.022003338,-0.8193705246870622,-0.013934998259175078
70665,SIDM00957,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-2.7680976,-0.095186174,-0.6195995053876092,-0.038369883964031945
56312,SIDM00146,Nutlin-3a (-),Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.2229754,0.035379574,1.0198254052159634,0.06926518740288645
62755,SIDM00097,JQ1,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2349825,-0.08160813,1.0016833040157267,0.06528561823564304
69742,SIDM00928,Nutlin-3a (-),PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.9327313,-0.019958962,0.41259039783603635,0.014069526650341316
28238,SIDM00875,AZD6482,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85505366,0.0665604,0.5623397101557935,0.024821681985034066
65860,SIDM00097,ZM447439,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7416384,0.039335754,-1.3594350722146742,-0.05179009390037596
41869,SIDM00832,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.1579264,-0.10457538,-0.8296560987650379,0.052649064639000466
6489,SIDM00872,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5706999,-0.020847144,1.2009393453901456,0.0475792848439835
6208,SIDM00776,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.8222089,-0.054115538,-0.40602318549566047,0.025708846607208628
25362,SIDM00933,Linsitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.1916842,-0.0594953,-0.06190440741400246,0.056821643465445694
88326,SIDM00148,Trametinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.98709214,-0.024137305,-1.253374312750783,-0.04702354226923625
44069,SIDM00933,Doramapimod,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,1.3249269,0.041015923,2.3179243114406383,0.08927099353990059
73184,SIDM01187,Taselisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6917814,-0.14625797,-0.14401722056787547,0.033286475862282866
84636,SIDM00950,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6725633,-0.08077381,0.04709409410260487,-0.00988549232047497
8933,SIDM01197,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.7919081,0.061206587,0.4509654391229726,0.06463245799128654
35289,SIDM00455,LGK974,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.404057,-0.05891362,-0.1167536592896462,-0.022106690886867567
16184,SIDM00097,Sorafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.4500647,0.14878887,0.9729875258417865,0.06184493345425129
86109,SIDM00826,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-0.9327559,-0.048616078,-3.2560924000134666,-0.16122141256358244
90775,SIDM00872,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3683586,0.036428582,0.6188893382015533,0.0507158125912426
3150,SIDM00928,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,4.772916,0.20401885,1.1020698057543865,0.006768492928167164
71626,SIDM00950,Dasatinib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.6772892,0.2861912,1.536201667555633,0.06857715490508563
84847,SIDM01197,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.40866,-0.21224798,1.391120684296401,0.09346346785145167
55907,SIDM00146,Olaparib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6947553,-0.033313196,-0.5487538780737019,-0.005072373976558574
12426,SIDM00633,Alisertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1802398,-0.08663299,-1.412928014733365,-0.04306188158439142
97499,SIDM00673,RO-3306,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3665321,-0.084177844,-0.3139028836809987,0.007085669610061427
78549,SIDM00673,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.21126089,-0.013006555,-0.21290691707436635,0.022282573098046304
27511,SIDM00877,MK-1775,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.5975015,-0.029536327,0.4133427399877169,0.024351884479929087
37252,SIDM00455,Navitoclax,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8578845,0.100685365,2.118025603040271,0.10663759968235453
39758,SIDM00633,Temozolomide,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.79338944,0.014143569,0.13156885566924995,0.0020909155027548213
87301,SIDM00633,OSI-027,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5343748,0.04419168,-1.2438266232215314,-0.07784215113838922
33653,SIDM00776,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.59154075,0.04478374,0.4360309490501203,0.05845083829412415
48183,SIDM00216,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.7406637,0.046332724,-1.4266997234348167,-0.05883975723430472
17102,SIDM00957,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.0791433,-0.0235477,0.42147498521264853,0.03409089298060624
67476,SIDM01042,BI-2536,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9896178,-0.007488925,-2.0397431684406704,-0.08684686268208963
52997,SIDM00148,Temozolomide,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8532062,0.026643222,0.3180307866047037,0.02105109258672985
13196,SIDM00933,AZD8055,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.4004705,0.18248439,-0.7824958153307474,-0.010298429561650831
31116,SIDM00633,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8293415,0.024419691,1.3702857808602094,0.04718282805644106
57429,SIDM00146,Alisertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.71296644,-0.06724057,-0.8838767738752694,-0.0323926889143422
91828,SIDM01197,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-5.7517347,-0.382448,0.6638598387365461,0.028468674265246435
9789,SIDM00950,Taselisib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.97155553,-0.08307045,-0.9785684957442666,-0.06673533403952668
14111,SIDM00633,PF-4708671,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.2552276,0.37518555,1.6760969704289528,0.11888301401620516
25915,SIDM00875,AZD6482,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1396705,0.097971894,2.8498883424851567,0.12092697817884761
99602,SIDM00042,Oxaliplatin,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.7128392,-0.15803966,-2.682894720210188,-0.09083525433565488
9648,SIDM00833,SCH772984,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6873539,-0.054008123,-0.2899415545556541,-0.006557573489671418
36629,SIDM00148,Crizotinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0324275,0.16178362,1.9702710096975116,0.06553392242867823
95162,SIDM00282,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.156913,-0.06677263,-0.5955089632065056,0.04483702527960825
95100,SIDM01197,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-0.69946754,-0.048992112,0.1372865328578574,0.016199715224773696
95742,SIDM00933,Vorinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.808452,-0.1186879,-0.4035350344743862,0.004439679874857571
32673,SIDM00933,ZM447439,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,3.274479,0.30308506,1.0586308093752195,0.07770464571977803
58169,SIDM00042,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.3836933,-0.11824461,-2.4803853327332703,-0.12777930747069138
34344,SIDM00455,5-Fluorouracil,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5930219,-0.08179093,-2.1130382883972567,-0.0594203959108788
23150,SIDM00928,Dabrafenib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.9488118,0.18996924,0.5568200650361057,0.031242987221401033
8049,SIDM00933,Olaparib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.3294166,-0.10883089,-2.050803916278328,-0.11628210301127198
10853,SIDM00877,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.2217107,-0.13301635,-0.7474410662509821,-0.05928913597209366
83644,SIDM00148,Nutlin-3a (-),Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.435852,0.13029408,1.3962636047783066,0.12413507891653551
98073,SIDM00148,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5323812,0.1299823,-0.14611054964051196,-0.06051250069577359
100459,SIDM01042,Vorinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.17942938,-0.020491945,-0.8720450619979758,-0.014934801886324614
61057,SIDM00633,Vorinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7963155,-0.062005613,-0.8197885862240821,0.013516655076001013
38532,SIDM00282,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.0578842,0.045141004,1.98628985647517,0.046504681013526096
67687,SIDM00633,Alisertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.75327784,0.058250383,-1.2765720707119141,-0.02737550764607308
74333,SIDM00875,Taselisib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2735598,-0.02937695,-1.2681954014842556,-0.029275456696823594
38850,SIDM00933,MK-1775,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.114731714,-0.0084539605,-0.2625549841512144,-0.001535798405740955
77568,SIDM00933,Alpelisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.3617866,0.22777757,0.18199406297795911,0.0744394244914
67402,SIDM00673,JQ1,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2420676,-0.13473462,-0.441514867912668,-0.0071580538565868095
69625,SIDM00146,Docetaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8128354,-0.03723679,-2.2035350241124707,-0.07622335916247203
44205,SIDM00097,Axitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.131648,-0.1245457,-0.9701849241437523,-0.06472929993949347
41119,SIDM00776,Trametinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.02540161,-0.002266483,-0.9844447921201429,-0.05119898784326114
25873,SIDM00875,RO-3306,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6028789,-0.16341403,-2.13432251758856,-0.14068852618801925
5171,SIDM00673,Nilotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.75866985,-0.03095132,0.9573195160918482,0.07587865426352547
83911,SIDM00455,AZD7762,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.3408254,-0.016127339,-0.06392640226590388,0.04230967241028384
102921,SIDM00833,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.8901265,0.073188804,0.15839892833170036,0.05692891453860919
102830,SIDM00875,Docetaxel,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.0586843,-0.19235343,-6.284942078554327,-0.3792831198418089
1896,SIDM00933,Paclitaxel,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.18640988,0.017256744,-0.1290956702149292,0.008816137060584787
3398,SIDM00872,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3234216,-0.05612672,-1.5458960782052236,-0.009998392280288931
45951,SIDM00282,Navitoclax,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-2.097727,-0.11838342,-0.45308610710545,-0.03945304610325623
30372,SIDM00148,RO-3306,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7908754,0.2833642,-0.36906269554450327,-0.05863588039361151
86277,SIDM00933,Trametinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.657058,-0.093915515,-1.3075178881341285,-0.037189278867505206
33279,SIDM00928,Luminespib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.9728651,-0.089416,-1.2472281330775095,-0.10962096243586227
72098,SIDM00455,5-Fluorouracil,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3915606,-0.04109282,-1.170018204936048,0.017390655717733083
81518,SIDM00146,SCH772984,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,0.25912398,0.0240552,-0.8037707020218678,-0.08436934632341214
84326,SIDM00837,LGK974,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,0.773028,0.022409027,0.9060187479423047,0.033863387729716844
87745,SIDM00875,JQ1,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54197943,-0.060272947,1.1676452961959312,0.07055577954538052
20592,SIDM01187,Luminespib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.59725475,-0.060416553,-0.8220587695262866,-0.06893475882334887
85615,SIDM00875,JQ1,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.661853,-0.14439152,-2.1001574563419156,-0.11195521467890522
103981,SIDM00933,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.3164422,-0.0009802515,-3.986797538981219,-0.09334165302740488
102565,SIDM00673,Dabrafenib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.1476356,0.025681594,0.5942972342166841,0.03231677388256625
39783,SIDM00835,AZD7762,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.598731,0.1472746,1.0116180172432316,0.0477040286029364
53755,SIDM00872,Doramapimod,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2577716,0.06347338,1.5280457623240071,0.09045798325090493
19094,SIDM00359,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5574647,0.048445497,1.1981390335609745,0.037081802892912546
77070,SIDM00826,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.607729,0.016712543,-0.9113770443994964,-0.025836437911886292
17292,SIDM00877,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.48466596,-0.049859397,-0.05611159587321462,0.027156577796417336
18735,SIDM00835,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.5676184,0.2048224,-0.2565865452668586,-0.040657766206165194
94668,SIDM00837,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.6456506,-0.03409425,-2.1235879606696075,-0.08987072546657093
30612,SIDM00097,Vorinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9254429,0.062442966,-0.3678436903053615,-0.04650164554266168
26578,SIDM00872,Pictilisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.94597983,-0.09432363,-0.66461034066358,-0.027043389636850528
26253,SIDM00933,KU-55933,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.7335165,0.13284649,1.59582296575631,0.08864149678574502
37894,SIDM00872,Olaparib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8680727,-0.03445593,0.5236391635512717,0.01868922323293529
83540,SIDM00216,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5383534,-0.027675508,0.3843955496912776,0.03911869326373506
94113,SIDM01042,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7655605,-0.022490505,0.9926356583632401,0.027833294701291617
44370,SIDM00776,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2855912,0.094217986,0.8553677870442847,0.08596283639395476
49084,SIDM00835,BMS-754807,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-2.3397458,-0.19871786,-2.016965256859274,-0.12836432950260307
70299,SIDM00957,SCH772984,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-3.0777433,-0.11896562,-0.7251867207266088,-0.0537690568816998
82844,SIDM01042,Axitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2427306,-0.22399455,-1.639477783170326,-0.13903650101467951
40202,SIDM01187,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6540769,0.049610294,-1.2517113230641888,-0.0717481486310654
3854,SIDM00148,JQ1,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.90822643,-0.080567434,2.407080082826093,0.04151696591467704
94065,SIDM00950,Navitoclax,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.339422,0.25941628,2.3808618840643856,0.16596298862588776
19987,SIDM00148,Entinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0186701,0.053522155,1.5571881108513035,0.09330335818943862
34895,SIDM00148,Pictilisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6821888,0.045646597,0.04522836249866149,-0.06074701753718095
12726,SIDM00833,Oxaliplatin,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-0.91814363,-0.07440572,-1.3843900906736997,-0.15296432782277225
83727,SIDM00146,MK-2206,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,2.3654191,0.1851225,-0.06267370450429838,0.0537079498094287
87493,SIDM00146,MK-1775,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.67908597,0.044738285,-0.17824562436629038,0.008873637677015446
103089,SIDM00928,Olaparib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.6189017,-0.095606275,-0.973922503076296,-0.04315091651465728
39430,SIDM00216,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.3218927,-0.13094711,-1.125040658582956,-0.06438478790948843
89520,SIDM00950,Gemcitabine,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1984334,0.1230094,0.034087261034279406,-0.022074438640734585
77102,SIDM00148,Taselisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.2265162,0.091955826,1.3005040586310326,0.037543207734482185
12098,SIDM00633,Bortezomib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6118339,-0.04851288,-1.2054895548164175,-0.05871320026902926
8999,SIDM00673,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.327419,0.23033766,0.012891482220335296,0.03391955598275701
15466,SIDM00928,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.6806478,0.06562778,0.06611059298114695,-0.022920023363596873
81974,SIDM00877,Paclitaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.5431181,0.15296617,-0.13283544643037992,0.04947283153858871
50163,SIDM00146,Luminespib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.7580522,-0.05487242,0.08552089643704437,0.04032604954112688
79484,SIDM01197,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.1239516,0.04985707,1.0419379564501157,0.015108969285540003
104789,SIDM00837,5-Fluorouracil,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,0.9570589,0.013609427,-2.032487292805911,-0.1088038140938015
40880,SIDM00957,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,3.3263192,0.056754146,1.6936812172726243,0.032961340304800885
30115,SIDM00216,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,-2.7309186,-0.14239033,-3.063606067519449,-0.1413492329793633
70096,SIDM00148,OSI-027,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1167198,0.10395255,-1.1235462627770485,-0.08502326958384475
23078,SIDM00835,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,0.5628323,0.04789428,-1.0473212882890828,-0.0042554399303499435
100484,SIDM00875,MK-1775,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1864642,0.0115158865,1.1553011475044817,0.06123603068259079
61851,SIDM00833,Oxaliplatin,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,-2.8449028,-0.20573804,-1.8168749553626982,-0.1277031018685453
48152,SIDM00146,ZM447439,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.1291643,-0.08289913,1.3003974768545377,0.08069251436327662
68624,SIDM00455,Linsitinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1972758,-0.07264397,-0.05316694076584099,-0.028103711054632066
45953,SIDM00673,MK-1775,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2412711,-0.09875634,-0.3752992595851323,-0.00017387406546646696
36941,SIDM00097,Camptothecin,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2845281,-0.012387333,-0.18089823967415994,0.057837499902066596
4099,SIDM00148,MK-2206,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5894578,0.054999314,-0.11779846632874645,0.040477791085259944
79778,SIDM00776,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.68146473,0.053499807,-1.071511817767683,-0.08670995971666798
61740,SIDM00957,AZD8055,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.5971494,0.0623783,2.1172730887308653,0.10868501955482665
7555,SIDM00826,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.4665979,-0.06858156,-1.0784742634231352,-0.04010265807776342
43953,SIDM00928,Afatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,0.8773225,0.09741486,0.6667150050782837,0.02419037857914814
86509,SIDM00148,SCH772984,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.2490175,0.1980814,1.786764826315294,0.04421818558211916
17712,SIDM01042,BI-2536,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.383866,-0.07565594,-4.257450871693729,-0.15760611236489136
9558,SIDM00877,PF-4708671,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.49301425,-0.040373843,-0.8193890108449121,-0.03838410292716234
7268,SIDM00826,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.942667,-0.04628949,-2.814273892661913,-0.04654659981208682
2592,SIDM00877,Paclitaxel,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,0.36893755,0.042280987,-0.17853967928951736,0.021821251033494193
38556,SIDM00148,NU7441,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.063023284,-0.006275275,0.2294547846021092,-1.464400326093706e-05
7730,SIDM00633,Doramapimod,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8338757,-0.14337075,-0.6461036031130037,-0.04254233869050334
63369,SIDM00872,RO-3306,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4580554,-0.07211673,-0.49709913650002724,-0.026314347324484545
101599,SIDM00455,MK-2206,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.416432,0.16637416,1.711684740594638,0.1588003236521246
27956,SIDM00148,Trametinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7395838,0.08757636,2.811898221496378,0.07759931938587299
36928,SIDM00833,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.55518174,0.00859912,1.2841741523707901,0.0010290700936083923
80156,SIDM00833,AZD7762,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.2132525,-0.09536737,-1.3563856819312305,-0.0981947681606541
41187,SIDM00776,MK-2206,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,1.8575424,0.16749133,2.2351203492144918,0.15806691675524806
68277,SIDM00837,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.7051004,-0.053689346,-0.8761031932409739,-0.07323366793671626
70425,SIDM01042,KU-55933,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.156356,0.24621339,1.466796041716345,0.04064181033963741
81055,SIDM00832,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-4.882276,-0.28264725,-2.2018201076571513,-0.17279587479690653
74909,SIDM01042,Ribociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.309534,0.03698502,1.322133236651936,0.005085100591383999
27886,SIDM00872,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9781867,0.059467357,-1.224418240243784,-0.02632389003657574
105230,SIDM01042,AZD8055,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8835901,-0.09285945,-1.4327348486512375,-0.022542580797796218
80288,SIDM00216,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,4.370844,0.059941515,1.9362320461066203,0.14862566402747573
74810,SIDM01197,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.2872821,-0.005762049,1.2604657852172634,0.03391856736422597
95984,SIDM00633,Taselisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5487534,0.028763687,-1.192256631321281,-0.028583512609014466
28010,SIDM00875,Ribociclib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27005106,-0.007838061,0.48368372797131154,0.03848256791593029
39108,SIDM00835,SB505124,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,1.6081485,0.1339686,-0.46998400626924863,-0.04776543828068295
32662,SIDM00933,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.4296014,0.041310716,1.7038880368038132,0.08653628813648906
88882,SIDM00042,Taselisib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.1049516,0.13978547,2.735605167354408,0.10877486740437058
52421,SIDM00877,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.8072208,0.033961173,1.869617767830894,0.08226033295248178
63454,SIDM00928,Vorinostat,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.6600199,0.16678189,0.5205761825440275,0.0866742299806227
63095,SIDM00957,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,3.0780447,0.04926919,3.0329137267656003,0.07845725565680844
107412,SIDM00282,Trametinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.43290928,-0.021109773,1.6684012703031108,0.16096544136392907
54385,SIDM00833,Taselisib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,1.2312682,0.09442899,2.1883777344384487,0.16763609612858552
100949,SIDM00146,Sorafenib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.20510598,-0.016939325,0.515321604924321,-0.0010451621578047253
25764,SIDM00633,Vorinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.8350816,-0.19773707,-0.6899194313596884,-0.06542674666408653
102606,SIDM01042,Entinostat,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7909887,-0.2281776,-0.7996100479113549,-0.03515274931066053
53750,SIDM00633,ZM447439,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7547985,0.0735583,-0.36206900495630523,0.02562653513047096
65772,SIDM00872,Lapatinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.36004615,-0.037993953,0.3831794242015162,0.03381753577687329
12952,SIDM00875,Lapatinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9802886,-0.090439536,1.4974842904756385,0.08108009541593089
29186,SIDM00928,JQ1,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.7028984,-0.080598146,0.6010216018735958,-0.035877620701992685
17086,SIDM00950,Cisplatin,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.489919,0.14819376,3.0756974553734127,0.15143285438224835
52869,SIDM00042,SCH772984,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.437805,-0.2239341,-2.11830442706602,-0.09134077512866154
21102,SIDM00097,Crizotinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6262377,-0.03747719,0.049863754521303656,0.009726665613085642
99136,SIDM00673,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.9573226,-0.2824511,-1.8173972715456825,-0.14476518172606248
80548,SIDM00282,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.8274241,0.0508254,1.8373835325823555,0.09019243357125781
67948,SIDM00633,SCH772984,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.0050135,0.24949929,-1.5623225902555373,-0.05907586766717694
52767,SIDM00832,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.1549478,-0.05005083,2.106638996027404,0.09958774523655071
25746,SIDM00673,BI-2536,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.49645486,-0.037663743,1.1701445810356133,0.06790417149086256
102464,SIDM00673,Venetoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5701164,-0.038453467,-0.09334060253809397,0.02698495531835822
66959,SIDM00875,Temozolomide,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84782666,0.02232897,0.4103818437897958,0.012818480220441764
52562,SIDM01042,ZM447439,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1000497,0.27029893,0.10171461253972867,0.024152248578458966
102190,SIDM00833,Afatinib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.4709034,0.121127084,0.17242918492366988,0.028335566822766497
51930,SIDM00928,Paclitaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-0.9828931,-0.09493268,-1.2201456687866523,-0.05655628009693203
54712,SIDM00933,BI-2536,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.3847919,-0.008853423,-4.18351382680658,-0.03230250372456528
99246,SIDM00042,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.323764,0.27823016,2.6792919994855153,0.11310538357341478
60305,SIDM00877,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8642886,0.091246784,-0.2692792524161162,0.058036391465820056
108330,SIDM00146,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0648878,0.03873582,0.3971004902516879,0.026517968468536098
52262,SIDM00826,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.8285128,0.011874596,0.3219424285773095,0.0001759416782832683
84370,SIDM00146,Lapatinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.92729163,0.09290538,0.9095259141232537,0.05971908226341281
35412,SIDM00097,Camptothecin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3925178,-0.08512387,-1.7475588242429274,-0.05456490564138232
6252,SIDM00872,JQ1,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.4553077,0.10008119,3.190299329228749,0.1498973475464932
46337,SIDM00833,Dabrafenib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,3.7825541,0.114291675,2.1516824287043073,0.07407354760247326
78591,SIDM00833,MK-1775,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,0.8059861,0.042371396,-0.8629163604692659,-0.04187702752514886
93272,SIDM00877,Uprosertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-1.0480664,-0.1025633,-1.7591901574259468,-0.05046218330704829
100809,SIDM00872,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.7843583,0.15913421,3.6438896018417166,0.09989626837137752
2135,SIDM00877,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.0637907,0.059192594,-0.25267698655635745,0.013057504385799027
105098,SIDM00877,Vorinostat,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.35549343,0.026977025,0.770744731908201,0.0008939849522772815
100678,SIDM00832,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.4965363,-0.16969588,1.0486427179065312,0.02511619584114659
58239,SIDM00216,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.106029,0.13880652,-1.3482170416237356,-0.10489621379579145
33155,SIDM00933,PF-4708671,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.5254523,-0.050946884,-0.5393740883370696,-0.004192225255059288
81759,SIDM00673,Nilotinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.7488001,-0.039315388,1.0199828447776893,0.0872091922270583
18877,SIDM00933,Camptothecin,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,0.25362253,0.022623543,2.939987862214836,0.13111736953490535
105627,SIDM00928,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.6101997,0.031844944,-0.37435937110399403,0.010672154174938827
27853,SIDM00146,PD173074,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1749271,-0.06972479,-0.9171317077377843,0.012204083467418067
107871,SIDM01197,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.2734418,0.057012677,-1.5655153772564319,0.0032716803345167944
89351,SIDM01197,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5438528,-0.096568376,-1.324035666937609,-0.03555228031746699
100043,SIDM00875,RO-3306,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06124258,-0.0070100096,-0.787312124726313,-0.05988478910676906
81235,SIDM00216,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.9123437,-0.028911594,-1.4186342128437885,-0.10963547691736034
72746,SIDM00928,SCH772984,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.76846725,-0.080794595,-1.1272017033932413,-0.061080557277471484
24255,SIDM01042,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3746276,-0.061036013,-0.7066636330438174,0.0073626316292224325
64861,SIDM00875,Entinostat,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5208993,-0.050339002,-0.1310988291794501,-0.03393607665384204
14321,SIDM00957,AZD4547,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-4.9554167,-0.09315194,-1.55555047471723,-0.021240851296629577
71340,SIDM00148,Palbociclib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9517415,0.21172453,-0.5465214939322842,-0.02691907743930395
83118,SIDM01042,Linsitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4522087,0.04178322,-0.13210108340633922,-0.017733814151064255
76539,SIDM00216,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.5875477,0.14599258,-0.8398633193918159,-0.06758740777151527
98850,SIDM00148,Sorafenib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.80903536,-0.06339799,-1.5793295558444123,-0.04004916865163226
61385,SIDM00146,Nilotinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0164497,0.09262121,0.8951903700236362,0.0893738567496016
8610,SIDM00872,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.36295414,0.023515798,-0.8300562346427067,-0.03126807361322864
60414,SIDM00826,SB505124,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-0.99410325,-0.055177305,-1.2889580803345764,-0.11890539875151142
52128,SIDM00148,Alpelisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.49147442,0.028914059,-0.6231468583634774,-0.04672276282860198
13253,SIDM00872,Luminespib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6829786,0.061973892,1.1053205785572673,0.08022943825634818
96195,SIDM00633,Alpelisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.9516842,0.07604152,0.6345628724412045,0.055435481457158
40276,SIDM00928,PF-4708671,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.725715,-0.11394284,-0.45618942423507935,-0.046917091774386896
40480,SIDM00928,AZD8055,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.5321037,-0.15809111,-1.2870449647161026,-0.11593996762819081
11672,SIDM00776,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.8421912,0.18822996,1.9417507713057138,0.16056767076333503
33232,SIDM00826,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-4.5565553,-0.07937804,-4.3534022194734785,-0.06784804057570813
93928,SIDM01187,Gemcitabine,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1992363,-0.058387153,-0.904729288206336,-0.059103095520624344
33040,SIDM00875,Nilotinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7127632,0.17667706,0.5710913104702736,0.06370772186111157
25304,SIDM00833,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-3.4985971,-0.11833124,-2.275009965757935,-0.0929979078201986
57738,SIDM00216,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.2485563,-0.020186953,-1.692897685190951,-0.08254392755615012
8464,SIDM00633,PD173074,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.303635,0.08644426,0.5055732800161893,0.05074435869010549
40043,SIDM00633,Docetaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.4763353,-0.21094947,-3.0646094010437617,-0.15663614116731267
46924,SIDM00148,BI-2536,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.87820154,0.020632146,0.44609800597326515,-0.011369401497418804
10152,SIDM00957,AZD4547,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.304658,-0.062775366,0.12042512942467905,0.025199360031389083
84253,SIDM00933,JQ1,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.38692224,-0.031882204,2.4231323229472728,0.1465183437185927
81012,SIDM00282,AZD4547,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.6179333,0.06403364,1.4010841324425556,0.022753198735387104
82808,SIDM00832,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.8693535,-0.10356369,-1.4136940225063674,-0.08733675584074409
36567,SIDM01042,PF-4708671,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4917046,0.095014386,-0.256409325791433,-0.0726821809060503
77242,SIDM00872,PD173074,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9039997,-0.040123004,-0.626527692936359,0.014672878261213707
2017,SIDM01042,Camptothecin,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41161975,0.049846027,-1.9694810914441327,-0.07474405679576303
64576,SIDM00835,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.9011105,0.059934027,0.6799556945262583,0.05217523954571375
10769,SIDM00673,AZD7762,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.27129567,-0.022898491,-2.495715601316598,-0.19313866452937276
90591,SIDM00928,Crizotinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.5157585,0.18792687,1.1346481817623475,0.05171063300642574
28284,SIDM00673,Doramapimod,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8997359,0.048575547,2.138009138377716,0.07117557106344075
18609,SIDM00875,Lapatinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3900976,-0.04525139,0.14003838358579818,0.006116434757069817
76314,SIDM00146,Uprosertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.941899,0.0774561,0.8043870696290721,0.18443389772870658
30362,SIDM00832,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.1121484,-0.10301623,-0.5802665604286543,-0.043904458418092145
92298,SIDM00872,BI-2536,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6102383,-0.1465093,0.01867290483083157,-0.006572623662847643
26862,SIDM00933,PF-4708671,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.543693,-0.043781906,0.47150757933661774,0.09463923339511719
9803,SIDM00928,Bortezomib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-3.0586588,-0.077372946,-1.6401912889951407,-0.08720323112570777
12544,SIDM00148,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3792665,-0.035360884,-1.6577987139243906,-0.09713012360457207
685,SIDM00826,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-4.5589676,-0.11304472,-4.082592765787615,-0.1539102643974593
329,SIDM00933,Gemcitabine,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,2.1944447,0.0041242414,2.8421667793950776,0.12785399939250594
2307,SIDM00826,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-3.9213955,-0.07573272,-3.5485910863743824,-0.08486658260174326
96386,SIDM00933,Olaparib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.4841828,-0.10446276,-1.8903467749781138,-0.05162879429837606
29696,SIDM00933,OSI-027,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.20933717,0.024420002,0.6741875562202684,0.09356049009065348
54889,SIDM00875,Afatinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2109505,-0.07579037,-1.41069218643952,-0.1323160930003496
89141,SIDM00633,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5164456,0.014739818,3.0995034711574725,0.08753387692293514
43771,SIDM01187,Crizotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.54764175,-0.037789,-1.3404894523292765,-0.07116750542138134
71458,SIDM00832,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.29029584,0.014990643,-0.47726981385634576,-0.02697943716884657
33049,SIDM00282,Olaparib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2944756,-0.023593504,1.124235011361859,0.0157075475690767
52361,SIDM00673,BI-2536,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.3712064,-0.03170543,-0.9999736776518733,-0.045070550099771074
93859,SIDM00950,Palbociclib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5095215,0.08055824,-1.7468856732674587,-0.042236666312752545
100790,SIDM00877,KU-55933,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.2480187,-0.05846207,-1.0404727022253495,0.03414654545160119
100900,SIDM00933,MK-1775,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.44706926,-0.03457665,-1.284371083336708,-0.07282582076524637
48401,SIDM00633,AZD6482,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0101656,0.09458553,-0.7662497394237123,-0.028735837904705967
71967,SIDM00957,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.30703843,0.008549443,-0.1593103593392526,0.025108111978015425
15596,SIDM00097,Bortezomib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7662464,-0.0500575,-0.49777936365175357,-0.04802042914923668
28411,SIDM00933,Venetoclax,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.6143389,-0.089075744,0.01665213637894395,-0.007633866029989638
70759,SIDM00950,Sorafenib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9005362,-0.12687494,-1.1791783134192442,-0.04004092619544635
78699,SIDM00832,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.7337568,-0.12299378,-0.6991498215805776,-0.06760887053402638
29581,SIDM00097,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9633767,0.0634415,1.746897640883324,0.09572255382161497
51677,SIDM00633,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3472569,-0.02104936,-1.3606710502417392,-0.08812823527050187
39328,SIDM00148,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1510745,0.050989743,-0.16695915446112883,-0.030032491702973223
91551,SIDM00359,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0046687,-0.11079751,-1.2353357328082288,-0.06522068602269854
64272,SIDM00216,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.40068108,0.012298021,-0.744079415376536,-0.039401617879381415
96143,SIDM00359,LGK974,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.217565,-0.03481865,-0.6920791468006618,-0.003422805614631138
51971,SIDM00216,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.7838655,0.1745347,0.9870298976683628,0.024214051797064203
47378,SIDM00957,Camptothecin,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,3.0504344,0.038646713,2.9258293039711107,0.11011523557884481
94889,SIDM01042,Pictilisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.27465594,-0.01940127,-1.2896602569096953,-0.03472990179279781
82429,SIDM00673,BI-2536,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2373854,-0.09572743,-0.05780365494822773,-0.0645909701826944
44437,SIDM01042,Afatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3725824,0.060294516,1.9508851703591836,0.08248244998944569
48664,SIDM00455,Ruxolitinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.10855272,0.0022339006,0.7606523908603403,0.06653720862430744
19195,SIDM01042,PD173074,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.772338,-0.13099408,-0.6378543366374442,-0.05547536764482505
81321,SIDM00872,Doramapimod,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.36900702,0.008624145,2.254136188449897,0.07608824811770175
70244,SIDM00776,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0770643,-0.06472011,-2.232478360280693,-0.03220200184118485
22365,SIDM00872,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.99634063,-0.053416107,0.2677011914638885,0.018859071433935462
34166,SIDM00633,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.282743,0.3232669,0.40030162166735317,0.07533904144088935
27257,SIDM00146,Dabrafenib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1166683,0.06782111,-0.029930526837665963,0.02950109441982105
87136,SIDM00359,SCH772984,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0137427,0.11237323,2.681041347232311,0.15762085894408268
34918,SIDM00455,Gemcitabine,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.1525605,-0.07801824,0.5138389820862463,0.017743501411397414
40647,SIDM00282,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.33797035,-0.011466075,-1.0400054271656998,-0.04904981757163635
79535,SIDM00146,Linsitinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.50876,0.0923012,1.5120926189877737,0.02296879507942913
67200,SIDM00146,PF-4708671,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.51567245,0.016868833,0.050356122024899,0.04967491081967041
84275,SIDM00872,Pictilisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0666381,0.09725293,0.7305008693574796,0.01783278634242794
72194,SIDM00146,Uprosertib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-3.4863448,-0.18275324,-0.14613564781543495,0.03790031221020833
20008,SIDM01042,PD173074,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7329369,-0.12102394,-1.2275182385671415,-0.044200019194325146
24274,SIDM00950,Irinotecan,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.590679,0.22593583,-0.0036823635959269928,0.0546089676354697
94966,SIDM00148,AZD7762,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5810109,0.040125657,-0.619496243150376,-0.004386862494459415
77647,SIDM00097,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6377788,-0.10670794,-0.72786583662243,-0.015739724247240315
80533,SIDM00673,JQ1,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8532584,-0.13592036,-1.1538610673631207,-0.0399254984920034
64113,SIDM00928,Tozasertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.1392815,0.07709332,1.540656101581735,0.028557028159587577
28007,SIDM00837,Dabrafenib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,-0.8571685,-0.02079218,1.3812455769142304,0.04718712982581168
62688,SIDM01042,Dabrafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5808214,-0.05013092,-0.0016317900230177504,0.014552415213831233
40704,SIDM01042,RO-3306,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7195974,0.08386649,-0.7716979452876607,-0.037824538822824855
15605,SIDM00835,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.3339993,0.021179345,-1.172852028387901,-0.05772268174284098
68847,SIDM00455,Palbociclib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.299957,0.12493564,1.1481973626820936,0.10990771530897803
43966,SIDM00097,Alisertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.123603,-0.11116923,-1.874809501602597,-0.062346557057353195
105130,SIDM01197,Navitoclax,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5813954,-0.1892363,3.6978671373858387,0.1405685976200779
68231,SIDM00146,Doramapimod,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0469851,0.12488092,-0.46790088816404796,-0.02997304586006258
77189,SIDM00835,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.550669,0.23716587,2.0559135123211827,0.12462036921105105
44722,SIDM00633,Docetaxel,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7441149,-0.11851393,-2.0013652358422247,-0.093318339353466
94364,SIDM00148,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7333387,-0.067425415,-0.5130570936358658,-0.03154890076328375
25499,SIDM00928,AZD7762,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4293774,-0.12769069,-0.08959917350784213,0.011059368407800278
75824,SIDM00832,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.6415979,-0.021808667,-2.6680841163795717,-0.04355266938066294
44234,SIDM00950,LGK974,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0126333,0.054796394,0.6116253684763843,0.026573610962368047
74779,SIDM00832,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.855606,-0.06640179,-0.8664017691292748,-0.010658474161526172
10839,SIDM00148,Taselisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.77750635,0.051751792,0.22831731750250248,-0.02474440110597766
76624,SIDM00933,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.88658786,-0.10988837,0.38985385021022656,-0.012461720987664258
98423,SIDM00826,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-4.6196246,-0.30090454,-4.448701960403823,-0.2303766696565566
54518,SIDM00877,Camptothecin,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.9860818,0.08834428,-0.7043049804671642,-0.03809021410392736
5388,SIDM00148,Sorafenib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.731619,-0.055524908,-0.9785927927982655,-0.08627981813673125
41906,SIDM00928,Palbociclib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.992804,-0.10946153,-0.9509714506318158,-0.05413509118389356
41942,SIDM00835,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.1923535,0.07170496,2.4398188933606053,0.10344750832112538
80312,SIDM00877,Lapatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.7348936,-0.1567604,0.5378744142339581,0.08914078545372904
101366,SIDM00148,Afatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.88405424,0.07860599,0.39862952602322244,0.04731977964951211
71717,SIDM00633,Pictilisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1187353,0.068945244,-0.6557842443298306,-0.028383189998291786
29823,SIDM00146,Uprosertib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7174494,-0.11045007,-0.32262556888788285,0.03059077944183118
100708,SIDM00148,Wee1 Inhibitor,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3913248,-0.14656745,-1.204518308357503,-0.09763653568671023
108006,SIDM00877,Trametinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.31092742,0.009654082,0.3322056238910359,0.09978959843900824
88716,SIDM00950,Irinotecan,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1927304,0.081176385,0.006933796473455532,0.05293540785116433
15243,SIDM00928,Sorafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.9100526,0.08039966,0.9648525401813716,0.07508615502310491
17389,SIDM00875,AZD6482,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2553108,0.114838965,2.0361956825603498,0.06750198255757488
54049,SIDM00950,Navitoclax,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7717414,0.13648745,1.3835560101765056,0.1367939301537027
46792,SIDM00359,Vinorelbine,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6304082,0.10363105,2.7187925376009394,0.18540725371549144
86670,SIDM00216,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.0582885,0.008610089,0.1253359894057236,0.00414087552902151
76888,SIDM00633,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.077619,0.09568522,0.4816496523557349,0.02577469089036845
57666,SIDM00928,OSI-027,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.5338132,0.15263548,-0.4950812886269544,-0.04360874338616931
81885,SIDM00875,Camptothecin,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94493794,-0.015990043,-0.24075211772814956,0.00673481755506339
20143,SIDM00826,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.0840279,0.027058143,-1.5387176914893095,-0.05820377561936373
54170,SIDM00633,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1758962,0.09982069,2.4755401840129907,0.05636299132088998
11281,SIDM00832,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.9450946,-0.22527204,-1.4900276007471973,-0.04429459268439366
38778,SIDM00148,AZD8055,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.30865526,-0.029044393,-0.14877554716713795,-0.04597312059012767
10971,SIDM00875,AZD8055,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56042385,-0.04583568,0.3228233522923339,0.034994380054945234
13762,SIDM00673,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7726458,0.11024855,1.40886167059365,0.08718601218137254
95085,SIDM00146,Linsitinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,4.1321874,0.109152384,3.11609876721002,0.06605896031896306
102249,SIDM01197,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.5571239,-0.044575687,-1.3102769125007363,-0.10959577989875333
92145,SIDM00146,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.2409658,-0.016382976,0.24927566869500747,0.0010687486353160548
61930,SIDM00877,Nutlin-3a (-),Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.7707611,-0.072125934,0.18313917044766412,0.0376383613149451
101476,SIDM00097,Dabrafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.39676,-0.088923045,-0.5827351728189064,0.008278858335096085
96643,SIDM00877,Crizotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.9048564,-0.04899252,0.18546262384505507,0.006145849942133798
69330,SIDM00633,Uprosertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6378591,-0.048648436,-0.8475545492402587,-0.04678762302125102
82561,SIDM00933,KU-55933,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6754476,0.032752898,0.1821113445824869,0.022133945082714095
81022,SIDM00455,Linsitinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.97391015,-0.057470575,1.1180699582850135,0.10841145505585241
3650,SIDM00097,Venetoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4159559,-0.037786353,-1.4022156077680035,0.00713489814337662
78266,SIDM00455,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,6.8792706,0.32210007,4.687234764356754,0.19164976785721866
101167,SIDM00872,PF-4708671,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.598867,-0.1678098,-1.3760016389644485,-0.048297754677247735
76200,SIDM00837,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,0.6464058,0.029828522,-0.28044789216639326,-0.01873412122793005
776,SIDM01187,Crizotinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.831647,-0.107858665,-0.6093829557946683,0.0006996128757741348
51602,SIDM00633,Uprosertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.73263186,-0.04373679,-1.7956512819231005,-0.038485892344658705
87716,SIDM01187,Navitoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.2871538,-0.019961195,2.0488017057958094,0.11776321556331477
97159,SIDM00835,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.44614705,0.018196726,1.848403858216865,0.07693504666330789
2739,SIDM00148,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2936323,-0.120101154,-0.04232615524103212,-0.051954231464319524
5393,SIDM00455,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.9918427,0.25762215,3.9770262196333213,0.25624329553805447
81912,SIDM00933,Crizotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.17997575,0.025161793,0.6730182064086749,0.046030512862201264
10303,SIDM00872,Ribociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.87377053,-0.01102934,1.707234871218153,0.04155280179608047
107881,SIDM01042,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5516779,-0.009569699,-1.1425001440175626,-0.046758657600562
74467,SIDM00872,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.68265384,-0.07098925,-0.8499651344112241,-0.1234855211856734
37053,SIDM01042,Nilotinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1202353,-0.086688936,-2.200550263965486,-0.06424174480717634
41681,SIDM00957,MK-1775,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-5.7793274,-0.17581658,-2.24057575876192,-0.03705822323129727
73697,SIDM00933,Uprosertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.4104393,-0.12826653,-0.9421391139011207,-0.0905337321127109
77083,SIDM01042,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8396186,-0.0930216,-0.6670106200644539,-0.02511204540108707
21894,SIDM00957,Olaparib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-1.7377838,-0.018045502,3.240762343604404,0.028883537601728442
49838,SIDM00933,Ribociclib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.36103085,0.008131001,1.618323701635825,0.024441995000909347
82045,SIDM00957,Vinorelbine,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.1037406,0.020682745,-0.22451793256670088,0.008593732298584776
91400,SIDM00633,Doramapimod,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.66909367,-0.053287037,0.1233879406920432,0.050110919057572985
23750,SIDM00835,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.4569004,-0.1540089,-1.037097030851815,-0.022426799334403943
66713,SIDM00875,PD173074,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7852758,-0.07674688,1.2091377440539253,0.06997362347964303
39180,SIDM00875,Camptothecin,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3676364,-0.040893227,0.2698753178925943,-0.021406830389738736
101013,SIDM00097,Ribociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1838269,-0.041984078,-1.8035594431233308,-0.061811868487512474
69179,SIDM00633,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0860145,-0.107390806,-3.2880631341042936,-0.14001531774108406
30031,SIDM00146,OSI-027,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6756251,-0.10383671,0.7829284927874458,0.04770174189276348
25663,SIDM00875,NU7441,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20936672,0.018627202,-0.4513760424565724,0.004123817695347522
12976,SIDM00146,OSI-027,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,-1.5186774,-0.04732269,0.6277568241262257,0.03762830679175357
29166,SIDM00928,Camptothecin,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.87390107,0.08264185,0.006571517130922273,0.05187215388981398
88244,SIDM01042,MK-1775,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8489645,-0.058360793,-1.8928999580683732,-0.11538925839328593
63972,SIDM00928,Linsitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.9958041,0.083634704,-0.15641808853818154,0.030042257226473374
28791,SIDM00776,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.0331652,0.14603348,0.8525145452451502,0.02970524018700505
7669,SIDM00282,LGK974,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,2.2687607,0.13165858,-0.599306265503711,0.025215748066844578
2019,SIDM00216,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,3.1548777,0.19464372,1.0288116058751429,0.0557266692504191
59942,SIDM00835,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.51636845,-0.021524375,-0.49443241811686967,-0.023140279324839738
39035,SIDM00146,Docetaxel,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.7960284,0.15401335,-0.10749543610060605,0.02689228583521014
5802,SIDM00673,5-Fluorouracil,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9980882,0.051170267,0.669863323238877,0.061513579472938236
78080,SIDM00872,Nutlin-3a (-),OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.49039772,-0.011907801,0.8572235296711199,0.04467009390456014
4292,SIDM00877,KU-55933,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.6359509,-0.06943773,-1.0807185029158894,0.013823681694765371
48468,SIDM00455,Trametinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3509357,-0.08657851,-1.3787076348663074,-0.046858853357086463
32549,SIDM00146,Luminespib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.5489962,-0.049628686,0.5061001311060404,0.0033502847188188914
11962,SIDM00633,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5716321,0.054661058,-0.7360725378616846,-0.014799521180954091
97624,SIDM00359,Linsitinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6440549,0.11382283,0.5043861914777333,0.08144400122346963
34913,SIDM00216,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.38450152,-0.021414302,-1.1233368216084179,-0.038094576355753036
10662,SIDM01042,Docetaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.274902,0.10657356,0.1628877692497701,0.0012306152923591421
30407,SIDM00835,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,4.6253953,0.21754713,1.972801980274745,0.06159308211159513
103319,SIDM00633,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2542439,-0.034113664,-0.6110216744643707,-0.02317215526628638
2003,SIDM00673,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.9384017,-0.20841253,-2.9881856950168184,-0.24705069272604752
27810,SIDM00455,Lapatinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.19614287,0.005918648,1.2803239351557196,0.09744920996951675
39234,SIDM01042,Alisertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.9674318,-0.19699112,-2.87089424250904,-0.12647813801229568
31619,SIDM00633,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6014056,-0.095848426,-0.5291784236496858,-0.010856073288511178
66200,SIDM00146,Nutlin-3a (-),Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.28849697,-0.007332822,0.4342595476460959,0.028335186682759545
39159,SIDM00359,Dabrafenib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0737748,0.17686836,1.1050857384576598,0.05727678125026995
101073,SIDM00633,Ribociclib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.071883,-0.030056477,-0.6492862143288493,-0.019814769329762404
56213,SIDM00832,SB505124,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.9866399,0.17667481,-0.3825552483075918,-0.016350413820797754
43405,SIDM00216,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.46428806,0.01023065,0.16793383573951193,-0.04456798091524293
82062,SIDM00633,Luminespib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9360535,-0.073476635,-1.8375466146373132,-0.05913004950073651
8994,SIDM00146,Temozolomide,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.5917614,0.01492771,1.1296094688050016,0.0787767856294843
101220,SIDM00832,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-0.899071,-0.05987927,0.4016411302276014,-0.00943508437193118
51730,SIDM00933,Sorafenib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.26605326,-0.024848804,0.26927575790703767,-0.014243515989299045
15924,SIDM00633,Ribociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5453541,0.07051201,2.480722823292923,0.062125216150341576
98651,SIDM00950,LGK974,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1752827,0.053185318,0.661144436683967,-0.002287069321402547
42744,SIDM00455,Irinotecan,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.5950687,0.1153244,2.038511037906665,0.14591013447949824
90996,SIDM00776,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.9178855,-0.056024265,-0.8171352387481207,-0.022184702981819644
68246,SIDM01197,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4707237,-0.0549517,-2.652683514875642,-0.14221542702622705
63917,SIDM00633,PD173074,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1026125,0.07503794,2.184169034274725,0.10365042373298519
19287,SIDM00872,Sorafenib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.37341043,-0.039710194,0.4485683534731435,-0.004959150553541102
22899,SIDM00877,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.238614,0.09062402,-0.28664013158212936,0.06265877160117422
68897,SIDM00097,KU-55933,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9612045,-0.09290274,-1.7818994399872152,-0.060998715831359476
81660,SIDM00826,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-0.8158846,-0.05968177,-1.3320847121527866,-0.11779521926507744
61917,SIDM00872,Luminespib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6085153,0.14766148,-0.022960114955085292,0.05577072286123758
17406,SIDM00216,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,2.981321,0.028270412,3.800176728657573,0.09997321378566014
17924,SIDM01187,MK-1775,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2057625,-0.11388325,-0.8419031357407221,-0.11974610965303514
47784,SIDM00216,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-3.2066987,-0.14463335,-1.2947219353854431,-0.08779598839591189
18929,SIDM00633,JQ1,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.20596647,0.018889364,-1.4156791545950884,-0.09734322506659976
702,SIDM00928,Vorinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.2578682,-0.111614875,-0.2865814116027356,-0.022330251700612206
57273,SIDM00875,MK-1775,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3711954,0.019937485,-0.5103453465567525,-0.02155671957157908
94872,SIDM00950,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.551559,0.09639663,-0.09443768903443737,-0.016210547212215837
27373,SIDM00148,5-Fluorouracil,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3610866,-0.11731792,-2.2276160214734646,-0.12456973044348259
46928,SIDM00282,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.8666918,0.052000135,0.017232904406050967,0.008879054582774448
52764,SIDM00877,Olaparib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.267548,0.0679669,-1.0944942768864578,-0.015325916923397496
43443,SIDM00872,AZD6482,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.230961,0.117911935,0.3194908562995891,0.02824831594622932
69225,SIDM00957,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.5487838,0.092436835,1.6632447596211763,0.10927310510439031
100081,SIDM00832,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0242593,-0.0855875,-0.8431697757307178,-0.06515890364531313
13866,SIDM00097,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.56015396,-0.035952583,-0.7440856763583583,-0.05284098487848174
28896,SIDM00633,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9678519,-0.0636648,-1.4915513545369368,-0.03905915443589401
65448,SIDM00826,Navitoclax,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,1.2410474,0.01830667,-0.05074196977281903,-0.027498678025913763
86107,SIDM01042,Uprosertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.39636582,0.0131071145,-0.9437201696773472,-0.08148191805925137
106507,SIDM00359,Camptothecin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8657072,-0.18883365,-2.7542562987676282,-0.11509597103416369
22686,SIDM00282,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7129568,-0.089653976,-1.70680014269714,-0.1281439662110217
76357,SIDM00673,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-3.1996696,-0.16771606,-0.26745702823801976,0.027618295047119185
40675,SIDM00832,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.7634132,-0.056494627,-0.2013916630387995,0.012285711944537174
101961,SIDM00359,AZD8055,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4255518,0.035724644,2.146368714881455,0.14190515492217773
31909,SIDM00633,KU-55933,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7243426,0.15313059,-0.8330467853735288,-0.011256252767876599
84098,SIDM01042,Bortezomib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.41398627,-0.025416862,0.4967377726162249,-0.023915458079439147
47982,SIDM00097,Alpelisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.53257716,-0.037980355,0.5024619376964674,-0.008865662916211164
93912,SIDM00877,5-Fluorouracil,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.4630193,0.11086829,0.429030565485736,0.04935796727902245
56016,SIDM00826,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.69334227,-0.042143956,-1.102139256851114,-0.03510082700577697
105022,SIDM01042,Taselisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6341032,0.045714017,-1.1628883873093323,-0.09188413614320627
11572,SIDM01042,GSK269962A,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.338959,-0.04504978,0.2501977431633157,-0.00901768134356523
107531,SIDM00933,BI-2536,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.23622957,0.0014483413,-1.4704914216909,-0.012790503393633764
56499,SIDM00776,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.5274274,-0.116513595,-1.2356704354704071,-0.13059275457611538
27214,SIDM00872,KU-55933,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.3832858,-0.062342297,-0.24292159538911004,-0.02410640143559176
51927,SIDM00359,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0906675,0.029607223,4.010934018406244,0.1605393423472667
74719,SIDM00455,Erlotinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.23755,0.12713903,3.9093301007884187,0.11004918885948904
62470,SIDM01042,Palbociclib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3172432,-0.016189503,1.0883321843234748,0.016818805401493643
64176,SIDM01187,Crizotinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1250881,-0.066471405,-0.26708405740885144,-0.006898271532914653
107428,SIDM00633,KU-55933,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.99107814,0.044641707,-0.12083885283083652,-0.01521711266201385
40611,SIDM00933,AZD6482,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.92057997,0.038643774,1.9330055508923525,0.19487968284238888
74311,SIDM01042,Olaparib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3780199,0.120685555,0.14252142722467936,0.09580262789879784
48397,SIDM00148,Palbociclib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8726528,-0.047838885,-1.2041037037409317,-0.01615847536954049
101438,SIDM00875,Olaparib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7160077,-0.058117148,-0.6106310994101196,-0.04226886546445053
23749,SIDM00928,ZM447439,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.9061937,0.22374305,1.2889398687143785,0.06917587833420893
12859,SIDM00042,Taselisib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.4582026,-0.10986607,-1.1721408328544303,-0.03306782367626682
60027,SIDM00833,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.7781577,0.045864683,0.8792575818923525,-0.006015272423876611
14070,SIDM00877,Wee1 Inhibitor,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.6137407,0.037723288,0.7265316680377438,0.022777489380154007
7834,SIDM00633,Wee1 Inhibitor,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2069547,-0.11682375,-1.1687170544117667,-0.04314562082991009
97818,SIDM00146,Temozolomide,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.47554567,0.012972258,1.2443048397020846,0.03568431992147056
97049,SIDM00835,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,-1.8572596,-0.14028883,-1.0577524163172394,-0.03909023338761088
80057,SIDM00148,Sorafenib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4491049,0.037672278,0.20714566039424964,0.03530861621687437
92705,SIDM00837,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.5239899,-0.124906406,-0.6085931469206939,-0.06223058241229904
83459,SIDM01042,BI-2536,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.4202912,-0.0392902,-1.0061312660120303,-0.043201440851671914
90916,SIDM00957,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.1676986,-0.0346428,-0.3179175834976646,-0.005640114070961683
78778,SIDM00455,Trametinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.287025,-0.14945023,-2.185611571890145,-0.06484947154129705
93685,SIDM01197,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,3.374027,0.22343637,2.5170712069530707,0.10163788445137613
77119,SIDM00875,SCH772984,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.906091,0.06031472,-0.5879606562492492,-0.08282737033765764
54549,SIDM00097,Alpelisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0997424,-0.07757608,-0.09451668097964207,0.016580089508374595
76289,SIDM01042,Luminespib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.61873835,-0.046798617,-1.318061160747628,-0.05332348962960261
16850,SIDM00148,Pictilisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6193042,-0.111970894,-0.20198722376717107,-0.08669131281655731
85117,SIDM00950,Crizotinib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.348931,0.21482755,1.6866665413266657,0.1730486515112752
7768,SIDM00146,Camptothecin,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.7687491,0.12860739,-0.33122553698667945,-0.028021064180076157
52652,SIDM00282,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9980648,-0.039443877,-0.4383283325024638,-0.024208410716692327
13197,SIDM00042,LGK974,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6675606,-0.06075588,-0.9751083591284848,-0.02012781067374494
97636,SIDM00633,Uprosertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.72002995,-0.056907132,-1.7611561349255105,-0.0733023779931993
59008,SIDM00146,Camptothecin,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.68122536,-0.06253387,-1.065191470999712,0.015536996514936969
43809,SIDM00146,JQ1,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.89308864,-0.07687961,0.39704907225427716,0.008327812957746698
6662,SIDM00148,PF-4708671,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.504785,0.12037311,-0.19378148002766274,0.03190513696219823
5156,SIDM00633,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9848559,0.090764746,-0.5332830583083076,-0.03534639992463127
44435,SIDM00875,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.058820404,-0.004096947,-0.46648654135346035,0.02825991941942492
33227,SIDM00146,JQ1,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8768592,-0.13862331,0.31373175804508796,0.07530778376025339
19421,SIDM00146,PD173074,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.35063228,-0.025290996,-0.8358944359819295,0.06410530336331152
32089,SIDM00097,KU-55933,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1091702,-0.070921995,-0.5196184035447088,-0.03750134500713323
40456,SIDM00633,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8005169,-0.026606465,-0.9641327724153658,-0.06449787074750411
24788,SIDM00872,Sorafenib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.3863018,-0.17691647,0.08765471243466849,-0.00881117765520589
63460,SIDM00933,Entinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.369729,-0.024852684,0.4855109416621133,0.030399803785308425
45126,SIDM00875,Paclitaxel,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5249838,-0.03539791,-1.3342784672479342,-0.08972013126341326
77188,SIDM00097,BI-2536,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4860127,-0.10550808,-0.6548179656120171,-0.06088543387955949
105,SIDM00148,5-Fluorouracil,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.1176987,-0.08525476,-1.301384070980757,0.0014505345853047058
51995,SIDM00826,MK-1775,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.6698928,0.082284376,-1.2714803684879157,-0.042163666692810464
33886,SIDM00872,Taselisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2627938,0.05532866,-0.43334984005013616,-0.08744063497886552
3871,SIDM00875,Lapatinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38711017,-0.03601856,0.30675843638226524,0.0063035699977235515
20123,SIDM00950,Irinotecan,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0059799,-0.06724341,-0.9046919023818445,-0.0176624142022655
43251,SIDM00837,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.4370627,-0.053561993,-1.340777376286168,-0.023172166431728574
24911,SIDM00455,Erlotinib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1285862,0.0308779,3.61833413414263,0.07416422890450824
43926,SIDM00875,NU7441,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3581314,0.099937916,1.5680569727328992,0.09409183041569508
95418,SIDM01042,MK-2206,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8446111,-0.033652406,0.3772721965727062,-0.03090514308337051
48421,SIDM00282,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-3.5620391,-0.15574189,-1.4456951462408252,-0.11125966104266234
46836,SIDM00216,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.051653,0.2247214,0.7940806629254303,0.05021696494129297
66293,SIDM01042,SCH772984,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.25710765,-0.01293054,0.6917354266127179,0.020553703651463327
25230,SIDM00633,Navitoclax,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.644265,0.08281363,4.719052434836816,0.18474368425309995
34614,SIDM00673,BI-2536,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.57038504,0.031190047,-0.9653957398318046,-0.0766747822606238
98189,SIDM00148,NU7441,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.60627717,-0.05547391,-0.16632888330304169,-0.031433845932350137
16581,SIDM00832,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,7.070463,0.34155864,4.2340429706825935,0.1716916115748344
52797,SIDM00776,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.0578111,-0.058870103,-0.8184384299587683,-0.07000681474330356
23480,SIDM00872,Palbociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5240239,-0.018954448,-0.34908765627233657,-0.030596736880504277
103129,SIDM00950,Paclitaxel,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-5.6176095,-0.477659,-3.807495974812098,-0.23872562064142366
10059,SIDM00097,Paclitaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9782146,0.047899287,0.7510736866469722,-0.007451053996915563
69270,SIDM01197,SCH772984,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7881255,-0.050915312,-3.0398989755464236,-0.07261203584217969
86698,SIDM00872,Doramapimod,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.57510567,-0.020248368,0.7708221623478801,0.05521430096977205
24117,SIDM00146,GSK269962A,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-2.1027203,-0.12907682,0.4321694880326999,0.06798822621866697
45465,SIDM00835,SB505124,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.5227334,0.12855133,-0.7414217828987935,-0.04528904784959704
62595,SIDM00633,MK-1775,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0509378,0.043802686,-1.457901267066258,-0.027025692950884517
18186,SIDM00872,KU-55933,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0427783,0.14705358,1.1026669335842878,0.058721870830485336
69670,SIDM00146,MK-1775,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.7677376,-0.21531457,-3.333974911978529,-0.22789658558065864
89440,SIDM00872,Temozolomide,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.17560327,0.0035168221,0.6849902395091721,-0.011072746901696358
4365,SIDM00933,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.6682676,0.12400168,0.6603777280800811,0.07510176247521981
40836,SIDM00148,Wee1 Inhibitor,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.037287638,-0.0037462122,-1.3647891412783568,-0.03649647350444615
81015,SIDM01187,Nutlin-3a (-),Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0701643,-0.09584505,-0.8771808344354948,-0.07379668001122786
23677,SIDM00832,AZD4547,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.0360126,-0.10109617,1.0854337310143964,0.027746602114613817
55565,SIDM00633,BI-2536,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.11297348,-0.011807779,-0.48437818637289154,0.03898944359297238
18906,SIDM00833,Olaparib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.222646,-0.0229733,-0.3163258799594795,-0.01315100197467589
8430,SIDM00146,Cisplatin,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.34912917,-0.012028432,1.1719202608029102,0.037386462476770146
100046,SIDM00359,Trametinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3702037,-0.06848919,-3.8346968496613028,-0.09402849471544111
98001,SIDM00216,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,8.017219,0.20282365,2.0256269288069593,0.12553682009135902
47162,SIDM00875,OSI-027,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8700865,0.09547099,0.453175993281455,0.07458093927771839
24034,SIDM01187,Cisplatin,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.4332895,-0.032902338,-0.6776355162991521,0.006042690734681974
15812,SIDM00877,GSK269962A,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.4974086,0.08423306,0.0916191447786624,0.012434668904732389
93067,SIDM00042,MK-1775,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.3160989,0.13436747,-1.2216787913404181,-0.02295209613107539
100503,SIDM00933,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.021204062,-0.0008396287,-1.8545466900368288,-0.05518071910983485
28022,SIDM00633,Bortezomib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.46998078,-0.036592044,-0.9114241394472129,-0.030417337723804515
85119,SIDM00776,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.77534384,-0.062117428,-0.62449157376145,-0.009594526447867494
32072,SIDM00097,Gemcitabine,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.54414296,0.019744925,-0.9930920097133976,-0.009488388948774044
103434,SIDM00282,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.9444878,0.12560529,-0.8118372328068104,-0.04609085813376213
80103,SIDM00957,AZD8055,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.410604,0.079487026,-0.0766928743739356,0.026947576395608845
39317,SIDM00097,JQ1,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5793386,0.095246285,0.6369908386360137,0.051786059926848024
2140,SIDM00832,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.50459546,-0.03637537,0.462093925767394,0.05946473233573626
80972,SIDM01042,AZD8055,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0309162,0.05836502,0.565130379142257,0.03297769179538489
50947,SIDM00042,SCH772984,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.2973723,0.20900139,-0.7982698641924851,-0.022434159739334377
30641,SIDM00872,Doramapimod,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.50440663,0.022031154,0.761988616683147,0.03547779792503958
18141,SIDM01042,Temozolomide,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.13637875,0.004891487,0.22958847780404198,0.011171428989154191
11274,SIDM00933,Entinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.52513427,0.031566326,0.6966745856987493,0.03086449854251602
34019,SIDM00633,AZD6482,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0748891,0.09496947,-1.107494012718134,-0.02658818609286729
32325,SIDM00950,Olaparib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7895305,0.078563765,0.4166015037714496,0.05261989384519975
51421,SIDM00877,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.9954886,0.16283806,0.4849039588044454,0.07752723363411414
49811,SIDM00928,Crizotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-1.6336516,-0.12904646,-0.39856261538084103,-0.08383744712214077
98579,SIDM00875,Doramapimod,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5133553,0.09493319,2.3733412495221646,0.06786905454910384
9072,SIDM00872,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0589544,0.08615276,1.3048361296256425,0.08516509179276545
88782,SIDM00097,Nilotinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8351915,0.050282322,1.3907845228576172,0.06122793101646157
180,SIDM00928,Ribociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.7137328,0.05627755,0.7203199061852434,0.01806682797278035
94459,SIDM00832,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.9441787,-0.06624664,0.03984322928940173,0.011626316965196636
62700,SIDM01042,Crizotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4600567,-0.04946669,-0.8628316156798332,-0.04715130063268764
13813,SIDM00928,MK-1775,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.2998521,0.20168447,-0.19766363204656756,-0.04183999513326623
53825,SIDM00359,MK-1775,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.8064954,0.17178209,0.9177143831174421,0.0706390707290959
1310,SIDM00872,Navitoclax,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.05887243,-0.00413945,0.8992035131792134,-0.006664422378571521
70120,SIDM00877,Pictilisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.94714105,-0.10707047,-0.5651204853073696,-0.09559754500886695
36655,SIDM00835,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-0.82941747,-0.036408357,1.262701883048322,0.1206762783380748
77173,SIDM00633,5-Fluorouracil,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0119126,0.061310787,-1.363789270456171,-0.053540430886133875
59617,SIDM00933,AZD7762,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.72096115,-0.10004266,-1.2633396777631698,-0.054855944093042966
56489,SIDM00633,AZD7762,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6471422,-0.051719595,-0.9349043226009727,0.010249126915276872
27363,SIDM00097,Alisertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4492067,0.09480684,0.1412867865342184,0.02099271855939816
66118,SIDM00776,AZD4547,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1586747,-0.03222323,0.11387336046994057,0.04564076588669176
75181,SIDM00928,AZD8055,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.435469,0.17347416,0.7662573920623628,0.023793520884379044
39192,SIDM00097,Camptothecin,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3369473,-0.044069014,0.07207590783184983,0.0029847574125840422
72199,SIDM00097,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.49240994,-0.034509394,-0.8902953132658632,-0.08188717487049664
15738,SIDM00950,Cisplatin,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8238276,-0.027321288,-0.28076843760389214,0.03244121021379776
71679,SIDM00673,Entinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9313321,0.15199383,-0.13740186291631712,-0.002932961588026069
45044,SIDM00216,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.4287032,0.02281149,-0.8918644435728906,-0.0026885749715842232
105510,SIDM00950,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2120491,0.0688209,1.755030726748511,0.10057079889437064
30567,SIDM00146,Lapatinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0380728,0.09617259,0.03070152460529034,0.02182865737740459
99185,SIDM00933,Linsitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.7450958,-0.1016457,2.57545746238877,0.10542166336677837
33571,SIDM00877,Doramapimod,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,1.7963079,0.2012799,0.3298023366147716,0.013080659944268885
22391,SIDM00146,Nilotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6537849,0.11938211,-0.24120622833844643,0.025939013741654512
10697,SIDM00673,Venetoclax,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5335741,-0.037128817,-0.420817211538914,0.027516080149692722
59876,SIDM00877,Uprosertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0324547,0.10969099,-0.045232233856885046,-0.014340411053675508
108158,SIDM00877,Axitinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.07496481,-0.007771846,-0.0921940643058342,0.030152498991410898
39474,SIDM00148,Alisertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.7750673,0.43545282,3.260108126809666,0.23025647250713988
15850,SIDM00146,Alpelisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.29867542,-0.014205314,1.050601118073858,0.10595769530819057
22206,SIDM01187,Gemcitabine,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7835877,-0.056939673,-0.38449678555138467,-0.03833722122862027
76032,SIDM00776,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.4916463,-0.11681116,-1.7980524702499552,-0.07366275101086883
74988,SIDM00673,5-Fluorouracil,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.72223705,-0.030911203,1.0053992780344447,0.0021676859854942907
17550,SIDM00877,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.2274158,0.2811718,0.5016756168307923,0.06516920627684242
25515,SIDM00148,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0960062,0.094193995,-0.7378404416405897,0.00163487482454116
9841,SIDM00928,Venetoclax,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.96772766,-0.029103506,-0.27709051749306046,-0.0017110764488457318
43819,SIDM00146,JQ1,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.1556568,0.12132305,1.0376654910610839,0.01631987376169372
83556,SIDM00957,AZD7762,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.6093395,0.05237527,0.7806826676343488,0.036736341205042516
10393,SIDM00097,RO-3306,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.254384,0.012689085,-0.6768963840057804,-0.02299908495219917
12647,SIDM00146,Camptothecin,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4988427,-0.04253209,0.10989693088637231,0.022909054688731046
59838,SIDM00673,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.1147194,-0.05757997,-1.2424977522695175,-0.00885800997707406
36577,SIDM00633,Sorafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6654474,0.05322034,-1.3315007119177016,0.007895556017179563
98711,SIDM00877,Bortezomib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.34818104,0.026504103,0.6502881512842833,0.03933763753188041
12821,SIDM01197,AZD7762,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-2.1044278,-0.08274106,-1.0845470751727235,-0.0975671478742527
99655,SIDM00097,RO-3306,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0723865,-0.07901867,-1.6147228012567005,-0.0547927611079957
6300,SIDM00097,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9652177,-0.05425305,-0.7996562770662079,-0.023315246186118535
13827,SIDM00877,5-Fluorouracil,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.5303844,0.11802931,0.5084599262551188,0.038071624807380515
43235,SIDM00216,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.2407975,0.013985145,-0.008716279789396982,0.010581734210337992
50326,SIDM00875,Venetoclax,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42960006,0.012013214,0.4186251630006343,0.006125141567694885
14933,SIDM00877,Taselisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-3.963806,-0.24930578,-0.29298799315597157,0.03417559166587348
31024,SIDM00673,Olaparib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1669838,-0.05490305,-1.8773580020632727,-0.04525785163699784
12549,SIDM00097,KU-55933,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.414856,-0.046542022,-0.6874458524952242,0.029902519382922686
92362,SIDM00097,Dabrafenib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.315425,-0.1072779,-1.9435274085747158,-0.06165828968515813
3608,SIDM00216,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.13279226,-0.004290922,-0.12527985479958048,-0.01572928248120103
105356,SIDM00146,Palbociclib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.67946,0.12654006,1.3624492557779817,0.1161172555226096
83927,SIDM00097,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7312468,-0.07832911,-1.4973085371168129,-0.06708941979311399
63169,SIDM00877,SCH772984,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.0029216,0.047531214,3.203315419833711,0.1682403902266541
64703,SIDM00146,SCH772984,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3690609,-0.115349025,-1.4146332655747809,-0.08470702663811393
52991,SIDM01042,Gemcitabine,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.57300043,-0.07118585,0.007527781504671758,-0.012418646254885752
79594,SIDM00833,Linsitinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.4132032,0.11307491,1.4412654327054883,0.07320754644884331
59682,SIDM00933,RO-3306,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.37411976,0.040138125,0.1629594063738519,-0.026945769924224202
20922,SIDM00826,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,2.9088328,0.02593144,2.8762621620204953,0.07947639373234451
71478,SIDM00933,MK-1775,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.3174163,-0.023779955,-0.024617961991749156,0.011960140450121663
105876,SIDM00097,RO-3306,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.33263,0.082044594,-0.12770345804475572,0.00020071926053770328
26219,SIDM00673,Gemcitabine,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6927348,-0.031186657,0.29199396204228895,0.09794146627180532
29046,SIDM00097,Paclitaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0553837,-0.20830043,-2.673232775193445,-0.14814859870904043
14253,SIDM00950,Cisplatin,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.352955,0.06113738,1.2478373568954955,0.10657892764492456
9886,SIDM00957,SCH772984,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.7301621,0.12171341,2.2243513067160996,0.16665806772409963
60787,SIDM00282,Palbociclib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,2.4806793,0.12400885,-1.1453201951353391,-0.05194742555960513
47575,SIDM01042,Axitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5812391,-0.108485736,-2.227254734045684,-0.092089000034504
56756,SIDM00633,SCH772984,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9530424,-0.13439345,-1.9570836201094652,-0.08808453204772017
80979,SIDM00359,Oxaliplatin,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6848735,-0.092504606,-1.3323427606794247,-0.01467629448849515
40914,SIDM00042,Navitoclax,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.5296727,0.03470136,2.5542508412208726,0.06884449399322909
44486,SIDM00146,Camptothecin,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.308904,-0.028392946,-0.6458691889616762,-0.009304666545280728
25780,SIDM00872,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.57671756,-0.020470437,0.2963589648548506,0.007601743428915758
69526,SIDM00872,Docetaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8767276,0.20446841,2.591019596186066,0.171287671833836
100972,SIDM00633,Dabrafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8181747,0.055397216,1.0817241475830277,0.056265343584234795
54566,SIDM00216,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,3.887126,0.17340074,-0.30636107781269073,0.029823423356305074
48151,SIDM00877,PF-4708671,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.1379485,-0.011697472,-0.5817240393926381,-0.034215148976907986
103957,SIDM00877,PF-4708671,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.12288767,-0.010337085,-0.2897106211060986,0.035910005586193776
86899,SIDM00148,Sorafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.69533485,0.05863446,0.1339084465100752,-0.012778655182784414
22178,SIDM00833,LGK974,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.1589234,0.044040166,1.0496912263602676,0.07800873218628161
9511,SIDM01042,Docetaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7068304,0.092038825,-1.5352845634316516,-0.06255184818599707
75291,SIDM00833,LGK974,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,0.8203069,0.032041166,-1.0716215752279723,-0.027521482263140867
12850,SIDM00776,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.220976,-0.10040597,-2.8363212617198963,-0.07967419802237448
24866,SIDM00872,Alisertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7999714,0.037681133,0.8682034716588479,0.03829532611063363
39716,SIDM00877,Gemcitabine,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.4813843,-0.02286301,-1.4268110658117705,0.0002652485158882543
105945,SIDM00872,MK-1775,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0814714,-0.111001454,-0.8198883578556437,-0.06185832855879133
27182,SIDM00832,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,2.0475917,0.079519294,1.0275354960374294,0.03257594354052794
5118,SIDM00776,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.1592765,-0.18186837,-1.7205300656453588,-0.11834433617494397
83614,SIDM00928,GSK269962A,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.5320126,0.04089487,-0.13584802232276422,0.039647672627098035
11473,SIDM00776,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.348889,-0.03830354,0.7962223712744818,0.03694628985625059
41925,SIDM00928,AZD6482,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,0.76070845,0.058591638,-0.3802891072568358,-0.007026009711505569
96191,SIDM00928,Camptothecin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-3.3640568,-0.19338988,-1.9894803674400339,-0.09310589037398524
69287,SIDM00146,AZD6482,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.5346726,0.12550019,-0.1528069304956994,0.0015842823435074274
69989,SIDM00835,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,0.84202933,0.07037225,-1.2730581546065918,-0.06787456009997057
92138,SIDM00928,Luminespib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4563569,-0.14799784,-0.3507261741464487,-0.046577551360681195
97303,SIDM00633,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9230098,-0.0965492,-2.052142849335643,-0.08278570058169858
22158,SIDM00633,Paclitaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.1368876,0.4866094,3.6845798638558334,0.14178765321331063
74923,SIDM00928,PF-4708671,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.2092555,-0.14073078,-1.364463008592814,-0.07315098654822721
87671,SIDM00455,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.32522926,0.016683064,-1.480460380374697,-0.009194597602008404
22431,SIDM00148,Entinostat,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0339892,0.13918328,-1.0173949363315011,-0.07123688831157997
7020,SIDM00359,Afatinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.69264364,-0.045529258,-1.3981282300132227,-0.035964562498496305
58902,SIDM00146,Ribociclib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.2147112,-0.07428593,-1.686332887465557,-0.046971192140266675
82977,SIDM00148,Axitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0546395,-0.0970901,0.4763919846380236,-0.002143269414793883
54089,SIDM00042,OSI-027,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.5914308,0.038215782,1.7780251156255493,0.047052927953391284
6309,SIDM00950,Dasatinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.0327253,0.38677606,3.1258408817619725,0.1871800366780814
3481,SIDM00148,Navitoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.81807005,0.044019926,1.4848609113538973,0.018528830431749372
89706,SIDM01187,Luminespib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.5864792,-0.15115368,-2.2995174155532645,-0.05642298608886026
107983,SIDM00928,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.753416,0.25621402,2.0455038550069706,0.17949573224069937
25401,SIDM00832,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.2714814,-0.025842557,-0.19032153796861861,0.04227139940072037
5181,SIDM00875,Nilotinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.583676,-0.05507005,-0.9772999635409509,-0.04794258616346806
67427,SIDM00928,Venetoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.7781425,0.087315165,0.7393479590687421,0.0543838443592768
29056,SIDM00633,JQ1,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.2883645,0.02477235,-0.3821150437490981,-0.013530316384951434
85233,SIDM00877,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.7368055,-0.0026940212,-1.1410013401120074,-0.035696407996701804
79889,SIDM00833,BMS-754807,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.77427506,0.054941453,-2.800128563438922,-0.13203991619913885
73361,SIDM01187,Lapatinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5559219,0.042310145,0.5636828877317458,-0.014747314484157965
31924,SIDM00633,Gemcitabine,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.4288163,-0.24934877,-1.3942803634901413,-0.06642391270095677
46573,SIDM01197,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.1010814,-0.0434206,0.5490044003736367,0.03661067427713086
34342,SIDM00282,Afatinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,0.67953295,0.031090781,-0.9932640215653333,0.020840121621879246
28090,SIDM00872,PD173074,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.2483237,-0.080159344,-1.7109185173492503,-0.07694359556645618
60983,SIDM00933,Temozolomide,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.8148113,-0.03455241,0.6056032085187951,0.008824522573709652
15088,SIDM00933,PF-4708671,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.8192611,0.07918616,0.6933320000715846,0.07720469283521092
59513,SIDM00148,AZD7762,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2860458,-0.091786936,0.021223219420191078,0.040176119880428886
53063,SIDM00833,Dabrafenib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,0.08163851,0.001797853,0.8887967112292231,-0.006358256974960778
8442,SIDM00957,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.745356,-0.18703339,-0.5434472997935637,0.004144314107009402
10841,SIDM00673,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.6984429,0.029208735,3.103742525073075,0.08988725849035761
47922,SIDM00957,Afatinib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-5.2664986,-0.13294446,1.816476071629009,0.10700771428239517
74818,SIDM00673,Ribociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.99417126,-0.035145722,-2.231150024998022,-0.05534672747847345
90785,SIDM00872,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.75021213,0.031368047,1.7197769637106224,0.09094071584443982
4886,SIDM01187,OSI-027,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.4915373,0.21329011,1.3081195252801243,0.10072907535460987
104331,SIDM00216,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.059903216,0.002489488,-0.18514853715427124,-0.0008091962553203735
72424,SIDM00877,Afatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.6349568,-0.08973859,0.17066971925088883,0.04799935282021416
101158,SIDM00928,JQ1,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.7748832,0.07959873,-0.4790190212941593,0.009656502069603255
36046,SIDM00877,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.5898964,-0.039041266,-0.5649210771839537,-0.030175687227263957
66699,SIDM00928,MK-1775,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.91911364,0.08720484,-0.3911391038269348,-0.03715514987688114
102362,SIDM00832,AZD7762,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,0.38594812,0.031229042,-0.848427731049901,-0.04608790063888683
16970,SIDM00933,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.735468,0.10900098,0.7658746215320007,0.025414752420720593
51359,SIDM00826,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.5062156,-0.03321018,-0.5541692801829593,-0.023140616388878918
86534,SIDM01197,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.5879186,0.10109541,-0.7145929963754557,-0.024782754784602797
33491,SIDM00097,Vorinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.74968004,-0.05448744,-0.5938419036016506,-0.044266787033146196
78329,SIDM00097,Gemcitabine,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9221011,0.040390898,-0.07194670437076905,0.017566834487615944
96811,SIDM00633,Temozolomide,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.59061474,-0.01188389,-0.027847309843132946,-0.0176820303101155
72654,SIDM00933,Camptothecin,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.48420244,0.04380397,-2.3466131579410012,-0.1639262115578232
45836,SIDM00282,Camptothecin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.24157354,-0.01269822,-0.6077147906994231,-0.08081156433017846
104001,SIDM00933,KU-55933,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.3994555,-0.046062976,-0.6409596575157176,-0.010357968989900563
50880,SIDM00146,Crizotinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.8564572,0.07242821,0.5537775631390761,0.07332958739522347
93872,SIDM00950,Taselisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.185485,-0.045966998,-1.4719459141314044,-0.08914484313404661
38038,SIDM00875,Linsitinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7675827,0.06461017,2.0844542952182157,0.03842967606346788
104406,SIDM00097,Pictilisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.628884,-0.21591672,-1.098004227007464,-0.03901498544416713
32220,SIDM00837,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.7211722,0.09508745,1.7751004700185045,0.10782157132197892
7604,SIDM00957,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.2407295,0.021481927,0.7780408858267958,0.03690814489024084
11628,SIDM00933,PF-4708671,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0684407,0.060217794,0.3141137511750563,0.08136200503314928
67344,SIDM00633,AZD8055,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6555157,-0.2280552,-2.1028624407408505,-0.1175398513810596
47048,SIDM00673,Temozolomide,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.2945123,-0.00641351,-0.03880341791964938,0.0030161801062411615
96566,SIDM00933,JQ1,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-1.2994955,-0.092030324,0.8603250169916274,0.10474146558553792
93854,SIDM01187,Cisplatin,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.5531564,-0.14467514,-0.8047157622657679,-0.00356788063962864
52442,SIDM00928,Nilotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.0361971,0.10823177,0.028025655994777104,0.05915077867965111
12588,SIDM00146,Venetoclax,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.4667246,0.0824826,2.1000365471013964,0.10600043005916948
41015,SIDM01187,Palbociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6578887,-0.09045217,-1.2759382417217195,0.011171743813141935
94974,SIDM01042,ZM447439,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2382405,0.15786092,0.785913361649243,0.02888315117880353
79130,SIDM00875,Nilotinib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74952835,0.07507416,0.6771251727098265,0.07873869538216441
6313,SIDM01042,Tozasertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5898508,0.18035159,-1.246243609000692,-0.0656440997593582
101484,SIDM00950,Olaparib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.218989,0.05287949,1.3639275704481468,0.07311967520124579
82239,SIDM00875,OSI-027,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.83500165,-0.023216685,-0.5963969416446442,-0.0023039596811787215
59494,SIDM00950,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6723223,0.08648656,0.08523888855755293,0.09765268677102873
2207,SIDM00455,Erlotinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.9342883,0.14431201,3.8260231742609507,0.1000984425821225
19553,SIDM00673,Linsitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1743134,0.021538146,1.576958796153193,0.01327385438279876
74721,SIDM00148,RO-3306,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.13421088,-0.012843531,0.2606466177341716,-0.04720674911738671
13187,SIDM00359,Taselisib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8078899,-0.07052523,-1.804474440264196,-0.09677624038368453
67647,SIDM00872,NU7441,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8838784,-0.10431711,0.8226728979160265,0.06597978961365111
105547,SIDM00928,AZD7762,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.560261,0.24288213,2.0157141783478663,0.10075449464532843
67175,SIDM00826,Vinorelbine,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.6572643,-0.023943868,-2.5419588596683647,-0.08948583099114728
20370,SIDM00872,Temozolomide,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1126701,-0.0022277178,0.13665989333429598,-0.0014241636147789582
50450,SIDM00877,AZD7762,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.6473599,0.050669156,0.04494259002260477,0.03471672644369492
13168,SIDM00148,GSK269962A,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.28236964,0.024236575,-0.025348271900582094,0.019757414622606165
106786,SIDM00877,Ribociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.0731239,0.017349478,1.1813174660988055,0.04401840649514035
29808,SIDM00837,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,1.197274,0.035945315,-1.122811864330994,-0.10751621357017459
30847,SIDM00097,PD173074,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3418832,-0.13121545,0.867136464255121,0.03662189023794874
36281,SIDM01042,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2545363,0.010156146,2.592554449592701,0.07371946452964107
105153,SIDM00933,Uprosertib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.0194346,0.10255054,-0.7515744947562987,-0.038653655336099886
81620,SIDM00872,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.183485,0.19813837,2.202521958681915,0.11668765917900854
108262,SIDM00097,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2473102,0.13489036,0.8965790227951997,0.035970884226397465
14462,SIDM00633,Sorafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.23664299,-0.022453832,-0.3869501759927066,0.0038313012008982963
26346,SIDM00673,Taselisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4839635,0.12479751,0.5784288835208522,-0.013205796160506903
108031,SIDM00933,MK-2206,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8406664,0.121073395,-0.3922598034371026,-0.05132467746739974
88890,SIDM01187,OSI-027,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9206344,-0.07453214,-0.17874269098701714,0.026643559780373978
42423,SIDM00633,Lapatinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1278808,0.01752602,-1.9541577698705428,-0.03606640972733347
42546,SIDM00832,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.4041796,-0.117406785,-0.4841560607856129,-0.04710675980667651
54181,SIDM00146,Sorafenib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.1831298,0.1673399,-0.7707350194016619,-0.05953609538868865
15146,SIDM00455,Dactolisib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.727802,-0.033611033,0.47089177223479556,0.04645345682474553
28206,SIDM00877,Crizotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6079358,-0.046623953,-0.062002541043007994,-0.026656804058745456
29898,SIDM00097,Palbociclib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0695462,0.05796714,-2.848171833655907,-0.058739062395186226
90663,SIDM01187,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.93586063,-0.08786405,-1.0472238602070891,-0.0831458022238302
92603,SIDM00148,Nilotinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7881784,-0.07948095,-0.23684592864814982,-0.014165672476933844
44459,SIDM00673,Pictilisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.90093017,0.07587929,-0.5140637047520099,-0.10345245205917289
12449,SIDM00837,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-2.7595465,-0.087483525,-1.8189367426212248,-0.10094447389519447
45457,SIDM00877,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.121882,0.12131256,0.6738556300594025,0.19410417160059296
20315,SIDM00673,Lapatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7054856,0.16964574,1.6062612857330332,0.09590407960494622
36869,SIDM00455,LGK974,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.2166111,-0.0872277,-1.8587082321416701,-0.04894351906095284
78239,SIDM01197,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.0817723,-0.13141969,0.21637908804982484,-0.022041890942303688
85744,SIDM00359,LGK974,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.150402,0.17678952,-0.5678933367036628,0.012730687795484778
50176,SIDM00933,Venetoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.45638382,0.025612088,0.811024003190969,0.07897151954634324
51499,SIDM00097,Afatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32924065,-0.020289058,0.21845381533471134,0.05464817130983986
82145,SIDM00042,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.806007,0.22094473,3.482540658743522,0.12033983666261805
92730,SIDM01042,Doramapimod,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.43339103,0.046777405,-0.5640241191107245,-0.025271280317652283
26443,SIDM00872,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.2042494,-0.13679446,-1.4476282613813316,-0.1301079911902802
51623,SIDM00950,Dasatinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.712798,0.24039678,0.09614638161855545,-0.01760867145792918
48418,SIDM01042,PD173074,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9653068,-0.069548085,-0.23453913603395132,0.029710710268296206
82172,SIDM00877,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.3780816,-0.03135211,-0.5687398402390184,0.037429368925203856
89431,SIDM00837,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.4432924,0.11939482,0.947153085866039,0.047122181706545016
105551,SIDM00097,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6527165,-0.09775605,-0.5633044297392377,-0.05770697626712421
73680,SIDM00282,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2077507,0.03684049,0.3724207663041355,0.025901266379611914
28366,SIDM00673,Cisplatin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.28880543,-0.010031226,0.454281961959842,0.006185738343205181
89284,SIDM00875,RO-3306,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.475042,-0.10266456,-1.3135594864401248,-0.08304757123206276
52544,SIDM00148,Lapatinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.75080967,-0.076240666,-0.46112613543070546,-0.008614950858066605
89833,SIDM00928,Tozasertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.8955697,0.06319554,1.7021082416842621,0.0411415908856911
102135,SIDM00833,Taselisib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-3.6442447,-0.17366396,-1.4097133045452872,-0.1078283779603521
2827,SIDM00673,RO-3306,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.1067953,0.10918985,-0.07898032634415342,0.030300828501527214
23665,SIDM01187,Lapatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5541912,0.038024355,0.6237729626064981,0.0055971509810571205
97771,SIDM01197,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6779636,-0.022936128,-1.216228262671,-0.022242060422268988
18820,SIDM00872,Linsitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.93821406,0.030551342,0.7192838779399455,0.07584630030817677
68434,SIDM00872,Luminespib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5128951,-0.113411784,-1.016085975482099,0.006139783164839098
81021,SIDM00455,Dasatinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.9636173,0.1578347,2.057799619308889,0.17025882579144921
42692,SIDM00216,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.3644905,0.009626354,-1.4187585312555564,-0.016335506407390517
71580,SIDM00776,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-1.9864935,-0.06542975,-0.24666553186987591,0.02856738948254058
81769,SIDM00875,Ribociclib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8378729,-0.0078234095,-0.46168916503067503,0.0033943314552193535
97284,SIDM00673,Sorafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3090707,-0.07425266,0.6781396667663376,0.08392192778530665
43002,SIDM00837,Olaparib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,5.8226447,0.36824074,1.4871594462307884,0.07107573748774836
5476,SIDM00633,Venetoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7653294,0.082197316,2.9559172361056736,0.09558748843578502
83990,SIDM00875,Paclitaxel,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.3765874,-0.54647064,-4.731889385051566,-0.31862625829349694
90435,SIDM00148,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.91610146,0.025206614,0.11240520711575873,0.002730347350739659
15487,SIDM00673,Afatinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5264206,0.041826367,-1.1365747984622154,-0.05186895945905287
42878,SIDM00875,MK-2206,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2153034,0.2276863,1.6725551401406822,0.12080134148315003
34681,SIDM00933,GSK269962A,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.8340446,0.17248595,1.2926112984688065,0.14033166822055293
102957,SIDM00837,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.4869306,-0.0626445,-0.7487703071989917,0.013038622346612306
23914,SIDM00673,BI-2536,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6931284,-0.05306898,0.2289757722934885,0.01870979536454226
84336,SIDM00673,Dabrafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.8857334,0.04421766,0.8931631621933541,0.04692009991475829
90991,SIDM00097,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3462481,-0.07480663,0.49322945418019637,0.02763041066346159
17064,SIDM00148,SCH772984,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5610657,0.06551704,2.7680416444464244,0.05452215324533356
11080,SIDM00097,KU-55933,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5694387,-0.08103221,-2.0859111458325437,-0.0450146827949668
19070,SIDM00872,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.04541929,-0.00488279,-0.8127072208274081,-0.09028304837923112
61098,SIDM00097,Temozolomide,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.44796228,-0.0074998783,-0.27464681505766486,0.002903146471658588
62927,SIDM00148,Ribociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.2402923,0.12101912,-1.3692478141029891,-0.023434861911451894
97360,SIDM00877,RO-3306,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.4014019,0.15532766,0.5235168590088592,0.039064891023165495
5648,SIDM00872,Pictilisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.3821416,0.19405536,-0.29034710661696994,0.013840944185932494
16284,SIDM00097,PF-4708671,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9489943,0.04363353,-0.816699529187606,-0.02329884060022774
84806,SIDM00097,Uprosertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5513718,-0.097562194,-1.263817442061304,-0.08500892880186728
84565,SIDM01042,BI-2536,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5130236,-0.01042168,-1.5603903789455382,-0.023102457007812553
53845,SIDM01197,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4336383,-0.050524626,-1.771925046614689,-0.07620444361808075
67245,SIDM00146,Sorafenib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6703495,-0.051217616,-1.3188987576865137,-0.08835854084183672
104486,SIDM00097,Tozasertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7903627,-0.053375397,-1.7140571827773274,-0.0540607512763915
102695,SIDM00148,Alisertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3413984,0.107242025,-2.099831649200313,-0.08497514353043759
9585,SIDM00957,Vinorelbine,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,4.843186,0.10469944,3.9506639155721524,0.025774054869295532
91477,SIDM01197,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5885798,-0.09592339,1.3999817331484135,0.07155562397310088
33964,SIDM00216,LGK974,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.4215946,0.009392356,0.4070361152162971,0.029227550523278644
48498,SIDM01042,Trametinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3037764,-0.09329589,-0.6738703630933381,-0.012094481353800963
100498,SIDM00148,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8179555,0.069035426,2.0358628071383413,0.08960456663627554
65625,SIDM00877,Sorafenib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.7985327,-0.106061764,-0.6789612458276079,-0.030802909483551834
27427,SIDM00148,AZD8055,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7692357,-0.056719262,0.46756031193619335,-7.871663347386177e-05
106025,SIDM01197,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.7044989,0.028674414,0.17055673344322295,0.030917301385983233
34866,SIDM00216,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.5662813,0.050210703,-1.1396568100714737,-0.028263449619750452
63068,SIDM00872,PF-4708671,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5461265,-0.12031745,-1.6415199939965566,-0.10053324490166275
31633,SIDM00872,5-Fluorouracil,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.546434,-0.030558947,-0.7958852243703124,-0.04648225037038931
17549,SIDM00826,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,1.1791426,0.025297686,-2.7889654730525812,-0.09344578275931519
18405,SIDM00282,Vinorelbine,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.26976654,0.017027628,1.5967735412634545,0.12220822268979134
26854,SIDM00928,Pictilisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.0766861,-0.17945756,0.7113433269495799,0.018318905877045606
44420,SIDM00875,Tozasertib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.612507,0.028996129,1.1186465860108756,0.05333659263296588
98311,SIDM00455,Palbociclib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.837074,-0.104072794,-1.8059631035320263,-0.0589906370102979
25513,SIDM00950,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.42155924,-0.04053621,-0.5763993262156208,-0.0269654299225716
39147,SIDM00673,Alpelisib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.7343284,0.12164044,-0.34887671992377134,0.04412260169720813
97490,SIDM00282,BMS-754807,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9604709,-0.05564136,-2.021117160017512,-0.11803006651390237
50915,SIDM00148,Axitinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0356455,0.1939237,2.6487388315121323,0.2077364272659361
32501,SIDM00146,Tozasertib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.27456066,0.020611884,0.9975193062082077,0.13405566424985155
11743,SIDM00928,PF-4708671,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.9300355,0.13764751,-0.20440574755756633,-0.02745532312912717
47706,SIDM01042,Linsitinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0207355,-0.114236675,1.5129085386801886,0.05011390663584653
19464,SIDM00633,Wee1 Inhibitor,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9027578,-0.077144355,0.23495126835025423,-0.033129403116822956
42121,SIDM01042,Palbociclib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1826181,0.07710826,0.12622102130246568,0.012266330897387441
33013,SIDM00826,AZD8055,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.7937196,0.10549446,-1.1226895674987536,-0.11808676399831279
51407,SIDM00148,RO-3306,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.625026,0.15426917,-0.5682014721046357,-0.05756294810390731
12413,SIDM00877,Wee1 Inhibitor,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.2126409,-0.06734581,0.28140769729513443,0.028750540774238706
71826,SIDM00928,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.346828,0.14343962,-0.2175883798191032,0.001892345460065374
2303,SIDM00097,Dabrafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7025828,-0.100321926,-1.176254717745995,-0.03807340404141154
4233,SIDM00673,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.48374,0.03679979,2.304449800220715,0.06492356253307315
69017,SIDM00872,Lapatinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0408851,-0.10687622,1.0147327313100964,0.109519458743377
108373,SIDM00928,AZD6482,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.03776081,-0.0026353765,-0.008030277629448253,0.01612430009588028
95995,SIDM00455,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.9022762,0.101389416,-0.4793163209120021,-0.06990293159967134
19192,SIDM00633,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5063987,0.11645024,0.32958553137539065,0.039920302109621095
7784,SIDM00872,Temozolomide,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.10671876,-0.0021005739,0.4365929200899616,0.017758008201120962
97750,SIDM00875,Dabrafenib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2361546,0.14250918,1.464902914175795,0.010840952686101727
83900,SIDM00872,Luminespib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4355323,-0.16590847,-0.3545867043109411,0.0015843922216483314
60282,SIDM00148,Entinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6364976,0.04939731,1.484451626933333,0.15191818210929914
12343,SIDM00928,Bortezomib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.0881269,0.065163895,1.2004452323690689,0.02158425402842992
2322,SIDM00928,Bortezomib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.41577664,-0.03127865,-0.46329533796713224,-0.04857137157959224
88327,SIDM00673,Cisplatin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.3562962,0.059182495,0.6619655920399552,0.013051723475712842
107436,SIDM00776,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.6816527,0.11908721,-1.746566861029521,-0.061722436394077033
51068,SIDM00216,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.18957743,-0.011863099,-2.009696619846741,-0.12105200784037219
91718,SIDM01187,Axitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.37224358,-0.028552223,-1.1782342733255784,-0.07766057768905121
71539,SIDM00875,Wee1 Inhibitor,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25975898,-0.01816468,-0.23214025118430684,-0.0034035296784712113
79443,SIDM00933,Alisertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.8328941,-0.028463444,-2.3158198455599095,-0.2724674329716439
103872,SIDM00928,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,2.4778063,0.21173789,-0.3859592756617708,-0.01101471658846965
4584,SIDM01187,MK-2206,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.197557,0.1343635,0.4318404549575018,0.0262248107551028
1145,SIDM00673,Uprosertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.82825375,-0.05580802,-0.20733991585339195,-0.027340670428593075
55951,SIDM00673,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.5184894,-0.09374777,-1.6388225366564906,-0.09289200108269766
87119,SIDM00950,Erlotinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4606202,0.10828784,2.1535277977011655,0.10904270151939245
86809,SIDM00097,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2390944,-0.045469053,-0.555785890016976,-0.04095077021748711
85520,SIDM00216,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.7251474,0.11533964,1.114587104859085,0.03799238593650384
87389,SIDM00877,5-Fluorouracil,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.4252233,0.026708668,0.004733470321235422,0.00048598298685891965
38196,SIDM00216,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,5.728868,0.19915192,0.9376589356247048,0.07795226469326028
50180,SIDM01197,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,4.3356977,0.13241999,3.081982345881892,0.10926675876871857
85385,SIDM01197,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.606766,-0.10171576,-0.8904122167931842,-0.02693636091302192
57457,SIDM00933,Venetoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-2.6963758,-0.097582795,-0.04657010937193587,0.02170575085978108
63216,SIDM00633,Tozasertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.6609526,0.15355052,2.709040748946374,0.07875413764821688
68702,SIDM00837,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.114686,-0.05189303,-0.1664154526905675,-0.06637863100399162
84461,SIDM00872,Nilotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6746736,-0.18749407,-1.339447800181402,-0.12955121744831746
29990,SIDM00877,Linsitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.7190613,0.1425484,-0.18568978216121446,0.014504930372702885
81119,SIDM00877,Docetaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.7706355,0.060065363,0.46476566974984973,0.08155657706256235
67355,SIDM00097,Afatinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55681723,-0.041504323,-0.8718777432092151,-0.03628435371770743
76225,SIDM00875,JQ1,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.39324,-0.100833446,-1.8546396094271158,-0.059339924164243295
29441,SIDM00877,PD173074,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.6025276,0.04161492,0.18180119055257257,0.06414017859912323
2503,SIDM01197,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.8559234,-0.1340268,-1.4177188163826588,-0.03660262243656259
64929,SIDM00148,Afatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6726327,0.09806723,0.7724747276014984,0.06846092619625918
70082,SIDM00148,SCH772984,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1758401,0.051639184,0.3180420476300404,-0.015174411571360237
44522,SIDM00455,Sorafenib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5218644,-0.078552365,-0.8897435832986961,-0.09137089003507066
4201,SIDM00097,Ribociclib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.574863,-0.081821136,-1.4123609718859318,-0.053331961399647944
81088,SIDM00928,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.90643525,-0.019062174,0.45642563259953567,-0.0230589474404686
10285,SIDM01197,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4193004,-0.05274734,-1.0535613503972077,-0.06214536122316711
79145,SIDM00776,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.184546,-0.084127896,-2.3859585933845606,-0.054510687206761506
87061,SIDM00042,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.1494331,0.19695485,1.9837249680024376,0.10439579794335622
69498,SIDM00933,GSK269962A,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0090169,0.09315487,-0.4999528263348307,0.003354379563968974
63740,SIDM00042,Gemcitabine,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.4348447,-0.15005724,-1.9972154809285505,-0.1349516214977011
77453,SIDM00216,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.5474987,0.11684581,1.2371508938793052,0.05041753232116957
38099,SIDM00833,Oxaliplatin,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.2716917,-0.07405624,-1.4265785662908483,-0.09115133583240151
99344,SIDM00146,Uprosertib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.6125238,-0.10835524,1.8032788854022805,0.2441398729470478
68953,SIDM00933,Temozolomide,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.36877936,0.015784249,0.47077061535143944,0.07509481655000798
5644,SIDM00673,Taselisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.7341296,-0.07367539,-0.32471287445986213,-0.04187799929955664
107829,SIDM00832,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-0.5660642,-0.04718097,0.18397899314806415,0.012017878249640145
36076,SIDM00633,Tozasertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8593619,0.049461145,1.9812308584610168,0.030757903342821646
98218,SIDM00097,Tozasertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0567403,-0.06498195,-0.5684688602839324,0.020052464357434564
17747,SIDM00877,Olaparib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.805021,-0.07226391,-1.0770511971024965,-0.03905436399468275
73139,SIDM00633,MK-1775,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4652722,-0.11908543,-2.080683218813408,-0.11443358627680265
54900,SIDM00455,Dactolisib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.1924562,-0.104686454,-0.8831452974032311,-0.04432907005522766
66130,SIDM00928,Bortezomib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.40600902,-0.033029363,0.024839568543715714,-0.025082432808238363
33598,SIDM01042,Alpelisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7645106,-0.12702203,0.3528837991740657,0.042003660334654226
25591,SIDM00455,Crizotinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1588373,-0.074817136,-1.8060099738693942,-0.09235605461472789
19343,SIDM00216,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1627069,-0.06585388,-1.916569754412735,-0.07626822183610267
61606,SIDM00826,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.1537974,0.12443135,1.0364866426567814,0.055545374057862265
76938,SIDM00148,Cisplatin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4120687,0.09107945,-0.23616567445710474,-0.002315759536661533
96824,SIDM00633,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6194127,-0.114181206,-1.3727268552172254,-0.07836879581569037
95729,SIDM00673,Trametinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6800463,-0.06016698,-0.8672019035462442,-0.0688668411799978
13340,SIDM01042,Nilotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8069135,-0.06357079,-1.6224786140046523,-0.08160890952779841
36332,SIDM00928,PF-4708671,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.9619106,-0.11910066,1.0044710044009537,0.06343250185886035
13934,SIDM01042,Taselisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.40142158,0.027304592,-1.819907076659133,-0.09743244917018652
78007,SIDM00872,PF-4708671,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7581905,-0.14072345,-1.6109955792403237,-0.1345105669010784
15784,SIDM00957,Olaparib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.8243124,-0.02540389,0.3262935362632231,-0.006777340851399821
49653,SIDM00673,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4182258,-0.07061234,-0.8080186632785265,-0.031094564352673215
19709,SIDM00148,Doramapimod,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0116096,-0.11382334,-1.7473233256260614,-0.034528117061563
54476,SIDM00146,Taselisib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.2518153,-0.1024711,-0.4089739860361591,0.01559793936384468
11264,SIDM00097,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9144967,-0.1645715,-0.07769045129960085,0.012150307009980637
27674,SIDM01042,SCH772984,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2385306,0.1634255,1.9822585753341255,0.040918784821056646
3120,SIDM00872,Docetaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1467073,0.115887895,0.5721066789348791,0.023402335050356663
64171,SIDM00837,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,1.0207216,0.07806821,-1.3648794563851114,-0.031027315930864066
103945,SIDM01042,MK-1775,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.31432742,0.024975743,-0.7251576033646315,-0.04591284012952444
69535,SIDM00282,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-3.1438234,-0.18410899,-1.0711944638199364,-0.13742246508624112
8805,SIDM00872,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.898065,0.06896523,1.485920212254883,0.058994533155085384
27371,SIDM00146,MK-2206,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.7256522,0.12054449,0.3459177749748885,0.03491657074803243
33956,SIDM00950,Trametinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3159564,0.12862438,0.6437854075118172,0.08323555328609546
25723,SIDM00216,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-2.6242602,-0.16654302,-0.34544746485322547,-0.05026205089039704
2576,SIDM00146,GSK269962A,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.0319952,-0.07369097,-1.0471997367588113,-0.04836014503211217
60756,SIDM00877,JQ1,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.29475954,0.032755557,0.1570367694766415,0.029790738071986206
784,SIDM00832,Linsitinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.0402895,-0.09485212,0.5045084646665189,0.049229887986845584
57538,SIDM01042,AZD7762,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9762437,-0.12872194,-0.5089606421165014,-0.08684094282047058
31207,SIDM00928,Palbociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-3.0534792,-0.11577781,-1.8186483808323382,-0.07601856110671194
40324,SIDM00950,Dactolisib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.93631744,-0.06607122,-1.5598889994899607,-0.11624077071391407
65523,SIDM00146,BI-2536,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.9276826,0.06201093,-1.208153479450017,-0.05710424372994051
42259,SIDM00875,5-Fluorouracil,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5450374,-0.04734673,-1.0028644396470343,-0.0014274466066218768
983,SIDM00877,Docetaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.6063399,-0.06347855,-0.6720072561084898,-0.03149617350539503
95429,SIDM00633,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9216187,0.10927487,2.507372194565913,0.050144111103272736
34531,SIDM00877,OSI-027,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.7758722,0.07199457,-0.4177090105297759,-0.009327226322530534
91222,SIDM00837,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.80954725,0.013474245,-0.9978065356409505,-0.06897869336867621
81804,SIDM00673,Nilotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1409678,-0.07858822,1.3424566058601797,0.074755421159823
9378,SIDM00877,MK-1775,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.4601577,-0.029411137,0.09232272536016732,-0.031151577228054717
36297,SIDM00146,Temozolomide,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.31888402,-0.007914329,0.16290066654039476,0.0162180490818376
71984,SIDM00282,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.68963665,0.049749654,-0.2969416236533229,-0.031087221961975442
16967,SIDM00832,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,4.7856736,0.21966061,3.0336923471943344,0.0818575574791499
93160,SIDM00875,Wee1 Inhibitor,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6056957,-0.05323251,-1.246100602164703,0.01726336437559963
15665,SIDM00633,Paclitaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0604484,-0.10944433,-2.424321040072479,-0.07622736286959042
91622,SIDM00633,Entinostat,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.2501122,-0.016097741,-0.4610993172411932,-0.0034669951087953135
81647,SIDM00673,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.17154782,-0.012966109,-0.15096073363757345,-0.05569209080454154
13955,SIDM01042,Navitoclax,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.24257089,-0.0283994,0.5938083282598247,0.03205330039869585
18561,SIDM00146,JQ1,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.2615738,-0.17322935,-1.3041425733068872,-0.04645395446086597
24814,SIDM01042,Entinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6597197,0.19995618,-0.7456281333994872,-0.01672206564588186
36170,SIDM00957,Crizotinib,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.5055847,-0.06496321,-0.29301669716456646,0.017143389802838863
31150,SIDM01197,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1201882,-0.039026268,-1.092960227847104,-0.05849816821572822
248,SIDM00359,LGK974,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0698828,0.032363124,-0.11366548534344173,0.028097040426387228
57627,SIDM00877,Venetoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.8318515,0.1894027,0.006995933163759027,0.05304355954948146
36372,SIDM00673,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1455024,0.037617277,2.162529181238572,0.12390032191026587
30863,SIDM00282,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,2.023477,0.09286008,-0.6825129145345163,-0.022977334528775022
49118,SIDM00097,Luminespib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.39877456,0.027392594,0.07261075677131139,-0.01908144193101138
26007,SIDM00875,RO-3306,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1715342,-0.10678355,-1.5480472092997013,-0.0461044821084427
60976,SIDM00359,Trametinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2924907,-0.047642164,-2.524854794507103,-0.07829253056961803
97810,SIDM00146,BI-2536,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.26703858,0.009517355,-0.9310854515219843,-0.04467499915297732
2570,SIDM00933,Afatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,2.196684,0.22082487,1.0549199086947796,0.10542089576180964
31612,SIDM00633,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9664448,-0.028820328,-1.8780686151874204,-0.06578356905448396
85607,SIDM00875,JQ1,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.95433724,-0.088866405,0.13864359125891407,-0.005518194116458617
97028,SIDM00928,Bortezomib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.6347258,-0.04521974,-0.44589682957956484,-0.034716217652974786
12481,SIDM00633,PF-4708671,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.87788326,0.075867854,0.7404511394597477,0.05976377215694908
93528,SIDM00826,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.29141742,-0.02051742,-4.089663300982355,-0.17532784837026966
60930,SIDM00359,AZD4547,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.29518187,0.017304558,-0.932399287320866,-0.017692959364063836
24838,SIDM00928,RO-3306,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.0673752,-0.11448958,-0.9585934127502296,-0.065414065477933
65842,SIDM00957,Palbociclib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.1602416,-0.026893284,0.33091002918082274,0.050979149539497226
43062,SIDM00933,OSI-027,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.45047286,-0.060002293,-0.25954854975588487,0.0050295706849587795
62218,SIDM00776,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3730202,-0.10524851,-1.170362549941039,-0.06938851714490729
86608,SIDM00872,Lapatinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.85402584,-0.09365855,-0.15607267804305472,-0.033230006309818476
76879,SIDM00776,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.6997916,0.025651475,2.0418996933657514,0.014241170614857464
13001,SIDM01187,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8649808,-0.16810957,-1.4435616090738708,-0.08290112354101495
83370,SIDM00875,Crizotinib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.49627677,-0.05551577,0.5866606722704029,0.02953395380534645
101886,SIDM00928,SCH772984,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.4037137,0.2729169,-1.3950133256219968,-0.07348602721423994
73408,SIDM00872,Uprosertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4712039,0.047987346,1.8229290123164636,0.14208439205221585
38407,SIDM00877,Pictilisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.9181069,-0.21157567,-0.5129197130958346,-0.008090977848206553
90765,SIDM00146,Linsitinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.2673335,0.032478254,3.3869034150870467,0.15653460526031746
14152,SIDM00097,SCH772984,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6000038,-0.031687953,-1.305457380431314,-0.06644412897578342
48769,SIDM00042,Irinotecan,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.262603,-0.13488825,-0.4185782696180792,-0.02786094999429321
43832,SIDM00146,Cisplatin,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4681807,0.0690709,1.3567678779713457,0.07771182818738953
72724,SIDM00216,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7412291,-0.020995982,-2.8689815406958825,-0.15298763817114613
68454,SIDM01042,MK-2206,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.33394814,-0.012285213,-0.5290423429177332,-0.05033889116022034
102495,SIDM00933,BI-2536,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.6584737,-0.004680337,-1.5720144337239776,-0.014176492195459267
81447,SIDM00877,AZD8055,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-1.3892727,-0.16157508,-0.26484135899201816,-0.005876917113937549
63397,SIDM00928,PF-4708671,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.1092416,-0.08160361,-1.0545119225472963,-0.05637802666656304
8827,SIDM00833,Palbociclib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.227351,0.03312381,0.7346659465191233,0.0056688988241990045
49603,SIDM00826,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.13439983,0.009805084,0.3464714578374685,-0.038233697276315384
26291,SIDM00633,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9675965,-0.07356781,-1.7082794065615696,-0.07727554114093693
16250,SIDM00957,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.5157804,0.010015149,0.5324618101143268,0.02365068803403545
10074,SIDM00872,Navitoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,5.21191,0.1985641,4.448086618401154,0.18168905429183085
92016,SIDM00957,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-2.6086323,-0.039628226,-1.1148261469907625,-0.033006885029357926
88958,SIDM00875,Gemcitabine,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-7.94189,-0.022729361,-0.9580517993724227,0.05657870019304419
52537,SIDM00872,AZD8055,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4324364,-0.041873116,-0.29781991317421525,-0.038185476520221855
36254,SIDM00875,Nilotinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6323508,0.06745115,0.10964429044540934,-0.0010902986125128145
85888,SIDM00097,Paclitaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3666887,-0.08527523,-0.6368078086435477,-0.06685904746787488
24373,SIDM00146,AZD8055,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9140386,0.06695438,-0.10364501700203883,-0.015103650324841901
26850,SIDM00835,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-3.630581,-0.28080136,-3.084698980848495,-0.23804176928360676
67277,SIDM00933,Tozasertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,1.2569807,0.124636345,-0.6448852862201545,-0.04336453868127366
53836,SIDM00146,Afatinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,0.6947261,0.04998279,0.2995671305003623,0.030383889720148036
5939,SIDM01042,Alpelisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.9426825,0.30544764,2.132153431113516,0.10951789595964696
61130,SIDM01042,Alisertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2379327,-0.21111678,-2.1100365881702845,-0.10964346697412254
73762,SIDM00633,Entinostat,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.71835124,-0.03421055,0.11377075794835216,-0.006178292478937792
10119,SIDM00877,RO-3306,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.024586,-0.1284781,-0.28892434243860815,-0.025461836838872043
75895,SIDM00950,LGK974,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3396969,0.030014638,0.45926194917789004,0.029436846529299406
61843,SIDM00832,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.622036,-0.13780554,-1.416030741973384,-0.07573215028269208
94421,SIDM01187,5-Fluorouracil,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.4379705,0.042674735,1.7006034525631768,0.09176836174678538
63016,SIDM01197,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5289283,-0.056226175,0.6174347132260919,0.05925458437306148
36100,SIDM00833,Olaparib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-1.7944406,-0.05395306,-0.8311184580311509,-0.00678933841055187
77216,SIDM01042,Palbociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.40468335,0.02306372,-0.32489017218491273,0.02048635740740692
43924,SIDM01187,AZD7762,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,5.6456456,0.27897012,2.1612097701476647,0.06591458113327729
105070,SIDM00042,Navitoclax,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.858627,0.049288906,0.32904622462645816,-0.00515827234361597
80964,SIDM00877,Linsitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.543941,-0.12890173,-0.0496057867405455,-0.0474711241633247
22406,SIDM00872,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.078472,0.112527825,0.754635953578461,-0.0015549435933420964
42556,SIDM00872,NU7441,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3599015,0.113893025,0.8772994542240438,0.05854004540802844
52232,SIDM00832,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.4276323,-0.12356542,-1.3565412630138003,-0.09495085844889244
91704,SIDM00826,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.7962273,-0.049655467,-1.2383887931960726,-0.08527506814667378
29373,SIDM00875,MK-1775,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34361544,0.02061234,-0.33845989139483096,-0.008517703794452689
17458,SIDM00875,Lapatinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30018827,0.034146674,1.8023962523682222,0.08173629454528167
96556,SIDM00875,Vorinostat,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4186293,0.15447158,2.742188566970965,0.13992096618412345
87522,SIDM00097,Bortezomib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.19580972,-0.009697249,-0.23679628456250876,-0.0309529364542773
97527,SIDM00928,MK-2206,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.075047,0.17862663,-0.021998924289108986,0.024841817141005657
87067,SIDM00216,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.792552,0.16085456,-0.6441744917356398,-0.031214437408939727
103730,SIDM00950,Gemcitabine,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.0593643,0.18648824,-0.042316705289909835,-0.0070041467120933055
77901,SIDM00837,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-2.3493614,-0.076252,-1.2065824341239453,-0.043196091158616674
34663,SIDM00633,Uprosertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6738869,-0.045683824,-0.21651910655619738,-0.05093777431028785
1266,SIDM01042,Linsitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6625388,0.060274273,-0.3337149088476002,-0.020160701098339867
46175,SIDM00832,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-0.19230099,-0.007523941,0.7031177832590556,0.026756670230333228
81955,SIDM01187,Taselisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.80284035,-0.06684317,-0.9879085968540262,-0.04664289552914888
9912,SIDM00837,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.4575827,-0.10864156,-1.0848431788907367,-0.08000269940369965
79857,SIDM00933,Palbociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,0.9310445,0.112136126,-0.9023005360075093,-0.059454850327640335
63375,SIDM00673,GSK269962A,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.640347,0.21347493,0.2348071126547208,0.0188301935600996
84281,SIDM00826,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.5074666,-0.087275155,-2.037408651188412,-0.1091641481124785
85401,SIDM00282,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.80264884,0.053019017,1.1159566035823165,0.09246889951977684
99412,SIDM00832,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.8540853,-0.04452241,-0.24699035747750414,-0.0394208159024532
64858,SIDM00933,OSI-027,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.42813295,0.06368589,-0.7524898179070034,-0.05601704125722867
37336,SIDM00097,5-Fluorouracil,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.38272,-0.09299044,-1.5108105291709322,-0.057017094320791405
47459,SIDM00673,MK-1775,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7329651,-0.069911055,-0.01818153043799544,-0.027024185251911196
105160,SIDM00950,Paclitaxel,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.2752147,-0.1722913,-1.1171456151959782,-0.01455850275471227
52511,SIDM00875,NU7441,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34616,0.031357832,0.8678319988262148,0.02979549777245194
105445,SIDM00673,Lapatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.539795,-0.13121599,-0.4220206703081217,-0.005840864399895329
94400,SIDM00928,Trametinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.7914116,0.1569098,0.5167619571852822,0.026461945941756777
49407,SIDM00875,Uprosertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5899253,0.2548098,1.5084665623032605,0.061538202143219256
89584,SIDM00146,Paclitaxel,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.662345,-0.2163438,-3.361699992681849,-0.26728249539948573
51514,SIDM00933,BI-2536,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-7.09918,-0.23377992,-5.979467469685659,-0.12058471625283415
61883,SIDM00933,Tozasertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,2.219449,0.18166398,-0.3388823666664707,0.015401242315934415
77335,SIDM00633,Pictilisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8724416,-0.09226459,-2.0618666939885335,-0.1219148887951466
32,SIDM01042,Uprosertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.69542396,-0.02947308,-0.4432447111770546,-0.03451643923538578
46399,SIDM01042,Alisertib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.59582895,-0.06759356,-1.1011429932603185,-0.06304888615459574
70722,SIDM00282,Trametinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.98080325,-0.06833849,-0.5371986769911482,-0.05709278913600141
11088,SIDM00928,Bortezomib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.88630015,-0.080652304,-0.13301549693979806,-0.03482035298279579
87513,SIDM00673,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,3.2564254,0.10334451,1.5191657502268876,0.05381804491752859
4592,SIDM00359,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.3279333,0.35622042,-0.5391307021047506,-0.0016305443942477911
46093,SIDM00359,BMS-754807,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.59324986,0.052924287,-1.970820499299038,-0.04171665608376554
17851,SIDM00872,Trametinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.71676093,0.065394096,0.9061506789668919,0.07530127988380957
91521,SIDM00872,AZD8055,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.7255437,0.22804077,1.0610658965138926,0.049635371647720826
101399,SIDM00148,Doramapimod,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4649486,0.03492931,-0.665259917788034,0.025693097717166394
51584,SIDM00933,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.38265112,-0.032124754,-0.022227428612991686,0.009636719886194179
73943,SIDM00872,Ribociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2932944,-0.027764007,0.18745923766013609,-0.001755487274328522
82803,SIDM00146,JQ1,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8414859,-0.06782902,0.10410223015790533,0.05235657110667118
49139,SIDM00673,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.64466214,0.04218143,0.3814282822417802,0.03092008458570248
59861,SIDM00835,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.51350266,0.015445288,0.4071072439708221,0.014733493733418057
101675,SIDM01197,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,1.5963627,0.088026114,-2.694299949438617,-0.07745188809689861
10797,SIDM00148,Afatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.43617946,0.030888928,1.2183473707311616,0.12693972613013202
22404,SIDM00146,Vorinostat,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.76025826,0.05752883,0.5476435645406679,0.04792382458141694
15782,SIDM00455,Dactolisib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.55826443,-0.0313897,-1.009071525659139,-0.06777718756255245
56854,SIDM00928,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.0596724,-0.1933966,-1.1669926462988127,-0.10772328743078526
18921,SIDM00282,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0206486,-0.019978639,1.3095099815660036,0.05957807540553213
56292,SIDM00950,Dactolisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.201192,-0.058985304,0.04648120901550971,0.01950284684383906
2956,SIDM00633,Paclitaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.82209986,0.05516134,-0.9781454338749223,-0.04028912585990166
59382,SIDM01042,RO-3306,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.44037485,0.051445175,-0.7307868366447197,-0.06975078615626856
42769,SIDM00875,Cisplatin,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38971278,-0.018847628,0.3048755669383894,0.03037456524730144
94589,SIDM00633,Luminespib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.683964,0.18754886,1.3947383860003555,0.08123582529530465
18833,SIDM00776,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.3240025,0.14745246,1.8954706734257494,0.11964053847400587
42221,SIDM00776,AZD8055,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.1305857,-0.19703698,-0.4918928684011323,-0.07915760673817612
30531,SIDM01042,MK-2206,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.92092294,0.017226074,-0.9779803646403095,-0.004414697939972501
10022,SIDM00877,5-Fluorouracil,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.2211386,0.0128261335,-0.09426493297125048,0.030497676225994263
338,SIDM00928,Alisertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.92079777,-0.03354652,-1.5595783652536563,-0.015198810579880425
100249,SIDM00877,Doramapimod,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.7784884,0.18191773,1.127715850540802,0.08435116123728702
21314,SIDM00148,GSK269962A,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0564358,0.14815918,1.2908022424629624,0.10128302157450754
10166,SIDM00097,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.1309713,0.0072780293,-0.4243129415536817,-0.04728426623468006
99016,SIDM00146,Entinostat,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.45782727,-0.0314643,0.4973033158424377,0.015646433975505705
96816,SIDM00826,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.9924604,-0.06794002,0.16482404418890723,0.08327812697648027
88414,SIDM00950,Palbociclib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.65410215,0.04684196,0.10817441731229861,0.01818132943564466
79272,SIDM00933,Pictilisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.28885454,0.041790675,-1.566935162646303,-0.09289254685810887
15851,SIDM00872,OSI-027,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.4446914,0.23132244,0.6854898892052944,0.055599802361227024
58175,SIDM00928,PD173074,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.506074,-0.031659864,2.041821944145738,0.04468304399543242
39380,SIDM00877,Sorafenib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.580277,0.073631056,1.0558790873860677,0.014176263862250496
107746,SIDM00933,Entinostat,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.5808692,-0.1000739,0.7384986121345262,0.08461756997570248
10658,SIDM01197,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7329319,-0.014595671,0.9606869600846573,0.05033452346743556
10011,SIDM00877,Lapatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.93966085,-0.084723674,0.05554098809584313,-0.0027817668368389594
88495,SIDM00933,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.74522334,0.044027857,0.3536043043492427,-0.03212904590727611
36388,SIDM00933,Linsitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3346599,0.1104457,0.5009547598456575,0.13059491236651305
71830,SIDM00776,Palbociclib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3362575,-0.0415597,0.9401103876758568,0.062571719062442
91605,SIDM00875,Sorafenib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6712208,0.07160897,0.5889730622473661,0.06030323274069156
96555,SIDM00928,BI-2536,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-2.3351023,-0.15803102,-1.4799166860097934,-0.09836177473745984
31053,SIDM00832,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-0.6965499,-0.023017477,0.9811340380194576,0.0009926256649035097
80676,SIDM00673,Vorinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.53021777,0.03807134,1.239864995712072,0.06373931191230948
78242,SIDM00097,Wee1 Inhibitor,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1801425,-0.07232507,-1.463078371337011,-0.11293269093461983
11470,SIDM00872,Temozolomide,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9864943,0.063089065,0.368810978022136,-0.011843385774142567
1344,SIDM00877,Temozolomide,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,2.082187,0.025314875,0.794950987510538,0.08401386937107048
25496,SIDM01197,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-5.0844464,-0.21961348,-2.471109999050413,-0.08168919338875576
1899,SIDM00928,PD173074,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.5534544,0.15156507,0.6618480397761756,0.035031481902636524
31104,SIDM00146,PD173074,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.3296144,-0.13724098,-1.3835650713020462,-0.016352223434572103
99750,SIDM00872,JQ1,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1624104,-0.026461786,0.5560946019870185,0.04942195577963893
51800,SIDM00950,Paclitaxel,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.023345,-0.16148059,-0.4630787259352322,0.013327408065374557
99961,SIDM00146,Linsitinib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,3.615866,0.15105322,3.6147399230330617,0.09973958140085643
103773,SIDM00097,Venetoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4999268,-0.06753302,-2.7172061319758245,-0.017699784854939952
9868,SIDM00875,Lapatinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.79043275,-0.08435523,-0.034452439235914886,0.039370294611675925
39007,SIDM00146,AZD7762,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.073891,0.10288093,0.016005302862853878,0.016872756392880838
15914,SIDM00633,Gemcitabine,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6283559,-0.13922507,-2.399859415805681,-0.1442174923120299
102656,SIDM00872,Camptothecin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.72486407,0.018247228,1.360495559403916,0.03226617731935401
46002,SIDM00928,Ribociclib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.0043250346,0.00010847953,-0.22465567265237887,-0.01312199336831557
47046,SIDM00673,Docetaxel,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8551651,-0.18745169,-1.3621529856966752,-0.06844621646323272
50920,SIDM01187,MK-1775,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7361575,-0.08966753,-0.6129093395057703,-0.0218509490035151
25478,SIDM01197,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.2060766,-0.1383953,-0.1954171534983873,0.005944196282407176
72892,SIDM00877,Tozasertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.0493928,-0.09901047,-0.3561089477585592,0.030868161637191107
52235,SIDM00933,Luminespib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.023359891,-0.0007562881,-0.7475292036003255,0.0012542335482195435
50909,SIDM00875,Taselisib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6633505,0.07634036,0.8230243779600221,0.06798297740028256
17567,SIDM00875,Palbociclib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8133864,0.027355207,1.0775942672838794,0.004010406845508647
80180,SIDM00872,AZD8055,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.65928423,-0.067194074,-0.12759447877568292,-0.05278747119079274
73633,SIDM00359,Palbociclib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6214918,-0.07846341,-0.7071071531803347,-0.01847583095839751
5236,SIDM00950,Trametinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.1432598,0.29099938,-0.7970770956460665,-0.05672214397950463
2538,SIDM00833,AZD8055,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.27380332,-0.008385519,0.609484492184132,0.010381725200667956
74357,SIDM00148,Sorafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7488799,-0.073658265,-1.567115738961713,-0.07041622482060092
22933,SIDM00833,Palbociclib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-0.6915512,-0.015684985,0.2652052473817864,0.015711965671051722
36314,SIDM00042,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.1363378,0.1848503,0.8052660315434966,0.07693489486703121
67533,SIDM00832,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-3.4527225,-0.12324266,-1.507444842163917,-0.03590613999141984
11259,SIDM00633,NU7441,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.153523,0.20511225,3.0741433256050623,0.11290549638049235
105225,SIDM00835,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,1.4125834,0.06468444,-0.6530526894114134,0.022155157703890257
379,SIDM00872,Wee1 Inhibitor,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9286721,-0.09703165,0.4862635143829616,-0.03651872236072366
88815,SIDM00673,KU-55933,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.5189254,-0.13517693,-0.3149902706664819,0.0655021932563465
102913,SIDM00633,Uprosertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.8907735,0.12594113,2.613377545430891,0.08728658651927577
5340,SIDM00872,Axitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7760563,0.06638709,-0.18550255146324188,-0.012147478832507882
23010,SIDM00877,Doramapimod,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.6170983,-0.10865874,-0.041280783463679145,0.009831844782537976
51631,SIDM00148,PF-4708671,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4218441,0.11456597,0.15150245019885525,0.03865976057715365
92427,SIDM01042,Luminespib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9667093,-0.062971346,-1.7723369398366202,0.01942842200652177
50271,SIDM00455,Erlotinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8829122,0.10811822,4.820640745284047,0.12290128480459099
16928,SIDM00146,Entinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.6489859,0.19822389,0.005554353373689278,0.0754181051160519
4316,SIDM00673,PF-4708671,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.164201,-0.113084204,-0.0011169114232887102,-0.012839847297382433
87999,SIDM00933,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.3255777,-0.042915426,-0.26689838821578693,-0.0033377437206888543
33425,SIDM00877,Dabrafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.3878793,0.040671717,0.9879667754130974,0.06807927660992244
9608,SIDM00776,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.7775313,-0.03170355,-1.7214815666799352,-0.06148032645692651
93682,SIDM00832,Olaparib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.8877941,-0.061236296,-0.039254181352264036,0.02252796980224727
16670,SIDM00950,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.99110687,0.099690616,1.7426732728870848,0.11493841973223996
82854,SIDM00826,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.8436619,0.06922235,0.2207407059496702,0.06501262984186859
52938,SIDM01187,AZD7762,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.37077,0.09071638,0.30199729366528555,0.02204658431437421
102162,SIDM00146,Navitoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.0657616,0.09866885,2.414626535166094,0.046486172866893244
45115,SIDM00957,Palbociclib,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.3814174,0.010139441,-0.4313996500882367,-0.00503913379198523
86221,SIDM00097,PD173074,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8968647,-0.10265612,0.745365685058357,0.0005732178500863555
69433,SIDM00097,Uprosertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4757814,-0.096298896,-1.1241867974195399,-0.07978773821511735
28249,SIDM00148,Wee1 Inhibitor,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.17267731,0.016801698,1.7056551891552194,0.07710055348094838
40311,SIDM01042,RO-3306,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0501263,-0.11535488,0.15427671963888842,-0.023605355017072543
3857,SIDM00835,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.6301231,0.03913426,0.04541566580088097,-0.014736215437662311
91775,SIDM00776,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.90046,-0.08026938,0.9653809348304969,0.08126816328382629
7776,SIDM00928,Sorafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.645984,0.067222595,-0.2774796007757407,-0.029126859047555152
67471,SIDM00146,Alisertib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.70355326,-0.05768085,-0.2533272029790383,0.02206148839079288
21194,SIDM00097,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0134858,0.059852567,0.6864806315993452,0.02449997293936243
77192,SIDM00776,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.69480133,-0.062779054,-0.4350364640920569,-0.06571425516168582
65187,SIDM01197,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.18124256,-0.009285243,-0.826587335371303,-0.020295074738388402
65548,SIDM00928,Dabrafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.51738673,0.022603992,0.8745806965853248,0.02403248773506489
92346,SIDM01042,Afatinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3367015,0.03924564,2.107402843967501,0.10484754805819996
47580,SIDM00359,Crizotinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.99568975,-0.06139238,-1.285866406469732,-0.09671009935902611
50278,SIDM00148,AZD7762,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.83793586,-0.06839466,-1.048116048046919,-0.08527405043955891
89206,SIDM00872,SCH772984,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.76741123,-0.0473963,-0.6838462483828937,-0.01821383756836188
68852,SIDM00097,Sorafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8052317,-0.036364194,-0.5142243972264733,-0.004403649548517383
79740,SIDM00776,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,3.6158676,0.19097759,0.5259352115783951,0.05650350575454857
87190,SIDM00146,Luminespib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.8622577,-0.07385922,-2.839527428467793,-0.10194336522361434
56833,SIDM00146,Axitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.2261827,-0.077742286,-0.5181274445219183,0.02539873581369
80540,SIDM00146,AZD6482,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.4632368,0.10858577,-0.019595743929255543,0.032688110184117124
103004,SIDM01197,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,2.381057,0.07239055,1.8420403186163345,0.04651643953567047
106381,SIDM00928,Navitoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.4080155,0.14940889,0.2652805488759834,0.012997641505955164
55778,SIDM00837,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,0.52984226,0.025939591,0.04338706157213935,0.011634056388590549
40371,SIDM00875,Vorinostat,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0300069,0.0949766,1.666767824884535,0.07683040086229534
87989,SIDM01187,Gemcitabine,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0939854,0.093707725,-0.9244085664097671,0.005236335180138504
38890,SIDM00872,5-Fluorouracil,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1080565,-0.054859478,-0.8909221339299221,-0.0031148142832219915
42538,SIDM00455,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.390691,0.29434258,2.554025546394889,0.1728315403483814
19490,SIDM00776,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,2.2525182,0.1423998,-0.8119385595133339,-0.06477070848171558
60799,SIDM00673,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0551031,0.024094347,2.265632157832141,0.049322878240956367
48117,SIDM00633,Afatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7160221,0.0060110567,-4.131621287502121,-0.07996731938704243
103947,SIDM00097,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8012028,-0.18855573,-2.8355246666150897,-0.14215288201096132
47881,SIDM00928,Axitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,1.1596274,0.10186599,-0.2776366214785674,-0.015856770041837432
79220,SIDM00359,Palbociclib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3924184,-0.08248301,-1.8770142670420298,-0.0491090134935695
53082,SIDM00877,AZD7762,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6331332,-0.049198363,0.49586542921222543,0.018924898366313097
28449,SIDM00148,Dabrafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1541024,-0.06114143,-1.331831313208571,-0.055593089287979416
16018,SIDM00826,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,2.2890363,0.09268619,-2.309956776946311,-0.0776453296279222
103628,SIDM00957,Afatinib,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.6532028,-0.09806052,-0.5269856659055204,-0.040406998736446535
7615,SIDM00933,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.7968034,-0.03336584,-0.12131672740080153,0.005124381343633382
63713,SIDM00633,Cisplatin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2736897,-0.08275404,-1.9763736051869263,-0.07368741485174214
7141,SIDM00833,Olaparib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.3548648,-0.04135356,0.1307076981256129,0.008715558386726184
54056,SIDM00835,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.0383482,0.19126876,2.9822246402982593,0.10826311324636477
51450,SIDM00097,Tozasertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2485428,-0.04054491,1.1471773598355444,0.05814330335757518
56775,SIDM01042,Doramapimod,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9077769,-0.10726391,0.17358522801056975,0.04568068521152781
38873,SIDM00776,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.68528664,-0.020518571,1.5746852805313571,0.044131233839453596
83049,SIDM00872,SCH772984,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.3798053,-0.11575444,0.41926219188607,0.017781348274035644
41834,SIDM00832,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-1.4991002,-0.11922795,1.3104696990482385,0.03987844220685228
16802,SIDM00826,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.27623546,-0.017128658,-0.8708807517748962,-0.054164194505527806
1114,SIDM00359,Trametinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5339277,-0.10883123,-2.4516389716367186,-0.07065990134404808
77141,SIDM00673,Bortezomib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.4921211,-0.028997354,-0.6250386471860734,-0.027523816529967226
73532,SIDM00282,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.5076014,-0.05073054,-0.1349772500279949,-0.009512163475768666
66250,SIDM00282,AZD7762,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.7676318,0.090275794,0.21456479840885576,-0.005574652726272282
92432,SIDM00097,Tozasertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.409734,-0.0703314,0.04826616132349235,0.014411740924342416
84068,SIDM00148,Luminespib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4212173,0.037209343,1.0475618684238794,0.046841978442703984
74901,SIDM00216,Trametinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,1.8543549,0.15860246,1.7583808857368852,0.08833581970765624
97279,SIDM00146,MK-2206,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9761806,-0.084302545,-0.3479793062377916,0.030503798487183757
50347,SIDM00282,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1369444,-0.064352736,-0.362723307163393,-0.02047415302213974
78184,SIDM00872,Sorafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0816731,-0.10625446,-0.14992376627565132,-0.06304531719789219
53496,SIDM00455,Dasatinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5529857,0.08330677,-0.6923527553511292,-0.02643816087620531
18008,SIDM01197,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5319387,-0.07804369,2.7430598566814806,0.18504743969734988
66070,SIDM00957,BMS-754807,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.3798422,-0.053197846,-0.6783644754016542,-0.007166381751575885
97358,SIDM00776,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.42317915,0.031004667,0.5703043004845213,0.030402020591004112
47283,SIDM00148,ZM447439,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4837749,-0.032013655,-0.6054837111825765,-0.00747542012362135
87869,SIDM00875,Pictilisib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19092146,-0.02096941,-0.41811763293595533,-0.007022955843547923
77719,SIDM00282,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4739643,0.06253073,3.118262614774764,0.2148848489149456
59752,SIDM00837,Camptothecin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-3.710896,-0.20100515,-3.465004664379862,-0.22837281494357578
57845,SIDM00928,NU7441,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.78995985,0.096120946,0.35782030067498566,0.02884956893980449
55396,SIDM00633,Alpelisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.77636033,0.049211796,0.042072850735610005,0.03931859990230966
83825,SIDM00875,Venetoclax,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17446533,0.00394536,1.1473405158430008,0.04071137105738477
96769,SIDM00872,Sorafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8545313,-0.07429788,0.034121551908598675,0.017008276485209334
100874,SIDM00216,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9266737,-0.027211493,-0.5271052619681134,-0.010843859631315294
94913,SIDM00148,Bortezomib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8494472,0.06574016,-0.303751898835101,-0.031589247433595216
51595,SIDM00042,OSI-027,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.1826723,-0.13010861,-1.537178726456301,-0.08573222280669912
40781,SIDM01197,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.87440777,-0.040051144,0.033816496733554156,0.004088533273050066
92297,SIDM00826,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.20316616,0.015748024,-2.5549818476692656,-0.1341185669976609
45505,SIDM00928,JQ1,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.0784063,0.13552074,0.265987025607586,0.02451082796747775
91469,SIDM00877,Doramapimod,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.1609352,0.15633556,1.139516292041959,0.06842279002838406
9773,SIDM00216,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.883292,0.068266466,-0.3983410602320355,-0.035659219798468936
52044,SIDM00673,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4219918,-0.04470783,-2.59496193406279,-0.01883677893215935
5745,SIDM00872,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.30449113,0.031949386,-0.5761804288730163,-0.0435891924375615
103126,SIDM00832,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,3.1387851,0.12344344,1.21429423286256,0.021882594666396027
99466,SIDM00097,Crizotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5937814,-0.08348456,-1.4386120305180015,-0.08008765062318157
49979,SIDM01042,Afatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.68004316,-0.09134816,-1.3048880266141403,-0.08507032460125817
244,SIDM01042,Sorafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8321144,0.083222166,0.30083020652848,0.0067061517270952525
45675,SIDM00877,PF-4708671,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.1575687,0.10770476,0.9944371746715808,0.07213733489272306
68381,SIDM00673,Navitoclax,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0754546,-0.07268162,1.9649422283339049,0.13147214595359968
70040,SIDM00359,AZD4547,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.55119866,-0.03014044,-0.5931138209452401,0.012899558421345787
62945,SIDM00835,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,1.453484,0.08643296,0.16973277497080488,0.06729023934246445
14366,SIDM00928,Alpelisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.44262516,-0.050678477,0.05233295981186281,0.01825455294391087
12250,SIDM01042,Ribociclib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.707338,-0.072014496,0.07592117863695598,0.002506042657623561
96522,SIDM00950,Dasatinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8212814,0.26908314,2.162053097652986,0.0896665939600633
50877,SIDM00833,5-Fluorouracil,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.42683673,0.02683611,-1.1136446061774374,-0.039712331679697795
63328,SIDM00148,Linsitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6137552,-0.060956705,0.4144717629374517,-0.028278723545977703
69994,SIDM00148,MK-2206,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.68181413,-0.05327407,-0.07464858546435899,0.004583776651383223
84849,SIDM00837,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,3.925654,0.055198926,0.6135569266969484,-0.032814092563163345
40363,SIDM00673,Ribociclib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3032687,-0.07294856,-1.7498262835022795,-0.02551987964573674
74548,SIDM00875,5-Fluorouracil,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10237387,0.011398602,-0.8039624217935633,-0.042725794228594405
33795,SIDM00148,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.357304,-0.12603727,-2.3962124511971825,-0.08771657008931302
77288,SIDM00359,MK-1775,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.778653,-0.29925716,-2.4348219132479363,-0.20669791440128352
9230,SIDM00933,Temozolomide,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.7394193,-0.029846145,0.7774011633802532,0.03536496300838203
38091,SIDM00837,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.88080263,-0.06411531,-0.9155350052565439,-0.059177631498944096
108455,SIDM00146,SCH772984,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.86444515,-0.07654365,0.46447348232369695,0.003316215957363115
81325,SIDM00097,ZM447439,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9752133,-0.056927547,1.4087841644778836,0.08075402455590845
40346,SIDM00673,AZD6482,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4933418,-0.08843275,-0.8524433437832752,-0.06537122901742959
88012,SIDM00633,Olaparib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3340945,-0.062404856,-1.4752934931829287,-0.06930271886813177
22725,SIDM00282,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.95931214,-0.050424363,-1.001658873813158,-0.04707038693327113
15506,SIDM00837,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,4.52683,0.08213762,1.4837826937451264,0.04234287171615178
23136,SIDM00833,Trametinib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.59870017,-0.029249016,0.08208890215649109,-0.003285866779737828
82141,SIDM00455,Sorafenib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6954734,0.037715,1.2407755961280091,0.10294058405825313
75797,SIDM00673,AZD8055,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.240547,-0.08952182,-0.6724741408193594,-0.04889254192090336
99037,SIDM00216,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.28965163,-0.02408748,-0.3864485711027251,-0.09134866037136886
4608,SIDM00835,Palbociclib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.674017,0.056030735,0.7854450235889535,0.05509694212376205
47419,SIDM00097,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.707212,-0.06679801,-1.3324465195602482,-0.06285898734043792
20251,SIDM00359,Olaparib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0255182,0.06258584,1.9938563394019757,0.03690257660026267
79353,SIDM00957,AZD7762,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,3.004027,0.04266388,3.2438802333441226,0.1052490196949387
73441,SIDM00835,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.1192905,-0.09354516,-1.2624881346417172,-0.10817332751309103
1290,SIDM00826,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.467586,-0.12203563,1.2379721297404542,0.031132268686753596
33416,SIDM00872,Navitoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,6.568299,0.27426526,3.565938677859026,0.15868503046718327
52577,SIDM00835,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,0.32741058,0.007466688,0.7315794415459637,0.00498566974391736
28187,SIDM01042,RO-3306,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0221212,0.22872388,2.0816964932547033,0.10282680301408312
52841,SIDM00148,Luminespib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.507945,0.0444498,-0.8992252250282546,-0.04254863971763742
105320,SIDM01187,Olaparib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6184876,0.1036567,-1.377837772001113,-0.025459584127777195
73271,SIDM00097,PF-4708671,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6871452,-0.08386819,-2.6418044638240334,-0.06552874370675861
97477,SIDM00359,MK-1775,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4696647,0.11063357,-0.751074709531124,-0.03985814882574931
100737,SIDM00455,Gemcitabine,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.47311938,-0.016087526,0.6031604072633523,0.09815923045108856
71873,SIDM00877,PF-4708671,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.6331822,0.15582119,0.30439575273107566,0.013399758792684001
73632,SIDM00673,Pictilisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6814511,0.05150109,-0.3238390545723854,-0.007325231298556303
82619,SIDM00359,Taselisib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8487836,-0.059187032,-0.26978711295684543,0.028909510527246805
38782,SIDM01042,Crizotinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.34392595,0.03469322,-0.9979236770400106,-0.04067650417629187
76421,SIDM00837,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.8167477,-0.04923314,-1.5265577160724402,-0.0942437978428691
82613,SIDM00097,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9903312,0.046405233,0.39024113840158736,0.010475623178353112
31882,SIDM00875,Entinostat,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41565192,-0.040256213,0.07318394316557383,-0.033539305153509
53049,SIDM01042,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.332518,0.16081765,-0.3309224179454443,0.01457410189222542
34917,SIDM00872,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5385359,0.055803582,-0.0662371157495212,0.006572644105149544
91842,SIDM00455,Paclitaxel,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2143854,-0.08132319,-0.7366792377551666,-0.026765066896903476
4157,SIDM00832,Olaparib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,2.5329204,0.12722556,-0.48824954139375026,0.022879356829200108
2695,SIDM00875,BI-2536,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.90126,-0.07609839,-4.559755203792223,-0.18357205734046805
7064,SIDM00097,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5863137,-0.08177141,-1.3052263950779102,-0.05864075502089293
52516,SIDM00673,SCH772984,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-4.3707547,-0.26860172,-1.1645739849330632,-0.038530446991189446
64639,SIDM00928,Paclitaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.84968674,-0.07768105,0.5212144235462272,-0.0007883562563837382
84454,SIDM00042,Sorafenib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.18886319,0.02062968,-0.9717545919351617,-0.0510306122559463
42202,SIDM00933,Wee1 Inhibitor,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.4098123,0.028551472,-0.44327404748588717,-0.06440195226574794
38377,SIDM00455,Navitoclax,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.1109703,0.13335423,0.42973702007580183,0.037593397803023704
41924,SIDM00216,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.77432084,-0.035082307,-0.4708168927924516,-0.0396321339026076
73623,SIDM01187,MK-2206,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8028954,-0.084642604,0.5363360878811069,0.021297802210658783
84856,SIDM00146,MK-2206,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1478039,0.07877314,4.2723687634247005,0.3401053328006401
92266,SIDM00673,RO-3306,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4089313,-0.12578593,-0.9414290212375006,-0.07175623707543442
62569,SIDM00957,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,2.9919343,0.053854287,1.693704413136008,0.06856720705087974
62309,SIDM00877,Olaparib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-2.6097646,-0.10278842,-1.475865149528504,-0.05657303278415419
71457,SIDM00282,SB505124,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.2044601,0.09339066,0.842070681277582,0.029470564741318914
43704,SIDM00146,SCH772984,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0108695,0.15908735,1.7360141246967482,0.14370569475291814
17095,SIDM00097,Paclitaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9794589,-0.1060648,-0.36777761687700444,-0.060091409603010945
58778,SIDM00950,SCH772984,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.5408175,0.2879136,-0.09266600856487131,0.007261218104562226
105630,SIDM00875,Olaparib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.0040071527,-0.00036179757,-0.36079829153051207,-0.002008075997490343
62063,SIDM00359,Dabrafenib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4494026,0.14126706,1.719206029474894,0.10645154463022606
98809,SIDM00633,Crizotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.410413,0.06849067,-0.7565710501577565,-0.02175752530807787
45026,SIDM00933,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.9103899,0.054136712,-0.6316418844537752,0.01864907843359321
58478,SIDM00877,Entinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.37825677,-0.037715867,-0.005233444051198848,-0.036049281089926284
95769,SIDM01042,Palbociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.449213,0.028053496,-0.9682045332008816,0.014511094122886266
98046,SIDM00359,Trametinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.588317,0.034502417,1.4762441813366103,0.029502274304444062
37095,SIDM00877,Navitoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3536996,0.042111274,3.071820551550657,0.02756721432167586
80968,SIDM00826,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.382701,0.03138535,-0.1948590178366873,0.00531595128518769
21108,SIDM00148,Vorinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.54428804,-0.0466431,-0.17413459060203731,-0.044425973336815645
46834,SIDM00633,Afatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2286359,-0.014728493,-1.7725564137073855,-0.05631945428126034
77371,SIDM00826,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.45457026,-0.0351663,-1.3163500108558586,-0.11130537161365503
215,SIDM00359,MK-2206,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0205238,0.059690267,-0.44990844603818236,0.027815859400132665
80396,SIDM00826,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.1441228,-0.05282495,-0.9455473355481644,-0.02497631161920459
86555,SIDM00633,JQ1,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3214712,-0.02864618,-3.2892117581854716,-0.17789958714227933
102992,SIDM00950,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.240888,-0.18450584,-1.403009279225435,-0.12559210050592629
29528,SIDM00837,SB505124,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.36881593,-0.016679242,-0.3154701361118181,-0.006264461815762024
88073,SIDM00146,5-Fluorouracil,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7642406,-0.04598059,-1.3762968219630987,-0.05865573842161294
65494,SIDM00933,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.54440355,0.011760851,1.4670985736633024,0.020919265774289215
1009,SIDM00837,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,2.0519507,0.13280609,-1.0699416157331116,-0.031909403349994384
21166,SIDM00933,Ribociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.6198004,0.0341532,1.6917100529095717,0.03701170614751581
53254,SIDM00837,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.4504864,0.025526727,0.368292490393351,-0.033247595308489565
81116,SIDM00148,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3145761,-0.16505863,-1.9240829394553889,-0.11764791643399677
51227,SIDM00282,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.125599,0.08188581,0.8660540880258727,0.14157138519595985
104703,SIDM01197,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.3201149,0.031289946,1.6828749168634491,0.041576431473494255
101640,SIDM00673,Pictilisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.16500875,-0.015944317,-0.6085419557786762,-0.06436689315621678
85147,SIDM00928,Docetaxel,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.761807,-0.1649249,-0.6991374590122801,0.0023527164284519305
72056,SIDM00826,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,2.4545507,0.033960767,3.004242844435401,0.07537768277431464
42223,SIDM00928,Entinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.26294452,0.025459807,-0.7650219553235978,0.04112122678798756
86529,SIDM00673,SCH772984,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.5726073,-0.18237042,1.1986912577478008,0.06771539073429901
41,SIDM00146,MK-2206,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1632464,0.16897254,1.142196432519862,0.13346858172703716
9774,SIDM00957,Trametinib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.743336,-0.10621789,0.45865502900714394,0.019797286153430335
44265,SIDM00957,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,2.4600952,0.033927526,2.840971039844236,0.08318187898034848
33752,SIDM01187,Taselisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.30907074,-0.025549632,-1.2640453471557054,-0.0614149269401938
3708,SIDM00877,OSI-027,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.40437976,0.028203696,-0.21791669151164356,0.07510440385594523
35760,SIDM01042,Crizotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.99573666,0.06405867,-1.2319538597241453,-0.03647783892994189
72262,SIDM01042,Entinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6312434,0.061731156,1.6127037899826875,0.032566205613522775
8513,SIDM00455,Taselisib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.8514281,-0.05701868,-0.7412219267270048,-0.03950368429104919
25827,SIDM00673,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.82177645,0.058213763,1.353017131323431,0.04897092452307284
44000,SIDM00832,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.0921533,0.04192559,-0.5295324104334752,-0.006183672093752769
32690,SIDM00776,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.7108489,-0.05895746,1.1157637951466517,0.03774549811886502
14326,SIDM00146,Alpelisib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.71330804,0.04047785,0.28707331005794157,0.04355993060208559
56864,SIDM00933,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.38232306,-0.033138927,-0.7638542293170053,-0.025825130890353373
106389,SIDM00877,Navitoclax,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2350459,-0.13367976,1.6052619943593356,0.083279829747986
12626,SIDM00833,Vinorelbine,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.0284617,-0.05712134,0.6175444597803432,0.00574045869938788
20726,SIDM00875,AZD8055,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.439529,0.0473233,-0.46940654272322535,0.013553578252877162
18905,SIDM01042,Trametinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.44686073,-0.029761378,-0.27308246580009476,-0.04201549549619953
81980,SIDM00950,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.482309,0.12295608,-0.4803383078056928,-0.08898091208427489
107178,SIDM00832,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.6593353,-0.018077547,0.7197259455212653,-0.0034208216948136342
7890,SIDM00875,AZD8055,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2749704,-0.028915863,-0.8208103644852434,-0.030336240000258436
26605,SIDM01042,Camptothecin,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.72300917,-0.056767926,0.022562583094013457,-0.009648494408130374
53862,SIDM01042,Palbociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.017977,0.068834625,0.5789389381108476,0.03600407263006255
98630,SIDM00148,Uprosertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.34927368,0.031697195,-0.5518236484597849,-0.06802584475183399
84520,SIDM01042,GSK269962A,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.17226318,-0.019305741,1.5005774657067434,0.0672657470485302
57427,SIDM01042,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.96274775,-0.10056186,-0.9042246236448278,-0.05826430206799282
52145,SIDM00673,Sorafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.3829359,-0.024715127,0.0648872517835329,0.010975384754281227
16848,SIDM00875,Nilotinib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5758995,0.17427263,0.9394582460017785,0.08875600061437663
79031,SIDM00875,Tozasertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.073261,0.07630294,0.6600943404223991,0.04743048639249696
76568,SIDM00877,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.815556,0.10580137,0.9458234009857519,0.057813412514113
3213,SIDM00877,SCH772984,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,3.0039172,0.07837644,1.651046799608152,0.05210836449693033
48122,SIDM00097,5-Fluorouracil,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.190419,-0.12755887,-1.8662441667777754,-0.05259340108388856
75120,SIDM00673,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3366293,-0.110337384,-0.8088586498349875,-0.07371000277187742
67908,SIDM00872,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.96902233,0.026511883,1.492394420440418,0.02566834731022601
46032,SIDM00933,Crizotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.5458957,0.058418952,0.2867975347960892,0.02199820078422292
9874,SIDM00633,AZD7762,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2137237,-0.058649186,-1.6182526401755186,-0.03952018850539726
48225,SIDM00673,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3980299,-0.1078366,-0.024719631899003353,0.0037716486214830337
25462,SIDM00097,Navitoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.79295117,0.046436712,2.4969442099958874,0.08893879486967658
39736,SIDM00148,Luminespib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.7829988,-0.16065569,-1.8119172113806896,-0.06068712122117476
12882,SIDM00455,Navitoclax,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.4266156,-0.02004655,-1.0582251514719643,-0.057841086279800544
32712,SIDM00673,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9920822,0.02817683,1.192352190033727,0.06335088755388642
30405,SIDM00877,Temozolomide,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.40548837,0.012626731,-0.9310896085614198,0.047268005143951755
96919,SIDM00933,Lapatinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.8666891,0.10065538,-0.44699243521924703,0.01845709807576515
4691,SIDM00633,Taselisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9788728,-0.132895,-2.9973763313220685,-0.11488030930197993
7428,SIDM00875,Axitinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3301063,0.03641955,-0.16354008954328117,-0.059336891605920594
54094,SIDM00875,Cisplatin,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3680911,-0.014408331,-0.34527567950197285,-0.014303314280766106
104410,SIDM01187,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.16893,0.116097294,1.486593492728022,0.06847660060430644
48354,SIDM00877,NU7441,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,2.7264185,0.20828173,0.6368852348666136,0.10032042869217236
16927,SIDM00957,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.0064356,0.026013318,-0.45018534777504243,-0.0033740981671699587
429,SIDM00833,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.5905142,0.073163174,2.7585486191833084,0.07580522739102603
105087,SIDM00776,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.6828686,0.03435347,1.3014204175471853,0.06428268420894212
35240,SIDM00877,PF-4708671,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8371459,0.08256744,-0.26390742192868116,0.00406163123598098
94417,SIDM00950,5-Fluorouracil,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7008126,-0.047767647,-1.074097485234068,-0.014729532810207226
75001,SIDM00928,Linsitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.4257288,0.25566053,0.5360479483374025,0.009074646473053193
4720,SIDM01042,Temozolomide,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.80944836,0.035144027,-0.6122288150117864,-0.012951834973875672
72094,SIDM00933,OSI-027,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.8787215,0.25053978,-1.4868178113852715,-0.05541157296987974
96494,SIDM00216,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5172782,-0.1405151,-1.7642936736584254,-0.14100745068520515
23872,SIDM00097,Ribociclib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9374275,0.09559073,-1.7698780478621285,0.015595722774501821
58857,SIDM00928,Lapatinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.9028304,0.26335037,1.9232706679092018,0.1572576251315975
17405,SIDM00776,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.2708035,-0.08180908,-1.3385650103685822,-0.0023165784336836416
99430,SIDM00826,SB505124,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.9888732,-0.13869934,-1.5037703652649794,-0.11795912527272276
86341,SIDM01197,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.7969288,0.053010028,-1.1052005502668707,-0.11521495720544805
14673,SIDM00957,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,0.3038992,0.011715993,-0.3004256725675898,-0.014685745575493975
100545,SIDM00928,Alisertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,6.9999394,0.5902754,3.9537275679118653,0.2851551852687907
86690,SIDM00872,Bortezomib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.17965418,-0.011950188,-0.33820081812945535,-0.009565166574765529
82314,SIDM00633,Bortezomib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.797464,-0.033703577,-2.5118192680356297,-0.057645967331817156
56336,SIDM00872,KU-55933,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8846917,0.05514333,0.2328716835672891,-0.004922202033009437
46315,SIDM00872,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.88182366,0.02888964,1.3338858802256306,-0.00017406217865745428
15459,SIDM00097,Dabrafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4237791,-0.051364884,0.10240626387497112,-0.01678937538632853
68862,SIDM00673,BI-2536,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.315087,-0.0241421,0.7870084436705244,0.007196228743981774
55035,SIDM00950,MK-2206,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.450069,0.13701017,0.3972338940863016,-0.018839400383537097
21358,SIDM00673,Linsitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.819655,0.017411951,2.9315262542736074,0.10457872327835593
2488,SIDM00872,GSK269962A,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.90965617,-0.08490619,-0.772141616666299,-0.08755105981397744
61359,SIDM00928,OSI-027,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.9831969,-0.07943983,-0.3496927505740065,-0.041996980484845375
6882,SIDM00097,Uprosertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.37040287,0.025382368,-0.1672391232108751,-0.02197554536489416
98612,SIDM01042,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1139295,0.068227716,0.5438978195631181,0.01254653520683122
61010,SIDM00875,MK-1775,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1101468,-0.078784704,-3.128367434457185,-0.20449682549433226
17495,SIDM00832,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-1.0618339,-0.07480446,-0.1229512003200419,-0.01598228473862877
52152,SIDM00776,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-3.0141878,-0.09886708,-0.9586839793738993,-0.03316678740777089
46363,SIDM00877,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-3.2545986,-0.014452819,-2.3485302544265036,-0.035436234463861654
26226,SIDM01187,Cisplatin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4733253,-0.09811,-1.6218854312117579,-0.08425432840286869
41516,SIDM00957,SB505124,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-5.321534,-0.089307755,0.20611878608544493,0.049221562750067366
31552,SIDM00282,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.22830075,-0.017534506,1.2066984491402044,0.07177794594932893
52233,SIDM00042,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.7489191,0.084473886,1.1722231290293614,0.10255911261811768
37117,SIDM00837,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.5522352,0.05218064,-0.3874637044160813,-0.057630625389832095
70797,SIDM00933,AZD6482,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.47834647,-0.015382434,2.0459127104971038,0.03792996653302497
4224,SIDM00872,GSK269962A,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7093181,-0.066916175,-0.09437359175701417,-0.0487286807189402
42301,SIDM00877,Gemcitabine,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.3172911,0.005014454,0.16146155773070048,0.002134614086236829
32040,SIDM00877,Docetaxel,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.0802733,-0.093560375,-1.7243716476906459,-0.13331852493905952
23254,SIDM00216,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.4864212,0.005987988,-0.8883347831350743,-0.06742107081170698
96737,SIDM00933,PD173074,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.7481082,-0.07372998,0.287619001037053,0.008460325154000447
46878,SIDM01187,Temozolomide,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6602019,0.018885823,-0.4146650442856006,0.019724079220900147
100665,SIDM00097,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5512269,0.10352699,1.3352484776653266,0.025231317249810925
16055,SIDM00146,Lapatinib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.22050671,0.020363472,-0.2086668099934927,0.022932150549102397
96788,SIDM00957,Palbociclib,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.1861943,-0.028032068,-0.3775444892580847,0.03116661765963353
26165,SIDM00928,OSI-027,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.136626,0.19550385,-0.2801184414063647,-0.045396609906842425
52215,SIDM00875,KU-55933,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4847134,-0.05738851,0.07276802196192853,-0.014472064893533353
61242,SIDM00097,MK-2206,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3922281,-0.114450835,0.7339901299378552,0.011533591306151086
13268,SIDM00042,Ruxolitinib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.5369376,-0.014784231,0.45019404321250717,0.021473372520908387
56711,SIDM00776,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.0032694,0.076422065,1.117666038772435,0.025108095222769106
43335,SIDM01042,SCH772984,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.52925295,0.029700672,1.1768419733463678,0.031020248901231375
14557,SIDM00877,Entinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.046391,0.02706114,-0.8975590465690279,-0.07793395037489642
87757,SIDM00673,Cisplatin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.14756809,0.00530526,-0.3071302762246021,-0.001944988104382575
83984,SIDM00875,SCH772984,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28616607,0.033242226,3.0408325465884944,0.16572127509784199
16251,SIDM00872,Wee1 Inhibitor,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.69188476,0.073941834,0.34269025519686086,0.029503621833886263
63045,SIDM00776,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-0.60198236,-0.03391814,0.2890412004049523,-0.051910448669322345
24457,SIDM00359,Vinorelbine,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.7792728,0.21570563,-0.4036647536772366,0.058186692898790665
3884,SIDM00877,Taselisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-3.510977,-0.083827786,-0.49632881935441314,-0.04396941395955346
95469,SIDM00216,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.18501185,-0.009629739,-1.3293265531666463,-0.0861216697119095
39127,SIDM00673,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.396999,0.057113875,2.469249752972726,0.15840033751287264
23621,SIDM00837,MK-2206,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,1.2306758,0.053356346,-0.4526468380112868,0.026253544884288747
93141,SIDM00872,OSI-027,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.53354394,-0.04814755,0.17855735162680747,0.0036468004838375177
27159,SIDM00933,BI-2536,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.53172463,-0.0031001384,-1.036935000961521,-0.05568165742752628
36651,SIDM00146,Vorinostat,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.42615947,0.03862654,-0.7377034187137556,-0.018127373930422335
10452,SIDM00875,Camptothecin,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9063964,0.24373727,1.310796160410107,0.12718364769724447
37178,SIDM00146,Tozasertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.5870947,0.108264595,1.0643449536163652,0.09212648286739786
104194,SIDM00359,AZD7762,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3003192,0.11528667,-0.6824107455374145,0.060816419601526325
106897,SIDM00673,Vorinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6513157,0.05419051,0.5917209038479035,0.04231245039184802
90127,SIDM00146,Docetaxel,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.787584,-0.24817927,-3.2403696483651925,-0.2718121677438826
61121,SIDM00633,Tozasertib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5628319,0.09352847,2.346766724473577,0.028378095427226618
71816,SIDM00875,GSK269962A,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6455305,0.3241586,0.1466114461189812,0.006831408832188015
58629,SIDM00950,SCH772984,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2951453,-0.23136163,-1.4710521520950488,-0.15415978585902138
61667,SIDM00148,Uprosertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6084,0.17197049,-0.8217796760629612,-0.04515487766665023
77723,SIDM00875,Paclitaxel,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6199076,-0.17415419,-2.9530996481255505,-0.18742755619823792
91576,SIDM00633,SCH772984,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6210905,0.112126336,-0.19109268052930148,-0.007018746432588236
67136,SIDM00872,Nilotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6830237,0.16996127,0.5003468988949645,0.011907393536790102
29891,SIDM00455,Dactolisib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5045187,-0.1306891,-2.2739441969616765,-0.13858429633529704
2294,SIDM00872,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.86649096,-0.08380871,-0.6782200999264035,-0.11082429249691243
24933,SIDM00359,Palbociclib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5027726,-0.05733413,-0.05121956421019778,0.05450073641698674
77694,SIDM00042,OSI-027,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.5843606,0.20036207,0.9054530173192706,0.04812799441640591
69249,SIDM00673,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7267158,-0.13653493,-1.1013175417991536,-0.07989944828888564
22467,SIDM00957,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.85967326,0.017936992,3.8061744023732524,0.113973919991582
48482,SIDM00216,SB505124,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.48280925,-0.042098634,-0.9641555284948243,-0.06443303355976976
21256,SIDM00359,AZD7762,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.99597,-0.093018346,-1.7781678939543433,-0.08254963582513981
85095,SIDM00875,Palbociclib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4133605,0.024302328,0.35802857109381875,-0.0013258758174789081
59,SIDM00933,Linsitinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.9651336,0.07602707,0.10413281786511376,0.040688541436382404
39832,SIDM00928,Uprosertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.9152679,-0.038332786,1.5126212997377841,0.049605077733663266
59183,SIDM00097,Wee1 Inhibitor,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1996818,-0.067504644,-1.3341867636242355,-0.07577324599440621
8753,SIDM00933,Sorafenib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.10037052,-0.00921918,-0.35252323162406257,-0.024945605998675912
11171,SIDM00833,Olaparib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.4890287,0.06726309,-0.033418434635132756,-0.022129522362484413
18579,SIDM01187,Gemcitabine,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.22097075,-0.019853419,-1.2897613679061264,-0.09361564965581615
15555,SIDM00146,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.7835836,-0.072877444,-0.8486399921591492,-0.03838669275226146
712,SIDM00148,BI-2536,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.06096193,0.0024614786,0.2982382723370535,-0.014328596954421626
19505,SIDM00097,AZD7762,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3032255,-0.11002038,-1.0794037237255707,-0.007569444448054554
101454,SIDM00933,Pictilisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.04981627,0.007147592,-0.5727489234734386,-0.03489091555862773
65787,SIDM00928,AZD8055,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.1906443,-0.13365605,-9.37275472853351e-05,0.006746449794554386
27496,SIDM00832,Dabrafenib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-2.6720572,-0.11065386,-0.12520799595449028,0.019173859376483502
99109,SIDM00928,Alpelisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.3283463,-0.14249238,-1.4281714961292435,-0.12213614441246572
89572,SIDM00776,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.3132311,-0.07981433,0.45885084412270477,0.06363298814141463
62372,SIDM00826,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.8001302,-0.08560098,-2.5331836896893396,-0.03835473500394952
13602,SIDM00928,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.6760876,-0.13870737,-0.9483979966248107,-0.05607716695566384
25087,SIDM00673,Docetaxel,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4521699,-0.14783928,-2.8147385562746106,-0.2516793262908862
42526,SIDM00148,BI-2536,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3598874,0.0336265,-0.45921357561966125,-0.04294957316684795
15074,SIDM00097,Lapatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.601228,-0.1514615,-0.3103634326838957,-0.03416063297039125
24587,SIDM00875,Camptothecin,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48277307,0.051066127,-1.3453148071054197,-0.07673294647135041
9373,SIDM00359,Crizotinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0526242,0.062732115,-2.2665393408433854,-0.07458605735831295
103058,SIDM00216,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,1.2773957,0.050997,0.048843661314023054,0.026037116289281674
62661,SIDM00877,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.27120176,0.031824797,1.4219458914132599,0.050577435083705366
51670,SIDM00633,Sorafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8261239,-0.069500275,-1.8087027574081533,-0.06471173598669135
20990,SIDM01042,Tozasertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4173467,0.22915128,0.29686138362357,-0.018041381472545567
29831,SIDM00216,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1199429,-0.03843274,-1.8521182123715096,-0.06248761878567857
103756,SIDM01197,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.8822734,-0.059847593,-0.557985801197754,-0.05019016257939667
15113,SIDM00455,Dactolisib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6201361,0.04412346,0.3230499046690547,0.030421609429784127
385,SIDM00877,OSI-027,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.211192,0.09665149,-0.22450577282627943,0.04872472746490469
40713,SIDM01187,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2289633,0.057960097,1.3266225939820762,0.09500783999390658
41077,SIDM00957,Palbociclib,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.0041493,-0.022316504,0.07620140387727994,0.04198857176215404
7086,SIDM00146,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.7362439,0.058897134,-1.1711373179541167,-0.04965135814591442
43614,SIDM00826,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.61695045,-0.015405949,-0.5762718547669816,0.01714442339974311
81800,SIDM00673,Uprosertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.772219,-0.18722533,-2.514857597540303,-0.10343570690474295
106669,SIDM00872,Vorinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7366657,-0.095486514,0.10462588617988763,0.005984339144403498
21371,SIDM00837,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-0.21834204,-0.01707453,-0.5646555456855259,-0.048319879191054585
86332,SIDM00455,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.0320597,0.1114425,2.1575373128824804,0.11837464516670923
14985,SIDM00928,Afatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.9725283,0.22970852,1.2040179905697237,0.08773351880509049
55853,SIDM00875,Afatinib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4922982,-0.13194807,-1.1828154386572975,-0.08460452146115155
40822,SIDM00826,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.98698866,0.07962728,2.195160169558097,0.07143033324226733
58306,SIDM00826,MK-1775,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.86273766,0.02514544,-4.627092347486934,-0.12850579127863979
86747,SIDM00776,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.12469,-0.053280845,0.16503618419784505,0.0033009750494299222
12322,SIDM00957,LGK974,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,-1.5940074,-0.023057666,0.14422268878824088,0.030117788656197495
29302,SIDM00957,Trametinib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.3876088,-0.055157546,1.146499920742538,0.11331669302342488
27060,SIDM00216,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.2004462,0.11041238,-0.8167781345999741,-0.019744350116548008
24074,SIDM00359,MK-1775,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5582158,-0.042013053,-2.1536824645239063,-0.08356488879901647
63563,SIDM00877,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.5947096,0.1611255,-0.34714909872958355,0.005796739889155986
3464,SIDM00875,SCH772984,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9728316,-0.14522767,2.219410999277895,0.10972806046445097
12540,SIDM00928,KU-55933,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.8584552,-0.11277249,0.5688626186039165,0.022427145728097782
61814,SIDM00835,Oxaliplatin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.9586213,-0.14000866,-1.7199095677925103,-0.11730833900478448
16169,SIDM00833,Afatinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-1.0725783,-0.059419367,-0.9576069928392784,-0.06925334309336326
92423,SIDM00928,NU7441,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.5580979,-0.06078024,0.833367354901418,0.010137779286468236
4565,SIDM00875,Tozasertib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19732888,-0.008586495,-1.0480457581536433,0.01532589251553793
50614,SIDM00875,Lapatinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.26928085,0.02828161,1.4193698564146653,0.06730115053931036
58615,SIDM00826,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-2.619282,-0.21317337,-3.9546761562682464,-0.16818531076773763
2530,SIDM00146,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3975328,0.052941035,0.613517032890746,0.01062658029445243
67276,SIDM00146,5-Fluorouracil,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.68423057,0.053388845,-0.5907676942775411,-0.00826927634353889
80776,SIDM00633,BI-2536,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5439343,0.15690553,0.4787255159205218,0.06648725128910735
91071,SIDM00826,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-3.312717,-0.12948763,-4.1195457613092,-0.1222132393992156
12099,SIDM00042,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.2967216,-0.10523846,-0.9071727030916903,-0.02853274694045305
38721,SIDM00673,Alisertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8774997,-0.0857522,-0.8782947656977472,-0.028650700447539108
32625,SIDM01197,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-9.130244,-0.23293474,-4.0970937829557945,-0.11873619397613261
90076,SIDM00833,MK-1775,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.3539441,-0.0704602,-1.5674269047534637,-0.06213408019094068
6047,SIDM01187,Docetaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5450267,-0.12185354,-1.483903926026715,-0.05708630097160396
72490,SIDM00146,Paclitaxel,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.2483648,-0.10272203,-2.5885381294981813,-0.20518025811171559
38417,SIDM00282,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.0447848,-0.070607536,0.7154119964695298,0.08599386508380825
557,SIDM00148,Camptothecin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0065491,0.27649635,-0.3575786735510535,-0.014977208738742035
40375,SIDM00673,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6069009,0.15533076,-0.5712047841169932,-0.06097798891557319
92921,SIDM01042,ZM447439,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8305135,0.108740866,-0.7852957214853127,-0.03039043921530753
887,SIDM00875,Vorinostat,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7680916,0.072015524,-0.5812289326524593,-0.061099890814074916
100908,SIDM00872,Sorafenib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.38261548,-0.039436117,-0.182862848140463,0.00673223878752529
18199,SIDM01042,Wee1 Inhibitor,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.24740021,0.013689583,-0.325107179389283,-0.024136424842430376
79821,SIDM00633,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3953686,-0.06865783,-1.3030470083115349,-0.05755510849898376
89413,SIDM01187,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7235367,-0.10345513,-1.6685131360334315,-0.0861319206464257
59969,SIDM00146,Gemcitabine,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9446096,-0.08993696,-1.4295382961430179,-0.05399308426045833
89198,SIDM00928,Afatinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.0216117,-0.19514702,-0.6522093566980237,-0.06022025463624102
71850,SIDM00776,AZD4547,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.1445365,-0.032222934,1.330553901055102,0.07639249918498658
78417,SIDM01187,Luminespib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.51808167,-0.05306364,-0.5746923695854393,-0.03386856891627814
101106,SIDM00633,KU-55933,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9324333,-0.030276638,0.6105147293431522,0.012883220158376707
74370,SIDM00455,Olaparib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.453179,0.11982084,2.552771437264711,0.06838554420828942
49364,SIDM00148,Crizotinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.926587,0.08710921,1.6124551390790098,0.0338494714133128
78149,SIDM00633,NU7441,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6688032,0.12901582,0.5454799005683316,0.028018072962967898
18699,SIDM00832,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.2996051,-0.18332167,-0.41985671461181534,-0.003595160214456374
8455,SIDM00826,Crizotinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.32921848,-0.029418992,-1.115017895967102,-0.05650419308067576
58383,SIDM00633,AZD7762,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5244071,-0.10724743,-2.4650373625292525,-0.09813167559535992
95371,SIDM00877,RO-3306,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6080242,-0.047763836,-0.27832169259477957,0.00613278359849426
77843,SIDM00872,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.16272533,-0.0033390385,0.498689841726885,0.010812331666132467
40021,SIDM00875,MK-2206,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8965449,0.18011688,1.4068589464262147,0.1362438130881842
54686,SIDM00957,Dabrafenib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-1.2865846,-0.013130143,2.8988435941358355,0.057881252210247175
89723,SIDM00042,Navitoclax,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.735246,0.065822065,1.3870468864862482,0.048086040441655556
72628,SIDM00933,Vorinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.57517266,-0.08084559,-0.8031883860906217,-0.03153068146254148
54910,SIDM00673,Venetoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.4739172,-0.034229144,-0.09461439041603087,0.06199913872884759
87967,SIDM00833,Navitoclax,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,3.8671324,0.14731117,0.5010962509580977,0.016675196482046153
22900,SIDM01042,Cisplatin,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.472171,-0.016807089,2.457327474807645,0.05991857044852661
13707,SIDM01042,OSI-027,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6583311,-0.06582923,-0.6056023292197582,-0.0312206613596047
1485,SIDM00872,Linsitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0942345,0.047943406,2.05891987216732,0.05783489681348962
47780,SIDM01042,Paclitaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6051928,-0.0597094,-1.9884677080858746,-0.09711987922423465
89352,SIDM01042,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8290753,-0.22912745,-2.132188364090849,-0.15304363624594042
89161,SIDM00872,RO-3306,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9093893,-0.04721739,-0.46133970226643944,-0.026415006594868357
73821,SIDM00928,Dabrafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.7336328,0.10295095,0.577018269336387,0.031232599416854648
35613,SIDM00633,Dabrafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.94443315,0.022573516,0.8479028175589106,0.049071653445720495
32114,SIDM00835,MK-2206,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.9114804,-0.08540127,2.0519103776896337,0.04725048134552835
86880,SIDM00872,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.84921384,0.037526887,1.7808915235473703,0.10016092347838104
12920,SIDM00837,Dabrafenib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.29857823,-0.005575237,2.7190990640844537,0.04216025227747494
88238,SIDM00875,Taselisib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4284055,0.14100789,0.5898805356785816,0.06892937205282373
44958,SIDM00933,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.6533941,0.11612741,1.7430965311934752,0.06231091768767236
85032,SIDM00933,Axitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.7977425,-0.22277798,-1.8196145001334594,-0.11157325023861951
92610,SIDM00216,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3658005,0.047060426,0.01878168102516812,0.014456798955871025
86764,SIDM00928,Palbociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.8315496,-0.09392184,-0.3127273028817711,-0.04422338819983245
31339,SIDM00455,Paclitaxel,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.47491404,0.034036316,-2.3927970672663474,-0.21777608054407757
74460,SIDM00875,Alpelisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.11097448,-0.0029081434,0.024812395214552054,0.014327741287311164
37376,SIDM00673,OSI-027,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6617986,-0.0645145,-0.017843389048152577,-0.035746590180900005
95245,SIDM01042,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.15406564,0.006874093,2.0316501391633914,0.07213944081750877
57327,SIDM00455,Oxaliplatin,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3307083,-0.09918348,-1.5586259376166427,-0.05965960303500181
81369,SIDM01042,Gemcitabine,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.886706,-0.103128314,-1.0761396784020254,-0.09609634598763102
106688,SIDM00835,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.6004874,0.031059833,1.0862073202836442,0.07586587780462363
9189,SIDM00148,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4467988,0.20889483,-1.213147408454328,-0.09118559226286542
90971,SIDM00835,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,73.0,-0.5491578,-0.04857029,-0.22315866678827231,-0.022012530963918007
10368,SIDM00833,5-Fluorouracil,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.67716527,0.05405607,-0.7815038366543885,-0.10202427680275045
72247,SIDM00097,Paclitaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5059261,-0.15795116,-0.9160738451116691,-0.07642278972762594
104497,SIDM00957,Taselisib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,3.9467406,0.14246944,-0.6421145865596942,-0.0066089470470447375
97890,SIDM01197,5-Fluorouracil,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.727491,-0.054278564,-0.8493790368146007,-0.06765799035892389
52001,SIDM01187,Axitinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1467463,0.10647749,-0.5211983711530512,0.015363922936210075
94945,SIDM00928,Navitoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.9743117,0.2103194,1.3841220894218138,0.056155203681418235
108353,SIDM01197,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.7174623,0.16761573,0.11671941566939449,0.028221561063289557
58324,SIDM00633,Venetoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.9029305,0.110120624,2.081260385917653,0.07931211722405777
13416,SIDM00877,ZM447439,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-0.78901416,-0.059940435,0.7557283418448761,0.1160042231411639
79843,SIDM00826,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-3.46689,-0.026242645,-2.8931510644643477,-0.09468319833536308
64418,SIDM00146,Vorinostat,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.3201145,0.02587499,-0.2501973548838673,-0.1312065018789291
53024,SIDM00673,Venetoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.72157085,-0.019500552,-0.32275123010447426,0.042009346818121296
100466,SIDM00146,Ribociclib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9367747,-0.059154008,-1.9188184147328853,-0.003380471922029739
95850,SIDM00776,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.0576322,0.050288238,-0.6455565603076906,0.02800231354925112
90302,SIDM01197,AZD7762,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.49238083,-0.037000533,-1.2293592184245412,-0.08550791379378683
59248,SIDM00282,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2030576,0.075417526,-0.5703903605839615,-0.0032650458143794864
50643,SIDM00950,Dactolisib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.47298622,-0.037033033,-0.39897210314632986,-0.045642814289145586
45970,SIDM00673,AZD8055,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.51283526,0.035812255,-0.38954009299379516,-0.02059596030413831
8674,SIDM00776,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8220438,-0.058023088,-1.1028497294357449,-0.012881416923919772
43021,SIDM00837,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.7088895,0.052795853,0.6486672176545089,0.036049800087016574
91163,SIDM00148,Alisertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.1597607,0.28247702,0.033144938690824265,0.0027679540564704464
23008,SIDM00933,Dabrafenib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.2703207,-0.10510116,-1.3116615843623982,-0.005022110595918752
77203,SIDM00957,Trametinib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-0.72258455,-0.032938763,-2.038203814303779,-0.08849805909533467
51380,SIDM00835,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.4049138,-0.035317123,0.001606730974453847,0.04433317587416901
32347,SIDM01042,Vorinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.19120666,-0.023373319,-0.8729554041283849,-0.020801166717748187
4332,SIDM01187,AZD7762,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.825418,0.058173347,0.7868812533501649,0.06425448826750034
89196,SIDM00933,JQ1,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.7715605,0.063581765,-1.048254914553289,-0.054264122298975474
41734,SIDM00633,JQ1,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1581211,0.06871928,1.4743537820966979,0.08121865751647657
40094,SIDM00833,LGK974,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-1.3739606,-0.044867154,-0.5441658781926799,0.02115317913405589
60219,SIDM00216,Afatinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1742622,-0.094749205,-0.6890009636327189,-0.05733538933456327
74624,SIDM00097,Sorafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.24780537,-0.011559652,-0.01186384868783879,0.02965068116415144
90822,SIDM00928,Entinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.29788956,-0.024363752,-0.8231423546974382,-0.02641088207246038
22374,SIDM00877,Dabrafenib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.7157648,0.114795685,2.078058388201167,0.033988344652634256
107932,SIDM00826,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.7731217,0.033484858,-2.4813298416895933,-0.06945496513317663
24127,SIDM00957,Oxaliplatin,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.8493483,-0.025775917,0.607942221325217,0.05759813196941614
61563,SIDM00633,Uprosertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.22989443,-0.016995484,-1.3397571730450795,-0.05011992244761421
108302,SIDM01042,Afatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.29605,0.07884894,0.34677642485487714,0.03483864696008938
33702,SIDM00148,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.0644,0.22853984,-0.5546889081834993,-0.007167050411246725
84021,SIDM00148,OSI-027,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.87786853,0.06773083,-1.091678949971199,-0.08725639103431738
5004,SIDM00282,AZD8055,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.429198,0.10572764,-0.2331356106081583,-0.04679314261023736
6802,SIDM01187,Docetaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.049381,-0.08539981,-2.3746711086140944,-0.09046072715542294
48103,SIDM00928,Linsitinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.7028962,-0.12733904,-0.030430293873247995,-0.05421549202358358
4837,SIDM00928,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.911998,-0.07326163,-0.5922648062220452,-0.0029705241125183033
22984,SIDM00146,Nilotinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.5823911,0.14646137,1.117581572441261,0.1140472308638516
43763,SIDM00872,Doramapimod,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.58622515,-0.020735519,0.453759502355056,0.03365674034123496
71987,SIDM00933,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6627035,0.057409205,-0.841960421205934,-0.03544244052969243
74924,SIDM00455,MK-2206,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.4289916,0.19358277,0.5230011780784878,0.036170607982722376
58862,SIDM00832,Olaparib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-1.497788,-0.042122096,-0.37803931497373344,0.027549173669062503
93643,SIDM00875,BI-2536,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6472153,0.02225677,0.2814121771894163,-0.037789458629436425
51270,SIDM00928,GSK269962A,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.62073034,-0.048928425,-0.15898801962544168,-0.01786648435391115
86914,SIDM00146,Sorafenib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7694069,-0.0666706,0.2884464389386517,0.0005369747742698846
90211,SIDM00877,Alisertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.9506534,-0.118214555,-0.9732117044757987,-0.03327411734517578
92938,SIDM00877,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.3092164,-0.051515575,-0.6640659404102495,-0.005384572343701914
35987,SIDM00957,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.9782188,-0.025391122,0.2790486189424034,0.024922311785613195
75950,SIDM00835,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,2.523905,0.10719247,2.3046509610991124,0.07331456712801895
18507,SIDM00872,Wee1 Inhibitor,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7701164,-0.075799786,-0.44723262131788694,-0.06917192383785911
93099,SIDM00146,BI-2536,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.0946014,0.038272236,-0.21771669743564792,-0.027080059834523856
78694,SIDM01042,Lapatinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.30918998,-0.038825877,0.15984646650891332,-0.02081913285118365
99667,SIDM01042,Afatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.35561,-0.15493456,-0.7652684066712067,-0.029303521877109318
103575,SIDM00875,Camptothecin,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23344718,0.02488145,-1.2806659650777523,-0.07936512086630701
65841,SIDM00148,ZM447439,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9578743,0.17051795,3.0703920874896737,0.2688953368340962
38142,SIDM01042,Bortezomib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.08376392,-0.0047083357,-0.6532423277798933,-0.03309165880665818
60719,SIDM00673,Gemcitabine,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-1.4549409,-0.083886385,-0.21592158665798142,0.043493657698968104
81903,SIDM00837,Navitoclax,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-0.48006746,-0.018412312,-0.12321520090287218,-0.09534171450592842
107391,SIDM00097,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9523766,-0.15614101,0.5849626421068937,0.021979174242411293
103862,SIDM00877,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-4.0135975,-0.025683783,-3.714053705541551,-0.1333151975912835
82833,SIDM00673,Palbociclib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6772928,-0.0299416,-0.49073617431881295,-0.043386810498717
63636,SIDM00837,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.9068012,-0.06218922,-0.16667432087264716,-0.06303412731035295
40149,SIDM00148,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4501706,-0.08122255,-1.0264787672554285,-0.018438760815528837
93807,SIDM00950,Olaparib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2325752,0.041912213,0.6767352530216402,0.062294885825554897
41231,SIDM00837,Palbociclib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,1.0413041,0.0775928,-1.2375050705092547,-0.015697448381101747
49550,SIDM00146,AZD6482,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.9205099,-0.10013202,-0.10931563213915534,0.02315741592558815
24312,SIDM00673,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.0705853,0.25167233,2.1059693521779583,0.2018332735956683
60321,SIDM00833,Trametinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.959074,0.032175764,0.6206020950243246,0.0067329575640889365
67238,SIDM00673,Afatinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8998685,0.15400317,0.13520748368760385,0.03775857121604525
89993,SIDM00282,AZD4547,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.3254218,0.089892074,3.049059293780799,0.07129457199284062
44862,SIDM00097,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1209847,0.0708217,0.6424268239489905,0.035453875777472055
29274,SIDM00146,Palbociclib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6561311,-0.044269376,0.729028901573273,0.13322579331224496
108258,SIDM00673,PF-4708671,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5770149,-0.09000255,-1.5089618335374382,-0.05765147658713995
67562,SIDM00673,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8877568,-0.08783646,-0.28184556808774863,-0.016069568727529578
101451,SIDM00455,Palbociclib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6845477,-0.07025728,-1.355661441752878,0.021249785763277493
1630,SIDM00877,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.0889992,-0.04926453,0.666940398395116,-0.003316335704790816
73016,SIDM00875,Olaparib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45954755,0.03624294,-1.7009689839993305,-0.012640345362504008
105598,SIDM00928,Pictilisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,3.5458586,0.23743317,-0.5592085991390686,-0.0015704154701949194
108390,SIDM00455,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8901663,0.04275762,2.5286674370912037,0.0830521072479573
77168,SIDM01042,Uprosertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.47669625,0.0136196,0.3711765016546735,-0.03785928033322977
68245,SIDM00633,Tozasertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.83655244,0.019958135,2.1740228191953315,0.02583675490047237
74657,SIDM00455,OSI-027,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.32308,-0.07198068,0.14332399628159867,0.032826661353280565
15163,SIDM00875,Ribociclib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6581908,-0.04818411,-0.18062003612757183,0.0023186136450214605
9700,SIDM00957,Linsitinib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.052831,0.026267465,2.057875077593761,0.08489270522322657
101251,SIDM00928,Gemcitabine,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,0.98218715,0.10277322,-0.15345197037412586,-0.06205056995777958
83450,SIDM00216,AZD8055,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.0653598,0.123293154,-0.313413529491546,0.0016087129759262144
10920,SIDM00950,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9348993,0.15384302,1.1721183424665331,0.0815312504990049
3075,SIDM01042,ZM447439,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9733486,0.25709417,-2.0309152208210532,-0.08738595797276527
47228,SIDM00359,SB505124,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8452375,-0.074546084,-1.9761287282649553,-0.10918655427009949
61426,SIDM00837,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.71756464,-0.06315072,-0.4618543241466239,-0.09503106439704784
39223,SIDM01187,5-Fluorouracil,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.753377,-0.22701342,-2.4144339476419305,-0.1923211630133591
81433,SIDM00928,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.5480063,0.24664629,2.0225391020550467,0.08642010435745323
98948,SIDM00877,Afatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-0.11435465,-0.01244955,0.5868737421841617,0.05354409309037902
64003,SIDM00950,Dasatinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.280468,0.49932182,1.2657530305231934,0.10502763889342155
1629,SIDM00933,Lapatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.24943338,0.023949057,-0.16698109612050793,0.028948413344840183
40860,SIDM00042,Ruxolitinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.9965719,0.01722078,1.4530668603927064,0.028691684780359862
50900,SIDM00146,5-Fluorouracil,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.64060396,0.05078251,-1.1046185947696054,-0.04977012945763656
14444,SIDM00933,Olaparib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.7178492,0.08459101,0.10069998813719766,0.035749725416775686
105512,SIDM01187,Palbociclib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6138316,-0.07314862,-1.122069367719994,-0.029632690023276273
49105,SIDM00875,Vorinostat,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.479942,0.05520833,0.08501320426531489,0.013857694496254265
8914,SIDM00928,Paclitaxel,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.73404264,-0.07061645,-0.7922794749479137,-0.03349261052539986
15110,SIDM00148,Cisplatin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.90178245,-0.042100027,-0.9048242294690789,-0.04604218380573278
10645,SIDM00673,GSK269962A,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.792915,-0.1477198,0.14878223381303216,0.0370047388786709
92156,SIDM00673,Gemcitabine,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.67853653,-0.04664628,-1.553040307748908,0.006598613833775495
103772,SIDM00877,Paclitaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.7330723,-0.1562288,-0.5202196846842223,0.017908199026447337
78083,SIDM00633,Gemcitabine,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2679852,-0.10449164,-1.3090170827666514,-0.06358770617562265
1555,SIDM00776,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,1.3050392,0.113651894,0.5071727207750747,-0.014583525738448492
35451,SIDM01197,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.1986313,-0.10553835,-0.5627766463722064,-0.06037639197101746
24570,SIDM00146,NU7441,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.79573965,-0.071799435,-0.48579804495734896,-0.017870805721271945
20840,SIDM00877,Bortezomib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.53557295,-0.044354964,0.48612842931451783,0.028898819601202146
99811,SIDM00933,Palbociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-0.73941004,-0.050105147,-0.38875606011138464,-0.0031545101913229884
13004,SIDM00832,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.0868357,0.0219056,2.0013788104189403,0.03966341831076454
2388,SIDM00633,MK-1775,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2247919,0.0941704,-0.2713493147849435,-0.019010032577996636
29392,SIDM00826,Trametinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.9264597,-0.006720856,-4.429127671162482,-0.06759897849234375
36578,SIDM00776,Vinorelbine,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.5036403,0.040516306,-0.21178624128366494,0.05566271964934748
33357,SIDM00042,Trametinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.0790486,-0.23947446,-3.1491022155767787,-0.07968948538762982
48691,SIDM00872,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3881408,-0.12584643,-0.5914785652929998,-0.05245157680570652
72852,SIDM00950,MK-2206,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.2428386,0.32116193,1.7878085305612736,0.06289712507981267
37082,SIDM00148,Venetoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5680614,0.13366294,0.6632236860322307,0.04116808775954589
68806,SIDM00776,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.3222212,-0.09982224,-0.8783758785413367,-0.13223646971018624
17391,SIDM01197,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.663646,0.099080354,1.4210730910248954,0.0430825197409163
88841,SIDM00835,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.273983,0.06754519,1.7188864937780464,0.11497891704192252
63805,SIDM00633,Olaparib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2527194,-0.013822702,0.8586957345046012,0.009151513144867509
2684,SIDM00837,Oxaliplatin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-1.6400753,-0.09901757,-1.60193148542873,-0.04748448808893482
108232,SIDM00837,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.97164834,-0.061007783,-1.2975712852999206,-0.07614120700684739
27102,SIDM00950,Dasatinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.207599,0.11692828,1.499371967723217,0.10845758694955109
63543,SIDM00875,Gemcitabine,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8428897,-0.004531931,-3.65241545628364,-0.12749584170453968
41315,SIDM00673,GSK269962A,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.11236699,-0.008873571,-0.7887011477987331,-0.05328418382167863
64408,SIDM01197,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.17290044,-0.004486652,0.5389585811409389,0.043667358781340995
11697,SIDM00146,Taselisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.9456912,0.074199855,-0.4331361673895087,0.060885493220674436
89071,SIDM00673,AZD7762,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2343104,-0.041585773,0.5302911382546989,0.12273975097890698
53494,SIDM00148,SCH772984,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1125706,0.04906721,3.0292849262378105,0.1629829465273861
2257,SIDM00097,MK-2206,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.21397,-0.23585825,-1.3816187083395792,-0.10757432768756252
32619,SIDM00673,Sorafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0001383,-0.050071254,0.05755660493876434,0.021739019745151772
36868,SIDM00359,MK-2206,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2589278,0.16853921,0.4858865716141973,0.04413436926636151
47558,SIDM00957,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.8898277,-0.08567245,-0.3621122842152172,0.026141368277238057
20215,SIDM00148,PF-4708671,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6624108,0.04862255,-1.7377581550443029,-0.05767219698136723
88469,SIDM00875,NU7441,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7460257,-0.09545668,-1.4909765130482981,-0.06461151040445375
87371,SIDM00359,Trametinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3330262,0.06468086,-0.7919643770449689,-0.026635787175553247
98623,SIDM00928,MK-1775,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.6571134,-0.06948786,-0.26801033600430196,-0.02948821716565551
101833,SIDM00097,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9221237,0.03971339,-0.7977940073873319,-0.020986837862585584
77545,SIDM01042,Axitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9825819,-0.12504415,-0.9203323764841342,-0.10894521843278532
37362,SIDM00455,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.159011,-0.21930553,-2.5863195798411907,-0.1935034231520412
98431,SIDM00877,Wee1 Inhibitor,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.8458822,-0.06302131,-2.2467638445271993,-0.09433950907228095
14193,SIDM00146,Axitinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.6823032,0.1406105,-0.5980482441087467,0.05081265169591155
40689,SIDM00875,Tozasertib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6413988,0.1099717,-0.010931437091484445,0.01184310272497184
39362,SIDM00633,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3749105,-0.018802445,-3.110439934318457,-0.10930028343585459
23525,SIDM00833,Olaparib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,2.0102038,0.090052135,-0.7104675292814113,-0.015141579645805803
49495,SIDM01042,Dabrafenib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1411003,-0.090067364,-0.2733832242199232,0.006034433845893681
4647,SIDM00633,PF-4708671,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1659486,-0.12942672,-2.209783976666479,-0.08667336444542237
58017,SIDM01042,Nutlin-3a (-),AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.91468143,-0.02670263,0.6355313571378531,0.02444591169413854
55517,SIDM00875,Temozolomide,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.547115,0.054668754,1.9705409532612344,-0.0008407100503924912
103663,SIDM00875,Nutlin-3a (-),AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8948456,0.020069048,1.455051123579824,0.006881065471652091
68788,SIDM00216,BMS-754807,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0409439,-0.03660114,-1.3448509518255007,-0.09465187258898299
26730,SIDM01042,PF-4708671,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.916802,0.14376216,0.09000732067011928,-0.011948036845791734
85107,SIDM00826,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-1.0618776,-0.0728243,-1.3865348184656359,-0.08788878567317515
61044,SIDM00455,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6085308,-0.037233803,0.12862866086849017,0.1221592367041341
45804,SIDM00957,Taselisib,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.130217,-0.058789805,0.5421079747581001,-0.02372559813297471
56202,SIDM00837,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.2852701,0.06353224,-0.5354454297580485,-0.004264265604113309
60116,SIDM00776,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5342578,-0.053302854,-0.13080232016941956,-0.0017018372455844262
84300,SIDM00148,Paclitaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.4882586,-0.21676251,-4.712556799568451,-0.26468217211538486
51667,SIDM00216,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.2916574,-0.20201465,-1.6665608204950473,-0.14679974524008615
76772,SIDM01042,KU-55933,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.65304,0.071945034,-1.4496393839956498,-0.09193734540268333
51057,SIDM00146,5-Fluorouracil,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.1612343,0.09392758,-0.6161694531519557,-0.0020633052753287816
10193,SIDM00933,AZD8055,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.609836,0.042498928,1.5521745496380341,0.15650060590284226
25552,SIDM00673,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.177004,0.0836871,3.263712388065897,0.13588971669927744
81730,SIDM00877,Taselisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.7842757,0.10370036,-0.7382366742472023,-0.05420876890305505
62324,SIDM00957,Crizotinib,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-3.006838,-0.0819231,-0.28417689334623847,-0.001448330490126565
13797,SIDM00673,Camptothecin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.384269,-0.040622707,0.5680249811898868,0.041879108162818424
58226,SIDM00097,Alpelisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4860874,-0.098902725,0.8821810725317617,0.01591024310753022
27888,SIDM00146,ZM447439,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.78946614,-0.04387023,-0.2563501342967956,-0.009636732121372458
90008,SIDM00933,Navitoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.0172374,0.14834115,1.3762939759310429,0.041275349900003304
105723,SIDM00633,Paclitaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3268075,0.20993301,-0.5801622187862971,-0.0032042673786114558
99525,SIDM00633,Alisertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2996871,-0.15805855,-2.0070038205596785,-0.07319249136722808
57574,SIDM00146,Uprosertib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.4803193,0.14032324,2.5507732941370223,0.24547944058692103
78332,SIDM00957,SB505124,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-3.7748916,-0.06513976,1.3222129349510259,0.08256979397076983
62165,SIDM00933,Bortezomib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.4199734,0.010387192,-1.3050333424594143,-0.04679167171904569
39394,SIDM00146,Axitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3217359,-0.04557333,-0.6052523250416126,0.04471340385128398
91636,SIDM00875,Nutlin-3a (-),Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38322535,-0.012169726,0.647604535470741,0.0023224237989905978
38150,SIDM00673,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.84965664,0.025103271,1.213893921552172,0.05717746064608686
42816,SIDM01042,ZM447439,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4148147,0.1794347,-0.2002942271720058,0.008441362795493556
40161,SIDM00875,ZM447439,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0008569,0.086374715,2.049651610306802,0.09971186807625973
75410,SIDM00216,Navitoclax,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.6503863,0.15093786,-0.5601266481359667,-0.03947431508777292
21509,SIDM00928,Pictilisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.0240438,0.19707239,1.370081287583248,0.11344970782687737
32427,SIDM00633,KU-55933,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0675898,0.16504152,0.6329381407243628,0.01892283948222205
63673,SIDM00957,Crizotinib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.5200198,-0.06949944,-0.691979654065079,0.002076396965620961
68857,SIDM00148,Gemcitabine,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7076763,-0.10016535,-1.445371980032699,-0.08642469854077434
86380,SIDM00097,Alpelisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4681134,-0.034445055,-0.5488430913621704,-0.038535672944371886
33847,SIDM01197,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.8577757,-0.051793035,-0.7726734810980551,-0.03941716682789429
15877,SIDM00877,Ribociclib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.7076819,0.01502399,0.08292316408085411,0.00965762113816099
30020,SIDM00933,SCH772984,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.66310817,0.058071956,1.6217342186949526,0.08224126429422393
30479,SIDM00146,ZM447439,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.823002,0.2918439,3.558569159534587,0.2322133247802274
25607,SIDM01187,MK-1775,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.1670858,-0.016072754,-0.19498857672982156,-0.04017905632678166
62701,SIDM00146,5-Fluorouracil,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1956098,0.0885094,-0.7467777861581169,-0.01361170469789826
108105,SIDM00928,Linsitinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.86558557,0.07475593,-0.013638447061800486,-0.009882335231026513
84630,SIDM00928,RO-3306,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.472912,-0.13224845,-1.7979173155121901,-0.09823209157804036
91999,SIDM00872,BI-2536,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9987003,-0.1774206,0.15553436011007166,0.006400566099391836
72303,SIDM00875,Wee1 Inhibitor,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23419628,0.01593089,-1.8316590757590658,-0.04134790387377133
23966,SIDM00835,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.46414086,0.012926727,0.010461374341246776,-0.01312409830045542
56351,SIDM00875,Venetoclax,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.44266325,-0.010081105,1.6358131252278942,0.007367862484141372
36481,SIDM00359,5-Fluorouracil,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.268339,-0.08771572,-1.3901298054816558,0.03287253121916381
42185,SIDM00877,Lapatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.9660105,-0.052600417,-0.11000614565978716,0.11583260825685612
27117,SIDM00359,Afatinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.22394516,0.015738156,-0.10684959545368375,0.034911992495894564
58729,SIDM00875,Trametinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.71376777,-0.01026218,-1.0707259562506821,-0.06483531952736653
41200,SIDM00877,AZD6482,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.7054993,-0.027762126,0.39192033078500427,0.0254329696247304
46945,SIDM00933,Linsitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.7240497,-0.044079006,1.0725099713225008,0.07493017363828751
45192,SIDM00957,Taselisib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-3.1538243,-0.07686081,-1.1100064195812722,-0.00926069274406307
77800,SIDM01187,Pictilisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.40728453,-0.025766524,0.09794894104726228,0.029917469639197693
63247,SIDM00928,BI-2536,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.552118,-0.16687302,-1.8105743134980108,-0.10259296433486398
820,SIDM00776,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2450032,-0.059564296,-2.059335508546898,-0.06815904097032359
32511,SIDM00097,Taselisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3844955,-0.079514764,-0.2685630233935292,-0.021651256995798927
24435,SIDM00875,BI-2536,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.522058,-0.15060845,-1.73713704535271,-0.10596783335540802
94249,SIDM01187,Gemcitabine,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9030214,-0.06801846,-2.117567227333893,-0.11546392221373869
13262,SIDM00837,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.7845883,0.10736716,0.10172240595476824,0.020161829089037932
36727,SIDM00826,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.4829872,0.043578103,2.8902994282105716,0.11827606569191196
58648,SIDM00872,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.4115412,-0.2765539,-1.1250416055477706,-0.16270859602109522
101378,SIDM00097,Uprosertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.899735,-0.13899861,-1.4295259865134309,-0.05310352156993721
93809,SIDM00877,AZD8055,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.49415237,-0.038258724,-0.8799584935089483,-0.034094106101593934
19306,SIDM00950,AZD7762,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.312729,0.18523076,2.3603536444340842,0.08307229258625638
38015,SIDM00146,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.4532406,-0.013051906,2.4016211492250523,0.11929921141023267
66848,SIDM00933,Docetaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.8741614,-0.12563202,-1.0511445729892526,-0.013180027988550247
21378,SIDM00832,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,4.668336,0.1247217,3.804419982568647,0.10770231412066483
103311,SIDM01042,Temozolomide,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.89417315,0.024815733,-0.045150215789344625,-0.014608053716034507
38129,SIDM00633,Palbociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0226952,-0.04114851,-1.809193003549506,-0.06426201179709035
103790,SIDM00872,Alpelisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.38017857,-0.03893524,-0.2776715775125913,-0.01689538214190277
55681,SIDM00837,Olaparib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-3.0175595,-0.09687948,0.029659636925875834,0.0037384751741983764
7622,SIDM00282,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6917439,-0.11516485,-2.7107167878165903,-0.20027127659521168
44119,SIDM00832,AZD7762,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-2.6128047,-0.1963774,-2.6338697886916647,-0.16379978008611148
5653,SIDM01042,Cisplatin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.36700785,-0.014227062,-0.22288385688673878,0.013495115348013075
91805,SIDM00455,Sorafenib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.8279543,-0.10406628,-0.6960676390903296,-0.0077038853545148556
13331,SIDM00633,Palbociclib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.783869,0.095492825,-1.1180564378300488,-0.04791132023959394
43992,SIDM00776,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.1890519,0.13547556,2.3575137323347897,0.18758580393946092
89553,SIDM00776,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-0.8380213,-0.07131012,-2.3276067494986257,-0.14662929513732684
51629,SIDM00216,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6088839,-0.04060214,-0.9259966982687516,0.002865633764713982
30330,SIDM00877,RO-3306,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.7741127,0.07756198,0.25367091654809626,0.010563380944524269
7252,SIDM00216,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3415265,-0.043443196,-2.1087270733500314,-0.08163044909756269
27910,SIDM01197,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.45386308,-0.013472444,-0.7531212857524102,0.04179444965677503
21643,SIDM00282,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,1.3031911,0.031700764,0.09764314441095762,0.006308243062060251
54232,SIDM00833,MK-2206,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7286394,-0.038638275,-0.3583613529904016,-0.0002915512997604591
103627,SIDM00875,Gemcitabine,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.525607,-0.0009160231,-2.211178416405835,-0.05456721879260243
61298,SIDM00832,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.054027,-0.18076992,-0.6193171251319283,-0.023946745859490037
33005,SIDM00673,Alpelisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2702773,-0.07363783,-1.5984677587080334,-0.07873247358980147
24909,SIDM00359,AZD4547,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3270766,-0.05603198,-2.175583874184763,-0.017780310336966202
72166,SIDM00776,Oxaliplatin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.7987953,-0.049470127,-1.2318547067409173,-0.07820746431829113
16010,SIDM00455,Oxaliplatin,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.878801,-0.11487247,-1.864292935594833,-0.024935389268821707
2377,SIDM00455,Taselisib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.0334554,-0.07264104,-0.7720781591492997,-0.05183102051901655
26647,SIDM00097,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5066403,-0.09609508,-0.8106884388681976,-0.07714234591972059
35664,SIDM00216,AZD8055,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,1.403239,0.08065278,0.78064764586075,0.027480059485579064
13351,SIDM00933,Palbociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.795068,0.21907693,1.138310895291165,0.07352340664455484
59526,SIDM00872,Gemcitabine,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4209477,0.041784048,2.5676378577953223,0.09301483705736045
77139,SIDM00146,Navitoclax,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.42215577,-0.02906447,-0.6904653333434794,-0.07358956005100223
16992,SIDM01187,Lapatinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3893383,0.09597586,-0.6499596889650466,-0.053395500448712586
23245,SIDM00875,BI-2536,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.347891,-0.064142324,-1.7224121901242977,-0.10060778520116273
17421,SIDM00673,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.5206378,0.032772332,1.2091414850067976,0.048728590267183264
85974,SIDM00928,Tozasertib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.28544953,-0.0073795887,0.5406670740300279,0.0013998679575634627
17723,SIDM00633,ZM447439,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5204978,0.11251848,0.5792421486622779,0.10719403254499738
102434,SIDM00359,SB505124,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1099899,-0.08590138,-1.0111029792843091,-0.052962540083683306
14230,SIDM00097,GSK269962A,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3296509,0.07057588,-0.5146914455703181,-0.03223570774014155
19719,SIDM00928,MK-1775,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.5197452,-0.14065999,-0.41583508097896815,-0.01606852375645879
97464,SIDM00933,Sorafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.5218359,0.043421075,1.1050430963641353,0.059914451027006946
50825,SIDM00097,Alisertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9824631,-0.16275714,-2.500826817644157,-0.11209890927945132
73575,SIDM00875,Gemcitabine,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-7.282704,-0.025070868,-4.575993677694966,0.013074022576347622
83679,SIDM00216,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7314157,-0.027609766,-1.6704908496782167,-0.11262507285260141
89996,SIDM00673,ZM447439,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.78734875,-0.034286357,-0.8027882763049151,-0.04038131399455009
86458,SIDM00957,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-0.8760736,-0.022096032,-1.2832422331378768,-0.01808014359404349
56407,SIDM00097,Linsitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5686331,-0.06478372,-1.2232992395652647,-0.059529890546980234
96631,SIDM00455,Dasatinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0347188,0.12359062,0.7146612932662758,0.04643888239878577
32234,SIDM00872,Pictilisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5480443,-0.059835386,-1.0549258600673566,-0.08680995101168273
3425,SIDM00776,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.2151262,-0.01901568,0.9098174934452047,0.03373445408235334
19323,SIDM00216,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.26238656,0.020083811,-0.37626129716212536,-0.02846677289438419
81971,SIDM00673,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.5831587,-0.08787451,-0.30147880419138495,0.016830147856522565
76261,SIDM00146,Alisertib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.83954865,-0.063265145,-1.221361067084159,-0.06966841741953489
48839,SIDM00097,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9205813,-0.24909532,-1.8960467342798186,-0.08732053317249337
5749,SIDM00146,GSK269962A,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.97049797,0.07891252,1.6419066217063671,0.09634343957969349
78137,SIDM00776,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0325503,-0.049103707,-0.7211762767852679,-0.06328610647886788
84290,SIDM00097,JQ1,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.46501526,0.02715283,2.4227296254982478,0.07117463498253376
106592,SIDM00455,Crizotinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.95687,0.19641952,3.0636686032159517,0.19234744362342768
55885,SIDM00633,Venetoclax,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.2532302,0.0058272565,-0.029077875607734744,0.013676884890126827
649,SIDM00957,Navitoclax,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-3.4305964,-0.10140656,-0.08469195731212466,0.004256691987364252
92884,SIDM01042,Doramapimod,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4069594,0.041033052,-1.1728396939795085,-0.053460239542121084
103435,SIDM00928,Ribociclib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.012010345,-0.00029848266,0.2320097747412015,-0.04195066009480265
11372,SIDM00933,Uprosertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.5190368,0.16037649,0.7514166598667902,0.1316033950809033
74920,SIDM00148,AZD8055,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0711706,-0.18690534,-0.18218789269072624,-0.05432260622694764
37161,SIDM00928,Trametinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,4.4125867,0.32840002,0.878958300024997,0.043348121215283655
18412,SIDM00928,Camptothecin,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.6181003,0.15732875,0.35781916661290764,0.07755616496032
66085,SIDM00872,Venetoclax,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8526806,-0.06531634,-0.17675865805065594,0.043918422500717855
29920,SIDM00928,Nilotinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.4702003,0.13566191,1.0512350264086567,0.029480208825934058
4210,SIDM00950,LGK974,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7106972,-0.04520488,0.7958987229268978,0.02523178050864274
5725,SIDM00633,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9594353,0.05379997,0.023584400810296034,0.03281032279681377
31967,SIDM01042,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9030959,-0.025973503,0.7831327995345414,0.03228267406179609
2985,SIDM00928,5-Fluorouracil,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,-1.6425879,-0.08533022,-0.8249495178759665,0.024849501297364834
29432,SIDM00832,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.9326856,0.015140518,1.3052656818038204,0.029672127487423136
99373,SIDM00455,LGK974,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.87808573,0.03872879,-0.5055053857199627,-0.0468337644582187
10002,SIDM00633,Crizotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.94456065,-0.03450411,0.4620225140107031,0.016838633861597705
26186,SIDM00633,Alpelisib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9233758,0.08391183,-0.24875134001048896,0.0058847394507440375
59508,SIDM00837,Linsitinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.0504987,-0.13838916,-0.555939770641612,-0.03702171213661801
22248,SIDM00950,LGK974,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7813637,-0.056799825,-0.7916266266831348,-0.01242939608755127
52549,SIDM00216,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.032097276,0.000872459,-0.9530833225204471,-0.05665483269951795
62440,SIDM00633,SCH772984,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3712076,0.13697615,-1.5732366645420484,-0.08396164119102158
7769,SIDM00832,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.7339818,-0.19607443,0.08804135161110407,0.0025439176820202325
13273,SIDM00835,BMS-754807,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,1.1534771,0.0957739,1.1227621918151311,0.007663243323263718
60486,SIDM00833,5-Fluorouracil,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.73629594,-0.053359475,-0.986588395183467,-0.07847771123242521
99227,SIDM00877,Axitinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.58766794,0.058047358,-0.10432389673547322,0.07855870802861134
11036,SIDM00146,Crizotinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.9427649,-0.07046285,-0.16049764733244132,0.042484301494966355
106251,SIDM00872,JQ1,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1257988,-0.024812419,1.8209828043574567,0.08602567725469534
23825,SIDM00455,MK-2206,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0057685,0.08357927,2.191725576173635,0.12945147347271674
103166,SIDM00833,LGK974,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,-1.2880877,-0.03862309,-0.8735995332903874,-0.030520643422611585
100669,SIDM00148,Taselisib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0252368,-0.07028949,-2.714810977778182,-0.10698600450857584
7100,SIDM00957,AZD8055,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.99735814,0.02291653,-0.18307027116651728,0.02385348694965234
54383,SIDM01187,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6665839,0.038872708,0.7444546655854929,0.02890780414337965
104731,SIDM00146,Docetaxel,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.15656263,-0.013623875,-0.46361714831444667,-0.0920998669827453
38360,SIDM00832,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,5.1909885,0.26823902,2.1373821497006937,0.07701672697517278
99230,SIDM00146,Navitoclax,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.2664731,0.019308705,0.8611650312007352,-0.004284503451835994
68785,SIDM00950,Irinotecan,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8599867,-0.09388183,-0.4468724252769875,0.010617558869189397
103074,SIDM00875,Alisertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6312454,0.1629323,1.5839227701353575,0.07893412807067797
65619,SIDM00216,SB505124,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2128319,-0.09464339,-1.156709174277724,-0.12036663770612556
42958,SIDM00148,Uprosertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0097924,0.060910966,1.137149708672328,0.045310142383055155
73759,SIDM00359,AZD7762,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0885565,-0.10950385,-1.5050247473005922,-0.08174500638077437
78888,SIDM00872,OSI-027,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0547683,0.21642418,0.09026745246688753,0.016866112365665327
92988,SIDM00933,Doramapimod,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,6.781176,0.19125086,2.567368153265577,0.05712484767593243
97452,SIDM00097,Sorafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9315451,-0.03892687,-0.37877345569024307,0.0027325268798653077
105825,SIDM00216,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.6240256,0.11054251,0.3633931059176087,-0.003170030793388845
3015,SIDM00359,AZD7762,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0868087,-0.17878076,-1.8092100717278081,-0.06654368349161276
100396,SIDM00928,Alisertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.2665974,0.113488995,-0.09377039829265041,-0.016809482671396956
7951,SIDM00826,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-1.153542,-0.058198515,-3.2576803759914092,-0.14401790793827032
4320,SIDM00872,Palbociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.39636922,0.016900733,1.9738321838367452,0.07216429176532164
29704,SIDM00455,Crizotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4152043,0.15956648,1.8367270999790422,0.0715349080267553
65019,SIDM00282,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.1733485,0.049389657,0.16972222053068414,0.005323024208520033
56144,SIDM00872,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.53680265,-0.054122493,-0.6552132620381675,-0.05978775181905062
3119,SIDM00216,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.40877452,-0.037335612,-1.0564301767564204,-0.09574138063759398
94045,SIDM00776,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.7498409,-0.14082241,-1.4784146284730424,-0.08218338820978412
9871,SIDM00833,AZD7762,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.78166467,0.05362563,-0.14691975165968804,-0.008527747361981376
1858,SIDM01042,Olaparib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.962556,0.10613156,-1.5357268088317926,-0.056452424901678885
47362,SIDM01187,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2865691,-0.0459116,-0.09077776205446464,0.006584875366610529
13096,SIDM00673,Doramapimod,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1595225,0.024707489,1.8792300231770975,0.07873185017579558
106868,SIDM00875,ZM447439,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3078929,0.14185138,1.2663552107125615,0.07065766330431358
35901,SIDM00673,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.7710848,0.20250703,0.5065101710636285,0.0069121517031807776
45357,SIDM00872,Nutlin-3a (-),Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.052830923,0.0014724563,0.5557281986822018,0.0215343024301048
98812,SIDM00097,Venetoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3222613,-0.061720178,-1.4163798508605652,-0.02774355459642795
85647,SIDM00872,Taselisib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6682432,-0.03890632,-0.1631629141723049,-0.03970442726463019
93541,SIDM00875,AZD6482,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3318584,0.057814535,1.93719234587909,0.08816115816600731
93961,SIDM00148,Nutlin-3a (-),Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.76982385,-0.07695206,-0.8371718854702185,-0.0816990823390806
98527,SIDM00835,AZD7762,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.2521937,0.12823461,0.10907307176889745,-0.001077528203043859
63230,SIDM01187,Bortezomib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6708892,-0.067608364,-0.45616801229102855,-0.00487056241419162
61937,SIDM00359,MK-1775,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9674524,-0.1462044,-1.9567955700299973,-0.07952453126836899
81426,SIDM00875,Temozolomide,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.82865286,0.018866217,1.0449669766005705,-0.00551764620682636
63063,SIDM00146,Nilotinib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.7770473,-0.07710119,0.1271080427795539,0.0030758037245446302
58753,SIDM00282,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.223775,-0.124240935,-0.028931304654981595,0.005638981734403924
30642,SIDM00950,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.2293227,0.22823435,1.1927664518612877,0.054937519890523825
30507,SIDM00826,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.217786,0.06913073,0.6426436127178822,0.03211614969774459
74160,SIDM00826,Camptothecin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.8727713,0.1345965,-0.6497795914710286,0.010066948335785189
37683,SIDM00833,AZD7762,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-0.7334457,-0.036335785,-0.953800610191227,-0.06901470023328993
40011,SIDM00872,Sorafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.48046473,0.046999678,0.18499968344204915,0.037182974270128566
2499,SIDM00673,Navitoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.6316886,0.39272425,1.5965266783100776,0.0782947824800893
98965,SIDM00146,Paclitaxel,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6419587,-0.14028148,0.2696090035141533,-0.015974659978499523
67110,SIDM00933,Tozasertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,5.379878,0.39196542,3.928511411334213,0.17151936156997302
77343,SIDM00042,Gemcitabine,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.830429,-0.09683687,0.17971538277397764,-0.022550454347714865
43292,SIDM00673,Tozasertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.788338,-0.20463099,-3.0253849462521467,-0.18808955460408636
89745,SIDM00957,AZD8055,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,0.50597954,0.010999159,1.8735921061524772,0.05960893615162071
78552,SIDM00877,Dabrafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.3824139,0.050001398,1.1942925176145696,0.01704923785797219
99477,SIDM00148,RO-3306,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6135508,0.045810178,-0.39516193206539973,-0.04274919375360238
87145,SIDM00097,OSI-027,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8479828,-0.121058375,-0.9686141455057469,-0.06832976043329234
30230,SIDM00835,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.2692217,0.104358606,-0.06035684830797486,0.027571904881726294
10561,SIDM00875,Trametinib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.80400026,-0.089746565,1.120615385956853,0.03660708785295717
54792,SIDM00833,LGK974,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.2165425,0.005412527,-0.6911251561228119,-0.0033080961273317705
89844,SIDM00928,Gemcitabine,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,7.7560225,0.34920743,2.9350201331161596,0.19450308011455048
34519,SIDM00933,MK-1775,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.54853326,-0.046189845,-0.5269324416868908,-0.0265402474736311
61960,SIDM00673,Alisertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.95141476,0.05661591,1.2739592935275807,0.07258541340670059
23495,SIDM00282,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3795317,-0.027308812,0.8168810571966898,0.02307407123531409
21303,SIDM00875,Axitinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6198784,0.04590212,0.7516584454658435,0.07155710657098215
84691,SIDM01197,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5420424,-0.039015003,-0.8552077434332848,-0.0236623701993323
76423,SIDM00042,Taselisib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,6.097672,0.28258792,0.33017010480219616,0.005038275010025627
85025,SIDM00673,Luminespib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8130877,0.16770157,-0.3719729001784808,-0.006625689437530162
21227,SIDM00837,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.738904,0.035556544,-0.18080253805346316,-0.03106972178426716
68593,SIDM00359,Palbociclib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9251801,-0.0973924,-2.880343843073068,-0.08162246640511771
86001,SIDM00875,AZD8055,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.94290316,0.10431864,0.834497890437937,0.10876111753021085
33866,SIDM00837,Oxaliplatin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.0901592,-0.07274611,-1.798334469923667,-0.13957952576281452
77159,SIDM00928,ZM447439,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.43858886,-0.047841124,-1.468119892615166,-0.09347096869979894
72934,SIDM00875,AZD6482,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0147841,-0.06718269,0.8137184434582145,-0.00828756320399336
69810,SIDM00833,Palbociclib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,5.8272486,0.30303934,1.112505301654961,0.07234857326365225
48534,SIDM00826,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,1.4190981,0.03701163,2.5933037654515103,0.08804730043392354
77582,SIDM00875,KU-55933,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8001194,-0.06955206,-0.47704935819454675,-0.023529260424549118
104795,SIDM00928,Linsitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.6045438,-0.09660041,-0.7494117490905424,0.003591491754035416
30426,SIDM00877,RO-3306,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.24680993,-0.022651909,-0.07934412102698836,0.06945193465255432
56467,SIDM00833,AZD7762,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,1.1122168,0.08988129,-0.3684929587242218,-0.05969907016743882
64616,SIDM00872,Nilotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.44215834,-0.03996836,1.3355544319351809,0.048059081808141724
5230,SIDM00837,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.2694638,0.08067662,-1.1481811189877842,-0.04708459657570273
45351,SIDM00673,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4218658,0.0741543,-1.1030261847765679,-0.0625963113184353
63678,SIDM00633,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3049256,0.12957774,-0.37340866398614403,0.01874144022055877
101116,SIDM00933,Vorinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.47103474,0.05303317,-0.5286040597074738,-0.05217443187396404
56562,SIDM00673,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6649681,0.042933263,0.6247602386085882,0.02520612867705755
41983,SIDM00835,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.1123374,0.07451316,-1.0263346811687477,-0.0023270627559618374
24442,SIDM00146,Dabrafenib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.540183,0.1612272,1.0060225980848363,0.03904869042753749
104434,SIDM00146,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.7411687,-0.1701651,-0.9912860184883068,-0.012075539302691216
95352,SIDM00097,OSI-027,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4191356,-0.029426225,-0.13541378044538774,-0.006704008468389095
79110,SIDM00875,Trametinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0998082,-0.17881948,-1.3935156738466454,-0.0684490255988719
66218,SIDM00950,Lapatinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7109687,0.15673517,2.9347148273791657,0.16533550066327296
106312,SIDM00776,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9766589,-0.08843711,0.7373922345658552,-0.005656105772456682
34224,SIDM00359,Navitoclax,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.193406,-0.068700455,-0.6185899982331686,-0.07539625485630436
59501,SIDM00146,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3197583,-0.120336406,0.774876920145317,0.025551996595488728
54673,SIDM00146,Camptothecin,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.8554804,-0.2343453,-1.9243496843153798,-0.14451576856224047
60817,SIDM00832,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,2.0561063,0.10040948,2.0032319666885985,0.06422012825007334
47318,SIDM01197,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.403434,-0.12003366,-1.7231818055564716,-0.11364036668305821
20609,SIDM00148,KU-55933,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1810399,-0.041561723,-1.4297887158472142,-0.03522637737630952
60747,SIDM01197,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,0.7186645,0.054654445,-1.917047260299412,-0.10963978908847381
29570,SIDM00957,MK-1775,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,0.86824906,0.03461814,-1.2716028163430855,-0.06173052866170891
94939,SIDM00146,GSK269962A,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.3700466,-0.12130628,-0.6810568244154587,-0.040224329652900355
9811,SIDM00933,Nutlin-3a (-),Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.76212305,0.07932017,-0.9366086665962224,-0.0643852361339464
65722,SIDM00957,Crizotinib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.85067016,-0.026288077,-0.3341205527278701,-0.003874889386668086
19315,SIDM00673,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-3.0495121,-0.15772843,0.13867995297245944,0.04131947462084336
53500,SIDM00933,Gemcitabine,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,0.13257034,0.0004513626,-1.205858085523307,-0.012541514059620446
55993,SIDM00837,LGK974,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.2553577,0.054012023,1.1104097735090814,0.04896211599473048
3354,SIDM00835,Navitoclax,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.1230527,0.05955036,0.6937779232130096,0.04400795120252098
60384,SIDM00928,Gemcitabine,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.7678895,0.094254516,3.2099437781022786,0.02410717800269689
66762,SIDM00633,AZD6482,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0530528,-0.09541699,-1.753616432003264,-0.086804528796764
94109,SIDM00042,Sorafenib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.41274852,0.042927273,0.35286346180548545,0.01580732357527533
73696,SIDM00455,Irinotecan,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8265679,0.03234537,1.0219751862453428,0.09439427805813225
86845,SIDM01042,Nilotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.56355816,-0.031135261,-0.18704499627584467,-0.03129231441371322
32320,SIDM00216,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,0.75851536,0.012719939,0.1590411132783154,0.006856495514055947
64345,SIDM00832,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.43576667,-0.03425347,-0.3448922498072565,-0.023079233449864248
67815,SIDM00148,Trametinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4192193,0.050307106,1.422915283573432,0.0539801717000899
5787,SIDM00673,SCH772984,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.5033123,-0.18025152,1.2512862949818269,0.09077064277847721
31048,SIDM00835,Nutlin-3a (-),LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.2650738,0.11118559,-0.4893253974224105,0.016755704283213234
38151,SIDM00957,Trametinib,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-2.4437392,-0.09900095,-0.9568707130691656,-0.031873477984345686
8814,SIDM00146,PD173074,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.5663811,-0.10050008,-0.6401847683999189,0.01292646172869832
90517,SIDM00359,Afatinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6426915,0.04103272,-1.2665688559638388,-0.0624979878312439
93567,SIDM00950,Navitoclax,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0755379,-0.11765885,0.910597503553917,0.08079261671042536
84606,SIDM00872,Tozasertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0871009,0.048234764,1.5886884176587022,0.05703498893023721
20050,SIDM00832,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-3.0765572,-0.09524972,-0.6211885530793909,-0.017683486056069567
103601,SIDM00877,Alpelisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.657903,0.065500885,1.483788655474249,0.0452746424818888
50998,SIDM00872,Pictilisib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8192937,-0.06753976,-0.9813196577067608,-0.021650259300214643
42052,SIDM00957,Dabrafenib,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.7359538,-0.022537917,1.3766879812029702,0.026006086210923554
49027,SIDM00148,Entinostat,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8081362,-0.04049105,1.4090074603879956,0.07696660144221558
52419,SIDM00097,JQ1,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3011384,-0.16302489,-1.913949928155258,-0.09661667050646729
82979,SIDM00148,RO-3306,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.8987162,0.13699193,0.1959352888381794,0.00465302599453845
20658,SIDM00875,Cisplatin,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8572031,0.047288746,0.7336606270557628,0.04913820868451862
66011,SIDM01197,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2384546,-0.08531689,-0.45954582933254023,0.0006878019956350459
10560,SIDM00933,Lapatinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.4323138,0.05453379,-1.8994612623542386,-0.09228220075668966
68138,SIDM00877,Cisplatin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.034695793,-0.0036438168,-0.5465659781562139,-0.005920688086945725
67139,SIDM00933,Afatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.8121515,-0.06880929,-0.2089087080290326,0.019081919104897493
81825,SIDM00835,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-0.5024007,-0.0368886,-0.26060403759346246,-0.010778596532582639
74604,SIDM00957,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.8317435,0.07824625,2.381065509312467,0.13772349154516242
63798,SIDM00928,NU7441,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.3011407,-0.14871988,-0.2587428249096566,-0.018971486431458996
34984,SIDM00673,Alpelisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.8343879,-0.09167476,-1.1686022036415378,-0.03400101787662622
62300,SIDM00282,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2578717,-0.04482462,2.745998033345924,0.13513449058113056
4095,SIDM00877,Olaparib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.33964074,0.01982424,-1.1461174152885512,-0.01939320560652503
69401,SIDM00872,Olaparib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6034844,-0.088403836,-0.27444191493403064,-0.013373568162654403
5373,SIDM00837,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.2347558,0.053093437,1.6159973940886567,0.02036338620927129
25576,SIDM00872,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.22023733,-0.016469665,-0.0020165285496713263,0.012910359704177865
91299,SIDM00872,Alisertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1251123,0.057548594,0.4554073675458352,0.0733525320547752
65036,SIDM00928,KU-55933,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.6795199,0.047051333,-0.025466221020341358,-0.02997837414732452
10714,SIDM00455,Linsitinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2491577,0.077977575,0.5439438068525585,0.044768585197824666
45744,SIDM00633,Entinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0944775,-0.05498143,-0.6454918399799151,-0.03605924502463711
104926,SIDM00146,Trametinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.280788,0.14165407,3.86832331303814,0.15272784289222277
43777,SIDM00633,AZD8055,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.75135183,-0.06488932,-0.22047331793277875,0.033112528388539474
14229,SIDM00832,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.6757618,-0.07671861,0.45220832900348346,0.02399053549525592
78344,SIDM00875,Crizotinib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1792529,-0.12267898,-0.3688943697411881,-0.007746928978863809
16788,SIDM00877,Venetoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-1.4699657,-0.055722028,-1.0124564846936412,0.004895147569997832
49939,SIDM01187,Palbociclib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.762434,-0.09210942,-1.4337618251852162,-0.01823935196223322
16529,SIDM00875,Bortezomib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71058136,0.054607317,0.6335227464916786,0.027838419258157936
48106,SIDM01187,Pictilisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0163947,0.055063102,-0.6443623134290839,-0.05399038282778416
9195,SIDM00673,Tozasertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.7535563,-0.19662207,-2.303503374238487,-0.1471167704098959
22911,SIDM00933,SCH772984,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.62769276,-0.048055794,0.05975847569342572,0.012707876355739329
23186,SIDM00933,Palbociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.5081041,-0.07742055,-1.4271875450136213,-0.02255119135825506
33799,SIDM00872,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.724306,0.081196025,0.8063250233206383,0.01757757853835304
10724,SIDM00359,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.8783672,0.1561483,2.9867702792810595,0.09047425036717516
77323,SIDM00933,MK-1775,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.42442593,-0.033688504,0.11139063450768437,0.015837699130698317
83394,SIDM00832,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-6.0883045,-0.12958102,-2.9965888040161377,-0.10615686142373937
27291,SIDM00957,Linsitinib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,0.65725833,0.011137783,3.684653321672757,0.1859391684508988
39605,SIDM00673,AZD8055,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3724741,-0.07994608,-0.32248832972454383,-0.04759672311852872
108436,SIDM00933,Axitinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.7925799,0.10639814,-0.08845393872363681,0.043236266819662694
24206,SIDM00097,Navitoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.77015084,-0.049207263,-1.2130577034706955,-0.06615424192275134
76694,SIDM00872,Paclitaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6147034,-0.06363891,-1.3281770228326628,-0.07396848659363946
12409,SIDM00148,Nutlin-3a (-),Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.18006875,0.017917614,-0.1988615856772751,-0.030066356443647597
6243,SIDM00282,AZD7762,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.1553917,0.026230596,1.902802820154964,0.1273129757456424
18016,SIDM00950,Palbociclib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6667669,-0.027956761,0.348468152021986,0.06716728651949248
104271,SIDM00832,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-2.7895377,-0.19372861,-1.9210463478900779,-0.14005478702728974
28386,SIDM00872,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.568972,-0.0202288,-1.581249274543736,-0.0645289107765418
11359,SIDM00776,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.23601666,-0.01114524,0.9055561107074477,0.06174511262698327
49065,SIDM00216,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.007743545,-0.00061688,-0.9193438196120106,-0.07257887706940008
63859,SIDM00097,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.0567784,0.31057003,2.2914476194488964,0.17929248037484388
88871,SIDM00872,Nilotinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3740253,-0.103928715,0.23412954768544256,0.01630962707271399
74191,SIDM00359,Vinorelbine,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5776811,0.08333395,1.3882884054173628,0.10012340699262429
75951,SIDM00928,MK-1775,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.0431017,0.10213959,0.22539996460542513,-0.004682920558500897
106047,SIDM00872,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3563383,0.14446081,2.9161504559971214,0.21777951214672983
31464,SIDM00928,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.7571194,0.15966693,1.3841419377472413,0.05477417909268303
79175,SIDM00633,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9771514,0.095146835,-1.7441880352817838,-0.10300226295672212
32550,SIDM01187,Lapatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.680531,-0.054141417,0.327448680327503,-0.016145148497404466
67639,SIDM00673,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.4711764,-0.26703784,-1.7445745351079949,-0.15934762273602252
17004,SIDM00042,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.63468,0.053948626,0.3250743580014822,0.007968156935669553
64197,SIDM01042,Docetaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2151117,-0.21055435,-0.6144303722831792,-0.02696108636300401
59836,SIDM00097,Palbociclib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.134548,-0.08048892,-1.1361994644394076,-0.0530688005069893
43535,SIDM00282,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0366505,-0.03206125,-0.14824352665573837,-0.002580845166898522
54169,SIDM01187,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4843506,-0.10742136,-1.3932297617583373,-0.0888874839762686
37900,SIDM00148,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.571972,0.13557912,-0.751289869961611,-0.013610011162098945
102498,SIDM00282,Trametinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.124617524,-0.008235802,-0.6118458315213858,-0.06695736332681186
29157,SIDM00455,Gemcitabine,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.0511372,-0.10834984,-2.1210837457660725,-0.04327834427349014
105531,SIDM00933,Paclitaxel,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-1.6225075,-0.12527497,-0.9786736187679765,0.014579233948567038
92912,SIDM00833,Linsitinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-2.042737,-0.08366641,-1.240535514462802,-0.06765568586502274
84857,SIDM00826,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.6179352,-0.050505653,0.06244475760313755,-0.0791218572282056
49922,SIDM00928,MK-2206,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.3848076,-0.11371005,-0.1193304138090955,0.016186934280848376
70392,SIDM00148,Palbociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4488711,-0.058213487,-2.4977699455858957,-0.08101295720133135
37226,SIDM00872,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.003124,-0.08597945,-0.01676887172381414,0.06393094778545114
106860,SIDM00928,Venetoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.3642871,0.24118708,0.3571742141808228,0.04352086481919416
39705,SIDM00148,Uprosertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3875844,0.10148377,1.928117926662217,0.09978613644823224
73227,SIDM00933,Palbociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.7074735,-0.055291023,-0.4355798492356316,0.0032381987441788738
11099,SIDM00928,JQ1,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.3958377,0.1493367,0.7406038136394362,0.0383769699322891
91776,SIDM00146,Dabrafenib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.9466523,0.1295194,1.4258635048455253,0.045499743262535974
87684,SIDM00950,Paclitaxel,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6894212,-0.08192623,0.14578091908873847,0.02393544732594886
59774,SIDM00146,Uprosertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.7265174,0.1364409,-0.6864834399530688,0.05261192631271071
40299,SIDM01042,SCH772984,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4342918,0.18424831,0.11609262666311386,-0.027717310113029917
36035,SIDM00146,Linsitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3749948,0.03935201,1.409464234017916,0.05365504893306333
68486,SIDM00837,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.83481234,-0.059982155,-0.6665638935476544,-0.032618335930597014
20991,SIDM00877,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.011149,0.13916762,1.6890019888949255,0.08308367007133259
47135,SIDM00928,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.4775977,0.122025564,1.1144047310565308,0.06252428033573483
32435,SIDM00282,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7443449,-0.049382277,-1.4436418935718647,-0.0629110716536544
108233,SIDM00146,NU7441,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1052405,0.0918377,-0.4331155125925761,0.0039805645770672315
42294,SIDM00933,5-Fluorouracil,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.57713914,0.080094926,-2.0211348598427534,-0.14121407548717554
83327,SIDM00097,Paclitaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.593712,-0.31028825,-3.6256210080379945,-0.29351667603851467
47799,SIDM01042,MK-1775,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7093361,0.052547902,-0.6550325263532866,-0.04255461452651491
92331,SIDM01042,Vorinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.961525,0.08760998,0.8210186825943336,0.026906395219779607
2161,SIDM00359,Camptothecin,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0623325,-0.066947,-0.5672039373243735,0.05151392751934389
24515,SIDM00455,Palbociclib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.493682,0.07927745,0.8823502018221686,0.06707778186078807
73012,SIDM00097,BI-2536,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9681839,0.059720077,2.2014070359513327,0.1325783935834578
88515,SIDM00146,SCH772984,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.0241086,0.08436255,-0.50793097691534,-0.04491563328192099
41960,SIDM01042,Linsitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0301542,0.06818433,0.8794268589685686,0.024528959151359275
14913,SIDM00928,Bortezomib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.5461491,0.047766015,0.2875491809378262,-0.02150714086076823
105398,SIDM00872,Luminespib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.0075927,-0.124006,0.17943127126825606,0.08748593089010487
96541,SIDM00776,Palbociclib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.68981427,0.025131777,0.9095703655722382,0.0214650569066383
28084,SIDM00872,Entinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0779405,-0.061063346,-0.04399758782971222,-0.0058472290896485965
77587,SIDM00673,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.299885,-0.1044004,-0.47078482733385957,-0.01898327533064295
33570,SIDM00673,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1230923,-0.119784,-1.3041583631133207,-0.04686042760796622
54875,SIDM01042,Vorinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.080994375,-0.008689977,-0.3556877582760028,0.046452291981145054
36476,SIDM00872,Afatinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9662148,0.103861965,1.0956004860771429,0.06928475282885933
10278,SIDM01042,MK-1775,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.827102,0.13513279,0.466840345825235,0.025677486260036388
27420,SIDM00877,Gemcitabine,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.1967578,-0.04556538,-3.189667082208795,-0.13234705576389527
45172,SIDM00042,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.4752756,0.05957937,1.646076659641057,0.05440078303869982
80326,SIDM00359,Oxaliplatin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1729336,-0.10404181,-2.3705082046419674,-0.052998872817777015
81481,SIDM00455,5-Fluorouracil,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.46224153,-0.021242185,0.2906238177149984,0.10489613417680024
8079,SIDM01042,RO-3306,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.65137506,-0.06564264,-0.8146529634569163,-0.047737518841350565
32203,SIDM00097,Luminespib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1383636,-0.12934832,-0.9891176245026538,-0.10388619942343665
67979,SIDM01197,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6237246,-0.06621834,-0.5581402016951593,0.008792611731950959
49262,SIDM00673,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.34729818,-0.035477575,0.0990687271249483,-0.07438506348679733
25798,SIDM00148,Taselisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.7366688,-0.15993017,-1.2102991602316477,-0.07376479508607756
35338,SIDM00455,SCH772984,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.511879,-0.050404567,0.38315614138639675,0.01994871442018666
79868,SIDM00933,Taselisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.40571997,0.04091167,0.3155245325676261,0.011813993481792961
87997,SIDM00216,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3368118,0.09846377,-0.3178299897147662,-0.0250158223361922
70870,SIDM00950,Dactolisib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.7017714,0.03269616,-0.7331274836164124,-0.03570888085141745
82236,SIDM00455,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.7509346,-0.12133961,-2.4425945229713077,-0.1003454375526036
73149,SIDM00933,Palbociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.2502747,-0.08023899,-1.3461314047575597,-0.04993215575553063
2185,SIDM00877,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.45069283,0.055062782,0.3928681336325816,0.043884497670069564
91880,SIDM00877,Wee1 Inhibitor,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.28414866,0.0189922,-0.31028602073574535,0.013847728684029299
55551,SIDM00933,ZM447439,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.74574417,0.020056967,-1.3987691076418833,-0.07285351733874834
12863,SIDM00673,Pictilisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22663304,0.02196138,-0.6896533692360549,-0.08730801679183117
56311,SIDM00633,Wee1 Inhibitor,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3905927,-0.037012212,-1.3538297279994238,-0.1010766206368467
39178,SIDM00832,Palbociclib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.3774538,-0.08262567,-0.6237151914215022,-0.02198235741949842
83306,SIDM00933,KU-55933,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,1.0074492,0.050197177,-1.3716926267412755,-0.022069684941176396
34403,SIDM00826,AZD4547,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.8014039,-0.0663131,-1.6447855863428715,-0.04901502526203356
87992,SIDM00875,KU-55933,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1332386,-0.04938123,0.19637733576627156,0.05934092283769757
45791,SIDM01042,5-Fluorouracil,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.57782096,0.020102281,4.304203435634391,0.09274179474842556
35677,SIDM00146,Afatinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.388669,0.08266109,0.8570685444284483,0.0664874473161564
33396,SIDM00359,Afatinib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5303295,0.18763635,1.0261445483944531,0.11261819491739936
6641,SIDM00833,Oxaliplatin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.2749224,-0.0767676,-1.2808816782448162,-0.09972257198057301
18568,SIDM00148,AZD7762,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.8431563,-0.24440236,0.01592751448619663,0.01619976000914456
12589,SIDM00877,SCH772984,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.2056001,0.037463255,0.6874877282610715,0.055945607340491074
98688,SIDM00877,Ribociclib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,5.784076,0.14819486,2.634791449604752,0.014796865892542817
33961,SIDM00950,Gemcitabine,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.32633,-0.076871134,-1.7109698362369643,-0.07365166439695363
30661,SIDM00957,Olaparib,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-2.1095524,-0.028306454,1.960587665666915,0.05501072506825537
21184,SIDM00928,Navitoclax,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.883673,0.22627063,1.7712325963789555,0.04717570941161736
102797,SIDM00837,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,3.152599,0.091979384,0.32229317021492876,0.0564650130465334
31993,SIDM00826,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.35854077,0.028823841,-1.222120502400004,-0.07979412100881096
6259,SIDM00872,Temozolomide,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.1906705,0.0035104991,0.859634081125243,0.020260263745276504
31846,SIDM00633,Alisertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0248027,-0.14235176,-2.3288250225747493,-0.10046975032457514
39399,SIDM00097,JQ1,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6886342,-0.10189125,-0.8447434212067593,-0.007333535169997585
22935,SIDM00146,Cisplatin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.3161133,0.009201484,1.2905344615386463,0.05860977757061699
69996,SIDM00097,Uprosertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6413922,-0.09242116,-0.0421357442718766,0.013915548727083572
48778,SIDM00776,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.7896051,-0.07053102,-1.7988116776585894,-0.09328293709491316
98851,SIDM00950,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.63772887,0.044220116,1.8083627680417413,0.08178086172259887
22000,SIDM00833,SCH772984,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.95109004,-0.07657956,0.7401400991966705,0.018096922905782718
91274,SIDM00148,Crizotinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.267834,0.25778243,2.622507482276095,0.1136826211603569
98129,SIDM00216,AZD7762,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-0.67594844,-0.05778953,-1.2318569743126122,-0.023348674608606335
18605,SIDM00282,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.1647732,0.055642497,1.932314639156504,0.07888175003018584
64242,SIDM00928,Nilotinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.1164753,-0.17693366,0.22817343425442488,0.0036646241103416577
11191,SIDM00633,MK-1775,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.07955,-0.15075912,-0.5377689679585079,-0.01089635224957762
12974,SIDM00928,Linsitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,3.3384538,0.29474446,0.5119514228742165,0.01939561449862983
13939,SIDM00877,Temozolomide,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.7012596,0.017908055,0.001247502534203759,0.03941375917911427
43637,SIDM00359,SCH772984,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.40692195,0.026912453,0.44175584570149085,0.03329868453082787
68619,SIDM00826,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-0.10312995,-0.00902035,-1.5499878738489863,-0.11772970644934919
81131,SIDM00877,RO-3306,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.6615222,-0.06489092,-0.20464901625632842,0.03766277221175826
72562,SIDM00835,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.23769386,0.015869647,-0.21991218329088938,-0.024274816045540746
46170,SIDM00832,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.6811413,0.14256331,-1.1473140764262508,-0.10004352405680464
71568,SIDM00776,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.9875958,0.047967408,-0.7006087744014111,-0.03878853363950034
79456,SIDM00933,Temozolomide,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.6077854,-0.022599565,0.2001346345818841,0.0818935023981765
36506,SIDM00148,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.88740146,0.05159933,-0.0883131471445425,0.019044779024428006
73445,SIDM00875,NU7441,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4253612,0.039166667,-0.471202917011442,-0.006486010309574137
83831,SIDM01042,Pictilisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3102945,-0.023979723,-1.4218885918988642,-0.04880287223916401
36179,SIDM00872,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5973372,-0.11920294,-0.37042148999310753,-0.006129252752136464
63053,SIDM00877,Sorafenib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.6481756,0.076000236,1.38859342453177,0.09675238196820816
86053,SIDM00282,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,2.4152353,0.07840917,2.6957073464189034,0.12591728076753253
83116,SIDM00148,PF-4708671,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7351186,0.112206206,0.44639250693332366,0.04849425917559736
69976,SIDM01197,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,0.8533378,0.008752964,2.003865124983334,0.04974004569915605
87394,SIDM00282,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6552331,-0.041449282,0.04156310254872545,0.02659893950665409
72550,SIDM00633,Tozasertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7426028,0.020827627,0.5213800495816766,0.015326633150220589
23578,SIDM00633,Vorinostat,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6091298,-0.1269399,-1.0804255398966922,-0.03483055824773331
72976,SIDM00776,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,6.2294765,0.22278824,2.1954675167820095,0.14547935723254563
57000,SIDM00146,Doramapimod,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.5411513,0.26178172,1.7699686746221952,0.07634529621850643
27967,SIDM00835,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.9215102,0.14277084,1.1177957503771263,0.0314594173007291
7276,SIDM00097,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1858264,-0.065462545,-0.23176207083645894,-0.0031014918072390842
58082,SIDM00933,Doramapimod,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.7534118,0.17388538,1.7801621017906943,0.08493706957955469
102346,SIDM00097,NU7441,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0462608,-0.08399713,1.5052147218080858,0.09877934390848495
85708,SIDM00837,Navitoclax,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.5437827,0.04348186,0.2659931368313405,-0.005704028939488197
90220,SIDM00933,Taselisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.23201482,0.015347189,-1.0685458350723482,-0.05268745657851398
50801,SIDM00148,Bortezomib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.07544045,-0.0051840134,0.05178717532379902,-0.028771365231382687
7197,SIDM00673,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.1840881,0.06862592,-0.3522856763785059,0.029335690367699507
37327,SIDM00776,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.3295261,0.08005963,0.24810435140634374,0.037339388648972203
27513,SIDM00957,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.6744158,-0.05569556,1.4198241423235691,0.05102062527151579
44238,SIDM00042,OSI-027,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.35708466,-0.036741618,-0.8639444604655163,-0.04889337792995691
105639,SIDM00872,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4126294,0.05700784,0.938533824525016,0.044246169472245404
94595,SIDM00097,Dabrafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1957479,-0.08274422,1.210803006464666,0.03511243911726029
57282,SIDM00148,RO-3306,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.29516,0.02770908,-0.7288418115826992,-0.08044032759672566
58967,SIDM00833,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.0069418,-0.0835683,0.1571791351449176,-0.02191947285236157
103114,SIDM00148,Navitoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.303522,0.103887565,1.4343158952520791,0.058158540006334226
51848,SIDM00633,5-Fluorouracil,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2939675,-0.047499638,-0.9170435378450451,-0.013196057476805786
2701,SIDM01197,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8368859,-0.10920117,-2.4388481843017034,-0.16179789971445907
84620,SIDM00950,Dactolisib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.29616553,-0.021226445,-0.4743373811394256,-0.018250322950544205
73676,SIDM00928,Nilotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.5761303,0.16923758,0.20196732398393233,0.02980459274368108
84807,SIDM00455,Ruxolitinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6054701,0.011514646,1.8659702116092896,0.09458703268493932
73270,SIDM00933,Nutlin-3a (-),Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.4237564,0.056508362,0.15359722759110409,0.01623676021492603
8166,SIDM00933,Navitoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.42681092,0.048154637,1.6980571013898134,0.11059422514669881
93002,SIDM01187,Vorinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.11270603,0.011821081,-0.4119985004891862,-0.03258094927397212
42691,SIDM00872,Nilotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5778371,-0.05207298,-1.3864449923085265,-0.10211477926272589
77263,SIDM00673,BI-2536,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.63383245,0.035010748,0.9812651638010401,0.08187904266394953
51922,SIDM00833,Vinorelbine,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-2.4658313,-0.13347824,-0.5029822249708499,-0.05042361082651006
105328,SIDM01187,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.1817384,0.12806326,1.2197921068207578,0.13315165958531117
70010,SIDM00042,Ruxolitinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6549213,0.015059546,0.6709594337937106,0.05347101493037397
91401,SIDM01187,Gemcitabine,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7382836,0.06770968,-0.546054752326328,-0.0018741621310298113
73257,SIDM00950,Ruxolitinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75346714,-0.024420941,0.11684320679291503,0.023477155061269978
75044,SIDM01042,PF-4708671,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7298804,0.073994115,-0.23212050489296432,0.05736065769496421
70855,SIDM00933,AZD6482,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,2.7210224,0.08597298,3.122812133384847,0.06257642211219831
85259,SIDM00832,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.0622003,-0.028324459,-0.33951085505454254,0.04468490323903156
28650,SIDM00097,Nilotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6022723,0.041166224,-0.9023528933980642,-0.03454474270717476
64363,SIDM00837,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.1930075,-0.045677748,-1.5406449680657825,-0.058537796564727684
32757,SIDM00359,Oxaliplatin,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2195766,-0.07869773,-1.93468161170051,-0.008253183281201212
14965,SIDM00673,BI-2536,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.40714896,0.026127495,-1.2924165179232103,-0.14010964175502624
88707,SIDM00455,Palbociclib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.7364876,0.13459705,0.3762600540931463,0.059455278256646885
26920,SIDM00633,Trametinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1395545,0.10507629,-0.038990244883315414,-0.0076681584086198094
18449,SIDM00776,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.409187,-0.043513957,0.5638886383262275,0.033406360599740656
24292,SIDM00877,SCH772984,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,2.4657419,0.1298367,0.6437044943938783,0.016033871151479192
59729,SIDM00216,Dabrafenib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.96532905,0.018059634,0.7962271757605462,0.07063221976847646
104422,SIDM00097,Bortezomib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8866146,-0.05129075,-1.790172078328037,-0.07654892921743577
81374,SIDM00872,Linsitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.87255627,0.037133824,0.7490683042347459,0.008860117647840032
66602,SIDM01187,Palbociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2232058,0.08517432,-2.3881367330196617,-0.08729713519532376
33540,SIDM00097,Vorinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0898988,-0.07957534,-1.073338134880012,-0.04768982553163253
71445,SIDM00282,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.5803972,0.10136597,-1.1263941605139867,-0.04193435698621063
67874,SIDM00877,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.48844874,-0.048568994,1.8010462637247495,0.12906935877872502
21555,SIDM00673,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.416389,0.102884136,1.9974550176728032,0.11547426810715607
17435,SIDM00872,Gemcitabine,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.45249,0.047184516,3.8035858056975336,0.11817075190767158
39700,SIDM00633,Bortezomib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6034129,-0.0445193,0.09863116734005907,-0.027881572866368803
94542,SIDM00832,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.3076268,0.004995118,-1.120865735956096,-0.037830111092000095
13431,SIDM00673,OSI-027,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5575273,0.05686903,0.9797559555287141,0.04854833645173605
85337,SIDM00875,JQ1,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0541816,-0.117628515,-0.5959192852100587,-0.06525688499541128
20795,SIDM00835,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.5080884,0.011558504,-0.14833101498084325,-0.02226551089924287
79402,SIDM00042,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.6873803,0.22365583,2.5685077527874784,0.13993109950630497
8592,SIDM00673,Uprosertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4086531,-0.06703382,-1.2562413952031926,-0.0458104279005297
31810,SIDM00957,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-3.3776882,-0.12444241,-1.3950115356305628,-0.09368481926130592
58779,SIDM00633,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4664114,0.11778274,0.18995375491524524,0.05197189260420049
76244,SIDM00928,Gemcitabine,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.3981997,0.13874891,-0.16832780354467208,-0.056040945716577646
92440,SIDM01197,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3855288,-0.15809399,-0.371284688399446,-0.03144647905421065
32008,SIDM00455,Navitoclax,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.9283104,0.215661,1.4729201008702102,0.09634503107041663
93477,SIDM00148,Vorinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5673033,0.12555474,1.9284055063721925,0.11802712480828408
6854,SIDM01187,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1874603,0.10447634,0.07725176407561718,0.008486984043975637
55761,SIDM00216,Olaparib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.9786994,0.067526735,-1.2004938683990556,0.007620739692582814
29835,SIDM00148,KU-55933,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1815743,-0.04178022,0.9679715320647491,0.05736755809496812
15291,SIDM00928,PF-4708671,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.1118059,0.08321688,0.45205812141476576,0.009900277172404345
71595,SIDM00146,AZD6482,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.5633008,-0.09812309,0.45974806848951577,0.04339289306250388
57652,SIDM00633,OSI-027,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.541335,0.15374155,0.7071352522549769,0.08691481503074196
29977,SIDM00872,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5905373,0.25857055,1.6656832038438185,0.1095442590146741
52397,SIDM00216,Camptothecin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.8185079,0.09518727,-1.370522673849328,-0.05900474844754008
51127,SIDM00826,Taselisib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,4.4634924,0.12267282,-2.1762342975164497,-0.04375281192395382
32191,SIDM00928,ZM447439,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,0.5641506,0.06845297,-0.22031833415058194,-0.025684030310793807
74985,SIDM01187,5-Fluorouracil,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6400285,-0.11936859,-1.8175678908684918,-0.03815778064655436
65417,SIDM00216,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.59492445,-0.03935579,-0.5186665633730403,-0.05133931856836084
58215,SIDM00216,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.47225922,0.012509209,-0.9812410146312316,-0.02356122628796289
2766,SIDM01042,JQ1,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9114807,0.019115796,-1.6298815644068032,-0.009316204607791758
22131,SIDM00097,AZD8055,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3904965,-0.15572774,-0.12417910727047828,-0.023044306633294112
102454,SIDM00673,Tozasertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.2976413,-0.189457,-2.3917348469223825,-0.16989633683014715
73229,SIDM01042,Dabrafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4559821,-0.10556025,0.261470327399355,0.007404458530615071
88836,SIDM00148,GSK269962A,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.26772833,0.023786834,-1.2600030953864325,-0.04355764676932315
52149,SIDM00835,AZD8055,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,1.5996779,0.10552977,0.7325876950625292,0.023030310561525415
95971,SIDM00776,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.4053289,0.048619166,2.087622238738949,0.07359887624926942
43921,SIDM00957,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.552132,-0.04833123,-0.3928144454893504,0.0359111964488106
13169,SIDM00673,OSI-027,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0822887,0.180732,-0.7961535954788246,-0.0894676686408496
36671,SIDM00146,Ribociclib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.0618849,0.20946935,-0.23508855540420026,0.051361891004235105
57661,SIDM00835,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-0.67110115,-0.055784766,-0.9876442743101538,-0.024465529664874308
47667,SIDM00146,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.094274,0.08877879,1.168101928618668,0.08942229545127743
9187,SIDM00832,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2202059,-0.07910661,-0.8044029513315621,-0.04118213392418012
63686,SIDM00950,MK-1775,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7672955,0.091182694,0.7422984038834823,0.06692129051530367
16064,SIDM00933,Temozolomide,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.553176,0.2948466,0.11696234545546551,0.0316066349951663
102618,SIDM00877,SCH772984,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.6088825,0.06419515,0.727824628814617,0.04956344319321616
56139,SIDM00875,PD173074,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.62577236,-0.030145105,0.6192848027620574,0.018443303052082645
30618,SIDM00933,Pictilisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.7270017,0.15724763,0.4007363101036954,0.07145601680415624
52864,SIDM00148,Taselisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.2707744,0.09226549,0.3218393582827855,-0.009803461495348937
3529,SIDM00148,Nutlin-3a (-),Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2435726,-0.1147484,-0.7316441363457316,-0.04846774472271103
60615,SIDM00872,Luminespib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6250986,0.15978451,-0.21800377335739915,-0.009868173607608638
100562,SIDM00776,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.4841957,-0.047743224,2.0190592588331193,0.06721301711233252
58904,SIDM00148,Trametinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5972307,-0.048001707,-0.9888744623226094,-0.041592542443096917
3333,SIDM00633,Dabrafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1729451,0.02610181,1.3263291051859138,0.029380831976246358
15068,SIDM01042,RO-3306,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4835899,0.057756923,-0.7084973060176251,-0.06188644926288579
38741,SIDM00877,Sorafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.38807666,0.043147303,-0.19069562388962855,0.03087921763133423
106499,SIDM00933,Vorinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.4125454,0.056025453,-0.6476909002151974,-0.05211824884444913
85692,SIDM00928,Sorafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.5083189,-0.1228448,-0.2355600507045535,-0.025450683812565936
46992,SIDM00875,Venetoclax,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.27993375,0.007447147,1.082691093471644,0.025642378796087606
86748,SIDM00826,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.35158527,-0.02137267,-2.6662887373493835,-0.10168274272926608
102569,SIDM00146,Palbociclib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.48682982,-0.032300666,-0.15935672658184272,-0.04036215784188783
53028,SIDM00877,Tozasertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.98739254,0.11398677,-0.6899992992910471,-0.050202490359342454
25680,SIDM01197,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.29763758,0.010452217,0.9883440114501288,-0.03967492535374069
97323,SIDM00832,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.445394,0.028793573,3.1225140021402003,0.07601233564327915
59547,SIDM00148,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.21697387,-0.015992463,-1.2871978529905517,-0.0710250336239032
32227,SIDM00928,Docetaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.9013157,0.26475877,0.9385672273045305,0.05011010686299953
92745,SIDM00875,Temozolomide,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7279745,0.019676767,-0.0770383719250405,-0.01697980239633953
36810,SIDM01197,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.6341698,-0.08796945,0.7907613542519638,0.05495761324535456
8852,SIDM00673,Doramapimod,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0551552,0.021583028,1.5361752495975052,0.04156283611821918
73672,SIDM00146,Tozasertib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2388227,0.10238273,-1.5593788128648252,-0.12021649886118596
95413,SIDM00826,SB505124,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.20545924,-0.014396863,-1.5917193164335888,-0.04352998039875057
97292,SIDM00933,Ribociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.6874225,0.08856056,1.9054745582174772,0.02909513962443125
49383,SIDM00875,Linsitinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.479949,0.34914503,3.812782400437389,0.16848327160293228
14062,SIDM00146,Vorinostat,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,1.0712458,0.093490876,-0.24608085192812354,-0.03915114715569732
88698,SIDM01197,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.620094,0.09815217,0.8486413873210267,0.06895167555174252
88032,SIDM00928,KU-55933,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.6941023,-0.05910389,-1.1218149266153972,-0.03426784556783409
52944,SIDM00216,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.9021132,0.113775425,0.03955083893040467,0.053866556876593544
29167,SIDM00148,AZD8055,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6349533,-0.05977822,0.18483781816256423,0.003196544814499825
2225,SIDM00216,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.3317702,0.24564165,1.3168578021426174,0.09817336568669137
87877,SIDM00928,SCH772984,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.7478368,0.31978115,1.318159457239624,0.1016526904715855
21025,SIDM00928,PF-4708671,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-1.2784497,-0.09530283,-1.3165536641957547,-0.07525488503107469
86671,SIDM00097,GSK269962A,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.995256,0.11395068,0.48132060908479035,0.03140023452661043
65959,SIDM00359,Oxaliplatin,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3794758,-0.024418723,0.46428745186246306,0.09945996256142518
18423,SIDM01187,Linsitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.1679788,0.07930467,1.4135172687641657,0.03997143680732134
19181,SIDM00826,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.15465684,-0.00572044,-1.1521045429611876,-0.0576191918161407
68527,SIDM00455,Lapatinib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7625531,-0.021027334,2.097234095338668,0.0989911247019556
14249,SIDM00042,Ruxolitinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.710633,0.15555304,3.34669057447916,0.07726631017333514
20061,SIDM00875,NU7441,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5533333,0.07314004,0.23166813922760382,0.02320918589217717
10488,SIDM00633,Luminespib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0452079,-0.07712845,-0.7917876889753096,-0.06406443006518087
86898,SIDM00928,KU-55933,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.4521568,-0.07022649,0.5502670690663642,0.00469460675819049
107990,SIDM01042,Ribociclib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0527058,-0.025171967,0.2878494281553629,0.023468071009738776
60742,SIDM00097,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5479037,-0.05326868,-1.0073685929447531,-0.008251673983969116
59929,SIDM00837,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.74391603,0.02468503,1.165667295771067,0.03560266138362016
51826,SIDM00042,Cisplatin,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.404202,-0.03800845,0.13767339092692196,-0.0033516780841021843
83236,SIDM00933,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.27238876,0.04185957,-0.3772710799324127,-0.03376389216952594
78442,SIDM01042,Uprosertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.8026536,0.043259416,-0.6903865301993136,-0.05557898327953341
18691,SIDM00148,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.61340487,-0.060874246,-0.7850125080789083,-0.042917540917595386
70137,SIDM00146,Olaparib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.0426524,-0.07433089,-1.0425900611640304,-0.027950807386620913
86582,SIDM00216,SCH772984,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0403934,-0.06601407,-0.950012365692436,-0.07292792371631363
94556,SIDM00633,PD173074,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6042833,0.048213135,2.7630917623738838,0.10349743041882853
81741,SIDM00933,NU7441,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.5980434,0.16114983,0.786136576027222,0.09148529657099995
103616,SIDM00877,Afatinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.2262344,-0.15798186,0.4905542135469151,0.07724251735352981
79931,SIDM00872,5-Fluorouracil,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,4.9793286,0.35785833,2.398283438556704,0.1497991095823159
107293,SIDM00673,Palbociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.63019925,0.022847366,-0.7815914517273476,0.027323275246220042
884,SIDM00832,SCH772984,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.6165245,-0.12794535,0.9996640444927907,0.01886321298464992
60021,SIDM01197,Afatinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.0511767,-0.075696304,1.9184549637261084,0.11536911031592104
70004,SIDM00148,Nilotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6354767,-0.059019487,-0.44791200932538067,-0.024322843813068255
103091,SIDM00673,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5643418,0.1101549,-0.06618749118368782,0.002366290479285713
89980,SIDM00633,Alisertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4027151,0.08976568,0.6002860746729047,0.09378718345010743
102474,SIDM00673,GSK269962A,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4740953,-0.14430192,-1.4707578946487976,-0.0986358806913234
18239,SIDM00146,Luminespib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.443942,0.044904225,0.6471276522173589,0.04200626501073093
96185,SIDM00455,Lapatinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.90229774,0.03325587,-0.07751654467678229,0.11129480049239951
75839,SIDM00833,MK-2206,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,3.3588147,0.17646515,1.4739342632289714,0.10843169954883816
1351,SIDM00455,MK-1775,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7506874,-0.04475738,0.43160458223401327,0.035483866613567346
57040,SIDM00042,Irinotecan,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1411446,-0.11551138,-1.7715235317761278,-0.06743692209742724
73030,SIDM00872,Vorinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.762246,0.24821998,1.4334034170403003,0.16034185852277494
99697,SIDM00933,Paclitaxel,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.8844604,0.35043716,2.8121387772321795,0.24140226344292962
36055,SIDM00455,MK-1775,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.82488006,0.056498267,-0.5824318900824783,-0.022118623802653066
67886,SIDM00776,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.6392639,0.04416049,1.7269113729024925,0.09042198256670764
83710,SIDM00097,RO-3306,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62749964,-0.030943511,-1.0489116180688771,-0.033232292732092744
10716,SIDM00146,Palbociclib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3987155,0.11178021,1.6556957324906483,0.09792081716006225
3594,SIDM00832,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-3.7895224,-0.10523897,-0.054479085588537694,0.0074091071530853255
27714,SIDM00776,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.1147594,-0.039973307,-0.3502139664832953,-0.0009461202464915603
106425,SIDM00633,Doramapimod,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.509389,0.047355592,-0.682064777070886,-0.0063990596028571985
95720,SIDM00872,BI-2536,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.3279173,0.11270593,1.6487746360525435,0.07472897672196871
38411,SIDM00673,Uprosertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8438214,0.109754466,1.6816017363817888,0.07569844439987829
6971,SIDM00837,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-3.471975,-0.1494608,-2.9975778048639543,-0.10878514005205489
42858,SIDM00872,Ribociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2711731,-0.026613174,1.5345219230062443,0.06435512120001019
14080,SIDM00933,Entinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,2.286924,0.086400904,1.2109661678626622,0.02929058380457273
54252,SIDM00148,Docetaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0610665,0.081764705,-1.8590193619390005,-0.09450182551571931
61472,SIDM00872,Palbociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39179444,-0.014409106,0.33467825652684746,0.014653185024328948
4414,SIDM00877,KU-55933,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.44012594,0.02860391,-1.4573146568631905,0.012170276490864473
41245,SIDM00042,Oxaliplatin,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.812048,-0.1984457,-1.940088666192582,-0.09396382726113899
53185,SIDM00957,Dabrafenib,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.0133277,-0.012796137,2.307709833669448,0.09354113274604808
64556,SIDM01187,Pictilisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1984661,-0.09653881,-2.0565449577422594,-0.035212240140735915
84195,SIDM00928,Uprosertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.85593873,0.04941723,0.25097631691813954,0.03160010788821893
94834,SIDM00832,AZD4547,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.8384972,-0.048203878,-0.31178562496663775,-0.0013793112323822305
15446,SIDM00875,Luminespib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0116686,-0.09537785,-1.2672716665687003,-0.13359188832536356
35999,SIDM00950,SCH772984,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5151073,-0.14477381,-1.7432200566872804,-0.06557132232225418
73418,SIDM01187,Cisplatin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.7040224,-0.1439807,0.08029415621635239,0.0344846966534996
81593,SIDM00833,SB505124,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.6627164,-0.09276529,-1.3317990939257018,-0.0920324333669291
57369,SIDM00950,Gemcitabine,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.9325376,0.24261184,2.9158672942755897,0.11144306641924967
45058,SIDM00097,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7973588,0.08049966,-1.6652895067862923,-0.06599704185408749
26521,SIDM00633,Vorinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9515383,-0.07296353,0.7361612318181371,0.014087737038552452
60195,SIDM00933,Palbociclib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.8631978,-0.11689396,-1.9491010750296205,-0.047102319211346895
11977,SIDM00633,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2059345,0.06580138,2.7192297406912616,0.09207013340523965
55361,SIDM00097,RO-3306,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9365298,-0.083294,0.37678832954752633,-0.009447429759784262
16370,SIDM00148,Doramapimod,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.44876269,0.034102857,0.03319891108746047,0.1019559512275559
12346,SIDM00837,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,2.5962558,0.15604389,-1.288701339913097,-0.08516965447953925
71083,SIDM00928,Venetoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,-0.6741841,-0.01979834,0.3390110086423725,0.029180981358611163
10815,SIDM00835,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.146317,0.1360238,0.7453792420334232,0.057076620123950705
74434,SIDM00933,PD173074,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.286123,0.2082588,0.7471032353890291,0.13783184721918443
39499,SIDM00957,AZD4547,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-5.0320745,-0.098712765,-1.5401562665191648,-0.03263207288266283
73836,SIDM00776,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.96476203,0.07565357,0.7419000697732719,-0.010376577006585739
28585,SIDM00957,Olaparib,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.3871176,0.065845646,1.1822215857765042,0.021410572972698824
11565,SIDM00877,Uprosertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.14290439,-0.014756717,0.6518791973265928,0.055655950170644126
92942,SIDM01187,Axitinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8656943,0.055495266,-1.6564312012945988,-0.03776114060470098
78071,SIDM00933,AZD6482,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.8872919,0.09283618,1.3569131127360872,0.04421762570195509
43087,SIDM00146,RO-3306,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.8763477,-0.052347153,-0.5262327741153111,-0.023242861262914482
93989,SIDM00146,Paclitaxel,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0141665,0.07856054,-0.4342016712672777,-0.03127553135369637
62485,SIDM00148,AZD6482,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5511483,0.12899373,0.34505337213680376,0.04189982724801604
64548,SIDM00455,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8209269,-0.055923853,-0.6916662739200962,0.030144282694262337
64561,SIDM01042,Ribociclib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1767743,-0.02945112,0.5264204061721369,0.028952889509241988
22794,SIDM01042,ZM447439,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.590767,-0.18977901,-1.118462208805028,-0.10483044580458811
37556,SIDM00933,Doramapimod,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,3.162903,0.12648018,3.2366546414053428,0.08470843352075752
60924,SIDM01197,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9322221,-0.056376737,-1.3548795937133897,-0.04379319413725806
61533,SIDM00673,Afatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.72932065,-0.05440642,-1.3090263332514553,-0.03521050314438175
26282,SIDM00928,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.5554156,0.33971933,-1.5362680096138157,-0.05535750067703525
60254,SIDM00837,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.2035315,-0.006336643,-0.008024492234866704,0.029539175522942454
107576,SIDM00957,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-4.158889,-0.16708608,-0.9129351138768517,-0.012470665966317828
60536,SIDM00359,Trametinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.3827314,-0.13736588,-1.2904590787637578,-0.055839825307675325
99315,SIDM00282,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3221674,-0.08841387,-1.9155430885580895,-0.1400682575280122
63772,SIDM00833,Vinorelbine,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,4.3891387,0.2169404,3.1027813343389523,0.1751355230256946
10232,SIDM00837,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.79482967,0.020760972,-0.1366910456839413,0.009271354723008744
105589,SIDM00633,Vorinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.87831193,-0.074159585,-0.591263963716216,-0.06315293008145591
22490,SIDM00957,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.809087,-0.058228344,-0.337597524010389,0.017795258477083967
47990,SIDM00835,Navitoclax,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.41658524,-0.030187333,-0.1674017659990975,-0.0035573310731483922
12927,SIDM00146,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1317276,-0.07804325,-1.2122619628474411,-0.06425805681800707
102093,SIDM00957,Oxaliplatin,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,4.6186666,0.101455376,0.5919606855619752,0.033217239551473994
46225,SIDM00633,Axitinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7321494,-0.071416885,0.06344366388359322,-0.01744580410158287
16523,SIDM00832,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-1.0835589,-0.07313665,-1.933157347630035,-0.0748985714811887
86300,SIDM00097,JQ1,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3805175,-0.10794804,-1.1173178670348884,-0.0938147917605496
19118,SIDM00216,SB505124,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.30975026,-0.012493752,-0.9933117260751319,-0.07770772900814767
91709,SIDM00933,Entinostat,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,3.640638,0.26223445,0.10370548887048926,-0.0011988501716296354
11300,SIDM00833,SB505124,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.5604672,-0.029914532,-1.303914205964337,-0.07166369315107893
37674,SIDM01197,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.69540197,-0.05402988,0.360610955134159,0.053310580998900875
14007,SIDM00957,BMS-754807,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.3604276,-0.08828113,-2.4306008507842582,-0.13708235116299022
27728,SIDM00826,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-1.3253585,-0.01338774,-2.0054773410941267,-0.0757810131654172
102922,SIDM01042,Camptothecin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4804511,-0.04327261,-0.1101354530862406,0.01723827251936346
29520,SIDM00833,Dabrafenib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.9737116,0.04492746,1.5288197175925151,0.027421840106789323
85589,SIDM00928,Afatinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.79877543,0.09039426,1.3849098219907168,0.08548387194312283
73863,SIDM00833,Afatinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.08723742,-0.007286969,0.1643113625553033,0.012837649137940155
59327,SIDM00872,Entinostat,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9535568,-0.05759815,0.022212049122266545,0.024473970103942463
46418,SIDM00148,Navitoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.21590547,-0.020338548,1.6336331288737187,0.037213875184564045
58678,SIDM00282,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6967013,-0.044014037,-0.34769443880746725,-0.008706449106196758
64468,SIDM00359,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7941403,-0.06607681,-0.36347769089528853,0.0014297072942722477
32284,SIDM00633,Alisertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.580251,-0.13383138,-2.3968106920586716,-0.14351976987614753
104487,SIDM00877,Sorafenib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.93676764,-0.06800635,-0.1379150960851788,0.037177297746138344
57624,SIDM00097,Nutlin-3a (-),Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6267357,-0.06862316,-0.5182323238631231,-0.002694348563117441
28043,SIDM00146,KU-55933,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0928416,-0.04726395,-0.00926867488461421,0.016303274352826688
76566,SIDM00933,Dabrafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.7659492,-0.14646189,-1.007884891640398,-0.03155800528539749
47737,SIDM00928,Ribociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.2247744,0.055821985,0.5455954746790364,0.007828637683449774
68208,SIDM00359,5-Fluorouracil,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0784885,-0.05839544,-1.0701655121103046,-0.019272399024304623
56691,SIDM00877,Entinostat,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2032511,0.0875854,0.6380970462172958,0.04741031444403399
84032,SIDM00633,Linsitinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.9863577,0.2656786,2.4315971581017823,0.06305579440249548
38455,SIDM00673,RO-3306,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.0309151,-0.06576847,-0.4503519981244423,-0.06537335941962402
73258,SIDM00877,PF-4708671,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.14267263,-0.0113851875,-0.8478458925721294,-0.031946332659367076
81920,SIDM00933,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.31566212,-0.024961406,-0.3269062738970237,-0.02882259251008109
39813,SIDM00933,PF-4708671,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.9194118,-0.13193531,-1.4680186024144324,-0.04734505169132804
17610,SIDM00933,MK-2206,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1900895,0.15388827,1.2026097918881207,0.10671613676144338
83605,SIDM01197,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.0766935,-0.071976654,-2.11085801449417,-0.041378732143382134
28801,SIDM00633,AZD6482,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4346662,0.10068979,-0.9974933207974571,-0.028653969375553857
91102,SIDM00097,Sorafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9253245,-0.037489146,0.10542717714086211,0.048105879648068235
29946,SIDM00950,5-Fluorouracil,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.935201,-0.09496921,-0.6295268374978068,-0.08635958970426844
36955,SIDM00455,LGK974,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2589751,-0.0434425,0.9630501300486957,0.03975958803377036
32913,SIDM00826,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-0.7790575,-0.0403174,-1.2082458793820203,-0.07145502869793062
55178,SIDM00928,AZD7762,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-1.3010747,-0.130188,-0.8503585237391263,-0.057381111204768596
6051,SIDM00835,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-1.182597,-0.0842747,-2.0915491953524894,-0.07123746849299915
46119,SIDM00872,Gemcitabine,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0244942,0.03204618,1.793050331172142,0.05880822263776938
93927,SIDM00833,AZD7762,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.1237775,0.086238235,-0.2502274431188149,0.014116528413129029
42194,SIDM00837,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.9066045,-0.057704598,-2.8593044630618483,-0.13624444822195
88948,SIDM00776,Afatinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.4933903,-0.12086825,-0.8776108833784698,-0.08853824308602926
10231,SIDM00832,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.5739731,0.028327987,0.8423348232447255,0.03077609581134626
44808,SIDM00776,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.34361032,-0.03131284,-1.5134106127795823,-0.09772836846728372
78736,SIDM00455,Sorafenib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.3383793,-0.015384031,0.11825583412511757,0.05960045359726194
38674,SIDM00835,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-1.489523,-0.11651203,-0.2670137781381668,-0.046988952635220974
21699,SIDM00872,Navitoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4603892,-0.029575884,-0.10094186758780267,-0.03888354747299805
82711,SIDM00097,ZM447439,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8577232,-0.03939536,-0.30615277565780646,-0.02005013286661706
69525,SIDM01197,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,1.1186703,0.0632875,0.9180701159445487,0.04405405949120949
93306,SIDM00928,Gemcitabine,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.4865618,0.11769831,-0.4183045969692338,-0.07040050388676891
17219,SIDM00950,Dactolisib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3176023,-0.09911252,-2.120753586265489,-0.1810819704776501
34959,SIDM00933,Pictilisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.3766697,-0.051699325,-0.1796099237635033,-0.001977023453216788
95897,SIDM00928,Trametinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,9.036618,0.19308312,2.9851256875644947,0.11777174218778381
98231,SIDM00933,Cisplatin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.6700646,0.20700659,-0.5540387984396578,0.020367767059392052
60600,SIDM00928,Sorafenib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.3017371,0.117240615,-0.8437137406680502,-0.027969705469541462
33578,SIDM01187,OSI-027,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6432911,0.14228834,1.612996490983868,0.16205230538486404
89628,SIDM00933,Tozasertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.9685485,0.22783928,0.6840744609205873,-0.06135244043737604
102592,SIDM00673,Palbociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.51067895,-0.021359988,-0.5231210073518496,0.026906169679849545
16572,SIDM00832,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-0.9684339,-0.078086756,-0.6206876682415652,-0.07083383349494089
69475,SIDM00146,Axitinib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.65063965,-0.0514566,0.015177820280555393,-0.003372887508596119
84058,SIDM00957,SB505124,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.023665,-0.04198259,2.2167769002368103,0.09172990591731744
67925,SIDM00875,AZD6482,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1021127,0.07906647,2.1835308037751684,0.10230065870030838
85996,SIDM00673,GSK269962A,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.9998722,-0.15939084,-0.16020990495948145,-0.0022105187069516555
7887,SIDM00148,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.90518355,-0.032628007,-1.1059318370564342,-0.03662843142454499
85510,SIDM00776,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.3507637,-0.04355175,-0.02513320915463452,0.008211927249940054
81096,SIDM00835,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.1850392,0.091061056,2.7527967199513634,0.18483968593524405
18939,SIDM00633,Taselisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2604973,0.0777866,-0.09322258655157202,-0.019431640471275477
95747,SIDM00282,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.5897105,0.07573333,2.212574637897833,0.04951807558250048
98047,SIDM00933,GSK269962A,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.0025781903,-0.0002691485,0.254778533488144,0.06400757531493531
67482,SIDM00633,Gemcitabine,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4448824,-0.16599295,-1.8146714166913682,-0.053883153478499354
46393,SIDM00872,5-Fluorouracil,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.702402,0.045859307,-0.5677485509445254,-0.031825262687942356
22961,SIDM00837,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.39361283,-0.010525327,1.9088696896463662,0.02346262941444229
28814,SIDM00872,Alpelisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8013604,0.14418477,0.6923825691587375,0.052436392094673
30732,SIDM00875,5-Fluorouracil,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1824548,-0.1162633,-2.1741534766951847,-0.11997811487170779
58624,SIDM00950,Sorafenib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.581423,0.10974006,0.09893620399247999,0.009363875622887177
77623,SIDM00776,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.7742832,-0.048000712,0.17565940980358005,0.033933016232177
91690,SIDM00877,Ribociclib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.76492584,0.01526285,0.19132991776907976,-0.0020187794064268454
85857,SIDM00146,Paclitaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9130962,-0.208226,-4.097740554518281,-0.2431464205255731
64291,SIDM00950,Palbociclib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0561624,0.14333358,0.5684629370959137,0.0460283444367263
60903,SIDM00833,MK-1775,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,2.2575853,0.07787392,0.6295822821654851,0.0364867055585622
68762,SIDM00875,5-Fluorouracil,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3348773,-0.16029696,-1.2630841306751883,-0.06943471581734312
25882,SIDM00216,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4681044,-0.08984728,-0.8764514368118362,-0.05254207884894153
103457,SIDM00097,Palbociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5091178,0.14816096,-0.819746875468312,-0.02311898739782179
31431,SIDM00833,Afatinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.6001663,-0.10719308,-0.8008989838378167,-0.09599127681998634
3573,SIDM00042,Taselisib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3733776,-0.038968034,-1.135070877283467,-0.06344399542673682
35222,SIDM01197,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.8833117,-0.1562027,-2.494697107690638,-0.13484364064189583
75098,SIDM00776,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3541176,-0.07462091,-2.9008385578330693,-0.0761502376827823
96131,SIDM00875,Uprosertib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.229936,0.04084923,-1.1292683706302913,-0.015208765590911388
7182,SIDM00877,Axitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.5685403,-0.09043849,0.42279671151014164,0.09487899589437324
47941,SIDM00097,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.6063666,0.24306315,4.944806508845979,0.22016273727166163
65823,SIDM00877,MK-1775,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.024618832,-0.0015771847,0.41422966454005394,0.026610660040828408
47387,SIDM00826,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.41222596,-0.019731253,-0.5993305849603496,-0.018584901627913937
77697,SIDM00148,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4226004,0.08097588,-0.0916883123440797,0.009735888057428747
99863,SIDM00673,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.39349622,-0.020705098,-0.09605708470024212,-0.014458425399460276
67802,SIDM00633,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.9696937,-0.15928355,-3.0924830227666122,-0.14765503439015915
95317,SIDM00148,BI-2536,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5065911,-0.064268135,-1.8581685305659381,-0.07496965440418854
10143,SIDM00933,AZD8055,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.9477139,0.2630149,0.37450828021680843,0.027114488808772114
76143,SIDM01042,Trametinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5430553,-0.13934307,-0.7418344845825485,-0.060843504332856714
1321,SIDM00877,Uprosertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-2.079173,-0.1273778,-1.4851178668236897,-0.03512021885597976
95640,SIDM00042,Cisplatin,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6222916,0.04387857,-0.44299471856778355,-0.01930566904807923
41891,SIDM00673,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1770064,0.027228957,0.6845733507662921,0.07715082023578061
52852,SIDM00872,Lapatinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.066556,0.10130748,2.5166297793875763,0.17871770710815493
92850,SIDM00633,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.47857508,-0.015248836,-1.0619118042165738,-0.03049299220300032
105082,SIDM00872,RO-3306,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4762473,0.11065278,-0.46030678301765804,-0.02155354303829107
27309,SIDM00826,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.697085,0.08574551,1.223677469766013,0.026376679008794344
63801,SIDM00933,Ribociclib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.83890504,0.00907451,1.9131204507953816,0.006769402091795259
32852,SIDM00875,Camptothecin,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4235723,0.1469229,0.22860032237890987,-0.012617798556342522
65032,SIDM00097,GSK269962A,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.60218966,-0.025233895,-0.09499909167159283,-0.03201029965149301
97076,SIDM00833,SCH772984,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.054564,0.08212088,1.4451580233920045,0.12351423279393674
4309,SIDM00872,Cisplatin,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.35443318,0.01121319,1.4087499818817317,0.08429875565463579
10685,SIDM01197,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5954695,-0.12234224,-1.842299110218013,-0.009479512554800713
9183,SIDM00633,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1549122,0.105986655,1.961126778697939,0.06543877584011172
25705,SIDM00872,Entinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7782241,0.061670613,1.00626704324791,0.06097966195867812
25557,SIDM00933,Taselisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.96064,0.15398254,-0.347643378891082,0.0032014979562972794
6221,SIDM00282,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4394978,0.10709906,1.5271824553524382,0.09981323649010178
99200,SIDM01187,Bortezomib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7699735,-0.05983222,-0.39817484028806066,-0.034041234327816916
44013,SIDM00633,Alisertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3248694,0.1313267,1.3757210434845493,0.05190287395413161
4035,SIDM00148,NU7441,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8374753,-0.07895107,2.13785588364178,0.1462869378803063
39823,SIDM01042,MK-2206,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6503706,0.043186408,0.11104261597478246,-0.020587057463086523
33372,SIDM00933,ZM447439,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.3529906,0.19938464,-0.07655425609251525,0.049729841270448674
79627,SIDM01042,Camptothecin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1742766,0.09188619,1.1475010909851115,0.010693611872921477
93077,SIDM00875,NU7441,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24255078,0.022156712,1.0255177007404142,0.05739489231519097
2819,SIDM00832,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.56201965,-0.021418476,-0.6775278030026013,-0.002492058575972185
9256,SIDM00633,Docetaxel,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.6429152,-0.24083443,-3.775230901510605,-0.27297943658908025
51101,SIDM00833,Oxaliplatin,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.78151345,-0.049807608,-0.7972690295379674,-0.044319473666389476
63848,SIDM00835,Navitoclax,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-0.3647361,-0.02635483,1.7228329238238282,0.0776047576361674
53293,SIDM00875,JQ1,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19338743,-0.020463334,-0.8430256334253492,-0.06318293190866951
102841,SIDM00928,Axitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,5.011259,0.406225,2.8647011874610566,0.25022685231388764
79974,SIDM00833,Navitoclax,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.6398218,0.11663551,0.721126667377173,0.05059102202781318
27283,SIDM00455,Oxaliplatin,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.1829042,-0.1230891,-1.7997448831619909,-0.03647972424103887
89841,SIDM00282,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.6221217,0.041341238,1.0653756009048534,0.11532229001219918
14818,SIDM01197,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1298862,-0.11655554,-2.178775151111045,-0.0646729166165733
94975,SIDM00928,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.0145676,-0.124163635,0.20438436485551453,0.07155660860335379
40989,SIDM00455,OSI-027,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8461926,0.057952523,0.6216702978202764,0.011937310109056212
28435,SIDM00832,BMS-754807,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.0992429,-0.03453015,-4.173292899137337,-0.1124408455030226
71765,SIDM00097,Vorinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.87982875,0.05682253,0.472579164038283,0.0032488085164180712
44270,SIDM00872,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0762028,-0.09198774,-1.2871027105506954,-0.10777515140717656
42882,SIDM00872,Palbociclib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5451109,-0.019913007,0.16798592281832936,0.0016956284863314356
71301,SIDM00950,MK-2206,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.67575,0.16951744,-0.22557606776836403,-0.036708139400887976
99305,SIDM00872,Paclitaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-6.0106626,-0.5363346,-3.392846460160463,-0.2956459149326584
55050,SIDM00097,Navitoclax,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36939386,-0.02611413,0.06027090035461991,-0.03501486311817347
86372,SIDM00837,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.40461096,-0.018450407,-0.15692221060485512,-0.02003667785794881
27923,SIDM00673,5-Fluorouracil,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.57920355,-0.023576519,-0.6606112838790513,0.0071963795488934924
100702,SIDM00933,GSK269962A,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.1351473,0.09741524,0.1938182114641317,0.08224494687218985
106781,SIDM00097,Lapatinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.745364,-0.13538526,-0.6569359291511153,-0.06626099885710138
3832,SIDM00877,Alisertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-0.4487122,-0.030530635,0.9963008853030397,0.10643352012981384
106172,SIDM00877,Alpelisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.5291865,0.0981928,0.5254885017665362,0.00820535913873185
74804,SIDM00826,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,4.092907,0.37044927,2.4372335405812553,0.19628120655361997
48324,SIDM00148,Lapatinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7948241,-0.079713255,-0.7344654129986059,-0.04713315645124102
27652,SIDM00216,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4705873,-0.07817891,-1.214872995333678,-0.049188480232016774
96132,SIDM00928,OSI-027,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.3344579,-0.08908461,-1.1801782767665503,-0.06068989511617376
55194,SIDM00877,Alisertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,3.0097775,0.33240926,2.725211735938174,0.1624443393204955
79180,SIDM00097,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.011882,-0.079609126,-2.786163499765484,-0.03192834689023717
25283,SIDM00877,Sorafenib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.6301285,-0.031223902,-0.34055524108274804,-0.023802418726203915
56274,SIDM00832,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,0.8208164,0.018254103,-0.5646364324004234,-0.011223535545956493
21917,SIDM00282,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.97522706,0.057156075,0.47235173397105373,0.043186453829977774
65282,SIDM00216,Camptothecin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5485377,-0.1341244,-2.4178020823314856,-0.15183499724325417
3056,SIDM00282,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.0795876,0.055736534,2.962693590893655,0.18316663290119134
77344,SIDM00633,Nutlin-3a (-),Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4621348,-0.14790426,-1.448672025229832,-0.08071227257428976
33106,SIDM00148,Paclitaxel,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5389524,0.20796463,2.637665915389291,0.17920531884648122
81137,SIDM00928,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.1979022,-0.08471085,0.21825688465783147,0.019169404176602206
69662,SIDM00148,Alpelisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2742903,0.12342408,0.7685233167139314,0.027158981084989632
64158,SIDM00837,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.74254245,-0.018419776,-2.211941727710821,-0.07431724788854503
18291,SIDM00835,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.6419108,0.047219697,2.9142495787250615,0.07506092904416398
11768,SIDM00146,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.8233355,0.04616272,2.1587869595612625,0.055251251239175014
9006,SIDM00835,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.9729898,-0.08782567,-0.17638280848485866,-0.025460369798050487
24465,SIDM00933,KU-55933,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.26899227,0.004720253,0.3421102205058401,-0.028331837370945905
1871,SIDM00837,Olaparib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.3273647,-0.06296597,-0.8823117189288677,-0.04321411218383048
77569,SIDM00933,ZM447439,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.044608,-0.053891957,0.6660293005609821,0.04667769588827662
52439,SIDM00875,Entinostat,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3924037,0.02857699,-0.801550989681522,-0.008692753289737364
104645,SIDM00957,LGK974,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.7449544,0.012830147,0.00168605483642577,0.004253346440631775
101222,SIDM00928,Vorinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.2279634,0.22487693,0.6643577012569846,0.07430192870097893
23183,SIDM00877,NU7441,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.54565686,0.06605665,1.048387485418132,0.09192758455071931
89636,SIDM00146,5-Fluorouracil,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.854904,-0.046662007,-0.5055806596171418,-0.031176715816820362
93291,SIDM00957,Palbociclib,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,0.057901967,0.001488205,0.04749794999467791,-0.010242119304777758
35238,SIDM00673,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.3554127,0.16598894,1.5464824029575441,0.06562436823729063
97531,SIDM00872,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.470967,-0.12111374,-0.5169218767484419,-0.019383493668255272
81337,SIDM00833,Camptothecin,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,1.6482581,0.124940686,-0.3651721469591115,-0.01996748691184636
68365,SIDM00833,MK-1775,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-2.0229661,-0.07430936,-1.472401442989249,-0.06158484639467725
73178,SIDM00833,MK-1775,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.42489538,-0.024516424,-0.6057724905636425,-0.027946229497947447
53326,SIDM01042,Linsitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1000702,-0.12555602,-0.39834847526587996,-0.04239928765374638
41208,SIDM00832,Taselisib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,2.7202318,0.11569742,0.33064727409324574,-0.00871603661037245
24004,SIDM00826,LGK974,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.27259922,-0.01634473,-1.2918371207949753,0.012054900471650138
88559,SIDM00875,Gemcitabine,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-9.2744055,-0.082446665,-3.7474222996510034,-0.10736576720096744
57793,SIDM00633,Trametinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7731817,0.039658323,-0.5153350405211825,0.019400719941678655
41995,SIDM00146,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.47620398,-0.013840902,1.019001974270964,0.06835366446566887
104995,SIDM00833,MK-1775,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.11508978,0.004832553,-0.18657011033373966,0.01721389834633665
100923,SIDM00148,Ribociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.29447678,-0.02231891,-0.9735333489832064,-0.025176621212294973
38505,SIDM01042,Paclitaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.8270798,-0.37008604,-5.340041909617404,-0.3188695780488099
83714,SIDM00042,Gemcitabine,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.22832511,-0.0249363,-0.6826355204248095,-0.06073567761441869
54419,SIDM00877,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.9862546,0.0539825,1.695001692832893,0.06425090051789496
86505,SIDM00148,Navitoclax,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.35479444,-0.031989735,-0.6677782411101394,-0.053221981061328395
102781,SIDM00928,PF-4708671,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.1522144,-0.092035405,-0.46701450082951224,-0.02537262709543204
53279,SIDM00776,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.2279242,0.11162055,1.3936547406118514,0.07922229096998351
24437,SIDM01042,KU-55933,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.0037930715,0.00037945123,-0.16833958603514115,-0.02083302008250374
764,SIDM00673,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2944522,0.08991363,1.9722990685218023,0.12061948813077467
7220,SIDM00875,Docetaxel,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.9104292,-0.29045182,-2.1839387944227053,-0.14211284245778372
36510,SIDM00835,Trametinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.3461163,0.058576442,1.9281532223695739,0.06057233254587779
58604,SIDM00097,JQ1,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1957479,-0.0643857,1.7981806078007878,0.09333378390758242
31448,SIDM00933,Alisertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,0.5652611,0.06273707,-0.7751395366254278,-0.024859411752148175
61090,SIDM00633,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1817014,-0.089527264,-1.0414531621990688,-0.0921874305991969
35608,SIDM01042,Pictilisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87429005,-0.06578396,-0.5209156911000782,-0.052510957070387304
15051,SIDM00633,Bortezomib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6121386,-0.047763024,-1.2937545896036948,-0.07961265002069617
78645,SIDM00957,BMS-754807,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-0.61610824,-0.024389395,0.5483086028016374,0.02007688917993316
63822,SIDM00877,Crizotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,0.40865678,0.038609274,0.021726827309665443,0.017548636870922004
425,SIDM00835,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.753819,0.1315514,0.9518091227802339,-0.017907128613037122
49731,SIDM01197,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-3.0385237,-0.0809929,0.4004643980293547,0.015785018122349066
42030,SIDM00933,MK-2206,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.4673922,0.30251232,1.5271283334380068,0.09619869174692264
102370,SIDM00826,Palbociclib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.79619455,-0.08324823,-1.454542922313644,-0.13840048944959019
98734,SIDM00146,Sorafenib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.4711083,-0.13124272,-0.47139763167987475,-0.02549016137800293
76308,SIDM00146,Alpelisib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.6243662,0.025212461,1.3512710551583051,0.129739683609337
102716,SIDM01197,Afatinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.0135655,-0.04704573,1.7835626078408893,0.09234913200517927
75555,SIDM00950,Taselisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9414531,0.04767088,-0.012832933603168974,0.013922298174951908
68152,SIDM00928,Olaparib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.2415648,-0.05007859,0.008289185553296042,0.032814993883865495
106273,SIDM00359,Trametinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6612337,0.03671949,1.6353087234516208,0.056943597124497106
57110,SIDM00933,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-3.154033,-0.078163885,-3.2170423943125455,-0.08173994820118348
34670,SIDM00826,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.6391033,-0.035955124,-3.381460920136907,-0.07129251787115766
29526,SIDM00148,Olaparib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1783578,0.060583375,0.23333517066309786,0.022846532792385434
26738,SIDM00950,5-Fluorouracil,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.99939805,-0.090740964,-1.2245142138668414,-0.08905077527956587
49531,SIDM00148,Venetoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,6.7257385,0.48879492,-0.1656675495197283,-0.00999631084094881
30421,SIDM01187,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.3864312,-0.19150697,-1.2701371951471,-0.04371084125109344
105321,SIDM00633,Bortezomib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5781846,0.09704898,-0.4905756981394238,-0.02400213403206326
70968,SIDM00097,AZD6482,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9166522,0.06154553,1.6731225037804651,0.05624654117734748
23182,SIDM00877,Sorafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.077118,-0.06615279,-0.00395235135127727,0.035602205866997555
61781,SIDM00673,Alisertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7440627,-0.1308107,0.00730389241984692,0.013321203050810068
81234,SIDM00875,MK-2206,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5367438,-0.03736351,-0.8613914083941966,-0.04717102380376888
13725,SIDM01042,Alpelisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2106069,0.105809964,1.1605519093525059,0.11933643645360566
10162,SIDM00673,Gemcitabine,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4898908,-0.09394255,-0.29840395350789856,0.03585814532824353
18337,SIDM00216,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2230386,-0.035129905,-1.864644278140903,-0.11749657310548023
21576,SIDM00455,Erlotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.032336,0.111893974,1.8935045154455485,0.049607156527773186
97322,SIDM00837,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-3.136678,-0.09241936,-2.1154221216628457,-0.13646754258808888
106194,SIDM01042,SCH772984,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6146914,0.11780827,3.2395231088750838,0.022223277306780906
82073,SIDM00950,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.5802464,0.10163783,0.9244615686019574,0.09995882658790656
28032,SIDM00216,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.623806,0.060524706,-0.9090505226233581,0.005066319651751187
96595,SIDM00950,Irinotecan,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1101823,-0.069855236,-1.666700019412215,-0.06583557164309035
13091,SIDM00957,Taselisib,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.6456994,-0.044465866,-0.24311024803296818,0.06105489904060477
60096,SIDM01042,Alisertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.28747758,-0.039644074,-0.6547004561801839,-0.04507514381253745
66554,SIDM00875,Gemcitabine,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6675031,-0.0015493915,-1.5977922087815808,-0.027937483304008585
81976,SIDM00455,Linsitinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3646233,0.122466415,-1.7072337788340808,0.006629644463964678
87601,SIDM00146,Linsitinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.5677185,0.033825908,1.7027472247865056,0.01578001594208287
52765,SIDM01042,JQ1,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.25573796,-0.00849821,-2.045948596574011,-0.13025675465422654
1868,SIDM00673,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.318241,-0.099680275,-2.330888482441881,-0.061643972489792496
99394,SIDM00146,Sorafenib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.9716485,-0.08784235,-1.1126490553324202,-0.08573558800559898
7820,SIDM00673,Sorafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8346353,-0.13646655,-0.3715114644919311,-0.031654552144034453
74304,SIDM00282,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3637477,-0.095390745,0.2830908644959242,0.01739578011830776
37115,SIDM00950,MK-1775,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.78801847,-0.06833233,-0.5880826823230939,-0.03887575018338445
26260,SIDM00872,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3766576,0.11464953,1.01542545074725,0.03400132489243769
59796,SIDM00216,MK-2206,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,3.8900247,0.29900396,2.1737913927634716,0.062181414898504754
44158,SIDM00146,Olaparib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.6797798,0.11344821,-0.18442971633281524,0.031702000067069164
58593,SIDM00673,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.8784142,0.058233466,0.015430303769132417,0.04821762325023628
105699,SIDM01187,MK-1775,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5438998,0.050394665,-1.333685251706613,-0.058016609470162996
93041,SIDM00148,Ribociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8694102,-0.047345165,-1.4082159967754706,-0.02763804185844657
74840,SIDM00872,RO-3306,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6767701,0.13074066,2.2720445013910275,0.12652388553854754
39281,SIDM00633,Vorinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3928775,-0.113500856,-0.6028616897000466,-0.03876925363015041
3254,SIDM00097,5-Fluorouracil,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3620415,-0.13864589,-1.5766188796419522,-0.08052913405755917
47223,SIDM00933,ZM447439,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.2193624,0.098714896,-0.262201799165181,0.04989148933504843
22525,SIDM00950,MK-2206,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2439955,-0.11025781,-0.572889226508634,-0.04778318191439129
48052,SIDM00928,Nilotinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.6861665,-0.2071004,-1.2547328444049857,-0.12356939221392228
60281,SIDM00950,Oxaliplatin,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.68538404,-0.043685358,-0.7554232705963971,-0.015049782558835226
80462,SIDM00933,Olaparib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.3779633,0.14072034,-0.5562414518171356,0.01992187950459143
9341,SIDM00826,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-4.008191,-0.22366457,-2.053417937162754,-0.14010835803993
76672,SIDM00877,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.3324426,-0.03857024,0.8540284582273118,0.026172231157124734
43134,SIDM00097,Cisplatin,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3205355,0.02579956,1.4526949877068487,0.06318073092773756
5993,SIDM00877,Crizotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.19031094,0.01751461,0.8081560575933936,0.04477468893726427
399,SIDM00928,Luminespib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.1880133,-0.09934226,-0.845210455616124,-0.07541321357752413
41626,SIDM00673,NU7441,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.5677428,0.20669729,2.0278403159866527,0.11141841039020939
104022,SIDM00776,Oxaliplatin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-2.5007954,-0.08330531,-2.290781390849846,-0.06409547829326978
82760,SIDM00633,BI-2536,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.177233,0.16510363,0.7209367626571233,0.039343051804373176
61159,SIDM00877,Pictilisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-4.9175067,-0.26594114,-1.8580680167787897,-0.1218134281428957
154,SIDM01187,Axitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.21544538,0.020152763,-0.7646198656129114,-0.03922793777098025
64978,SIDM00877,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.54207283,-0.024690304,0.29377377937796023,0.02314329600733571
92968,SIDM00933,MK-1775,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.28542346,0.018774766,0.1897870579472323,0.03647402745279543
30683,SIDM00633,GSK269962A,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.35940346,0.029634343,-0.15414375948490494,0.016319081051465407
14772,SIDM00633,GSK269962A,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.72352636,0.06775176,0.467499007249805,0.018815181658376968
57199,SIDM01042,KU-55933,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6978885,0.075506665,0.361356809518462,0.04542565400473551
95036,SIDM00673,MK-1775,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.621548,0.059801053,-0.6987241232951967,-0.05119233379347979
71343,SIDM00146,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0776203,-0.08392741,-0.15468013107472697,-0.06756063631716382
106201,SIDM00872,RO-3306,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.63027567,0.04272968,-0.005649754994770107,0.016308526715177088
34803,SIDM00633,OSI-027,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.8976493,-0.14800839,-1.8890890426406555,-0.07188348912400123
107747,SIDM00928,OSI-027,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.6505622,0.09472054,0.8376573858136176,-0.006160454936476093
3988,SIDM00835,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.6477045,-0.042427026,-0.5766117379862078,0.034052195529294775
48606,SIDM00877,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.61655384,0.06957315,-0.46541028272154306,-0.002391656089915363
76951,SIDM00097,Olaparib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2277775,-0.022348084,-0.24522959723379437,0.008862872463233359
67325,SIDM00455,SCH772984,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2582337,0.08316929,0.8235627972418201,0.04802297916003028
33373,SIDM00928,AZD8055,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.1279868,-0.096490346,-1.15797118751864,-0.05060634369967601
97152,SIDM00875,Entinostat,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48198608,-0.044390455,0.15445730775414973,-0.043923057488169485
86299,SIDM00826,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-3.051318,-0.10895661,-3.840886450102467,-0.15461083241309728
19238,SIDM00933,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.2910907,0.13367777,-0.5588013399265883,-0.010140473759133396
23042,SIDM00673,OSI-027,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.5824753,-0.059935905,-0.43958661034917057,0.004760086921629813
102111,SIDM00455,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0819187,-0.15091045,-1.367273879188733,-0.08468910085367094
31550,SIDM00833,MK-2206,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,3.5770595,0.25293064,0.3473480813781334,0.060781229025766166
32311,SIDM00097,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9339131,-0.08960168,-1.1400950514267338,-0.027620304678057133
565,SIDM00928,Temozolomide,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.8065134,0.04806978,0.9094441594901695,0.010549239255841223
65429,SIDM00950,MK-1775,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7643551,-0.0556882,0.08178943608085404,0.03802163241690567
13880,SIDM01197,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.0299029,-0.024772367,1.2474632170549917,0.07074546836907378
28886,SIDM00950,Trametinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.4665337,0.3483765,3.1952385967916737,0.18516137117677917
64481,SIDM00877,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.55466986,0.059856754,-1.4608223025004468,-0.005538482580554933
95591,SIDM01042,Ribociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4438089,-0.0657199,0.3503052048470967,-0.00901390027989762
15568,SIDM00832,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-2.007607,-0.08256818,-1.4512596559705517,-0.05293040381790712
64303,SIDM00826,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-4.2484007,-0.09465282,-3.7308036643226465,-0.15857040241169543
98854,SIDM01042,PD173074,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.761626,-0.13564537,-1.6666899454695308,-0.09733280837362089
29081,SIDM00950,Navitoclax,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7391183,-0.07380709,-1.8135724330788028,-0.0657776865933064
97994,SIDM00148,Dabrafenib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2035449,0.09030976,-0.5172462816093717,0.00669216079495346
34897,SIDM00877,Paclitaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.5631485,0.122207806,-1.2661756022025066,-0.05060436336288693
10328,SIDM00875,PD173074,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6264875,-0.07548727,-0.34011849043700687,-0.014371339690622001
23134,SIDM00875,BI-2536,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6862808,0.04807397,0.527534588614758,0.0023266747139263745
25305,SIDM00097,OSI-027,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1681793,-0.19471177,-1.6523840507198777,-0.1454948131276978
78628,SIDM00875,Paclitaxel,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7550272,-0.05746572,-0.7756090433335475,-0.030429184002958017
92117,SIDM00875,Temozolomide,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.58564305,0.013946297,0.4154765382322253,0.01327185771979096
91510,SIDM00833,Oxaliplatin,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.6595054,-0.048158325,-1.7044012424393644,-0.13005625594440742
35590,SIDM00633,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2893654,-0.055844836,-1.525428600181509,-0.06592028412408289
94325,SIDM00875,ZM447439,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74311644,0.07785484,0.8822321979922112,0.05611827064657444
90951,SIDM01042,Tozasertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.83132136,0.08979808,-1.198975712407552,-0.08992577935265683
82750,SIDM00877,Temozolomide,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.86846197,0.013510896,0.17735884142323496,0.06994995393109078
94990,SIDM01197,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1395903,-0.03771853,-1.1100663422282802,-0.043337160886394784
47736,SIDM00146,Trametinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.6915567,0.15974523,0.3958065521376932,-0.012556916827913607
89286,SIDM00933,Gemcitabine,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.9308944,0.0043206257,1.884220793580061,0.08727673337507391
88386,SIDM00835,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.9684573,0.16574709,0.7627012659970954,0.06044283984955648
54697,SIDM01187,AZD7762,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1554664,0.035564087,1.0937878614088674,0.06992399726433694
96607,SIDM00633,Palbociclib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9447421,-0.04126954,-1.4048445759607835,-0.04580169900418548
65776,SIDM00455,Lapatinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.4426436,0.23307398,4.512669901669453,0.26946075012547416
82222,SIDM00950,Taselisib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2399853,0.06959981,-0.08770205864217977,-0.05108154731502471
65365,SIDM00455,Paclitaxel,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.89166796,-0.06163433,-1.0303915866689821,-0.10028839298186676
79617,SIDM00875,Dabrafenib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37998015,-0.014965035,-1.0032405113743734,-0.05016596180803075
34480,SIDM01187,Trametinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4924943,-0.040123597,0.9680234928885413,0.08477807490792233
107460,SIDM00928,Vorinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.5142808,0.23939699,0.6546309080808695,0.14468513038013
11876,SIDM00928,BI-2536,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.578548,-0.17156652,-1.502536970162105,-0.0881680449459397
75939,SIDM01042,ZM447439,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0745102,0.13627584,-0.7970768370327171,-0.05377240996209319
95321,SIDM00875,Taselisib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4777642,-0.13562395,-0.8449339285471252,-0.04856295858484819
98334,SIDM00097,Alisertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.212684,-0.06346239,0.21919008129922,0.0685800494587534
42730,SIDM00776,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.14596885,-0.008615946,-0.09697639633980148,-0.0398371474214244
18431,SIDM00826,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,1.5869374,0.0776193,-0.2842767127458838,0.0028712163683540536
18434,SIDM00875,Lapatinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8446206,0.09298587,0.8703208709263982,0.06539227909880752
74498,SIDM01042,Vorinostat,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.33108824,-0.038433097,0.32673371915948857,0.029544800128379203
13126,SIDM00928,Sorafenib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.1941088,-0.09146517,-0.1598426113588304,-0.012577408651372187
93006,SIDM00875,Camptothecin,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.095495,-0.18028337,-2.4849531605327315,-0.15728880564882616
108346,SIDM00146,RO-3306,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.2282848,0.10128913,0.21623862136201913,0.06378234301099289
91223,SIDM00928,Dabrafenib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.23250625,0.010347997,-0.47717521032659066,0.04419919745022678
59218,SIDM00875,Nutlin-3a (-),Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9710883,0.08425399,1.611477981917953,0.06127645518590008
1446,SIDM00928,Docetaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.2305558,0.26416257,2.3255312346418378,0.17211372818819798
42400,SIDM00216,Camptothecin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,-0.16856645,-0.013692754,-1.2230872946174125,-0.0034123703071361152
68835,SIDM00872,AZD8055,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.35000217,0.028937794,0.7056341227280998,0.035152213783644824
31033,SIDM00282,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,2.5922155,0.18490808,1.6417525864722602,0.18256561214822545
950,SIDM00359,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.7423418,0.07580785,2.398106134318452,0.06477312655770577
85609,SIDM00950,SCH772984,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.7390594,0.14674093,-0.7821650480577955,-0.022490864801448806
90657,SIDM00633,Olaparib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6522443,-0.07576004,-2.022568833973128,-0.0827557479140563
107928,SIDM01042,Alisertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0948635,0.13404259,-2.5798435081468116,-0.20507000131264455
87288,SIDM00097,Docetaxel,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-6.527218,-0.2875082,-4.07084975887223,-0.2587707614825843
100842,SIDM00875,MK-1775,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8120833,0.03732217,-0.88366737435858,-0.05016838000836079
74582,SIDM00673,Axitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9408572,-0.16895434,-1.9647983719252309,-0.14954806003601284
51508,SIDM00148,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.244967,0.025603453,0.16876422962800156,-0.0013175526800165182
66608,SIDM01042,Gemcitabine,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.637805,0.2444228,0.5287077532433734,0.02369368302117459
46830,SIDM00872,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0645821,-0.09678312,-1.4265948605219974,-0.08473410342023156
82543,SIDM00216,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.0875242,0.07392745,-0.18289913090165735,-0.023250300262729062
86999,SIDM00933,Axitinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.2078974,-0.16435786,-1.491329359929858,-0.08033612522190625
17972,SIDM00928,5-Fluorouracil,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.787294,-0.09180868,-1.4749574547955029,-0.026569829846412915
101676,SIDM00097,Lapatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.035814,-0.100413725,-0.11972358962319483,0.024871481577282153
75851,SIDM00146,Nilotinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.7989931,-0.06889168,-0.527769288660998,-0.02088117435541242
47944,SIDM00776,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.1716037,-0.03919223,0.529290307516604,0.008607653309514726
3482,SIDM00633,ZM447439,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5701151,-0.1361365,-1.7910454342734117,-0.07424054986988787
70258,SIDM00928,Crizotinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-0.9576173,-0.08933988,0.6797788725539697,0.0026657397487042517
57174,SIDM00933,BI-2536,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.26551864,-0.0015706857,-2.475792328822202,-0.010405180472059504
23036,SIDM00097,Crizotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.1372067,-0.008666909,-0.8069958021759378,-0.04467457555636372
105728,SIDM00097,MK-1775,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.68626285,-0.048420496,-0.6724175820685196,-0.076444203313918
1082,SIDM00950,OSI-027,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.866561,-0.03825558,-0.38058182652609523,-0.0034770136454667457
99598,SIDM00933,Taselisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.2245817,0.12805821,-0.15445686551608834,0.005062143218602358
102500,SIDM00633,AZD8055,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5800573,0.16211914,-1.2571616805011325,-0.11968042128099506
20297,SIDM00957,Vinorelbine,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.1182593,0.021759938,1.4244502608187932,0.04508615473953918
41936,SIDM00832,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.4191654,-0.07516384,-0.953584231675286,-0.03298519379657729
33047,SIDM00633,Vorinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3255713,0.05749342,0.7809012728957129,0.06766227719745091
92305,SIDM00148,Olaparib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8445367,-0.029777419,-1.6128733093501368,-0.07930269447407343
4704,SIDM00837,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-1.6335227,-0.07701444,-3.0865374986370644,-0.1004517384170996
105335,SIDM00282,AZD7762,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.9992008,0.14289449,5.79211378339081,0.35309527349714326
57700,SIDM00837,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.55242705,0.026992586,-1.277740228281451,-0.08440307307462057
18874,SIDM00776,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5216748,-0.13639762,-2.319311013961525,-0.06805910662582117
108481,SIDM00957,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-1.9900655,-0.02568413,1.7645093141956274,0.044310807441217175
46074,SIDM00673,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.7903777,-0.13163254,-0.4954998065065631,-0.023275714198762586
51795,SIDM00097,Docetaxel,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0263278,-0.11966199,-0.7650212489811014,-0.018488369731875398
99771,SIDM00950,5-Fluorouracil,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.47969738,-0.031672295,-0.7198200479086427,-0.024933988049934318
89504,SIDM00148,Taselisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.3488948,0.01586995,-1.5186575174456494,-0.03314504002995517
77221,SIDM00950,SCH772984,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.95579314,0.0816388,-1.391084127083624,-0.08237092699614154
61471,SIDM00673,Crizotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9389465,-0.15525866,-1.162383936860843,-0.08058308837110362
29885,SIDM00673,Navitoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.73060495,-0.055911124,0.1406906837464675,0.0021798268185581173
56111,SIDM00875,MK-2206,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19024496,-0.016249035,1.1191866272373112,0.03789590197175384
45738,SIDM00633,AZD7762,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.857586,0.13394022,-1.0713473982945954,0.01084003082679314
101878,SIDM00877,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.9393258,-0.10103653,-0.589492914741864,-0.09372187431893834
20402,SIDM00875,Trametinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5725889,-0.061735395,-0.09247201949770893,-0.01548880198628534
76081,SIDM00933,Tozasertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-2.3616812,-0.20403977,-1.0751852777318491,-0.055751122752055175
44745,SIDM00455,MK-1775,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6294902,-0.025810316,0.6790545005309192,0.024840364064003532
97501,SIDM00146,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.0187128,0.08526362,0.36550742176085566,0.03641760621114728
26352,SIDM00928,Uprosertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,4.588164,0.4066641,1.8072445869069662,0.12448438178286346
1169,SIDM01187,Palbociclib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2361778,-0.0710782,-2.38595916439479,-0.08793382476580612
6177,SIDM00872,Sorafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0412923,-0.10696183,0.04772613994976319,-0.0053144181011881685
56233,SIDM00148,JQ1,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0411367,-0.09034385,0.6199575378573304,0.05951154225380867
101107,SIDM00877,Ribociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.5875252,0.025158124,1.3367157695906835,0.050512446915481075
14402,SIDM00633,Bortezomib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.43763974,-0.0225499,-1.768851175892389,-0.053971554423985185
73457,SIDM00776,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.604759,0.057196938,0.007807671947521963,-0.01234132736491178
97553,SIDM00148,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8220213,-0.079628736,-1.0260726651858074,-0.09221820128240764
84810,SIDM00833,Dabrafenib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.4318473,0.0901715,1.2110188110756315,0.06273741269470252
67382,SIDM00875,Paclitaxel,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.1852055,-0.42306662,-4.462935857548854,-0.2629434699853534
9984,SIDM01187,Olaparib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5157146,0.02754264,-1.3814153188656133,-0.009244604528821308
2436,SIDM00826,SB505124,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.6820929,-0.04993801,-0.9940030365168755,-0.086975423414088
30056,SIDM00146,Ribociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.571961,-0.046047732,-1.1426980236900963,0.027409461942270414
53323,SIDM00950,Lapatinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5644712,0.03889313,1.0628102048773558,0.058243474429789326
958,SIDM00148,AZD6482,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6714603,0.11934528,-0.030534019224412335,-0.009908770816129073
97680,SIDM00148,Bortezomib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5774077,-0.058392968,-0.8198146464959961,-0.08846148085026871
59072,SIDM00872,MK-1775,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.68727887,-0.06493486,-0.3178031303973796,-0.016016104018687194
30283,SIDM00148,Taselisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3040267,0.07580892,0.24442107884065611,-0.01906680485229195
10117,SIDM00146,Vorinostat,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5836751,0.052027773,-0.419163707288004,-0.042543860634175645
78973,SIDM00148,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2183923,-0.045825895,0.7166765722508269,-0.006373305514603393
44866,SIDM00673,KU-55933,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.9440114,-0.13484569,-0.6066723943980857,-0.008894624643912014
1984,SIDM00097,Bortezomib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.28526062,0.017963486,-0.07267320714139791,-0.041559761382553795
26751,SIDM00837,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.28123653,-0.0227916,-0.32320041399241284,-0.0586450865530598
35172,SIDM00872,Palbociclib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3089374,0.060959566,1.7999133486584167,0.08873668525647797
29017,SIDM00146,Docetaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0777081,-0.10233832,-0.9742751125542084,-0.010002777673386044
51315,SIDM01187,5-Fluorouracil,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7932824,-0.1606491,-1.7546681127077888,-0.10650093815905079
62555,SIDM00875,PF-4708671,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74844056,0.03814794,1.3101464080828324,0.05143974471870705
44948,SIDM01042,Tozasertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0584574,0.21230043,0.595552600119849,0.03359720660783039
34569,SIDM00673,Navitoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.1653447,0.1931312,2.3137938430571516,0.10717825673682917
10498,SIDM00673,Uprosertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.52412564,-0.03863766,-1.178929147108194,-0.042462693830124715
44855,SIDM00673,Olaparib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6340224,-0.027180318,-1.2790400403611626,-0.02925913559866352
46862,SIDM00933,Alpelisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.40084273,0.037475128,1.1977169240207122,0.09457106121713167
86766,SIDM00933,PF-4708671,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,1.0050249,0.09959581,0.27312560282583176,0.10615470298652245
53925,SIDM00148,Camptothecin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6537153,0.065835536,0.3914944375170384,-0.03755856530662816
62529,SIDM01042,RO-3306,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.81306607,-0.096396,-0.6950079648250772,-0.055877359230423196
62846,SIDM00877,OSI-027,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4136167,0.119631596,0.109019409258842,-0.008288431165575554
81203,SIDM00673,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.59276325,-0.023924457,-0.0334073194993286,0.023079926919079046
36611,SIDM00875,5-Fluorouracil,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5361434,0.060171157,-0.4672971055979843,-0.018520527052566252
10578,SIDM00837,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.14172454,-0.009486678,-0.049452060102858776,-0.032343795126658526
48260,SIDM00282,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.68624836,-0.031175423,1.3296972034700318,0.08857326057618292
98437,SIDM00933,Olaparib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.4936872,-0.11991323,-1.8425865440355584,-0.07270798682081836
44570,SIDM00832,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,0.57039547,0.016477937,2.0170416999194547,0.08558615363912944
20887,SIDM00216,LGK974,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5200024,-0.07179778,-1.0627069047946882,-0.020167033185899026
99920,SIDM00832,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-6.788071,-0.4351828,-3.839030497242946,-0.2627646856343877
68553,SIDM00097,PF-4708671,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1895621,0.05475727,0.1114195174244067,0.042634405925701446
59091,SIDM00950,LGK974,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6921421,-0.059978615,0.3079137555438088,0.012050270800285656
98590,SIDM00148,Wee1 Inhibitor,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3629243,-0.13874061,-0.2220582046067354,-0.03904976653917717
63245,SIDM00872,AZD7762,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6576248,0.0650056,1.1451627244695777,0.05595675005609907
90694,SIDM00148,Nilotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5817639,-0.14394252,-1.5639750026737425,-0.07650281774372612
29337,SIDM00455,Taselisib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.5850635,-0.24364538,-2.292949092782786,-0.1695256712843807
48779,SIDM00950,Paclitaxel,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7370388,-0.033692695,-1.131913499257466,-0.023008708194864433
96387,SIDM00835,Trametinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,0.73524344,0.03277946,-0.1016856449224674,-0.010295343083763434
24589,SIDM00148,Afatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0777305,-0.060282834,-0.24415370713911497,0.034181965512493105
42545,SIDM01187,MK-1775,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.35804218,-0.034863774,-0.6210613242175635,-0.030888442613792963
108220,SIDM00148,Trametinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6432256,-0.0504409,0.9024700500532795,0.059916817943511634
81682,SIDM00875,Venetoclax,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43876445,-0.009636934,0.299722289834103,-0.0016596672039127618
95278,SIDM00833,5-Fluorouracil,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,0.23909079,0.016047748,-1.4694246091570378,-0.05228883865168702
60704,SIDM00146,Tozasertib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.7674196,0.1539332,0.49357746470478153,0.071571321878414
81163,SIDM00875,AZD6482,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8455367,0.057757873,1.9980052974883082,0.12564242034238657
71321,SIDM00950,Ruxolitinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.8070955,0.16520782,1.2513951899902862,0.021144660259345725
71208,SIDM00776,Vinorelbine,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.11609996,-0.00870792,-0.013929266113663291,-0.03296314901616035
47481,SIDM00835,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.6603985,-0.041497584,0.4964003625508629,0.01351949888291279
101636,SIDM00097,KU-55933,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4388645,-0.09338981,-1.4834912175812942,-0.04941197114706237
79808,SIDM00875,PD173074,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2408162,0.078589134,3.1201175015498377,0.11647136391780995
12876,SIDM00673,Afatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.2120157,-0.08572774,0.6229891872278213,0.053264593460069135
3735,SIDM01042,MK-2206,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.847781,0.020861689,-1.3845082019336528,-0.08923614375652453
7236,SIDM00875,Nilotinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2987714,0.14651576,0.8059137860925724,0.11146105230454421
107483,SIDM00148,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1400305,-0.043866344,-0.45575251679753864,-0.02179204976182212
61530,SIDM01042,Alpelisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0013435,-0.087363645,0.9131195438370909,0.06163212856742304
63634,SIDM00455,SCH772984,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.2972775,-0.1759167,-0.9295479711845587,-0.0193316629497939
51635,SIDM00633,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.77757955,-0.016813964,-0.3633002510087364,-0.018681403625982113
90808,SIDM00928,Olaparib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-2.778032,-0.105291076,-1.507198661746136,-0.049345995774662026
2565,SIDM00097,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.117911,0.0859049,1.0218643513220607,0.05640333814911076
22488,SIDM00833,Crizotinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.298023,0.1726895,0.6814395324065697,0.0582981027702564
17731,SIDM00875,Paclitaxel,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5230079,-0.058872286,-3.3167464037829144,-0.13793244051040118
54411,SIDM01187,Navitoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6692481,0.06391887,0.6964891361341286,0.06224008649952024
43508,SIDM00875,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.21602099,0.013464871,-0.5809983699746603,-0.014730139949902651
17080,SIDM00928,MK-2206,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.7062565,-0.05719048,-0.0683129841036763,0.00043613606448076486
90464,SIDM00832,MK-2206,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.9582708,-0.06669183,-1.4038952558305091,-0.04242438525195943
10471,SIDM00872,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.46580848,-0.03261123,-0.058473583688567136,0.02891057914572393
29202,SIDM00877,SCH772984,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.6811023,0.07543508,0.8120454513940332,0.012116459288737452
97,SIDM00933,NU7441,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.6207878,-0.06021485,0.05792171361414536,0.06594009782933945
5612,SIDM00776,SB505124,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.29740682,-0.022918738,1.081852549955862,0.060094058420434235
3964,SIDM00359,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.1890064,0.015882632,0.6250755547916699,0.042306886034901105
3463,SIDM00826,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.1587807,0.030166151,0.6935708314103124,-0.014972123345174672
35143,SIDM01042,Afatinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2408241,0.12575302,-1.4589475667226686,-0.022373987389830777
44632,SIDM00928,Axitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.9141533,0.078304805,-0.8409159311389228,-0.023733615468202844
63096,SIDM00875,MK-1775,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4524946,0.021624194,-0.7979504011880185,-0.053175545976306464
62332,SIDM00875,Temozolomide,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2056463,0.07863683,1.1763562598059958,0.03540832246586126
88837,SIDM00950,Olaparib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8275921,0.0813588,0.9765260962955067,0.055819350665160125
90993,SIDM00455,SCH772984,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.928971,-0.041037913,0.9999218675211179,0.0910043353238987
54789,SIDM01042,AZD8055,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.53467315,-0.05703402,-0.8271368808118102,-0.015285263652829928
1517,SIDM01042,Paclitaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6150387,0.05247779,-0.6781379260217019,-0.027959084388533083
44028,SIDM00216,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0913982,-0.064848274,-0.5434958893169259,0.03260788194370893
24229,SIDM00933,Entinostat,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.37024602,0.02896463,0.2871672011849491,0.08315494743369538
3837,SIDM00928,RO-3306,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.08534,0.09985472,0.7067505739809399,0.03817975793597325
1990,SIDM00148,ZM447439,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.9809666,0.42409673,1.2883513353860394,0.0790601139948182
102686,SIDM00950,Dasatinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7022715,0.26353675,0.555080668485329,0.05939260242003063
104150,SIDM00928,Uprosertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5092249,0.11026135,2.111631975764241,0.15668224491889549
26506,SIDM00148,BI-2536,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0442833,0.035721786,0.2946682700753864,0.009743531985104215
47809,SIDM00877,Pictilisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.32084,-0.1529801,0.044275788994281674,-0.07986176525587194
95699,SIDM00216,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.792691,-0.27460086,0.06718069907724515,-0.04097169200550636
54149,SIDM00872,Entinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,5.192268,0.28650576,2.672964815541144,0.1292830792631832
101064,SIDM00359,Oxaliplatin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1723583,-0.09641737,-0.8191880575910688,0.009612974786534558
47194,SIDM01042,Navitoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.532379,0.11205201,2.342765944555337,0.06356421659208772
34956,SIDM00875,Camptothecin,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5944734,-0.13135985,-0.9217491579468663,-0.09769593128139137
48409,SIDM00146,BI-2536,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.28609037,0.009169392,0.2739623964043131,-0.03792187340217138
78279,SIDM00826,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.18282904,-0.00727619,0.7954067155069361,0.14272706194781803
13670,SIDM00957,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.2153795,-0.04231967,0.07700760926967637,0.01015210345040435
8883,SIDM00933,GSK269962A,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.73107547,0.07774535,-0.11860729597222323,0.019187673492009543
44447,SIDM01042,SCH772984,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7679981,0.0454769,1.425950412784265,0.019992361689676885
16125,SIDM00776,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.7188969,-0.042984977,-0.9717452062484551,-0.04192539459622097
21873,SIDM00146,Bortezomib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7481364,-0.059369765,-2.3590398660783403,-0.05402078875141439
35938,SIDM00455,Cisplatin,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.2360911,-0.06625661,-1.5231264547303602,-0.004738818970381244
99991,SIDM00950,Sorafenib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.3471144,0.012602661,-0.7334598161365695,-0.004087738452825793
39734,SIDM00872,SCH772984,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4917454,-0.08551328,-0.8474711114887681,-0.04176394799221118
50835,SIDM00282,MK-1775,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.99685043,-0.0644212,-1.0773193201796945,-0.05887378645562557
6555,SIDM01197,Taselisib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.93180674,-0.04892548,-0.0460363399009542,0.011532081422878015
36341,SIDM00877,Trametinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.338878,0.044903062,1.0538322768375519,0.06373834215858973
38300,SIDM00148,Bortezomib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.29986045,-0.025444562,0.21974952776819556,-0.03756145259744948
46527,SIDM01042,GSK269962A,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4817656,0.1822631,0.5866174812122474,0.017135970208199264
64724,SIDM00282,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1674662,-0.08731265,-1.015621113991237,-0.11151369350565207
101589,SIDM00877,Crizotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.13356732,0.01240019,0.5294074304496316,0.015473176866364987
26452,SIDM00673,Nilotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.164718,-0.117270544,-0.6537833084255592,-0.03963073360485264
64681,SIDM00673,KU-55933,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.6976497,-0.16584784,-0.7439189306951379,-0.06270627098290993
27057,SIDM01042,Uprosertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2518624,-0.040196087,-3.5976641813448476,-0.14371040461937876
73077,SIDM00097,PD173074,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8154323,-0.14444426,-1.2005680205738092,-0.09091108498763009
63895,SIDM00928,AZD7762,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.4943962,-0.14949527,-0.55108851745764,0.04198721972109199
80877,SIDM00837,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.239373,0.06279718,0.25984497053737904,-0.014125129163766247
24197,SIDM01042,Pictilisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4999378,0.053350605,-1.9533096882891159,-0.0794503477499568
5723,SIDM00877,Tozasertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.9210578,0.23295695,0.33245663451179996,0.02009183906872577
108294,SIDM00833,Afatinib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.519443,0.1122953,0.6328142130110681,0.02745046239167825
15669,SIDM00673,NU7441,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.1409943,0.15590079,0.9388617731171642,0.047672665606821055
56176,SIDM00148,ZM447439,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4442593,0.111436285,1.3748877656424607,0.07472253117165108
76729,SIDM00148,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9737594,0.07865388,-0.16798419687554764,0.0035249952266535943
54024,SIDM00097,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7323976,-0.121032126,-1.7070974550944225,-0.14707783601425745
97936,SIDM00148,JQ1,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3333054,-0.12371025,-0.29053237861781256,-0.048126558619049936
53321,SIDM00148,Entinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.046908,0.14488235,0.04340259126163203,0.021396918491621293
34416,SIDM00872,Entinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6056623,-0.12649237,1.3878319307750204,0.0792329695141942
16488,SIDM00833,Afatinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7649627,-0.06312939,-0.5427435372139544,-0.07857547100571581
64195,SIDM00872,RO-3306,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.83106226,-0.04681267,0.4060003926695776,0.020655539575304572
15270,SIDM00872,Tozasertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5578088,0.08165738,0.42228786334086055,0.00986041479066851
24773,SIDM01187,Nutlin-3a (-),Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.2629952,-0.17537092,-0.9324525495931129,-0.053626842570704984
6606,SIDM00633,Afatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7477365,-0.008574368,-0.7685865008078041,0.006582778912148867
43375,SIDM00826,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.7571954,-0.03263612,-4.095631384093208,-0.13557086751123207
42618,SIDM00928,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.9906242,0.16532944,1.6374305780701555,0.12455694351543392
37297,SIDM00097,Camptothecin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9539496,-0.06608677,-0.5800447635145951,-0.016675420809379008
65292,SIDM00832,Trametinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-0.9087206,-0.03519163,-0.9744194875207494,-0.031681200061540946
61028,SIDM00875,Afatinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.548382,0.11020074,1.2281398292401542,0.03031462973048642
49698,SIDM00837,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-1.9455849,-0.04980484,-2.5650023497616177,-0.13002296259761215
27387,SIDM00148,Cisplatin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.594698,0.160496,-0.11472213881253414,0.029848517561020062
108359,SIDM01042,Afatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35466802,-0.025230471,1.0033452241776153,0.03997757223867274
9458,SIDM00148,MK-1775,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6593227,-0.05914047,0.20807573642731644,0.021590910968166087
73926,SIDM00282,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2667652,0.04793494,1.9324889830157386,0.10823244259000048
37429,SIDM00148,Camptothecin,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3929273,0.13435528,-0.6804203433952996,0.008758759731864926
39719,SIDM00633,Luminespib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.59337515,-0.047284327,-0.6274565999488447,-0.044282589435513026
86288,SIDM00928,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.5235407,0.05894493,-0.7209630445941071,-0.05930234528332172
14258,SIDM00877,Trametinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.2782084,-0.008353407,-0.9831797475395891,-0.019827877062518977
94605,SIDM00776,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.31708598,0.029566865,-0.2101778890801588,-0.00950811829036051
100175,SIDM00148,BI-2536,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4940554,-0.07320688,-2.0555061186419246,-0.0603833836670247
77670,SIDM00633,Bortezomib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.777586,-0.087548606,-1.583990590012329,-0.06808518190865799
14235,SIDM01197,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.2823277,0.15739177,-0.26174459042136644,0.026858839117655884
106422,SIDM00877,Alpelisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.1880107,0.19405985,0.43755040507114523,-0.023047451900933484
86894,SIDM00933,PF-4708671,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.5975151,-0.119641446,-0.38138919289057904,-0.027247302891306512
93923,SIDM00833,Vinorelbine,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.3561642,-0.0969396,0.27286274374641145,-0.006587481967966153
62942,SIDM00633,Alpelisib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1019104,0.1044479,-2.3099762383816493,-0.05436841270597192
9589,SIDM00148,Alisertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7247028,-0.090479106,-0.05765647570332126,-0.006428214207200119
13194,SIDM00673,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.271758,-0.030143099,-0.658018507821218,0.04349595063727195
41347,SIDM00776,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.6225737,0.086242184,-0.31927871435488003,0.007478415018289569
99057,SIDM00928,Lapatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.3762152,0.21942776,0.2353789148580179,0.06079652835009388
16015,SIDM00875,PD173074,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1969438,-0.0599391,1.678519523665004,0.08918594299574531
95409,SIDM00872,Sorafenib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3853799,0.042536344,1.7293432610036261,0.1261174398005809
34391,SIDM00826,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,5.9533043,0.38841835,2.952309766633641,0.20228914261171668
90370,SIDM00097,Taselisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2811899,-0.08744682,0.9539832906584237,0.028137478201427688
10823,SIDM00673,RO-3306,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9349426,0.073617704,-0.37498992621988536,0.019913704941631534
87234,SIDM00776,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5872968,-0.06649566,-0.27142088561719463,-0.02485916702760324
81068,SIDM00148,Afatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5948812,0.055841945,-0.31503102808135025,-0.05026067089225134
81537,SIDM00097,Olaparib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2385842,0.031108212,-0.5989240242157435,0.004533066344772019
78248,SIDM00950,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.5214632,0.20444891,1.6797618763530213,0.1474732156687867
55173,SIDM00928,Olaparib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.5922642,0.24001127,-0.43839736325987916,0.07371870822389417
20464,SIDM00673,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0919805,-0.15906711,-2.111947438218066,-0.09423133559000099
67198,SIDM00875,Pictilisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.200102,0.13433357,0.8494348065424083,0.12222713526210077
106910,SIDM00146,Afatinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.32977653,-0.025112344,0.7545638037064158,0.06709786371975422
8934,SIDM00957,SCH772984,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,4.0333867,0.17192437,1.6218338160456025,0.10254916428225566
12804,SIDM00148,PD173074,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.706219,0.10960919,2.0522104632296014,0.061102470242043724
48972,SIDM00833,Vinorelbine,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.7782474,-0.05107944,0.14419461906080513,-0.02808988835796643
64622,SIDM00148,Olaparib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9699483,0.033981152,-0.057121304265890294,0.011459323665371661
30669,SIDM00877,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.268778,-0.23351753,-0.7531471878678894,-0.01651558786974647
59127,SIDM00146,Uprosertib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-2.9609208,-0.1747258,-0.3629904646483735,0.053183423356390265
40881,SIDM00835,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.8600269,0.07154685,-0.6279102918659464,-0.07851647737733487
34584,SIDM00872,5-Fluorouracil,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.693378,-0.03584323,0.9319909431955774,0.0381350811961423
103426,SIDM00833,AZD8055,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,2.964439,0.05348274,3.8958554531007157,0.12187298245846634
31797,SIDM00933,Alisertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.5299203,-0.0460217,0.3367255057828012,0.012633088324851126
69140,SIDM00875,Afatinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.85850275,-0.060991935,-0.5938904061032265,-0.0509669822190766
45252,SIDM00833,MK-2206,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-1.1302354,-0.053275153,0.9122814623759576,0.04439197386594839
96749,SIDM00833,Vinorelbine,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.290137,-0.14743894,0.03634376585747514,-0.05845570372730469
94540,SIDM00776,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.1455936,-0.035396617,0.9538192559811416,0.031386333987985716
59123,SIDM00097,BI-2536,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.97586656,0.06834929,0.9559602068062549,0.12363691368690777
72305,SIDM00673,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6347507,0.14554621,-0.089085865387396,-0.023525467023480955
31654,SIDM00097,Ribociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.031033,-0.08424451,-2.65089144792258,-0.07235489342674742
93053,SIDM00875,Temozolomide,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7022085,0.049232177,0.901048142515162,0.03729572569030436
91496,SIDM00216,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.6905547,0.024954,1.6358649011203072,0.08984641104409687
33904,SIDM00875,Olaparib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.8072886,-0.16613267,-1.5257612433724146,-0.07215337482794555
40231,SIDM00875,Uprosertib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9418437,-0.15205084,-0.5067135313996295,-0.03344866391379822
12663,SIDM00826,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.27400297,0.006543075,-4.886641398703751,-0.11018069299863248
18785,SIDM00146,Bortezomib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.50898814,-0.033068907,-0.1370596733935739,-0.014206373420015196
77749,SIDM00928,JQ1,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.45507756,0.053181864,-1.5400479563740592,-0.07882080136035782
36354,SIDM00146,Vorinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.3028262,0.16198303,-0.5045493827116861,-0.04717737675417506
23496,SIDM00872,Nutlin-3a (-),Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2304797,0.042618725,1.8621720884329427,0.05966977343861158
32291,SIDM00216,LGK974,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.1845459,0.07316798,0.5997708903478325,0.048180750541433906
100212,SIDM00877,Docetaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-2.539428,-0.17327403,-2.6059132918072834,-0.14445791409210657
41153,SIDM00877,Temozolomide,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.1499209,0.0029725574,-0.535895681960755,0.0326498437417774
47926,SIDM00826,Dabrafenib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.6905267,-0.051400352,-2.3671278507211855,-0.12569339594463358
11855,SIDM00216,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.4980085,-0.20923404,-0.9137634379440609,-0.03723134098585343
1087,SIDM00146,JQ1,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.9708649,-0.14190726,0.22933616425071082,0.031466882057825
3806,SIDM00282,Camptothecin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2460233,-0.08962289,-1.174521195912735,-0.11151442242330772
60873,SIDM00872,Taselisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,3.0171666,0.04528202,-0.4263141649710151,-0.02726884615804276
20534,SIDM00872,Ribociclib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3766375,-0.031996045,0.49172011553002665,-0.008271401237751077
64769,SIDM00957,AZD4547,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-2.0415049,-0.044840816,-0.36138499036390415,0.012442373512772014
103889,SIDM00950,Oxaliplatin,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7017004,-0.09420964,1.216168447222464,0.08406517179325664
24751,SIDM00933,Trametinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.1675242,-0.14248294,-0.5269304400666225,0.03155152238977943
88481,SIDM00928,Afatinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.7249088,0.08757273,2.0217241088500004,0.09889978062317349
53143,SIDM00875,Trametinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.18200967,-0.017214302,0.603035525868207,0.0490346612441256
105578,SIDM00148,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.90568656,0.07965979,0.2590895959770439,-0.012882958232470753
63674,SIDM00148,Entinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6112319,-0.042203687,-0.508251546708578,-0.02069664091005805
102467,SIDM00835,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,3.5525076,0.25624388,-0.24319917948970762,-0.002747632080932298
89941,SIDM00933,Crizotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.647381,0.22189167,-0.3913736723618603,0.03477934796613106
17698,SIDM00933,MK-1775,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.6588808,0.039678823,0.8902541343213832,0.09020919202806155
11503,SIDM00872,Alisertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,6.094644,0.29785827,3.6076752066840965,0.11521046808592526
91357,SIDM01187,Trametinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1240857,-0.04732976,0.7355451476192513,0.07322384746404492
20378,SIDM00455,Palbociclib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7202699,-0.03480646,-1.0994115855010766,-0.028281392245145417
29170,SIDM00872,AZD7762,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.30814904,-0.029090429,-0.2174794840451551,-0.024397653283143528
2085,SIDM00776,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.8152486,-0.030040832,-0.11612223241113849,0.01787077342661757
29900,SIDM00097,Doramapimod,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9804666,0.09772674,2.373813784106733,0.04398251355481173
102589,SIDM00877,Wee1 Inhibitor,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,1.0406924,0.042494535,0.017266312353094938,0.0370485757352083
70944,SIDM01197,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6457936,-0.057093915,0.17396447976229273,0.00012510148276056996
93907,SIDM00837,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,0.8739078,0.01580757,2.0140731128853915,0.05082518248584755
29511,SIDM00837,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-3.8163607,-0.122480124,-1.4252842950765132,-0.12922049528461124
2295,SIDM00957,AZD8055,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,1.1567429,0.024418294,2.1771381689178124,0.08621107017280744
83001,SIDM00875,AZD7762,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.44226333,0.022618532,-1.252477908664815,-0.08429699716699943
81872,SIDM00633,Wee1 Inhibitor,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3962147,-0.03920039,-1.6605054671581845,-0.1120678907210797
31080,SIDM01187,5-Fluorouracil,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.476601,-0.24775203,-2.2606070418300623,-0.1888140250182462
46178,SIDM00877,Dabrafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,3.4174907,0.051770262,1.658896687057964,-0.005980841311581928
76775,SIDM00875,Paclitaxel,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2431233,-0.09137788,-3.350663443537861,-0.2112832351105578
60864,SIDM00042,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.9547652,-0.15747316,-2.567386060929166,-0.12549401942496993
57201,SIDM00633,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3169639,-0.09338399,-2.812697326239513,-0.12715900578305234
6849,SIDM00216,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.7328076,0.038554396,-1.117958080825037,-0.07423341102243657
28123,SIDM01197,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-2.747041,-0.055410713,-0.8304214479604908,-0.020430569720291135
75605,SIDM00097,Nutlin-3a (-),PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5447702,-0.07148938,-0.8212242062980231,0.0050144923015331576
13242,SIDM00148,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9520467,0.04546551,-0.04881510554071114,0.025343847508811204
90226,SIDM00776,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0163661,0.08638437,0.19483429020374307,0.03752878232951714
44752,SIDM00097,Axitinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.909962,-0.07793469,0.20738745509505876,-0.012070644040202035
18859,SIDM00933,Alisertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.1745667,0.11202573,-0.19121362027499422,-0.017289513615138103
7761,SIDM00146,Tozasertib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3925248,-0.041438837,-0.7218698317718834,0.012892966112816229
16003,SIDM00042,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.96905905,-0.08190216,-1.3389246454746098,-0.04744075960028175
38215,SIDM00928,Camptothecin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.68991655,-0.053730775,0.6581012898378983,0.11715687966394867
59019,SIDM00633,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3505251,0.014463746,0.9823935751570336,0.05011854799528078
99699,SIDM00875,Ribociclib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1765206,-0.038698662,-1.0312308203547773,-0.004380014283587969
97979,SIDM00826,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-2.944926,-0.098581254,-2.9353709726404555,-0.09645805332146172
107024,SIDM01187,Temozolomide,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.5560715,0.047444586,-0.3720435927469656,0.009347993044534653
29321,SIDM00826,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-4.42431,-0.15292399,-6.0864325947069275,-0.15192799654721603
4067,SIDM00148,KU-55933,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2785873,-0.047049858,0.619561845652643,0.03596562038530565
42027,SIDM01042,Wee1 Inhibitor,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.90646845,0.022013253,-2.5672098277748523,-0.08584047959415483
29137,SIDM00826,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.6350691,0.051620137,-0.9008147315216917,-0.05420064683240076
2115,SIDM00928,GSK269962A,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.67554176,-0.05344026,-0.6324699842778916,-0.02162449585400372
59458,SIDM00928,ZM447439,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.4037035,0.20503892,1.617098375205934,0.08675893939573631
55091,SIDM00875,BI-2536,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3070323,0.058186606,0.2887123346178576,0.008119736142599313
78646,SIDM00776,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.3980426,-0.021811482,0.6946029096433716,0.033428299218772835
21079,SIDM00097,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6580846,-0.056552615,-1.8379462321144218,-0.07063680122172855
86497,SIDM00837,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.5086259,0.026902534,-0.20918007855206283,0.010778314703725112
82416,SIDM00042,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.702022,-0.07148686,-1.6562001511091153,-0.10583034422537059
82679,SIDM00872,Palbociclib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.49743193,-0.018206455,0.19001898857749072,0.028581547750761428
18094,SIDM00928,Lapatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.7711997,0.33415958,2.2888061150627097,0.1627531398657846
48609,SIDM00455,Taselisib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3810605,0.0833948,-0.7510264879990561,-0.06111998019042188
3567,SIDM00833,Linsitinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,2.6509666,0.20045929,-0.7217943196807635,-0.06800795788377217
85530,SIDM00146,Cisplatin,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8718957,0.027534723,2.0129174646473458,0.10300572311504527
20360,SIDM00633,Axitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1008484,-0.06790394,-1.095063612881094,-0.07117912329899145
84615,SIDM00216,AZD4547,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.48074457,0.041949507,0.1711454552713494,-0.004981743102594143
22758,SIDM00633,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8480076,-0.02361155,-1.893329825984016,-0.03399437206267986
66675,SIDM01042,Cisplatin,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.471468,-0.018777058,1.4027271122437526,0.017320551292166416
21488,SIDM00633,Temozolomide,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8268989,0.019155921,-0.003637924311613326,-0.00915437943028014
55187,SIDM00282,LGK974,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9157301,-0.038171757,-0.07487100185241036,0.0022010705427596648
104137,SIDM00776,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.4484931,-0.037853643,-0.5157905883772598,-0.03458682379856296
3882,SIDM00933,Alisertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.1658525,-0.08470183,-2.556498080826698,-0.16341231453474278
11780,SIDM00146,ZM447439,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.1909762,-0.0143821845,-0.26277158093795366,-0.00513636483748591
23697,SIDM00146,Dabrafenib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.8900913,-0.04194189,0.09884936244385056,-0.019803268186476337
64081,SIDM00832,SB505124,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-2.0722663,-0.16678652,-0.7002186080573227,-0.05171107108277992
54977,SIDM00097,JQ1,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0189569,0.06136521,2.695730683341894,0.1564854750429462
85302,SIDM01187,Bortezomib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.60087204,0.037100405,-0.39354077998223286,-0.007750859013028608
31534,SIDM00928,MK-2206,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-2.6813285,-0.11144286,0.32301932735290306,-0.02233309914718794
93236,SIDM00455,Oxaliplatin,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0824876,0.048252508,-0.43316303986295684,0.0925529531770729
85481,SIDM00216,AZD8055,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.0218854,0.15802337,1.224303305082748,0.07414049063640453
53545,SIDM01042,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.43387708,-0.015599407,0.6506041909735305,0.005767708916542645
61695,SIDM01187,Palbociclib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.91186154,-0.050125178,-1.1145287109057012,-0.0262316569670177
77527,SIDM00872,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.65769917,0.019291269,1.5701393906209404,0.08902591755916882
103164,SIDM00673,AZD6482,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.58966446,-0.04991342,-0.762885105442207,-0.07548925522110025
40561,SIDM00455,Dasatinib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.095683,0.31838647,2.7676402722548232,0.19757077532323
21245,SIDM00097,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7275116,0.05927799,0.2597003032422955,0.023786667021591275
7161,SIDM00673,Dabrafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2001662,0.056060832,0.7247321959603998,0.02847911831585338
69981,SIDM00042,MK-1775,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.4551321,-0.08603001,-1.262476996513436,-0.047711546082939954
58949,SIDM00950,Olaparib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.875425,0.027972799,0.32070002351083543,0.043435428770117024
69855,SIDM00957,Vinorelbine,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,0.6301844,0.012098198,0.8292649299431422,0.016047790441702698
11537,SIDM00455,Oxaliplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4300466,-0.105590105,-2.2165915361151494,-0.07135195113238832
32534,SIDM00875,Navitoclax,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47827503,-0.051626496,1.5123085948043449,0.0644515785393571
24240,SIDM00216,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0868185,-0.034721956,-0.39361441921185425,0.011242288349509272
87683,SIDM00359,MK-1775,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0495887,-0.090856,-2.196076645142215,-0.0692576282259902
90514,SIDM00835,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,2.0464916,0.14656292,1.0079244070065794,0.057891234368887365
14777,SIDM00875,JQ1,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70144683,-0.07456997,0.14934566462327267,0.00884363894965613
41436,SIDM00826,AZD7762,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,0.5510572,0.026523042,-1.9272021381695654,-0.11014056120469137
90871,SIDM00877,Vorinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.7647486,0.018405447,0.6413750732639836,-0.009395822001931219
17557,SIDM00833,Vinorelbine,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.15828419,0.010263332,1.721652002372922,0.08349002369791152
34469,SIDM00872,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-4.689202,-0.3113947,-3.440983145768816,-0.29207611288253316
36392,SIDM00673,Vorinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0809572,-0.08804225,-0.8251398603543383,0.005149630087169252
44431,SIDM00282,Afatinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0460324,-0.047822207,-0.39416108486260876,-0.01947929855849789
62228,SIDM00673,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.32207716,-0.011425137,0.15625561862442125,0.03604486229145214
32014,SIDM00933,Olaparib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.8464582,-0.13415258,-1.4776475954635502,-0.03361583916774062
21567,SIDM00097,OSI-027,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4458033,-0.0816115,-1.8981404597386626,-0.0922258756474297
53004,SIDM00148,Docetaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.8369498,-0.2650574,-2.405055058251969,-0.11893821353519385
6593,SIDM00097,Palbociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.309286,-0.08166269,-2.105635998546776,-0.06612032670256904
55655,SIDM00633,Dabrafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1898748,0.031668086,0.9238678043922667,0.011815929155082958
21962,SIDM00148,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4779023,-0.110743046,-1.0140744694405543,-0.12142931141957904
38231,SIDM00633,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.4097612,-0.14699447,-1.6258164232663368,-0.0806670813492724
2902,SIDM00957,AZD7762,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.2988245,0.05662767,1.9391870051017819,0.10719448831533407
87386,SIDM00148,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6809383,-0.04179536,-1.9248598080591564,-0.08580809988111308
22268,SIDM00833,SB505124,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-0.5398249,-0.035555586,-0.6651335979122495,-0.032085688575377344
61182,SIDM00835,Trametinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-2.8382988,-0.18334404,1.6196625150260224,0.025551732636298573
74824,SIDM00875,Crizotinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4220933,-0.048550647,-0.3645536941964584,-0.035917699679819004
102376,SIDM00957,Olaparib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.2786852,-0.017401066,1.24993621691947,0.020141715888947045
76899,SIDM00928,Entinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.46253967,-0.043207873,-1.028793068316637,-0.003034816365450334
32694,SIDM00957,Oxaliplatin,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.3324562,-0.01783129,-0.23869825117609642,0.012602047589738404
53572,SIDM00957,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,2.4784384,0.06802831,0.1480594739685964,0.012712953687945372
47483,SIDM00359,SCH772984,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7424164,-0.053140845,-1.5867865969867836,-0.062023657620187946
25253,SIDM00216,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.48710248,0.024787953,0.10073848775132456,-0.03338168331466166
39216,SIDM00673,Palbociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5612603,0.028984278,-0.3042455241516103,-0.02275042155120082
6224,SIDM00633,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.43900415,0.036024895,-1.4645562119027058,-0.037154232271864686
74894,SIDM01197,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,4.1372423,0.101590455,4.315975626634972,0.14695792480267417
46492,SIDM00872,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.025386,-0.075656,0.10898710563887769,0.009855866156843557
24475,SIDM00875,AZD8055,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.86906594,-0.08745381,-0.7607701214574044,-0.04254518209566274
96669,SIDM00148,Paclitaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.5248222,-0.27740222,-4.4539738283663866,-0.27027679572964525
53587,SIDM00097,Afatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8184983,0.061617367,1.1641549590695581,0.10117558711313374
58384,SIDM00928,MK-2206,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-2.3435085,-0.07696417,1.1554009025752356,-0.03465157059246064
24683,SIDM00673,Bortezomib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.40369073,-0.01827736,-0.7000116505118975,-0.03573966174757109
104796,SIDM00933,Vorinostat,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.11914696,-0.016820863,0.4165917479119633,-0.008482826781289103
52010,SIDM00776,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.6587889,-0.09692418,-0.0981721784263267,0.02890120098464908
45768,SIDM00776,Taselisib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.8638562,-0.06642399,-0.6874141951489323,-0.045447650344286786
88708,SIDM00877,Olaparib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6041251,-0.04555874,-1.4691278649961326,-0.008531700366869174
61438,SIDM00776,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.3823406,-0.03572818,1.037584182864208,0.06020358606787389
73343,SIDM00776,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-3.7418475,-0.2518998,-0.7514858524910855,-0.04156051582013264
49878,SIDM00455,Sorafenib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.8204925,-0.028480137,-0.7195552115488922,-0.02723816078328301
88535,SIDM00148,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.28698245,0.030054348,-0.7051791406001844,-0.05000598699472746
94570,SIDM00933,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.7892427,0.24079879,1.6206763682917247,0.12396284771716264
61047,SIDM00455,Linsitinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9070529,-0.052968368,-0.6719580763846629,0.0018917807668113258
100714,SIDM00933,Sorafenib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.1839759,0.01638645,-0.9453677763714524,-0.0824293969389903
17798,SIDM00282,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.5738307,0.11025281,-0.7928445259802537,-0.03137676745346563
72013,SIDM00933,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.2047552,0.0119857425,-0.6601353079731738,-0.05062095122595885
76029,SIDM00957,Vinorelbine,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.3389195,0.006513661,0.45263339934196595,-0.010633841033344424
56709,SIDM00455,SCH772984,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.0117257,-0.05072336,-0.30479913159968697,-0.08711431069745089
74950,SIDM00833,Camptothecin,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-1.7565117,-0.1083224,-2.1622509856658967,-0.13609357782096898
106257,SIDM00875,Alisertib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9110867,0.08981877,0.511185353129027,0.03643086176289499
84181,SIDM01187,Trametinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.3664463,-0.08981141,-1.3902146885152993,-0.03660735750836686
2906,SIDM00042,Erlotinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.7843266,0.20637229,2.482536590001154,0.1671375256407374
38773,SIDM00097,AZD8055,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.34617874,-0.02360585,-0.5406372249151291,-0.02967743700212085
81448,SIDM00872,Taselisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7383301,0.061342742,1.6809542031090876,0.022454442111061717
4351,SIDM00872,5-Fluorouracil,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.42084292,-0.023607615,-0.37348478257296147,-0.020494056557356498
88686,SIDM00872,Doramapimod,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.56853396,-0.019962305,0.8861144102145246,0.059367820480537806
91342,SIDM00455,Paclitaxel,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.1894937,-0.18596722,-1.1204865945022633,-0.08014802361000377
16636,SIDM00359,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6507372,-0.04804464,-0.6152513867989949,0.016135074568436224
23022,SIDM00877,Alisertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.693378,-0.01552307,-1.0565716988128488,0.005538654259831986
57621,SIDM00282,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.3972824,0.08410602,1.9911150401892814,0.16613814012355896
76875,SIDM00776,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.7607262,0.14918542,-0.03834864521977025,-0.021559234129699106
38874,SIDM00826,Dabrafenib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.86914057,-0.06930151,-1.9360866605898097,-0.07508627947430901
80849,SIDM00148,Vorinostat,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9699176,-0.095784344,-0.44165539492206324,-0.05064234496362428
15505,SIDM00957,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,-1.2734872,-0.017465068,0.18241474043463377,0.029822499064433912
108368,SIDM00837,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.0023258,0.040117376,-1.0607527184927557,-0.040110183752575926
55502,SIDM00148,Gemcitabine,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3332261,-0.025349103,-2.5280926856132506,-0.14860726789355957
108259,SIDM00928,PF-4708671,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.5095105,-0.15626934,-1.8450664475910088,-0.10838691112498493
105817,SIDM00957,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,0.6896381,0.011601567,2.6051044604044176,0.0842690752735552
38774,SIDM00148,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7487761,-0.020421218,-1.1387145973092747,-0.017907812592240214
84163,SIDM01187,Temozolomide,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5164926,-0.012777527,-0.8947415809187231,-0.000999390371995293
52985,SIDM00146,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4546638,0.09080982,-0.6898433185391684,-0.006702126112082442
64369,SIDM00359,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1396359,0.028349496,2.0949867296818154,0.06958009121285486
53893,SIDM00455,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9071655,0.15731208,3.6105205284979998,0.21134447954098956
84200,SIDM00455,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9353607,-0.2023975,0.21193108779688208,-0.05699398671252417
6123,SIDM00633,KU-55933,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3018452,-0.036092144,-1.1565593248154928,-0.022630221211563818
97616,SIDM00146,Taselisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.9924216,-0.14681791,-0.8350600241943604,-0.022679016869373715
28675,SIDM01187,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.51544887,-0.037403334,-0.3198812466333407,-0.027124103371029874
61114,SIDM00673,Alisertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.0572944,0.20189479,0.2749117981595674,0.03310348532910384
28305,SIDM00455,Irinotecan,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.4204314,0.15762621,3.5383905291338564,0.22338752987796184
6776,SIDM00835,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.9180966,-0.07809279,-1.2892778713123918,-0.10015443682739097
85453,SIDM00216,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.44515216,-0.044725284,-0.8744212174710373,-0.09563190843131704
58028,SIDM00875,Palbociclib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.9546757,0.14137685,1.9491714348172122,0.09776129794270878
56246,SIDM00148,Wee1 Inhibitor,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.81579906,0.07503837,-0.2158472296084196,-0.01341840867165673
23438,SIDM00148,Nilotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7350461,0.16034368,0.9626295444076715,0.05153222998562973
75759,SIDM00928,Ribociclib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.4376891,0.049518887,-0.04760004063906864,0.016682318371061447
68914,SIDM00673,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,9.900486,0.32601428,1.0509372541292792,0.1701478717269702
37412,SIDM01187,5-Fluorouracil,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.1071222,-0.19653027,-1.1224530522319132,-0.07068392895573916
18454,SIDM00359,Vinorelbine,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1495633,-0.04533305,3.203518895911809,0.16247404607284685
27126,SIDM00933,Vorinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.6371145,0.08365544,-0.13698342600515434,-0.029514407646068056
60130,SIDM01187,Luminespib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0775328,-0.1106476,-1.7903777990940177,-0.11918691679578393
12699,SIDM00877,PF-4708671,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2760193,0.07950398,0.7830322632252922,0.08501075389077536
29350,SIDM00282,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.050924,-0.06868407,-0.6398870042649566,-0.061796973206005815
81520,SIDM01042,Dabrafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6160634,-0.1024187,-1.4746944424404702,-0.07090509016422133
27433,SIDM00776,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.4916005,-0.1283409,-0.8424206184317016,-0.06688996336362289
93193,SIDM00146,Doramapimod,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.0292981,0.058675166,0.8212175099055338,0.0345923254874377
21778,SIDM00826,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-6.021084,-0.28170982,-5.919160212027362,-0.19553887319500768
28303,SIDM00776,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.7628497,-0.051528927,1.8768656392112266,0.10924532177212476
40614,SIDM00776,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.25684568,-0.02055673,-0.11315215028130124,-0.033514297892258633
34077,SIDM00148,Venetoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.889968,0.041013103,0.16533908071855186,0.028273177643661534
16001,SIDM00877,Venetoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.5069168,0.06599721,1.624116290581314,0.06846259956415877
84968,SIDM00877,Navitoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.9141367,-0.0879677,0.12959575539548338,0.002024323500334795
68356,SIDM00148,Nutlin-3a (-),PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1210525,-0.11112326,-0.5893279574628415,-0.10139746126421256
20324,SIDM00957,SCH772984,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.200825,-0.081191115,0.04395323667768279,0.0003190781364447982
81512,SIDM01197,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.3985088,0.026605887,-1.2952901621212798,-0.08710362660673926
99718,SIDM00359,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9380951,-0.053545985,0.9059506270103014,0.06491140826984663
77906,SIDM01187,MK-2206,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3537819,0.08637515,-1.419319383391869,-0.007066961686465535
15319,SIDM00933,MK-2206,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.4335283,-0.05442035,0.6782936145951558,0.049138851480532056
17866,SIDM00957,Linsitinib,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,2.9333258,0.08097187,2.034577033804887,0.10709677669889034
40768,SIDM00633,BI-2536,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.587193,0.26083323,3.8120219845735805,0.20004730191599415
60828,SIDM00148,Palbociclib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4291596,-0.07636069,-2.0672860814536813,-0.04254327929866354
16200,SIDM00673,Uprosertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.19530532,-0.011847787,0.07737433721096432,0.005825829529421956
47386,SIDM00837,Navitoclax,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.300361,0.04836101,2.262194827903735,0.018723614077537937
31164,SIDM00950,5-Fluorouracil,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.52904737,0.05171693,-0.8562309625586372,-0.05196014830770625
85975,SIDM00455,Palbociclib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.676778,-0.048373204,0.3183722913641937,0.0764461658772663
62315,SIDM00933,Lapatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3097749,0.16103601,2.5978575975825735,0.20775786225935744
105295,SIDM01197,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-5.4372854,-0.11519367,-0.8229117077327182,0.0016136859495324658
49707,SIDM00359,AZD4547,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4324226,-0.10563112,-2.6456427237736277,-0.03433817020053152
16706,SIDM00097,NU7441,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.69478035,-0.035672992,-0.04431859548902095,0.007421184744505282
98375,SIDM00633,Crizotinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.4337354,0.1694385,1.862999690785634,0.021147951573317978
47898,SIDM00673,Wee1 Inhibitor,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2961514,0.09134179,-0.879576467555288,-0.01137053206759989
42402,SIDM00832,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.7503869,0.040720936,-1.480228370274564,-0.10725922181607778
83909,SIDM00042,Lapatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.1689782,0.12948528,0.3422879596999957,0.09509424853647035
42316,SIDM00633,PF-4708671,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5310946,0.048554014,-0.6732804535619824,0.010565110009457796
106940,SIDM01197,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-0.77987146,-0.019760262,1.306681878423532,0.06952773693992503
39282,SIDM01197,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5739295,-0.16271965,-1.5611736530017335,-0.06942037292752883
23767,SIDM00933,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.4299055,0.0621357,0.2724183969171823,0.01843434948991542
22829,SIDM00826,Palbociclib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-3.8852212,-0.17005573,-2.757802260498044,-0.10421898189309146
29295,SIDM00877,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.6303265,-0.17548832,-0.7009044577626409,0.009029360468464217
11939,SIDM00928,Alisertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.9810376,0.08109893,0.2862191756538054,0.06288689913936975
1151,SIDM00776,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.810945,-0.12006939,-0.8674775810896724,-0.08461804388266692
77960,SIDM00957,Nutlin-3a (-),LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,0.09422886,0.002930223,-1.2436302438630478,-0.03285487112825097
35779,SIDM00877,Crizotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-1.0192039,-0.09659704,-0.23275925394266897,-0.03906120383241712
12074,SIDM00832,Crizotinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.276947,-0.11337402,0.8651915698024669,0.042168698591440276
6639,SIDM01197,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.45528486,-0.009688637,0.7187084460189396,0.0561624955323434
50751,SIDM00673,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.2982441,-0.10898756,-0.1397727410757119,-0.05828135749272612
6998,SIDM00877,Navitoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.112802,0.17168422,1.674234470994175,0.09762103283028388
15864,SIDM01042,Entinostat,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3779552,-0.16358298,-0.45062749383899653,-0.01891850934636223
15613,SIDM00673,Gemcitabine,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,5.2082067,0.47452438,2.324772760946244,0.15115556003032637
43711,SIDM00097,Afatinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0018971,-0.07261166,-0.9491466089521394,-0.07352630863620087
60908,SIDM00282,Trametinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-2.775093,-0.09590165,0.44570767603976263,0.08381021752534377
104666,SIDM00872,MK-2206,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3856478,0.14544813,-0.5134727024333532,0.04106971379531551
53245,SIDM00673,Venetoclax,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.9487226,-0.01551644,-0.19918079996949484,0.027805467814781118
78665,SIDM00933,PD173074,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.44240367,-0.038474433,-0.4813956744131968,0.03001774317126648
59289,SIDM00216,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.3579237,-0.14505439,-2.33619640866235,-0.1522753648678877
105365,SIDM00872,Doramapimod,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6121494,0.025869794,1.0224632406204073,0.05622867083826011
66575,SIDM00933,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.73750377,0.05894741,1.5646320844732446,0.12990840055625286
22393,SIDM00097,Bortezomib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.47114554,-0.02894096,-0.3193887960508325,-0.01229620453778162
13554,SIDM00146,AZD7762,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.17790012,0.01596536,-0.2616325347358133,-0.07537924197200438
87631,SIDM01042,Paclitaxel,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7641548,-0.098164506,-2.361574175956719,-0.11994221170338462
90505,SIDM00097,GSK269962A,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.53665406,-0.023387738,0.01752458099410875,-0.012035704953571667
76526,SIDM01187,Docetaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.142063,-0.013249969,-0.7141725013975241,-0.025286620263586797
43658,SIDM00837,Camptothecin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.5597985,-0.039597157,-3.0955629660674515,-0.10546430214112956
47652,SIDM01187,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.84032273,-0.071589045,-1.184958402603079,-0.01731086828134592
71546,SIDM00097,ZM447439,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.486502,0.0834086,0.5218434561895671,0.05331054793226486
101646,SIDM01042,Afatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.178035,-0.07345968,0.43375531594507505,0.037760715112168705
108311,SIDM00928,Camptothecin,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.3009808,-0.15133876,-0.7694300546457088,-0.006280188127258147
65513,SIDM01197,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8931109,-0.10385036,-0.7310166084966172,-0.05761643858863302
102443,SIDM00933,Lapatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.51811063,0.066165365,1.477015523255073,0.1381527560746779
85766,SIDM00872,Entinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.283064,-0.11062299,1.5232967863359448,0.09658606929685917
93976,SIDM00673,Afatinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8996276,-0.065132834,-1.0537202557221823,-0.03388855998872337
35937,SIDM00875,Nilotinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0568237,0.081553,0.9392304516774224,0.11853925718707656
67412,SIDM00872,Paclitaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.00887,-0.17666057,-0.7130642190867075,-0.06128601057749192
80768,SIDM00633,Nutlin-3a (-),Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.44885147,-0.0274179,0.2272594504000115,0.02551295905375385
108216,SIDM00148,Entinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0412754,-0.06368357,1.390114907351284,0.05746490711775173
66480,SIDM00776,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.1433213,-0.065852605,-1.4758218910089445,-0.040428175230072944
103373,SIDM00875,Tozasertib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4499526,-0.018058868,0.22227299599539713,0.003083697908867706
38278,SIDM00826,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,3.77207,0.050530266,0.760060756559391,0.005871264477513211
91089,SIDM01042,Palbociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.21423756,-0.010495726,0.19745376136242354,-0.007719511500368033
17490,SIDM00216,BMS-754807,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.22875,-0.044583783,-3.743143746636753,-0.15897316760324584
69170,SIDM00359,Olaparib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1361724,0.032643747,1.444679700760154,0.034836916445671516
50599,SIDM00933,MK-2206,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.98914397,-0.123550914,-0.4184704044104165,-0.003556846950004638
37664,SIDM00877,Uprosertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.2503548,-0.08705652,-1.027684352106759,-0.08576007892396892
95883,SIDM01197,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.3599288,-0.1815274,-1.8466790130797595,-0.15782056103542463
61136,SIDM00097,Linsitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.80754,-0.10443422,-1.0104184657073825,-0.03061177320974547
5598,SIDM00928,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-3.201118,-0.17269807,-1.6618038319012451,-0.0752036869481137
66771,SIDM00633,5-Fluorouracil,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.78214204,-0.04293525,-1.8653195132421676,-0.06861831591453756
65060,SIDM00146,Alpelisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0455174,0.06079428,1.0022290145650543,0.07669375339669784
45657,SIDM00933,AZD7762,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.038769275,-0.0045919176,-0.3352270435352729,-0.026538486102474494
52373,SIDM00957,AZD4547,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-4.2717295,-0.092252016,0.25577642052969424,0.039804457601264644
91667,SIDM00282,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.0164808,0.03799058,-0.4796004738504372,0.0230991238522093
67934,SIDM00673,BI-2536,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.0341415,0.16102222,0.43887631250163434,0.006905394259713597
101785,SIDM01187,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0973735,-0.035354458,-1.4490942260850195,-0.020934427287503197
93204,SIDM00148,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5684218,0.04821946,-0.6327649044019037,-0.06009401509462744
42896,SIDM01197,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5950532,-0.14552994,-0.823440559389453,-0.0349833048681876
57484,SIDM00950,Dactolisib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6990497,-0.11103843,-1.9770400062648859,-0.05865738030620125
90185,SIDM00875,Nilotinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.791198,0.19465396,0.8787884898056515,0.05544542463853641
61076,SIDM00826,Olaparib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.385256,0.11645949,0.1831262785111939,-0.009598188748907697
10521,SIDM00950,Oxaliplatin,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.81633604,0.06504314,0.4725152717519257,0.026105194396020444
72617,SIDM00097,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4169037,0.096760795,0.34464000711296927,-0.001146878810183601
37139,SIDM00633,Entinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.48961848,-0.030973148,-0.8907969346931318,-0.04344463277877585
9813,SIDM00833,Dabrafenib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.66973996,0.013681902,0.36190285617361023,0.00011577873713037066
93155,SIDM00146,RO-3306,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.34787405,0.028586395,0.09543003963829834,-0.025110137567595017
41905,SIDM00097,GSK269962A,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7618102,-0.034374684,-1.1480255600439102,-0.048110938298026304
26998,SIDM01042,Dabrafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6923034,-0.11038473,-0.5204640401446959,-0.04787718483973471
63889,SIDM00872,Luminespib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4780657,-0.10924483,0.188686633464358,0.015176029246780043
58932,SIDM01197,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6840043,-0.042402215,-0.177712185154834,-0.06434504981966908
11041,SIDM00826,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.7437711,-0.050678376,-2.9905299933723155,-0.09419439174901051
60663,SIDM01042,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1097252,-0.027731143,-5.241720870035817,-0.10348805142790947
49770,SIDM00097,Vorinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5040748,-0.088434786,-0.8031757816783048,-0.05594787725676016
43289,SIDM01187,Axitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.9764123,0.27794543,2.232226045331514,0.16808175364284128
65275,SIDM00872,SCH772984,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.15601574,-0.010607442,-0.5768155233299024,-0.0029244275078542914
3939,SIDM00837,Palbociclib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-2.4490767,-0.10593556,-1.7094514833538759,-0.05553199304989814
50011,SIDM01042,Bortezomib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.02036197,0.0010533759,-0.10284262186796066,-0.058216581934635296
99642,SIDM00097,ZM447439,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4650973,0.08558945,-0.9679011968886849,-0.025425718388524313
97932,SIDM00872,Entinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.388501,-0.10717013,0.14098044165448245,0.019415254205644154
7916,SIDM00826,Dabrafenib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.7038974,-0.05746375,-0.5312937725670416,-0.004577621628057563
46361,SIDM00933,SCH772984,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.0790803,-0.09978523,-1.0514130606570344,-0.05031632137675751
89188,SIDM00875,Cisplatin,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.2768807,0.37635264,4.281684123615667,0.2163428337712435
105505,SIDM00877,Paclitaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.61915153,0.0693801,-0.09142260640479138,0.006400692634908438
69376,SIDM00097,Entinostat,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6894057,-0.035203636,2.302655032223726,0.127490756049196
27562,SIDM01042,Trametinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7357374,-0.04647888,0.6699579691834592,0.09305483499265926
67578,SIDM00216,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,-0.45475945,-0.04609569,-2.0105497072415184,-0.11704987354593635
30861,SIDM00282,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.0868356,0.06769662,0.31342229104290525,0.026228082602848705
62532,SIDM00633,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0026329,-0.07409777,-1.6201018882977831,-0.04494720417918948
57394,SIDM00950,Ruxolitinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6794952,0.08943853,0.8968786492220012,0.03114049163948245
31901,SIDM00282,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.7893524,0.056172512,-1.1772274154823126,-0.048862039930862244
60566,SIDM00877,BI-2536,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.1855863,0.0004955254,0.9637859071361191,0.021420677297682128
104334,SIDM00148,OSI-027,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.19775216,-0.019819181,-0.05161815668175249,-0.03327712673071545
74286,SIDM00877,NU7441,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.4165967,-0.046899784,0.5737061854705376,0.04009825197788812
47574,SIDM00957,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.7047759,0.033513173,-0.5608957155938353,0.0643006179244258
47731,SIDM00928,Luminespib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.7984182,-0.14816713,-1.7395806080050507,-0.11674444250141458
13110,SIDM00950,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.0544477,0.107811034,2.6704167896651247,0.05057148940137088
97565,SIDM00216,AZD4547,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.40954667,-0.033906862,-1.090452042567303,-0.05189281808538058
59001,SIDM00042,Sorafenib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.2094693,-0.109867685,-1.7642802671022344,-0.1061041647101421
7525,SIDM00833,5-Fluorouracil,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,3.1245024,0.23482676,-1.1089050795215052,-0.012940266633844523
14480,SIDM00837,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.7772693,0.016830122,-2.3441583595743856,-0.07737389807866103
40383,SIDM00837,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,1.0973574,0.026018709,-1.944590745833309,-0.06398170538529464
55632,SIDM00282,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.65060693,0.03280733,1.319939722639129,0.044046848686221364
6940,SIDM00837,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.9878361,-0.059923943,-1.9051785447529783,-0.08650121506052495
20218,SIDM00933,SCH772984,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.6528587,-0.10070913,-0.08847637033035192,-0.012925242971295041
13715,SIDM00957,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.5124922,-0.060478974,2.091723183573721,0.11879968701952513
97791,SIDM00097,Cisplatin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91801894,0.020064283,0.37758879782147675,0.024701322300189628
98489,SIDM00872,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.42454898,0.04382751,0.199331792637445,0.02350930081427953
21644,SIDM00877,GSK269962A,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.24886015,-0.028867323,0.3610506181600222,0.03244271193510889
107087,SIDM00148,Luminespib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8833351,-0.11570137,-1.077843459901713,-0.029985115216871715
38456,SIDM00673,Alisertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.83165634,-0.047759302,-0.026320025090442078,0.02460536266923657
12199,SIDM00148,Docetaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.97066605,-0.06895674,-2.1334540698397593,-0.12444784960687016
86992,SIDM00933,Camptothecin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.1739395,0.09632927,-1.0327694606804319,-0.044419890166282505
103746,SIDM00928,PD173074,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-1.6452006,-0.04900157,-0.501694447011334,-0.0019068608889668962
68889,SIDM00148,Wee1 Inhibitor,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2253335,-0.108348794,-0.8923514073562572,-0.07374335311878208
77361,SIDM00835,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.7723455,0.14145744,2.573881799638473,0.1282722728438911
39681,SIDM00928,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.277696,-0.08684098,-0.9202826110439917,-0.008054202082015396
8441,SIDM00146,OSI-027,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.7450555,-0.066705875,-0.6392819679483616,-0.04503935179365271
72494,SIDM00097,AZD8055,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5199776,-0.15556563,-1.670886806439895,-0.15392844182280738
47619,SIDM00776,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.2757825,-0.1001895,-1.3143191271818964,-0.0811527997938714
74659,SIDM00776,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.71709967,0.050519884,0.13532127982495512,0.04860202901445761
53869,SIDM00875,Dabrafenib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1316897,0.06412183,0.030580827900878987,0.00707296585518318
74185,SIDM00216,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.42263144,-0.011646465,-1.0127631794160805,-0.03145481249878737
81298,SIDM00877,AZD6482,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.112318926,0.013046392,0.8189010180729162,-0.012147414657270936
38614,SIDM00832,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.031454,-0.06546071,-3.1880500742617413,-0.11239646996226701
91613,SIDM00835,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.5771213,-0.117287785,0.3536681366965731,0.06556273152685867
22008,SIDM00633,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.59174144,-0.050125536,-1.7957669279350548,-0.05215708520746036
94959,SIDM00633,Palbociclib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.056936,0.085741475,-0.7897658826742104,-0.011068856761796163
104513,SIDM01042,Luminespib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9626486,-0.09317105,-0.6931579263767,-0.0417487935488697
55139,SIDM00837,Palbociclib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-1.6123854,-0.10201016,-2.1485908757126166,-0.10997938876490172
30974,SIDM00148,Navitoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6749176,-0.06009339,1.2487367657764292,0.03845880223260436
73199,SIDM01042,Camptothecin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.48699,0.24357624,2.4239859976921942,0.1998101557175087
61115,SIDM00872,Docetaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7480672,-0.073217064,-0.8051804048484047,-0.022131224016268883
65459,SIDM00097,SCH772984,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7234427,0.041903593,-0.6513446147038496,-0.035713459469449794
10504,SIDM00957,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,1.9299852,0.03116072,1.5406521766112797,0.05486517571230624
71899,SIDM01042,OSI-027,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1819904,0.11454641,-0.2446826842365618,0.033428369573462964
104268,SIDM00833,Camptothecin,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.2834257,-0.08367603,0.30887763288299475,0.01820771131736235
6608,SIDM00146,Axitinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.046024,-0.07154895,-0.617209575752014,-0.02117228817961188
95021,SIDM00877,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.1472478,0.037553202,2.5817589951563216,0.04176556694129794
4230,SIDM00148,Gemcitabine,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.55387443,0.035952765,-0.600692919087255,-0.05679448059513505
85968,SIDM00097,AZD6482,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6999049,0.11153979,-0.6552108629181517,-0.024129056173295554
93711,SIDM01042,MK-1775,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.54956526,-0.028208861,-1.486191785545838,-0.10663665326078267
20373,SIDM00042,Lapatinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.0338023,0.111056626,0.3946645778972282,0.02106597223030983
18028,SIDM00950,Palbociclib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.8317377,0.020802012,0.6353333818027318,0.04462652422660338
11729,SIDM00933,Crizotinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.68775517,0.08515153,0.1326687673237606,0.04563478491446066
70177,SIDM01042,Sorafenib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.36924088,-0.04123298,-0.403204423429746,-0.04019335722857514
108225,SIDM00872,Palbociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2968246,0.012841781,1.8548812578627418,0.07389134693057836
676,SIDM00633,AZD6482,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2712003,-0.10031521,-0.8922242224173529,-0.06227963443384963
45612,SIDM00673,Sorafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.484482,-0.11742738,-0.27493690339325044,-0.03359734484615127
27434,SIDM00146,Cisplatin,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.9706215,0.095509276,1.5172648595177105,0.05843004089265887
97245,SIDM01187,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5229009,-0.13088942,-0.783695862729587,-0.06052676664869052
107716,SIDM00872,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.52223366,-0.012936996,0.550590434715062,0.0052245389177530315
102458,SIDM00957,AZD7762,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.5919578,0.05141773,1.7088135056694318,0.09055868112285903
53248,SIDM00957,Trametinib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.033819,-0.047013596,-0.816828168858928,-0.05707257368210899
4715,SIDM00928,OSI-027,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.6852657,-0.16403197,-1.0755767244181726,-0.08209875453026784
5244,SIDM00833,Afatinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.5063316,-0.04029984,-0.37576843586904185,-0.052391767398856585
57444,SIDM00835,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.61187094,-0.024437021,-0.2202711541913634,0.06529050498658284
58644,SIDM01042,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8631037,-0.024022708,0.7399826134511256,-0.0021821174265399972
29438,SIDM00875,Doramapimod,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9221423,0.070729874,1.2743862316599923,0.031230611521349524
61819,SIDM00950,Paclitaxel,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-5.096834,-0.45770618,-3.2525621019909523,-0.2544921797307914
117,SIDM00928,PD173074,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.5747657,0.21133484,1.6206946464030196,0.10107058873802453
55850,SIDM00455,Dasatinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.20273086,0.007706878,0.7126678223371687,0.020256920413276175
7825,SIDM00875,Wee1 Inhibitor,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28952864,-0.021388542,-0.9758289867799523,-0.025020856611827375
770,SIDM00146,Taselisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.47864482,-0.03860235,-0.0656463819245872,0.05347301118387074
72517,SIDM00148,Alisertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4249669,0.08778286,-1.9073262839844858,-0.034783682215300565
89312,SIDM00875,Lapatinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5183886,0.15620902,2.9576717612782124,0.16823168967300645
33194,SIDM00957,LGK974,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,1.305791,0.023312043,1.8383845756223924,0.09452471268620066
28381,SIDM00146,PD173074,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6516557,0.12827675,-0.09100013537166668,0.005702960689545513
93925,SIDM00673,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.4861836,-0.07527158,0.509815048720382,-0.005543791385327763
28365,SIDM00148,Nilotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2063972,-0.1223049,-1.4924756412393683,-0.12310618555946043
34130,SIDM00148,Luminespib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.68349034,-0.06481104,-0.36498392972645527,-0.06428439831851561
17001,SIDM00832,MK-2206,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.5229616,-0.042681143,-0.17689870881427072,-0.02096178900431693
93020,SIDM00633,OSI-027,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.50753665,-0.039100215,-0.8907293191253913,-0.09851276770926125
58484,SIDM00633,OSI-027,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7256633,0.057668503,-0.7084454023446078,-0.03560043240071025
35909,SIDM00877,Gemcitabine,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.39284548,-0.004089526,-0.6518540603696928,-0.01827735779205361
103777,SIDM01042,AZD7762,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,4.1384025,0.2606286,0.9335514271687669,-0.03772845565719927
58512,SIDM00875,Ribociclib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3311223,-0.042839255,-0.763723212386059,0.024259133980911042
602,SIDM00097,Taselisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.592135,-0.22264433,-1.0950217599124112,-0.08146700409595024
77384,SIDM00928,AZD7762,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,3.2042935,0.28472444,-0.18479240204158984,-0.07714244208535492
67980,SIDM00673,Alpelisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1468253,0.09944266,1.5732131708348338,0.08978617754692286
2177,SIDM00097,AZD7762,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0071487,-0.09425952,-1.3532523007630959,-0.03264495615228071
68065,SIDM00673,Sorafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5174744,0.034057986,0.009091214373136862,0.018523571101860054
46,SIDM00877,BI-2536,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.3339648,-0.011768141,-1.8641086547226222,-0.025250885506965783
85034,SIDM00097,PF-4708671,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5146767,-0.051277306,0.9070113236654759,0.049592784070231655
70731,SIDM00875,AZD6482,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7334812,0.15643711,0.9841670449334109,0.04931698413395744
92191,SIDM00833,MK-2206,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.9667786,0.12310856,0.09972814909190039,-0.010635153160270045
51056,SIDM00872,AZD8055,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.74015325,-0.07368993,-0.6769222325852804,-0.09018329353621847
3778,SIDM00826,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.99933463,-0.00618689,-6.5971591939307075,-0.16519738463347616
60174,SIDM00837,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,3.1913278,0.11118428,1.8366384772974131,0.05879858419228991
41578,SIDM00875,Venetoclax,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.279275,0.009502768,2.2032975557997565,0.0005413900012411436
20166,SIDM00097,PD173074,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3588796,-0.05205959,1.4803893466703129,0.026696259834364047
70387,SIDM00673,SCH772984,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-4.180489,-0.25750327,-0.7218254881149612,-0.015946015155128012
13626,SIDM00875,Nilotinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5373882,0.15899451,0.5861003956472585,0.04157024381974176
78783,SIDM00826,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.84273744,-0.022637257,-2.0438979920725395,-0.040003244663191884
95333,SIDM00837,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,3.5145814,0.04728662,-1.1025645911190496,-0.07456180308928606
14081,SIDM00826,Navitoclax,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.41548184,0.011235532,0.25960752880329574,-0.023617402101136407
9062,SIDM00933,KU-55933,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.0220106,0.109850675,-0.07070484725682454,0.02371965080505135
83063,SIDM00877,Entinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.3845668,-0.06087884,-1.2109802464352273,-0.011623422837686852
11053,SIDM00950,Paclitaxel,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3970747,-0.1879273,-2.5114852673647743,-0.10748789545169188
37019,SIDM00826,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.62259114,0.033364743,-1.838554525279888,-0.10047809691153214
88599,SIDM00776,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2460473,-0.039546583,0.3602113203898667,-0.003298411122546196
43799,SIDM00673,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.7151037,-0.1086655,-1.7403921224603995,-0.04566542691415968
5568,SIDM00097,Vorinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4408886,0.06970816,1.8794077868844086,0.09271695869027008
55720,SIDM01197,Navitoclax,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.5762105,0.13597362,2.868634804793447,0.1297274449649339
71099,SIDM00950,MK-1775,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6789938,0.124076866,-0.3844691289986999,-0.03334652866605062
105610,SIDM00146,Entinostat,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.6417562,0.04810743,-0.3288194654100501,0.010974302350599653
34529,SIDM00877,Olaparib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5865648,-0.07002519,-1.2447170434364818,-0.029865147447079653
40791,SIDM00148,Taselisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6206041,0.040520713,-0.06461607605751228,0.027555299199019542
48490,SIDM01197,AZD4547,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.3571567,-0.015055574,0.019283767206028063,-2.9233730709039343e-05
42481,SIDM00216,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,3.5652246,0.18316755,-1.1846912791013933,-0.05535485874841289
55412,SIDM00832,AZD4547,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-2.5598295,-0.12728916,-2.104182226415092,-0.09814427161130253
52200,SIDM00826,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-1.7004325,-0.006156069,-3.8761869556057733,-0.06088268316207865
40983,SIDM00833,Olaparib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.372071,0.05647041,0.4152266388534505,-0.00016974400627727497
40368,SIDM00833,Crizotinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-2.215491,-0.09603847,-0.5810444442351397,0.010052401546197864
44149,SIDM01042,Entinostat,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8427546,-0.101043396,-0.4662480450768578,-0.007527911726802106
13529,SIDM00359,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7552981,-0.061161563,-2.7303783968858033,-0.07531184146451009
48201,SIDM00148,Alpelisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3569274,0.18993798,-0.22174705060007896,-0.047807565239369104
67401,SIDM00633,Crizotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0365047,0.09621142,1.308936366792786,0.02099712613053844
53778,SIDM01197,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.0745335,0.039199878,2.520745093105805,0.06854382962809011
62178,SIDM00933,OSI-027,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.28090698,-0.03956344,-0.2698792702891467,0.01849444546769965
18300,SIDM00933,PD173074,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.05228129,-0.005980398,-1.1412915118397322,0.0012423141534068506
59997,SIDM00673,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.94671863,0.094998576,0.9892009460567219,0.045919872244778115
18453,SIDM00097,NU7441,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0164493,-0.047863502,0.010553007437688514,-0.0015565260031571346
102122,SIDM00950,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.47981885,-0.051996116,0.8718624829284402,0.07787098001987348
6796,SIDM00673,Axitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7468178,-0.12415577,-0.2944686491563598,-0.022955973917880686
87864,SIDM00872,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9633368,-0.09435384,-0.8137941263895336,-0.047693083165722204
50570,SIDM00359,MK-1775,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3682644,-0.11428504,-1.5173910961988297,-0.06530560616692756
92398,SIDM00872,Linsitinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6514143,0.077305906,2.531880441162217,0.15165966916716359
47712,SIDM00359,BMS-754807,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.09811304,-0.007521576,-2.5950303888198674,-0.1237653611517255
101544,SIDM00875,Lapatinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30698273,0.0347224,0.6934571471196854,0.011845374649963963
65922,SIDM00455,AZD7762,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4480705,-0.082847096,0.261292313155601,-0.02177806407802539
97203,SIDM01187,Cisplatin,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7154419,-0.052568253,-0.11609982743551339,0.029105547555202144
58816,SIDM00673,Nilotinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3661314,-0.06561534,1.5721880237111814,0.10524549849837522
30926,SIDM00097,AZD8055,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9954941,0.13258721,-0.46693416245080993,-0.06214310197023906
77056,SIDM01042,Doramapimod,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5400518,-0.19992743,-0.5548538428546823,-0.022309347299820516
105586,SIDM00146,PF-4708671,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.561856,0.01691981,2.1590728521602225,0.10511812297979056
16827,SIDM00872,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.77330166,-0.07249267,0.1944622872817357,0.041552716421754544
98742,SIDM00928,Tozasertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,3.1704078,0.16601497,0.8638119561610353,0.0377334576262162
95533,SIDM00216,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.9682744,0.045646686,-0.6849636521280772,-0.05604059473694185
71572,SIDM00633,KU-55933,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.073327,-0.034833018,-1.3088753763588754,-0.024504294847642202
47618,SIDM01042,Pictilisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5047582,-0.040132497,-1.1778364145497604,-0.05345002809331914
35542,SIDM01042,Bortezomib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4938244,-0.033870712,-0.16048279572331514,-0.046769820987535446
76531,SIDM00148,NU7441,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5964012,-0.10632488,0.8368090799458439,0.05167500885728816
15075,SIDM01187,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9711587,0.02775563,3.2034707025791693,0.13057760756527492
21726,SIDM00455,Irinotecan,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7535795,0.06528783,1.093707865466229,0.10870521983110945
68587,SIDM01187,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.92691773,-0.09576671,-0.7759316939634737,-0.06289856810419256
82021,SIDM00633,AZD7762,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.8835409,-0.109376535,-2.1427983884516104,-0.07897706929455067
57278,SIDM00042,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.87208146,-0.09529969,-1.2116517567953382,-0.06562015096592627
98894,SIDM00872,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.91685903,-0.0855415,-1.738072372488673,-0.19604872012569713
1823,SIDM01042,GSK269962A,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8483483,0.08802382,-0.4778969997093492,-0.040093614620401084
38435,SIDM00776,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6243287,-0.04600907,-1.247199497789086,-0.10249269727106564
78942,SIDM00826,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.4511378,-0.004329142,-2.182968521084011,-0.04537534331634009
10727,SIDM00933,Lapatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.5785068,0.054365557,0.6106959779902128,0.08195274659875107
29161,SIDM00933,Palbociclib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8412239,0.094623104,-0.36763582154535834,0.011314974082222228
89882,SIDM00633,Vorinostat,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.5906074,-0.18409124,-0.7929363998859061,-0.07522437773697252
104572,SIDM00877,KU-55933,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.3113806,0.17655747,0.5523617234472754,0.07041201310164794
79001,SIDM00148,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2080764,-0.09162929,-0.13747222945265103,-0.03224818798989884
65230,SIDM00146,Cisplatin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.6490517,0.095042296,2.5600591358945746,0.11774500548315445
45977,SIDM00633,5-Fluorouracil,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.645228,0.19309886,0.7433100858557317,0.016651024524240315
40593,SIDM00633,Dabrafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1835862,0.027428042,1.119299722777948,0.03563114189591933
104017,SIDM00673,Cisplatin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.20757474,-0.00698984,1.0523924904335493,0.07110454793394386
95743,SIDM00455,AZD7762,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5339267,-0.07037177,0.6206768234754743,0.06662648884468951
54534,SIDM00633,OSI-027,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.91568244,-0.060061045,-0.8273367580198889,-0.02403480627901034
104642,SIDM00097,Nilotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.97331166,-0.054680973,-1.4571085477151635,-0.12716427575693967
17242,SIDM00837,AZD4547,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.4317868,0.14837353,-0.190217769351668,0.05238073449300345
75436,SIDM00282,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-3.5602262,-0.15281516,-2.1408531376835893,-0.12867521041545904
44645,SIDM00835,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.326997,-0.059049454,0.3084601124140673,0.042025410670164624
82944,SIDM00833,Nutlin-3a (-),LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.45083213,0.009752387,1.4936805629666035,0.005167732904754964
18477,SIDM00872,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8641132,0.036766604,1.0148674543136622,0.07245435017169219
76667,SIDM00097,AZD6482,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.485313,-0.13687846,0.561212932748261,0.00300637193865661
31754,SIDM00216,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0626527,-0.06311091,-2.2741080244178473,-0.13073807549443112
16382,SIDM00216,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.6236804,-0.04992466,-1.6728872048445815,-0.07031189312567071
78675,SIDM00872,BI-2536,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2520205,-0.12027967,-1.014427521078406,-0.058225183385952214
76509,SIDM00673,Crizotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.39706156,-0.038378805,0.08351378949509015,-0.005366169358570381
48143,SIDM00097,ZM447439,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.86866957,0.04573912,-0.3745525072172515,0.014365176776889844
86872,SIDM00837,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.18577021,-0.013351803,-0.8585188348080758,-0.043952143195663464
92309,SIDM00633,Nutlin-3a (-),Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.0704584,-0.16716759,-1.0510752780000623,-0.08003423236285152
27882,SIDM01042,GSK269962A,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3151271,0.10989037,0.9008879997867599,-0.00587519122267759
88048,SIDM00950,Lapatinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6391617,0.06994392,0.23992368747151718,-0.05631452965221863
104791,SIDM00957,AZD7762,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,2.7375956,0.038888454,3.3805648344952983,0.07083108381379709
65177,SIDM01042,Luminespib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.40850344,-0.048521176,-1.0547571540021021,-0.022679098443877835
24007,SIDM00633,SCH772984,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.602518,0.3737617,1.46278013676774,0.10020075094391176
83213,SIDM00950,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0285116,0.035780635,0.7823042157960753,0.03734601533145561
28399,SIDM00835,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.2563953,-0.029096546,0.3829141427514993,-0.0051974284930288725
71859,SIDM00928,Luminespib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.67824227,-0.069589816,0.22777091900611213,-0.0029622325801934362
64913,SIDM00832,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-0.9542441,-0.022909641,-0.8028228517841786,-0.019202871044748892
67204,SIDM00633,Afatinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5709366,-0.0062325606,-0.6554583846718287,0.008639131642124629
36193,SIDM00455,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4681399,0.09977944,0.004762122720821983,-0.02564998571982468
62369,SIDM00877,OSI-027,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.3104069,0.10225466,0.16214830336195074,0.05411146772483242
69779,SIDM00633,Paclitaxel,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4220446,-0.0875959,-2.917040972702452,-0.1133131969889538
85075,SIDM00933,Trametinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.5055438,0.071043946,1.9572128511355822,0.17381599122314617
35600,SIDM00455,AZD7762,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.0597265,-0.11380647,0.6302720081099383,0.08400551959641109
82498,SIDM00835,Crizotinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.5276709,0.18836537,0.042425004908822804,0.047588251811327524
18245,SIDM00633,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.03882,-0.042459153,-1.1903666888458524,-0.025532351855758424
86745,SIDM00957,Nutlin-3a (-),Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.6162516,-0.043841366,1.2756614311765417,0.08653003787544293
89974,SIDM00282,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.182049,0.06350207,0.47499127558249976,0.07234177072573639
80311,SIDM00673,ZM447439,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1071416,-0.09182816,-1.2332491409568445,-0.09112511581007038
8315,SIDM00097,Camptothecin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1201699,-0.048104618,0.38857040053451436,0.03245586577578776
43981,SIDM00148,Gemcitabine,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.077195,0.1032225,2.194625523987098,0.09575181123903781
87188,SIDM00359,Afatinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2263451,-0.10637754,-0.9327992691752238,-0.06523982609420613
30042,SIDM00146,Dabrafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.20979653,-0.010319407,0.39052923252650307,0.04363584307284573
10855,SIDM00928,5-Fluorouracil,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.356588,0.11621651,-0.06279100649724124,0.01565027366423447
26329,SIDM00928,Axitinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.7656438,-0.074911244,0.1848271068536368,0.01718885386412614
70442,SIDM00216,AZD7762,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,1.9318686,0.118954085,-1.0808423835212317,0.004157721661210829
12042,SIDM00826,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-2.3535979,-0.015188637,-2.6102694485757145,-0.0036695121525979115
14051,SIDM00833,Oxaliplatin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7811229,-0.059666626,-0.9689228230394192,-0.11948620268411773
15196,SIDM00875,Vorinostat,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9851347,0.10437112,1.3236315728231165,0.0409348313643239
47053,SIDM00877,Docetaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.6506888,0.1685083,0.13807873220398428,0.03728969418442148
44772,SIDM01042,Gemcitabine,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73198736,-0.08884875,-0.8533474608535606,-0.04391759491750857
39466,SIDM00872,ZM447439,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7399507,0.0751019,0.9683036633470202,0.04643304584567601
9876,SIDM00146,KU-55933,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.119618,-0.069975816,-1.3584991746339787,-0.007792111270259214
34669,SIDM00633,Navitoclax,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9948776,-0.07423523,-0.17889856887152994,-0.021404736451396112
55546,SIDM00673,Tozasertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4861537,0.12098523,2.9678677550647294,0.15569708395603613
4792,SIDM01042,JQ1,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7204412,-0.053421773,-2.156587089931645,-0.05615033427935818
105029,SIDM00875,Temozolomide,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8373927,0.048358288,1.213765491035061,0.0077031954462019
90736,SIDM00835,SB505124,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.1723527,-0.08769998,-0.7613875489973865,-0.06646958816626727
98094,SIDM00950,Olaparib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9942436,0.07763981,1.6374450177235804,0.0785732592438325
78256,SIDM00776,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.9482881,-0.1350363,-2.1847963167489834,-0.13457722142717568
64427,SIDM00928,Temozolomide,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,4.1395545,0.22012307,1.2755982049165064,0.0370691369248486
98363,SIDM00097,Docetaxel,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.514883,-0.13522825,-1.1396668849973992,-0.0833448162393213
97014,SIDM00633,AZD8055,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7158435,0.07371053,-1.206552006284424,-0.049907218050958775
48775,SIDM00957,AZD4547,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-3.8338926,-0.070842706,-0.3117438248200603,0.0031795968706909315
66831,SIDM00673,Gemcitabine,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3227781,-0.08732918,-1.654353090352383,-0.035067669223605547
72007,SIDM00148,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7564082,0.15668519,0.011458479661022066,-0.039798289172835316
19147,SIDM00933,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.35672253,0.043978322,1.3587017116859772,0.14004368475272327
69997,SIDM00837,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.50390303,0.006268952,1.5800033524570685,0.04171628077815371
105517,SIDM00875,Trametinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5787214,-0.060946483,0.6894166439994817,0.020916740808216913
69915,SIDM00146,Alisertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.31434616,0.029125439,-1.8152710414349975,-0.06661618460337367
83311,SIDM00877,Doramapimod,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.1310619,0.0492605,1.1058483491373265,0.02821632299311755
84307,SIDM01187,Trametinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4963644,-0.051884703,2.8449296380422986,0.11058999042365689
98635,SIDM00148,Palbociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7131088,0.1788534,-0.8488796310546873,-0.0033958915397065467
32127,SIDM00042,LGK974,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.87277097,0.053830348,-0.9164422438737192,-0.01802662932650411
78897,SIDM00673,Bortezomib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.14962544,-0.0076579917,0.3989929893667807,0.00815278831198528
31900,SIDM00146,Afatinib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0591125,-0.0956207,0.6314182068082784,0.040258141503434416
43967,SIDM00455,Dasatinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6186159,0.09527972,0.8851717972543961,0.13423513928105424
37607,SIDM00216,Olaparib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.820108,-0.015304431,-0.06215585989079477,0.027178727917001252
104889,SIDM00146,Linsitinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.0974474,0.07183943,4.465453463842899,0.22644460632481322
56633,SIDM00877,AZD7762,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.744994,-0.14744706,1.6106533289335265,0.14032907809516135
84214,SIDM01187,OSI-027,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1929038,-0.08528776,-1.1983874817327904,-0.03824574121102389
93491,SIDM00872,GSK269962A,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.952899,0.08610448,0.1469840086176293,0.00034553078251379067
33001,SIDM00455,Paclitaxel,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.907955,-0.114256784,-1.753592267897187,-0.12630085963943355
65975,SIDM01187,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.8527746,-0.14130417,-1.3309776378610103,-0.051880578558734756
67464,SIDM00633,5-Fluorouracil,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0491089,-0.048311137,-0.4163087324360693,-0.011842327485687467
96292,SIDM00928,Camptothecin,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.4199923,0.14400725,0.5206845097314612,0.05179116258765901
30065,SIDM01197,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3746874,-0.09375391,-0.6965345250140459,-0.05183251909754561
7547,SIDM00455,MK-2206,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.780297,-0.08662282,-0.7466892483880646,-0.015558800424737096
17524,SIDM00875,Palbociclib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3038957,0.104819186,2.2968817529113643,0.06622187312016888
61152,SIDM01042,Palbociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3724082,-0.019373616,-1.134138827954203,-0.010627495172092877
75249,SIDM01042,Sorafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.43459713,0.042305704,-0.5122731458695372,-0.041810028774682324
90827,SIDM00933,Nutlin-3a (-),Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.45212603,0.06720648,0.4210893465426842,0.0177756387850075
1209,SIDM00875,Vorinostat,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2476025,-0.09703707,-0.05822207980995515,-0.0014716705193208413
38682,SIDM00826,MK-1775,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.45635414,-0.02935065,-1.2884580611640322,-0.04420023855910465
29172,SIDM01042,Wee1 Inhibitor,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41007644,0.02211955,-1.77697520966174,-0.05706072255319873
51693,SIDM00833,Navitoclax,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,1.9043618,0.11496121,0.7708691412818872,0.026198442836842292
74682,SIDM00872,Trametinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4103167,-0.18037513,-0.7861420648500919,-0.09756054095352423
24499,SIDM00872,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0495226,-0.08581945,-0.3321343132159157,-0.04755138174192516
94484,SIDM00633,Taselisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.75612295,-0.043100163,-0.3469918818605536,-0.0303275839491707
47564,SIDM00673,Dabrafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,4.676258,0.10018971,1.105329662769042,0.047159097114594234
27248,SIDM00833,Camptothecin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.8232418,-0.08610972,-1.2922232705887444,-0.027907483124427784
96667,SIDM00146,Lapatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0233103,-0.08022676,0.9846969558820439,0.06398787196745187
28621,SIDM01197,Linsitinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.99823934,-0.038453236,0.5532757013025486,0.08863277024465077
3389,SIDM00957,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-2.6209092,-0.04018138,-1.1718295399941172,-0.014324642135670002
36404,SIDM01197,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7688419,-0.10150483,-1.0770158582798506,-0.07484294797458349
5954,SIDM00826,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.08159617,0.002083315,0.35010199602624703,0.053733172098162564
2599,SIDM01042,Pictilisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.119133435,0.0066910563,0.40294827935300087,0.016440348753208826
68532,SIDM01197,Vinorelbine,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.7330081,-0.22856183,-2.78656807745242,-0.21128472520188935
31717,SIDM00146,Dabrafenib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.4731812,0.17958902,-0.24188684072277583,-0.011601616784110633
34084,SIDM00455,Cisplatin,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.4440046,0.011484741,0.8087958972967236,0.05319866301026002
18930,SIDM00877,AZD7762,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.6726526,-0.05834552,-0.45932178665051426,-0.05634965624298462
54217,SIDM00455,Dasatinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.2241328,0.19716358,0.6957931612592305,0.08750126796187357
31049,SIDM00877,Nilotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.7426876,-0.07687898,-1.801446899266167,-0.03378674188047455
36591,SIDM00455,Sorafenib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.122314,-0.067146115,-1.0746826746411113,-0.015317251205212165
3731,SIDM00633,Temozolomide,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.39646012,0.005687171,0.08066450020441335,0.027089828955645805
29871,SIDM01042,Vorinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5215104,0.100427225,0.12486820700601393,0.05873312532233179
21286,SIDM00148,NU7441,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7819148,-0.051856406,-0.546503514092053,-0.07084175249132305
104452,SIDM00146,Axitinib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.4056451,-0.15643527,-2.075883069974739,-0.09892303314030826
50044,SIDM00146,PD173074,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0969226,-0.1332919,0.9563074266905155,0.13304953401354544
70334,SIDM00832,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,0.96351016,0.015319674,-0.7619239224459176,0.006974719913752422
26041,SIDM01042,Docetaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3712908,-0.15956248,-2.1076227403456813,-0.08688751920618161
67927,SIDM00673,Paclitaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-1.0158442,-0.061149176,-1.1764819638055375,-0.090875221395259
69927,SIDM00776,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.42656058,-0.028926939,-1.5114420219914575,-0.07762575354563563
77478,SIDM00146,Sorafenib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1377053,-0.09250304,-1.115443202152028,-0.11150462336781529
105311,SIDM00633,Vorinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.144063,-0.19330005,-0.791057332636479,-0.04262414240499787
88979,SIDM00832,LGK974,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.3387485,-0.12333313,-0.5245262984435777,-0.046002052494211854
103849,SIDM00042,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.58824974,0.06723203,0.8877810557084623,0.005976373113992686
1228,SIDM01197,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.214494,0.008707568,1.4022275761755805,0.09878600521334296
100647,SIDM00933,Wee1 Inhibitor,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.30087337,-0.025287012,-0.39759855924890025,0.034188454274877905
101138,SIDM00872,Entinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3318975,0.10675439,1.6428323156567477,0.13838371819861192
73280,SIDM00928,JQ1,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.95526254,-0.056601603,-0.2593293884555289,0.024100004799612117
51551,SIDM00933,Navitoclax,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.6404116,0.059059933,1.3197715163508812,0.03118875504884831
75112,SIDM00216,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.5332082,0.031157576,-1.4080605316699648,-0.07363943805532586
40887,SIDM00826,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.35001516,-0.018650101,-0.8719385302278245,-0.03214163989470556
68412,SIDM01042,Palbociclib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.25449148,-0.012659485,0.20919266375347026,-0.008006320844577046
67490,SIDM00216,Navitoclax,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.3289788,0.2558155,1.0466336695354157,0.11519628057505654
84634,SIDM00633,SCH772984,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0244577,-0.18358718,-2.352168602901124,-0.11708452832622311
84046,SIDM00835,Crizotinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.1548063,-0.09130942,-0.07060265632733635,-0.046787004095862755
2659,SIDM00832,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.0642915,0.11651007,0.1816887759068155,-0.0470599200404276
33375,SIDM00097,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9789348,-0.10840375,-0.6450022491804094,-0.10887148539011766
52629,SIDM01042,Luminespib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2163868,-0.11241048,-2.779690631664031,-0.04173989377205451
14077,SIDM00673,Tozasertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.88390243,0.060563095,1.0101578762818468,0.03890570597428881
74504,SIDM00872,GSK269962A,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1204392,0.10451747,0.6476935594063373,0.08224818519859665
50403,SIDM00872,Sorafenib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6492269,-0.13973185,0.767492877615425,0.059708106859790534
16513,SIDM00837,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.4121993,0.14529712,-1.1087083649868787,-0.06006323408333235
9735,SIDM00216,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7890006,-0.037882533,-1.4883391079805564,-0.09249671581104472
95707,SIDM00835,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,1.074344,0.064344674,0.6847974067389667,0.04960078729668824
12555,SIDM00776,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0295948,-0.06378477,-1.0330074290201838,-0.005357474222824191
66199,SIDM00673,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.0498145,0.11117452,0.15352854923565698,0.002262935832387513
61697,SIDM01187,Vorinostat,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.14956172,-0.015380384,-0.4464757946216196,-0.008936042097070124
61612,SIDM00097,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5750043,0.10779222,-1.3007347055261058,-0.008411661725454501
12109,SIDM00216,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.8088326,-0.13190536,-3.61336765658157,-0.20226002050421885
50218,SIDM00826,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-4.4758,-0.23464745,-6.076440208464094,-0.30624268096032836
84515,SIDM00872,Nutlin-3a (-),Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5129734,-0.012634284,1.0725137721975655,0.033979239825942864
37537,SIDM00875,Bortezomib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74088967,-0.026458146,-0.35855802713935553,-0.08335632683497411
7316,SIDM00877,Docetaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.5711958,0.2861711,1.2443786808909958,0.15698236941679508
46534,SIDM00216,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.43773437,-0.04291406,-0.2736508902804759,-0.03852505740312662
102134,SIDM00097,5-Fluorouracil,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0537018,0.05944773,-1.7060229256336963,-0.09420596111661057
74648,SIDM00148,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.5352702,-0.1665982,-2.3617362572646363,-0.15329672106691294
71994,SIDM00872,Vorinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.98027,-0.11390489,-0.6228987343899339,-0.06979043966534645
27865,SIDM00633,Taselisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.426898,-0.05924568,-0.8630340541524902,-0.04813151075386342
108047,SIDM00872,PF-4708671,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.278756,-0.09478442,-0.14901249091342902,-0.05421184706023394
94021,SIDM00673,Nutlin-3a (-),Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5294625,0.04806186,0.16288956038648741,0.01023991955918621
41676,SIDM00359,Vinorelbine,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.308675,-0.06599172,0.6284861830955859,0.06885827167015676
11523,SIDM00872,Nilotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4581484,-0.07492045,1.9739419973139571,0.05730903437503663
41769,SIDM00148,Gemcitabine,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8491293,0.047629073,-0.9895584232460348,-0.035071244923098654
86349,SIDM00837,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.85588807,0.014189545,-1.0812509342675989,-0.07080234939330768
98604,SIDM00833,Taselisib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-2.248576,-0.10950599,-0.4274447006660111,-0.07407342635615821
25336,SIDM00877,5-Fluorouracil,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.567212,0.10681442,0.556072818843778,0.07411706777506771
71720,SIDM00455,Dasatinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6978115,-0.029787984,-0.9818039074254712,-0.036138728241082656
68845,SIDM00933,Afatinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.979223,0.17398502,-1.056393479834265,-0.008566621820838604
108138,SIDM00455,MK-2206,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.890363,0.10094266,-0.4431035566430165,0.07436479461884841
96260,SIDM01187,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.660614,0.1899046,1.9288015765491102,0.08235310124275215
9335,SIDM00776,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.6207612,0.06351669,1.2315446909948164,0.04609794767093148
93106,SIDM00872,Ribociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2381711,-0.026009686,0.5337971791376819,0.02207843911675598
18471,SIDM00673,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.6905696,0.097774096,0.6170003360692686,0.0631868755638095
101922,SIDM00148,MK-1775,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.551066,-0.05248644,-0.7443315288566306,-0.04932691792273275
2647,SIDM00832,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2752641,-0.048548274,0.4777337330932508,-0.028678205880927014
42437,SIDM00875,Entinostat,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4758297,0.04923854,0.5002095476054235,0.06958812392430866
105307,SIDM00933,Uprosertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.044439,0.24025592,0.510653386329985,0.08462901135975726
22425,SIDM01042,5-Fluorouracil,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7330801,0.17780817,1.8775906957975674,0.03406880663519521
56933,SIDM00359,Navitoclax,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8915915,-0.0653073,-0.3835597191334942,-0.011186290482710031
33687,SIDM00933,Alpelisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.339696,0.11974363,0.4679965990907349,0.07058685357999597
83883,SIDM00633,Taselisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.71075135,0.038541444,-0.5025363631276368,-0.02609241605974499
90166,SIDM00835,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.8608472,0.06196824,1.025998665476045,0.05233511111839662
82838,SIDM00148,PD173074,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8300215,0.04496139,0.5432175378095767,0.06358934983310204
91444,SIDM00148,Navitoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8062547,0.07699542,2.0124028432711625,0.05570412228191145
75083,SIDM00877,Venetoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.4035087,0.08517419,-0.2787656698646164,0.031108254244288227
43445,SIDM00673,Lapatinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.793736,0.16776848,0.648259237585854,0.016130605686606625
87296,SIDM00928,ZM447439,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.4289947,0.17776412,1.1422829835005401,0.011371885662725121
1125,SIDM00875,Alisertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3111082,0.12680247,4.436197020974092,0.2443642917850419
44214,SIDM00832,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,1.9987775,0.071669504,1.621534805728837,0.05306666613090234
80926,SIDM00146,SCH772984,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.3275795,-0.12562114,0.008803777812280809,-0.04768121798078312
76169,SIDM00633,Axitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1061935,-0.05888088,-0.8570423713131546,-0.03304412440957182
84886,SIDM00877,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.78692335,-0.051778648,1.9402550109173833,0.16269224260356394
56838,SIDM00950,Crizotinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.53781474,-0.058588337,-0.3346573462990904,-0.06627672951413985
104714,SIDM00872,ZM447439,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1004782,-0.10165623,-1.021515426200902,-0.06601425108195853
92682,SIDM00673,Docetaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.91172224,-0.09368511,-1.4284690296248752,-0.0573851052417262
105694,SIDM00673,PD173074,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3535206,-0.10175326,-1.9204034711420128,-0.08338366854488538
100283,SIDM00148,Tozasertib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6395137,-0.047646336,-0.8641902534754624,-0.05568436535636073
85172,SIDM00282,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1232413,-0.043043405,0.2856090959501604,0.042113283141251956
69449,SIDM00097,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.967181,-0.15569577,-2.804299196508658,-0.10550636232252364
8453,SIDM00146,Lapatinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.3274801,0.12316979,1.0277740770225916,0.02337331520709925
15045,SIDM00097,Luminespib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.478482,-0.13989283,0.1880024397846491,-0.029491239063016136
16701,SIDM00933,Uprosertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-1.0109756,-0.093822375,-0.4094194102737971,0.05491242846841018
514,SIDM00673,Nilotinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2618136,0.14872769,0.6322517739865741,0.055598092646766455
29103,SIDM00835,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.5155702,0.25360888,1.7629745950845817,0.05155340832091057
7688,SIDM00455,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7165233,-0.07364252,2.7149019371047265,0.13478420008085784
56991,SIDM00455,AZD7762,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.7651458,-0.10503042,-0.5568959544415193,-0.015486766521739387
19780,SIDM00673,MK-1775,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.5722669,-0.056392007,-0.27985858650796147,-0.010600854617022277
89611,SIDM00875,JQ1,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.8065457,-0.17189617,-0.42016787897914387,-0.015659888952119696
1383,SIDM00148,Paclitaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3034239,0.1119128,-0.7241192992753962,-0.04540859600519992
104748,SIDM00875,KU-55933,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.21139073,0.008956905,1.2556664805809796,0.0518263651743487
106400,SIDM00148,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5377541,-0.0491738,-2.0564579479002023,-0.18412831760285406
24522,SIDM00933,Venetoclax,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-2.3904018,-0.074047774,0.8418824320284477,0.03248010691852838
69796,SIDM00633,Sorafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.34491244,-0.030557044,-0.512048203827785,-0.012141263481965864
96071,SIDM00042,Ruxolitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.1354196,0.112906255,0.7115708737175502,0.0468919887283566
75037,SIDM00282,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.5117385,0.15050614,3.830902427833155,0.1466280694480445
9215,SIDM00146,Entinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.68345654,0.05367658,0.813473185240734,0.05358807810083236
108419,SIDM01042,Dabrafenib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7343554,-0.066612154,-1.617263414773298,-0.07745901216601504
106462,SIDM00832,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.935151,-0.090971895,-0.8116817518085423,-0.06681939983621016
14699,SIDM00673,Alisertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0172741,-0.049988747,0.31472702076869047,0.03864113177309662
44869,SIDM00282,Crizotinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.6647582,0.09474879,1.4481367481641751,0.11663508330620119
56697,SIDM00877,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.4062791,0.09471105,1.8774986336532764,0.12504225960824253
102432,SIDM00455,SCH772984,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9390028,0.16544366,2.5377262825517923,0.14845327566623892
62713,SIDM00832,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.4762545,0.02064195,1.0438151789448817,0.037201668756401886
43517,SIDM00872,Nilotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0419031,-0.09169723,-1.25924593640408,-0.11076674026113903
61703,SIDM00673,Ribociclib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.7980788,-0.08137545,-1.8101751019819565,-0.040816559254628
89859,SIDM00928,Tozasertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.7539604,0.13994633,1.1393661031703377,0.06183984537633073
41653,SIDM01197,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.5902084,0.04575383,-0.6426122266827311,-0.01936057316425716
16824,SIDM00148,Alpelisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0718805,0.10194905,0.1907093697164037,0.011956557001740172
36919,SIDM00359,AZD8055,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6127042,-0.081191964,0.2593258738511032,0.06053242284678345
96349,SIDM00957,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,4.1452985,0.08327154,1.999479585611894,0.08185713983498648
96313,SIDM00148,Vorinostat,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.49053818,0.04460583,1.9189169202920286,0.13500972849934664
58850,SIDM00877,Wee1 Inhibitor,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.40053725,-0.032100216,0.1526313824167204,-0.003058507911181437
97086,SIDM00933,Doramapimod,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,1.7055298,0.060446244,1.1534603592999613,0.04987724361680608
71908,SIDM00673,Camptothecin,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.8673463,-0.022479149,1.124637973687055,0.06381253732049012
27823,SIDM00633,5-Fluorouracil,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1951855,-0.05869288,-2.0025724112306933,-0.09035457160014368
107607,SIDM00833,Crizotinib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.47135338,-0.0337512,-0.7607604201170072,-0.02564731064497537
17727,SIDM00633,Ribociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.92297924,-0.025652163,-0.4693933773911279,-0.017400046080553167
75390,SIDM00633,JQ1,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5716855,-0.046291586,-0.732860374222803,-0.04824724079773299
33384,SIDM00928,Nutlin-3a (-),Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.89061564,-0.018533971,0.8880402977639732,0.015434920441724512
48070,SIDM00877,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.0078404,-0.17199753,-1.1360095450105803,-0.035567771152494446
70603,SIDM00957,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.540529,-0.031395268,0.8246237381847851,0.0015012019090042915
105354,SIDM00837,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.843811,0.06976105,-0.7274901213613049,-0.03134755106203534
95332,SIDM00875,Alisertib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.57324314,-0.03608355,1.2163132859328334,0.03699643082455341
11178,SIDM00950,Erlotinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9939802,0.24232006,1.2512433972306085,0.04716540555950223
37035,SIDM00872,Vorinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6519507,-0.09550424,-0.40488134031124334,-0.015044937114682808
1773,SIDM00633,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6570604,0.030636368,2.9195819514506622,0.06650269914865593
107989,SIDM00042,Irinotecan,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.5251806,-0.18878806,-1.4335920257937782,-0.09143448156774496
72788,SIDM00877,MK-1775,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.37093228,-0.024295399,0.10341995694097468,-0.021952882593668732
103519,SIDM00933,AZD7762,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-1.1327871,-0.11717211,-0.9514072245856383,-0.04693706185653061
90816,SIDM00633,Sorafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.9022832,-0.07700147,-1.0784136426036373,-0.018255234665426043
49281,SIDM00359,MK-1775,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8088366,-0.055233955,-0.2713474852271044,0.03406256548284855
102171,SIDM00872,AZD6482,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.77030945,-0.07374566,-0.29093180549884273,-0.06932512769766347
33657,SIDM00633,MK-1775,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.48681,-0.06369928,-1.8001961747966004,-0.08302397416702861
37236,SIDM00832,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.1025946,-0.11050646,-1.4388322031140455,-0.07041329100235648
23926,SIDM00877,Tozasertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.61979276,0.066292025,-1.6382877251512835,-0.05189599318533709
88159,SIDM00875,Alpelisib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22423291,-0.020821255,-0.24686892730563473,0.0023343226857439185
104515,SIDM01187,Linsitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.4815443,0.088062905,2.0946188110964252,0.08895535075856084
5716,SIDM00826,Vinorelbine,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-0.79094213,-0.034660757,-2.7302877152815848,-0.07047919480937928
97462,SIDM00673,GSK269962A,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.2574428,-0.08510915,0.5138163115688392,0.03858224165499119
83015,SIDM00826,Camptothecin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.82222193,-0.03214088,-1.5009909334306952,0.016217268946349343
97954,SIDM00148,Tozasertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0282874,-0.08635069,-0.2890650003224836,-0.0005643464953856821
97971,SIDM00872,Dabrafenib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20775783,-0.004310031,2.29921860663953,0.056057661746489074
106473,SIDM00455,MK-1775,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5452694,0.109477066,1.037989166699795,0.07643197060369801
12291,SIDM00216,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,4.208649,0.33379322,1.348472002382558,0.12779345382103244
7508,SIDM00837,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.69307035,0.030651633,-0.6738008387872698,0.018552386409599685
17836,SIDM00872,Linsitinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20133924,-0.006363061,1.3778954449964067,0.06819514476392569
23031,SIDM00146,KU-55933,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2390226,-0.053278327,0.0715118192734912,0.08526916258411416
19463,SIDM00957,AZD7762,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.3147566,0.038247705,2.9216374256904016,0.06089617041113834
98999,SIDM00872,Alisertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8584117,0.10672106,0.5473211822482534,0.052023684509690075
64198,SIDM00673,Bortezomib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.16833873,-0.008977969,-0.7892318092735531,-0.004830059687930041
78092,SIDM00673,Camptothecin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1843327,-0.035357073,0.3307310077796095,-0.01471821234355244
6389,SIDM00957,AZD4547,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.0198426,-0.04857269,-1.4748533407268023,-0.036443924285202274
37570,SIDM00633,Alisertib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2076238,0.094737224,0.9715668422333604,0.07997157091211991
99878,SIDM00673,GSK269962A,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.8198833,-0.17956221,-1.0679957393963924,-0.06202534881099784
71420,SIDM01187,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2460706,0.091499776,0.28133158894097343,0.013860462333699617
107643,SIDM01042,Afatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.31950688,0.0365706,0.8821742002318447,0.047299132247049784
100109,SIDM00833,SCH772984,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.8868232,-0.06291856,-1.3504087853787363,-0.05858384502514037
84539,SIDM00833,Dabrafenib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,2.8341928,0.08701078,0.582025385871852,0.027469905006889915
97500,SIDM00875,MK-2206,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3704028,-0.14012964,0.3540815751805614,0.049874860621272527
106372,SIDM00146,JQ1,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8629436,-0.13556673,-1.5728285507743456,-0.10399272137471316
53087,SIDM00950,Sorafenib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9998745,0.09794961,0.20081775253891795,-0.00960387541122372
30245,SIDM00673,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6963513,0.12696198,-0.5739601334927937,0.029952307552594072
74458,SIDM00633,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.42204,0.2643731,2.1907792709439406,0.1065438444389485
43627,SIDM00633,Pictilisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9809214,-0.10083531,-1.1398244825565411,-0.052299628918352624
80618,SIDM00957,LGK974,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.3946967,0.04863705,1.0998914624685912,0.06131366025774117
64865,SIDM01187,MK-2206,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.2244809,-0.17946574,-1.1371519568078723,-0.050831012215852726
49571,SIDM00673,Venetoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.29229084,0.008503255,-0.9222303135117329,0.007878535359367759
70538,SIDM00950,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6177324,-0.046847813,-1.5526433212584225,-0.0636519177113978
26120,SIDM01197,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-3.065107,-0.10326913,-1.1880262643160457,-0.048367135981353025
9935,SIDM00928,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.32900614,0.029499864,0.471640351566131,0.02293610444843111
37130,SIDM00872,PF-4708671,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5340453,0.052491084,1.0091395370345573,0.020588967611170964
47893,SIDM00875,Vorinostat,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.36032742,-0.034644693,0.05896496153090469,-0.05279548342041726
26415,SIDM00928,Taselisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.9068442,-0.088510334,-0.6411717950038244,-0.014538379425700272
60356,SIDM00872,AZD7762,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35540736,-0.035452366,-0.33979662261669985,-0.008053848528646962
19458,SIDM00633,ZM447439,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.375224,0.10451457,1.180481500257069,0.015966863102138115
82234,SIDM00146,Afatinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.9696407,-0.0800158,0.5855370347709009,0.04198618639447296
98257,SIDM00950,Gemcitabine,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.035952,-0.11764591,-1.319205661760654,-0.056357780274322755
27168,SIDM00633,5-Fluorouracil,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2801787,-0.066617206,-1.9895763081077606,-0.08756185057836102
844,SIDM01042,MK-2206,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.396806,0.010074447,0.5619877611758882,0.018064842067925933
36285,SIDM00933,Gemcitabine,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-4.2059846,-0.06599638,-3.786110683543833,-0.11366415198329413
88355,SIDM00928,Afatinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,0.6566682,0.07875414,1.120241201953185,0.0602627144183729
13599,SIDM00146,Paclitaxel,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.93079776,0.07525975,-0.6084323135320613,0.008244469487034743
42168,SIDM00097,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5306055,-0.020275211,-1.8249073677130623,0.010332391040657278
70182,SIDM00148,Axitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.17031105,-0.017267717,-1.1140439548744923,-0.10019364916605916
21153,SIDM00216,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.24665019,0.004375976,2.453012466979651,0.09760495865703714
96201,SIDM01197,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.73947275,-0.03667909,0.29794530572943817,0.008472826108599165
65316,SIDM01042,Docetaxel,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.65625,-0.28672743,-3.0101550135370077,-0.20334185621200337
9114,SIDM00826,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,3.2824512,0.21151543,0.4044682324147505,0.04449950125019315
6005,SIDM00928,Cisplatin,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.1994016,0.10488339,1.0821284045560697,0.06630068116648032
30149,SIDM00455,MK-2206,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8860908,0.09468184,-0.16969269612266008,0.07810172013198502
4655,SIDM00216,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.3719134,0.014064113,-0.3201970357804187,0.00536542692078245
46788,SIDM01042,Afatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4079134,0.119428195,0.9335264687185045,0.02477505779502517
46681,SIDM00673,Luminespib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3821232,-0.13546382,-1.4354795061551284,-0.09484177397223403
45988,SIDM00673,NU7441,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.573725,0.20881018,1.631651656351105,0.05503457635115487
106795,SIDM00148,Wee1 Inhibitor,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.9602733,-0.17686541,-2.863180614088718,-0.14223135766261177
79672,SIDM00875,Luminespib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.50990975,-0.04649479,0.64701150354996,-0.015994551688140908
33823,SIDM00832,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,1.8310041,0.13759875,1.2964107557211526,0.060696912977927266
15560,SIDM01042,Venetoclax,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6376187,-0.06608578,0.19420465478304366,-0.011937786094910986
42284,SIDM00877,BI-2536,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3846719,-0.0031068071,-1.49152805524059,0.000461365111172558
37970,SIDM01042,Camptothecin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.313251,-0.12293263,-1.2898540387890385,-0.045475232305800535
72167,SIDM01042,KU-55933,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.61271024,-0.057926588,-1.746569969229996,-0.09602428097977049
30269,SIDM01197,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.4676895,-0.11386526,-0.1246511541278534,-0.019545835116430692
54555,SIDM00633,Palbociclib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.90311605,-0.041856,-1.2247153909475283,-0.09506516857747126
41822,SIDM00872,Cisplatin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.14768896,0.0046673114,0.7018689807793183,0.012753677114691116
85121,SIDM00097,ZM447439,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1282916,-0.08234683,-0.05773387623065382,0.0017003573723149725
32117,SIDM00833,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,3.893264,0.06829219,2.438649750608949,0.03646786519212529
27075,SIDM00455,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6830633,0.012528485,2.0840721214549647,0.0695406892424413
48548,SIDM00097,NU7441,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.38978833,0.013548203,2.1429447385074867,0.1082271619814717
88006,SIDM00872,OSI-027,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.10795307,-0.010908008,0.4481436483175728,-0.018327928534848072
93159,SIDM00673,Doramapimod,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9099338,0.047955837,1.719830562380949,0.0522683921058727
42491,SIDM00455,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.2154087,0.029131243,2.8707673336715134,0.0897123402940048
102186,SIDM00875,Alpelisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9841235,-0.08012194,0.5427799659211909,-0.006614841963221738
86353,SIDM00776,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-0.80857486,-0.028577102,0.5137213373080985,0.010687745499683942
106830,SIDM00877,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.6883211,-0.05697258,0.02945637089016306,0.025180729835143533
55560,SIDM00146,Afatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.3376365,0.11664063,-0.4578057792425278,-0.011535396288614375
82267,SIDM00933,Cisplatin,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.4654585,0.20664181,-0.9214007786151847,-0.05817905527299061
82162,SIDM01042,Gemcitabine,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.7349658,0.21905304,2.1367096194320783,0.139698127977526
6405,SIDM00950,MK-1775,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8921399,-0.0968677,-1.8250614214736196,-0.12151714513166575
44202,SIDM00933,RO-3306,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-0.8529533,-0.07245102,0.027251274703784408,-0.04737783788814216
23828,SIDM00933,AZD7762,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.1937013,-0.09866291,-0.7666325998966194,-0.03805974957389374
67811,SIDM00148,Axitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2441041,-0.19690399,-0.38502504430410395,-0.053132838023828594
590,SIDM00872,Taselisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.29812118,-0.016430676,-0.886213457123702,-0.11921497504558566
63622,SIDM00359,AZD8055,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.30255866,0.023889296,-1.360355986754618,-0.08921807950722388
63610,SIDM00835,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.561526,-0.15029515,-1.2588519639234683,-0.08021448167080487
23214,SIDM01197,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.20313022,-0.01618266,-0.7795416135570707,-0.04126190208433049
12252,SIDM00835,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.4759336,0.08541386,-1.2034286355809078,-0.010783033483246584
94402,SIDM00835,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-0.5282173,-0.024149494,-1.3407850897356468,-0.035539040203761696
23384,SIDM00875,Paclitaxel,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.054467,-0.18334907,-2.905339806603402,-0.17845392912237568
60764,SIDM00359,Afatinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6442633,0.131721,1.6219119741280996,0.12927815621166433
104788,SIDM00148,ZM447439,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2318517,-0.08184627,-0.37273017309871004,-0.008379097756968538
97588,SIDM00933,RO-3306,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.35760108,0.03905741,-1.186047055447298,-0.057800478957257956
101696,SIDM00875,Temozolomide,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52436876,0.012734911,0.26012703790228375,0.001850548783354896
90608,SIDM00877,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0959088,-0.02114184,-2.1117939344768826,-0.16157273373639586
8744,SIDM00146,Temozolomide,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.0354614,0.17178099,1.0428835539956909,0.10074433571421787
75105,SIDM00633,PD173074,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.441865,0.020518651,3.090995168494925,0.13240890548645504
108171,SIDM01197,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3957446,-0.060049724,0.2115633488808976,0.011551009151799891
58914,SIDM00633,Vorinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0440166,-0.04862139,1.4404791338829872,0.0968701704836872
64752,SIDM00933,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.2603242,0.033209942,-0.9749938525553776,-0.10692607464851234
31883,SIDM00833,Dabrafenib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,2.0330472,0.06253487,0.6426733415812681,-0.03362109033922719
38035,SIDM00282,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.7015435,0.025057541,-0.10443235733905581,0.03348865472534458
2254,SIDM00933,Uprosertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,0.39825994,0.0427671,0.12974648665801364,0.018203804984640876
101836,SIDM00872,Lapatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4916592,0.12854457,1.1480529272308426,0.09702264390098302
78831,SIDM00957,Navitoclax,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.64318794,0.02055813,-0.4469358098059796,0.019316486510166302
41730,SIDM00957,SCH772984,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,2.4398239,0.097196236,-0.26358182892304827,-0.0011152924474205823
62885,SIDM00872,Sorafenib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.29366332,-0.0321745,1.1182651312708678,0.07923968034245048
44287,SIDM00835,Linsitinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.3174672,0.07521379,-0.27253048841587363,0.04175320308336592
86307,SIDM00872,AZD8055,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.35489556,0.03707186,0.018727297121232524,-0.00917499595185373
67397,SIDM01042,Axitinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6738918,0.15959576,2.420017485196541,0.15027341103958927
28240,SIDM00148,OSI-027,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9391651,0.068486065,1.2352605095047382,0.05885635303637518
57884,SIDM01042,Taselisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3169664,-0.011087118,-3.493539685399999,-0.15024604465026417
36768,SIDM00933,Nutlin-3a (-),Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.832772,0.26807627,0.0011463401377277307,-0.022886418479504667
93138,SIDM01042,Temozolomide,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9954727,0.08317788,0.36772791168777225,0.0013268294398446263
72610,SIDM00776,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.7059175,-0.03871117,0.1432311202199998,0.033285801556105186
38605,SIDM00146,Temozolomide,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.064133,0.034226365,0.8102940299277073,0.04182157000150872
7846,SIDM00933,MK-1775,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.10437064,-0.00800088,0.3710860014511907,0.005638063383922521
73595,SIDM00455,Oxaliplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.36256495,-0.019544499,-2.6406091860625485,-0.0787593641221438
6115,SIDM00146,PF-4708671,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8083409,0.055026088,2.471117975071382,0.11322321963446712
32202,SIDM00776,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.4292362,-0.08885859,-0.3844279925727082,-0.06755305020034563
81740,SIDM01042,AZD7762,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5524043,-0.07454951,-0.14723664931440408,-0.06546196458767134
23836,SIDM00146,Alpelisib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.4473014,0.15970512,2.185488517748739,0.15049786353486105
107603,SIDM00957,SCH772984,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.0284889,0.086437516,2.2299655426921916,0.14001991733195607
47866,SIDM00833,Vinorelbine,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-5.024477,-0.2901439,-3.2144047326297316,-0.2751984814713926
50913,SIDM00776,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.9358509,0.15539525,-0.14857184337722076,0.016995978229320835
51889,SIDM00776,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.9331571,0.16042674,1.634135927759134,0.10101783905400917
22831,SIDM00826,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.41788965,-0.038994078,-2.659900855910057,-0.14106493743497767
67548,SIDM00933,Camptothecin,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.1353759,-0.010040947,-0.11197627745154326,-0.08898532974787303
97762,SIDM00928,SCH772984,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,4.0011644,0.35064635,2.098890828763042,0.10186638587060926
76245,SIDM00877,Trametinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,3.2422888,0.100461714,1.698587300378797,0.0962512157683495
2783,SIDM00673,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.626161,0.034779593,2.0037418774271236,0.06201501967386711
27171,SIDM00146,NU7441,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.5034154,-0.046289686,0.2823344944569068,0.03378430061333849
14628,SIDM00832,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-3.0574176,-0.24894325,-1.2368433883894079,-0.0777703679264068
90036,SIDM01197,Olaparib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.282968,0.019376537,1.3218861647289113,0.05167625220175298
7017,SIDM00633,Linsitinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.950483,0.15425994,1.185409407364162,0.03926592963381013
86275,SIDM00875,GSK269962A,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9483364,0.06993734,-0.05529714441507733,-0.007092874327434324
82567,SIDM00673,Nilotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-2.6263835,-0.11041404,0.6297103181451167,0.013945277006036995
92430,SIDM00673,Trametinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3684348,-0.11132468,0.2575493608538853,-0.05158477813318454
28977,SIDM01187,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.33102572,-0.02308606,-0.8323605988145455,-0.03932099887728312
46065,SIDM00097,AZD8055,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99650866,-0.06502268,2.479166212713017,0.14785925400672353
96682,SIDM00933,Venetoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-2.1534438,-0.081870995,-0.15216064337939206,0.014110373892556836
62279,SIDM00877,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.5406952,-0.060423933,-0.04229725907822257,0.09637506957803005
96655,SIDM00832,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.215844,0.049230237,2.1404634112954457,0.07680466446305136
101453,SIDM00148,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.6612108,0.33989587,3.2914058306170957,0.20470238625353998
9751,SIDM00835,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,0.91299444,0.022025602,0.44853593793596774,0.028606412244346312
78301,SIDM00359,Navitoclax,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3654024,0.0226458,1.2591151191585592,0.0061300348057736175
68284,SIDM00875,Alpelisib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6022907,-0.10731416,-1.127083435355681,-0.032553249776653
56794,SIDM00832,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-3.2878861,-0.15835774,0.04830458117062949,-0.02460998283446818
13442,SIDM00826,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.46702155,0.038363624,-0.9371145991562996,-0.07473926392298323
6039,SIDM00928,JQ1,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.0221379,-0.11663645,0.09926565378139243,0.019157648583822344
61555,SIDM00877,Tozasertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.4196985,0.15270187,0.3188640258927309,-0.010023394188673816
79033,SIDM00872,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5113121,0.11047034,0.5421962674749206,-0.0025875308481575292
107454,SIDM00097,AZD7762,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4573555,-0.11603048,-1.7098724483055967,-0.051274219183209804
103232,SIDM00872,Ribociclib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4719481,0.06007273,1.5510719326166535,0.025511175944451327
8898,SIDM00673,MK-1775,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.9574571,-0.09268269,-1.1703351843682681,-0.0567645602617565
42295,SIDM00928,Docetaxel,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.512335,0.16344461,-0.3068004449271312,0.007571069026587872
54685,SIDM00877,PF-4708671,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.206765,0.1085284,0.753795880713874,0.08400534475635368
91006,SIDM00097,PD173074,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9181726,-0.08470903,-1.0057424521136156,-0.046869891919320304
75949,SIDM00832,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.6978281,0.034176342,0.8272406687319886,0.04440991937460131
36927,SIDM01042,RO-3306,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.69624656,0.0838699,-0.41832562778863547,-0.02877244536267696
89531,SIDM00097,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3703427,-0.060862724,-1.3143329152464966,-0.04510831541493421
50988,SIDM00837,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.1006603,0.09479276,0.8023043662870935,0.0036669370696107246
66658,SIDM01042,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4699012,0.10342717,0.2565727692490938,0.015301445040218556
81075,SIDM00146,Palbociclib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9255235,0.069189236,-1.2840250561978772,-0.085319195620563
107938,SIDM00673,Temozolomide,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.097502545,-0.0021586204,0.5481609973269388,0.009954823224031129
32470,SIDM00875,OSI-027,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3067745,0.1264941,-1.111121815164523,0.0019407870028468228
27276,SIDM00957,SCH772984,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.52846235,0.019350603,0.7124520139163736,0.04944083234538574
48700,SIDM00950,Gemcitabine,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.204708,-0.16640753,-2.8268390107066055,-0.21505412484356246
98836,SIDM00148,Navitoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6220438,0.12640236,1.7462338837420823,0.04453530103265534
62934,SIDM00359,Crizotinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6538143,-0.05663434,-0.8498997350493763,-0.046946368382756794
101639,SIDM00359,Olaparib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9809374,0.026781213,1.1857347244756924,0.02539172884517523
64069,SIDM00148,Olaparib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9555283,0.167674,-0.13693746712331967,-0.010274456543546752
91649,SIDM00282,BMS-754807,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7584713,-0.08521811,0.026348124550429956,-0.021468762918405243
75053,SIDM01042,Venetoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6281425,0.044096593,2.674606189578709,0.062082274324626326
42689,SIDM00875,Sorafenib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6604481,0.07113836,-0.22070352425698644,0.001016397320633531
72714,SIDM00776,SCH772984,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.4124544,0.1013416,2.083721378352377,0.1759754364536579
23043,SIDM00835,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.1384428,-0.05619969,-1.2731430793727023,-0.016287045757275305
17831,SIDM00933,Alisertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.101282015,-0.010744489,-0.9406939511771252,-0.043304412184706265
103759,SIDM00776,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.633437,-0.03933031,1.4160067452201397,0.13607832477638124
102822,SIDM00875,Alisertib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.25647783,0.023943756,-0.6021107781216742,-0.025762433264587332
91445,SIDM00633,GSK269962A,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.866915,0.0860621,-0.745273163020935,-0.039290690822786085
19293,SIDM00146,RO-3306,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.91264796,-0.064330585,-0.007358594888135762,0.037684994169760073
3903,SIDM00097,Alisertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4470956,0.0594838,1.655503834937399,0.07816818249757151
101010,SIDM00872,Axitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.33078995,-0.023325698,-0.04726941654592408,-0.01818071515546788
86150,SIDM00673,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.64327615,-0.037402593,-0.5246633253720079,-0.014024218363026779
106845,SIDM00833,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-2.343186,-0.075585,-0.38839258084568057,-0.03253672290521156
35554,SIDM01042,Alpelisib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8572072,-0.13644221,-0.21689192460218593,0.01511689119840062
73738,SIDM00833,Linsitinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,1.3775942,0.074816816,-0.5429678259628198,-0.022499103801972637
107164,SIDM00832,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0770562,-0.029812096,-2.2316754709493596,-0.08225264031304054
62148,SIDM00832,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-1.3557417,-0.09550182,-0.23469245711603562,-0.036682897250955755
61222,SIDM00872,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5346348,-0.14297813,-0.9858858532696393,-0.08642376505075176
67218,SIDM01042,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0312939,-0.11869882,-1.9013152958167987,-0.07926015916178583
27475,SIDM00872,Alisertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.036758,0.19126998,1.8395160572198264,0.13056572428463936
768,SIDM01042,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8144064,-0.16963552,-1.6716199654149122,-0.07290594792292847
68276,SIDM00875,Pictilisib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0823002,0.100906104,1.2230973635023936,0.11059586065585707
86019,SIDM00875,Paclitaxel,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.052169025,-0.0030039998,-0.36960627252686834,-0.02394916129866843
45646,SIDM00097,Temozolomide,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.19992718,0.0035366847,-0.08671055802556703,0.029816746274443775
58864,SIDM00875,AZD6482,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4705806,0.03821399,0.10712958626009533,0.02153757573955981
103017,SIDM00148,Tozasertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2374861,-0.102468245,-1.165356176856535,-0.07075510773606954
23472,SIDM00146,Tozasertib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.4654671,-0.09044866,-0.2175251077467336,-0.005573263061112148
55774,SIDM00633,GSK269962A,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0654751,0.09739947,-0.24075305817883036,0.03296193891319667
19014,SIDM00928,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.8228436,-0.14733365,0.5033893129375548,-0.0008091483244098483
1077,SIDM00146,Uprosertib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3613231,-0.08120334,-1.0078214799672607,0.007793350474293705
44839,SIDM01042,Afatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6712615,0.095600076,0.03146709716157105,0.04407460969780769
7850,SIDM00455,SCH772984,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7293622,0.117875785,0.2670942470363955,-0.03554919506308103
50462,SIDM00837,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.4315705,-0.09882617,-1.1670255094485933,-0.09695336134592049
91501,SIDM00633,Uprosertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.1173473,-0.008371957,-0.94558592125624,-0.04277798842609447
99862,SIDM00877,Uprosertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.56787056,-0.038475826,0.825704508411601,0.026652972484286386
40761,SIDM00837,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.80966324,-0.024344118,-2.094803840581463,-0.0740401020968051
4044,SIDM00875,Alisertib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5965226,0.050911907,-1.0376593044333455,-0.025373867213179153
94377,SIDM00148,Luminespib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5395126,0.04866652,-1.6359493686631255,-0.10067432559576789
88241,SIDM00148,RO-3306,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6199432,-0.056972217,-0.7902647419563503,-0.03253944064626362
36942,SIDM01042,Ribociclib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8543518,0.067080855,0.36877986103453886,0.07208862665832873
83201,SIDM00359,AZD8055,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1182423,-0.098923355,-0.8084787303916792,-0.021139333824203358
36585,SIDM00148,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.38252807,-0.028905015,-1.1170969117731997,-0.07286402164363312
73130,SIDM00950,Gemcitabine,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.698609,0.16299139,3.492796655236823,0.16695853089628382
11673,SIDM00872,SCH772984,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3911474,-0.077979065,-0.21180334855680225,-0.009828695793775214
71204,SIDM00097,Nutlin-3a (-),Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.322905,-0.056873202,0.603122772327872,0.04732286014418955
46951,SIDM00933,PF-4708671,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0457425,0.1039996,-0.973979204223756,-0.03905842554583424
41508,SIDM00148,PD173074,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6256609,0.054984115,-0.5870870362584403,0.002231925920289608
50710,SIDM00933,AZD6482,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.1375211,0.05137572,1.2811024413420156,0.10066858435603555
6071,SIDM01187,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.80643064,-0.05985139,-1.1648497544764425,-0.06350642014659523
82588,SIDM00950,Trametinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9555718,0.2076562,-0.42831477931755063,-0.001303044995164331
15445,SIDM00097,Bortezomib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.63393575,-0.04252169,-0.9047751160117563,-0.07576080139281159
76673,SIDM00097,Camptothecin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.576422,0.13175204,0.49611002060869247,0.06255184051125257
2945,SIDM00877,GSK269962A,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.8288814,0.113576755,0.6365620320528148,0.022513629990133226
13693,SIDM00875,Gemcitabine,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.154348,-0.020264056,-3.5768101540072395,-0.14181737735274627
49320,SIDM00837,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.67805856,0.053511698,-2.2701604212784745,-0.10556716879325266
27408,SIDM00872,Doramapimod,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5454438,-0.018968027,0.7942267062874029,0.042509443020529045
51326,SIDM00833,SB505124,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.9119063,-0.03814103,-0.9627607051033192,-0.029697593392692994
44870,SIDM00875,Temozolomide,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5756006,0.015822217,2.4674496724262442,0.03038486906393267
62299,SIDM00832,Crizotinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.5129577,-0.10262135,0.13741562997945683,-0.03564075106355121
12669,SIDM00872,Temozolomide,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.38139075,0.0063565937,0.8095933801638563,0.01899973519884648
104840,SIDM00837,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,3.2671182,0.13948295,0.16894895212409455,-0.01342091501713824
12002,SIDM00875,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5571985,-0.035099804,-3.553623370108235,-0.084047206094387
104899,SIDM00633,ZM447439,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2224362,-0.18453915,-2.6025018798854522,-0.14958942733242306
52107,SIDM00877,SCH772984,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,1.644621,0.07320514,0.9215907624371702,0.08054776832474878
43001,SIDM01042,Lapatinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5347913,0.06666769,-0.04512437340348572,-0.009269451801201846
24809,SIDM00146,Crizotinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.8961281,-0.078150675,0.9490816561618155,0.09818607591181597
35721,SIDM00673,Pictilisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0632567,-0.112771705,-0.48354419852931185,-0.03594476132262564
4054,SIDM00633,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1252522,0.021904329,1.0495894335625144,0.01624652206060359
2994,SIDM00282,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,0.96820337,0.06133497,1.5964273999570493,0.046984827979094805
57142,SIDM00455,Crizotinib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3701401,0.070602894,0.9296490591808702,0.11973369711898067
49449,SIDM00633,MK-1775,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.537544,0.06851826,-1.483044995836448,-0.01706461144492378
48434,SIDM00673,SCH772984,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.770568,-0.1319916,1.3570829809289848,0.0771193696855317
99982,SIDM00042,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,5.3751783,0.19368751,2.748650146199873,0.07785953497569567
93921,SIDM00148,BI-2536,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.38601196,-0.0092907045,-0.5045417124842962,-0.04907756096164966
9468,SIDM00957,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-5.444111,-0.16931985,-1.806331617604164,-0.08770239469264629
9830,SIDM00633,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.54025,0.17408368,3.614314565613064,0.21340547795487713
80803,SIDM00875,KU-55933,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0332062,-0.07485711,-0.4835348029419336,0.007131265963230642
44450,SIDM00097,Docetaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1217532,-0.042173073,-0.37920759711059226,-0.008632458623886568
25565,SIDM00776,Palbociclib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3048706,-0.036581848,0.36224000248786703,0.016102707434947242
47420,SIDM00097,Uprosertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6031816,-0.18886547,-1.5050227094979052,-0.0607544368454816
76327,SIDM00950,5-Fluorouracil,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.694966,-0.23111011,-1.6040028211476998,-0.11381484390125231
25642,SIDM00146,Pictilisib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2321217,0.105593316,-0.8730545169306322,-0.05957651633419412
17326,SIDM00933,RO-3306,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.3295885,-0.03522367,0.19416530475299593,0.03838378716458781
104117,SIDM00872,Linsitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.7821894,0.16343483,0.7033596633826896,0.026011095071163972
23510,SIDM01187,Temozolomide,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.0066598193,-0.00010516396,0.5767313461527911,0.018673938694279593
86246,SIDM00950,Trametinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.726664,0.29261833,3.1399548520683247,0.1632769471435081
89265,SIDM00950,Linsitinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.45657268,0.014686497,1.7459505928589019,0.10746071963012098
20155,SIDM00875,Crizotinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2863262,-0.030484717,0.08645887665015609,-0.04870685322798899
25296,SIDM01042,Ribociclib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9645869,-0.088140085,-0.7436431954796663,-0.002383893876741913
50391,SIDM01197,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.81237036,-0.057269108,-0.551263333467857,-0.044104729926981744
35819,SIDM01042,Crizotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7755012,-0.06403572,-1.9914327154680778,-0.07280415902761356
81635,SIDM00673,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.5355798,-0.069347695,-1.6233588982278921,-0.08040324703941114
62482,SIDM00875,Camptothecin,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42480072,-0.04742546,-1.8332109878850822,-0.11524831074151762
92769,SIDM00148,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2766823,0.07104224,1.870196925261151,0.06625370257077375
79692,SIDM01042,Dabrafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3193334,-0.094526924,-0.32202732380578675,0.02029587436531598
59571,SIDM00872,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3824509,-0.111536756,0.1070908783112683,-0.017404783347062695
65236,SIDM00148,Alpelisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.77084863,-0.080515556,1.0180821097210733,0.060800854627501004
36861,SIDM00673,MK-1775,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.49033257,0.025295552,-0.32361010752491964,0.012084499396937086
265,SIDM00776,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.9521201,0.06648949,-0.8524139141323149,-0.031429374343292044
15344,SIDM00872,Gemcitabine,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.509457,0.047016013,2.2254292823163513,0.036134995571009604
96436,SIDM01187,Cisplatin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.19753571,-0.010256454,-0.5270616535500443,0.017446806192239633
95613,SIDM00928,Vorinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,2.8556526,0.24301971,0.2871104153056589,0.037379363207065176
17309,SIDM01042,Pictilisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.41119826,0.028473852,-0.9265518327766371,-0.07877079955512904
54710,SIDM00148,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.74896115,0.058611225,-1.363181405635995,-0.04695383025757158
89576,SIDM00833,Palbociclib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.7651873,0.081946924,1.3681504373519118,0.07286767619547047
3714,SIDM00097,Linsitinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.764549,-0.10676333,-1.6893564537092813,-0.06143836580911905
90026,SIDM00097,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55360246,0.0070235687,1.5481750688404952,0.005762675877542627
24249,SIDM00835,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.1522074,0.23600125,2.8469450386724398,0.108625688798488
36245,SIDM00875,Lapatinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8358133,0.17764416,0.5816599034913695,0.06390585665770859
17202,SIDM00957,Camptothecin,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.4840515,0.0629288,2.720293032007195,0.12081445722647331
91360,SIDM00148,Navitoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.42486742,0.03767384,0.8907517744274462,0.035087571669716426
47032,SIDM00832,Trametinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.1151317,0.032351848,0.612018657794464,0.037896760552688216
98859,SIDM00216,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.0108322,0.042122878,0.37931382300622,-0.009380269251227522
9121,SIDM00673,MK-2206,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7385594,-0.14803754,-1.3168351429148148,-0.08825493469507688
93290,SIDM00633,Lapatinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5795417,-0.016234402,-1.8241851182977527,-0.08629700686670815
85324,SIDM00042,Gemcitabine,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.911806,0.076197155,-0.22154796734636062,-0.08310210630564052
5044,SIDM00146,Olaparib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.4394584,0.14251804,-0.03145206698593434,-0.0014506565504130407
91758,SIDM00097,Dabrafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3333527,-0.058718447,-1.4033881867284654,-0.07877198067173714
53352,SIDM01042,Dabrafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8113725,-0.13718978,-0.6467241838673046,-0.0057940531008216604
50351,SIDM00826,LGK974,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-1.7191678,-0.055244688,-0.8080066304000576,0.004207404611855722
27864,SIDM00933,Cisplatin,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.4138763,0.17346229,0.6425438649363188,0.06026115807269502
27604,SIDM00359,Afatinib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.17389801,-0.014869003,0.3536587051232185,0.0266527968031176
39745,SIDM00877,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.9639945,-0.08932384,-0.07982141239868003,0.06369855196280047
19385,SIDM00875,AZD7762,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.537646,-0.029135283,-1.5485871083813632,-0.12099070747357184
28696,SIDM00875,Afatinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4089783,-0.12703675,0.055918103664087386,-0.057194983631155466
79904,SIDM00633,OSI-027,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.27239305,0.023488684,-0.11320031492320494,-0.03798070181380738
89539,SIDM00835,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.5256107,0.19438258,1.1232223577749143,0.08052374234942805
21265,SIDM00097,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9181391,-0.061717376,-0.5227621906934788,-0.016708413042767063
81060,SIDM00776,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0391283,-0.06062723,1.82157645426838,0.07932837758740272
62013,SIDM00097,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6359577,-0.15951027,-2.0939508593287224,-0.09218558813193065
35361,SIDM00833,Linsitinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.9698769,0.11355174,1.1310779695880941,0.04621173167633723
13824,SIDM00835,Olaparib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.0526097,0.031159474,1.3187653049888242,0.032795606579528694
99666,SIDM00835,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,4.328466,0.30879006,0.9419098483154285,0.11209636605514814
82851,SIDM00455,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5372136,-0.08543737,-0.21677162716062445,0.04551942430088311
80123,SIDM00673,Pictilisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0815202,0.090810046,0.8893612335582344,0.04871107857427151
5585,SIDM00455,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.38369367,-0.00876733,0.6423941690343216,0.03306424803587202
105840,SIDM00875,Dabrafenib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9449381,0.12452188,-0.3173837304401583,-0.009165167045825625
13877,SIDM00877,NU7441,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0449901,0.0348974,0.3135390500987333,0.0028106056448395514
88692,SIDM00146,NU7441,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5109517,-0.04573021,0.2702600531453613,0.009279099573597564
46615,SIDM00837,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,0.8061676,0.023765933,1.8044900463450297,0.11462057481571758
54410,SIDM00933,JQ1,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.7096288,0.3462231,0.353603550863662,0.06996907803836151
27883,SIDM00835,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.5157228,0.024128713,-1.2442482256264926,-0.07340604502857777
25210,SIDM00872,Venetoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9875219,-0.040179674,-0.8536444600630799,-0.0003612296145941077
25391,SIDM00097,Camptothecin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45575723,-0.015991855,0.2732658945564136,0.009741089532210763
43248,SIDM00042,Oxaliplatin,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.96039194,-0.09166165,-1.490103518791165,-0.07205565006182474
29008,SIDM00097,Doramapimod,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.92407715,0.02975118,-0.09071038494505966,0.03244160957674036
81293,SIDM00837,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.31326443,-0.013706449,-0.5989326564242728,-0.058169571954374846
47174,SIDM01042,Docetaxel,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.4801557,-0.283818,-2.4209916303294152,-0.18457260703947842
90346,SIDM01197,LGK974,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,0.3824389,0.02283387,-0.7845702261084975,0.011289178024289232
14893,SIDM00872,PD173074,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2765986,-0.053505834,-1.0582928485844443,-0.050254377534328314
102877,SIDM00933,Afatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.6001652,0.0481145,1.2474395748731537,0.10993287930779665
28809,SIDM00097,Olaparib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.67174506,0.017491953,0.6025869772780967,0.04492020951742056
70260,SIDM00877,RO-3306,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.079686,0.107484646,0.520863170049837,0.045173755715074454
97681,SIDM00877,PD173074,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.2121916,0.07047482,1.6011906463338537,0.1575626580353685
92416,SIDM00146,Alpelisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.8946941,0.1096704,0.6121276611154238,0.07659455618952275
71896,SIDM00957,MK-1775,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-4.032704,-0.13414742,-0.6993830064049931,-0.056637669372907026
58398,SIDM00776,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.035032637,0.002404949,-0.1401477252934422,-0.008525955014073994
78198,SIDM00097,Afatinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.57112736,-0.041472238,0.1011698724520626,0.02409198073041926
5602,SIDM00957,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-2.504543,-0.060758237,-1.3752029534104813,-0.03935881341551924
39005,SIDM00146,Axitinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.8609928,-0.12513405,0.6438154249059631,0.0959636746420146
2386,SIDM00928,MK-1775,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.926702,-0.063334376,-0.47455685593932917,-0.05008087092840424
1462,SIDM00633,Dabrafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7239425,0.034766357,2.6057428688724107,0.062175774024194275
6341,SIDM00957,MK-2206,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.1518946,0.04102572,0.9784351294187977,0.11688903030038611
92173,SIDM00633,AZD8055,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.75837904,-0.074450314,-0.7668887495500093,-0.088745358100259
52259,SIDM00282,5-Fluorouracil,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-0.28399292,-0.021905385,-0.39611363956968537,-0.04785742587330309
37779,SIDM00832,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.5994327,0.091130346,1.643149211441152,0.1172299616064477
37317,SIDM00872,NU7441,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2486659,-0.016968831,2.4530153590429933,0.13650840460599012
59261,SIDM00875,Axitinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81358653,0.060701806,0.5379345909372915,0.0027097906148040645
7819,SIDM00950,Olaparib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.5614672,0.053247668,0.8758368879092003,0.048339857358846744
32275,SIDM01042,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0374858,0.07913862,0.7084195809799255,0.04969536457459116
26878,SIDM00933,Gemcitabine,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-8.074092,-0.40612012,-4.979926838830796,-0.2500536129075334
47721,SIDM00957,SB505124,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.03026,-0.07501285,-0.7121982355321275,0.013424517748934973
98386,SIDM01197,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.115997,-0.026669947,0.9320372270412685,0.021424752650702948
14701,SIDM00928,Crizotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.3054212,-0.1255318,-0.5596956831453328,-0.009023194263733002
75459,SIDM00928,ZM447439,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.37804234,0.04222484,-0.6545251155034386,-0.07457734282201571
10207,SIDM00359,LGK974,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3160999,-0.043194216,-1.8029565902802887,-0.01297841546793979
82792,SIDM00877,Doramapimod,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.8941373,-0.11942937,-0.2755812694664095,0.07081069421486759
93506,SIDM00957,Taselisib,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-3.1053414,-0.08548536,3.068862662123089,0.22590910172066653
100951,SIDM00933,Crizotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.0489613,-0.10770442,-0.9927132262030814,-0.03806573922503549
40100,SIDM00957,Taselisib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-2.294675,-0.04481139,4.1762334288390965,0.14527882569808337
58297,SIDM00877,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.514533,0.24891232,0.8691789481349058,0.07268265142848186
59668,SIDM00928,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.42251515,0.045543432,0.3319732701229156,-0.037640074191057526
16838,SIDM00097,Linsitinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2882539,0.014496259,-0.4100330995436476,0.00843076920499441
98855,SIDM00877,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.8111873,0.09325232,1.3918567308269378,0.1739133286958964
2442,SIDM00826,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,5.295019,0.11961468,3.282613973741315,0.07608963678415531
18311,SIDM00837,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.860683,0.10398462,0.30582301804684664,0.05440270647241971
37644,SIDM00928,AZD8055,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.6073787,0.2354568,1.5128078534710387,0.14799335834815103
104665,SIDM00928,NU7441,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.143503,0.101475075,1.0720131637020007,0.014013234565475168
67593,SIDM00673,Gemcitabine,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.111165136,-0.008352629,0.18883293698763706,-0.01741748122591569
99814,SIDM00216,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.7825785,0.14777318,-1.100960653717626,-0.04087715752378074
44304,SIDM01042,Crizotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3443724,0.0905546,1.3174802222219804,0.09620516436523195
58382,SIDM00282,Afatinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3885553,0.052716207,1.2597381418768694,0.06279966926216302
47432,SIDM00282,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.827483,-0.053750485,0.31701345142401965,-0.04254966819636361
21897,SIDM00097,Nilotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8387448,-0.11879873,-2.7614835060575915,-0.15263550473883178
67589,SIDM01187,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0931547,-0.0779008,-1.5372513321904466,-0.05853341295142509
101956,SIDM00633,RO-3306,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.33309,-0.086495996,-0.8423182732170745,-0.10143371528848216
52011,SIDM00875,Afatinib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56496507,-0.04643994,-0.9251656997660714,-0.07294756165877764
81496,SIDM00097,AZD8055,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.233222,-0.13404272,0.00708947036698685,-0.017845357081366534
31568,SIDM00673,Nilotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.138921,-0.094241396,2.032794272458481,0.09418759854568881
98064,SIDM00933,Trametinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.77692974,0.103678524,1.1965214299219407,0.11225381080257926
89096,SIDM00673,Palbociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1020188,0.13948199,-0.05678470619322707,-0.009877816318748359
93568,SIDM00950,LGK974,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.753427,0.2082333,1.364098919190515,0.012355569387050677
93958,SIDM01187,Olaparib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.1774657,-0.07355168,-1.978039036428913,-0.015014136250384249
82390,SIDM00933,MK-2206,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.6024924,0.0652457,1.118403395001258,0.08766244100020333
99943,SIDM00928,Vorinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.077128,0.103083745,0.25102857295118686,0.030152072183718563
100435,SIDM00633,Venetoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4840696,0.08413933,0.02636045255018409,0.01564140445956863
53555,SIDM00872,OSI-027,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6027262,0.15866451,-1.2783197256751109,-0.04006899914602139
86704,SIDM00872,Taselisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6966461,0.06082777,0.7453743047209358,-0.004362063126007618
72895,SIDM00633,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6430621,-0.09604854,-2.6297836802189813,-0.06688972260698621
43969,SIDM00833,LGK974,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,1.8290281,0.090024725,-0.29736131413257466,0.016195844220294648
34672,SIDM00282,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.2927544,0.09365591,3.988458219251654,0.2873306279558258
30339,SIDM01042,Gemcitabine,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6471497,-0.0741919,-0.41221562344051516,-0.0677007780504438
77046,SIDM00673,Uprosertib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.68913615,0.045982987,0.933232629666269,0.028543249164973295
25893,SIDM00950,Cisplatin,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.378157,0.13995393,0.5021064879299383,0.061642338658700946
46169,SIDM00673,BI-2536,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.34622124,-0.02367017,0.10919748512347316,-0.009163146782100985
6685,SIDM00957,AZD4547,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-4.134925,-0.08151442,-1.2283605701441476,-0.04102969134294246
91518,SIDM00826,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-2.5436306,-0.073918566,0.5817275998591085,0.15461955912939349
61994,SIDM01042,KU-55933,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.46731293,-0.044952292,-0.616664861301069,-0.07128839768309037
3950,SIDM00877,Doramapimod,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.9154677,0.044386994,1.7791639220589182,0.07008950008524208
94559,SIDM00875,Bortezomib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49748552,0.046005804,-0.1874759571774004,-0.0016985510092084918
93438,SIDM00950,AZD7762,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9773662,0.09748315,-0.09379847117199254,-0.053606456025801164
66902,SIDM01042,AZD7762,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6405488,-0.059262156,-1.2019901885373236,-0.08584932274039113
46048,SIDM00826,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.42114377,-0.013732035,-2.2550073253656584,-0.08932921116988254
90613,SIDM00673,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9131222,-0.08754223,-1.8124287249950177,-0.18758405166659395
85791,SIDM00673,ZM447439,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3430054,-0.020001972,0.7033458880322292,0.02297553678424113
9951,SIDM00933,Paclitaxel,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.36986217,-0.03354632,-3.023223360728687,-0.11255977554494755
91219,SIDM00833,Dabrafenib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,5.039084,0.19537768,1.1874031106891043,0.03707776053743215
43494,SIDM00633,Cisplatin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8183556,0.02014619,0.11419430101522683,0.036354998487532604
55549,SIDM01042,Dabrafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2513834,-0.09700475,-0.26403912296617804,0.0031334886765503394
38842,SIDM00835,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.2343817,0.15948644,2.00140721647379,0.0834484849487807
54066,SIDM00673,Gemcitabine,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,3.4184225,0.3418297,2.936538862490206,0.28979220257022126
47252,SIDM00148,Linsitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.187764,-0.11822599,-1.5033000729512127,-0.06965926230167663
4375,SIDM00097,Sorafenib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4881165,-0.060408123,-0.2902728681982335,0.05980319907224171
92832,SIDM00950,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0629333,-0.07325617,-1.5553280515100325,-0.09321304531729056
108045,SIDM00872,PF-4708671,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39804626,-0.035354007,-0.4149929451570702,-0.013475389827673033
95265,SIDM00146,Docetaxel,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.37557468,-0.02749547,-2.671667265335519,-0.1505928970169516
68179,SIDM01042,Taselisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.49236727,0.030064045,-0.6544876745903222,-0.04068905808081702
9636,SIDM00875,Venetoclax,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.27102333,0.0064400826,0.33180326332517773,-0.010026504579469337
6753,SIDM00146,AZD6482,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7452383,0.035902154,3.0347911697482552,0.15793020112519265
88960,SIDM00633,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3494778,0.2736428,3.1663524592940955,0.23022558388904998
44712,SIDM00826,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.81899405,-0.040557895,-3.3115760676869046,-0.10952491663484783
77428,SIDM00872,OSI-027,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.75434524,0.07467004,1.24375624459978,0.07670593306881444
1854,SIDM00872,AZD6482,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.608508,-0.1378475,-1.5361100961988536,-0.08342269255364876
21870,SIDM00148,OSI-027,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5253543,0.11854137,1.3907073072748077,0.07599147012572512
32791,SIDM00673,RO-3306,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.673172,0.18689999,-0.5332321838512195,-0.03913382948477074
93051,SIDM00148,MK-2206,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.85731953,0.08810517,0.7857357808812355,0.020498423956591117
72915,SIDM00833,MK-2206,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.9656393,0.05273219,1.8937497436348365,0.11109122875047248
68614,SIDM00455,SCH772984,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.3154483,-0.23811822,0.14514525207308476,-0.09523149345335767
68811,SIDM00097,Temozolomide,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3218898,-0.0056150644,1.451846412408021,0.015513872952208954
57361,SIDM01197,Trametinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1639707,-0.033132948,-1.7892374101858897,-0.0751067265336995
96465,SIDM00455,Trametinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.56618,-0.25172338,-1.173599810660892,-0.09160033013385956
57169,SIDM00148,Pictilisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.48631936,0.028723733,-0.5048536354754248,-0.021041168037742627
61616,SIDM00148,Paclitaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7673234,0.10854132,-0.5386123206901369,-0.01271997701555506
23443,SIDM00097,Paclitaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.560717,-0.11071561,-2.0308080727017623,-0.13294612072444162
62649,SIDM00877,GSK269962A,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.1084566,0.19812489,1.8693348904658558,0.18929348545718877
24078,SIDM01042,Axitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0752184,-0.13286737,-1.271911822803706,-0.09783388193696037
26365,SIDM00875,Afatinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7065111,-0.060287055,-0.33226839615316595,-0.03124946236488072
32637,SIDM00633,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,7.17417,0.35568544,0.8751939611415775,0.03906912109955184
44718,SIDM00359,MK-1775,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0231026,0.077009514,-1.211151705990972,-0.0681949753129809
66222,SIDM00146,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.66773206,-0.019571321,1.3372375928266773,0.027638089913938523
100112,SIDM00282,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0648341,-0.046433214,-0.915002949018098,-0.07775708735712093
34427,SIDM00148,ZM447439,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2887828,0.106750004,-0.38730166212135614,-0.030680075308088348
16176,SIDM00872,Doramapimod,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2876273,0.011725131,0.7388560281012924,0.06043049244432798
63653,SIDM00826,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.0198836,0.04856867,1.6107862229734564,0.03282265932607907
97554,SIDM00826,BMS-754807,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.47072193,-0.003492933,-3.296198038981326,-0.10103724929016862
10427,SIDM00148,Nilotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8011901,0.11892119,-0.6746473305636299,-0.06465575752202289
63442,SIDM00146,BI-2536,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.2249093,-0.09427979,-3.8147534336838924,-0.0967872510917218
81296,SIDM00146,Temozolomide,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.30661714,-0.007598479,1.1582792523777126,0.07023187768679333
25016,SIDM00826,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.634136,-0.12311785,-2.4845246019924625,-0.10596702454780012
17403,SIDM00216,Olaparib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8787465,-0.068725884,-0.5130463850855593,0.023625397025357462
84999,SIDM00875,Luminespib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5540838,-0.027809285,-2.9999627695047613,-0.15372248390649024
39316,SIDM00875,Axitinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1399028,0.08701987,2.0079052392090744,0.12373104834282578
75896,SIDM00633,Crizotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6251386,0.07852251,0.07367513258367663,-0.002639071993489035
52482,SIDM00097,KU-55933,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.7290635,-0.104010396,-0.00024628940025251403,0.034183009785240165
43669,SIDM00872,Ribociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3728089,-0.03162198,0.040187341746593115,-0.0018294008369420759
42791,SIDM00933,JQ1,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.1676948,0.10403965,0.51392702825542,-0.0063614018721864195
17488,SIDM00633,Entinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.001958,0.36271456,1.6473106021061767,0.079659654058734
102311,SIDM00950,Taselisib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.1319597,0.0539262,2.5495970011889404,0.09399349978256326
83408,SIDM00097,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0620645,0.041945625,2.1352399213289965,0.0806931075248269
5146,SIDM00872,Entinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.558215,-0.11743306,-0.5549864819007132,-0.004954525257484967
19067,SIDM00282,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2216272,-0.08951605,-0.9833952576486952,-0.01734861011979107
40940,SIDM00933,Venetoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-1.4217981,-0.06263882,-0.7103508991210254,-0.016326212050578884
28165,SIDM00148,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4520566,-0.044283208,-1.0834889761811846,-0.06376954526562127
102034,SIDM01042,Afatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.17505242,-0.022107456,0.4370385543958845,-0.0008744720625353246
99379,SIDM00146,ZM447439,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6244562,0.12656498,0.853751090222283,0.14634818227995222
68900,SIDM00633,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.323423,0.12643655,3.890399629018866,0.1111047494134485
47884,SIDM01197,MK-1775,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2453257,-0.041982383,-0.9732210355699968,-0.0388028073669334
104975,SIDM00097,Camptothecin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0805764,0.06000539,2.792457143313337,0.15525533326153274
60301,SIDM00282,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.592595,-0.09115063,-0.9076890769466839,-0.03067201672768421
35111,SIDM00146,MK-2206,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,3.8644981,0.23395716,0.5886954313839804,0.09659700632552556
64246,SIDM00877,Tozasertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,4.3933434,0.23383446,0.09601077891301589,0.04899735863815446
104636,SIDM00359,AZD7762,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7410052,-0.13759705,-1.9249031195248223,-0.05998129081016962
97098,SIDM00837,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.0723674,0.005427644,3.1988408662351455,0.08142563541034971
100950,SIDM00633,Tozasertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.93045235,0.024834836,1.0645500871963078,0.0503589559268846
703,SIDM01042,5-Fluorouracil,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6729265,0.03503101,0.6779556170688115,0.03302688128331637
7970,SIDM00832,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.8604124,0.073134795,0.7424516775446193,0.04276052257961592
86816,SIDM00148,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.024203,-0.16669185,-2.3297793652485685,-0.16523555641095822
23309,SIDM00097,Camptothecin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.081056,-0.07962503,-1.1360036734025682,-0.009739092236113914
54833,SIDM00832,AZD8055,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-1.6633645,-0.113738745,-0.7186734870051079,-0.013734170017458145
105564,SIDM00928,Alpelisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.0672257,0.1866811,0.6867865690990086,0.07120115422621567
70589,SIDM01187,Navitoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2419152,0.09261562,1.2465195669966567,0.04914718122241643
103326,SIDM00673,Vorinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.20504922,-0.02233454,-0.332883665104571,-0.06754756106257302
62922,SIDM01042,Tozasertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.14052776,-0.013193554,-1.102485169408039,-0.022046566377270045
83314,SIDM00877,Ribociclib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.2232424,0.036736622,0.770644455198618,0.024105460019528794
57358,SIDM00933,Temozolomide,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.7286838,-0.030673472,0.05726787773643226,0.0419446780549206
56055,SIDM00875,Trametinib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4860004,-0.15395205,0.6891001870614463,0.0005169664643114657
97718,SIDM00216,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.7404714,-0.09288508,-1.90251626983229,-0.08578327655442927
85576,SIDM00877,KU-55933,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.5531071,0.031382322,0.9581193778632772,0.08330753077386348
67713,SIDM01042,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.2956035,-0.020081576,0.20507777285762924,0.03398675842564691
70817,SIDM00957,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.001899,-0.032074343,0.03419735491937395,-0.0267102507662396
50576,SIDM01197,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.33933312,0.009591792,-2.4370793694105655,-0.09590834269848514
4007,SIDM00875,Docetaxel,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5037496,-0.13423868,-2.3533158034070714,-0.16454508665505063
49680,SIDM00146,Venetoclax,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.189948,0.09712949,1.3124889972986618,0.044894698635929126
28599,SIDM00872,KU-55933,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.88870364,-0.0438484,-0.30996117108247784,-0.01934512862908591
95857,SIDM01187,Axitinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.5731474,0.1497095,0.94077431564461,0.07662103565685327
93179,SIDM00928,Cisplatin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.6124907,0.28417268,2.28443320335671,0.138776748005218
97204,SIDM00875,Navitoclax,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.51239663,-0.05703591,0.21313478710846448,-0.014386894288938728
654,SIDM01042,Ribociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2563697,-0.06309472,-1.7081830658433823,-0.04941953312765467
101846,SIDM01197,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.591967,0.11277505,2.3789249943289277,0.1319251680009182
58283,SIDM00282,Palbociclib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,0.7169025,0.029958759,-0.08245058411108663,-0.009131704231034633
104441,SIDM00826,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.4493028,-0.11649047,-1.8845179338666225,-0.11007238979549887
98720,SIDM00146,KU-55933,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7696907,0.04340637,-0.6623619053374552,-0.0012206968278368334
72849,SIDM00359,SB505124,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5077123,0.035170503,0.16107897772228158,0.0700102519110725
46837,SIDM00875,Entinostat,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29200956,0.030107263,-0.06414329351320687,-0.008283575233903709
47215,SIDM00928,BI-2536,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.8437681,-0.043674022,0.7500781690411219,-0.039342216777038606
72799,SIDM00872,AZD6482,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1024103,-0.10462483,-1.0105875243133569,-0.06655472303589888
40228,SIDM01042,Wee1 Inhibitor,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6772466,0.04624433,-0.7817048834822076,-0.01313329097717574
17562,SIDM00877,Luminespib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-2.5163324,-0.06439159,-1.328822833341165,0.005325372838560178
65517,SIDM00877,Doramapimod,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.64705235,0.022496069,0.18295725046246974,0.04055890172612377
88114,SIDM00216,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-2.1382804,-0.09493471,-2.4293999448485457,-0.1237084980895913
105604,SIDM00957,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-2.0851474,-0.05526137,-1.4184089965922568,-0.03359008032048814
420,SIDM00042,Sorafenib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.32417205,-0.017827632,-0.9742059407526923,-0.0757729788144563
48850,SIDM00875,Luminespib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0364299,0.09620991,-0.2138992606267663,-0.024889148502711764
6035,SIDM00928,Temozolomide,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.09684,-0.026691133,0.32398658457754503,0.00483679859898996
80014,SIDM00872,Temozolomide,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6366284,0.013217762,0.4386208425662899,0.00627982473882591
85347,SIDM00872,BI-2536,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39664707,-0.04056092,-0.5234860446037005,-0.07362090443333769
87291,SIDM00933,Navitoclax,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.1971439,0.02288488,2.1308293970343275,0.10749404426886064
55986,SIDM00148,AZD7762,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4059521,-0.03639954,-0.6310719229694138,-0.09567926970540754
5149,SIDM00933,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.5514284,-0.02081219,-1.160957577072534,-0.04162540147490456
90365,SIDM00950,Oxaliplatin,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1501833,0.061078873,-0.5835888095448247,-0.028654770849311173
52469,SIDM00833,BMS-754807,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.6413006,0.12236439,-0.36398169406346936,-0.055382860138005266
41205,SIDM00633,Pictilisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4202756,-0.09196885,0.381923787388024,-0.011950825599164095
42574,SIDM00216,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,5.61827,0.24044688,2.0589867407236766,0.05988327930588111
80073,SIDM00633,Sorafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.79254603,-0.046741605,-1.469112231378475,-0.02144774594546938
85375,SIDM00673,Wee1 Inhibitor,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3414173,0.023263535,-0.6959367843454619,0.017524965637879093
94425,SIDM00776,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.2376094,-0.1861833,-1.0177789056461537,-0.07972018044321051
70104,SIDM00633,Axitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.90655,-0.14684907,-2.2895214008361693,-0.12281091822314315
13435,SIDM00673,Palbociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.4713813,0.07570347,0.1837384099162353,0.0927815091826431
9622,SIDM00216,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.4321072,0.03344559,-2.9302576670409985,-0.10701250940094727
81340,SIDM00837,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-3.2621417,-0.036839534,-4.819522771368939,-0.13410656275604854
90072,SIDM00633,Venetoclax,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7100465,0.09792518,1.362527623154376,0.03500997814065401
48967,SIDM00776,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.49892062,-0.029004551,1.0820665007002592,0.05393415450755076
49726,SIDM00872,Afatinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.172658,0.11695477,0.4024227775558936,0.047816506449072885
33350,SIDM00148,Alisertib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3550628,-0.07961894,0.7910782600732881,0.04664961552933158
94532,SIDM00146,Paclitaxel,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.38782012,-0.03682123,0.1993621311455539,0.019450431679501202
67119,SIDM00359,LGK974,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.41844144,-0.011618018,-0.01854337788449213,0.06146809514795552
120,SIDM00633,Trametinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4741457,-0.058750384,-1.1527385216600128,0.006758276065585548
52494,SIDM01042,AZD7762,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73473346,-0.08755509,-1.1210657783084241,-0.07569133774950204
58036,SIDM00097,Dabrafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1591847,-0.11433296,-2.1844528631737608,-0.07123720090703393
69122,SIDM00455,SCH772984,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4488482,0.12547334,-0.02859078176814852,0.044785149052608504
48499,SIDM00877,PD173074,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-1.16258,-0.068705186,-0.8759946373163354,0.010135846866408497
13810,SIDM00633,GSK269962A,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.47739017,-0.04149341,-1.0226072195575961,0.006526453024194835
75902,SIDM00633,Navitoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7403514,0.123275705,1.8800652437644192,0.14932752616509773
93801,SIDM00933,Nutlin-3a (-),OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.8370639,0.098268524,-0.21346808447612142,-0.008299779278441997
49988,SIDM00872,Vorinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1968114,-0.07932685,0.01970780965271077,-0.0021430466317312047
106749,SIDM00835,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,0.98204994,0.07046788,-0.15668582433772973,-0.0031791492334504712
95625,SIDM00148,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.67930794,-0.02310494,-0.7513610198713943,0.004148522694987838
11258,SIDM00933,Vorinostat,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.7356516,-0.10662599,0.4414552382147646,0.07688833267864237
17663,SIDM00933,Taselisib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.18784523,-0.020726047,-0.7630925212069039,-0.029675267548801364
11331,SIDM00826,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-3.662248,-0.01635791,-1.1508571674893417,0.01383876300230121
32073,SIDM00148,GSK269962A,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5988485,0.029037224,-0.33657514790640397,-0.01566503868734653
83194,SIDM00359,5-Fluorouracil,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2586584,-0.103062496,-1.1314644904335336,0.008345581263402216
65435,SIDM00359,Palbociclib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4380759,0.029787924,-1.3723358753281905,-0.020786264308046497
52161,SIDM00673,Taselisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.3313327,-0.15783551,-0.9795216537923085,-0.0812976693538044
48473,SIDM00146,Vorinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.89773226,0.07756243,-0.04868858852825538,-0.019366150936337454
80250,SIDM01187,Temozolomide,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5238392,0.016969208,-0.9212540019923502,-0.006028614114863417
61604,SIDM00216,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.33390793,-0.033010807,-1.1827956353474764,-0.09876556487220504
47257,SIDM00837,SCH772984,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,3.4781234,0.086879335,1.3309058373454283,0.08358669275411038
8697,SIDM00042,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.8561717,0.036127124,0.9353264023077567,0.010417682194485462
87836,SIDM01197,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9472666,-0.09887598,0.7252999397615131,0.058815644000957436
26838,SIDM00957,Camptothecin,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,3.0761023,0.052832738,2.340689833718088,0.11904541361564461
108282,SIDM00148,OSI-027,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2029278,0.10237419,1.8731449100919901,0.08845965342282394
9112,SIDM00673,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.5492794,-0.049410913,1.230266265668097,0.0353782752923574
18980,SIDM00673,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7350908,0.030472912,0.7896307051545132,0.005599664096430688
68091,SIDM00877,Afatinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.2922193,0.034830403,1.6071606515780201,0.12762201084126154
643,SIDM01187,Trametinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1302804,0.064276084,0.06830314078844131,0.02108882224773411
23805,SIDM00216,Camptothecin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2417142,-0.10709329,-1.327379546698389,-0.09150668028853308
91107,SIDM00928,KU-55933,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.380156,-0.06371272,-0.6946220921776605,0.018336444000021972
26409,SIDM00835,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.358567,-0.1829496,-0.7687323098396502,-0.043920517778949675
13438,SIDM00148,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.69083756,-0.06545222,-1.2453411149010254,-0.06326709140699602
106802,SIDM00673,ZM447439,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.0275466,-0.08721407,-1.4591384004721424,-0.1044005389187326
9936,SIDM00826,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,4.0752807,0.11929379,0.07652440648601375,-0.013545301020925084
72440,SIDM01187,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7467698,-0.1723458,-1.562040115685537,-0.10599691412234058
41669,SIDM00872,Paclitaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6812753,0.057650384,-0.27243665976167786,-0.002740327424938232
101736,SIDM00148,Cisplatin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.26430783,0.012445258,1.5392216694318182,0.1527589634476529
71314,SIDM00933,AZD6482,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.97318166,0.04099294,0.8417297341052875,0.01778148008116726
18361,SIDM01187,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7907436,-0.0744337,-0.9185426824853506,-0.05220343720384372
28813,SIDM00633,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.098604,-0.15497194,-1.7702951542974976,-0.07110717355926291
20404,SIDM00673,Docetaxel,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0328611,0.092425615,2.6443530287939225,0.15136353170008043
53222,SIDM01187,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7317172,-0.017954161,-0.7829045631708571,0.0001254554509934784
98009,SIDM00776,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2820233,0.109305784,0.055064050996630504,0.014665254524847132
6182,SIDM00282,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6073979,-0.072797805,1.2213297104513487,0.12530174744889222
74039,SIDM00957,SB505124,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-5.6150007,-0.100813635,-0.014401763495377303,0.005664880172592265
28044,SIDM00282,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.88928807,0.055703543,0.2747109857735351,-0.0011695827780734717
62976,SIDM00148,Luminespib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7756914,-0.08716231,-1.544355894306163,-0.09372547099301991
66615,SIDM00875,PF-4708671,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.82856745,-0.032049038,-0.5893998540018083,-0.01328456501129488
46343,SIDM00673,Camptothecin,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.4290443,-0.013071353,1.6188680329013883,0.07300825028925767
72754,SIDM00957,MK-1775,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-4.8581247,-0.15082258,-1.34195822714061,-0.04825555247013135
62437,SIDM00673,SCH772984,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-3.24083,-0.23023929,1.6883204762562454,0.04368503914329278
31811,SIDM00673,Uprosertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.3277775,-0.022355964,0.7208993005355975,0.004057892665480273
8881,SIDM00216,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4974385,-0.017843902,-0.7258485328638619,-0.0779046017528455
32270,SIDM00097,Luminespib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3091314,0.0902011,-0.6885033726977613,-0.07087327039807347
103072,SIDM00875,MK-1775,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5566474,-0.028919699,-0.2781227143611047,-0.03893790350051458
73813,SIDM00877,Trametinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3829477,0.054087833,-0.08535739929711346,0.019812894706137694
33863,SIDM00776,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.5015207,0.042692102,-0.6798446820004025,-0.03339323258019863
604,SIDM00148,Linsitinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8205309,0.07577531,-0.23045435759868296,-0.009105489063476628
44672,SIDM01197,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3484112,-0.064675994,-1.6132927628916618,-0.07208149223075141
85586,SIDM00957,Nutlin-3a (-),Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,0.76389045,0.024451062,-0.3382074541960738,-0.017559195194434666
29818,SIDM00875,Afatinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6775532,0.04470075,1.1886416126388628,0.06939963349061237
86047,SIDM00673,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.632916,0.13353051,1.2740665123254333,0.11438260571695576
98442,SIDM00146,Nilotinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.63376516,-0.05186736,-0.9504354275060589,-0.009718171078271352
18036,SIDM01042,Tozasertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4069247,0.16406634,-2.2338674404562524,-0.11677575195925204
12038,SIDM00933,Taselisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8563113,0.08032949,-1.0222071826981716,-0.01467693056691181
50554,SIDM00826,Navitoclax,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.012659594,-0.000570834,0.9509795019086527,-0.03269127523702221
49516,SIDM01042,NU7441,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.31202662,0.025576452,-0.7138273306456748,-0.034996210168770685
40683,SIDM01197,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.32350793,-0.006557727,1.276853439380424,0.04095789453506151
47732,SIDM00928,Luminespib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-3.820413,-0.13529684,-1.9448416439191596,-0.11967254113589747
34030,SIDM00875,Entinostat,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.36077186,-0.03446403,0.5160595742247499,-0.0326073902111279
76505,SIDM00877,Lapatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.70473,-0.06161749,-0.5468193216975094,0.0009263549446055235
14704,SIDM00877,Wee1 Inhibitor,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.9141324,-0.06581702,-1.540141083874203,-0.0698855889211147
74225,SIDM00928,Taselisib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.64419776,0.060506243,0.19584380543919364,-0.009757220082480087
57167,SIDM00146,Camptothecin,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.4972513,0.046671633,-0.2214220013101838,-0.018422075806779275
79125,SIDM00776,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.58006513,0.0472978,-0.5134878207348657,0.009875118985992207
2235,SIDM00455,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6014143,-0.039133903,-1.311415129246956,-0.03407567652839996
23094,SIDM00928,AZD6482,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.9385096,-0.0978051,-1.417846449153726,-0.05129432727227965
92317,SIDM00875,Venetoclax,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6564728,0.044703703,-0.13301491228486773,-0.028417617619297182
102103,SIDM00673,ZM447439,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9473953,-0.070344605,0.06186569634364513,-0.029224483144034866
57816,SIDM00633,Nutlin-3a (-),Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3600225,-0.091617286,-1.3258592499485928,-0.012246067631441072
82654,SIDM00875,Pictilisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6620283,0.1412869,0.3449478809318028,0.056172058389996574
102043,SIDM00875,ZM447439,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3907357,0.124140985,1.8359964458384506,0.058725859067926114
58073,SIDM00872,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7731637,-0.08218233,-0.30001202211895484,-0.02332409967637777
39325,SIDM00776,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.2614303,0.016836911,1.1834620156202986,0.002906546688495844
63444,SIDM00928,Tozasertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.76854545,0.027637612,0.4259304426805745,0.03170994989554516
80969,SIDM00633,Bortezomib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8894582,-0.051372416,0.03136679136198006,-0.008556442133803114
23711,SIDM00837,AZD4547,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.69788677,-0.041654292,-0.8210582948294635,0.005049193910967421
106134,SIDM00933,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.70924515,-0.1008104,-0.5806079651501208,-0.050717268733273715
74345,SIDM00877,Temozolomide,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.93941176,0.023165252,0.01533925999511981,0.06857554383744884
22367,SIDM00776,Navitoclax,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.787646,-0.054064166,1.4396476842526116,0.04490893788751811
20580,SIDM00835,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.2360067,0.19356436,1.7280449678629652,0.11495130421641928
50423,SIDM00146,Sorafenib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2344767,-0.111760154,-0.5247543449516074,-0.06873293999930771
88009,SIDM00146,AZD7762,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4052496,-0.03609394,1.351522455301045,0.09394530005421278
90676,SIDM00097,Crizotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5595405,-0.048156045,0.18387972598962105,-0.026709094464717746
99152,SIDM01197,Vinorelbine,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.4010509,0.028693972,0.3435042101101418,-0.046016346984882994
108313,SIDM00950,Dactolisib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.53648895,-0.03570601,-0.7320132487846395,-0.022315418384319607
99682,SIDM00875,OSI-027,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4322,0.1534029,1.6655445599691674,0.16135122543010186
1960,SIDM00928,Lapatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.859683,0.07440951,1.7716080407933137,0.12058073269738499
41321,SIDM00933,Tozasertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.1164097,0.07888036,0.39075348105190527,-0.04585902814306023
85546,SIDM00950,Navitoclax,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.185925,0.039665144,1.669636816521368,0.07231725679104553
39920,SIDM00455,MK-1775,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9491732,-0.14233208,-2.065487862923289,-0.13866506070286821
27268,SIDM00872,Luminespib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0407525,0.09866555,-0.4894609279669939,-0.040996838172260776
26925,SIDM00633,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.52614653,0.049672633,0.3866303771656295,-0.046861936316820056
50581,SIDM00776,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.052128,-0.08457237,-2.0587517813205127,-0.17079125218609728
32258,SIDM00633,JQ1,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.75032616,-0.059227824,-0.6937149244091286,-0.025367509135423863
11044,SIDM00837,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,2.4615452,0.07518787,0.866298983555738,0.03990911379355823
44742,SIDM00673,Alpelisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.082722,0.07600131,0.17755152892454715,-0.002921130211751123
105231,SIDM00633,Afatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.59875035,-0.007206796,-1.3841634530760558,-0.0383040351119492
68090,SIDM00950,MK-1775,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.7227478,0.14547838,1.563890553157845,0.05968549795327611
93112,SIDM00832,Linsitinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.094431,-0.0783859,-0.973435170656256,-0.057749241883885014
12888,SIDM00950,Oxaliplatin,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9838323,0.07740076,-0.9868358063922208,-0.03280318489518414
41785,SIDM00872,Lapatinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7726017,0.07146636,-0.40405584333592526,-0.03665514483172675
39124,SIDM00673,NU7441,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9119721,0.07131914,0.15544639806815516,-0.029772045997467324
16716,SIDM00877,AZD8055,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-2.1657925,-0.22614257,-0.4666642945330116,-0.019371689535329074
34046,SIDM00832,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.234301,-0.1342421,-0.59346002823959,-0.05406211409234187
74201,SIDM00933,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.2380922,0.26200366,2.0105580133254493,0.1284409087110084
45957,SIDM00877,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.3261285,0.14484316,1.4488530863921927,0.10436953822988837
85817,SIDM00950,Irinotecan,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.4107778,0.22313106,-0.08449045348930834,0.05964809967427297
6134,SIDM00933,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.4827632,-0.06775945,0.5197484547541978,0.05183772251096941
41591,SIDM00359,SB505124,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.19098575,0.012449523,-0.8939623172635759,-0.01768219983767944
59275,SIDM00146,AZD7762,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.19730513,-0.015808627,-0.4715421350441833,0.014887896599521703
48164,SIDM00146,Alpelisib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.658319,0.12063805,2.2926448910990667,0.13955927514235986
44639,SIDM00673,Docetaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-4.639435,-0.15931714,-2.208497241612456,-0.14739249994282863
15797,SIDM00875,AZD7762,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.21847925,-0.014936991,-1.0740567285040585,-0.07974174909928736
17901,SIDM00148,OSI-027,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1220057,0.06262244,0.15885388820784724,0.009589108839612014
40187,SIDM00933,PF-4708671,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6848147,0.065359935,0.34290992846959933,0.09927286829146315
40873,SIDM00933,Vorinostat,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.4877442,-0.070456095,0.1332611451446318,-0.04153068462529401
50187,SIDM00282,AZD7762,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,1.5708139,0.053805083,4.494085040353863,0.24935449694090508
29790,SIDM00097,Paclitaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.47567558,-0.029336665,0.2278425458293676,-0.01715051099675215
94475,SIDM00837,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.917381,0.034917958,0.6594556522428265,0.04385261519009517
27978,SIDM00877,Alisertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.1959219,0.110029645,-0.16502089618001517,0.040280768284044303
60533,SIDM00875,Axitinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34176728,-0.02086672,-0.21017869176904233,-0.02527121968947602
40179,SIDM00928,Gemcitabine,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.70218843,0.07572784,0.7944514953094446,0.019023601574413105
24022,SIDM00833,MK-1775,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.86893445,-0.034351174,-1.2394537038450764,-0.06579071080892883
16265,SIDM00877,Paclitaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.8966324,0.094256565,-0.4878122358552906,-0.011111032315827279
93786,SIDM00933,Nilotinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.147937,0.12896344,0.27071522057644587,0.009988761935810522
80135,SIDM00950,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0119125,0.037380565,0.22771039632348863,-0.0030735029773235737
39352,SIDM00950,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4887727,-0.11878527,-0.5484563378000175,-0.06893015780772328
82716,SIDM00872,MK-1775,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.882136,-0.087774284,-0.3342906953797072,-0.04115277539868359
86284,SIDM00455,Irinotecan,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2948772,-0.032727186,0.4794945007104351,0.13077332565262687
68978,SIDM00097,Venetoclax,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.985889,-0.05570269,-1.5818322232766706,-0.04294869931347063
84045,SIDM00097,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1825671,0.1260708,1.2836203759076297,0.11359111453660847
108044,SIDM00928,5-Fluorouracil,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.6196173,0.035450205,0.14590196731375407,0.031011942095256744
105584,SIDM01042,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6084069,-0.11796836,-0.7794866677092253,-0.048362793563681096
6072,SIDM00826,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,2.081928,0.07568004,-0.46727867868638684,0.05311444536872066
72942,SIDM00877,Camptothecin,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.87773365,-0.08485478,-2.2519864386753055,-0.15342936884996566
107534,SIDM00877,BI-2536,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.41069758,-0.0012783953,-0.7260368774290001,-0.033005855997142126
16062,SIDM00097,KU-55933,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.15554,-0.0715024,-1.2443572623791732,-0.03373286933861
80844,SIDM00673,Palbociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2403115,0.071431346,-1.1452659691999094,-0.04543381130376169
80033,SIDM00928,NU7441,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.4958008,-0.057219647,0.23900621942534825,0.000937495336364411
91097,SIDM00146,Ribociclib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5881877,0.0957157,-1.2577596470850623,0.0008735288852127348
46212,SIDM00633,Uprosertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.45617336,0.031801652,-0.42828869653080387,-0.017902697023585625
24540,SIDM01197,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.7308738,0.059307434,2.5878817120108715,0.1123501151637138
82094,SIDM00146,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0525429,0.03173922,1.2560314987963639,0.07318652816379431
24652,SIDM00957,LGK974,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.42249486,0.006600305,2.0659866721058706,0.08111778895279073
6858,SIDM00957,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.8544426,-0.016741838,-0.5941162522845185,0.027519352944498154
64103,SIDM01042,Afatinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6496818,0.16373318,-0.9023518240331796,0.00548212569775511
79750,SIDM00216,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.6576781,0.2535878,0.3526348538771099,-0.00800442559877815
78114,SIDM00146,Ribociclib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,-1.1127582,-0.03017061,-0.8525583690962718,0.04227823944574634
73021,SIDM01197,Dabrafenib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5917869,-0.1074624,-1.1349974765269142,-0.04028261797895046
75972,SIDM00282,Trametinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,2.190929,0.14065236,1.8773729105759078,0.11045254149700708
28601,SIDM00950,AZD7762,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.820019,-0.11900826,-0.26104607207548775,-0.0727957290333898
93426,SIDM00359,Linsitinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6858704,0.14925008,-0.7886624249298755,0.0004979365174412805
46778,SIDM00928,OSI-027,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-1.5791895,-0.1422419,0.02566484832963395,-0.033978533153067425
20594,SIDM01197,Vinorelbine,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.8870214,0.026469724,0.9481231634884516,0.01060315647714864
5338,SIDM00146,Ribociclib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3064266,0.06983761,-0.6285110032348274,0.003385267367719437
93856,SIDM00832,Vinorelbine,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.134813,-0.108753756,-0.32473699717518567,0.005470816534427754
65588,SIDM00216,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.26061556,0.004932077,0.35036483114112266,0.017021781241979575
53787,SIDM00928,JQ1,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-0.41472384,-0.049272507,0.3988074111847627,-0.012278533970861793
78111,SIDM00837,MK-1775,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.34823725,0.011824888,-0.4616466911944734,-0.013986622437565033
101875,SIDM00872,Olaparib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2110689,0.0768699,-1.8174889824077674,-0.05591608751865226
54450,SIDM01042,PF-4708671,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3090658,0.15195419,-0.4613470837505139,-0.06854345778616976
29068,SIDM00950,Irinotecan,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0933449,-0.07308924,0.8532214926992597,0.07627254056827006
84719,SIDM00455,Sorafenib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.36032566,0.023127398,-0.19001202014319835,0.06010376764582846
97617,SIDM00928,Cisplatin,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.357422,0.095284306,2.0795538765743595,0.12454233171297746
69818,SIDM00633,Trametinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6909494,-0.0472512,-0.9721120598942419,-0.034759649289241336
59392,SIDM00872,Camptothecin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9176184,0.05974179,2.15977213221401,0.08910011184607118
15210,SIDM01187,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5341222,-0.085123956,-2.1327894710840978,-0.052454044029367215
76004,SIDM00633,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6189747,-0.02178695,-1.0905170705545917,-0.05164051155098572
16355,SIDM00455,Cisplatin,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2444521,-0.036949195,-0.48549834985889007,0.016903942626546195
18288,SIDM01042,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.1590436,-0.2439937,-0.5907324596125227,0.003839430144552608
49376,SIDM00673,Navitoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.94970685,-0.06589693,1.283079511022065,0.08850878047680724
28019,SIDM00282,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.5010606,-0.05743955,1.5030184633635644,0.14995942649823787
93305,SIDM01042,AZD6482,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,4.4255853,0.09133729,-1.1081177581061543,-0.0639656854437629
106703,SIDM00148,AZD8055,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8329533,-0.12607765,-0.5559208005451782,-0.002223094958544138
50750,SIDM00875,Paclitaxel,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7013909,-0.05099551,-1.9882168948450507,-0.10813749476717877
58352,SIDM00097,MK-2206,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8617558,-0.20284517,-0.614657547530638,-0.05270701635484317
56021,SIDM00832,Linsitinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,1.1747746,0.054425288,1.247742032855173,0.07606033545237789
96209,SIDM00097,Navitoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.945013,-0.17169535,1.1797883601881751,0.02837311983655563
98260,SIDM00148,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3186529,0.09925174,0.4605507734787755,0.04309569982344969
49178,SIDM00673,MK-2206,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6374627,-0.047104154,-0.8475139046830977,-0.05382543284391648
61030,SIDM00673,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2577794,0.080260925,0.8022855448766482,0.08725332034484323
10668,SIDM00042,MK-1775,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.40616915,0.041987646,-0.6560747692204624,0.0131913983390097
56340,SIDM00950,Trametinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.5265307,0.31341702,-0.2178974291250786,-0.06721232911321194
3677,SIDM00832,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.8153045,-0.13227287,-2.164874983507928,-0.06116779267621098
46969,SIDM00875,AZD8055,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.623663,0.066525415,0.02614179842661607,-0.014175918498595024
88570,SIDM00928,NU7441,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.89865804,-0.10369808,-0.6430437233606723,-0.0605221104881699
17707,SIDM00837,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,-0.25960818,-0.021147761,-2.8315573520179753,-0.13461631223425613
62028,SIDM00826,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.6945893,-0.04805111,-1.8511481157302718,-0.10394516665855173
100931,SIDM00877,ZM447439,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.9719326,0.09751347,1.6137955515243287,0.1551761551134071
77483,SIDM00673,KU-55933,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7009317,-0.08699553,0.25055458679910786,-0.01366594740980298
68027,SIDM00928,Docetaxel,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.3302034,-0.14041759,-0.9819862468909977,-0.09903607914102901
19473,SIDM01187,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.81763345,-0.049568024,-1.752227107118113,-0.0773851692394083
48894,SIDM00872,Venetoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6479025,-0.082019456,-1.2958426584495504,0.020381799647728696
47414,SIDM00097,Alpelisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.26465046,-0.018504344,-0.6471915018459392,-0.03568215635442508
33312,SIDM00633,BI-2536,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.72614276,-0.073351316,-2.166873897853778,-0.08840141467429723
92857,SIDM00957,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,1.9152595,0.04561366,-0.3207036853490993,0.018106462365354216
43140,SIDM00950,Linsitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.0453167,0.29020622,2.489625103166417,0.11029265393165176
99822,SIDM00097,Venetoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1920378,0.046555124,-0.8891500779550445,-0.023885450149499336
13794,SIDM00146,Entinostat,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.41999605,0.030334197,-0.9508372589443883,0.0011306228834273475
42544,SIDM00933,Lapatinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8360497,0.09605699,0.5180891351792488,0.05182421422089434
17883,SIDM01042,Docetaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2041949,-0.13437831,-2.1298261806023153,-0.0848357454301623
79559,SIDM00455,MK-2206,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.5611386,0.223455,4.336256271976939,0.2879466945059294
86820,SIDM00097,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.02239,-0.055040363,-0.6655030571938969,-0.05250966034063551
9610,SIDM00282,AZD4547,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.5631231,0.010676609,-0.11805910168090088,-0.018596102388071443
52122,SIDM00833,Afatinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.8868204,0.09313954,1.5483960987118461,0.07732610930093588
74774,SIDM00950,Erlotinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5732346,0.16007403,0.849954269164557,0.040344630597819335
3649,SIDM00359,Palbociclib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3304179,0.10226933,-1.3554176749530193,-0.048686402427631184
103982,SIDM01042,Venetoclax,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.34647614,-0.018557405,-0.5376937520973988,0.019748256134607078
7853,SIDM00042,LGK974,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.0953865,-0.078178085,-1.9789249154831783,-0.004649215760042317
73870,SIDM00097,ZM447439,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9493237,0.049323864,-0.1110973635811237,0.045923629382763925
64255,SIDM00146,Trametinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.8856694,0.060556892,0.014907039153419692,-0.010020914697078168
26615,SIDM00633,ZM447439,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1284335,0.117639676,-0.8731384718473636,-0.027526526135942097
72029,SIDM00875,Bortezomib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4835231,0.04747696,-0.700150619329452,-0.027235962463956414
11249,SIDM00216,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.8365262,0.10385997,-0.20530907419620748,-0.0015156620988999647
105727,SIDM00877,Taselisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.7019936,0.09402804,0.2509451959368347,-0.03476021219870193
5901,SIDM00877,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.4207335,-0.14218827,1.240191941693472,0.024293360657855676
10621,SIDM00455,Irinotecan,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.586855,-0.047669183,-0.45033780502819276,0.0426113350342401
73025,SIDM00673,RO-3306,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.41131,-0.10139751,-0.6380051027655348,-0.019975661145515317
64225,SIDM00833,AZD7762,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,2.2123303,0.18393221,0.5121535264365806,0.11937926201323211
25530,SIDM00146,OSI-027,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.9102736,0.078698404,1.6115262354018627,0.09189993939836569
37311,SIDM00928,Crizotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.77676654,-0.081135966,0.8160333238984895,0.03394584752993353
16231,SIDM00957,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.0987701,0.025815891,1.700849758131081,0.0241277911965272
66987,SIDM00097,GSK269962A,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5810298,-0.06944061,-1.7310212593041348,-0.08606942194883986
38519,SIDM00928,Ribociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.033232167,0.00078436366,-0.2609425239804957,-0.01466238022543508
23337,SIDM00872,AZD8055,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5864401,-0.06407216,-0.19079834259291564,-0.05372952375555406
79728,SIDM00933,Cisplatin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.2784709,0.16504964,0.1543698851244028,0.02939562076016897
20600,SIDM00673,Olaparib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.8910099,-0.08678237,0.04641682493242216,-0.010767823421725066
45079,SIDM01042,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9279175,0.05108829,0.4808060592890252,0.044318759727753204
29485,SIDM00148,Doramapimod,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7636075,-0.051693745,-0.8581092392500698,-0.04514291705589459
88154,SIDM00633,Tozasertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2180895,0.0340679,3.1668287572230436,0.1350063260633263
986,SIDM00875,Axitinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8307524,0.0647076,-0.11988469203742579,-0.019264008128463198
86941,SIDM01187,Nutlin-3a (-),Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7696557,-0.16432092,0.18461974684840968,-0.03540961727048337
1688,SIDM00359,SCH772984,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.0573575,-0.13040504,-3.581640990713992,-0.11932215166210783
8150,SIDM00148,Palbociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.436958,-0.07412575,-1.837019214658748,-0.061834585793325486
3071,SIDM01042,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.73326606,0.077788375,1.045797053958878,0.03372632166819206
15316,SIDM00216,Linsitinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.7851158,0.058927804,0.2455023464929619,0.02364275024167816
71504,SIDM00957,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.1671131,-0.033109184,-0.44765721080746723,0.0005623252308142251
69049,SIDM00837,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,1.8252152,0.03334967,-1.0417341609252764,-0.08259009205309263
104656,SIDM00097,Taselisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6364512,-0.10969879,-0.8597674331365089,-0.09672189669304035
61693,SIDM00673,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.9269028,0.1874246,-0.13551102362110728,0.04859604249205364
82960,SIDM00950,Palbociclib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6472087,-0.01758346,0.5859723520072019,0.013903340490448066
32747,SIDM00950,Palbociclib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.621708,0.1823697,1.1970773368416014,0.07059508401336816
95280,SIDM00776,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.6617754,-0.14188236,-1.2212638473136526,-0.09531833425897547
45976,SIDM01187,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5007982,-0.14016905,-1.0213125277921296,-0.06678263806401215
6979,SIDM00833,SB505124,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.09768846,-0.007910219,-0.8553608728284329,-0.05050154140355798
91216,SIDM01042,MK-1775,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.23219928,-0.018659357,-1.7302667853698526,-0.07491664276402422
36557,SIDM00872,Alisertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.7181036,0.24798267,1.3613869619219332,0.10554521867952754
11989,SIDM00950,Cisplatin,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.6331825,0.26365533,2.1513352424703216,0.12230982904391201
6122,SIDM00928,Dabrafenib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.4708736,-0.019822758,-1.3429300192102556,-0.03595349477417251
21615,SIDM00933,Alisertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.36046475,-0.03747644,0.881024135998569,0.05703959949821126
1487,SIDM00146,Nilotinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-3.1135795,-0.25167048,-1.216666624517345,-0.1027152346303546
85585,SIDM00933,5-Fluorouracil,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.35719326,0.050112013,-0.1804919888572289,-0.009338371433774733
103740,SIDM00833,Crizotinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-1.7510111,-0.07656461,-1.7380452938365456,-0.032564639355943586
8717,SIDM00928,AZD6482,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.25973475,-0.018035231,-1.1114821539594977,-0.07243866606484438
44751,SIDM01187,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.36832497,0.019627564,-0.32150517243015847,-0.00783534519018644
12266,SIDM00872,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.23251179,0.02208199,0.7471296375722727,0.049735484778805385
44963,SIDM00148,Paclitaxel,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3291154,-0.19702613,-0.5063866845361682,-0.04860665992876786
64870,SIDM00950,5-Fluorouracil,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9882568,-0.113550976,-1.9303987335525417,-0.13634637885617648
5650,SIDM00633,MK-1775,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.562994,-0.1250212,-0.9354223219302654,-0.03431949608982179
69632,SIDM00455,Sorafenib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.92078865,-0.028420938,-0.5889194828573139,-0.010576845611650273
59500,SIDM00216,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.42360175,0.02536114,-1.7825107896639398,-0.1105392488456913
8245,SIDM00455,Navitoclax,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,6.4090014,0.25182486,2.150125564370453,0.17556548905622466
24625,SIDM00146,BI-2536,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9222455,-0.13351786,-2.8214055741766377,-0.17510718096769526
93547,SIDM00928,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.5337151,-0.011935988,0.25087952804539504,0.001270126533191852
83934,SIDM00146,AZD7762,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0137372,0.09491423,-0.06582036948064289,0.039727645923645076
48650,SIDM00633,Axitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1605976,-0.10255404,-1.6349758818841684,-0.07790147130449723
76463,SIDM00835,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.35210755,-0.014357502,3.0734044167061,0.16219200485956944
101083,SIDM00872,Dabrafenib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.26782534,-0.0051910407,1.2111296356556194,0.048310748822766036
30404,SIDM00359,Trametinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0667205,0.04490546,-0.6799482215446081,-0.0020385938944812365
13965,SIDM00877,SCH772984,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.8240881,0.02982417,1.4151208231887473,0.11425087330617834
40591,SIDM00877,Wee1 Inhibitor,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.42077252,-0.032622825,0.45794758520006285,-0.00397145448903379
90956,SIDM00832,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,0.35504243,0.03262686,0.2932271358589211,0.01194703826060932
70419,SIDM00837,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-0.37182167,-0.00230021,-1.1039427962847623,-0.015216453352007966
29201,SIDM00877,Ribociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4111147,0.042071067,1.1180133202002258,0.06376673634996145
39405,SIDM00833,Linsitinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,4.149682,0.29855144,0.8053049026870155,0.05564072940849808
82620,SIDM00872,ZM447439,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.4666727,0.14819793,0.8935109579520456,0.031449852925359956
69963,SIDM00872,NU7441,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2514853,0.09479418,1.2083012108042546,0.07884288679852536
62046,SIDM00216,Afatinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3538333,-0.06993848,-1.0887409006945048,-0.05258943762926066
87044,SIDM01197,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9565073,-0.06218509,-1.4655858653517224,-0.06952416557623183
89840,SIDM00455,Cisplatin,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6723426,0.021007808,0.272294680696001,0.0724399213000972
90403,SIDM01197,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7926128,-0.029905157,-1.1874420028426191,-0.04195333089178243
50727,SIDM00282,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6142813,-0.076501384,0.40156353224379854,0.03823456889661973
49120,SIDM00877,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,5.2321897,0.094755985,3.2172929048683163,0.06411826968660708
20692,SIDM00633,Wee1 Inhibitor,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.001705,0.16042028,1.947927827202816,0.09189979435364973
101021,SIDM00455,MK-2206,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0059333,0.10409016,0.42809712861952526,0.07086156626377611
44362,SIDM00216,AZD4547,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.7479312,-0.07255345,-2.656442396529918,-0.15722414641714003
42059,SIDM00146,MK-2206,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.1012754,0.24185249,2.0459902922194977,0.12844067656252747
14095,SIDM00776,SCH772984,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-4.1038494,-0.23098363,-2.6017505387777202,-0.11294667255042627
72883,SIDM00957,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.4192386,-0.034737714,0.28460454987683687,0.015217826718029943
3599,SIDM00042,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,5.9980254,0.20162115,3.1574293392944264,0.10607872450936402
64670,SIDM00216,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.8543938,0.01588231,-0.6721677092672292,-0.041962224964229036
16745,SIDM01187,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8071064,0.050505128,1.5770276912811738,0.08623397317453493
15719,SIDM00097,ZM447439,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.650028,-0.067998536,-1.5435640202804806,-0.03411596498960827
76770,SIDM00673,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3401098,0.14504012,-0.23903022672772262,-0.025973901990151437
868,SIDM00148,Uprosertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9782449,0.049137656,0.21123946024584872,-0.041351867100077905
67846,SIDM00875,Alpelisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3944407,0.12815662,1.3972920648120055,0.04788480916951236
101757,SIDM00933,Bortezomib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.13918462,0.014078512,0.24358149905290188,0.016976013631554553
89353,SIDM00282,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.71977943,0.015071258,1.6005468025214713,0.04731602520418428
39841,SIDM00097,Gemcitabine,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4279444,0.044450328,0.3595727352379993,0.013863441484846292
40501,SIDM00877,Ribociclib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6859385,0.050594408,1.0618749697810255,-0.015270201090330567
26766,SIDM00282,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,2.6938424,0.19010761,1.8692749073370918,0.11188269882079412
67623,SIDM00837,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.034389,0.024466127,-0.9723645100229193,-0.012149659440790276
46700,SIDM00633,Ribociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2198588,-0.032583535,-0.8308260054727385,-0.001987574278774513
11668,SIDM00633,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6325815,0.10696818,-1.7118480933931208,-0.052940356415007155
93855,SIDM00872,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.62635624,0.027449047,1.031902124653543,0.08178808604606665
85674,SIDM00673,Lapatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.4198661,-0.03817691,-0.4175104264777067,-0.05525780351099946
87331,SIDM00042,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.0919063,-0.22645238,-2.806474987079423,-0.11255193360089322
53844,SIDM00673,MK-2206,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.5418376,-0.11956165,-0.8515874006035958,-0.0837667150098829
10386,SIDM00928,AZD7762,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.5878292,-0.15789549,-0.2769419260233328,-0.030095646714073793
98995,SIDM00673,MK-1775,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.93854773,0.09075327,-0.09828684863971673,0.011119411859046201
53443,SIDM00950,Oxaliplatin,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4352336,0.08403291,-0.494270477879599,0.013266667187585998
105431,SIDM00928,ZM447439,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.348163,0.33278957,3.3033710311270723,0.17328429971209705
71940,SIDM00148,PF-4708671,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3469261,-0.013536927,-1.72842490238361,-0.03396567636804673
17401,SIDM00928,Docetaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.2491535,0.12331425,0.8968540185177943,0.0329206744359708
86427,SIDM00833,MK-1775,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.5972944,0.025735483,0.07229768548890095,0.026833422671389173
61375,SIDM00097,Olaparib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2695943,-0.020039639,-0.24956251116501116,0.0434942188125358
104638,SIDM00875,ZM447439,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7107781,0.04710102,-1.9729481506934146,-0.11067275554953308
83663,SIDM01042,Palbociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.31964037,-0.017031116,-1.2194726613745248,-0.009650980492346271
23954,SIDM01042,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1798171,-0.098588146,-3.247443719492628,-0.12854763587262474
67672,SIDM00148,AZD8055,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0685496,0.08147129,1.6072925406731777,0.05175618232216635
73162,SIDM00673,Doramapimod,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.3861375,0.06366326,4.1276565995556265,0.1092568274411953
28158,SIDM00875,PD173074,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0173136,0.06855869,1.252780746709676,0.0449285149141637
87722,SIDM00633,Tozasertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7253649,0.020186864,1.0890293170192624,0.03367480680508865
74559,SIDM00633,Luminespib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6560574,-0.060113918,-1.751536080591049,-0.03743024194479247
84945,SIDM00148,PD173074,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6247189,0.050282944,0.007020740035896021,0.015259412521961219
96455,SIDM01197,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.33650106,0.019159468,0.15363465416112315,-0.008912450733812806
5871,SIDM00832,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.0816377,0.041801672,-1.0209526308205454,0.012958056500904109
103644,SIDM00875,Trametinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5521308,-0.061323076,0.5278839587367261,-0.0376775291207158
69479,SIDM00146,Palbociclib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.3659106,-0.024143392,-1.5422564269255485,-0.0877990294996742
56558,SIDM00148,Entinostat,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2137158,0.10480129,-0.3722799983922088,-0.027106815901497654
29690,SIDM01042,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0484463,0.094406225,1.2208952901318924,0.06047068513976426
83403,SIDM01042,Afatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5643708,-0.19752379,-0.894777554337384,-0.06544891607275602
92578,SIDM00933,Alisertib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.334799,0.2617783,-1.6533619373065322,-0.10342405372163338
70302,SIDM00359,Dabrafenib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.99870986,0.056737673,-1.5477395255892068,-0.05685940076347397
93818,SIDM00833,Trametinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.4225721,-0.057278752,-1.2618029857812796,-0.07680853057569487
41045,SIDM00146,Uprosertib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.5740068,-0.10483441,-0.42338836178767913,0.06321153480357646
21021,SIDM00875,PF-4708671,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3720931,-0.047651663,1.4502762713362303,0.08155238524207367
93143,SIDM00673,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-5.857934,-0.44181535,-2.7933557126328816,-0.23778004861216087
19835,SIDM00097,Nilotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0647606,0.078240745,-0.1490391927654879,-0.015048402999894036
84476,SIDM00673,Tozasertib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.952561,-0.14440453,-1.9096043992185128,-0.060055300956633285
29973,SIDM00042,Navitoclax,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.9462267,0.075516716,1.6051923621043416,0.06306106645168157
54793,SIDM01187,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8277087,0.062030483,0.10799123974957688,0.09445547484350487
85737,SIDM00146,Trametinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.8481585,0.105914384,-0.48106122117330397,-0.011635196635395553
74007,SIDM00875,MK-1775,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.38627657,-0.022470167,-0.20733236115102419,-0.0192531082754385
75464,SIDM00146,ZM447439,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.7888449,0.05783752,1.0636859903032627,0.07388083288802552
38572,SIDM00148,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.263795,-0.26162857,-3.065443719477594,-0.24256793943412583
91630,SIDM00875,MK-2206,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2267729,0.10600148,0.17424888162508745,0.023048343106432494
1859,SIDM00875,Crizotinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.61878943,0.05695625,0.7985762278987731,0.016242752588367392
4178,SIDM00933,AZD8055,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6282435,0.048045356,1.2091687505989774,0.08021761349554467
54242,SIDM00933,OSI-027,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,2.128035,0.2225482,0.7324460721490709,0.05379409328040282
68974,SIDM00875,Alisertib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52807957,0.05111058,-0.2612030771746498,-0.02200566228524212
17788,SIDM00957,Vinorelbine,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,2.3781607,0.054794002,1.4955578709014385,0.031221125768632004
76118,SIDM00933,GSK269962A,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.4332339,0.15090701,-0.49281795576125415,0.03771520526972132
76901,SIDM00877,Dabrafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,3.2718716,0.1411707,2.5634170666110836,0.09871077627246866
67885,SIDM00832,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-1.0197202,-0.05412835,-2.1309890027561336,-0.1306368927619338
71755,SIDM01042,Dabrafenib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0887064,-0.088903315,-1.3553506475586,-0.05959752312200932
59775,SIDM00633,Axitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0604718,-0.03642037,-0.5696697481898522,-0.024623919807513023
94090,SIDM00933,Temozolomide,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.7752189,-0.03198459,-0.7116390051130598,0.009404739556376293
62316,SIDM00928,Lapatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.6163532,-0.10097134,2.6713334148475267,0.19824657791358166
96692,SIDM00776,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.4530976,-0.17048283,0.19986313523483412,-0.017358918665266045
12399,SIDM00933,Gemcitabine,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.5608761,0.0016015298,-1.2791738559696664,0.005057509771550296
15374,SIDM00835,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,2.0481944,0.17657998,-0.06831708628237185,-0.00034754426675772233
51828,SIDM00933,Cisplatin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.3312585,0.044481624,0.3741352545077516,0.028172218558313703
19683,SIDM00933,Doramapimod,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,3.1534095,0.1198229,2.1856898020775626,0.05284462395298053
58548,SIDM00148,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6424901,0.1707998,-0.9406630920528432,-0.009859104059837165
83150,SIDM00872,Olaparib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1334082,-0.04625243,-1.4863064417225322,-0.025328497188542416
17450,SIDM00957,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.8052131,0.01638801,1.4869030553078817,0.06945411000762149
107212,SIDM00933,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.824034,0.13294064,0.48083885128822984,0.01696620835870254
85835,SIDM00673,NU7441,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.38228244,0.029290663,0.39342257167902966,-0.016734016257529336
101063,SIDM00673,Palbociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.0405045,0.09004447,0.11522635017096801,0.10026021668385073
46288,SIDM00673,Pictilisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.290348,-0.16944328,-0.6115878683376623,-0.0567938750243953
42547,SIDM00282,Taselisib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2206213,-0.13297787,-1.3471641262631548,-0.09528822781680954
16907,SIDM00673,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4312913,-0.07765865,-1.242702314990499,-0.025025343848308595
3052,SIDM00148,Venetoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.7499845,0.14769915,1.662036702719399,0.08008801845991234
36540,SIDM00673,KU-55933,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.74450195,-0.047291096,-0.5198372170676752,-0.035533620466885275
91337,SIDM00875,NU7441,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1932168,0.21453698,1.2461675036049598,0.06383218022011825
50198,SIDM00455,AZD7762,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4678752,0.04048112,1.365092890145492,0.11246621573170756
106625,SIDM00359,LGK974,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.7557263,0.21789034,1.0546183953527184,0.020049430575814427
99310,SIDM00148,Crizotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6683543,-0.01983379,1.3234414935967795,0.02045341929378549
20175,SIDM00148,Pictilisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.27606398,-0.017949684,-0.02365497468736716,-0.056727431526518296
45279,SIDM00872,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0174335,-0.08874129,0.1839469170710214,-0.011647244339493719
27890,SIDM00928,Ribociclib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,5.3141065,0.36225656,0.5687704030539041,0.024699338471139903
99396,SIDM00673,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.5846663,0.011640673,2.510773528920699,0.07501588377418027
89740,SIDM01187,PD173074,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.55174714,0.044995833,-0.5982664267906822,0.004771820354258724
79319,SIDM00148,ZM447439,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.8961723,0.38189313,1.0920665706928592,0.1108466221366575
41557,SIDM00872,PF-4708671,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.31475767,-0.02590659,0.1199780961747066,-0.0024257327679391093
43804,SIDM00928,Alpelisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.52884424,-0.037225973,-0.0030418511046979187,0.026603285193686554
41417,SIDM00928,Temozolomide,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.471659,0.10173944,1.3800050386492058,0.06894636961188286
88003,SIDM00957,LGK974,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.3478019,-0.020104138,-0.05495423695410637,0.055594464670585764
21105,SIDM00950,Taselisib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3108714,0.056481514,0.9630286699204316,0.021408368191256084
53510,SIDM00455,Dasatinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.9869385,0.08665807,1.6451652676824757,0.1283320248188921
93410,SIDM00455,Crizotinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.255183,-0.10147681,-0.31293150524434343,0.009550224269164713
80989,SIDM00633,Bortezomib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.56591153,0.019335639,-2.315827263878001,-0.04318470496864966
35252,SIDM00633,Ribociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2341961,-0.033171095,-0.6273194604746795,-0.015859112873817364
7871,SIDM01187,Vorinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.13718568,-0.014069825,-0.6757451918946956,-0.05912249248814616
51358,SIDM00146,Ribociclib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,0.25805655,0.011873405,-1.3210520577219884,0.0189224288355005
33428,SIDM01042,Cisplatin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3957356,0.07290093,2.020735473843017,0.11028723336702399
75346,SIDM00832,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,1.299572,0.048967414,-0.12347374874111372,0.02014171594100339
52615,SIDM00928,NU7441,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.2081716,0.10518251,-0.43712339140407086,-0.05374491379137862
61103,SIDM00282,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6522454,-0.053600036,-0.7701792182707513,-0.034111309039300625
90088,SIDM00097,Doramapimod,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.35939002,0.010673498,-0.051423460846828126,0.006516318411993533
63029,SIDM00097,Gemcitabine,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2393761,0.053497426,-0.2097831170446407,0.014293413213236978
32778,SIDM00872,Navitoclax,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35330123,-0.022425326,2.094456963371741,0.1473840826743826
63866,SIDM00833,Taselisib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.108362,-0.10087268,-1.590417658480503,-0.08917723459947795
100553,SIDM00673,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,3.0465298,0.1904383,0.9466788376610424,0.09329440349306609
66492,SIDM00042,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.0083368,0.28854504,-0.9224267371334952,-0.04212548691158294
73007,SIDM00633,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3422744,0.16511494,1.3110341639050687,0.11786996321559683
26276,SIDM00872,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5861391,-0.05424596,-0.663987164861075,-0.01997212590260696
50869,SIDM00928,Cisplatin,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0090278,-0.027266927,0.8899927807774135,0.008743501526248223
108355,SIDM00633,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2741147,-0.035061926,-0.4824214750079247,-0.009858772021587919
37106,SIDM00673,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.8177503,-0.07836518,0.013890891557341804,0.08912325026098443
14112,SIDM01197,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.10670563,-0.007743289,-0.3479435723865438,-0.05289847207442699
103666,SIDM00216,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.6776636,0.12641054,-0.23514172448150492,0.051353034175822834
71322,SIDM00928,Lapatinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.1968492,0.10911516,0.29456362516959217,0.0280055625439153
15974,SIDM00359,Olaparib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5929496,0.038196635,1.9797525842562667,0.07316996665974371
327,SIDM00826,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.99687976,-0.007084292,-0.3195965560109656,-0.033188800235839096
106673,SIDM00673,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.77643687,0.065797456,0.3871063576409716,0.003557021859618336
40316,SIDM00928,Alisertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.96555424,0.08607658,-1.1558258243074009,-0.04126933218768941
28551,SIDM00933,Cisplatin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.0954429,-0.11591627,-1.3283515303658273,-0.07340474884507649
8836,SIDM01187,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.6593277,-0.20469719,-3.0871127101269757,-0.18200333195468088
100870,SIDM00832,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-0.98391783,-0.024065351,0.20853470793188641,0.04461507720545034
100744,SIDM00933,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-2.694395,-0.10447077,-1.8440770021097665,-0.09665583867576151
80948,SIDM00933,AZD8055,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.0371205,0.07262675,-0.3415265499233305,-0.050015999991278245
20263,SIDM00097,Camptothecin,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.354557,-0.0965308,-0.2789362690924063,-0.02622387238954696
78967,SIDM00455,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2953522,0.13760075,-0.2665726271089222,-0.023946672325129474
38265,SIDM00933,Dabrafenib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.5863855,0.050820712,0.18197199318884982,0.01681172692646199
45146,SIDM00875,MK-1775,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48403668,-0.01344216,-0.8773909440556714,-0.044504786697513975
53251,SIDM00872,Palbociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.09402316,-0.0031781865,0.48380816664431964,0.04177649775150392
73093,SIDM00148,Dabrafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0281534,0.07909612,-0.9285813337734824,-0.029478383425493016
2835,SIDM00837,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-1.3641317,-0.07483053,-0.9861542130970536,-0.07646477366346742
76066,SIDM00826,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.18489823,-0.013603047,-1.3506825864068268,-0.022239124186581763
3230,SIDM00832,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,0.57878685,0.01763434,1.9068420207488719,0.04324846597616915
20256,SIDM00875,Luminespib,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.38396943,0.04125416,0.4498800728524857,0.03249167066471672
35495,SIDM00837,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.3123415,-0.05849911,-2.8226787967481584,-0.10337162036420332
40242,SIDM00097,NU7441,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5229734,-0.070218995,0.9152771629180896,0.0165163224001952
31892,SIDM00097,Navitoclax,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.24038391,0.017618822,-0.46447584600139863,-0.0617143489392222
21777,SIDM00146,Dabrafenib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,2.8192518,0.17786713,1.1858621707322168,0.059993426642762734
73368,SIDM00097,Trametinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86483866,-0.02670111,-1.2518430222243357,-0.008372566536525421
104727,SIDM00148,Temozolomide,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.21154788,0.003846256,-0.1785476818208126,0.010873284236527699
78731,SIDM00928,Uprosertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2385402,0.112063535,2.9798579081097896,0.14220078757701113
33282,SIDM00146,GSK269962A,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.0776863,0.09120463,-0.2873981382191573,-0.057143539981928074
3301,SIDM01042,PF-4708671,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4013543,-0.096457206,0.09019575970825788,0.0038342898689131375
9045,SIDM00673,5-Fluorouracil,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.604302,0.23435366,0.08091647212972018,0.03801303627870791
14291,SIDM00148,KU-55933,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1006752,0.05901708,-0.33208816406312647,-0.036512410964056094
94779,SIDM00933,SCH772984,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-1.110383,-0.07564144,-0.20327060534546929,-0.012271314213749258
78378,SIDM00148,SCH772984,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.2024004,0.10779924,0.33797831303552045,0.01544635504483
91110,SIDM00146,Luminespib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.5642399,-0.049781546,-0.8156850467063916,-0.08808318629115855
102279,SIDM00872,SCH772984,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.732411,-0.093168885,0.40998892458795433,0.03479548418822295
71525,SIDM00673,Venetoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,3.548266,0.17639951,-0.952435854856892,0.015230498441449783
60893,SIDM00673,MK-2206,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6980052,-0.037210062,-1.9774947883527856,-0.07308660416400957
78483,SIDM00872,Nutlin-3a (-),MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6937519,0.020382829,1.1477392510553897,0.02514365718497502
52251,SIDM01197,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.9920373,0.058848258,-0.4096240215772909,0.006361232840166058
70378,SIDM00148,Camptothecin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3992325,-0.033085488,-0.27552377779445536,-0.006277511813398934
72220,SIDM00673,GSK269962A,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.4263942,0.15288088,-0.39540744091770086,-0.030963548646336554
61221,SIDM00826,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.0651307,-0.025326004,-1.7325531743008376,-0.08426145919569658
56640,SIDM00875,Sorafenib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1767774,0.24439603,1.092342576479831,0.12287377963833834
44124,SIDM00872,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4216503,0.009736102,1.3438682745970656,0.05970218366994247
93273,SIDM00776,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.04538,-0.064307146,0.48974841121740553,0.022987977623062254
9562,SIDM00148,ZM447439,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.9462998,0.29890883,1.527574720195429,0.07961639983859131
76,SIDM00837,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,0.39483047,0.01414299,-1.05583349154584,-0.04217674842739808
95006,SIDM00673,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-4.949192,-0.30828577,-0.8449279223253716,-0.03207524795432687
63687,SIDM00282,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.5475478,-0.14776272,-2.2587912286314014,-0.1666096051419848
32247,SIDM00148,Lapatinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.58911693,-0.044328127,0.3631644695674898,0.006108870228486233
10947,SIDM00826,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,1.4488701,0.027403748,1.7680149730780748,0.040541980197064446
24016,SIDM00833,SCH772984,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.8962744,0.066089906,2.1454148258355374,0.13522029513275505
5609,SIDM01187,PD173074,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.270134,0.10652885,1.3134217112200555,0.02990313173216862
56295,SIDM00148,Trametinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.62214893,-0.023559649,1.304557619960914,0.0343523054106384
25592,SIDM00933,PD173074,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.335285,0.04275583,-1.0544135176676501,-0.062327757760388416
11261,SIDM00146,Camptothecin,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.751311,-0.06379832,0.23786337602259885,0.08826605806584327
52208,SIDM00877,5-Fluorouracil,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.7689362,0.05200252,-0.33173615608471757,0.007545440337868455
53272,SIDM00950,Paclitaxel,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.65949726,-0.049535844,-0.7869156768607802,-0.052229827788385294
73101,SIDM00146,MK-2206,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1096876,0.1620049,-0.04046249167712507,0.03281847129427123
34871,SIDM00928,Crizotinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.2829502,-0.09604126,-1.2172681236223,-0.07257544613756191
107419,SIDM00826,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-3.094463,-0.100376755,-3.3128339393216377,-0.08205235126671016
107625,SIDM00875,Doramapimod,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5973787,0.096773036,2.7452073274772872,0.0625160943386286
43883,SIDM00633,Crizotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5351323,0.068738215,1.1643913247257924,0.02748915009188862
94474,SIDM00455,Trametinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.173454,0.12433421,0.8730953540069748,0.10269276477686258
88554,SIDM01042,Lapatinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6370567,0.051764607,-0.3406216416480267,-0.02499909634508483
68739,SIDM00877,Tozasertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.7783115,-0.07769127,-0.35947368974832106,-0.01583869369342338
48134,SIDM01042,Venetoclax,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4379623,0.09751118,0.28930970779692344,0.027765875065098745
64304,SIDM00957,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.4367104,0.022263967,1.7934376674667312,0.0342667734983966
53815,SIDM01042,Olaparib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2245167,0.06123779,-1.3745394512261857,-0.011780464440907449
56327,SIDM00832,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.7929018,-0.050384615,-0.8863717305594621,-0.031698901864226615
31969,SIDM00872,NU7441,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.139579,0.09394117,0.062028145188767064,0.02793464642333701
39045,SIDM00455,Oxaliplatin,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4847288,-0.07720749,-2.5035195112839244,-0.031916455231949435
51349,SIDM00455,Cisplatin,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2155962,0.074721366,-0.34237820390362256,0.04559990767745265
19808,SIDM01187,Luminespib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7989489,-0.07666421,-0.9807402747767877,-0.007894192472820364
94858,SIDM00673,GSK269962A,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.222273,-0.084581055,2.8399998991144337,0.175598766488427
30181,SIDM00950,Navitoclax,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6708482,0.067822784,0.9312256110735185,0.0607380490070655
85143,SIDM00776,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,6.862506,0.12289594,-0.043265650899747696,-0.09048065046813222
26873,SIDM00872,Trametinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6960003,-0.13434945,-0.04150165053698571,-0.017560686208527975
55868,SIDM00877,Ribociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,4.8185315,0.12232378,1.3722728681006904,0.020684708538942113
96042,SIDM00875,Nilotinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.884992,0.09338801,-0.7918962876729465,-0.008950168367886502
56402,SIDM00877,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.7718657,-0.0846398,-1.3968078836266025,-0.019612844538314435
98267,SIDM00282,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0316637,-0.069642834,-1.5553740936698472,-0.1170271120095006
60297,SIDM01042,Olaparib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5808564,0.057888933,-1.3718412357600216,-0.035633008272799416
12717,SIDM00097,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.917571,-0.10127285,0.3689847652144397,0.057886412706847856
36779,SIDM00826,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.1393225,-0.08655535,-2.5234821283494897,-0.07010772737827588
84647,SIDM00933,Dabrafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.1017892,-0.076891676,0.7064074127028639,0.07273362571562317
99264,SIDM00877,Venetoclax,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-1.4676871,-0.05555909,-0.4807778845580459,0.013226183794876747
62506,SIDM00097,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.423615,0.06254008,0.30507827292750644,-0.016455119852212922
35519,SIDM00832,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,3.8014698,0.23342222,2.2185344654458095,0.03508694077521251
100428,SIDM00146,Crizotinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.2010447,-0.012655724,-1.2489624654931397,-0.04870042194025719
106346,SIDM00877,KU-55933,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.6190305,0.123866215,-1.247375076400302,-0.014930853612829148
47862,SIDM00832,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.853292,-0.11488278,-0.5067872116141809,-0.006014692778462757
5437,SIDM00097,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3481333,-0.0965313,-0.8098739765587548,-0.09700371552495075
58223,SIDM00872,NU7441,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.88169146,0.058527123,2.9756438133632517,0.14281434758920636
7116,SIDM00455,Navitoclax,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.39421153,-0.025034599,-0.5345415469434879,-0.03093780578269465
89837,SIDM00832,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.5796175,0.09486994,-0.9073973724561188,0.016623150909055803
76928,SIDM00928,Sorafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.2315991,0.023703054,-1.1548143122198116,-0.057743495630201806
12582,SIDM01197,Olaparib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,1.5004625,0.025645163,1.716899709889573,0.061045329511174196
1056,SIDM00633,Cisplatin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4011079,0.061562832,0.9646801086411798,0.012683982253635298
38369,SIDM00950,Sorafenib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.1963624,-0.016331233,-1.1717562958374392,-0.01490321542186999
6947,SIDM00950,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2088598,0.11076226,1.151320619260392,0.06413190396304172
81830,SIDM00455,Dasatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8457754,0.11140156,0.3542466008610841,0.14420103628216965
32885,SIDM01187,Pictilisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.1726756,0.08521448,0.25660486950912864,0.009936385597119134
70272,SIDM00216,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,0.3018227,0.010988569,-0.44250216456277847,-0.04439492358731928
48112,SIDM00877,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.478795,0.17221265,-0.07789463145197907,0.01582810669165737
30854,SIDM00146,MK-1775,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.47866863,-0.042196814,-0.5008774476263688,-0.014357925504422258
89203,SIDM00933,AZD7762,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.14922316,0.019339731,-0.16494268363767753,-0.018873918336024552
84051,SIDM00097,Vorinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9509729,-0.059766352,-0.30153746827532535,-0.010115413209936112
98042,SIDM00950,Olaparib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.811236,0.14288197,0.655320513553498,0.07366222400749776
101619,SIDM00957,AZD7762,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.4844823,0.04288429,2.410175730208033,0.08912960038150074
85634,SIDM00146,AZD6482,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.3308377,-0.13402164,-0.15619594461886666,0.053159907661358044
39155,SIDM00148,AZD7762,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.36756304,-0.033523936,0.16042872844843192,0.12529046004336672
36575,SIDM01042,AZD8055,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.016717,-0.076709434,-0.5490261455177246,-0.03318114589161451
63046,SIDM01042,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6077895,-0.068487614,0.5790372120773785,-0.004216257815651213
15140,SIDM00455,Sorafenib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5885874,-0.05693099,-1.1466624216520853,-0.05289830651030646
95939,SIDM00097,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.4102125,-0.1913691,-1.7641859764662828,-0.09789869006203449
35740,SIDM00148,Sorafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0567226,0.07810295,-0.16238220236259399,0.003187099852504555
48981,SIDM00837,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.5285223,0.008444007,2.5132385219038866,0.08939921348206294
100088,SIDM00097,Palbociclib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7159541,0.08818063,-0.9467270283908102,-0.029440460096409733
48043,SIDM00872,Temozolomide,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.1620552,0.0031113303,0.4488589965181817,0.020439165388573103
72952,SIDM00875,Doramapimod,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1411994,0.07020909,1.3965824299786198,0.04547592814464275
39836,SIDM01187,Olaparib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1736138,-0.032648772,0.3024631935922656,0.014887790156314544
51950,SIDM00146,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2919676,-0.10355234,-0.07926770061604112,0.019688564647930454
72036,SIDM00872,Gemcitabine,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0505716,0.033080384,2.474998526141363,0.050816008040017416
12941,SIDM01197,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3308731,-0.06010982,-1.2034466725183692,-0.02858793844993698
91158,SIDM00633,NU7441,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3354375,0.18552078,1.1730340765438483,0.0773781212164387
6496,SIDM00042,Sorafenib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6760991,0.067803584,-0.7204005908923972,-0.025771132215043457
24588,SIDM00872,Sorafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1817768,-0.019347016,-0.020168393296479938,-0.037744763599918685
54436,SIDM00216,Navitoclax,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,3.0050087,0.27364203,0.6648490378976553,0.043314509652402945
29911,SIDM00673,Axitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.5310867,-0.10865812,-0.764851076083004,-0.043383527652269646
15354,SIDM00148,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9585428,-0.096840166,-1.5329593024439265,-0.07545014493314718
81596,SIDM00957,AZD8055,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.0497525,0.07887941,2.7056031585881906,0.14664639679594454
21462,SIDM00826,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,0.6216216,0.021685194,-1.2894844718521397,-0.023537889307944367
12232,SIDM00933,Linsitinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.4643707,-0.082182325,0.7862701374735203,0.14770856158109555
74919,SIDM00837,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.3725765,-0.09028892,-0.3898092027687824,-0.04471539834928138
2076,SIDM00633,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8686312,-0.15211378,-3.067341789084647,-0.18328364343429357
2485,SIDM00673,Entinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2759358,0.0995374,0.2967288064770379,0.0025062017475691854
61165,SIDM00933,Gemcitabine,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.2476309,0.00084202393,-0.6309956268450122,0.005079711191133956
15296,SIDM00872,PD173074,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.9673746,0.105579406,2.663093241699671,0.08876531319315625
93733,SIDM01187,Trametinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8724034,-0.056404196,-0.7954047316055561,0.043780510397861516
67724,SIDM00146,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.303563,0.107937865,-1.0925916626245649,-0.06162653469731062
102334,SIDM00146,Temozolomide,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.07426751,0.0016961196,0.8476641087836722,0.07795480772451248
9033,SIDM00148,Navitoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5139213,0.091920584,2.8242373274463333,0.10209390066336987
10314,SIDM00875,Bortezomib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.33233938,0.027605586,-0.5370403943424189,-0.039490673255359154
45196,SIDM00826,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.8014752,-0.08142223,-2.7481640005413617,-0.0831283461364329
4453,SIDM00633,Paclitaxel,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6619647,-0.14289677,-2.787202483098599,-0.11203314491158776
91951,SIDM00872,Alpelisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6262447,-0.068277314,-0.5959543220376362,-0.028677416603632346
15073,SIDM00837,SB505124,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,2.0304291,0.14538066,-0.3874149258726415,-0.0009540659445205138
34444,SIDM00872,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,3.2137103,0.1933453,2.6569361131188867,0.17008099206443694
68039,SIDM00877,NU7441,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2838708,0.15452906,0.8106694372304766,0.043044569812041786
16445,SIDM00633,Taselisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.745464,-0.11553635,-1.0935892514964907,-0.058647424587208744
66582,SIDM00633,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0652599,-0.03495214,-2.307778009315193,-0.04989936599448218
44661,SIDM01042,Entinostat,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2287093,-0.13270418,-0.3728577262328033,0.018843914634508505
104114,SIDM00042,Erlotinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.753207,0.17238118,0.5216168229562631,0.01616890006085412
4846,SIDM00872,Temozolomide,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1629027,-0.00334311,1.1675374836629997,0.02869689727636963
33859,SIDM00837,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,2.1862397,0.06072565,1.8750963053985834,0.04784970224060579
56046,SIDM00097,Venetoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6852407,-0.019987933,-0.03679398942247774,0.016898035147008238
26719,SIDM00282,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9745718,-0.09128407,-0.9048273030315388,-0.060606886938439304
5353,SIDM00875,JQ1,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0872822,-0.16604307,0.04460820308062153,-0.005212798275331658
90136,SIDM00146,Linsitinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5559165,0.0141166095,2.748196388497966,0.09429933401719284
92475,SIDM00359,Navitoclax,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2373617,0.07199402,1.3603341249222887,0.054534248263500874
54384,SIDM00833,Afatinib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.4816874,0.098231465,1.2386863843358968,0.0892094183513623
51574,SIDM00833,5-Fluorouracil,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,0.115944415,0.004079734,-1.4963680196335716,-0.07699634603061895
63893,SIDM00148,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2064955,-0.07180983,-1.4671377168179256,-0.025734584265254903
12973,SIDM00950,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.0626514,0.13669202,2.2970131260936104,0.07106303792236322
100173,SIDM00933,Dabrafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-2.6599574,-0.1516618,-0.1472878940183329,-0.010561835937711187
980,SIDM00877,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.2831165,0.13784556,0.24048869184222815,0.005109292614343769
92121,SIDM00359,Trametinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7480619,-0.06728803,-0.8507394564359755,-0.02352772709199024
5414,SIDM00872,NU7441,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9236404,0.100944206,0.7601329781949149,0.06267407115022557
90767,SIDM00216,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-4.685401,-0.07296211,-2.3919400521197836,-0.09504139509921505
93573,SIDM00673,RO-3306,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.60094786,-0.03633811,0.12455718902427818,0.0010771535147279959
59665,SIDM01197,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.86109,-0.08732943,-0.04211314163049365,0.012562834790574535
70048,SIDM00928,Vorinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.753545,0.23672886,1.95883410248887,0.1397622243523961
29298,SIDM00875,Alpelisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5591114,0.12428397,2.1078581654383277,0.07428644807684372
74386,SIDM00776,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.4026507,0.097367816,0.43989974354015293,0.05537827117826462
103353,SIDM00146,Uprosertib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.762569,0.059262436,1.3758585699670967,0.14838967260064287
25102,SIDM00097,Temozolomide,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.11893662,-0.0020457979,0.693678029283654,0.030739654991756977
70065,SIDM00833,LGK974,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.21529022,-0.00855617,-0.8253094897364512,-0.026182006051099563
82200,SIDM00933,Docetaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.3668539,-0.046175174,-5.63172427684139,-0.34496624612670185
87580,SIDM00097,Alpelisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.81511,-0.17286114,-1.0297490706975392,-0.030412697128566233
45270,SIDM01197,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.1413264,-0.1285834,-2.4905570489101136,-0.07750671571455806
73041,SIDM01187,Crizotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6253805,-0.09520012,0.0991662335644144,0.008679666991064977
38769,SIDM00877,Lapatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.24005,-0.07055194,0.5767625837481902,0.07102157788691274
58272,SIDM00933,Venetoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.6686404,-0.068324864,-0.0157946695788928,0.007802328795621154
102320,SIDM00957,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-3.6509483,-0.06523708,-0.3161897609304495,-0.014864320193290374
95142,SIDM00148,Alpelisib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9323574,-0.07359072,-0.3976781848635974,-0.01133040864583302
39279,SIDM00933,Nutlin-3a (-),MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.53926903,0.071765795,0.21207089810876506,0.02382343803479437
105429,SIDM00146,5-Fluorouracil,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7169794,-0.045802504,-2.172490595916489,-0.09841563644831951
7270,SIDM00148,Navitoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.34958154,0.027450508,0.3124526543228339,0.015558213158186429
104489,SIDM00097,BI-2536,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86072725,-0.05737364,0.4732215688574712,0.08649538415035742
91890,SIDM00928,Alpelisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-0.5101387,-0.055981066,0.005629171734097595,-0.004225241986955288
105269,SIDM00950,Gemcitabine,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.268959,0.10157651,-0.5597214865994687,-0.052079750157596895
49266,SIDM00673,Olaparib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6429206,0.03962878,-1.185726508018158,-0.04878527077568663
39265,SIDM00833,Linsitinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.9414457,0.050427537,1.0415194339622453,0.03135807341997576
19047,SIDM00877,Afatinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6605712,-0.15184382,0.06146417970245576,0.004009169625886787
18729,SIDM00872,BI-2536,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.59281814,0.062973484,-0.7846672905811314,-0.06704504134286944
8639,SIDM00633,Cisplatin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7728492,0.028706534,-0.07130130419735506,0.06690025871995949
72680,SIDM00872,AZD8055,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1839262,-0.12503366,-1.0587479996114586,-0.11963574675069823
19233,SIDM00950,Cisplatin,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3352,0.28637055,3.036084020931382,0.19930513647185696
50435,SIDM00875,PF-4708671,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.297524,-0.0428532,0.24427593334074765,-0.00021334422005604042
60641,SIDM00359,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4256917,0.120857574,-0.9613549585693905,-0.07846625569303405
75973,SIDM00042,Erlotinib,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.8082292,0.14026715,2.135637561746117,0.12752757926782637
45985,SIDM00875,Pictilisib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.79794526,-0.08966814,-0.9984892289392691,-0.0721343983858047
27788,SIDM00832,Crizotinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.85825986,-0.06719902,-1.4252106294067808,-0.07593236612584142
68375,SIDM00928,ZM447439,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.8331406,-0.086807415,-0.04425519864605881,-0.06271917563778866
14822,SIDM00633,Nutlin-3a (-),MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0539591,-0.075564556,-0.4319781636017612,-0.010542710990204826
105116,SIDM00928,Tozasertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.3483677,0.09019288,1.8936571955764656,0.07449031095741636
103044,SIDM01197,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3958479,-0.042009275,-2.069914143745454,-0.11128202264906387
18715,SIDM00835,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.5904088,0.0489189,-0.010143894908127985,-0.01759651451501394
48838,SIDM00633,Luminespib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0750339,-0.080553934,-1.5552371953970454,-0.10707351913427168
99450,SIDM00673,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.4456327,-0.12359436,-0.6456199034488426,-0.024113791770652638
105785,SIDM00042,Trametinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.7812206,-0.1954662,-1.1573011359640797,-0.07813045265195571
27160,SIDM00933,AZD8055,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,3.466508,0.32154974,1.1195754278119565,0.1191704048766811
30093,SIDM00872,BI-2536,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6560637,-0.06299851,0.3709672872042715,0.01296976151297948
30190,SIDM00146,Vorinostat,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2050066,0.08335366,0.045278158697079136,-0.0445005062424953
103486,SIDM01187,Crizotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0947022,0.08555446,-0.875597202025213,-0.04642045816065987
18478,SIDM00826,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-2.5982602,-0.077113375,-3.4247552978915876,-0.11325407544338127
30903,SIDM00950,Erlotinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.70793855,0.07083503,0.32564693240902703,-0.00011228855398441819
63582,SIDM01042,Dabrafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.50926423,-0.036184553,0.13055658117072091,0.018814857175396712
59016,SIDM00097,Afatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.35296094,-0.02516763,0.7564102737566452,0.032649322515568346
59402,SIDM00928,OSI-027,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.6800519,-0.1776433,0.24651506065693604,-0.03583778202450019
1362,SIDM00928,Temozolomide,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.4958065,0.049054574,0.1291983356234993,0.021450866605306398
70802,SIDM01187,Gemcitabine,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.27499726,0.024270631,-0.7653697030632454,-0.06901203037580175
34598,SIDM00877,GSK269962A,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.78955054,-0.02175235,-0.32767553985149017,0.014467753335054746
42117,SIDM00877,JQ1,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,2.3530865,0.08115815,0.4462345135382247,0.0037601675787931367
26663,SIDM01042,PD173074,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.069847,-0.11325752,-1.4901902100828819,-0.049265331199746895
23898,SIDM00216,Linsitinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5720974,-0.048766833,-0.4678358389218218,-0.008039143611274308
104279,SIDM00833,5-Fluorouracil,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.34342512,0.022943202,-1.8737664193163903,-0.12954571682962215
79217,SIDM01042,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9105805,0.10545489,-1.757167023499176,-0.08373711364383915
69092,SIDM00950,Cisplatin,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.60607797,0.02710946,1.120106989766641,0.06898793916739783
35186,SIDM00673,Tozasertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.458423,0.033835668,0.2624401851107153,-0.015622469352438424
48853,SIDM00148,SCH772984,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9172781,0.041016478,0.7410472982095784,0.004476249696012927
43285,SIDM01042,Lapatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48616225,-0.05914758,-0.6000593651979254,-0.07559361655491167
74915,SIDM00673,Palbociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.53927076,0.027658401,-0.761009559947508,-0.006192795388896775
10464,SIDM01042,Sorafenib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.1991916,-0.021110617,-1.7080896756469055,-0.09004953921257969
39878,SIDM00042,OSI-027,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.28397757,-0.031164933,-0.964454352575835,-0.004167411929715433
927,SIDM00832,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.2840984,-0.046956908,-0.47127098479763996,-0.06196260765266292
70355,SIDM00148,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.80129,-0.13651055,-3.569773885227467,-0.15834787643464557
79714,SIDM00633,PF-4708671,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6735002,0.062012445,-2.01088476386312,-0.06396368898580283
90977,SIDM00455,5-Fluorouracil,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1100271,-0.031598326,-0.8879664526501073,0.018679618376077938
3978,SIDM00216,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4271489,-0.029020634,-0.5101952842776705,-0.05326857849074669
105360,SIDM00877,NU7441,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,2.916324,0.32703474,1.3778347099275312,0.12424499010720781
43828,SIDM01197,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.3510984,0.10277181,-1.3819482905619611,-0.09981856020672841
88232,SIDM00933,GSK269962A,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6863123,0.06952994,-0.17643818024435418,0.021228448360921078
14200,SIDM00928,Navitoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.4004214,-0.1877519,0.7114608389228887,0.03139964540666593
81836,SIDM00042,MK-1775,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.9313904,-0.1735378,-3.2533897956922746,-0.11775709583911971
35838,SIDM00833,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.105684,0.22348368,0.550319855267689,0.09620555419649865
64744,SIDM00835,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.56864715,-0.045127604,-0.8378500113607169,-0.0443029341372037
48773,SIDM00928,Nilotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-3.7540357,-0.2398259,-1.533708770604703,-0.10761466050657813
69138,SIDM00148,PD173074,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.961926,0.03473955,-0.7859666824521937,0.04558887974766132
104720,SIDM00957,Crizotinib,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.2580551,-0.035944276,1.897446196859008,0.10930055409094386
43588,SIDM00877,Docetaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.187397,-0.10631407,-2.1996579010159265,-0.09623676325556924
42944,SIDM00673,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9402909,0.095495686,0.7884303000100575,0.030482493142252133
63094,SIDM00877,Bortezomib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.2902127,0.026202692,0.4591649621315923,0.018906298350400308
106342,SIDM00097,Docetaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9085512,-0.12666214,-0.8975758417463962,-0.06750557643459025
8786,SIDM00146,Alisertib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.26541275,0.023433207,-0.3431803551557092,0.03365636127224788
91421,SIDM00950,Cisplatin,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.092064,0.34357807,3.456553746392014,0.22261796195779676
63507,SIDM00282,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1367764,-0.056792423,-1.0707315623687492,-0.07592306761527448
63789,SIDM00875,Nutlin-3a (-),Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.71161264,-0.021197813,0.9576857607226765,0.014153427474221322
4068,SIDM00148,Doramapimod,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3790507,0.17749958,0.21322275553554626,0.054143780851113876
24618,SIDM00146,ZM447439,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4306153,-0.02916495,0.646064680992262,0.08943806827657125
46255,SIDM00832,SB505124,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.1803017,-0.09658704,-0.5548084627600158,-0.05964278820104061
45895,SIDM00146,Crizotinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.410032,0.18504559,2.951725658849235,0.1777524998107516
80251,SIDM00933,Alpelisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-1.8792231,-0.13199395,-0.014691498359927882,0.005568985851397885
72796,SIDM00633,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5917163,0.043384932,1.684632464848221,0.05090128096547987
92120,SIDM00097,Alpelisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.785402,-0.049625307,0.3761842388457209,0.020773164870465446
3633,SIDM00928,BI-2536,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-0.8930773,-0.048340734,-0.4199005345699145,-0.035745894395564116
107323,SIDM01042,AZD6482,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6214797,0.083653584,-1.8597479001294506,-0.08560007826614657
59393,SIDM00933,Afatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.2080184,0.01890324,0.7830956593109013,0.07051600358195752
98433,SIDM00216,Camptothecin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.18686004,0.009512853,-1.3287349153797976,-0.09627698684222578
107709,SIDM01042,AZD7762,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7658729,0.09150064,1.4402413585958023,0.03294638563809
50235,SIDM00776,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.71060985,-0.0533137,-0.7390905362141005,-0.040459794815472926
36997,SIDM00957,SB505124,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-4.6481047,-0.078650534,0.6153677915574685,0.04613082894761053
71770,SIDM01197,Crizotinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.46763337,-0.033233657,-0.9304112861654065,-0.09779486702237591
27789,SIDM00928,Palbociclib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-3.008586,-0.11253237,-1.1332970613849467,-0.0792052035235715
27506,SIDM00928,Olaparib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.5271163,-0.09078694,-0.7848654007288743,-0.028872296827512425
69553,SIDM00933,PF-4708671,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.0150262,-0.07292514,-0.6062479351262934,-0.014433586481330312
48922,SIDM00933,Paclitaxel,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.26585189,-0.023070496,0.7089517542922815,0.09483628497393116
47779,SIDM00875,Taselisib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.24860461,-0.029375007,-0.4257937169029466,-0.06490935594180976
70972,SIDM00877,NU7441,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.2992768,0.2120528,0.9177491179352948,0.13931272320848248
103576,SIDM00097,NU7441,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9504089,-0.08123443,0.6388209820599428,0.03787817002957728
23809,SIDM00950,Palbociclib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9514608,0.20417486,0.9748506991915274,0.09977179415481181
93828,SIDM00957,LGK974,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.3202167,-0.019975908,0.5229572470182493,0.04416109823481495
46179,SIDM00957,Afatinib,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-2.9533687,-0.101307474,-0.21345083187184144,-0.010272671217012957
2409,SIDM00875,Taselisib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8931198,0.1028674,-0.3856524858136839,-0.05950921532655132
96599,SIDM00633,Taselisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.362438,-0.1875089,0.2501591006992593,-0.00940224769502123
27204,SIDM00875,Palbociclib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9068894,0.077801265,1.8598767222007033,0.050343918990581486
81488,SIDM01042,Palbociclib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2449648,0.13472842,2.4776342677224426,0.025529009277358034
108000,SIDM00826,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,2.6345134,0.15991394,0.8306028390905129,0.02088112969492249
77392,SIDM00832,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,0.34987453,0.022661323,-1.5734891377211038,-0.06843475387582483
6101,SIDM00097,Alpelisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9090772,-0.063179635,-0.7922233158350841,-0.040867175254973354
24238,SIDM01187,AZD7762,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.572236,0.21263604,1.1008853527054705,0.0875448854842516
66559,SIDM00833,Olaparib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.16952708,0.007347393,-0.7755015224126589,-0.03630030592191761
48012,SIDM00928,AZD8055,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.3164809,-0.12366118,-0.24131829984671244,-0.007919830717674381
4987,SIDM00148,Entinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0817852,-0.07015103,-1.2228169658986092,-0.030093760885346488
86587,SIDM00148,MK-2206,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5514443,-0.09793543,-1.789780248831722,-0.06523954024374158
14181,SIDM00877,Vorinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.62773687,0.02302919,-0.42883102370628956,-0.018922179864984782
12496,SIDM00875,GSK269962A,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5521446,0.032545477,1.4742415018210262,0.06900999766804645
6803,SIDM00776,Palbociclib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.3458978,-0.020360108,-0.05193951191770558,0.0021502366904801572
98834,SIDM00877,Dabrafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.345161,0.04063407,0.7516159881336227,0.049571657591738955
47997,SIDM01197,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,1.4161512,0.102243975,1.05487533601439,0.059269499300745536
3124,SIDM00877,Trametinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,1.8174003,0.07934693,-0.6483034075961592,0.038766730140317354
72311,SIDM00097,Axitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1457632,-0.115349695,-0.33209548742631134,-0.005812865323021319
60843,SIDM01042,Crizotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4591472,0.009921237,-1.4729169195473497,-0.061790835897327256
79572,SIDM01042,Linsitinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8059756,-0.060488753,-0.10669710112569122,0.004462138544766938
82861,SIDM00633,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.996194,-0.18690306,-2.592533327577511,-0.11705468564127795
77476,SIDM00928,NU7441,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.91117,0.10684245,0.3505540723386681,0.01653434307953207
86042,SIDM00933,SCH772984,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.6771532,-0.10165238,-1.0599214542609847,-0.012262537794824177
3936,SIDM00928,5-Fluorouracil,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.7613871,-0.08540566,-1.0766858029562598,-0.026338933885449826
75263,SIDM00950,Irinotecan,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1023993,0.07364077,1.2322836888619282,0.09991708577884609
99945,SIDM00282,Vinorelbine,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.70090616,-0.0420472,1.0896392461695708,0.08535339847580041
84862,SIDM00146,PD173074,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-3.6854208,-0.19055712,-1.0401911969599282,-0.03401782702222068
37568,SIDM00875,Dabrafenib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6187844,0.08986641,0.49323900655583686,0.01767880468179507
41711,SIDM00835,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.3536427,0.016723242,2.2262594119672823,0.08599379525325161
55448,SIDM00872,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1552688,0.09411839,2.1550890605383333,0.13727574460828443
1230,SIDM00877,Pictilisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.93004686,-0.09052543,0.4868202988683778,0.004017074859496381
12226,SIDM00776,BMS-754807,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.3328247,-0.115138926,-0.4062066295010204,-0.05576884884010787
94192,SIDM01042,Pictilisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.10050657,-0.006863809,-1.2436502303708945,-0.08888908248861495
104799,SIDM00359,Afatinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9803023,-0.1491367,-0.3439521923039512,-0.012045368180591718
48852,SIDM00950,Dactolisib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9473429,-0.1324931,-1.45008847107821,-0.047989491765222846
94115,SIDM00933,Alisertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.5246755,-0.051355496,0.5659496319101857,0.05889358383445371
4956,SIDM00872,PD173074,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9958827,0.06460887,0.3575459193644006,0.026026607566148777
80314,SIDM00097,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.20197299,0.009983409,-0.256029876204536,0.009054454115695144
45490,SIDM01187,Nutlin-3a (-),Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9059568,0.08514243,0.9267067285491392,0.0124139938057126
13142,SIDM00359,MK-2206,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9710144,0.059466653,0.0625340239340285,0.07575080334033535
28725,SIDM00950,OSI-027,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.39956114,-0.028791236,-0.48704354433978597,-0.006645361079307958
60707,SIDM01042,Camptothecin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,4.2310963,0.45607603,2.447983083995409,0.17571290621619798
3784,SIDM00359,AZD7762,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7616327,-0.15138054,-1.4859723237884714,-0.04161589078610479
5375,SIDM00146,Bortezomib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.4516914,-0.031390823,-1.1042747435762956,-0.0766552344631321
55418,SIDM01187,Nutlin-3a (-),MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5178972,-0.07919612,-0.2100604219255794,-0.013630075292883383
20786,SIDM00216,AZD4547,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5593644,-0.031726032,-1.3145363667567789,-0.0445496735298224
66768,SIDM00455,Irinotecan,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.75801015,0.02748813,-0.47000543070040895,0.024469382075228974
1130,SIDM01042,MK-2206,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5732962,-0.021002384,-1.412270028826247,-0.09774317457517036
23958,SIDM00282,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2917533,-0.034597658,-0.43156978851225397,0.008454205943202299
48772,SIDM00633,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.82464886,-0.038146343,-1.5769758846543975,-0.046355052275834696
8011,SIDM00877,RO-3306,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.19384585,-0.017374039,-0.6426034261115301,0.003814351015552735
50314,SIDM00146,Cisplatin,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.1284069,0.049146283,1.69492770146993,0.05910464897255382
49889,SIDM00928,Taselisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.327601,0.1446731,1.7850484162617348,0.018291028589575497
55460,SIDM00282,Taselisib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2652875,0.057107188,1.2170142277774176,0.07207453755409401
78243,SIDM00832,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.1863258,-0.039698333,-0.40091837995489576,-0.00676003114341291
34559,SIDM00875,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3497909,-0.02497643,-0.8299264568570557,-0.07340118623497853
48728,SIDM00216,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.69908434,0.012003303,1.2633855200716222,0.07088904446517455
101710,SIDM00877,GSK269962A,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.7414399,0.09040899,0.14734513748954442,0.024509297252447375
82356,SIDM00835,Olaparib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.8559412,0.020338137,1.4685538129649969,0.0640877633312029
80182,SIDM00837,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.48565546,0.008321097,-1.861304563308881,-0.0325487409887922
84162,SIDM00146,Bortezomib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.2530838,0.032395355,0.5225492222069557,0.04214272028634511
76915,SIDM01197,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.5032108,0.029250521,1.7636691660728498,0.05668061638645093
57228,SIDM00877,OSI-027,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9796009,0.013187808,-0.1460793655552199,0.002255038799892704
42412,SIDM00837,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.5752532,0.108934514,-0.8517996480813204,-0.06763004697829388
102746,SIDM00455,SCH772984,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6846856,0.10003084,-0.5961725942959192,-0.06526401753302259
63597,SIDM00673,Alisertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.9794464,0.17247002,1.2808990937741356,0.09638298115581069
8222,SIDM01042,Dabrafenib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4272565,-0.09911043,0.42717619431824316,0.04476868181841485
65103,SIDM00146,Tozasertib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.4729989,-0.09165416,-2.2500756284691743,-0.09165849051607584
38494,SIDM00148,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5289402,0.07492453,0.17349318866754077,0.021017640702741335
106538,SIDM00832,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.05903,0.012586559,2.342103431746653,0.04091762525357219
56982,SIDM00146,Navitoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.3134867,-0.0140476795,2.502297965931011,0.03881936518005351
38033,SIDM01042,Entinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.221893,-0.1539958,-1.131984488096335,-0.035358877851021396
37968,SIDM00633,NU7441,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9667614,0.20884836,2.0301302092211913,0.10646321684756642
6897,SIDM00673,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7801643,0.052338686,0.45085624054184936,0.039308757692951855
52769,SIDM00833,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.22586,-0.09132057,-1.0404342665656152,-0.17924956587963128
97163,SIDM00875,Linsitinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5456592,-0.03295899,-0.12557555773148604,0.012994526313455601
56734,SIDM01042,BI-2536,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5671136,-0.015018592,-0.756311911506674,-0.046997086399669076
12271,SIDM00928,Ribociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7067835,0.009374148,0.8187227541542675,0.025159888009832116
93445,SIDM01197,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9599189,-0.086174905,-1.1062699229207378,-0.008847904359636267
4785,SIDM00146,Uprosertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-3.7602446,-0.19693282,-0.7033428650123432,0.04183588346210081
62535,SIDM00148,Paclitaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.412852,-0.14578922,-0.9842990633839034,-0.0050314708790062225
87459,SIDM00673,Nilotinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.0746083,0.31395766,1.2849313154542603,0.08695359212096307
19899,SIDM00282,Trametinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.7100052,0.048503507,-0.22897466141580147,-0.019714069516245693
94175,SIDM01187,OSI-027,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7998801,0.0630985,0.9879534008166672,0.043379534393367
70669,SIDM00673,Navitoclax,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9473956,-0.12721156,-0.18343942585427367,-0.006388682411252973
104955,SIDM00097,Gemcitabine,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.361335,0.06679882,-0.22077636136966725,0.04384107686117174
104611,SIDM00216,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5742523,-0.03532571,-0.6387572676069334,-0.050590204415396266
28229,SIDM00633,Temozolomide,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6997586,0.047915477,0.28547409751429964,0.008509783377758373
17593,SIDM00933,NU7441,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.9866275,0.10117513,1.6959761007921768,0.0741007142368972
102014,SIDM00833,Trametinib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.3119857,0.044945728,0.9586312397859335,0.004709162671425028
33272,SIDM00359,Olaparib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8019986,0.058275618,0.5271949396120241,0.0291930268268585
23310,SIDM00950,5-Fluorouracil,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8086668,-0.08046645,-1.4905592097754738,-0.06744908082577343
106071,SIDM00875,Tozasertib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.32706976,-0.015414251,-0.3151321325302346,0.006475156597481022
29138,SIDM00359,LGK974,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9612262,-0.031569373,-0.7576509694151077,0.007267201719890362
33061,SIDM00957,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,0.78963435,0.011855794,1.5358221639461154,0.07698607486352989
55777,SIDM00928,Afatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.3698293,-0.14201875,0.8115711475948136,0.06529063647001425
73104,SIDM00875,ZM447439,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.017197568,-0.0014299318,1.6953754926550046,0.05705367120056269
32036,SIDM00877,BI-2536,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.1862714,0.0023055656,-0.5298290438732709,-0.01964727342306527
84201,SIDM01042,Paclitaxel,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8375714,-0.09270981,-3.708521565356047,-0.2863471040559489
38244,SIDM00950,Dactolisib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.9810085,-0.1508785,-3.211200086261562,-0.15420038087710342
22855,SIDM00826,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.3743455,-0.13334881,0.17113167200600954,-0.07489674311398091
97454,SIDM00877,Nilotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.57375807,-0.060893424,-0.9907717574603913,0.027598594764864794
59320,SIDM00875,Ribociclib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5072091,-0.04235242,-0.2902466485252331,0.007603698064991154
42998,SIDM00832,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,2.397318,0.1689166,-0.860787419709285,-0.0149680399317791
58895,SIDM00455,LGK974,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5069773,-0.07335765,-0.7275117754541306,-0.008240916469935362
67280,SIDM00776,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.5431582,0.023546137,1.1587855036249948,0.0370625756287594
4091,SIDM00933,Docetaxel,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.9344645,0.10180668,-2.9925627643981576,-0.08035162140503999
35511,SIDM01197,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-2.2337406,-0.13600436,0.0021646978194005562,-0.041879732299190585
81716,SIDM00826,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,3.7854812,0.063096195,2.85825474708666,0.0637719891855347
71178,SIDM00837,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.5782031,0.052005127,0.9725980147584302,-0.020406291431913966
27488,SIDM00146,OSI-027,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1934303,0.10760622,1.6413530582879914,0.10464203457343438
60943,SIDM00146,5-Fluorouracil,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.52603555,-0.03240506,-1.5885792652445256,-0.061855070016458034
76458,SIDM01042,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5234001,-0.047142852,-0.4146266459114038,-0.030749923338311405
92839,SIDM00928,Uprosertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.2850327,0.31895363,1.3451760560277353,0.057647478650832404
33635,SIDM00146,Nilotinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2093663,0.118672825,0.4166497592157981,0.07662806161494415
70189,SIDM00835,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,3.4236984,0.23058677,-0.7827319213359871,0.05937951363600859
39528,SIDM01042,Uprosertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2575986,0.009111493,1.2410952262184243,0.006886099314191165
28980,SIDM00673,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1241084,0.026884006,-0.3407166356268318,0.005331263131230492
65336,SIDM00832,MK-2206,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-0.17579368,-0.01119314,0.7151435114660915,0.043880031481860045
44539,SIDM00673,AZD7762,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3162093,-0.117699884,-0.8388044925017204,-0.08732972313501537
69425,SIDM00957,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,5.1638455,0.20696315,1.8379577416536275,0.07088966432714515
80459,SIDM00148,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.87416637,-0.07324572,-1.2459927971173712,-0.058930050073712395
86024,SIDM00833,LGK974,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6432453,-0.022174612,-0.4422462946363277,-0.005799705774141217
9819,SIDM00359,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.16602327,0.011296149,0.4307014168613277,0.05822333957089997
95446,SIDM00216,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.1722353,-0.10933864,0.04389268700964075,0.039804498445382766
70457,SIDM00832,5-Fluorouracil,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.1297667,-0.10290943,-0.7036736181272121,-0.06114455754239888
31445,SIDM00950,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.910818,-0.08705397,-1.224141753786619,-0.03088346067866542
38423,SIDM00097,Navitoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8193391,-0.05746566,-0.08287744691112892,-0.02398449210056456
44992,SIDM01042,Linsitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7395364,-0.085744396,1.5552757577727927,0.07205454893059844
19580,SIDM00216,MK-2206,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.80585194,0.011613171,-0.21262533411881543,0.012634303384770942
24880,SIDM00282,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3221946,-0.09141304,-1.4752129668251377,-0.12867184859737
75529,SIDM00146,Camptothecin,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3301056,0.031371325,0.0846873975050534,0.02156982980233386
2009,SIDM00933,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,3.1664014,0.13226612,-0.055130761086068535,-0.029326922344387926
104924,SIDM00875,GSK269962A,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.92447,-0.087826334,-0.7956359003824949,-0.038445404009538914
32709,SIDM00877,Luminespib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4966329,0.11155168,0.5329815822061597,0.03845664461435071
4928,SIDM00146,Axitinib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.3882618,-0.12852973,-1.7778967710161058,-0.08074569510543363
49343,SIDM00455,MK-2206,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8474547,0.08923788,0.023564387255709994,0.059749468539683936
87325,SIDM00837,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.58558536,0.031167986,0.39195613520926526,0.024431261585754788
38408,SIDM00928,PF-4708671,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.9378351,-0.10788159,-1.1731804819387968,-0.04054771358404595
100867,SIDM00837,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.3018848,0.012750921,-0.3325214621832989,-0.015486059402266833
54434,SIDM00928,Palbociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.0642965,-0.10650244,0.9077415053155733,0.012097248038703441
78086,SIDM00837,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.7432287,-0.10471315,-1.549294414837385,-0.10712527591001056
91060,SIDM00216,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,1.6445653,0.14631687,0.4740155515964229,0.019234698155252732
53412,SIDM00146,AZD7762,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.73490167,0.0682001,-0.8782113409565127,-0.015123640346131426
64526,SIDM00146,Vorinostat,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.61710465,0.055002727,-0.7007683311549583,-0.05133523161872152
79510,SIDM00950,Oxaliplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.93374723,-0.03382645,-1.1086014374988733,-0.011993851048493967
101411,SIDM00148,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6635251,-0.03982449,-1.4401620957242336,-0.0733487770546336
12480,SIDM00146,Uprosertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4365994,0.096022226,2.6037395686377645,0.197854248803157
27196,SIDM00146,ZM447439,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5154895,0.13256751,2.206513568855101,0.14832085233923595
83114,SIDM00673,Venetoclax,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4685785,0.040514532,0.3537740721442331,0.0693973986793889
49074,SIDM00148,5-Fluorouracil,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.367994,0.116558135,-0.5166323117878936,-0.03142114957858143
39431,SIDM01187,Taselisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5802048,-0.07627897,-0.5337279957621721,-0.029844995636167822
15794,SIDM01042,Trametinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4211198,-0.08897089,0.27186958223973684,-0.010682395359500054
82589,SIDM00633,5-Fluorouracil,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6712914,0.11040221,-1.0504988750895898,-0.005006007234133964
49510,SIDM00455,Trametinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.57054204,-0.033927772,-1.633506020590947,-0.07149535767064201
14988,SIDM00833,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.0456904,0.0825152,0.1700476250198604,0.0019202436539203737
64620,SIDM00872,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.70839226,-0.068161905,-1.1707475988183969,-0.07650602066211125
48388,SIDM00950,MK-2206,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.347099,0.29577187,2.624640130672126,0.1826838205124939
23515,SIDM00833,SCH772984,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,1.0419241,0.082767926,-0.14948862250265899,0.01743449553712992
30277,SIDM00633,Bortezomib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9318914,-0.073881924,-0.37326471664487804,-0.03485961790754144
75091,SIDM00835,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.007288,-0.111312345,-1.0409378788422423,-0.05900429223630015
7818,SIDM00633,RO-3306,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2976245,0.123396695,-0.4975086075610642,0.01671798506131485
3136,SIDM00950,Linsitinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4283314,0.17633343,1.9435355394707812,0.15569876472431032
47660,SIDM00833,Dabrafenib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.48571295,0.009654032,0.4917817272702207,0.014810115452792748
50460,SIDM00673,BI-2536,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.176554,-0.095248826,-1.403001933066083,-0.12533360489779008
43312,SIDM00633,Dabrafenib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4366333,0.029505413,1.1311096243298695,0.030961778802872163
67440,SIDM00148,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.34105605,-0.026287232,-1.576709183293617,-0.08640548411944722
29411,SIDM01042,Uprosertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2180836,-0.056505095,0.36912335722207995,-0.008594076091721605
2400,SIDM01042,MK-2206,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6080943,0.014239393,0.8516048442323244,0.0008085901709230548
63890,SIDM00097,KU-55933,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4423535,-0.068686,0.3984118073527382,0.029625571620723185
104188,SIDM00455,OSI-027,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.458728,-0.14225215,-0.8997107653689438,-0.05312125345789984
90716,SIDM00877,Camptothecin,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.45897982,0.047470693,-0.3150946823134509,-0.010941974754237187
35387,SIDM01042,Nilotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5153809,-0.038944986,-2.1545322509282983,-0.11412514369360147
11597,SIDM00933,KU-55933,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.8089643,0.0985855,0.47265866200053175,0.03648565905154052
96641,SIDM00933,Docetaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.35132128,-0.04765582,-0.16867537445306094,-0.030004937501013854
44590,SIDM00928,Nilotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.8734222,0.08819623,0.08216797913677812,0.024879180774738344
63472,SIDM01042,Axitinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5201069,-0.12448567,-2.218209425975966,-0.07789058287340733
9533,SIDM00832,Palbociclib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-2.027619,-0.07394398,-0.3260796285022889,0.013365298599821674
15551,SIDM00359,Camptothecin,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.65502375,0.057987142,-0.23780584189830944,0.046092457631551766
47175,SIDM00673,Paclitaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2907091,0.08907147,-0.15570631775087326,-0.030348490273299993
93667,SIDM00097,Dabrafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.768768,-0.09830352,-0.9490119884407641,-0.028046931238321336
88399,SIDM00877,Bortezomib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.6138239,-0.054668,-0.157292239464835,-0.014955910436097676
50758,SIDM00833,MK-2206,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.1425095,0.0709717,-0.6608105930639879,0.010433312052261277
106066,SIDM00146,PD173074,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.24915527,-0.0144666275,-0.43244167638442216,0.037117405734607985
47185,SIDM00950,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.81637543,0.033441003,0.19680825688883016,0.04423570870594352
57182,SIDM00673,Dabrafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4995338,0.030005079,1.9113326998012303,0.08681067435152516
44349,SIDM00835,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.2798125,0.03815756,0.5778489316865968,0.029369742917512185
77500,SIDM00776,Linsitinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.7977486,-0.08835145,2.6010706254006934,0.07814592797945108
13767,SIDM00146,Gemcitabine,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.123353,0.07525781,-1.4787541960745132,-0.08668911615822188
73804,SIDM00832,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,1.5153697,0.1209402,-1.0938055667862485,-0.09188916216788623
10272,SIDM01197,SCH772984,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.78733003,0.025142865,0.5057643930086868,0.016937628427091716
5758,SIDM00872,AZD8055,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8396924,0.11865746,0.46190377495066554,0.007641710156260656
72473,SIDM01187,AZD7762,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.617289,0.05434781,0.9317160160813445,0.012333463030043583
91169,SIDM00950,Dactolisib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.16092274,-0.011938551,-0.64853575583584,-0.04785805604735431
11045,SIDM00826,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.5265697,-0.04323796,-3.467895585451001,-0.0950960081300982
59851,SIDM00833,MK-1775,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.0708635,-0.07277977,-1.9617612206747888,-0.09298906900271492
42071,SIDM00832,BMS-754807,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.0295103,0.055994004,1.6762361356329398,0.04007960185965633
23903,SIDM00359,Crizotinib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6541464,0.058355983,1.9945435947894796,0.0740243885974799
52056,SIDM00875,Alisertib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0622466,-0.07421822,-0.7926480942976767,-0.01501518413481028
43449,SIDM00933,Sorafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,0.20563564,0.01870261,-0.14817021176557904,-0.00029298828436283617
8834,SIDM01187,Temozolomide,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6339202,0.05591247,-0.11625352647251566,0.0008981523320584664
83418,SIDM01187,Docetaxel,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2500163,-0.09468767,-0.13884147847373576,0.04901496176928475
92953,SIDM00872,Luminespib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.654981,-0.1685107,-0.606102662986994,-0.030486806592351874
53746,SIDM00957,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-3.5043283,-0.110420525,-1.1891760506604983,-0.018089933254069962
30901,SIDM00826,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.615806,0.043040518,-5.589100240417699,-0.15203432703861
38709,SIDM00146,Gemcitabine,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.32542312,-0.022917064,-0.6602154485976099,-0.054444002135702864
50979,SIDM00877,Alisertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.20621786,-0.017859297,0.24478996705263978,0.04889574698172787
5708,SIDM00826,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.303682,-0.028158141,-3.8433271032886065,-0.12363849088935012
80472,SIDM00148,Nutlin-3a (-),Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1665317,0.12057328,-0.6567200327022773,-0.09077360354217878
97659,SIDM00826,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-0.9480233,-0.005400658,-4.349316310037742,-0.08599084631429821
93933,SIDM00282,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-2.521791,-0.14749536,-1.5193306570446832,-0.06445423482947335
55621,SIDM00877,Venetoclax,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.1389273,-0.0438305,-0.10369390418725401,0.052175594950176984
104332,SIDM00957,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.0712335,0.038572967,0.23034176308345022,0.02938115552200905
92625,SIDM00957,MK-1775,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-4.7247086,-0.094715334,-0.9904474654470319,-0.03139061836188072
14261,SIDM00359,Vinorelbine,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2129773,0.031893477,1.9114404728489036,0.05121728264010602
70194,SIDM00928,Alpelisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.2104204,0.22805585,1.2657964574744272,0.10390077602510707
28706,SIDM01042,Uprosertib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9711546,0.04870292,-1.1252152902595687,-0.005387864021813192
47938,SIDM00216,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.4284482,-0.044420887,-1.1820201569314532,-0.07842965240806493
100895,SIDM00097,Crizotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.739021,-0.07800599,-1.5199387668759872,-0.05546670085585098
10552,SIDM00950,Erlotinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4095258,0.13915578,0.7657918065131867,0.04018720470911344
91014,SIDM00877,PD173074,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.6784967,-0.08544427,-0.5304999235294088,-0.014404315772636796
7522,SIDM01042,Olaparib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5406563,-0.14038053,-1.6939706702595103,-0.0705324926795532
33465,SIDM00933,Cisplatin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.2662032,-0.030896142,0.2950517291895239,0.03744332124377127
37007,SIDM00455,LGK974,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5665206,0.071574755,0.20804362983935654,0.01479918831780913
102206,SIDM00673,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.7248592,-0.08608106,-0.6533355940970951,-0.02352682372833802
24825,SIDM00928,Crizotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.68907773,0.07617973,0.6179867033626674,0.06390217807488037
60673,SIDM00957,SCH772984,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-5.7219825,-0.22407642,-0.5669247567361866,-0.016233100180511748
56444,SIDM00833,Navitoclax,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.3154453,0.07186478,-0.20596147571905005,-0.002298152520175905
34848,SIDM00673,Sorafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6703338,0.040207785,0.32035601879049175,0.08590694425470287
76144,SIDM00928,Nilotinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-1.9063371,-0.15798905,-0.19238014599219702,-0.07934383061000767
16278,SIDM00928,Sorafenib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.9184393,-0.08334153,-0.5964974229450017,-0.03970180598922502
21026,SIDM00455,Irinotecan,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2647071,-0.02679049,-0.6876062101100516,0.05027999854937923
96155,SIDM01042,Tozasertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.97194386,0.07667812,-2.2037942357053164,-0.10981575032067589
32663,SIDM00835,Vinorelbine,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.2796029,0.014806825,-0.5145332595330327,-0.028511800586130325
76467,SIDM00875,Afatinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31495738,0.006225344,-1.7310196124709194,-0.09114115030105974
34826,SIDM00875,Venetoclax,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48845276,-0.011047487,1.408426760500193,0.04712348485533004
40970,SIDM01042,AZD8055,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5790871,0.034890786,-0.4256814391737825,-0.029562528141953016
93070,SIDM00872,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.19836527,0.0056965873,0.7718786284222122,0.002979230349509329
64594,SIDM00872,PF-4708671,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5372132,-0.118397586,-0.5787822795593055,-0.04100648753660619
75868,SIDM00359,MK-2206,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7437253,0.09572764,2.2920772435310086,0.17868115703365842
43686,SIDM00835,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-1.3424287,-0.076093234,-2.0410409104905303,-0.11442248712042004
98844,SIDM00097,PD173074,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3352995,-0.11892644,-2.3469843408763174,-0.12675363565791922
12685,SIDM00455,Dactolisib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0416632,-0.114345916,-0.6706700526231275,-0.08928745612071913
28975,SIDM00359,Olaparib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.8287973,0.050755292,1.5531109351371903,0.04595713130418407
45322,SIDM00673,Pictilisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.3609307,-0.03666823,-0.2941659800392465,-0.03618592548076147
43189,SIDM00282,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.71805567,-0.033914655,-0.24729350371056574,0.028019324757723313
6778,SIDM01042,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6873755,-0.06738624,-2.3460601966271977,-0.10151825098160731
77269,SIDM00097,Bortezomib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.15619342,-0.010408887,-0.36957591927778416,-0.027591254167031357
106382,SIDM00928,Alpelisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.799717,0.18510371,0.7306713230766616,0.07065922942479134
59081,SIDM00833,Navitoclax,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.93077904,0.060071655,0.2466024191941714,0.014499316989553469
45822,SIDM00042,Taselisib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.719357,-0.15248306,-3.4097190194737146,-0.14723401770539885
104844,SIDM00455,Olaparib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.629993,0.102328785,1.3310865055722736,0.052591037629028135
24291,SIDM00148,GSK269962A,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5342875,0.05144179,-0.21386133692295217,0.0025781896569253638
46634,SIDM00097,Venetoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.914123,-0.051113136,-1.6516071520890971,-0.027336050123405075
26847,SIDM00833,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,0.8472083,0.014419862,0.3721504505279323,-0.01700355644003705
89491,SIDM00673,Uprosertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.5641723,-0.10889513,-0.9467779162035118,-0.07026715821050189
84808,SIDM00097,SCH772984,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0881948,-0.09313626,-1.1180222462628233,-0.05290103578807511
91646,SIDM00832,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.7191981,0.08785216,-0.26327199878352375,-0.006914243877754674
96015,SIDM00455,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.613718,0.038156185,2.148339964519321,0.20571526939542303
52137,SIDM00633,Pictilisib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.42215046,0.031776134,-1.3031509553643892,-0.0910555042928163
49482,SIDM00957,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.7117131,-0.04724803,1.803223938510809,0.1036576945812813
58976,SIDM00776,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,0.8671177,0.031037614,-1.6720439374499223,-0.07644661480943994
106387,SIDM00673,Sorafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.42166469,-0.025825232,0.4091626192340894,7.885881578601453e-05
18879,SIDM00950,LGK974,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2958864,0.022165649,0.3515158721258898,-0.005665774374009394
49610,SIDM01042,Dabrafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9215784,-0.13785243,-1.6837753739851065,-0.0700242927086078
107724,SIDM01042,Docetaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8234946,0.19383043,-0.7228842596826035,-0.002868980879773216
45586,SIDM00633,Afatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8882065,-0.010437036,-1.9622329504849794,-0.0290508305966464
104294,SIDM00633,RO-3306,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4553509,-0.113589965,-2.233832929242011,-0.09786165477014055
56893,SIDM00872,ZM447439,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.106258,0.11836719,0.46615293758390497,0.030286910153484586
90727,SIDM00837,MK-1775,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.1336942,0.04139162,-0.7656159967174537,-0.03449784220438477
62177,SIDM00832,MK-1775,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,0.23468582,0.011878619,-0.6367253425033098,-0.0215233097765808
102508,SIDM01042,Nilotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0234985,-0.072789244,-2.267557057368625,-0.1288771988993625
55306,SIDM00875,Palbociclib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0665866,0.029924234,1.3162710586942918,0.024344512233920382
56812,SIDM00837,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-0.4596081,-0.016270582,-2.2777798365430058,-0.1285545848955635
36680,SIDM00216,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2417848,-0.07177104,-3.0110955359370783,-0.1750368646072336
13359,SIDM00872,Alpelisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6766037,0.067014754,1.7078790842669052,0.10595076693156988
67441,SIDM00148,Tozasertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2646409,0.10906014,-0.8908203931182289,-0.06338226596138567
70962,SIDM00872,Bortezomib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.28871894,-0.021565897,-0.7210792095596728,-0.024203023799568735
6267,SIDM00875,Lapatinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4544908,0.14154781,1.054395077278703,0.0355077970035741
5942,SIDM01197,Afatinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9671589,-0.0626623,0.009462278731304792,0.006174416228053123
88867,SIDM00872,Alpelisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.47111827,0.047786504,-0.19029666443508353,-0.0335574810198695
69702,SIDM00146,AZD6482,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.85528076,0.048476752,0.2565516138763003,0.005505499933383476
90016,SIDM00933,Trametinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.4373101,-0.053346954,0.8453339449969574,0.05913871037181704
47016,SIDM00148,BI-2536,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6513029,0.024448479,-0.5801076853032866,-0.04922015461420656
29475,SIDM00826,AZD4547,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.5960793,0.126756,-2.1225355053383215,-0.05357567566210957
84894,SIDM00835,Palbociclib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,1.8578378,0.061239347,2.507658266716822,0.05715936990725532
31425,SIDM00928,Cisplatin,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.96035796,-0.025328878,1.1917048930096779,0.0670966839748455
77810,SIDM00148,NU7441,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8180729,-0.11091479,1.3745148425707059,0.01793514205550959
2392,SIDM00928,Camptothecin,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-3.1989107,-0.18899848,0.0822023621948782,0.01809943032927638
18273,SIDM00957,Olaparib,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.5713929,-0.016821109,0.573999004789389,-0.018938178899224906
13570,SIDM00633,Uprosertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.70808065,-0.05038978,-1.0557258201790556,-0.04816277734940683
16884,SIDM00933,Gemcitabine,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.69955117,-0.0031217819,-2.749931692541801,-0.08935327670650993
8937,SIDM00146,Linsitinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.7883859,0.021853045,1.2385449775912114,0.08645876738708212
102085,SIDM00928,MK-1775,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.9802808,-0.102266625,0.06045585037104955,-0.0074981052760739395
30691,SIDM00877,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.1247733,-0.07421234,0.5275463732653142,0.06482512893691059
5259,SIDM00877,PF-4708671,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.5299008,-0.0107027795,0.2107331001516155,0.03287974021877757
101352,SIDM00933,Tozasertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.6475273,0.13898538,-0.1552693306086264,0.012367180981662585
3983,SIDM00933,Venetoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.3232312,-0.078903675,-0.28475346017785785,0.00034128319039456833
99454,SIDM00216,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.4908465,0.1400326,0.49595102776989236,0.023092222045095572
36758,SIDM01197,Trametinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.474284,-0.007690199,-0.23043070440633634,-0.011316057348770251
102869,SIDM00950,Crizotinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.3518974,0.031311713,-0.5997845005836799,-0.03276683798912104
1019,SIDM00872,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7730067,-0.063282155,0.546282597691991,0.007320130909008837
5588,SIDM00872,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1251899,0.07763809,1.7835861303257214,0.12806971719311352
57716,SIDM01042,Dabrafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9284568,-0.073321074,-0.06340040298534279,0.0239137686528709
47679,SIDM00826,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.847175,0.00821333,0.27533024586983273,-0.04102660704818838
107808,SIDM01197,Dabrafenib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5682676,-0.10541511,-0.9805808429825699,-0.013673037522747542
18356,SIDM00877,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.124557,-0.17642713,-0.7596780030717767,0.06284581333350713
87900,SIDM01197,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.4441449,-0.032580905,-0.15616796501541602,0.031531186335762136
26418,SIDM01042,Uprosertib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.25698486,0.008736957,-1.4728895763755339,-0.0629931429974407
43039,SIDM00097,Entinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0462396,-0.085830286,0.13741697072782938,0.05810253520604322
63735,SIDM00957,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.29936665,0.005589925,1.5679606891231241,0.03211216076188394
83292,SIDM00872,JQ1,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.838112,-0.020282822,1.7105281397296792,0.14225213077253615
72758,SIDM01197,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.9338402,0.029190404,0.21902598587422864,0.02467809092518808
24279,SIDM00875,AZD8055,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.66510034,0.054456893,1.0151530728241713,0.12188833607462102
42829,SIDM01187,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7223575,0.056415215,-1.6667356824167217,-0.10638127389749324
21480,SIDM00957,MK-1775,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.5133595,-0.05741399,-1.2989472398576027,-0.07086444155050024
26354,SIDM00877,BI-2536,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.6682687,0.0016228048,0.1740198107603904,0.022886959140245067
27252,SIDM00359,Oxaliplatin,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.40146,-0.13428253,-0.936247643678739,-0.03841003766524945
98566,SIDM00097,Taselisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6986263,0.15068486,-0.3595336191413034,-0.027174409507207273
34284,SIDM00875,Taselisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34881434,-0.039941963,-0.27808640773374027,-0.023542503507560646
46222,SIDM00877,GSK269962A,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.23822579,0.028579013,0.6291070999142397,0.06609756688073563
52171,SIDM00877,Alpelisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.2580005,0.025846366,0.05782242746695124,0.010758833364387871
53436,SIDM00837,Camptothecin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.27052695,0.007764489,-1.5580598396638174,-0.06825366399922904
67348,SIDM00832,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0763682,-0.09234301,-1.3449675423743384,-0.09162889324841009
100801,SIDM00933,KU-55933,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3665798,0.073325254,1.2298983070708978,0.09052391732572437
41752,SIDM00282,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.0961208,0.037276264,2.0210551461896067,0.03462124146551432
94490,SIDM01187,MK-2206,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2358594,-0.074262634,-1.3657004352124884,-0.02930120927528732
16009,SIDM00872,Olaparib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.0854692,-0.0627254,0.09494605003332922,0.022780240512424034
55719,SIDM00359,AZD7762,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3895369,-0.028213155,-0.808590966978388,-0.0231674613259261
64392,SIDM00776,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.8355575,0.043393575,2.2233110891747754,0.09998018636352247
3625,SIDM00875,Doramapimod,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,6.0199075,0.093320124,3.27539245561799,0.08202983506849369
61916,SIDM00877,Doramapimod,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.87374115,-0.040749025,0.866543344789957,0.05517872803243159
28459,SIDM00875,Crizotinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7594224,-0.15015048,-1.04860405256345,-0.03944278076065788
31125,SIDM00832,AZD8055,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.492503,-0.0692996,0.312648786826909,0.024874777553523585
43269,SIDM00872,GSK269962A,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.14052,0.22265933,3.082540384280175,0.19912898611221483
68446,SIDM00872,JQ1,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4164443,-0.010780759,1.1644191789266485,0.10715348019817907
23286,SIDM00875,PF-4708671,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7201608,-0.023648102,0.8629526954626154,0.029533326234187918
87015,SIDM00455,OSI-027,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.0094926,-0.20472562,-1.154880315666959,-0.07372691407697012
38048,SIDM00042,Oxaliplatin,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.5282689,-0.14139637,-2.320309556502876,-0.10794638697044613
97394,SIDM00826,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.6813959,0.024820765,-1.5629187030784182,-0.005862502076022578
43250,SIDM00832,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-3.3173625,-0.21192029,-0.07577852793511952,-0.030429439921232416
91322,SIDM00633,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.205638,0.027685942,0.0491918714255053,0.002777475678662499
11239,SIDM00875,Trametinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4587502,-0.116178066,1.7697388993635041,0.10078455198883948
32486,SIDM01042,Pictilisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7445264,-0.06081898,-1.9832661531475848,-0.10286097950013579
79687,SIDM00097,BI-2536,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.2192329,0.013909793,0.24023142427381888,0.032657654534006764
69531,SIDM00933,Ribociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,0.17453589,0.0038359447,1.3625837017152267,0.057051262094576456
96778,SIDM00282,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.6287658,-0.1374675,-0.8773454797194395,-0.08635630103057045
22531,SIDM00673,Entinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.7113132,0.15205866,0.5233343775653435,-0.001602988214003062
10510,SIDM00146,MK-1775,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.32449704,-0.025436396,-0.6496652018877856,-0.02479305073080488
107800,SIDM00776,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.5366278,-0.14166236,0.49257646589640586,-0.007782921846197603
15583,SIDM01187,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.4390671,0.19973916,1.1130724485245493,0.0803633184580152
25817,SIDM00097,Camptothecin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36769393,-0.017225126,0.3462412514251358,0.0161608039103896
48182,SIDM00875,Sorafenib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8950676,0.054699462,-0.780381262992642,-0.025365969018057908
95819,SIDM00282,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.43730882,0.031602435,2.0742818848610134,0.11414251674979209
26095,SIDM00146,Linsitinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3368098,0.033301663,1.459390261558618,0.0637619953832781
85594,SIDM00877,Luminespib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3355738,-0.107794,-0.25197582594166634,-0.025782971786271647
85658,SIDM00872,5-Fluorouracil,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2654829,0.035629146,0.41470965795432585,0.06400448208139452
81763,SIDM00148,Ribociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4313276,0.18499742,-1.0200983678686943,-0.02614034681570781
95287,SIDM01042,Palbociclib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5263199,0.033618074,-0.5057363142605668,0.01115717387915655
31866,SIDM00146,PD173074,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5802086,-0.044690862,-1.2291394079522022,-0.040955104463897704
95848,SIDM00933,MK-1775,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.7038661,0.040546164,-0.12231284956557298,-0.014405256536337443
98270,SIDM00776,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.6106029,0.06944558,2.1305989191099477,0.08111790495300217
52693,SIDM01042,MK-1775,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0543087,-0.054487336,-2.603731809151316,-0.16748101056618156
75844,SIDM00872,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0169555,0.108319245,-0.19627994309170518,-0.03399364937276611
25069,SIDM00673,Palbociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.7404764,0.18716456,-0.473689962538036,-0.00380471731974263
69298,SIDM00776,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.765656,-0.14900601,-1.8032952802907518,-0.07328715467082646
52300,SIDM00216,Oxaliplatin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.3485061,0.031311553,-2.0943892205673156,-0.08503487468571141
18500,SIDM00146,Vorinostat,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7154166,0.0625677,0.3793921370334358,-0.0203826932346551
58650,SIDM00826,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,4.8043275,0.4439907,2.0289348872587567,0.21536709568235257
99807,SIDM00875,PF-4708671,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3076051,-0.04344391,-0.22795596917281194,-0.02313274654220662
45333,SIDM00633,Trametinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3284392,-0.09173266,-0.7111348249761921,-0.0045282610421081785
13921,SIDM00455,Palbociclib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.111983,-0.11707686,-1.8501774128908923,-0.05365560087107012
24326,SIDM00875,Tozasertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0552337,-0.03841301,0.9824172637713684,0.03558743022740068
29614,SIDM00282,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4530331,-0.060495913,0.588228964989543,0.01553345528302502
30719,SIDM00872,Pictilisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9814653,0.0945911,-0.08635217205613051,-0.00567270169048176
98669,SIDM00833,Trametinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.0599444,-0.054293737,-2.410793915616239,-0.09759997581204347
1086,SIDM00950,Taselisib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4379668,-0.035328988,-2.322490847560276,-0.15650035812165738
101630,SIDM00950,MK-2206,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8371758,-0.21335867,-1.021903317632785,0.006997410650249446
59898,SIDM00957,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.3634837,-0.015863415,2.6731799470327795,0.10606793239566481
22282,SIDM00928,Camptothecin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.4492643,-0.11272102,-0.6053146872122221,-0.012421195049708351
97236,SIDM01042,Wee1 Inhibitor,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.30051178,-0.02795394,-1.1770923462090275,-0.05977927940572619
82922,SIDM00877,Vorinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.71388125,0.047455326,0.3513631670611131,-0.009825765326047904
59692,SIDM00776,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,2.0351565,0.11673104,1.0499945707636555,0.045532240846001985
1340,SIDM00933,OSI-027,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.15307638,0.022885023,-0.5249881019174438,-0.06180054549499303
37330,SIDM00097,Doramapimod,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6328229,0.032921553,2.7583472647116944,0.06207901741343071
44906,SIDM00957,AZD8055,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,3.3979099,0.067541406,2.552523414583892,0.12062774361688175
104183,SIDM00950,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.8176503,0.21912938,-1.5010163417919877,-0.054842742069550615
84077,SIDM00950,Lapatinib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5337648,0.15067336,2.107362872308119,0.16950006512706536
84469,SIDM01042,Camptothecin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.66261625,-0.06502885,-0.014302814320662568,0.007569143140486182
105308,SIDM00146,Wee1 Inhibitor,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.3358322,0.024439543,-0.08205622172610204,0.025467975677547838
19547,SIDM00933,Doramapimod,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.2892964,0.109458975,2.3024634536717627,0.0469206831072967
42065,SIDM00832,AZD8055,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.74786603,-0.06047309,-0.8467402766604842,-0.05498241438670974
2396,SIDM00633,Afatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0593929,0.0087991515,-0.4534763755196879,-0.0234648015334927
91774,SIDM00875,KU-55933,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2715702,-0.052889753,0.42045465238115676,0.022103542105449812
79427,SIDM00875,Alisertib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8780547,0.08499888,-1.4316412322486596,-0.014579736636676128
17482,SIDM00633,Doramapimod,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.079073,-0.09023,-0.7790794677487056,0.024645540797960885
33242,SIDM00097,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3257117,-0.08092684,-0.39441399143939343,-0.03193036188808955
82546,SIDM00950,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.786803,0.1662516,2.8266977302158307,0.2131276762320129
60036,SIDM00933,Pictilisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.70441437,0.08342256,-0.792551761975071,-0.07350203600766506
97905,SIDM00455,Erlotinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.2425766,0.124026544,4.994333540669658,0.21268863613360203
42864,SIDM00928,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.8698534,0.20422268,0.8554666036478555,0.11736397337742943
5893,SIDM00042,Trametinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.5608976,0.15944582,2.37075550117154,0.11486556876059185
9221,SIDM01197,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.7658072,0.104876235,-1.2855701996445807,-0.06141888285274312
60060,SIDM00835,MK-2206,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,3.6940885,0.2412697,0.8952640717992562,0.027418868370720405
91234,SIDM00950,AZD7762,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.38706133,0.041902516,0.03912209240306363,0.016595818704635522
31980,SIDM00633,Alisertib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7784943,0.067847155,-1.974621863354188,-0.06325547510157485
39480,SIDM00673,KU-55933,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.4047503,-0.15334408,-1.8951899422312009,-0.10621736995306887
97487,SIDM00282,Afatinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1974205,-0.06345941,-0.8159239265302403,-0.09310582010350607
40879,SIDM00872,Doramapimod,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.8084671,0.10035703,2.9744252903976136,0.11548832496506503
48093,SIDM01197,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2172983,-0.10811553,-2.347865586419766,-0.09112100863291288
32239,SIDM00957,Afatinib,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-1.7034445,-0.06314005,-0.13630036573136475,0.0036789861440936784
44006,SIDM00282,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.8525981,0.06625884,2.182000160849299,0.06332634814642624
11056,SIDM00933,PD173074,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,3.2817175,0.32449055,0.26133830824722304,0.07035092430164204
39441,SIDM00928,Trametinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.9352707,-0.10092338,-0.18442745319209858,-0.007705067873426127
93716,SIDM00146,JQ1,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35382047,-0.02952137,-0.6117896547186061,-0.006446829354842301
107552,SIDM00957,SB505124,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.755727,-0.075053625,1.0099769765763893,0.0628338617764196
26237,SIDM00148,BI-2536,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3924366,-0.05291135,-1.916085734711982,-0.09274689776216838
34352,SIDM00832,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-1.1294711,-0.0976654,-0.309097828791548,-0.03219388399177425
45278,SIDM00776,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.2016615,0.08463585,-0.6110973576875822,-0.051087702652921826
16315,SIDM00877,KU-55933,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4788455,0.10539896,0.39790054420551013,0.07087763209746138
59488,SIDM00835,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.55921453,0.048150852,0.11150406504711209,0.006635899418077451
61089,SIDM00097,SCH772984,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8707395,-0.076529525,1.1903830832551432,0.017931879303345895
73495,SIDM00837,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.5661968,-0.05036356,-0.9568176465557078,-0.05638063386299995
50137,SIDM01042,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8027006,0.13486691,0.22988757469797216,0.01516052474557573
76251,SIDM00875,AZD7762,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6690804,-0.033375293,-0.6560017934904411,-0.10844800467290745
101601,SIDM00633,MK-1775,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1513897,-0.09022686,-1.1733701807809138,-0.0763596507518386
40796,SIDM00148,Paclitaxel,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2328161,0.11185278,-0.6228650431601145,-0.10632000715963
26062,SIDM00872,Paclitaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-6.2059813,-0.5390811,-4.673983355611853,-0.38276596542154706
76316,SIDM00877,Axitinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.1715627,-0.10706581,-0.24121058820308156,0.04911081579059242
28241,SIDM01187,MK-2206,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.37173072,-0.033089757,-0.07996072843546453,-0.028298186553784913
46739,SIDM00216,Dabrafenib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.2285931,0.009686032,0.9686445560273994,0.06505381677465077
2679,SIDM01187,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,5.351932,0.32143185,-0.4293026619945787,-0.011014103371352921
22904,SIDM00877,Docetaxel,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-0.9285673,-0.0754559,-0.3902642641548287,0.03238697372700364
101408,SIDM00928,AZD8055,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.6786208,0.20288953,1.8480067486538145,0.09840534287157279
85316,SIDM00875,SCH772984,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26398134,-0.026054537,2.0540104696464807,0.06323531607296262
56704,SIDM01042,AZD8055,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5505317,-0.17922686,-2.4879498773341178,-0.10425107904181692
38816,SIDM00216,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3709227,-0.015495098,-0.03436410208946866,-0.05196307804823412
78475,SIDM00957,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.576797,-0.022536898,0.8392083936384358,0.018694306899073615
3720,SIDM00776,Trametinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,2.67309,0.14626819,-0.29244890666728346,0.029977061027612453
41689,SIDM00359,Olaparib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7141318,0.045764912,1.584773467157283,0.04167007018679227
14840,SIDM00872,Linsitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7210416,0.085462585,0.20260904466739382,-0.0020600290513585868
88513,SIDM00673,Linsitinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2958115,0.0274964,2.2779667534960972,0.02894451033992679
86180,SIDM00359,Crizotinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8057157,0.05938199,0.5428321775845266,0.052340577803561945
6095,SIDM00359,LGK974,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.739707,-0.023999695,-0.37047354980484176,0.008681521956977765
90645,SIDM00957,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.32246098,0.004383724,1.7708101507957246,0.04755629600912418
29805,SIDM00872,Cisplatin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,4.0275683,0.21828066,3.6796986912598855,0.1551171620067791
95072,SIDM00097,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.98026514,-0.045540094,0.057175409761748994,-0.01633838226105081
25907,SIDM00928,Alisertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.7034157,-0.04650005,-2.3540609813739386,-0.08240381851459042
6398,SIDM00776,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5569743,-0.055086,-1.2763311259440628,-0.036150462257917085
7757,SIDM00359,Camptothecin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.711636,-0.12504438,-1.509646607735719,0.0009445129026592942
60053,SIDM00455,Olaparib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1283206,-0.026394,0.9095400432266568,0.04819062338718061
104471,SIDM00097,Axitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6893077,-0.13477477,-1.447773768967364,-0.05574513641335049
95251,SIDM00673,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.874215,-0.15663074,-1.58033315760836,-0.07270815418040506
94860,SIDM00146,Nilotinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.83892906,0.08427575,0.059529052037832625,0.004531631225480496
76692,SIDM00148,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1869085,0.061379157,0.2540651755710722,-0.019409592940472325
47994,SIDM00776,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4172192,-0.075343564,-0.3074421205052356,0.02894389114016703
93153,SIDM00282,BMS-754807,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.7204651,0.10076573,0.8306543219033938,0.00792958067410684
59413,SIDM00673,Crizotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2509153,0.10629687,0.5154200312408516,0.03285382424158293
93626,SIDM00282,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7126206,-0.10259967,0.11850472773177391,0.030806250453703176
19628,SIDM00097,Ribociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6325072,-0.050940394,-1.1031202119139791,-0.0102720535731413
96150,SIDM01042,Olaparib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.659373,-0.1536232,-1.8604052016336718,-0.07302261913956011
95457,SIDM00835,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.0798494,-0.08430057,-0.8188080552729623,-0.11277456601909691
60691,SIDM00875,ZM447439,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4279156,0.060809225,-0.6015140581134248,-0.005485582567113818
99633,SIDM00928,Linsitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,2.063795,0.19412003,0.8758613171540046,0.0049328592565974876
41862,SIDM00148,Olaparib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1415915,-0.04086357,-1.5753913937468573,-0.05884781554288085
67254,SIDM00216,AZD7762,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,3.4173846,0.1878632,-0.9643471448223717,0.010011633254717218
67748,SIDM00875,Cisplatin,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48323092,-0.023970945,0.38323402746962004,0.03294311224132866
7411,SIDM00673,Paclitaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0725931,0.08702901,0.46689516282207405,0.014395957373686062
84114,SIDM00872,Cisplatin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.28515542,0.009041632,0.6261393229419426,0.054306374513478334
103911,SIDM00633,OSI-027,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5947669,0.11631806,0.12828307498862637,0.08980278912366806
5627,SIDM00359,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32179895,-0.026292263,-0.5124625575643823,0.023736343089490783
15014,SIDM00877,Nilotinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.41668478,-0.037380293,0.25521414598131176,0.01657851079360131
10749,SIDM00148,Tozasertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.74259967,-0.052761763,-2.139586249270723,-0.10653419091103836
31141,SIDM00950,Sorafenib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8971035,-0.14531268,-1.577895795988749,-0.11441151932677833
80934,SIDM00877,GSK269962A,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.3214097,-0.10373626,-1.3129629620635819,-0.0546911543779211
80867,SIDM00282,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2959421,-0.024269767,1.4280732427028613,0.02990871282425486
105935,SIDM00875,Olaparib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2127988,-0.09522116,-1.6700871190651476,-0.05313199136530453
63183,SIDM00933,Nutlin-3a (-),AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.26641673,0.026679438,-0.45667914055792325,-0.03715260768713186
75018,SIDM00875,Bortezomib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22564451,-0.01859067,-0.06286102702249799,-0.018193880333298162
106414,SIDM00928,Linsitinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.3473955,-0.110460654,0.05381811392702083,-0.02992758825673422
4496,SIDM00097,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3143789,-0.07962296,0.47795886381841424,0.028554058010201135
23556,SIDM00097,JQ1,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9657376,-0.1516604,-1.7054746678404369,-0.08280718583842209
58472,SIDM00928,NU7441,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.0007627,-0.09665789,-0.19315907134581822,0.03201288184307185
2348,SIDM01197,MK-2206,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,1.01929,0.03813147,-0.212323494713758,0.021261034630448972
22073,SIDM00673,MK-1775,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.97452277,0.0952932,1.4260375143980668,0.11193633552971995
2757,SIDM00673,Paclitaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2954998,-0.10422241,-2.233369589816131,-0.19360372192454114
14174,SIDM00776,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.0749568,-0.08430175,-0.1439180057984343,-0.01928142330878451
107510,SIDM00826,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-3.2109869,-0.015646635,-3.0214511016875614,-0.011323294521554018
102649,SIDM00877,Lapatinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.2081399,-0.11054584,0.7631313106848134,0.10925613840951262
24037,SIDM00633,Dabrafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3521632,0.036330376,1.176708834799348,0.047437868786339335
64763,SIDM00826,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.8115643,0.13233174,-0.4476947813916363,0.012935376076967969
99700,SIDM00148,Pictilisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0092367,-0.031104695,-0.5122303599006944,-0.014768393129748321
33136,SIDM00872,PD173074,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6414566,-0.06356919,-0.2669693905890169,0.015922460081543348
29599,SIDM00673,Vorinostat,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.8099733,-0.08573462,0.07384411747667757,-0.032464660067868814
16700,SIDM00875,MK-1775,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25857785,-0.0159078,-0.6884677038366275,-0.03249394754446689
77261,SIDM00776,Afatinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.60177094,-0.051368244,1.2773446456577804,0.06730777760700833
74090,SIDM00673,Alpelisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.70793164,0.04463676,-0.43842754074453605,0.00980843558300739
36177,SIDM00877,GSK269962A,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.3521861,0.123743035,-0.7960697627662731,-0.04237370990503011
31324,SIDM00875,Tozasertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0935369,0.1449124,5.402680959722791,0.23688054794965768
75575,SIDM00950,AZD7762,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.97524726,0.09284083,0.19870839206936988,-0.05145874098918988
10862,SIDM00148,Nutlin-3a (-),Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1059706,-0.07657836,-0.5166665740027682,-0.041348057775545476
108372,SIDM00933,PF-4708671,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.842966,0.07079348,-0.03595239857416239,-0.00024053341957107975
20833,SIDM00097,Axitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7048402,-0.095009215,0.05461137115419758,-0.002866553452425795
76239,SIDM00872,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8379746,0.09139253,3.1090560904834033,0.19057069579754543
82405,SIDM00950,OSI-027,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.34976625,-0.029122844,-0.5272717804131363,-0.0544024446867938
93756,SIDM00833,Taselisib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.76407987,0.060051437,0.017484571740896755,-0.0009021069679162559
1024,SIDM00042,Gemcitabine,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.1486256,0.30749014,4.02512232375818,0.16847069400482237
15836,SIDM00673,Axitinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0601597,-0.10386511,-0.7659533919237319,-0.13032688059135786
15080,SIDM00359,Afatinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3971584,-0.14338228,-0.525536449603133,0.006882106207915782
97345,SIDM01042,Lapatinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87335646,-0.11261655,-0.34992700683571065,-0.01997373473324743
92550,SIDM00148,Temozolomide,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.66463685,-0.019045375,-0.5631215628503199,-0.001613332733836075
3873,SIDM00455,Cisplatin,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7783621,-0.0199302,-0.1336918626357754,0.05382473546109459
32307,SIDM01042,PD173074,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.343791,-0.030104134,1.7686863970452187,0.054418584812689574
34775,SIDM00148,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.1943064,0.14832644,1.140149109661644,0.06677009125454801
31618,SIDM00875,Wee1 Inhibitor,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.05191746,-0.0035893787,0.13775344978154272,-0.008206732050602412
55118,SIDM00146,MK-2206,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.2524204,0.14595574,2.4532844533715563,0.1842566123694742
57502,SIDM01042,Gemcitabine,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5112385,-0.17930949,-3.462381067153379,-0.22718480152667664
65321,SIDM00826,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.9218152,0.025599683,0.3206969086429302,0.012125437055610819
18494,SIDM00832,SCH772984,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.8515815,-0.064649574,0.7726975134614323,0.024400234479987955
9083,SIDM00875,Nutlin-3a (-),Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6361295,-0.019353166,1.82177236332247,0.08808627808720156
9367,SIDM00097,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1581559,-0.054071847,1.2950501374956278,0.04482791267862688
70277,SIDM00833,BMS-754807,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.54127526,-0.04489085,0.39085405212008545,0.000655240172907441
32946,SIDM00875,NU7441,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7373641,0.06574988,0.46401819059583205,0.011800149521126927
38825,SIDM00872,Lapatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7776072,0.073198,1.3024125105604782,0.0020360261879077742
63228,SIDM00928,RO-3306,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.5576361,-0.09210288,-0.7151742927802677,-0.023983003452286027
96602,SIDM00673,Dabrafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.1616976,0.100381866,1.2574079451289246,0.04205928541277474
97898,SIDM00148,Taselisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5531531,0.03437697,0.1723446306548675,0.04230435816751678
11815,SIDM00146,Entinostat,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3418417,0.11577135,1.3716358924292291,0.14190521924206392
94075,SIDM00148,Uprosertib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.40096104,0.01785492,-0.775781804694816,-0.03242323511750377
84319,SIDM00872,Alpelisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.97719324,0.0911404,-0.2424948024715943,0.02264684951033541
88231,SIDM00673,Gemcitabine,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.1614406,-0.13264672,-2.0284585983746113,-0.04150838836587808
5582,SIDM00673,MK-2206,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.5838552,0.03850195,0.7872340038649791,0.00836238300445783
105812,SIDM01197,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.7787395,0.07619326,1.5753456187903871,0.054041721290450366
13410,SIDM00826,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.1391165,0.039856736,1.7244922964438207,0.05270597527588406
18843,SIDM00933,Palbociclib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.88054717,-0.07170918,-1.628282878646443,-0.044074398006643055
23021,SIDM00835,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,0.88335156,0.06031897,0.1292668578804748,-0.06198053503754204
67388,SIDM00928,Tozasertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.39055702,-0.010557113,0.9406129911591345,0.025626839985848218
108199,SIDM00875,AZD7762,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25736678,-0.017045777,-1.5510445384131841,-0.10578155867559332
49520,SIDM00826,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.0326087,-0.03429658,-2.864462064197569,-0.10577910932805507
62005,SIDM00042,Linsitinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.0703202,-0.043709107,-0.49465681856671634,0.007360003830405149
53016,SIDM00097,SCH772984,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1912012,-0.11480838,-1.2161828761154572,-0.018913386224041387
86578,SIDM00833,Afatinib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.20245168,0.01691926,-0.31082166894269975,-0.09386044946416176
47725,SIDM00673,Lapatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3160162,0.23188794,0.6826509531987328,0.007424414013837818
39236,SIDM00837,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.6676404,0.10321312,0.056773886150302315,-0.04706532232111339
18374,SIDM00097,ZM447439,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0172677,-0.07401155,-0.591161461219538,-0.011435032906516165
61777,SIDM00950,Sorafenib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.28235656,0.028180085,0.15131349806251637,0.037003615713405325
50497,SIDM00950,Olaparib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3708016,0.07387908,1.0044008795801245,0.07193781054874909
21214,SIDM00875,Cisplatin,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.94608325,0.05835446,0.17418242115906168,0.030253968141384476
70844,SIDM00216,Linsitinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.206068,0.18935552,0.7402061844437715,0.08693412414404794
97660,SIDM00633,Afatinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5050705,-0.0057941345,-3.172249516128819,-0.05194261044067244
40220,SIDM00833,LGK974,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.5977899,0.026456308,-0.5146063681903573,-0.0006642273288365604
35933,SIDM01042,Nilotinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8356249,0.053975355,-1.429884508024086,-0.08845593510965456
58653,SIDM00928,RO-3306,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.0669069,-0.065667644,-0.19203609047338474,0.04528023668701824
12869,SIDM01197,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.0418804,-0.10530279,0.22823685444048056,-0.004540667280260521
90863,SIDM00933,Dabrafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.7115163,-0.10504621,-0.03448969427650981,0.02109596177772927
13692,SIDM00877,Wee1 Inhibitor,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.609841,-0.079783954,-0.507529578203879,0.002748529200543516
88700,SIDM00455,SCH772984,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0378103,-0.116158865,-1.3906813551232724,-0.12791927346786702
91016,SIDM00633,Paclitaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7059155,-0.08921445,-1.6773130320794127,-0.04722859566073535
32430,SIDM00359,Palbociclib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7442942,-0.09280599,-2.050551212808398,-0.05769789347198809
4192,SIDM00146,5-Fluorouracil,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.674446,-0.07239003,-3.0606200573774345,-0.06402855324607014
28389,SIDM00359,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9205773,-0.13393523,-2.4140044156998335,-0.09759318524306995
73474,SIDM00455,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9503133,0.11358954,3.7177758452965426,0.2731294217767417
15094,SIDM00872,Doramapimod,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8051392,0.037073184,1.4138339789537344,0.08596543222974735
53568,SIDM01187,Gemcitabine,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.70793647,0.06277513,3.1492761138583574,0.14894964049410592
50783,SIDM00872,PF-4708671,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.65496075,0.06568184,-0.37048206982824083,-0.06940056414509804
98295,SIDM00673,Venetoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7171795,-0.0094612995,0.2478948419824945,0.04900774058399777
62848,SIDM00148,PD173074,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.4211183,0.31963614,2.68393315461551,0.12117562895895778
60394,SIDM00282,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.29877,0.073982485,0.9877155673077115,0.09709827915483986
55316,SIDM00928,Dabrafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.060654,0.12326282,0.6509262159426209,0.020016583429782294
56707,SIDM00877,PD173074,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.3566089,-0.03460486,-0.558451614152728,0.0013297505024365919
39548,SIDM00877,ZM447439,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.4705899,-0.043802056,0.05651895359286561,-0.008590245628559206
58854,SIDM00877,Navitoclax,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.365998,0.1497199,0.8953652737749334,0.06990792407204587
30811,SIDM01187,Docetaxel,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.683236,-0.063283496,-1.24024968661724,-0.07386885889363651
74767,SIDM00928,OSI-027,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.3542123,0.19079761,1.0907322079599193,0.04045571121715719
20353,SIDM00042,Trametinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-4.5952983,-0.24161161,-4.22340290913812,-0.17260741184924722
60781,SIDM00359,Camptothecin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.54055184,-0.04395296,-1.421949573325788,-0.05761979842179348
53924,SIDM00832,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.6246401,-0.009025358,-0.561868025368288,0.023930624188810007
44766,SIDM01042,Linsitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4555126,-0.089437865,0.2237583162440541,0.04891306588866681
92549,SIDM01197,MK-1775,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.5860777,-0.043624632,-0.10407400702246872,-0.02706945940153928
68796,SIDM00872,Olaparib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8828113,-0.063751034,0.23208585234908785,0.04244003357546669
56405,SIDM00673,BI-2536,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2787816,-0.022476181,1.0035985887839187,0.016474732209952745
75847,SIDM00933,Vorinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.16375747,0.02012581,-0.06956843212631961,0.01173954906413986
55417,SIDM00673,Tozasertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.3161697,-0.18295205,-0.3235747250192065,-0.019989828742409958
84777,SIDM00877,Alisertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5032213,-0.09179129,-1.8334533965542403,-0.03772769538716906
105133,SIDM00877,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.7575618,-0.08940584,-0.31209124360224477,0.019744197200518888
81956,SIDM00673,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4735537,-0.025265021,-1.0306079339742702,-0.012906074480166044
21264,SIDM00097,Olaparib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2297782,-0.022927102,-0.6301304599697868,0.030026340354744392
47863,SIDM00872,Camptothecin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.87191945,0.02285463,2.1106847162036404,0.05062299617847833
39613,SIDM00148,Bortezomib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.14808425,-0.0114980405,0.6185071220000213,0.04820960464271827
84573,SIDM00875,Alpelisib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5099346,0.047502622,1.3867809276087877,0.12308808501943352
37316,SIDM01042,Taselisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.17162272,0.013135464,-0.7332282598758618,-0.03300551837576765
11375,SIDM00148,Camptothecin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.91835475,-0.07594096,-2.2803532713467236,-0.07595649845607579
18925,SIDM00633,Doramapimod,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9936585,0.22679071,2.140376708124953,0.13247918954865817
103100,SIDM00633,Navitoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2271507,0.18305746,0.502954945852233,0.039423661090422515
36535,SIDM00148,Axitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.659683,-0.23462231,-1.7159916133545046,-0.11844695541848685
70911,SIDM00633,Tozasertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.1131554,0.072874896,4.472237417432241,0.09015329289436358
1078,SIDM01187,Olaparib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.74067914,-0.032193255,-1.641620987992909,-0.0062728634807328225
94985,SIDM00359,SCH772984,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1851141,-0.1369853,-1.8373650874776932,-0.0697432686671039
23230,SIDM00633,Tozasertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5810807,0.16407463,2.4361362943628913,0.0638982399735489
60184,SIDM00928,JQ1,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.9708698,0.11264883,1.1965684037722149,0.06078879868357323
34666,SIDM00933,MK-2206,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.7444776,0.10645953,-0.1291847080398819,-0.009161714986797699
101847,SIDM00928,Dabrafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.1379172,0.06453137,-0.43956269300716755,0.0031617537266928754
93750,SIDM00872,SCH772984,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0585198,-0.06294482,-0.33020443832245505,-0.06361074783722283
66188,SIDM00833,Palbociclib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,6.5589447,0.3196363,1.0703910585354306,0.04219404932449646
62384,SIDM00950,Taselisib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0568771,0.06409061,-0.48443117301567434,0.0057421497985424555
31322,SIDM00957,AZD7762,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.5243362,0.028303351,1.1441376813019468,0.06167148750253134
10763,SIDM00957,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,8.437727,0.2677732,4.3709849196957045,0.12706006158106609
20757,SIDM00146,Pictilisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.8696358,0.07937405,-0.7754209729257425,-0.00617493562648567
58345,SIDM01042,ZM447439,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2124348,0.15648906,-0.8946221585470517,-0.048726994166993776
50809,SIDM01197,AZD8055,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,2.5516863,0.19837707,-0.052244057204460306,0.03686124118788636
52792,SIDM01042,AZD8055,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.79647046,-0.08938723,-0.5657443716077266,-0.059278521706862534
35979,SIDM00875,Olaparib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.56504864,-0.038459726,-0.3640532355561764,-0.012520873104999945
106043,SIDM00146,Wee1 Inhibitor,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.77495193,-0.06296475,-0.5913337173165877,0.029429145674573328
85795,SIDM00872,Camptothecin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.85381526,0.022228055,3.277961926257044,0.1258851836385311
35565,SIDM00282,Taselisib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2527208,-0.092292234,1.8581143037949166,0.10394758830112391
62853,SIDM00875,PF-4708671,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80057734,0.01267936,2.21661844040474,0.11871323770936242
7505,SIDM00877,MK-1775,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.5816129,-0.02525236,1.1771903630296332,0.024071633789296797
85706,SIDM00928,AZD8055,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.6277677,-0.15894493,-0.9422758623381033,-0.08139979429932659
85113,SIDM00633,Palbociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4995475,0.068700105,-0.1557128322705042,0.015967323478890554
41432,SIDM01042,PF-4708671,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4548451,0.14912672,0.6069201454591072,0.08866594701742055
96112,SIDM00359,AZD8055,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.42498198,0.031540345,-1.1596684052252035,-0.04265324689059427
74883,SIDM00872,Tozasertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9353293,0.050794,2.960733051567039,0.06870048190031493
68206,SIDM00872,Venetoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6838567,-0.08584481,-2.1037477342394926,-0.047236112786487865
17211,SIDM01042,Navitoclax,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.35013717,0.03813869,0.4462829492187538,-0.012497631031183405
29223,SIDM00097,Gemcitabine,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5593857,0.02201621,0.1401042412250289,0.04448418154615905
76671,SIDM00832,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.1282672,-0.0488487,-1.0223598487375793,-0.004995384630966759
95900,SIDM00872,MK-1775,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8714229,0.09204174,-0.07781153742754306,-0.005038906068244931
26842,SIDM00835,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.48119792,-0.03606727,0.1175561007343834,-0.0164257239973078
83936,SIDM00832,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,1.1984748,0.08442236,1.692213096628805,0.01990105311206337
100139,SIDM00832,LGK974,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-3.2025433,-0.1592014,-1.676751749338819,-0.10981099076847489
95235,SIDM00875,SCH772984,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0620584,0.1987536,2.184027367383192,0.1573257688062156
28134,SIDM01197,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9667492,-0.10226402,-0.34836935122580326,-0.0644835506806799
49467,SIDM00832,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,2.917148,0.1488057,0.7170417550703543,0.034220150536968204
62971,SIDM00872,Cisplatin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1006209,0.039877325,1.6282239201870077,0.06629019968394424
60862,SIDM00633,Taselisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4985502,-0.08830712,-1.9114703180335058,-0.09122298693527331
80644,SIDM00837,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.6417242,-0.091668144,-0.19786547509286123,-0.04966895634372688
83749,SIDM00148,GSK269962A,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3151586,-0.15914881,-0.4596758070490011,0.0005829156899593935
31818,SIDM00875,Palbociclib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8358675,0.027961528,0.9015979910559945,0.01638992753102593
34597,SIDM00872,Wee1 Inhibitor,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.60608184,-0.061432272,-1.2515943843145063,-0.10899323460602257
74031,SIDM00776,Linsitinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.886656,-0.08986398,1.3055483320031998,0.08209540191237513
27785,SIDM00833,MK-2206,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.73162013,0.04988024,0.429359771600614,0.014173933530106654
2569,SIDM00875,JQ1,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.45942175,0.045508366,0.014069047758157534,-0.010690613668694966
65658,SIDM00148,Wee1 Inhibitor,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6495073,-0.14086325,-1.7106876408834026,-0.09670935575429766
32222,SIDM00933,Ribociclib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.379536,0.061251555,1.9000632964113013,0.016906881749746992
27694,SIDM00097,Luminespib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7767301,-0.09166373,0.51343515680863,0.07135174048197743
91017,SIDM00872,Entinostat,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5569775,0.12521233,1.8013876365109014,0.10061230888406542
57357,SIDM00837,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.3175886,-0.09232759,-1.313519967235003,-0.05643248498097145
26648,SIDM00146,PD173074,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-3.5147104,-0.14644012,-1.9173903669589365,-0.047917255799526326
41845,SIDM01197,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.1088083,0.079263955,1.6326309376323338,0.04766701759164205
68068,SIDM00097,JQ1,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0959128,-0.053985927,1.8562892957497688,0.08953931168300293
101944,SIDM00957,MK-1775,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,-3.2559383,-0.10973303,-0.743133102801001,-0.024972407161695968
28931,SIDM00673,Afatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.6674639,0.09969592,0.6784384340663793,0.07721912003019427
79590,SIDM00933,Pictilisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.8304477,0.20199212,-0.7711411647435307,-0.0032910895023507683
70273,SIDM00872,Cisplatin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6529694,0.023008594,0.5156270253302403,0.0331343986647136
14120,SIDM00833,AZD7762,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.7502186,0.05190288,-0.2775297848857254,-0.0840132207622563
36748,SIDM00872,Olaparib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.0940673,-0.07217253,-0.7118531218772968,-0.007113176523888513
11504,SIDM00872,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2694709,-0.1315317,-3.513560987308132,-0.25681611725050213
12553,SIDM01187,Olaparib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0333924,-0.06877067,-1.2663117424057877,-0.04145573988590237
31693,SIDM00928,Ribociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.39089203,0.010141629,0.9695294972357376,0.02925219712586122
30111,SIDM00282,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2791287,-0.08292586,-0.9403433028349903,-0.10483395656203026
19927,SIDM00928,Entinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.8224502,-0.07068927,-0.6120670754613114,-0.004116193816697556
22562,SIDM00877,Navitoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.32357037,-0.039485257,0.08045114712670554,0.028868398637920026
95852,SIDM00872,Alpelisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1025875,-0.11682272,-1.0336162581407877,-0.10247594125583127
61129,SIDM00455,Olaparib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9226022,0.09242405,1.2248982667133488,0.04051131597857733
41010,SIDM00837,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.9805758,0.061536495,-1.5610711659130438,-0.049390251528074525
24642,SIDM00875,Cisplatin,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23625328,0.012544591,0.9111103128009314,0.042543746122967956
41778,SIDM00837,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.2285964,0.030264828,1.2604129425803374,0.02467157620974831
91080,SIDM00148,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.71256846,-0.031033808,-0.1178135063414721,0.006015288857608585
45001,SIDM00835,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.6373098,0.18570292,-0.0297257240903671,0.015526423903404899
15763,SIDM00097,Doramapimod,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5245829,0.09443874,1.1904761240228412,0.04137851153925943
46993,SIDM00877,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.8080558,-0.07292669,-0.4425152163663818,0.06082436224649082
84062,SIDM00146,Temozolomide,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.4940484,0.06778558,1.453418910282863,0.05874748516555862
4851,SIDM00950,AZD7762,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1545477,0.18109062,0.6107113098985741,0.06357650913100953
18459,SIDM00872,Sorafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7955664,-0.077123456,0.1155076001111868,0.04643827133881289
74316,SIDM00673,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.4450073,0.09251011,2.1297286694781765,0.12965141411327052
86524,SIDM00875,Cisplatin,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6540907,0.01837702,0.6364150453658659,0.009406110283274928
39436,SIDM00950,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.920032,-0.12694278,-3.111945863389673,-0.08320017471670557
95574,SIDM00148,NU7441,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.575996,-0.15496099,0.7401932639457909,0.03278959944942842
64194,SIDM00633,AZD6482,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9313493,0.07168993,-0.5269896103643965,-0.030784322655698245
33288,SIDM00872,Taselisib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.36305055,-0.017152645,-0.7987538613026247,-0.04812983656179742
74813,SIDM00826,Oxaliplatin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.35462838,-0.036784478,-1.6330974794447266,-0.07392284714089217
77238,SIDM00928,Axitinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.4485009,-0.1250858,-0.15038674848096917,-0.00044610012463611333
39843,SIDM00875,PF-4708671,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1007098,-0.032218505,-0.32915050090350945,-0.007161137609674559
4223,SIDM00928,ZM447439,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.40298685,-0.04336751,1.6165607654383247,0.03747716196376474
56426,SIDM00872,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4610255,0.12994176,0.1479169071328166,0.04247144751959887
25479,SIDM00776,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.5796032,0.051742747,-0.43481151274960067,0.006460766329472066
30198,SIDM00833,AZD4547,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.7030402,0.049552146,1.1885896284210296,0.04314516565781607
101365,SIDM00950,Dasatinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8200681,0.24716699,-0.07688142425044446,-0.0021504417650187067
98002,SIDM00146,NU7441,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.8526321,-0.06807021,-0.2391190981091168,0.02996484772572675
92337,SIDM01042,MK-1775,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.16227701,0.011551961,-0.7180340436596052,-0.02328435460067343
108397,SIDM01187,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.3282824,0.16043079,2.833012641599508,0.10386407915312412
90005,SIDM00872,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6081489,0.012819528,1.4499538048344873,0.04402327011862418
6481,SIDM00633,Sorafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4364865,0.17306922,2.2191281015052144,0.09909460393930765
16574,SIDM00776,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.6797975,-0.03020016,0.13382416785602494,-0.014519420078190032
82304,SIDM00950,Trametinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2092588,-0.1291296,-1.7480872752264889,-0.09435778917641399
72967,SIDM00673,Lapatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8702933,-0.07406794,0.25161157144085616,-0.01737234641386987
53870,SIDM00933,Tozasertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.8054125,0.24031565,-0.9390474315144566,-0.009755645887102914
20318,SIDM00146,Wee1 Inhibitor,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.8312396,0.059130993,1.369002527536604,0.09035455809376114
106308,SIDM00673,GSK269962A,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5356872,-0.04163263,0.3817271929429893,0.008832408935808438
69947,SIDM00146,Axitinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2705793,-0.08596443,0.16519077921180866,0.055201646975487545
57524,SIDM00872,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6169206,0.061276935,0.7448093059343873,-0.004482815872634887
70673,SIDM00833,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.2055601,0.03232887,0.9845215668938023,-0.0012916573030467716
26222,SIDM00359,LGK974,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.368033,-0.041417338,-0.18318596477928528,0.032585708099928126
12835,SIDM00146,Pictilisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1329117,-0.08886294,0.04789736667810967,0.02216378723616804
73901,SIDM00673,Wee1 Inhibitor,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.0407875,-0.08524741,-2.887275385746722,-0.03560140483444142
80715,SIDM00928,Temozolomide,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.91016996,-0.022423709,0.18820666331200997,0.0244845898983378
524,SIDM00933,Crizotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.11424,-0.13892931,-1.7336845107044148,-0.08764242841605666
46702,SIDM01042,5-Fluorouracil,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4838725,0.06092359,1.6466961301124938,0.04754854384375558
104896,SIDM00832,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-2.8450413,-0.09728606,-1.1502175268297357,-0.062168744959276837
59083,SIDM00146,Uprosertib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.7414916,-0.1151141,-0.044580787916199474,0.13052348725055365
54746,SIDM00835,MK-2206,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.5073473,0.14982742,0.9929312304595534,0.06598270567898235
107206,SIDM00928,AZD8055,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.7740872,-0.18751556,0.20359447512984288,-0.0344799017192442
83860,SIDM00042,Taselisib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.7316322,0.060207684,-1.5193573529445947,-0.08555136266101515
1801,SIDM00877,Alpelisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.208545,-0.13154288,0.1752593387780178,-0.03640520841301594
61070,SIDM00872,Nutlin-3a (-),Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.46357208,0.012519266,1.8343172866368944,0.08605459901049019
15469,SIDM00835,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.712488,0.10455575,0.2880271181239393,-0.01817513666687274
77100,SIDM00950,Olaparib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8470185,0.051359486,0.5434188757218982,0.05697456454902062
94782,SIDM00148,AZD8055,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-4.0552983,-0.24500462,-0.9528347666106471,-0.10122912455183679
55978,SIDM00872,NU7441,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1653076,0.08871175,0.627228874300124,0.06050796498069053
40769,SIDM00928,Docetaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.5773872,0.121289,-0.2909104549864736,0.00047941590964183236
64080,SIDM00673,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.5175381,-0.109586544,0.9401353404999584,0.08692223281756588
61415,SIDM00877,Alisertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,1.1286267,0.08690891,-0.011334082991614902,0.03395889985151189
42438,SIDM00877,Axitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3870375,0.041868456,-0.1804327815576259,0.055106095287335566
56723,SIDM00875,Temozolomide,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4381166,0.017981302,1.3202671474828547,-0.033571822095098056
67950,SIDM00877,ZM447439,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.9115107,0.08248587,0.4580122784914394,0.015769419800014638
78916,SIDM00826,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-2.983084,-0.13923346,-1.6608535500546033,-0.039995560197193365
23856,SIDM00826,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.8974971,0.044998605,-0.9452566848361798,-0.02466076861130178
21150,SIDM00359,SB505124,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5066992,-0.07082672,-1.3823626527768902,-0.04029395056900043
38069,SIDM00455,Lapatinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2597036,-0.03800344,0.9325650618696119,0.0846997215184047
68865,SIDM00216,Camptothecin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,2.452376,0.12096406,-0.6330834166719964,-0.033141834374221336
18541,SIDM00148,Luminespib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.08145863,-0.007523104,-1.9842229392068407,-0.08161101327620512
68052,SIDM00933,Sorafenib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.82581556,0.06211605,0.2251932974350074,-0.002131413851314651
7203,SIDM00933,Entinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.7086766,-0.04034928,-0.5568053617408891,0.011662365532994289
3006,SIDM00833,SCH772984,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.99902844,-0.083501145,-1.0542720092516673,-0.08039657404477991
45097,SIDM00455,Erlotinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3134882,0.07807077,2.5852163621463853,0.0646266785300958
4176,SIDM01187,Axitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.4822631,0.04508833,-0.01202124354338598,-0.017329140275585624
91399,SIDM00837,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-1.571403,-0.022342386,-0.251833115506086,-0.042817227223409984
53439,SIDM00216,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1500659,-0.012957046,-0.022466014697737256,0.034355979098327605
48636,SIDM01042,Lapatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6325486,-0.08607444,-0.7051681258003001,-0.05981496495577971
45705,SIDM01042,Alpelisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9046881,0.4886491,1.8662533810995627,0.022050749014109874
107661,SIDM00216,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,3.589513,0.33912674,0.7366035729530901,0.016145257317074908
75016,SIDM00875,Dabrafenib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.857695,0.20340064,1.5322517002231282,0.05981928044469746
62362,SIDM00872,Uprosertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.26105985,-0.024353603,0.010300425489926346,-0.03648828794396624
63996,SIDM00872,Camptothecin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7519143,0.027913386,3.708147675478574,0.0692466886237017
55267,SIDM01042,SCH772984,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5260061,-0.02533494,0.9289475572773346,-0.013104538718165073
42486,SIDM01187,Linsitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2583272,0.03559608,1.0425451858037522,0.02448434445638065
43563,SIDM00282,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3196753,-0.08727489,-1.699770837343139,-0.1610082039524519
65144,SIDM00633,Docetaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6923504,-0.13755232,-2.07029888518033,-0.06656858389851338
43145,SIDM00933,Alisertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.5601046,-0.1291579,-1.763168638058624,-0.1425044510274251
79143,SIDM00146,Alpelisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.8648323,-0.04211364,0.20868037590845268,0.025877918441022225
87607,SIDM00872,Pictilisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.75264597,-0.07095804,-0.773875606037693,-0.06225406252575978
52502,SIDM00928,GSK269962A,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2179047,0.111144885,2.085319282084151,0.15464062455371339
21317,SIDM00933,Temozolomide,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.46065438,-0.02020716,0.18773670496871772,0.053617313331124385
105025,SIDM00146,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.690216,0.050382156,0.9338100316732489,0.08067107731941456
43400,SIDM00875,Nilotinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1805702,0.018630262,0.6526846058687048,0.03710463039153222
94717,SIDM00673,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.131248,-0.08369636,-1.0107240045167647,-0.10102610053177223
34912,SIDM00673,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0810045,-0.058244213,-0.6348329103517181,-0.015497940069278252
46171,SIDM00928,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.7070155,-0.0674873,-0.6878136397777304,-0.023380460239014644
94761,SIDM01042,AZD6482,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7784162,0.03201517,-0.629988646520408,-0.09586138621479365
60915,SIDM00097,Nutlin-3a (-),Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3079445,-0.075169526,-1.4660748732453674,-0.03933076553462332
2439,SIDM00875,Bortezomib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.32775944,0.03090287,0.5729232572496258,0.00663550150947798
59718,SIDM00282,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7573411,-0.112493366,-1.34913632051516,-0.13460977034950714
83661,SIDM00148,AZD7762,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2897394,-0.16417235,-0.9571231645773807,-0.06763310253221988
70306,SIDM00832,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.9614332,-0.14473818,0.4668886081444082,-0.0015779124818378698
93509,SIDM00673,Bortezomib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0265133,-0.030877657,-1.6720512448555438,-0.07040896052883275
5925,SIDM00875,Crizotinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48715466,-0.05586517,-0.5221541297340482,-0.07448324623582585
27323,SIDM00928,Nilotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.263368,-0.1762933,0.16891645537199798,-0.03674351947419825
30236,SIDM00673,Bortezomib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24009638,-0.007443281,-0.36291990199835533,-0.02659774893349038
102224,SIDM00042,Irinotecan,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.97563666,0.08008672,-1.1890233649621653,-0.05588751809880746
54342,SIDM00872,Doramapimod,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35258338,-0.011315945,1.8301404679906812,0.11972411703361151
11997,SIDM01187,Palbociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.3767873,0.023353698,-1.5012736231326655,-0.05646460256884499
14307,SIDM00933,PF-4708671,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.27595454,0.025179772,0.21911016230915561,-0.026169383159400948
50636,SIDM00957,Crizotinib,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-1.1266496,-0.031928852,0.5413013867808838,0.07036073641406707
68145,SIDM00933,JQ1,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.4568979,-0.03460506,1.1934791593561538,0.13090875787711956
68531,SIDM00872,Doramapimod,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6125686,0.027204262,0.5054546208635649,0.046545990328827065
17608,SIDM01042,Lapatinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7405267,0.067125015,0.15535495159187435,-0.006483106293589566
275,SIDM00933,MK-1775,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.31752858,-0.025896592,-0.7326460386195297,-0.001323871425889044
18775,SIDM00359,Camptothecin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.18674198,0.012700029,0.10933889034405708,0.054467275193501793
43356,SIDM00933,Taselisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.19037093,0.020910768,-1.8650518282767914,-0.11590565527280876
105394,SIDM00359,Oxaliplatin,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.804489,-0.04380588,-1.240774992996769,-0.01406513108756344
24612,SIDM00097,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.231199,-0.1680209,-0.340504034565285,0.000956578608436408
62894,SIDM00455,MK-2206,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.1008148,0.07436505,0.05696116137376529,0.05072252503856575
11412,SIDM00833,Taselisib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.9069114,0.13983417,-0.05158164493211789,0.040822194256976405
55901,SIDM00097,SCH772984,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8401587,-0.10075837,-1.2005824874296276,-0.0411133805107233
21043,SIDM00673,Olaparib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.893351,-0.062377572,-1.7577948197165292,-0.034566330642120294
64412,SIDM00146,AZD8055,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.95708984,-0.08968004,-0.6766365399380965,-0.06006048317144946
1824,SIDM00872,Tozasertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.78209436,-0.02699613,0.3470148785527658,0.00176090946293397
90108,SIDM00826,MK-1775,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.56507546,0.018365653,-1.9565130165478208,-0.04528120246064164
5347,SIDM00950,MK-1775,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8322161,-0.12422477,-1.3886344084265374,-0.09507337949191993
75486,SIDM00933,Entinostat,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.9994272,0.089100756,0.25645439315916935,0.07124955939334243
75039,SIDM00875,Crizotinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2468606,-0.035536952,-1.853653804559664,-0.08810793958470681
67895,SIDM00877,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.75682104,-0.03891225,-0.07718657228378217,0.02409364251187924
11612,SIDM00216,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.4523313,0.21854933,2.4059891191981775,0.2305903190774278
13288,SIDM00673,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1458184,0.04028372,0.059219240819185746,0.038966696394309025
58725,SIDM00455,Lapatinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2512394,-0.039435897,2.3393041873925524,0.17019985984657324
46265,SIDM00359,Taselisib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7220354,-0.13265978,-1.830591271162492,-0.0864522074523687
82418,SIDM00216,MK-2206,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.97843885,-0.05885556,-0.3623721492181796,-0.04192008303246256
94877,SIDM00359,MK-2206,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.0862913,0.22388585,0.7885711706933697,0.14059601374872943
77805,SIDM01187,MK-1775,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.2858424,-0.10707828,-0.6654393073439663,-0.010385823775012138
26046,SIDM00455,5-Fluorouracil,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.100569,0.05179721,-1.651472964777321,-0.02587195503373113
47093,SIDM00776,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.8968185,-0.16345921,0.21827192233723533,0.013679386132760776
47365,SIDM00282,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.3909953,0.1607735,0.7238309933398172,0.0708604033427303
77239,SIDM00216,Linsitinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.08516797,-0.006927531,0.9953371981391631,0.012625000805510144
15519,SIDM00633,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.821335,0.29801604,2.7925742676774057,0.17034513343318847
21244,SIDM00216,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.6824203,0.14907777,2.5244289242507767,0.12148707236904933
58224,SIDM00359,AZD7762,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8225625,-0.063798524,-0.5231336659094046,-0.03568716370044634
45637,SIDM00950,SCH772984,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.6043808,0.06742382,-1.4128086784092495,-0.08517987819820078
6371,SIDM00877,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-1.6547885,-0.15672728,0.035219726628693666,-0.005741480005032035
84406,SIDM00148,Palbociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.003125,-0.09894288,-2.1103604159204035,-0.08165024546012274
10346,SIDM00776,Olaparib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3811464,-0.07747795,-0.3273363875295647,0.00405027527067293
105961,SIDM00633,Bortezomib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2630173,0.08881458,-0.6024426228128593,-0.03328614439498188
3510,SIDM01187,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.32682475,-0.029467707,-0.6201508661824565,-0.04233969056792279
1878,SIDM00673,OSI-027,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.34894815,-0.035484225,-0.5047814728355676,-0.05553134749499635
25394,SIDM00928,Vorinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.7844274,-0.07243516,0.40683214138647,-0.0100924858081758
2544,SIDM00148,Doramapimod,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5432755,0.12884049,0.2273823876414162,0.04540769854074048
62650,SIDM00835,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.1936499,-0.02627895,1.0689445182426727,0.04071334036112046
50602,SIDM01042,JQ1,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.24838081,0.006514776,1.4012893999864533,0.039535962586413745
47282,SIDM00933,SCH772984,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8733003,0.07556014,1.8201368747431823,0.12012992913858953
86692,SIDM00148,Docetaxel,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1752896,0.10602919,1.7824494319668884,0.1570664319278468
6687,SIDM00673,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.84824884,-0.07780329,-0.5209080853601942,-0.04476804203688763
90630,SIDM00633,GSK269962A,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5420158,-0.04950673,-1.019654455385574,0.016511582769672004
54620,SIDM00097,Luminespib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9931139,-0.066995464,-1.1398389199768535,-0.09415777561768691
108263,SIDM00146,Entinostat,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.3084445,0.20029247,0.4136927239059224,0.06559142604793676
80361,SIDM00833,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6832376,-0.053117245,-0.46256145624594225,-0.05199930852922565
9998,SIDM00148,Vorinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7478422,0.069742285,0.29446490348005067,0.020101652384060285
48347,SIDM00832,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,4.3749075,0.3130353,-0.44737381923989167,-0.04233427575720795
75619,SIDM00950,Sorafenib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9024084,0.07106619,-0.29236660218100946,0.014501978403201334
47703,SIDM00933,Nutlin-3a (-),MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.8486106,0.16103598,-0.7196718682373839,-0.00025058201276070174
7514,SIDM01187,Luminespib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.68238676,-0.06925686,-0.7264981835793585,-0.05423341331958972
39033,SIDM00826,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.929864,0.0647411,1.7120249367998828,0.10007029458281173
75448,SIDM00877,5-Fluorouracil,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,1.3886849,0.10564214,-0.4051560201228879,0.014697555364634645
77777,SIDM00933,AZD6482,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.3759636,0.05785536,2.8349413157901076,0.1755342345792197
738,SIDM00097,5-Fluorouracil,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0445454,-0.09501025,1.4349263550046105,0.12027369907307467
64940,SIDM00455,MK-2206,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.607639,0.105083294,0.9497725383675311,0.1151830225574476
91732,SIDM00097,Wee1 Inhibitor,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.16133428,0.009695744,-0.6734565706518477,-0.06172674908772134
62287,SIDM00776,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.65674675,-0.021071555,0.2608557285068573,0.011454440798816237
29478,SIDM00835,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.9398259,0.16293299,1.2019942332054052,0.03974124872470305
71713,SIDM00673,Bortezomib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.16972326,0.0055065504,-1.0190627156307208,-0.04676004172930727
19727,SIDM00957,SCH772984,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.0067273,-0.04554274,-0.5285920422550446,0.020260014608956385
877,SIDM00950,Dasatinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.8204036,0.34504962,1.2461020388805641,0.08186731438136459
60300,SIDM00875,SCH772984,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5684693,-0.12587263,-1.5477828607380428,-0.11589722568791735
9731,SIDM00673,JQ1,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,4.328369,0.335772,0.5449615483165965,0.06759935986108588
64,SIDM00633,Alpelisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.99326974,-0.09628623,-1.1124823127681944,-0.02929495631172033
96011,SIDM01042,Axitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7591364,-0.08599287,-1.2254367409956137,-0.07182708973451117
59052,SIDM00673,Venetoclax,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.39575,0.09657847,-0.2018075911290331,0.020825481828519232
10821,SIDM00837,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-2.4115944,-0.085630774,-3.0076197640240623,-0.13911543335947285
55210,SIDM00097,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5569701,-0.10940887,-1.6504015041949036,-0.09806760883777578
45739,SIDM00875,BI-2536,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5732131,-0.064642146,0.010942290185016183,-0.03943994968049825
79574,SIDM01187,MK-1775,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9422626,-0.14412467,-0.5516155217987522,-0.005598295700469601
13246,SIDM00875,AZD8055,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6421467,-0.050188012,0.9357843757481218,0.08745209713699396
28269,SIDM00950,Lapatinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.777862,0.26169395,1.4839096868357453,0.12669380735824257
84818,SIDM00673,Linsitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.59225756,0.011727164,2.2558127937894654,0.013275330830741498
41907,SIDM01042,Tozasertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1362498,0.03596048,0.4384018220233412,-0.030874606099056335
33727,SIDM00875,Doramapimod,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2692018,0.1492509,1.6167488604120754,0.03237929897267437
52084,SIDM00673,Wee1 Inhibitor,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.8383188,0.05587961,-0.6606559681571367,-0.0072296361956097855
102591,SIDM00928,KU-55933,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-3.058172,-0.12359059,-2.484802910621357,-0.10778388649339192
96900,SIDM00957,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-1.4295144,-0.050499983,-0.8516961075156241,-0.08025151717540742
100094,SIDM00673,Palbociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.5058208,0.022407083,-0.5121719141276317,0.04319022083509755
18432,SIDM00875,Palbociclib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3070358,0.03271465,1.3485251547022648,0.08277214429754806
61520,SIDM00633,Uprosertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6048965,-0.03109022,-0.0032113668817274105,-0.003179133677153208
58545,SIDM00826,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.19937612,-0.009132905,-1.4910283077134256,0.0023159171221050854
2947,SIDM00455,Dactolisib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7318378,-0.053245425,-2.1279494119065987,-0.06127895360683543
75956,SIDM00148,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-5.7125955,-0.3667952,-4.2506658652615075,-0.2785027117897244
24946,SIDM00673,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2321248,0.11372728,1.2377087999244514,0.04287523184388297
103587,SIDM00928,OSI-027,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-0.6773348,-0.07598891,-0.7001929378285622,-0.05881478643548285
66870,SIDM00837,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.77048093,-0.017309776,-1.8018251688523566,-0.08885597738844722
16181,SIDM00146,Doramapimod,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.1052765,0.064657226,0.45502634105647616,0.016529310738407108
66759,SIDM00832,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-3.25739,-0.18324679,-1.6424838340470749,-0.09791394275288225
8583,SIDM00148,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.35381883,-0.036205377,0.5426774891298741,-0.04005468003197652
5921,SIDM00875,MK-1775,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.35898855,0.021477085,-0.3870554710608247,-0.025979236444370193
60117,SIDM00673,Venetoclax,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.4982266,-0.035272174,-1.028823579486308,0.0074500340912448055
70279,SIDM00872,Paclitaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0978372,0.048456408,0.9972919688763282,0.010327261440300085
41073,SIDM00148,PD173074,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.5869129,0.13340592,1.3108440649959119,0.08282438563995372
34779,SIDM00216,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.5668615,0.13002238,0.8155678969452892,0.048641799653402276
24725,SIDM00673,Tozasertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4128836,-0.089784995,-1.5104793042262106,-0.07666678900006015
76044,SIDM00097,Gemcitabine,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.0753794,0.2287215,0.31091705003586956,0.026544748609169368
76675,SIDM00833,SCH772984,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.4255097,0.10735543,2.660328034967021,0.21810492542540355
71121,SIDM00776,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.2448511,0.10702238,-0.32591865761396355,-0.05791855207604343
34639,SIDM00928,MK-1775,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,0.9061313,0.09259414,0.6619368757116624,-0.009936088762454972
74631,SIDM01197,AZD4547,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7181956,-0.051630776,-1.3120445040869644,-0.0504035452722346
6683,SIDM00282,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1835244,-0.043169044,-0.7640392948012221,-0.038646980524949665
100811,SIDM00042,Erlotinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0493648,0.038289562,-0.19495462791046597,0.005192401151015819
53465,SIDM01042,AZD8055,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0406435,0.087490745,0.18063692610345644,0.024345244215926803
33401,SIDM00097,Nilotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7576479,0.047972355,0.33521474085575276,0.05770419229059051
18503,SIDM00875,Bortezomib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52166235,0.048635177,0.06930870797411075,0.02317102079994265
103936,SIDM01187,Pictilisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5583836,-0.04567678,-1.0885524276662155,-0.027515399329472667
25865,SIDM00928,Ribociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,5.956444,0.4459504,0.3164062613734068,-0.03110547234535483
54940,SIDM00928,Dabrafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.1432894,0.063346185,0.5147089699127673,0.018123698259474023
68969,SIDM00633,PD173074,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.509142,0.08013657,1.496711097110782,0.034958737222726896
101329,SIDM00957,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.6514918,0.0238312,0.5814254913053081,0.08393071236805041
96715,SIDM01042,Taselisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7014802,0.03899326,1.883024945109962,0.0051913475086393
56448,SIDM00837,Navitoclax,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.7368823,0.04062396,-0.16223262764431046,-0.021509073163775146
58876,SIDM00146,NU7441,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.9853637,-0.086104095,0.6649861413486635,0.04080922250110084
58965,SIDM00872,Docetaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2759659,-0.1069067,-0.5768924303154065,-0.07797454057683803
98690,SIDM00673,OSI-027,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.51687366,0.05287778,-0.8745095904178687,-0.03319594401448517
84830,SIDM00875,RO-3306,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.6869075,0.29425046,1.740871333528312,0.15812719793797647
10979,SIDM00148,PF-4708671,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6529222,0.11003856,-1.6073206039536365,-0.045799292961119495
61685,SIDM00148,Palbociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.5248213,0.31484294,0.12869633353973314,0.02976645000537088
38105,SIDM00633,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2719607,0.055200476,-1.7521417202223057,-0.03520811008362897
62183,SIDM00933,Dabrafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.0955403,-0.12139424,-0.6318637718262863,-0.005885882254193638
77702,SIDM00673,Cisplatin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0799626,0.04810357,0.5334134796255098,0.015429429216667505
62275,SIDM00950,Lapatinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0106742,0.10304714,-0.35476498189625294,0.01990351130574621
35058,SIDM00146,AZD7762,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.7452374,-0.10208646,-1.0022243812847105,-0.009261840864313748
34293,SIDM00282,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.9279631,0.060949855,0.6036853025876281,0.04010495820671984
41059,SIDM00282,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1797127,-0.03074354,0.5888899964029982,0.06080197135640433
25879,SIDM00928,Linsitinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.5223703,0.24029106,-0.32350770187500405,-0.0013433722456066435
86518,SIDM00216,Afatinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.578246,0.059859022,0.6379967801717747,0.008107677266477003
75802,SIDM00776,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.1421492,-0.108209886,-0.9308916947995881,-0.06043973217089798
81280,SIDM00877,Camptothecin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.97504216,-0.11679176,-0.7681930730550445,-0.07474928590084622
72145,SIDM00146,RO-3306,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7260695,-0.0502337,-0.1638605460944971,-0.03954615009024031
27770,SIDM00633,Lapatinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9147164,-0.019749247,-2.447392203497663,-0.08599603964875274
69600,SIDM00832,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.4392627,0.008363036,-0.306723488325285,-0.05901766331033626
87651,SIDM00872,Axitinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.642309,0.048133556,0.08504716658014026,-0.023821580645201408
56614,SIDM01197,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-2.2045584,-0.11911207,0.33647423035503704,0.029176565190536265
93968,SIDM00837,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,2.3184307,0.020907111,1.475654935551409,0.05033732313716226
60665,SIDM00837,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.9753907,0.012408234,0.5426741378842127,0.023331061900503925
74284,SIDM00148,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.87423205,0.026899168,1.790304714941196,0.08216571433030885
100948,SIDM00148,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9691598,0.16267802,2.179160797156097,0.09008523888307714
105203,SIDM01187,Gemcitabine,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.2581222,-0.020626398,-0.33083514104636924,-0.016670122236211556
12123,SIDM00835,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-1.9346337,-0.049533743,0.04663048201404602,0.024822339488626995
18734,SIDM00146,Olaparib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.6858526,-0.03807151,0.08198812147208691,0.008768545870721057
93596,SIDM01197,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1556103,-0.10327012,-0.6675068668172605,-0.008032492218054488
48255,SIDM00933,BI-2536,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.90935266,0.003350159,-5.2492314040303345,-0.10818716319966437
51894,SIDM00826,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.0489634,-0.070051745,-1.9945431049572526,-0.09505059112676147
75850,SIDM00832,SCH772984,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.186662,-0.18639772,0.7440056589585129,0.06869900375394915
56685,SIDM00872,Axitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8093844,-0.04485972,-0.5325964007698344,0.020792415399981605
79133,SIDM00148,ZM447439,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3554032,0.17289989,0.5864218055193406,0.06011238321666099
873,SIDM00633,Venetoclax,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.6714032,0.1188082,1.2659020954157185,0.043056014258718016
70691,SIDM00097,PD173074,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.4083414,-0.1503355,-2.0131267333562564,-0.06351749364662626
19274,SIDM00097,JQ1,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5381982,-0.061841585,1.0327602118749228,0.050888416039048257
30858,SIDM00146,MK-2206,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1718223,0.08204124,0.4800598742799468,0.05575319693618124
11495,SIDM00097,Bortezomib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62221634,-0.03970699,-0.7815923061551502,-0.05505649126594574
104204,SIDM00148,Axitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.19891563,-0.019296644,-0.6382781330012607,-0.04214490593784887
21738,SIDM00833,Palbociclib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,3.415314,0.14450723,1.7247613633319163,0.0716613475852844
37369,SIDM00928,Trametinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.3480725,-0.23931135,-1.564446190567097,-0.1145604931686249
82309,SIDM00872,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.10496656,-0.011436333,-0.2945942995931201,-0.016235595401492397
5928,SIDM00282,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4890361,-0.08618438,-1.0136410498342543,-0.06120343711285962
86679,SIDM00832,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-3.7507339,-0.2566265,0.5133570581717607,0.044172142654800725
44858,SIDM00097,Vorinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62537354,-0.044586692,-0.8320014043655126,-0.06581299034252973
54728,SIDM00146,Bortezomib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.27958247,0.016576458,0.2692056442229639,0.0056513227278120895
47081,SIDM00928,Uprosertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,0.73770684,0.052351125,-0.10659894348853852,0.023870280030324154
64562,SIDM00933,5-Fluorouracil,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.09633398,-0.013916263,-0.5781224089731208,-0.04113714775308573
90721,SIDM00148,MK-2206,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.358688,0.13531888,-0.1571875019262251,-0.07125777168370215
83763,SIDM00146,Doramapimod,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.83399457,0.04688524,1.1060885999060348,0.11413965203002568
62402,SIDM01187,Cisplatin,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0785353,-0.12073162,-0.5754830134787253,0.00749869654803336
33497,SIDM00455,Navitoclax,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.7130161,0.037319634,0.1044960173763593,-0.01809397452969274
76722,SIDM00776,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.938514,0.14719784,2.9223548189973707,0.13171548821691498
23810,SIDM00933,AZD7762,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.40919432,-0.055150665,-0.11428408427657107,-0.022627040848605246
25575,SIDM00633,Alisertib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2771003,-0.07994261,-0.009892739711577057,0.021497548793770686
42377,SIDM00872,RO-3306,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1669438,0.16516724,1.1168561620073385,0.060306605367849396
46468,SIDM00359,Navitoclax,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6263499,0.035774358,2.2373455419221755,0.03936597665628421
85810,SIDM00872,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35035592,-0.035422765,0.41495155835283865,-0.019027284585561327
76613,SIDM01197,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.5177786,0.037381176,0.12218206400830998,-0.04081258363509196
10297,SIDM00633,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.4583917,-0.2611067,-4.451184986162286,-0.2616469669935192
22408,SIDM00146,AZD8055,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.039639708,-0.0030953924,2.1221511067126304,0.09119914714064516
68554,SIDM01187,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.47555566,0.03969706,-0.1484958021509622,-0.009082213438410407
102296,SIDM00928,Vorinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-1.4933448,-0.11619559,-0.33800009082060267,-0.012968351975333244
52412,SIDM00872,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,4.3559422,0.122881554,2.9794176481418586,0.09835482567233927
66677,SIDM00776,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.128054,-0.028350133,1.7038332727958727,0.05910882418246765
62036,SIDM00933,JQ1,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.9515045,0.256534,1.0592334709345361,0.055722506650101214
89165,SIDM00148,OSI-027,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1077821,0.15735054,-0.8129817845611726,-0.0445390853023033
44987,SIDM00928,Dabrafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.674015,0.20158646,0.06956257543131228,0.02075658897915061
57436,SIDM00097,Uprosertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5199046,-0.08791692,-0.765848473416031,-0.09115793908976888
43808,SIDM00148,Docetaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.35441515,0.034721326,-0.9659571415487164,-0.09134621195192669
40990,SIDM00097,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.7250934,-0.1936329,-3.4379119736236694,-0.13981607648366404
60901,SIDM00097,Trametinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8176107,-0.023247372,-1.8237565802001428,-0.04130148954917077
105808,SIDM00837,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.5516341,-0.044235915,-0.41981965063018256,-0.011604664144328982
7967,SIDM00673,Lapatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2194336,-0.019461948,0.6934831157392805,0.004945945401570675
23803,SIDM00097,Doramapimod,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2889723,-0.0072878134,0.4248914299919213,-0.010702981309211271
71909,SIDM00877,RO-3306,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.3016481,-0.1497862,-1.4823098759770503,0.014541887812039956
54749,SIDM00832,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-0.96262056,-0.03920673,-0.47653206222297745,0.014670882846278002
16517,SIDM00455,Palbociclib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7598317,-0.039695907,0.10574754849823707,0.05302659081290749
87566,SIDM00216,Taselisib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6121389,-0.10414598,-1.1960443451186853,-0.08833651124116283
29975,SIDM00455,Dactolisib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7420048,-0.09024308,-2.0524765117418475,-0.09496843793146564
102679,SIDM00148,Doramapimod,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6332293,0.20218582,-0.22183624292111045,0.035835716243475514
56620,SIDM00146,Cisplatin,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.5157748,0.0706822,1.317080644287707,0.0867086288641903
40706,SIDM00216,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5058026,-0.022497483,-2.3409969666293287,-0.18164220511133053
89690,SIDM01042,Olaparib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.3366268,-0.09296364,-2.576578798820103,-0.12319764530384471
52383,SIDM00148,Afatinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8984668,0.17529836,-0.2870751427671376,0.02757160656503959
22040,SIDM00455,Navitoclax,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.25209153,-0.016315438,-0.031171139446720904,-0.0035653075587429514
107158,SIDM00455,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6840318,0.018175282,1.8739402047414162,0.10713994248354415
11092,SIDM00359,AZD8055,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.176802,0.13040768,-1.2840093478566474,0.02233502920775997
48736,SIDM00933,Venetoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.37599006,-0.019246949,0.394056028673042,0.04029412108086183
42451,SIDM00146,Linsitinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.678421,0.19344965,3.0683727223134207,0.04593598606246241
23084,SIDM00872,Afatinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4222678,-0.13160689,-0.36418109728517334,-0.08659792344066682
83174,SIDM00832,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,2.842028,0.10223056,0.6719518293972025,-0.011938667160963685
94780,SIDM00957,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-1.5960275,-0.07124234,-0.5006421733909039,-0.009540685090761176
76365,SIDM00933,SCH772984,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.6168892,-0.1444568,-0.1076186374743385,-0.03176348895742822
99788,SIDM00933,Palbociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.6005061,-0.09623792,-1.1181072496785824,0.008900684706760838
63067,SIDM00146,Camptothecin,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.27048013,-0.026371261,-1.324053370667606,-0.1194391830415984
98685,SIDM00216,Afatinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,0.56377065,0.04201081,0.05532452876724297,-0.0019187394440094438
18738,SIDM00673,Axitinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.1997669,-0.1941828,-0.8900881600690729,-0.10836597237301007
41423,SIDM00216,MK-1775,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5939775,-0.061812736,-1.2966264125407476,-0.04663561090732005
2062,SIDM01042,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7088315,-0.23639783,-0.8289865057083409,-0.08321009381726158
34226,SIDM00359,Linsitinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7505548,-0.09238873,-1.2945439492692854,-0.05696507689324408
46362,SIDM00950,5-Fluorouracil,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9412189,-0.1413848,-1.5849721884420556,-0.08729615233326646
66514,SIDM00928,JQ1,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.68261,-0.08017795,-0.2618803464775806,-0.06277610046933443
38442,SIDM00957,Afatinib,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.976941,0.078915685,2.7812370722984903,0.22976818632571944
71961,SIDM00148,Camptothecin,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3685635,0.14164774,0.6795315255016176,0.045732320570477124
92743,SIDM00216,Taselisib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.0432644,-0.17453107,0.4462531043857418,-0.01356539489450873
30449,SIDM00877,OSI-027,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.9064698,0.1588377,-0.17718866615245146,-0.00620130877828593
49307,SIDM00877,Pictilisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2924536,-0.11780593,-0.1345618999059125,-0.04701206785612938
93040,SIDM00042,Irinotecan,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.5136626,0.24630159,3.7121123172350456,0.17069661781613388
45450,SIDM00146,Lapatinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.0056813504,-0.0004744688,0.35853735538480125,4.7005023139803585e-05
30313,SIDM00877,MK-1775,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.388742,-0.024952289,-0.17266168468989868,0.011791618758658636
98307,SIDM01042,RO-3306,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1643406,0.13322514,-0.043640823720206175,-0.0018043124907926515
39327,SIDM00837,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.35604185,-0.02504983,-0.09780695732970715,-0.028748863637814495
31343,SIDM00833,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.38437,0.03478594,1.0994469919377992,0.03843358471192202
54795,SIDM01042,SCH772984,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45908514,-0.020648614,0.09493859707232677,0.023128202935877844
81393,SIDM00877,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,3.5086298,0.22376564,1.762557507281171,0.049276240420596744
78194,SIDM00928,Luminespib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.8569236,0.07403533,-0.553678928358581,-0.04715063899429506
4288,SIDM00957,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,1.5440102,0.027619667,0.4362382855108622,0.004141337675719416
31643,SIDM00146,Vorinostat,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.9546938,0.05270633,0.038239228061521136,-0.0777889088331279
62863,SIDM00097,NU7441,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.834278,0.094944164,1.52976655758082,0.11686693454912023
661,SIDM00673,Olaparib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6255823,0.022910064,-0.15353510817269148,0.03850998964354273
94982,SIDM00835,AZD4547,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-0.51202744,-0.011625179,0.9640095297167809,0.020913914544825468
68279,SIDM00216,SB505124,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.24238916,0.022476234,-0.8647852106222023,-0.05325601098467935
19125,SIDM00957,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.3919575,-0.06039498,-0.39348536315779487,0.01802184996033103
80130,SIDM00633,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6225518,0.056983784,-0.9695164852823964,-0.05582336346806713
72433,SIDM00359,Camptothecin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0169266,0.08798767,0.9615353681620116,0.05905865194778978
40404,SIDM00633,NU7441,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.90632993,0.064309224,-0.8630442605655118,-0.04440925736929641
43602,SIDM00455,Lapatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2011652,-0.038127135,0.23107110211577914,0.03639599885716724
74737,SIDM00359,Palbociclib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.150638,-0.10105641,1.3624585762243768,0.08826475993116488
102185,SIDM00216,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.34236094,0.018296922,-0.3926933060607917,-0.003667738386423139
19559,SIDM00042,Gemcitabine,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.72307277,0.083017014,-1.1860406300219803,-0.061357328232192074
54831,SIDM01197,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.8341706,0.25831717,2.9776260709279723,0.11772423570938366
38375,SIDM00148,Entinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5638497,-0.10168914,-0.9982797727168132,-0.051788732144743665
48541,SIDM00148,Pictilisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.74906313,-0.055588365,-1.6839573508286212,-0.059666083014929795
51662,SIDM00146,Trametinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1054118,0.12648544,2.503190549808471,0.12707522109104458
14597,SIDM00633,Sorafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.38907045,-0.02616862,-0.03032055989994881,0.02128454480297976
71374,SIDM00097,Pictilisib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.90111476,-0.061350927,-0.9240462292242972,-0.045416062997568014
40533,SIDM01042,Crizotinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.32653204,-0.03477522,-0.39054662324842937,0.0028019680228511053
89521,SIDM00633,Gemcitabine,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.0226984,-0.284574,-2.351719160509331,-0.1442012558467365
51459,SIDM00877,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,5.9916563,0.27694336,1.4878245170188487,0.10410971269837221
62735,SIDM00933,MK-2206,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.3201424,0.17250803,0.8084879176367885,0.023953818754396537
40930,SIDM00872,Paclitaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.80664474,0.0673317,0.3685967320581225,-0.003632114360740792
9914,SIDM01197,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.20064515,-0.013458573,0.3237176488977262,-0.03313915669191749
65822,SIDM00042,Oxaliplatin,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.239129,0.2620464,0.5446859418942801,0.08104450440750845
85304,SIDM00455,Cisplatin,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.56126,0.07967554,0.11634591577239072,0.064040949323653
77763,SIDM00282,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.6775334,-0.10998692,0.28362692047627186,-0.0018648342843405935
68611,SIDM01042,Tozasertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1819153,0.2417238,-2.414124094875798,-0.1449471712779256
24010,SIDM00933,Axitinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.560952,0.16529419,-1.3234951025362791,-0.035972297125785826
3250,SIDM00633,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0609035,0.035491847,0.5460603423986436,0.0268309660894396
94607,SIDM00148,AZD6482,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.610312,0.22929095,-1.3354856310376657,-0.0718807331986395
108176,SIDM00146,Olaparib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.8122735,-0.03448832,0.7517665743354163,0.04702243114199238
2790,SIDM01187,Temozolomide,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.4335023,0.013516105,-0.3136894587035842,0.02503135553337099
58341,SIDM00826,Dabrafenib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.1670482,0.060383976,-1.8785423196684299,-0.05042462172608519
57697,SIDM00875,JQ1,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.6012824,-0.0897929,-1.7573918298078095,-0.07080813255184869
89338,SIDM00633,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1128346,0.022615405,-1.0861182104789677,-0.03407614747852668
59078,SIDM00957,SCH772984,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.53948116,0.02432472,2.297997536223379,0.16614768339966424
39847,SIDM00933,Crizotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.88923836,0.12843111,0.2985044462617929,0.05864013154000802
71404,SIDM00835,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.7271628,-0.048752572,0.11497674719912106,0.019576202973934618
108411,SIDM00933,Venetoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.9051307,-0.070281096,0.5855344806349204,0.03883956673899584
106017,SIDM00875,Vorinostat,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42262655,-0.04567095,-0.009448115897903208,-0.010578097713711546
9049,SIDM00833,Crizotinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.70949894,-0.035465352,-0.3713540656210967,0.016894521594268363
39616,SIDM01042,AZD7762,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6798109,0.075039744,-0.3313538518766029,-0.10686036350838611
38070,SIDM00872,Venetoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.418173,-0.07070162,-0.9507266652300955,-0.008286038974736334
3108,SIDM00877,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.4391495,-0.03843731,-0.7510461674151783,-0.08265376586748059
99318,SIDM00835,AZD4547,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.8719753,-0.01948735,1.723405724982429,0.03773068049636294
98723,SIDM00832,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.71902555,-0.049533237,-1.1093353900047649,-0.0668306454455247
100789,SIDM00835,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.4054252,0.112927,-1.4126552571029305,-0.0680688896126049
63140,SIDM00950,Crizotinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.90505415,0.08101424,-1.5273501729123986,-0.060888824771816265
89856,SIDM00877,PD173074,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.7106101,0.0157725,0.6670067136113402,0.050126639068353
2047,SIDM01042,Camptothecin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2658341,-0.122020245,-2.575362504851266,-0.1208950863416396
86125,SIDM00673,OSI-027,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.55930525,-0.055028223,-0.16260531190006527,-0.025391992767416126
93959,SIDM00673,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5570297,0.011909428,1.2311194702526724,0.06442674179963379
25939,SIDM00776,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1443632,0.10395154,-0.3522988058469243,-0.006093008945158462
91045,SIDM00837,Nutlin-3a (-),MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.8158791,0.08775981,-0.4332550346505365,0.002155673853742423
5162,SIDM00877,Paclitaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.4315706,0.11499996,-0.6836363995338645,0.014594927853320797
15069,SIDM00097,Uprosertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.31515366,-0.020687116,0.20043122045245385,-0.03196031908951047
22412,SIDM00359,Dabrafenib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.37498525,-0.01808398,-0.7566229206974731,-0.04421468285759583
51695,SIDM00673,AZD7762,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3264759,-0.063501716,-0.8678976252869339,-0.07319483013193218
31621,SIDM00837,AZD8055,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.221459,-0.06749555,-0.2667608388516036,-0.05785318817125315
52939,SIDM00633,SCH772984,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.3717189,0.037287597,-0.589057199554943,-0.0549112672553863
34399,SIDM00826,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.0922935,-0.11848573,-1.8333006956312343,-0.11042172005160018
71268,SIDM00933,AZD8055,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,4.2488904,0.3333954,0.7660323563460151,0.11099209544177924
68103,SIDM00633,JQ1,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.0118895,0.46492684,0.8885340372511471,0.13527182497772786
71557,SIDM00148,Nilotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33901533,-0.033937603,-0.08014843638234581,-0.030089822551692784
97460,SIDM00776,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.44805577,0.02788861,0.24838336304515252,-0.005730549716018007
35381,SIDM01042,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7977398,0.05726037,-0.49145812449801646,-0.041643729985946704
61277,SIDM00097,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4190239,-0.029614365,0.2971382561227328,0.018793488008035538
12273,SIDM00872,Navitoclax,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6456989,-0.08910595,-0.8739889385312836,-0.08933234741681678
23557,SIDM00872,BI-2536,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0347196,-0.093258455,0.6025770514748442,0.05314422808775393
83078,SIDM00835,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-1.1329226,-0.043191914,-1.8594940717372965,-0.06747958791421452
66387,SIDM00872,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4040257,-0.033265136,-0.6864318266138477,-0.002062627424280318
38956,SIDM00282,Vinorelbine,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.52153814,-0.03796938,0.06699667292696555,-0.03482215876547346
15799,SIDM00933,Nilotinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.5073853,0.098760195,0.8734982026269822,0.03544456195977921
3014,SIDM00877,Lapatinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.0624115,0.079122975,0.9151795256571369,0.09973026130554209
96212,SIDM01042,5-Fluorouracil,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4266333,0.017351205,-0.3645833299633418,0.03124313860741884
66328,SIDM00146,Entinostat,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.2985805,0.10665463,0.007088416237789096,0.062667214568305
89098,SIDM00673,MK-1775,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1394253,0.11221853,-0.5591953094383713,-0.02687916967143954
51627,SIDM00673,SCH772984,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.87999,-0.3080371,-0.41250993638031974,-0.05601502732532863
18044,SIDM00872,GSK269962A,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.124923624,0.01252734,-1.134283274521458,-0.050233193648111366
23746,SIDM00148,Vorinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0686486,0.16902752,-0.14847943623493592,-0.02947784225197154
58843,SIDM00146,AZD8055,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.076071,0.1513785,-1.4527108610985136,-0.03477627303961686
11189,SIDM00875,KU-55933,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.59481555,-0.025825283,-0.7036137317494824,-0.003894403663567794
57410,SIDM00359,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2737836,0.08491893,-1.7936563353490562,-0.03919401731037947
85099,SIDM00826,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-2.3562176,-0.053094335,-0.7426625486365875,-0.01742017104457758
3704,SIDM00282,BMS-754807,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,1.1519665,0.07112258,1.434816581661811,0.11175482038426511
26173,SIDM00359,5-Fluorouracil,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7589633,-0.0728802,-1.2143932014221768,-0.0013353632489775862
104648,SIDM00872,Cisplatin,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9281847,0.086031,1.75636657751938,0.09493944330041415
10154,SIDM00928,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.818259,-0.0720298,-0.5597768058122398,-0.04977927839734874
11816,SIDM00359,Taselisib,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0283872,-0.09101571,-0.7782376216006219,0.023708469215305266
18443,SIDM00673,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.20754671,-0.020911034,-0.11286481429661605,-0.029472539596750242
88800,SIDM00928,GSK269962A,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.49965033,0.042024218,0.6650891189703475,0.023227029067920707
95828,SIDM00872,Luminespib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0065666,-0.073430926,-0.024122390869807216,0.04088538753372678
83516,SIDM00673,NU7441,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.4842592,-0.032863673,0.24861276586075043,0.02137048556877383
46765,SIDM00950,MK-1775,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2617427,0.035009123,-1.0507400638665942,-0.030492220943498356
10345,SIDM00826,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.8678079,-0.07015567,-1.6425636808460666,-0.0662819620965094
67164,SIDM00776,Crizotinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-2.2589426,-0.15449163,0.7557724359516887,-0.008200564140670663
108261,SIDM00957,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.3995717,-0.01911273,0.9031348658113949,0.04698012158950159
46024,SIDM00826,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,1.7782179,0.06922732,-0.27922444935484086,-0.008798115568373791
12961,SIDM00877,Camptothecin,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.25777355,-0.025515206,-1.1819303557205143,-0.0569700584349074
72243,SIDM00359,MK-2206,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4693378,0.09967766,0.06557953940271724,0.03785944544264403
106493,SIDM01042,Gemcitabine,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2064714,-0.13592887,-2.1227141255739657,-0.07123515027334044
101047,SIDM00826,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.58808947,-0.014032564,-1.9451958944413037,-0.0608305352364428
104206,SIDM00875,Sorafenib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.67302984,-0.063019514,-0.35925849636231283,-0.027272731362800128
33907,SIDM00826,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-1.2469296,-0.024488883,-1.9414933542250512,-0.1345729408158657
2745,SIDM01042,GSK269962A,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.23918979,-0.029337896,0.3092459986202008,-0.026020120080123256
24583,SIDM00832,Taselisib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-3.548987,-0.16109894,-3.8015052114069334,-0.09623183600387787
27972,SIDM00950,OSI-027,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0814283,-0.0140265245,1.0763451395292067,0.04559818336764953
28883,SIDM00633,PF-4708671,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.45637485,0.036127985,1.413259463300611,0.08556168868230021
12055,SIDM00957,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.56440806,0.01739473,-1.4534976844319016,-0.03649017545273157
100222,SIDM00928,PF-4708671,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.3727031,-0.09689399,0.6645253087915591,0.07770983677382454
65464,SIDM00950,AZD7762,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.83275145,0.08491397,1.7120517752767104,0.07917117002288952
3082,SIDM00933,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.5716668,0.14383209,1.284049198726256,0.13300587664018015
5247,SIDM00097,Lapatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0682093,0.073533624,0.7179985974645603,0.08219067675082942
63326,SIDM01197,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-4.1033425,-0.11451563,-1.984095775898902,-0.13243520741942977
13317,SIDM00872,JQ1,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,5.432501,0.22836383,3.7618994635815923,0.16242392310246265
78023,SIDM00148,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.77464026,-0.07107771,-0.636143378568602,-0.055560009616405406
8452,SIDM00877,KU-55933,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,1.4757736,0.115241826,-1.5114166461419825,-0.021321442446859514
12125,SIDM01187,Cisplatin,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3265476,-0.089785285,-0.41040870723382333,0.010749594257688
16175,SIDM01042,KU-55933,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.858978,-0.17383146,-1.869402308042454,-0.09142603304398077
49548,SIDM00826,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.5798955,-0.009661736,-1.8549340057743322,-0.049831353889063686
47763,SIDM00832,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0952054,-0.027618608,-1.995456871459902,-0.02410555245391082
100532,SIDM00957,Navitoclax,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.0617944,-0.03295263,0.9794192949277728,0.05204095430583118
5664,SIDM00097,Wee1 Inhibitor,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3293236,0.022105888,0.24767084629303138,0.030876796288130545
52353,SIDM00833,Olaparib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-2.1473224,-0.072064444,-0.8233225882410925,0.0007642706131631406
37807,SIDM00633,MK-1775,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1079906,-0.09046122,-1.5886672244742932,-0.068319030829528
102535,SIDM01042,Camptothecin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.990865,0.09040272,-0.05267273755539972,0.03175974511451574
51230,SIDM00282,MK-1775,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9026767,-0.03322599,-0.363678404778581,0.003414839305996048
49769,SIDM00216,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.79842603,-0.045837257,-0.1442581475313511,-0.0007542531954702535
82517,SIDM00097,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8608082,0.013457294,0.5375994471576758,0.01932723341843083
70803,SIDM00359,LGK974,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2495015,0.036051862,0.20485673642927604,0.026069732117388462
20011,SIDM00146,Cisplatin,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.54966444,0.020892564,1.4836713166062145,0.08432829128895132
103396,SIDM00957,Dabrafenib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.7992673,-0.022326546,1.337229591390699,0.056332554158848504
61051,SIDM00928,Afatinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.824938,0.097979866,-0.0035381645240801425,-0.06819299781758006
17195,SIDM01042,Sorafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6347831,0.06957813,0.05140152511102559,-0.016569353810324487
90587,SIDM00928,KU-55933,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-2.8898761,-0.1138295,-1.9513364874133223,-0.07103706784554183
104633,SIDM00928,Luminespib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0819945,-0.08680595,-0.6300486312774525,-0.09066437340149128
42091,SIDM01187,Cisplatin,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2651188,-0.055521626,-0.048591564827760475,0.03498888403684639
14227,SIDM00837,Afatinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.9801755,-0.073308334,0.47249969830752625,0.010066529892164137
97726,SIDM00933,Sorafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.06273864,-0.0047970167,-0.08217218913390141,-0.004899402600384583
57416,SIDM00833,BMS-754807,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,1.5585245,0.12138362,0.9093817870742498,0.09420883446464942
79029,SIDM00950,Navitoclax,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7651187,0.1655223,1.011194175746116,0.05363099192490415
44781,SIDM00933,Alisertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,0.45883492,0.049907934,-2.3627761038789585,-0.092558099039165
75934,SIDM00950,Lapatinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.94639826,0.10309167,0.7360671799501672,-0.0007267854810332071
92891,SIDM00933,Linsitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.0708581,0.102124706,0.2650735318238168,0.06836870888465194
86822,SIDM00957,Trametinib,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.1268148,-0.07766427,0.31016439710927307,0.05062598496677407
12331,SIDM00837,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.23285876,0.007050729,-0.10524139474722922,-0.009114803802477445
6043,SIDM01187,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.5945227,-0.21122162,-0.6678846981187366,-0.07602949676288794
89702,SIDM00832,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-1.2843983,-0.04362966,-3.259553044925904,-0.11992787553373817
77844,SIDM00455,Taselisib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.26810944,0.018813279,-0.8959797257850148,-0.11558424043064776
78859,SIDM00216,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.89888215,0.05256521,-0.7463370861765294,-0.007869989833085586
97441,SIDM00957,MK-1775,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-5.091326,-0.12126099,-0.013465229003063526,-0.0055185790706979805
27704,SIDM01042,AZD7762,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.86152434,0.07855047,-0.8564694150028986,-0.07788799813370986
24818,SIDM00833,AZD8055,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,3.507476,0.12204833,1.8014100994028832,0.0006381303135714401
28358,SIDM01197,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.1055071,-0.057975102,0.4057146726954398,0.03785649458831577
40008,SIDM00673,AZD6482,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6038323,-0.051757853,0.6125839064209445,0.004917168247276988
27881,SIDM00950,Linsitinib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.5586047,0.43347958,3.586088883608845,0.17560919101141054
2300,SIDM00933,SCH772984,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.0064553,0.06861885,0.6301088943215097,0.031407890104444995
33248,SIDM00933,Ribociclib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.7219928,0.016423589,1.1427547423114843,0.04296510421045382
80855,SIDM00877,ZM447439,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.4047184,0.2485377,1.8766007552214512,0.18054661135981592
57183,SIDM00455,Ruxolitinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.207807,0.11761077,2.535254494718458,0.0875561075825972
100703,SIDM00097,Tozasertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3033118,-0.06964053,-2.0351612850627316,-0.02941447746434173
25153,SIDM00832,AZD7762,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,1.1107361,0.1004565,-0.6287181906600553,-0.079538054719349
107538,SIDM00928,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,0.91945696,0.0712768,1.2732661524247302,0.014314318108385234
33503,SIDM01187,Luminespib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.52805537,0.045809038,0.8099943710832037,0.06698114035483771
73653,SIDM00933,Navitoclax,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.3330193,0.039043818,0.8804191518758985,0.05560293928546791
11483,SIDM00837,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.3047223,-0.04200927,-1.9930182708309616,-0.09660690588274778
22459,SIDM00146,Trametinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3767542,-0.12182772,-2.073946498306451,-0.1468260256676336
24785,SIDM01042,Entinostat,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3375746,-0.16281502,-0.03897614194683182,-0.058883556217610246
107897,SIDM01042,Trametinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0866543,-0.07849173,-0.3637234654575929,-0.0007473839888909713
95061,SIDM01042,Gemcitabine,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8813314,-0.32334024,-1.7650775609181129,-0.10362579601375656
92516,SIDM00216,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.4082632,0.1377607,-0.6541081472092848,-0.01732870261935124
41985,SIDM00673,RO-3306,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0116307,0.07480351,-1.4939906961941547,-0.06540305961599763
14294,SIDM00832,Camptothecin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,4.0606227,0.29848355,0.5618881906057097,0.04047175146890019
88553,SIDM00872,Taselisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2160914,0.052684024,-0.1949491211902503,-0.05280926292651266
32452,SIDM00633,Afatinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3027822,-0.016059913,-1.0024272665623621,-0.012979324473373967
4295,SIDM00673,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.26920477,-0.022354359,-0.4044601880312021,-0.012935051978900276
1392,SIDM01197,Trametinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.60219705,-0.016207118,-0.30122250114409843,-0.027019299558968233
10512,SIDM00146,Wee1 Inhibitor,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.409981,-0.03490778,-0.5839857674183856,-0.004160625327401138
86098,SIDM01197,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-3.652993,-0.10804063,0.9322373718663576,0.021807173213249282
3344,SIDM00957,AZD8055,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.3521788,-0.026689356,0.4341750518114035,0.07217730974096417
12112,SIDM01197,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.90045285,-0.01884474,-0.02631968899876013,0.025114484405244407
64096,SIDM01042,Sorafenib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1040614,0.09363327,0.11818123420231168,0.021814061323399317
39534,SIDM00776,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.8439686,0.06410568,-0.6297194085648352,-0.035331240627842
6463,SIDM00455,Trametinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4828043,0.16316473,0.717277789070878,0.187158029791206
42167,SIDM00837,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.3546226,0.1090322,1.1108938336570917,0.03858751322820474
78792,SIDM00933,Afatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.068910696,-0.0062757274,0.3119116230252095,0.044917236810150564
10330,SIDM00928,Nilotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.5598025,0.15716165,0.3001876078777055,0.015192044491652207
42159,SIDM00875,Nilotinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6858386,-0.13723959,-0.573835474665236,-0.004062374827982192
103552,SIDM00673,Axitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.6705081,-0.1577251,-0.5169831274845725,-0.08165272207070086
69093,SIDM00933,Lapatinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.7538711,0.026958857,1.3053819596891623,0.07990704212996408
90173,SIDM00835,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-0.49733102,-0.02068573,0.7945961285860832,0.0415890081781182
99285,SIDM00673,Entinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.20207511,-0.016234335,1.0475416566378852,0.0060475325521870335
40516,SIDM00875,GSK269962A,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.62809,0.10316857,1.6984114027780337,0.08932282395972979
62213,SIDM00928,RO-3306,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.7177045,-0.08671627,-1.1382019791981255,0.007956867831819184
49577,SIDM00282,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7810618,-0.045533072,1.2147014020106475,0.06507966160565426
102112,SIDM00673,Trametinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.708957,-0.13181819,-0.40391500029629185,-0.07268549227128641
53852,SIDM00950,Linsitinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.50922114,0.037541553,-0.8526481245140165,-0.015823750698320947
57847,SIDM00826,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.38128296,0.008701379,0.6440458052821841,0.008845283258558928
81923,SIDM00455,Trametinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7889322,-0.08175296,-0.655226587209997,0.006059413404534725
45436,SIDM00837,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,-2.5772,-0.06996664,-0.6487614348280651,-0.002058680058350115
9080,SIDM00216,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.7610917,0.122681074,0.5145644234268248,-0.005592359480290083
1939,SIDM00216,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.630081,0.018559609,1.769474939694391,0.01587233170983022
37015,SIDM00933,Lapatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.25578916,0.027556252,0.4225258810783648,0.060184152910227044
30310,SIDM00928,JQ1,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.6447568,-0.07526242,0.17310622127015163,-0.00615309856521333
37265,SIDM00832,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.1907775,-0.2137994,-1.0624639911767002,-0.10621492043436136
94898,SIDM00950,Paclitaxel,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.923666,-0.25482893,-0.773662747278886,-0.024329076025012244
40050,SIDM00148,Olaparib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3763564,0.04565587,0.8939094445826458,0.04348321502335373
35102,SIDM00928,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.301848,0.09722159,2.659279978684572,0.08081593167454705
107059,SIDM00928,Olaparib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.8516574,-0.06163368,0.12082310766210724,0.023828115177090967
44923,SIDM00359,BMS-754807,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5163522,-0.031807505,0.5629627243698502,0.057202818324918046
75051,SIDM01042,Temozolomide,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3655374,-0.012418708,-0.03245737960705025,0.006303220344425608
36325,SIDM00928,KU-55933,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.42808092,0.028970266,0.4062094336526011,0.008483759689794867
19023,SIDM00950,AZD7762,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.79054046,-0.030825108,-1.1807303086000331,-0.08650444629015629
57467,SIDM00933,Afatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.3752931,0.12744617,1.0839602242024395,0.07263919553830561
85063,SIDM00097,Nilotinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.356154,0.17218885,0.9354334005700354,0.04484743198669794
93939,SIDM00282,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7706581,-0.06723437,0.9678459173640537,0.1213090734815672
83918,SIDM00282,AZD8055,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.69985557,-0.04664373,0.010998405539346641,0.0231198963467193
20673,SIDM00928,Paclitaxel,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.7448908,-0.06838356,-0.3914005277653626,-0.05404439618874432
62037,SIDM00097,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0960388,0.07999323,1.226746151727735,0.10214293381006181
52068,SIDM00633,KU-55933,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.43602,-0.04444335,-1.3080602890760409,-0.04667840441348775
78922,SIDM00097,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7816093,0.039495643,-0.7468637628162645,-0.022792804034884918
34578,SIDM00673,Nutlin-3a (-),Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.35240576,0.008949375,-0.02847370369331687,-0.011594390780724011
97648,SIDM00359,SB505124,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.8031082,-0.2163424,-1.0224450479931513,-0.06344496584996033
58445,SIDM00928,Dabrafenib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.1082702,0.13446479,0.8970491533890534,0.024441088438196576
44160,SIDM00216,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.229706,-0.03401377,-0.347146964815166,0.023838039407430314
59863,SIDM00826,5-Fluorouracil,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.1346129,0.07128276,-2.222202271236735,-0.07125197016451115
52639,SIDM00282,SB505124,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,2.8740845,0.1309066,1.447819697968891,0.10605628225974154
49906,SIDM00146,Trametinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1825416,0.055682786,0.29621503372105545,-0.009731029514659154
57123,SIDM00928,Tozasertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.2177234,0.04030099,1.01927510269309,0.03252452312526503
69403,SIDM00359,Palbociclib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.012572,-0.04759466,0.5733504280836108,0.053806453523988475
82915,SIDM00633,Palbociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2181011,-0.046818938,-2.4883821030833717,-0.07327003705686481
33977,SIDM01187,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.908828,-0.16454886,-2.003811238027337,-0.19330308672329202
51799,SIDM00097,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32411617,-0.0057958257,0.48919545173235385,0.021581199205072416
31372,SIDM00950,MK-1775,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.39448783,-0.03736685,0.3212896551856248,-0.0077338755907521
42462,SIDM00146,Tozasertib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.5423597,0.13126498,0.8640299590069207,0.06741608892859034
63152,SIDM00872,Vorinostat,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0076119,-0.06512945,0.5567169489162993,0.04917755226926544
10371,SIDM00673,Ribociclib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1618383,-0.049868625,-1.6285104030459996,-0.03217810769777439
30265,SIDM00455,Crizotinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.92366725,0.053204216,-0.6933243879350487,-0.04547874167359523
43328,SIDM01042,JQ1,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5065397,0.029865881,-0.16354194636806432,-0.012095362001325743
89724,SIDM00872,Afatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4637547,0.1565557,1.4337024035925272,0.097976494754882
98275,SIDM00216,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.3540072,-0.017876834,-1.7869725723989671,-0.054814474272266156
98187,SIDM00359,Crizotinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.276773,0.10386685,-1.2300773112493129,-0.014445852688051633
65349,SIDM00872,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.456142,0.13860154,1.2863450171764261,0.07238217779419162
55103,SIDM00633,Pictilisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.45204008,-0.03188041,-1.0668835412395132,-0.05787994059274771
22785,SIDM00877,Dabrafenib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.5557681,0.04323169,1.813204039311021,0.07313261784851216
102263,SIDM00950,Sorafenib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7752681,0.1045115,0.3677110915754536,0.0789685013595457
68584,SIDM00877,Tozasertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.33489156,-0.01935421,0.3403377121634372,0.07338907099425197
53736,SIDM00633,Dabrafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4155482,0.029111002,1.818652875826103,0.06132838906962207
87802,SIDM00673,Navitoclax,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-1.5970932,-0.0951555,1.5107372160063322,0.05141234276462723
74238,SIDM00875,MK-2206,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.5578015,0.22494705,1.5608592262168854,0.12925457519880218
50039,SIDM00633,Alisertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8624841,0.062677935,-0.056874435306521184,0.00517395973796538
10976,SIDM00216,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.87964875,-0.08727509,-0.7485491435361333,-0.043385095205588385
33158,SIDM01042,Entinostat,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.156912,-0.13025269,-0.2866086411937137,-0.026593210870334227
2857,SIDM00776,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.44652435,-0.036396757,0.19169309949077815,0.013343721790518511
3878,SIDM01187,MK-2206,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0274892,-0.094888784,-1.035331949552312,-0.09518370189544564
4128,SIDM00282,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,4.052218,0.11001434,1.297279489880067,0.06374416800832645
57855,SIDM00148,Doramapimod,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.736899,-0.09685954,-1.7139010596599282,-0.04461133058380283
50103,SIDM00833,AZD4547,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-2.700087,-0.1004871,-0.8545439164958891,-0.08012708406340571
46033,SIDM00216,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.0969129,-0.113077484,-2.692607631647459,-0.15864643305472614
25403,SIDM00826,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.0711122,-0.077998675,-2.7343736117858333,-0.014308093478979553
6032,SIDM00148,Uprosertib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.61813986,0.054350287,0.247592697773952,-0.027159875419242342
96403,SIDM00877,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-1.5567869,-0.07117852,0.1311742714349725,0.005402686927533802
97463,SIDM00146,Entinostat,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.41167563,-0.02783951,1.0127353722223627,0.13282403663361186
71131,SIDM00933,Luminespib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.28480974,-0.0074471384,-0.9919995651363595,-0.024245897011927513
101016,SIDM00097,Pictilisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6703162,-0.18281108,-0.7631364972541143,-0.053520384056944016
6647,SIDM00359,Dabrafenib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5905305,-0.07126585,-0.9363014501483107,-0.030169255444412974
82886,SIDM00950,MK-1775,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2511117,-0.11855774,-0.8624917728215731,-0.050876300205292255
89986,SIDM00933,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.35757223,-0.039838128,-0.7960235356116099,-0.0068638123928266475
79595,SIDM00359,Dabrafenib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.74187225,0.04228923,-2.6788880665536596,-0.06865614313516806
55801,SIDM00097,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8357553,-0.054846145,-0.07692990555587267,-0.020466414626889987
18638,SIDM00875,Navitoclax,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.33902913,-0.037666414,0.9288794718456006,0.03924037172626566
61569,SIDM00359,5-Fluorouracil,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.556505,0.042712763,-1.0409137409192009,-0.054807751074432816
74514,SIDM00776,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.8196427,0.047597118,-0.06915938767123825,7.497583600925558e-05
50922,SIDM01197,AZD8055,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,1.4139653,0.08215521,0.7434113787358662,0.0621291824416412
10848,SIDM00872,ZM447439,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4256818,0.13566363,0.5686111327753328,-0.00041250916474460644
58184,SIDM00455,Trametinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.4273002,0.1801897,2.093735608765125,0.18327812005709015
30146,SIDM00359,LGK974,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1703793,-0.036226794,-1.2722345702228957,-0.015183570739079303
38673,SIDM00875,Sorafenib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7277292,-0.062671855,0.03208398952265591,0.01128744086032088
13971,SIDM00776,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.6077383,-0.15361848,-1.3453742329210103,-0.035215649363799895
3864,SIDM00633,Afatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2414508,0.007572531,-3.496552612437238,-0.022204319326965604
88632,SIDM00148,Bortezomib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4522189,0.025614578,-0.8702501606132613,-0.0552960939197284
19523,SIDM00359,BMS-754807,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9473636,-0.17688188,-2.351441918048117,-0.03599445535382644
60935,SIDM00835,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.45221558,-0.010686391,0.7211132679296038,0.007250321199760494
76766,SIDM00872,Wee1 Inhibitor,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.57419646,-0.05941791,-0.4847893061400651,-0.04813306581479795
37557,SIDM00875,5-Fluorouracil,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5011159,-0.049187846,-1.7976713439552263,-0.10372247647846189
100308,SIDM00359,Vinorelbine,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2906139,-0.053166606,-1.41770215067727,-0.040977791781178594
13907,SIDM00148,Crizotinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.45725268,-0.013961914,2.0929465435507857,0.059863615690006956
53921,SIDM00216,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3865345,0.12260295,0.6688729331294372,-0.0008160703257906092
52880,SIDM00673,Alisertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.0885681,-0.031678744,-0.33014875913099456,0.06080323799215099
86167,SIDM00957,Camptothecin,AZD7762,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,3.7197695,0.07141384,3.908760605034282,0.1923563909406321
61287,SIDM00872,PD173074,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6960514,-0.06416276,-0.8383698727026345,-0.04474646090519708
31607,SIDM00872,AZD7762,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.15946586,0.017324232,-0.23745780522802512,-0.08269076224063428
44981,SIDM00673,Taselisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.31538123,0.015112956,-0.4274607271725161,-0.042516857404320645
36702,SIDM00950,Navitoclax,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3217666,0.20658688,2.9651482394749458,0.1698593999838343
84107,SIDM00673,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.017586,-0.114354745,-1.2968946547875915,-0.03949904115962197
37332,SIDM00957,MK-2206,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,5.440529,0.097812414,4.531563592293139,0.22208401162305097
71782,SIDM00837,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-0.87495816,-0.07089354,-1.0131732978241792,-0.07515141148305116
97570,SIDM00837,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.13195556,-0.007679964,-0.09366725454173663,0.012692600695117318
57355,SIDM00146,ZM447439,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,2.2726815,0.19330093,1.2572632510824655,0.056502110295182935
42671,SIDM00835,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.7850504,0.06656838,-2.228581096423887,-0.1305518036579081
88678,SIDM00835,AZD8055,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,1.900166,0.11912931,0.9487458277610858,0.07252389470552442
16878,SIDM00359,AZD4547,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8155065,-0.104802996,-0.5903822408597743,0.04015497742901947
83080,SIDM00835,5-Fluorouracil,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-1.7631994,-0.06908954,-0.24844763980375426,0.0023801303788033067
85847,SIDM00776,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.3551854,-0.103461884,-1.8322763486462057,-0.07402657908287948
9277,SIDM00928,Nutlin-3a (-),Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.8248991,-0.01708863,1.3774613121901502,0.027848729594873826
79741,SIDM00282,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-0.084704965,-0.005618486,-0.2556805494848239,-0.004065543877865214
38573,SIDM00216,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.9085563,-0.034743086,-2.296631970050959,-0.14154004343741305
21862,SIDM00872,Taselisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0767024,-0.069703616,-0.2752604414087457,-0.05286006283677349
15513,SIDM00933,AZD7762,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.31262535,-0.042835142,-0.540793534987889,-0.040857973318100545
97993,SIDM00872,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5298954,0.1369322,1.202239026084031,0.08910829947055374
40160,SIDM00148,Tozasertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3570274,-0.0689518,0.02331609252080131,0.017476955907164176
53388,SIDM00776,SCH772984,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-3.107384,-0.13159151,-0.6544785071139441,-0.0399546116404469
84104,SIDM00928,ZM447439,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.38152155,0.04124371,-0.05715556055135517,-0.06705559600227784
66753,SIDM00875,Alpelisib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1870834,-0.042929493,0.8931080129963491,-0.010559668418043292
88919,SIDM00833,AZD8055,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,3.984614,0.20145047,1.332201214825538,0.020636736559140546
33002,SIDM00832,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-2.6617799,-0.10265804,0.8998641946163717,0.054006483026055874
101945,SIDM00097,Docetaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7733979,-0.11556133,-1.853764249712067,-0.11536011855299501
46443,SIDM00875,Afatinib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.577418,0.13389355,1.7682480246034487,0.044593039045589755
9574,SIDM01042,OSI-027,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.77544993,-0.079740755,-0.24694525903605996,-0.00965829359045043
51219,SIDM00146,Doramapimod,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.737561,0.10810231,0.9691748036969887,0.03712903216128659
80294,SIDM00875,ZM447439,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8807951,0.195769,2.72213444901471,0.17367534073266025
26985,SIDM00146,Pictilisib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.0155227,0.21834919,1.372747066240683,0.14934644767871508
102986,SIDM00826,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.55395114,-0.025808683,-1.2689849815811316,0.015226937038810031
70139,SIDM00633,OSI-027,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0580661,-0.08468765,-2.3810149576711686,-0.123485811900812
87233,SIDM00146,Afatinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0423235,-0.08858645,-0.6184085434558452,-0.047673617912483986
81692,SIDM00957,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-3.5075524,-0.0890485,-1.4294213312485464,0.00121636234156522
102430,SIDM00872,Crizotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.0163262,-0.12858537,-1.3258887046162289,-0.09468353071877368
97057,SIDM01042,Cisplatin,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5636222,0.018010166,1.2195077328662094,0.02839937538806359
99786,SIDM00148,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8227402,-0.060286283,-1.370724714698068,-0.09413228097087552
77630,SIDM00146,Trametinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.9333533,0.059719153,-1.9037961176631357,-0.04638473042069302
69661,SIDM00148,PF-4708671,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.55103874,0.04047911,-0.23439014571513475,0.03922319335781834
27876,SIDM00933,OSI-027,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3021712,0.17613465,-0.07829036894504984,0.04937551336196714
103638,SIDM01197,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6609615,-0.026677845,-0.25392192267235436,-0.027396848373070562
79855,SIDM01197,AZD8055,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8637923,0.07117133,1.6576088434700775,0.10476803704787953
92666,SIDM01197,Navitoclax,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-2.136585,-0.16287199,1.0866698736409799,0.10259364477158492
71081,SIDM00673,Sorafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.83757854,-0.05115809,-0.27483689787929166,0.011813702518068734
72709,SIDM00455,Oxaliplatin,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1336015,-0.038317073,-0.7103259013471858,0.032554910792375796
42608,SIDM00146,AZD8055,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0676603,0.09412406,0.6701814459589887,0.02624405197294813
11290,SIDM00837,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.1099558,0.062237646,-1.6099388641590298,-0.05005399705613064
21966,SIDM00455,Erlotinib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.6260948,0.091692954,4.084116190896997,0.10339590358634915
40337,SIDM01197,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1297333,-0.11509094,-1.8672153311467912,-0.07847294599335956
87235,SIDM00673,Vorinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.6332014,0.13029091,0.7184600203331156,0.02234665634409149
37216,SIDM00633,Olaparib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1427987,-0.06135047,-0.8315302505974246,0.005252871298253329
1534,SIDM00042,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.9441718,0.03360713,0.23242789633030603,0.04639324399603715
72069,SIDM00359,5-Fluorouracil,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6472037,-0.09559438,-1.1375379534384624,0.022654902978556688
17559,SIDM00875,Temozolomide,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5718667,0.013565437,0.7974526605987615,-0.0241954697701103
25733,SIDM00928,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.8102918,-0.18570952,-0.8543853607683971,-0.06196088838792259
10975,SIDM00837,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.5117775,-0.024874667,-0.023187803731789455,-0.02261478847330109
51572,SIDM00933,Wee1 Inhibitor,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.68737483,-0.061988264,-0.2166326061006815,-0.047542464663123896
15268,SIDM00673,Dabrafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1946752,0.036207218,2.087126616090081,0.06489150393234154
59725,SIDM00877,Cisplatin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.31522948,0.03352768,-0.15182634918291957,0.07619644428519017
15394,SIDM00146,NU7441,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.3268907,0.11808192,-0.4179729334404585,-0.028356351959519518
8591,SIDM01042,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.6555917,-0.05821094,-1.9031505891482279,-0.08686225025187433
11177,SIDM00832,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-2.0122771,-0.064045265,-1.3544535572411143,-0.013058706022645005
52310,SIDM00146,Luminespib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.70348954,-0.060429115,-1.3947334241960643,-0.11720974158879637
41211,SIDM00872,RO-3306,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.016207544,0.0009965897,0.27457122646635984,-0.0454380032121206
9208,SIDM00042,Sorafenib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,6.5111346,0.3583115,-1.8113052074846798,-0.03524095477408875
49521,SIDM00148,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.74006003,-0.07221469,-0.7483696636243523,-0.07796628885953237
66052,SIDM00097,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.52074593,0.022521991,0.5811152172346675,0.0371492517985654
37116,SIDM00933,5-Fluorouracil,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.5596191,-0.077847935,-0.8592102410399425,-0.07304832418510035
70667,SIDM00877,Wee1 Inhibitor,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.99962455,0.05826027,0.015996679185598234,4.547263195970252e-05
101052,SIDM00872,Cisplatin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5060388,0.017229732,0.44714363053636863,0.034127142336540024
67959,SIDM00837,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.4610202,-0.11025695,-0.689598729235836,-0.05326523513584622
20253,SIDM01042,Sorafenib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.095387585,0.009877703,0.2511483877987199,0.008813799881510187
16893,SIDM00097,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2369555,0.06491774,-0.28326559498244347,0.018107013648501917
100248,SIDM00950,Paclitaxel,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1439228,-0.1585712,-0.235495708107738,-0.00752243676448892
79404,SIDM00928,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,4.9321737,0.44938317,2.287846362373099,0.12778337958062191
55930,SIDM00950,Ruxolitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5628982,0.039938636,0.46024704699262203,0.02056060658648421
91084,SIDM00826,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.9396065,-0.041105375,-3.0250353757252046,-0.14256824478005709
53840,SIDM00872,MK-1775,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8635286,-0.08937626,-0.27570458721486063,-0.03526556034608117
50897,SIDM00216,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.74616206,0.046579234,-0.07546746007324526,0.029915796765838623
59749,SIDM00877,Docetaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.45408332,-0.04131082,-1.6780419056846811,-0.10375570637500119
4,SIDM00633,Palbociclib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7454818,0.10742654,-1.3101565542950875,-0.040895168767613815
1293,SIDM00148,MK-1775,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6605785,-0.05922138,-0.18401656652389062,-0.04395397255140671
56118,SIDM00833,Oxaliplatin,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-1.5898471,-0.11242538,-2.169661798641155,-0.14373960013667741
30814,SIDM00042,LGK974,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.0001824,0.11168768,-0.8891937259091124,0.008893828722377132
104900,SIDM00282,Linsitinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.2639039,0.12764458,1.1396781015124076,0.09152667745568654
41204,SIDM01187,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3220536,-0.081621915,-1.7002031565683302,-0.09946309186072107
51945,SIDM00633,MK-1775,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.8259995,-0.20183268,-2.4264959341970607,-0.18431998812224681
66931,SIDM01187,Gemcitabine,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.75054055,-0.06379786,-1.1414836492213702,-0.041759876780919365
49833,SIDM00148,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6784179,-0.06971601,-0.07240668558835518,-0.02475313603433488
79482,SIDM00957,SB505124,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.8808517,-0.08725673,-0.1960812227351479,-0.005981669974349617
105946,SIDM00832,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-1.3453877,-0.065291144,1.54338271945243,0.008826452284186805
32461,SIDM00633,BI-2536,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4708384,0.14997262,-1.8513091748097716,-0.03039082875061791
101049,SIDM01187,Navitoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1735395,0.097566694,2.8765303318368987,0.11673665592962516
7325,SIDM00282,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3885871,0.018083004,1.7326219274146297,0.06462684416937022
88752,SIDM00146,Cisplatin,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,3.9077075,0.15211114,1.999286577499047,0.08847238262067753
17738,SIDM00633,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.19463,0.05494128,1.00506506932689,0.016948005290286235
68266,SIDM00933,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.2733215,-0.032008097,-2.3061338076543874,-0.14341732051537712
3256,SIDM01042,Uprosertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.475449,0.013616729,-2.383309498369624,-0.13470629873390388
94124,SIDM00872,NU7441,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6878724,-0.044723213,1.896639287559739,0.08248262262305582
36206,SIDM00872,Camptothecin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0903639,0.027408337,2.279188829714842,0.0718388735983624
94120,SIDM00455,Irinotecan,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.120285,-0.059496876,-1.0851205581243346,0.033548469185385926
48893,SIDM00633,KU-55933,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3575615,-0.04199854,0.7889687960930893,0.02148115514612671
8406,SIDM00633,RO-3306,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.74726415,0.061689287,0.2271152157638301,0.00811014900204598
71304,SIDM00833,AZD7762,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,0.7618308,0.04242769,-1.180317612027501,-0.10233921987813896
80098,SIDM00146,PF-4708671,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.6875626,0.05905695,1.056885187805546,0.06337373623711616
64254,SIDM00455,5-Fluorouracil,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.16664511,-0.00753684,-1.0080094342807155,-0.0020023732016652366
32136,SIDM00826,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.92303485,-0.09285128,-2.9344906655585414,-0.15839166159077636
96001,SIDM00148,Paclitaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0715348,0.103440434,-0.7461874663112109,-0.07554761590713607
41920,SIDM01187,Linsitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.829601,0.060476895,0.9988338341357891,0.03939903915385055
50839,SIDM00042,Cisplatin,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.0927528,-0.09214095,-0.5896250926615008,-0.03904873319206732
41255,SIDM01042,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7450895,0.14449024,1.2425889426692962,0.04412899826064381
65834,SIDM00837,MK-2206,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,0.77102137,0.05788372,-1.951689315661463,-0.1197414774062832
36365,SIDM00455,Taselisib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.66204154,-0.0438098,-1.6257847952267188,-0.1427991293674997
72254,SIDM00826,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.8530741,-0.059241448,-1.2927022844382487,-0.04955766131819623
17874,SIDM00633,MK-2206,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8167327,-0.061875477,-0.9795783801003047,-0.07340366610554819
13492,SIDM00832,Camptothecin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,2.7547994,0.15866141,-0.7382252584428033,-0.0331506728115098
35247,SIDM00933,Afatinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.7401485,0.24638864,1.8814280195520596,0.23396397362147042
76018,SIDM00673,PD173074,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.71470374,-0.040104654,0.09899521515272737,0.02400547576314826
49657,SIDM00877,Linsitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-2.0865557,-0.048941236,-1.4229411686756912,-0.00950919601691388
83115,SIDM00042,Ruxolitinib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.47791365,-0.01238529,0.5228170524857784,0.035967302904314186
99062,SIDM00832,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-0.6926839,-0.058407277,-0.5122346492281518,-0.05951813705727428
62020,SIDM00148,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.077798,0.11870219,2.059119640122615,0.06030237291208511
60014,SIDM00148,Palbociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4582384,0.031315707,-1.2768548300587603,-0.08361668074796222
7075,SIDM00835,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.8774237,-0.02005332,0.8942557744758395,0.04355061160051303
96094,SIDM00148,Axitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3014071,-0.114770144,-1.477775219682391,-0.04965488896190466
100174,SIDM00933,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.4539662,-0.0014864875,-4.1541262744090925,-0.11695062520460527
1469,SIDM00633,OSI-027,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.0376868,0.22561222,2.2359270620818896,0.08316000638053324
98114,SIDM00148,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9100853,0.07231596,3.4496585933176087,0.07209126826813335
9171,SIDM00673,Dabrafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.3104808,0.027740918,1.4328787361260293,0.04815929484078262
48489,SIDM00097,Paclitaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.82816815,0.046965864,0.19901394996626443,0.039009370006818214
105420,SIDM00455,MK-2206,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.010352,0.1276186,2.2494995470951014,0.14909042811911707
73876,SIDM00282,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6293527,-0.06222252,0.0080590345680755,0.025387165727510694
24577,SIDM00097,AZD6482,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8672223,-0.14402269,-0.3919100269696474,-0.009292536362280992
39357,SIDM00633,BI-2536,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7885305,0.06603439,-1.6223879942117143,-0.06605784663130347
31514,SIDM00875,Taselisib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4549825,-0.041790783,-1.522025966327363,-0.10984024132852944
51055,SIDM00146,Tozasertib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.1952329,-0.11168073,-0.3467580011933061,-0.044429326011934465
81591,SIDM00826,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.35868126,-0.030662496,0.4349249295492764,-0.02859140835743592
24376,SIDM00872,Alpelisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8374825,-0.08796418,-0.48584180123546017,-0.051991557197039545
60675,SIDM00928,ZM447439,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.5481402,-0.061116975,-0.09402834370876956,-0.020214501614733038
66941,SIDM01187,Crizotinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9032232,0.07327132,0.28584196961336394,0.037081602264627284
80321,SIDM00950,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.0670094,0.124101266,3.2922151950718015,0.17210865030366582
76402,SIDM00826,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.479777,0.05635859,0.773050705043408,0.029605688555547714
88171,SIDM00097,Nutlin-3a (-),Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.216368,-0.07134183,-1.1142909185442884,-0.06150778613357683
102059,SIDM00148,Alpelisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8996667,-0.18978094,0.24237175147924014,-0.0072648677112520585
50706,SIDM00833,Camptothecin,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.68033063,-0.036726706,0.2709576494879144,0.003278856413006314
38058,SIDM00673,Olaparib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.5426738,0.03236422,-0.330275410354128,0.034796479112872494
106143,SIDM00833,Oxaliplatin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.6561611,-0.052497994,-1.054337932444139,-0.05978904002365181
104742,SIDM00950,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2249793,-0.06960273,-2.055206163693298,-0.09502318228419325
4916,SIDM00359,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.4485867,-0.121060334,-2.4281325794588806,-0.07183426889610908
15214,SIDM00826,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.1149354,-0.017136144,-1.942415904460219,0.02094427183900735
22360,SIDM00872,Entinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4384897,-0.12001659,0.19009238591656996,0.05722836045737588
71199,SIDM00832,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.5432115,0.019011678,-1.1963373813725047,-0.046723225810219565
69424,SIDM01042,Navitoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.93342966,0.08876227,0.32499510382569696,-0.011090911807218036
106371,SIDM00148,Temozolomide,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.29257447,-0.008869366,0.12608169868253455,0.024707700764650592
97843,SIDM00832,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,1.5545089,0.023906762,3.4063790921240953,0.05360338589178705
95009,SIDM00835,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.8749659,0.06705221,-0.4596198398861183,-0.015967185145141945
59844,SIDM00633,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6215825,-0.092536375,-1.3305361496544938,-0.030009403080706817
61503,SIDM00282,Trametinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,0.6506949,0.04798676,-0.5172063074496229,-0.0016364356443016245
39038,SIDM00835,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-2.0450575,-0.05105507,-0.7369878035768977,0.022483775241632864
23827,SIDM00835,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-1.7507524,-0.11519766,-0.4584637889307908,-0.05763693105280725
96489,SIDM00933,Lapatinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.38483813,-0.053663153,0.321667346757967,0.006506906115280016
100736,SIDM00950,OSI-027,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5574865,-0.118951045,-0.009632013244050991,-0.024499837742468868
55959,SIDM00673,Cisplatin,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.4180477,0.20373379,1.5180888839612905,0.11449403087589623
10221,SIDM00833,SCH772984,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-0.47998822,-0.03627283,-0.4120369553571668,-0.0012348547602237104
75239,SIDM00633,Uprosertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4350586,-0.122193895,-3.8114100578665107,-0.15249362061587377
6990,SIDM00872,GSK269962A,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.512854,-0.04646987,-0.00662189010452032,-0.002378105102539546
40803,SIDM00359,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0934186,0.0505416,3.1530519224965863,0.10334210446767837
92957,SIDM00833,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.5872617,-0.035007004,-0.08189916381369787,-0.023109888684546713
81712,SIDM00875,Camptothecin,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0791417,-0.12393487,-2.401000846213284,-0.16383615184840114
49738,SIDM00633,Crizotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.345253,0.09922044,5.632974675634498,0.1515991361825285
23811,SIDM00877,GSK269962A,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.2629374,-0.11695122,0.29246302438476773,0.013233666227884189
96741,SIDM00872,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.25447914,-0.01621171,-0.24092692013794775,-0.026228318882727992
68498,SIDM00633,Olaparib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.221944,0.06631842,0.8321683369268669,-0.0031875141867846366
48870,SIDM01042,RO-3306,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2762178,0.12192606,-0.7206848458001676,-0.04108607425519009
55533,SIDM00359,BMS-754807,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1272578,-0.18709984,-1.8757719058778963,-0.0021249680556744313
33486,SIDM00875,Doramapimod,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3264998,0.043796416,0.6356574296507702,-0.0006051278655098769
4366,SIDM00826,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.8080675,-0.003041241,-0.6304185870814698,-0.003670071070690837
102593,SIDM00146,Taselisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-2.8084068,-0.15640128,-1.5694988879085536,-0.07594530467210091
48104,SIDM00097,Doramapimod,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5776403,0.08862192,1.3573102268347117,0.06449024557487726
33479,SIDM00872,Docetaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2151698,0.114633076,-0.38974825803496366,-0.020451294033875408
1705,SIDM00148,Nilotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1315176,0.20759572,0.765571270691498,0.0661707141615389
103099,SIDM00950,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6925225,0.06779685,1.0693220459294246,0.04034337981229753
54598,SIDM00837,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.78808707,0.028373588,-1.0513563195931328,-0.025219312380866526
66478,SIDM00455,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5420067,0.097049735,1.5213138711962872,0.11316344956559096
106353,SIDM00146,Luminespib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.19180031,-0.016051304,-0.05779631314042392,-0.06291616755514003
8501,SIDM00148,Alisertib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0156518,0.076599024,1.322026497442627,0.07696426625838682
84518,SIDM00928,Afatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.5449336,0.20600389,0.815447079790969,0.06399425071861982
103940,SIDM00835,Trametinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.61844987,0.029814145,-1.0592144418034333,-0.08885202819889843
105511,SIDM00833,AZD4547,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.5339873,-0.053820103,-0.53484168084208,-0.05687883032110305
230,SIDM00776,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.8720767,0.14887407,-0.9900001385862662,-0.016489237339131137
11368,SIDM00148,GSK269962A,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1975744,-0.10279348,0.03658880618566302,0.018729440332867806
48037,SIDM00950,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1396818,-0.10979081,-0.25816881615479115,0.007247930767116007
51918,SIDM00837,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.499667,0.028189642,2.2633774363187746,0.09174107914522846
74570,SIDM00359,Trametinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5224865,-0.016609918,0.7638632187397527,0.004764749473353815
16793,SIDM00146,RO-3306,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.44078,-0.03242555,-1.2284775513266555,-0.09847807390540395
19264,SIDM00359,BMS-754807,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7138844,0.12097917,1.2695003178818496,0.0923352819210458
20623,SIDM00148,Linsitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.46303537,0.042991348,-0.6977349563540047,-0.016431846281769927
965,SIDM00875,Nutlin-3a (-),OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7322916,-0.022070182,0.9313091899844036,0.04104968673814165
84148,SIDM00835,LGK974,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.3327875,-0.036498837,-0.12392184605256275,0.005075844429569096
28955,SIDM00835,Oxaliplatin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-1.878691,-0.12561336,-2.8422299608902746,-0.09430078402680579
50655,SIDM00833,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.2175005,-0.004672992,0.09527579293542432,0.005931679106875357
10024,SIDM00776,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.9127896,-0.07736543,0.1889458815046213,0.026173262381783864
34301,SIDM00928,KU-55933,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.6802388,-0.08391467,-1.8036645049447766,-0.08000211401944575
58446,SIDM00872,Wee1 Inhibitor,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.62403256,0.0659039,1.0122333572772018,0.002740487544639518
96927,SIDM00933,AZD8055,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.9970052,0.1665389,0.8806021662322865,0.08786442400313071
67485,SIDM00872,Bortezomib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2126172,0.013695607,-0.1528408413112433,-0.024084779478308557
21033,SIDM00933,Afatinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.2534413,0.12170962,-0.20052123421624962,0.01583506063480821
84052,SIDM00928,Dabrafenib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.4925062,0.023598138,-0.06859541092600131,0.012380647806170134
51149,SIDM00148,Venetoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0326831,-0.03896329,-0.945027577550893,-0.05373183235474206
78563,SIDM00455,5-Fluorouracil,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.1511154,-0.063326366,-2.74254130357182,-0.08226833968298461
59599,SIDM00148,Temozolomide,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.67340064,-0.019899301,-0.5156961762245993,-0.013463118913447326
6763,SIDM00875,PD173074,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5644819,0.09698067,3.103787790979341,0.10761954336350957
90048,SIDM00216,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.0452452,0.13031304,1.9436676217851483,0.05454001677525383
106480,SIDM00875,Linsitinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.644554,0.3053283,-0.3529214098513983,0.03842399639369131
43616,SIDM00957,Taselisib,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-3.0426142,-0.080060095,-0.4916986176625845,-0.029905454521524637
90707,SIDM00835,Navitoclax,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,0.9779997,0.060622774,2.415978030379138,0.04889136803771124
32343,SIDM00872,Entinostat,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2797842,-0.06934984,0.49833294132223843,0.011873705334719755
6748,SIDM00148,Tozasertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.6834598,0.3550312,-0.2927623986830732,-0.01613844568083563
57333,SIDM00148,Trametinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6360053,-0.04885945,-1.1978703505072774,-0.04228599315752246
100971,SIDM00097,Bortezomib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.525496,0.031371098,-1.059198683438182,-0.07163404732664103
32163,SIDM00673,Luminespib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.684734,-0.06901847,-2.023939842989645,-0.09203537407760312
11242,SIDM00148,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-4.7804666,-0.20146391,-2.5420336914858406,-0.14932928557797492
20643,SIDM00875,Navitoclax,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0354906,0.089940086,1.3775334496271323,0.06575636906149539
87845,SIDM00832,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-2.8720875,-0.11747967,1.469166707188531,0.04599329977008462
57935,SIDM00455,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3050241,0.04286088,2.664836856927025,0.0594060258105011
72079,SIDM00877,Docetaxel,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.1579666,0.13990605,-0.15036389556759605,0.07677770287877804
69397,SIDM00928,Alpelisib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-1.3260783,-0.14292283,-0.3864333837609945,-0.012115632522843341
27303,SIDM00359,Olaparib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.6282191,0.07946379,1.8071481557981348,0.059246755891408126
34733,SIDM00833,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.69198143,0.05245987,0.2000222849767733,0.011827047253022104
45814,SIDM00832,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-0.96403277,-0.03500594,-2.60696921413571,-0.08359483155296536
84203,SIDM00097,Pictilisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2023609,-0.13474709,-0.40805800304117007,-0.06385019266798803
76257,SIDM00833,AZD4547,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.4545205,-0.058374807,-0.8012321042340504,-0.05685200567112557
76878,SIDM00282,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3960065,0.07626933,0.23390616155749383,0.015828104391804407
55803,SIDM01042,Entinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5181731,-0.19589236,-0.10571167137865373,0.002601728576089714
77068,SIDM00872,Entinostat,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.25421745,0.018653404,-0.04781689810048862,0.04730639582667255
61864,SIDM00148,Dabrafenib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.47201958,-0.02668676,-1.5983041213633622,-0.05757664574159501
40952,SIDM00872,Alisertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.37939155,0.01725029,1.485437530013706,0.09380128925528232
8274,SIDM00673,Temozolomide,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.107489586,0.0022616081,0.21201951273642564,0.024172308220750845
70987,SIDM01042,Crizotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.85526365,-0.06880969,-2.468939774934766,-0.07980686748378077
82174,SIDM00633,Cisplatin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1360013,0.12056125,-0.7964789626178586,0.034844036558608245
59059,SIDM00832,Vinorelbine,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,0.86768717,0.0352589,-1.5503115642496008,-0.003688462493256846
44125,SIDM01042,JQ1,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3454069,-0.046545245,-0.2355591650195308,-0.02087669281931875
101060,SIDM00928,Camptothecin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.7487223,-0.17010796,-0.6198696850932254,-0.05141640355138281
72413,SIDM00877,Axitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8951491,-0.083650395,0.1740320705705492,0.004832707304991841
4137,SIDM00633,Uprosertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9505881,0.029449867,0.2453099271857988,-0.0030620608690474457
67378,SIDM00957,MK-2206,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.0210435,0.03581573,0.8135563423955902,0.09764704355663832
3019,SIDM01042,GSK269962A,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22838354,0.031269968,0.5360841540257092,0.005790354903473221
67026,SIDM00875,Wee1 Inhibitor,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6546661,0.03925996,-0.6278116451745263,-0.035365897909269424
78631,SIDM00633,Lapatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5212808,0.020938234,-0.9728474781544961,-0.05246036556832831
80431,SIDM00928,Nutlin-3a (-),Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,2.1450791,0.07891918,1.2028643051871502,0.05020543935631213
59681,SIDM00216,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-3.09738,-0.024122475,-3.85595718083904,-0.17150706601062948
24297,SIDM00933,SCH772984,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.4535423,0.032251865,0.21642981409965417,0.018280930581816474
80115,SIDM00776,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.52209735,0.045636892,-0.8985434768604518,-0.08414040272978268
106311,SIDM00877,Cisplatin,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,2.3116682,0.23889308,0.5087897902206246,0.054439923820052895
31691,SIDM00872,Navitoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7979035,-0.0944256,2.3497885778230905,0.11578881766359733
77127,SIDM00957,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.67929,-0.022082282,-0.12650323556116141,0.01404672206864637
105031,SIDM00776,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.848412,-0.023400495,-0.18216558435242222,-0.016096058391419043
22519,SIDM00928,Olaparib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.2989721,-0.0769033,0.07503293813379253,0.0017127658228177148
83639,SIDM00872,Docetaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4585644,-0.14413437,-2.7159646429131654,-0.25246503599434234
12878,SIDM00933,Olaparib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.2133408,-0.12983568,-1.291396379863093,-0.04612037287024909
64519,SIDM00216,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.0977395,0.063718684,0.009313878213562308,-0.019380405232471344
51342,SIDM00042,Taselisib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.5540163,-0.05027718,0.2962660114015961,0.010198586942177486
22927,SIDM00146,Lapatinib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.4181379,-0.036263604,1.29356338042244,0.13232690453777154
1950,SIDM00928,Linsitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.2263515,-0.112386,-0.4115145800368432,-0.05369987531801935
29765,SIDM00282,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3555832,-0.025559224,2.874169724846239,0.033195288614205704
36284,SIDM00875,Nutlin-3a (-),Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6172737,0.020984016,2.4608914006265574,0.08682735808311699
79459,SIDM00826,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.24232657,-0.018966908,0.18134884464279152,-0.012607816851521004
98278,SIDM00673,AZD8055,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7062271,-0.057513718,-1.147694248680561,-0.0975081142723628
73721,SIDM00148,Palbociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7981807,-0.040813424,-1.557124629546879,-0.051851818919976596
18850,SIDM00282,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.5067519,0.023766613,-1.7546535530243326,-0.063480455947414
4596,SIDM00148,Gemcitabine,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1564882,0.07145394,-1.520101238200148,-0.05998356303710668
25520,SIDM00950,Palbociclib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0321195,0.1665093,-0.2609189571108681,0.006831871864020623
38598,SIDM00826,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-1.1607072,-0.036908753,-2.452341441690139,-0.08127629850190699
73558,SIDM00950,Ruxolitinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7661698,0.0985819,0.6487109927946216,0.02245661799814425
43867,SIDM00776,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.9762795,-0.23533556,-2.40682191028788,-0.15290398928100396
32351,SIDM00673,Wee1 Inhibitor,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.0070095,0.06725925,0.21363556969164746,0.03405173651656325
78542,SIDM00097,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5249941,-0.09024666,-1.175669973697021,-0.07932328447308383
55149,SIDM00359,AZD4547,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.26016945,-0.017143134,-1.2892660422389592,-0.022710620714565293
78892,SIDM00826,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,1.8007323,0.042163037,0.9370896415019341,0.018890997279497643
54340,SIDM00833,Camptothecin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,1.1561174,0.07554923,-0.6257184232760269,-0.012886586573315732
30482,SIDM00933,Cisplatin,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.4528672,-0.04391604,-0.7751348014647717,-0.02753417044631216
31921,SIDM00148,Pictilisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.57219774,-0.03880625,0.658683425284896,0.0035044249404004276
10624,SIDM00872,MK-1775,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.675954,-0.07262904,-1.5541429223046945,-0.17717055385629274
28862,SIDM01197,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.42334104,0.032618765,0.673729024491974,0.05272144288512239
74179,SIDM00282,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7723467,-0.091351956,-2.15646498764376,-0.1531667688936103
60098,SIDM00933,Doramapimod,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.2188501,0.07926345,2.6253590513428287,0.07142882683797964
6266,SIDM00042,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.1570637,0.09332269,1.6383040745962338,0.07872395381535288
73654,SIDM00097,Dabrafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0927992,-0.10886573,-0.6870592662658832,-0.05121242918390269
61173,SIDM00282,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.3600948,-0.08217367,-1.3023424555489211,-0.08567303372872322
66794,SIDM00835,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.2471292,0.2431028,3.115617361468824,0.20415574708207726
57550,SIDM00455,Gemcitabine,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.2145696,-0.12521222,-2.0083522120854678,-0.021781504808793997
52140,SIDM00146,Entinostat,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.331803,0.15267844,-0.06816749949129447,0.02992396771872837
102469,SIDM00933,OSI-027,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.5638087,-0.06624801,-0.6905734049687917,-0.003105654157028923
47981,SIDM00877,Paclitaxel,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.9693629,0.086875774,0.47395914067979567,0.05417195426052675
40915,SIDM00957,AZD4547,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.6450615,-0.050661836,0.8664279058342668,0.027485588743441498
38636,SIDM00359,LGK974,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5814003,0.017770028,-0.25802240409054183,-0.0017881551546709915
78932,SIDM00633,Alpelisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1539018,-0.10968796,-1.8039047462521216,-0.07018872901450897
75059,SIDM00216,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,2.6229138,0.22499788,1.7902053369693833,0.10712306831766427
9675,SIDM00826,Taselisib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.73310274,0.05532123,-1.2397363522091658,-0.06976079915179313
8263,SIDM00835,Olaparib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-0.8100055,-0.019603387,-0.5488899853313337,-1.1508302107625314e-06
35532,SIDM00832,Camptothecin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-3.5815535,-0.16914432,-1.4747228123833023,-0.09724772696161611
44338,SIDM00097,OSI-027,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5841541,-0.15366745,-1.2335656453242019,-0.09424252459267851
43000,SIDM00832,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.6473372,-0.2047807,-0.8953336956842813,-0.07406518774404479
85478,SIDM00455,Sorafenib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5811058,0.11235335,0.44035871088744,0.06307760738501848
30173,SIDM00097,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.514605,-0.09871581,-1.3534162277635235,-0.06659515719731846
67151,SIDM00872,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.46674848,0.04605962,-0.879199571218358,-0.05421412079673388
74497,SIDM00875,PF-4708671,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8803762,0.10663374,0.685727414005957,0.0340237938587905
47986,SIDM01187,Gemcitabine,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.69830394,-0.06440999,-1.4678901063849643,-0.09171636456234764
36376,SIDM00776,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-2.85694,-0.10971342,-1.8699679219207255,-0.03886582761399015
27817,SIDM01042,Navitoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.92815554,0.08306233,1.121387511929463,0.0992396342387993
93972,SIDM00146,Ribociclib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.396416,0.08819745,-1.3013825898832174,-0.018035183519888816
77164,SIDM00928,Entinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,2.9331334,0.30419487,1.1850023447408815,0.0903602392484044
1662,SIDM00673,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.409993,-0.07624974,-0.5386845088731709,-0.02355406299186362
96102,SIDM00877,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.74850816,-0.047764447,0.0514127075437435,0.0067943420839701296
98903,SIDM01042,AZD8055,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8895361,-0.22159617,-0.69615165352694,0.01298207971158096
61445,SIDM00455,Dasatinib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3398654,0.11717883,0.9025065220388149,0.11586011853478026
57702,SIDM00928,AZD6482,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.8498859,0.065873526,1.4875587335726428,0.07013025140937158
49683,SIDM00148,NU7441,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.71769595,-0.07267794,-0.24442648066034375,0.01075962304836049
108123,SIDM00633,Pictilisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.73920965,-0.05901629,-0.07469890671424767,-0.014382596461379878
26721,SIDM01187,Trametinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.359795,-0.06326492,-0.8989849771316806,-0.029308988294559114
52687,SIDM01042,Sorafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8485421,0.08496278,-1.2661097433235873,-0.06726077463775972
94211,SIDM00216,AZD7762,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,0.5657442,0.039400302,-0.4861945815603137,0.015009335330330194
101891,SIDM00633,KU-55933,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.006248,0.0580101,1.2453250154489703,0.04356639310036559
107200,SIDM00832,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,2.4276986,0.07218887,2.6558376882285906,0.10116035689035748
40353,SIDM00872,SCH772984,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3550554,0.025734115,0.5131731030000131,-0.013939326610580916
11210,SIDM00097,Alpelisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7071964,-0.12256668,-0.551293808421283,-0.06813475273862085
4271,SIDM00148,AZD6482,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8050325,0.08228178,-0.13523385996777354,-0.045551253118625755
21676,SIDM00837,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.581199,0.051832315,-0.6191495323024739,-0.014934503090167705
44373,SIDM00872,BI-2536,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5901687,-0.053949066,-1.0777103390327432,-0.0579994242714524
4198,SIDM00928,Alisertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.8530653,0.17574637,1.1444253963607136,0.12065064944484186
45240,SIDM00877,Taselisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,2.1431103,0.12644558,1.4582421982570166,0.07023116618848031
64358,SIDM00957,Afatinib,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.0644324,0.043343965,1.4935064986131843,0.13263076943314517
24950,SIDM00097,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.55221313,-0.013221257,-1.548367746336938,-0.011151065560316224
58474,SIDM00950,Ruxolitinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.8841088,0.023820883,1.4695736027710806,0.03929757726912072
100033,SIDM00950,MK-1775,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3623543,-0.021309622,-0.7314575361919343,-0.016465496287359983
86759,SIDM00146,AZD7762,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6550831,0.15213244,0.42997253950221287,0.10819217827037371
36203,SIDM00837,Navitoclax,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-0.4879421,-0.029585157,-0.5003298663463328,-0.016526042792905447
36443,SIDM00877,Nutlin-3a (-),Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.4875125,-0.06415765,0.3311254056063358,0.03139882708389104
54699,SIDM00359,LGK974,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0400683,-0.027669258,0.11005668886874471,0.014522077224926254
68712,SIDM00933,Camptothecin,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.42371285,-0.038073428,-0.8814056564973258,-0.06419947107678269
62052,SIDM01197,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.964246,-0.15412341,0.08501365036913619,-0.0028657631155324763
84893,SIDM00950,MK-2206,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.952448,0.20265605,0.3429120596001283,0.02086984527598303
21989,SIDM00097,Palbociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0788683,0.055305813,-0.6885774302465207,0.012401032311897877
51390,SIDM00633,RO-3306,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.763925,0.06793493,-1.2865759267403232,-0.03633921650011498
11057,SIDM00633,AZD8055,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.65521324,-0.06360437,-1.0315230371102597,-0.08727209257289877
60248,SIDM00872,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.59485424,-0.058196962,-1.2279083131611004,-0.09188683781632936
19524,SIDM00455,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.14732847,0.0029979977,1.3821327772693695,0.07031571653118363
6063,SIDM00148,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5262252,0.04753204,1.2420278522940003,0.03385147257051286
67187,SIDM00359,SCH772984,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4969733,0.1319933,1.446636199724517,0.10813243523432216
5528,SIDM01042,ZM447439,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.71007496,0.08980761,-1.7044686407074943,-0.09873484618575235
75601,SIDM00146,Doramapimod,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.93030405,0.038527306,0.07728682325300858,0.0042803970154899115
26996,SIDM00933,Temozolomide,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.0249689,0.030652734,1.6747981690801503,0.06516695467929591
83513,SIDM00933,AZD7762,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6632755,0.077259734,1.1944253916726815,0.0988888446012457
47753,SIDM01197,Afatinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9533951,-0.07354714,-0.20107699166569595,0.017800615427349897
14123,SIDM00933,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1806746,0.16276179,-0.9016218132302183,-0.08471704516480973
10631,SIDM00146,Vorinostat,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.2167087,0.22189762,1.9538652308883184,0.10274276729267895
82396,SIDM00837,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.6953017,0.08269823,0.5538192835112006,0.06317980101194785
28193,SIDM00146,Docetaxel,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.66462076,0.06203403,-2.24144802682913,-0.14274485469345682
23303,SIDM00928,MK-1775,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.9730196,-0.27972457,-2.0889172019815723,-0.23991769147026754
42177,SIDM00875,Tozasertib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3903852,0.021699702,-0.3752801842677991,-0.029451540752727014
45073,SIDM00872,Venetoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5372624,-0.054484062,-0.7235842373175082,-0.005713447754300712
34853,SIDM00837,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,3.83011,0.058786955,1.549613800778193,-0.0017267976676757601
12730,SIDM00097,SCH772984,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3629749,-0.015682546,1.9748949108283946,0.09483839980627516
37373,SIDM01197,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-1.577165,-0.04541486,-0.667162359549886,-0.029433786303471935
19518,SIDM00455,Trametinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.1019683,-0.19280392,-2.3580463426248306,-0.07944717908894522
2999,SIDM01042,5-Fluorouracil,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1339372,0.03751518,2.5677477416102548,0.07395953414001613
48720,SIDM00633,PF-4708671,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8938635,-0.07258801,-0.7125240659244679,0.028133623270839743
19112,SIDM00359,Crizotinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.83417994,-0.05285247,-1.5437662443547187,-0.046705014855823665
73826,SIDM00950,Gemcitabine,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6896073,-0.17737842,-2.550334457123458,-0.15583236334835285
33292,SIDM00633,GSK269962A,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.14587536,-0.013575207,-1.0349730308782987,-0.035441277669342935
98818,SIDM00633,Wee1 Inhibitor,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.360186,0.120063,-1.4293631197572434,-0.022119861708074347
6840,SIDM00633,Dabrafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7324203,0.05103586,2.0031729801075233,0.06555373427288146
48283,SIDM00148,NU7441,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.50821924,-0.044075295,0.8112184231490455,0.03686231893778891
12315,SIDM00633,Axitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3575377,0.09896147,-1.2634551596667858,-0.0855431256344082
76361,SIDM00875,SCH772984,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.084237,0.1188191,2.2855339311457437,0.12924000300502045
59732,SIDM00875,MK-2206,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3941014,0.24752003,2.40332119720233,0.18128956229327386
28767,SIDM00933,Ribociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.042010427,0.000797971,0.4794459461504164,0.03091267859629865
50344,SIDM00875,Docetaxel,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.887548,-0.070283554,-1.7127955770294296,-0.08086833641241599
16216,SIDM00148,Lapatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0628365,0.08662408,0.41036053282749385,0.019670685763281712
100029,SIDM01042,Crizotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.91391903,0.06695507,-0.5165224570762703,0.01466082285300029
98969,SIDM01042,JQ1,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7522777,-0.07895705,-2.052120345304218,-0.1400420063431431
5359,SIDM00146,MK-1775,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7490158,-0.062523276,0.2145905860388116,0.02362305034119777
104224,SIDM01197,AZD8055,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.3562436,0.08593176,0.8319405208153007,0.06926278447121144
107915,SIDM00933,Alpelisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.5141386,0.14820424,-0.1860195177357395,0.016187821540492472
10886,SIDM00148,Alisertib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6370897,-0.087533616,-0.7782777508284531,-0.02410841227256273
11209,SIDM00776,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.0676043,0.097718336,2.1217948462141143,0.08605438286128053
34504,SIDM00146,SCH772984,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.4242872,-0.1327805,-1.3550144902137584,-0.11705914730901669
39156,SIDM01197,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.39941257,0.02732976,0.37067552095316736,-0.0019275617098095477
89705,SIDM00877,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.53258723,-0.04844243,-0.02412295266256406,-0.027252451813133894
11766,SIDM00872,Paclitaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7097758,-0.11682981,-2.588970809444373,-0.12430934448437812
93826,SIDM00928,Nilotinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.6033548,0.17236397,-0.09140779435895904,-0.01015143222647965
31859,SIDM00146,Taselisib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.7569227,-0.050616123,-2.421338506415874,-0.10632133641892126
7336,SIDM00826,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-2.4830039,-0.1763758,-0.852416862636592,0.06311281281726921
62963,SIDM00097,Alpelisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.139991,-0.00996318,0.8343531691908501,0.03316093749171741
6331,SIDM00673,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,4.053294,0.14604306,4.8607111922535555,0.3400144187998234
282,SIDM01197,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5101073,-0.101957016,-0.7744596920737397,-0.012246067741063581
16063,SIDM00877,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.1833835,0.01774846,1.4668984568998544,0.082331449240152
10555,SIDM00833,Crizotinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.9405561,0.07203787,-0.5808104459302841,-0.03726144274176198
104521,SIDM00216,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-7.3327003,-0.29476202,-5.079269853498038,-0.3109558208005881
69455,SIDM00673,AZD8055,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.19488595,-0.015907928,-0.40592838893991107,-0.028540460957905054
102761,SIDM00826,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.2830617,-0.06701302,-2.6559890697512336,-0.09012695757711156
89389,SIDM00776,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.1794709,0.067127995,-1.1767958519221071,-0.018142782809147037
18654,SIDM00950,Gemcitabine,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0903068,0.15662463,1.3030276516504151,0.07189536160141127
31675,SIDM00872,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.34665683,-0.016131328,-0.8382131417924056,-0.020230569393261885
92779,SIDM01042,Tozasertib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5293304,0.057009425,-0.5864155661830929,-0.036977340468069234
67837,SIDM00455,Oxaliplatin,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.7885432,-0.13625707,-2.2575312514372743,-0.0892715641324326
60444,SIDM00837,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,0.54419076,0.046968915,0.11754440101105551,0.009228542957985605
106741,SIDM00826,MK-2206,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.4629953,-0.11416415,-2.681090308617496,-0.06189935489410061
94341,SIDM01042,GSK269962A,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9398801,0.12179771,-1.1531106116227299,-0.08419598654296817
84095,SIDM01187,Bortezomib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2810578,-0.12868215,-0.6560884678461886,-0.04434162274278404
29248,SIDM01187,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.22347522,-0.00423406,-0.13959794476177112,0.011221067417335175
3247,SIDM00097,Bortezomib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.662435,-0.043711238,-0.6360553871794382,-0.06613189455238831
23,SIDM00097,Venetoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.74735457,-0.024050396,-0.5399233306610706,0.010423379403055537
95480,SIDM00633,JQ1,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.977748,0.091354236,2.2738919855242568,0.08331419586465726
38808,SIDM00877,GSK269962A,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.070337,-0.1029787,-0.6102101151460899,-0.07250319779429251
533,SIDM01197,5-Fluorouracil,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.0047307,-0.052489553,-1.206774235636302,-0.07287041712342808
55688,SIDM00097,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3042672,-0.073046446,-1.4637837828573361,0.011257102905417817
24628,SIDM01042,JQ1,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.22386383,-0.007004483,0.3400471792418653,-0.003616529635104004
90969,SIDM00146,Afatinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0480397,-0.092826925,-0.7751852974230135,-0.0152804286264162
9825,SIDM00148,Nutlin-3a (-),Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8402942,0.06789811,-0.5556650849641056,-0.006752902622511503
1387,SIDM01197,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.49256378,-0.013785405,-0.20374000895233865,0.0016335099609795902
1303,SIDM00455,Lapatinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4766353,0.048636734,2.9334137531639883,0.19409430102769856
33378,SIDM00928,AZD7762,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.2863297,-0.21893026,-0.9749686901133426,-0.09498100435408306
84067,SIDM00875,Crizotinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2252192,-0.10026357,-1.2491479234488534,-0.10500537910497638
4314,SIDM00832,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.863403,-0.057306662,1.4752262821243507,0.06887733923488276
48683,SIDM00148,GSK269962A,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.93046784,-0.05320909,-0.5972120871165393,-0.03402185800279356
52463,SIDM00832,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.8088865,0.21872662,1.9552610403134971,0.04481812036780231
96663,SIDM00928,JQ1,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.69183934,0.08363402,0.22840745471516988,-0.003918168886386342
77580,SIDM00673,Bortezomib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.6151659,-0.033551384,-0.8207611164800132,-0.031155552012895545
99164,SIDM00877,AZD7762,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.5743105,-0.07310162,2.0112695278009505,0.08254255297640874
80195,SIDM00928,Bortezomib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.69001406,-0.06269737,-0.49207787726099056,-0.06478264507709869
91982,SIDM00928,SCH772984,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,3.0540185,0.29823738,1.9336062375394645,0.11045195659931975
5575,SIDM00928,Entinostat,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2509205,0.122109845,0.5438988409393556,0.08760404623930305
41826,SIDM00216,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.1224877,0.062364716,-1.4717597600841887,-0.06918014864005805
69897,SIDM00148,SCH772984,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1183115,0.053498548,-0.833475095684536,-0.07521052899538748
38565,SIDM00282,Trametinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.6047045,0.036417022,-0.20860087271878813,-0.010658859503545958
23139,SIDM00282,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.90049237,-0.05126388,-0.45528466510989635,-0.05121621888188634
97634,SIDM00097,Nilotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5079127,0.034102008,0.3996884320998798,0.0688649795167463
38245,SIDM00957,MK-2206,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.7486165,0.08289943,0.3359364385268209,0.052416001701236864
7151,SIDM00359,Trametinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3201786,0.034299947,-1.1117883071026256,-0.04795582094445451
103987,SIDM00928,Olaparib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.6978196,-0.060569882,0.516756467146561,0.050190673854886174
108445,SIDM01042,Uprosertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.84739757,-0.036687534,-1.3647489294409931,-0.09083880829282232
57740,SIDM01187,Lapatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.5432304,0.11846278,0.04895575104611614,0.0025017023505893034
71022,SIDM00928,Afatinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.470303,0.2402043,1.4271841486779628,0.08504560800201404
60470,SIDM00835,SCH772984,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-1.4090358,-0.12325958,-0.5768910488813302,-0.07429866670530876
6392,SIDM01042,Dabrafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0026537,-0.07582215,-0.17275224189628768,0.027818782233174334
7085,SIDM00455,Irinotecan,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.97017354,0.033062674,0.6778273012253887,0.06785411402867506
33214,SIDM00872,Bortezomib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.21276033,0.015161315,1.3233986331534477,0.04358431041876077
44341,SIDM00928,ZM447439,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,0.7324654,0.087444074,1.5473379735576,-0.004009233514090275
100362,SIDM00673,PD173074,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.3889079,0.10193758,-0.2154901690899526,-0.009435954467827811
84500,SIDM00673,Venetoclax,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4552649,-0.037166238,-1.3687398716165942,-0.015085198363101801
24096,SIDM00673,JQ1,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.2380884,0.1798932,1.1199748206257225,0.0717349467954575
31963,SIDM00928,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4094435,-0.08114314,0.22356214613148864,0.013494634028586886
94002,SIDM01042,MK-1775,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6840874,0.04508336,-0.35103097081182555,-0.048833086382033694
85630,SIDM00359,AZD7762,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.80464536,-0.05348929,-0.4079819075973603,0.046660788451020105
79137,SIDM00097,Axitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5690866,-0.16516675,-1.5895232756455884,-0.06270591732089374
92853,SIDM00875,PD173074,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43238723,-0.02453442,0.23386320449086595,0.034237063945405044
85429,SIDM00872,Luminespib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2587379,-0.09915386,-0.11116569209504258,0.002915553468540183
30437,SIDM00633,Entinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5216599,0.2410003,2.0521135070247847,0.08956231170128615
38128,SIDM00633,RO-3306,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7657956,-0.055137604,-0.32409206240580407,0.010621154097507798
10407,SIDM00146,Venetoclax,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,2.3401408,0.08572429,0.09301804656198354,0.03487752660229473
93429,SIDM00146,Taselisib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.3218915,-0.10806418,-0.95353445071035,-0.07743366337510382
11631,SIDM00872,Gemcitabine,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1300573,0.089809015,1.2520330939619764,0.06687836682927653
61768,SIDM00933,JQ1,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.5825541,-0.042691752,1.4340575193744851,0.15703204436259718
59288,SIDM00097,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.33229628,-0.005202799,0.1755025348513305,0.004008575484002414
32285,SIDM00837,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,2.2697585,0.103406735,-2.07143149128791,-0.05016285689578379
62989,SIDM00146,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.5340504,0.01627899,1.011617208274913,0.04093853040847272
50253,SIDM00673,JQ1,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4715966,0.110800065,-1.053197946128233,-0.050158171703502896
43031,SIDM00877,Linsitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.6852684,0.08288722,0.39021914580336103,0.0194908536433189
35798,SIDM00455,Ruxolitinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0796741,0.022661354,2.289834007191626,0.08518876344165115
31947,SIDM00146,Alpelisib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.7223927,0.10973058,0.5017611495746025,-0.008339632377392232
101776,SIDM00872,Wee1 Inhibitor,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6279014,0.06116122,-0.30097905797719376,-0.023762105621258717
47486,SIDM00633,OSI-027,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5458226,-0.091156594,-1.848908929054279,-0.106646712076883
8470,SIDM00673,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.0887284,0.090287626,1.1048023314751187,0.07247794007368195
36303,SIDM00928,JQ1,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,0.80910206,0.094933875,-0.30978457346631405,-0.015415706505384954
106725,SIDM00282,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0554986,-0.058485433,-0.405778373810801,-0.036386829246949415
50129,SIDM00928,Palbociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.8346269,0.15786333,-0.7308876804229351,-0.0419478449641965
90044,SIDM00877,Bortezomib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.37543845,-0.030841455,0.06968314150222733,0.022570338859762614
78035,SIDM00633,AZD6482,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2692972,-0.095812745,-1.4407907258309818,-0.06479620087057611
57648,SIDM00833,Dabrafenib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.1879848,0.03034497,1.225060167986616,0.037508139801625456
83623,SIDM00148,BI-2536,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3001177,-0.13174605,-3.379941015997135,-0.16096727951849504
42317,SIDM00633,MK-1775,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.68051845,-0.05959392,-0.5477785133660742,-0.06502387835919876
62349,SIDM00633,Uprosertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9616414,-0.039075848,-2.4267783813376034,-0.11596496202755817
16084,SIDM00148,Afatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0682204,0.17832425,0.8258598851832012,0.1439180006566703
88229,SIDM00957,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-2.3215086,-0.063152105,-2.1563728967440117,-0.08812578562928465
7243,SIDM00875,GSK269962A,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.884157,-0.083454534,-0.7927368579536791,-0.033848749607108236
92936,SIDM00673,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7145685,0.017198479,0.3456750540710761,-0.01515524433834759
54471,SIDM00282,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8197787,-0.034321845,0.7556734406592774,0.04536492170022842
56813,SIDM00673,AZD7762,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.34233588,-0.023030918,-1.2389719544161637,-0.07033236694183445
27543,SIDM00282,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.1773102,0.15435864,-1.5778352286110884,-0.08873104729249418
91248,SIDM00835,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.4053857,0.007065494,0.5628109967428504,0.04252367442669829
78312,SIDM01042,Palbociclib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9518916,0.05679018,1.1049706230996037,0.025744336354705088
46128,SIDM00875,Afatinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1519547,0.07116033,2.686035540513944,0.0996444420032515
96024,SIDM01187,Linsitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.6416228,0.14983666,1.2708179254000038,0.0292892303502025
13125,SIDM00933,5-Fluorouracil,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3341786,0.16291846,0.9012403976641693,0.10014153542758825
65685,SIDM00216,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.2136512,-0.123777494,-0.8527634839460156,-0.04244052561255437
36450,SIDM01042,Nutlin-3a (-),5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.96350956,-0.02907401,-0.4683066123255488,-0.007248217512410791
108460,SIDM00148,Luminespib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.68943,-0.05193635,-0.38614208101507935,-0.04289307032866027
72761,SIDM00837,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.12379878,0.005467832,-0.5157115361390533,-0.0012135262273343468
63523,SIDM00928,Dabrafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.3994343,0.07922144,0.20914394451855747,0.0031257322769486506
78760,SIDM00216,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.34267598,-0.03238722,-0.16832129172903645,-0.04482913891354
5111,SIDM00633,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1505475,-0.04854043,-0.8598169882648087,-0.02956901773993764
100767,SIDM00877,Taselisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,2.0517828,0.12722106,0.5628944879939926,-0.011139421585424768
84501,SIDM00148,Luminespib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1687839,-0.085867256,-1.0578067908757038,-0.04713639812500608
101410,SIDM00872,Paclitaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.59879524,-0.05753133,-1.7287529792442329,-0.15376580698095088
64650,SIDM00042,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2915848,0.03809927,1.9687879425875467,0.09721585955395018
4032,SIDM00928,Palbociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.4582694,0.20573407,-1.2812547521108821,-0.06517689767450052
78769,SIDM00877,Camptothecin,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.38617662,-0.04337007,0.38822301006180193,0.009836043678118038
68011,SIDM00148,Linsitinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2819216,0.113327,0.19541377666346613,0.014509268599844846
77229,SIDM00673,Luminespib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.498245,-0.1588162,-0.9063501168595101,-0.08038722616400228
95388,SIDM00872,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1637878,0.08858371,2.5157853674263633,0.11624995757919124
94458,SIDM01042,Vorinostat,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.29580483,0.031201065,-0.5035123693598653,0.00252841283070437
91875,SIDM00097,Nutlin-3a (-),Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4030383,-0.048109055,-0.18679438071731033,0.006373922481904144
11054,SIDM00633,NU7441,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.091251,0.1361472,1.5821575542245088,0.06298125776965761
97189,SIDM01042,Camptothecin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1851251,0.13929616,-0.6489622155010935,-0.05337012185490224
10686,SIDM00933,Trametinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.6043581,0.06516839,-0.8285916386018546,-0.024103669793175055
72047,SIDM00835,AZD8055,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.9089549,0.12152985,3.230278989504504,0.1366324410872607
33024,SIDM00455,Taselisib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8308154,-0.077868015,0.046266819167132094,0.052122336955704396
80602,SIDM00950,Cisplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.47790095,-0.025381789,-0.3410051401908029,0.002523514439175888
80672,SIDM00875,Gemcitabine,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.4352293,-0.020099668,-5.062857888366587,-0.16483232938707848
358,SIDM00146,Pictilisib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.15658997,0.009612912,-1.1012273730492088,-0.031066785732378886
35304,SIDM00097,Doramapimod,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7794755,0.04594937,2.4429955734886657,0.06688888714219403
99951,SIDM00928,Venetoclax,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.5856364,0.16874914,0.31225337344343523,0.012319963183421568
107375,SIDM00835,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.6948221,-0.02855991,1.0925332909183239,0.024921660377163007
83783,SIDM00875,PD173074,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26324365,-0.01481597,-0.2572744231067676,-0.01340744420574084
55223,SIDM00872,Vorinostat,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,2.2648652,0.14747608,2.142688613113437,0.10999011566913897
39957,SIDM01042,KU-55933,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6362978,-0.13113487,-0.5402891859508465,-0.04601909119335392
100087,SIDM00042,Erlotinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.1648655,0.2086137,2.4709137686238902,0.1409568662185356
87095,SIDM00950,5-Fluorouracil,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.165727,-0.08363727,-1.19425321237436,-0.027708074536931932
75040,SIDM00216,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9632884,-0.07040681,-0.8186936822441985,-0.056018501013684024
3705,SIDM01042,Docetaxel,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1572425,-0.11953175,-2.995462852939366,-0.24559921341439062
41447,SIDM00146,Alisertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.183085,-0.1510585,-1.6857270045995763,-0.061245545687423034
70012,SIDM00877,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.2886202,0.14479946,-1.5890039386986612,0.002575576584611587
19045,SIDM00826,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-5.2091994,-0.18063319,-3.6020232087193884,-0.15622890139037263
97580,SIDM00148,ZM447439,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0014782,0.17902935,-1.2542404914172065,-0.07641957218308824
106444,SIDM00877,Afatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.5954287,-0.061187427,-0.17031497091849593,0.042325875057850224
107276,SIDM00933,Ribociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.08550025,-0.0017454274,0.6674064284202568,-0.034529159575817835
4683,SIDM00933,Camptothecin,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.5530194,0.10987298,-1.4091595381102617,-0.1294581063114803
21104,SIDM00933,KU-55933,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.7844822,0.09477165,0.7977991885075625,0.0771595213993069
7450,SIDM00455,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8108464,0.020584749,1.2749326400140364,0.09384942976842103
71139,SIDM00933,PF-4708671,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.9501024,-0.14488147,-1.1585781409403457,-0.04325439164759695
14283,SIDM00042,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.824645,0.19050431,2.5769056126141994,0.06782909741517085
43730,SIDM00633,Entinostat,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.72610676,0.052993443,-1.8192291791322204,-0.0386958475001055
55290,SIDM01042,Ribociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.810319,0.15981963,0.6158165488415835,0.0036568344451549943
8015,SIDM01042,Olaparib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7215304,-0.09848546,-2.0999574005394215,-0.07682052333304477
47883,SIDM00837,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.6972172,0.13551316,-0.6999778055392848,-0.08198269211682857
77186,SIDM00957,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.3952045,-0.01505576,1.6004886297490235,0.07333307955866956
1334,SIDM00875,Luminespib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.975084,-0.1030559,-0.06522313193209532,-0.07144414345884349
18881,SIDM00875,Doramapimod,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4090431,0.043374173,1.077347345554811,0.004788395987917355
40626,SIDM00826,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-1.7719395,-0.08644528,-1.1453251811291805,-0.07948501603917611
56483,SIDM00928,Alisertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.3053565,0.11900757,2.1750419862282264,0.1259720453194399
23547,SIDM00673,Crizotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.34387478,-0.033198684,-0.4289320515628116,-0.02799210260077228
74890,SIDM00872,Ribociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3067676,-0.031479005,0.443726319475402,0.01370696036516912
102883,SIDM01187,Vorinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6201004,-0.059888627,-0.6103754383804065,-0.0612434399181638
2031,SIDM00833,Linsitinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.2588446,0.07707208,0.9304443643744147,0.0214782692451917
35988,SIDM00282,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.855198,-0.053869173,0.06260802936403925,-0.03284388655387917
84490,SIDM00875,Linsitinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8776946,0.13238472,0.7378373233283055,0.053279330875385604
43481,SIDM00673,AZD8055,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9373065,-0.14901696,-2.0352477255635457,-0.1074507110796583
87521,SIDM00282,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2535017,-0.11495338,-0.8747275866663441,-0.06067419873295628
3191,SIDM00933,AZD7762,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.5660385,0.061111756,-0.5381654378282619,-0.0062045403211897256
47015,SIDM00872,Vorinostat,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2936121,-0.07770509,-0.2834626114996819,0.003808110072167155
37614,SIDM01042,Trametinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.530731,-0.13844235,-1.119634744420787,-0.040601162750591675
76975,SIDM00455,Olaparib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.6263843,0.080634914,1.6514680370404522,0.05639857712128941
102208,SIDM00957,BMS-754807,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-0.34781235,-0.013899207,-1.6567508054296658,-0.05445205491445333
76893,SIDM00673,Luminespib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-3.3496456,-0.17875756,-1.7923440688666752,-0.1099673223204261
23047,SIDM00872,Camptothecin,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0798662,0.029032322,2.7619515785154176,0.10119583401800845
7458,SIDM00875,Luminespib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37623549,-0.04023203,0.4250056004168798,0.02466767664200263
3729,SIDM00216,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.23146944,0.019924914,1.3699290033961198,0.10486694096359347
75192,SIDM00148,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.50245327,-0.03671837,0.4840087318034833,0.01838075367607713
65475,SIDM01197,Linsitinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.57656246,-0.045519315,-1.3167968198739852,-0.09916785788102933
8530,SIDM00146,Luminespib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.73106724,-0.06364467,0.05537628176352458,-0.009192419192949655
31284,SIDM00957,AZD4547,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-4.3027973,-0.061053015,0.7090556772765149,-0.0017827059736083752
100230,SIDM00146,Linsitinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.8057738,0.021659961,2.0872172360180063,0.05751931980180513
91482,SIDM00950,MK-2206,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.4353906,0.04890318,0.016070860956105847,-0.008628167340739012
63777,SIDM00872,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.447723,-0.10580791,-0.20489869976394778,-0.06365134248985362
70622,SIDM00146,Tozasertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2481465,-0.07702591,-0.7252145298839666,-0.025782095161627366
89102,SIDM00826,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.2682657,-0.00901439,-2.1977569310883664,-0.06046820664561914
10362,SIDM00833,Palbociclib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7316215,-0.018282244,0.6444625055683864,0.027922872527658234
2029,SIDM00633,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8535093,-0.06749239,-1.4494086299436182,-0.0849769632160124
102721,SIDM00833,Trametinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,-0.573762,-0.027933994,-0.6258636277350184,-0.03687714325081505
97845,SIDM00877,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.58212864,-0.057350993,-1.1900223417462048,-0.032519877308349564
2255,SIDM00097,Cisplatin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2641828,0.02820921,0.3397192631308738,0.026261544966251323
93066,SIDM00872,Nilotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4307022,0.13694346,0.8913498422481222,0.0637136033371441
14758,SIDM00282,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.76239604,0.012313392,1.6559904382218926,0.02222346070577287
56880,SIDM01197,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.1827455,-0.12480932,-1.8194925602815697,-0.04768998565871439
48647,SIDM01187,AZD7762,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.377237,0.20283292,0.6691389016740701,0.0774419552699179
17125,SIDM00933,GSK269962A,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.5124884,0.13526353,0.08247684319833011,0.0428761261179074
61923,SIDM00832,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-4.5685096,-0.2764731,-4.203193338064077,-0.21265843080707986
71116,SIDM00877,Nilotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7717913,-0.072025925,0.16833418912749842,0.09597687197345056
107236,SIDM00042,Oxaliplatin,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1920778,-0.07540113,-1.2171387716877655,-0.04773519714366993
24545,SIDM00928,AZD7762,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,1.4466851,0.14195924,0.14281697794649376,-0.013218332421584619
85013,SIDM00282,SB505124,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,0.7606876,0.024893595,1.020898018655802,0.06650367239415846
88723,SIDM00950,MK-2206,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.1864307,0.1287206,1.3129508366612799,0.09739456307725866
60286,SIDM00933,Gemcitabine,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.5393757,-0.0021539975,-2.3218488856119555,-0.09036945275754714
35510,SIDM00148,Afatinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.007928,0.079408646,-0.3997461095731327,0.0660122234684874
85964,SIDM00933,Navitoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.23718102,0.02655192,0.8388364653427239,0.055208367227162825
35522,SIDM00877,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3012618,-0.071096525,0.13859261331218556,0.04103316647626021
98979,SIDM00957,SCH772984,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.7524529,-0.07383827,-1.1069881391770544,-0.040560281028736864
65110,SIDM00216,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3734468,0.08913573,-1.0765469423890677,-0.0778096934772704
90675,SIDM00633,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8427583,-0.12754591,-0.881377785633831,-0.05269872558086347
53372,SIDM00097,Crizotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8103612,0.0416899,0.33906176591939713,0.046874232145134594
32691,SIDM00928,Docetaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-3.347802,-0.06824218,-2.117579933892413,-0.15038042611752797
95018,SIDM00877,Doramapimod,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.32572648,-0.014963147,1.4756201167415992,0.09419794771163713
4703,SIDM01187,Temozolomide,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.718693,-0.017339796,-0.5026740563889533,-0.012622248925853098
900,SIDM00950,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3490872,-0.22230054,-0.7440701486328032,-0.030231836982880005
44118,SIDM00455,Taselisib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.67849374,0.049188934,-1.20709518905018,-0.07814155484901937
76701,SIDM00042,Trametinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.213921,0.1204385,0.052924050880872424,0.031542497370137874
102894,SIDM00359,LGK974,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0720947,0.03289336,0.8868975793433836,0.05822479504179462
40745,SIDM01042,Alpelisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6940608,-0.058329437,0.7968246152946052,0.060788429714720406
50687,SIDM00633,Nutlin-3a (-),Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1084604,-0.06301535,-0.6645535270376707,-0.01429890600035276
99459,SIDM00875,Sorafenib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17858815,0.014375415,-0.17421136993531502,0.014353319600616529
20339,SIDM00933,Doramapimod,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,4.2336087,0.056483768,3.911955275768814,0.10501929618167674
17688,SIDM00216,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.31441268,-0.017915074,-0.31038981621467965,0.023461241232411157
16664,SIDM00837,Crizotinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.08651508,-0.005206293,-2.045888743799661,-0.07538163051774766
69673,SIDM00928,Nilotinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.3801771,0.14362036,0.4397511646460351,0.04737239978728529
80904,SIDM01042,Wee1 Inhibitor,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.069643,0.07347551,0.7067193309629853,0.06875505838758174
63775,SIDM00837,SCH772984,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.630708,0.10789251,2.192310409736293,0.08610193579163063
50711,SIDM00455,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4924073,-0.137908,-0.9283947257449139,-0.05656113951203171
105372,SIDM00673,ZM447439,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0328507,-0.17225558,0.46827869666491617,-0.0014385155437969597
92903,SIDM01042,NU7441,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.32769078,0.014783369,0.3884902065040587,0.022247653159023488
57092,SIDM00097,Lapatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0224133,0.19004956,-0.23853401064522278,0.04495123326432553
43493,SIDM00877,Tozasertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-1.9564775,-0.12834626,-0.21092509757746922,0.06643548290885407
38564,SIDM00833,Linsitinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,4.0683575,0.29292923,2.1660701792297092,0.0766220055527945
7371,SIDM00216,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.8010235,-0.13137104,-1.665978773194482,-0.09866314502839497
17543,SIDM00835,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,0.39290512,0.021240922,0.8325002909665119,0.021804241459982325
25402,SIDM00673,Vorinostat,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.65950763,-0.06865727,-0.6957354707997411,-0.044652116453889605
4652,SIDM00933,NU7441,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.43010584,-0.042771664,1.2661910378967103,0.04623152579792652
29517,SIDM00455,Irinotecan,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1554507,-0.028717397,-0.6888047039135493,0.08335267732705297
42919,SIDM00216,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.8459825,0.013143943,1.4165764307288156,0.04766616414100909
10987,SIDM01197,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8708193,-0.09095985,-1.7650732526505593,-0.06328518372433962
90111,SIDM00633,RO-3306,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.023645,-0.06368284,0.14095906525868582,0.046840351993877934
36559,SIDM00950,MK-2206,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9961755,0.24999107,2.7094934156157358,0.1602440661664309
76668,SIDM01042,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9634672,-0.11319501,0.5168896018829195,0.03588113156040677
53725,SIDM00455,Trametinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6178409,0.025890384,0.3774255083154858,0.12190220038311605
76413,SIDM00877,GSK269962A,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.76393676,0.09028812,0.6797127299710403,0.06442684201939818
100170,SIDM00148,PD173074,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.298151,0.16267847,2.926543590261775,0.09004165964666905
85781,SIDM01042,Olaparib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7761742,-0.111576,-2.156230801151583,-0.07302219472363203
36056,SIDM00633,PF-4708671,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0721624,0.035387356,0.9494767401036472,0.08442039839988325
90857,SIDM00933,Docetaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.3545605,0.15524825,-0.16227482709549879,-0.01683285673880162
23728,SIDM00148,NU7441,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.78475267,-0.071251184,1.2192672900997144,0.04825161063131641
21899,SIDM01042,KU-55933,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3039534,0.15072808,-0.0448882913829441,0.044130415513060094
102550,SIDM00148,Afatinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1873788,-0.08868788,-0.9801875262989561,-0.023689956634227707
42198,SIDM00933,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-2.9698653,-0.019544002,-3.249147508297586,-0.02761579199900782
105316,SIDM00097,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7680068,-0.07601555,-0.5671146692851825,0.009037942064113869
107657,SIDM00835,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-2.0184696,-0.13099489,-3.086809448999881,-0.1013689536842201
52800,SIDM00455,Lapatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.747666,-0.019353403,1.081795052446895,0.0688736552187984
36619,SIDM00877,Navitoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.32228896,-0.03903328,-0.5714798664468487,0.038625570509792526
105209,SIDM01187,Navitoclax,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6860175,0.06775244,0.8192095203324418,0.05242662795943874
103769,SIDM01042,Nilotinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8603203,-0.06591962,-0.08898319807426236,-0.051548106026073265
47425,SIDM00146,Sorafenib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.48359525,-0.041913364,-0.8816475964466898,-0.07902788699996638
83866,SIDM00148,Cisplatin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4511647,0.14921239,0.4884517607712248,0.07050654064843727
18910,SIDM00455,Gemcitabine,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3410271,0.07386197,1.5047898168075389,0.12299475403611854
25547,SIDM00957,Crizotinib,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.9731193,0.030984383,1.048429400959857,0.10076486746447853
13658,SIDM00455,Cisplatin,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9001184,0.09890077,2.1402216768828026,0.1416503335850558
51651,SIDM00776,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.4248871,0.01973696,0.9728512244995184,-0.006119214012117542
54120,SIDM00877,MK-1775,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.6326474,-0.033927042,-0.7951908489072371,-0.05605555665894136
11115,SIDM00673,Temozolomide,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.6658689,0.016458884,0.7276573058382777,0.033896753861640684
64631,SIDM00146,Sorafenib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8223165,-0.07687061,0.5012955148518029,0.011041364118502473
52881,SIDM00833,Navitoclax,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.6382481,0.07166631,1.0151462691439093,0.03851668300801585
104802,SIDM00872,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.48033038,-0.045476235,0.2643433571405583,-0.008092337017234668
1140,SIDM01042,Taselisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.27415434,-0.022856664,-0.9352238692020839,-0.10426458602982745
70455,SIDM00826,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,0.029341703,0.002265198,-2.0498100777072983,-0.1417487070715659
107386,SIDM00877,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.0326939,-0.0835886,-0.14367268288953416,0.015887961891750978
82180,SIDM00097,5-Fluorouracil,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0054862,0.0417443,-0.5839373563122562,0.0054660135071900205
49263,SIDM00146,Lapatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.29138184,-0.024110591,-0.02812513768860116,-0.0050141128988305346
47240,SIDM00835,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.266762,0.1465761,3.0667505702249267,0.08151967415810402
94317,SIDM00832,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-2.0067406,-0.112025104,-0.9744635034071232,-0.0689291329764557
34512,SIDM00835,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,3.487337,0.10540109,4.4147954506136795,0.11285452609646919
102740,SIDM00097,Crizotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6427422,0.10818002,0.6973876064938723,0.024283139445791604
9624,SIDM00455,Paclitaxel,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.3191957,-0.021616466,-0.13836010268814372,-0.042770768094125146
84440,SIDM00928,GSK269962A,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.6944306,-0.16287568,-0.5038016914900342,-0.055011525364849836
51158,SIDM00673,BI-2536,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.33702654,-0.02735603,-0.5795839985405441,-0.08786356893671816
98884,SIDM00776,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.374812,0.03806474,1.3386920042719428,0.08714115721508887
10873,SIDM00837,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,1.5478057,0.02014086,-0.716659742009985,0.005089349492068659
68481,SIDM00673,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.15258773,-0.016084092,1.4981349557803032,0.0744513815477343
8920,SIDM00933,AZD7762,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.2536333,0.028659662,-1.1388329423641401,-0.03218528521083944
37079,SIDM00928,Docetaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.8107831,-0.18002683,-0.9698068522150651,-0.02092612836149051
100614,SIDM00673,Venetoclax,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.51314473,0.010490516,1.4654313487050137,0.11846469864173949
77657,SIDM00633,Uprosertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.25943536,-0.0189629,-0.7455127693022506,-0.012815989271938194
16953,SIDM00875,Navitoclax,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8796842,0.083307914,2.9256697759636094,0.09461649019853419
29719,SIDM00835,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,2.4685178,0.09299934,0.6486534717304446,0.0330239359730959
45027,SIDM00928,Afatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.3043754,0.23991157,1.6723801766896542,0.10854550060759825
17961,SIDM00957,Olaparib,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.0044081,0.017454721,0.0508512135955326,0.0023204534864832045
83205,SIDM00633,MK-2206,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9526706,-0.04705913,-0.43500980424712,-0.06080610551555735
81069,SIDM00875,AZD6482,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4457742,-0.032620065,0.24218886835624087,-0.008226723505948661
24057,SIDM00455,Dactolisib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.91451436,-0.057449523,0.7500978324936266,0.00037980847126940553
23097,SIDM01042,Ribociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5990225,0.039836936,0.9669134462446496,0.07853389412306187
58684,SIDM00148,Crizotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5939487,-0.017253652,1.8758340963807916,0.05172128659276616
91403,SIDM00877,Lapatinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,1.55888,0.13110027,0.957829495407503,0.07594473129432527
50071,SIDM00097,Alpelisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2454934,-0.078865096,-0.3825568250303657,-0.05510007894577475
46508,SIDM00933,Pictilisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.2280877,0.030036123,-0.8497822839764072,-0.03676606804092083
36124,SIDM00633,Linsitinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.086285,0.09277217,0.8591931256205421,0.012218138332731563
69872,SIDM00282,Oxaliplatin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8202592,-0.05984442,-2.1502772271624586,-0.1411244931974767
18421,SIDM00872,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.2576134,0.0740431,1.4904479934992376,0.06654044817164471
8658,SIDM00826,Trametinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.0091901,0.004557562,-1.0349172500529635,-0.014743228297541619
89409,SIDM00148,BI-2536,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.958414,0.06774617,0.0808115919690751,0.017695446988450568
30171,SIDM00673,MK-2206,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.13492471,-0.009025448,-0.933251593885113,-0.07180578766217673
82486,SIDM00097,AZD7762,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4302847,-0.07625984,0.10723477442534868,0.04441158492495844
76530,SIDM00875,AZD6482,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0278233,-0.07009262,0.7127193929371366,0.03174181631017537
31722,SIDM01197,LGK974,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.6701328,0.032143205,-1.784328092652789,-0.07105226046844883
16729,SIDM01042,KU-55933,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.93469983,0.09328615,0.6306109224133969,0.06684480474543134
3756,SIDM00837,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-4.458655,-0.030261302,-3.5308152557954835,-0.13004389068193425
44773,SIDM01197,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.5413956,0.010168228,2.7861426765698925,0.12116708712553445
49210,SIDM00146,MK-1775,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5723838,0.04177776,-1.892240044160458,-0.11093993103880706
89151,SIDM00148,Ribociclib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4678844,-0.050977048,-0.5503755388894247,0.0006807727529358787
259,SIDM01042,BI-2536,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5775542,-0.013824814,-1.157484466369402,-0.023684640959071003
79106,SIDM00148,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3276643,0.111592874,-1.0698416280123495,-0.02849340061479073
31192,SIDM00097,Sorafenib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8231437,0.09219817,1.3810234994265158,0.09449338259880118
99948,SIDM01197,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7753859,-0.040487584,0.4861983373972084,0.008871090405365887
20764,SIDM00282,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.8353167,-0.037945673,-1.050144558905245,-0.030836484452610457
48425,SIDM00877,Nutlin-3a (-),Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.3584034,-0.042410225,1.1619775664438696,0.038267832503346956
71120,SIDM00928,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.5833521,-0.0582172,0.018398510826004633,-0.004514441207682769
9818,SIDM00877,OSI-027,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8610359,-0.07226971,0.38575090761792935,0.016993787949065167
82795,SIDM00933,Docetaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.6592853,-0.22939838,-2.7939750702366783,-0.18280781908019772
98338,SIDM00872,Linsitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5727668,0.1378401,1.3100331320084047,0.06315537335212337
55837,SIDM00455,5-Fluorouracil,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1315373,0.060173407,-0.9211880823922761,0.015387588160706124
56967,SIDM00633,Wee1 Inhibitor,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.462546,0.0839991,-0.7277134118953371,-0.04689185192799622
51114,SIDM00950,SCH772984,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3028078,0.08725089,1.4257725406931907,0.057154518840583375
104039,SIDM01197,Camptothecin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,1.1496167,0.070010275,-0.3478894168065668,0.01049568070840752
33023,SIDM00673,Camptothecin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0763737,-0.029058984,0.268019291780499,0.010284642897544558
36188,SIDM00875,Olaparib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.1016846,-0.17747895,-1.3466184379426376,-0.04342630360581958
35212,SIDM00950,LGK974,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.023407,0.13504258,1.616298829714225,0.09147193358862486
53243,SIDM00957,AZD4547,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-4.784288,-0.08384118,-0.33785805463854274,-0.024493529033623
32859,SIDM00673,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.9328501,0.094898246,-0.9302840931901875,-0.0304789572464087
94740,SIDM00673,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.26262012,-0.020280072,-0.20508900621144407,-0.03602531743344539
37984,SIDM00950,Cisplatin,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0515507,0.023411354,0.6882004000952864,0.07285403132179588
55201,SIDM00455,AZD7762,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0029323,0.07680098,0.4537072307123268,0.057724283423618065
3548,SIDM00877,JQ1,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.4392278,0.04427515,0.09793760862126026,0.012931783964204245
24702,SIDM00633,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.25422564,-0.0028004562,-2.058464601474129,-0.06453077779753692
15778,SIDM00872,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.21538223,0.0063990657,1.560782107240466,0.07830743825953451
26530,SIDM01042,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3681064,0.03161887,-0.3676753919275203,-0.021880296643173765
53670,SIDM00097,Camptothecin,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0526936,-0.028586993,0.37189725987622124,0.020887505099301144
107241,SIDM00146,NU7441,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.2197073,-0.11449363,-0.3093687424189789,-0.019678421121233136
41544,SIDM00097,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2713304,-0.13716364,-1.2716514601340467,-0.05297209794772136
23130,SIDM00837,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.9745088,-0.036146834,0.9342251117787158,0.029521950614189576
28833,SIDM00837,Afatinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-1.234542,-0.08750981,0.23244499318917694,-0.04193854248902199
92664,SIDM00776,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-2.8049557,-0.22072423,-3.251366985199733,-0.2223565644842164
75593,SIDM00872,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.13257012,0.0038674485,1.110559943740072,0.04053643966111037
87953,SIDM00826,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.5756841,-0.117380925,-1.5336537471559957,-0.10095932049047687
108435,SIDM00146,Crizotinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.051081374,-0.0036285603,0.6099971973089579,0.12675080231002214
27285,SIDM01187,Crizotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7365139,0.16066739,-0.4909261198061175,-0.04362006268891386
49031,SIDM00826,BMS-754807,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-5.103705,-0.08289233,-2.9323368435822155,-0.08551058167971735
85226,SIDM00826,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-3.8998594,-0.18190815,-2.9326399291976797,-0.1795333580950818
17835,SIDM00633,JQ1,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.108936,0.10715862,0.5975622810266352,0.07550605419817914
39020,SIDM00875,Wee1 Inhibitor,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7473185,-0.054362655,-1.4612912638194508,-0.11826289806726635
87251,SIDM01042,Temozolomide,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2374141,0.05384489,1.5222042306635677,0.03223507692026894
45431,SIDM00148,Ribociclib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4738183,0.12436366,-2.4409153434720134,-0.03507415474501069
100684,SIDM00673,Crizotinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.832193,0.042515025,0.7494827229748996,0.037856719036260776
28704,SIDM00148,Uprosertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5429837,0.111533605,0.40932955007703714,-0.02135066928304043
33835,SIDM00359,MK-1775,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1080779,-0.09718497,-2.8942911152043624,-0.15404180877799362
92974,SIDM00875,Tozasertib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.55070835,-0.007973417,-0.4233150366937198,0.0034838524789391383
38793,SIDM00933,Palbociclib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.0694181,-0.07998906,-0.5285173194051221,-0.008060668480960835
9741,SIDM01197,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.8517306,0.02077974,-1.3427698081483326,-0.00978252243724726
50379,SIDM00872,Paclitaxel,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.17382613,0.017232466,0.8744346199276057,0.03369734852506338
66196,SIDM01197,AZD7762,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,4.378501,0.22946103,1.4039534825468565,0.051451579736408265
70025,SIDM00148,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.069081,-0.09141695,-0.8084282015137217,-0.0416456464864471
54547,SIDM00146,GSK269962A,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.44327223,-0.029152354,0.6695392330892359,0.0460166352798179
79264,SIDM01042,OSI-027,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5329894,0.049099952,0.525794871800032,0.015883627565161478
42937,SIDM00148,JQ1,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.71431,0.15034632,0.9915376087166843,0.013875975785535183
53766,SIDM00875,Wee1 Inhibitor,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.66949207,-0.046902124,-1.415292971113716,-0.09881514364544246
17918,SIDM01042,AZD6482,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.65321296,-0.039530084,-1.0930683542529225,-0.05782726060236717
84071,SIDM00877,Pictilisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.8365094,-0.048136983,-1.1215318939984384,-0.12097761515167037
15928,SIDM01187,Palbociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.0854914,0.123232126,-2.0353577024476217,-0.02943184016921645
34982,SIDM00776,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.26456892,-0.018684734,-0.6517096953412818,-0.0075566581924229916
84123,SIDM00826,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.5814557,0.07102256,0.5898568457952725,-0.024210340744052004
6131,SIDM00928,Trametinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,5.825272,0.1624856,2.4817436022708264,0.09257523777629852
23189,SIDM00875,Cisplatin,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.52076197,-0.026096763,0.9247446848051085,0.06909627695368786
55493,SIDM00633,Afatinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-5.2533736,-0.047435954,-5.626248536445947,-0.12816833794622742
49712,SIDM00957,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.8850577,-0.06331338,-1.3708759487962123,-0.0700856517904784
71363,SIDM00097,Axitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9959626,-0.120618664,-0.990276876451931,-0.07445124455377744
95104,SIDM01042,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0594091,-0.023159422,-1.9793726063779415,-0.0517034770928771
55397,SIDM00146,KU-55933,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.992372,-0.075353615,0.2803223270096915,0.11214253915579876
108229,SIDM01042,Vorinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0089855,0.08433579,0.8256450361905686,0.08437200944937566
10174,SIDM00933,Cisplatin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,2.0985396,0.26680058,0.8951635473380919,0.09163709743920496
58331,SIDM01042,JQ1,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.92753744,-0.031713717,-1.607214468171634,-0.12068746841491877
99268,SIDM00148,Camptothecin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8310066,0.077944405,-0.536883515892464,-0.031915093267571575
9002,SIDM01187,MK-1775,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.40769953,-0.038094565,-0.31069947486837496,-0.026815053100389216
41199,SIDM00097,Gemcitabine,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.6388335,0.26184326,3.8832739183652265,0.24313584932396143
75744,SIDM00146,Wee1 Inhibitor,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.5136277,-0.027149359,-1.8108757664781363,-0.06557253859932377
100742,SIDM00455,LGK974,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7873428,-0.055697523,-0.41336315303573473,-0.025355735958000104
69374,SIDM00216,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,7.3611445,0.31341353,0.40645576232959946,0.048767039655312074
60579,SIDM00837,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.48198614,0.02842398,-1.1464968297272793,-0.027299810952838843
12949,SIDM00950,Dasatinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4163988,0.22320338,0.3797725708407377,0.062045835531046395
92371,SIDM01042,Luminespib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5666412,-0.063118406,0.2202032267147414,-0.03065560607010292
18293,SIDM00872,Sorafenib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1884362,-0.020259155,-0.5371019988897473,-0.057557172133276026
24658,SIDM00097,Doramapimod,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2272708,0.07813863,2.3219001031437547,0.07125917845597121
101774,SIDM00097,MK-1775,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2605708,-0.13272497,-0.43834836420217715,-0.07647021274900245
63037,SIDM00282,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-3.5904531,-0.17309473,-0.5802438415830831,-0.06686033221396318
56143,SIDM00455,Lapatinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7530456,0.07328541,2.217665968479136,0.13088488238837204
10653,SIDM00097,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.049108,0.13378114,1.9472677739071556,0.2056801458762253
35885,SIDM00359,Palbociclib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.91381174,-0.044383142,-1.3971877835333928,-0.020712548080914796
51831,SIDM00832,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.97017795,0.08517038,0.6925469045854603,0.023501126913485857
103898,SIDM00216,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,2.1767952,0.07769004,-1.336371723030086,-0.062440635870146984
8547,SIDM00832,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.7674326,-0.044260047,-0.35880836707057,-0.027962965782094912
74253,SIDM00776,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2953551,-0.110496745,-0.7714812237853954,-0.12396553729713486
93830,SIDM00872,PD173074,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1911821,0.1452127,1.289718742043255,0.09409634328577758
24753,SIDM00950,Erlotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1337594,0.12214572,0.1731121635001932,-0.012442642168498231
57771,SIDM00359,AZD7762,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.1113477,0.1444588,0.009236944858325583,0.08195389664290731
63793,SIDM00933,Afatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,2.5868013,0.22982031,1.1226163421108228,0.1640960145843387
25768,SIDM01197,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.7200522,0.04485066,-1.4400144083416848,-0.09230789561050662
28923,SIDM01042,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8527627,-0.024094744,1.3581476689404421,0.02116800593174836
67171,SIDM00875,Cisplatin,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28257412,-0.01197311,1.2639603289040444,0.0546355192943441
105255,SIDM00928,Sorafenib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.18381917,-0.015962994,-0.3231835300523878,-0.012119027914475226
36487,SIDM00875,MK-2206,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8018348,-0.06036833,1.2877729470797377,0.07617296440107815
27014,SIDM00957,AZD7762,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,3.9162564,0.08467282,-0.01618365458291646,0.04527800205822657
24997,SIDM00835,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.342553,0.17548048,0.30304106888712795,0.07360161685310376
80685,SIDM00148,Lapatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7766931,-0.061805617,-0.4459468365080752,-0.07899108120498212
62410,SIDM00776,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-2.0148137,-0.06310926,0.00690499788992068,0.02600743727360376
24045,SIDM00832,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-2.3421068,-0.086946264,-2.784977516277736,-0.07290405292148494
97922,SIDM00872,JQ1,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2036791,-0.02838393,0.39908290364103083,0.0023990470881843085
49099,SIDM00826,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.794053,-0.092197835,-3.1525362156189085,-0.1321487095039025
71930,SIDM00146,Camptothecin,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.0341613,0.15546207,0.5601102239913485,0.05640996121749018
74269,SIDM00633,GSK269962A,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.54860973,-0.04853386,-0.8549761204665891,-0.041296321922507116
39427,SIDM00673,GSK269962A,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.9305195,-0.13435595,-1.6242464268502836,-0.08912923157431887
95588,SIDM00872,Afatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9143035,0.19512184,0.9429606813194307,0.06117985307761835
12950,SIDM00837,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.046945,-0.04329258,-2.523246414176152,-0.13497956613944453
20595,SIDM00097,Pictilisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.510021,-0.11161533,-0.6732374764727769,-0.04139165331557446
82285,SIDM00097,Nutlin-3a (-),Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8801204,-0.04731117,-0.6731754670572687,0.019204675453146604
42452,SIDM00148,Vorinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.54099345,-0.050415106,-0.8671909884334947,-0.05091803283336882
88578,SIDM01187,Vorinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6159115,-0.060669314,0.09671801772257929,-0.021719915207741292
11065,SIDM00872,MK-2206,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6729135,0.0719623,-0.6533905312162358,-0.07713282053700317
27832,SIDM00872,Uprosertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1131016,0.12288427,0.6665957928130861,-0.004348551035270512
68178,SIDM00148,Entinostat,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6557356,-0.04571405,-0.3064961118251097,0.004692178062745347
4663,SIDM00146,5-Fluorouracil,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.1358774,-0.06666608,0.06280572130410138,0.044494537401896704
101631,SIDM00877,Taselisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,2.3381076,0.11695582,0.7408640686859878,-0.016617529226197678
15181,SIDM00042,Sorafenib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1819392,-0.09103742,-1.4403372326593595,-0.05925867457236055
26740,SIDM00832,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,1.2916694,0.01862142,0.9642959321015568,-0.006954763523706964
89400,SIDM00837,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.3969978,0.0708734,-1.2112990218746642,-0.024074615099015068
74744,SIDM00826,LGK974,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-1.7406527,-0.057696715,-0.9773423171181247,-0.0520249500056773
31178,SIDM00455,MK-1775,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.4481527,-0.088448904,1.1297423683221453,0.05636540253176113
18034,SIDM00633,Alpelisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.93695897,-0.0758892,-1.8687374732906932,-0.028608195550036762
37707,SIDM00673,Camptothecin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.685518,0.02518097,1.5430736978199664,0.07377011138209393
59530,SIDM00875,SCH772984,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28385273,0.03195683,0.6955056283050716,-0.030313459096054284
9023,SIDM00359,Dabrafenib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.37695616,-0.019233195,0.03640061666725861,0.00015851850142356317
104098,SIDM00933,Paclitaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.56395537,0.05616631,1.0311499942872437,0.0658273169571872
96798,SIDM00146,SCH772984,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.3544036,-0.09858366,0.059242133893638804,-0.0042009263470667475
57150,SIDM00146,Uprosertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.1174486,-0.11763782,-0.010713894386549268,0.06771672342150849
24006,SIDM00875,Linsitinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6656393,0.11176114,0.18241330225169552,0.029775435331737432
82381,SIDM00837,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,2.043096,0.028582951,-0.18309058166341052,0.030198297227079132
102327,SIDM00097,Alisertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.407241,-0.1601065,-0.8198399914640622,-0.008839024768738352
15126,SIDM00146,Luminespib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7676846,-0.06826237,-0.33256138125475415,0.024384598887713556
22325,SIDM00837,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.8549035,0.07886372,-0.05276270138079054,0.08437693494336104
85080,SIDM00875,Tozasertib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.513358,0.029687187,-0.6957713635710375,-0.0007036941881741798
31196,SIDM00359,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4555275,-0.08548112,-2.629415890833962,-0.07370906154683557
70945,SIDM00832,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-0.8410681,-0.013988694,0.6802284071531385,0.008568322456267671
97894,SIDM00933,Cisplatin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.2050836,-0.18967713,-1.6234199877658924,-0.07426377229981251
32128,SIDM00957,LGK974,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.7861679,0.05530114,-0.22103985918465932,0.05106123287986129
68306,SIDM00877,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.064355,0.18922259,0.3976942849420135,0.030785358388649178
13721,SIDM00872,Nutlin-3a (-),Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5653175,-0.014381737,0.6850886244641399,-0.0067181719366055615
43222,SIDM01042,ZM447439,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0737439,0.14028117,-0.4932026808696748,-0.05644310529044186
77588,SIDM00359,Crizotinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.88330764,-0.061660238,-0.8121300124477556,-0.012647985549452824
28253,SIDM00877,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.93984735,-0.053935975,0.0001333215953789815,-0.05766989104136716
105555,SIDM01187,Navitoclax,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7279432,0.054970656,1.62290919358703,0.11383866892930834
101900,SIDM01187,Axitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.62288314,0.059903245,-1.5638251269614152,-0.1393133747454452
70580,SIDM00776,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.0969908,-0.05734093,-0.8825183521304163,-0.021474712611764427
71001,SIDM00875,GSK269962A,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8302868,0.058579814,1.0568369634864923,-0.007330595942616621
86008,SIDM01197,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.09665,0.058774304,2.8979814906267887,0.08063341635036361
48692,SIDM00455,OSI-027,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.9488051,-0.12267032,-0.9048453882431979,-0.05410675400044187
82696,SIDM01042,PF-4708671,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1587523,0.09186783,-0.2408946696177219,-0.040198930456797045
6253,SIDM00928,Docetaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.6760999,0.18045133,-0.17925921248377544,-0.049936507879232164
56181,SIDM00933,Wee1 Inhibitor,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.7198109,-0.06309677,-1.4078245782015113,-0.06118824423290383
43366,SIDM00875,GSK269962A,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8782402,0.053077567,0.11099022980429595,0.06772981933783938
93270,SIDM00776,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.4170423,0.16117838,-0.9881747010208336,-0.030929074608560272
13015,SIDM00933,Paclitaxel,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.3682456,0.03474289,-1.877346248179695,-0.08960536042369577
95630,SIDM00928,Nutlin-3a (-),MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.9101729,-0.019313078,0.8043660123916113,0.004141990913043887
8926,SIDM00832,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.4934525,-0.09623682,-0.4014030577199431,0.008840755797672198
16941,SIDM00933,MK-2206,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.0205587,0.1282885,2.1492397312748124,0.1062613309023443
41428,SIDM00835,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.2066772,0.041362826,1.992078446675894,0.053451156865413
37420,SIDM00875,Temozolomide,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9634257,0.024001334,0.3840958207657974,-0.013917721773753184
23514,SIDM01187,Navitoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0915186,0.10226588,0.8780396954328094,0.04121099048124262
25854,SIDM00875,Alpelisib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.94057465,-0.06730191,0.3087759796126631,0.048785326845572845
90466,SIDM00146,Nilotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.8831617,0.08889322,-1.4452179325076646,-0.028172453082468876
23393,SIDM00826,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.19012918,-0.013976539,0.1374199120678903,-0.054250073038630234
104836,SIDM00875,Wee1 Inhibitor,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3195127,0.018506376,-0.4285391606248488,-0.0018024364195681189
41274,SIDM00826,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-1.8488872,-0.1294902,-1.6171851578951197,-0.10285420979431878
78681,SIDM00832,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.6266778,-0.08369209,0.3245935682577619,0.022256761491936613
81975,SIDM00928,Taselisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.1622702,-0.12067648,-0.6340206913068218,-0.08954776737729583
82113,SIDM00832,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.73891497,0.027660957,-0.8279678152123916,-0.024881862788739773
62960,SIDM01042,Alisertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7272351,0.14880995,0.12563794236187262,-0.007360733997323916
12566,SIDM00282,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2579074,-0.1231965,-0.2707509823473835,0.010846230832363878
32955,SIDM00833,Dabrafenib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.6784922,0.012433144,0.45604027947346937,-0.0045097362983671325
4674,SIDM01042,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7113054,0.027078148,0.34353045788443903,0.042993276503374346
91500,SIDM00673,PD173074,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.975862,0.04791894,0.4764988617487343,0.15256795128275302
100546,SIDM00776,AZD8055,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.49782652,-0.041586425,-0.441011589641538,-0.09131914553747184
790,SIDM00146,Olaparib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.8261272,-0.07269241,0.30538457183297907,0.029937571713015955
52923,SIDM00877,Cisplatin,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.29358,-0.10818077,-0.5873753765285604,-0.052096104345088386
8394,SIDM00216,SB505124,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3227506,-0.05821611,-0.8295548965517436,-0.02786181854507086
41457,SIDM00835,BMS-754807,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.7145288,-0.20839997,-2.512855867311724,-0.16482694282020038
74404,SIDM00875,AZD8055,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.66545236,-0.018099274,-0.6823781059576337,-0.031684344961205
22523,SIDM00146,Docetaxel,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.5568751,0.03811502,-0.7066113757299756,-0.02230831741070197
61011,SIDM01042,AZD6482,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3679787,-0.06155011,-1.297853086300309,-0.08871077562282145
10418,SIDM01042,Paclitaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0613735,-0.25343224,-2.597039528057135,-0.21867523840378697
27863,SIDM01197,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,1.1555865,0.03817806,-0.580522332732809,-0.036557545799462195
67743,SIDM01042,Navitoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2864844,0.032207217,0.47910731951502566,0.042919306725525894
49711,SIDM00837,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1723874,0.0402053,1.2854646395467957,0.01645295111223464
49880,SIDM00097,Alisertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.637237,-0.13009894,-1.514156674234141,-0.04076070723042292
74861,SIDM00359,Crizotinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6998919,-0.06296216,-0.5695544238437085,-0.04169677141453648
51004,SIDM01187,Axitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7503493,-0.0613449,-1.3744171977497155,-0.08075956052221754
106063,SIDM00875,Vorinostat,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31463024,0.034520045,-0.7876096429368016,-0.022756126969734166
70831,SIDM00633,Olaparib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2852972,-0.05729347,-1.8883268122966834,-0.06189473682862386
43196,SIDM00359,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8202476,-0.030752407,-0.8850700583758819,-0.019503421026549176
73797,SIDM00875,KU-55933,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.834025,-0.05729284,-1.8496451552397475,-0.037709479468104413
72232,SIDM00832,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,2.2484972,0.050091274,3.299342235972072,0.06479390227078512
102435,SIDM00097,Pictilisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5397147,-0.038381554,-0.493195443367833,-0.03882547450082112
23520,SIDM00097,Temozolomide,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.48012528,-0.008186663,-0.2227562653186161,0.013535952255477568
98532,SIDM00146,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,1.1969489,0.09638069,-1.1879003907247796,-0.045252927355005884
83618,SIDM00097,Linsitinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.65150964,0.0330912,0.44407783816480767,0.041059119666199226
4494,SIDM00097,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.87884164,-0.021911476,0.19415577798521477,0.027083692682379305
56896,SIDM00835,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.3303739,-0.065338716,-0.2625838753019886,0.002110696566920864
54580,SIDM00928,AZD6482,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.9232968,-0.05350677,-0.1807819873271422,0.008636105045515435
69031,SIDM00633,Entinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.01366719,0.0009544196,-0.7755533424580264,-0.04427742066917663
92951,SIDM00633,Afatinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7885947,0.012806031,-1.765064352714295,-0.01597157483059983
35968,SIDM00282,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.26481038,0.016646575,-0.5700675763385683,-0.07068631566678217
4466,SIDM00832,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.3585697,0.0727042,0.4091269611308378,0.03691282986302934
4714,SIDM00673,Alisertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8354429,-0.04713343,-0.2913063612505435,0.010107127552967022
80886,SIDM00835,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.0004091,-0.051668998,-0.807829150273302,-0.028882200207747632
99773,SIDM00146,Venetoclax,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.3008146,0.032751545,2.1935544917242367,0.07101465238945363
101897,SIDM01042,Nilotinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4937725,-0.13046342,-0.8287206711379439,-0.04439633964783191
59550,SIDM01187,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.46199846,0.043470565,-2.203546613686158,-0.09403813861717628
15266,SIDM00148,Afatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4767631,0.12803872,0.4009491154584492,0.038254349073190766
67109,SIDM00633,Navitoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1243272,0.14265321,2.700775495680963,0.18597621016722413
8974,SIDM00455,Crizotinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6143701,0.043825425,-0.44332348826807866,-0.03721444506838457
57818,SIDM01187,Docetaxel,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0907859,0.10828376,-2.6752918703924053,-0.10603328832154636
2144,SIDM00146,Nutlin-3a (-),PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.59480065,-0.01696501,1.1756518851918127,0.038173482971988304
60778,SIDM00148,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0322733,-0.18715453,-0.6561663859771725,-0.04934035965946701
10969,SIDM00872,MK-1775,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0220069,-0.09989368,-0.7444925848108133,-0.13147616526577297
12830,SIDM01197,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.9648127,0.06649228,0.4117940594606931,-0.019036992637731058
48586,SIDM00633,AZD8055,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.44701815,0.047392886,-0.1120316911443306,-0.02513167160677539
16563,SIDM00826,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.9329712,-0.15180916,-3.072120915536736,-0.11660728754194094
99853,SIDM00957,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,0.5658976,0.005763149,2.47272474537817,0.0562712067970195
73740,SIDM00633,MK-2206,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8556912,-0.12964389,0.6642605894170015,-0.030448357078523662
94398,SIDM00872,OSI-027,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7936118,-0.07731643,-0.5724654558497082,-0.046020754200021406
34731,SIDM01042,Docetaxel,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6876845,-0.22078371,-3.9022208061406647,-0.2105937727404588
55532,SIDM00872,Palbociclib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4888201,-0.017586187,0.6568045252436161,0.0038651121736356445
56905,SIDM00148,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.68492645,0.047693074,0.6422879377816652,-0.0371391546650995
84477,SIDM00673,Pictilisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.25538418,-0.01961964,-0.9359072405381783,-0.07000877972750363
66114,SIDM00872,Nilotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.206239,-0.20415153,-0.23000011091629896,-0.009926048054612557
140,SIDM00933,Paclitaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.35766008,0.033522762,0.2227035682090519,0.03421617372637261
79957,SIDM00359,Palbociclib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.66906714,-0.032210484,-1.5821189930605961,-0.03455543815629692
25722,SIDM00957,AZD7762,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.9930744,0.056645107,1.1792074903941328,0.016775094700052735
7881,SIDM01042,OSI-027,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0898051,0.14590137,0.9414792778652283,0.08066196962874449
72105,SIDM01197,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.30546093,0.024362048,-0.03470088389610974,0.022007203293049376
21526,SIDM00216,5-Fluorouracil,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.39113006,0.029945897,-1.0146152584291657,-0.07706376530917884
18151,SIDM00928,Uprosertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,5.549547,0.50561804,1.4635047805354737,0.08295532253478223
33548,SIDM00146,Luminespib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.9413744,-0.06598952,-0.6252142634095254,-0.018695631062904727
102421,SIDM00875,Tozasertib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.38632,-0.042507585,1.0928154372687082,0.04559955292256098
46818,SIDM00216,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3575699,-0.043131035,-0.24269616192152058,0.046446451113375246
96230,SIDM00776,AZD7762,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.185744,-0.016347213,-0.7374667240215804,-0.011798883660252115
37773,SIDM00872,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3607245,0.013893115,0.7431815837970337,0.027317988945713547
2359,SIDM00877,OSI-027,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.8918837,0.14637062,0.6427980013191721,0.0701951774700692
61022,SIDM00877,Cisplatin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.55603784,-0.05794031,-0.22090385448067718,0.017512590484757954
85053,SIDM00826,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,2.7305782,0.039097123,3.6728017792186325,0.10473231512068187
87464,SIDM00877,Dabrafenib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.819175,0.047760896,2.2781723339995748,0.03232198893930234
65466,SIDM00877,Nutlin-3a (-),Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.62881804,-0.021123542,0.8191656974951722,0.061990038370098005
65665,SIDM00826,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.5306442,-0.09293578,-1.673569524200722,-0.08753084009661519
98422,SIDM01042,Luminespib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.1819504,-0.019001432,-1.1088345572340657,-0.004087619664348138
55188,SIDM00833,LGK974,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.5176625,0.16481487,1.021316107247039,0.009577430929087577
90087,SIDM01042,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9469988,0.14761536,1.4398131210698348,0.1313149386758077
83741,SIDM00950,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.66140795,0.017755559,-1.0986045372471664,0.02156809575319205
42139,SIDM00833,LGK974,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.91715115,0.037287135,-0.5786060373551495,0.0018073063386872734
76422,SIDM01187,Taselisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6312795,-0.14291556,-0.30669370884868735,-0.051559282701223674
16499,SIDM00832,SB505124,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-1.6537848,-0.12052867,-0.07691957841949407,-0.042220451323505256
92255,SIDM01042,Navitoclax,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5945518,0.10135125,2.455791246790618,0.09724181124853003
50732,SIDM00933,Crizotinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.2862556,0.16550139,-0.21397306409351538,0.028955163048731757
10090,SIDM00097,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6843155,-0.030742757,0.21216716138888356,-0.03887887848711716
84397,SIDM00097,Alpelisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2476057,-0.08287427,-0.07277475495599744,-0.04111916951381307
71633,SIDM00776,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-0.22893493,-0.017803214,-1.2826397838080419,-0.08877488622951454
89858,SIDM00872,Axitinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.27261335,-0.020032644,-0.4765476280919,-0.038116341854915727
4839,SIDM00146,Entinostat,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.14292507,0.011116246,0.5866449042004711,0.08005229881118063
93858,SIDM00933,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.38589516,-0.052786965,-2.3310382647280776,-0.118653222104391
83834,SIDM00877,Tozasertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.440308,-0.17445782,-2.0642865167151667,-0.0255243639971154
5222,SIDM00633,Vorinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.2845674,0.01340851,1.864709698177808,0.1396244659996387
101825,SIDM00872,Gemcitabine,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,5.9301944,0.39982703,4.311471557702551,0.20574606490863928
19043,SIDM00950,Taselisib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0710024,0.071016,-0.6657015242176155,-0.05838576985639779
19376,SIDM00146,Vorinostat,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1972425,0.092291094,0.6368398998163707,-0.0038487053703247336
6937,SIDM00455,MK-1775,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0038279,0.0707913,-0.18531227494421784,0.0035393968098837015
77593,SIDM00928,Nutlin-3a (-),MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,4.839288,0.16656971,2.8705337603498715,0.0952662151353507
47844,SIDM00928,Tozasertib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,3.5050406,0.1959797,1.9089625024210168,0.07552018732806087
96856,SIDM00837,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.7004294,-0.06228627,-0.7590617329386444,-0.0480793341813774
75649,SIDM00216,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.37172818,-0.012161799,-2.1657402071271483,-0.07271165928847656
74289,SIDM00950,Gemcitabine,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0903434,0.08366384,-0.37325977874933197,-0.023051589539485738
58590,SIDM00148,MK-2206,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4419292,-0.0427195,-1.027587237237625,-0.03322692528903198
97365,SIDM01042,Tozasertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8944077,0.22426336,-2.3923195953527525,-0.11422252341862707
82611,SIDM00146,MK-1775,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.5345063,0.028409576,-0.7052301297162784,-0.02416816265168043
46365,SIDM00875,ZM447439,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5237079,0.0610869,1.2039407536667497,0.057250955229205716
59020,SIDM00875,NU7441,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.855798,0.082032695,-0.48894357509397735,-0.0349744785772528
14690,SIDM00877,Venetoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.566236,0.15334234,-0.34550339435000593,0.00417932513521085
47593,SIDM00673,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.4214811,-0.102441266,-1.7177940030057923,-0.035160795781445535
11325,SIDM00875,Temozolomide,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.994056,0.12292549,1.035241203729721,0.01900753676511347
10863,SIDM01042,Vorinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4289658,0.09225903,-0.07618026597961651,0.010615581533040605
10595,SIDM00633,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9561206,0.060312614,-0.13030410354029523,-0.03808771209652287
86657,SIDM01197,SCH772984,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8290173,0.014216659,0.3699928275907296,0.01659391274817034
61204,SIDM00148,Ribociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.75492847,0.06457631,-1.6066673119406452,-0.07244541221287133
38806,SIDM00826,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.2324398,-0.06311424,-1.550662314525732,-0.06969105059448884
102545,SIDM00872,Alisertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.24436717,0.010068826,0.48547966594524294,0.06104760984822689
29331,SIDM00633,AZD7762,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.2792935,-0.11990216,-1.3495801345072123,-0.10109893359150972
75450,SIDM00928,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.2325015,-0.085850246,-1.6031484186780853,-0.10774146463864633
13014,SIDM00633,Doramapimod,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.83188206,-0.068652794,-0.04418126293915749,-0.0038473886429264354
55917,SIDM00872,Bortezomib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.36412475,-0.027890535,-0.2695513534689307,-0.02988471031206692
48957,SIDM00148,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33471757,-0.030302096,-1.8055252471222305,-0.09401300455982761
11531,SIDM00097,Navitoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8129094,-0.052251317,0.9533482982083831,0.03689624946371075
34876,SIDM00950,Crizotinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.37406033,-0.041332837,-1.194952771187903,-0.0725140412785106
21943,SIDM00097,Entinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0577843,-0.07839594,-1.744424162503162,-0.0383359706183598
103491,SIDM00928,5-Fluorouracil,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.302762,-0.11594624,-1.1179579819823826,-0.06255784414141931
52174,SIDM00875,NU7441,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.31790838,0.029049976,0.1624420659901237,0.03495533145877388
39776,SIDM00833,Afatinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.7925462,-0.04547354,-0.774433461956494,-0.05322588970256903
89780,SIDM00776,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.6415023,-0.1383148,0.9179649820450612,0.039001987169813235
35501,SIDM00633,ZM447439,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9166587,-0.08491977,-0.3710742498547893,-0.03447796244838983
24881,SIDM00837,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.85571736,0.006113873,2.2004020560470186,0.08260402145729302
43526,SIDM00957,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.885412,-0.1003748,0.018013637952489468,0.08728720761780052
57562,SIDM00455,5-Fluorouracil,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.8463964,-0.0983001,-2.574803946194691,-0.024259473872169965
85159,SIDM01042,NU7441,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5471918,0.03809142,-0.18722300709040518,-0.020874884749121324
3968,SIDM00776,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.46124798,-0.04251161,-1.3118984029210596,-0.10882066023307421
21837,SIDM00928,Paclitaxel,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-0.24767251,-0.023290299,0.5986800185169049,-0.004561354273158302
72174,SIDM01042,NU7441,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1044937,0.06925256,-0.9149855312310486,-0.01008873332829859
32021,SIDM00928,Alisertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.5234363,0.04038768,-1.659594908105505,-0.06841836802451715
26313,SIDM00359,Taselisib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.5668814,0.15702926,1.8217471724685503,0.14770142135799783
23670,SIDM00148,5-Fluorouracil,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8399676,0.0821136,-0.6063135693194812,-0.03340221867443967
105864,SIDM00832,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-1.653579,-0.11204953,-0.8615726158407093,-0.06929854205982458
63413,SIDM00148,GSK269962A,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5952912,-0.060974155,-0.6525458632706872,-0.017864315105106263
94469,SIDM00148,MK-2206,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2118828,-0.121689945,-0.9664934635508771,-0.06458748661306354
76953,SIDM00042,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.9479866,0.16963217,0.24338788596192698,0.00045966976394052613
1249,SIDM00633,Gemcitabine,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,9.132537,0.32479385,3.241882178544173,0.12656184643689924
17229,SIDM00872,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.34370756,0.017234692,-0.04379010082308187,-0.050802857161005945
60177,SIDM00833,Oxaliplatin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.7952583,-0.08528594,-1.5929118248763523,-0.10363727362876332
55070,SIDM00146,Vorinostat,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.503966,0.08681277,-0.36105157770740304,-0.040969311437698594
35167,SIDM01042,Luminespib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4229217,-0.04868731,-1.0396024355034337,-0.06703820127800489
70494,SIDM00673,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8506424,-0.12399015,-1.1528090056025115,-0.11063777164125602
105738,SIDM00826,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-1.9821655,-0.045930162,-4.526751360249022,-0.0936800929523472
8156,SIDM00633,NU7441,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.7429004,0.14870252,4.798263216422138,0.13565562436903586
40978,SIDM00950,Linsitinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6450414,0.055563882,0.804120922324745,0.007527373385851718
31087,SIDM00633,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2291594,-0.12261117,-1.994579590281676,-0.05061613586670428
23335,SIDM00216,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,4.0520654,0.2986203,0.8949883267091603,0.04810855336779207
5614,SIDM00633,Vorinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0590305,-0.17296562,-0.47659502262424136,-0.04013051969140563
49170,SIDM00875,Alisertib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7635821,-0.023329785,-0.9106723770947733,-0.0753414698189137
46938,SIDM00097,Taselisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.207238,-0.14221974,-0.18986969092052614,-0.03419201108507441
11018,SIDM00875,Venetoclax,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.14203198,0.0028192885,2.532475242061308,0.061113480375737134
85416,SIDM00148,OSI-027,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5382803,0.036025524,-0.5659180824408828,-0.04621771980589459
36705,SIDM00359,SB505124,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7494498,-0.11063382,-1.6414974802883842,-0.06190588044450678
8385,SIDM00359,AZD4547,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6211338,-0.14545935,-2.7326548663645087,-0.09126554142037631
86803,SIDM01197,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5419865,-0.10436339,-0.8955042689841306,-0.0976022717859341
82506,SIDM00875,KU-55933,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.61419165,-0.030376181,-0.10648209037005636,0.007052303089369038
31904,SIDM00633,Gemcitabine,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.7568886,-0.14336483,-0.42888331525752965,-0.06904168939171294
50728,SIDM00933,PF-4708671,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.38460413,0.029913427,-0.2844845537463797,-0.013323064488862108
25448,SIDM00042,Crizotinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.5044439,-0.14678219,-2.051082140844674,-0.10973072950726317
74144,SIDM00673,Doramapimod,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.839842,0.08782355,2.182782521363123,0.057605148336055324
27984,SIDM00097,Dabrafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0629694,-0.07073477,-0.9781842306321357,-0.012420563811277404
23212,SIDM00877,Paclitaxel,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.3985983,-0.048039813,-0.6611359051642863,-0.02265363695733274
21976,SIDM00673,AZD8055,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.41026667,-0.033792526,-0.7719279597702353,-0.06163428385549828
42006,SIDM00933,Entinostat,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.5989932,-0.042133372,-0.024216095020853493,-0.0020105704287436115
28214,SIDM00673,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.794746,-0.15036327,-1.4453818325198478,-0.11635291543600979
81786,SIDM00673,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.29517913,0.003890606,1.2327353959725742,0.02669285223019601
73592,SIDM00835,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,1.305718,0.04254234,0.5909697809426007,0.05591326779466905
55426,SIDM00146,Venetoclax,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.64480704,0.017424062,2.20249222921747,0.04461449787867711
86984,SIDM00148,AZD6482,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0443608,0.08776161,1.0331056676344867,0.0728311072651305
104508,SIDM00950,AZD7762,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0902703,0.07999901,-0.26669167728761545,-0.016425189616215797
37887,SIDM01187,Linsitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1598479,0.03414576,1.3575011486249502,0.05570590812506911
43455,SIDM00950,MK-2206,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3775117,0.11307828,1.2216666801094513,0.11404388654190993
66457,SIDM00826,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-5.874372,-0.087931745,-7.669306529512664,-0.20654072087007933
64891,SIDM00633,Ribociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8281048,-0.024964495,-1.0266885458883677,-0.02970951900452838
21784,SIDM00042,Gemcitabine,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.8531233,-0.18053576,-2.3300901667215883,-0.11756426236819718
58634,SIDM00359,Trametinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.712647,-0.15045042,-2.3043436848665926,-0.06025436704916034
62301,SIDM01042,AZD8055,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.31797397,-0.02628608,-0.053448084626719454,0.031338275169762224
77552,SIDM00950,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.033211,0.07223486,1.8792740334074383,0.11553666329582633
34725,SIDM00148,Vorinostat,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4479596,0.043401863,0.01691181305599913,-0.016536078733304038
33786,SIDM00877,Uprosertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,0.585903,0.02983715,0.7056954085278457,0.03815493370475703
91320,SIDM01197,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9401941,-0.032841925,-2.1098733551908624,-0.09234813389367658
88614,SIDM00877,Dabrafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6675929,0.045433037,1.7468156011182163,0.07520961266681282
49515,SIDM00837,Olaparib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,1.5408697,0.05533394,-0.04642594607927923,0.00011451859543823308
65096,SIDM00216,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-4.103132,-0.14268729,-2.908407536425381,-0.1360089810952862
28407,SIDM01197,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6051494,-0.041511513,-0.12506321132602038,0.03661300178037659
7335,SIDM00097,PF-4708671,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.8840127,0.28390953,1.40634373936622,0.057172861242896535
49923,SIDM00933,MK-2206,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.9469022,0.12845379,-0.9422186306178505,0.010690511851405392
74334,SIDM00875,Camptothecin,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.60321724,-0.07000463,-0.9523248913710963,-0.11755464645284132
94187,SIDM00875,Luminespib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3537608,-0.11368706,-0.9983376718848754,-0.08669685617204663
10194,SIDM01042,Gemcitabine,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7851661,-0.101544015,-1.5683614952612943,-0.059561907480089216
67711,SIDM00933,GSK269962A,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.4382597,0.14070179,-0.07946480804262934,0.04925440436434498
14912,SIDM00950,MK-2206,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2346947,0.09931575,-0.7485809959277521,-0.001595120141601959
24509,SIDM00877,Pictilisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-3.7437265,-0.2308216,0.10000942847178708,-0.014734471198674657
37817,SIDM00146,Entinostat,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0410241,0.07904486,-0.1798538292361606,-0.031857419909015146
81494,SIDM00359,Navitoclax,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0475113,0.041748703,2.4359378563165826,0.04511895251405782
22115,SIDM00933,Bortezomib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.31903356,-0.024750201,-1.4424419636275898,-0.0380006397721801
83173,SIDM00097,GSK269962A,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8379199,-0.03366142,-1.2026516047362474,-0.01786225013704919
82714,SIDM00837,Afatinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.62716293,0.026587533,1.461980013486529,0.009959373053657041
69973,SIDM00872,Wee1 Inhibitor,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.37509978,0.037249267,-0.7981571339817687,-0.028667187165363865
30034,SIDM00875,Alisertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1109618,0.103493705,-1.500077636886185,-0.03539423336091634
49064,SIDM00877,AZD8055,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.686183,-0.08165206,0.16593856855196068,0.00447304528352016
57791,SIDM00146,Doramapimod,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,2.788042,0.20552671,-0.2504786766840063,0.0028500794585447995
90507,SIDM00097,Paclitaxel,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6173803,-0.09639818,0.24405270553394123,-0.037178543799043305
1229,SIDM00633,SCH772984,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5680239,0.15974018,-1.0805014998696547,-0.04379816942178001
3290,SIDM00875,Trametinib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37334275,0.042526145,-0.15009631902641934,-0.07117620689777199
37081,SIDM00097,Trametinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,5.116362,0.2503442,0.10220138539440912,0.01598205342059312
45802,SIDM00833,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,2.5701323,0.06392922,2.1920821223852847,0.058283501509788616
13068,SIDM00877,Axitinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-0.4961866,-0.04140205,-0.46051901519238664,0.06395003988829756
47034,SIDM00216,AZD4547,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9230883,-0.06838219,-0.8751429182218177,-0.05647958603934634
10945,SIDM00673,Ribociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.5513012,-0.07596142,-1.4502324297487545,-0.017043853554478357
66321,SIDM00673,Luminespib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.97206765,-0.050736453,-0.6616376096281027,0.031230648377285994
56595,SIDM00872,Uprosertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3475654,0.035989102,-0.7602543081510789,-0.08483528489014716
72991,SIDM00875,BI-2536,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.5704412,-0.09273319,-1.3430572274693555,-0.044411675822900155
30942,SIDM00146,Paclitaxel,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.9288866,-0.08936767,-0.5263995326504397,-0.0351014599915838
60485,SIDM00148,Cisplatin,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8567335,0.052873913,-0.709441640096114,-0.044520352796203845
22304,SIDM00875,Nilotinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43677512,-0.040893346,-1.0343546522564102,-0.05634599107002617
95975,SIDM00933,Linsitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.5417222,-0.053907633,0.33658533241633815,0.020764497163271955
36588,SIDM01197,MK-2206,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.4276676,0.07741706,-0.14838783762500787,-0.021943960484765553
57132,SIDM00833,MK-1775,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-0.6434824,-0.031234996,-1.2126491483642574,-0.03931414964976147
36397,SIDM00455,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.24265549,-0.015674908,-0.4446600406294807,-0.04395553988073554
102357,SIDM00148,Alpelisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.18094876,-0.016512768,-0.19208513901886387,0.015571242046582513
105475,SIDM00633,Lapatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6335661,0.016847914,-0.3436755490989455,-0.03862087707188813
61189,SIDM00933,Trametinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.7327265,-0.2067273,-0.4672974171788318,0.006171286686263017
92155,SIDM00097,Sorafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4874917,0.05741572,0.7877418376092475,0.05796061206513424
72847,SIDM00833,Navitoclax,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.3716998,0.11856705,0.3569085287970342,0.024955937180928162
68160,SIDM00872,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,4.5199428,0.1327185,3.6525586862744674,0.11167112289739341
23137,SIDM00832,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,2.0032701,0.12326234,0.7377801091883611,0.0768083430145467
101844,SIDM00875,MK-1775,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.50504684,-0.035525385,-0.8062799935067296,-0.028858201302677966
64473,SIDM00633,Luminespib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.134591,-0.17128202,-3.1238378247719742,-0.09538807759755391
40049,SIDM00146,SCH772984,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0061833,-0.099789865,1.3425320622469181,0.02041266879614035
22011,SIDM00877,Pictilisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4603521,0.10787115,0.8114474990386497,0.0710547196221859
54319,SIDM00877,Entinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.7093076,0.05420475,1.0088837381706919,0.06977337965381325
54321,SIDM00875,5-Fluorouracil,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2680153,-0.10564062,-0.8130218334460385,-0.01779813698610746
3248,SIDM00928,PF-4708671,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.9381531,-0.1288605,1.052859922601976,0.09767707178702782
98608,SIDM00097,MK-1775,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8854869,0.050812148,0.09244308553904923,-0.00966405774191889
4155,SIDM00957,MK-1775,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.1480963,-0.0775717,-0.061552187542675885,0.018090633673333387
25618,SIDM00146,GSK269962A,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.0104307,-0.07308996,1.2322552360973067,0.12016792530973673
94411,SIDM00957,Camptothecin,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,4.0554786,0.07464408,2.945362559084348,0.05657250894181433
104682,SIDM00148,Venetoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6972415,-0.022986814,-0.4447804756363225,-0.026690193173656583
89602,SIDM00146,ZM447439,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-2.1580403,-0.13878709,0.13152320050604338,0.011783082187553315
95559,SIDM00633,ZM447439,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.0037165,-0.15016739,-1.7390505844550221,-0.08519029725309729
62343,SIDM00826,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,1.3680397,0.12407395,-1.4981339936352767,-0.08420994725624412
98196,SIDM00216,SCH772984,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.5273464,0.023686443,-1.353327547153049,-0.06350573736672466
18192,SIDM00097,Alisertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0866401,-0.1384942,-1.7906723860321287,-0.08860834020945518
56362,SIDM00633,MK-2206,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6693175,-0.046317697,-0.13338081477584637,-0.007250439689404367
50168,SIDM00933,Camptothecin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.2063303,0.1567665,-0.9679891630921419,-0.09344674942689474
35570,SIDM00146,MK-1775,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.44112688,0.029843044,-0.19745016789996653,-0.03292044331632514
54180,SIDM00455,MK-2206,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.596795,0.07662496,2.8741276353453555,0.20599211069963377
25687,SIDM00673,Dabrafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.6551408,0.037958987,1.8116859470376934,0.05545787191503614
64609,SIDM00875,AZD6482,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9588612,-0.06526421,1.1665303710885409,0.08439580582775408
32528,SIDM00933,JQ1,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-1.6640607,-0.11397724,0.48021388701299356,-0.039008813387121484
40413,SIDM00455,Cisplatin,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3523579,-0.08669484,-0.36328751351551886,0.039539139092050535
83768,SIDM00148,RO-3306,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6374339,0.053953703,-0.6186469515929465,-0.07032826921110158
7050,SIDM00928,Trametinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.3454982,0.13901979,-0.7086386481373635,-0.0021542755981553596
72075,SIDM00928,ZM447439,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.6174513,0.19249827,1.6646453868985798,0.0700586329603667
28480,SIDM00042,Crizotinib,Erlotinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.5564727,0.05631458,1.0620106298605612,0.04460880529760687
59890,SIDM00875,Navitoclax,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1779735,0.06787278,2.6110739584871134,0.05762695428254366
64916,SIDM00148,Dabrafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6279256,0.043348853,-0.3602567130860591,-0.011812344032405588
39077,SIDM00826,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.72318363,0.045222905,-0.35299529601880814,0.044513769387688994
106470,SIDM00833,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.2136633,0.02599006,2.4084377905832786,0.09643563094545804
2877,SIDM00146,BI-2536,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-1.4648944,-0.06273641,-0.7400951134081709,0.018820954972608345
18486,SIDM00877,Vorinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,0.4468213,0.035634488,-0.12736151892249478,-0.028123767553033488
63432,SIDM00146,AZD8055,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0973713,0.09295188,0.8739081224470684,0.07524493054670874
53370,SIDM00097,Wee1 Inhibitor,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3053285,0.017076053,-0.3114201929016667,-0.012637307842038703
9253,SIDM00359,5-Fluorouracil,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8996756,-0.15764609,0.9398296711448862,0.1031938206241785
55001,SIDM00933,Doramapimod,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.1138031,0.05696751,1.9945684808038509,0.08970158433582383
75103,SIDM00877,Venetoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.9745073,0.067812376,1.19383556453748,0.059490047969908005
80782,SIDM00872,Dabrafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3057005,0.03164214,2.637514818556426,0.06545017549251139
53203,SIDM00928,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.6587073,-0.061047122,-0.673054768928642,-0.02875719343042114
25791,SIDM00872,Ribociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3940786,-0.0327372,0.0378618014653899,0.025402211408364687
66466,SIDM00872,Entinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.7755127,-0.135307,0.10355542250134027,0.015317192714713523
54076,SIDM00872,Bortezomib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.72608334,-0.04739049,-0.4853955654578302,-0.01983517956486257
26604,SIDM00826,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-3.9340699,-0.08979369,-2.2894473092967362,-0.06241703064667929
106005,SIDM00872,Vorinostat,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7345955,-0.10386756,-0.10998638079393484,0.06933164088120465
15137,SIDM01042,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5662846,0.03769978,1.8107153041283457,0.08592314447090613
49718,SIDM01187,Pictilisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.961424,-0.1633861,-0.6925009298218905,-0.037761242726827834
45933,SIDM00950,Trametinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4696851,-0.051616456,-0.2861235998041693,-0.0629597682817521
28852,SIDM00872,OSI-027,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6207102,-0.057301093,-0.37904404547273146,-0.019320565879301407
18139,SIDM00872,Afatinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.0546281,-0.18438242,-0.3174833206249202,-0.07014741999950491
101834,SIDM00928,Trametinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.9583006,0.26718512,2.7169272302215663,0.19234316608985222
66345,SIDM00875,Trametinib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3566941,-0.1462049,-1.2037634574140033,-0.07325368972388314
80650,SIDM00933,Docetaxel,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.0992694,0.22911367,2.061827882331763,0.20364308110296123
3314,SIDM00928,Entinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.3762565,0.1413527,0.8978844696077775,0.03861497707512498
89109,SIDM00875,Afatinib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47178686,-0.03471827,1.132911522549487,0.03011514141906537
1880,SIDM00877,Olaparib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.746176,-0.047045276,-0.6711986677509364,-0.02173237236288866
107708,SIDM00148,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.3169786,0.030983612,-0.13510954004623618,-0.054770376393937614
60667,SIDM00282,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.97575414,-0.03730831,-0.4506504795171932,0.0018220343615650207
24608,SIDM00875,Docetaxel,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25365952,-0.020976366,-0.947819757483262,-0.07273012845165118
65270,SIDM00146,NU7441,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.7520894,0.10825065,0.3804878891618259,0.024239287696615455
10952,SIDM00097,MK-1775,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6104877,-0.107378095,-1.6374506465259775,-0.12410569119763845
76895,SIDM00826,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.7444543,-0.104204066,-1.5948253584156382,-0.09859741361186725
23907,SIDM00957,Palbociclib,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,2.0126796,0.04704543,0.8534995748741786,0.016483757451737982
60274,SIDM00826,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-4.390317,-0.25201342,-4.56629695036869,-0.2701409760613758
58541,SIDM00633,Gemcitabine,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6848838,-0.20112005,-1.8967321360010436,-0.03704115685488184
20176,SIDM01042,Taselisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1403378,0.06480759,-1.7157347844968696,-0.04831577869037688
69833,SIDM00146,NU7441,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.2228476,0.07735052,1.9280395612447845,0.09519688310189552
68227,SIDM00359,MK-2206,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.55941534,-0.03248,2.0923209906359506,0.1282063595585167
22598,SIDM00673,Palbociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.281556,0.16100411,-0.18015382450848993,0.03603012819541653
18134,SIDM00146,Camptothecin,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.3365982,-0.18224628,-2.5404926321334647,-0.1831621367002805
85485,SIDM00872,Pictilisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35857627,-0.036689885,-0.3318736492402511,-0.030775486915026618
39181,SIDM00146,Lapatinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.3433826,-0.115204655,0.18127002877345288,0.018389993817269586
18464,SIDM00957,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.1087176,-0.014996652,0.9987504742486665,0.051181729651251354
98976,SIDM00928,JQ1,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.9607067,0.1148981,-0.044881041582085085,0.01114289428115964
53198,SIDM00776,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8767934,-0.14968319,-0.40739469372731313,-0.027404666903668745
87384,SIDM00776,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.9910004,0.304981,0.7945714956763048,0.11428765535299117
39895,SIDM00282,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.7793835,0.12903824,-0.4971772259544471,-0.01695163732366182
61824,SIDM00928,Paclitaxel,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.54948956,-0.047546394,0.5585399254507319,0.015213854989737879
90134,SIDM00359,Camptothecin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.434826,-0.10002307,-1.9704680437829374,-0.05664200742733822
103881,SIDM00928,AZD8055,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.2007569,0.1513326,-0.15739973961996215,-0.022342726786803425
101324,SIDM01042,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.1295216,0.057491656,-0.8606588368161759,-0.06813037813896296
64055,SIDM00042,Erlotinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.5269797,0.17498206,0.8299031294299429,0.05265856184000286
27190,SIDM00950,Palbociclib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1125615,0.13370682,-0.46346997155870323,0.020141238819026668
13134,SIDM01197,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.6468444,0.18135655,3.32165273454159,0.10930493395145831
52561,SIDM00146,Trametinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.8329695,-0.0678913,-1.1025346503785425,-0.06729175768458578
53286,SIDM00633,MK-2206,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.293688,0.112115726,0.11267872828465107,0.016246420995158675
43509,SIDM00835,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,73.0,-0.28795317,-0.02423414,-0.2825974951461613,-0.02102150767194645
60221,SIDM00359,Dabrafenib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7252089,0.06400539,-0.7414889998153238,0.020345396373551324
102770,SIDM01042,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2604506,-0.20393327,-0.5332199126239041,-0.07112140706085343
15744,SIDM00875,Axitinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8886464,0.27788717,3.179941675754317,0.21949968255391009
17049,SIDM00826,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,1.965667,0.04969599,-1.9325632358375455,-0.04369830054178761
53207,SIDM01042,Linsitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0296528,-0.0675459,0.00472670161348426,-0.008101500187532445
28290,SIDM01187,Palbociclib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9752326,-0.10284396,-2.400717371367268,-0.10607500933064754
19743,SIDM01187,Lapatinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5800024,-0.051971752,-0.8892404945116112,-0.07298045163043082
55884,SIDM00832,BMS-754807,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.9968054,0.041856937,-1.9485585978086426,-0.003781088771859012
95241,SIDM00455,Irinotecan,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0543144,0.08290954,2.2863519703772375,0.14855814912083096
108335,SIDM00872,Olaparib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.986634,-0.07173595,0.40430567753969543,0.07068857341219127
32585,SIDM01042,RO-3306,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.708366,-0.16805756,-0.7498031406277582,-0.06159315770411824
67993,SIDM00148,NU7441,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9160081,-0.08594373,0.12496970596370952,0.01062699973096905
16403,SIDM00933,ZM447439,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.9882413,0.18510993,-1.3107536598116263,-0.037683393834052406
73137,SIDM00042,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.16877373,-0.016706273,-0.10414845767436481,-0.04735918675697707
1611,SIDM00950,Crizotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6533566,0.16133624,0.8206816575735446,0.07274500431132902
1933,SIDM00359,Palbociclib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8259068,-0.049863745,-1.6983136715125167,-0.014730122344174531
50269,SIDM00633,Venetoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9893847,0.06491138,1.535378688888498,0.05044137654362753
100211,SIDM00833,Oxaliplatin,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.658433,-0.052488387,-1.5907406888616151,-0.10916047849931862
14986,SIDM00216,MK-1775,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.55619717,0.016334724,-0.260438103568349,-0.011189797577580807
37149,SIDM00933,Paclitaxel,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-2.928504,-0.17054805,-0.6362193722825538,0.0423997368966885
14654,SIDM00097,ZM447439,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6754891,-0.07182944,-0.9481325429179978,-0.0450795285820142
96268,SIDM00933,MK-2206,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.7509076,-0.09353246,-0.16747865429275124,0.0660297439563017
73269,SIDM00359,AZD8055,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5542629,-0.12735349,-2.154117643942122,-0.07540844795499303
91451,SIDM00673,Trametinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.7451395,0.17134179,-1.137955460798945,-0.06538956449156451
34483,SIDM00933,Crizotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-2.4758534,-0.19588585,-0.8302536845386262,-0.006707944014322338
91259,SIDM00833,LGK974,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-2.049832,-0.0688608,-1.5067010080308463,-0.04520779414504966
23619,SIDM00877,Trametinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.6924866,0.046140894,0.23224215141840962,0.028924015847318997
6932,SIDM00950,Paclitaxel,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6558394,-0.12414367,-0.4222379480980914,-0.05793732042504669
68110,SIDM00928,Docetaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-4.3497167,-0.37880418,-2.4350029567207234,-0.2076817500073766
32576,SIDM00282,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.7740272,0.032838065,-0.12343282789972711,0.004793434429607183
43460,SIDM00928,PF-4708671,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.3763587,-0.16180402,-1.9388223098327808,-0.12217684338167717
47210,SIDM00633,Vorinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.217288,0.16237941,-0.34900289585890615,-0.0014705164771827458
51747,SIDM00633,SCH772984,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.4060187,0.37931398,2.9894849277367794,0.13554092658477312
36296,SIDM00957,AZD8055,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.9378176,0.020952156,0.30351249848776307,0.06756704247837549
50755,SIDM00042,Navitoclax,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.835326,0.059586108,1.7318789111324702,0.03165480617211474
21694,SIDM01187,AZD7762,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.9580367,0.04844699,1.508236506092633,0.04140245438683438
58208,SIDM00928,Uprosertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.1251571,0.08056164,0.4807121666121851,0.048655364212257995
44012,SIDM00097,SCH772984,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2034113,-0.009967712,2.0940378335556415,0.09218118904229675
33796,SIDM00042,Irinotecan,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.7630959,-0.23719342,-2.090450715191969,-0.1493291612906682
52978,SIDM00148,Entinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.67138267,-0.049133915,-1.9739816443571063,-0.10064924397187956
59369,SIDM00875,Venetoclax,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6265794,0.05536607,0.558867224070339,0.046495725314386754
5937,SIDM00148,5-Fluorouracil,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6057305,0.14611442,1.4979197915291438,0.13458141283386013
40081,SIDM00673,RO-3306,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0363941,-0.11743309,-0.8928426294891079,-0.015565395849850663
76299,SIDM01042,Bortezomib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0622468,-0.03779741,-1.3444511922253488,-0.08455024590009681
21800,SIDM00875,MK-1775,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.626179,-0.033213496,-1.2097421064896903,-0.07372664427656014
49668,SIDM00042,Erlotinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.09187,0.037101656,0.6968669801718373,0.02448950754944155
29580,SIDM00928,Axitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.5866349,-0.06956205,-0.5862911795616336,-0.005942608684036939
102237,SIDM00826,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.5819107,0.016398897,-0.09859947825147695,-0.019350881872173435
73336,SIDM01187,Cisplatin,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9302171,-0.11536386,-0.7470055916316398,0.004882056353903215
68646,SIDM01042,Entinostat,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.442696,0.16864988,-0.20439525830742067,-0.020439205899370174
54221,SIDM00776,5-Fluorouracil,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,6.622,0.48824686,2.9981390739111187,0.14853537795610677
53667,SIDM00633,NU7441,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5475358,0.09690835,-0.3211391734920851,-0.005342869651207825
32760,SIDM00673,Alisertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.0638046,0.078672834,0.15222020138002595,0.04777819965756608
64806,SIDM00875,Olaparib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0598109,-0.039039563,-1.1463275641893795,-0.06512559465143099
104892,SIDM00097,Entinostat,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.092937,-0.03732571,1.6069481479211525,0.09262986470550139
92435,SIDM00933,AZD8055,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.715823,0.24454065,1.2482287549168953,0.1067829680642274
98961,SIDM00835,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.6407152,-0.02790582,0.3916315649274267,0.06784326514703842
72076,SIDM01042,Trametinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0828011,0.117362686,-0.8993222720484567,-0.045227202446359145
23960,SIDM00875,Paclitaxel,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.05760766,-0.0039889114,-0.16229037688813747,-0.01636187105024146
23132,SIDM00826,Taselisib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,1.2449498,0.05880089,-1.586962414218939,-0.051377141225805445
3342,SIDM01042,SCH772984,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.57252455,-0.026994819,0.876050115113962,-0.024816023240678914
33913,SIDM00933,Venetoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.4207883,-0.08131812,-0.35162854037609254,0.02353964139519724
37787,SIDM00359,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.8458066,0.020641914,1.5069411081077957,0.04584273507860197
67014,SIDM00633,Linsitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2582653,0.047886167,0.7221356208126457,0.007824628450536584
63341,SIDM00148,Axitinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.183016,-0.11323237,-0.8951355939684001,-0.08744151771742197
26984,SIDM00837,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.303052,-0.18540795,-0.9688860932753981,-0.12153047970856451
76142,SIDM00877,Gemcitabine,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-5.9312496,-0.20085646,-3.499650550214091,-0.09172877716424062
14711,SIDM01197,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.67497844,0.04652991,-0.429825178269318,-0.04479435812240615
60722,SIDM00097,ZM447439,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.7906973,0.17610799,-1.3684368400960698,-0.04354886940652325
18129,SIDM00216,MK-2206,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8063331,-0.14748944,-0.8095656722882554,-0.08089735589822582
74562,SIDM00359,MK-2206,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9051639,0.047114454,1.1909200613009576,0.1185350401390914
106131,SIDM00950,SCH772984,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.8937954,0.08711817,-0.6064993336516753,-0.04765213680498023
22242,SIDM00148,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.22339635,-0.022433095,-1.5452162675277306,-0.08092047404885512
104713,SIDM01187,5-Fluorouracil,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4196993,-0.1306041,-2.21085792050459,-0.11705299036079668
101351,SIDM00633,Tozasertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7092955,0.059334103,2.0631629019947706,0.042955055088861854
98497,SIDM00957,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.606994,-0.022743454,-0.20644730151940102,0.022557786607241996
4181,SIDM00832,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.2335522,-0.038718384,-1.829535707246958,-0.016992667661137602
13983,SIDM00933,MK-1775,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.28368896,-0.017958991,-0.9431719441424494,-0.0396885087792104
71931,SIDM00097,Pictilisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.80184656,-0.055504855,-0.7104669039356032,-0.07875073237039623
98646,SIDM01197,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5110178,-0.065049045,-2.0102862953932665,-0.10450154789647455
16753,SIDM00097,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0847943,0.05604368,-1.5652159962929888,-0.034319451365433226
41902,SIDM00282,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.124968,0.11590194,0.7105447119771285,0.00857242077404287
44231,SIDM01042,AZD6482,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1972148,0.032536224,0.538299884729773,0.002670688463485155
75716,SIDM00097,Dabrafenib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8537179,0.04630732,-1.1177673591249457,-0.02536504836121893
83647,SIDM00673,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.285775,0.23238619,1.745426196011456,0.07195931937688478
21487,SIDM00359,Linsitinib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3083825,-0.12257829,-1.9391599920410036,-0.10341351778943605
97156,SIDM00877,ZM447439,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.9063907,-0.13629285,-1.0866624494465824,-0.019607340060145532
51776,SIDM01042,Linsitinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.528361,-0.036240686,0.19057832055666366,0.018004066761289943
63956,SIDM00950,Crizotinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.49233043,0.045719583,0.38854132450757595,0.07398353005972151
55886,SIDM00148,Nutlin-3a (-),Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.74121886,0.072272666,-1.191286683547681,-0.02812869924545955
24822,SIDM00146,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.71647495,-0.059588924,-0.2669595764212708,-0.04751717504027659
5783,SIDM00826,MK-2206,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.83272266,-0.03307756,-0.8879757779135634,-0.0034766348527331906
10597,SIDM00455,Oxaliplatin,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0930548,0.12737094,-0.9672551685948241,0.03508225877683408
14551,SIDM00455,Palbociclib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.118042,0.062234443,-2.4529439699795055,-0.05281247783521781
37560,SIDM00633,MK-2206,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5096883,0.08344699,-1.6801771887446884,-0.055565262420258374
106013,SIDM00146,Alpelisib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6703617,0.039462313,2.4338136282245117,0.1590749468580083
21074,SIDM00633,MK-2206,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9234629,-0.068414874,-1.890210162096325,-0.11192720935536314
60397,SIDM00875,Dabrafenib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8997135,0.10539666,1.2450423176696894,0.09805843580155965
47103,SIDM00877,NU7441,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.73452616,-0.0762625,0.7025611552060763,0.056891495443182165
27138,SIDM00933,Linsitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-1.5018456,-0.0818884,0.6533432679301219,0.06260155653263694
68339,SIDM00097,AZD8055,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5014906,-0.10577466,-0.8368889853217131,-0.04228906247058166
23260,SIDM00633,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.2188776,0.26345587,1.4410603034490186,0.09354543383716676
53939,SIDM00872,Afatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5240161,0.1621511,1.5962682338215988,0.07134652148012972
34498,SIDM00957,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.1829128,-0.042916004,-0.7771887886291547,-0.013007457955480478
39697,SIDM00933,Vorinostat,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.3340652,0.16242039,1.1349802864841825,0.11136806898506954
99767,SIDM00933,ZM447439,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.057784,0.27186188,1.335934067935423,0.08658304455533072
30447,SIDM00146,Pictilisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.1343665,-0.0845145,1.0773098780247607,0.0852321717240213
93415,SIDM00837,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1168481,0.053743977,-2.3795455077034284,-0.14247827345048433
107994,SIDM01042,Doramapimod,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.18292992,0.020771846,-0.07624175948683773,-0.0069771898489368565
47079,SIDM01197,Afatinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.5589557,0.040251557,2.616828706246645,0.14977304109595374
22469,SIDM00673,Ribociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-2.666578,-0.07696996,-1.1984538010790555,0.011918325310700252
48709,SIDM00933,Pictilisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.4337999,0.16221206,-0.1477777640950418,0.013986661730340062
89101,SIDM00146,Navitoclax,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.9402999,0.09883077,0.9226603858281098,-0.007690437682595308
19591,SIDM00950,Cisplatin,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9102125,0.25591338,1.102907343038181,0.07092977473210223
34076,SIDM00148,KU-55933,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.7918434,0.26668474,1.2295084876261164,0.05353423783965165
76369,SIDM01197,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.242851,-0.049049743,-0.15306517763729183,0.018029334596581174
26205,SIDM00282,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4664993,-0.070442185,-0.04138107047808641,0.01818355088855098
44500,SIDM00359,MK-1775,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4700787,-0.041310385,-0.1929104852887615,0.011449012124329186
26540,SIDM00837,Olaparib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-1.8776158,-0.05386647,0.08504387955239788,-0.010997184748488615
67869,SIDM00097,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9443074,0.051965035,0.4221295058234313,0.057004362434564686
101136,SIDM00837,SCH772984,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,3.3218098,0.12996061,-0.7651446011011661,0.014105850305782795
103619,SIDM01187,Temozolomide,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.73680437,-0.018744934,-0.08319004655438526,0.02505858662936017
54756,SIDM00957,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,6.0875983,0.1557925,0.28120164115796636,0.10463625877796674
7038,SIDM00042,Taselisib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.92468363,-0.09952206,-1.6478736270200824,-0.09974387005684322
87994,SIDM00455,5-Fluorouracil,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.4308446,0.016378483,0.3468370897335626,0.05438865075526223
42920,SIDM00933,Uprosertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.339526,0.25451228,0.3788819871467435,0.10728617713315175
102391,SIDM00928,ZM447439,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-0.30548233,-0.03269377,-0.3431443721327021,-0.045166116580899085
76198,SIDM00933,Olaparib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.1206303,-0.118266284,-1.7158465513258636,-0.11265902292852228
13311,SIDM00042,OSI-027,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3921431,-0.043761883,0.13506685148119432,0.010399611105385086
27009,SIDM00933,KU-55933,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.6286374,0.0763625,0.3489292499636359,-0.004601562281405218
106529,SIDM00633,Doramapimod,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6901839,0.125163,-0.9355836932903022,0.006857807554096766
82598,SIDM00872,ZM447439,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6467527,0.060131725,-0.6803923705784742,-0.033684633858664666
50498,SIDM00097,PD173074,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8500613,0.03023291,0.7401653342662403,0.05252908603593335
43181,SIDM00928,Olaparib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.4207623,-0.08064756,0.44130385347311124,0.09729148632842834
72873,SIDM00633,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.765698,0.054951377,-0.06080750019246017,0.011799902168600582
12504,SIDM00872,5-Fluorouracil,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.96436065,0.04440991,0.6791605557176371,0.02566513807687545
5823,SIDM00833,AZD4547,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.6292666,-0.08042877,-0.9559557701592575,-0.0330848719320591
12430,SIDM00097,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4331567,-0.1757326,-1.4173421415612033,-0.08681708098235594
80528,SIDM00928,Temozolomide,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.1108354,-0.027258275,-0.24499539261755268,-0.012094677130887573
39040,SIDM00042,SCH772984,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.9308052,-0.12136982,-0.9272870744784026,-0.042497084891722756
7436,SIDM00835,Crizotinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.2882053,0.11050571,-1.4487495119049927,-0.10726856076400398
44164,SIDM00826,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.4087874,0.028303966,2.752680643435492,0.09280773123537622
11551,SIDM00877,Nutlin-3a (-),Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.8176097,-0.07613307,-0.15142692994844617,0.01788744771212017
96471,SIDM00950,Dasatinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.7874556,0.44066137,2.7022914483960614,0.17831660705235586
89810,SIDM00826,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.8265892,-0.06073658,-0.9667888357523996,-0.056527389508219186
9982,SIDM00633,Cisplatin,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9428786,-0.065330625,-1.5258778520245198,-0.018278191911744825
43482,SIDM00042,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.8070649,0.09681812,1.1943864174719478,0.06564443534182689
70642,SIDM01042,PD173074,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7373538,-0.10172881,-0.2418936606831756,0.006630816815257712
99193,SIDM00875,Pictilisib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.307694,0.029771632,0.03760638273550336,0.012893212150784863
51089,SIDM00877,PF-4708671,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,0.13743025,0.012106851,-0.4540920552869649,-0.02016641524804033
85405,SIDM00877,RO-3306,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3668249,-0.06880963,-0.3799855365831763,0.046828756371948124
81077,SIDM01042,ZM447439,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1398183,0.09145339,0.6443672657577953,-0.013835106472529656
67090,SIDM00282,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.68584657,0.041148737,-0.11034456482225583,0.028090993606373897
63521,SIDM00833,Dabrafenib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.4409933,0.017090615,1.7902871266467917,0.010223985133310378
44436,SIDM00872,Camptothecin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7886724,0.019753113,2.978963143841376,0.11419711882251306
21886,SIDM00950,5-Fluorouracil,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.42212638,0.032163545,-0.7134296638504819,-0.0710623269335012
67964,SIDM00928,Dabrafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.7651524,0.039708383,-0.2710123742964519,-0.0025018625138387447
17245,SIDM00835,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-1.3898548,-0.037907623,1.2093952188839256,0.08945068519881691
43531,SIDM00673,Afatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.32772672,0.024282774,0.4957301716082175,0.06956538322659657
27464,SIDM00146,AZD6482,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3078017,-0.08260608,0.570026612717751,0.08966030693942749
23804,SIDM00835,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.9604274,-0.12932287,0.9039078610414591,-0.004558713912619972
45907,SIDM00877,PD173074,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3791358,0.12344908,-0.23996682783141746,0.0028675290627655603
72876,SIDM00877,Nilotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.7451497,0.081742436,-0.12863078122315275,0.004055993719738251
79641,SIDM00097,Paclitaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2984881,-0.08957428,-2.1018887494702447,-0.13958524484300744
81373,SIDM00673,Palbociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0209095,0.09570634,1.0762277805057434,0.0502191205506686
65937,SIDM00957,5-Fluorouracil,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-1.2049448,-0.01726758,2.7621902463889376,0.04253575085551618
73425,SIDM00673,Axitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.34855676,0.03411658,0.8551268047327423,0.04921675217979976
85120,SIDM00146,Alisertib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.75801945,-0.061825648,1.658882970554156,0.11506257037690004
30119,SIDM00148,PF-4708671,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9091438,-0.029380359,-1.1331391213529676,-0.03309566864683672
44823,SIDM01197,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8529826,0.09871739,1.2296091058079774,0.11551898269474073
102905,SIDM00950,MK-1775,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.036519,-0.062314417,-0.28281999159515614,-0.005154715623787502
92400,SIDM01042,AZD6482,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.74018097,-0.041871563,-1.6161151805418799,-0.060923109823418725
16891,SIDM00832,Oxaliplatin,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-1.5318109,-0.12051562,-1.9317688529193977,-0.13132906268386338
91040,SIDM00146,Wee1 Inhibitor,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.38884485,-0.03217916,-0.8831762379421645,-0.041941163848813134
72639,SIDM00146,Gemcitabine,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.26285338,-0.018808054,-0.611899616119159,-0.052530161781899586
39635,SIDM00875,Taselisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2384288,0.13808541,2.3180729957771717,0.09862735445398993
96043,SIDM00872,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.102317,0.1250015,2.480331225288095,0.06882905121348308
97984,SIDM00673,Nutlin-3a (-),Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.480055,0.012124878,1.232937573124515,0.03870126023181214
105285,SIDM00928,Axitinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.0625556,-0.07442979,1.2737879689878424,0.07953470087680686
3277,SIDM00933,JQ1,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.48306733,-0.03665865,1.2385442285639519,0.0956896684264145
74239,SIDM00872,Crizotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.23176157,-0.019287175,-0.1741215469526934,-0.0331862310464784
74337,SIDM00933,Luminespib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.4240031,0.012947382,-0.15267592330679197,0.0770273205841245
59285,SIDM00776,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,2.4778438,0.1610375,1.6299434785381026,0.12150584401053305
55572,SIDM01197,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9733946,-0.08056571,-0.45247023597989183,-0.03532248595418469
35726,SIDM00148,Dabrafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.94085735,0.065315664,-0.5442617135499496,-0.015451431908660994
100993,SIDM00148,PF-4708671,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6740221,-0.09538001,-1.6219338997247885,-0.03880758198941741
89417,SIDM00877,Paclitaxel,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.5706843,0.073553234,-0.4354922580996863,0.05253807202347926
86020,SIDM00875,Docetaxel,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.12944245,0.01038312,-1.8083642673213391,-0.15632538663907034
1432,SIDM00928,Olaparib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-2.7390184,-0.09667731,-1.3262115132838441,-0.027786836213089926
56196,SIDM00877,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.364921,0.14836612,0.4040934732849418,-0.020849274757553233
28329,SIDM01187,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.053557,-0.0637308,-0.9640570231806627,-0.010716401461491155
97349,SIDM00933,Ribociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.3747205,0.008171608,1.1368651882746257,-0.004786939421077599
10260,SIDM00097,Gemcitabine,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,6.0733757,0.3557189,2.8800702905507722,0.13322802127407585
45492,SIDM00216,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.2405092,-0.01614405,-0.6851620077111891,-0.03019167057523015
73316,SIDM00875,NU7441,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.98767,0.07419752,1.1482593993283392,0.0679899938937617
12591,SIDM00875,ZM447439,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5807104,0.061421815,1.1852802308266357,0.03324294411000553
53662,SIDM00877,Trametinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,2.348184,0.06903826,1.1011709314942875,0.10976260085416836
50259,SIDM00146,AZD6482,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.409054,0.10705293,1.4950314071699533,0.1402090380615111
30537,SIDM00875,JQ1,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2534408,-0.022590656,0.15304654331888132,-0.013619463630184925
41596,SIDM01042,NU7441,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6670955,0.094298325,-1.2393591069453485,-0.08181599363374532
47805,SIDM00933,BI-2536,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-4.6940107,-0.019107044,-7.093153171361346,-0.060154992650471764
88252,SIDM00633,RO-3306,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.96705365,0.07146243,1.184948008780621,0.009708721688551594
92799,SIDM00928,Ribociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,3.6809022,0.20523277,-0.2882213942614665,0.00486596572536779
45864,SIDM00928,Palbociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-2.6205468,-0.10765134,-0.7908247314126167,-0.048397965723207884
38888,SIDM00928,SCH772984,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,2.0039344,0.21031444,1.1472778491047468,0.047738525081447346
33622,SIDM01042,RO-3306,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2029682,-0.15394539,-1.4645704995331537,-0.13464151373654448
47704,SIDM00148,MK-2206,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2420014,-0.117070995,-1.205885429468891,-0.08694784451237704
65867,SIDM00826,Trametinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.9942244,-0.005594076,-1.9797216437604912,-0.06276335978028186
32966,SIDM00933,AZD7762,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.37237704,-0.03642864,-0.43629278277310596,0.01087077319586094
67795,SIDM00957,Taselisib,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.7609634,0.13645808,0.004179964109463275,0.05241518714668225
53712,SIDM00835,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.4728959,0.12099393,0.5689271376939192,-0.018597143004444247
39555,SIDM01197,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-0.8839879,-0.027425598,-0.18857843096829655,-0.012202050709411362
73877,SIDM00097,Luminespib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8618608,-0.12013427,-0.05008803105691902,-0.036943415010182105
40909,SIDM00776,Crizotinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.70497173,-0.06333191,-0.62693005364444,-0.04403917897900304
88402,SIDM00216,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.0006652,0.2740499,1.0757396025803847,0.0858590385278621
13120,SIDM00148,PF-4708671,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8616668,0.06608208,-0.5715500964321287,-0.011440307842698809
56823,SIDM00776,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.5088078,0.11133502,0.11201171028266446,0.044846426426195726
57176,SIDM00950,Olaparib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6371864,0.021497127,-0.26116462527233575,0.06830905287691819
67495,SIDM00148,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.18418275,0.0030341183,0.1589564348215053,0.0025196572049407625
10145,SIDM00673,JQ1,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.2127283,-0.1322391,-2.111196996496701,-0.06291420033472758
83082,SIDM00673,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.37713835,0.03067554,-0.9198215459809659,-0.11293809109412305
44761,SIDM00872,Alpelisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.73933005,-0.079239406,-0.47768307281971223,-0.05689898551109712
101822,SIDM00933,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.9728015,0.08920523,1.0743977439368768,0.07921951393388718
24228,SIDM00673,Axitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.4692956,-0.14051865,-0.2370042093419826,-0.08633770281114668
35921,SIDM00875,Uprosertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3513546,0.2368362,0.7359625160125299,0.08002849708759834
2382,SIDM00877,NU7441,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.9664951,-0.0374026,-0.5675972483058235,-0.03558238769656301
54030,SIDM00832,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.831393,0.089960985,1.186974900249343,0.07916185786222893
65652,SIDM00957,Trametinib,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.1148195,0.09823748,1.4309713536036626,0.1441992493372674
62398,SIDM00933,NU7441,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.7699838,0.16171966,-0.23135618115049006,0.01717114791581616
46521,SIDM00875,Alisertib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5516558,0.03966097,1.9960109601488165,0.13842591016989536
48441,SIDM00877,Tozasertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.0986962,0.22342399,1.900026981768828,0.19917327007468827
58198,SIDM00837,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-4.8091884,-0.12351839,-1.1663460270795796,-0.06234146801451723
19837,SIDM01197,BMS-754807,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,0.19864714,0.006686251,-4.782720900029201,-0.17503228436784918
100712,SIDM01197,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3191917,-0.032087095,0.09501902876345121,0.030257868667546598
6417,SIDM00673,Entinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.9106447,-0.1423202,-0.6720527798032592,-0.06474840598113638
85696,SIDM00146,Bortezomib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.23896612,-0.015387609,-0.125467314595137,-0.041634554383799226
107335,SIDM00837,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.26814914,0.011241715,-1.075445057624323,-0.056524819290747146
81871,SIDM00146,Nilotinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.95658123,0.0961733,-0.06676528050363241,-0.016490778165270684
80493,SIDM00872,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7019635,0.010145454,1.8780745920208166,0.030830609991131262
56254,SIDM01042,Temozolomide,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5115627,0.04754691,1.0342736274584943,0.021066774695132053
107085,SIDM00146,AZD6482,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.9180343,-0.10828941,1.0087160798333559,0.09453784904922008
49777,SIDM00097,RO-3306,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5240107,0.093852915,-0.3100092404291913,-0.016898014642172665
28555,SIDM00097,Afatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1775742,-0.19532092,0.18614362037113694,0.07287121296100862
90915,SIDM00673,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,2.5707672,0.09659465,1.1283963944326652,0.03980940546897555
49466,SIDM00148,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1893333,-0.06339023,-2.0878684815133575,-0.06806529880762874
92180,SIDM00673,SCH772984,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2110322,-0.15812507,0.3059847989952488,-0.013920973595504742
73784,SIDM00146,RO-3306,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.3293496,0.018582253,0.34992491310647383,0.053153187229238216
90165,SIDM00835,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.0721793,-0.08192464,-2.246224940954256,-0.14703746962979153
76726,SIDM00673,BI-2536,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.6348424,0.15925068,-0.00839955657243738,-0.02735286439210606
12775,SIDM00359,Dabrafenib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3831053,-0.06177525,-2.348743321359873,-0.03301973563443394
26888,SIDM00097,Crizotinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.50638217,0.03324019,-0.8347651179006697,-0.047879349361694315
29702,SIDM00148,SCH772984,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5445886,0.023399724,0.05229117409528973,0.018110077415426785
79100,SIDM00633,Entinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.4621427,0.2729624,2.2236906400660605,0.08166428486417998
95065,SIDM00146,Tozasertib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.200888,-0.116196506,-0.38583115956337377,0.012808005183427243
59160,SIDM01042,Uprosertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.88770425,0.023409871,-1.894592548533981,-0.16596254858216658
55683,SIDM00833,5-Fluorouracil,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.8494657,-0.08067393,-1.6260978527084995,-0.08730945355550694
8291,SIDM00872,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5711712,0.054317545,1.7051679007293017,0.0439120658801511
89327,SIDM00097,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.90831697,0.015977884,1.620304338660295,0.02427730765609237
6444,SIDM00146,Gemcitabine,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,0.3777048,0.026971593,-0.7366966887327777,-0.04978054985689442
11308,SIDM00455,Linsitinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.7895088,0.16400059,1.3615165338423745,0.05658680492385607
78033,SIDM00148,RO-3306,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6888546,-0.14652786,-0.40246554305001786,-0.05670512532394192
64879,SIDM00957,Nutlin-3a (-),SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,3.9039981,0.13693915,1.3366408299381245,0.05757742301030082
35515,SIDM00455,Gemcitabine,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.200859,-0.05713041,-0.43080679836389474,0.033281312217872984
88810,SIDM00928,AZD6482,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.2796378,-0.071522966,-0.1585042932553805,-0.042929015786870764
4248,SIDM00875,JQ1,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5232368,-0.056339618,-1.7821913447200344,-0.11625786656637221
14919,SIDM01197,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.9077237,-0.12244122,-0.7964005348489849,-0.0171753047415169
82233,SIDM01187,Pictilisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.81424695,0.049901318,-0.40925972300825264,0.0032039845545992884
60250,SIDM00928,Nilotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.1330594,0.10827868,1.2534339793440303,0.07760142830062604
91803,SIDM00633,MK-2206,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8015827,-0.1130398,-0.6343552890395576,-0.07518017311097376
30240,SIDM00928,Entinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.7394729,0.0758548,-0.30028328438266766,0.02620631676233789
70566,SIDM00097,MK-1775,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7710887,-0.07804422,0.02359381794414907,-0.029613486514353308
6383,SIDM01187,Bortezomib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4354627,0.09268297,0.10090575932582846,-0.008494514835478535
4499,SIDM00837,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,0.11171803,0.004625078,-1.8738986735125174,-0.09221600397542783
29839,SIDM01187,MK-1775,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8404344,0.08579522,0.4607722126384695,0.01662780692143045
95276,SIDM00832,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.32324895,0.026060943,-0.9161836273237963,-0.026759818024516994
20528,SIDM00837,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.70819527,-0.016091624,1.1368943953813349,0.015394016061822124
29922,SIDM00633,JQ1,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3306316,-0.026975987,-1.6923664078127059,-0.07607925919197184
4819,SIDM00933,Tozasertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.1836584,-0.0914052,-2.442369598615884,-0.23817362699348837
35586,SIDM00950,Crizotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3374472,0.1776147,1.102149187149819,0.06587849201449364
49654,SIDM00148,ZM447439,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.335408,-0.07811316,-1.0692260027569358,-0.0058847935722411825
104091,SIDM00148,Taselisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.16661645,-0.011683062,-0.6262786868722419,-0.027420099581747202
81457,SIDM00282,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6386233,-0.033246566,-0.7685121266779948,-0.03139745152730142
68106,SIDM00146,Sorafenib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.6242638,0.13350804,1.53478699085834,0.07801779173589114
74198,SIDM00097,OSI-027,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.7431498,0.15962856,0.045248130216408264,-0.020704459630329325
93765,SIDM01042,Pictilisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.76369154,-0.060983118,-1.6105571658044355,-0.12875674536931847
106713,SIDM00933,AZD8055,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,0.78736174,0.061982226,-0.41099860438089447,-0.02020151921014331
51616,SIDM00877,Nilotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-1.5717075,-0.14631361,-0.6980921914661975,0.040984750928117646
87933,SIDM00832,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,1.084764,0.09433483,-0.7543857837753124,-0.06150847774971518
93264,SIDM00877,Trametinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.264604,0.04060045,0.08499304016718685,0.026274089740351905
85932,SIDM00875,RO-3306,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.52276444,0.057331868,-0.19103577493583151,5.629128301327378e-05
39364,SIDM01187,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.5436387,0.13495734,-1.2140610439858621,-0.03950705201268752
54437,SIDM00097,Navitoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5431663,-0.085877985,1.0973878847463086,0.024819163205282088
35207,SIDM00835,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.53564733,-0.029205685,-0.6674295129546951,-0.02454582013096493
42948,SIDM00673,Ribociclib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.8725417,-0.085088976,-1.3719228363680254,0.001224519498044744
107307,SIDM00872,Olaparib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.638369,-0.062897265,-1.240212334683444,-0.024265795185436197
27031,SIDM00877,Olaparib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,1.762993,0.11893781,-1.0404319002823181,-0.027271275973384836
57612,SIDM00097,Lapatinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1894677,0.15567425,0.5269707728612554,0.0023946039628450952
32147,SIDM00833,AZD7762,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,0.5613202,0.04024127,-0.07418157518296417,-0.03538788857300371
9452,SIDM00633,Linsitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.4164324,0.28424978,1.6340505156258773,0.04199739632353109
104920,SIDM00957,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.87285185,0.024279734,1.1164166562033933,0.046040774686252714
14603,SIDM00146,JQ1,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.9491524,0.07148164,-0.8285061756292068,-0.06279164977525677
100053,SIDM01042,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4682705,-0.14676116,-1.2477431692024814,-0.04257092772965188
8310,SIDM00933,Palbociclib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.8124208,0.24505974,-1.4555934586964088,-0.04106359446595955
44886,SIDM00673,5-Fluorouracil,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.7959552,0.28103194,0.9025557806752939,0.08386706477418729
102837,SIDM00875,AZD8055,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2307827,-0.12085042,-0.4181899286651644,-0.02606958921072507
60888,SIDM00146,Gemcitabine,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.43784958,0.028479027,0.7101722444313759,0.029889421402577745
41267,SIDM00875,Entinostat,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1219573,0.116318226,1.736822949690391,0.08883754652786152
95617,SIDM00216,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.81741095,0.024440797,-0.23927880946978494,-0.01255301606890785
85959,SIDM00097,Venetoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.576567,-0.040566836,-0.9324088381505702,0.0026623475057499647
33294,SIDM00776,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.95359945,0.061718907,-0.06514008347172281,-0.014278137447474661
51752,SIDM01187,5-Fluorouracil,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5647632,-0.14682983,-0.7685828880011647,-0.07164281983019793
44806,SIDM00832,SCH772984,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,2.2231553,0.17749241,1.7967484183161426,0.052919880169218024
77013,SIDM00957,Linsitinib,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,1.020304,0.021756057,2.068464776621158,0.13380609982567251
43426,SIDM00826,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,0.59109604,0.020885993,0.558864282334324,-0.04795682497566484
92754,SIDM00146,Alpelisib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.6662596,0.1042938,0.07384440873176576,0.05254809678106627
67738,SIDM01042,Taselisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3289791,0.07959122,-0.545945047232739,-0.05453524442113911
67345,SIDM00148,AZD7762,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.5287485,-0.1934881,-2.018548615195261,-0.17380256241825962
21653,SIDM00826,Trametinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.125546,-0.005131991,0.8216341037501105,-0.0309685428101314
80384,SIDM01042,Paclitaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0224487,0.0919227,-1.205134082480146,-0.04108494666576756
17852,SIDM00455,MK-1775,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.4330168,-0.05906506,-0.19104050678867812,-0.015889567518716268
51890,SIDM00359,Vinorelbine,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6614875,-0.07534172,-0.5009905158584164,0.0031351187668206496
43111,SIDM00097,RO-3306,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0968937,0.065113045,0.4055304775300131,0.021688261075725194
32106,SIDM00673,5-Fluorouracil,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.31169376,-0.013316861,-0.12461548882948965,0.007765614408999471
47924,SIDM01042,MK-2206,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6493147,0.018986939,-0.28047212986925874,-0.022980240657303856
68666,SIDM00146,Taselisib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.5881886,-0.11815106,2.7364845604548247,0.15673101742218307
74075,SIDM00877,Pictilisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.3562552,-0.13460682,-0.9348612136068245,-0.03823135321366855
63819,SIDM00835,MK-2206,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.5058222,-0.07293898,0.8793780034357445,0.03693775138554534
26048,SIDM00950,Sorafenib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.74604076,-0.06880988,-1.7089017054270357,-0.05188684201703481
71171,SIDM00042,Oxaliplatin,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0726777,0.092589,-1.7654873373019613,-0.07581389101951379
45922,SIDM01197,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.26521313,-0.014370387,-1.4903731684012325,-0.09753405295969485
64347,SIDM01042,Bortezomib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.19856694,0.00994028,0.2762887155475634,-0.0006137043316438664
46736,SIDM00673,Tozasertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2121096,-0.15288909,-0.7066794262437879,-0.040498897626466815
51472,SIDM00950,Olaparib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7214675,0.17093773,1.6566200589460995,0.12489631206697832
16187,SIDM00633,PD173074,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1246014,0.06157869,0.511503120642301,0.012074920762770485
81699,SIDM00359,AZD4547,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.30916435,-0.01691014,-1.887610685789586,-0.05346486109687759
86836,SIDM00146,5-Fluorouracil,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.5989809,-0.09046765,-1.2654628161473862,-0.04276670990930213
95080,SIDM00097,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.86279213,-0.01877293,-0.39836300535721786,-0.001028445384584707
36267,SIDM00933,AZD6482,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.6498855,0.024950517,1.9185622737625405,0.08216320557687869
39344,SIDM00875,Vorinostat,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5045376,0.058963496,-0.719698499233266,-0.05689186941447111
29916,SIDM00097,Camptothecin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.0569808,-0.0024244871,0.3794923416594373,0.025299916160143737
11740,SIDM00875,5-Fluorouracil,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8380716,-0.086353675,-1.5860751369267592,-0.09229872376582796
91901,SIDM00282,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.920504,0.20979217,1.8571222845143351,0.11358320327213219
93337,SIDM00359,AZD8055,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7842147,-0.07713717,0.7953536241880798,0.06461308738200788
92247,SIDM00877,Navitoclax,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.62093854,-0.07578274,0.34458620725080935,0.029835370208607263
21518,SIDM00146,PF-4708671,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.1543413,0.039637547,2.6506376029283913,0.12583571996909643
26498,SIDM00875,Lapatinib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1629753,0.123387106,1.8776453285732788,0.12027183511845857
51766,SIDM00833,Linsitinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.6415664,0.03752995,0.3667266530074496,0.026722424629043146
58288,SIDM00837,Trametinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.7487948,0.053159017,-0.3222479093049757,0.0018219983207003292
53730,SIDM00097,Docetaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-6.298429,-0.33491483,-3.802784590996825,-0.2614313013233785
60159,SIDM00455,OSI-027,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.2305355,-0.14347014,0.8312639374882694,0.033083252053037436
33887,SIDM00933,Wee1 Inhibitor,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.3965535,0.12648281,1.2127043353680702,0.06956558944388695
36508,SIDM00633,MK-2206,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4524547,0.082753435,-0.5229391874540662,-0.014464592792105291
68036,SIDM00928,SCH772984,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2931451,0.1460107,1.7874581149241227,0.07060733140416076
94830,SIDM00455,Dasatinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8666852,-0.0807692,-0.7948405663526521,0.011155279672720609
82082,SIDM00097,Nilotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0001391,-0.058436472,-1.0024101901358307,-0.05377991728063582
49658,SIDM00097,MK-2206,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1616375,-0.07639558,-0.7721289872589077,-0.04551560642940532
86944,SIDM00928,JQ1,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.29730028,-0.03524983,-1.430569586958233,-0.04458948278434024
63446,SIDM00872,Sorafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3665613,-0.082464635,-0.03255516128738772,-0.022998782563735724
23300,SIDM00097,Luminespib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.19611824,0.013846043,-1.0474537087751146,-0.040878118707988555
89315,SIDM00872,Wee1 Inhibitor,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6879645,0.07528113,-0.39094631409870645,-0.024716022538371685
72791,SIDM00282,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1575656,-0.067406595,-0.3797433523685391,-0.07359114090367624
105827,SIDM00216,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4114386,-0.10052781,-2.075063367030745,-0.07771170056854632
70947,SIDM00776,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3548281,-0.11294498,-1.3321670060693949,-0.08345597546145614
7298,SIDM00282,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8579559,-0.06345263,-0.8251259425515655,-0.07365704979768412
36957,SIDM00933,Gemcitabine,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,1.0920855,0.0029304114,-0.642262417269563,0.010824252990180255
25823,SIDM00146,NU7441,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.8480905,-0.082366094,-0.6792488771856058,-0.0739617195135458
100603,SIDM00933,JQ1,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8741488,0.07783779,-0.9537088393945656,-0.05923230944009233
76520,SIDM00877,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,4.5247326,0.17110197,1.4661713953571371,0.07189428353214183
13859,SIDM01042,AZD8055,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.66894674,0.06412659,-0.2995606253437751,-0.010001513533272305
45627,SIDM00957,MK-2206,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,1.4276769,0.028111078,-0.4326968911253162,0.06711589710004559
43865,SIDM00950,Oxaliplatin,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.176218,0.06313094,-0.3915025160298024,0.01703703099068554
80665,SIDM00097,Tozasertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9888655,-0.061981265,0.17281762474899345,0.02837112593118055
73890,SIDM00097,Alpelisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8867398,0.06527975,0.3873260227568227,0.036347542960344814
50630,SIDM01042,ZM447439,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.788219,0.09901089,-1.2195263051035075,-0.04976510662242311
53124,SIDM00216,MK-1775,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.46942708,-0.025625223,-0.7156359758842221,-0.019412677785288865
45142,SIDM00097,ZM447439,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.92637646,-0.033429317,-0.7056867619426019,-0.01385974117652214
101678,SIDM00097,MK-1775,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6510136,-0.041681077,-1.0010431253473213,-0.07217932446423171
24056,SIDM01187,Vorinostat,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.59607095,0.057754662,2.0949027078484326,0.13692089152365813
90114,SIDM00832,Nutlin-3a (-),5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,2.3216312,0.078955375,1.5459754877901317,0.04446592557527562
83938,SIDM00148,Pictilisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6728166,0.04246501,-0.6623846893166389,-0.05884502041068155
64433,SIDM00673,Axitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.21462782,-0.021538781,-0.9244989158602488,-0.07027263814118613
24369,SIDM00148,Nutlin-3a (-),Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1867385,0.09317717,0.46950872773184005,0.00850118904330044
18978,SIDM00216,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.599771,0.097711615,-1.336370513890325,-0.03815773217662257
107672,SIDM00042,Cisplatin,Navitoclax,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.57622,0.30419132,3.2582383148167633,0.21397517877427846
1568,SIDM00950,OSI-027,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.96016294,-0.0706035,-1.3031487815991725,-0.07945226609385043
32414,SIDM00146,Lapatinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.85640085,-0.06497596,-1.0012470175075707,-0.10465220353719831
40644,SIDM00933,BI-2536,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.6331923,0.0096687805,1.2846316187532618,0.016647553304679187
9091,SIDM00875,ZM447439,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.43794852,0.051721074,0.30887485630824024,0.009253411929813904
64356,SIDM00097,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4386305,-0.029539501,-0.8857364908699247,-0.003846028041889473
30765,SIDM00928,Vorinostat,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.070187,-0.15353537,-0.19200837378357513,0.047333442139265866
101682,SIDM00097,5-Fluorouracil,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2452786,-0.14104247,-1.420707845916311,-0.0651768791602376
4018,SIDM00282,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.8234333,0.10631515,1.9922763769708163,0.15180721530983834
85631,SIDM00673,ZM447439,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.93388647,-0.066147156,-0.6313529682510997,-0.06074369351043084
48588,SIDM00875,Tozasertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1417696,0.14371854,-0.37816059283380243,0.006702008145531378
79816,SIDM00832,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.5123972,-0.018899137,1.2560601834005007,0.012243129982036216
45356,SIDM00282,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,0.36231205,0.02561031,-0.8836682743013471,-0.023377879756599277
68625,SIDM00673,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.7367618,0.17700726,1.1405791308220297,0.015020307812191195
84848,SIDM00633,BI-2536,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.84404576,-0.073668845,-0.865177893989016,-0.05885495413022741
45199,SIDM01042,Paclitaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2516632,0.07393381,-0.9221861771926965,-0.04394502530115918
6117,SIDM00832,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.631806,0.023503935,0.35766169570320944,0.018712355402948543
98339,SIDM00928,Trametinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7080476,0.06744052,0.11806985682753685,-0.055919950877955316
108135,SIDM00097,Linsitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7820913,-0.052458882,0.4456604298272816,0.011748230219919852
8110,SIDM00933,Alpelisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.5365825,-0.040112205,1.4636198844931643,0.13138622197799849
98477,SIDM00933,Taselisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.2775123,0.085486084,-0.24766129884706511,0.0068534182909525294
72100,SIDM00933,Alisertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.7678266,0.1945015,-2.2266743869384547,-0.12166391073525906
36730,SIDM00097,Palbociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8870276,-0.03768181,-0.9614108831213521,-0.004925930773082455
35324,SIDM00957,MK-1775,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,2.668299,0.10700669,0.7821465253162039,0.009765666271120793
90031,SIDM00455,5-Fluorouracil,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.1461442,-0.07959765,-1.4289397662140737,0.01255895818302523
25508,SIDM00957,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-0.9146743,-0.010846596,1.857642383265435,0.027616799609676224
22582,SIDM00216,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,3.2481928,0.23031296,-0.2640300490972854,-0.015011602163213816
32650,SIDM00875,GSK269962A,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4526187,-0.062163714,-0.9149861174201355,-0.05231557958589171
83056,SIDM00833,Linsitinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.7150983,-0.06745618,-0.4971810522620012,-0.012580921654585612
90938,SIDM01197,Palbociclib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1870801,-0.06994911,-0.8550412929378706,-0.0049241775423901485
85803,SIDM00837,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.71420634,-0.029671853,-1.1106761241452296,-0.10001202963014046
51777,SIDM00148,KU-55933,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.44305703,0.018336564,1.172465121517307,0.024326904158789502
90409,SIDM00633,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9222827,-0.07703114,-0.0973561920748095,0.0023375661854796205
89782,SIDM00872,AZD6482,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.33008638,0.03185789,-0.029560628514918686,-0.020539138465418848
95431,SIDM00832,MK-2206,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.4272097,-0.034462757,0.03475406840185308,-0.01393151408670566
47601,SIDM01197,Olaparib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.8848838,0.02317703,0.8119587521739893,0.04029753910176404
54689,SIDM00216,Palbociclib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.4624853,0.15799919,-2.235711424742042,-0.12694726902466602
25610,SIDM00928,AZD6482,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.45062825,-0.03081103,0.4021660152220471,0.0259007065656106
57349,SIDM00875,Vorinostat,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54101646,-0.058224972,0.32276030416786233,-0.026126485050572676
56333,SIDM01042,AZD8055,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2609668,0.113703094,-0.6438600990772086,-0.020886218781979927
60136,SIDM00146,OSI-027,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1712894,-0.11186605,-0.0959825894032477,0.027621435117323803
81644,SIDM00146,Crizotinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.7280642,0.059243076,-0.3366967982234743,0.07077628537201064
62043,SIDM00359,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.60824746,0.041879565,-0.90487860738989,0.029273717893654537
106716,SIDM00216,Camptothecin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.1026495,0.13899685,-0.2524425727911769,-0.0444535756657172
6015,SIDM00928,Trametinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.7303874,-0.16777696,0.1043829831702934,-0.0383892673731422
27129,SIDM00673,Olaparib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.0740347,-0.08880971,-1.5007642477540943,-0.06434404870415823
22054,SIDM00872,Venetoclax,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.21599273,-0.009119043,0.47815913892491124,0.021761786921625666
58713,SIDM00097,Palbociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1348283,0.039331015,0.2607646302409446,0.04125478528239399
30795,SIDM00148,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9342458,-0.13737956,-0.4744768791649406,-0.07407155159267885
92680,SIDM00633,PF-4708671,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2099522,0.11582223,0.5724984261958816,0.0560655535690213
55521,SIDM00673,Navitoclax,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2410426,0.22104253,0.2873155493085722,-0.018574471456114582
65522,SIDM00673,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.50227565,0.043455254,0.753573347844972,-0.010170612426372431
34916,SIDM00957,Trametinib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-6.566843,-0.1777048,-1.3324090016550076,-0.06811024712079097
93798,SIDM00933,Afatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.957988,0.2895968,1.0427328290593942,0.07473928837885008
12219,SIDM00148,RO-3306,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5395583,0.15379058,-0.42002819962578897,-0.01709840297795353
47792,SIDM00872,Dabrafenib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.00051467813,9.712337e-06,2.1162271491005478,0.06943114858358444
90842,SIDM01187,Crizotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9899893,-0.09452411,-1.9966706988979093,-0.0755206999362384
98936,SIDM00282,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,0.34125337,0.022609735,0.6845003986066727,0.055513329559754854
91691,SIDM00146,Alpelisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.548902,0.10152943,0.9849882387369238,0.0798405845981935
92057,SIDM00097,BI-2536,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3691976,-0.17225213,-1.6832206584963838,-0.15053584258336422
48943,SIDM00928,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,2.0790443,0.07321189,0.7960153056526021,-0.003682652232864258
99841,SIDM00633,Doramapimod,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1134443,0.20653974,1.0954369355855595,0.07892627955920932
99202,SIDM00097,Camptothecin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.37619004,-0.018866751,-0.07831371904084006,-0.014964706252608692
14498,SIDM00776,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.8722856,0.03838303,-0.37622449451253576,0.01862133142756647
85303,SIDM00928,Paclitaxel,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.4237586,-0.03826474,-0.5632537495860063,-0.05178882277655187
65612,SIDM00673,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.0927615,0.09253429,0.5056997341932643,0.016617708781150924
98171,SIDM00832,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,1.479051,0.05305129,-0.9968647125636482,-0.025191850486900928
49431,SIDM00146,Afatinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.331318,-0.115907066,1.100326383679642,0.0017803198055537297
85682,SIDM00837,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.3364515,-0.038649354,0.6837587768690029,-0.01979110796825917
79986,SIDM00146,Nutlin-3a (-),Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.41504622,-0.010991798,1.621194714531709,0.07672633596134783
50376,SIDM00957,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-0.86223596,-0.016449422,1.1270020111314705,0.044018195409019835
13668,SIDM00950,OSI-027,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.98601353,0.06829806,0.7443869166096484,-0.007866411824118626
52957,SIDM00359,Linsitinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1153572,0.08284921,0.8568574183413643,0.012987533971100324
90573,SIDM00872,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2959477,0.04537114,3.005384996097919,0.09963733813326618
79666,SIDM00826,MK-2206,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.3353765,-0.027642194,-0.9065882969186925,-0.08821489395513132
48101,SIDM00146,MK-1775,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.5371977,-0.045847077,-0.6407379555578139,-0.016409092535042327
34423,SIDM00933,ZM447439,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0216758,0.08286717,-0.605991662116143,-0.035740474803077314
108286,SIDM00877,RO-3306,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.2314708,-0.03933184,-0.7536136572621613,0.029673232352994655
6887,SIDM00957,Oxaliplatin,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-2.1594834,-0.035553988,0.9939769407938006,0.01002135095926892
9075,SIDM01187,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.54145086,0.045155484,-0.2734943979069788,-0.005785042007410212
601,SIDM00837,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.2556734,-0.05159671,-2.2295353195429204,-0.0965059865985192
50127,SIDM00826,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-0.7553095,-0.028526515,-0.8771697294578407,-0.012957311583308052
46609,SIDM01042,AZD8055,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2337148,0.19957617,-0.6009430260376486,-0.015361005878747747
95674,SIDM00042,Lapatinib,Sorafenib,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.141155,0.2344029,2.1262622375634885,0.08979224698139984
43600,SIDM00042,Erlotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.8928583,0.16468617,0.447364120858845,0.04481302405128455
92387,SIDM00872,Vorinostat,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8096302,-0.05680233,-0.5909709311028141,-0.0257526154358525
45128,SIDM00282,Palbociclib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,1.7627374,0.070431665,-0.14470198754576238,0.035809361697182525
62705,SIDM01042,Ribociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8991785,-0.0816059,1.1450012236196725,0.03416100050570512
49078,SIDM00776,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.46278974,0.022061603,-0.2204781517673167,0.01382373621461591
87368,SIDM00673,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6150811,-0.05034629,1.236958370285372,0.11669997433318709
28828,SIDM00282,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,0.5581,0.025284221,-1.7049049339869475,-0.07590987665548492
29863,SIDM00877,RO-3306,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.9636813,-0.08979423,0.058466797290833566,0.07561737764028825
19995,SIDM00933,Doramapimod,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.642959,0.049174055,2.553504093285348,0.1063621351959454
30933,SIDM00928,Ribociclib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,3.5521715,0.19146495,-0.2064598492292157,0.00984612325829801
24839,SIDM00875,Ribociclib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47567326,-0.0028138126,-0.3676047497195919,0.023955820142086415
69904,SIDM00673,Entinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6814139,-0.106766865,0.3613701553148624,-0.044543759890586766
74916,SIDM00146,GSK269962A,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,6.7379637,0.3839492,3.966882251817214,0.22073318147166424
85439,SIDM00673,Olaparib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2687973,-0.051725484,-2.6392686442664486,-0.08784718357248011
17465,SIDM00826,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.3390399,-0.046355553,-0.5857664120313594,-0.07971434307758604
85638,SIDM00673,Lapatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.8967959,-0.07683599,1.169546102726346,0.04695141314465088
6723,SIDM00837,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-0.9536118,-0.024099682,0.8727313692149824,0.023805641733737122
41332,SIDM00933,Luminespib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.3463035,-0.018676987,-2.6585218661419656,-0.07082933368247023
83271,SIDM00146,Camptothecin,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.1631598,-0.15335067,-2.2756285801259692,-0.14990075676348408
1701,SIDM00877,AZD7762,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.3057628,-0.017738666,2.0783568967835997,0.13649000056938262
52727,SIDM00455,Palbociclib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.085684046,0.003917719,-0.5152341750105683,0.0002505111195616993
75701,SIDM00877,Navitoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.37164104,-0.043524202,-0.12692364616736548,-0.015911149237668995
65398,SIDM00835,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-1.0242369,-0.024492202,0.9791811416560972,0.008736396395559695
41353,SIDM00097,5-Fluorouracil,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0032947,-0.083064884,-1.4453075497909,-0.049906152492595585
91270,SIDM00097,Doramapimod,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1839195,0.03228505,0.8942755650820258,-0.008108659013049507
40417,SIDM00835,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.6073743,-0.116372906,-0.982990606010212,-0.022817349864765732
51003,SIDM00928,Axitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.2976472,-0.09390505,-0.8248354844001459,0.004075005308478694
22817,SIDM00455,5-Fluorouracil,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.41304198,-0.015362037,-1.4996373612182257,-0.040055729466922874
95992,SIDM00216,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.54089975,0.028167507,0.6535977431398703,0.06672416313801878
70678,SIDM01042,MK-2206,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.38025808,-0.011683202,-1.5615039410548097,-0.10465070855964077
65488,SIDM00872,5-Fluorouracil,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.978642,0.061656877,0.12839493769429325,-0.0014208362983578688
44775,SIDM00872,OSI-027,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.48839146,0.050208263,-0.494140239070884,-0.052825638343588895
4550,SIDM00146,NU7441,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.2266576,-0.2105052,-1.5809232228185741,-0.1103760653437707
91277,SIDM00837,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.6459559,-0.035581756,-2.0475050225191302,-0.10813462062761416
26702,SIDM00933,Luminespib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0359124,0.03175064,0.4730361986665028,0.0038657730606369654
34182,SIDM00872,PD173074,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7554936,0.11023929,1.4612138106020687,0.06727409059671924
59512,SIDM00837,BMS-754807,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.60218126,-0.011489211,-1.2890242790122683,-0.07056268720377486
81991,SIDM00875,Entinostat,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2720276,0.12850961,1.9984309957032953,0.09978395749248008
82621,SIDM00146,RO-3306,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.9742483,0.1654338,0.9225782964166185,0.06045616779365589
84578,SIDM01042,Camptothecin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8601449,0.10150587,-0.24009013250925063,0.028489765018152348
94904,SIDM01042,Uprosertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5152261,-0.022239394,-0.666291573630666,-0.0630059797631286
96766,SIDM00950,Cisplatin,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6610347,-0.07356072,-0.5451364001293943,0.0132511082973381
4204,SIDM00837,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.0160801,0.05342772,0.9557926078277754,0.03637396846666803
94911,SIDM00832,Afatinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-0.42186558,-0.032810245,0.9746175436639896,0.03563625757663363
2758,SIDM00282,Trametinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9253161,-0.049245466,0.027264248051377248,-0.018412211009234788
98284,SIDM00673,Axitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.399334,-0.13142383,-0.4152575668813839,-0.06636003977110719
48964,SIDM00097,Camptothecin,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.9745874,0.33162284,2.732419245625519,0.19465391720832043
8433,SIDM00875,Navitoclax,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.28973442,-0.03370103,0.29357140128108505,-0.021407214580284526
82934,SIDM00875,Navitoclax,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0713766,0.09245049,0.7945238546619279,0.028539326080127433
49792,SIDM00875,Navitoclax,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.431002,0.046846747,-0.04107532783778852,-0.004370224113626342
75539,SIDM01187,Gemcitabine,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3222735,-0.09908354,-0.2548737114430205,-0.05721285474896316
23534,SIDM00837,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.5792933,0.13946357,-0.5768193995430999,-0.013341864373188614
72955,SIDM01042,Entinostat,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2265102,-0.14461373,0.6216786827607605,-0.043075935831556625
73370,SIDM00146,Uprosertib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-3.0337489,-0.17726776,-0.02510780198214656,0.09662311890791096
59385,SIDM00933,5-Fluorouracil,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.54821116,0.08271766,-0.5769356048687158,-0.04997962375260173
85688,SIDM00359,Crizotinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.77019155,-0.047336303,-0.8675850369782073,-0.06333374717336171
90043,SIDM00837,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-1.1443275,-0.090290904,1.2982040127028385,0.06988493369486803
32540,SIDM00837,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,1.6703134,0.060954086,-1.1113073250448091,-0.045629224505341626
61069,SIDM00933,Venetoclax,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.2999184,-0.06442554,1.890252959726383,0.05631020157358594
99579,SIDM00877,Alisertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,5.6919756,0.2815168,-0.014959224412018567,0.024034225387154592
28694,SIDM00957,Afatinib,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.9229558,-0.095725976,0.881489482776777,0.0557582213285595
43877,SIDM00933,Uprosertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.22520304,-0.02327252,-0.6004801343282677,-0.017582210562903756
100729,SIDM00673,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.60672563,-0.05068122,-0.06514477687260879,-0.000783232335617732
106548,SIDM01197,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.136452,0.09785443,1.067339511255434,0.0867485883907131
42857,SIDM00928,Luminespib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.4164051,-0.12284533,-1.0230858803885552,-0.04507027323524651
29324,SIDM00673,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7040308,-0.05920928,-0.8234358450552092,-0.045282440629388625
7001,SIDM00872,AZD6482,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3773791,0.038862623,0.1779179117248735,0.007776734118668155
3181,SIDM00928,Afatinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.91851944,0.10377666,0.7644448737670144,-0.026172011141604216
42569,SIDM00216,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6343847,-0.043005068,-0.45833250447076596,0.0017519919187388626
4164,SIDM00097,Axitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2977357,-0.13581128,-1.7494777004562814,-0.08644571402190657
22281,SIDM01187,Navitoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9984863,0.092676446,1.5169380495227929,0.09372857108462751
28202,SIDM00359,Dabrafenib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.4161234,0.20844626,-1.734764632344515,-0.007785983181109944
98929,SIDM00933,KU-55933,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,2.7274494,0.15905294,-0.032778353093144655,0.04477402535888894
80836,SIDM00633,Cisplatin,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.95922583,-0.04307959,-0.7347147406938234,-0.02980307121706901
38848,SIDM01187,Olaparib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4292338,0.075914115,0.29916952627750676,0.07664227478020037
60932,SIDM00832,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.5605643,0.06590199,-0.0785854060816423,-0.02275841544423159
21222,SIDM00933,Uprosertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3279558,0.13283093,-0.4649391417964777,-0.01992267358806474
11829,SIDM01187,Nutlin-3a (-),AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6893057,-0.06667618,-0.9599800380672132,-0.07961879181581764
27684,SIDM00455,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0285091,0.028722692,1.0129127051924636,0.1355411049608494
72686,SIDM00872,Gemcitabine,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,2.161671,0.09373501,3.8440158049694246,0.12683244776249245
62341,SIDM00950,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1039536,-0.19371639,-0.8839908815228666,-0.06000078553563732
17988,SIDM00146,Palbociclib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.0909448,0.23082541,0.41602541965419976,0.08059158664545323
44356,SIDM00673,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.2585318,0.07628159,1.8401282607945793,0.0520983934297604
60262,SIDM00933,JQ1,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.1748655,0.32109606,0.9650532486020329,0.06079034893024368
20024,SIDM00877,Nutlin-3a (-),Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.7795109,0.1323583,0.4969434872384179,0.027216238044162518
28375,SIDM00359,Crizotinib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.78009784,-0.054132584,0.031008384770482064,0.011804033636084968
32195,SIDM00673,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.2697046,-0.048280638,-0.24565215459954698,0.07928513545243786
25123,SIDM00933,Nilotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.9406415,0.14604402,0.850913932403151,0.04755555341593369
77678,SIDM00826,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.1688944,0.03529778,1.4735895884246981,0.019512226257924897
34556,SIDM00833,Trametinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.1859455,-0.05807486,-1.6484709482452136,-0.0675662017764369
76177,SIDM00872,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8965303,0.06522961,0.936444789768614,0.041726735065834325
10768,SIDM00872,5-Fluorouracil,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20206483,-0.011259031,-0.2553215575642672,0.0011423778351157855
7232,SIDM00216,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.66920924,0.05548888,0.01746478832600509,-0.0016196003347785654
69929,SIDM00928,Navitoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-1.4811817,-0.13161315,1.2947998667238527,0.027964233526844757
53452,SIDM00097,Alpelisib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.24167718,-0.015366999,1.2728677466941183,0.036616069312280765
61127,SIDM00146,RO-3306,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.7812356,-0.058019266,1.3687336050053935,0.06655597858908503
75698,SIDM00833,Afatinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,1.8200774,0.14032191,1.4008612403308873,0.03689393884783208
21811,SIDM00933,Docetaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.2085243,-0.17706884,-1.411816492607796,0.002561313446181881
70358,SIDM00877,Bortezomib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.45618215,-0.040103562,-0.2957703232347902,-0.018449398520462533
27137,SIDM00216,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.7882052,0.011863014,0.5379714413747447,0.040906619213739136
46464,SIDM01197,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.44126165,-0.014212037,-0.6022945930669142,-0.05937411006195076
41975,SIDM00282,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.446694,0.075414106,-0.6020777492160893,-0.010477858889411744
26473,SIDM00359,Crizotinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7790958,0.05783704,-1.1745106831507535,-0.06602605064420808
18051,SIDM00673,Afatinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.46736708,-0.035574343,-0.6388850956114849,-0.018169944301476334
93174,SIDM00933,RO-3306,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.55403715,0.060843635,-0.18437668423002734,-0.04721333081463474
40230,SIDM00097,JQ1,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8445585,-0.07332803,0.7745003214162213,0.03938067591189297
101478,SIDM00148,5-Fluorouracil,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2887249,0.13276796,0.6836060581325215,0.07764703947896592
58776,SIDM00875,AZD7762,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.056826305,-0.0038487234,-0.718339164247239,-0.07314238455084518
74778,SIDM00633,ZM447439,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.44999596,-0.031314068,-1.31850327526678,-0.06030911854821848
100314,SIDM00877,Vorinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.5187122,0.08301479,0.3227184378183673,0.04412309748571337
62520,SIDM00872,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.029171,-0.24643606,-1.2933639758081847,-0.13224918594803042
95119,SIDM01042,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.94986236,0.04635622,3.7699554505621347,0.16205063315004403
72899,SIDM00146,Gemcitabine,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.48787677,-0.03752076,-2.4732290811687228,-0.16473827849333836
6617,SIDM00832,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.2458442,0.10554556,0.6202248032945608,0.03850620620069629
17062,SIDM00673,Docetaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3598963,-0.13273095,-2.1111785253524893,-0.2163439015195096
15005,SIDM00928,MK-2206,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.7181523,-0.109166235,0.06864037338909945,-0.03675295054438798
33616,SIDM00146,Navitoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.4643554,0.032767102,1.9242451841928025,0.01083221620284631
82341,SIDM00282,Vinorelbine,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,0.9051904,0.07050727,1.6197482787421615,0.07568201305775678
94518,SIDM00872,Olaparib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5560803,-0.083563544,-0.14690639888802298,0.04535046941221266
21629,SIDM00097,Alisertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8139796,-0.1640662,-0.16730653121775785,0.010010253179633994
70276,SIDM00872,Lapatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,4.082166,0.14857782,0.7479309698234392,0.04446896887786043
14384,SIDM00928,Venetoclax,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.7759124,-0.0230714,-0.2696699432645772,0.032365059045434574
78161,SIDM00776,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.5801493,0.066738494,1.9583590547304617,0.0710148762316983
64977,SIDM00097,Venetoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.149322,-0.049338765,-0.363576663321125,-0.011132580195882407
90256,SIDM00359,MK-1775,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.86663854,-0.07213514,-0.11822577032467675,0.023405081185346063
34962,SIDM00875,PD173074,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4190524,-0.066752575,-1.1237059769336168,-0.02912315857547065
2520,SIDM01042,Trametinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5877721,-0.13510919,-0.8058629778651623,0.012814773021223955
51105,SIDM00826,Trametinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.3648232,-0.006842778,-3.1335724459930185,-0.05854596040463294
17053,SIDM00097,Pictilisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3184318,-0.021232098,0.7954120811606183,-0.0040729829453415465
19958,SIDM00282,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2826335,-0.043656908,0.2028174142168559,-0.005697644707435064
28127,SIDM00148,Crizotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2689348,-0.008247206,2.4793339208375866,0.06547163000564869
50518,SIDM00097,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2180233,-0.086182766,0.6321171094212303,0.005283060690798636
2678,SIDM00872,Camptothecin,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8727923,0.02394117,2.3944635300762482,0.05822510410304416
40967,SIDM00832,Afatinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.9136366,-0.17179285,1.8202268635347751,0.0740983273769181
29794,SIDM00875,ZM447439,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88089293,-0.06967709,-1.2374772213192917,-0.10099719950892717
26292,SIDM00872,PD173074,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1881114,0.060511462,0.10987636229488197,0.048033367275446985
65427,SIDM00837,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.6227814,0.037498966,-1.0221484774630205,-0.04919533641134236
54997,SIDM00216,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.8119012,-0.057454217,-0.6256581915950497,-0.022802658630450952
19706,SIDM01042,Afatinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.38583368,-0.050114773,-0.5818623708966573,-0.03259409819343633
55297,SIDM00282,Afatinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.42789167,0.01700659,0.46142311298765193,0.018494641029458053
67684,SIDM00837,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.8782429,-0.072567806,-0.6971090777613582,-0.07223124307565844
89414,SIDM01042,MK-1775,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7477375,0.05475665,-1.0184151992819772,-0.015493263064122466
84692,SIDM00933,Tozasertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.249332,0.118699215,-2.02484963444446,-0.11073899773262878
14526,SIDM00826,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.8877263,0.053201012,-2.418450694233424,-0.08407589395149052
19638,SIDM00216,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.53772974,0.017922835,-1.3747098445697092,-0.026515621467245325
24533,SIDM00097,RO-3306,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2896264,-0.1034244,-0.9637700604894278,-0.04642095850302425
22989,SIDM00950,MK-1775,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3368168,0.041184165,-0.5699901141935243,-0.0076414908893530885
83574,SIDM01197,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-5.074341,-0.16366994,-4.276271563692648,-0.16349540312844618
37688,SIDM00877,Temozolomide,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.35577735,-0.009703495,-0.5910557150521559,0.006459887354707019
20772,SIDM01197,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,3.5972838,0.22629513,3.1350559950422245,0.08471764239691792
102114,SIDM00875,Pictilisib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.25192022,-0.01319358,0.234883644071245,0.024082681125902724
78985,SIDM00097,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3192482,-0.15617082,-0.6694246623041036,-0.09312664327381469
46759,SIDM00146,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.056648124,-0.0047447355,-0.12242376143792426,-0.027061217495609996
50879,SIDM00776,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.67119825,-0.049993213,-1.321144122331983,-0.07491841432619492
90879,SIDM00950,SCH772984,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7121768,0.19455093,1.6798313623369874,0.133945570794349
26150,SIDM00097,MK-2206,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5350446,-0.09331154,0.2972191459817431,0.020759346116719216
67195,SIDM00282,AZD4547,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,2.1532373,0.056908716,1.7316999547047034,0.08241597003373234
5285,SIDM00950,Paclitaxel,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9500566,0.112502344,3.839978719335976,0.11957576167928585
67037,SIDM00833,Crizotinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,1.8108685,0.13050228,1.77760250199352,0.03954337129203167
75883,SIDM01042,Entinostat,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.4725766,0.10246462,1.2637453968576073,0.0793906180567418
72215,SIDM00872,Lapatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8194531,0.079806305,-0.12916538105450345,-0.06700427701911284
18401,SIDM00673,Bortezomib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.6821662,-0.029716346,-0.3960154122846812,-0.01992757277524266
28453,SIDM00933,Linsitinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.2974677,-0.077775456,0.727760734915048,0.05579563004094274
70057,SIDM00359,Camptothecin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.803478,0.15355283,1.6176844476819903,0.1723153261156012
73203,SIDM00455,Dactolisib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6153259,-0.10597316,-1.895367403076164,-0.1155590477164282
45168,SIDM00148,Vorinostat,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.44279265,0.04143101,-0.8952006775390533,-0.07292683911111153
58234,SIDM01042,Camptothecin,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8026537,-0.08588437,-0.5690918582041676,-0.015927031683772307
47488,SIDM00633,Cisplatin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3570347,0.09459264,0.2944158412438483,0.04402507736321327
94797,SIDM00097,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1543647,0.06246868,-0.03638494081873831,-0.001790085536259183
68064,SIDM00148,Venetoclax,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3176826,0.06412216,-0.11616585634635342,-0.04200191766483431
75869,SIDM00833,Trametinib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-1.9922159,-0.075893074,-1.4216635385203027,-0.08550188074558496
23998,SIDM00877,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.45999274,-0.05248995,0.43212775031102474,0.01061991055026023
65313,SIDM00673,Cisplatin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,2.336068,0.13170433,0.6916943780768606,0.050958620433247434
94397,SIDM00776,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.2161771,0.09938739,-1.3302730579898892,-0.00855187950872115
80076,SIDM00950,Paclitaxel,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6495197,0.063007906,-0.18395767713678696,-0.03885880757690288
47280,SIDM00148,Docetaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-4.4364543,-0.19348405,-2.1486483155718155,-0.10161918162521882
62430,SIDM00877,Sorafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.10664825,-0.012620079,0.5735284626055744,0.062245158775789095
106726,SIDM00455,Palbociclib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.66858065,-0.025127474,-1.4123829271540045,-0.034594548161937945
88369,SIDM00633,AZD8055,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1221601,-0.10972232,-1.3898085212878364,-0.0643272967375965
75560,SIDM01187,Trametinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.487935,-0.10281722,-0.9117313009825045,0.03497324605723374
38396,SIDM00148,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4026703,-0.011929738,-0.042668389179953276,0.0021247123278454196
77698,SIDM00673,Sorafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.8318306,-0.04796834,0.11726479236434599,0.021815674793786585
12890,SIDM00673,PD173074,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.17785,-0.09920729,-1.129719863324449,-0.06878954829474702
16114,SIDM00282,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,2.5121043,0.07932135,1.4542649068273095,0.037656254324765916
42550,SIDM00957,Camptothecin,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.7097535,0.0439883,4.718911425665055,0.13138400369598288
62680,SIDM01197,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.08204975,-0.003416016,0.6083051189436469,0.06369446329811915
6962,SIDM00877,Afatinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.49151576,0.05456493,1.0441314074089652,0.03313075086724286
30762,SIDM00837,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.92346793,-0.037523467,-1.1202543458689254,-0.09382065831038094
445,SIDM00835,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.3770698,0.110311754,0.7160363852970284,0.012012804147476486
76872,SIDM00673,Doramapimod,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0107124,0.022841161,2.140201588629269,0.06768214158046684
58691,SIDM00148,Taselisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3602977,0.082115024,0.03900108873040681,-0.010482567322905867
66408,SIDM00875,Wee1 Inhibitor,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.92363083,0.047382392,-1.0627436496273008,-0.06464948894493615
20409,SIDM01187,AZD7762,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,7.376891,0.44425327,3.191884706239864,0.1536825669658479
81985,SIDM00148,Cisplatin,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8301539,-0.036366403,-0.3341965051545957,0.012759219939336607
85865,SIDM00837,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,4.620911,0.19999704,1.942466263087368,0.011052919586959416
27419,SIDM00833,Crizotinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.009711642,-0.000714278,-0.3262387704842427,0.03802778688435393
62027,SIDM00216,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,4.284038,0.2104961,0.9549823828220005,0.09934205677180023
39831,SIDM00148,Venetoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6906618,0.014616954,-0.5044616951097478,-0.03931212981891572
73536,SIDM00148,Uprosertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.660954,-0.056778416,-1.1232400656780168,-0.04732648523661337
104169,SIDM00148,Taselisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6298158,0.077618845,2.022323323144448,0.1530033454197158
106855,SIDM00216,Palbociclib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,4.0690174,0.33256367,-1.7524642896930287,-0.09369482582696148
44847,SIDM00042,LGK974,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.6983187,0.19798534,-1.262820787177179,-0.024201456996289613
30631,SIDM00933,PF-4708671,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.2031096,-0.054327726,-0.2418787965473282,-0.012734812770261119
97985,SIDM00282,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,3.226509,0.18503655,1.109645795713517,0.06114992031685268
17222,SIDM01042,OSI-027,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7651385,-0.068054326,-0.21085112420135882,0.05528158722454151
102473,SIDM00875,OSI-027,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6402634,0.16971028,0.7995245945251063,0.13468713839171123
8789,SIDM00837,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-1.1886806,-0.09574044,-2.1846260459140763,-0.10719393040245832
37419,SIDM00875,GSK269962A,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1791874,-0.036097433,0.273124793530271,-0.011414542718273968
26123,SIDM00872,Afatinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9274007,0.10021102,1.0929454271092838,0.010316488654801732
38819,SIDM00097,Nilotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9734349,0.12121504,-0.15763015103590833,0.009064173474508103
90102,SIDM01042,Entinostat,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.82991046,-0.096659884,0.23134160006539167,0.04289673781195081
6783,SIDM00950,OSI-027,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8985297,-0.06756801,-0.538904361545543,-0.06695673817486127
89929,SIDM00877,Afatinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.0382335,0.22082512,1.2875056043599642,0.056387045224467566
92554,SIDM00148,PF-4708671,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.1011975,0.2295505,0.10079117410926827,0.0499337126194245
57707,SIDM01042,Axitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.462002,-0.060525313,-0.19777426400053438,-0.03023364867468915
48578,SIDM00833,Oxaliplatin,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-3.3336568,-0.094832554,-2.1763324325321394,-0.11034511847786203
13930,SIDM00875,ZM447439,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9813162,-0.09936052,-0.10659539929178209,-0.024751259855171372
1384,SIDM00146,Alpelisib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.77062446,0.04598619,0.4638354756389196,0.04079282098961784
79662,SIDM00455,MK-2206,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.398424,-0.07755975,0.9037235128843808,0.07617275897125904
4917,SIDM00833,MK-2206,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,2.817887,0.12043854,2.8939476180080974,0.1699483990870601
82556,SIDM00633,Uprosertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3814971,-0.10575245,-1.0398721078782267,-0.07650021660433759
99242,SIDM00146,AZD8055,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6904163,0.058304947,0.9820627524935824,0.04300682758619331
86907,SIDM00097,OSI-027,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3609262,-0.14237742,-0.736919850305262,-0.04816491137602269
82751,SIDM00776,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.45040688,-0.032088716,-0.8737540580861863,-0.05213408106990145
102294,SIDM00928,Bortezomib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-0.5617066,-0.036649507,-0.12445836735300621,-0.021822100029191344
26314,SIDM00633,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4408495,0.1705149,0.7930073796670943,0.0862858512180412
22941,SIDM00877,Venetoclax,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,4.635136,0.24993683,2.066318763881909,0.15634666645413917
44428,SIDM00957,AZD7762,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,1.841302,0.0350279,3.328409808526986,0.12391693587191956
77600,SIDM00950,Erlotinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8621776,0.2809481,2.035769668023555,0.13833007200167044
58523,SIDM00933,Nilotinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.7153206,0.061957918,0.7010760590666402,0.06643026657202288
8973,SIDM00359,Trametinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7218273,-0.12038619,0.7055302835074755,0.022147291910445954
29932,SIDM00146,KU-55933,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.3447716,-0.048422437,-1.8374158959877303,-0.04582426382464312
95645,SIDM00832,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.5841703,0.18939216,0.7748293083835527,0.02942634249588024
49107,SIDM00146,RO-3306,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.19278666,-0.015606568,0.5433136669351397,0.036661726589359865
45685,SIDM00826,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.5177181,-0.084704794,-1.5244358739199027,-0.04242655338545813
60518,SIDM00826,Camptothecin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.8033611,-0.043898664,-1.8316872626270844,-0.04589803512599011
68201,SIDM00633,Bortezomib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.50070804,-0.040375993,-1.3196172176602963,-0.0650888469628931
95295,SIDM00872,ZM447439,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.0010993966,-0.00010784492,-0.8913365393728281,-0.05587531933280885
41142,SIDM00837,Linsitinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.1052077,0.03374126,0.41052562268375953,0.020915127204256045
69022,SIDM01197,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.3556377,0.047974307,0.21409440552474773,0.016375198000564726
15269,SIDM00097,NU7441,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6257458,-0.076522574,0.8385611662306245,0.05448146555827306
64508,SIDM00950,Linsitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.7404847,0.25009716,0.8316012595853892,0.08818371608701142
27296,SIDM00928,AZD8055,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.6364994,0.17555061,0.5194872580997829,0.019500053427549548
39477,SIDM00455,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.157875,-0.15560366,-3.6398857630431074,-0.21024193963301088
87122,SIDM00097,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.162512,0.15084356,3.031980410554867,0.16783609774738142
18560,SIDM00097,Luminespib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.12421146,-0.008404121,1.0320433219343654,0.039609107139961935
11404,SIDM00633,Crizotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3674808,0.18845762,1.0879799395109266,0.04954597922324951
93423,SIDM00957,Crizotinib,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-2.403105,-0.0664656,0.1066080817176932,0.018645278896654967
95475,SIDM00872,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.0178645,-0.21136272,-1.174498851521403,-0.11018850329862583
45506,SIDM00097,Axitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4951692,-0.114031866,-1.239449249796654,-0.07252160992818364
20913,SIDM00146,Pictilisib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.1895759,0.08487917,-0.09479501755618372,0.040171964007350285
97108,SIDM00146,JQ1,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.194846,-0.10414369,-1.0834310919529493,-0.04313314529820667
32362,SIDM00928,PD173074,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.8048337,-0.04630658,0.23119541982025948,0.0168604972389946
97836,SIDM00877,Nilotinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.1027099,-0.10508478,-0.05098285120896186,0.06642277675918712
32594,SIDM00835,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,2.0631583,0.12662031,2.907067101087354,0.07411101251089319
19173,SIDM00837,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.4722738,-0.04987528,-2.662703680195881,-0.08421209241244355
103623,SIDM00216,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.1197357,-0.05014391,-4.679606509211286,-0.108420791189103
28056,SIDM00042,Gemcitabine,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.18136817,0.016927106,-0.555550882065211,-0.055040534136143904
62628,SIDM00146,Tozasertib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.0356513,0.078250304,0.11160387046066006,0.017716602570970054
60138,SIDM00633,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3665996,-0.080120474,-1.6185435473859011,-0.07967535059333405
48685,SIDM00633,Alisertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.472059,-0.08777659,-0.7779039520500656,-0.03195320814002663
5420,SIDM00042,Sorafenib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.9989292,-0.09540232,-1.7351961105323905,-0.0467555074129662
3718,SIDM01042,Alisertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3673283,-0.1715975,-0.32439682556208266,-0.10710475099071286
43268,SIDM00776,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.2742815,0.004219816,2.234212514787198,0.09370615715553189
70187,SIDM00633,Sorafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0747147,-0.07193697,-1.4421099250031122,0.005217478826773583
15998,SIDM00933,Alisertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,2.7725353,0.27146736,0.9300147580044268,0.09862111626509912
103824,SIDM00826,Afatinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.3772472,0.0375719,-0.04872087487959273,0.04857555302203657
56637,SIDM00872,AZD8055,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.61518234,-0.06577699,-0.3488573819337593,-0.0510661831682995
48563,SIDM00872,Lapatinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.124659,0.11199706,-0.07167036185411232,-0.021340245016030074
27748,SIDM00455,Taselisib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.5510667,-0.040064715,-1.4195406350893427,-0.12385663191390416
46532,SIDM00148,Venetoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,6.2942405,0.32619023,1.291709745823122,0.052507281487633645
87247,SIDM00282,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.5223844,0.05608451,1.1448056336419592,0.06430013618727409
102155,SIDM00877,Paclitaxel,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.1911114,0.08120418,0.3185625784151287,0.03584949945208649
51171,SIDM00359,SCH772984,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0765057,0.08341662,-0.575934727772505,-0.012936792271771675
108405,SIDM00216,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2775238,-0.058808126,-2.5940126713318024,-0.16772207209435042
73776,SIDM00673,Ribociclib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.6735935,-0.08147737,-1.1592624096908932,0.016187131177729724
34568,SIDM01042,ZM447439,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2762209,0.15763925,0.4333093916992158,-0.035747928026357435
68083,SIDM01187,Linsitinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.3347318,0.08844634,0.6715406539750902,0.029578541414576946
12664,SIDM01042,BI-2536,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1828964,-0.017617501,-1.4878400675575048,-0.09066522960321717
86304,SIDM00776,Palbociclib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.9259175,-0.05933934,0.1629725843580205,-0.009921247676840977
9827,SIDM00872,Lapatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.084091246,-0.008675058,0.20379041441365187,0.032749466984011835
15443,SIDM00837,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.5018937,-0.025564758,-0.006687362450869897,-0.04811269387888492
93870,SIDM00928,Vorinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.5751294,-0.13512047,-0.13686408963325508,-0.015669511381616135
65302,SIDM00832,LGK974,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-2.0146234,-0.117492996,1.3089028855261853,0.08382772982585804
47231,SIDM00875,Axitinib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7612826,0.05724838,0.9388454702191853,0.0348413404331125
60985,SIDM00928,Gemcitabine,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.6134238,-0.16147113,-1.4605583908722568,-0.16147881299060615
100335,SIDM00146,Pictilisib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.4862974,0.20984979,-0.2508519905399801,0.07709859255674502
29301,SIDM00097,KU-55933,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.0183144,-0.11675276,-1.5461460847823034,-0.0805227811507242
24647,SIDM01042,Nutlin-3a (-),Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4057047,-0.013456187,0.47641232730861993,0.07894251015072132
29102,SIDM00837,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.5151696,-0.17304464,-2.0878203437333003,-0.09469828502993849
47370,SIDM00832,Camptothecin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,4.3373513,0.28147188,2.125028841536021,0.13330045782494868
101580,SIDM00359,Dabrafenib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3161943,-0.05907947,-1.2623885324540036,-0.004860475592839618
77084,SIDM00673,OSI-027,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.0519083,-0.10486737,-1.303921795113402,-0.1058806692779437
93871,SIDM01187,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.0686495,0.30186862,1.3979348249148242,0.19691411308334864
33769,SIDM00148,Nilotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1921307,-0.12234519,-0.36960712123474687,-0.042468708734618235
72110,SIDM00832,Palbociclib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.6852672,-0.030516878,-1.1078561709908272,-0.06106254998623083
106405,SIDM00146,ZM447439,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5949835,0.050293725,-0.49356251153462705,0.019594246669433237
100502,SIDM00673,PD173074,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,2.7101092,0.20823942,1.0740048270254041,0.11847414777090137
95341,SIDM00928,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.025467,0.18562925,1.8056764693214324,0.16878789098437091
106026,SIDM01197,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-4.2628655,-0.1251776,-2.7281521883992634,-0.13877321533484985
73685,SIDM00097,Taselisib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8768114,-0.11865524,0.313956993443311,-0.030422017397866274
57352,SIDM00877,Entinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.49609017,0.040150773,-0.26417238453736785,-0.015188618331667604
65229,SIDM00872,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.48431325,-0.038340803,-0.29688358920104674,-0.04496604587349452
45767,SIDM00042,OSI-027,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.3221734,-0.0885931,-2.719648604418406,-0.09593924454133039
49333,SIDM00148,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5626222,-0.0537981,-0.707935588161056,-0.09395235966322786
104865,SIDM00928,Docetaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-3.405825,-0.2627771,-0.8303645008348657,-0.025817370635848342
73311,SIDM00933,RO-3306,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.404831,-0.06255017,-1.2699732899242089,-0.045432357356073955
41395,SIDM00148,Taselisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.779991,0.14911759,-1.0180042795598845,-0.0631596783935926
87278,SIDM00928,Alpelisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.5456461,0.16374631,1.030064133129908,0.0728160414373224
21135,SIDM00633,Olaparib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6982274,-0.07995297,0.5635844088348109,0.013695019411932467
81714,SIDM00673,OSI-027,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2216625,0.022713171,0.14346216203025536,-0.010559372034960319
45862,SIDM00455,Taselisib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8341825,0.1552557,1.819583422224798,0.11146366770836144
29338,SIDM00957,MK-1775,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.0174954,0.04194703,0.444321465323062,0.03430215851848938
28637,SIDM00877,Sorafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.7627943,-0.079806834,-0.282128107807814,0.005504295433245456
26479,SIDM00148,ZM447439,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5358299,0.13385399,-0.9770264006575491,-0.021359229940858183
5874,SIDM00359,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9490036,-0.10750366,-0.8971982671294988,0.00859067654253325
62069,SIDM00833,Navitoclax,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,3.4416733,0.11224472,1.7116299303688676,0.06817345593669015
40212,SIDM00455,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8263865,0.16890338,2.302091223367084,0.19837250871445003
35036,SIDM00673,Paclitaxel,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.8245766,0.22537503,3.7295161376604193,0.16062634110674412
77813,SIDM00872,Pictilisib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5535322,0.1350982,1.3369900731420532,0.043567140143377335
48910,SIDM00148,KU-55933,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.910786,0.09291356,0.41884049535975515,0.04327450036825355
11522,SIDM00776,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5867555,-0.091282256,1.6010737941440922,0.1120888717703779
45035,SIDM00776,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.5810107,-0.09274199,-0.0033493196728426864,-0.008047487245372537
82411,SIDM00097,Doramapimod,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.31558943,0.009246074,0.7207527364349282,0.02412260368508276
57831,SIDM00832,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.43330523,-0.03503084,-0.4423694685922988,-0.04319448050490856
37128,SIDM00837,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,2.2130654,0.1114264,-0.4746721788152468,-0.025897027781034004
77275,SIDM01197,Trametinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,5.2630844,0.051878437,1.7950277062046194,-0.006147489383802857
6717,SIDM01042,MK-1775,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.34694818,-0.027048778,-1.292564146459376,-0.07245569951900091
22376,SIDM00146,AZD8055,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9017864,0.07991042,-0.12382710396108326,-0.01352927297455324
94129,SIDM00872,Uprosertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.55249834,0.058174018,-0.4865392620332624,-0.012042429495691174
40185,SIDM00872,Pictilisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.45414963,-0.048539735,-0.29748177567168466,-0.027490144093341433
28100,SIDM00633,OSI-027,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.96427226,-0.08043034,-1.6406907262953223,-0.08748204066452756
90117,SIDM00933,Ribociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,2.5991902,0.0938256,2.421856616661276,0.02635179325110118
92386,SIDM00359,Vinorelbine,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7576236,0.10658112,0.4998376456611258,0.04702071822755191
6041,SIDM00928,Luminespib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,-0.7199955,-0.071153946,-1.0326500396697216,-0.10509662932357415
6029,SIDM00633,Bortezomib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.0800447,0.12711471,1.8698590655656493,0.07123854632772807
61233,SIDM00832,Camptothecin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-0.9898188,-0.087403975,1.8695406422146088,0.12472429567552867
94790,SIDM00148,Entinostat,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5870084,0.13308197,-0.6066732891177751,-0.01918337270780246
77170,SIDM00872,Alisertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7618113,0.037143726,1.076094046152442,0.026773023460006005
105240,SIDM00928,Alisertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.4457022,0.101946235,2.0773019796770194,0.10647389291577122
78816,SIDM00832,Vinorelbine,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-6.8805823,-0.5133211,-3.2566516986818574,-0.18460935806216394
59139,SIDM01197,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.0053124,-0.13885292,-0.679097045152423,-0.040152352188825395
83374,SIDM00875,PD173074,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3133902,-0.0038563209,1.2695477754058828,0.023970887006606812
99316,SIDM00042,Crizotinib,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.4310919,-0.0456519,-1.1688826530388945,-0.04394500783574142
73430,SIDM00673,Olaparib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9728868,-0.048067726,-0.042757220870838795,0.038596453316779814
42634,SIDM00875,Nutlin-3a (-),PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.74090815,-0.022438342,0.5699927421673008,-0.011971978977076714
345,SIDM00148,AZD7762,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3739513,-0.11064517,-0.3226477081890037,-0.02287439495406817
71634,SIDM00872,Pictilisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7167181,-0.07531345,-1.1158709003019212,-0.09298431280872227
80031,SIDM01197,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.31037408,0.009807016,-5.2831119289822,-0.09113604560491324
81855,SIDM00928,Alisertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.4441237,0.113833226,-0.07588136418913174,0.04237727582193549
20903,SIDM00877,5-Fluorouracil,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.81518143,-0.040441237,-0.25153301127928285,-0.000464850379413342
72137,SIDM01042,Bortezomib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2465502,-0.02463794,-2.2292142891371793,-0.08611319745001411
72664,SIDM00875,Lapatinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2464762,0.21738957,1.7850038812676534,0.12491086743460339
62066,SIDM00833,BMS-754807,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,2.2703292,0.16788982,-1.496710557269374,-0.10391960872261276
55819,SIDM00216,Oxaliplatin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5397325,-0.05108769,-1.8824049740342252,-0.1534869745759424
30289,SIDM00833,Palbociclib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.7780368,-0.019273568,0.22325053758314953,0.013578676870246272
107950,SIDM00872,Pictilisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8131875,0.08456238,-0.1511746925127842,-0.06773686827556889
58748,SIDM00933,Cisplatin,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.41356856,-0.048950475,0.009070143963358547,-0.00564872122335132
93339,SIDM00957,SB505124,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-4.4396815,-0.06432819,1.844686613812631,0.05439038459256477
101744,SIDM00872,Crizotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.92568535,0.08051567,0.47863568543838664,0.011203501470477082
10728,SIDM00633,NU7441,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.90001464,0.06450993,-0.36475212639871435,0.03234136975660428
75158,SIDM00933,MK-1775,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.27356815,-0.022158576,-0.07522374709712672,-0.02206015817445952
41809,SIDM00837,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-1.6840248,-0.05862967,-0.37391229506074247,-0.0296426636978694
27186,SIDM00826,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.9032476,-0.10807438,-2.45990815996137,-0.04772130781178518
82004,SIDM00146,BI-2536,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.1853623,0.086294666,3.164081065354664,0.06884134293124688
37490,SIDM00148,Trametinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4301252,-0.045985084,-1.3879148148075229,-0.08117712914003551
58840,SIDM00875,Taselisib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17812139,-0.020808423,0.7909352150187839,-0.009315209064785333
36936,SIDM00148,Lapatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6212114,-0.05734037,-0.09101425042255398,-0.04332712551110828
77471,SIDM00837,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,2.142056,0.05833677,0.13192009729809595,0.01013170332743124
22194,SIDM00097,ZM447439,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3044499,0.014451628,1.5687241832302201,0.1007096949017935
31557,SIDM00928,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.4611223,-0.056902517,0.8244862966448351,0.018489167811433144
58519,SIDM00950,Olaparib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8205387,-0.029134845,-0.3551025910019466,0.03721402089579735
68354,SIDM00455,Lapatinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8460501,0.029408174,3.1404250473030757,0.09054320687578395
84919,SIDM00216,AZD7762,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,1.4324468,0.1431756,0.09052838467047682,0.0699717090183759
82374,SIDM00633,Trametinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.696025,-0.15855841,-2.6433582560397184,-0.09268913600976053
103411,SIDM00673,NU7441,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,0.25960943,0.02058213,0.5404719208475669,-0.0023728541689267786
82504,SIDM00950,Trametinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7888991,-0.059792493,-0.01739537356692162,-0.04159890848133322
12510,SIDM00833,AZD4547,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-0.56773233,-0.020216027,-0.3946577926643461,-0.021146096923007826
67786,SIDM00097,Camptothecin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8249222,-0.03839968,-0.822861740035289,-0.01135717157875293
98131,SIDM01042,Trametinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7947477,-0.116251454,-0.34261703570029867,0.01065939802234038
80039,SIDM00097,Bortezomib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4348125,-0.028890863,-0.1933590010402001,-0.00567659261217391
43611,SIDM00097,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.8191905,-0.14782554,-1.5831984191420818,-0.06238878430492927
55174,SIDM00957,Olaparib,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.1061049,-0.02516621,0.00939323341829566,-0.025255461414680637
97585,SIDM00042,OSI-027,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3098554,-0.0343998,-1.3004528734933203,-0.08285965712074361
91391,SIDM01042,BI-2536,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.93641925,-0.0077026277,-0.9587633809907332,-0.07060393527864639
60079,SIDM00928,BI-2536,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-3.0396655,-0.21885927,-3.4352472818363213,-0.1325258513788168
72648,SIDM00633,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7260486,-0.1304389,-1.1395206183366842,-0.07520289060930715
72917,SIDM01042,AZD8055,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.129431,-0.22180279,-1.7804240042961992,-0.09147005095504727
8935,SIDM00933,Dabrafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,1.0742283,0.09621614,0.3896697246114988,0.0568195516615504
28787,SIDM00216,Taselisib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.1120815,0.07773729,-0.7106776625851126,-0.0741005685302402
107446,SIDM00633,Tozasertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7819017,0.06188884,1.487036791657676,0.018692739780926428
11260,SIDM00097,Taselisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1103032,-0.1515781,-0.7279851874623798,-0.058803630567992
91123,SIDM00148,Alisertib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.8552942,0.24962312,0.8290659922474444,0.05132679681687778
74285,SIDM00455,Gemcitabine,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5909706,-0.040299725,-0.8453427412102392,0.01974325870379643
40679,SIDM00872,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.56735575,-0.020294134,0.3356421397833467,0.04706511489661857
41998,SIDM00826,MK-1775,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,-0.13983364,-0.005918859,-2.2917986870083316,-0.0984290839185579
94694,SIDM01042,Pictilisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5747519,0.060769036,0.24612972115361395,0.011859170572440764
12472,SIDM00097,Docetaxel,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6853065,-0.1519074,-0.4158699610515876,-0.057580985059233356
25393,SIDM00837,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.188276,-0.14021124,-1.1791548324689487,-0.10807396989852171
65070,SIDM00148,Dabrafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8471704,0.058315307,0.8490135265070705,0.04239270159871818
47268,SIDM00957,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.6053843,0.11325985,2.8200609101499032,0.1468279211806113
73952,SIDM00957,Palbociclib,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.23811227,0.006368,1.4024826245106325,0.07132551722002123
22830,SIDM00776,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-3.4196706,-0.116311386,-1.500051559829918,-0.036190342807068086
49943,SIDM00835,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,2.1716576,0.16400595,-0.04738669430058146,0.03688019608222048
25134,SIDM00673,Docetaxel,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3895077,-0.092457734,-0.10515110788579843,0.019605773671746894
14805,SIDM00826,LGK974,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-2.1637082,-0.10246856,-0.8044204029292963,-0.06389709127434968
6414,SIDM00826,SB505124,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-1.4635966,-0.025825305,-3.2274494094047355,-0.1267067167070065
64942,SIDM00146,AZD8055,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.54586273,-0.046499126,0.25348878565481214,0.02618100467148867
11678,SIDM00359,SCH772984,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5731493,0.09205347,-0.8308341409234901,-0.019663245875195565
5267,SIDM00875,Alisertib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0467476,0.022504557,0.9201421653094268,0.0061842542150422905
80458,SIDM01042,Nutlin-3a (-),Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87597305,-0.025011716,1.768150815951225,-0.0006804657446640906
73377,SIDM00833,Palbociclib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.1678252,0.11595461,0.9454284267354273,0.033727615599033256
86797,SIDM00146,Nilotinib,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5944487,0.046475865,-0.5877649027880836,-0.02883131830800659
89718,SIDM00282,Navitoclax,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,4.079932,0.18729715,3.4058626096343687,0.20737227263602698
81865,SIDM00146,PF-4708671,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.7030466,0.05567301,0.5079793352117344,0.024898748571544112
96370,SIDM00359,SB505124,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.79151684,-0.04821017,0.07680340738992669,0.03663090732849269
26575,SIDM00833,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.497752,0.040672082,1.2006404344442665,0.04271087356578825
77024,SIDM01197,AZD8055,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2418092,-0.08943731,-0.5124210850309434,0.01729371716967367
104402,SIDM00835,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-1.0113626,-0.022423005,0.7776497452148622,0.02579587736798808
81111,SIDM00776,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.7067157,-0.027002087,1.4643256164959744,0.06560203667071887
71703,SIDM00282,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,0.7221378,0.050360426,0.7818220898566075,0.0063190821256447136
103046,SIDM00097,Venetoclax,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6177586,-0.032978248,0.7651939798070859,0.029235339818572095
94080,SIDM00673,Temozolomide,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.6166965,0.008293256,0.7163525170540298,-0.002818003739356156
85938,SIDM00282,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.934483,-0.0411666,0.44473410928379864,0.017163368061378123
68540,SIDM00875,Palbociclib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34060088,0.010631023,1.0490328855373805,0.03939482425844263
11374,SIDM00877,BI-2536,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.9447647,-0.0034773136,-1.9960654194575413,-0.015514742353091578
90169,SIDM00097,Vorinostat,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5600185,-0.10372372,0.21473151202501062,-0.028000169805144644
89078,SIDM00146,Docetaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6797146,0.06364014,-0.9351222336905528,0.005431210662415455
99087,SIDM00673,Trametinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.75752443,-0.064302996,-0.5429090543211608,-0.008474832208245731
45727,SIDM00877,Bortezomib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.50919807,-0.036874384,0.31644537859827454,0.03187793827938372
47833,SIDM00928,Palbociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.704721,-0.082643524,-1.0871960637713263,-0.02714970536070529
88482,SIDM00872,Crizotinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.19266245,-0.016024223,-0.47396579534947225,-0.058416638471284636
60660,SIDM00097,Nutlin-3a (-),Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5600063,-0.046224315,0.7930779579117745,0.02866769399999083
77008,SIDM00877,Afatinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.5029968,0.064242765,-0.20189862290915822,-0.003738682919320367
95233,SIDM00957,MK-1775,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-5.824815,-0.17883289,-2.5459516731848177,-0.13053046560379347
3898,SIDM00832,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.3233821,-0.15945466,-0.737509118032251,-0.03690840006585567
91587,SIDM00872,AZD7762,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1501105,0.11583932,0.7408050005532678,0.05277760715544342
14721,SIDM00826,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-9.193584,-0.104162134,-8.317903697638537,-0.22746434463730666
37881,SIDM01042,Taselisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.880095,0.04097653,0.10486948156329874,0.029188930330447605
29798,SIDM00933,RO-3306,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.881857,0.0913076,0.025628310422431508,0.022249364784944707
74527,SIDM00877,JQ1,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,4.9449253,0.25281703,-0.1255396902781142,0.012319118364152561
80297,SIDM00216,MK-2206,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6811101,-0.12081445,-0.8907342367713734,-0.078287064382596
41345,SIDM00872,BI-2536,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.9980326,0.28048596,1.8051477269545777,0.13257076370922452
105046,SIDM00455,Taselisib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0932126,-0.098719485,0.23312042902505462,0.0006800165891475942
21422,SIDM00928,Nutlin-3a (-),OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.7516345,0.045462463,0.7939069039814213,0.02845799172020183
7290,SIDM00282,AZD4547,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.7837453,0.043328367,0.24758425936555695,-0.009164258582317168
8262,SIDM00835,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-1.9067543,-0.13621636,-2.4673870796026467,-0.10616470382071246
53837,SIDM00872,Olaparib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.81569904,-0.016182203,-0.002867615632944975,0.024858520866815097
77105,SIDM00146,ZM447439,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.22096078,-0.017955119,0.2994084042342208,0.04584856116942527
48333,SIDM00933,Dabrafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-2.139469,-0.13534172,-0.8616832581451085,-0.016143234745407326
52220,SIDM00455,MK-1775,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9896343,-0.061775126,-0.22175361236722896,-0.03714359968127265
87766,SIDM00933,Sorafenib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.22431107,-0.02073613,0.33660343270458626,-0.013817000191305263
94144,SIDM00833,MK-2206,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,5.5797944,0.1933475,3.3966974261324574,0.15427618315636119
33496,SIDM00957,Dabrafenib,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,2.8222237,0.05017311,2.7549065031669078,0.09175447599476488
31697,SIDM00877,AZD6482,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.7346647,-0.07817804,-0.9489544601295863,-0.009052894454607175
36214,SIDM00928,Sorafenib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.4573013,0.037029497,-0.5389541738784582,-0.032348330107887936
22870,SIDM00875,MK-1775,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.13998172,-0.00861438,-1.3724207621435014,-0.07655655682928632
72122,SIDM00097,Temozolomide,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.1809628,0.0035617615,0.8356258022606016,0.02790527700144776
51048,SIDM00872,Bortezomib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.18027508,0.012367963,0.4092315583451897,0.011354535067254366
5461,SIDM00875,Alpelisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6161945,0.16403145,0.8892452763407253,0.07038017843265874
27381,SIDM00216,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.59499246,0.008391979,2.052421323689592,0.05546548423813176
100188,SIDM00455,Sorafenib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.3211457,0.020219117,-0.7241644655429815,-0.035098652513100626
36301,SIDM00875,Cisplatin,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.0043550176,0.00017453167,1.605217099130974,0.07517053247452338
30990,SIDM00833,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.1269333,0.058601167,2.7991345959739844,0.05420576181515296
13527,SIDM00042,LGK974,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.93820405,0.06393202,-0.9967925541629641,0.0006268273879516574
64341,SIDM00097,Bortezomib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6736236,-0.034916606,-0.8849007740949724,-0.05893158911946184
105204,SIDM00875,Alisertib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.20023988,-0.013852954,-0.06626816410926223,-0.010340011654419255
63402,SIDM00875,Crizotinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.76278037,-0.06930807,1.1899664511728427,0.027200137121944454
71517,SIDM00875,Alpelisib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0122871,0.10343497,0.7983875897310792,0.06509709636382749
94116,SIDM00633,Taselisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.331221,-0.072324604,-1.0025453512791456,-0.04723776170645453
86423,SIDM00928,Alisertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.53940636,0.04615474,0.6869358685243933,0.09273579097646553
67269,SIDM01042,KU-55933,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.367959,-0.09470119,-1.484753218615698,-0.0859829992625988
2035,SIDM00282,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.4990287,-0.14567782,-0.04737317809554431,-0.0562578758143928
39224,SIDM01042,Taselisib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.95370746,0.048087653,-2.023195814663256,-0.07116308957736808
95284,SIDM01042,Taselisib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.72284985,0.051502857,-1.4659255833650076,-0.06554554286361168
102466,SIDM00872,AZD7762,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0284764,-0.10983206,-0.9838476475740626,-0.13727885242233853
12483,SIDM01187,Temozolomide,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.51081145,0.014158809,0.1947561655009976,0.015202565449819612
6187,SIDM01197,Linsitinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.02792,0.1517641,-0.7754623920016974,-0.0015579985699638067
84790,SIDM00928,MK-1775,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.93159384,-0.098376796,-0.09335804920413236,-0.039526047685517554
53419,SIDM00950,AZD7762,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.12246712,0.009432412,-0.8655176421979287,-0.046161691310597164
46602,SIDM00872,Lapatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.86065257,0.08337602,-0.09739956864380023,0.019836491501361058
58699,SIDM00633,Docetaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.5403867,-0.15600275,-2.7748357728023625,-0.17603679367697542
54573,SIDM00872,ZM447439,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1250054,0.10940992,0.6606648353277752,0.08234474361579674
61009,SIDM00837,BMS-754807,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.6225513,-0.011742067,-0.4190036233643071,-0.0319170328075623
91923,SIDM00933,Entinostat,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.3143709,0.11080297,1.396767801918632,0.16361823397596154
77598,SIDM01187,Taselisib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.1289332,-0.2083833,-2.526366991418318,-0.12569912934997
15814,SIDM00933,Linsitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.63354665,-0.044891756,2.2669789054540233,0.14364973758045652
54479,SIDM00673,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9443417,-0.11660914,-0.4032072446959687,-0.03865956677706211
81254,SIDM00359,Palbociclib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.46223333,-0.029599901,-1.7930015842643325,-0.02166873460587265
103466,SIDM00835,Linsitinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.2849295,-0.052111555,1.5087955517120637,0.0868821719888053
105648,SIDM01197,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8656212,-0.039142985,0.7886866907171739,0.005736638111276262
63237,SIDM00872,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6293423,0.046559833,1.5612100695004631,0.08965667280448879
62961,SIDM00282,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2099683,-0.0553947,-0.21899982092306175,-0.06195930828367582
6308,SIDM00933,Vorinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.63747126,0.07603865,-0.5578187378967532,-0.000448943021550246
86089,SIDM00833,Afatinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.2816448,0.15803176,1.7425091740346133,0.10259522755859364
86620,SIDM00146,Camptothecin,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.50322527,-0.04074223,-1.2896210750610906,-0.061704764191773204
45266,SIDM00875,Doramapimod,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5360556,0.055232868,0.7069363661322738,0.00816683724563124
79861,SIDM00875,Wee1 Inhibitor,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3429035,-0.019015357,-1.8675287001630925,-0.0669951421058057
40090,SIDM00776,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.2445755,-0.18521734,-1.0404816672770114,-0.11415440780254416
103063,SIDM00928,PD173074,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-2.0664077,-0.053951826,1.1679602205224022,0.012534566265293522
64299,SIDM00148,Camptothecin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6419952,0.06356954,-0.31262942451210884,-0.027074878861425906
22963,SIDM00146,Dabrafenib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.5116719,0.08778696,0.7123046714769597,0.0203553292049906
46726,SIDM00933,Afatinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.5414559,0.12769708,1.9285516498165054,0.12088671170453417
26790,SIDM00146,Pictilisib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.72477293,-0.058710154,0.9165904791260442,0.17580057514302952
43258,SIDM01187,PD173074,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.2660837,0.28618813,1.5680994959971024,0.14083930081646515
23739,SIDM00875,5-Fluorouracil,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80913436,0.01583973,-1.2700248671369105,0.03792145857277695
11614,SIDM00872,Navitoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,4.4446874,0.38069764,1.247752016917096,0.09692948725133559
91722,SIDM00877,Pictilisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7507671,-0.08017506,-0.05577464672656014,-0.0774877714183852
51488,SIDM00097,Lapatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5013484,-0.053897973,0.5023995463382064,-0.004557116243928439
42379,SIDM00928,Ribociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.1711118,0.08378223,0.3432309937247123,-0.00973920247216483
75616,SIDM00633,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6314492,0.10316439,-0.6546095821839066,0.019619093081820558
81328,SIDM00875,MK-2206,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.69437325,0.052126784,-0.8285051635401305,0.01769089960178298
35566,SIDM00633,PD173074,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2922046,0.085246615,-0.303458761025055,0.006496306562186491
27537,SIDM00146,Linsitinib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.3740754,0.042902347,1.7183881563150116,0.050179630830555336
42087,SIDM00950,Oxaliplatin,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7981985,0.09894528,-1.0673778513482104,-0.008355434277624557
20204,SIDM01187,Linsitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.1748662,0.08884499,2.413879249961703,0.036617022196154383
67840,SIDM00837,LGK974,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.5463207,0.06730263,-0.03345483129827237,0.03741989237896958
62383,SIDM01042,Camptothecin,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9293876,-0.09694379,-0.6019218654839432,0.006984200586365941
21711,SIDM00148,Camptothecin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0925059,0.088901795,-0.5996963862011728,-0.021704327166533175
87792,SIDM01197,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9924967,-0.0573733,0.18135297418213342,0.034177474321060206
107704,SIDM00216,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.5468846,0.049716074,-0.3302684835407338,-0.0694986729682266
1927,SIDM00872,Vorinostat,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4226829,-0.08814222,0.30701170774335396,0.03227957256365599
87364,SIDM00148,Nilotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.20877224,-0.020457717,0.23561934458684136,0.0046259398028967134
84506,SIDM00826,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.48516384,-0.029164268,-2.012556334429929,-0.07577548852477137
50323,SIDM00359,Camptothecin,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.316504,-0.100480646,-2.0509495553812678,-0.10630382100934586
107720,SIDM00835,Linsitinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.7700746,0.10872754,-1.1449014333704088,-0.02809600152675535
61207,SIDM00633,Pictilisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5493377,-0.044503186,-1.3103386959845906,-0.07657759808473374
57090,SIDM00148,Wee1 Inhibitor,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4313877,-0.044896763,-1.7269009682952134,-0.103971518022908
73517,SIDM00146,Vorinostat,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.0517018,0.091831595,1.5154784810589859,0.12156463288705258
40865,SIDM00455,Paclitaxel,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.79652065,-0.03883276,-0.007686052899343759,-0.05000290430395682
84003,SIDM00833,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.8026006,0.040702473,1.6371857498915507,0.055029024409132925
87098,SIDM00097,NU7441,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5337799,0.08367888,0.5267552845128958,0.01004793958148877
12849,SIDM00950,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5186144,-0.10708651,0.953071565079051,0.03606037156787146
34018,SIDM00776,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.3260998,-0.11165793,-0.6223154862879403,-0.05022795715324417
75591,SIDM00950,Crizotinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.5028913,0.2861416,2.7600971526459777,0.16157763092034647
36918,SIDM00146,NU7441,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.52417225,-0.042718485,-1.0868846128989111,-0.0773504514310691
57530,SIDM00832,Trametinib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,0.8572874,0.025711214,-0.8312606034253077,-0.018066597972645385
56528,SIDM01042,Nutlin-3a (-),Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.94564223,-0.02813754,-0.8349429358640309,0.006782869965065504
68143,SIDM00928,Gemcitabine,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.058755,0.11158322,-0.331737068141271,-0.07789124619635533
10245,SIDM00832,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,3.14165,0.04680497,2.428241685676072,0.07261998548899005
87287,SIDM00359,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1887876,-0.050998777,-1.7285527492447441,-0.042633703374144905
22734,SIDM00877,Temozolomide,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.42106864,0.00809733,-0.5159592225901303,0.04297902217746779
44508,SIDM00950,Dactolisib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6009043,0.07416669,0.13561268145775066,0.02902200347596035
31079,SIDM00455,Navitoclax,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.433615,0.22054721,2.118702357159367,0.1643826373144755
64204,SIDM00216,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.1485611,0.005106276,-0.7876391208395209,-0.0141681103666068
53759,SIDM00833,SCH772984,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-0.9603855,-0.07504287,-1.1670420174696954,-0.059453988367841513
47903,SIDM00933,Palbociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.34475383,-0.026013216,-0.3807313211895249,-0.00892626469114342
55247,SIDM00359,Crizotinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0089678,0.07116152,0.5201096762176015,0.02348317780112946
42955,SIDM00146,Camptothecin,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.5846575,-0.09999247,-1.6693177183267491,-0.062917360139729
73220,SIDM00146,MK-1775,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.6263172,0.046753936,0.12623091385241436,0.056459310281270686
6794,SIDM01042,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.914636,-0.02655136,0.03674793168632661,0.029759352067562615
30801,SIDM00833,Nutlin-3a (-),Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,3.864757,0.15301627,2.459644490000959,0.06385239843805658
104785,SIDM00872,OSI-027,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4480922,0.04601513,0.4236358464177255,-0.0049378262073543275
24927,SIDM00826,Dabrafenib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.546481,-0.06877283,-3.1136505570449393,-0.09730301330101897
100416,SIDM00097,Linsitinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7749374,-0.1059934,-0.4542491358639117,0.03704827029925745
10115,SIDM00455,Dactolisib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1776701,0.08014093,-0.11427504632606764,-0.05778160700139863
78331,SIDM00875,Navitoclax,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.15049554,-0.016901646,-1.3693925748819573,-0.09193361427205016
392,SIDM01197,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3569818,-0.06176736,-1.090020668360063,-0.07398539434489614
92595,SIDM00146,SCH772984,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.589418,-0.05189243,-0.07318353387515393,-0.05418482220893543
61194,SIDM00928,Pictilisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-1.5044379,-0.1498481,0.1737108278898012,0.04042811147982278
89523,SIDM00148,BI-2536,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1529773,-0.05386819,-1.6335116245645265,-0.03130551657205364
81099,SIDM00097,Trametinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.59089893,-0.014767762,-1.0419917905386906,0.007818958665672221
17604,SIDM00146,Navitoclax,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.2360297,0.07566678,1.0596849750412876,0.01149718491619739
59039,SIDM01187,Pictilisib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4599206,-0.10962036,-3.2128744147774015,-0.13508615414681546
101720,SIDM00673,Wee1 Inhibitor,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.7430116,-0.044250064,-1.3573826264485866,-0.030060543770326756
16591,SIDM00833,Navitoclax,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.7573436,0.06710548,0.19998565307754013,-0.011933851127779161
78424,SIDM00455,Sorafenib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3546938,-0.06864955,0.6554137775595692,0.006205119942005086
87733,SIDM00633,NU7441,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.68589276,0.03638495,-0.33696676065884795,0.009341091501794548
13157,SIDM00146,Navitoclax,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,2.005984,0.124243565,2.022629588745659,0.003084957779988637
83290,SIDM00950,Gemcitabine,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.198116,0.08131207,-0.5669653447185491,-0.00977330315183141
67709,SIDM00148,Crizotinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5090987,0.017973129,0.8838108125623138,0.04152654548052414
69370,SIDM00148,Trametinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9873348,-0.03382703,1.734818520800533,0.034160048443536005
20411,SIDM00928,Trametinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.4366424,-0.1288393,-0.6501295653138158,-0.08307426377249326
63977,SIDM00872,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.24201263,0.0088952845,2.068694275584067,0.1151740422110683
71391,SIDM00928,Pictilisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.1147242,0.12041679,-0.9463966319919218,-0.06593449720544348
41173,SIDM00957,MK-2206,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,1.7393858,0.033856764,-0.8443153769607176,0.005823036034633165
42904,SIDM01042,MK-1775,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7204671,0.049119238,0.9980081809040755,0.04417420855946474
65576,SIDM00933,Alpelisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.87789565,0.057867214,-1.1764775361313877,-0.06503980276241295
95514,SIDM00872,Trametinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.909529,0.088039964,0.1217091179105805,0.01976840181603129
37553,SIDM00148,Dabrafenib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7433554,-0.04350878,0.1919724000615457,0.017684828698083434
85270,SIDM00872,Cisplatin,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8445558,0.030389404,1.1596204389378268,0.06991115910461279
76470,SIDM00875,MK-1775,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19184683,-0.012186086,-1.2108739950822582,-0.07749795085888575
60639,SIDM00633,Navitoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.254369,0.24550055,1.3693288941544168,0.14220761780609165
79042,SIDM00872,MK-1775,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5460391,-0.057279825,-0.42197105522367634,-0.01154511998044805
42513,SIDM00872,Cisplatin,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.33538982,0.010912508,1.2967955887121958,0.06281466994760611
89131,SIDM00673,Venetoclax,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.2921472,0.12007908,1.1380794351353516,0.07426399961798039
85029,SIDM00216,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-3.6473222,-0.08294934,-2.153925557570826,-0.08512377777646991
67424,SIDM01042,PD173074,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.87032086,-0.036674306,2.1587042372645233,0.12861104829641373
22373,SIDM00633,Trametinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.855914,0.15429813,2.3512852284179497,0.07628896251466329
36306,SIDM00633,5-Fluorouracil,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7311702,-0.036112543,-0.8394739121734566,0.007010075877835418
49275,SIDM00148,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.97220933,0.0949017,-0.25360570305372593,0.019486308360977454
54311,SIDM01042,Nutlin-3a (-),Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8572545,-0.024351731,2.336432316974625,0.07215573765060702
4130,SIDM00776,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.3907532,0.016136982,1.0440522900936093,0.07689506013372212
60982,SIDM00673,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4656837,0.06894081,2.330001677700543,0.08100073851612764
15592,SIDM00826,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-3.785612,-0.23370528,-3.4751918545450606,-0.19989612229681442
42981,SIDM00877,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.5886935,-0.112923436,-0.5418220489539618,0.03344156444689966
71760,SIDM00146,Bortezomib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4123601,-0.028149704,-0.7634046747209048,-0.07539934374708158
73790,SIDM00877,OSI-027,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.8264958,0.06655702,0.874307076834608,0.05671839206810361
83185,SIDM00933,Gemcitabine,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.340088,0.0030149666,-0.6081862690665883,-0.009126795709794158
101939,SIDM00877,AZD6482,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.249221,-0.09619524,0.5205157562142917,0.05123466655794367
54551,SIDM00826,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.763822,0.014760264,-0.7376745627223095,-0.04441045212133794
64275,SIDM00957,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.5767671,0.02436434,2.7112342054277483,0.05769763031170649
85188,SIDM00146,Linsitinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.359959,0.03604871,3.1956367555241965,0.10546611523293396
60419,SIDM00455,Cisplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.135596,0.06030241,-0.24070389470158096,0.02221831113027943
406,SIDM00826,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.5063417,0.05032193,-0.7782997248452439,0.004656563346330073
90852,SIDM00877,NU7441,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.23620574,-0.026136663,0.2667743957962955,0.03794707891788119
85493,SIDM00872,Cisplatin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2218068,0.006589629,1.2115434576812247,0.04299258996927129
3948,SIDM00097,GSK269962A,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5655201,-0.025102938,-0.36444375544774466,0.013083148305443658
100795,SIDM00950,5-Fluorouracil,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.7072868,-0.22145842,-2.688812744973284,-0.1680780169168682
41704,SIDM00875,Olaparib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2646563,-0.055817835,-1.4783014391267153,-0.10293937918111445
52320,SIDM00216,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.7784424,0.18889207,1.4966610422242588,0.08833570748255189
31638,SIDM00146,Doramapimod,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0708765,-0.047942866,-0.004584118973599047,-0.0018238664023501122
59567,SIDM00875,PD173074,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4883313,-0.004192623,1.2285917210227764,-0.00013156688062617784
56374,SIDM00877,PD173074,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.1373533,0.08878666,1.1275842214541871,0.10876411336102969
101984,SIDM00877,Sorafenib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.6747448,-0.07695593,-0.27530734852729627,0.027900972707240627
26587,SIDM00933,Ribociclib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.45037028,0.010634179,2.1310541824818894,0.07770444447387738
50075,SIDM00872,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2564089,0.02711738,-0.5691957345250925,-0.06149215592176652
59356,SIDM00633,Axitinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1761208,-0.058943592,-1.361979819844961,-0.09637747157378358
40322,SIDM00833,LGK974,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-1.6604787,-0.04712692,0.3605396174022194,0.03217625317106629
69415,SIDM00950,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4972477,0.13481794,1.7694636734614728,0.07617199468488907
75236,SIDM00832,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-0.1825232,-0.005572482,-1.879852272330888,-0.06894681857080773
38654,SIDM00826,Palbociclib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.264181,-0.12143423,-2.510130724512417,-0.13406130043972725
61713,SIDM00933,AZD8055,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.94032604,0.07638434,-0.26857665569464945,-0.03925743070349843
16259,SIDM00875,OSI-027,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3001196,-0.1498053,-1.2914117575203732,-0.029896674333801183
42470,SIDM00872,Camptothecin,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,8.064049,0.53769386,5.558885612820732,0.2951625498651046
59163,SIDM00832,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-2.529802,-0.18385422,-1.8078983194292593,-0.11578821334395796
88897,SIDM00097,Temozolomide,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6227503,0.037422188,-0.19204146208835846,0.006488472161658514
10033,SIDM00776,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.7318485,-0.046619385,-0.23100671239642354,0.004456062056427179
89127,SIDM00146,Entinostat,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.7918997,0.31239623,2.247144799014802,0.12377929233088857
99297,SIDM00097,Linsitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.290378,-0.0872338,-1.2237547522934127,-0.020106325149786723
9287,SIDM00837,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-5.641335,-0.06709943,-4.59864630024405,-0.13614900909598926
98178,SIDM00826,Nutlin-3a (-),AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,2.1088803,0.036712922,3.088773452556851,0.11110307644424519
97397,SIDM01197,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.0396508,0.077400774,-0.34485577674358564,-0.001933260619596132
93321,SIDM01042,ZM447439,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7977068,0.1098155,-0.18364764479065396,-0.023412093154691595
52819,SIDM00837,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,1.2780602,0.03765476,-1.1713827859309942,-0.07497406559851894
20319,SIDM00216,AZD7762,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.7097033,0.13613518,0.16439155838778224,0.04159689578996231
103262,SIDM00835,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-1.0725002,-0.07701878,-1.0744743346181247,-0.09279978528021858
10618,SIDM00359,AZD7762,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.79863626,0.056800105,0.6664047330167616,0.09906208963897978
53761,SIDM01187,Temozolomide,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.80917436,-0.020630805,-1.0876734881903398,-0.028392799601142167
50144,SIDM00835,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-0.65325457,-0.057644032,-0.2228414022765051,-0.03097136551646943
12262,SIDM00833,AZD8055,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.7987403,0.027916385,1.0308254905054963,0.024203398400214966
8862,SIDM00872,Alpelisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4861399,-0.152713,-0.7993510828194628,-0.06782720190322214
100183,SIDM00928,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,5.111181,0.30238354,1.8245579218437362,0.05430627151176655
66006,SIDM00957,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.6111045,0.04521119,1.1966645448433353,0.039436943341022636
75253,SIDM00933,NU7441,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.6597136,0.06852339,0.5695773760030503,0.06457742857120843
31493,SIDM00875,Cisplatin,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5463778,-0.027576076,-0.3059982182852781,0.004945793325804623
104171,SIDM00832,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-2.1325836,-0.07584405,1.1674022132088016,0.12467187087063097
78992,SIDM00097,Tozasertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2912204,-0.04363236,-0.038756560949605605,0.005246494132043857
12907,SIDM00928,Nilotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.1369852,0.10113256,1.292559130679304,0.049782471776084414
100274,SIDM00148,Pictilisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.91053283,0.044951994,-1.298652662070275,-0.11372717163338976
57803,SIDM00933,Olaparib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,1.444006,0.1936639,0.11403896288591492,0.057171283499985834
63385,SIDM00673,KU-55933,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.7251897,-0.09839463,-0.45415774550235716,0.0029234537422308977
32161,SIDM00673,MK-1775,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.66081244,-0.03707191,-0.43112440506568583,0.04455323541058384
71106,SIDM00826,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.6076055,0.023446996,-0.09887738032540466,-0.014258099863451558
77997,SIDM00933,GSK269962A,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0165111,0.10514475,0.4971474319499875,0.08704898988261853
92366,SIDM01042,Paclitaxel,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4122688,-0.0428938,-1.774196049541325,-0.05123891537895944
89994,SIDM00833,MK-1775,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.9283674,0.067541435,0.6295437965598507,0.06396660006021702
84628,SIDM00933,Docetaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.9697707,-0.13259092,-1.158863619862032,-0.025190980667058285
5030,SIDM00872,Temozolomide,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.15000148,-0.0030494283,0.45762697531239444,-0.002241537092297905
95972,SIDM00455,Palbociclib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.227478,-0.10173412,-2.5532724022564084,-0.03858311373136851
93654,SIDM01042,Palbociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8402486,0.04993523,1.639949455773035,0.039371246116394115
43738,SIDM01197,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9322763,-0.046703912,-0.5661381973708685,-0.010343079718407016
44098,SIDM01042,KU-55933,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0785475,0.100227244,-0.34826797422925276,0.0005501348895351532
103291,SIDM00832,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-1.8564897,-0.1259721,-0.7880855490577486,-0.03387704504594184
18131,SIDM00837,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-3.8557792,-0.15661988,-0.15542256805185328,-0.06912565427595921
47062,SIDM00673,MK-1775,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.40762258,-0.028660635,-0.7916034523300496,0.017179651158854534
96219,SIDM01187,Olaparib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.3727522,-0.081756614,-1.5502027564017196,-0.06542642827603082
43775,SIDM00633,OSI-027,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.37441722,0.030553842,-0.21073613228595128,-0.051376630415446885
16422,SIDM00877,Entinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.5282785,0.10569932,0.6547319819241461,0.011123107478314995
94388,SIDM00148,NU7441,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6375965,-0.16296506,1.4063780566962116,0.03703254496530337
82634,SIDM01042,Doramapimod,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.38125318,-0.044546407,0.25609649266496104,0.011665812308752039
16608,SIDM00359,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.2057168,-0.16649927,-2.160142121330631,-0.05124687723591435
44482,SIDM00633,ZM447439,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5224928,0.15729237,-0.2177323344685374,0.003602371465157492
24530,SIDM00877,Crizotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.61315304,-0.054841094,-0.6845450824080737,-0.09193517565019949
107455,SIDM01042,Cisplatin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.369387,0.14539583,4.188132518780087,0.10289394756190509
31630,SIDM01042,Tozasertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9842415,-0.13692407,-1.596595779219061,-0.09089253522543286
90558,SIDM01042,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.47095498,0.040946454,-0.4570333822192292,-0.04790035815193203
63506,SIDM00097,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4258187,-0.09123858,-0.7861854545523265,-0.08705106970485244
43495,SIDM00633,Trametinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9883811,-0.060950927,-1.2015459432022804,-0.061325419161738455
70769,SIDM00877,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.77953917,0.057273705,-0.3579106437729865,-0.06033902530780877
102729,SIDM00872,Axitinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6193661,0.049618192,0.02169934079818017,0.057876329038312115
96508,SIDM00455,Navitoclax,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.52859604,-0.021312824,0.3767086939810999,0.007131398867735683
27650,SIDM00455,MK-1775,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9117681,-0.05276145,0.9939947318911487,0.05983470064109841
44971,SIDM00776,Afatinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.2916129,-0.024526631,-1.0817765939173254,-0.08006036566774793
80359,SIDM00933,JQ1,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,2.5557103,0.23235103,1.9040919537962342,0.2209589988742814
90983,SIDM00928,Axitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.1139174,-0.07704666,0.10423687884556086,0.040836434757209134
67196,SIDM01042,Palbociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.42798546,0.017430132,1.1498818246911244,0.032613942797924955
104613,SIDM00950,MK-2206,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.4736255,0.044255756,-0.8422379386758407,-0.06354747878977039
29016,SIDM00673,Alpelisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.31560525,0.020013198,0.26357465066701463,0.055666443746272255
89289,SIDM00216,LGK974,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.31255117,0.005208378,0.05174196626851451,0.004158715856900656
106948,SIDM00216,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.4623729,0.07920364,-0.521916609431463,-0.045023882911421016
75331,SIDM01197,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.395562,-0.05193151,-0.48987310200644235,0.011723486582464622
104286,SIDM00146,GSK269962A,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-1.0219499,-0.07039756,-0.5888754857463347,0.02239939909421044
27820,SIDM00097,Alisertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3741018,-0.068983994,-0.0474186547674457,0.05384338512936723
80628,SIDM00148,Wee1 Inhibitor,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.2961062,0.028547224,0.6574297121212265,0.036610674620672544
26563,SIDM00455,Crizotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.44973528,0.01855003,0.2256648873273321,0.021281217350008628
107594,SIDM00282,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.59737813,-0.033289753,-0.507474770197412,0.017343365845221476
54559,SIDM01187,Docetaxel,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9176892,-0.04277004,-1.2985319957162267,-0.029919792245224897
10375,SIDM00097,Paclitaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5976566,-0.10823889,-1.2355274487931787,-0.10586000833497601
14108,SIDM00633,Ribociclib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2532519,-0.034582097,-0.6593573621466531,-0.032690037219425434
53312,SIDM00875,Afatinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.62738425,-0.0138523625,-0.3830555789838157,-0.012052409299749581
69883,SIDM00957,LGK974,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.4948263,0.025073066,0.5682051714358409,0.004931645378944096
6530,SIDM00097,ZM447439,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.44301727,0.02065832,0.44764396167718473,0.015620130211653292
59077,SIDM00673,AZD8055,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.74678373,-0.060411066,-0.4378118604690835,-0.040503900164237674
4868,SIDM00872,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.81100404,0.06574234,0.21153671818667316,0.016863389662581392
7227,SIDM00097,Uprosertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1394606,-0.13287602,-1.1189023786789145,-0.06621663573878872
70866,SIDM00097,Trametinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0830294,0.04071271,-1.2027098377053391,-0.03856419448188327
106844,SIDM00933,Paclitaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.75157917,-0.064601906,0.31324323037294977,0.09456992010215358
88844,SIDM00776,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.2857462,0.055508085,1.969815940822749,0.04955508074822013
56670,SIDM00042,Lapatinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.7308002,0.12057432,4.051013310710053,0.18044855972777274
77516,SIDM00633,BI-2536,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3221772,0.083045274,2.4720815038333033,0.08846080521211129
47822,SIDM00455,Linsitinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.59255856,0.040333174,-0.8109335690156508,-0.06876852273322583
49863,SIDM00633,Gemcitabine,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.673673,-0.035869084,-1.6544245758380358,-0.07396370010542533
50708,SIDM01042,Taselisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4769358,-0.04090351,-0.37941475476731734,-0.05185936147558628
65028,SIDM00950,SCH772984,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.60189706,-0.068817236,-0.632750808503732,-0.043950441182992926
60146,SIDM00146,PD173074,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.0204976,-0.07140353,0.2949695972619796,0.03800267804035586
4250,SIDM00872,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1358874,-0.027202303,2.3983906537071236,0.07708316801164888
34753,SIDM00957,5-Fluorouracil,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.3658753,0.005259021,1.4726124005928694,0.04912701357797549
90521,SIDM00877,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.1258816,-0.055295795,-0.5354138483904308,-0.03498963226401604
100860,SIDM00776,Taselisib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.6872927,0.14070329,-1.120595978697043,-0.09911600159898837
62292,SIDM00877,Lapatinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.1647532,0.1680738,1.0444003804377116,0.11793717896075144
105922,SIDM00875,Nutlin-3a (-),Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43466273,-0.013013855,0.5510126412573787,0.023282919614374217
86108,SIDM00776,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.800449,-0.046783626,-0.5177324006224558,-0.00856000945092287
73074,SIDM00877,Tozasertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6565462,-0.12867908,-1.568364463013349,-0.04908415644971069
75606,SIDM00872,Alpelisib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3527621,0.1361146,0.41244987953478357,0.05284520531991489
60323,SIDM00837,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.7301,-0.08143117,-1.6824455394357194,-0.03738781003945127
13424,SIDM01042,Linsitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.496742,0.11277932,1.7926992745503738,0.06303006296838996
57236,SIDM00928,Entinostat,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.5405291,0.16854477,-0.08165451234720156,0.011761122908250085
10188,SIDM00837,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,1.388472,0.055192336,-0.3187126793300593,-0.03483533300000731
22567,SIDM00872,AZD8055,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8318164,0.086017676,2.4934724909200754,0.1155431419754162
66669,SIDM00950,AZD7762,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3692406,0.091671556,0.19499990808554818,-0.013573633675105853
104317,SIDM01042,Doramapimod,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0022771,0.093156025,0.40763633039875935,0.01395140421219234
101700,SIDM01042,SCH772984,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5425314,-0.025710586,-0.44427750760760587,0.016179372171246865
14251,SIDM00282,Dabrafenib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3117553,0.043224424,1.1360006454031832,0.07324921389103801
1408,SIDM00282,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.7830398,0.058190223,-0.2021433142862705,-0.01044058483366017
38820,SIDM00877,OSI-027,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.0774751,0.0721838,-0.026247704248085816,0.027446452565096834
106967,SIDM00673,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.9537169,-0.08593292,-1.9012643673995968,-0.06088435522480275
83375,SIDM00148,Wee1 Inhibitor,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.291273,0.1139894,-0.48460162705114707,-0.036539484542498446
42306,SIDM00148,Alpelisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2900604,0.118136756,-0.004406204113084113,-0.030814170454011445
68902,SIDM00875,Taselisib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3573498,0.1310031,1.6464132914349363,0.01866842114306968
107717,SIDM00877,Alisertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.1598454,-0.1338598,-0.11687455822472968,0.031226635518815844
2057,SIDM00673,Paclitaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.78602636,-0.06251132,-0.07408912390820926,-0.04926067682554609
94800,SIDM00359,Linsitinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.054692134,-0.004354673,0.27716541398618916,0.0036256548197507333
68237,SIDM00776,Trametinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.0799907,-0.09028169,-0.7863783368547913,-0.07314697940305598
64496,SIDM00633,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8901887,-0.05204273,-1.5299535001744005,-0.01959206538286488
31616,SIDM00928,Nutlin-3a (-),Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.81072533,-0.01693419,1.147210595850169,0.04670547086264265
9375,SIDM00148,Lapatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.38886032,-0.03869504,0.45954195693880395,0.02755642508879945
8549,SIDM00933,ZM447439,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.938551,0.15518773,0.30323160572016444,0.07714660123355932
7274,SIDM00146,Afatinib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6614649,-0.065002285,-0.7774356451128968,-0.006731783751752937
9417,SIDM00455,MK-2206,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6283997,0.07382965,1.077179441910949,0.0845694545851944
88998,SIDM00837,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.820611,0.25173506,0.1085894767335011,0.0358713773304707
77066,SIDM00097,Vorinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99357605,-0.05462703,-0.18743378904123634,-0.03307824531645347
34900,SIDM00872,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.9053595,-0.14221433,-0.5996557805770585,-0.018870184381570402
93739,SIDM01042,Doramapimod,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6389224,0.062624834,0.816948591660288,0.015887936053357483
82131,SIDM00359,BMS-754807,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1954919,0.09453857,-2.7907094265880104,-0.08079709307551751
26257,SIDM00633,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2499471,-0.033910457,-1.6586440408786705,-0.05832879622787749
49841,SIDM00455,Irinotecan,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8273667,-0.05662866,-0.8594997478354264,-0.03822798334679199
104308,SIDM00673,Ribociclib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.5177894,-0.06059905,-1.14827419727748,-0.010950458456613807
42465,SIDM00875,OSI-027,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22739974,-0.022152478,1.4104671699997837,0.13158780251152496
77855,SIDM00933,Camptothecin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3947873,0.11217141,-0.08267040298817538,0.003785796675158593
98621,SIDM00875,KU-55933,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4359485,0.08748912,0.521785818629076,0.03588749922295733
87124,SIDM00148,Taselisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3884752,0.11327362,-0.2168276554117116,0.002329537476050965
98035,SIDM00282,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.5310879,0.11190664,1.4919557863066748,0.10060203876869454
72946,SIDM01042,Cisplatin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3408536,0.07784498,1.07241186549164,0.06816271055544511
87466,SIDM00950,LGK974,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8174881,0.05958222,0.0020353398905998605,-0.006040812642568078
45562,SIDM00950,MK-1775,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8916924,-0.04286429,-0.9380604578002005,-0.002290452146978336
39293,SIDM00833,MK-2206,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.9395862,0.06432457,0.1646124489000858,0.04504662503181634
15951,SIDM00633,Alisertib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.271201,0.56211084,3.2512457537158,0.19549318581202807
5805,SIDM01042,Paclitaxel,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0118916,0.14481963,-0.337818729250781,0.017859914883182254
88487,SIDM01187,Nutlin-3a (-),Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2274122,0.109977834,-0.2268947529793912,-0.04832712979296843
10682,SIDM00872,Axitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1940205,0.10290822,-0.2363063990275808,0.06543552947654484
45892,SIDM00455,Trametinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.35109,-0.1356493,-0.6658897291617161,-0.06912712029762866
66308,SIDM00877,Afatinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.1964333,0.13262978,0.5559084684501305,0.0048567892625435965
56917,SIDM00837,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.0928972,-0.028382601,-2.009493235411838,-0.06675832057877254
33484,SIDM01042,Sorafenib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.04644019,-0.0037115067,0.017011169591774074,0.006500108372955054
694,SIDM00872,JQ1,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1709347,-0.02685332,1.1153602976418826,0.029978617342719945
94710,SIDM00097,Sorafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5319139,0.07863602,0.63606300949398,0.07135294477148084
31346,SIDM00826,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.9286518,-0.07615859,-3.8059469213746078,-0.13438286244318096
10258,SIDM00826,Olaparib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,-0.9290882,-0.04723198,-0.39454119215497563,-0.05878881093536069
85672,SIDM00950,Dasatinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.8781192,0.32418147,2.5315981713927274,0.18053909290148704
33025,SIDM00148,ZM447439,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1208371,0.0797901,-0.5048320134306145,0.011284929952146045
34808,SIDM00282,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.88702375,0.050795596,0.03529623906011795,-0.030100906981114905
64371,SIDM00097,Gemcitabine,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0562046,-0.03672619,-1.1650741871679156,-0.03509268396890265
9552,SIDM00957,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-5.1690183,-0.07837736,1.7438531774673587,0.08233145336410867
57663,SIDM00833,Afatinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.1973362,0.15887077,0.8340635909575032,0.06148518371765344
69350,SIDM00933,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.48573,-0.13574313,-1.8539146141514455,-0.09800015477107572
56989,SIDM00042,Oxaliplatin,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.899471,-0.10607284,-2.4821488826107223,-0.05194171293434901
20418,SIDM00633,Docetaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-5.4192495,-0.2908361,-3.8705163678656107,-0.2381683656514425
34936,SIDM00877,AZD6482,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.584995,-0.1408978,0.44264203248361916,-0.01927014654152314
65558,SIDM00148,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8213652,-0.17389718,-1.872288882483241,-0.18354357581345881
51452,SIDM00146,Luminespib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.7237024,-0.10611802,-0.48586124001723147,-0.08755330195704598
78841,SIDM00633,Venetoclax,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.917861,0.13237956,2.025941673341848,0.07808655559256658
79683,SIDM00877,Linsitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-3.0326276,-0.15913245,-0.627810406685827,-0.054418655208993916
10558,SIDM00872,PF-4708671,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.78386974,-0.06519364,1.3227820633121086,0.04250998626969621
65172,SIDM00097,Doramapimod,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6155357,0.0956238,2.632311804403755,0.07295689135903884
79815,SIDM00826,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.0655732,-0.081674635,-1.3200741609559445,-0.1295608684511421
44461,SIDM01187,Vorinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5464256,0.05359436,1.0729747724700764,0.0564470950902924
56236,SIDM00633,GSK269962A,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7478122,-0.052678134,-0.5857502581275567,-0.02086712762414314
39552,SIDM00837,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-3.5015259,-0.16914222,-4.55284998029927,-0.2474935117135262
35404,SIDM00877,Doramapimod,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.8729764,0.20995785,0.4842059572950718,0.05526479706240777
88505,SIDM00673,Olaparib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0953434,-0.037205152,-0.7628829367643213,0.024171016746968227
51689,SIDM00216,LGK974,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.3407015,0.077544115,0.023536288323391354,0.012884243661433342
22427,SIDM00833,BMS-754807,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,5.547097,0.26214552,1.453476681315206,0.15144036554542756
33658,SIDM00282,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.1840959,0.03713384,2.265924489995832,0.11172252305707694
86420,SIDM00875,Doramapimod,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8183202,0.05152119,1.1326927854410909,0.03182810426898618
67861,SIDM00216,AZD8055,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.682181,0.19701433,-0.5796745628872964,-0.020291317345879623
29538,SIDM00633,Pictilisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2833052,-0.0999031,-2.0586099921431726,-0.10804319243785913
21803,SIDM00928,Entinostat,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.9219468,0.29532263,1.4838891297490453,0.12416960420484188
46481,SIDM00877,Sorafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.33162755,-0.04099863,0.6098055124059619,0.045254620612223545
71433,SIDM01042,PF-4708671,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2000774,0.12977092,0.12468748426465777,-0.02064324776474045
46291,SIDM00877,Uprosertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.47704628,-0.017387131,0.14739279095421165,-0.012018272675354153
2694,SIDM00097,BI-2536,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.58654416,-0.0395063,1.4407234135644285,0.08544540876556614
12197,SIDM00633,ZM447439,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2441431,0.091508746,-0.021697119504526324,0.028352142626465848
24396,SIDM00875,Sorafenib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41833985,0.043909468,0.21831865408512882,0.04971657046334937
34761,SIDM00928,Olaparib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.0667286,-0.064328015,-1.2738760200035577,-0.03311040412981889
30267,SIDM00359,Olaparib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.27371725,-0.006230327,0.7684250880910362,0.04292384301140951
33926,SIDM01197,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7900533,-0.04448553,-2.5363806362531682,-0.13538445399360188
42939,SIDM00875,Ribociclib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6202993,-0.017816542,-0.5272415358327526,0.0004901898787520619
33736,SIDM00146,Alisertib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,7.158573,0.21053936,4.527982612495895,0.2460292981571096
67703,SIDM00148,GSK269962A,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.26151198,-0.024703555,-0.30866136028206526,-0.016782862561099905
94882,SIDM00776,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.6182046,-0.21618125,-0.49695621604913065,-0.050486313010683403
11371,SIDM00633,Sorafenib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.13435297,-0.011908426,-1.2417533801027245,-0.00010918522042018523
13038,SIDM00833,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.55006,-0.15660524,-1.9247609517562017,-0.13029318735860757
86414,SIDM00148,Dabrafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.96133703,-0.05778578,-0.6107969429587152,-0.013530686623766358
96733,SIDM00837,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.1612645,-0.05906341,0.09101226690927909,-0.00841652208499278
95938,SIDM00146,Cisplatin,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.4521227,0.14251018,4.443539447942003,0.15694354704986785
21346,SIDM00877,Lapatinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.72833467,0.05555926,0.22501940701043163,0.01929031859336284
32321,SIDM00633,BI-2536,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.15549582,0.016178599,-0.4035172071685982,0.0015993469926902705
73706,SIDM00148,Linsitinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5417224,-0.050468773,0.21684362826967948,-0.011269877455625996
70153,SIDM00146,Axitinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.3363011,0.028242934,1.6151019751665383,0.09593132287959713
69889,SIDM00933,Bortezomib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.52821136,-0.05987754,-0.23953180416270245,-0.042831243296982485
46785,SIDM00359,MK-1775,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4632185,-0.16060571,-1.4443522427035866,-0.05925485289539141
29944,SIDM00633,MK-1775,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6010791,-0.1329662,-2.066504650914444,-0.1111023215276067
59637,SIDM00146,Crizotinib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.976646,-0.07407052,-0.18978103228001725,0.05698487885717052
36237,SIDM00933,Lapatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.5793856,0.046031214,-0.848190303484245,-0.04734091601258414
11090,SIDM00957,Trametinib,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.1548392,0.054622844,-0.6128716471374652,-0.031816273190512494
78381,SIDM00928,KU-55933,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.422294,-0.098609164,-1.0376753798920195,-0.028601065409444477
94240,SIDM00832,Navitoclax,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,0.26748827,0.010867476,0.34246716963667534,0.009872527085815598
48571,SIDM00877,Alisertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.8834865,-0.1051692,-0.8651743645149949,-0.012589763107523003
5557,SIDM00933,Axitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.4004295,-0.16069461,-2.1889977830444334,-0.15946262934646654
85937,SIDM00872,Linsitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6498394,0.024576085,1.4814951637950087,0.0888311259339833
31554,SIDM00146,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.11575738,0.008325249,-0.12287028473700123,-0.005356032031698951
740,SIDM01187,Trametinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.7255073,0.34896776,0.9874301775960993,0.07303955839117035
94005,SIDM00877,Alpelisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.8295697,0.1651324,1.3156525462780546,0.03677743644640379
75519,SIDM00673,AZD8055,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.091587,0.06112649,0.18937121545723323,-0.003610624951214564
16256,SIDM01187,Luminespib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.46608767,-0.04795038,-0.7066372367230604,-0.06166252614556323
79780,SIDM00837,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,2.8433497,0.20176372,1.6553192668556087,0.11314295444019402
100800,SIDM00950,Oxaliplatin,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3952162,-0.07317368,-1.4623538665929792,-0.04600084907778554
106809,SIDM00216,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.4605434,0.23016106,1.0648565796235203,0.07947363613799921
963,SIDM00832,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.2456014,-0.06828496,-1.5664894617251997,-0.022810829288318377
23156,SIDM00872,5-Fluorouracil,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.41239238,-0.02073058,0.2015235662900479,0.034235555407089974
15591,SIDM00933,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.5377724,0.28223425,-0.5664490505194759,-0.047321432543607066
51969,SIDM00148,Paclitaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.173624,-0.21438497,-3.2949341872819473,-0.24206934059412225
72276,SIDM00633,Alpelisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2419327,-0.12703691,0.020411071811388775,0.07684834517720912
93215,SIDM01187,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.1187923,0.1917134,0.25779970045562495,-0.003134085052119295
80902,SIDM00673,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.48364717,-0.04137951,-0.7111052950663306,-0.038544463423374614
106401,SIDM00359,Vinorelbine,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.98650885,-0.040202726,0.9347335524395607,0.08620105834701065
11025,SIDM00875,Taselisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2992412,0.13923863,0.07848805250787987,-0.0177828547287844
23101,SIDM00957,BMS-754807,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.603473,-0.08815408,0.3362481060142823,0.021103720253539793
77828,SIDM00633,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.188675,0.20831405,0.20006162365658992,0.046512168624795014
58130,SIDM00877,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2235645,-0.14505474,0.2070733623694833,-0.006233121909827021
26197,SIDM00835,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,-0.2924837,-0.008119016,0.4064732355305908,-0.0004892688468339714
94015,SIDM00633,Linsitinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.651614,0.15378718,-0.26321146434852183,0.0008044425115964891
65233,SIDM00875,BI-2536,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.089191,-0.115699895,-2.1645630775186797,-0.09316501785168793
32087,SIDM00877,Nilotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.4998962,0.17336594,0.8519759936812503,0.07519431916573771
31592,SIDM00950,AZD7762,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.72647905,0.07043833,2.889776270364256,0.11991666316779565
76119,SIDM00877,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.482392,0.038697105,2.047636441471414,0.12367765232567358
5141,SIDM01187,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4572381,-0.08057799,-0.17497034022427385,0.023136030035064033
44786,SIDM00957,Taselisib,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.9137793,-0.06307985,-0.27733752531333467,0.058403350562975714
39152,SIDM00097,Alisertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.99581337,-0.058103994,-0.4980223518746838,0.03493469624179741
40395,SIDM01042,Pictilisib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9018956,0.051405523,-0.15075390363936833,-0.025939463986510328
90829,SIDM00148,Olaparib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9395449,0.03999304,-0.11009585346296798,0.0016847678917911884
63814,SIDM00877,Crizotinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.54675543,-0.04041013,-0.041212427924710734,-0.050338057903320875
39464,SIDM01042,AZD6482,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5226727,0.06842737,0.03495513564828065,-0.016881299591794678
81603,SIDM00833,AZD7762,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.236703,-0.094016984,-1.9471918295082875,-0.17487025880447385
13379,SIDM00957,Camptothecin,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,3.2741659,0.060109515,2.5830164381281797,0.09816940602892506
47091,SIDM00097,Nilotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.96904266,-0.06540091,-0.8254318171441619,-0.0671649674888384
26924,SIDM00097,Sorafenib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6937525,0.0963968,-1.3363892459778672,-0.018815333197766414
50590,SIDM00673,Vorinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.89798427,-0.086657085,-0.6426108567674291,-0.08316558843603909
57070,SIDM00148,KU-55933,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7520743,0.03928508,-0.7672874069976431,-0.0400863476458638
17213,SIDM00875,Linsitinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.661572,0.025539685,0.9632123753795497,0.015116219035923084
27555,SIDM00776,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.94466454,0.07038861,0.4113598175253033,0.07826886172502578
9573,SIDM00950,Navitoclax,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4882696,0.1548518,2.3828662443523174,0.17049868759479528
53783,SIDM00933,AZD8055,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,4.3316765,0.3160851,0.4263322627951316,0.055164981931995156
84030,SIDM00872,MK-2206,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0690132,-0.10819186,-0.4924573288596679,-0.0662440472809248
100084,SIDM00146,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.45742908,0.029598178,0.16279935219511502,0.03144589834005572
10884,SIDM00673,Gemcitabine,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.5888146,-0.09438677,-0.040755443658622444,0.04947625170912854
17491,SIDM00673,MK-2206,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.49797058,-0.032826167,-1.4552748715670862,-0.06574351156648456
57972,SIDM00097,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5445662,-0.13496536,-1.3913467876224408,-0.07291204535358155
47588,SIDM00148,Pictilisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3500729,-0.026327323,0.20252922102652254,-0.04033581046042683
60634,SIDM00148,Paclitaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-4.6794214,-0.31695375,-2.8817865327709313,-0.2662815667171425
45267,SIDM00875,Luminespib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.41216278,-0.03436488,-0.4465651970634857,-0.07768585788812286
51069,SIDM00148,KU-55933,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7216046,-0.02555789,-0.15135002919538734,-0.012747149170039931
16781,SIDM00872,AZD7762,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1026835,-0.011080117,0.06721963315474536,-0.026474962198100475
9946,SIDM00933,OSI-027,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.75541776,0.08939175,-1.1709433515783654,-0.06018570681714785
43965,SIDM01042,Lapatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5476083,0.065332554,0.4262385557225614,-0.016300854174163052
84264,SIDM00933,PD173074,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.7232462,-0.14938934,-1.4175890678508778,0.0005796929258581811
14188,SIDM00826,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.17302248,-0.008058569,-3.5603077975836714,-0.13758727604982357
13906,SIDM00673,PD173074,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.1600906,-0.060226142,1.4496247490587162,0.11296177189932671
85993,SIDM00877,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.91190743,0.09700403,0.731537132007766,0.05761789335458371
67153,SIDM01042,Tozasertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1996577,0.2751204,-0.4598213574205388,-0.01834337124143925
59220,SIDM00933,Olaparib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.3826132,0.14115408,-0.7969140501099214,0.02634888806400144
30663,SIDM00950,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2819583,0.05136151,2.0803355576056304,0.10496513080957977
102329,SIDM00776,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.0729187,-0.058713555,-0.43451711884570987,0.01317008688887837
75161,SIDM00776,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3784056,-0.07333843,-1.355488013026731,-0.022802839049467637
33144,SIDM00837,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.4782283,0.09733141,1.6736703301729294,0.055152484225956845
22574,SIDM00146,Dabrafenib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.5486318,-0.021682179,0.8016899079872853,0.054587379979835766
68941,SIDM01197,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.0773556,0.06579424,-0.46108980970304597,-0.047598352909223
83908,SIDM00097,GSK269962A,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.26133698,-0.011370924,0.3774505094350976,0.01149724921622819
37124,SIDM01197,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.985305,-0.07124652,-2.383724850172195,-0.09450529762868672
32924,SIDM00875,Sorafenib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.079806834,-0.008126803,-0.5606808293791304,-0.011718635677605676
55358,SIDM00928,Sorafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.2097127,-0.10097941,-0.4371673425403838,-0.024580558649591064
9015,SIDM00146,Trametinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-2.724315,-0.14117882,-1.9526243052824988,-0.12459876924052718
52555,SIDM00673,NU7441,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.216093,0.08518105,0.762225949174729,0.026489546810854376
1354,SIDM00875,Uprosertib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0738271,0.11317135,2.199021201160485,0.12358844318924894
96164,SIDM00148,Olaparib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6249709,0.07931199,-0.5382100905016396,-0.026534232397823078
53878,SIDM01042,AZD7762,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7633998,-0.09663453,-1.1803248231744639,-0.11077235443021242
34254,SIDM01197,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-0.14415072,-0.008951628,-0.2102350738611625,-0.02133123460629057
66327,SIDM00148,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.91332644,-0.08162767,-1.941450068426684,-0.14486549771830373
104870,SIDM00776,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.5625464,0.09896561,1.5669944021543112,0.10714679851094601
76680,SIDM00633,KU-55933,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3968016,-0.044151798,-1.854845071099224,-0.05339184673509337
78880,SIDM00673,Navitoclax,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.753476,0.28922877,1.0448203470088608,0.04472499221693802
101592,SIDM00928,Docetaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-4.954076,-0.36565617,-3.4033752498655376,-0.28366794079985275
106252,SIDM00633,RO-3306,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7669675,-0.073010504,-1.0016083632895267,-0.10296985000766003
101615,SIDM00359,LGK974,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.058099,0.034769792,1.8546535113357328,0.07426957798973734
22157,SIDM00826,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.8897954,0.060699787,-2.1694917522398893,-0.05496122646402718
18110,SIDM00282,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7694492,-0.044519555,1.7415260564273176,0.19298327370220528
101236,SIDM00282,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.8163774,-0.07888792,0.38854495010540235,0.03134985137408921
30770,SIDM00455,Erlotinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.0800853,0.086142346,4.684217503616771,0.15370703858984022
27216,SIDM00216,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,3.0658126,0.022974199,1.1766236256314277,0.03535572958772017
68265,SIDM00933,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.1652912,0.11168311,0.8758297541617208,0.13316383033953896
41415,SIDM00097,Docetaxel,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6631376,-0.09758884,-2.771314387786991,-0.2408351297055503
59295,SIDM00359,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.3203135,0.04852095,3.0410648328446768,0.11750421836287457
62867,SIDM00042,MK-1775,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0597812,0.08364246,-1.2424415594579192,-0.03485840033990785
91179,SIDM00928,PD173074,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,4.513332,0.32599187,2.191047986393936,0.09918345283105012
16632,SIDM00933,GSK269962A,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.0384834,0.18604948,-0.1345922347966573,0.05541373785415387
20128,SIDM00837,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.38902608,-0.010912886,-2.497288192521229,-0.15955746243091148
23368,SIDM00826,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.1794636,0.023232743,0.30112862714535765,-0.025387717719787012
70928,SIDM00282,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.62443876,0.041555334,0.3872716727317834,-0.008288319079007981
81984,SIDM00148,Linsitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.29674092,0.027595902,-0.5617862505535643,-0.019474153593337765
90773,SIDM00359,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.3547896,-0.023025611,-1.271376278719097,-0.058188851721066595
88861,SIDM00146,Venetoclax,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.605472,0.014039367,1.9589443885450288,0.08324090889621216
27539,SIDM00957,MK-1775,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-5.594919,-0.1288569,-1.2119978691903128,-0.03383857256503025
69773,SIDM00776,BMS-754807,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.62940216,0.058170483,0.9782519398357051,0.07732559965655665
71726,SIDM00148,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.975409,0.15414424,2.7024694625858823,0.1925541190425816
55053,SIDM00148,Vorinostat,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4868786,0.13128558,1.0520467463229235,0.059211989337345436
46151,SIDM00933,BI-2536,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.70316315,0.0035941412,-1.2433851572456232,0.003007908936284191
95390,SIDM00097,Palbociclib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2025172,-0.03697358,-0.4187097579704479,-0.0013988702997999023
72641,SIDM00673,Uprosertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.6738344,-0.0713355,-0.1047733856966476,0.0037825642231105938
2279,SIDM00933,Dabrafenib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-1.2356578,-0.08698306,-0.3778395945973135,0.012952117375559442
60788,SIDM00875,Linsitinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85146016,0.019014198,0.4951283408490996,-0.03384562838520542
98526,SIDM00148,MK-2206,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.96584874,-0.09793027,-1.325284794967239,-0.10159383759873448
50729,SIDM00148,NU7441,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.0318785,-0.14256616,-0.1945449029823966,-0.00668772977802674
88521,SIDM00872,Venetoclax,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8131754,-0.06565602,-0.4834955409076156,-0.008328481995319128
71247,SIDM00933,Temozolomide,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.6750965,-0.026268434,-0.7622290357746475,0.010860950914244808
85852,SIDM00928,Pictilisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.5241871,-0.14539875,-0.5871180460504993,-0.04230401750440216
71607,SIDM00875,AZD7762,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.24285933,0.01462865,-1.1774289233004398,-0.0769154732662448
64390,SIDM00148,Docetaxel,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.97012144,-0.09276412,-4.657013416615186,-0.2858913694227358
29416,SIDM00097,Nilotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.23698929,-0.0154358875,1.2084721732626122,0.05009293065215445
16696,SIDM00673,Trametinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.817917,0.24847615,0.1341969226069374,0.015462854271948313
774,SIDM00933,Bortezomib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.23952897,-0.024203604,-0.3112636742791106,-0.009565235505255586
86419,SIDM00097,Entinostat,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1495295,-0.12267182,-0.7310730461359762,0.012641259306049575
25227,SIDM00633,Entinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1079239,-0.05815572,-0.8390068150165287,-0.026923220464054824
80207,SIDM00148,Lapatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.31336775,-0.024251137,0.3430583250185554,-0.0016203511536749624
4262,SIDM00042,MK-1775,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.1847398,0.01869101,-1.4626065195781077,-0.05796467487104003
28571,SIDM00282,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.0625354,0.06740914,0.2419165629438357,0.0478335919883884
32763,SIDM00872,RO-3306,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,2.136662,0.155859,0.6737835327500765,0.022456104883185873
70282,SIDM00928,Linsitinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.4432663,-0.110956304,0.0815652616016293,0.020429397730209853
53276,SIDM00957,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.9888774,0.018163001,3.1081716603087544,0.08612326725424169
77874,SIDM00455,OSI-027,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5127302,-0.063936174,0.5960585838757425,0.04265574331995135
27485,SIDM01187,Linsitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.6898282,0.080032595,1.8081627266491207,0.06864483479147457
18017,SIDM01042,Nutlin-3a (-),Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2597604,0.060160715,1.6742171601828397,0.04839118716695488
79025,SIDM00776,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2971612,-0.042851266,0.2535357901804007,-0.00211298183865918
66930,SIDM01197,BMS-754807,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.43150166,-0.015447755,-1.988135377169797,-0.06779042679166157
8163,SIDM00282,Dabrafenib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,-1.826272,-0.036802616,0.8828759424436369,0.03548224109994344
98718,SIDM00042,SCH772984,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.072934,-0.20012772,-2.0617271222259137,-0.07602765215261703
37072,SIDM01042,Cisplatin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4908108,-0.017641539,1.5038274471218855,0.032366330724506356
27218,SIDM00633,Ribociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0160533,-0.024855342,-0.6889860459071027,0.0028202920864766772
6958,SIDM00877,ZM447439,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.1935923,0.13507235,1.6361924715027307,0.1581307252834141
3418,SIDM01042,Olaparib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5826366,-0.105325796,-1.8318650149005604,-0.05834945495738529
36204,SIDM00097,Crizotinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93527174,-0.05767338,-0.8886969250004586,-0.07747433957639598
4542,SIDM00837,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1896223,0.07403694,-1.5655709569477456,-0.08197741667207357
65599,SIDM00146,Olaparib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1501672,0.0592484,-0.5720862987689015,0.02214609700905816
94083,SIDM01197,Taselisib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.266597,0.04146626,0.8780615781550162,0.04745901878796483
68660,SIDM00872,Palbociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5010199,-0.017956087,0.6566740244251073,8.418379492528409e-05
89838,SIDM00877,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.4638052,0.053902134,2.491720532770387,0.07144622045356198
33414,SIDM00872,Bortezomib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7122684,0.046026424,0.03641069924162922,0.017935041868302627
58847,SIDM00928,Luminespib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.5381901,0.17381626,1.4511095600165855,0.007135100267575698
24584,SIDM00872,Afatinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.875289,-0.16772051,-0.2375353227605802,-0.04668941716543491
42130,SIDM00875,Axitinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.69836,0.20498383,1.862755238490229,0.12293930406670216
29508,SIDM00957,BMS-754807,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-0.9644481,-0.03900356,0.641767807357797,0.026223356906401173
102899,SIDM00933,Sorafenib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.2730612,-0.023504727,-0.3390959117052368,-0.054662243447199124
65208,SIDM00455,Irinotecan,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6868394,-0.019439444,0.9127115145109778,0.10668264170152264
81046,SIDM00928,Cisplatin,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.469101,0.09758794,1.7746523226415054,0.08752106986176428
104618,SIDM00097,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0410683,-0.043783575,1.541261709713183,0.045002700104031304
44137,SIDM00928,Luminespib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-0.4867072,-0.043883387,0.08907778432796086,0.033557119549183306
87951,SIDM00042,Ruxolitinib,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.0176468,0.16072533,1.3989506034733126,0.03395181647660943
54064,SIDM01042,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1330502,-0.023850456,-3.8368445073359667,-0.15975653382521685
77987,SIDM00148,Cisplatin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.781556,-0.026768785,-0.24995099333151735,0.04264062065842419
92872,SIDM00282,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2309146,-0.09364732,0.06331490397580784,0.005343769118034746
9571,SIDM00872,ZM447439,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0376835,0.21229053,2.0785796785429222,0.19219792586963722
19321,SIDM00826,Oxaliplatin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-3.7195518,-0.16639766,-2.1610806888895726,-0.08551745294188944
34170,SIDM01042,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,4.193721,0.3262382,0.9266580711112715,0.06820856333863852
57684,SIDM00097,AZD7762,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2407877,-0.068474576,-1.3755661562676125,-0.027411891288964707
18240,SIDM00673,Temozolomide,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.22477354,-0.004710164,-0.596269441589106,-0.01697822628697402
90066,SIDM00928,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.179676,-0.18988095,-0.6354035751919823,-0.030735309630330436
75809,SIDM00633,Vorinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.86886513,-0.06410896,0.9199387794946424,0.06879514674368889
19989,SIDM00957,SB505124,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-5.077991,-0.09161048,0.4422122517592106,0.07114472913443884
17373,SIDM00146,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.608521,-0.05577429,0.6701815119691074,0.09592592947651536
60569,SIDM01042,MK-2206,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.873903,0.03274771,-2.5868415950185457,-0.09700159561094993
37575,SIDM00877,Pictilisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.92141604,-0.10020112,0.3237131864364188,-0.03063794858121304
17513,SIDM00146,MK-2206,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.9091467,0.10866338,0.7172822516706342,0.06428527032475022
4759,SIDM00872,Dabrafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8341594,0.050631985,1.2811013232523003,0.04250564433175885
23751,SIDM00097,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.304568,-0.07649535,-0.24036425974390452,-0.028400351645121415
96217,SIDM00673,5-Fluorouracil,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2852122,0.0685381,-0.16897597137560263,0.008754076144884597
100872,SIDM01042,Taselisib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7417097,-0.056077354,-1.0316250069830442,-0.017771662549365873
90167,SIDM00928,Luminespib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.1148405,-0.16368034,-0.9017645053919017,-0.09511224302453433
34872,SIDM00877,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.6899766,0.07570048,0.0791638986214062,0.013050773203459789
16976,SIDM00148,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.47427052,-0.013572266,1.5994722203144354,0.05902998127601969
60631,SIDM00835,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.0741823,0.1852573,0.2121029878007895,0.06555251278215078
50906,SIDM00933,Afatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,3.111399,0.26432824,0.31088830104395976,0.08449519462006296
28608,SIDM00146,Dabrafenib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.43264633,-0.021148408,-0.8470128088132961,-0.03592411976102321
54516,SIDM00673,Entinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.6638892,0.050555676,1.6650867045163562,0.07764659909061929
28875,SIDM00146,Alisertib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.4423388,-0.033904966,-0.4538041077424313,0.020545803577509
58930,SIDM00097,Nutlin-3a (-),Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8382237,-0.08258048,-0.14457925705373534,0.010150016390805544
76001,SIDM00042,MK-1775,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.84344643,0.084175706,-1.114128882264707,0.0026178724605185337
17783,SIDM00097,Vorinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9187151,-0.060097154,-0.4367963989737907,-0.07148591021266379
39573,SIDM00835,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-2.083516,-0.0532379,-0.8143804938293498,0.011617986816673309
67918,SIDM00872,Palbociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.82142496,0.016284097,1.0915595436288197,0.043786851266377914
42014,SIDM00042,Gemcitabine,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.76348615,-0.08240322,-2.2703116958598875,-0.13697179872958432
97073,SIDM00097,SCH772984,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.62640643,-0.0334826,-1.2394590155027627,-0.06041880648736825
6642,SIDM00633,Luminespib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1376913,-0.08547925,-1.8117627260660738,-0.048748349946161694
64114,SIDM00928,AZD7762,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.0432966,-0.11452515,0.4095064910886791,0.029303972512406323
38731,SIDM00282,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.1136265,-0.07820852,-0.4151575165410045,0.002121482477655619
86336,SIDM00928,Taselisib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0069503,-0.06681677,-0.5861182391046009,-0.0314432720771903
95221,SIDM00633,Crizotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7093222,0.10547896,1.5794706583165674,0.06704488049195874
24389,SIDM01042,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.197616,0.009140853,0.18873821865604593,0.023694687944112145
57035,SIDM00950,Ruxolitinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.35558197,0.01267383,1.4021560282828114,0.07119770552728732
25988,SIDM00455,OSI-027,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3749238,-0.06538524,0.9664285238207828,0.02362393672180344
17576,SIDM00837,MK-2206,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.17985772,0.015261748,-0.20812857027669568,0.0035536544828696187
55997,SIDM00933,ZM447439,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.4636048,0.12536451,1.0865190449467417,0.1301979437105402
105134,SIDM00633,Alisertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.69717264,-0.048413537,-0.9859172381734067,0.018176606158744796
13614,SIDM01197,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.612426,-0.03248031,-2.2481138221596884,-0.026484688172095226
89610,SIDM00872,NU7441,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6109343,-0.09206097,-0.7284812793127671,-0.029822970880406755
49052,SIDM01187,Crizotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.3244628,-0.019625416,-1.5205424456010612,-0.025229370825268233
61187,SIDM00633,Docetaxel,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.895012,-0.117831275,-2.070159069863905,-0.07669835411966545
48162,SIDM00097,BI-2536,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.41064852,-0.030014427,0.2573036926426314,0.004264327208649498
28107,SIDM00872,Cisplatin,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2266623,0.047349263,1.3467036473736076,0.0585359440619406
17031,SIDM00837,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-0.7596069,-0.024458276,-1.445198342312443,-0.10321355263713757
36327,SIDM00928,BI-2536,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-2.843822,-0.19838665,-0.5398615699250656,-0.025150042926183856
77291,SIDM00146,Tozasertib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.1727855,0.16912428,-0.15141423817025473,0.014747676215324726
72702,SIDM00832,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,1.8738723,0.045976594,-0.9319289982886378,-0.053416581489161424
38591,SIDM00950,Dactolisib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0960665,0.04569314,-1.0935071145362758,-0.029052703263822605
9581,SIDM00673,Wee1 Inhibitor,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5139404,-0.029886749,-1.4835534675579072,-0.06681797051269155
6551,SIDM00875,ZM447439,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0455025,0.11947701,0.1996358700984556,-0.0022495811483198786
83912,SIDM00148,Lapatinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.79637545,-0.060688224,-0.6292077233862364,-0.046872074752173
27226,SIDM01042,Afatinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4130011,0.15300019,-0.44337612136342525,0.05217284140736593
60019,SIDM00633,Temozolomide,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.047745,0.038425945,0.5669646158456597,0.015560259584249555
84592,SIDM00877,SCH772984,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,3.5831203,0.11740065,2.0029160307592666,0.05431193911930714
92899,SIDM00455,Linsitinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.61272573,0.04230531,0.28318314656307164,-0.02230968287609846
36706,SIDM00833,MK-2206,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.0812697,0.062852845,2.700177701264503,0.12810482732700942
5711,SIDM00957,SCH772984,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-4.832764,-0.18861684,0.6371143041474542,0.06336871684202294
90900,SIDM00042,Irinotecan,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.009704,-0.11493397,-0.400410691255985,-0.007038998371406095
10711,SIDM00282,Vinorelbine,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6181592,-0.04414279,0.5027442156143823,0.03342139999526068
72608,SIDM00146,Alisertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0808325,-0.09631333,0.149612796244231,-0.003848767674514789
7645,SIDM00148,Nilotinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1075748,-0.107381895,-1.5714304469290628,-0.09844304586813854
28870,SIDM00872,MK-1775,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5271189,0.05162129,0.6096052924636333,-0.008928031209158969
72476,SIDM00826,SCH772984,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.1321528,-0.036754206,-3.8288739203968762,-0.11635820135103274
11713,SIDM00832,Linsitinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,1.807004,0.15523233,1.4872585963914131,0.10637417764371823
5641,SIDM01197,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2669365,-0.03930096,2.884317523998174,0.11323759778258885
69559,SIDM00633,Doramapimod,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0568669,-0.08014911,1.0246253365326197,0.11453021716994642
90513,SIDM00832,AZD7762,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.3560365,0.028971523,0.9314401061467692,0.06293677792429542
75567,SIDM00875,OSI-027,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84687996,0.08121543,1.1267337412475191,0.06543298630529247
67842,SIDM00776,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4788291,-0.03622491,-1.3024588878221064,-0.017934813992103435
39595,SIDM01042,RO-3306,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8730782,0.10578229,-0.23715297717668662,-0.05398671810447069
22006,SIDM01187,MK-1775,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.40945795,0.037482902,-1.1325458528776509,-0.015032061728552577
13434,SIDM00933,ZM447439,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.7501199,-0.04870513,-0.17268619579779212,0.027341735167293324
32626,SIDM00835,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.261675,0.08519464,-3.579469118756894,-0.1234658070636473
101852,SIDM00872,Axitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6771617,-0.02148562,0.07412337951674573,0.026087207931245596
52222,SIDM00633,Uprosertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9684934,0.059795715,-2.0472696198010274,-0.039253457161747114
56675,SIDM00633,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.3889604,-0.12085145,-2.1056574367253766,-0.09400771113244279
78135,SIDM00877,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.2176596,-0.10633931,0.24317054959869905,0.03463136063184966
13991,SIDM01197,Nutlin-3a (-),Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.5340235,0.022391727,2.4227538263888517,0.07566290248425929
41565,SIDM00837,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.247874,0.06585714,1.6181086399675346,-0.016457611649411254
41749,SIDM00950,Taselisib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.6469557,0.052031007,2.7078279142204105,0.143327807107358
1440,SIDM00933,Pictilisib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.44916764,-0.0518194,-1.3962864994309954,-0.09977738442083492
58299,SIDM01042,Navitoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0918353,0.10901415,0.8773659820671865,0.02797756140154644
80210,SIDM00928,Luminespib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.43854713,-0.041132636,-0.5853303998309247,-0.10048750075834595
37443,SIDM00933,KU-55933,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.7572494,0.032889113,0.05736564153189047,0.06346917229650895
16173,SIDM00877,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.105165,0.048512973,2.299247955986971,0.11953137476294992
61347,SIDM00933,KU-55933,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.2785889,0.055563044,1.1312599295539187,0.05789607428725115
22714,SIDM01042,Axitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9984801,0.11306465,-0.9465857660630865,-0.08027114692826484
91935,SIDM00877,Crizotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.6452967,0.060088515,1.3040348204184184,0.15156081173662564
79115,SIDM00832,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-4.943697,-0.21218283,0.02105336324482191,0.02584888540400261
14365,SIDM00673,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.61848253,-0.014753598,1.564565455825795,0.04617200861739273
91443,SIDM00633,Pictilisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1144238,-0.08970879,-2.0270395922447273,-0.11640391515102909
63198,SIDM00359,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3657944,-0.059424214,2.0367279807672727,0.1644267140906858
92841,SIDM00872,Tozasertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.56302434,-0.020433491,0.1818335102741614,-0.031969187161679485
84737,SIDM00148,5-Fluorouracil,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9726276,0.08728606,-0.8483432225848075,-0.10013043171736277
52600,SIDM00633,AZD6482,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.7191682,0.11485831,1.8586296189085785,0.05448161631145367
105370,SIDM00359,Nutlin-3a (-),LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9829005,0.058616765,1.8922805357046713,0.07017791249303719
50211,SIDM00146,JQ1,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3233244,0.097499005,-1.5611372457853052,-0.05603322377300172
73868,SIDM00933,BI-2536,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-1.1410884,-0.009411313,-2.0592673639859553,-0.10400509374151952
98007,SIDM01197,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7034568,-0.04816098,-0.052538817893795206,-0.02907320885029809
99133,SIDM00826,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.286868,-0.092035756,-1.275589984246634,-0.04005371808902203
105072,SIDM00933,AZD7762,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.768811,-0.24235232,-1.925971116083922,-0.18274952524781995
78145,SIDM00933,MK-2206,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.668554,0.24417803,0.5887542206864073,0.05667845766027801
36731,SIDM00097,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.82644004,-0.0584152,-0.5067840321270971,-0.05835213545348176
46677,SIDM00928,AZD7762,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.0308683,0.19931236,0.11525494778436761,-0.030163017921328326
14653,SIDM00875,Lapatinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2837955,-0.02728005,-0.17143373853918478,-0.012100467901084704
58199,SIDM00872,AZD7762,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2059251,-0.12649384,-0.8847581076853915,-0.08998636402647228
91550,SIDM01187,Bortezomib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.34992832,-0.030084021,-0.506485140335421,-0.025700398959220504
101415,SIDM00148,Gemcitabine,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.728852,-0.046935722,2.112129173618232,0.11740731378375337
44577,SIDM00872,AZD6482,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.24001221,-0.021561306,-0.31728615339634353,-0.002998971029775635
43042,SIDM00673,AZD8055,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.96418804,0.06617799,1.2034014937571025,0.027967638462990458
96435,SIDM00097,AZD6482,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7019035,0.043924175,0.8879168304268037,0.06340370995984508
12693,SIDM00833,5-Fluorouracil,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,5.876753,0.37730056,1.8708699900035344,0.14204203954180727
83119,SIDM00673,AZD7762,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.5848875,0.04519314,-0.4821587281420856,-0.03455404346798224
105006,SIDM00097,AZD8055,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9334412,0.0696641,-0.6338437821405176,-0.0627708149705031
87068,SIDM00633,Luminespib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9189444,-0.060809143,-0.7078085264495966,0.029046731432907973
3797,SIDM00957,Dabrafenib,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.8635437,-0.022632685,0.85286699304529,0.06542482652591845
13572,SIDM00933,Lapatinib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.73049253,0.08384859,0.38111067784480185,0.06399051675265847
83835,SIDM00359,Crizotinib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9520613,0.14151406,0.22068445404066497,-0.019273218274738414
91716,SIDM00146,Venetoclax,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.707487,0.14748952,2.4179907352103505,0.06646703193543374
100883,SIDM00146,OSI-027,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.91449964,-0.090426214,0.015013247886478584,0.004545288568471986
25699,SIDM00673,Wee1 Inhibitor,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.8149744,0.05528391,0.4104890949929021,0.031823280362564536
37473,SIDM00282,Palbociclib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.24425155,0.009145887,-1.7638192314303915,-0.06973221545343432
14241,SIDM00673,Paclitaxel,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1817569,-0.09253086,0.4765747045003298,0.012412757813611177
20570,SIDM01187,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.76751924,-0.068980694,-0.5950427270923705,-0.04959999345831957
51065,SIDM00282,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.4670871,0.09568905,0.9262241463107863,0.10073162836202156
84583,SIDM00776,Camptothecin,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2650802,-0.09131741,-0.8721767662181975,-0.02765106970630059
42529,SIDM00146,Sorafenib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6716823,-0.06098088,-0.40457049310082377,0.006114060241781858
60597,SIDM00097,Trametinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2045519,0.04582225,-1.16455317806143,-0.05086637224047471
76199,SIDM00837,AZD8055,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.8698269,-0.055750262,-1.3545898508035399,-0.09236344548808602
35977,SIDM00633,Luminespib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0344757,-0.085084915,-1.5071101482355285,-0.05465869266776783
16806,SIDM00148,NU7441,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8601382,-0.08924921,-0.08118525005539498,-0.02559692732879451
54706,SIDM01197,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,2.096267,0.13381733,0.3092075653971044,-0.009076325948966148
74888,SIDM00097,Alpelisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0917845,-0.111129664,0.30042265570620974,-0.013427242754108707
91212,SIDM01187,Bortezomib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5334096,-0.05305094,-0.6159260163252454,-0.01837523112761574
8770,SIDM00282,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-4.1454077,-0.18326576,-3.031248951789438,-0.23949845757114493
49869,SIDM00776,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2338823,-0.10618871,-0.5602473956838826,-0.06874026491025152
13106,SIDM00216,Navitoclax,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,5.208749,0.19561976,0.6988804272158099,0.03497136700464011
93838,SIDM00359,AZD4547,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5376583,-0.09423676,-1.3169661913107822,-0.03511538161428734
3685,SIDM00146,Dabrafenib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.57968116,0.01735155,-0.5302339707165841,-0.0036398069051380728
88225,SIDM00455,Navitoclax,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.5254707,0.096100986,1.4147384761265485,0.12491024191760726
17217,SIDM00872,Cisplatin,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.0072046095,-0.00022291811,0.9777550729585051,0.02217882708495599
27662,SIDM00146,Palbociclib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7805021,-0.06847616,-0.22362078982651426,0.007397086518971588
56859,SIDM00146,Uprosertib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.14905728,-0.011292368,1.3267857374205874,0.15616272931572164
105361,SIDM00837,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.16527833,-0.00903662,0.20172057763805526,0.011536505241965667
61162,SIDM00875,AZD7762,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5805898,-0.035378862,-0.23234961507734017,-0.028288869699534352
56681,SIDM00877,Tozasertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.1061327,-0.12258346,-0.21672881423605958,0.08365435814569737
80575,SIDM00216,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,6.8246994,0.21427731,-1.7584887889322025,-0.09305145143384772
105095,SIDM00455,AZD7762,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1897625,0.05294555,1.8704509816708839,0.1391451318426958
85746,SIDM00146,PF-4708671,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.6230707,0.059220158,0.644099910260814,0.033803137242251216
92391,SIDM00928,AZD6482,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.3160719,-0.07382202,-0.21896534449579272,0.017545433475107397
9480,SIDM00950,MK-2206,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4451852,0.15124913,0.3435365088949325,0.0002689740239079024
89017,SIDM00877,Wee1 Inhibitor,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.1371634,-0.058647726,-0.5156391058872376,-0.022275059832338254
53620,SIDM00877,Luminespib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-3.8587189,-0.18910617,-0.2774126732280642,-0.000669043817629641
1551,SIDM00633,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9694082,-0.15700525,-1.502683166314501,-0.09233155975525041
70175,SIDM00673,PF-4708671,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4163269,0.029297505,0.743304400929965,0.05536006536304188
8472,SIDM00877,Venetoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.62086415,0.012219629,1.8969933246334019,0.07660523755880018
54443,SIDM00359,AZD7762,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.86994714,-0.061079454,-1.254950772164894,-0.057887427710898165
58397,SIDM00872,Crizotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7834702,-0.12413316,-0.05683284579715375,-0.04386998829224872
74995,SIDM00216,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3316594,-0.042856358,-1.8679074848553368,-0.07660046417190032
67029,SIDM00455,Taselisib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.13982226,-0.007414989,1.119979322210886,0.032465809401801896
74549,SIDM01042,Lapatinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.536918,0.083022796,-0.5874456568485926,-0.04887980327481215
83322,SIDM00875,Tozasertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5067977,-0.047740486,-1.4113177796852738,-0.039407088939368805
6410,SIDM00826,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.68242735,-0.058771934,2.6571504081933144,0.049967705832450124
44085,SIDM00097,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2428117,-0.06032971,-0.3835261278347876,-0.000809526303847446
103361,SIDM00146,Olaparib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.2449489,-0.047232818,0.19330538663032973,0.016729649436890957
71835,SIDM00833,Linsitinib,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,0.41754854,0.027773924,2.626145615162266,0.14624508664661345
107387,SIDM00872,Tozasertib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8008111,-0.028360864,0.4116315409876174,-0.0006460693219717316
31513,SIDM00928,AZD7762,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.0201647,0.080926925,0.936541597299175,0.056597724109377294
670,SIDM00282,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-4.150811,-0.19187018,-0.08060194426078855,0.008030583306689766
82064,SIDM00146,Doramapimod,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.1945349,0.068284206,0.8764231317346195,0.04632244890373298
29498,SIDM00832,Olaparib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,2.5534267,0.12657674,-0.31906851230513555,0.025412194814683285
68669,SIDM01042,GSK269962A,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5302797,-0.07084926,-0.12017885891960799,-0.0338478698156289
94084,SIDM00837,Linsitinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,2.6993,0.07995939,-0.5447627087970509,-0.012888257250382373
21020,SIDM00875,Alpelisib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4534293,-0.036333308,0.8316714189191635,0.031282968914421706
107742,SIDM00933,SCH772984,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.86017764,0.07741265,2.015594080267011,0.14670501346154938
107673,SIDM00950,5-Fluorouracil,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0450479,-0.038885094,-0.7781672542967716,-0.046054678049880955
393,SIDM00928,Taselisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.9724913,0.14193527,-0.385389977462727,-0.02737854911951237
74838,SIDM00097,ZM447439,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5602584,-0.10403775,-1.715798298923407,-0.06409064296514413
62958,SIDM00877,Temozolomide,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.638691,0.119257115,-0.8210944411360608,0.01672453028945571
93538,SIDM00042,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.3257782,0.29863143,0.8297754917213371,0.09237825233258486
55639,SIDM00928,Venetoclax,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.7319193,-0.021865921,0.6109590389157371,0.07304232662576968
30377,SIDM00832,Olaparib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,3.046385,0.1931236,-0.057094673707095464,0.04163351001261393
83700,SIDM00359,Navitoclax,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.41735166,0.020987183,0.4610355115154821,-0.01451053337745173
79869,SIDM00877,Sorafenib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.57512563,0.06433919,0.5193618492011473,0.058799269747370354
29398,SIDM00673,Trametinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.2797059,0.111643955,0.013293523614980906,-0.005037987830686307
2422,SIDM00097,Nilotinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.5238793,0.15506536,1.0081459280768172,0.07057269488786483
17377,SIDM00872,Wee1 Inhibitor,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.98633796,0.10693224,1.9940343456854361,0.1277345878278375
16129,SIDM00633,Wee1 Inhibitor,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.39967564,-0.039282795,-1.000379869756475,-0.028376299352134458
18188,SIDM00833,Palbociclib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-0.72021455,-0.017324137,0.45213693647829145,0.0007043490051514751
16132,SIDM00673,SCH772984,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.6299036,-0.25382873,-0.25130479815326345,0.008521372421787821
22636,SIDM00148,5-Fluorouracil,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.153234,-0.11305526,-1.292072982006087,-0.11220416175832024
48281,SIDM01197,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.2064202,0.109117985,0.14022190186164005,0.0011925691143618692
99499,SIDM00832,SB505124,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.6497518,-0.13027583,-0.3869918146978769,0.01734730892453713
3411,SIDM00148,Venetoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7191309,-0.02615313,-0.5655265439603598,-0.04737081125908869
48719,SIDM00957,AZD8055,AZD7762,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,1.2528014,0.029983304,0.32539583816364265,0.004861182185905387
94133,SIDM00832,Crizotinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2652384,-0.10754927,0.032828864180273684,-0.017813268392378387
56740,SIDM00872,Crizotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6866231,0.05500047,1.3223894260597306,0.06287573780744783
8415,SIDM00837,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.6936603,-0.0952933,0.13406409487595755,-0.07032928246994626
81708,SIDM00146,Alpelisib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.63078916,0.032753915,0.9125222812687291,0.08887320622937137
64367,SIDM00872,Palbociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.49269232,0.019553676,0.4516447747465275,0.019618396719789395
62373,SIDM00282,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.2095188,0.06996182,0.4543091960935995,0.047185976583201866
44598,SIDM00875,Gemcitabine,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.661667,-0.0014263188,-2.7239325491819293,-0.043197831082464465
99290,SIDM00872,AZD7762,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.2534013,-0.23767781,-1.9512869340795918,-0.26254481975227234
5392,SIDM00957,AZD8055,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.4743881,0.081426434,0.5618951087765185,0.004448363569604407
26935,SIDM00673,Palbociclib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.1111245,0.117372215,-0.09489300297725917,-0.016553532571158828
52824,SIDM00148,Olaparib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.490259,-0.05034322,-0.4946646910399164,-0.02470114593466121
48971,SIDM00872,SCH772984,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8196955,0.056800447,1.835840926446244,0.07979569015884327
42077,SIDM01042,AZD7762,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.852129,-0.10695974,-1.1592794687438355,-0.04473657373299907
57393,SIDM01042,PD173074,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9512006,-0.11225862,-0.6258640938271615,-0.017935617873312885
35961,SIDM00950,5-Fluorouracil,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2401606,-0.10342309,-2.05037913347898,-0.1403323248847666
101479,SIDM00933,Trametinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.27266943,-0.036907062,-0.7131556923376327,-0.01637527405212476
23404,SIDM00832,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.35155606,-0.009353695,1.4447015099418408,0.036049027349265454
106457,SIDM00833,AZD4547,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.2300572,-0.0900077,0.1869535414929702,-0.02760759503909758
29035,SIDM00875,Uprosertib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5709438,0.060105998,0.5412187770965531,0.1191340768185538
33448,SIDM00877,Gemcitabine,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-5.4699397,-0.027195046,-0.4145145181370727,0.011181769787423945
67630,SIDM00097,AZD8055,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.362813,-0.1463724,-1.876081451388089,-0.15489256126431553
86651,SIDM00146,Alisertib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.9529417,-0.19935864,-2.56918622149289,-0.24140544301739125
78216,SIDM01042,Doramapimod,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.348398,0.07859671,1.260932339238249,0.06588125878621122
97883,SIDM00776,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.8653357,-0.12212635,-1.8179280550907446,-0.03496807004638518
10343,SIDM00097,Olaparib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3946669,-0.030195402,-0.373924511417107,-0.007168725952326497
2549,SIDM00097,MK-1775,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.61200947,-0.042367518,-1.0276256886173138,-0.11402590299846325
26105,SIDM00933,Cisplatin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.33257467,0.042714104,0.24705569335630065,0.019775931964053257
44271,SIDM00148,AZD6482,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.46092856,0.0488471,0.26072301763912303,-0.007512466766705699
94213,SIDM00928,Paclitaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.2151496,0.09481772,0.4387392738922974,0.010940578946641048
26509,SIDM00359,Vinorelbine,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8949432,0.074990265,1.71389160979126,0.1122421295251029
44478,SIDM01187,Pictilisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8662217,-0.09871639,-1.4057911612451752,-0.0984003782188834
39678,SIDM01187,Lapatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7937113,-0.13660644,-1.8587651500762155,-0.10999011432850547
53497,SIDM00875,Pictilisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34511063,0.03118834,0.9253056553232027,0.06594028137197637
11000,SIDM00872,Uprosertib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.69108206,-0.07011134,-0.6986698995843585,-0.034958935791569085
25121,SIDM00875,KU-55933,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0399083,-0.046567407,-2.1805179059390207,-0.04749953221339121
21997,SIDM00833,AZD7762,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.8463377,0.057800125,-1.1286254323003944,-0.09010961536192541
80150,SIDM00877,Gemcitabine,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-5.6078835,-0.068659656,1.74659781772119,0.050999858279698426
101210,SIDM00826,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.8602276,0.20572232,-0.3496710033048208,0.01937459880283351
18446,SIDM00097,KU-55933,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4534159,-0.09833771,-2.3831342179672386,-0.03774596560661139
54822,SIDM00282,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.35741934,-0.015306434,1.2752755779798555,0.06731411892161224
69649,SIDM00673,Sorafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.764106,-0.06939847,-0.1749251574049797,0.028575958758642498
92894,SIDM00835,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.16897807,0.006528835,0.07107930300556456,0.09550482795998784
78918,SIDM00359,Olaparib,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4869192,0.013263862,2.9166934316280058,0.07745987118159516
29115,SIDM00957,BMS-754807,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,1.2518023,0.053575307,1.128264169243848,0.050160416092254384
97770,SIDM00148,Ribociclib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.3176503,0.37719554,-1.1586762028745992,-0.023605808086984672
18604,SIDM00872,Venetoclax,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2834265,-0.04716963,-0.6366833419327452,0.047767174681051405
232,SIDM00455,Crizotinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.89626235,0.06281221,0.4385985562940052,0.06298590353035999
76367,SIDM00148,MK-1775,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.183025,0.30723438,1.6694027381712448,0.07266298470162268
13746,SIDM00146,Navitoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.2507203,-0.017896898,0.855056383420923,0.018804337804464194
87964,SIDM00633,Temozolomide,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9049631,0.05249381,0.5774700335421057,-0.0012513493865241843
72321,SIDM00776,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-0.4317364,-0.026989682,0.19473686424610717,-0.027937607894448137
13241,SIDM00146,Pictilisib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1924337,-0.08311632,0.7240402921002956,0.07892035314062237
108452,SIDM00826,SCH772984,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,0.62234926,0.00832587,-2.684344747693296,-0.0475717740228155
78048,SIDM00877,JQ1,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.7323122,0.2774743,0.18029154171048414,0.06032543313706814
28574,SIDM01042,Uprosertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.201465,0.05016201,1.1897397132290994,0.02169062187219338
16000,SIDM00872,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8890824,-0.13008587,-1.4206319847287707,-0.12953820227938373
13121,SIDM00875,RO-3306,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4851086,-0.13202877,-1.4949045911372139,-0.09760435547273404
22787,SIDM00282,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.9805679,-0.06946966,-0.4415228259328999,-0.07598358018252499
9963,SIDM01042,PD173074,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7701669,-0.13524212,-0.23153398876754544,-0.05287207887232166
4264,SIDM00282,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.21521723,0.014921065,0.8387729646602676,0.08964612025280931
23775,SIDM01187,Nutlin-3a (-),Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5220655,-0.13758312,-0.7848724644258518,-0.02334388832140956
89027,SIDM00826,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.6739252,-0.012615433,-1.1271113498501681,0.025314556377338912
81575,SIDM00833,Olaparib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.6339468,0.060346372,-0.5425234773318411,-0.007023909844299683
10807,SIDM01187,Olaparib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.3233066,0.15165573,-1.6947766452206885,-0.041097708893217906
43423,SIDM00832,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-3.7038357,-0.28408304,0.11100731270512072,0.016314980315461042
36446,SIDM00872,Uprosertib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5818813,0.16085671,1.209630611073965,0.03853790801425061
27140,SIDM00957,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.8262957,-0.021766875,2.023326405339872,0.037960116456571526
74040,SIDM00837,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-0.8046982,-0.02556419,-0.8225127119466064,-0.05230171715117757
38378,SIDM00877,Navitoclax,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,3.6216607,0.18120678,2.3858879849160113,0.09719373971425732
58018,SIDM01042,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.70257473,-0.03272502,-3.5724723488265955,-0.12925030664528295
46667,SIDM00877,Cisplatin,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.55574626,0.03639842,0.774633237718758,0.08566568258950696
34406,SIDM00950,Olaparib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5111068,0.047774628,0.9949110621568181,0.08374695705652972
26394,SIDM00872,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4298292,-0.044571765,-0.3307769045056427,-0.05598572513925065
50548,SIDM00146,Lapatinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.7724596,-0.15583663,0.8149593445510438,0.09471818358504315
12937,SIDM00776,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.230534,-0.07471159,0.6248380519766588,0.037360830575242074
99688,SIDM01187,Temozolomide,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.39150468,-0.009744469,-0.31810539827846224,-0.002182260340461493
105366,SIDM00148,Lapatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.44408792,-0.044174183,0.5851345455610322,0.0007485367468810753
73937,SIDM00216,LGK974,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.99852467,0.013147134,-0.2154418202441115,0.0013336675090174156
35761,SIDM00950,Lapatinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.86845565,0.03094075,0.7149941902852595,0.006110598438509937
11643,SIDM00875,Sorafenib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3118336,0.0322028,-0.5522169262027747,-0.012994864530765968
69002,SIDM00835,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,1.5828189,0.13414624,0.6854609878982525,0.09715736933644915
36066,SIDM00776,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.2126272,0.074169844,1.6775636880045346,0.09702129194993532
37364,SIDM00146,Sorafenib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.15404163,-0.014615217,-0.8584750836713775,-0.07219142657248642
44035,SIDM00042,Lapatinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.9607022,0.24712339,2.514745831383323,0.14359018932658454
10526,SIDM00837,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.2985288,-0.009440215,0.3541264166803913,-0.02373482954077989
35944,SIDM00872,Alisertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.30812055,0.013484761,0.3671385513705369,0.060223751032543606
49443,SIDM00875,Dabrafenib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7730478,0.03718005,1.0393372876887992,0.00936525413644307
77122,SIDM01187,AZD7762,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.3979435,0.11102926,2.181121778122577,0.06139523672159296
68894,SIDM00872,Palbociclib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5334642,-0.019368928,-0.02713322983693099,-0.024324363414283214
62461,SIDM00875,Alpelisib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.29303044,0.027019704,0.2060081459068181,0.01782871155721123
71869,SIDM00872,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.70985997,0.077664755,0.280634408367583,0.015542486520434828
73103,SIDM00933,Pictilisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.3980547,0.16443986,-0.07504226010349112,-0.0047493320056621584
50550,SIDM00216,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.166923,-0.054073837,-2.0014765723411756,-0.08914296039991709
85580,SIDM00833,AZD7762,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.49340457,0.0381624,0.7160527913773708,-0.03615630821551871
80762,SIDM00216,AZD7762,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,1.3593906,0.09252735,-1.3530517014918761,0.0065481173304569795
28344,SIDM00877,ZM447439,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.71033645,-0.06712554,0.12224813802433869,0.03652381354651647
63781,SIDM00875,Entinostat,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4304094,-0.091901705,1.6108548662284525,0.12789794761929682
9943,SIDM00833,AZD7762,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.0668545,-0.045163397,-0.7561718789809234,-0.0425440423825041
288,SIDM00832,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-1.2863759,-0.042455718,-0.9560905318298887,0.011507682370847119
57940,SIDM00216,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,6.095398,0.1002962,-0.17685302616278006,0.013990313109528004
104660,SIDM00633,Alpelisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2620101,-0.09764108,-0.5171749516213908,-0.01427598799163828
33708,SIDM00148,Dabrafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1644228,-0.046992198,-1.813633582028927,-0.0568248549239392
59785,SIDM00148,Alisertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.680003,0.24412513,-0.6190813617641234,-0.012101923431419694
101180,SIDM00950,MK-1775,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6574763,-0.17064008,-0.8495088792033002,-0.052900132457668586
27560,SIDM00776,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.78849626,-0.073825814,-0.919924985022423,-0.060509973171300864
79548,SIDM00950,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8456116,0.11684322,2.210072790316869,0.08824219569419603
30138,SIDM00835,LGK974,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-2.1036537,-0.054250456,0.3077245751772462,0.005176986504524136
81344,SIDM00673,MK-2206,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.83906084,0.04435327,-0.17728479644524986,0.0065752319861162286
45684,SIDM01042,PD173074,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2919222,0.09419134,-0.5177726605045326,0.0007853791578024744
55314,SIDM00872,Camptothecin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8503406,0.02025807,2.16023450573928,0.06313201715919686
16771,SIDM00872,Gemcitabine,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0602512,0.032781236,2.5458382645074833,0.07871024107887294
26752,SIDM00875,Docetaxel,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.475946,-0.42685556,-2.9699332133401364,-0.2548796993706629
23049,SIDM00148,Wee1 Inhibitor,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0576826,-0.10885228,-0.7589858734206429,-0.09118384458771944
72257,SIDM00933,ZM447439,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,0.3634973,0.028027019,0.9990018352438318,0.08712630232857073
41035,SIDM00933,SCH772984,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.8172841,0.06896165,1.9949774326096659,0.10646315609032277
39165,SIDM00875,Alisertib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1297666,0.095827624,2.1211587171631576,0.09310966242523075
51632,SIDM00826,SB505124,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-0.42565304,-0.034235653,-3.0387149145262984,-0.09559041815442319
92677,SIDM00673,Taselisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3636198,-0.14013414,-1.4473716754195072,-0.07988732381416484
33089,SIDM00835,Oxaliplatin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-0.70707005,-0.053716294,-1.534016237457856,-0.06931923817503181
16516,SIDM01197,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.8829342,0.05481519,-0.651380301294368,-0.02686521120496633
82031,SIDM00673,SCH772984,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-5.3595605,-0.3048996,-1.0831087931664547,-0.07432800196480754
85667,SIDM00875,NU7441,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23582843,0.018813938,0.3576425012875736,0.02269088949367773
38190,SIDM00833,Trametinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.7152055,-0.033272304,-0.663540307681107,-0.018306503813586415
87811,SIDM00928,Uprosertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,0.6388536,0.043529723,0.9086999306826631,0.08912540301332333
39359,SIDM00673,JQ1,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0206995,-0.06662416,-0.6315388522227336,-0.0005782244485132816
28281,SIDM01187,MK-2206,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7312204,0.108709365,0.2195001741743644,-0.030506304666394483
105858,SIDM00633,Taselisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0549936,-0.13248375,-2.482819777913424,-0.10178761762150554
99286,SIDM00455,Irinotecan,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.6248677,0.096363515,1.4197982835749978,0.14450551096169703
75336,SIDM00875,Cisplatin,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0210896,0.15259981,3.4207507264818213,0.1754930243584931
91511,SIDM00928,OSI-027,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.64899457,-0.06477857,-0.02100035244420654,-0.013977368847922798
64762,SIDM00633,SCH772984,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1450249,-0.0967857,-1.637044273427392,-0.059059419238887315
86195,SIDM00148,Uprosertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3729156,-0.03428053,-2.3142412993121133,-0.1714157403738074
93651,SIDM00455,Sorafenib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5869212,-0.111731015,-1.3103124009318985,-0.018999506510258824
95281,SIDM00877,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-4.7595344,-0.4045752,-3.6915492176501776,-0.2102011017276003
56799,SIDM00146,Luminespib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.9872762,0.06009504,-1.3222416904718186,-0.035409658401411984
7984,SIDM00832,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.8320051,-0.041513648,0.48676202398850504,0.005645491645200624
86463,SIDM00957,Taselisib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.8044276,-0.04835188,0.5657805666036776,-0.004894217919838184
34435,SIDM00933,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.4971417,0.09091034,0.4867159429109068,0.032155562999598056
97706,SIDM00928,Afatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.7952937,0.09611761,-0.482329677257646,-0.04425637459308773
69856,SIDM01187,AZD7762,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.116989,0.19934663,2.0063357250560356,0.08421517251964218
84553,SIDM00928,Temozolomide,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.9528125,-0.021461587,-0.12234594755001957,0.014629820822178877
59963,SIDM01042,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6747129,0.05876257,-0.5658703283317772,0.018443634567830085
100664,SIDM00875,MK-2206,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2475487,-0.09179126,0.11390813249326066,0.019138586716040063
12277,SIDM00928,Lapatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.7875487,0.1774643,1.543790615162261,0.20282781289735524
96646,SIDM01197,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9026253,-0.12784417,0.7212420717180946,0.05156313041590491
16197,SIDM00826,Taselisib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.98757505,0.07147849,-1.5694498624559365,-0.11527043142954906
8617,SIDM00146,Sorafenib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.4044781,-0.03576455,-0.10108020875215067,-0.00015270030232284292
69544,SIDM00633,KU-55933,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4107885,-0.045065466,-1.6556627900507768,-0.07113920842067475
47509,SIDM00633,Bortezomib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.807014,-0.17093354,-1.517811396702507,-0.0788916555724804
25165,SIDM01042,Entinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4054497,-0.164357,0.5452251836541309,-0.0020812291172411976
34637,SIDM00282,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.887824,0.17233944,1.8523967558338095,0.12620994558761023
95583,SIDM00097,Nutlin-3a (-),Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0485215,-0.09405025,-1.5254813857256917,-0.055964941620813835
34940,SIDM00928,Linsitinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.3261507,0.20310909,2.8458988449294553,0.07977599751399048
16130,SIDM00673,MK-2206,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.44359732,0.025911946,-0.6477063342788046,-0.03379959856962994
24098,SIDM00042,LGK974,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.7726647,0.1207237,0.5995668395218129,0.03315337232517962
40168,SIDM00875,Alisertib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7120548,0.16251403,1.9937437478914173,0.11137142290490838
34677,SIDM00877,Entinostat,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.2005955,-0.11039709,-0.20492489533180824,-0.06624572228630803
49054,SIDM00875,Olaparib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9001685,-0.12740889,-1.221050147005473,-0.0947088388484869
28446,SIDM00826,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.1324306,0.18396538,0.06078945931366517,0.024305823004718143
48340,SIDM00928,BI-2536,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.4547884,-0.15994817,-1.8228118024027957,-0.09835539635010654
105266,SIDM00097,Dabrafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.237407,0.010923544,-0.10760935772752876,-0.01838635094842409
51155,SIDM00875,BI-2536,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8467482,0.022329908,-0.4856895732101575,-0.034518253864445424
43450,SIDM00928,Afatinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.33528438,0.039066292,-0.41096868679896753,-0.05444793043843675
101080,SIDM00875,Entinostat,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8685934,0.09154504,0.877603691749284,0.026834350545381302
95787,SIDM00837,SCH772984,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,2.490144,0.10479676,-1.7425789380146284,-0.060723536931411304
64159,SIDM00673,Linsitinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1442899,0.015551177,2.171978160277618,0.049915918763192874
72588,SIDM00957,Trametinib,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.7396067,0.03395531,-1.1622487226890479,-0.04635221611893461
34711,SIDM00097,BI-2536,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6985935,-0.12085027,-0.2026659061026613,-0.05481841940107497
16446,SIDM00146,SCH772984,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.5529737,-0.05018173,1.5084528857941726,0.07384990607438438
91319,SIDM00928,Paclitaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-5.5887346,-0.41417718,-4.036075369869093,-0.3041716799568781
67848,SIDM00146,Dabrafenib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.34186766,-0.015918985,0.9270209719077721,0.04936887683126107
30232,SIDM00928,Dabrafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7736349,0.02061757,0.07762272877127116,-0.0038786191638430748
13948,SIDM00928,Lapatinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.9639423,0.08872921,0.23558775344740154,0.07185336781539639
18901,SIDM00872,SCH772984,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.68268466,-0.04073046,2.2835930819308046,0.16279346867009192
47948,SIDM00146,OSI-027,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.69221467,0.047954716,-0.4198378037679818,-0.0037267075881848655
70535,SIDM00359,Palbociclib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8625971,-0.097571164,-2.554560568796815,-0.08237264495031656
15255,SIDM00933,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-3.6625295,-0.052796297,-4.44529039576151,-0.04967932170933219
57876,SIDM00875,RO-3306,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3298929,-0.16126853,-1.8251580864278674,-0.10264342512725379
31932,SIDM00633,Trametinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.15972647,0.009033627,-1.1524157108884467,-0.04839066743714154
82941,SIDM00928,Docetaxel,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.7251211,0.15496138,-0.19443866595071002,-0.05057269118133104
19454,SIDM01042,MK-1775,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1751947,0.080129586,-1.4795003119471681,-0.07409363145590565
59594,SIDM00872,Cisplatin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8593705,0.033358548,2.066606297508239,0.05924132574773094
34514,SIDM00933,Pictilisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.15520658,0.019742105,-1.3545031293785017,-0.10834026064893909
97300,SIDM00928,Lapatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.2886312,0.124098964,0.4759658164432969,0.07628115427558071
2665,SIDM00097,NU7441,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8651637,-0.0867064,0.9655024784573473,0.032769077946874836
101243,SIDM00359,Navitoclax,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7555298,0.0403916,0.386968011332371,0.01304505577764965
66381,SIDM00097,KU-55933,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.6454036,-0.10175909,-1.1464556985619734,-0.04282995894861552
5551,SIDM00148,Cisplatin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.430869,-0.06046845,-1.6665893806845902,-0.0830936352772839
10640,SIDM00832,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.87879777,-0.04858477,-0.400893221490811,-0.008537654013269917
102939,SIDM00928,Venetoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.94325227,-0.027887393,-0.27331999057360495,0.006005638088623904
32914,SIDM00957,AZD8055,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.5456722,-0.029903783,-0.3312346879021521,0.03698081149049858
79171,SIDM00042,Navitoclax,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.3610996,0.06652283,1.224056381696895,-0.018590546630312794
60531,SIDM00097,Alpelisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.36342043,-0.025475381,-0.4875948730064565,-0.03759667534331134
67905,SIDM00148,OSI-027,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4518781,0.032671798,0.3476102646965537,-0.021460401653587417
24840,SIDM01042,Temozolomide,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.27475303,-0.008843527,0.21083841359454383,0.01727271877652097
58313,SIDM00455,5-Fluorouracil,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.596755,-0.08997782,-1.6819387536948802,-0.060140064267203946
90035,SIDM01197,Taselisib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.497604,-0.026408775,-1.9748629842303007,-0.10331397616930993
50132,SIDM01042,ZM447439,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0832443,0.26110223,-1.2447712039092134,-0.07954431252538496
100904,SIDM00673,Docetaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.24918868,0.020254426,-0.7343118717535967,-0.061583200452204404
43641,SIDM00148,Alpelisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7328255,0.11364422,0.5314890546135174,0.04130151448201484
106102,SIDM00146,MK-1775,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.54688156,0.030848635,1.7863715743606452,0.10167052220345736
52298,SIDM00833,SB505124,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.700062,-0.05773662,-0.2925562174273487,-0.060476906656823495
459,SIDM01197,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,-0.65922225,-0.023523789,-0.8851440284672335,-0.0566765846802307
50439,SIDM00633,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.6844733,-0.13331002,-0.43921554765528337,0.004511167899987597
3033,SIDM00957,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-0.81385124,-0.020160357,-0.37439255663004356,-0.02105083186238929
86937,SIDM00875,Nutlin-3a (-),Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6509566,-0.018728908,1.085270573251871,0.0338024250632646
3887,SIDM00875,SCH772984,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9214348,-0.15749446,-0.3396731112784216,-0.025506883686953547
9547,SIDM00097,Olaparib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2950795,0.029317776,0.3764790586223622,0.005078372306357952
81866,SIDM00875,Tozasertib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5308702,-0.04898372,-1.4245536796703167,0.011581423187412287
60168,SIDM00146,Crizotinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.4154029,-0.037005562,-0.30030881856632247,0.03654966352506298
27636,SIDM00148,Olaparib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9747025,0.048817545,-1.5489373733232328,-0.0778335106364254
74702,SIDM00776,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-0.99538845,-0.08492218,-1.565514432677319,-0.13533904576121603
25315,SIDM00633,Venetoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.217412,0.19365534,1.6506755882111461,0.05601522391704614
16522,SIDM00928,PD173074,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-2.059373,-0.053498577,-0.08976062472145277,-0.024569615024235988
75412,SIDM00928,Sorafenib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.5530479,0.05452732,0.29096032990533127,0.011323122102176928
94030,SIDM00832,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.8028356,-0.06544752,-0.3127288103442762,-0.03925884355837383
1053,SIDM00877,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.1399697,0.09624203,-0.3213434229068021,-0.007312526240139418
62236,SIDM01042,Alisertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.917774,0.22880201,-0.24717516992882807,-0.0020632020666536874
78876,SIDM00837,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.5515263,0.044201933,-0.5097431303649499,-0.026207575290119925
103534,SIDM00833,5-Fluorouracil,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.43067163,-0.033061203,-1.2642665216847637,-0.07291968516104333
26824,SIDM00877,Venetoclax,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0162832,0.058613837,0.31614502561265684,0.03447831728990861
108431,SIDM00832,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-2.2613993,-0.10998128,-0.7410576691837649,-0.011947282903758278
12612,SIDM00359,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.445443,-0.077494256,-1.4585551920075392,-0.02635168159712175
103499,SIDM00877,Lapatinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.9329786,-0.07177455,1.6846927149385096,0.12155518588516102
32446,SIDM00776,SB505124,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.6028171,-0.046908848,-0.3873788078865662,-0.03129097788966579
74656,SIDM00933,Tozasertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.0955997,-0.14832158,-2.379416907875395,-0.15854374889649483
31918,SIDM00872,SCH772984,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8595222,-0.09683957,0.02872760916289219,0.015446649764943596
11847,SIDM00776,Afatinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.41511965,0.030174686,1.2846496879991465,0.016232386730090413
15159,SIDM01042,Venetoclax,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.081371,0.07085608,1.358154098120379,0.07063468321680223
42064,SIDM01042,OSI-027,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.99368036,-0.1108869,-0.5192030311454382,-0.025631902174523907
77807,SIDM00835,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.124357,0.12270962,0.5213566732129534,0.04881169384205484
54948,SIDM00933,JQ1,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.6331522,0.25384626,0.7831096793724698,0.08730007328376625
44433,SIDM00633,Olaparib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2588205,-0.06139023,-1.4231245725805306,-0.04596905438257675
30131,SIDM00950,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.9372735,0.13739778,3.083272792018453,0.12240804587825946
66529,SIDM00933,Camptothecin,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.69511646,0.055947863,-0.9084789031398529,-0.0714205376849325
74734,SIDM00455,AZD7762,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.0599785,-0.09162049,-1.1238046605440313,-0.02326893725007093
75984,SIDM00877,Olaparib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.8371913,-0.03853136,-1.4779766335110802,-0.035611675723402236
28615,SIDM00455,Cisplatin,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.006687,0.09482168,0.6729573509398934,0.06783840993541464
81894,SIDM00673,Paclitaxel,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.520822,-0.285591,-3.0383616309206576,-0.2879860224974692
107114,SIDM00833,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.5316992,0.009850486,3.1619685255703494,0.1009149755138505
16123,SIDM00826,Crizotinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.197962,0.091932684,0.8103217096453709,0.01878091813855351
15576,SIDM01187,Navitoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5988383,-0.062494963,0.2956684044093496,-0.003822870132214515
7629,SIDM00950,Palbociclib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0202907,-0.043333326,-1.360774732820279,-0.04659400913510818
5423,SIDM00097,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.38658428,-0.021892468,-0.44815605048897256,-0.03423366383658687
48945,SIDM00633,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3310268,-0.087665245,-1.3768682113115491,-0.08318274310647923
83873,SIDM00146,PF-4708671,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.8849424,0.06851821,1.95297711652141,0.13379361613784355
53359,SIDM00832,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-2.5123277,-0.15018724,0.24188139746529602,-0.03443019788726791
21111,SIDM00835,MK-2206,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.5129738,0.20433225,3.484185345794557,0.11915644665725274
8989,SIDM00826,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.5354676,-0.09605832,-2.9835969020977515,-0.1493795359715277
77825,SIDM00875,Trametinib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8928352,0.027338557,-1.2678625094059504,-0.08966911109863031
43982,SIDM00933,Alpelisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.5896623,0.25911352,0.3341680424438242,0.062104851923113456
99864,SIDM00673,Alpelisib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.48161453,0.028502218,1.0762538042153573,0.0709640229839581
54358,SIDM00146,Sorafenib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-1.3545594,-0.12193375,-0.5025224211880597,-0.04733640087309849
9802,SIDM00833,AZD8055,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,4.79776,0.23052765,2.4304997150135743,0.11888272020253043
53567,SIDM00097,Dabrafenib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7888134,-0.033880766,-0.8109204234709332,-0.02665344706030358
58347,SIDM00833,Crizotinib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,1.1984714,0.09233707,-0.22327621647589355,0.01389972848629137
17721,SIDM00148,Doramapimod,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4377046,-0.084721416,0.4670440958914478,0.10512504081910373
5376,SIDM00282,SCH772984,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.18738179,-0.011217599,0.4354699329576007,0.11333851451685806
102301,SIDM00957,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.9850016,0.02807733,1.6856853378022258,0.03477084641673081
86700,SIDM00872,Navitoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4310305,-0.081507966,0.610764005717659,0.05426939230818327
57774,SIDM00832,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.0118576,-0.030514643,-0.4842892190353817,-0.018909999795185733
61306,SIDM01042,Palbociclib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7180419,0.045067035,-0.5706134438224032,-0.00547685107722923
63619,SIDM00633,AZD7762,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.731142,-0.12495201,-1.8654594749856273,-0.10077369396678977
75889,SIDM01042,Paclitaxel,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5091239,0.08723459,-1.357250937348288,-0.04259226096380056
96688,SIDM00097,Cisplatin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0403571,0.020990117,0.9641639337887905,0.021863753926105137
38879,SIDM00832,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.8611971,0.06510847,-0.1940965925051148,-0.028221225546933144
9753,SIDM00837,Vinorelbine,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.47225973,-0.021837788,-0.7443056272813756,-0.03956967974607799
44679,SIDM00633,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3448192,0.093218304,-1.9092540032190715,-0.06310641663194244
16540,SIDM01042,MK-2206,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.53539276,-0.019440705,-0.36033574696434995,-0.05414281093027874
52784,SIDM00875,Navitoclax,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1504271,0.11447428,2.2652933623480793,0.07554905890099531
2446,SIDM00832,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.1749843,-0.08501119,0.9480423184991552,0.07955238153362186
99025,SIDM00673,Camptothecin,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6018987,0.057444472,0.9885390947276815,0.05608734205632518
30442,SIDM00832,Olaparib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-1.7559394,-0.05876346,-0.5577145449813347,0.04555411280462853
67817,SIDM00148,JQ1,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.24056835,-0.018847326,0.7711178967536929,0.0059942550730707105
37714,SIDM00633,Pictilisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.41010922,0.02741293,-1.485208132594657,-0.03816573305788498
6413,SIDM00633,KU-55933,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.87368655,0.04091342,-0.8238601793540838,-0.01726404139016096
88125,SIDM00097,GSK269962A,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.274318,0.16764945,1.0509677044986698,0.07035406875679637
8229,SIDM00877,Alpelisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6303567,-0.0743205,-0.010260940302298288,-0.011545878420117528
99404,SIDM00097,Luminespib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4157436,-0.025061298,-0.40166050598665737,-0.021749848897815435
87174,SIDM00957,Camptothecin,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,2.4713368,0.043515686,1.838774157486815,0.07144893430409986
42078,SIDM00148,Wee1 Inhibitor,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.56073815,0.055234402,0.0022682202250454073,-0.03433919629846581
80668,SIDM00875,Palbociclib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.750528,0.06309893,0.9383630116524554,0.034277557598453766
19169,SIDM00950,Gemcitabine,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.8044403,-0.3763296,-3.5738104210975306,-0.33443732883321137
25985,SIDM00673,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0836499,0.10406581,-0.5046517138376874,-0.03607508642511882
12244,SIDM00673,AZD6482,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7147254,-0.06137631,-0.2615309117472526,-0.009131139271150307
52675,SIDM01042,Nilotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.17132898,0.010620046,-0.9297167761656446,-0.10247742159367058
42081,SIDM00832,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.7939932,-0.112311125,0.21989536201468293,0.002996277333326491
99487,SIDM00148,Venetoclax,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9364822,0.18842807,0.9894390075960718,0.00566010268700877
46431,SIDM00633,Venetoclax,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.12358982,0.002695642,0.9500098468877199,0.028410188107109262
47182,SIDM00146,KU-55933,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.4487162,0.08089096,0.40871958122687385,0.023228858833389033
14094,SIDM00148,Alisertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7903547,-0.096902,-1.8704669535331053,-0.0528354042397195
73900,SIDM01197,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.1059816,0.04858783,-1.1810297644495866,-0.04565259925947045
84611,SIDM00673,Temozolomide,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.14901958,-0.0032970875,0.5759907368455808,0.0049597684116835065
74109,SIDM00837,MK-2206,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.4240675,0.10413225,-0.7162169405560377,-0.06533527331018638
32890,SIDM00673,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.1080127,0.1484965,0.33216368788603806,0.07717524072118931
62024,SIDM00633,Sorafenib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.73202324,-0.046583135,-1.3726923163642153,-0.0019712786239614224
62546,SIDM00097,Pictilisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.89384496,0.056359798,-1.1074128098608322,-0.011462397186213906
64867,SIDM00872,RO-3306,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9809482,0.07154356,0.08278849101478473,0.05823143875721443
11930,SIDM00146,Dabrafenib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.7137935,0.17167181,-0.10987662409311509,0.01730471995730313
58328,SIDM00875,Pictilisib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.37642732,-0.041884154,-0.7825602316405166,-0.017751795460185436
2120,SIDM00928,Bortezomib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-0.88595915,-0.058833998,-0.43211747846708376,-0.04608582328288904
23151,SIDM00673,Nutlin-3a (-),Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.0564306,0.0746328,0.5070331601093987,0.03223171408555772
36323,SIDM00633,Cisplatin,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7029644,-0.04942081,-0.7596471841432271,-0.0017370297151897214
33361,SIDM00928,Paclitaxel,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.18933932,0.014828484,-0.3287590916537073,-0.02539701515076003
107196,SIDM00872,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9724412,0.18664098,0.07047556878358008,-0.0036590369194756988
94791,SIDM00148,NU7441,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.34907356,-0.03363626,0.6268103610355359,0.005211689358624832
39171,SIDM00097,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.7534437,0.29723406,2.8040256963850854,0.17834279032833728
40190,SIDM00950,Navitoclax,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.2582677,0.026792344,-0.30838764783417194,0.014298118259368308
43203,SIDM00950,Dactolisib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2730572,-0.098216325,-1.4232901154436512,-0.10077683153981909
8710,SIDM00872,Ribociclib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4174093,-0.033981938,0.5677072398251639,0.003431379194004188
89121,SIDM01187,MK-1775,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.4403708,-0.1522501,-0.22969415238381566,-0.059686374848691555
20589,SIDM00633,Docetaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.756884,-0.07969029,-0.8818707141700904,-0.03384917330038363
48229,SIDM00872,AZD8055,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.78652173,0.08478055,-0.5640002033435427,-0.08126235505627226
35722,SIDM01197,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.462782,-0.051387783,-0.979403722708016,-0.03506777117207028
54364,SIDM00146,Gemcitabine,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.149561,-0.15336145,-2.3667700695590295,-0.1674638744255292
41271,SIDM00877,AZD8055,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.81799084,-0.08690193,0.10826961820654857,0.017211940784013058
1893,SIDM01042,Lapatinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.059116,0.11501736,0.44583792145009815,0.03229068368690053
75627,SIDM00776,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.6376933,-0.041220147,0.2658741990677202,0.011144433436966271
74639,SIDM00872,Paclitaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.21415384,-0.019862408,-0.2642829673484303,-0.02999433839464994
9244,SIDM00633,Temozolomide,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9958671,0.01866951,0.29179227677249076,0.015180000016708613
30855,SIDM00933,Tozasertib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3230736,0.13551818,-0.004541721462736817,-0.00611983362851607
14246,SIDM00872,PF-4708671,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6767676,-0.18762675,-1.3907558626858176,-0.11988032222873471
63246,SIDM00875,Doramapimod,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8298322,0.05058368,2.1460317258990114,0.062052960577664955
64919,SIDM00146,RO-3306,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.940004,0.07645188,-0.8670313467040818,0.021383836517203776
80439,SIDM00877,Alpelisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.8401611,-0.09686364,-0.18622366045802075,-0.04838378647979395
58338,SIDM00148,Entinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.31281233,-0.021824239,0.47075955971421,0.025435996300901303
44973,SIDM00832,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.2565298,-0.112483084,-0.4505610042173811,-0.011946335148586652
11770,SIDM00872,Axitinib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0659952,0.0886332,0.8572792585432584,0.08644019134663566
107332,SIDM00146,Temozolomide,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,3.0368993,0.13181013,1.2135829331608308,0.048134886649839344
78950,SIDM00146,Axitinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3674147,-0.097740665,0.04014773072914752,-0.004295942137870278
42461,SIDM01187,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4708389,0.11582218,-1.0295057666879526,-0.030132701128691385
54626,SIDM00875,Gemcitabine,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48331103,-0.0010608595,-4.059194347728701,-0.05834757257165964
82040,SIDM00835,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-1.5602399,-0.09772091,-1.0593363227598527,-0.06175781023293223
343,SIDM00776,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,3.3026574,0.11063929,0.2297771512764791,-0.051361570980569024
61167,SIDM01042,Uprosertib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7918014,-0.033778146,-1.04931834782913,-0.09113030431371177
87312,SIDM00957,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.94098,-0.088997826,0.6505571699768296,0.046237036896825325
36855,SIDM00216,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.869672,0.012570893,0.17257105325653765,-0.006915402071197059
77994,SIDM00673,Wee1 Inhibitor,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.548983,-0.033887427,-1.2216151502736396,0.005713517563696042
78499,SIDM00455,Taselisib,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.2887664,-0.01934824,0.48483438482515767,-0.03064165510256492
33879,SIDM01042,Vorinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6849445,-0.082486585,-0.7424387502149852,-0.012989922078125549
21631,SIDM00875,SCH772984,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5700607,-0.30234092,-1.0540599277385634,-0.03490342433306799
96854,SIDM00837,Nutlin-3a (-),Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,-1.182089,-0.060143456,-2.350460578355164,-0.1401459510662427
108128,SIDM00633,Bortezomib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9856247,-0.07085622,-1.344722828045884,-0.0626609970462019
68629,SIDM01197,Nutlin-3a (-),Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.8953513,0.019911557,2.1859689606972053,0.08416759753357092
53054,SIDM00872,ZM447439,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.86969495,-0.07871785,-0.6916892575605355,-0.08283659868009959
49813,SIDM00673,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.6496816,-0.057155058,-0.3030168897016521,-0.03517167061925567
88379,SIDM00097,Doramapimod,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0786414,0.12029583,2.9281175916457993,0.10376238648575518
25681,SIDM00282,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2759993,0.037497904,2.172289871684976,0.10949091668644269
25516,SIDM00148,Olaparib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8715928,0.04197115,-0.350047291722388,-0.01048068756175676
28092,SIDM00933,Wee1 Inhibitor,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.48845348,-0.03742156,-1.2656045072191946,-0.045092819530177006
85571,SIDM00933,NU7441,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.9412502,0.19170603,0.9832938540913682,0.06637688832849575
104893,SIDM00933,Luminespib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.22834024,0.009370021,-0.14512751335853588,0.004235618412025125
55477,SIDM00832,Linsitinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,1.5352565,0.1151717,0.6996717404908204,-0.03272514924555264
74006,SIDM01197,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.634031,-0.26852173,-0.32394722899334694,0.0066340539906162305
85790,SIDM00826,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-3.4775977,-0.18532985,-4.029521136129469,-0.17229539815383252
38992,SIDM00933,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.6685153,0.17096385,-0.28412917022827905,-0.006765990180051492
18611,SIDM00950,5-Fluorouracil,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.25531086,-0.023212174,1.4752187535975536,0.09369452246461615
56151,SIDM00928,Paclitaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.458789,-0.13816902,-1.4281943183661534,-0.12666544341917918
61422,SIDM00877,SCH772984,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2995661,0.048350308,2.0752677221832654,0.06421829797127163
107151,SIDM00776,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,1.4989792,0.0914449,-2.1563466976489956,-0.07398951159277176
33389,SIDM00933,Nilotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.52293575,-0.054564018,-0.11649166259238752,-0.033419277862451545
106384,SIDM00455,LGK974,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1969393,0.051477212,-0.44302228651149084,0.01696968797918246
28657,SIDM01197,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.29780683,0.00519542,3.0814899865174827,0.08402920778728099
61048,SIDM00928,Navitoclax,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-2.4045148,-0.18855128,0.9907398733661965,0.035683269179899474
39358,SIDM00933,Alisertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.14337529,0.01485943,-0.6657479935412219,-0.008280064748958664
32771,SIDM00928,Alpelisib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.90068907,-0.102212444,-0.4611327344150019,-0.06057995698298411
10083,SIDM00673,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,1.3099737,0.0778307,1.5962425221661738,0.12327732956352386
94435,SIDM00673,BI-2536,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3935174,0.031133575,2.9635358147901254,0.1366292232332574
96500,SIDM00950,Cisplatin,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6797212,0.04389309,1.3703333768879211,0.037886343558792335
57917,SIDM00282,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.20981441,0.009726408,-0.545638720489899,-0.06237460850895906
72954,SIDM00928,AZD7762,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.4729548,0.1455647,-0.5215406541410753,-0.05406079159602128
45668,SIDM00877,AZD8055,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0183922,-0.115232736,0.384687532424608,0.033996631685677195
84805,SIDM00957,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.1805233,-0.026088562,-0.9437789023522604,-0.007705904000594041
82688,SIDM00148,Cisplatin,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.225588,-0.053661477,-0.10041163109706912,0.039758254110975125
9877,SIDM00833,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,3.8304622,0.10015003,3.595971717088703,0.14396304896862885
31687,SIDM00826,Navitoclax,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.5127375,0.013687508,0.10025726347267139,-0.03096360550325203
69345,SIDM00097,Alisertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8320477,-0.124157414,-2.0713349425624616,-0.09960597998861628
5744,SIDM00042,Trametinib,Gemcitabine,Pancreas,0.01,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.4359896,-0.21390428,-1.2990910879017739,-0.09345259061903037
39390,SIDM00872,Luminespib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7628236,-0.1281767,-0.2600925877650095,0.0056328289899554036
90331,SIDM00673,Paclitaxel,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6984065,-0.1185846,-0.8906184711966535,-0.08658183656304273
38656,SIDM00933,Vorinostat,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.6095227,0.14108248,1.30110739452724,0.07061501620070758
91449,SIDM00833,Navitoclax,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.46172598,-0.034253947,-0.6165440910436245,-0.07706094182475805
91627,SIDM00148,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8260424,-0.032074653,-0.3576465387326215,0.013341920385014267
70432,SIDM00957,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.250044,-0.050072517,-1.8006729477373877,-0.1126346686216686
68162,SIDM00042,Taselisib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.86294,0.18136708,-0.03137999714049455,-0.0024078874039767805
26003,SIDM00359,MK-1775,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.817741,-0.16296546,-2.5465630586530685,-0.10838510476730814
5502,SIDM00097,Taselisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1324854,-0.19371456,-0.07995506190292972,0.02564663534486053
79241,SIDM01187,Temozolomide,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.492292,0.011503813,-0.037643515824857816,-0.0015327555364960466
43984,SIDM00875,Nutlin-3a (-),Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6717522,-0.019560369,1.1912796049602825,0.03830262999522274
86931,SIDM00776,LGK974,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-3.0925214,-0.10569905,-2.435017111297256,-0.049357641861992436
91537,SIDM01042,Temozolomide,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.41488385,-0.012988035,-0.6280560928861069,-0.013347984233567676
19033,SIDM00042,Linsitinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,7.3291674,0.48248613,3.1565424750588216,0.11095595118879681
74124,SIDM00633,Navitoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.628159,0.13946451,-0.005755185145603429,0.018661102943435683
5308,SIDM00673,Gemcitabine,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,3.0418751,0.21368735,0.5464870515305807,0.04915192682798679
76280,SIDM00146,Afatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1674534,-0.07591368,-1.047041954232611,-0.05680895990419382
46835,SIDM00877,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2197565,0.08328502,0.7668212759170375,0.11433083151400177
50136,SIDM00673,OSI-027,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8404768,-0.08240066,-0.5256115645343014,-0.06874281701083951
81487,SIDM00872,Uprosertib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.73383564,-0.07291131,-0.36442727952595877,-0.06263375134676274
84915,SIDM00872,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.16089065,0.016657557,1.5873493579663625,0.10736869049891477
42008,SIDM00872,Doramapimod,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.220284,0.057928313,1.0398860969520463,0.08615433846782937
43206,SIDM00146,Gemcitabine,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6831374,0.040619712,-0.9276299293653374,-0.0627810036016353
62774,SIDM00877,Nilotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,0.7487376,0.088467196,-0.8522529820652357,0.010217902923258996
39288,SIDM00833,LGK974,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.3758512,0.028491268,-0.11912289157016463,0.020009867761415594
23105,SIDM00875,Venetoclax,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47550476,-0.010624375,0.614108524574517,0.01533780081528311
70438,SIDM00875,Tozasertib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7483717,-0.06400687,-0.8243081958184557,0.00937881193709546
69798,SIDM01042,Linsitinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4710974,-0.09127647,1.8947200809650653,0.11928146225159499
16080,SIDM00950,Oxaliplatin,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.7457978,0.020146294,-0.028478004595116835,-0.030147167909174644
21100,SIDM00928,Nilotinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.2655435,0.13478997,0.9474519112957467,0.08344467670108789
30199,SIDM00872,RO-3306,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.24113739,0.015695427,0.0336878363025578,-0.040433641385303205
11386,SIDM00877,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6167412,-0.13481179,-1.764088206706418,-0.09094320364037797
27206,SIDM01187,Temozolomide,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.31086954,-0.006634342,0.33499618823395355,0.019218917813122915
107321,SIDM00872,SCH772984,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.97785425,-0.056939617,0.42377310605564594,0.016921190206367644
53012,SIDM00148,Camptothecin,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6131839,0.057783764,2.170407595894947,0.2096870865758873
4110,SIDM00148,Dabrafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6781837,-0.09100908,-0.15053810135661358,-0.025081537034224922
40684,SIDM00872,Sorafenib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5086272,-0.04949719,0.4662379919312419,0.03739666565557879
15034,SIDM00950,Linsitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.122545,-0.1496443,-2.3870828078346795,-0.04512647831165754
12340,SIDM00837,Vinorelbine,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.18870263,-0.004534219,-0.5396054878278647,-0.012854617244208687
97860,SIDM00673,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.994482,0.18746896,1.203755021544844,0.10334595226729616
31449,SIDM00097,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1195805,-0.07596018,-1.0702841428700531,-0.07242372316507836
107486,SIDM00776,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.3563666,-0.11722491,-2.715585762029154,-0.06074842612032393
32506,SIDM00148,Entinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3803359,0.11865309,0.4924019135418948,0.06373133657979516
93564,SIDM01042,Pictilisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5710959,-0.040301055,-4.315426664179447,-0.21236012857882153
106329,SIDM00148,Afatinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.23131512,0.020676944,-0.1885386233806683,0.01479187011411811
40022,SIDM00957,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,3.1764348,0.057451002,1.6418260331485113,0.021023056972124584
1269,SIDM00875,AZD8055,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4473511,0.14418142,0.37228672212052144,0.011697497934794184
52980,SIDM00673,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9053454,-0.13645919,0.043014085848731155,0.03504268822286137
20733,SIDM00877,Ribociclib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.5150798,0.011980282,0.2094933906366836,0.03670147699432439
57506,SIDM00282,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.9090822,0.03740225,3.079597285150107,0.19393723258343318
14606,SIDM00833,SCH772984,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.0174968,-0.1272078,-1.1753920569491105,-0.07541316478643097
65031,SIDM00455,Trametinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.641032,0.095764935,0.5762569695178155,0.022566973984846132
45213,SIDM00875,OSI-027,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4139979,0.1373469,0.6129601891952575,0.08916578448666372
38167,SIDM00877,5-Fluorouracil,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.1006441,0.07228473,1.3872162924951439,0.0671706247037089
74664,SIDM00633,Navitoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7341318,0.20956168,1.8495427305648595,0.09457259044751676
86142,SIDM01042,Camptothecin,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,3.8580203,0.37094033,1.0580858219846907,0.09492322379534728
63080,SIDM00776,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-0.9743357,-0.057618394,0.11850446809364891,0.07801877342473829
91874,SIDM00359,SB505124,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8206357,-0.07167011,-0.04972829567887383,0.022270134470691493
100113,SIDM00872,ZM447439,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9124137,-0.08303878,-0.12435208559828911,-0.04382778299017894
32632,SIDM00950,Lapatinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.7736509,0.1820655,0.06357855485886528,0.023714616530432393
58736,SIDM00673,Venetoclax,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.66830176,-0.0130193755,0.7934795920989752,0.0689311673502886
43559,SIDM00148,Crizotinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1132954,0.04270872,1.2008348002912346,0.028847276208658637
92699,SIDM00148,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.25168923,0.023613555,-0.2649631231837024,-0.018104630021984053
70946,SIDM00216,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.3450087,0.008070928,0.6210701117061895,0.009347631283396277
98402,SIDM00928,AZD6482,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.1849765,0.091212384,0.3791428755597136,0.0410823564481325
68722,SIDM00950,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9414322,-0.11098948,0.22830357621511566,0.0035028148935808247
96091,SIDM00097,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8108597,-0.07477695,-1.2505050518316283,-0.08722420581844369
106193,SIDM00776,MK-1775,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.9715607,-0.07019668,-0.5181007876024841,-0.04750187653523293
49494,SIDM00928,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.2295822,0.04546616,1.1133560705425662,0.049352117995167685
93107,SIDM00833,Dabrafenib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.90568566,0.01894323,1.3151822481341877,0.006212321139783657
105283,SIDM00673,Palbociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.5403739,0.030404123,-1.0062322545417688,-0.011682714645943691
44002,SIDM00877,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.9836794,-0.028080221,1.7953048598442845,0.1219852514637686
105561,SIDM00216,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.3932456,0.025640024,2.1578559767417844,0.10451742472138456
78851,SIDM00282,SB505124,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4025482,0.039863423,1.531301661715874,0.03562415032513643
70763,SIDM00950,Paclitaxel,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.758307,-0.40174907,-2.7526636992911513,-0.2206967982209699
42222,SIDM00933,Tozasertib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-1.6166544,-0.16041999,-1.057132853758017,-0.04320375629556905
74425,SIDM00950,MK-2206,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3519965,-0.100716144,-0.4863132616219324,-0.08681037088476183
41466,SIDM00826,LGK974,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-1.2381659,-0.07113124,-1.146702571935347,-0.020787012066866044
52434,SIDM00455,Lapatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7931266,0.07677017,1.8770435537599144,0.12989833389670727
37437,SIDM01187,Crizotinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.45885083,-0.035109356,-0.9184822788456106,-0.03721117108976099
28436,SIDM00832,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.5149809,-0.053986855,-2.327162475352383,-0.08323861203541154
91456,SIDM00832,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-1.4789655,-0.09778913,0.591286520822514,0.02892928125599799
76574,SIDM00928,Cisplatin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.4892669,0.1238906,2.207303117761399,0.09676855300240124
2794,SIDM00835,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,1.7000716,0.11964768,0.3051638139454275,0.011237950365947305
96354,SIDM00776,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.0532213,0.08558981,-1.4504117740897302,-0.07644699106737594
17237,SIDM00673,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4270365,-0.06143211,-0.4204415592012646,0.04824937973541927
79036,SIDM00833,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.27016646,-0.01651681,-0.14623907567770245,-0.01132410718989775
80520,SIDM00957,LGK974,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.9901729,0.04036249,1.121428070410569,0.06549637018630045
103418,SIDM00097,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.8579211,0.2633964,2.69663175619061,0.18589102440618727
30676,SIDM00359,BMS-754807,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5617512,-0.05053239,-1.8391844793457162,-0.03865201114950991
37158,SIDM00933,Bortezomib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.21502438,0.021895643,-0.2584355416095554,0.04990763807694238
58307,SIDM00282,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-5.103816,-0.18995914,-1.7220660731292436,-0.10294945825210249
26613,SIDM00833,AZD4547,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-2.0885556,-0.09210751,-0.554819689161375,-0.05091808322241406
80569,SIDM00633,PF-4708671,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1518644,-0.07739401,-1.9811636556247103,-0.07948452900793936
14984,SIDM00673,Paclitaxel,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1818764,-0.16427296,-1.6004865599481397,-0.14706995400292863
49686,SIDM00146,Crizotinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.9931452,-0.08075308,-0.019870258699387727,0.006506744824951387
37153,SIDM00837,SCH772984,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.49096394,0.010248611,0.6962292664328457,0.011623886441107067
106299,SIDM00835,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.1394598,0.09317973,-0.4068854259953602,-0.06730179823232817
3692,SIDM00455,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.414122,0.022200722,2.1194788432875096,0.07592181608454492
61201,SIDM00837,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.2756138,-0.08536732,-0.897280200458725,-0.023353108525477166
56596,SIDM00832,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-0.52358454,-0.03768917,-0.7551848672582895,-0.009974627451144528
91598,SIDM00833,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-2.5772715,-0.1033531,-1.421722928290089,-0.07733790986230418
23901,SIDM00928,Ribociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,5.973106,0.3436569,-0.05159836604848361,0.00278435549629766
25177,SIDM00957,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.73855346,0.012917639,2.9147133080782743,0.029153618425352655
106483,SIDM01187,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0733562,-0.08689183,-1.9308122774228123,-0.006300364184864951
95524,SIDM00877,AZD7762,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,0.6410788,0.015876427,-0.5429532699083329,-0.041535968237443335
67745,SIDM00826,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,70.0,0.89533734,0.05682728,-1.9509470101493522,-0.019945831557173773
77165,SIDM00875,Afatinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59154665,0.03913356,1.9376899782342456,0.027903176862781
39128,SIDM00872,Sorafenib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.25317872,-0.0269482,-0.06852878604542031,-0.02316606724175839
1030,SIDM00933,Entinostat,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-0.6093099,-0.040320348,-0.24605097204108897,0.03564540688616336
37068,SIDM00875,Camptothecin,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.4088125,0.2221183,1.7162659813378989,0.1412731403722541
75750,SIDM01187,MK-1775,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0134666,-0.09112015,-0.5695312064357705,-0.05589622024518336
82700,SIDM00673,ZM447439,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.0934547,0.066351674,0.09559802387446405,0.061434809026784304
69952,SIDM00872,Paclitaxel,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.72173923,-0.070986494,-0.5457383882529875,-0.05037075886762422
98687,SIDM00673,Temozolomide,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.12645563,-0.0028818948,0.07604940128466466,0.0024479039896548463
28783,SIDM00826,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-3.1138887,-0.1419003,-4.515109514685779,-0.1896982429674677
82638,SIDM00673,5-Fluorouracil,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.35285047,-0.015105485,0.2987680233475895,0.05992892636610756
21312,SIDM00933,Camptothecin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.1952581,-0.20894869,-2.636881392256547,-0.16536984981396993
77523,SIDM00633,ZM447439,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4590183,0.11428183,0.6799791595583149,0.03607799032106003
68005,SIDM00282,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2512249,0.080940984,0.743643524377933,0.06643850501020929
2041,SIDM00633,Sorafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5757868,-0.05217288,-1.9644789399468991,-0.07262795863710252
85175,SIDM00146,Ribociclib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.91650516,0.0503926,-0.7248857482836625,0.017837222767490012
58739,SIDM00097,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5151837,-0.13909172,-1.8840817920060315,-0.1158708223126016
625,SIDM01197,MK-2206,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2511742,-0.12465002,-0.8891489711233751,-0.047591015017730366
10355,SIDM00832,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-3.5428443,-0.1474252,-0.8895749385442608,-0.04121795929848889
79914,SIDM00875,NU7441,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4111447,-0.034884673,-0.7337741186004991,-0.030486985303266295
96032,SIDM00673,Dabrafenib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,3.0526586,0.078088984,1.7168494797493794,0.07240715209827965
40465,SIDM00673,Doramapimod,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9076793,0.048354167,1.5524369520312766,0.08023393813526701
4413,SIDM00042,Lapatinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.2919703,0.13010275,3.0364217387260575,0.09672637583557263
86321,SIDM00633,Afatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.58083254,-0.0068160477,-1.483032464345229,-0.04390792856989207
15556,SIDM00877,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.3374994,-0.028957194,-0.856529222528027,0.021388900814479164
5241,SIDM00872,Gemcitabine,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9671115,0.033436514,1.6254463528380705,0.04673175409848562
20486,SIDM00826,Linsitinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.88732356,-0.06900237,-1.0712095437038254,-0.03093593520643708
71195,SIDM01187,Cisplatin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.7759454,-0.15678711,-1.562244588383603,-0.00403287137149233
786,SIDM00097,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.8428435,0.19210331,2.536102412606695,0.17460927246195782
24908,SIDM00928,Lapatinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.0620213,0.29658863,1.220367580516049,0.08519926583765969
45511,SIDM00875,RO-3306,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2206435,-0.1244906,-0.8382909527274715,-0.10827249652362451
25297,SIDM00148,Ribociclib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.487568,-0.101214595,-2.286201619813351,-0.06472660649552497
22313,SIDM00832,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.8623588,-0.1494635,-1.2068640405720308,-0.08254815236231948
7534,SIDM00933,Doramapimod,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.4393816,0.08316522,1.6572758232633915,0.0689416447971713
26456,SIDM00148,Trametinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33041906,-0.012787277,0.7466581150510596,0.02161021592821166
46766,SIDM00673,Alisertib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.41128242,-0.02295518,-1.1470435215096875,-0.009708206774194116
97050,SIDM00872,Luminespib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.66348666,-0.052964933,-0.9164262218749318,-0.018695827594692082
86120,SIDM00633,Venetoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.03200616,-0.0007286882,0.24942172462986914,-0.0014764408179835503
77363,SIDM01042,Gemcitabine,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.7214193,-0.28634214,-1.059993373202353,-0.06907682795467703
39621,SIDM01042,RO-3306,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.705068,-0.26115394,-1.8710840404399731,-0.16847507577470133
55480,SIDM00837,LGK974,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,2.7957597,0.018803092,0.8561796784415007,0.02888634022058756
1018,SIDM00359,BMS-754807,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8467404,-0.11139683,-1.791080604537478,-0.016634788521253257
19330,SIDM00875,Taselisib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2398416,0.027893825,0.1036193420769431,0.017181766937951103
92918,SIDM00148,Trametinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7693237,-0.053252023,-1.0377847874260346,-0.05219774640864919
15830,SIDM00673,Nilotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3083024,-0.06456866,0.7600209591132443,0.05256121828921458
6381,SIDM00835,Navitoclax,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.22807793,0.015859557,-0.0659902692656999,-0.03358471881712523
76887,SIDM00872,PD173074,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6724133,-0.06718849,-1.8216884332588146,-0.0769969811875458
26510,SIDM00832,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.0637299,-0.03405537,-0.44477867731800647,-0.05062322582223044
55689,SIDM00837,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.70961,0.045065433,1.7133588147247194,-0.003942790600403072
71493,SIDM01197,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1970569,-0.092841834,0.2277572479407656,-0.01719171506752289
56105,SIDM00455,Taselisib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8459909,-0.13227883,-1.1129144127514763,-0.09910102494937928
46475,SIDM00928,Luminespib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.8725249,0.08829752,0.16993017812892758,-0.04724532894722519
70661,SIDM00877,Docetaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.61047995,-0.0226951,-2.11624169200908,0.00359701751411273
77635,SIDM00146,Tozasertib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-2.0531583,-0.106920116,-0.40184626537278273,0.04692527272496937
32863,SIDM00877,PF-4708671,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.0533235,-0.11600324,0.1942030503456133,-0.000260835548092609
78595,SIDM00877,Entinostat,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8284649,0.066650346,-0.06109666563089443,0.00397449200748639
87628,SIDM00359,Oxaliplatin,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3494327,-0.091180734,-0.8231770513423453,0.033346283416198635
50182,SIDM00950,MK-1775,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.31214195,-0.024011936,-1.2295397690898169,-0.04819329683167387
48962,SIDM00877,Nilotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.53432786,0.06250229,-0.8113118975266149,-0.022889013637181117
18282,SIDM01187,Axitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.5522815,0.027765604,-0.0774852093883088,0.02547414530737828
52527,SIDM00957,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-3.2683003,-0.13746151,-0.4963850670789727,0.0013361053768617178
91932,SIDM00933,Wee1 Inhibitor,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.7530509,-0.06530233,-0.9022091410464923,-0.036402482983110405
104439,SIDM00872,Pictilisib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7611764,-0.08000627,-0.748678288833385,-0.09622314471110027
5478,SIDM00933,AZD7762,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.27156833,0.02936251,1.2908581706034186,0.13108950333275676
4568,SIDM00875,Doramapimod,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.462027,0.051925912,0.18006938136143497,-0.000707461242888102
62669,SIDM01042,Alisertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5346411,0.1948499,-1.8080717309087577,-0.06584226239278657
101250,SIDM00877,GSK269962A,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.2423204,0.025989342,-0.41974325926075223,-0.019065558844341933
83793,SIDM00776,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.7458172,-0.045372263,-2.0950188034599306,-0.06759296311621112
33700,SIDM00875,5-Fluorouracil,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70498836,-0.0683892,-0.3647049776927734,-0.034017734342137326
1675,SIDM01197,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,5.7845654,0.18991499,2.7723643207523145,0.11471714663573297
78153,SIDM00837,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.8259608,-0.043457504,-1.7599462057039772,-0.06185453665968797
32766,SIDM01042,OSI-027,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8554578,0.06607452,-2.0089964039690584,-0.050968387837188614
92372,SIDM00146,Olaparib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.9745133,-0.059873458,-0.6789804419355983,-0.004242156146895198
102739,SIDM00832,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,2.4502554,0.20779823,0.15873718492670927,-0.035598604041395296
27468,SIDM00148,Nilotinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.17285277,-0.018105118,-1.0452132754481616,-0.0860961592322984
33817,SIDM00957,AZD7762,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.8036678,0.06816528,0.8165046230654277,0.04239484486609721
68487,SIDM00877,SCH772984,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,4.83226,0.3203222,1.3418199876016181,0.04409025660320715
77954,SIDM00633,MK-2206,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0479411,0.018440573,-0.09559822131589563,0.0020115247565273566
54208,SIDM00097,Dabrafenib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5270271,-0.060179528,0.17505290320838798,-0.01425239749325253
65091,SIDM00097,Crizotinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.242719,-0.07559818,-1.7784182062215075,-0.09646931713337305
79772,SIDM00097,Lapatinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.785429,0.033016156,1.1143419197262237,0.06349442971190943
27377,SIDM00097,Sorafenib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93274933,-0.03793455,-0.944148606863619,0.018108297658305305
44484,SIDM00933,Gemcitabine,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.15700008,0.0005490069,-2.647718280029923,-0.057669567184801
57462,SIDM00928,Gemcitabine,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.2533891,-0.12402329,-0.6422190164335132,-0.08568547444926915
24212,SIDM00097,Sorafenib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.03445,0.05318088,0.09751202123478518,0.029398400364728974
42382,SIDM00146,Paclitaxel,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.9037983,-0.21786399,-0.8743977231908353,-0.03207162384185067
107119,SIDM00875,Vorinostat,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5176704,0.14986035,2.080178283016273,0.15073917024584182
759,SIDM00776,5-Fluorouracil,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-2.013839,-0.065355904,-0.12720745574717712,0.011712909880462787
29724,SIDM00837,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.19050747,0.005297401,0.2500863950780403,-0.021586836291698455
36083,SIDM00928,GSK269962A,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.6825169,-0.12457812,-1.2583700886589972,-0.04412920156770466
104102,SIDM00633,Linsitinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.289515,0.09874314,1.0565756278318854,0.04496168787804453
105410,SIDM00957,BMS-754807,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.3561649,-0.053004056,-0.6705291660787761,-0.03125198257257625
92902,SIDM00216,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.4566872,0.087603725,1.0131153502036367,0.06716217428954484
27981,SIDM00928,Linsitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.31691,0.102943674,0.5058236547732163,0.04740747306571537
36062,SIDM00928,Camptothecin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-1.1876231,-0.08697169,-0.6393149627521653,-0.016384795844005175
67881,SIDM00633,MK-1775,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.40126872,-0.028060853,-0.11715762645745358,-0.037268181421422165
102629,SIDM00633,Dabrafenib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5664506,0.041757964,1.7637492034920568,0.01900765552611733
21165,SIDM00633,Tozasertib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.53673846,0.014395192,0.3814963182291127,0.00471325690045267
55512,SIDM00042,Crizotinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.8828745,-0.15111092,-2.174746436210222,-0.12366716099868415
105644,SIDM00455,Erlotinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6880032,0.037294865,4.825110397754033,0.12335685177486874
107864,SIDM00042,Crizotinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.7111292,-0.09393538,-1.7107166424075033,-0.07782655197367531
29255,SIDM00833,Camptothecin,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.3162388,-0.085359685,-0.6483042238134018,-0.04870291662810429
29150,SIDM00928,Palbociclib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.8429883,-0.05538362,0.9127851629475198,0.02111968557134455
82366,SIDM01042,Crizotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8740976,-0.12869498,-1.5174617187527373,-0.08145933266429617
86344,SIDM00633,5-Fluorouracil,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3113219,0.0666033,-1.5826709789812803,-0.022663445539193746
68711,SIDM00872,Dabrafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2877503,-0.005443822,1.3085073643991436,0.023149564886496072
99551,SIDM00837,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.48118457,0.011611762,2.752678897078008,0.0793839234300723
90380,SIDM01042,AZD8055,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8178401,-0.21085075,-1.2170203497809733,-0.03147350464667353
78466,SIDM00875,ZM447439,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3912765,0.13125782,-0.7494737954895697,-0.07090504413001499
5314,SIDM00282,LGK974,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4375257,-0.057243753,-0.8960548626481342,-0.06195964638300055
21866,SIDM00950,Trametinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.4252846,0.11558015,0.9104229834808611,0.09942156571566707
29951,SIDM00837,BMS-754807,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-1.1952962,-0.028803602,-0.018705425158492033,0.00697294919110631
42651,SIDM00835,Vinorelbine,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.2748882,0.066435166,-0.8202624295550623,0.02262767368576151
16798,SIDM00877,Alpelisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0988699,-0.12726231,0.052719193016592544,0.00035406262448678426
3826,SIDM00837,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.8147879,0.11763696,1.5988516686658651,0.060668922703703575
94663,SIDM00933,Tozasertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.6541654,0.15874419,0.2766569782986433,0.01909275893945417
27227,SIDM00282,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.8876123,-0.09053662,-0.40678762738168445,-0.06832254481650445
68120,SIDM00950,Ruxolitinib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.32954007,0.014267,0.7839853539845232,0.050206052741633464
79898,SIDM01197,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.3123252,-0.0767257,-1.2189820123963442,-0.1157303877162878
62575,SIDM00673,Olaparib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1739812,-0.05710841,-1.0271039238834132,-0.058632096586558165
80722,SIDM00097,Olaparib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6442444,0.07448067,-0.4733503423389471,0.006868563809438503
4901,SIDM00832,SCH772984,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.2880874,0.10364078,0.24731514780031744,-0.0229374568788271
32449,SIDM00359,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0163059,0.024979573,1.850035463935382,0.051776786619838026
48603,SIDM01042,SCH772984,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.67881733,0.04088879,1.1536886270731441,-0.016616974499480894
96730,SIDM00148,5-Fluorouracil,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.4112608,-0.17898718,-2.2335856353090193,-0.17024464094207198
3717,SIDM00097,MK-2206,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.009597,-0.19583763,-0.5654634601895121,-0.03545877925631743
78044,SIDM00826,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.20503049,0.004107554,0.7985015555045889,0.012661447264994468
104249,SIDM01042,Tozasertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,5.966772,0.5869811,3.637153338534284,0.22002442726440008
94748,SIDM00455,Crizotinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.2608247,-0.13145638,-0.8759794573588086,-0.06548685639211177
88423,SIDM00673,Dabrafenib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4580531,0.029696196,0.35559953041262576,0.03874163847636968
68920,SIDM00950,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.5572667,0.3508494,2.387491197959978,0.17274437116221708
31175,SIDM00928,Ribociclib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.444826,0.15253633,1.6367117067229844,0.020011032850702413
15416,SIDM00877,Olaparib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.062214,-0.013974438,-0.24302317761606163,0.09606098613754914
41047,SIDM00146,MK-1775,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.40900734,-0.030841695,0.19611271609831107,-0.0026802089851137192
63786,SIDM00633,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7306205,0.06850739,-0.35557835259397297,-0.06107375740644405
17916,SIDM00928,BI-2536,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-3.105657,-0.20676498,-1.229329972294526,-0.07538581577383692
57802,SIDM00216,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-1.9824408,-0.017789243,-1.5887911123144294,-0.039914103168863915
57849,SIDM00148,Axitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.69163513,-0.06431071,-0.5206708442697109,-0.05559767778047235
55111,SIDM00877,Bortezomib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2942635,-0.08700123,-0.3476534402703775,0.023490303266266235
44620,SIDM00933,Palbociclib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.6064514,-0.12073601,-0.6545777687118461,-0.023412707106043745
42464,SIDM00633,Paclitaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4134765,0.111901246,1.4681038563698967,0.06773352735587508
10205,SIDM00216,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.8965749,0.10711247,0.8543280790930793,0.037354342582959284
16835,SIDM00928,RO-3306,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.5253091,-0.09374431,-0.14588126246427105,0.005301824136469812
30701,SIDM00933,5-Fluorouracil,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.99905366,-0.033879936,-2.530716459278063,-0.16931152702628227
88283,SIDM00097,Axitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5673165,-0.080782756,-0.657714626000508,-0.026777499599989964
54160,SIDM00928,Crizotinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.4528832,-0.02966701,-0.8411050634024085,-0.06929400140346843
45590,SIDM00146,RO-3306,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9099033,0.06740001,-0.18929840533147185,-0.006128702981293869
53487,SIDM00148,Gemcitabine,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.374766,-0.07843582,-3.0268888175141555,-0.16606593583472454
18544,SIDM00633,Ribociclib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9879853,-0.02633878,0.036271791693862104,-0.010943961861223248
27234,SIDM00928,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.3753046,-0.14180075,-0.9764980554572634,-0.10167419736918923
58220,SIDM00928,KU-55933,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.7437077,-0.08755193,-1.7295625887922923,-0.0774928823225323
14534,SIDM00776,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.9133534,-0.1027436,-0.9712626653369292,-0.019855771176662786
95439,SIDM00875,AZD8055,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8350222,-0.08274029,-0.368781877782463,-0.000975736684610279
51706,SIDM01042,Pictilisib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.09524221,-0.007002937,-1.176985252824753,-0.08703111539937965
30342,SIDM00042,Ruxolitinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.55865914,0.014772617,0.553686957445559,0.04133549104787356
92197,SIDM00833,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.5712945,-0.12220676,-1.6005165025906747,-0.11772533104649674
64056,SIDM00832,Afatinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.0389624,-0.0804302,-0.5309499914335934,-0.03556463283505705
83937,SIDM00875,Axitinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8435247,0.052214563,0.7840749829173993,0.052563536592005765
91783,SIDM00633,NU7441,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.64313,0.042859133,0.11791352062265552,0.0008821899931238677
104786,SIDM01197,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-3.8741462,-0.13471453,-2.0548684914801205,-0.052960804402128386
39767,SIDM00359,AZD8055,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2511084,0.08720075,-0.8820101631876045,-0.07727035029284621
83332,SIDM00042,Sorafenib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.0737729,-0.06690125,-1.116348771869295,0.0006523691156846777
93787,SIDM00933,Uprosertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.86481994,-0.08376005,-0.14142534255421105,4.705033052231543e-06
38784,SIDM00146,Olaparib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.71725273,-0.029750738,-0.11925008551304919,0.005254700499106028
58401,SIDM00875,OSI-027,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0290643,0.019041982,-1.4117352470701794,-0.023973069102253233
56335,SIDM00933,Linsitinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.7199213,-0.052680057,0.0837789192541895,0.09211533170517726
102129,SIDM00957,MK-1775,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-3.8976157,-0.1366529,1.8034716460034859,0.12154126758920578
9035,SIDM00928,MK-2206,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.7162642,0.20536122,-0.9121093120672927,-0.02569259741407779
48615,SIDM00359,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3303986,0.104456045,2.98277121582982,0.10379910029712018
34963,SIDM00146,Entinostat,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.7816031,0.13613603,-0.8691300583374756,-0.05078088758457847
40207,SIDM00872,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2935749,-0.028444031,1.290718914317324,0.02557901290352805
28456,SIDM00933,Dabrafenib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.5821787,-0.08293923,-0.3395680887890017,-0.002916052421747172
26799,SIDM00673,SCH772984,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.1928563,-0.23666073,-0.6011955422691907,-0.04351029568644422
66276,SIDM00875,PF-4708671,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3546461,-0.014092919,0.38106042391648576,0.03615726637898389
63409,SIDM00633,Taselisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.034752,0.02998587,-0.6119766008921478,-0.06998605032903168
81490,SIDM00933,Olaparib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.2292215,-0.027821824,-0.14780972645457102,0.02526823768453343
15609,SIDM00928,Docetaxel,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.8764552,-0.1777438,-0.5836591677615327,-0.013990353779885202
104612,SIDM00826,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-4.9580226,-0.038169734,-3.919256161895115,-0.12870854934342454
98607,SIDM00282,Afatinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9273757,-0.08606184,-1.0048592566764247,-0.04634838204231909
24428,SIDM00148,Vorinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6657941,0.050325412,1.3388571625254704,0.05763697708213384
48047,SIDM00950,Navitoclax,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0323322,-0.109285265,-0.267088451582875,0.00010824127271226526
77748,SIDM00216,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-4.0078354,-0.051758803,-2.9261762635021205,-0.10086049635715864
37197,SIDM00835,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-0.4458702,-0.008781652,1.5983951861167462,0.045488714671973934
69789,SIDM00933,Nilotinib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,2.052738,0.124015234,-0.08543742186292508,-0.049318012366911926
0,SIDM00633,OSI-027,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.55106187,-0.035905436,0.18367174979618084,0.008459720630200979
96564,SIDM00146,Lapatinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.4566605,0.09078012,1.2983695968384306,0.07799983807102655
90729,SIDM00359,BMS-754807,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5003646,0.041377507,2.17020560974971,0.12954924899475076
81309,SIDM00148,RO-3306,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.55346066,0.037779238,-0.8138751656591356,-0.023305774584472902
35855,SIDM00875,Sorafenib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8950115,0.095839225,-0.031623150148236204,0.014946025907660983
105794,SIDM00833,AZD8055,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,2.0584862,0.07529906,2.176884956391009,0.0584878854936025
37479,SIDM00216,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.378708,-0.016983848,-1.203477886573249,-0.09405170162086739
48799,SIDM00950,Dasatinib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2643589,-0.100000925,1.752785143796713,0.1338228272433159
15983,SIDM00835,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,1.6353912,0.07133139,0.024077684347033515,0.02952818285688319
30203,SIDM00928,PF-4708671,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-2.2103283,-0.14085433,-0.0339252993847979,-0.016547397723620356
81760,SIDM00042,Crizotinib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.9959058,0.111294895,0.9107139858998029,0.0388147341061648
72627,SIDM01197,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9710841,-0.022628943,-0.26355024143128614,-0.0023173759593110377
84366,SIDM00933,Luminespib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.0173979,-0.017733427,-3.2833193257595634,-0.07744331988285195
93904,SIDM00877,Uprosertib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.29153073,0.033329625,0.8075842969728414,0.05426713784209717
104461,SIDM00877,Camptothecin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.6829744,-0.080247834,-0.0051511112219065685,-0.015715487523410607
102673,SIDM00633,Doramapimod,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6638551,0.0640941,0.281637077037892,0.03342926655360417
10999,SIDM00146,Axitinib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.978569,-0.13676654,-0.7086957244983849,-0.030106583541283715
44650,SIDM00872,Trametinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9783412,-0.0704612,-0.1865565234840479,0.00619508248450796
6581,SIDM00933,MK-2206,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.7078123,0.15880862,0.2943267438099651,0.02736179147905414
61148,SIDM00928,Palbociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.5899177,-0.10314991,-0.7938344555484182,-0.04950921868745631
43169,SIDM00950,Erlotinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8356547,-0.071660295,-0.216562955079815,0.001174476104716318
80457,SIDM00837,BMS-754807,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-4.3175073,-0.064673804,-2.0161529077024296,-0.05001625097927905
28030,SIDM00872,Docetaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8547264,0.08246434,0.1285261842439643,0.0145647538028067
42531,SIDM01197,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.8219865,0.017102173,-3.1483562575006254,-0.07625561581010659
20219,SIDM00633,Entinostat,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2220775,-0.06858402,0.15783753708233986,0.013794624851669952
95664,SIDM00872,5-Fluorouracil,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5324225,-0.07413929,-1.677854340501007,-0.05636949842768743
93703,SIDM00877,Bortezomib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.7369581,0.060836215,0.4736207761439898,0.04015012287311712
8740,SIDM00875,Alisertib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6965352,-0.057917777,1.237005235959725,0.10179195542906155
3648,SIDM00875,Nutlin-3a (-),Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6831895,0.026477536,1.0570704841125906,0.037996209781147976
87921,SIDM00673,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,0.54684156,0.04544011,-0.6655423904094645,-0.017095703288500186
90985,SIDM00832,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.2006785,-0.060476806,-2.045400848754482,-0.048498448879713336
33987,SIDM01042,PF-4708671,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.72766316,-0.062836625,-1.4819794598292444,-0.141409193002811
43688,SIDM00146,Navitoclax,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,7.240593,0.15571462,2.529558570728665,0.028728383051843047
46668,SIDM01042,KU-55933,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2184914,0.111215286,-1.5093376840715755,-0.08874322363752386
10544,SIDM00877,AZD6482,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.75507313,-0.045020476,1.5630731887033342,0.13659956812511936
18863,SIDM00837,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.5933336,0.029083824,-1.4257363450901055,-0.09789099737562247
95685,SIDM00928,OSI-027,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.3791513,0.26622742,0.6536002584531647,0.0371394106144993
93735,SIDM01197,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1639163,-0.14439127,-1.9335881948197766,-0.10248885094917735
51093,SIDM00216,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4407396,-0.06926224,-1.5905116416255354,-0.1178956164017217
41407,SIDM00872,AZD8055,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0562564,-0.1086263,-0.48062156439011905,-0.06756115696692999
96871,SIDM00146,Lapatinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.9535063,0.08096219,1.7293333509297093,0.12191756330413987
75625,SIDM00872,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9584565,-0.04264265,-1.1138356704014147,-0.028059915075886493
73095,SIDM00042,Ruxolitinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.3412284,-0.008832853,0.5962839299243325,-0.0031513256756701973
34929,SIDM00832,SB505124,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.0373983,-0.074844226,0.7515169325121455,0.07958984762123406
85349,SIDM00928,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.6922136,-0.07106371,-0.003364840113389049,-0.014118018320760059
16447,SIDM01197,Linsitinib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6502521,-0.049191352,0.831950827627006,0.05430413637296453
5699,SIDM00097,NU7441,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0606356,-0.097550474,-1.1464067542161627,-0.058175387541941286
3519,SIDM00359,SCH772984,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4993013,0.10389967,-2.2455953020417216,-0.04139465927670028
96721,SIDM00455,Linsitinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.21194445,-0.012176957,0.4827483466972608,0.07686224313393053
14352,SIDM00359,Oxaliplatin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.21702914,-0.013858061,-2.3454839302407255,-0.020705298685700244
80470,SIDM00673,Taselisib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.4179488,-0.041169055,-1.842257246283831,-0.11025220131797313
25450,SIDM00950,Trametinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6875284,-0.15780915,-0.767293454435499,-0.057039327100458156
11844,SIDM00673,Nutlin-3a (-),Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.73537636,0.019732816,0.38757001929642504,0.03178104221408401
2232,SIDM00950,Taselisib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.84411806,-0.061712638,-0.18615544547621615,-0.022587729571517712
84669,SIDM00097,Cisplatin,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.7186399,0.035105452,0.9995906744422572,0.024319441287001798
79006,SIDM00826,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.927041,-0.10111139,-0.730910860112603,-0.021744834972669175
80029,SIDM00933,Crizotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.2499714,0.18015827,1.5282853796154698,0.12007442708832468
68887,SIDM00833,Crizotinib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.5360042,0.039308425,-1.23656268357374,-0.08406301462234661
9815,SIDM00877,Nilotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.0950514,0.073177695,0.27849681815827654,0.06857056680975473
145,SIDM00933,ZM447439,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.2318733,0.20727901,1.770224619281109,0.12727475170874192
27096,SIDM00216,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,5.1079345,0.32932255,0.48894810679196476,0.05035591132989986
71379,SIDM00148,Taselisib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8135288,-0.028511737,-0.08017057184552127,-0.015384173460418636
76017,SIDM00877,AZD8055,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.1156485,-0.12468331,0.5487856117435167,0.043579697862993566
78527,SIDM00877,Cisplatin,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.4727323,-0.1343108,-1.520907457668289,-0.0033258738522052543
39603,SIDM00875,Vorinostat,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.39669386,0.03483493,1.2867476616100657,0.033041380391092195
56190,SIDM00042,LGK974,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.9407132,0.22967178,-0.46799661706332274,0.023382679609360857
55956,SIDM00928,Uprosertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.97385174,0.07171415,-0.4451343203174233,0.01707879875414906
62322,SIDM00148,Paclitaxel,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.75910527,-0.07895434,-0.657676319461154,-0.05067840019679262
7735,SIDM00146,OSI-027,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3388108,0.12570775,1.0172411246832496,0.09656682564336636
102367,SIDM00633,Alisertib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.461168,0.095765024,1.7300643492756125,0.0914230221131956
79644,SIDM00933,KU-55933,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.8051217,0.10056263,0.39408024352934606,0.04264993528094692
13987,SIDM00359,Afatinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.54915404,-0.044610485,-1.0910367447086535,-0.05603264117978343
21758,SIDM00928,Ribociclib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.620339,0.102440365,0.3632401019961,0.008434128220918448
29767,SIDM01042,Vorinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.37277213,-0.046570547,-1.0077732988894834,-0.022524651699024317
5691,SIDM00148,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.8999805,0.15724161,-0.26338920378229624,0.008947773430745657
102375,SIDM00928,Gemcitabine,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,0.7568341,0.075129636,0.17852500096983698,-0.030041499713458562
92325,SIDM01187,Pictilisib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.867298,-0.06966337,-0.42287641446165825,-0.05241069726059358
99883,SIDM00833,AZD4547,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.80464244,-0.037925687,1.035358996180568,0.02591552374665397
86574,SIDM00928,Sorafenib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.5649316,0.16623725,1.5965113198652081,0.12774406359421872
94621,SIDM00146,Axitinib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.8071382,-0.15246849,-0.8127026110210045,0.008203419841053515
6727,SIDM00633,Docetaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5289114,0.2157514,-0.6544357041056449,0.04743546174217102
31937,SIDM00928,Uprosertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,5.9925404,0.55646974,3.170224835399634,0.1883637296424078
14591,SIDM00216,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.34390372,0.029510211,-0.3758193833903454,0.0022506589430081616
42074,SIDM00633,PF-4708671,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8493618,-0.06814814,-1.587690551982004,-0.06519338712343994
42365,SIDM00097,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4691963,-0.078759894,-0.5691086238984621,-0.02214188291183046
34395,SIDM00832,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-1.3685223,-0.062440183,-1.5860836432334107,-0.035391097312890404
9406,SIDM01042,AZD6482,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.415768,0.018213833,-0.4872925362551436,-0.028895762957678126
25435,SIDM00877,AZD7762,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.30683744,-0.02601182,-0.17799522853213232,-0.0324017834501995
14205,SIDM00673,Gemcitabine,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.84956753,-0.032438897,0.6160505042078734,0.09285378788480848
89012,SIDM01042,MK-1775,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.60921574,0.044040814,-0.33816853942038455,-0.013746052714030366
51882,SIDM00148,AZD7762,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.63018715,0.061652146,-0.9829137029029485,-0.09383681205333014
41145,SIDM00097,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8200071,-0.11030848,-1.1797272692085092,-0.048797130678024166
22428,SIDM00455,Lapatinib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2544423,-0.036323477,1.077769875176653,0.12632175488587274
39021,SIDM00097,5-Fluorouracil,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2519474,-0.09876682,-1.1146437691860926,-0.09058977800836884
23844,SIDM00832,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.1096604,0.054001343,0.16646594311255936,0.031923211523313996
32753,SIDM00875,Ribociclib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6562096,-0.048333205,-0.5238763015626928,-0.013816976628825034
39709,SIDM00933,Trametinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.53474313,-0.057000607,-1.3782415672866575,-0.06476064280781833
85934,SIDM00148,Alisertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4099535,0.11420329,-2.466966186954043,-0.06367375666680357
18766,SIDM00633,JQ1,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.10745926,0.0072353915,-0.14206292403032453,0.005319010142043248
14271,SIDM00826,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-0.8891766,-0.06507018,-3.353636432616155,-0.16799758692558922
81506,SIDM00833,Taselisib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,1.2586169,0.09561294,-0.21489774574504406,-0.05042342991718726
95310,SIDM01042,Alisertib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,7.697883,0.4592304,3.739769823762789,0.20475786578829255
96180,SIDM00837,Linsitinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,0.70516384,0.024152294,0.029500463312685906,0.004173160833712336
2898,SIDM00455,Sorafenib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.5308478,-0.13575712,-1.2350321824050694,-0.061157078369946244
59959,SIDM00877,Afatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.308061,-0.02033365,1.3711812555642586,0.10225555788708948
27658,SIDM00872,Camptothecin,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2679777,0.03683061,2.3102925104968244,0.07202732124386219
14316,SIDM01197,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.0022905,-0.057011243,-1.6579481727434302,-0.08052901626901683
35453,SIDM00950,Gemcitabine,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3118057,0.15882227,-0.30212094396243244,-0.004354202733059793
77930,SIDM00633,OSI-027,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0932982,-0.090162165,-1.4777542919491071,-0.09918141457819218
54696,SIDM00673,Nilotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0173662,-0.090026766,0.9341955049067642,0.07488539273259538
27239,SIDM00872,AZD8055,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.51174563,-0.054347117,-0.39144412536856815,-0.07209650130261701
99566,SIDM00933,Taselisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1617587,0.08435229,1.8696093937929252,0.09384736675865998
59797,SIDM00933,Uprosertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.50050163,0.05184239,-0.4330316736481754,-0.013372124448751502
17129,SIDM00933,Venetoclax,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.2450287,-0.08485717,1.2470922254980328,0.08803551495262013
9433,SIDM00832,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.88913256,0.014234085,1.109557138202628,0.02136711595113893
29270,SIDM00776,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.95097756,-0.0446911,-1.4361619069724427,-0.06072193629682248
87712,SIDM00673,PF-4708671,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.6082933,-0.10780513,-0.5276423128332698,0.017648485030997422
19299,SIDM00928,Nutlin-3a (-),Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.9373719,0.063405894,0.8370163911252694,0.02021128635549381
11943,SIDM00875,Nilotinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7138005,0.1635282,1.6571456248005658,0.08947843288335763
38189,SIDM00673,Navitoclax,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.0906678,-0.07612837,0.8323841439463866,0.04007398089562044
64378,SIDM00359,Trametinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.62227494,-0.023248777,-0.7070974897774037,-0.01350235679339239
82889,SIDM00928,BI-2536,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.3653176,0.07542708,3.1051535484028565,0.02465374440001465
107316,SIDM00933,Crizotinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.613361,0.21360159,0.07764044159610274,0.048146408002382075
55440,SIDM01187,Crizotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1928331,0.07457949,-0.2113540470642751,-0.014506451237855243
96443,SIDM00933,Wee1 Inhibitor,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.25088558,-0.020445013,-0.02948403658081687,0.005295198059960095
72602,SIDM00633,Doramapimod,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7484702,0.06474042,0.47795036995124296,0.022493196303430975
16483,SIDM00146,PD173074,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.52447563,-0.04023781,-0.7927037444548497,0.000809887344687915
45194,SIDM00877,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.64562726,0.03311513,-1.6037153209486166,-0.1287885124325765
48428,SIDM00673,ZM447439,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.66466993,-0.055090014,0.13906823244541783,-0.023022682394896438
90455,SIDM00633,BI-2536,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5006981,0.135717,0.3357951552760599,0.10627338758836855
104972,SIDM00950,Ruxolitinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0599422,0.072805785,1.3302487529569886,0.022790800541980995
73904,SIDM00633,MK-2206,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9020859,-0.06129155,-0.9543637553724263,-0.06766957912283304
78720,SIDM00633,Crizotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.8245254,0.22834256,1.4356191810969068,0.03912904399963562
22815,SIDM00146,Crizotinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-1.4840894,-0.116375506,-0.6587622842571729,-0.04078576817662493
8456,SIDM00872,PD173074,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3089364,0.08212286,-0.18319499956547283,0.013207999325178257
10967,SIDM00776,Afatinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.65932125,-0.060679372,0.522204754360898,-0.006987271061325625
79667,SIDM00673,Ribociclib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2597744,0.12894098,0.202026309573499,0.009653619848605303
7097,SIDM00146,Nutlin-3a (-),Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.9254786,0.035657566,0.22149723013201975,0.0537421384610465
102607,SIDM00359,SB505124,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.70445365,-0.045798656,-1.3331878716440633,-0.05562507257550921
16374,SIDM00826,LGK974,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.8177592,0.035907883,-1.7514439859753825,-0.05135013427226491
78963,SIDM01042,MK-2206,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9012568,0.0252062,-1.5352397545662242,-0.13442893636933725
15119,SIDM00282,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.6656379,0.11161709,1.367797085411981,0.11240137474965933
53801,SIDM00633,PD173074,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1231918,0.076652065,-0.07994613446548081,0.02784246723097613
15423,SIDM00148,Pictilisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6875821,0.08298738,1.5413536089980318,0.10810466250455986
104027,SIDM00097,Nilotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.186288,-0.19652368,-2.4973394288100716,-0.2065382432520348
47331,SIDM00148,Olaparib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0682422,-0.026478764,-1.2188648020393698,-0.04646091851390153
31266,SIDM00148,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.59463894,-0.011527376,-1.7725644482633567,-0.06012007194984477
5637,SIDM00957,Palbociclib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.2934183,-0.029955626,0.07609356558560618,0.017113908638877733
26327,SIDM00673,PF-4708671,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-3.269589,-0.13058524,-1.6713787581309145,-0.03272215219285434
91778,SIDM00455,LGK974,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.7714374,-0.066363186,1.3258192074855761,0.038349380902992024
47887,SIDM00837,Oxaliplatin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-0.83010256,-0.011731849,-2.1407485176153545,-0.07069485626194258
2810,SIDM00928,Sorafenib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2929565,0.123569444,1.0216639587062064,0.06541103251452965
229,SIDM00872,RO-3306,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6968306,0.13082993,-0.43775083544667914,-0.03539903134196229
73099,SIDM00146,Nutlin-3a (-),Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,5.9772787,0.25419182,2.2683186561575206,0.0623267554685974
39081,SIDM01197,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-0.48039773,-0.03280479,-1.4087357157574747,-0.05990494381756003
52276,SIDM00148,JQ1,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.05628,0.12120277,0.34196093850106407,-0.016514948841026153
83359,SIDM00875,Lapatinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2576339,0.14071381,1.3877453852778374,0.1196647641528124
41258,SIDM00875,AZD6482,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1782942,0.30365983,2.4907736830334763,0.1391079872753702
4127,SIDM00832,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.2140018,-0.048291303,-1.3167905111072733,-0.06555750936866375
74956,SIDM00957,Olaparib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-1.9099867,-0.023835788,2.1591800885703334,0.039454130346357474
91698,SIDM00877,Nutlin-3a (-),Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.3816142,-0.044600055,0.6554218859610755,0.021743923891993044
78236,SIDM00872,Nutlin-3a (-),Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5319726,-0.013258327,1.3283593328707153,0.03609386896094023
80704,SIDM00928,Vorinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.325251,0.22435364,0.13433908716644707,0.028972970085960104
97533,SIDM00875,AZD7762,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.12326387,0.006948473,-0.8632961990763987,-0.04254526304992038
9929,SIDM00950,Crizotinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6338184,0.15041268,1.1321703365063105,0.07913220549244257
79329,SIDM00933,Axitinib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.3356623,-0.041977253,-1.2054460645390757,-0.04893834581145425
20971,SIDM00673,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6441991,0.118423134,-0.5391033006292247,-0.04844989915568966
46340,SIDM00833,AZD4547,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.6763086,0.103657186,-1.05266525728987,-0.06370315821185288
18933,SIDM01187,Gemcitabine,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.49341553,0.04562439,-0.8570135217835156,-0.05962579333763497
71989,SIDM00282,Navitoclax,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.3731775,0.12562633,1.73034388235378,0.05745459130583594
6369,SIDM00928,Pictilisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.1536045,0.20429254,1.4086896951882573,0.11053365037249
1027,SIDM01197,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3065283,-0.06139875,0.04975617797435957,0.0124985938265012
65857,SIDM00826,Olaparib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.3138015,-0.08912085,-1.7951326411420268,-0.10340417769542455
102792,SIDM00872,Temozolomide,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.047047846,0.00081812625,0.9668706984518456,0.01220513742998933
92070,SIDM00097,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0353396,-0.111305885,-0.8325201468796426,-0.06958569339370506
108314,SIDM01187,Crizotinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.45567137,-0.027980478,-0.0581760166647555,-0.01808969521069686
24574,SIDM00146,ZM447439,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.2574062,0.09786513,0.5011388252073266,0.06279410035434443
105834,SIDM00146,Temozolomide,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.1802084,0.025686622,1.0801708997059407,0.07009080626761108
98517,SIDM00148,KU-55933,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.2668147,0.32220986,0.2979774204114136,0.027585503943093642
46445,SIDM00875,AZD8055,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6528223,-0.08892708,-1.075107106567821,-0.06224555586987216
34456,SIDM01197,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.156445,-0.11865385,-1.868954636511856,-0.07237049274020098
97043,SIDM00835,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,3.7480588,0.28887823,0.5589095019673849,0.004735046571572879
84533,SIDM00673,Linsitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.9053078,0.015200201,3.416633487931191,0.09039314402438484
18483,SIDM00837,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.9148616,-0.061771434,0.04253189870947284,-0.06803240562733036
37335,SIDM00146,Ribociclib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.64608896,0.031544037,-2.2834366776159656,-0.038457560041057104
75945,SIDM00097,Crizotinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1078168,-0.0664457,-0.5901381919913677,-0.02728569627180317
66,SIDM00776,Vinorelbine,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,1.4020283,0.11421101,1.0909901820060994,0.08316240399683025
48651,SIDM00928,Vorinostat,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.248003,0.19131339,1.2208418424165275,0.044744743064631165
42305,SIDM00832,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-3.9175642,-0.17603815,-1.5488187506068622,-0.04283888616723119
66158,SIDM00148,Nilotinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4181111,0.123365216,1.1127810746000244,0.016471407593320164
47368,SIDM00146,PD173074,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.1781219,-0.079498634,1.148136215880908,0.1260155670718973
81152,SIDM00146,Afatinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.3253452,-0.028624492,0.8783748023790288,0.055925771164761794
8967,SIDM01042,Gemcitabine,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.77971405,-0.08305835,-1.1647302831450381,-0.08547762332415118
42189,SIDM00826,AZD7762,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.59492,0.19300652,0.7956091899645428,0.03542728321191548
75080,SIDM00872,Dabrafenib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.31733686,-0.006112794,1.3540639645463257,0.027603319743535627
66017,SIDM00875,Taselisib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.13163798,-0.012203997,-1.2255318895850205,-0.09593338582093046
60230,SIDM00877,AZD8055,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.0260631,-0.1150827,-0.5261162816956174,0.01999996244974303
96261,SIDM00146,PD173074,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.5923072,-0.043686386,1.0151515663063682,0.09800166174093247
67188,SIDM00875,Paclitaxel,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.25258613,0.016654247,0.06404176147146703,-0.009408322888579235
71091,SIDM00097,Axitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6469927,0.09955304,1.9737083999835279,0.17849599396066806
99819,SIDM00832,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,3.505134,0.26842955,-0.18429960256899508,-0.06315067003023472
69516,SIDM00633,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.091689,0.10026663,-0.03031497426361204,-0.013496408248670383
60276,SIDM00146,Crizotinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7018718,-0.06802509,-0.955475701445012,-0.005194485783127347
36164,SIDM01187,MK-2206,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,5.4954166,0.25022763,1.414787565420735,0.07794193167656358
66817,SIDM00833,Palbociclib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,4.6856656,0.1720501,0.8181930766578185,0.021991821233650996
67063,SIDM00282,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.1126466,0.0945544,1.3374066853640973,0.05144162441841891
16629,SIDM00216,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6225889,-0.09854541,-2.399364824840188,-0.1363773700385303
59539,SIDM00633,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5531822,-0.12273426,-1.3517558191007069,-0.03734692414799208
94072,SIDM00950,Paclitaxel,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-6.6162825,-0.44356644,-4.582898625114191,-0.3130050296531675
24482,SIDM00957,Navitoclax,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.88489133,0.032371487,0.02683185575074077,0.028144349935783523
57991,SIDM00282,AZD7762,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.9465772,0.026728166,0.7553090240296145,0.0838721733270823
11611,SIDM00826,Linsitinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-4.075921,-0.14102454,-4.294529917226901,-0.2328287807661343
7868,SIDM00933,Docetaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.36400294,0.05031158,-1.1368709168210778,-0.04969571351319083
46190,SIDM00877,SCH772984,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.9156108,0.1537083,2.8922524282317834,0.11345713454936372
79420,SIDM01197,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.9480176,0.28511468,0.6385327192843743,0.0824198368496491
26821,SIDM00097,Vorinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.73000866,0.04729166,-1.145288780925471,-0.046150107207929586
31450,SIDM00877,Doramapimod,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2023017,0.11355004,1.4253357732003888,0.06898284507021164
6269,SIDM00359,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8076822,0.15152751,0.5481066914136767,0.05349679826159245
5139,SIDM00832,SCH772984,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.82578397,-0.07184913,-0.7665855820994365,-0.0723338995791817
95348,SIDM00833,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,0.55981016,0.012500014,1.3010388668138066,0.010886009289201982
75047,SIDM01197,SB505124,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.76014745,-0.054384325,-0.41266649866449534,-0.033845978493758866
78716,SIDM00216,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,0.14564459,0.013290892,-0.726120011519485,-0.07435334859412551
66136,SIDM00837,Taselisib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,2.1306732,0.05820269,-0.5751443717973308,-0.05430201986904065
12969,SIDM00872,AZD6482,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6921285,0.06281434,-0.48840453553379215,-0.05782414774892138
17093,SIDM00835,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.7255108,0.24256772,3.1585053272097467,0.15659885817309038
80246,SIDM00933,KU-55933,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,3.5904822,0.2259451,0.5446760081785198,0.04843847700236323
14539,SIDM00673,Nutlin-3a (-),Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.23530512,0.0054930993,0.8752493769036586,0.006074327328197284
107430,SIDM00833,Navitoclax,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,3.5523,0.15658768,0.9978415645761187,0.10624761200991628
35851,SIDM00877,Cisplatin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5621456,-0.07370738,-0.05370418514652007,0.11895959340795566
45207,SIDM00359,Afatinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5720333,-0.11583615,-1.955290251359699,-0.05586096396280357
17838,SIDM00146,Bortezomib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.19190702,-0.010287421,-0.18677115989521711,-0.0060338559417235415
695,SIDM00148,Docetaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9451239,-0.09647503,-1.4742050259800887,-0.1400051092836993
76683,SIDM00875,MK-1775,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.16988313,-0.011319651,-0.2784202297120971,-0.01844006743852117
74049,SIDM00928,Entinostat,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,0.68224597,0.06291922,-0.5530791127543038,0.0031906083227175182
94081,SIDM00875,SCH772984,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9158118,-0.19512938,-0.025448534677941646,0.009408738806477059
61285,SIDM00872,Alisertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5513084,0.076244116,0.9974624070320756,0.09620750816310548
34267,SIDM01197,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.162553,-0.04718364,-0.09869671943151734,0.032440375699481966
71801,SIDM01197,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.19954558,0.015701808,-2.393218525878121,-0.05363317338636616
51454,SIDM00928,Taselisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.877071,-0.1797078,-0.6021783200840086,-0.08804479678657356
86625,SIDM00216,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,2.3097665,0.07050461,-2.121289607447799,-0.10328828668248914
64062,SIDM00146,Palbociclib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.25239864,-0.01733116,0.05436309394357959,0.028498011621999296
70628,SIDM01197,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.432453,-0.032036968,-0.83684048268684,-0.0772369459143422
65851,SIDM00216,Olaparib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.76162267,-0.024089344,-0.08196028194152774,0.05152460144344
94599,SIDM00875,Bortezomib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.17854622,0.018976036,-0.8544199306608637,-0.01612590482037216
15301,SIDM00148,ZM447439,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.323247,0.20164564,0.7319337964642313,0.04907331251607808
7546,SIDM00282,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.41031718,-0.010717361,0.6637133583306936,0.05276536991092668
50845,SIDM00042,Lapatinib,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.4301087,0.0538932,0.8376603222608305,0.05921484769724873
72151,SIDM01042,Trametinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0500255,-0.10826264,0.9882917619786279,0.03874251486231988
54113,SIDM00832,MK-2206,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-0.5079922,-0.043783393,0.5451858936216871,0.021429150675103027
17043,SIDM00875,Vorinostat,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0433491,0.116583355,-0.013808324774291983,-0.014004553635685027
53912,SIDM00837,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.217196,-0.060808796,-2.5461103758038606,-0.14243048377648815
1243,SIDM00837,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.2838371,0.008902772,-0.7123902306901664,-0.04071749501959375
56370,SIDM00148,Nutlin-3a (-),MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.61039543,0.0587502,-0.4509148349002177,-0.0028699583116823216
20970,SIDM01187,MK-2206,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.42273664,0.034532536,-0.5725697857988977,-0.043821333215235236
107246,SIDM00835,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.8080462,-0.065764606,-1.3616567955476484,-0.07940692636989134
64030,SIDM01187,Lapatinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.002858,0.1386917,-0.14907562294761267,-0.015255040184140985
21076,SIDM00872,AZD6482,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7298768,0.073793694,0.4263198495692026,0.01258523640719312
28742,SIDM00872,AZD7762,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,3.0921388,0.24513695,1.0614584090748689,0.038693155114913176
93353,SIDM00673,AZD8055,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.1454514,0.06413399,0.3382013641572272,0.023146249970174112
54524,SIDM00282,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.5275957,-0.028565666,-1.4758043506502077,-0.11814805078659017
70410,SIDM00455,Lapatinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3837428,-0.041388538,0.11605059954833842,0.07566843872162107
102849,SIDM00837,Camptothecin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.1564561,-0.03768283,-1.8722303951300274,-0.08462373515710289
51970,SIDM00146,AZD7762,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.4896185,0.20154482,-0.4593333757464783,0.02703565019479289
17607,SIDM00832,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.8776242,-0.03921252,-0.47596946078552,-0.01574933922427879
55740,SIDM00097,Wee1 Inhibitor,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.56422573,-0.033937834,-1.0173028254392094,-0.04329856088994565
11741,SIDM00957,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-5.0330358,-0.08907047,0.7027259541076887,0.04289109662385541
69149,SIDM01187,Luminespib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2527776,-0.083512604,-0.46353738172391623,0.0650137311776638
92369,SIDM00148,AZD7762,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1465864,-0.09618239,-0.49224225269213223,-0.04443998919072361
56429,SIDM01042,Tozasertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.638353,0.18062069,0.5789310112145157,0.020921571874089034
20224,SIDM00359,Trametinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1401885,-0.035866216,-0.5645738275252267,-0.004490067930139711
74790,SIDM00673,Gemcitabine,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5711986,0.11076051,-0.00037004203879674756,0.1216002826365816
30798,SIDM00933,Afatinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.35134846,0.031905577,0.09070358718103226,0.029541640644358894
12624,SIDM01042,JQ1,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.1790538,0.004493551,-0.6327006892761108,-0.05987274535367514
70701,SIDM00933,ZM447439,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,4.5913506,0.35750738,1.7682785866516548,0.07931017156365787
76618,SIDM00146,Navitoclax,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.9312491,0.109680474,2.089545566564983,0.09454717141589712
5741,SIDM00826,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-0.2270578,-0.004216874,-2.133783052420977,-0.10531658015226851
65450,SIDM00832,Camptothecin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-3.409452,-0.25193226,-1.2960513596010583,-0.10155909350493546
89337,SIDM01187,Cisplatin,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6193753,-0.07409858,-0.771347230612452,0.01376533107496235
54805,SIDM00872,Camptothecin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1787251,0.024119243,2.802688092241659,0.09336063604251213
3340,SIDM00633,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.57059985,-0.04520019,0.0009138012935204234,-0.012070824510862098
6358,SIDM00875,JQ1,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.57652557,0.05694468,0.4456445523789048,0.052150907650203006
71378,SIDM00148,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.24104246,-0.021966754,-1.1631556528698075,-0.08663559874471678
11481,SIDM00877,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.9643683,-0.034417246,0.32605237965231,0.07780667380038456
61816,SIDM00872,PD173074,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.83240473,-0.03756016,0.3208178354507713,0.05192516331093651
5536,SIDM00633,Taselisib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.173948,-0.05745308,-2.0653465002725246,-0.1229903358722031
10473,SIDM00872,MK-2206,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6267838,-0.06936221,-0.28872535208603317,-0.040047208051332564
35334,SIDM01197,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.7328911,0.018300727,-1.0290934068539912,-0.08755592948057583
69293,SIDM00042,LGK974,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.23505637,0.011764725,-0.3946246310425084,0.005160812341391615
93695,SIDM00928,Alisertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.3120571,0.12197576,-0.452425962314956,0.035660867217996994
12790,SIDM00776,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,3.324123,0.18797638,2.0696701386914067,0.1808312417059548
27531,SIDM00875,OSI-027,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81931317,0.08456008,-0.13083702122298838,0.05909369857250249
60790,SIDM01042,GSK269962A,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.15484403,-0.018605245,-1.1021481028498648,-0.0828777457546843
3334,SIDM00146,Pictilisib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.9757976,0.08529732,0.03430750669464986,0.10107763975271819
74358,SIDM00673,Entinostat,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5854208,-0.046764437,0.2738274050039909,-0.011849288435277742
87123,SIDM01197,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6223332,-0.054283887,0.30265246759417486,-0.0037940471385862796
75959,SIDM00877,Linsitinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.1302892,0.09458903,-0.3750094292514873,0.004690683663443516
48140,SIDM00148,Gemcitabine,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6561728,0.034369316,-1.2977599492940326,-0.11847342577508128
55122,SIDM00097,Tozasertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2995245,-0.059669882,0.38359818255703737,0.02596939128907798
49959,SIDM01042,MK-2206,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35037088,-0.013616379,-1.6112330929517402,-0.0835275372894028
30808,SIDM00673,RO-3306,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.8931696,0.053902775,0.4164206587594801,-0.019776289757509904
11319,SIDM01187,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0176289,0.087057844,1.1596175688552017,0.07764148816505533
53969,SIDM00359,AZD8055,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1454103,0.08245787,1.3128777508739657,0.11249017608854961
12655,SIDM00633,PF-4708671,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0500287,0.087973185,-0.7642483589090774,-0.06002093777961262
55881,SIDM00148,KU-55933,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.332411,0.27162606,0.6020875298523225,0.05555741247427591
27608,SIDM01042,Vorinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.46875507,0.050190203,-0.6134109802648511,-0.0024200298696727177
92991,SIDM00833,Vinorelbine,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.064414784,-0.005103257,-0.06227297242604244,-0.03179175384149488
51863,SIDM00146,Pictilisib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.2746422,0.023255954,-0.714317744979887,0.01225140924518797
67624,SIDM00928,KU-55933,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.75826406,-0.041661214,-0.662802564113931,0.002000848338626828
57100,SIDM01197,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.4819221,0.20144163,1.2196077393205158,0.06780340864399709
74315,SIDM00097,PF-4708671,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2951472,-0.06877966,-0.7489346994414461,-0.04786819397524609
26550,SIDM00633,AZD6482,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8812957,0.08676441,0.31583316639025566,0.002292996491033422
102269,SIDM00146,PD173074,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.74609524,-0.04462618,-0.40838191699338705,-0.011520371247742836
38797,SIDM00933,AZD6482,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.4690316,-0.015020741,1.9027610851391374,0.13446271805385246
57959,SIDM00146,PF-4708671,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,1.6477365,0.06538702,0.8359803586609306,0.05720407626555333
64154,SIDM00148,AZD6482,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3145287,0.12641264,-0.1164748206639509,0.006481210936556392
51917,SIDM00146,Afatinib,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.60053605,-0.05924319,-1.3620105827412485,-0.0858420137122352
21968,SIDM00875,Pictilisib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.81767005,0.09044845,-0.8315527104817577,-0.026774033907384892
85210,SIDM00097,Luminespib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.098655,-0.124825835,-0.6482030671851708,-0.07472143008867152
100779,SIDM00455,MK-1775,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.006353,-0.17447092,-1.2985882412855232,-0.05335713134805608
78953,SIDM00826,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-1.9608396,-0.13241388,-2.3630962387197703,-0.13472449539571307
90276,SIDM01042,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73830074,-0.08342463,-0.16108794924486464,0.010196738137183052
100151,SIDM00875,Cisplatin,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6348189,-0.030828234,-0.5183083025206269,0.0023701142690087437
55647,SIDM00673,PF-4708671,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4869955,-0.055853743,0.3861132419128133,0.07369163126432757
89420,SIDM01197,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,5.399955,0.16046593,1.5651154918286927,0.06242201754906212
64838,SIDM01187,MK-2206,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.5961297,0.20641486,-0.8747895930697519,-0.019310215907815967
85384,SIDM00877,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.5672886,-0.07028302,1.1623346886310264,0.16816904652017528
552,SIDM00097,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.54568,-0.09975459,0.24587377596847335,-0.013267116693827179
53396,SIDM00673,PD173074,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6386142,0.1252359,-0.38556955389592823,-0.008402089520405387
5205,SIDM00933,Doramapimod,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.769288,0.11216158,1.7917436449886361,0.07246744777833646
106925,SIDM00950,Lapatinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.646248,0.2639658,1.3995515327770716,0.11666782892663921
27701,SIDM00833,MK-1775,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-2.6882112,-0.077429414,-1.745415031747483,-0.06191183216866693
66884,SIDM00216,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4767587,-0.035711005,-0.7957578226306116,-0.046985788581476826
48733,SIDM00877,AZD7762,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.55903375,-0.03977823,-0.4806116695592418,-0.03205758335738595
29738,SIDM00826,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-2.3192976,-0.096218884,-2.23659549335919,-0.09919098377885296
34623,SIDM01042,Nutlin-3a (-),Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7841169,-0.020445194,0.18191111999337495,0.0062974859969002475
91624,SIDM00837,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.3798958,0.038539436,0.9233910468535121,0.012837024614056067
37368,SIDM00282,LGK974,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2848413,-0.07171213,-1.2611422124616003,-0.051717823976643984
5377,SIDM00872,Crizotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4559968,-0.049818154,-0.26791060654534216,0.0019527215777479867
102836,SIDM00455,Erlotinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7777091,0.0457345,4.349407087891747,0.1389649676485276
53399,SIDM00097,Vorinostat,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4550328,0.079849,1.2077075884179667,0.04444949753330094
76440,SIDM00933,Trametinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.979571,0.20723356,-0.36950289081919463,0.00010638264834172086
44054,SIDM00097,Tozasertib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5149556,-0.047399607,-0.5045860013048192,-0.04261318987467639
105666,SIDM00148,PF-4708671,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9694206,0.15146065,0.6601312530625014,0.04871319190275971
44215,SIDM00950,Dasatinib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.887707,0.27328077,1.9232962688627284,0.12647683367641868
14495,SIDM00933,MK-1775,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.72407204,-0.05751822,-0.5559280925609685,-0.003226170778064253
55525,SIDM00455,Gemcitabine,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.6907752,-0.13120219,-1.0288236741448136,0.000751564359976709
7902,SIDM00950,Linsitinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2630938,0.10022815,0.41926646833425957,0.015036067333598817
40111,SIDM01042,Temozolomide,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.32112294,0.0075312494,0.3010977123918235,-0.023735879080677855
13234,SIDM00826,SB505124,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.2128966,-0.01759266,1.0739036185048083,0.027072480742082072
57242,SIDM00837,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.2835644,0.03581484,1.4362854158429454,0.007491868523263287
81816,SIDM00877,Axitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6202408,-0.11544276,-0.2419865312487709,0.028736522282570814
81704,SIDM00928,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.9743888,0.16189146,1.2122557239950649,0.04002239016834755
34310,SIDM00097,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8113935,-0.12382604,-0.5931203812743978,-0.050632276259889544
56093,SIDM00875,Trametinib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2270846,-0.10407909,-1.6891860464351471,-0.07966649139984187
23162,SIDM00776,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,1.666166,0.07100257,0.8033982460755756,0.046180780778906534
68776,SIDM00877,Nilotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.8134624,-0.10246014,-0.8801060312229526,-0.03650298498170459
71438,SIDM00633,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.67597723,-0.04698673,-1.6825876449551929,-0.10208805387024296
89614,SIDM00633,RO-3306,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.902675,0.45502105,0.7226930425102847,0.06113118101660401
14187,SIDM00928,Trametinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.8701618,-0.26549593,-0.5589144499308808,-0.031430472834219465
17994,SIDM00875,Navitoclax,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.253022,-0.029065939,0.7749431822415334,0.04761277914887042
79221,SIDM00282,Dabrafenib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.3899255,-0.05197561,0.34846823799155463,0.0035649313810786486
52205,SIDM00833,SCH772984,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.3679066,-0.10284123,-0.8758422096977867,-0.0781493672010825
41440,SIDM00837,5-Fluorouracil,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,-0.61340934,-0.045182467,-2.0917653939225445,-0.08752558369185236
72658,SIDM00875,JQ1,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17592977,-0.01920822,-0.24070797248847844,0.02972393088734423
14296,SIDM00872,Bortezomib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39930066,-0.017902955,-1.3014272247355263,-0.039282806048800425
82386,SIDM00957,Camptothecin,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,5.6822467,0.11914213,2.617874439005604,0.06401452786531527
35458,SIDM00673,PF-4708671,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.3575032,0.15863991,-1.4310126701259587,-0.04597262340124788
7866,SIDM00872,Alpelisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.089051,-0.11976292,-1.8241225631431872,-0.16824045975312985
18152,SIDM00837,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.48540595,0.029590582,-0.5231770385008124,-0.04140412832378861
20157,SIDM01042,Taselisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7362847,0.046384614,-1.340648765418346,-0.023608692239027576
54298,SIDM00673,SCH772984,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-4.204853,-0.2446074,-1.1658171386069034,-0.09978624193998425
25431,SIDM00933,Doramapimod,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.2807958,0.14639162,1.2131547694153189,0.03547562189068985
2734,SIDM00146,Crizotinib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.4987228,-0.04333176,-0.34676704080855153,0.022955204779830648
40627,SIDM01042,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.044382,0.041011766,0.35450935974344133,-0.0027347197439053666
52846,SIDM00933,Nilotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.0840414,0.08610563,0.39440204930427614,-0.02380408360472721
12445,SIDM00877,PD173074,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.8423342,-0.094151005,-0.17265677895680687,0.04349476490231051
96018,SIDM00455,Trametinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.335654,0.30957806,1.1844891065336152,0.15418647118646078
62502,SIDM00097,OSI-027,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.8420522,0.22219576,-0.10930801845162348,-0.013211723430456382
5166,SIDM00146,Temozolomide,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1670367,0.03454508,0.2821310966254305,0.003704772854747086
71882,SIDM01197,AZD7762,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.09749624,-0.006063325,-0.45879120390965733,-0.05166782834215247
5499,SIDM01187,Gemcitabine,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.240173,0.12751378,2.1310741587412965,0.1229296235187784
102880,SIDM00216,Dabrafenib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.7349967,0.013989319,1.3295805187338716,0.0456223240103601
77153,SIDM00832,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.5328016,-0.0903354,-1.9240392258877326,-0.09889911289492812
8810,SIDM00832,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-1.1528952,-0.084419936,0.17392354453813244,-0.02552675342737133
80550,SIDM00835,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.85413,0.1849709,0.9150137510857806,0.027740894662151235
56785,SIDM00835,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.3479123,0.1416779,0.9979873676357212,0.04790218138037874
79163,SIDM00833,Trametinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.5699507,-0.053345934,-0.2695213531934695,-0.01935695586263099
64462,SIDM00148,Afatinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5378024,0.048361737,0.4251342606731367,0.005909288064349407
99562,SIDM00146,Luminespib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.4280936,0.033377986,0.1735424707380538,-0.010571158159325196
80124,SIDM00837,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.4652157,0.20768759,-0.20044626911533014,0.06183816649665569
67094,SIDM00359,Linsitinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7192267,-0.111601174,-1.3743737964935852,-0.07924175952816293
71312,SIDM00933,Bortezomib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.5671712,0.04197709,-0.18196209122030274,-0.008732272538926543
40631,SIDM00872,MK-2206,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8708629,0.09437224,1.0430679695236809,0.07622812510557868
71856,SIDM00776,Linsitinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.5572779,-0.08527919,0.597844508490955,0.04653849951794707
83511,SIDM00933,Pictilisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.765001,0.1988413,0.04737709435236611,-0.008516652654824687
90581,SIDM00832,AZD8055,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.3581184,-0.08901579,-0.31311086563803026,-0.006192203370397894
94531,SIDM00216,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.5836554,-0.152374,-2.165066972113006,-0.16945039668094444
35378,SIDM01042,Lapatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.21679536,-0.027815513,-0.6229565852709743,-0.008846343597166895
100668,SIDM00146,Cisplatin,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.91948754,0.03899884,2.3021331967162713,0.09116289617374487
74453,SIDM00097,Dabrafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6020975,-0.07975189,0.5636577663411697,0.03682301896640785
23164,SIDM00877,BI-2536,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.10110933,-0.00030128888,-0.39369419523694893,-0.0042547092927619585
2094,SIDM00872,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8439918,-0.11513367,-1.2457821394663744,-0.09994432984563052
9456,SIDM00835,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.2734742,-0.0642469,-1.751461849918448,-0.06037899799868063
74597,SIDM00928,PD173074,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.5793798,0.09713439,2.986089787838191,0.12006406358345822
16902,SIDM00872,Ribociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3546251,-0.03324171,0.5317916327024085,0.01190312985473624
103460,SIDM00826,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-0.911806,-0.01375849,1.8939127054394083,0.02304818716740368
4797,SIDM00148,Doramapimod,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7490399,0.14117673,-0.7742331514363433,-0.040400370789762045
92660,SIDM01042,ZM447439,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.66835386,0.08743113,0.6580586064132837,-0.0482087492667083
11904,SIDM00872,KU-55933,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4318811,-0.06482804,-0.2918908683193014,-0.0229312091735263
103559,SIDM00875,Uprosertib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2978125,-0.11339575,-0.034257748858339085,0.044687512192229814
68745,SIDM00146,Vorinostat,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.2774425,0.10720767,1.1616403634440489,0.06109836794126964
36138,SIDM00359,Trametinib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3122936,0.007712194,0.7035729259737213,-0.007733206396773216
20599,SIDM00877,AZD8055,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0563525,0.11841905,1.1742681779516173,0.097689227908252
65492,SIDM01187,Lapatinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.57734066,0.047271926,-1.1121790519185921,-0.046876719420010655
22453,SIDM00097,Pictilisib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2064579,-0.20513892,-1.6741495107508797,-0.10601076704238331
50724,SIDM00835,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.9272573,0.26199853,1.2100949452711827,0.06467114560101318
79401,SIDM00933,RO-3306,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.40171072,-0.038048442,-0.580153761675999,-0.04807658067863343
7399,SIDM00877,Axitinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,0.24660276,0.027134374,0.21137125763849307,0.00940931727222403
43845,SIDM00933,Olaparib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.73761296,-0.07661638,-0.6048237217393615,-0.02834556452475848
100479,SIDM00776,Taselisib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.4511099,-0.11653773,-1.1367853038623774,-0.07723966095482962
32875,SIDM00837,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.717525,0.072052516,0.184235645368355,0.031115194430965738
23412,SIDM00872,Palbociclib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.87844837,0.03653103,0.9051328426648401,0.06098824047179001
50515,SIDM00877,Tozasertib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.96925783,0.062600404,0.15197531584059568,0.07160445413544515
79795,SIDM00097,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5836797,-0.187295,-1.604277261804598,-0.10061134496496185
76984,SIDM00148,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8991241,-0.1246761,-0.9651549564651565,-0.011927523088713905
39445,SIDM00837,MK-2206,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.24208713,-0.014196948,-0.4022113597285847,-0.018319102505680782
91244,SIDM00633,GSK269962A,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0194688,0.08520147,-1.2465940869662706,-0.014846762077330301
78269,SIDM00097,Tozasertib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7185609,0.02979434,1.2623632196803973,0.04272618231718132
9536,SIDM00875,OSI-027,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2314022,0.024386607,0.3043187518590982,0.06176824629146481
28663,SIDM00455,Dactolisib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1919318,-0.066377535,-0.23425787337890655,-0.009632679926188987
35758,SIDM00872,Afatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.22062,-0.19733737,-0.5801348242625398,-0.08334731696498658
23301,SIDM00837,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,-6.447122,-0.2811593,-3.050711728653976,-0.18454624093137567
54393,SIDM00872,Venetoclax,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6015282,-0.07719484,-0.90836425386776,-0.002768248383437594
25652,SIDM00875,Linsitinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.01631,0.17091924,1.0977350496211387,0.08914982060415258
75031,SIDM00633,Palbociclib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4938735,0.09049023,-2.2181792017306416,-0.10767602070861058
57283,SIDM00455,SCH772984,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.199949,-0.15358868,-2.1883717589333176,-0.09186555439307009
3726,SIDM00633,MK-2206,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-5.8919816,-0.23928045,-1.5811324102672972,-0.11931693398504775
12164,SIDM00877,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.5034249,-0.060541824,-0.19426279890547515,0.04309945168543716
84012,SIDM00933,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.75573,0.20608021,1.8681602606225884,0.05983186120849288
74280,SIDM00877,Venetoclax,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.3758228,0.18322839,0.005305435879633608,0.010894595760660057
13244,SIDM00146,GSK269962A,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2727456,-0.0841983,0.15242041055681246,-0.0001839151576379333
33720,SIDM00875,Afatinib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4229264,-0.101230524,-0.39306256755653896,-0.023271484788826433
82675,SIDM00826,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.006837278,7.57e-05,0.157747258896544,0.0034085434559448223
61395,SIDM00673,Sorafenib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7185726,-0.04465246,-0.6787937067606681,-0.0198786830887046
88607,SIDM01042,Gemcitabine,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,9.798302,0.30701697,2.6950109024172226,0.13415205655827311
71282,SIDM00950,Lapatinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.713516,0.09106314,1.3476457781803075,0.03366642564629584
53970,SIDM00833,MK-2206,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,4.1350017,0.29050893,1.2418356458848872,0.09507798667617542
77073,SIDM00872,GSK269962A,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.3463974,-0.032777485,-0.02045118886154533,0.038873525294066055
74200,SIDM00826,AZD4547,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.3784395,0.0999284,0.5474623629925708,0.07018077708650707
107432,SIDM00928,Docetaxel,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-3.694846,-0.17054588,-1.909811798060547,-0.0763762560884701
41029,SIDM00877,JQ1,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,0.52146477,0.0602039,0.5913746355392524,0.02513377636853011
46166,SIDM00928,Alpelisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.7648567,0.21245065,0.11551225069672201,-0.0057989933951213
94147,SIDM00826,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.1140579,-0.032962143,-1.696793722567582,-0.058987598564472506
76979,SIDM00875,Gemcitabine,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.27333945,-0.00046173434,-3.3970118991097427,-0.06599747577499906
13543,SIDM01187,Navitoclax,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4748651,0.12813821,2.3414322408170714,0.13849050437795304
30956,SIDM00933,RO-3306,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.1293225,0.27156767,1.7345959189674545,0.1385197802673334
17828,SIDM00832,Taselisib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.9101355,-0.121013716,0.2431740357810897,-0.04156148315197537
6896,SIDM01187,Luminespib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0478362,-0.075462975,-0.8620468436802428,-0.05301727246941604
82075,SIDM00673,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8924242,0.071702026,0.5593450251207029,0.025016142562595583
98864,SIDM00832,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.4526658,0.02382736,-0.33538996799028425,-0.024845542832502433
77536,SIDM00875,Cisplatin,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6358545,0.14581753,1.66317964910929,0.07623911072016507
73174,SIDM00359,MK-2206,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7277682,0.11521893,1.570767309291635,0.06961376059982245
92287,SIDM00950,Palbociclib,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.7831,0.34213865,-0.5133121623297893,0.013852599096438822
64102,SIDM00097,Docetaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0708401,-0.1339459,-1.2964965748839687,-0.07293053089756622
104944,SIDM00833,Afatinib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.7023515,0.058688037,0.4710088872331209,0.017060264958591788
86978,SIDM00282,Crizotinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.3879426,0.107849285,2.7682208383485802,0.13752489714388522
80168,SIDM00877,AZD7762,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.4917769,0.03813861,-0.3011868992872862,-0.02875480583523353
5820,SIDM00673,5-Fluorouracil,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.5647961,0.090907685,-0.019902176492352572,0.06094190405273829
24740,SIDM00872,Crizotinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.41268173,0.03636366,-1.0800095850706957,-0.07209259215578619
105333,SIDM00877,Sorafenib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.22959313,-0.025144,-0.21686138189127604,0.01185959337331212
9837,SIDM00928,Uprosertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.6778228,-0.06557443,0.11215858690005338,-0.010495941390927561
45153,SIDM00872,AZD8055,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6362755,-0.06850348,-1.622486104416308,-0.14584241877116866
72621,SIDM00957,SB505124,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-5.2066216,-0.09697802,-0.4421045731293638,-0.008175792843983353
28511,SIDM00826,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.45713958,0.03905357,0.554107050668908,-0.02167214362056003
73009,SIDM00877,Cisplatin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0564013,0.11452534,-0.41888336096808704,0.016220374579970987
42088,SIDM01197,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.035619438,0.001090758,1.115017214375917,0.003991882111150142
94646,SIDM00673,Taselisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.8359737,-0.21510553,-1.8962295549222619,-0.0974605640819021
83096,SIDM00835,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.35984746,0.0100797,0.6736339110914101,-0.0034199330106737245
82606,SIDM00455,SCH772984,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.7995803,-0.16901407,-0.850909414960562,-0.07340353250499396
103050,SIDM00146,Trametinib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.0202539,-0.07307275,-1.668237801272227,-0.08853732698425977
92125,SIDM00282,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4267921,-0.02794904,1.5421476547537836,0.04482154231733549
90053,SIDM00673,Crizotinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.7142166,-0.06342354,0.008480134938421455,-0.005621555102677695
87776,SIDM00633,RO-3306,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.79296684,-0.076025054,-0.9460015137285199,-0.0929838074740419
1663,SIDM01042,Ribociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4949521,-0.056938037,-0.7391879728651665,0.014622959601759744
100573,SIDM00146,ZM447439,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.398252,0.12518403,-0.25094870600763874,0.024214613368064537
36343,SIDM00148,PF-4708671,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.1888199,0.0093765315,0.3478499732944349,0.009793075756723786
105824,SIDM00928,Venetoclax,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.38742474,0.009979297,1.4411356238118744,0.027202741484188053
6572,SIDM00877,Camptothecin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.3181794,0.029022306,-1.2804495590072875,-0.09651568608200067
33462,SIDM00837,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,2.4760377,0.028971197,-0.3212948923823656,-0.02202775283848077
9822,SIDM00872,Dabrafenib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.33302712,-0.006269057,1.8872971353916024,0.056837738150982774
56924,SIDM00146,Bortezomib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.30093452,-0.019123157,-0.7217054145986151,0.006416909052130435
94216,SIDM00933,OSI-027,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.5106024,0.16353819,-0.28292097436128394,-0.011598160822484315
80760,SIDM01042,Navitoclax,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.46298164,0.05344326,2.5831518753257625,0.08666884259450015
61125,SIDM00216,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.7494516,0.1648332,-0.4903753753567458,-0.05779903959555639
91196,SIDM00877,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.5238794,0.09137845,-0.19438693046079392,-0.01515090491994166
26976,SIDM00633,Paclitaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1120781,-0.05262699,-1.286626353912633,-0.0492868425209336
73828,SIDM00872,Olaparib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.207243,-0.08058509,-0.3336253685224903,-0.01576275706387764
8579,SIDM00148,Nilotinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6376344,0.13851376,0.4983165919810672,-0.0019069202468909971
105526,SIDM00097,Wee1 Inhibitor,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.982307,-0.1158208,-2.43524037673394,-0.10848138920161413
90389,SIDM00146,RO-3306,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.44040433,0.036289137,0.14307871123669674,0.06466149585666325
53391,SIDM00832,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.4934132,-0.080204286,-1.2025788367373913,-0.06941625067015265
54017,SIDM00957,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.0517724,0.04397484,3.3729113056878073,0.08899949254212808
21012,SIDM00837,AZD8055,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.45485526,-0.033506103,-1.2897797609806432,-0.04480391042618253
3101,SIDM00633,Lapatinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2669201,-0.044457562,-0.5550976099787615,-0.028293630835321014
96213,SIDM00042,Ruxolitinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.7377283,0.016049031,1.082227584377197,0.060444186133302345
22793,SIDM00833,Palbociclib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,3.9264681,0.17187747,1.6697084548406413,0.06019036078440042
30872,SIDM00776,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6127815,0.034767777,1.1997854761759073,0.041959132188183104
44172,SIDM00877,Luminespib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-1.2807318,-0.11490087,-0.23287588145617072,-0.0021768049304579855
48809,SIDM00282,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.107897684,-0.0048006,-0.7705086458994025,-0.016754549130164026
6883,SIDM00097,PF-4708671,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2908373,0.06025377,-0.024889857704023636,0.00399657157367412
46489,SIDM00877,Dabrafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,2.8527033,0.050097723,1.6254766222672907,0.022209750531795063
60972,SIDM00097,Navitoclax,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.881163,-0.04470552,1.3368558864172737,0.058135201973587944
50663,SIDM00877,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.097478524,-0.0016002511,-0.09456559657267426,-0.03316587474540833
10442,SIDM00455,Ruxolitinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.82199305,0.0202065,2.231938772600152,0.052371945387198846
83071,SIDM00146,Cisplatin,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,2.2453072,0.11107002,3.911030237563744,0.24458948623632484
16721,SIDM00872,MK-2206,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2350364,-0.120276764,-1.2909359778640512,-0.1249565086108458
105991,SIDM00877,NU7441,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.15573108,-0.016672906,-0.5778843930998455,-0.024335650947621683
86922,SIDM00877,Venetoclax,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0543115,-0.04314625,0.45126215242323753,0.04346613523685748
6625,SIDM01042,Navitoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.48200414,0.043249957,1.9906994233812176,0.039431867632397144
104197,SIDM00455,Trametinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.2614021,-0.13045664,-1.787770884750423,-0.0717841226369977
69958,SIDM00359,Oxaliplatin,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.782173,-0.11549777,-1.1686452787537112,0.010572663747027491
83631,SIDM00877,Entinostat,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.05770342,-0.0055574463,0.4092025143830589,0.012988124443477585
30948,SIDM01197,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.7244008,-0.11173809,-0.8948722982527185,-0.006131312373651354
20730,SIDM00877,Vorinostat,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.8761609,0.05514818,-0.7816581982166031,-0.06831815177925582
45222,SIDM00359,Palbociclib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.533413,-0.028996173,-2.345878278847128,-0.012422069563400692
86236,SIDM00826,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-1.9992039,-0.039331615,-3.8312743540913066,-0.13000724546329614
43427,SIDM00872,Bortezomib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4757004,0.030329503,-0.13891019265393115,-0.016832542794704863
44226,SIDM00455,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5142893,0.095403165,1.5128021836324421,0.10534251437703296
24713,SIDM00875,Lapatinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1637872,0.020163035,1.5184686000998984,0.08717122089581111
42984,SIDM00877,Nilotinib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.31799793,0.032259118,0.036565264607664585,0.037866683220510164
6561,SIDM00148,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8622887,-0.05940832,0.3368657395013576,0.03406335942557001
20531,SIDM00933,Luminespib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.49412447,-0.010456525,-1.40245037417436,-0.06351761629425365
2596,SIDM00776,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,4.218741,0.105035275,0.693938402460322,0.014570357363159876
100547,SIDM00776,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.211177,-0.06842761,-1.1747608071833378,-0.044247951310570945
57062,SIDM00933,RO-3306,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.7958554,-0.08181247,-0.5154112190816873,0.004769598538620848
72026,SIDM00835,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-2.1986063,-0.1541048,0.0966952658319172,-0.03502845034428488
34842,SIDM01197,Vinorelbine,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.012602,0.055374123,0.9303291358997403,0.03623080417261894
44260,SIDM00872,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0915656,-0.024872318,0.8508179859431394,0.05165316124947977
18679,SIDM00928,SCH772984,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,4.7095942,0.42903426,3.077432352832524,0.1758947017355546
54423,SIDM00833,Navitoclax,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,0.8122396,0.052608743,0.6461217684130511,0.017317594239779088
43150,SIDM00872,MK-1775,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.10848519,0.009723911,-0.829344064274008,-0.040392652628585185
15668,SIDM00875,Luminespib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.49056804,-0.04404227,-1.3240720693881844,-0.070552004018673
38419,SIDM00042,Lapatinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.4015973,0.013256562,1.1872618103092953,0.13081557886004486
8078,SIDM01187,Taselisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.188511,0.0842389,-0.6213482706132808,-0.030303051841119037
43573,SIDM00875,AZD6482,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7983577,-0.105522744,0.4249235877568884,0.0050975783811553965
92442,SIDM00042,Linsitinib,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.3661774,0.05123663,3.5931571266146567,0.12672021414645915
81858,SIDM00950,Irinotecan,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.032686,-0.10720388,-1.8946392099837368,-0.06760904821283203
88881,SIDM01042,Doramapimod,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8727838,-0.10413448,0.11105269471764652,-0.05259622665159079
25643,SIDM00359,Olaparib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9490008,0.100196466,2.0266078566825056,0.03756611117720319
24700,SIDM00146,Docetaxel,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7382537,-0.071123496,-0.26702116417612465,-0.024230809948842847
62089,SIDM00633,Wee1 Inhibitor,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.4877202,-0.033181626,-0.26886888837878814,-0.03561595328106488
54612,SIDM01042,Axitinib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5162747,-0.06051691,-0.8910074006061894,-0.05151993755264786
94949,SIDM00776,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-1.9154015,-0.0524822,-0.09311189837304537,-0.01801931332052129
81867,SIDM00933,Vorinostat,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.34863946,-0.04642736,0.24940515023688647,0.022873352899270845
76195,SIDM00776,Dabrafenib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.0602336,-0.034817018,0.4971853409503431,0.009909954676462098
108205,SIDM00872,Vorinostat,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0710646,-0.0702263,-0.27144083513321654,-0.014080730392953404
19678,SIDM00933,Cisplatin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,2.5862792,0.31173638,0.05368154278268366,-0.005658947360588889
54050,SIDM00633,Docetaxel,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.646962,-0.2340011,-2.9362671269068263,-0.12056472107942827
89562,SIDM00872,PF-4708671,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2594922,-0.10351943,-0.5378480857854482,-0.08753609238786683
45288,SIDM00673,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-2.1538954,-0.064452685,-0.5900667561875232,0.002900086666793093
57143,SIDM00633,Navitoclax,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1382184,0.088780895,0.6353678732673451,0.057336469330512625
93287,SIDM00633,NU7441,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2453809,0.17843297,0.8224755093715435,0.04101809766366304
64551,SIDM00216,Dabrafenib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.56587267,0.010965515,1.241914990530636,0.05212175610866435
102273,SIDM00633,Taselisib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1670976,-0.06774069,-0.1607832570902075,-0.04772373212204392
31447,SIDM00776,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,1.9267246,0.09620738,1.5706068932121828,0.11301904048520169
55261,SIDM00872,ZM447439,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7448485,0.18013673,-0.478989789888004,-0.02278255711556597
92768,SIDM00633,Axitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6850749,-0.08164314,-1.3421448048705882,-0.06210103140661284
45021,SIDM00933,Doramapimod,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.6294436,0.05434197,1.4835730520219803,0.029293734454946787
97540,SIDM00216,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.8253988,-0.08082863,-0.8467580763974689,-0.03860334700063119
17871,SIDM00097,AZD8055,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.73647994,-0.05441006,-0.50741734542168,-0.06956865301012548
104269,SIDM00950,Palbociclib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0385612,0.077988155,-1.020277627281749,0.022219319863944684
34653,SIDM00875,BI-2536,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.865686,-0.18455909,-0.394894189325577,-0.015222765220035935
68438,SIDM00832,Palbociclib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.7661791,0.120685175,-0.11147317990266928,0.0005246293355853669
7228,SIDM00148,Luminespib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.59415495,0.053543255,-0.4027524433710559,-0.04168807075601453
39138,SIDM00832,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.20409226,0.011083981,-0.48803849254165066,-0.053980621141904064
44129,SIDM00877,Linsitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.088835,-0.056043632,-1.597492562345564,-0.09690716274559866
51485,SIDM00776,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2008593,-0.030646058,0.013788750438466906,0.036039985299072076
90396,SIDM00928,PD173074,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,5.897065,0.48990682,0.9109092784564228,0.07602455200009424
32869,SIDM00455,Paclitaxel,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.8977973,-0.12627842,-1.1524538251132501,-0.057045122560625376
90876,SIDM00928,Alpelisib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.7605482,-0.1238792,-0.061047238377742105,-0.009466314965394232
72491,SIDM01042,Afatinib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1557295,-0.14523795,-0.7661047855169257,-0.015106420932949133
24392,SIDM00673,Nilotinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.6636206,-0.026541974,0.7256285688034984,0.05430233104372293
74594,SIDM00933,Cisplatin,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,3.9098854,0.4155007,1.8198694284865506,0.09424458408576981
94568,SIDM00933,Entinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-1.6080953,-0.10001586,0.684217701069298,0.07705252071085027
89011,SIDM00872,Alisertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.458749,0.08008629,0.6150468982191891,0.03759017285727891
15762,SIDM00933,Bortezomib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.041343503,-0.0041112397,-0.02695312417958804,-0.033938472814257784
98350,SIDM00673,OSI-027,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0153865,-0.100953065,-0.18423977203907804,-0.019954810381971222
21425,SIDM00950,Sorafenib,Ruxolitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.16995168,-0.017530238,-0.2990382575625468,0.003939669668203427
81691,SIDM00776,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.1795594,-0.04375197,-2.1072953526882574,-0.03157460656478598
50495,SIDM00673,Sorafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.9902188,-0.048223708,-0.4464131937582211,-0.02419859108628071
77610,SIDM01042,Luminespib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1407115,-0.1475912,-0.8601303064591315,-0.01163991858253746
65563,SIDM00455,Palbociclib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4821666,0.06786837,-0.08759122796299651,0.06920694185675798
55378,SIDM00097,Lapatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.43955368,0.029364241,-0.5861580738664695,-0.029136008542206274
33429,SIDM00776,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.3548057,-0.111653976,-0.7013678947921275,-0.09609595994518265
65633,SIDM00776,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.5344266,-0.030850189,-1.0446148183585298,-0.03490408792503624
25254,SIDM00042,Oxaliplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.728909,-0.077838965,-2.30868573065423,-0.11742986360141305
26674,SIDM00216,AZD4547,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.27695763,0.024452915,-0.9352935218073368,-0.04982937885015542
5238,SIDM01042,Alpelisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.42755562,-0.037922714,0.01573214780013011,-0.006556847753859748
93025,SIDM00835,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,2.9043307,0.1993241,0.5668681973845127,0.01707391325715042
2593,SIDM00928,Docetaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-4.675345,-0.38866237,-2.911800908344503,-0.29307424914446917
19017,SIDM00282,Afatinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.36875713,-0.018939553,-0.12434628497877893,0.01474973065717696
94241,SIDM00097,SCH772984,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4806824,-0.02555156,-1.2931310963326779,-0.09624510601580526
19800,SIDM00282,MK-2206,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.3254032,-0.1274482,-0.33247341278892006,0.016508752061451054
81659,SIDM00097,JQ1,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6191906,-0.08174611,-1.1182372338448097,-0.06923121147155253
100555,SIDM00673,Linsitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.5247148,0.010801463,1.8873606960003062,0.04355147205563125
13057,SIDM00148,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.504419,-0.14514513,-1.3505341275059781,-0.07241795707152165
94609,SIDM01042,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.59706056,-0.06348012,-0.7853497040637908,-0.044598116899511556
102749,SIDM00957,AZD8055,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.3707768,-0.026280852,-0.7247996128351759,-0.007800849116883838
72028,SIDM00957,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,2.3898282,0.053770803,1.6460795403624324,0.059984284636684204
7189,SIDM00832,SCH772984,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.6645982,0.039553333,2.4734423845620457,0.11242551376349506
80906,SIDM00282,Taselisib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.032634,-0.04902137,0.06086362583987716,-0.023182354786969186
99523,SIDM01197,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.3815393,-0.1471208,-2.620734402501225,-0.07567043438463508
63684,SIDM00097,AZD8055,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4677482,-0.09894882,-0.8227528560452846,-0.056473004510390015
80388,SIDM00633,SCH772984,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9606378,-0.17828342,-1.1013658338057475,-0.07745349628235249
53118,SIDM00872,SCH772984,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5486529,0.039275438,2.2805441321859194,0.1278231242301782
57863,SIDM00146,Camptothecin,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.4333284,0.19782208,-1.1349513893931715,-0.05715645874296624
74530,SIDM00097,Crizotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1343162,-0.10925364,-1.9922011823202044,-0.1174861410022198
84714,SIDM00875,PF-4708671,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2697387,0.12057127,1.8198966016132074,0.08591591795705608
18538,SIDM00875,BI-2536,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1279204,-0.043660235,0.85789068701099,-0.02622578679227057
58565,SIDM00097,GSK269962A,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5090782,-0.019110804,0.1055838539992158,-0.002726033982347771
24892,SIDM00042,Ruxolitinib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6065408,-0.016959442,0.4249521350807677,0.02999066463181749
49733,SIDM00097,Paclitaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.3904953,-0.23177853,-2.95807109831393,-0.23960285337229803
102047,SIDM00875,Axitinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.6672425,0.054248653,0.4895208990450593,0.00914461001132918
55758,SIDM00097,Ribociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4308681,-0.0639256,-2.915023906001089,-0.05278633298656934
92466,SIDM00875,JQ1,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.822636,-0.09893611,-1.0268605534881428,-0.036506023657923686
36424,SIDM00833,AZD8055,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.2331736,0.09118353,1.277214355952627,0.041533041967675065
25830,SIDM00146,NU7441,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4258418,0.103929594,0.6807240594069857,0.012469385887233928
106334,SIDM00359,Vinorelbine,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0357869,-0.053485624,-0.0128853568006018,0.04235424692229306
20304,SIDM00673,MK-2206,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.4034712,0.097883455,0.7820255970109482,0.031220705872704372
50912,SIDM00833,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-1.6785623,-0.10445231,-1.499480716025779,-0.11147565036767618
31263,SIDM00455,AZD7762,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8520553,-0.0747455,-0.0330855202541416,0.06037571764484951
46318,SIDM00877,Gemcitabine,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.367427,-0.027487796,-1.1609537744376717,0.018935708383464932
26779,SIDM00933,Docetaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-0.92319113,-0.11609577,-2.3396965612672926,-0.13214776664885441
91028,SIDM00146,Ribociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6013954,-0.038378343,-1.1128422853390356,0.023568325166654008
70350,SIDM00097,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.843926,0.05790474,2.3839000747709522,0.05464331338913004
83683,SIDM00359,BMS-754807,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.42324814,-0.037603054,-0.33977181407581775,-0.024181834128247395
67174,SIDM00148,Uprosertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6837438,0.102187596,0.337603161926321,0.003984116071137223
21619,SIDM00148,PD173074,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1568865,0.0359209,-0.3906424787267082,0.0031907969722706755
37487,SIDM00875,PF-4708671,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6022069,0.02902149,-0.05023421932568711,0.02672032177644937
40845,SIDM00146,ZM447439,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.8223244,0.1669364,-0.14363275405670956,0.0007702615908941061
60070,SIDM00148,Crizotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.23250847,-0.0069304653,2.040908853750129,0.021624012148184806
37471,SIDM00877,GSK269962A,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.3830469,0.110144086,0.14838201444444574,0.027280764156755892
69647,SIDM00455,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3306841,-0.033431713,0.03389941494607986,0.06128127650712563
50975,SIDM01042,ZM447439,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.610138,-0.14830555,-0.9631681797929881,-0.04864592031106837
67101,SIDM00097,SCH772984,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1754124,-0.0901677,0.2739090196135062,0.009753381600896418
6203,SIDM00097,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7706302,0.013791699,0.016463854429400644,0.026935457533301725
8735,SIDM00455,Lapatinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.68087715,0.015412436,1.9589156790621913,0.13884321829511415
21983,SIDM00950,Irinotecan,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0210578,0.08554751,0.9631002040552211,0.11411355323096876
71810,SIDM00673,Paclitaxel,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-4.8070397,-0.25740427,-2.149139758822186,-0.1154040660124915
89781,SIDM00875,BI-2536,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,6.479431,0.08567329,2.355139744844239,0.06739248293093027
97756,SIDM00673,KU-55933,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.757369,-0.13752392,-1.0715369376303858,-0.03218862253659481
82661,SIDM00877,Olaparib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0061998,0.050249014,-1.5782181463426697,-0.0010270172850024724
49534,SIDM00633,Crizotinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.74091494,0.031524375,-0.24935492193188002,0.026208700937408354
103052,SIDM00097,Luminespib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1155372,-0.05960429,-0.12355756096167862,-0.034867512724690686
77348,SIDM00928,Olaparib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.1119297,-0.06895988,0.7642234897959297,0.05510214920916047
43431,SIDM00837,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.9654541,-0.052041385,-2.6838305653452803,-0.19847620309127031
92776,SIDM00933,Wee1 Inhibitor,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.5883686,-0.05225694,-1.0876405753637721,-0.02015443561230118
57862,SIDM00835,SB505124,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.5937169,0.12592956,-0.20324711584647565,-0.0034771110586837915
76604,SIDM00832,SB505124,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.22398587,-0.018441405,-0.5769909046145906,-0.08102010897742587
108119,SIDM00835,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.8498442,-0.020652996,1.8844534740478027,0.014584367540799302
27457,SIDM00148,Sorafenib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.613436,0.05521866,0.08429085647107674,0.010237117949897458
33231,SIDM00928,Alpelisib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.1359279,0.11528025,0.29497461518853685,-0.014886102550812453
103034,SIDM00148,Bortezomib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.35089463,-0.031769276,-0.33094142010672845,-0.06916358150633457
43324,SIDM01197,Afatinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.724066,-0.05247574,-0.1777203902455703,-0.0029556807257865142
25963,SIDM00877,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-2.4537196,-0.1275993,0.009408056808536206,-0.020455454868833683
74028,SIDM00282,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-4.230558,-0.16158976,-1.638672173225901,-0.14816728023714504
12467,SIDM00877,RO-3306,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.39393875,-0.031510096,-0.21980131547147957,0.003369044772946877
26488,SIDM00933,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.3795771,0.039869413,-0.7756892953463163,-0.03900434784043452
1828,SIDM00933,Axitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.0043604,0.31645718,3.1532162417661858,0.17701818938441727
34109,SIDM00875,Alpelisib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6211582,0.059607547,0.16629018460881975,0.00767792846342771
81464,SIDM00872,Alisertib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.43821016,-0.016815232,-0.022274595101647036,0.01177577352447426
12169,SIDM00872,Uprosertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0359266,0.17957018,2.1044574103481755,0.12211694572649175
25921,SIDM00928,5-Fluorouracil,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.7649132,-0.06926275,-0.12139923539038737,-0.002531724174710182
79157,SIDM00872,Uprosertib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4375937,-0.13208349,-0.6582150841495609,-0.12846972804903928
70884,SIDM01042,Dabrafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2013577,-0.0936251,-1.1310915274251667,-0.058462716525435374
52252,SIDM00928,Bortezomib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.5728093,-0.0476381,-0.5156516964955675,-0.06281230805733619
89199,SIDM01042,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6880653,0.07714407,-0.15594458499719355,-0.008358003461937923
106631,SIDM00933,Crizotinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.86211646,-0.09569686,-0.9784515627492923,0.021344122388465697
50476,SIDM00146,Lapatinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.9862893,0.08609816,0.5242405462285048,0.049774982875857264
76744,SIDM00633,Temozolomide,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.77841794,-0.016186964,-0.6752149386933062,-0.04831083707088512
93860,SIDM00216,BMS-754807,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.3693756,0.03247406,-0.8525487762610215,-0.0470667769226725
20455,SIDM00146,Venetoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.18941003,-0.0044895303,2.878560188002007,0.17973411700123304
27311,SIDM00933,Trametinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.0430804,-0.08324932,-0.10280683976278436,0.030139598287767386
31486,SIDM00148,AZD6482,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.14586896,-0.013047925,-0.5285110965610277,-0.028330467269608414
82247,SIDM00835,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,2.6416671,0.20278804,-0.5237651262096233,-0.04948292092916473
46657,SIDM00216,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6923814,-0.055475418,-1.1341870699477938,-0.06816430758819615
89273,SIDM00097,AZD8055,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6839616,-0.123897955,-1.8069728983760491,-0.1510397434586279
9740,SIDM00216,Afatinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.5035789,0.097821884,-0.07834185087303312,-0.03626181678141157
74934,SIDM01042,BI-2536,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.304918,-0.066160716,-4.762700110267015,-0.13914393512093892
55627,SIDM00359,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.2065017,-0.109119646,-1.3630936975870507,-0.048605048446237815
50267,SIDM01042,Temozolomide,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.37433425,-0.011431163,-0.7403963141391433,-0.004997212911306163
20672,SIDM00837,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.6128184,-0.015944025,-2.4160492024116142,-0.10500105311083163
83442,SIDM00633,KU-55933,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.91893786,-0.030750984,-0.7769127458309331,0.0076656075016453135
100962,SIDM00633,Axitinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1545727,-0.055439368,-1.5056775323522256,-0.04899243543504481
43354,SIDM00833,Navitoclax,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.5360423,-0.039595768,-0.03448993897211075,0.0037545601622751136
105748,SIDM00216,LGK974,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.9337709,0.058165085,-0.3108515173284394,0.02483428298553332
64465,SIDM01187,Vorinostat,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5222662,-0.052425142,-0.4135809537881617,-0.007162546064742123
81540,SIDM00148,Navitoclax,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.54147667,-0.043875113,0.682268914138965,0.011210744757173749
33433,SIDM00950,Ruxolitinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.5274103,0.12241028,1.598321435763908,0.054773868865993204
8215,SIDM00877,Alpelisib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.21813604,-0.014160851,0.3835056254577654,0.0020903723185477134
79524,SIDM00146,Paclitaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.5354364,-0.1253448,0.4962493348471732,0.03024372890741321
77985,SIDM00097,SCH772984,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1096293,-0.05725987,0.2591283951533932,0.013524197159805228
56171,SIDM00933,MK-2206,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.5883196,0.079274125,-0.2173845519650776,-0.016024993795756094
48660,SIDM00673,Entinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.66021115,0.053790238,0.6425036183766163,-0.019979536626917555
73542,SIDM00216,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.56708413,-0.056649175,-1.484459588986101,-0.0791481347635017
55677,SIDM00826,BMS-754807,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.6674722,-0.018987618,-1.007838046421757,-0.03201489826063408
42598,SIDM00875,Nutlin-3a (-),Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4262651,0.059212044,0.09432643789416209,0.021990252130123466
2208,SIDM01197,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.2402305,0.003988488,2.196084932424481,0.08566386805958486
103566,SIDM00282,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.62094,0.039376806,0.8000940304205323,-0.021348240863050053
47157,SIDM00146,AZD6482,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.4411733,0.18966198,1.1815279841153952,0.13584819508438828
102051,SIDM00835,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.6691047,0.14234307,0.7544035942520247,0.05410408822423534
19498,SIDM00875,Taselisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.7818184,-0.10738003,-1.710428191021457,-0.11723882202236048
95651,SIDM00826,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.13776,0.057848297,0.6734958974709958,0.05476759386992241
18037,SIDM00146,Camptothecin,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.4813347,0.13578634,-0.5072820933379295,-0.03256354793250203
8540,SIDM00933,ZM447439,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.3981104,0.21925104,1.4506917904621828,0.07119059850899243
97478,SIDM00875,Gemcitabine,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.5894077,-0.0084700845,-2.410658442258585,-0.07397972815606944
23579,SIDM00097,Docetaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.946598,-0.098901756,0.12021876931230603,-0.0003541466535338064
57933,SIDM00877,JQ1,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.8053887,-0.10096025,-0.4125463224743947,-0.05305773805539122
106476,SIDM00148,OSI-027,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7260747,0.14419848,0.8252204022840502,0.019985199487468002
74389,SIDM00875,OSI-027,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.76776665,0.06645418,-1.5798445763729452,-0.031103833225993815
41089,SIDM00146,Axitinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1869812,-0.07938615,-0.6877036874448546,-0.07573711086232765
74186,SIDM00837,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.6609843,-0.045558076,0.4432266416972609,0.02139556594770451
2470,SIDM00673,Entinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2041577,-0.09683703,-0.10967020743397561,-0.05865999510198608
84365,SIDM00833,SB505124,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-0.72779936,-0.05310688,-0.432835858917948,-0.0589116489080848
54858,SIDM00835,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-3.4116945,-0.2133732,-2.5553353530685565,-0.11647459611669797
64952,SIDM00957,Afatinib,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-0.86780304,-0.03340646,0.36934987384419876,0.005157246336250897
52723,SIDM00146,Trametinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,3.7106228,0.18087313,0.34821989041072077,0.020982009455422397
39187,SIDM00216,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.0474734,-0.09381547,-0.3633863882609262,0.003301375084669409
45645,SIDM00877,MK-1775,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.47748336,-0.02455503,-0.09708085599734029,-0.015484635274322932
95610,SIDM00148,Ribociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.040544,-0.10766874,-2.2116292292101902,-0.0666874121928121
27830,SIDM00837,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-0.86131763,-0.04643183,-1.357464242438874,-0.04709048135454105
93065,SIDM00633,Olaparib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2835977,-0.066539854,-0.7808154769138592,-0.02106206439984094
16032,SIDM00673,GSK269962A,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.6843076,-0.12483665,0.39034445040229626,0.02075181838562772
32184,SIDM00872,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9207284,0.029341057,1.976939656592993,0.04141655644301047
53589,SIDM00826,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.8968499,0.007311706,-2.324907810271839,-0.019415518297881774
47740,SIDM00933,Tozasertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.6692793,0.19263497,0.5855248518925461,-0.02746993968322074
2667,SIDM00146,Nilotinib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.7231032,-0.06759958,0.21190530222128967,0.024207935138754955
89865,SIDM00872,Alpelisib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.19861081,-0.021574184,-0.31586269203621775,-0.059052149442827606
79786,SIDM00097,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64872515,0.03586821,-0.41464639275763254,-0.05325108929884347
106156,SIDM00928,BI-2536,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.27430785,0.013084531,0.21949098309166232,-0.027514026247980074
57264,SIDM00673,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,2.4264147,0.06630441,1.7861006064199536,0.0761154642185341
44607,SIDM00673,Ribociclib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.0259323,-0.045875117,-0.7036615976457123,0.03371795012603407
22973,SIDM00097,KU-55933,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9398284,-0.056741394,-0.25856021251652894,0.02707734901413553
85788,SIDM00928,AZD8055,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.6660697,-0.16875641,-0.6765526486630545,-0.05968973077855764
99208,SIDM00832,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.1680646,-0.106691636,-1.1212755034865707,-0.055763199546257115
11738,SIDM00148,PF-4708671,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.90295696,0.067825206,-0.38156662778897166,0.030695577228260888
89477,SIDM00928,Bortezomib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.67604613,-0.048824072,-0.3068881062715336,-0.04117064702277926
45904,SIDM00633,Gemcitabine,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.5107706,-0.1786486,-1.9761655280744799,-0.11780684698772682
54260,SIDM00928,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.0995214,0.1668837,1.0570835681180213,0.08951809143031514
72763,SIDM00633,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1848402,-0.051954344,-0.0678392590894673,-0.0046196933935761285
76731,SIDM00933,Camptothecin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.34897205,-0.026625318,-1.0546347771355238,-0.10962167298536248
29249,SIDM00928,Alpelisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,3.0682557,0.2611474,1.1451245541816821,0.07983797956965265
35018,SIDM00097,Uprosertib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.82663053,-0.05261377,-0.4585470399107003,-0.05382915135370152
81489,SIDM00957,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.7991546,-0.041020133,-1.0356191674475415,0.015756527410139744
81749,SIDM00872,Olaparib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6137497,-0.05965726,-0.9399857599333289,0.0018139488909201015
78434,SIDM00872,Bortezomib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.32573804,-0.02445353,-0.38797812284039274,-0.04776489241366451
105870,SIDM01197,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.5724021,-0.0404021,0.054150655381129655,-0.03516983494680359
49403,SIDM00146,Cisplatin,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.81395,0.110783115,1.9832574484556071,0.0644871405148515
13396,SIDM00833,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.6422052,0.19684379,-0.08009398118446759,-0.012878991965297022
28641,SIDM00933,Uprosertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.1868563,0.2059557,1.2105011330800945,0.15531664824882435
56263,SIDM00933,Docetaxel,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.804525,0.10971477,-2.961854082433924,-0.14514191156802303
46223,SIDM00097,Cisplatin,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2285591,0.026721219,0.5264015086640373,0.023669238870156994
86839,SIDM00826,Olaparib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.117843,-0.123990245,-1.36489010729677,-0.023701169757692358
92867,SIDM00832,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.2275847,-0.092399485,0.19880836531689533,-0.025719114390724416
96614,SIDM01197,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.49307042,-0.03939519,0.6049265460093368,0.023351414243086063
68459,SIDM01042,Nutlin-3a (-),MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4537733,0.07473391,2.3985731586715806,0.07439104912725582
7600,SIDM00877,Ribociclib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.8280884,0.04094161,1.1078795843189153,0.05611801501049154
6121,SIDM00837,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-1.1571822,-0.04981499,0.005427596594446245,-0.0037644206355734702
55169,SIDM00833,SB505124,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.5863742,0.09578519,0.13056851162105704,0.05111548885068552
100699,SIDM00673,GSK269962A,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.4922943,-0.11950855,-0.1095963885774963,0.046478966252044604
69583,SIDM00875,GSK269962A,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8162145,0.016436314,0.461707963053511,0.010384935120936804
42633,SIDM00933,BI-2536,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-4.396691,-0.026487455,-7.774464560349273,-0.19477435686406933
92672,SIDM01042,Nilotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4562008,-0.121714026,-3.0545063398353762,-0.15976883456231197
84285,SIDM00359,SB505124,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.272948,-0.07389552,-0.3567064689653473,-0.014666351882428767
56273,SIDM01187,Trametinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9944497,-0.064929545,-0.734070808464547,0.005677485884903731
44909,SIDM00455,LGK974,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5783439,-0.04518178,-0.5885291041040106,0.009904960274073326
17806,SIDM00928,Gemcitabine,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.7327528,0.1751191,0.31751420479931625,-0.010303361855222324
57108,SIDM01042,JQ1,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6558297,-0.022973856,-1.8186278352342684,-0.11116204786938816
102184,SIDM00950,Cisplatin,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.931403,0.13266946,1.6639733904422844,0.10084193420762269
44580,SIDM00146,Taselisib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2420922,0.021567333,-0.4721192707975494,0.010442021440460247
107481,SIDM00832,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.719822,-0.046283882,-0.05697238823873776,-0.05003712507478449
103461,SIDM00877,Venetoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-1.196792,-0.047535487,-0.38922457628490387,0.0110541283994998
88904,SIDM00877,Crizotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-1.1981561,-0.024738137,-0.9086655420999405,-0.05669971540264315
24029,SIDM00673,JQ1,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.895233,-0.112739384,0.15641956260194947,0.0999104906846018
106861,SIDM01197,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8207669,-0.051629536,-0.7220012047066157,0.008780685040084092
28050,SIDM00875,PD173074,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5034307,-0.028428625,-0.6142524179104751,7.795329802253738e-05
7309,SIDM00877,Sorafenib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.45820123,0.057981443,0.11103523645349353,-0.005267100007147713
89525,SIDM00872,Docetaxel,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.84941036,-0.08700322,-1.7026181260620366,-0.10908575183874691
48511,SIDM00633,Venetoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8743062,0.021752667,0.33297797305976373,0.024581875352561816
5069,SIDM00146,Bortezomib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.103831,0.065061085,1.103190279795909,0.035720225136894115
80436,SIDM00673,JQ1,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,1.1006627,0.078711905,-1.086358649254598,0.021702519507899053
75453,SIDM00216,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.91928977,-0.07391784,-1.6772684727561442,-0.08610147255691528
25886,SIDM00933,Navitoclax,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,5.0828333,0.17798114,1.7188837946675184,0.12070040120839272
76110,SIDM00933,Axitinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.80118346,-0.09661743,-2.0341708381096537,-0.1684871321198544
30351,SIDM01042,PD173074,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8190408,-0.10350435,-0.9313372569817178,-0.08032051005486528
158,SIDM00146,JQ1,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.8461832,-0.16148178,-0.894947664193681,0.03127584563267861
25079,SIDM00928,Dabrafenib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,3.7688375,0.28171504,0.9815277341577402,0.020824979041997056
32762,SIDM00146,Linsitinib,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.4454886,0.045700267,1.0359009973529045,0.02677865150075009
60856,SIDM01042,PF-4708671,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8489926,0.06468531,0.8088491967054489,0.040168465757584
102048,SIDM00097,BI-2536,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6073209,-0.11180812,-1.5443355182701055,-0.09153265790770358
3843,SIDM00148,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.6372995,0.43757963,1.3001075937612794,0.1262495009532882
106147,SIDM01187,Temozolomide,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.025172466,0.0006805867,-0.30756952824055356,0.02246201289287793
42195,SIDM00833,Palbociclib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,2.9785893,0.0898619,1.0006238295800378,0.006455240474253534
45809,SIDM00455,Dactolisib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.89263135,0.063034154,-0.31487467851663703,0.0025102934817060932
84371,SIDM00957,AZD7762,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,3.8414416,0.07423825,1.7230771613425013,0.05521349160746678
92553,SIDM00148,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9642686,0.18547057,1.2985800197044108,0.11980481763934303
84736,SIDM00148,AZD6482,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3323653,0.08909335,-0.9133411125785438,-0.052094830552705494
88192,SIDM00216,Crizotinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.61848503,0.052165426,-0.21864488916773994,-0.013424802083428777
21115,SIDM00928,Linsitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.2458715,0.15537226,0.8045943180288064,0.07215660585856193
76514,SIDM00359,Dabrafenib,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0335038,0.11974582,-1.4250017264282673,-0.017970793259758595
28027,SIDM00826,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,-0.3898943,-0.009671836,-2.4428057725247787,-0.10054616611074482
100597,SIDM01042,Venetoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48943114,-0.026582364,-0.7461460180046426,0.004647643375877263
99474,SIDM00875,KU-55933,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.07377,-0.07731031,-1.1150726731358718,-0.027437963800774116
92970,SIDM00359,AZD8055,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.765717,-0.11288135,-0.6037797378508079,-0.025521686289853344
88785,SIDM00097,Cisplatin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.94316584,0.018843869,0.5746814168644861,0.04021258243593205
43626,SIDM00833,Afatinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.664712,0.17183897,1.6466216831295246,0.12154027715215177
15618,SIDM00148,Venetoclax,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,5.0132627,0.30576348,1.0144829734955296,0.048368252542493835
18467,SIDM00148,SCH772984,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.20038,0.07334554,3.1152941374214653,0.17502239551690585
39227,SIDM00148,Luminespib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.57491255,0.05008449,-0.6006615378849908,-0.08710676072797759
43241,SIDM00875,Palbociclib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.71042347,0.023648327,1.472783534439952,0.014807156585196234
102345,SIDM00835,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,0.991098,0.018362636,2.0500845584909575,0.039171601515503536
50814,SIDM00146,Wee1 Inhibitor,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7298161,-0.058502734,-0.3892066252557182,-0.051953153886830035
58940,SIDM00933,Camptothecin,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-4.089424,-0.35007578,-2.7144480569463316,-0.2337466380866429
5137,SIDM00933,Venetoclax,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-2.576448,-0.085572116,0.24774739276401114,0.034504225961724054
89922,SIDM00875,Camptothecin,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34927455,-0.039901484,0.00846088994661069,-0.052093596185785324
33643,SIDM00928,Tozasertib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.5435171,0.017997492,0.8456721829217162,0.022285667202372593
99340,SIDM00875,Nilotinib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70938724,-0.049642343,0.0343989545941194,0.04365932068776815
75188,SIDM00282,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.062391,0.13257577,0.1613260796293289,0.05269082628543489
13538,SIDM00928,NU7441,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.5439151,-0.05167783,0.5913290075588877,0.03314703267519087
107097,SIDM01042,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0411392,0.020929182,0.2775560193848909,-0.009131578840970002
95441,SIDM00933,Alisertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.25396,0.026014239,-1.2998763942080576,-0.09070420175027766
40963,SIDM00837,LGK974,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,1.4794577,0.063929744,-0.4112557767373065,0.02716150465250061
99958,SIDM00633,OSI-027,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1801782,0.08419123,0.49262634824092943,0.0583667282255832
79451,SIDM00673,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5121075,0.095578656,0.14311430856330448,0.02854844874719714
4847,SIDM00633,Vorinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6377478,-0.13833943,-1.267894685050594,-0.05330948673173637
42536,SIDM00875,Vorinostat,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0149043,0.10565142,1.0487066468722306,0.06813643960009673
63776,SIDM00877,ZM447439,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.2433697,-0.015965736,1.3121452729495795,0.14298119047103894
67545,SIDM00957,Dabrafenib,Vinorelbine,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-1.886172,-0.023165867,0.6427134627083367,0.06117156353049853
13107,SIDM00837,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-0.33145344,-0.010237855,-1.0222478184432533,-0.028709793504084386
44721,SIDM00148,Lapatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1039096,0.08005005,0.5190868414689395,0.05180270387770334
108389,SIDM00359,Olaparib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.48508874,0.007646536,2.3868653070698613,0.053102705836554964
68695,SIDM00673,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.2482777,0.08779294,-1.8147302522922253,-0.12966037953290624
69319,SIDM00933,Entinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-2.1090114,-0.12070848,-0.17265904930233056,0.003778699379775693
17359,SIDM00776,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.5079413,-0.046023805,-0.702140140620138,-0.06101686829481025
4109,SIDM00042,Ruxolitinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.1453503,-0.0033154124,0.7431608313455136,0.02075159468177931
57477,SIDM00633,Docetaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6105506,-0.116323516,-2.4629585872380315,-0.13424343407063732
7396,SIDM00097,SCH772984,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6012461,-0.06985146,2.5090340323728,0.12748584424946602
60034,SIDM00875,Gemcitabine,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0016544,-0.0023376546,-2.8959438254100434,-0.052459414428059986
7690,SIDM00455,AZD7762,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.25152,0.18979533,3.3570556176208033,0.3075223331439517
23175,SIDM00673,PD173074,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1021543,-0.0917933,-0.6426670240408064,-0.048266666398576706
88975,SIDM00282,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-1.960848,-0.07373866,-1.3841530042675028,-0.02041127800208635
51062,SIDM00633,Lapatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.94156116,0.016553197,-0.15140692398173936,-0.035899827095983924
32017,SIDM00872,Luminespib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.8164237,-0.18199146,-0.6944204720918795,-0.08242652159350129
63734,SIDM00928,Dabrafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2511752,0.12585369,0.4972597425975311,0.03658066987531725
14858,SIDM00832,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.2845091,0.010944999,0.41726846327821143,0.022120682216540167
29277,SIDM00148,Gemcitabine,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.78335,-0.22549744,-2.471908609712992,-0.18947258770306558
8511,SIDM00097,NU7441,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6688874,-0.034784783,-0.06596724254911987,-0.007128305580009607
48228,SIDM00933,Paclitaxel,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.2710919,-0.09834263,-0.049830990166119055,0.02142675749105177
23432,SIDM01042,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0231148,0.043502074,2.0128906865622658,0.037893857634970884
178,SIDM00835,SCH772984,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.9588026,0.14989766,0.00991884062401027,0.014385576013606802
102937,SIDM00877,ZM447439,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.5083344,0.055121128,0.8481387112658192,0.05826586835501162
77745,SIDM00148,SCH772984,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2064484,0.040576447,0.9555306164645861,0.021977507632400847
99851,SIDM00837,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.6253541,-0.036452834,-0.45913069376402116,0.03004845087698257
11502,SIDM00633,Olaparib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5992856,-0.031856712,0.11955740629755565,0.05134957375391567
91505,SIDM01187,Pictilisib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.8691848,-0.054754697,-1.3504412911894659,-0.049168821227014485
74984,SIDM00928,Cisplatin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,1.6045637,0.068010226,1.6414621712190398,0.0802584417206818
79295,SIDM00837,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.1231468,-0.15162931,-1.2817088490619413,-0.08066638696447896
22824,SIDM00833,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.93575037,-0.054916404,-0.12981956040586182,0.017129984171355018
105612,SIDM00776,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.909757,-0.16441843,-2.1289897582277146,-0.0961654506487049
100286,SIDM01187,Gemcitabine,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5785965,-0.105323866,-1.4357871878946944,-0.14692321039633693
97320,SIDM00673,MK-1775,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.2197927,-0.086681835,-0.7416750846834382,-0.04478397406484746
59243,SIDM00826,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,2.8332686,0.029523147,4.946778363975484,0.1995480456132336
104761,SIDM00097,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7865202,-0.069900215,0.699552562601874,0.014249856215636179
25654,SIDM00633,Gemcitabine,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.7414088,-0.1997191,-2.1889917997164714,-0.1351344569598041
75343,SIDM00673,Nilotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.4033514,-0.06992259,-0.07386527995729139,-0.02522630879197469
3629,SIDM00875,Ribociclib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6431423,-0.04717448,-1.0321988676937714,-0.003940241555437813
25182,SIDM00359,AZD8055,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4386994,-0.10439812,-0.5894103553694812,-0.0679192569958103
72778,SIDM00832,AZD4547,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.5052437,-0.060749695,1.7305545049267017,0.10151120853085503
1996,SIDM01042,Sorafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7187176,0.1354334,0.7208589159191304,0.035775493202838946
98879,SIDM00776,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-1.0828456,-0.07504027,-4.428008583219435,-0.08309355889435649
100133,SIDM00146,Camptothecin,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.008569609,-0.0008561353,-0.4523789428839142,-0.03018735803106511
101178,SIDM00146,Crizotinib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.5497138,0.052337166,-0.3109326594802574,0.06313837880889814
65723,SIDM00359,Taselisib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.683421,-0.11878254,-3.0047780654916143,-0.1152211593732234
22606,SIDM00455,SCH772984,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.9271596,0.06483159,-0.5248527591841466,-0.057174071341038295
16365,SIDM00928,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.5870886,0.2593695,2.6452096957702937,0.06578088291987454
23502,SIDM00148,Uprosertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.547872,-0.09517556,-1.3582725135091631,-0.0515215462835117
96535,SIDM00877,Uprosertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8454073,0.08535732,1.2102502441729575,0.05721649691581496
26708,SIDM00826,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.92469335,-0.008126379,-0.45702715571536595,0.0027677587230860302
102852,SIDM00455,Trametinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.723818,-0.17443985,-0.47409250134906766,-0.025786601930313676
70881,SIDM00146,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.65805155,-0.0194551,-0.15773596382348626,0.013684408839082845
25634,SIDM00928,JQ1,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.71237934,0.090217374,-0.24908332438831027,-0.0026616359193527136
21992,SIDM00148,OSI-027,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6911754,0.06378115,-0.1282406351032963,-0.06148843976670997
40776,SIDM00877,Wee1 Inhibitor,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.3009275,-0.024118247,-0.1515802796990438,-0.03313047444650042
1458,SIDM01042,Bortezomib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4778195,-0.030118577,0.01395700063734526,-0.06559811324747339
62080,SIDM01042,ZM447439,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2579079,0.2537883,0.5605573310903094,0.024822542017713688
51589,SIDM00872,Gemcitabine,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7866265,0.026576178,1.15239364956864,0.005655949383790841
17823,SIDM00872,Pictilisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1862478,-0.12750281,-1.3673834807341625,-0.10287411687853448
18168,SIDM00875,AZD7762,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.19435123,0.011809811,-0.34891551524083975,-0.05020428934793383
91333,SIDM00673,MK-2206,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.4363575,0.026758378,-1.027604499851383,-0.12124672185841116
55456,SIDM00826,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,3.4681969,0.13399659,0.5640128098183401,0.04776743157736476
7586,SIDM00042,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.2580595,0.10229641,1.1362214591514157,0.0230861924830163
7725,SIDM00359,AZD8055,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6289711,-0.09406539,-2.4215989455835945,-0.11864800895244111
41054,SIDM00933,BI-2536,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-2.720365,-0.021092972,-3.7770281385583573,-0.09240954769537843
31045,SIDM00872,OSI-027,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8162337,-0.079340175,-0.81220181580694,-0.06853686680048184
89773,SIDM01197,Taselisib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.1168272,-0.11661766,-0.16498401014608519,-0.04652995128687093
752,SIDM00877,Gemcitabine,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.98540604,-0.019184528,-0.07935767768575777,-0.05669149488512835
37038,SIDM00875,Paclitaxel,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7147823,-0.04442341,-0.7383799562879706,-0.06513072635130208
56819,SIDM00673,Doramapimod,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,2.3887331,0.0469097,3.5092127371775326,0.09335631327567986
78505,SIDM00455,Taselisib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2901142,-0.08630827,-0.3389364462379678,-0.07138720717871594
43747,SIDM00833,AZD8055,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.6351743,0.09403726,2.702716685158733,0.10156996824946189
105939,SIDM00455,Ruxolitinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5140843,0.033594538,2.942171335223234,0.08931491288859238
30279,SIDM00097,Luminespib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3766327,-0.07516543,-0.9464027088183352,-0.06451511194607741
69336,SIDM01197,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.4751325,0.0923074,1.6462900967267606,-0.017767109571126607
32110,SIDM00933,Dabrafenib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-1.5102247,-0.09624989,-0.8233561133782098,0.016961074773867303
22778,SIDM00097,Ribociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3551441,-0.04318177,-1.7146882370420875,-0.059976662660464614
39898,SIDM00282,Crizotinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,0.54886764,0.032402582,0.12339340054425911,0.011027107374519585
88034,SIDM00216,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.5302854,-0.19547787,-2.713838481605708,-0.08445663007347312
97135,SIDM01197,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,-0.5558935,-0.040529322,-0.3627383183445151,-0.014501731713489615
58308,SIDM00097,Vorinostat,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.46995986,0.0333422,-0.5488688485970299,0.0023540739062139996
29962,SIDM00673,Palbociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.91081244,0.02502571,-0.6871183393588556,0.004219593347879875
71897,SIDM00776,BMS-754807,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.8468678,0.20575184,0.24103839636355368,0.013310693200464865
44689,SIDM00832,Nutlin-3a (-),MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.5102658,0.08730109,2.807601123755683,0.05084808381774541
65529,SIDM00872,Entinostat,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6842551,-0.12892948,0.2192060911728483,-0.04824917448020032
80916,SIDM00872,Nilotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.62834436,0.06162634,0.5924835255415895,0.0321042252936892
37,SIDM00146,Luminespib,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.5819395,-0.11725864,-1.0585994045527565,-0.03921746951406577
20228,SIDM00833,AZD7762,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,3.7933,0.3021236,1.0922375819385013,0.1382722641659361
47547,SIDM00872,JQ1,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.98876417,-0.022366162,1.5816694976336771,0.12276588942906563
19723,SIDM00928,PD173074,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.292367,0.19601718,1.7393147550327595,0.07834351153449763
65966,SIDM00673,Navitoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9258559,0.07731025,-0.5458216251970154,-0.054004971113865596
15412,SIDM00673,GSK269962A,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-1.2308376,-0.08982088,-0.3185393716692677,0.009776385784557803
11525,SIDM00877,GSK269962A,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.18309247,-0.017715517,0.5871990973024481,0.024884093455643193
91590,SIDM00826,SCH772984,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.23571807,0.00427154,-2.460732746267671,-0.10743723064579891
36681,SIDM00097,Axitinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.43478975,0.026920019,-0.09953061181888478,-0.04235269481281521
100634,SIDM00837,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-2.7909257,-0.09457917,-2.5974976299420955,-0.11160427623198281
104821,SIDM00826,Crizotinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.33556065,0.02838567,-2.7252048526916424,-0.12200487555292727
87127,SIDM00097,KU-55933,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4065917,-0.09145269,-0.27965715519105644,0.011576574682992873
11818,SIDM00146,Bortezomib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.4108533,-0.029117303,-0.86993131715897,-0.026382093723627327
7800,SIDM00097,Ribociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0312943,-0.0684226,-1.9401578625332128,-0.041753248863805506
98562,SIDM00148,Bortezomib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.21777652,-0.018815124,0.4727613722315569,-0.022193011043266174
82150,SIDM00097,AZD6482,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0326078,-0.13183618,-1.0707810770586517,-0.07312971971677386
4811,SIDM00875,Bortezomib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06062069,-0.006285513,-0.6180828537994234,-0.0580542634100333
95453,SIDM00826,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.30470327,-0.028392347,-0.6673267043987149,-0.10857071301875888
84657,SIDM00673,Dabrafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.4147935,0.071138136,1.290975582468011,0.042184804039676164
52283,SIDM00148,Sorafenib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.79093313,-0.08010852,0.05187290435993021,-0.008330225162088284
32196,SIDM00928,SCH772984,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,0.6996321,0.08862773,-0.13919418930869537,-0.017676681648443895
96188,SIDM00282,BMS-754807,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.5814362,0.105539955,0.17150686123203235,0.010823053067055988
65480,SIDM00455,Sorafenib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6594967,-0.0917125,-0.3229913946495509,-0.013637216902995523
8466,SIDM00833,Oxaliplatin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.3874611,-0.09406859,-1.0884003674677063,-0.09599318141789427
71078,SIDM00928,Venetoclax,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,0.51763386,0.019116241,0.3981782921699226,0.0010907066146431492
80467,SIDM00832,Dabrafenib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,0.54937184,0.025406279,0.9657087413754316,0.026703119786578834
11625,SIDM00097,MK-1775,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.3687825,0.025880374,-0.24507008298800148,-0.045039304158482125
12056,SIDM00216,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.78096896,-0.012512827,0.3287589791780445,-0.017457581773385675
58907,SIDM00872,NU7441,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7622444,0.05980096,0.6788233271443223,0.05930661854216639
13750,SIDM00146,JQ1,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,0.7181172,0.0556303,0.8249079141849134,0.10808745083824998
54182,SIDM00359,Olaparib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32960224,0.005572295,1.893479542358588,0.07606370129624589
48076,SIDM00148,NU7441,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.17003524,-0.017762223,-0.0744992278358555,-0.04883003019383267
5706,SIDM00837,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.6885135,0.020768473,1.40313405616269,0.0359528154082379
3079,SIDM00633,Pictilisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.214654,0.13538703,2.5886123641761776,0.10256652828927669
53420,SIDM00877,Uprosertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.7978431,-0.20745774,0.1447629912368753,0.013391140413241078
51460,SIDM00872,RO-3306,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9422932,-0.044224963,0.08178645416346929,0.00907528566237268
61108,SIDM00146,Tozasertib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.60674495,0.048157416,1.2941676446674641,0.0508364225430811
32193,SIDM01042,Olaparib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3532583,-0.056819905,-1.8838898570048719,-0.06930856620507121
65805,SIDM00633,Axitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.299467,-0.13058044,-0.706567962158483,-0.06054307311574438
890,SIDM00872,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.23024955,0.004847388,0.4646243953131937,0.008569239506348462
72141,SIDM00146,PF-4708671,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.8472044,0.07611834,2.3875408034462193,0.1335689598713147
62068,SIDM00928,Tozasertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,6.548178,0.41380826,2.196902871345637,0.1170213534922471
8523,SIDM00359,SB505124,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.31977054,0.026122814,-0.5425644461489147,-0.05878405233093764
30250,SIDM00359,Navitoclax,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.12814322,-0.008147637,0.6455657538894539,0.025225286578941988
15892,SIDM00872,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.6850667,0.12562557,1.1524836962781442,0.05074512578458793
91321,SIDM00776,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.5901416,0.043636862,-0.42382803445202266,-0.036366379334950495
78444,SIDM00146,Tozasertib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.617977,0.50562125,5.159193390954728,0.2347447129323059
107968,SIDM00097,AZD8055,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0540106,-0.1408829,-1.615047752851224,-0.13810573388260217
85387,SIDM00928,PD173074,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.9552276,0.18292253,2.330178024732564,0.12256048942388308
19936,SIDM00148,Docetaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.177046,-0.29922804,-3.0111580317222124,-0.2484538790659113
96369,SIDM00928,Linsitinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.1180413,-0.1503702,-0.42806541088772,-0.04873322952087424
19540,SIDM00928,SCH772984,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.6406933,0.17476423,-0.14637253420922455,-0.010044594582617593
103239,SIDM01197,Linsitinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.75572634,-0.057322796,1.1102331036996667,0.08731496488774738
43275,SIDM00877,Axitinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.7960306,0.085323304,-0.7044976095217742,0.058040699963149256
101291,SIDM00146,Afatinib,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.207716,-0.1085615,-0.7610762053156994,-0.06996571869874992
83509,SIDM00928,Olaparib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.909103,-0.10545243,-2.1982431440211365,-0.0718082740313534
78038,SIDM00673,AZD6482,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.0149621,0.065905154,0.9068532052343967,0.03485550642324721
6206,SIDM00455,Olaparib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.4604261,-0.033714272,0.3055152962690166,0.036634949876458794
89930,SIDM00633,Alpelisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.47836763,-0.045766063,0.48569280412504123,0.03946989029930988
98846,SIDM00872,Alpelisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.14324939,0.0151504995,-0.6835864352761533,-0.04081492537939612
28266,SIDM00146,MK-1775,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.27874777,-0.021254698,-0.7270048414013225,-0.007202106820372385
49130,SIDM01197,MK-2206,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.064706,-0.1165534,-0.9925850731607795,-0.024356848581528295
29246,SIDM00673,Alpelisib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0947547,0.16011828,0.07340140235703473,-0.01825836139176809
65148,SIDM00097,Axitinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.154637,-0.15081362,-2.0572514196353433,-0.13563503803932284
7497,SIDM00776,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-3.2123535,-0.14725113,-2.1770796031877295,-0.0523012195846787
32388,SIDM00933,GSK269962A,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.89395714,-0.08445236,-0.9490280513422786,-0.05976835196108253
44951,SIDM00875,5-Fluorouracil,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5734019,0.050114956,-1.0801933401299606,-0.08598971062743505
61903,SIDM01197,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1422741,-0.08395331,-0.683931309249846,-0.029272824152555037
93944,SIDM00950,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.216476,0.19739646,2.992466176782325,0.1119424889961504
56663,SIDM00832,Trametinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,2.2307847,0.054290757,-0.07592846764671775,0.002269558670604998
34847,SIDM00933,PD173074,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.9252182,-0.09411106,-0.9265783573948118,0.009511067317783561
36432,SIDM00455,Gemcitabine,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9644333,-0.04341176,0.3168468503141192,0.008973509418859282
17233,SIDM00455,Dasatinib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0708066,0.059505276,1.169139413051218,0.07282779475751133
56377,SIDM00455,Lapatinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.0934157,0.13024625,3.5211958269702626,0.2141375036587138
36515,SIDM00455,Taselisib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2366016,0.13684295,1.9364624369162406,0.057558053395102574
56879,SIDM00097,Paclitaxel,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.55923975,0.04172542,-0.6014485456335327,-0.05883395350859049
66937,SIDM00148,Entinostat,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8723229,0.12207748,0.08822186184631864,0.03253658932454424
54952,SIDM00633,RO-3306,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.13476,0.27364972,2.670593682543621,0.1509885750375349
72818,SIDM00875,ZM447439,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9364464,-0.10749379,1.0255031301779405,0.03167395011647787
88887,SIDM00877,Luminespib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.5982673,-0.089084655,-0.9384806727142693,0.0007849014250919717
56373,SIDM01042,OSI-027,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.60008484,0.051847417,-1.3648745475343669,-0.061742369225370235
53441,SIDM00957,MK-1775,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-5.17062,-0.16552176,0.28807837375766226,0.02534627136355096
67800,SIDM00833,Linsitinib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,3.7181394,0.29750222,1.39455341961034,0.08233639138514644
105289,SIDM00673,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-5.3373914,-0.43157908,-3.953832771551365,-0.35279065564119594
106239,SIDM00776,MK-1775,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,0.33689296,0.021118352,-1.4370143439247307,-0.07984819264602315
104793,SIDM00097,Afatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.62008756,0.045677766,-0.5599390637385523,-0.036330894756661666
86541,SIDM00216,Navitoclax,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.5929966,0.20191461,1.9116466939563268,0.10798339872115857
49062,SIDM01042,NU7441,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9420501,0.04417765,0.5206748670230362,0.008771151772448436
103075,SIDM00872,Paclitaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.2400863,-0.23882338,-2.5150865742180915,-0.27353830756938363
96762,SIDM01042,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0726684,0.11201127,2.872525169060072,0.15419314169601078
27646,SIDM00776,Olaparib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.3589915,-0.0522655,0.855686571899236,0.04515902460965324
141,SIDM00673,AZD7762,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6872192,-0.053679664,-0.1813997072655997,-0.015890910477679408
16710,SIDM00957,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,5.263864,0.138159,0.05987930683700988,0.00924492305997982
17725,SIDM00928,Crizotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.9156679,-0.09213471,-0.19735953514500265,-0.008697695983874293
13722,SIDM00933,Nutlin-3a (-),Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.4015392,0.1448388,-1.3137805351027743,-0.06768406637971085
27,SIDM01197,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.336848,-0.11280793,-0.7600383940972808,-0.07945451429966803
80142,SIDM01042,SCH772984,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5845617,0.10704313,2.2561876895324215,0.12747871223127658
91256,SIDM01187,Axitinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2613735,0.118601784,-0.9222269174482789,-0.024915156527116466
40957,SIDM00837,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.6388725,-0.08021391,-2.2011981505401783,-0.09084460598063139
30412,SIDM00835,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.9904397,-0.113782816,-1.9409746380383328,-0.056096223832596256
42406,SIDM00832,LGK974,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-0.7821908,-0.04948928,-1.6616385474568056,-0.10086849116439887
52724,SIDM01197,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6125547,-0.051441073,0.16567613283452237,-0.009033168783318774
27690,SIDM00673,Temozolomide,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.23938791,-0.0050442233,0.26114456522792306,-0.004365326414181065
79650,SIDM00673,GSK269962A,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.7747433,-0.11990187,0.31062663767463167,0.0017394580347715283
59069,SIDM00776,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.0045338,0.11694918,2.856823882070945,0.13865289330769223
72740,SIDM00776,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.7654303,-0.043778133,0.6017173430814075,0.011167061375734956
55394,SIDM00826,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.4638065,-0.1130498,-2.4881568173130924,-0.13769301318443505
94863,SIDM00097,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9180799,0.09629863,-0.010558076611508026,0.03645631923821489
34553,SIDM00776,Olaparib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.1888726,-0.038383093,-0.5816973572594851,-0.008905909991954147
58601,SIDM00776,AZD4547,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2236884,-0.032138757,1.009828177185363,0.08676889207433484
35397,SIDM00146,Entinostat,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.63945657,-0.04461135,0.3346476860079965,0.09174765950586057
63733,SIDM00872,AZD6482,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0774903,0.17063424,1.5360526470307811,0.07615707010263868
59947,SIDM01187,Palbociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4883026,-0.06450539,-2.435619383626482,-0.09466075133993894
24179,SIDM01042,5-Fluorouracil,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8753671,0.035773456,2.0830121075708594,0.037635111140988095
50815,SIDM00146,Tozasertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.1455506,-0.07593888,-1.5728914783709553,-0.0585002823984731
93268,SIDM01042,NU7441,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.37564015,0.026847895,1.188194703087031,0.03790288594288186
60040,SIDM00097,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4908226,-0.07645832,-1.0048109836302594,-0.00744733221835913
73519,SIDM01042,Trametinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2174516,-0.10562709,0.4042214339489829,-0.009259648284410015
56061,SIDM00832,BMS-754807,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,2.3632822,0.046224315,-3.332296944565236,-0.014622138437422667
80407,SIDM00633,Lapatinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.46553078,-0.01454173,-1.0758014438745251,-0.02284501818553084
101423,SIDM00832,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.44582754,0.022544118,-0.26918931887512454,0.029005963164318353
63877,SIDM00097,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8915653,-0.1201944,-1.8396940215484292,-0.07905735636443588
84690,SIDM00950,Erlotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.343639,0.22805929,1.4994737779816976,0.11238775964337909
45742,SIDM00673,5-Fluorouracil,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.622795,0.016157452,1.1024086635118988,0.08290701369136504
50166,SIDM00359,Dabrafenib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9265393,0.11707179,0.11182006178728159,0.03855572017092078
8746,SIDM00933,Luminespib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.35726345,-0.014205324,-0.5159442320800869,0.02287280232129503
100844,SIDM00833,Vinorelbine,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.8041394,-0.14782104,-0.13545343959370498,-0.012823347870616751
88304,SIDM00872,Navitoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4564791,0.08962658,1.0706019119521581,0.11115667004708704
86426,SIDM01187,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.929257,0.11320654,1.2194531433058247,0.07821399544293889
37666,SIDM00282,AZD7762,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.0859065,0.034832515,1.161223501451573,0.05734767444761181
86237,SIDM00928,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.0178192,0.032576036,0.3817784395759205,0.029653608386235
43415,SIDM01187,Vorinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6663408,0.068787694,-0.37063431092495513,-0.02269633939062375
79573,SIDM00875,Doramapimod,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.469201,0.085495435,1.4727929812993679,0.025184964393520522
89292,SIDM01197,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.52963597,-0.0369614,-0.6607768613657693,-0.04113932782191641
105249,SIDM00148,Camptothecin,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.123876,0.09990149,-1.7554393359540152,-0.06732894240156295
106113,SIDM00933,KU-55933,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.6319046,-0.018296376,0.5862353648058366,0.06821549762485939
37450,SIDM01042,Cisplatin,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4144016,-0.014526955,2.24500606169044,0.05988536622450635
4784,SIDM00950,Erlotinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9066589,0.0934113,-0.4963763321601567,-0.05231148776739251
43011,SIDM00282,MK-1775,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-0.72946995,-0.049593583,1.1806248444555278,0.06188645190260636
88243,SIDM00950,Olaparib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.417856,0.06856151,0.005565929345424014,0.07138360083110296
78999,SIDM00216,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.2504307,0.011434792,-1.207586431215208,-0.09719680690839681
37447,SIDM00633,Crizotinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4055214,0.12984805,-0.3914209538330089,0.009666542709161776
10481,SIDM00146,NU7441,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.56908125,-0.053273875,0.3514270585959353,0.025757443366936698
42454,SIDM00872,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39697856,-0.007844258,0.8822342322270035,0.039184171156881754
70484,SIDM01197,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7391156,-0.034383584,0.9527425259590321,0.03123501716167869
69695,SIDM00872,Crizotinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.77316,0.07912997,1.2040940350271903,0.01344046582708136
52338,SIDM00146,Entinostat,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.66195434,0.053812437,0.12817622801942344,0.006119480955785963
75288,SIDM01042,Olaparib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2887063,-0.06433969,-2.367562799889794,-0.11413108329258058
20420,SIDM00282,Oxaliplatin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-4.4401555,-0.16308954,-1.7146684518367128,-0.13035436956459454
98105,SIDM01187,Olaparib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.61172384,-0.015460186,-0.4694077044906918,0.0068625015865886015
33026,SIDM00673,Docetaxel,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2664508,-0.10783118,-0.8530437147976335,-0.0649738323994312
26528,SIDM00950,Oxaliplatin,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.119626,-0.06954486,-1.1023677377615155,-0.06111760568487477
100769,SIDM00957,SCH772984,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.8187609,0.110516384,0.4697855969486196,0.0413985764598517
90566,SIDM00148,AZD7762,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2296128,-0.14794686,-0.525985693102224,-0.08344250376137194
21915,SIDM00146,PD173074,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-2.989283,-0.15815948,-1.714306278567067,-0.09552676149554774
22043,SIDM00097,Lapatinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9437369,-0.058757454,0.30230750814192836,-0.0355451287287359
87835,SIDM00146,Venetoclax,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.74392724,0.013642306,1.2585087917859665,0.04927946545718731
90193,SIDM00282,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.3984358,0.08556788,0.9110849216057856,0.06935029396744068
38288,SIDM00837,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.74465144,0.06350386,-0.6807068061498398,-0.07694061550136531
29305,SIDM00928,MK-2206,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-2.23388,-0.06858918,1.5619567683635014,0.017183747860464883
46242,SIDM00877,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.48517877,0.05739515,0.8876817861532003,0.10016239666584115
75669,SIDM00359,Taselisib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5045353,-0.04500178,-0.7419969600870492,-0.038717636080015175
100823,SIDM00928,Venetoclax,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.6632484,-0.018270547,-0.2514625628580467,0.02411255348145993
79806,SIDM01042,Dabrafenib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1660858,-0.063763455,0.9362205053918881,-0.00365344176071565
63834,SIDM00835,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.48713967,-0.020860905,-0.26976012696937784,0.004169455616214607
41452,SIDM01042,Temozolomide,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2270482,0.12312972,0.4701349173611829,0.020553980235627108
17680,SIDM00673,AZD8055,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.0147628,0.049703527,0.3990276598642464,0.048532084397890994
45427,SIDM00928,JQ1,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.9456007,0.16264921,1.4664933065428727,0.0511765762351866
83182,SIDM01187,Nutlin-3a (-),MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0944642,-0.07934779,-1.5661568108365558,-0.05673389286794568
51511,SIDM00837,SCH772984,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.5243726,-0.028747035,-0.4836108320023977,-0.018221794615698512
71167,SIDM00837,AZD8055,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.7984514,-0.0957076,-0.9143089095450799,-0.014756527466425395
32609,SIDM00872,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0638047,-0.10459624,0.1380116942694631,-0.03208453178350677
20212,SIDM00950,Taselisib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9077427,-0.044286836,-1.8273470640498133,-0.10978802134177512
93824,SIDM00957,AZD7762,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,3.5298235,0.07848312,1.2697669126119364,0.03871396896014348
81390,SIDM01042,Axitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1917822,-0.17176796,-2.345789112106791,-0.06626263874931723
26831,SIDM00148,Dabrafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2838318,-0.054845665,0.17896469007174046,0.018494571035890445
70501,SIDM00097,Luminespib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.749872,-0.099414065,-0.4377794984565235,-0.034351764383131256
19309,SIDM00633,Olaparib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0533109,-0.043244373,-1.099733083756363,0.0034326382159347245
3494,SIDM00097,AZD7762,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5681262,-0.12478825,-2.3062104335463736,-0.00640037077456925
100,SIDM01187,Bortezomib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.98753726,-0.05449728,-1.0830808900203444,-0.038140076061181805
32398,SIDM00877,Uprosertib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.26636922,0.02705,-0.41366480816579804,-0.027991116696617798
101685,SIDM00673,Gemcitabine,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,1.0119246,0.089589275,-1.2349462409725958,-0.0018532419545750696
54701,SIDM00148,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.797537,-0.15984887,-2.5186170174818536,-0.16605273137565646
7369,SIDM00148,Cisplatin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0161091,-0.04519286,-0.6715696860723095,0.011093638518773472
73303,SIDM00146,Alisertib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.51392466,-0.039582763,-1.4181327651825584,-0.050692593510841794
37987,SIDM00146,RO-3306,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8959674,0.17741795,0.568571295087696,-0.028222845556498805
51456,SIDM00146,Pictilisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.9099941,-0.12874888,0.4646120948933443,0.11207883301584655
75720,SIDM00877,Trametinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.978791,0.074084476,-0.32952733824477476,0.04464145171089095
56732,SIDM00875,Dabrafenib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1245077,0.04664416,-0.749343703436545,0.0024590310879809324
75782,SIDM00633,Afatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2906103,-0.037464503,-3.2880113142017513,-0.10332731241188185
95402,SIDM00875,MK-1775,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4927854,0.021421999,-0.41484925147121143,-0.03162179414835486
87352,SIDM00148,Navitoclax,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3025425,-0.028202547,2.094352375374206,0.07321556970019587
89502,SIDM00833,AZD8055,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,1.6738887,0.0642019,2.102674399542389,0.05161825452958218
24542,SIDM00282,Trametinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.0749043,0.07872949,0.5321034341191173,0.05389317330926843
30763,SIDM00872,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1679142,0.18660863,0.6728394251326624,0.03170097868237912
59561,SIDM00950,Gemcitabine,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6122434,0.0870097,-0.8754026558713011,-0.08974704860713303
46706,SIDM00359,AZD7762,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.71859384,0.054764286,1.5067284233100817,0.05739194486113465
40419,SIDM00928,AZD7762,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.88557655,-0.09309292,-0.2508814736702802,-0.020419521749570037
16854,SIDM00673,Doramapimod,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5797619,0.02573469,3.5306398701638093,0.08500906518148725
88437,SIDM00872,AZD6482,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.59765434,0.0633757,-0.026262564984447918,-0.016120902631357577
23222,SIDM00872,Alpelisib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5580859,-0.05998719,-0.5243018849409599,-0.051127957866335116
68331,SIDM00877,PD173074,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,2.081599,0.19896203,0.4000794859507193,0.026808498859711916
72712,SIDM00097,Ribociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5046587,-0.07130186,-2.224487616529177,-0.02701690433899782
103160,SIDM00933,Luminespib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.48571566,0.017291717,-0.9791649392264179,-0.04822767824621491
6226,SIDM00877,Dabrafenib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.855556,0.05022466,2.133430927235411,0.024828111013979352
27241,SIDM01042,Axitinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.9029262,-0.45268425,-1.8185759375432582,-0.11738386025060624
81259,SIDM00872,PF-4708671,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.62790823,0.06105478,0.3441458981895958,-0.019246707407962468
67230,SIDM01042,Entinostat,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.59135664,0.05248804,1.291882789840348,0.10659014342236643
100047,SIDM00633,Cisplatin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9573404,-0.027870117,-0.2216230410897605,0.02450883820076731
31950,SIDM01042,Uprosertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.77508867,0.021488938,2.083457362999834,0.03176000941483956
20897,SIDM00148,JQ1,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7716308,-0.06834895,1.2067274048419125,-0.0029836767673386815
32403,SIDM00872,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.8456023,-0.10947942,-0.6052668920372359,-0.048624421111427896
74029,SIDM01042,Olaparib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.50448924,0.03515794,-1.2334639619212446,-0.038159229704524976
101835,SIDM00673,AZD6482,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0862986,-0.08943411,-1.2575013038280078,-0.07396298351872783
81216,SIDM00042,Lapatinib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.8675294,0.04684012,2.537083304440445,0.101492831749886
46066,SIDM00933,5-Fluorouracil,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.0444647,-0.11673787,-1.1480910399422954,-0.055382600616557205
48562,SIDM00216,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,2.96925,0.23733923,0.8531949776309402,0.07766491409216034
72045,SIDM00216,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,1.1134357,0.084503286,-1.824048785128713,-0.12120598441430144
63193,SIDM00877,MK-1775,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.56173915,0.025767757,0.2802561625826621,0.021236603374169466
81172,SIDM00957,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,4.7435155,0.12048344,0.7225102858272492,0.058723192102220906
833,SIDM00146,Taselisib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,1.5092506,0.12634565,-0.4158232417827426,0.01174532513048298
89543,SIDM00633,Olaparib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2208421,-0.05340277,-0.9550590028623358,-0.04675938886464462
44502,SIDM00875,Ribociclib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6878674,0.027665641,0.08173219140051599,0.023780665850867883
21901,SIDM00875,Olaparib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1007822,0.109993264,-0.7404439532470126,-0.004500175209792168
64348,SIDM00148,Venetoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6857681,0.04880741,0.37422183867831366,0.011991758981281521
20290,SIDM00835,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,0.7067453,0.055876914,-1.4749184014929817,-0.11509141865846345
107409,SIDM01042,JQ1,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8234451,-0.021975711,0.4307893681292278,-0.008744489782887182
32785,SIDM00148,AZD8055,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9621267,0.080725096,0.3216878343216429,-0.037271668265172926
96936,SIDM00833,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,2.4441032,0.13838251,0.9859567972682285,0.027905387893761274
5679,SIDM00097,ZM447439,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1651005,0.048455022,1.3829605655575332,0.06170617602822201
34200,SIDM00928,Tozasertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.8065023,0.027764382,1.2215380728459277,0.039619286145097035
65525,SIDM00633,Linsitinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3713667,0.052695237,1.523886801205913,0.029547173115873838
62563,SIDM00835,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-3.862788,-0.17172568,-1.2752088054034043,-0.031337854059898834
11310,SIDM00928,OSI-027,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,1.7059975,0.16389759,1.1105481815943163,0.07185767859334231
37786,SIDM00872,Tozasertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.055614,0.049381945,0.6680128723234104,0.049650136717973914
91474,SIDM00282,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.7768381,0.08175117,-0.7230139342638416,-0.06776171118044506
23454,SIDM00097,MK-1775,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3628334,-0.09483109,-0.47943481087036216,-0.03781516707595588
43782,SIDM00776,BMS-754807,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.5637491,-0.04805704,-1.25291565608903,-0.09422950568699653
23521,SIDM00833,LGK974,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,2.000447,0.09165599,0.09633659778996562,0.039046739244816366
26280,SIDM00928,Sorafenib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.8055814,-0.072251864,-0.19027364353431706,0.005574031253758832
19545,SIDM00148,Trametinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4242464,-0.043934543,-0.5240012264101899,-0.03554587441300536
76485,SIDM00933,Docetaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-3.9497652,-0.35321406,-3.5550083477199292,-0.22974126855838106
83303,SIDM00097,Gemcitabine,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8393066,0.03918191,-0.9246268681179287,-0.001461787726567678
16661,SIDM00877,Temozolomide,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,6.5907574,0.39940056,-0.016840768467786746,0.03297865624359006
67621,SIDM00877,MK-1775,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.47482532,-0.03145253,0.4092958718522772,0.01713767042800057
88916,SIDM00928,BI-2536,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.7657291,0.06049742,-1.4945934818403026,-0.06504191384799171
95536,SIDM00832,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-3.6877322,-0.14711392,-1.0552474858712806,-0.056430123559209164
9419,SIDM00455,LGK974,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6730258,-0.03792394,-1.136187015093807,0.02280257069383306
47197,SIDM00776,Oxaliplatin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.61507595,-0.030428609,-0.9619473360793412,-0.030342409620897418
81577,SIDM00148,Dabrafenib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6315929,-0.081906304,0.8442239993801248,0.025781555003763112
29075,SIDM00957,Camptothecin,Afatinib,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,3.887988,0.058784932,3.441902106925769,0.09328375570062883
56338,SIDM00872,JQ1,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0899966,0.03716312,2.8150949718198657,0.11390797490851787
27107,SIDM00832,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.75955176,0.045426782,-0.10637811042147205,0.005662252297143287
24925,SIDM00673,KU-55933,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.646207,-0.11964589,-0.42454948094195655,-0.017912455358010764
102954,SIDM00633,Ribociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.44989556,-0.012220692,0.39820142736322345,-0.0005688659621681537
38351,SIDM00950,OSI-027,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9493558,0.066063926,-0.20809401840598138,0.001380583972753224
63187,SIDM01042,JQ1,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2351637,-0.04262558,-2.5900203497497283,-0.11819787898884623
36441,SIDM00875,Dabrafenib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6953601,0.10779004,-0.06382933037145468,-0.025849138269828
10808,SIDM00837,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,0.2867718,0.005429013,2.8250268380746206,0.06582165406550154
16733,SIDM00216,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-3.1119757,-0.014006511,-4.393134515698275,-0.16090914681736357
88571,SIDM00835,Olaparib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-0.35969195,-0.008872377,0.6557299340161872,0.024676275535091673
56889,SIDM01187,Docetaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.214044,-0.23466341,-3.0207726353897626,-0.21666628000668992
68374,SIDM00359,Crizotinib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.820849,0.054247677,-1.2539169538698718,-0.061553359492168204
106780,SIDM01187,Axitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.1398792,0.13155282,-0.9149330064074304,0.020242802660499798
64985,SIDM00282,5-Fluorouracil,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3665433,-0.07682551,-0.6507470258572003,-0.031951312420220306
64251,SIDM00776,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.2094433,-0.09375095,-0.606262647201254,-0.0383614656812718
94535,SIDM00837,Trametinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.90805274,-0.037173226,0.16480917742673692,-0.0399645950730564
107264,SIDM00673,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3942046,0.085441016,1.3649455168661146,0.09660862779200596
19581,SIDM00148,Luminespib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.71289116,0.058192823,-0.2530077313270672,-0.041870378407122565
48457,SIDM00933,JQ1,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.5684486,0.049807727,0.9063463695351116,0.10069726138612704
74472,SIDM00633,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2705104,0.036583047,0.34504680535745086,0.025141960779265175
68766,SIDM00216,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.631668,-0.11883329,-0.8020765029336813,-0.044456960758278395
107108,SIDM00633,Lapatinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1287221,-0.03724458,-1.4064375914231018,-0.04270002313369522
42880,SIDM01187,Crizotinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.237939,-0.060533345,0.9254408378932858,0.05536519173504045
81362,SIDM00097,Camptothecin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6251264,-0.098357745,-1.792763099448522,-0.07390341159368843
78150,SIDM00042,Trametinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.35376015,-0.033467334,1.2131836268622467,0.0468911633847242
26472,SIDM00673,Docetaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.5193321,-0.050064374,-0.5588096696993395,-0.047518046090277245
69477,SIDM00875,Dabrafenib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.139119,0.22405173,0.24996047879632005,0.010470755221214153
17690,SIDM01187,PD173074,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4978715,0.119699195,-1.0777888243203047,-0.06991894692529602
93055,SIDM00872,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8896048,0.090913504,0.2784809790132582,0.02035001606823475
21063,SIDM00776,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.52853024,-0.010051425,-0.1861027343401045,0.035149248996205265
47781,SIDM00875,Axitinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6325496,-0.027927153,-0.7806761566427699,-0.08285803721011233
99576,SIDM00216,Nutlin-3a (-),AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0584538,-0.06244339,-1.1960466275410466,-0.0815768708116824
97542,SIDM00933,Temozolomide,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.5832905,-0.023305638,0.21244054356377712,0.032040900018193604
69816,SIDM00832,Navitoclax,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,1.3416572,0.03007583,2.045709639388922,0.023163379334945295
3046,SIDM00872,AZD6482,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2025564,-0.10850823,0.3533875977795529,-0.014168779404614506
74421,SIDM00633,AZD8055,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.4040837,-0.20170105,-1.6982537902654404,-0.10001655070619116
94355,SIDM00097,Venetoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9283616,-0.025619088,-1.16468679384865,-0.008246316274055596
85262,SIDM00776,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.1279068,-0.087289475,0.4073427231889639,0.01138250866657609
3129,SIDM01197,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,2.2603488,0.1597124,1.2704979809893557,0.11718542373540346
74347,SIDM00837,MK-2206,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.63870955,0.036194973,-0.7018850705598735,0.006993800631077545
74397,SIDM00282,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.6229354,0.12309358,0.8343857470440491,-0.0040230374590129675
70816,SIDM00826,SCH772984,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.6957279,-0.017050166,-1.7513572309740575,-0.060179535529903405
55569,SIDM00776,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.1970702,-0.08442277,-1.5524335401015128,-0.06504729092615993
50374,SIDM00216,Afatinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.30189753,-0.025998456,-0.1552445932938241,-0.03517057164729055
4963,SIDM00933,Ribociclib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.4926472,0.08800079,1.5357898686252096,0.013745739250968031
463,SIDM00957,AZD4547,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.7195466,-0.06072606,0.9503088202207535,0.06135444033667407
82144,SIDM00633,Entinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7225823,0.17474234,2.409842342121743,0.08933185916885375
71319,SIDM00776,Oxaliplatin,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.6166131,-0.12832643,0.5822244427753455,0.07417867526806989
93642,SIDM00928,AZD7762,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,3.5646298,0.35962102,0.728666625242538,0.024628300561571326
35407,SIDM00933,Alpelisib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.9780216,0.28891942,-0.5551386348148852,-0.032344966225324186
22579,SIDM00455,Lapatinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.20965777,0.0078031793,2.5339519398538206,0.1500233506520673
76792,SIDM01197,SB505124,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,2.9388752,0.15929666,0.3565158124390896,0.031852721942322186
48267,SIDM01042,OSI-027,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9106935,0.10972147,-2.434270252048064,-0.1059030666581304
80957,SIDM00146,Linsitinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,5.7059946,0.28500086,4.835112954051039,0.18934112462656938
16027,SIDM00097,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.076536,-0.14300436,-2.828507337934762,-0.1287691286399313
28181,SIDM00837,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,4.0234323,0.09974417,-1.1486482983771917,-0.005983837519407186
15767,SIDM00950,Irinotecan,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8874024,-0.0908007,-1.7861506019632496,-0.03291389952178652
67374,SIDM00282,MK-2206,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-1.675538,-0.059228476,2.375937177565507,0.12822912662297598
49987,SIDM00146,Cisplatin,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.7383569,0.029999562,0.3615031896152862,0.019635968926014734
7564,SIDM00933,Crizotinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.3648261,-0.050830636,-0.6711141649903037,-0.016541208515518598
26836,SIDM00673,PF-4708671,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.7389565,-0.09799984,0.36554698102076727,0.020411581241133344
90327,SIDM00146,Temozolomide,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.741172,0.017440217,1.8751605027781604,0.06752612263873493
49736,SIDM00872,Trametinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3633384,-0.108897164,2.4392105055633615,0.15378483056769102
76124,SIDM00673,Palbociclib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.51576334,-0.022138458,-1.396043093199708,-0.00018628938107586094
54333,SIDM00148,PF-4708671,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.478255,0.2232841,1.5252321563790738,0.08030311734561399
97295,SIDM00957,Olaparib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.869284,-0.021037994,2.120304414260318,0.018122008730559396
28709,SIDM00928,RO-3306,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.5738375,0.13458674,0.22815874684079224,0.04322614400856283
100030,SIDM00872,OSI-027,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.35956764,0.037551094,-0.5411669071233013,-0.02576233036621771
96644,SIDM00673,Palbociclib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9353969,0.05481706,-0.9753157076462634,0.007308920211023604
58625,SIDM00933,Bortezomib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.4947943,0.04670065,-0.40598612502248094,-0.006812575485108553
23213,SIDM00875,AZD8055,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1607125,-0.110594176,-0.8467499100715649,-0.05628851954687576
86026,SIDM00216,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.4103786,0.10753353,-1.2632617980333505,-0.02558503132295792
16067,SIDM00148,PF-4708671,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5726311,0.15248607,0.4896578740755206,0.05414304285635791
33851,SIDM00832,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,2.357618,0.114288725,-2.3379072211632557,-0.12428697886966236
80595,SIDM00835,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,1.1869227,0.0730581,0.10486649058538787,-0.014999830219357168
51253,SIDM00877,Alisertib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.62812346,-0.018123917,-0.9909282757156013,-0.10932143246292837
1664,SIDM00875,Uprosertib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.47908,-0.10463775,-0.2643208471806236,-0.007291137004563589
66667,SIDM00928,Taselisib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-1.6168368,-0.14401948,-0.6466946174585246,-0.0994525280716976
96460,SIDM00928,Palbociclib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.6766837,-0.058222614,0.5164225366553067,0.011123775479964597
21439,SIDM00933,SCH772984,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.0962428,-0.07431588,0.013693225908452945,0.05583203538474491
7745,SIDM00928,SCH772984,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.4296133,-0.05281057,-0.44875689728267737,-0.0704051296784066
61171,SIDM00097,Entinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1968234,0.13921528,-1.2397946229665686,-0.009424048049650361
54484,SIDM00832,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.2459416,-0.06289236,-1.240546134758808,-0.03204496432281724
22253,SIDM00833,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-3.5904953,-0.24547325,-1.0987825929882673,-0.12742334939484604
65622,SIDM00877,ZM447439,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.0562047,-0.033730563,-0.2681878334232318,-0.03717694181793563
54231,SIDM00455,MK-1775,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7524574,-0.04280019,-0.8503017664294462,-0.023030757433202872
104725,SIDM00097,AZD7762,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2312317,-0.048864096,-0.16520390318691766,0.020295925383171202
64301,SIDM00146,Sorafenib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.67808056,0.03124924,-1.4474916207695865,-0.07265393457633257
81719,SIDM00928,Crizotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.214212,-0.12314748,-0.30158691262521925,-0.06599341902602324
36947,SIDM00928,NU7441,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.41313466,-0.050122134,-0.46047264344728367,-0.044539624327936296
17201,SIDM01042,Sorafenib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9145099,0.090864465,-1.1078938559693114,-0.03716863745322613
56320,SIDM00146,Pictilisib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.0780112,0.08625302,-0.056253995322185876,0.06361784093678267
105576,SIDM00933,Venetoclax,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.3955051,-0.039204676,0.3935363807778429,0.014712637327868597
84468,SIDM00833,Trametinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,0.1767949,0.007221151,-1.783021766653726,-0.08729988123385407
56549,SIDM00933,Linsitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.97732574,-0.0683598,0.12511548147184942,0.03571270111030857
30569,SIDM00776,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.8572272,-0.019010603,-0.6511097922472552,0.017553827609594015
57237,SIDM00957,SB505124,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.4694316,-0.060361363,1.5530217363148924,0.06725965315719339
90448,SIDM00833,Dabrafenib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.8454336,0.0225073,0.887927293010149,0.00855779481136362
93277,SIDM00282,AZD4547,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.5309253,0.059043463,2.5197079087624616,0.05481274758242883
49772,SIDM00776,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.5046685,-0.06777918,-2.1521235534154703,-0.057474166611613926
47418,SIDM00826,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-0.9119104,-0.016495164,-2.3539802673207957,-0.08599773136278824
101238,SIDM00633,Paclitaxel,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2491552,0.08783106,-1.331024935702219,-0.047790560844454856
6059,SIDM00875,Lapatinib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.75352955,-0.072044834,0.11933987406328647,0.01900868499295317
81990,SIDM00872,Venetoclax,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6364036,-0.08081185,-1.750698129691718,-0.04117590737541806
9922,SIDM00875,Nutlin-3a (-),Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9161038,0.023389675,0.9209885457138541,0.01425033114408981
33656,SIDM01042,PF-4708671,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.518166,0.16875303,-0.22678431027354137,-0.03481576127973878
49005,SIDM00928,Venetoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.6402287,0.07560722,0.15921115076406214,0.02263549927626655
90970,SIDM00950,Linsitinib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3009627,0.1323233,0.9647254359265628,0.07245398764172911
91069,SIDM00872,Crizotinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.84487396,-0.05909039,0.23760691177843205,-0.021712221674889284
37559,SIDM00933,PD173074,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.16581294,0.017885586,1.202758259624295,0.13098498987711243
31815,SIDM00933,Bortezomib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6464699,0.059811898,-0.4543796073925121,-0.01479835282524216
29680,SIDM00826,Dabrafenib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-1.3680559,-0.105346635,-1.8800348940148757,-0.1268361866834826
103240,SIDM00957,MK-2206,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,3.8316717,0.086554445,1.2807894863275227,0.1351981244704671
73221,SIDM00673,Vorinostat,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5464973,-0.051828828,-0.7081724863451289,-0.07102073680835722
65328,SIDM00633,AZD6482,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9745057,0.22586684,0.8571591888377261,0.048883051224595526
50616,SIDM00359,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.65472096,0.058585368,0.27227655761554703,0.02632739465950872
69025,SIDM00950,Lapatinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0696197,-0.08793329,-1.3427714366207046,-0.08880412454199542
54477,SIDM00359,BMS-754807,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0957279,-0.07097177,0.6808200574601696,0.08132437456487396
71693,SIDM00928,Palbociclib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.6871672,-0.10008936,-1.1232992915753746,-0.044350014831362174
61456,SIDM00633,Pictilisib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.211273,-0.11716949,-3.8879694201728,-0.19166337073830705
24906,SIDM00633,Uprosertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2946279,0.06480007,-1.4145545898081648,-0.05756987232428033
36309,SIDM00776,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.8791158,0.13562062,1.2890037661916502,0.09434487170770597
71811,SIDM00832,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.5888152,-0.031581827,-1.5540274940413428,-0.07941534395594568
31300,SIDM00832,Olaparib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,3.5729363,0.18982945,0.9367089213597746,0.04499266321194037
43577,SIDM01042,Tozasertib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.9657192,0.15424384,0.6038295068074263,-0.030975561036415043
24430,SIDM00097,Alisertib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9919554,-0.09720689,-1.3372288476562677,-0.028128365941654205
55784,SIDM00835,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.5160766,-0.06646626,-0.13056281881343632,-0.025925873081274062
18493,SIDM01187,Bortezomib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.4566977,-0.040785108,-0.905469301694162,-0.034041895042302886
24246,SIDM00933,Luminespib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.42425862,-0.013170951,-1.6662978589593451,-0.09982439134377964
31919,SIDM00928,Gemcitabine,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,3.4395144,0.09776471,0.11990773392739905,-0.057519449250421475
69340,SIDM00097,AZD6482,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.54122484,-0.03799658,-0.010144166757415246,-0.03016138307569217
40068,SIDM00673,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.1680744,0.062381573,0.856505216722948,0.0622899054901546
93317,SIDM00097,GSK269962A,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0155525,0.050212335,-0.4347923963773653,-0.009703297928991635
72657,SIDM00877,PD173074,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.7046595,-0.083967954,-0.6343041277157623,0.01077078395424094
73729,SIDM00673,AZD6482,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1226107,0.06151289,-0.9395725482792185,-0.025576761564764357
9295,SIDM00872,Axitinib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.321787,-0.053132027,0.2648910942208482,0.05263786092930636
64517,SIDM00633,BI-2536,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8941572,0.09377271,-1.5473506917754185,-0.07648829243972129
78271,SIDM01042,Alisertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.011557,0.12630843,0.8118746651337554,0.027527784556114605
71109,SIDM00833,SB505124,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.22472146,-0.019127516,-0.6509472424425377,-0.0361100142649354
88282,SIDM00359,Olaparib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6408895,0.014400874,1.7112139973832645,0.07850549740382531
107474,SIDM00148,MK-2206,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.28806013,-0.029256362,-0.3177447236727663,-0.011672463728809744
65272,SIDM00146,Taselisib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.2723646,0.15779328,2.717772576561095,0.18792952234683963
103771,SIDM00673,NU7441,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.8366136,-0.061339255,-0.004316488749084664,-0.004857737910127961
106773,SIDM00633,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3005054,-0.13579665,-1.4102796894656584,-0.07056959833172845
46674,SIDM00826,Afatinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-3.5555663,-0.16990483,-1.369784165729817,-0.012375870017224537
59452,SIDM00928,Paclitaxel,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.3351998,0.028366689,0.16498591661144762,0.03338271169922273
59055,SIDM00776,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.2769613,-0.06549333,0.030294404106040798,0.023704046422007293
83282,SIDM00359,MK-2206,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3523272,0.07889811,0.2988524207924867,0.0882684217571765
73166,SIDM01042,5-Fluorouracil,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2688679,0.010642468,1.1888884481886135,0.03667269819588779
59089,SIDM00097,Nilotinib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.38453633,-0.02605889,-1.316785507588536,-0.08138619877208063
205,SIDM00875,Uprosertib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3355027,0.14200293,1.0424245772338399,0.11761659419270194
40018,SIDM00872,Linsitinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.1967468,0.17160226,1.6735977209923214,0.09661250823346984
55696,SIDM00097,Doramapimod,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1275169,0.03256007,1.1689203234318928,0.050183434516107996
60209,SIDM00875,Luminespib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.29161283,-0.032454565,-0.7173295092429631,-0.07638955333595875
36685,SIDM00875,Dabrafenib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2293865,0.008469276,1.1705998629493155,0.05599958765874024
83018,SIDM00875,RO-3306,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37243447,0.03718422,-0.35284629298649695,-0.029202054656109293
88081,SIDM00928,KU-55933,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.9251139,-0.05011915,-0.1930995133477313,-0.004218370685256673
79862,SIDM00835,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-1.3208532,-0.035016503,-0.7110372994868485,0.00408855940086216
4552,SIDM00455,Dactolisib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2367126,-0.077735886,-1.6601997710513676,-0.11957377135713955
97207,SIDM00928,Cisplatin,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.6993692,0.06984903,0.7666968635423128,0.0744700133898182
99421,SIDM00832,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.2965363,0.12112653,-0.6014678001080267,0.01189991493543276
83136,SIDM00933,Bortezomib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.41200536,0.038313832,0.8582266570689192,0.04696424796360812
49713,SIDM00928,Alpelisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.0399518,-0.10989316,-0.010962926600309777,0.009866210608264722
43787,SIDM00933,Alisertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.1401854,-0.11020941,-1.8245569111296502,-0.11673430490618278
86699,SIDM00148,Temozolomide,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.70800996,0.0182487,0.3381620000231617,0.0656682167564246
50772,SIDM00097,Uprosertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42400444,-0.026712317,1.4556182594777474,0.05139271391474927
63367,SIDM00776,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.69729835,-0.03039857,-2.015627552354432,-0.012053354418437651
16239,SIDM00826,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-3.5915663,-0.16850832,-2.4262977989144847,-0.08318476174113203
98689,SIDM01197,Vinorelbine,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3949165,-0.08878865,0.4439818735056621,0.00022370370860005841
42322,SIDM01197,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.2355565,0.030871116,0.41166485673836606,0.010081071969256606
21925,SIDM00633,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3951672,-0.04928044,1.9069202782500503,0.09383576018701818
6564,SIDM00455,Gemcitabine,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.5367618,0.22830087,4.121624797368984,0.2803112893362274
63580,SIDM00957,Linsitinib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-0.6333415,-0.01289626,1.3688889223458178,0.10308701674223239
21261,SIDM00933,GSK269962A,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.4783599,0.13877106,0.5810281962472866,0.020348504597288125
89296,SIDM00950,Ruxolitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.845369,0.25716895,1.3110858071389417,0.02566750261436745
95541,SIDM00832,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.70974636,-0.022656998,-1.4798527998170594,-0.06327911237777266
822,SIDM00933,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.0463967,-0.07213623,-2.2102497348769847,-0.017740237956404108
53749,SIDM00776,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.5886846,0.07183741,0.9991200509259759,0.00287638355318987
99934,SIDM00673,Paclitaxel,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-3.505924,-0.16445637,-0.42218514739987345,0.03237072558933242
83124,SIDM01197,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.93806714,-0.07227298,-0.7861180675835683,-0.07838251871870637
22735,SIDM00633,Linsitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.0025823,0.09709869,0.6333878359702371,0.01605120513407672
5294,SIDM00673,Temozolomide,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.25524846,-0.0057083555,-0.06605927158486236,0.0009836169969501026
50372,SIDM01042,OSI-027,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.532531,-0.055680234,-0.6794641124062321,-0.03469135743239895
84023,SIDM00832,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,0.41871715,0.014536457,-0.76456151145208,0.01609158150696966
79495,SIDM00633,Docetaxel,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5697452,-0.1037451,-1.8118472903840874,-0.08504464415590485
67674,SIDM00875,NU7441,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7830768,-0.059763767,0.8694201676945287,0.04914226308014398
96605,SIDM00148,JQ1,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3660796,-0.1253774,-2.6929343476565344,-0.19416154251266074
12008,SIDM00673,5-Fluorouracil,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.019779172,0.0006607299,0.40322018583180846,0.023864045968206217
15121,SIDM00148,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.392008,-0.11802143,-2.348059161533719,-0.12433000585269953
85842,SIDM00950,5-Fluorouracil,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.48587433,0.042130746,-1.1034875656165475,-0.0526555527579601
7989,SIDM01197,AZD4547,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7817123,-0.11209332,-0.7324262613932605,-0.02728664833616503
74445,SIDM00359,Taselisib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.389936,-0.15246516,-1.1484815692298571,-0.06461840343230772
77632,SIDM00097,PF-4708671,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.52394724,0.023273755,-0.6263848935784306,-0.0033601748642158326
6204,SIDM00837,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-1.740199,-0.049644887,0.4345873322060089,-0.010476442233440816
9835,SIDM00148,GSK269962A,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.2685786,0.026516305,-0.7384580733391091,-0.03730444097426564
58690,SIDM00832,Afatinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,3.1610773,0.12595987,1.5723976499535797,0.013563011689423579
84546,SIDM00776,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-1.52118,-0.06814942,1.4166079093131638,0.1071738175053263
58159,SIDM00359,Crizotinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.30116275,-0.024286881,-2.144785994570248,-0.12559734334790176
35497,SIDM00633,Uprosertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.72614837,-0.046151746,-2.656742093939747,-0.14078308557686922
71608,SIDM01042,Uprosertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22132908,0.007818366,0.31864058989927246,-0.020184322603717025
83687,SIDM00455,Erlotinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.5105635,-0.012083721,1.4119396899412386,0.03656938186357338
85198,SIDM00875,KU-55933,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4945076,-0.04841801,0.16346546384580107,0.0036726347802558353
35006,SIDM01042,Ribociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3413271,-0.02125413,0.23661199887308798,0.04976241085356894
77759,SIDM00097,Pictilisib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.5577865,-0.24194479,-0.8940125049825851,-0.05681953937925843
70510,SIDM00928,RO-3306,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.770324,-0.10735275,-0.3762247348041642,-0.061444691686717956
105010,SIDM00877,Alpelisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.8627445,-0.02464458,-0.7925266329172507,-0.04813276524177839
9123,SIDM00875,Temozolomide,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2009536,0.030430967,0.2255832177783901,0.006119210631197232
14756,SIDM00875,MK-2206,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.4444141,0.1115642,1.060898166597835,0.060791557731286215
50529,SIDM00872,Linsitinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.1106246,0.106714524,0.7775043744759056,0.009237676705810244
72044,SIDM01042,5-Fluorouracil,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.05247541,0.002235008,1.3220232558135614,0.011214970546356052
71995,SIDM00216,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-0.9014759,-0.031911936,-2.8939482901907203,-0.05707048221077807
82736,SIDM00673,MK-1775,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4711918,0.046169244,-0.5956748987352597,-0.051867502150619686
98752,SIDM00837,Navitoclax,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.5509024,0.029764617,-1.0724089377786468,-0.07304033329593068
90175,SIDM00875,Paclitaxel,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46269557,0.03080195,-0.5412975668452216,-0.006052278441428131
96320,SIDM00957,SCH772984,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-2.5008087,-0.09622008,-0.2567745224155059,-0.02420442449770127
69636,SIDM00835,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.4853233,-0.065839045,-0.6774963669774002,-0.04837583108621162
58055,SIDM00875,Gemcitabine,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1434551,-0.002912103,-3.7563478084570563,-0.08569926102670551
53705,SIDM01042,KU-55933,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.53569585,-0.053458467,-1.7111926547764502,-0.07489554925503662
37400,SIDM00148,Temozolomide,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.78818166,-0.022043755,0.6474286090902147,0.007194196461815016
9704,SIDM00148,Ribociclib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.7231102,0.25019443,-1.834186624728007,0.03329415933725487
84989,SIDM01197,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.9802726,0.03201712,-3.2583634774158745,-0.05322105555751735
65155,SIDM00933,AZD8055,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.9178042,0.17248496,1.0201484057042702,0.12746484702408534
38107,SIDM00950,Crizotinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.2835261,-0.030994583,-0.5524303391765985,-0.008126508011722064
50824,SIDM00148,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.60694337,-0.05565282,-1.8918888751520022,-0.1334834701026185
100885,SIDM00216,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,3.7457504,0.3059424,-0.04885568766643753,0.0036608500452414896
16785,SIDM00877,BI-2536,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-5.430827,-0.0644122,-4.529163044826118,-0.07506063347304781
18970,SIDM01042,JQ1,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2625709,-0.0668107,0.5968016252106595,-0.016077327801636055
30156,SIDM00673,Wee1 Inhibitor,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.8745448,-0.05151667,-1.0450912876080058,-0.03162520230033547
9304,SIDM00216,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.10287708,0.002512514,1.4708963750617643,0.05736687214962661
57071,SIDM00835,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.5712404,0.12253851,0.679902965904902,0.06065210068394358
57575,SIDM01187,Cisplatin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.104271,-0.12564461,-1.1171483003403777,-0.017668602539637132
21482,SIDM00957,Olaparib,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.2746533,-0.017067341,1.2160028136710195,0.025745890061661288
63637,SIDM00933,Gemcitabine,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0269383,0.0027429608,0.49010886874886717,0.028099784994653026
28328,SIDM00957,MK-1775,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,-5.5456824,-0.15194973,-2.7720241300022064,-0.16288145112382846
5133,SIDM01042,GSK269962A,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8775849,-0.10714917,0.5864076243462533,0.04360263115485231
70041,SIDM00042,Cisplatin,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.3029746,0.07285057,0.11860555305480495,0.008201107105827481
30464,SIDM00282,MK-2206,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.5539782,-0.12252374,2.1459710575074995,0.17632052278837634
51929,SIDM00633,Doramapimod,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1688564,-0.13423793,-0.7974414931371253,0.0016666731918174996
87810,SIDM00933,5-Fluorouracil,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.35794672,-0.039552752,-1.886026014886799,-0.12951345162955252
35116,SIDM00097,Venetoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.077081,-0.058385454,-1.1612828130166144,-0.016184060389643876
100356,SIDM00776,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.6804725,-0.014216922,-0.04779171239513279,-0.0029396327349022026
73251,SIDM00359,Afatinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.84235775,-0.0658587,-1.3648267993597205,-0.08055178173950253
49519,SIDM01042,Alpelisib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1820675,-0.09846372,0.8906676696073413,0.01562674613621785
36806,SIDM00455,OSI-027,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6537331,-0.03838725,1.4333385275812676,0.03708105060887796
36677,SIDM00148,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.65661,0.07789282,0.9925761657101918,0.017788379638035735
41910,SIDM00928,Camptothecin,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.7057724,-0.16686146,-1.4020427643424003,-0.08937442620231005
57645,SIDM00875,PD173074,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.021659,-0.079933085,-1.216155734411347,-0.02423651908333964
84363,SIDM00950,Navitoclax,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.97098523,0.06909913,0.17272688939461625,0.04879178651019323
95417,SIDM00148,Camptothecin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1059368,0.10460436,-2.47823656605497,-0.14577928386010724
76876,SIDM00933,Pictilisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.6618466,-0.095589675,0.17046366859076964,0.02590242469269356
25981,SIDM00146,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1855478,0.06123224,1.9984479622922515,0.03684146129903479
63647,SIDM00146,Nilotinib,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.106156,0.09383119,1.6900705496878603,0.10123483457660137
25572,SIDM00877,AZD6482,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.1195908,0.13717769,1.5622851340894404,0.04817126195141494
39979,SIDM00837,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,0.96054935,0.08543812,-0.7913086733427106,-0.0688580477460089
14087,SIDM01042,PF-4708671,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3296423,-0.095189616,1.2947824340728848,0.0930977438052682
11343,SIDM01197,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.3174053,0.038931984,-0.4833739372416366,-0.0022080399784064745
31689,SIDM01042,Crizotinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.42568326,-0.046395347,-1.5789311549232248,-0.08015106120961356
20456,SIDM00673,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1022248,0.09465034,1.8525087467766925,0.09143942334282579
13361,SIDM00950,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3027587,-0.18928084,-2.3264760639424185,-0.1255756541766648
29059,SIDM00673,Gemcitabine,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4594148,0.03417571,-0.26640333902502544,0.04000736407149234
40123,SIDM00933,Wee1 Inhibitor,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.25402978,0.019219868,0.3346802306513567,0.004099966608826184
1263,SIDM00928,Nutlin-3a (-),Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.7581842,0.033630885,1.218205381163458,0.03241258558387597
22537,SIDM01187,Trametinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4763178,-0.064922296,-0.3522210707351011,0.06678456786580222
92206,SIDM00148,Palbociclib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.52821404,-0.0233436,-0.9258850037201556,-0.03597640889624794
12894,SIDM00146,SCH772984,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.2963883,0.10496897,0.4090082825007397,0.03313413521877495
63299,SIDM00832,MK-1775,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-2.2382202,-0.062834,-2.0566845951555077,-0.0571159198279882
80507,SIDM00957,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.4283612,-0.036608957,-1.311677230142949,0.005338230796083411
96379,SIDM00933,AZD7762,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.27575007,-0.038511664,-0.46692567307318034,0.0237956724379538
42839,SIDM01187,MK-2206,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.289783,-0.07256219,-2.107818345349601,-0.06853249481702588
98212,SIDM00455,Taselisib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.066715,0.10726213,2.51765368753283,0.1471788122838785
27021,SIDM01042,PD173074,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6336879,-0.09441709,-1.6531551037335512,-0.0890153666923342
87770,SIDM00455,Irinotecan,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.162499,-0.061992925,-1.0918866407456431,0.03604909432447061
60287,SIDM01042,Dabrafenib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.75044173,-0.06745968,-0.8148291620396885,-0.021039459478339566
4456,SIDM00455,Irinotecan,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8816473,-0.04937004,0.5939670573778842,0.0774313568891239
70650,SIDM01197,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.2283132,0.0388446,2.0360009493534874,0.0317796894172137
102510,SIDM00673,Afatinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0604256,-0.0750989,-0.3269849780443507,-0.0097863354911401
5786,SIDM00146,AZD8055,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.2510832,0.022894641,-0.07153610183438006,-0.027538986029309008
246,SIDM00877,Ribociclib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,3.481973,0.17255457,0.24728918411003434,0.024050309858182413
58468,SIDM00673,Afatinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,2.6775825,0.18276699,0.6737615341960053,0.10103648951566899
95849,SIDM00282,Linsitinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6170452,-0.034907114,-0.028415265552053225,0.026897791744528363
39944,SIDM01042,Uprosertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.89765847,0.025545571,0.2539091811056746,0.017851654127089136
15413,SIDM00928,KU-55933,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.6956937,-0.0830836,-0.417249132646614,-0.036098307274105935
24443,SIDM00832,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,3.0479407,0.19094664,1.0482152770077067,0.06013914090962013
11924,SIDM01042,Bortezomib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.41415003,-0.02341429,0.05315816492976345,-0.09472267692286972
62125,SIDM00875,PF-4708671,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8408818,0.088343844,1.974622588361005,0.07946122420498908
76716,SIDM00928,KU-55933,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-2.9336848,-0.118252665,-1.2653156376416017,-0.03363098081711076
102425,SIDM00148,Paclitaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.92494565,-0.0899502,-1.4524339245006583,-0.13222041484905933
24772,SIDM00359,MK-2206,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.088428,0.076342784,-0.25180775239663583,0.0011693326426777601
56761,SIDM00877,PD173074,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-2.0452275,-0.079711325,-0.24767004184189062,0.05933882241639169
46675,SIDM00146,PD173074,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4415604,0.07582356,-0.8189238206749364,-0.001339003385577494
67868,SIDM00097,GSK269962A,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2389438,-0.040769346,0.05419388154942353,-0.031392173438336196
48374,SIDM00833,Dabrafenib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,1.1397712,0.015333151,1.3162624278689434,0.007454612918172004
65690,SIDM00872,KU-55933,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2584609,-0.04900616,1.9268452942442458,0.05594727030643536
49796,SIDM00928,Axitinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.8835257,-0.062404033,-0.8081758593982914,-0.025622950281876933
225,SIDM00877,RO-3306,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.0256623,-0.0023369193,0.3330079269473187,0.01737590490251726
67896,SIDM00148,Dabrafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0905035,-0.04455676,0.5284325248804654,0.033380092203636344
95020,SIDM00826,SB505124,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.0189131,-0.08237665,-1.087984353107408,-0.0688858048118466
3126,SIDM00042,Cisplatin,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.27757257,0.027174277,-1.5306789856303789,-0.07748882141586798
60542,SIDM00097,Pictilisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.660457,-0.040579256,-0.35182826093799574,-0.04173888378815623
47579,SIDM00146,JQ1,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.5683275,0.037960414,-0.047662188364657666,0.014787531119614785
19655,SIDM00633,Nutlin-3a (-),AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.8449693,-0.16718596,-2.1941580679804864,-0.10328702101124038
101908,SIDM00097,AZD7762,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5322679,-0.06295899,-1.8247646895149583,-0.027992043744499106
58014,SIDM00633,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.870734,0.077880025,0.21889010324615524,0.08819477250629983
40124,SIDM00097,JQ1,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.230941,-0.065666705,-1.0194429337391702,-0.07408284359757265
58456,SIDM00673,Uprosertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.4054292,0.023946442,1.1248722729293146,0.07479894496005968
51529,SIDM00148,NU7441,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8820964,-0.086702056,1.5154412922130307,0.03132254391511308
5305,SIDM00837,Oxaliplatin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,4.091489,0.18816847,0.33504609113074674,0.05544749194125588
85266,SIDM00950,LGK974,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.081643,-0.03886272,-0.5610592069278544,0.005132344064742172
28486,SIDM00673,Pictilisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.6825111,0.12811427,0.731927321190968,0.011691445701918454
106152,SIDM00957,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.4888626,0.04483694,0.41628314328313454,0.02846237418640538
71267,SIDM00633,Bortezomib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.60136646,-0.04752611,-1.137137412577357,-0.03587747116463115
63602,SIDM00872,Uprosertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4661436,-0.09248031,0.05487536320322231,0.012029369409562623
36564,SIDM00042,Trametinib,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.27137908,-0.026776135,-0.6344970535698458,-0.02409057862969551
29428,SIDM00148,MK-2206,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.24242942,0.020462828,0.5917173916039701,-0.005212581957848311
86967,SIDM00950,Sorafenib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6429825,0.06641864,-0.10683606307890493,0.006025797518198608
33724,SIDM00872,NU7441,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6008962,0.041360807,0.6256325502377376,0.08189182052104263
88415,SIDM00146,Axitinib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-2.0274992,-0.1452409,-0.3230656612736328,-0.0179220800740295
79311,SIDM00875,Uprosertib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9763393,-0.08315714,0.7536039423699236,0.04700501953108063
51200,SIDM00633,Lapatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.66823435,-0.023047239,-1.2548639984744316,-0.04899785963845214
46326,SIDM01197,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.405287,-0.015153536,-3.442812149649734,-0.10357881683625345
63990,SIDM01042,Venetoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6117923,-0.06906224,-0.8812553255784235,0.018258441876886567
36687,SIDM00837,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.6332732,0.08868122,-1.046733829821772,-0.003334734966288089
90867,SIDM00359,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.1026149,0.098589346,2.2440152908931874,0.04091850454230891
51015,SIDM00950,Dactolisib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6002951,0.03395342,-0.7925529329025179,-0.0526672432946779
4625,SIDM00776,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.9324768,-0.21776283,-1.2400492695091487,-0.07419201890962943
69541,SIDM00826,BMS-754807,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.1996127,-0.015216657,-4.097625803224441,-0.12427822361502569
99294,SIDM00877,Vorinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.39010277,-0.035169493,-0.21218749936727954,-0.03731393599766465
44820,SIDM00633,Ribociclib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.61194944,-0.0155599415,-0.5603521359283723,-0.02596841131368088
34431,SIDM00455,Oxaliplatin,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4972646,-0.10893012,-1.8926343160635315,-0.03818915121975924
5343,SIDM00877,AZD7762,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.83110243,-0.07526451,-0.6098186927163113,-0.04908646924992382
12883,SIDM00148,KU-55933,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2806472,-0.047037575,-1.848990263820766,-0.06850402543094096
5387,SIDM00928,Lapatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.137916,-0.11950472,0.10716145586772277,0.04253026021528506
49200,SIDM01042,Navitoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8602436,0.07989878,1.0673378560990172,0.025786669958864406
10868,SIDM00673,ZM447439,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.6361927,0.044829704,0.5062822463562727,0.051684670411261555
74869,SIDM00042,Crizotinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.566932,-0.16809057,-0.8655148804466577,-0.011878709108734523
46940,SIDM00148,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8148015,-0.05615856,-0.8398274742992533,-0.03503664507857143
106983,SIDM00633,PD173074,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1812005,0.048924793,1.8074714629212136,0.1189406979540435
96734,SIDM00673,RO-3306,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.37506893,0.028357528,-0.2891150866251934,-0.046929769157556436
64222,SIDM00875,Olaparib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.093503,-0.13339463,-2.0426181169036455,-0.056845214232659196
35438,SIDM00359,Olaparib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.18058515,0.004172754,2.17425354537472,0.046759081164889645
95319,SIDM00950,Gemcitabine,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.1561017,-0.1507201,-3.6275414797123022,-0.180694844603235
91161,SIDM00877,Pictilisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.907334,-0.13151816,-0.06842967502986844,-0.08206437398280969
105956,SIDM00148,ZM447439,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.241897,0.36386794,-0.07085953176108621,0.012894772348953252
15135,SIDM00872,Crizotinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4412891,-0.03648431,-1.0704736483373936,-0.06796008758187934
71971,SIDM00146,Camptothecin,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.1414435,-0.08591675,-1.8237628690984478,-0.07611541420877288
72632,SIDM00835,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.1728768,-0.097272985,0.036230440651825804,-0.01272287447347714
91768,SIDM00832,Oxaliplatin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-0.30190548,-0.025522383,-0.986377305751293,-0.05604727527629742
53699,SIDM00148,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3674928,-0.13401918,-0.18025625644399804,-0.04829362293486032
97127,SIDM00673,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0545037,0.13874601,0.7709083286057933,0.11978706667073534
20112,SIDM00835,Taselisib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,3.5601308,0.14522152,3.849896699482169,0.1715166656888544
63424,SIDM00455,Irinotecan,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4245946,0.1132363,2.466489226005398,0.22309350441843204
47556,SIDM00673,Linsitinib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.62370193,0.012123369,1.53880840214267,0.0032160957537040774
51396,SIDM00833,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.98754007,0.06403801,0.7898861129394269,0.011216936395235275
22023,SIDM00837,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.24794433,-0.003450495,-4.136143734897101,-0.09998157774662152
64093,SIDM00875,Dabrafenib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2186238,-0.00950965,0.16806632460752557,0.01609196696806181
104061,SIDM00933,ZM447439,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.3922865,0.10010562,0.5782062556971088,0.03864265341644094
34911,SIDM00833,MK-1775,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.17527287,-0.010639633,-0.8704963129353269,-0.040984592847721886
70049,SIDM00097,AZD8055,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.97932625,0.07110093,0.3059384963137043,0.03810813612751832
37936,SIDM00832,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-1.133387,-0.024700034,0.7183215205485523,-0.01235088497845704
51312,SIDM00455,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,6.3560147,0.36842617,5.1048077418506335,0.33012834568570865
33042,SIDM00833,Dabrafenib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.096083,0.026549611,1.088858982625574,-0.01265212048246152
86498,SIDM00097,Venetoclax,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5633595,-0.039008055,-0.668715603515624,-0.0020899634487609856
20976,SIDM00282,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,0.8852936,0.06278714,0.6217561667409917,0.029699978650338566
72068,SIDM00832,SCH772984,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.7003864,-0.15194447,1.4277062116862755,0.052768200442605974
51466,SIDM00455,Ruxolitinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.55739653,0.010422427,1.7624666551688553,0.06942848823949915
88744,SIDM00872,Navitoclax,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.71761495,0.049749058,1.136475562016905,0.06744909411803025
31112,SIDM00148,Nilotinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.810397,-0.15500206,-1.6298704349246351,-0.11871906651054787
5747,SIDM00875,SCH772984,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96445644,-0.027878065,-0.6890369409822718,-0.019828114690579705
53492,SIDM00148,Crizotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.32650402,-0.010193344,1.406583896837373,0.02427880888644215
34053,SIDM00875,RO-3306,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.847588,-0.048403975,-2.9793926828052935,-0.08580386734216161
62854,SIDM00673,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2060508,0.07146965,1.0488272295407173,0.05068153537193916
49341,SIDM00835,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.1030836,-0.0541231,-0.510096488995026,0.03719071548744397
56512,SIDM00455,Gemcitabine,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9695761,-0.09772894,-1.9379597175064853,-0.024993184324987584
19751,SIDM00957,SB505124,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-5.1610923,-0.08501513,1.0802545607481278,0.05794511153324005
29401,SIDM00455,OSI-027,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.9989457,-0.0868422,-0.9299513468831426,-0.01832068196096834
61942,SIDM00826,MK-2206,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-2.0604753,-0.078485355,-2.4838815890884747,-0.13551045111119422
10431,SIDM00957,Taselisib,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-3.705482,-0.09212771,0.07505652489744591,0.03308417515874467
74812,SIDM01187,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.19404337,-0.018535476,-0.6098709206552722,-0.04136112848328757
63307,SIDM00875,AZD8055,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22019836,-0.02285038,1.2923324827570772,0.10486371728360569
26638,SIDM00673,Wee1 Inhibitor,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.740894,0.1263387,-0.9302451581537075,-0.012880033581755233
63435,SIDM00148,AZD8055,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0295833,-0.098060295,-0.1852762849755867,-0.042486544488698236
9575,SIDM00148,JQ1,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2752508,0.09102429,-1.9496140171722278,-0.12980742791344926
52956,SIDM00872,Linsitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7641348,0.07881529,1.6488310347827797,0.08509291941768943
42398,SIDM00933,Wee1 Inhibitor,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.06331124,-0.003776608,-0.34627987192567267,-0.04049143933977004
14489,SIDM00146,Temozolomide,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.32837304,-0.008188303,0.7788413258383997,0.046240670067554446
25742,SIDM00875,Uprosertib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1845282,0.13023467,-0.11139084790458367,-0.043166613513746586
63313,SIDM00933,SCH772984,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.6921154,-0.11198253,-0.04040512617047289,-0.0006988182581640101
61322,SIDM00633,Temozolomide,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5351304,-0.011366627,-0.44935512529378435,0.005757357647883731
80497,SIDM00928,5-Fluorouracil,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.2322673,0.09445695,1.074646240538688,0.07966931295529048
9640,SIDM00673,Lapatinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8751438,0.09763936,1.670486459417888,0.04344105226272726
54734,SIDM00928,5-Fluorouracil,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.6184546,-0.09278523,-1.6248958590203881,-0.043842518813525445
54072,SIDM00835,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.0850117,-0.13821018,-1.537470306257853,-0.07636406817994108
66808,SIDM00097,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.532374,-0.13683613,-1.4284251519305913,-0.11151839038694356
4218,SIDM00042,SCH772984,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.8792116,-0.09940257,-0.3943756481473499,-0.030621232769078206
71824,SIDM00928,Sorafenib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.8872019,0.083698876,-0.4277793330711207,0.01684224643105766
93358,SIDM00633,GSK269962A,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8241075,0.07143958,0.10380582043429501,0.050311536282810564
12147,SIDM01042,Dabrafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.145193,-0.012766835,1.2259977238219335,0.08921230866909895
106560,SIDM00833,MK-1775,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-0.35206106,-0.018702885,-0.2366025660603107,-0.010446160856799433
16242,SIDM00097,Entinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8170793,0.049140114,-1.189397403942331,-0.048766633688623294
107733,SIDM00148,Crizotinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.49577466,-0.014740182,0.47379749793617665,-0.0029642082191367073
98978,SIDM00633,RO-3306,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5090479,-0.039303884,-0.7352022180924493,-0.03737345959677607
67036,SIDM00933,Vorinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.0713059,-0.1146666,0.8040258649101659,-0.003943279370841334
47708,SIDM00673,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1453968,-0.080398,-1.4049855883326392,-0.09795250246922124
44073,SIDM00826,SB505124,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.35606763,0.012192495,-2.0160875642789886,-0.06687697774559666
25829,SIDM00673,JQ1,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.54871494,-0.038050696,0.05997922650510677,0.06865223149386697
762,SIDM00776,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,2.212604,0.10643629,-0.6990300623711547,0.00014280108697497054
104722,SIDM00957,MK-2206,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,4.177812,0.085506134,1.2315669044339232,0.06704720593806553
3995,SIDM01042,PD173074,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.098153,-0.113039196,-0.41206306537281767,0.029414569987941914
97316,SIDM00146,Palbociclib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.4943035,0.117712535,-0.521347227923668,-0.03219877249845671
92322,SIDM00928,Taselisib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.0498757,0.087559514,-0.7398102608933171,-0.10603524598455795
3571,SIDM00097,MK-2206,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32723305,-0.024131559,-1.5428639829990332,-0.06152239446957004
96894,SIDM00042,LGK974,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.8054637,0.10322837,-0.6534428379244266,-0.02292766341311598
12744,SIDM00633,Temozolomide,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8753605,0.051505573,0.4096241415408603,0.0029572222985745486
28388,SIDM01187,Taselisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.40679482,-0.031060452,0.13779987777998676,0.004929154548032991
84266,SIDM00872,Axitinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4337324,-0.031553976,-0.36996209643639866,-0.006552756070726884
4008,SIDM01042,PF-4708671,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4635268,0.11946873,0.031847834204715264,-0.018750045747574526
66061,SIDM00875,Trametinib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3871677,-0.041467696,-0.09803854335996288,-0.025348649764971618
4585,SIDM00673,NU7441,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.7449523,-0.0558375,0.44699655686030604,0.016878644856673623
106892,SIDM01197,Crizotinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4633764,-0.1100662,0.015915394339955664,-0.02854446896565078
79749,SIDM00928,Alisertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.1825323,0.111137986,0.46676912484903543,0.04331920603074455
42104,SIDM00282,Camptothecin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.47371078,-0.035759415,-0.7587228709365612,-0.06169596313021071
20014,SIDM01042,AZD6482,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5556479,0.053546622,1.1033972243997598,0.020719024707615368
50908,SIDM00875,KU-55933,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6351703,-0.019207483,0.191677633428566,-0.009741700573555345
74317,SIDM00928,KU-55933,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.9597983,-0.08202197,-0.5417718380137526,-0.04301986446464954
76840,SIDM00837,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.617727,-0.118621156,-1.9719586114142278,-0.16026488714705547
99173,SIDM00837,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,0.9686211,0.044216897,-1.2433937676249969,-0.10050568325911342
35965,SIDM00933,PF-4708671,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.3753656,-0.08987619,-0.4208738455170001,0.030731982561799022
61581,SIDM00282,AZD4547,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.6875367,0.07432584,1.3610700679630163,0.05981775403111525
63820,SIDM00282,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.5751617,-0.1459628,-1.2797248262495886,-0.052942776875675855
44105,SIDM00148,MK-2206,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2796997,0.102709435,-1.7748845924449836,-0.08564972756789735
41883,SIDM00633,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.709331,0.03372414,1.4245511671224735,0.08683830339406272
67130,SIDM00146,Olaparib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6932739,-0.033162862,-0.7369064519202306,-0.003440078742901845
15192,SIDM00633,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9888474,-0.089337215,-0.8046856958651053,-0.06096049408941423
71573,SIDM00148,Trametinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4818687,0.12003386,-0.09545440372457263,-0.020022030406354085
84906,SIDM00872,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8056162,0.0297214,1.4254909125303799,0.11614474569945545
72462,SIDM00673,PF-4708671,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.6385456,-0.08888996,-1.2814816555349937,-0.04519137173178183
66932,SIDM00933,RO-3306,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.9427353,0.10349364,1.0036267687358778,0.05901550906373016
94319,SIDM00148,PF-4708671,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.8522408,0.23503913,0.6038029244016133,0.08241411253217042
49,SIDM00042,Irinotecan,OSI-027,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.4349482,-0.09082227,-1.3123433387595824,-0.0870809370443787
58394,SIDM00359,AZD7762,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.9098644,-0.3282221,-2.9194724944729438,-0.19215115588332973
5097,SIDM00673,MK-2206,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.5804446,-0.07347465,-1.312477517200613,-0.0633953916316325
47056,SIDM00673,Palbociclib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.39784455,-0.016067674,-0.370024946226283,0.01520251974749731
82834,SIDM00833,SB505124,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.428585,-0.101453796,-1.1536937622515233,-0.05673333523912218
55933,SIDM01042,Docetaxel,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6862865,-0.07702694,-1.5548192478993885,-0.039640464565809226
40630,SIDM00877,KU-55933,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9002624,0.055013184,-0.9261460336024647,0.033858395105266295
90322,SIDM01187,Crizotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6974347,0.05731364,-0.9331094636633587,-0.0016704925021915464
25948,SIDM00933,Axitinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.4207156,0.06011529,1.0678575833383257,0.08161654876581222
39897,SIDM00933,OSI-027,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.39355567,0.053868845,0.633491781284687,0.07895886366834862
11705,SIDM00875,Vorinostat,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.58147454,0.028420426,0.015595979988540884,0.0156234682862921
86311,SIDM00872,Docetaxel,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.75111896,0.07751588,-0.29614703834826117,-0.03735455761340054
25587,SIDM00928,OSI-027,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0595347,-0.1038116,-0.6828565115503158,-0.054788334742351834
21793,SIDM00933,Uprosertib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,3.4822383,0.14039432,-1.555633069769977,-0.040337753811527446
25027,SIDM00928,Crizotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5763003,0.17039347,2.121014469952316,0.12980679879972348
30354,SIDM00146,Crizotinib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.09531821,0.008141918,0.8951530709067183,0.034928062584357315
94387,SIDM00455,Paclitaxel,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.720572,0.09764603,0.569761148656786,-0.021588336199990097
33587,SIDM00957,AZD8055,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.7043827,0.039538566,1.4103215976223717,0.07544713798820131
60815,SIDM00097,JQ1,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7466898,-0.12369149,-1.3310766925655393,-0.0820092766299643
4795,SIDM00673,Afatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9911801,0.15451048,0.9841705471670957,0.06780303139097017
67717,SIDM00455,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.96239,0.1626233,1.7671239440193915,0.10653132579703699
96743,SIDM00148,KU-55933,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.79823595,0.03405323,-1.635403525439217,-0.07293628659569654
75084,SIDM00216,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7429068,-0.06658954,-0.6317682636623778,-0.06501664586962823
38733,SIDM00776,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,2.593825,0.10249097,1.533290735859679,0.07495780756594361
9632,SIDM00875,Crizotinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0474048,0.19257073,2.4459120291448833,0.12577138886275163
85268,SIDM00957,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.4104517,-0.07636226,-2.394668846649283,-0.09073939178177606
86740,SIDM00835,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.8184412,0.19463915,1.46324261349443,0.15461741488913222
61392,SIDM00146,Alpelisib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,2.373351,0.15046638,1.0168895279340335,0.12835935964317402
83983,SIDM00933,Trametinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.71632844,-0.098972335,-0.8112348791318407,0.012423102871417862
58761,SIDM00673,Pictilisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.2084742,0.105971836,-0.09446561370876719,0.02861494160881326
82628,SIDM00146,Afatinib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.18844624,0.015796157,-0.7185699225165018,-0.05983485096916818
32344,SIDM00835,MK-2206,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.7875226,-0.07328122,0.6928183771533394,0.0177751203217065
14531,SIDM00872,KU-55933,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.8014488,-0.10383492,-1.1280094023776068,-0.0707221443040153
96531,SIDM00928,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4772869,-0.15391894,-0.9458857525412728,-0.09493074244294442
68419,SIDM00455,Crizotinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.20499647,-0.0138740605,0.6192760301453972,-0.02851662264876633
35749,SIDM00826,LGK974,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-0.91625595,-0.027236303,-1.9128215441320593,-0.032658115573105655
57186,SIDM00146,Docetaxel,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.4373732,-0.13851438,-0.5835965562841728,-0.043730619268215996
37595,SIDM00633,KU-55933,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3419127,-0.04169728,-0.3854483453211948,-0.030086614313484025
26627,SIDM00835,Olaparib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,-0.46959308,-0.0116183,0.9928568012718092,0.033514278497466576
54096,SIDM00872,JQ1,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1728872,-0.026943399,1.2148679798684532,0.02939364299092195
71124,SIDM00673,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5529439,-0.04106572,0.13352259292257818,-0.05521188557852928
78399,SIDM01197,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,0.43375444,0.03188094,-1.3173454890147236,-0.06313899751989004
68697,SIDM01042,Cisplatin,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.67272615,0.032481305,0.780318854069215,0.04711701103558294
75067,SIDM00455,Crizotinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1197838,0.07759271,-0.40186065994136244,0.013557381226147112
37540,SIDM00832,AZD7762,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-0.42022446,-0.027156962,-0.9760514284721663,-0.05231323825665827
42283,SIDM00673,Camptothecin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.6563627,0.06825157,1.0098593167844012,0.06787175069981075
36022,SIDM00633,BI-2536,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.11970388,-0.012163069,-0.13321594187959424,0.014219277945311245
1608,SIDM00148,Sorafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.18682802,-0.017376883,-0.814089942435158,-0.0816652137366578
65277,SIDM00877,Sorafenib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.48164353,0.05706141,0.40021174097549717,0.008978504052030628
14124,SIDM01187,Linsitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.9289305,0.049760852,2.389287435531117,0.055949268388601335
57888,SIDM00872,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5874527,0.0464674,0.49643183430386745,0.04672181328536038
54040,SIDM00957,BMS-754807,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,0.5845254,0.020186817,1.526944590003916,0.048785051052686455
54430,SIDM00875,Bortezomib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9069803,0.070499085,-0.075770001755357,-0.044755393372413875
79711,SIDM00776,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8563743,-0.042077567,0.7973076766677595,0.040173970608330355
99908,SIDM00455,Olaparib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7238256,0.05625246,1.3896212341927323,0.05153910289856107
13502,SIDM00633,Gemcitabine,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6730652,-0.13582252,-0.3593876651116964,-0.04477544270807212
69051,SIDM01197,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,2.815499,0.10893782,1.2652507709155305,0.08888262260292058
17318,SIDM00832,BMS-754807,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,0.9431507,0.025544135,-3.5600133789402593,-0.08470152747133687
89366,SIDM00872,Venetoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6132717,-0.07840521,-1.3408789316185525,0.016801103918319973
21098,SIDM00673,BI-2536,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.45328024,-0.02551089,-0.6016924942230027,-0.0022524385194394765
36827,SIDM00877,Camptothecin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.3389863,0.03690798,-0.3967935464468979,-0.06579163018592406
52281,SIDM00872,Cisplatin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.45480514,0.014027231,1.4613725384892662,0.05696703417127359
89293,SIDM00673,AZD6482,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1244657,-0.07041248,1.267288604178702,0.03227639951579405
19950,SIDM00928,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.179191,0.19751403,1.6808374178101495,0.17600883365043296
17856,SIDM00872,SCH772984,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.83524,-0.052675065,2.0709998774047356,0.11823515879092036
17407,SIDM00776,Taselisib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.7707445,-0.06638567,-2.338474935231832,-0.08425803430125321
59621,SIDM01187,MK-1775,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.28513506,0.029029012,-0.6336814288859641,-0.017047987354888407
21203,SIDM00633,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1018481,-0.07433331,-1.786776819963088,-0.0977434902623465
33107,SIDM00835,Olaparib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.81956184,0.02376654,1.6528903560327817,0.036201558473364995
89779,SIDM00097,Axitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.218008,-0.10685782,-0.7959344072451862,-0.06585491252140743
9566,SIDM00837,Crizotinib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-1.5578469,-0.059617423,-0.6758453525177783,-0.04047495613534173
13937,SIDM00148,Entinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6099702,-0.04341977,-0.7113308387199707,-0.04652007950153061
101635,SIDM00833,Trametinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6775296,-0.025470957,1.083263452296001,0.024316282870882742
40917,SIDM00776,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,1.1947346,0.0963257,1.317700363822005,-0.027336025383965363
78264,SIDM01187,MK-1775,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6576072,-0.10396912,-0.4173250533043758,-0.004235548344320727
71750,SIDM00832,BMS-754807,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.7983322,-0.046462283,-4.757698933213012,-0.09069358182994627
66031,SIDM00832,Taselisib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.8725505,0.06814679,-1.0331730237678634,-0.026834910141135877
105975,SIDM01042,AZD8055,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5775896,-0.06487381,-0.3356213705983737,-0.004511907391917618
99369,SIDM00872,5-Fluorouracil,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4056787,-0.06478901,-0.8835923308201525,-0.01590970604773202
56106,SIDM00148,Uprosertib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1351482,0.0967065,1.0701048867514238,0.03654779274270957
102456,SIDM00928,AZD7762,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,4.254308,0.43222243,2.1969282699809245,0.13993885489209504
47761,SIDM00146,BI-2536,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.1782148,0.03531718,-0.26279360705848,-0.022180196129003658
75366,SIDM00216,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,56.0,2.2632642,0.17556402,-0.7663902690883114,0.04101759813256182
44045,SIDM00875,MK-2206,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.509911,0.20684388,3.539800339965795,0.15459117774375386
38106,SIDM00146,JQ1,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.4473388,-0.100828394,-0.5293857816039891,-0.02851293986442713
105422,SIDM00455,Erlotinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.027672,0.041458707,4.001208154686169,0.17867754466264107
55588,SIDM00146,Entinostat,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.9288815,0.064019494,0.3953249437408289,0.01938744406401643
87955,SIDM00872,Venetoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.595709,-0.081953116,0.3972207837701048,0.038266573310756044
83597,SIDM00933,SCH772984,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.29397002,-0.023166543,0.805048123567548,0.09872392315403136
75653,SIDM00950,Trametinib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1165142,-0.11291694,-0.3264970683616248,-0.06966911627615488
38766,SIDM00875,Docetaxel,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0111582,-0.06761061,-0.14303687759675554,-0.07344881695986522
57421,SIDM01187,Cisplatin,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.2192239,-0.013630922,-0.5696617760985111,0.006501327544709614
65416,SIDM00282,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.1889795,0.05555372,1.8496310282156931,0.1040070615110287
92840,SIDM01197,MK-2206,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,East Asian,71.0,0.79504883,0.031504523,0.8498942396716678,0.012674416016119435
85783,SIDM00097,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5510094,-0.105449624,-1.6875576168770667,-0.09689660911369775
53060,SIDM00837,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-2.7418149,-0.13433342,-4.192832749341378,-0.1348742531153396
48918,SIDM00776,Oxaliplatin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.7150152,-0.09386743,-1.967331494746922,-0.07595844970492076
95814,SIDM00933,Nilotinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6263226,0.062201597,-1.6137611632970434,-0.10928342378672391
14099,SIDM00933,AZD8055,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.21175794,-0.014250205,-0.38625967643531156,0.006289821162010416
15575,SIDM00877,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.1191432,-0.11091569,-1.0612132723873084,-0.07227810354260913
70977,SIDM01187,Lapatinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.810865,-0.14761063,-1.428590997241606,-0.06852459965123586
11910,SIDM00673,SCH772984,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,5.1472,0.21016984,0.007009446103760753,-0.0021926929491675514
57995,SIDM01042,RO-3306,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0548427,-0.11024614,-1.0724309578567477,-0.09149550716052333
49157,SIDM00933,Alpelisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.2862858,0.11253702,0.337533881171257,0.08792050268271263
73972,SIDM00097,BI-2536,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3988204,0.10129916,-0.21261389675291817,-0.04333026706476195
73133,SIDM00877,OSI-027,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.8246415,0.14878882,0.45115335985486166,0.11132815934956909
26398,SIDM00872,PF-4708671,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8374106,-0.12234156,-0.913142684878511,-0.06688172737803029
9357,SIDM01042,Nilotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0258132,-0.08540002,-1.7089449365984297,-0.08646341406264746
106051,SIDM00455,Trametinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.748722,-0.1508123,-0.8831128442851265,-0.045447146304261644
52041,SIDM01042,Doramapimod,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1613007,0.09925547,1.0596425981834225,0.08872941866435444
92927,SIDM01197,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3637737,-0.03246006,2.016589433205602,0.06337126406352546
35396,SIDM00877,Alisertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2337171,0.07173268,1.001544160917098,0.12359715897780314
97479,SIDM00216,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.5153041,-0.036045775,-1.0159841744763622,-0.07790568336616316
70632,SIDM00832,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,3.5403385,0.11056992,0.4837618289057613,0.0361220277491065
41375,SIDM00928,MK-1775,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-2.110142,-0.1930143,-0.6395924081709672,-0.025548007800425838
76080,SIDM00148,Alpelisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4257752,0.09138251,-0.06278807403993908,0.015780311730234132
84465,SIDM00673,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.16178672,0.014943139,0.5062288598586362,0.02138385490325211
76658,SIDM00950,Paclitaxel,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.861632,-0.30760235,-5.060710389912554,-0.33560061034145694
47356,SIDM00282,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1262197,-0.069430836,-1.2236287711022467,-0.066441563483706
95836,SIDM01042,Camptothecin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5118804,-0.12777293,-1.064875235604408,-0.040664613954824964
15320,SIDM00875,RO-3306,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96881926,-0.103052676,-0.3899090335825321,-0.030141120858897693
1149,SIDM00148,Taselisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7434463,0.04694987,1.2916609623175945,0.04031381745662637
101779,SIDM00933,RO-3306,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.94312316,0.10060115,-0.10558709709059222,-0.023642498269184728
92636,SIDM00877,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.9748844,-0.038503718,-2.529034404489058,-0.1166810855372815
41787,SIDM00875,5-Fluorouracil,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2260394,-0.10520908,-2.481212203522483,-0.11367562139205217
89182,SIDM00875,PF-4708671,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.139155,0.018714571,0.8319918311133062,0.0692702616422442
29278,SIDM00216,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6388679,-0.044336457,-0.15491816068167694,0.004566618755484495
18024,SIDM00933,KU-55933,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,4.079862,0.24349315,-0.3630811116499251,0.018051843488354934
84340,SIDM00633,5-Fluorouracil,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.9093938,-0.03108619,-0.6654216751858879,0.03050085703509566
69653,SIDM00928,Vorinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,3.0037804,0.24938521,1.6746196303517449,0.11701793371578231
40062,SIDM00933,Venetoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,-2.374185,-0.07825525,0.07396762363691389,0.017705836154911593
91335,SIDM00826,Olaparib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.90062535,-0.039786614,-1.0015799106205812,-0.0500596900831756
82426,SIDM00833,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-2.3629575,-0.14736608,-1.8265586214083798,-0.14462703560159512
65055,SIDM00933,Dabrafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.0542244,-0.069365755,-0.3104052630322811,-0.008516159071076
37135,SIDM00832,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.5707529,-0.1563108,-0.26273972776793175,-0.03196136160999933
32600,SIDM00877,Docetaxel,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.7708269,0.09169185,-0.7045389380343052,-0.0309057105846011
65502,SIDM01042,Bortezomib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7084439,-0.115562156,-1.1158493807907686,-0.0936445438678911
6036,SIDM00097,Alisertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4188021,-0.059933774,1.022845402420937,0.08784190995914712
39598,SIDM00633,Venetoclax,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.8438404,0.112249196,0.14874446318922407,-0.013037606650770776
93945,SIDM00097,MK-1775,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4557636,-0.1041733,-1.27816598173819,-0.09445592305902668
83613,SIDM00359,Camptothecin,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3981134,-0.10930622,-1.3095683011600314,-0.021752933700814055
91203,SIDM00877,Temozolomide,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3967367,0.0062200367,1.7725886340572816,0.06630361044292196
39036,SIDM00146,Dabrafenib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.4423578,0.16368322,1.2887561787054127,0.05465257570689394
75811,SIDM00148,AZD6482,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0974722,0.08643053,-1.7016175920839776,-0.1792012965106703
39655,SIDM00673,Crizotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8845525,-0.12552853,-0.4116045160071743,-0.009531301983909795
3103,SIDM00875,Temozolomide,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.51036793,0.013189923,-0.17039489064586635,-0.00632045787576653
43726,SIDM01197,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4943447,-0.08952603,-0.23182909269465454,-0.04052826902751089
76780,SIDM00359,MK-2206,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75783604,-0.042605903,0.3325407219137998,0.055912710222903395
84507,SIDM00673,Tozasertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.90087706,-0.06255274,-1.3441042536843857,-0.08176115952426945
96495,SIDM00826,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.3804063,0.14160703,0.09390226588878427,-0.040629754296028914
99367,SIDM00042,Sorafenib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.25002953,-0.021781763,-2.527862054360705,-0.10570400799135556
86484,SIDM00872,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6699475,0.06541364,-0.17299525596973228,0.009007001832750957
81536,SIDM01042,Bortezomib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2637268,0.031658307,-1.1730806282088306,-0.07855630242129151
69048,SIDM01187,Docetaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6572736,0.060657952,0.07853247999694728,0.0841928908756257
97335,SIDM01042,Trametinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0827093,-0.12895638,-0.8555285491060304,-0.044311164563151484
15392,SIDM00633,PD173074,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.96357566,0.028242674,-1.0450297164365066,-0.020805861758840825
14608,SIDM00877,Uprosertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.2059258,-0.11008248,-0.9532993003298158,-0.04773901997774005
1595,SIDM00146,Paclitaxel,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.29390362,0.02678779,-0.8762280463489004,-0.11596448399954941
10392,SIDM00359,SB505124,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4607842,-0.10099888,-0.96192980740409,-0.03937769434795753
45750,SIDM00097,ZM447439,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0510724,-0.05171436,1.7494933023758397,0.05911038556168199
107662,SIDM00833,MK-2206,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.8112564,0.11194991,1.0590214963338767,0.07899794517046634
49022,SIDM00146,Entinostat,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.57851833,0.046702582,-0.5681568835128458,-0.0007690047191792438
76656,SIDM00928,MK-1775,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.1214042,0.1893476,1.1637040725804835,0.07337547767740642
93501,SIDM00833,MK-1775,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.8148365,-0.038884588,-1.7884394832180313,-0.08202347329900361
44800,SIDM00455,Erlotinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8986511,0.09561467,4.904246366433758,0.147828689439492
809,SIDM00455,AZD7762,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.6447875,-0.13354032,3.1638679646708017,0.21652038723587877
63926,SIDM00933,KU-55933,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.1955495,0.12563911,0.46371156842788,0.07792393173057069
51157,SIDM00875,MK-1775,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8030741,0.03735253,-1.568664391976796,-0.08081882976697143
98802,SIDM00097,Bortezomib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0147971,-0.057330072,-0.11531997553896735,-0.013503397791359596
28761,SIDM00875,NU7441,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8984847,0.083755195,2.014600068993453,0.12998759614316982
44218,SIDM00097,Docetaxel,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.719371,-0.16249833,-1.3655175459025,-0.14055392249747584
98033,SIDM00928,Docetaxel,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.2918411,-0.09819293,1.0862345651818284,0.08988050357604646
14809,SIDM00826,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.4690479,-0.102114014,-3.0166150015251065,-0.11932595211462672
46258,SIDM00673,Ribociclib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.3242662,-0.07356731,-1.4803341275802826,-0.015691534185086124
15806,SIDM01187,AZD7762,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8643,0.025664277,0.6785217454212702,0.04291169713973732
26801,SIDM01042,Nutlin-3a (-),Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7649289,-0.021708373,1.465070635250355,0.07072730082756636
42543,SIDM00359,MK-1775,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1166466,-0.09378041,-0.9569562629532856,-0.04432827340276192
9284,SIDM00933,Nutlin-3a (-),Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.11403934,0.016525572,0.8619671573660399,0.02943949281448161
35781,SIDM01187,PD173074,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.84393865,0.061892305,-1.0572102707550375,-0.06370739580220326
81273,SIDM00957,BMS-754807,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.7522388,-0.11385787,-1.3557533451432966,-0.05219803876748353
65052,SIDM00146,Afatinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.5472753,0.16105938,1.2719128905731207,0.05503695076444755
30401,SIDM00832,Afatinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,3.8106406,0.19400203,1.8649613611783873,0.0805732035031225
28350,SIDM00875,Gemcitabine,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.70983976,-0.0015774263,-1.27829609170384,-0.02477891133246221
74622,SIDM00282,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.43608138,-0.03242438,-1.5694632451969288,-0.12897349219615017
57996,SIDM00633,Sorafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8675513,0.06989149,0.132015554283404,0.03574228115006854
29613,SIDM00673,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.153296,0.08395324,-0.15755317016583714,0.02495817077286095
67838,SIDM00872,Uprosertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.17307945,-0.01721698,1.1111204999936841,0.059016807441926146
35399,SIDM00933,Nilotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.2004169,0.061481893,0.5094357751260162,-0.015670517706610407
28109,SIDM00832,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.7107052,-0.058167335,-0.06467874776577988,-0.008160713622261591
38618,SIDM00633,Dabrafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1178122,0.109788135,1.8890687716714125,0.03831104601069921
38037,SIDM00833,MK-2206,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,4.750733,0.30541727,0.8491677929262823,0.1373171285589562
6831,SIDM00933,MK-2206,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,2.885127,0.34041443,0.2645248046506314,-0.040347633849411556
55432,SIDM00673,Alpelisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1676984,0.08131133,-0.34660809202686965,0.016968064078630444
20233,SIDM00282,Nutlin-3a (-),MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.2964466,0.01761732,0.22468154837683446,0.02278265368965511
78099,SIDM00832,Crizotinib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.2081388,-0.095465586,0.18656103879434005,0.008812666261504854
38795,SIDM00928,NU7441,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.6379101,-0.1807565,-0.21844377285921981,-0.0331410283985863
63035,SIDM00877,Taselisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.7296307,-0.057347737,-0.12748811428707854,0.01820698941013812
49446,SIDM01042,PF-4708671,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.856352,-0.12267773,-1.6333905169348146,-0.045103214373601735
55824,SIDM01187,PD173074,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7168553,0.09646615,-0.06696671210045553,0.021880569855850376
83620,SIDM00833,SB505124,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.49948746,0.030551966,0.1990227137527898,0.02133310368197297
73469,SIDM00455,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3917086,0.108031206,1.5986056524656662,0.12514960714159967
56783,SIDM00148,Venetoclax,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2713478,0.06618937,1.0897244538639546,0.0009314675937520331
73661,SIDM00146,Venetoclax,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9100339,0.025250226,1.5638495489314135,0.06323502398457216
40741,SIDM00146,AZD8055,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,0.39192748,0.035915017,-0.454486915453442,-0.05465609281606003
80140,SIDM00148,Nilotinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.668934,0.13991773,0.08233688624162794,-0.020697817345913676
83907,SIDM01197,Olaparib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.029017,-0.023211533,0.3060721632659668,0.04815647676982881
4747,SIDM00877,Vorinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.22228304,-0.018090261,-0.7447168273929576,-0.03449663105698901
82229,SIDM00148,BI-2536,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33648202,-0.014662211,-0.7728155165898646,-0.03805072339402412
49391,SIDM01187,Cisplatin,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7350101,-0.0742933,-0.44185659456915977,0.017471221013249574
5665,SIDM00146,Docetaxel,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.7898872,-0.1426828,-2.2893523510929428,-0.22566839740978728
13384,SIDM00950,Irinotecan,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5006555,0.13242483,-0.3633953533123557,0.009364232766416592
46386,SIDM00216,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-4.7264905,-0.22843894,-2.778387452682884,-0.10823336595028417
77325,SIDM00282,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,0.93578136,0.054488808,-1.1262758429640518,-0.08751166697468458
102416,SIDM00148,Ribociclib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6926054,0.15653817,-1.6641975325742455,-0.07202474430660678
55503,SIDM00832,AZD7762,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,0.74615,0.045481995,-0.02667583089511509,-0.018687204783931127
25841,SIDM00875,BI-2536,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.5447588,-0.17144218,-2.30148483072526,-0.14064024225852592
48568,SIDM00872,Doramapimod,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.59310555,-0.021038929,0.7557116765944326,0.030308478755818703
48,SIDM00928,Sorafenib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.0884388,0.0071235485,-1.2218355267986265,-0.0642311779268719
22982,SIDM01042,Wee1 Inhibitor,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.78471875,0.060495153,-1.894556686387048,-0.08994957508283846
255,SIDM00957,AZD4547,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.5476134,-0.054930106,-0.48946783792778714,-0.01569162926289355
92689,SIDM00146,JQ1,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.9590168,-0.08191166,-0.09861295588359345,0.01700449598592155
76111,SIDM00216,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,4.4778957,0.39801624,1.407036151621706,0.09920772346782858
51636,SIDM00833,AZD7762,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.5553895,0.04348194,-0.450886820877963,-0.045487053537685264
97024,SIDM00282,LGK974,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0240434,-0.037552904,-0.9340122186507663,-0.038143424692899074
84697,SIDM00928,AZD8055,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.24049874,-0.029429067,0.7593642269376137,0.043999477668258846
104941,SIDM00933,Nutlin-3a (-),Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.53479594,0.06750584,-0.20899191868148648,0.01360285342131219
85840,SIDM00146,Sorafenib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.5829159,-0.055856932,-0.16317055491689367,-0.020411033456265618
95794,SIDM01197,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.5783658,0.08413535,0.03220582075865503,0.018010936428868585
105275,SIDM00933,AZD8055,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.8631804,0.16449839,-0.023316915714051558,0.002313680872368059
42448,SIDM01042,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.2492347,-0.3202885,-0.8761442357263771,-0.11084751628303242
82637,SIDM01042,Taselisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.983728,0.108054124,-1.3430532827024533,-0.060666998214966746
34318,SIDM00216,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-0.84627414,-0.04051581,-1.4247013399125972,-0.09483562976863066
19079,SIDM00042,Irinotecan,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0010461,0.09763698,-1.9706567510862822,-0.09105312505376578
21869,SIDM00359,Navitoclax,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.74892664,-0.055580225,-0.04662280003792137,0.027522965921339328
106262,SIDM00933,Cisplatin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.8911737,-0.09729764,-0.750543026949063,-0.01899441709732134
20645,SIDM00957,SB505124,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-5.629987,-0.08353515,1.8270407132241933,0.06124960997012349
29362,SIDM00837,SCH772984,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,3.8059797,0.12873204,-0.017681916327692913,-0.03457261573562621
103040,SIDM00832,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-3.038117,-0.17301618,-0.16282964844351033,0.027321406835588584
80993,SIDM00673,Tozasertib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.473752,-0.19929257,-3.078053432753185,-0.1558673173012184
8187,SIDM00282,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-4.0825334,-0.17805944,0.40383989981673335,0.0015464917702212207
100041,SIDM00148,Bortezomib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0537306,0.04935688,-0.7219676736903902,-0.06551992975662575
89850,SIDM00835,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.051416,0.10310032,1.488143685743232,0.021882418232589178
72551,SIDM01042,Sorafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0259944,0.08903198,-0.3140454938831498,-0.005441754954235622
27105,SIDM00928,RO-3306,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.42920038,0.034830824,-0.9891879341859428,-0.042566437590406514
39875,SIDM01042,Navitoclax,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7130322,0.07431424,0.9892331828879515,0.05446428938459449
1765,SIDM00928,Paclitaxel,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.1513252,-0.12565504,-3.1188427710048767,-0.16745547424231394
25179,SIDM00776,Vinorelbine,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.3553977,-0.023038557,-0.02141949315207101,-0.0004496506961743231
81546,SIDM00928,Tozasertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,0.50970984,0.017228564,0.4682153572992372,0.018420758613750463
31025,SIDM00875,KU-55933,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7624718,0.014086444,-0.4163733964488633,-0.017514566891556956
33468,SIDM00832,Afatinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.9896203,-0.16422278,-0.13730701040385032,-0.04879388229809091
93407,SIDM00877,MK-1775,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.2785355,-0.016929632,0.32023973401481337,-0.004415646759396061
107868,SIDM00877,KU-55933,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2495772,-0.037614122,-1.549396023458656,0.010143413693575975
51364,SIDM00097,MK-2206,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.725891,-0.2584182,-1.0880756647548144,-0.07609077575222208
34703,SIDM00928,Navitoclax,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,4.4109497,0.37246954,1.9896289197685235,0.10036452571795976
59808,SIDM00097,AZD7762,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1820343,-0.11284689,-1.8804002848752162,-0.0528263476768379
56462,SIDM00950,Erlotinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.53468,0.14462017,0.8877492217718703,0.041662450672607154
39130,SIDM00673,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8591271,-0.037322357,-1.006616878290495,-0.061043894903907055
75009,SIDM00148,Temozolomide,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6962267,0.022760065,-1.255728477715446,0.009133552029025818
6037,SIDM01042,RO-3306,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0958428,-0.22537807,-1.5668431407844163,-0.0747647017277047
80191,SIDM00673,SCH772984,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.3091521,-0.17191432,-0.9561520695031327,-0.0677470469947847
53509,SIDM00633,NU7441,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5025733,0.2685064,2.7854871915879733,0.10395600751594153
39049,SIDM00146,PF-4708671,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.385154,0.062333707,1.5340687925226746,0.027166149383234146
16343,SIDM00148,MK-1775,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.07092416,-0.0032098012,-0.5915742652822132,-0.026732626403836078
48048,SIDM00455,Dactolisib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6011662,-0.06501718,0.654193660132248,0.0499417596843416
73616,SIDM00097,5-Fluorouracil,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.09718832,-0.004667448,-0.3635395160096919,0.013220498563468937
94852,SIDM00216,Afatinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.8726012,0.111156605,0.6931703151509636,0.042077544858224104
76848,SIDM00877,Tozasertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.7562878,0.087408245,0.10687201845571423,0.00019011575015759054
65596,SIDM00146,Linsitinib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.4831765,0.04526526,1.982305073100682,0.07025399499162541
1800,SIDM00875,Alpelisib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6627357,0.06005691,0.9570750203376329,0.04815142365863965
107233,SIDM00633,JQ1,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2426245,-0.11901364,-0.6389646686689657,0.000590710072816876
6357,SIDM01042,Trametinib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6216223,-0.14298196,1.6489096874897493,0.07477518507376649
41377,SIDM00872,Crizotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5156503,-0.039749384,0.10937080108889476,-0.030784579314952258
63003,SIDM00776,5-Fluorouracil,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.932013,-0.06452032,0.40202989308861603,-0.0045416876657325
63625,SIDM00832,Camptothecin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-3.0756884,-0.19521308,-1.27743563080063,-0.07936966828104007
31667,SIDM00455,Dactolisib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.615991,-0.15793343,-4.0713221346960236,-0.20094535825882912
51993,SIDM00837,Linsitinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-0.61868393,-0.017064214,-1.05783914736649,-0.11388316640007505
24626,SIDM00097,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1113062,0.07711927,1.567887303908332,0.0721104142287208
100639,SIDM00776,Crizotinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.6735471,-0.05149831,-0.05834427436140408,-0.021948624281574947
76730,SIDM01042,RO-3306,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5986458,-0.07393195,-1.5427164639581596,-0.10280621100505234
34735,SIDM00826,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.2209053,-0.010782569,-6.403395882113568,-0.10453752326603384
58896,SIDM00928,PD173074,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.3086275,-0.032110397,0.3176265058396322,0.03646378587926149
36467,SIDM00455,LGK974,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.9538504,0.040638164,-0.1430925109205869,-0.01996786815260007
63320,SIDM00633,BI-2536,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1687558,0.1255929,1.256445797536097,0.046023647062180685
16389,SIDM00097,Uprosertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.50238,-0.13107817,-0.7412074004566793,-0.04787457717717648
95985,SIDM00673,Lapatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6466653,-0.055270646,0.9868077290693094,0.0294130514074538
77477,SIDM00872,Nilotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1823137,-0.016355436,0.08286746854185822,0.03511811950075955
61105,SIDM00146,Doramapimod,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.521654,0.22122566,0.5123704042020775,0.027483679342689162
83379,SIDM00148,PD173074,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.4683387,0.12679768,1.5257837439752624,0.07930197012073675
13444,SIDM00877,ZM447439,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.7753686,-0.07050211,1.1280971068016472,0.07745952006070735
19957,SIDM00933,Temozolomide,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.29031563,-0.013285075,-0.006396437167561075,-0.0011228644887930623
95203,SIDM01197,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.8304696,0.12515016,2.333904554158612,0.16566873349703615
86561,SIDM00835,Palbociclib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.7540528,0.022412756,0.5583085841141372,0.03574068710730421
17244,SIDM00826,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.28124887,-0.018424075,-1.832836618781967,-0.0842272867179426
100180,SIDM00146,Venetoclax,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.8165096,0.020588083,1.404007654770966,0.06463919187810054
104300,SIDM00928,Vorinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2535908,0.07992109,-0.04319373554583224,0.04550656630703792
96041,SIDM00673,Camptothecin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.38364163,0.010159352,1.2123944857922562,0.08467583515768079
74658,SIDM00216,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.746813,-0.098742634,-1.7632673375621302,-0.09150796847580246
17017,SIDM00097,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.127831,-0.054157205,-0.9905814801551581,0.020247123566143166
80175,SIDM00148,Alisertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8040227,0.12659164,0.5555013893191499,0.09129951464020812
46484,SIDM01042,Ribociclib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4230229,-0.070368245,-0.7325930837867523,0.026794871799192026
96454,SIDM00455,Dactolisib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.7315445,-0.15892486,-2.407504673608888,-0.17717381903671786
50318,SIDM00957,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.9837083,-0.025991635,0.7495008056819471,0.024696242294650415
28338,SIDM00835,Taselisib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.8594278,-0.10030915,0.35089275455811697,-0.05729699392573823
68366,SIDM00633,Pictilisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.70763075,0.045202255,-1.878246735144066,-0.11303162467118272
80382,SIDM00826,Oxaliplatin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.7524439,0.1753861,-2.8337144256783757,-0.11930080105832899
12680,SIDM00455,Erlotinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.5171647,0.13039586,4.971324592245269,0.18595992129160926
16681,SIDM00877,Cisplatin,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.33037648,-0.03194786,-0.7501430190770535,0.003994331049896881
57628,SIDM00872,NU7441,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4499792,-0.085760444,-1.0624814315652502,-0.05143300819936392
52568,SIDM00933,Afatinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.0709972,0.103951305,0.7347951452470348,0.08343929232530656
92083,SIDM00148,MK-1775,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.358112,0.016896792,0.11723036573132334,-0.026813108511509302
57692,SIDM00933,Luminespib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.08180651,0.0034692583,-1.2955742287997996,-0.045402448481463915
104890,SIDM01042,Afatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6317869,-0.07857948,-0.8255376357846381,-0.051175967712718956
94638,SIDM00928,KU-55933,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.10374637,0.0051309364,0.7784406649385097,-0.0029403580592571917
51165,SIDM01042,AZD7762,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1980827,-0.18333356,-1.2835170620578331,-0.12795689526773138
107242,SIDM00633,KU-55933,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3011863,-0.03709637,0.17460675213014126,0.028562496615868356
63981,SIDM00455,Erlotinib,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.76618594,0.017493699,1.936760812363507,0.055046686013620796
1581,SIDM00042,Trametinib,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.169644,-0.17706212,-1.13026203839823,-0.06540629940631375
89046,SIDM00146,Luminespib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.80450815,-0.06574492,0.36331454541799374,0.023808415855007987
22998,SIDM00950,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.5437975,0.34250578,1.821791539420892,0.15354538268874504
105851,SIDM00673,NU7441,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6622762,-0.0474718,-0.40683152510951354,-0.06888265473886303
62097,SIDM00877,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.4368697,0.049540214,-0.21841806445497486,0.036813635757949624
105649,SIDM00832,Trametinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.3772805,-0.08411199,-1.510862392235265,-0.04504080909333334
102725,SIDM00282,SB505124,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.6311895,0.021741651,2.013015160970179,0.10257389619035744
35428,SIDM00673,Temozolomide,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.15823546,0.0024322113,0.5664198978711074,0.015978842054540084
98487,SIDM00877,Luminespib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0827664,0.09769441,0.32500468551596856,0.009133502951160785
38132,SIDM00776,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,0.45529386,0.028000573,-0.6535547759783871,-0.0034820020138070468
85747,SIDM00877,Nilotinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.32507968,-0.0315801,0.6738529946502143,0.09322598410758616
65066,SIDM00673,SCH772984,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-4.2720437,-0.2967205,-0.6914976388197357,-0.10011890672363055
38676,SIDM00097,PF-4708671,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.539796,0.19197814,-0.23539601710335112,0.03054998322096012
1424,SIDM00835,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.0863712,0.20315854,1.454635080605527,0.06227200988840552
23692,SIDM01187,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9060364,-0.04387906,0.16113066175221935,0.029346911635526152
107879,SIDM00928,NU7441,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.591758,0.06919349,-0.340309167326097,-0.03576771207097179
85977,SIDM00282,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,2.3354657,0.13386108,-1.131262745139999,-0.09476124556625228
60872,SIDM01197,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7176747,-0.10915462,-3.153948627933947,-0.13800190652810132
67807,SIDM00957,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,0.10224722,0.00424833,-0.8263861225160073,-0.08065061048672985
63988,SIDM00875,OSI-027,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.80461925,-0.06368971,0.12145191351132442,0.016864398920488466
86,SIDM00872,GSK269962A,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6942061,0.06995089,-0.29587400452921925,0.00032743756766481395
4114,SIDM00875,Crizotinib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.19301695,-0.022503871,1.2624393167487773,0.06652777910589618
78753,SIDM00216,AZD4547,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-2.471685,-0.043836646,-0.005892376100720019,0.029754161707587445
90688,SIDM01042,GSK269962A,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4878879,0.18378305,-0.18360652408639208,0.0001610119077369144
89422,SIDM00877,Alpelisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-1.3413551,-0.15279229,-0.18769682904376628,-0.033054263449809655
921,SIDM00833,BMS-754807,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.7519122,0.059313703,-1.8155083223579505,-0.08290603584299032
26872,SIDM00146,Entinostat,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.102001,0.18183498,-0.6872832262213013,0.021489019906933242
22197,SIDM00673,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.5020753,0.14641888,2.779163583442521,0.17097474429270423
4283,SIDM00928,AZD8055,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.1984804,0.23145114,0.19570639528861583,0.052532315934577474
15696,SIDM01042,GSK269962A,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.62006617,0.07067936,0.22955926700100007,-0.03265030496596621
78598,SIDM00673,Nilotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.363458,-0.09707358,0.35197922724088454,0.08753288820279781
16944,SIDM00832,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-2.8148842,-0.16275555,-1.7690975858979698,-0.14967656100532764
22549,SIDM00933,GSK269962A,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,3.708232,0.3394424,2.3765229638742515,0.2114854541163275
5584,SIDM00957,Taselisib,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-3.3160973,-0.08808663,-0.24545855397179991,0.06229586993637337
11022,SIDM00146,Taselisib,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-3.1896293,-0.19559096,-1.0883827107465882,-0.03242096684878493
33198,SIDM00877,Alisertib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.96582884,-0.0490696,1.0096187479731074,0.10004461521176304
70297,SIDM00877,Axitinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.766191,0.19921304,1.0021971466093558,0.15201264447857227
100523,SIDM00957,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.4704667,-0.015057391,1.0977256192112108,0.037000199450307775
31597,SIDM00928,Vorinostat,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.4096062,0.141294,1.026135133906751,0.08026314905456232
89474,SIDM00933,Pictilisib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.799551,0.20853285,-0.9590628071731926,-0.06583949257805281
80089,SIDM01187,Pictilisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.9329075,0.10665631,-0.06836430642569558,-0.0003787828257367379
106854,SIDM01042,Bortezomib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.30737466,-0.019443166,-0.4038134762252368,-0.06619632001592875
84820,SIDM00282,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.0121439,0.06533853,-0.7113029360965127,-0.06925802348024439
77521,SIDM00042,Crizotinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.0560331,-0.17650093,-0.06720157427418247,0.010289718343443936
36844,SIDM00455,Dasatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1854345,-0.03909986,0.45768032513940066,0.01317230981532907
75774,SIDM00832,BMS-754807,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0557326,-0.043059826,-2.7111240964362096,-0.05662125860340479
89299,SIDM00928,Olaparib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.0956836,0.11659659,-0.4391568795507308,0.0217533272177267
98519,SIDM00146,Gemcitabine,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,6.3434443,0.19760036,0.09512433057474033,0.002693595904508569
64781,SIDM00216,MK-1775,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.09564968,0.003666619,-1.3299816865436145,-0.002780148588853269
89904,SIDM00933,AZD7762,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.56698203,0.045549106,-0.34316562570693865,0.017912878747700887
5399,SIDM00877,ZM447439,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.7256503,0.05124144,0.9984121912220346,0.05817886335034953
87262,SIDM00826,Trametinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.2205112,-0.009633948,-4.02842834668957,-0.04917472972032952
57813,SIDM00950,Crizotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3982145,-0.114510246,-1.827209844756822,-0.10082520860499958
55832,SIDM00877,Crizotinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.6662635,0.061509144,0.1356493021036238,0.03645878470493343
100628,SIDM00097,AZD7762,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.185777,-0.0394673,-0.8714561204705776,-0.025094757971436583
39683,SIDM00673,Sorafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2576393,0.080818735,1.0938122527468364,0.07704697113342465
88853,SIDM00837,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.47665218,-0.021197487,-0.5165076949089239,-0.08682922021712301
37066,SIDM00928,Temozolomide,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.1578002,-0.029171837,0.15236005286049595,0.03612094569594003
69159,SIDM00776,AZD8055,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.8441982,-0.071147315,-0.3597276401407682,-0.0827543770609955
90241,SIDM01042,Crizotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2706076,-0.13540818,-1.6805495293282056,-0.09469207591257818
93455,SIDM00097,PF-4708671,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.166212,-0.06291906,-1.017556382374882,-0.03319074535052676
101611,SIDM00359,SB505124,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75984645,-0.036779176,-1.528674495686049,-0.03241991823492835
82732,SIDM00455,Paclitaxel,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3247617,-0.062092215,0.1891664937044681,-0.06938405362853789
113,SIDM00875,Luminespib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39765707,-0.04338731,-0.9051122446799604,-0.10289645112547695
74846,SIDM01187,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.12750567,-0.007563252,-0.85172877218112,-0.02286283942358379
28757,SIDM00872,KU-55933,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4884393,-0.090532295,0.35114129658424054,0.019612205891727696
12827,SIDM00837,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,0.9023801,0.023709456,-2.211732414096644,-0.14224126951579097
9150,SIDM00826,AZD8055,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.90813327,-0.02939676,-2.2076676907943793,-0.06861543143157803
103696,SIDM00097,Dabrafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.3912232,-0.12298773,-2.223577924448419,-0.07891768996584521
22853,SIDM00837,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.7058291,0.03655506,1.1152012421364328,-0.001844164878295543
12709,SIDM00833,AZD8055,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.8893863,0.044901375,2.470522585380224,0.09530830470229944
93656,SIDM00673,Venetoclax,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.654114,-0.017514851,-0.3987255182304168,0.04980223092726373
95490,SIDM01042,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.185726,-0.098888,-0.0010871984238022135,0.02474891261392466
31682,SIDM00928,Entinostat,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2050238,0.13639326,-0.6222570539361253,0.02796216079892369
54164,SIDM00837,AZD7762,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.6170727,0.01675292,-0.8275968386698177,-0.07079690268718802
35799,SIDM00837,LGK974,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,3.7854855,0.19623074,-0.047145617975766746,0.0149412102350907
97940,SIDM00148,PD173074,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.2363043,0.14328457,1.1212700288077968,0.007583852926239236
27409,SIDM01042,5-Fluorouracil,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.1924953,0.05714593,2.4573134846825146,0.06352857437732395
53506,SIDM00146,JQ1,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,3.4543912,0.18101865,2.0084583510926377,0.12110120176906428
45481,SIDM00146,PF-4708671,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.6953495,0.060801122,0.3823077254747277,-0.0005329838678087523
71456,SIDM00833,Oxaliplatin,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.8116127,-0.06228878,-0.9464390026513683,-0.09890665217636761
21047,SIDM00359,AZD4547,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.588206,0.21666417,-1.0020268807088888,0.02879135478231897
79522,SIDM00950,OSI-027,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5658853,-0.10167535,-0.31899022933793403,-0.05535886181988024
46980,SIDM01187,Navitoclax,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.23146996,0.022422321,0.39356657017535684,0.010513345550280669
92300,SIDM00832,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,2.3697789,0.08369826,1.8224181642091766,0.11231619611737904
40203,SIDM00872,Afatinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.535841,0.05710448,1.493406309555141,0.0969679366263081
98258,SIDM00097,Crizotinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.69324607,-0.040131476,-1.0531770180479116,-0.07253275326878544
73728,SIDM00933,Axitinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-1.2652622,-0.16710983,-0.7033904127781936,-0.02810627589032506
4977,SIDM00835,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,5.9387774,0.3801881,4.0715564913833875,0.1843694333946482
93764,SIDM00633,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8784741,-0.038153253,-2.1886349781476655,-0.10191713926679206
60819,SIDM00832,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-3.2127092,-0.100089386,-2.1247133876657482,-0.138289372201992
53043,SIDM00875,Camptothecin,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2685269,-0.14519125,-0.6632214625129761,-0.06084444825172976
91339,SIDM00633,RO-3306,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.331682,0.105358124,0.3919735217359398,0.014766061692580367
91665,SIDM00673,Ribociclib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.7381396,-0.05901345,-1.857317941537378,-0.03066508440152768
37460,SIDM00872,KU-55933,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5228161,-0.06667524,0.057319807959826816,0.013555509735324238
72338,SIDM00928,Venetoclax,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.49109334,-0.010538126,-0.33503062520478727,0.0006348324144850752
50000,SIDM00933,ZM447439,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.4462142,-0.07589544,-0.6513641971041338,-0.004913872170219846
16951,SIDM00216,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.33431768,0.021695215,-0.42473082629859477,-0.014366838593434841
64258,SIDM00933,Ribociclib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,0.398023,0.009485546,0.24734305328290707,0.017111018364551804
100408,SIDM00837,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.654737,-0.100344524,-2.4339293386326117,-0.1701606181231547
59755,SIDM00148,Ribociclib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.6074789,0.34481,-1.719602824100792,-0.012098478800387604
19449,SIDM01197,Navitoclax,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.0038695,-0.29203075,0.49887486160714484,0.05318593960974506
27118,SIDM01187,MK-2206,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.69509315,-0.055958577,-0.5261104130820161,-0.001375545750311582
2056,SIDM00148,Palbociclib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.1842942,0.20018099,0.7156877829337924,0.07259686889735167
71636,SIDM00282,Crizotinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.5480559,0.027628709,-0.6855696536611675,-0.029453028208963682
105110,SIDM00148,Luminespib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.45047814,-0.03940371,0.36481993436048754,-0.011594495240219724
62238,SIDM00042,Oxaliplatin,SCH772984,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.995606,-0.13038681,-2.031948824744983,-0.08686952490930056
75435,SIDM00933,Axitinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.594613,-0.053927675,-1.0781294386919527,-0.06492147271157472
81733,SIDM01042,Vorinostat,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0695227,-0.09125589,-0.8236842745431184,-0.0005357265431791267
107908,SIDM00872,PD173074,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.96078473,-0.043177627,-1.1316518464837335,-0.029353124380516564
102552,SIDM00776,5-Fluorouracil,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.8105819,0.039086156,0.1375105931184353,0.036170003656999405
5985,SIDM00146,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.036158323,-0.002804277,0.40510384361774643,0.044076788110288645
92994,SIDM00148,Afatinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3426188,-0.029384864,-0.5613185843268985,-0.049743593001320016
6563,SIDM01042,Doramapimod,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.45241725,0.020190798,0.4455178608456301,0.007884442167439602
17402,SIDM00833,AZD7762,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.4413011,0.113094084,0.09390040521989709,0.016392367980470637
71274,SIDM00673,Cisplatin,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,4.3259764,0.24765028,1.0605757799439541,0.057504590432350546
27247,SIDM00928,5-Fluorouracil,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.2069577,-0.05044701,-0.6594157455241084,0.021261538979476986
9670,SIDM00928,Crizotinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.0003393,-0.08880551,-0.3241458923710968,-0.03739051668726537
74050,SIDM00673,Axitinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,0.46004188,0.049276643,-0.4212014438723976,-0.06337574078209213
97133,SIDM00928,Taselisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.196745,-0.104356885,0.7318732445105615,0.016318079609709022
64001,SIDM00928,Docetaxel,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-3.9837954,-0.347546,-1.8488626994535344,-0.19888927264855352
38194,SIDM01187,MK-1775,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.8999101,-0.15210487,-0.9506370152593274,-0.03946934448194225
36695,SIDM00872,Sorafenib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3181096,-0.13377513,-0.16779471901952728,-0.03955393392749406
43278,SIDM00216,AZD7762,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.8630822,-0.06968209,-0.7331492075805024,-0.07888139229990077
9226,SIDM00875,MK-1775,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.208943,0.010924893,-0.2624513575914829,-0.018593236689303624
102354,SIDM00673,Gemcitabine,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,3.2109487,0.28591236,3.374413972014835,0.17205026664276427
36900,SIDM00359,BMS-754807,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2468898,-0.10416642,-2.165446246634127,-0.1148843846822696
44430,SIDM00146,Gemcitabine,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.7169168,0.12228465,3.4122280525783224,0.1373929171150217
8173,SIDM01042,Dabrafenib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0037222,-0.1487492,-1.9134020314262534,-0.09101276907633801
23674,SIDM00875,Crizotinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6341188,0.06704714,0.913241041573239,0.02841423791057558
76488,SIDM00216,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.07066,0.01882396,0.8531345835232637,0.01753929246876059
61140,SIDM00872,Entinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9741066,-0.10669466,0.6763873949205235,0.034261575523013954
17019,SIDM00928,Axitinib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.6944026,-0.053955473,0.5126131170620702,0.030345397376491976
8723,SIDM00455,Taselisib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.689993,0.112069234,-0.24759608773229855,0.0037153793220584303
38380,SIDM00216,SCH772984,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.9116205,0.05755572,-1.1748869818125145,-0.07546840040706079
21883,SIDM01042,Lapatinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2825588,0.15377319,-1.6783248407922,-0.11763905411956889
72794,SIDM00146,JQ1,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.64697933,-0.05513606,-0.08942448972608147,0.024584278231773657
70929,SIDM00933,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.5529667,-0.036472753,0.13785860825446963,-0.019657214212725732
101489,SIDM00835,Navitoclax,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,0.83701813,0.050457403,0.7306419875928408,0.004818692973788569
73874,SIDM00832,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.9895928,-0.04676037,-1.5962848539001921,-0.011680079305695267
95359,SIDM00832,BMS-754807,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.6667896,-0.023530323,-0.4916541169048506,-0.006545814365682381
11196,SIDM00872,Taselisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39900762,-0.022106787,0.24202828277997146,-0.061788913311497766
34550,SIDM01187,Taselisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.48725456,-0.041343395,-0.8491848801983259,-0.02741172361534536
95128,SIDM00933,Dabrafenib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.2109369,0.10873522,0.4927920869294675,0.08561815222710728
66253,SIDM00872,Gemcitabine,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6359532,0.06417383,2.7115727470320667,0.13074204762911376
80664,SIDM00877,Docetaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.6227342,-0.07425423,-3.678605256316525,-0.18698250620382204
54744,SIDM00950,MK-1775,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.69587094,-0.061736763,-0.14317575502270222,-0.013696910247286786
101647,SIDM00146,AZD8055,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.31552348,-0.019532537,-1.4936498497472341,-0.134197766575335
101540,SIDM00633,RO-3306,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0011853,0.08915833,-0.34560425204150674,-0.029402312746202443
104133,SIDM00957,Dabrafenib,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.766192,-0.02055535,0.9438687949611937,0.03841089005303138
46435,SIDM00097,Olaparib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6419692,-0.032928802,-0.602874844609817,-0.008290459503289733
106004,SIDM00146,Tozasertib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.429917,-0.08790389,0.4589681042702188,0.043941987246136925
35192,SIDM01187,OSI-027,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.2809782,-0.02381728,-0.9344417621342852,-0.08072516427241885
60007,SIDM00875,Taselisib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4932157,0.04292894,3.039761391487323,0.10907958420687851
63590,SIDM00633,Doramapimod,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8631824,-0.14911206,-0.5367085636531901,-0.030937438607955735
55075,SIDM00633,Palbociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3475559,0.042199746,-1.0368991337835878,-0.00045124002598736053
99684,SIDM00877,Doramapimod,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3869501,0.14431098,0.9939577095596657,0.0418016864842442
35853,SIDM00928,PD173074,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.9815542,-0.023599528,0.5319214602175717,0.039958258514381464
16820,SIDM00148,SCH772984,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0522172,0.05164118,0.1978144506384033,0.04274571749945407
107598,SIDM00633,Pictilisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.54006404,-0.037940808,-0.8008968249196726,-0.07330796081756784
51091,SIDM00216,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.9929748,0.081334084,0.4605444037331798,0.06084243733459032
37220,SIDM00673,Navitoclax,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.965864,0.10891817,2.2650716942627724,0.045877948658478794
37148,SIDM00148,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.46860752,0.04204431,-0.7918700282795305,-0.03520194576385587
89588,SIDM00837,MK-1775,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.53981775,0.012990547,-1.5860507570270919,-0.08055907614072295
26224,SIDM00776,Camptothecin,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.6667257,0.047132477,-0.8753014555933104,-0.02252418493849381
7732,SIDM00673,Trametinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.9664938,0.09458006,-0.41589947457821275,-0.02678776545086226
58645,SIDM00148,ZM447439,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.178946,0.25186622,2.0930268036407993,0.06210404255671425
47323,SIDM00633,Trametinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1461365,0.054004453,-0.43444384927456237,-0.03402928026971491
27104,SIDM00950,5-Fluorouracil,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4071995,0.11581992,-0.26890839139618966,-0.008149001000282553
28545,SIDM01187,Navitoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.13455887,0.013996477,-0.8369590769885671,-0.05620077703783879
18633,SIDM00148,Trametinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5354702,-0.040833313,0.5864208292793694,-0.0063389625194695005
9139,SIDM00928,Palbociclib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.6500742,0.2177308,0.897493893164236,0.02152876617048768
23595,SIDM00950,AZD7762,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4339341,-0.028588215,-1.252505193482842,-0.05637311045887601
8365,SIDM00933,Sorafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.5347596,0.04311881,-0.19864516224337828,-0.020637940109811473
1117,SIDM00216,AZD8055,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.6605259,0.12253179,0.026102221348257352,0.00114580976185131
91711,SIDM00928,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,2.4806569,0.21818975,1.3623796029037163,0.06155372161308145
105528,SIDM00673,Venetoclax,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3396512,0.0455822,1.252189797306852,0.11214809721870755
13894,SIDM00097,Axitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.9985604,-0.1647432,-0.9893884330660242,-0.05931075072342138
86884,SIDM00950,Cisplatin,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.90871483,-0.040297173,-0.6393781169574917,0.02500894633773153
107121,SIDM00933,Nilotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.7764727,0.05702513,-0.19081330591719214,-0.04920374957741223
75985,SIDM00633,MK-1775,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.4192953,-0.17371264,-1.4550955381930883,-0.05637994404089268
74805,SIDM00042,Sorafenib,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.2403855,-0.06415734,-1.4176847259053116,-0.08176561511506795
87801,SIDM00875,Crizotinib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.144238,-0.03212812,-1.0069145754250504,-0.05768721615572268
6118,SIDM00042,LGK974,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.0758392,0.0704227,-0.8105851900513007,-0.01590880734491887
52814,SIDM00833,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.0973954,0.11520735,0.5773567152085939,-0.0032581396180943497
17978,SIDM00877,Luminespib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.45241058,-0.03975982,0.29784353606447705,0.04863603968305325
14141,SIDM00216,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.1744027,0.18191887,-0.20916385787639694,-0.029778078994868937
85597,SIDM00875,Doramapimod,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.550829,0.045603845,0.9121297088472264,0.009756372000653303
11527,SIDM00146,Lapatinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7201455,0.065872826,1.4879191417782625,0.1493911574789348
8145,SIDM00455,Lapatinib,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8356085,0.09627772,3.0556412292732524,0.16787787694466477
28619,SIDM00097,5-Fluorouracil,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8116233,-0.12404557,1.287526487093483,0.07576067213842108
73131,SIDM00835,Palbociclib,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,73.0,-1.2082734,-0.026812637,-0.38976741264655157,0.009329262948322732
24293,SIDM01042,Afatinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8396267,0.08821706,-0.7293136045031389,0.017017150248468525
107912,SIDM00933,NU7441,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.6288805,0.06547359,0.11131981006614308,-0.02829563008769711
12975,SIDM00950,Taselisib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7852826,-0.079627976,-2.970358528062565,-0.1259630578622976
67154,SIDM00826,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.534932,0.029547442,2.6957718593630515,0.08685999042969499
11845,SIDM00146,RO-3306,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.26400104,0.021757688,-0.027534923416677768,-0.053081282746905684
59922,SIDM00877,SCH772984,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0948321,0.035383135,0.9434003650451452,0.09115670903586895
25598,SIDM00097,Cisplatin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5302054,0.034435816,0.9028727671776741,0.03981558080422835
72046,SIDM00282,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.74561906,-0.011821876,1.9289441762720332,0.08059734262221789
58035,SIDM01042,AZD6482,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.91497594,-0.057532836,-1.279665608162862,-0.14381072779678586
70600,SIDM00282,AZD8055,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,0.2462587,0.013158343,-0.0939046953528283,-0.004152067491702897
63174,SIDM00826,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-2.1233962,-0.036041103,-2.7215291426642176,-0.08474420381485466
66257,SIDM00776,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,2.2641335,0.16575491,2.0248797266508363,0.07328524163957156
71579,SIDM00097,Alpelisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7946431,-0.05753152,-0.5539136129765704,-0.018453788690286188
7301,SIDM00633,Alpelisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0085083,-0.10331585,-1.3656799127603791,-0.044990026232051325
81838,SIDM00928,AZD7762,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.227305,0.21181367,2.6341343091508658,0.18096410391547207
61235,SIDM01197,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.269982,-0.11409596,1.4399789722829779,0.10780684362175434
49626,SIDM00826,Camptothecin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,3.7658472,0.357915,-0.03560489636168676,0.07123639954094292
78383,SIDM00148,Navitoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.33306515,-0.03108369,0.022928753827186905,-0.057160470447147844
31110,SIDM00872,JQ1,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.34346703,0.009522544,2.186043097526722,0.0993293310399244
43701,SIDM00875,Cisplatin,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.348005,0.019977825,0.44254227818377484,0.015490255054498553
11897,SIDM00875,Sorafenib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3932226,-0.038213003,-1.1527902234973402,-0.02426125868407676
78782,SIDM00097,Linsitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.789357,-0.092569165,0.2590341615294223,0.05486302960876
32713,SIDM00957,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.8435078,0.065801024,1.4607808073416826,0.0738140778903014
90994,SIDM00875,Navitoclax,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6545105,0.071565665,0.4850153799529426,0.04281067951938
88476,SIDM00216,BMS-754807,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-0.48122823,-0.016472025,0.9987506336471659,-0.01593886128619805
51860,SIDM00872,OSI-027,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,2.4372976,0.26206747,1.4914824627778671,0.11015650723091054
61719,SIDM01042,5-Fluorouracil,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.11251658,-0.0051287045,0.07388880097418304,0.0023374423201167043
83261,SIDM01042,MK-2206,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.62815523,-0.023799552,-1.0339340876755565,-0.040291087786838965
104082,SIDM00835,Navitoclax,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.54443467,0.03589874,-0.10379968369604858,-0.0012816441440419496
100472,SIDM01187,Trametinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.41610658,0.021411126,-1.0357457500414708,-0.016109862361767025
26458,SIDM00835,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-2.077129,-0.0526288,0.49406679685618055,0.07462317195725408
57180,SIDM00837,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,4.2843194,0.17651474,-0.6952128565429814,0.009275335667845191
66517,SIDM01197,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,East Asian,71.0,-6.6775455,-0.35809234,-3.8462606618704274,-0.23015577586259037
73718,SIDM00833,Crizotinib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.5163502,-0.029946437,0.5942465750434784,0.08012774068727165
71051,SIDM00359,Trametinib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.79902077,-0.032201193,-3.7330008297631894,-0.05461335068664072
104609,SIDM00837,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.0087955,0.047496308,1.2033672102411699,0.04989349632220818
10782,SIDM00148,Crizotinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0854058,0.097710826,2.2093216261179474,0.1016135584618302
56252,SIDM00042,Sorafenib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.2497129,-0.017893346,-0.786202909914539,-0.004634019597264383
21678,SIDM00146,Alisertib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.9380512,-0.08360831,-1.1405332683051326,-0.011161994378583803
48969,SIDM00673,RO-3306,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.5563599,-0.084388934,-0.5058483842613483,-0.04923279909594559
10440,SIDM01187,5-Fluorouracil,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.857961,0.23235652,-1.3714617899562844,-0.06500526712388865
37652,SIDM00877,KU-55933,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.77239937,0.05332824,-0.22023584246481867,0.008306717159312143
45704,SIDM00146,OSI-027,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.4112022,-0.13114713,-1.2982701283430453,-0.0795498738121188
4994,SIDM00455,Oxaliplatin,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.0619586,-0.07525409,-1.9470962748401426,-0.002464061787020078
27964,SIDM00216,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-0.66173583,-0.00749988,-2.2006044984619386,-0.08309026213776573
73111,SIDM00833,SB505124,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.108255,-0.03681015,-1.8790734319618387,-0.09108703662625427
100073,SIDM00673,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8476069,-0.1565978,-0.31217029087393017,-0.029428651354592536
103613,SIDM00933,PD173074,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.08817099,0.0089968,-0.5294260620375502,-0.021566767589169634
34202,SIDM00933,RO-3306,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-2.3758507,-0.21425022,-1.2672269222289618,-0.11679765463471989
47554,SIDM00282,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,5.4848475,0.09112722,2.550233887941601,0.08121261273981188
82892,SIDM00877,AZD8055,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.370321,0.14419495,0.6286062204834397,0.05732073530999976
4809,SIDM00933,Lapatinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.0354427,0.0747521,0.9133489633870829,0.10804310742262623
15917,SIDM00872,5-Fluorouracil,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.61697984,0.03654976,-0.0632952690130433,0.01078299347709675
2432,SIDM00832,Oxaliplatin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-1.4819409,-0.1108648,-0.7505338005091857,-0.03659230645358848
96318,SIDM00633,NU7441,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3884538,0.09838253,1.1654464526801176,0.06019212941152948
50651,SIDM00832,Trametinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.5741382,-0.12537283,-2.483264705213444,-0.09019503043921163
105088,SIDM00933,NU7441,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.0360513,0.24618284,1.5773033333461048,0.1230353326714938
70211,SIDM01187,Navitoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0221126,0.09461463,2.616105890387456,0.11328661086313882
22948,SIDM00928,Lapatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.3484278,0.11095926,0.25012620752545484,0.10467381255729981
78247,SIDM00875,Camptothecin,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.77136743,-0.07004289,-0.6552593489370884,-0.03797202998078813
10013,SIDM00148,Pictilisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4627686,0.08290192,0.35098874238896266,0.0313124714106751
64395,SIDM00455,Cisplatin,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.191476,-0.07096994,-0.8795239787246003,-0.04087427962497827
19448,SIDM00146,Venetoclax,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.8308985,0.105603114,1.217097763595133,0.056397074147892905
86767,SIDM00359,Palbociclib,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5526639,-0.04462178,-0.7181575208765663,0.021313945889890468
42343,SIDM00928,Palbociclib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,3.7909834,0.34446514,0.7429685138061728,0.037915239375297796
107274,SIDM00877,Alpelisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.09428595,-0.010803825,0.14901566755251752,-0.022207611950679912
598,SIDM00097,Bortezomib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.67125046,-0.03607729,-0.0023779598418197717,-0.02384630953745125
852,SIDM00877,JQ1,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.14153434,-0.014335665,0.3771339529957948,0.0406021517973412
35286,SIDM01197,SCH772984,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,0.55813015,0.017443795,-0.8551249091068976,-0.017066611346096945
65024,SIDM00146,Pictilisib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-0.87810624,-0.07039496,-0.8263341726465833,0.008700229387010509
13728,SIDM00455,Dasatinib,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,6.68966,0.42364153,1.9598966176170372,0.13281602966397157
59492,SIDM00673,PF-4708671,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.4891171,-0.056314096,-0.5201705956936687,0.013910977210222986
104387,SIDM00950,Oxaliplatin,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6640256,-0.041308306,-0.6142034290302022,-0.020858286825359545
26244,SIDM00455,AZD7762,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.3154993,-0.12448378,2.768590382481954,0.2524824157833842
15700,SIDM01187,PD173074,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.89498675,0.07583025,-2.3308482721424597,-0.12542324004482802
66422,SIDM00877,Crizotinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8729189,0.073386796,0.9407827856451239,0.057692054016108586
72624,SIDM00928,Palbociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.7897258,0.17516029,-0.0818016068447042,-0.015879423516638735
106388,SIDM00633,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.94796073,-0.026759677,0.6148868709601951,0.02664072346427357
33398,SIDM00633,Alpelisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5074395,-0.049056344,-0.39292243210469996,0.002688533475968419
90759,SIDM00826,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-4.3324156,-0.1991697,-2.449641732698524,-0.09492858791911378
4710,SIDM00875,Trametinib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30604362,0.033168755,1.400039016644105,0.05929079321603757
27926,SIDM00832,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.2682966,0.09776161,-0.6868428430988214,-0.013514764440662892
69934,SIDM00837,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-1.9079998,-0.029514082,-1.8895002704795063,-0.046701585330720385
101670,SIDM00633,Docetaxel,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.6103761,0.28284633,2.1038910442943854,0.1440513273648625
29845,SIDM00148,Trametinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.77068114,-0.017712625,0.8156040645151882,0.01921797736606934
101339,SIDM00146,RO-3306,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.27448598,0.02404722,-0.8917556789251002,-0.0856659905512357
106185,SIDM00872,Bortezomib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.27936286,-0.021663135,-0.3841701402723592,-0.026797901807939197
59322,SIDM00933,Sorafenib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.50870526,-0.04542722,-0.4335722626870836,-0.046042822806385934
60412,SIDM00282,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,5.091069,0.1870669,2.3085170577121863,0.13001624310341328
49082,SIDM00928,MK-2206,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,5.5003424,0.3167905,1.5914706810885144,0.10467828856256187
33949,SIDM00359,SCH772984,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6680495,0.0969244,-0.7337975381842173,-0.012614436460627505
44727,SIDM00673,Dabrafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.5554113,0.033527642,2.0112156893785946,0.04650014345433505
58266,SIDM00633,PD173074,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7254767,0.021667473,-0.30944234442804397,-0.013600960921278937
64546,SIDM00097,Camptothecin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9895263,-0.08113165,-1.191798503458239,-0.024158352139052118
31538,SIDM00633,PD173074,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.19674112,0.0057940297,-0.4096129892144648,-0.006518853409353183
30611,SIDM00216,AZD8055,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.7935061,0.13368922,0.09993427237896597,-0.03075158270820666
60666,SIDM00872,Alpelisib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.58102345,-0.05698823,-0.06771601939163831,-0.03527250006802795
54531,SIDM00097,Afatinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4942906,-0.09887861,-0.03589605167841601,-0.0201382323222041
63336,SIDM00933,Nilotinib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.3864911,0.11660952,-0.23775360210091595,-0.02429173877276177
35931,SIDM00097,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8603079,-0.052015737,-1.0340168546847046,0.002552961339138005
38180,SIDM01197,Camptothecin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,2.8963912,0.21030737,-0.6169790619067593,-0.00942956529548724
49215,SIDM00928,Gemcitabine,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.0940918,-0.1133049,-1.4017803961844943,-0.17934392594307172
102778,SIDM01042,Dabrafenib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.59965324,-0.05067114,-0.9915530471681643,0.00030785094371899317
44227,SIDM00877,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.316241,-0.19672798,-1.1646498180342946,-0.03813114788337514
79334,SIDM00146,Nutlin-3a (-),Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.59026456,-0.016713666,1.3558681611352368,0.08166606190960511
38863,SIDM00837,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.2567701,-0.06309547,-1.5367688677972753,-0.03132417344408323
14016,SIDM01187,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.30245012,-0.017220542,-0.9154671937902602,-0.04478573055452045
60659,SIDM00872,GSK269962A,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.85344857,0.08864831,-0.3257188401535247,-0.0011501113646678013
104640,SIDM01187,Palbociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9405061,-0.10024106,-2.447312639271408,-0.08341475679986766
70918,SIDM00875,Vorinostat,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1209177,0.10902627,0.7587763291322779,0.021569329730517756
6403,SIDM01197,Camptothecin,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2561716,-0.05107278,2.338895456407526,0.13277318410881744
102570,SIDM00928,Nutlin-3a (-),Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.313795,0.030779695,1.6825699708077284,0.05818400919062504
71122,SIDM00148,5-Fluorouracil,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.49207973,0.03197349,-0.6164635017385895,-0.03970763579713841
26944,SIDM00673,Paclitaxel,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-5.1564465,-0.31400073,-3.9796075611185215,-0.3019492445648034
87267,SIDM00146,Venetoclax,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.29125854,0.0068429722,1.5867516511831097,0.08527763658022353
32369,SIDM00148,Alpelisib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.89645225,-0.08937501,-0.2003282171223136,-0.040339837928575664
17330,SIDM00957,Trametinib,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.5139593,0.068512306,2.712006808639406,0.16354440138368076
93458,SIDM00148,Luminespib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.42495415,-0.03664128,-0.05657822269398452,-0.009757523502525374
22999,SIDM00950,Palbociclib,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.528238,0.28854382,0.4162234577472082,0.0451204847809391
102298,SIDM00877,SCH772984,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.9768583,0.05153589,3.629756691189182,0.13403910085457577
62651,SIDM00933,Navitoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.15990032,0.017959388,0.5123895347741969,0.04419839736306515
10843,SIDM00875,Gemcitabine,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0098975,-0.0025263545,-0.6853924342106716,-0.007003526890283814
41455,SIDM00148,Ribociclib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.559154,0.13825843,-2.062812635734855,-0.05437505758966322
38684,SIDM00776,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-0.7062765,-0.04632836,0.06436521592941251,-0.011875300088028316
87560,SIDM00837,SB505124,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.8299476,-0.034926284,-0.16622499190895995,0.024095398848589505
67558,SIDM00933,Luminespib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.49785024,0.016633976,-0.7800136028165049,-0.033056394669487274
6985,SIDM00673,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.8747779,-0.090527564,0.38189029465602287,0.01263516966425162
17265,SIDM00933,PD173074,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.6049643,-0.06454825,-0.08519551241057972,0.044933318801099555
99781,SIDM00950,Taselisib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.28402,0.13346563,1.9092317556751666,0.1355720022068696
70534,SIDM00837,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,-2.2622871,-0.11601901,-2.842314117220105,-0.16647586572649994
82881,SIDM00097,Nutlin-3a (-),AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.305583,-0.075450435,-1.394017227239568,-0.04314996525937514
6629,SIDM00633,Doramapimod,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8918138,0.08503423,-0.9423079534690165,-0.011593359145714922
35128,SIDM00875,Paclitaxel,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8118193,0.12573783,3.1602029203222086,0.10386850822362147
97208,SIDM00146,Doramapimod,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.4986393,0.08300029,0.35978693424992847,0.0275520934755588
38043,SIDM00875,Docetaxel,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5411528,-0.118296236,-0.5212503356173755,-0.07486548343130192
46261,SIDM00148,Doramapimod,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.1100497,-0.11191439,-0.06545472124150138,0.010259802825858644
39988,SIDM00633,SCH772984,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.5447493,0.1048106,1.4306014248641963,0.10955014200639838
19193,SIDM00146,SCH772984,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.9210877,0.2077048,-0.17491247701801002,0.004146040388139658
71660,SIDM01197,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2901201,-0.10644211,-1.8349998946040902,-0.098735829552207
5544,SIDM01197,Crizotinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.63369644,0.016111348,-0.17433200962656853,0.023103791186048103
101312,SIDM00455,Erlotinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.4825332,0.13733053,2.336317789734854,0.07764222096903685
90693,SIDM01187,Docetaxel,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0536742,-0.07632323,-3.0731374040792248,-0.21435133972514006
85604,SIDM01042,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.96350956,-0.02907401,0.20122077906019417,0.003476748905272691
16842,SIDM00633,Paclitaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4603295,0.07865405,0.5476804230697775,0.060609413827968195
15053,SIDM00097,SCH772984,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7067368,-0.11920299,-0.5100340176470014,-0.06862925738433935
39039,SIDM00146,Uprosertib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.8932841,-0.10223323,0.023873478621763134,0.10636704001451819
84909,SIDM00835,MK-2206,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.9216046,0.16838802,-0.15347016310396172,0.041896675002685346
68815,SIDM00928,NU7441,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.66269666,-0.08078606,0.33549641248563944,0.02409135421185428
90393,SIDM00872,Venetoclax,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.530743,-0.0706857,-1.3308762352753325,-0.012818127760774966
9785,SIDM00673,Linsitinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.7177393,0.0154681625,1.653375561256485,0.018555927081518018
65948,SIDM00776,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.9647031,0.06617049,0.7940822839106391,0.096267772635387
4243,SIDM00872,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.13412046,0.002535211,0.41558158366270714,-0.012511170117590878
37440,SIDM00633,JQ1,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6817862,-0.055222794,-0.96956683521493,-0.0811550742308071
87698,SIDM00826,BMS-754807,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.1127282,0.009603345,0.7147157729745437,0.015882154203168027
14925,SIDM00097,Doramapimod,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.191012,0.028055344,1.5365571141746572,0.04246834284084543
53211,SIDM00216,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-4.7975345,-0.14032157,-1.7680739484170327,-0.08509733677220484
31498,SIDM00216,MK-2206,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,0.5726403,0.05664788,-0.5312949923629797,-0.04659319377485114
69110,SIDM00933,AZD6482,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.41182575,0.015600898,0.612789738993397,0.046346156465444995
11807,SIDM00216,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.208489,-0.05898561,-2.4533628865530916,-0.14157012526979676
74698,SIDM00673,Luminespib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5275517,-0.052974164,-0.8734030219445685,-0.07395695515481467
87670,SIDM00673,Luminespib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.22598536,-0.023250086,-0.4631405621486912,0.005746325962491992
58053,SIDM00148,PF-4708671,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8132199,0.061309237,-0.6867443631176113,-0.008626703248266037
51683,SIDM00928,RO-3306,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-1.3230299,-0.087122805,0.36345329220960215,0.04496319370937507
36220,SIDM00872,AZD7762,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.77489465,-0.07821231,-0.5956800330107761,-0.04362583242269044
96486,SIDM00933,Axitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.9585333,0.1342503,0.0933186991962878,0.0054719297411190875
65720,SIDM00097,Docetaxel,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.5452123,-0.23423858,-2.8018850858178195,-0.21082527024764036
36084,SIDM00832,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.6395006,0.11161012,-1.425707688124624,-0.03784015728592192
107686,SIDM00928,Alisertib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.5465282,0.043833736,-0.348025375352699,0.016149011673920285
97122,SIDM00875,AZD8055,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1327152,0.12820755,0.17246644284274817,0.01700680160757173
50430,SIDM00872,Alpelisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0197439,0.052975398,-0.6228889154176572,-0.037506099437467855
1620,SIDM00950,MK-2206,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8474029,0.19298126,0.7563490866052448,0.0006058113558927489
30453,SIDM00633,Temozolomide,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.3369524,0.08835791,1.2614997761467013,0.027157363200814345
610,SIDM00933,AZD6482,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.094430685,-0.0034048518,1.3061199422477712,0.03633202243618686
87420,SIDM01197,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4505547,-0.07203847,-1.3440295804840743,-0.06164853464924445
27260,SIDM00146,Docetaxel,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.51111144,-0.0435564,-1.1224226854856134,-0.03334145879420259
22103,SIDM01197,Camptothecin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,5.1403127,0.39924514,2.9970928099712157,0.20540991324464575
14683,SIDM00097,Tozasertib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5725093,-0.076527156,-0.5280473841180012,-0.02515062710182036
48205,SIDM00633,Trametinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.0356293,-0.2911442,-2.0274803632393654,-0.08173843844003027
101688,SIDM00872,Ribociclib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.87126416,-0.010981628,1.14235928026378,0.028299891142524715
8709,SIDM00097,Camptothecin,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4398837,-0.048419278,-0.06935961477582865,0.023614117686344506
76348,SIDM00455,5-Fluorouracil,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.80748934,0.041124005,-1.5586150123177667,-0.04205408002160663
47225,SIDM01187,Linsitinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6470124,0.053545445,1.1879198740052705,0.08397322458863274
27500,SIDM00146,MK-1775,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.0756998,0.07800752,0.24534609719654116,0.01736933866531235
79742,SIDM00633,Tozasertib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.0997689,0.051415596,1.9133304022392934,0.050419661230152825
90502,SIDM00148,BI-2536,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.347585,-0.06550471,-0.838471106834006,-0.022557703414533805
104140,SIDM01197,Palbociclib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.2045555,-0.071545884,-1.4816977664283573,-0.019612734674639462
105143,SIDM01042,Paclitaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6919413,-0.14890021,-0.9630333158881842,-0.02108402661172854
64420,SIDM00875,Crizotinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6239597,0.07111721,1.2966277406138267,0.06249031682236718
53061,SIDM00455,Erlotinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.4419818,0.1186496,4.32613793805403,0.1370748687869802
4249,SIDM00673,Gemcitabine,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.949435,-0.06501848,-1.583732762855847,0.00845307510515863
54705,SIDM00146,Alpelisib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5315202,-0.026809553,-0.21365606917621088,0.03866034333805778
92574,SIDM00146,Paclitaxel,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-1.321112,-0.1186147,0.07790386703755928,0.04331375259556214
25064,SIDM01042,Trametinib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.7042437,-0.15172136,-1.6735115871388366,-0.06426764005759618
91526,SIDM00148,Palbociclib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0209905,-0.055070132,-0.8379329751933113,-0.05428341710882855
83887,SIDM00933,Cisplatin,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.7338525,0.099207364,-0.47829363520631346,0.0019337859644432548
8447,SIDM00933,SCH772984,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-1.7259414,-0.11483176,0.4356043718651981,0.0476995707795571
35003,SIDM01042,AZD8055,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0266123,-0.24582645,-1.5692062379668388,-0.08041820242673504
50135,SIDM00633,Entinostat,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7228555,0.05047488,-0.32886552237636996,-0.010817121424276334
2105,SIDM00633,Trametinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.963449,-0.15378265,-1.9750610522430647,-0.044454712671064586
3700,SIDM00933,Crizotinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-1.4015802,-0.17096049,-1.0128086870982564,-0.031813145339922536
105548,SIDM00148,Uprosertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0460782,0.0874562,0.49232743965354664,-0.0175843730855544
19953,SIDM00146,PD173074,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.3671663,-0.10550143,-1.322398269701591,-0.03311387026025984
83583,SIDM01042,Olaparib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0031219,-0.05899308,0.4056974168366322,-0.003228496480392352
20691,SIDM01042,GSK269962A,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.57467926,-0.07112823,-0.6478373829121913,-0.023429358268511058
73117,SIDM00097,Trametinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7450895,-0.043852195,-1.1332213700479192,-0.032711656517523266
106652,SIDM00872,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.72961885,-0.034242887,0.6634619013654431,-0.0006482471354719272
107902,SIDM00633,Trametinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.670113,-0.11423209,-2.420901407300569,-0.033800019862829794
68780,SIDM01187,Pictilisib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5153611,-0.058011875,-0.034076438546452203,-0.017660879335569646
66485,SIDM00933,Tozasertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,0.7103708,0.07681788,-1.006378490298164,-0.012730591048819998
7370,SIDM00835,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.9287694,0.30211195,1.984698382938514,0.11224302635792435
83890,SIDM00673,JQ1,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,4.792562,0.34252733,0.3480243314451968,0.06839019226185168
7903,SIDM00835,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.0774024,0.049786486,1.418029794550509,0.007070061266339066
13764,SIDM00875,Gemcitabine,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6922559,-0.004018117,-2.6287533597840826,-0.09047568771154785
94215,SIDM00875,AZD6482,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2209982,-0.065569386,-0.9492961962027439,-0.07014129662703818
32654,SIDM00928,SCH772984,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.330352,0.15761052,0.5748054644511675,0.03404165816352065
69190,SIDM00933,Navitoclax,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.27222413,0.031133931,0.9517018006782393,0.0677277754908418
21212,SIDM00146,Ribociclib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.9633307,-0.04185547,-1.3508328129630434,-0.03160029051459961
66315,SIDM00833,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.52419436,0.03513378,0.4998656055599405,0.01690886451087949
23721,SIDM00216,AZD4547,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.943856,-0.064684294,-1.3982468829100785,-0.07767935106568778
78557,SIDM01187,MK-2206,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.0154345,-0.17379983,-1.0747409904197995,-0.08521031823626644
37183,SIDM00837,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.2906659,0.08912142,1.1989387898236654,0.09774295197072444
95936,SIDM00928,Luminespib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.80452174,-0.05868791,-0.3811746261712905,-0.06562421018168198
90590,SIDM00877,JQ1,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5479333,-0.10501674,0.6892194207111944,0.06040679436583616
12548,SIDM00928,Ribociclib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,3.0545092,0.14658362,0.591577171164345,0.01806238315636331
24047,SIDM00875,Nutlin-3a (-),Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7204645,-0.021632472,-0.11071689784819362,-0.024485369003806344
39298,SIDM00776,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.18554808,-0.012089998,0.5844803118797551,0.015270946816590343
89601,SIDM00148,Olaparib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9325416,0.11613343,-1.0561648878248124,-0.06535574723443317
29269,SIDM01187,Docetaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.7938628,-0.22928604,-3.695182071256704,-0.19801292919836816
62208,SIDM00673,Bortezomib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.250042,0.009792914,-0.21984396498397638,-0.03590750541207683
24851,SIDM00776,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8985893,-0.05838438,-0.184389478546307,0.026123271080815906
19096,SIDM00950,MK-1775,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.706979,0.109534845,2.301964602011958,0.09300219898955556
70017,SIDM00950,LGK974,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.8224103,0.09154997,1.3994371181306715,0.027691058979505617
62119,SIDM00877,JQ1,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.24585666,-0.025478423,0.9944531045483319,0.11735884024551088
84913,SIDM00928,Bortezomib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.0205567,-0.069047764,-0.8635654391003778,-0.07659344352300203
69118,SIDM00928,Entinostat,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.76705116,-0.067654,-0.20250976567074896,-0.005176127149185687
2241,SIDM00359,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3203259,-0.09138537,-0.6365088402311,0.013994735815694626
95459,SIDM00957,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.1581948,-0.016043415,2.5302907432245703,0.11057711075160738
11777,SIDM00875,Palbociclib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.8011117,0.19894205,2.4180896370440212,0.12086353740334832
64649,SIDM00455,Navitoclax,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.4911046,0.17275825,1.499713571728118,0.09548742095303316
98743,SIDM00933,Pictilisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.2837123,0.15600006,0.200562589911768,0.05564828803292088
73894,SIDM00928,MK-1775,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.6461848,-0.0684844,0.2492301075707759,-0.04992832126659771
59479,SIDM00872,Taselisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0477616,0.04749933,-0.6528500625630353,-0.08101013918539468
33868,SIDM00877,Uprosertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.17797987,-0.02019045,0.3132313058554776,-0.013159828598694233
69960,SIDM00928,RO-3306,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.5172567,-0.08978587,-1.076265650824792,-0.07691064114739801
14811,SIDM00872,Wee1 Inhibitor,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5461772,-0.05430819,-0.4765039860713047,-0.013677278006410283
1516,SIDM00216,Dabrafenib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.59559745,0.017396403,0.587399344046386,0.061317687878555224
73237,SIDM00928,OSI-027,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.9559441,-0.16171171,-0.7359715845290272,-0.08316559027538702
84041,SIDM00282,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.625161,0.055789016,1.7490063060552083,0.07087640791378451
17675,SIDM00950,Dasatinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.025177,0.18213142,-0.24666676741222968,-0.0010420467635911936
60640,SIDM00148,Taselisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8704731,-0.0656375,-0.963615963998191,-0.014217586680490278
35569,SIDM00633,Venetoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.4168325,0.00901131,1.6469334671679785,0.03757112608843202
50029,SIDM00282,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.5516468,0.051022287,-0.46834105510099877,-0.020297344141491258
23832,SIDM00933,Lapatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.7945832,0.047673047,0.10835781368985802,0.05470905020646308
48682,SIDM00146,Bortezomib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.17575863,-0.011972412,-0.5050260308550913,0.005642494394937439
47172,SIDM01042,Pictilisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7657864,-0.03932534,-1.2396299375037174,-0.06202941712239289
28991,SIDM01042,Trametinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8264036,-0.12214361,1.8413605839757596,0.05066782819774246
2551,SIDM00146,Olaparib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7615961,-0.036477406,0.1819011685977815,0.0333592285558504
21517,SIDM00835,5-Fluorouracil,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.8440993,-0.032618385,0.18531686026601304,0.019835402233187624
66215,SIDM00957,Taselisib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-3.5220633,-0.08956648,-1.0461879922990587,-0.025598163688890566
58222,SIDM00950,Taselisib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.103638,0.027507612,1.2216181093043266,0.03328739245282225
91206,SIDM00933,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.52518314,-0.07401484,-0.9564990814268386,-0.07805988812608607
79826,SIDM00875,Ribociclib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0304295,-0.014982191,-0.14457073380074215,0.04509059795284135
13657,SIDM00835,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-4.0089507,-0.18075708,-1.8576567947884932,-0.06860435239754592
63376,SIDM00776,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.95810026,0.03873329,0.8048800890814114,0.11919286926612299
86065,SIDM00928,Venetoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5463133,0.08237106,0.176208461924686,0.02807283584433828
33684,SIDM00835,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.2674276,0.030701255,1.5237590273243382,0.011594615167053431
91022,SIDM00146,Nilotinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9334549,0.087897524,0.5369405051641791,0.10082342465334194
14678,SIDM00877,Camptothecin,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.9277187,-0.06799611,-0.6361008238858158,-0.06767746802170534
82682,SIDM00877,AZD6482,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.28620666,-0.03354718,0.6227934653683983,0.011803273586846089
70750,SIDM00359,Camptothecin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.69595426,-0.055657063,-0.7939758246906987,-0.018397281901919322
67066,SIDM01042,Bortezomib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.80255497,-0.055413105,-0.8215618385453909,-0.04511277882863678
101084,SIDM00633,KU-55933,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.132991,0.054908536,0.21711415878299906,0.035899313236504686
57639,SIDM00950,Paclitaxel,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9984014,-0.3215452,-2.9352716779661034,-0.17529494355253256
65346,SIDM00928,Pictilisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.982285,-0.20956105,-0.5731295110572836,-0.06670384232415423
89056,SIDM00950,Crizotinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6755378,0.14862184,-0.7476640205997431,-0.025392229440202897
11166,SIDM00933,Pictilisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.48001102,0.0641062,-0.9016325955859992,-0.07192328564254241
77925,SIDM00097,BI-2536,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.29983103,-0.02069966,-0.252921887492465,-0.02328673505537602
85048,SIDM00872,AZD7762,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8614365,-0.05888618,-0.08114019520246779,-0.05695170959980255
68592,SIDM00148,RO-3306,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2519584,-0.14349402,-1.272944282566449,-0.09043230884716512
50546,SIDM00957,MK-1775,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,4.0128794,0.1680634,-0.6884840033093521,-0.03895329594060439
40486,SIDM00148,Camptothecin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.76254326,0.07807684,-3.078083680772124,-0.21550460979019403
90788,SIDM00633,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4929894,-0.117866464,-0.6450549148927962,-0.018972108102775005
82338,SIDM00673,MK-1775,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.3393453,0.03237903,-0.27163501685171343,0.017527747582524393
93472,SIDM00875,Trametinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.842025,0.09312917,0.2001771484189471,0.011187745503694467
34011,SIDM00148,Doramapimod,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4872248,0.12104085,-0.7286296466624304,0.013274760795540547
20802,SIDM00455,SCH772984,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.6110817,0.10777106,1.8970095177243884,0.197135575517943
18309,SIDM00282,LGK974,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2746719,-0.027177135,0.1389955861770249,0.010060482941546005
70536,SIDM00673,Entinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.7996086,-0.06661114,-0.5162223634960434,-0.043919279152699164
104673,SIDM00282,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3594904,0.07387029,0.16557320357473487,0.0419647796001384
91352,SIDM00633,Dabrafenib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4723599,0.041202407,1.8723167089151842,0.041096405600852516
75290,SIDM00826,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.9544445,0.026786953,0.33285466844347544,0.021327568473291803
58106,SIDM00776,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.6155232,-0.067694,-2.2770672205142732,-0.09346064634209328
32555,SIDM00833,Navitoclax,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.9614716,0.055008918,0.7299512244484041,0.02276793968463904
63823,SIDM00928,RO-3306,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.8053183,0.06187865,0.9245212401353383,0.06112164066989806
67867,SIDM01042,Luminespib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2511318,-0.18903106,-0.805328177943464,-0.05195855537348273
57770,SIDM00633,Crizotinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.529735,0.1141333,0.13812199837907682,-0.008452468622323676
37012,SIDM01042,PF-4708671,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2283784,0.117467545,0.5762452359449427,0.04972626673738848
60422,SIDM00673,RO-3306,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.8060227,0.055497836,-0.21078641989299515,-0.023801894262678612
4589,SIDM00148,5-Fluorouracil,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1149472,-0.095368095,-1.1120341738630355,-0.0570527661778451
27546,SIDM00673,RO-3306,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.44870615,-0.029211074,-1.425582649251847,-0.06551552140447099
89563,SIDM00833,5-Fluorouracil,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.51713693,-0.0340335,-1.1022056949014425,-0.05386547099958535
22012,SIDM00359,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5023791,0.039841942,1.5357116755719606,0.05714175449952056
3435,SIDM00633,NU7441,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0342761,0.06938616,0.2582924951917962,-0.006837259858002812
88743,SIDM00933,PD173074,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.3947868,-0.12049428,-1.6489855343394124,-0.05775096409947548
1957,SIDM00875,Docetaxel,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6894433,-0.05438714,0.04849259403158254,-0.02345750402473383
5372,SIDM00633,Nutlin-3a (-),Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8634597,-0.02810004,0.23773195024554059,0.04510765932350455
48027,SIDM00835,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-0.6920819,-0.033780325,-1.2669061221158409,-0.07415874463212206
46731,SIDM00928,RO-3306,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.7094526,0.22577004,3.2415735811438116,0.17890767611585845
26293,SIDM01187,Pictilisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.86467254,-0.056448832,-1.5154424601975987,-0.08003762630158309
28507,SIDM00776,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4616531,-0.10062292,1.023888020945286,0.05650331983752939
4648,SIDM01042,Wee1 Inhibitor,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5472059,-0.054192185,-0.8185947153570755,-0.10329140951725285
104379,SIDM00950,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0041251,0.07750322,-0.6668322158455505,0.03050181918899984
108063,SIDM00837,Navitoclax,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.38647,0.04745186,1.638072876406895,0.010555197997311128
2090,SIDM00673,NU7441,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.9819446,0.07723059,-0.4834917355680341,-0.02505092907750431
36020,SIDM00833,Oxaliplatin,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.5384711,-0.098665714,-1.5182638899851606,-0.0832533221577849
104237,SIDM00633,SCH772984,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6853528,-0.065113515,-1.555397262796487,-0.07360769285119124
107575,SIDM01187,Nutlin-3a (-),Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.26303124,-0.023617255,-0.20423942323588573,0.011287112100932209
29169,SIDM00928,KU-55933,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.8046939,-0.07885589,0.7112811418565059,0.015170571667837314
35986,SIDM00875,Linsitinib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0909669,0.081856,1.3998797448513993,0.06611510254110102
98371,SIDM00826,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-0.68406796,-0.055221345,-1.6875090520940967,-0.0719454044729458
28076,SIDM00673,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.8493285,-0.09784482,-0.14641559436352047,0.017113992521913226
373,SIDM00933,Temozolomide,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.7226773,-0.028877007,0.151222923193517,0.03944683377731645
71549,SIDM00359,Trametinib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2894875,-0.03886561,-1.328117806985273,-0.05924023978608755
18323,SIDM00673,Tozasertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0161288,0.042599592,-0.5191633145816998,0.018772882328936005
78372,SIDM01042,AZD8055,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8533162,0.07246895,-0.6524001395175616,0.0036833966696292533
103569,SIDM00673,Sorafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.625586,0.15668313,-0.0035118317486465926,0.04550255321099992
104409,SIDM00673,Lapatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.84969944,0.082210034,0.9325003315846516,0.07713166991402505
94410,SIDM00282,AZD7762,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.8419383,0.097922824,1.6473488218881136,0.04715623551976461
38140,SIDM00282,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.74931383,0.0424331,-0.03481520808610966,-0.010576217781348091
64410,SIDM00826,MK-1775,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.53114355,-0.036610756,-2.601835060883421,-0.1350095078410943
66037,SIDM00877,AZD7762,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.2506291,-0.10080919,0.09598999670369623,0.0003290794531571793
27576,SIDM01042,KU-55933,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.367188,0.20725228,0.6291106671951275,0.002226233830594029
8269,SIDM00216,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,56.0,0.46197054,0.010964032,-1.2008030329668185,-0.04729921705482363
90918,SIDM00673,Temozolomide,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.25929758,0.00355888,0.05243377598801624,-0.0037494991619879438
104391,SIDM00933,Entinostat,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.47394708,-0.03163119,1.7751870578450297,0.04952913313872275
13591,SIDM00148,Palbociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9631174,-0.098449335,-2.205692359006076,-0.08352122846887988
34603,SIDM00359,Crizotinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5674777,0.030627716,-0.33113375216489477,0.005863812647458099
14353,SIDM00216,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-4.69821,-0.24368724,-4.137605860264144,-0.25712039657942426
29336,SIDM00097,Camptothecin,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3470745,-0.08223061,-1.9178360809101238,-0.07844496844612014
70429,SIDM00455,MK-2206,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.3573847,0.15339617,2.1924591163498945,0.13784216249817896
43653,SIDM00673,Doramapimod,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.5255998,0.03705197,3.0408579346418,0.11153215910664777
9637,SIDM00928,Taselisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.012698,-0.099587485,-1.30669828795939,-0.07869426880496345
26121,SIDM01042,Luminespib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3691977,-0.12313376,-1.4435259272361325,-0.0809946347960314
13077,SIDM00097,Sorafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.642771,0.08919337,-0.26120506295207563,0.03705013519304703
90730,SIDM00933,Dabrafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,1.4429836,0.12045563,-0.3803872532151693,0.02564252959271875
75312,SIDM00835,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.48375398,0.041199222,-0.12281719678770422,-0.044975766554366726
54990,SIDM01042,Palbociclib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.063555405,-0.0032661674,-0.23630033726310803,0.019040299498951842
93307,SIDM00633,Luminespib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.350645,-0.095560655,-1.026678394909746,-0.05377279589227765
80837,SIDM00146,Ribociclib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-2.355781,-0.08478268,-0.4288121794638965,0.030916068067754526
69696,SIDM01042,Wee1 Inhibitor,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.2511481,-0.022532813,-0.4620442923941504,-0.03576844027575641
43083,SIDM00216,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-1.9108164,-0.062504105,-1.1964857134513451,-0.04035096199170334
53822,SIDM00455,MK-2206,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.352738,0.09876937,2.09260497609629,0.15159613630637336
528,SIDM00673,Afatinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,3.733427,0.20513894,1.935784768160217,0.13584126278205552
54144,SIDM00146,Olaparib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8700876,-0.037475027,0.321615734820743,-0.016071176218277704
9494,SIDM01197,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7433944,-0.09698898,0.20067373806758493,0.010355764314873232
6083,SIDM00359,Linsitinib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0420034,0.121165775,-0.3510811281829407,0.03427844243755315
102982,SIDM00776,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-0.34441197,-0.024604728,-0.28041511307769346,-0.03969589776167415
43404,SIDM01187,Palbociclib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.049121,0.2664343,-0.828058203835875,-0.004710597202040947
81440,SIDM00933,Uprosertib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.3669249,-0.117839314,-0.12362838228306278,0.04521418841284762
57593,SIDM00097,Luminespib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9392742,-0.12217621,-0.6224151073180015,-0.029449305956292804
63841,SIDM00097,Ribociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7683513,-0.071219705,-1.3700465413724172,-0.017456474821907195
52390,SIDM01187,Bortezomib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.81766516,-0.0835681,-0.19760553232536532,-0.030180014287019778
5618,SIDM00776,Oxaliplatin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0396136,-0.06172587,-1.392858537630538,-0.04943339813932949
86595,SIDM00826,MK-2206,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.10146107,0.002380092,-1.3185156716061177,-0.017128523927485036
33867,SIDM01042,Luminespib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5252768,-0.06285828,-0.47101182216263754,-0.047526208844938175
9366,SIDM00282,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0299613,-0.04345013,-1.001129057051918,-0.036377486950359646
98277,SIDM00282,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1844009,-0.056373715,-0.41281891809125804,-0.038110851171758185
14161,SIDM00633,Linsitinib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.734924,0.0731707,0.3616739952433656,0.00013840623216890052
59614,SIDM01187,Nutlin-3a (-),Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9316835,-0.07496655,-0.5150939303141493,-0.06120628398246616
31259,SIDM00673,KU-55933,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9596387,-0.079451084,-1.2429610188072433,-0.06529336707483765
69090,SIDM00097,Ribociclib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4059439,-0.053633496,-1.5453394805346383,-0.00505495454023323
67958,SIDM00148,Sorafenib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5295639,-0.115122326,-0.3669134601069648,-0.014836983002046665
43723,SIDM00776,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,-0.024059597,-0.001440948,-1.273099995022617,-0.0706147868020631
95648,SIDM00148,Uprosertib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0127108,0.08214091,-0.5891717149723039,-0.05098234659763887
17066,SIDM00455,Palbociclib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.1243787,0.15399507,0.5008781648076066,0.08490146824489864
77491,SIDM00872,JQ1,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.047596,0.03664247,4.4416971966823775,0.22217425382092537
50598,SIDM00148,ZM447439,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.56128436,0.043943025,0.665901777475451,0.07052050288344218
47336,SIDM00835,Oxaliplatin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-3.3011582,-0.1179731,-1.8480010626223684,-0.08571615718659974
23315,SIDM00146,PF-4708671,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.9945838,0.026768653,0.9121794209230747,0.07425067700736797
13006,SIDM01042,Venetoclax,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2510809,-0.04667106,0.7931223264508679,0.057600161826430935
107117,SIDM00832,Camptothecin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.6549747,-0.20279309,-0.6898515756108362,-0.08476977471609878
47972,SIDM00097,Afatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.94405556,-0.05091329,0.9849233317144885,0.07522780910383144
36502,SIDM00097,Paclitaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.761544,-0.29452804,-4.434908989871804,-0.2808370628624522
54807,SIDM00877,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.44524774,0.026060676,0.8208639894444623,0.1026559871349367
27761,SIDM00928,MK-2206,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,2.2349913,0.18805778,0.33041511546848035,0.011076405921481106
73665,SIDM00633,Lapatinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1679827,-0.033434972,-1.3939572658108643,-0.07191287068063251
97811,SIDM00359,LGK974,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8850614,0.09522,-1.4698896558412893,-0.005194352444731338
54110,SIDM00042,Taselisib,LGK974,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.4829885,-0.050713886,-0.6916119665106812,-0.044763785268880085
63122,SIDM00872,Axitinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.814589,0.16340098,1.3652593703751605,0.1197129789440174
9526,SIDM01042,Doramapimod,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7877598,0.047957495,0.5662882908212762,0.027212758164240115
5188,SIDM00282,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.151768,0.1381056,2.069274254026503,0.12472518806731248
70634,SIDM00875,ZM447439,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.828557,0.08498229,-0.9667287701113222,-0.08652435966503357
100121,SIDM00633,Olaparib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1476312,-0.057416152,-0.7226562601472257,-0.030035664773479215
26757,SIDM00875,Nilotinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8279701,0.08668066,0.9853022825919652,0.09064835514491859
75050,SIDM00282,Nutlin-3a (-),SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6406354,-0.04354638,-1.1547578516750099,-0.011120386337407516
11350,SIDM00148,Gemcitabine,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2896451,0.08235226,-1.0113380563492238,-0.02861625469073234
43381,SIDM00148,5-Fluorouracil,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8983057,-0.18274908,-1.1432210319382428,-0.12090278577215521
91250,SIDM00216,MK-2206,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.7769438,-0.0957132,0.6346294654350572,0.043013654344331256
69077,SIDM00872,Venetoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5875187,-0.07939795,-1.3521011017818758,0.01237926936442363
86397,SIDM00837,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.8102727,0.047961213,-0.5061632547365251,-0.01725995214322769
75730,SIDM00282,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.0044904,0.06607789,1.7610480791158716,0.14087339784255204
60189,SIDM00835,AZD4547,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.9982417,0.06995495,1.7440767891495945,0.03244044789529863
63438,SIDM00826,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,0.3460852,0.027291158,0.9409514659483994,0.03618556510949181
1799,SIDM00282,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.67596555,-0.04367389,-0.37260283598663874,-0.02649842672580716
22887,SIDM00455,SCH772984,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.9305663,-0.21992284,-1.2635513010312027,-0.13834780710844735
10172,SIDM00950,Ruxolitinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.83674175,0.013787217,1.6827054847939646,0.018989425733395838
42604,SIDM00673,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.5069687,-0.06381686,0.31774367858663705,0.0538516950183068
51967,SIDM00148,Paclitaxel,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.40482923,-0.040971737,-0.550326258932473,-0.05364860679668228
1438,SIDM00928,AZD6482,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.6518395,0.32084328,2.153397232356075,0.1291823371358028
26895,SIDM00837,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.001624,-0.103653416,-2.1873737440960084,-0.12357505694147598
100804,SIDM00148,Paclitaxel,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.785107,0.14084896,0.19084784178717082,0.026350873586796462
92094,SIDM00835,MK-2206,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.544768,0.15886855,1.298581474475633,0.06696795254907678
63829,SIDM01042,Docetaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9850702,-0.17959665,-1.9626560029105458,-0.12363548145355428
34381,SIDM00950,Linsitinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.0842366,0.11111653,3.0625606022327907,0.16925610373135228
12385,SIDM00455,LGK974,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.3057017,-0.09348687,-1.6381123248112182,-0.047605547341222625
33339,SIDM00877,Entinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6837525,0.11944993,0.07295574549440169,-0.013510599720459475
29928,SIDM00359,AZD8055,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2910302,0.13834752,-1.2655895887528523,-0.003358618128134147
103853,SIDM00633,JQ1,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7299653,-0.12036228,-1.681862068785192,-0.12185496216374296
54760,SIDM00633,AZD8055,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8259735,-0.17394698,1.0138472027172938,0.050395985686550286
22712,SIDM00833,SB505124,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.0411626,0.07740376,-0.2536590423897622,0.027712509751622483
53467,SIDM00872,AZD6482,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.45727566,0.04694923,0.3108880120240902,0.008423105364206998
98647,SIDM00877,Luminespib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.77726257,0.052433103,-0.40447351848992946,0.01610341830492139
105662,SIDM00633,Alisertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.74405396,0.06979576,-1.120080364378031,-0.10897041919085801
31656,SIDM01197,SB505124,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,0.5485148,0.030791566,0.2952625631366443,0.010350221693411633
35723,SIDM00832,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.2321918,-0.06427738,-1.8093084524175407,-0.1295192276585322
87852,SIDM00877,AZD8055,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.249442,0.083688565,0.596613612815413,0.08816512419999088
30140,SIDM01042,AZD6482,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9130478,-0.10208338,0.4523974539014971,-0.03119982726631766
72589,SIDM00097,AZD7762,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4226685,-0.08850355,-0.9365820709738382,-0.03876146239613313
71949,SIDM00875,JQ1,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.33207065,0.03522382,-2.390906870669864,-0.1265814175297194
2168,SIDM00933,PD173074,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.60459685,-0.06391677,-0.17342626537187206,-0.01118501114928391
18865,SIDM00455,LGK974,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3956424,-0.026653461,-0.972174775301599,-0.018025888931247312
32274,SIDM00837,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-0.8187296,-0.050428413,-0.2980478026821807,-0.06316516683390104
16901,SIDM00097,NU7441,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0391614,0.12343437,2.802937620216715,0.16743134522712702
17215,SIDM00455,Olaparib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7616952,-0.020595612,0.6794011002283541,0.060023775975892535
20267,SIDM00950,Irinotecan,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.7785681,0.059081405,0.6009887373104132,0.10205911404889999
68414,SIDM00875,Afatinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.11135,-0.03820993,-0.6449343327105193,-0.018706629818080637
84785,SIDM01187,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.0931244,0.1558449,1.4583365623456943,0.09580824311349638
63603,SIDM00097,KU-55933,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3285227,-0.075398855,-0.270879273393306,0.030484768284635005
40610,SIDM00826,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.1328957,0.03327831,-0.7606970815930632,-0.028894597335839236
54885,SIDM00933,5-Fluorouracil,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.2813888,0.039804228,-1.1079258487734784,-0.06410718753796356
106573,SIDM00673,Ribociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.4072297,-0.053079072,-1.7679374303674478,-0.06943125853019515
8928,SIDM00872,MK-1775,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,2.034623,0.16024837,1.6411140560417339,0.06317412796521357
44,SIDM00148,Bortezomib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7734731,-0.048492536,-0.9181986954168326,-0.09263422665959983
24573,SIDM00950,LGK974,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.53694,0.07499963,-0.6326084711277488,0.028381659192940615
60342,SIDM00826,Navitoclax,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.118218996,0.004405325,0.629773806501866,-0.008625018688630196
90279,SIDM01042,Alisertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4710959,0.056545462,0.8365837904905822,0.025339439746262613
17339,SIDM00950,OSI-027,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7913594,-0.11208733,-2.0250268635407633,-0.12477722156509612
49742,SIDM00148,Axitinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.93005633,0.06859472,0.757879084687326,0.04277935658208832
52624,SIDM00776,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.8987111,-0.09397836,0.2261114598320972,0.02939060226247641
48977,SIDM00837,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.7866296,0.011967841,1.538148355750055,-0.011542343287565041
44900,SIDM01187,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0535322,0.030473761,0.32335828734974587,0.020399315630731656
85774,SIDM00673,Tozasertib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.46830153,-0.03516196,0.02117142102274924,-0.026815009459216454
56902,SIDM00877,SCH772984,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.256619,0.106921904,1.8269221800005027,0.08137257131073729
42739,SIDM00928,Sorafenib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.15544,0.22197358,-0.6112925606354499,-0.037602513548767494
75320,SIDM00877,Bortezomib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7063056,-0.055524938,0.3268752071782185,0.0675102002884671
31032,SIDM00928,Axitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.5310954,-0.069872536,0.5004685902804249,0.07722044389005647
28357,SIDM00776,MK-2206,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-0.6981689,-0.055411022,0.07698500225305621,-0.009632414740191872
95663,SIDM00826,Taselisib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-2.913604,-0.16752927,-3.80737569328914,-0.18268940358647814
6917,SIDM00832,AZD4547,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.5834522,-0.15352532,-1.1635545497257245,-0.04245038952803839
55343,SIDM00776,Oxaliplatin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.371464,-0.117849976,-1.6513702157239616,-0.036268764769963484
70046,SIDM00826,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.868891,-0.13944943,-2.8654689924934447,-0.15068497566774192
92560,SIDM00875,Ribociclib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5628376,-0.042976618,-0.8535087272081024,0.010266539034652725
10572,SIDM00933,Gemcitabine,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.77722234,0.0021141444,-2.6500639193569175,-0.0752687943834005
39385,SIDM00455,Linsitinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.2294762,-0.17032439,0.11908663256567587,-0.021454071836764232
106064,SIDM00872,Olaparib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4081359,0.08855992,-0.351333605589357,0.033731091967487616
61153,SIDM00875,PF-4708671,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7995874,0.03531267,1.4653528827978373,0.0950547600487056
8033,SIDM00282,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.81566423,0.05327314,1.0025995490849129,0.12611021715263357
80432,SIDM00148,5-Fluorouracil,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3998637,-0.21614756,-1.658136627073022,-0.13070684271663374
96889,SIDM00826,MK-2206,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.60212666,0.009837455,-0.514820339123601,-0.024036147943916418
21558,SIDM00875,PD173074,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9682931,0.15228873,3.6971732353977607,0.13957330378246058
70313,SIDM00877,Uprosertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.69025624,0.06824307,0.35696335841641996,0.014194588309983954
20169,SIDM01042,Camptothecin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.1555933,0.018681139,-0.3861044837910885,-0.021615136236987863
36449,SIDM00877,Nutlin-3a (-),MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.309065,0.05527731,1.598103466067523,0.06746237941108346
81064,SIDM00455,Crizotinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.65290123,0.038565144,0.3299782935618897,0.022459712499991652
32517,SIDM00875,GSK269962A,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0301468,0.17379062,0.30778559329026933,0.022044907436263007
58497,SIDM00875,GSK269962A,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1393433,-0.058350112,0.34287090605791637,0.02853315856208634
41033,SIDM00957,Nutlin-3a (-),AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.6097516,-0.044373702,-1.6296519074404956,-0.039883532156259234
25600,SIDM00146,Ribociclib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.132874,0.13358757,-1.8299697459350255,-0.04210986740013834
72132,SIDM00097,Sorafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.581262,-0.062573805,0.14180768989261408,0.03343892017765357
28060,SIDM00877,BI-2536,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.31946555,-0.0010600314,-1.3111713367653612,-0.032836845471430516
93906,SIDM00282,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8665303,-0.063256495,-0.9824645471780443,-0.07202320458569249
6540,SIDM00877,Lapatinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.7769024,-0.019804306,0.70116607099534,0.08078671412387353
51136,SIDM00835,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-2.0120795,-0.049141947,1.7095115556247726,0.02718692055962403
61876,SIDM00633,Venetoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0185801,0.026049793,1.3668111976484034,0.046010333692044054
43823,SIDM00216,SB505124,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.67941576,-0.04610146,-1.5101487869467087,-0.07867249859708393
86441,SIDM00673,5-Fluorouracil,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2201257,0.010504625,-0.6709422002663258,-0.0038732426088232044
65504,SIDM00835,SCH772984,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.3615704,0.1173809,1.4373268353176554,0.13679748227267197
67253,SIDM00097,Axitinib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9155185,0.055086292,0.4781135295679899,0.021971347385804432
11316,SIDM00832,Crizotinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.6534836,-0.29102373,-1.21116899370038,-0.0615774529748433
8604,SIDM00282,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.3989271,0.08965989,2.246845259904145,0.10913491737075816
105742,SIDM00282,Vinorelbine,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7744337,-0.10987112,1.6006951718315685,0.03212457720550686
14934,SIDM00957,MK-1775,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.98799765,-0.031252947,-0.06784375722741176,-0.03826269521372991
11723,SIDM01042,Cisplatin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3917667,0.01838701,0.9859722320590558,0.057374472200410004
46138,SIDM00216,BMS-754807,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4468846,-0.04541428,-1.4192992982634638,-0.03423422491778009
15222,SIDM00148,KU-55933,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.74990463,0.038662642,-0.7201481083990628,-0.05690227622087947
26943,SIDM00042,Cisplatin,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.3782186,0.030644689,-0.6247577661861802,-0.015508474118858067
106908,SIDM00832,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-3.1909978,-0.124510795,-1.5655106128444487,-0.03449427525139081
15168,SIDM00359,Camptothecin,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8503847,-0.12822913,-1.6870500720093151,-0.0472332488945216
7598,SIDM00148,OSI-027,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1905007,0.11675009,1.1994926179597265,0.11097305993627526
38936,SIDM00776,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.77776027,-0.07023391,-0.34901095513570896,-0.0800958548936598
65531,SIDM00875,Camptothecin,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.63833606,-0.06850153,-0.4662737959579204,-0.0425254505897764
69014,SIDM00776,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.512352,0.17097136,0.4945030644115569,0.02547462892167963
90460,SIDM00097,Doramapimod,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.0392714,0.103684574,1.5951562570562052,0.05481934441751267
71157,SIDM00933,Alpelisib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,0.9380711,0.08720061,0.3919659977927273,0.024418943440122184
62656,SIDM01197,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.18019389,0.004048842,0.9424189469760521,0.05542599179852092
80643,SIDM00835,Taselisib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.9007403,-0.05361333,-0.2885512350351752,0.02806996940031141
81802,SIDM00148,NU7441,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.69588596,-0.07082922,0.2754911950713598,-0.014139739010673724
23291,SIDM00455,AZD7762,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9336545,-0.101354964,1.5368057247298295,0.18090814739357722
92995,SIDM00875,Doramapimod,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8160517,0.124702424,1.683424075183271,0.030690137113878864
102064,SIDM00875,Crizotinib,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42578563,0.042436976,0.16566120289146563,0.0011813356327125858
31820,SIDM00837,Palbociclib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,1.7447406,0.11436911,-0.42925970483720793,-0.009195651957769738
57947,SIDM00950,Palbociclib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3300285,-0.06256687,-1.7834833156698933,-0.022813233717249606
107937,SIDM00928,SCH772984,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,1.7137011,0.19989613,-0.3219935093620674,-0.00043208241703179075
30714,SIDM00832,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,4.4834776,0.2733317,2.0316168818750326,0.09348647517792903
10827,SIDM00776,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,3.671855,0.1945603,2.159656180161931,0.11161714135570315
63106,SIDM00097,Temozolomide,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5619914,-0.010023926,-0.5321412601194242,0.007255682649293226
107632,SIDM00950,AZD7762,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.2129219,0.12704839,1.6406413639401662,0.040207142250478486
93000,SIDM00875,Docetaxel,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.4977567,-0.05453164,-3.6366290539272264,-0.13157828807240768
108351,SIDM00282,Nutlin-3a (-),Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.591555,-0.03866758,-1.3072241201222554,-0.09094444216899703
27445,SIDM00933,Trametinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.17536128,0.024376873,-0.9056127497307188,-0.020671961915141212
106375,SIDM00933,Uprosertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.9321611,0.10241994,-1.1083103827707736,-0.07681567868729397
63013,SIDM00455,Paclitaxel,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.101752,-0.2058765,-3.476112405996199,-0.22294900831911407
35835,SIDM00875,Navitoclax,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91993433,0.094606206,1.4068779290421658,0.0691307901190769
17065,SIDM00832,Vinorelbine,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.3456616,-0.024271384,0.21297597907045734,-0.02258014917961538
60375,SIDM00148,Ribociclib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3629937,-0.09818608,-1.98732771498321,-0.08712711625365589
105177,SIDM00928,Trametinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.069672,0.18388079,2.2289578066169202,0.042328217848982816
102972,SIDM00455,Paclitaxel,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.18098862,-0.013152371,-0.4786519468413052,-0.03533988402004198
34118,SIDM00872,Pictilisib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4926581,-0.049377404,-0.34559061079782183,-0.07608772481343751
46986,SIDM00146,Tozasertib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5980131,0.045752626,0.07605032195177451,0.04823356302545862
84734,SIDM00359,Linsitinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.51510566,-0.03297213,-0.4142294084566273,-0.045354493563124244
38381,SIDM00875,Luminespib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9914293,-0.04473258,-1.9700872292567406,-0.11332349031544543
70499,SIDM00216,Taselisib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-4.1830487,-0.14336483,-1.9553703331665624,-0.15041126907092559
108248,SIDM00097,Navitoclax,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5784802,-0.17548288,1.0032146385231462,0.03115142467277977
69145,SIDM00673,AZD8055,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,0.55804914,0.033097763,0.625641946460324,0.02175589355097071
102380,SIDM00833,Trametinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,-1.5381515,-0.045212884,-3.0556890638032344,-0.13738492249098153
28118,SIDM00673,SCH772984,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.072107,-0.16008411,0.7912300825816959,0.043843796993849084
31780,SIDM00872,Sorafenib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7832652,-0.07969028,-0.18488573215740298,-0.02710043896999905
15286,SIDM00928,AZD6482,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,0.69071317,0.050601065,0.312823905898829,0.02982363598486033
12286,SIDM01042,Navitoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.743687,0.073460825,0.14526834539914976,0.056936969581980905
100609,SIDM00826,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.3608059,-0.031198058,-3.342823512770791,-0.08308560600076419
69760,SIDM00097,AZD8055,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1341659,-0.082046434,-0.386447530179248,-0.03648314774140651
87069,SIDM00673,Tozasertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.278879,-0.08470724,-0.7851133249727039,-0.04571804789388213
77785,SIDM00875,Vorinostat,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2682705,0.124289714,1.4586486860611945,0.06975672318112151
108403,SIDM00148,Uprosertib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6541467,-0.060625114,-0.566626747917051,-0.031299621769520204
88426,SIDM00928,Tozasertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.32080376,-0.0084200725,-0.0531953697511893,-0.02838715654807013
37625,SIDM00835,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.9035716,-0.06950504,-1.4778013702915578,-0.09662788369921838
52377,SIDM00933,Dabrafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0077846,0.088935934,0.3921425609232058,0.06393621276322273
81859,SIDM00633,NU7441,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8354641,0.054794446,0.3551269642244887,0.03692791844853489
101321,SIDM01042,BI-2536,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-4.5748887,-0.051775213,-2.564719956566159,-0.07978901164644296
17486,SIDM00833,SCH772984,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.6707773,-0.11226684,-0.47794686955543064,-0.0074494021033659945
94771,SIDM01197,Nutlin-3a (-),Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.34667262,-0.007109181,1.4075103060510028,0.05310203935027361
59119,SIDM01197,Dabrafenib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8787736,-0.077445775,-0.6007691746505471,0.006113312245153357
46619,SIDM01197,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.14821115,0.004357467,-1.586754343473125,-0.005679422826761363
21584,SIDM00833,Trametinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.4012158,0.0740033,1.6207702697157933,0.07095141638212173
106872,SIDM00633,AZD6482,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.6003723,-0.1533716,-2.298285228610489,-0.1372530671266963
65861,SIDM00877,AZD6482,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.47297585,0.057805665,0.9817397345233299,0.027831911975019868
4454,SIDM01197,Navitoclax,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.8733739,0.059278686,1.2589806245933752,0.08659717710828323
83792,SIDM00097,MK-1775,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.010015491,-0.0007104143,0.6799991256247373,0.013779053190600795
72505,SIDM00826,Palbociclib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-4.082004,-0.10885502,-3.7396601472607283,-0.12368386248688075
15926,SIDM00359,Taselisib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.719968,-0.093882486,-1.3551932212542526,-0.005907458037068335
68772,SIDM00928,NU7441,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.4893626,-0.13043134,-0.496428001119202,-0.03930903073651551
56446,SIDM00097,AZD6482,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1908665,-0.13164012,-1.0157208120119776,-0.08854335207607777
68654,SIDM00282,Taselisib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,0.30456215,0.015989445,0.5525272761943573,0.04051173648658206
100225,SIDM00872,Tozasertib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.235203,0.05345694,0.5790647859907133,0.02905048035388213
33060,SIDM01042,KU-55933,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.113471076,0.010522722,-0.36220994633799763,-0.01156133615928175
93548,SIDM00872,Tozasertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.6004028,0.14171988,1.195076623983756,0.024523928208422884
20661,SIDM01042,BI-2536,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1748536,-0.023354633,-0.8405220957374824,-0.07143275263442779
17840,SIDM00872,Uprosertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.048975598,-0.00506647,-0.7555232824143793,-0.09147256995221449
16937,SIDM01197,5-Fluorouracil,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-2.131834,-0.115327545,-1.9456324691560811,-0.13609192518950453
43155,SIDM00877,Navitoclax,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-2.5210729,-0.20459978,1.284153634520759,0.027663483353950025
37662,SIDM00875,KU-55933,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7783208,-0.068267964,-1.2637361637742932,-0.04295091325792968
87831,SIDM00097,Wee1 Inhibitor,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6038324,-0.09443508,-1.3628063639895929,-0.07624714784522883
33884,SIDM00833,Nutlin-3a (-),Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.5735396,0.038684297,0.7258429430940989,0.01983556804611401
1502,SIDM00928,JQ1,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.20987923,0.024585126,-2.0514377502316097,-0.1654840938841838
101284,SIDM00148,Camptothecin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.79908675,-0.072715074,-1.1070401013553615,-0.143242838731363
15624,SIDM00928,Tozasertib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.22776829,0.005006129,1.3351588634889648,0.026863999886085344
47105,SIDM00776,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.8493404,-0.021410193,0.6947368162548868,0.019801883970443773
79561,SIDM00146,Pictilisib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.3813806,-0.14293459,-0.8937104376584704,0.0009754564999396382
77357,SIDM00875,Entinostat,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3463434,0.14193296,0.5629858517773461,0.008791854005170024
14657,SIDM00148,Alpelisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.4100645,0.2103959,1.3529322022760273,0.025899872497287913
62284,SIDM00832,Palbociclib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.9167099,-0.012211519,-0.009496123411001891,0.0023698732985563244
66128,SIDM00933,AZD8055,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.8392885,0.058544938,0.23181283170793218,-0.0177837433715867
2131,SIDM00875,Bortezomib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8420757,0.06572878,-0.32739636101198044,0.012915808225631579
83973,SIDM00933,ZM447439,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.913402,0.24667779,0.33918585357344727,0.01752439165171939
10921,SIDM00148,ZM447439,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1822804,-0.07802401,-0.10875700433990666,0.011961559071667077
77790,SIDM01197,Vinorelbine,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.7708774,-0.21579607,-1.554363100848826,-0.1612487956849868
20153,SIDM00097,Taselisib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3652456,0.12929483,-0.890976920502497,-0.07262984868421635
68135,SIDM00826,Oxaliplatin,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-2.9625163,-0.17729709,-2.2970577793455997,-0.15483655253265796
52706,SIDM01187,Luminespib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.3578737,0.036449272,-0.43676460856935395,-0.06523563711551068
66734,SIDM00359,Nutlin-3a (-),Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0835763,0.02421937,2.0786128773559605,0.07451471517847
83203,SIDM00950,SCH772984,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.953523,0.09569861,0.5730662525016248,0.06740277819182006
37004,SIDM01197,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4170483,-0.10220124,-0.06029605914343785,-0.06164195457207064
57039,SIDM00928,Dabrafenib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.39615557,-0.016573407,-0.03722563638250089,-0.007848313466697747
90509,SIDM00776,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,0.2791061,0.026037386,0.3156734802175933,-0.034763441608764815
43022,SIDM00933,Venetoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-1.4528967,-0.04591113,1.0393247633367924,0.06080136896349686
74776,SIDM00633,Wee1 Inhibitor,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.887785,0.019223584,-2.2307023617140502,-0.07069231687602054
56809,SIDM00877,5-Fluorouracil,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.0042546,0.041094482,3.09088537583796,0.12354239502212311
66137,SIDM00928,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-0.87083465,-0.017883481,1.3809650872529833,0.02025533746313797
65319,SIDM00359,MK-1775,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5436883,-0.13699614,-1.9035115576087327,-0.09408499742988781
66139,SIDM00146,GSK269962A,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.99178004,-0.07076755,0.13541224914380748,0.014935931532716785
43047,SIDM00835,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-3.5369842,-0.1751877,-2.258336788276664,-0.11004307155799006
52758,SIDM00877,Cisplatin,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.8246501,0.08737307,-0.35944229186586996,0.0519180539957612
75699,SIDM00282,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7525732,-0.01638015,0.2564124487369905,-0.0013737095420729357
95888,SIDM00097,Doramapimod,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42772764,-0.0112616215,0.3211254036095504,0.02807509924138323
97226,SIDM00877,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.65503526,0.082783304,0.6336098147725879,0.03270971000972608
82605,SIDM00097,Trametinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.044623,-0.056162454,-2.2047465195467137,-0.046330145610890786
49830,SIDM00950,SCH772984,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0914764,-0.119856894,-1.3227606162854357,-0.09447380922961016
35004,SIDM00148,Docetaxel,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2393762,-0.022607021,-2.433374581845373,-0.1345202632467595
99975,SIDM00833,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.21943228,-0.017928155,-0.1253373878184479,-0.0372316173053073
52484,SIDM00872,Paclitaxel,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.06510276,-0.005107478,0.4889451436061359,0.02034347740732954
47180,SIDM01197,MK-2206,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.3718582,-0.025896056,-1.1232307881806873,-0.07696534998168425
68130,SIDM01187,Axitinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7866417,-0.11527844,-1.201823444839763,-0.05619747898315616
94117,SIDM00875,Olaparib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9242545,-0.10633673,-1.3619913489970512,-0.021974599777394663
97006,SIDM00455,Paclitaxel,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.4687366,-0.17602454,-3.64365048756478,-0.1985798753202326
86258,SIDM00148,Bortezomib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.18121319,0.0071275965,0.09478936292814039,-0.0332705437668734
80200,SIDM00097,Doramapimod,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.82144177,0.023839867,0.5418226134493489,0.006486250095399264
80092,SIDM00877,Entinostat,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.10527906,-0.010180721,0.17681538841533465,-0.02607990204928841
24269,SIDM00877,SCH772984,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,4.3572226,0.10211939,1.9689462657666061,0.026831217040956645
75428,SIDM00837,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1088254,0.04222872,-0.11989420251071638,0.014406364778397402
25257,SIDM00835,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.285602,0.006048438,-0.17890688825451667,-0.0018565766275677586
85799,SIDM00832,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,0.95121294,0.029870268,-0.418147093455432,-0.008200752785074221
75715,SIDM00097,Wee1 Inhibitor,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.948561,-0.118239015,-1.552519902438016,-0.09969763362322645
61218,SIDM00146,Lapatinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.7347183,0.10512416,3.456814677395721,0.17592264169725003
45661,SIDM00957,Navitoclax,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-0.5191738,-0.017340936,1.4598391148395717,0.12042624333965841
23792,SIDM00950,SCH772984,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1874278,0.1556538,-0.013732319638447546,0.01791879665570678
25624,SIDM00826,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,70.0,-0.7446102,-0.071839444,-2.957182494682369,-0.19765157707469677
17413,SIDM01197,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,5.852428,0.105707996,1.028828605455491,0.010814700146774367
61882,SIDM01042,Trametinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4145534,-0.10369241,-0.6825081238528286,0.01818917225499309
38020,SIDM00455,Trametinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.5769126,-0.03433687,0.014770798019120127,0.06337877887015772
100697,SIDM00875,AZD7762,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6990454,0.077176325,-0.1562339092565287,-0.07211009760948262
73087,SIDM00877,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.6013542,0.067366734,0.6331004716664169,0.025073607419760578
71527,SIDM00877,Nilotinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.9486347,-0.09399127,-0.12296523028149581,0.0671933157436384
102884,SIDM00928,Bortezomib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-0.6159242,-0.04893234,-0.018182369167377196,-0.019704471341676414
64669,SIDM01187,Vorinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.26554587,0.027491588,-0.09907871439083951,-0.022221490305146606
85729,SIDM00282,Olaparib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.55041,-0.011445762,1.1389639875941309,0.015616750598214824
31320,SIDM00833,AZD4547,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.7507331,-0.09323264,-0.650994985465745,-0.03931810807269733
75547,SIDM00148,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7182329,-0.16132207,-0.2269597386328604,-0.007397086714143979
58019,SIDM00872,GSK269962A,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8342753,-0.073282294,-1.305526467568207,-0.043125301981674
43663,SIDM00359,Oxaliplatin,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0973039,0.07976977,-1.6534031361529953,-0.051456043693066604
70993,SIDM00928,OSI-027,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.47531396,-0.05288438,0.4891923720003972,0.05112503152363285
13182,SIDM00928,MK-1775,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.4206573,0.11401951,2.100654830293364,0.10206523764926191
103335,SIDM00928,Crizotinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.5585694,-0.16159834,-0.7364580597903527,-0.09949754895703508
30733,SIDM00950,Oxaliplatin,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3233507,0.08445402,-0.7403805430303484,-0.008039223060069238
103799,SIDM00872,Axitinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.588742,0.04842558,-0.19103856678245404,-0.02744117262235256
42973,SIDM00933,Camptothecin,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.9346375,0.1312922,-1.1908176427363681,-0.06431878426397535
106648,SIDM01042,Alpelisib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.42958456,0.038933843,2.261927027124799,0.15304008645837885
97903,SIDM00146,Docetaxel,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.3498755,0.3106289,2.34230313977731,0.20761470307868338
101699,SIDM00928,MK-1775,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.0510888,0.10702407,0.03425006580108198,-0.08608948120138085
12966,SIDM00097,PD173074,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8442433,-0.088911615,-0.6554904491352684,-0.009720736499750728
27996,SIDM00148,Trametinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1748155,-0.024567798,-0.24307058844983126,-0.01808113517837328
47389,SIDM00282,Dabrafenib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9370834,-0.04961376,0.12662670904040002,0.027939545803710233
67366,SIDM00832,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,0.9727259,0.021514583,0.8443990944261531,0.05148125824869273
91009,SIDM00633,MK-2206,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2214049,-0.077532366,-1.156598590632969,-0.08965320747786973
107448,SIDM00776,5-Fluorouracil,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.0195456,-0.06661251,-0.760411119323557,-0.016306320017063933
6327,SIDM00933,Paclitaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.9465296,0.2905509,1.4905176325500324,0.10552192283803853
31075,SIDM00097,PF-4708671,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.969765,-0.032252055,-0.15480212200361498,-0.01615604739598771
54563,SIDM00776,Afatinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.66545,0.05582993,-0.902227866150284,-0.0831440845133461
33146,SIDM00776,MK-1775,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.5251204,-0.11954275,-2.6876109056485467,-0.11219991676993492
58387,SIDM00877,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.3804135,-0.09587216,-0.31635618732079646,0.019137984106260407
74341,SIDM00148,Trametinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4009786,0.07706076,2.936059139425423,0.09598789997113963
56349,SIDM00875,Axitinib,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0701869,0.080636874,0.9208818158685195,0.021142445468920346
79391,SIDM00872,GSK269962A,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2072512,0.11859144,-0.05591341782384607,0.030698934723706994
49660,SIDM00673,Temozolomide,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24135739,-0.0051531666,0.0854950191324042,-0.015262592463055311
62021,SIDM01187,Vorinostat,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.9096677,-0.09520505,0.5478087451443353,0.020927086390616367
81771,SIDM00097,Pictilisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0416489,-0.1794411,-0.9936419807706303,-0.11156832081603972
100638,SIDM00875,Bortezomib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.95246863,0.084135346,0.02735230630240933,0.06805634536828599
9937,SIDM00146,Nilotinib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.7479339,-0.042022534,-0.33638937793201285,0.025366807755838144
64514,SIDM00826,Navitoclax,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,0.31430012,0.005145579,0.8822536119120165,0.07643679225972454
31705,SIDM00933,Dabrafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.97369665,-0.06801331,-1.5076412546023823,-0.07574249681790268
26039,SIDM00875,Lapatinib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2286282,0.07501143,-0.6015697146395931,-0.03679492559604709
99611,SIDM00928,Paclitaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.0042541,-0.08591451,0.05264146261045168,-0.04774568289549299
40531,SIDM00148,SCH772984,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6991622,0.13261536,3.6645571760902365,0.1450184053522047
103496,SIDM00633,AZD6482,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3662266,0.13531584,-0.739743870619478,-0.038511023780621746
60962,SIDM00148,AZD8055,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3416795,0.09759137,-0.5919847059914611,-0.05911382626588449
60695,SIDM00877,Ribociclib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,0.77237236,0.020919695,0.9421088595459971,0.07873933547659961
75639,SIDM00875,Gemcitabine,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-8.348851,-0.16951227,-4.791144534844099,-0.26458907692409056
5462,SIDM00146,KU-55933,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1030244,-0.047571942,-0.4605185127467778,-0.031156884600953134
32338,SIDM00097,JQ1,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6677363,0.17418322,-0.4165784843693185,-0.021798423261252326
53108,SIDM00875,Crizotinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.014480743,-0.0014620874,0.05605114034135278,-0.017022536881825333
42851,SIDM00455,Ruxolitinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7898701,0.050165776,2.07875398556557,0.07825285608260105
86283,SIDM00455,Olaparib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.5882836,0.0098747155,1.4254143648890074,0.0743892719678523
20742,SIDM00148,Alisertib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.8183974,0.11611332,-2.3543062386016467,-0.05194829218238878
972,SIDM00877,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.4010217,-0.016011298,-0.5022151389024908,-0.02433678981911167
99806,SIDM00673,Uprosertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.66576475,-0.03629216,-1.0070029024261453,-0.10524295801485205
35599,SIDM00877,Ribociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.4751291,0.07976956,0.42741386380107405,0.031006354987253265
100097,SIDM00148,Linsitinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.54959226,-0.05301578,0.5381891965166556,0.006968540590483115
20850,SIDM00877,AZD6482,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.99961716,-0.109961666,-0.10413124697848503,-0.03452942931531148
15803,SIDM00875,Taselisib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5930367,0.14124294,0.7946863460982369,0.06621496506153689
52774,SIDM01197,Camptothecin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7754525,-0.095693775,0.8913408986380182,0.0558381165871717
16993,SIDM00148,Olaparib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5288216,0.059085473,0.22243909786299956,0.016969262661397175
55160,SIDM00216,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3593832,-0.08023575,-0.02776698191257588,-0.008573098812266106
101066,SIDM00633,PF-4708671,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.924943,0.08870295,-0.22389322484122268,-0.000567115548423951
90836,SIDM00877,Nilotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.7132769,0.06818819,0.8291126641725158,0.09282595046106376
38610,SIDM00826,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.6731977,0.06091623,0.10545643935328662,-0.007429863850382986
87619,SIDM00097,Pictilisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3954793,-0.028240547,-0.020712572462022745,-0.014657856648263634
7666,SIDM00835,Olaparib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,2.3005223,0.08406869,1.364039441714912,0.04711183408358045
25436,SIDM00875,AZD6482,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5294716,0.034776952,0.888833524420933,0.04490790886820624
24872,SIDM00875,Luminespib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.48480934,-0.045091897,-0.6509750351413812,-0.023222488342368713
100118,SIDM00146,OSI-027,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5093954,0.041194748,-1.952261524300538,-0.043785099697533754
36684,SIDM00872,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8772589,-0.088575326,-1.4624339093810723,-0.1108299763683221
47648,SIDM00097,Wee1 Inhibitor,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5159593,-0.019764641,-1.3356156234630192,-0.0340694258755931
57533,SIDM00146,NU7441,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-0.9988886,-0.065013334,-1.3642502313187435,-0.06109611615605907
106611,SIDM00673,OSI-027,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.1331034,-0.06523025,0.9663352062469335,0.10187228865339004
26206,SIDM00633,Wee1 Inhibitor,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1358197,-0.10972062,-2.328391693725818,-0.08677683097437212
39057,SIDM00875,OSI-027,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0912768,-0.10188527,-1.580945070948387,-0.05263873377740409
95106,SIDM00928,Gemcitabine,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.4275842,0.15090162,-0.9171174320801284,-0.0584931506346157
2623,SIDM00455,Oxaliplatin,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.6781652,-0.07905828,0.41958724865732855,0.027021692129537787
77823,SIDM00097,PF-4708671,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.98006725,-0.023656366,0.937477041010188,0.028310959285220257
45096,SIDM00928,Afatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.7228322,0.2708894,2.843374779386842,0.14308727366460067
22757,SIDM00875,Palbociclib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.36776683,0.011545025,1.0048273094067572,0.014558167372227619
5299,SIDM00097,PF-4708671,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3772904,-0.04650283,0.46366794043711157,0.015949697463138346
91151,SIDM00359,Taselisib,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.9090304,-0.2264947,-3.1134117793471265,-0.09762861025396054
64903,SIDM00875,AZD7762,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2138883,0.013917483,0.40568719545887244,0.0018848789851900543
17047,SIDM00872,Tozasertib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4479667,0.07347317,1.5691945086261272,0.08972549078109185
33277,SIDM00835,Olaparib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.500075,0.028186042,1.167552750973884,0.03058381590143996
97982,SIDM01042,Luminespib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.38218936,0.033359434,0.14311549297007292,0.05771902913158878
3631,SIDM00455,Lapatinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,5.1750493,0.27905387,3.70153719352905,0.1942511649162869
66239,SIDM00877,Alisertib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.2761194,0.12131968,1.4067519907779362,0.11920635765878905
29515,SIDM00633,AZD8055,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2646687,0.117957085,0.20293923379904186,0.0259270923743376
105950,SIDM00835,Oxaliplatin,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.8494731,-0.13671516,-1.8615807150849704,-0.08658997394387856
17797,SIDM00877,OSI-027,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,1.4425387,0.11534801,0.767233308814692,0.10897604462027677
84456,SIDM00875,Olaparib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.0737123,0.25776422,0.42774700019713774,0.04926570132996031
88625,SIDM01042,Lapatinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9883064,0.11972689,-0.5230557732347085,-0.026259925528693787
105463,SIDM01187,Temozolomide,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.78211933,-0.019795807,-0.5808111052958557,0.010059103000389107
54659,SIDM01042,Gemcitabine,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,8.835194,0.23777294,0.09966655292082918,0.04304833163625257
49068,SIDM00837,LGK974,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,3.4809198,0.08675431,0.8277971795734413,0.02014403698135096
65143,SIDM00933,BI-2536,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.24220274,-0.0016633326,-1.55726773771235,-0.06222715436185994
812,SIDM00833,Vinorelbine,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.9892945,-0.08877111,-0.3623467080885007,-0.06741306692604898
53793,SIDM01042,Luminespib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.47890082,0.04925441,-1.0888503635913762,-0.016665802695955977
50622,SIDM00673,Wee1 Inhibitor,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.6051661,-0.066090696,-0.29631743672244987,0.03678385063327244
92124,SIDM00216,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.2217224,0.029060235,-3.5585056132720965,-0.13502388786751465
16120,SIDM00146,KU-55933,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2950276,0.04907358,0.19850699219941512,0.010881482756542053
107226,SIDM00950,Lapatinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5518059,0.12546226,0.1092843001212927,0.003216468526885885
88172,SIDM00146,Luminespib,Temozolomide,Breast,7.5,Breast Adenocarcinoma,Female,White,51.0,-0.45350444,-0.038064655,-0.348952424615791,-0.05099187846789428
33640,SIDM00950,Olaparib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.6525292,0.36564615,1.720837574268382,0.11425581048046675
64855,SIDM00633,Bortezomib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.39827293,0.028788546,-0.48996458379569224,-0.03504023036045458
59141,SIDM00633,Nutlin-3a (-),Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.4183786,-0.20281152,-2.305533541772066,-0.1612993925308047
64938,SIDM01197,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3893243,-0.091973655,0.7693203354684535,0.031433372882398586
26126,SIDM00673,Nilotinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.28691378,-0.014103074,0.14370489046275428,0.041985539798585644
27127,SIDM00835,SB505124,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.0533243,0.07764655,0.2999941366226418,-0.024096514141425062
2584,SIDM00872,Vorinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3579209,0.10635899,0.23403101549223157,0.11167050742524594
60685,SIDM00928,Navitoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.063218,0.24634148,1.9972061556991683,0.09234581047286997
2743,SIDM00673,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,2.7233343,0.1760202,-0.29653709997207345,0.06724765416203587
17177,SIDM00633,GSK269962A,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9963459,0.09333843,-0.9433812608663833,-0.024528728274071238
60906,SIDM00950,OSI-027,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8149602,-0.12450356,0.01216658959621358,-0.013627475955014786
105636,SIDM00877,PD173074,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-2.190866,-0.10654024,-1.2394656338343946,0.006518343440957468
66499,SIDM00872,Tozasertib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,2.3881636,0.11427847,2.4740420517807107,0.1204076436540581
39438,SIDM00673,AZD6482,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.79266894,-0.06320045,-0.15835509475051723,-0.02465618790625507
53175,SIDM00928,Linsitinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.7371204,0.07247122,0.42043691195483807,0.040713544310919406
18163,SIDM00872,Docetaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3429956,-0.058004152,-1.906169806711871,-0.10616095658850015
50771,SIDM00455,Lapatinib,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1822768,0.047428213,1.9607191847480936,0.09833571701881873
30490,SIDM00146,Pictilisib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6300769,-0.043894168,-0.49977627473516745,0.08189577421186728
59949,SIDM00097,Dabrafenib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.211668,-0.063618936,0.032814133283024655,0.005677682527402599
4772,SIDM00359,AZD4547,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.45914868,-0.03205475,-0.4486853866824929,0.04445182623841593
61390,SIDM00837,AZD4547,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.9009635,-0.05928601,-1.1072165623404615,-0.06977998967209728
58104,SIDM00877,Afatinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.3062656,-0.08907206,0.08455921906548532,-0.03632627630183927
74212,SIDM00928,Taselisib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.533068,-0.14462116,0.4269890256264146,0.010835386085061467
100059,SIDM00673,ZM447439,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.42791727,-0.035051093,-0.18309116272029544,-0.011024924779548919
34835,SIDM00673,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,2.5738857,0.08668012,-0.6509199928392897,-0.01981644230517194
44746,SIDM00455,AZD7762,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.5104933,-0.096571796,0.41842557417194265,0.05028225915090774
63337,SIDM00633,Bortezomib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.41841733,0.02264249,-1.8672496226046733,-0.008858442202856044
79485,SIDM00837,SCH772984,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.6275375,0.11335493,0.634274764246252,0.022666206628702015
70698,SIDM00933,Camptothecin,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.29536417,-0.009894192,-2.538622537600098,-0.13998694418926597
93964,SIDM00877,Alisertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.89463925,0.091382645,-0.23524580775211543,0.011013678598803483
19947,SIDM00097,Uprosertib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9032714,-0.10256809,-0.4795286523357601,-0.056354532899833096
9220,SIDM00928,Axitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.99045503,0.08699487,1.2739586015564859,0.13518021672604025
89824,SIDM00957,Nutlin-3a (-),BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.106081,-0.047963623,0.49144193228037053,0.059164177666795506
47543,SIDM00877,OSI-027,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.95449525,0.08884523,-0.1377855923437265,-0.004565612713858887
42760,SIDM00455,Oxaliplatin,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0768663,0.062539145,-1.5261909341272097,-0.03545668525026515
83098,SIDM00216,Taselisib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.6292139,0.048640676,1.4322801085671066,0.05232664855874782
93044,SIDM00633,Dabrafenib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4116104,0.049587205,2.095893514490535,0.06936328371279814
20091,SIDM00148,OSI-027,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6895146,-0.07125309,-0.9208379438687059,-0.049173754788857466
76445,SIDM00872,GSK269962A,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9725958,0.1058662,-0.7844893395628317,-0.021544243977327147
69917,SIDM00826,Navitoclax,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,0.46736595,0.014414457,0.7638138640652856,-0.023655664348511546
40868,SIDM01042,BI-2536,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2724802,-0.009507494,-0.17203730005426018,-0.021695717668029378
68262,SIDM00933,Trametinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.5150822,-0.12027084,-1.8618501920872197,-0.08914248342804157
88102,SIDM00359,5-Fluorouracil,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.2460861,-0.14373584,-1.586526685796909,-0.05923131790758709
92081,SIDM00216,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.1871405,0.08802945,0.33891867310230767,0.12539397961179713
39730,SIDM00877,5-Fluorouracil,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,1.6848215,0.0736696,2.2853947403725035,0.1684381803341551
4903,SIDM00455,Linsitinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3773335,0.076394066,1.6779370377502612,0.14457069160229225
54273,SIDM00216,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,0.56217575,0.050841156,-2.182704014296886,-0.08028049555487082
100968,SIDM00673,SCH772984,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.6135106,-0.25072503,0.10283934760339698,0.008836485491833536
16577,SIDM00928,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.073746,-0.09280534,0.5922520517055769,0.06549900480193095
49438,SIDM00875,Docetaxel,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0409527,-0.082525305,-2.076246348791749,-0.1405071931445347
68131,SIDM00933,Temozolomide,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.6766129,-0.027727788,0.7153615171026365,0.012554308255423077
88274,SIDM00933,Nutlin-3a (-),Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.3183699,-0.1696009,-1.142132745878336,-0.10039494085033038
23271,SIDM00933,5-Fluorouracil,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-0.4429726,-0.059860747,2.2254529922194894,0.1385039406461087
52087,SIDM00875,Entinostat,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3362571,0.14247602,2.2587428730063364,0.125560680806997
12660,SIDM00146,Ribociclib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.1262822,-0.07719967,-1.190603342478923,0.014410675998652223
55877,SIDM01042,PD173074,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6062949,-0.09923952,-0.056917083605614684,0.038452102963533775
29881,SIDM00097,NU7441,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8441719,-0.040150553,0.2261746785084549,0.022425713789902095
62716,SIDM00835,MK-2206,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,-1.8262305,-0.08265077,0.9801699701056799,0.06591692223122861
48238,SIDM00875,Doramapimod,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.579287,0.124263994,2.0039929430623866,0.04444797783048115
50513,SIDM00216,LGK974,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.89928,-0.030758193,-0.5412272227647914,0.0016996284804766974
97383,SIDM00877,5-Fluorouracil,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,1.2574769,0.0854471,0.9133056118176941,0.055276984383158735
85619,SIDM00928,PD173074,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.577859,0.23608163,1.2451263661964673,0.0676335723256099
108396,SIDM00826,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,0.77661043,0.013539862,-0.6984495396596595,0.00042465777623552876
77904,SIDM00877,Camptothecin,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.34500617,0.034589555,-0.19002769316891469,-0.025674872041597574
26453,SIDM00832,Vinorelbine,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.5227391,-0.014073744,-0.6934469754415856,-0.005418567431678042
30028,SIDM00837,AZD8055,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.75240225,-0.026640609,-0.3026723722146562,-0.03203803414334338
39950,SIDM00872,MK-2206,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4832867,-0.115521386,-0.7877712230552333,-0.029949742185597338
46920,SIDM00875,Afatinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4914237,0.0811504,1.281563909136044,0.05036675321203589
26397,SIDM00097,AZD7762,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4945745,-0.080647066,-0.8910947866182592,-0.020621577982546695
32630,SIDM00097,OSI-027,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9792218,-0.11958888,0.45640748762975397,0.02351943824721175
47804,SIDM00216,Nutlin-3a (-),AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.46151963,-0.040307917,-0.7509973870227915,-0.07805162907455337
74852,SIDM00877,Crizotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.18837515,-0.01634826,-0.31243000163370976,0.04312917812656783
70290,SIDM01187,Luminespib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7058738,-0.065315165,-0.5201884704308353,-0.05462234277685668
50220,SIDM00148,Cisplatin,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.88701856,-0.040706348,-0.8994706342256525,0.019150344554617522
15901,SIDM00097,Cisplatin,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9479829,0.038588762,1.1552128105369643,0.04206129826589414
41625,SIDM00097,Palbociclib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1826556,-0.08737378,-1.474080435797182,-0.05988751383261276
68156,SIDM00875,Taselisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.0953952,0.00293794,-0.5784820483648032,0.00817336758994444
39625,SIDM00282,AZD7762,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.2691007,0.09361791,1.7872506409606204,0.1164856383879601
17171,SIDM00933,Axitinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0707561,0.13608295,-0.49385212432117304,-0.031947770889882494
98245,SIDM00146,Docetaxel,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.9922589,0.17610432,-0.12892034682286596,-0.0055102390243199975
18684,SIDM00455,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3954692,0.033513732,3.1721092008064598,0.08674840473456256
107621,SIDM00875,AZD8055,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5742242,-0.1375812,-1.0725337169895688,-0.028980928506007586
89281,SIDM00146,RO-3306,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.3662359,0.12601522,-0.29263421010934937,-0.025854946741902512
78251,SIDM00928,Dabrafenib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,4.1757593,0.28323856,1.0551860415836658,0.027844875243595947
68918,SIDM00359,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.5625875,-0.14181578,-2.646739206704793,-0.047142397285090946
86391,SIDM00455,OSI-027,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.9430308,-0.27076086,-0.6313664686720744,-0.06458486053934348
101416,SIDM00833,Taselisib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.1041126,-0.12462556,-0.5728546965608555,-0.03009770976314156
16503,SIDM00833,Palbociclib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,1.1249189,0.03600702,0.5094160685274419,0.02846831315331412
24126,SIDM00633,NU7441,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3841865,0.10045837,2.5255280080017664,0.11178818263527344
87945,SIDM00633,Ribociclib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.47548863,0.01500066,-0.8907616122750831,-0.00561240709086971
39200,SIDM00957,Vinorelbine,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,0.35566244,0.007078638,-0.5858037262189152,-0.07746150193172784
17296,SIDM00146,Ribociclib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.6606865,-0.059837688,-1.3403962168193322,-0.020539927484347284
89436,SIDM00872,Nilotinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2725142,0.1325205,0.09067316398403868,0.029246419942255405
61262,SIDM00832,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.5602049,-0.0477566,-0.55980133145931,0.00509127175107895
81047,SIDM00872,SCH772984,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8218002,-0.02664768,0.6314716186922686,0.03695654783283902
11992,SIDM00933,Camptothecin,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.06991462,0.0067821634,-0.7137074630769391,-0.04115451262981418
24259,SIDM00872,AZD6482,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7104081,0.074206375,1.8692483556173292,0.15112898723707818
7786,SIDM01197,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.8749302,-0.016098663,0.08526547066255118,0.04781890003898328
32773,SIDM00826,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,1.3614088,0.028599706,1.8870252008202972,0.09358348467181325
82787,SIDM00148,5-Fluorouracil,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.86635816,-0.084854595,-0.5669322652857356,-0.08350076207095025
63881,SIDM01187,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.8255491,0.27373105,-0.32143101882995445,-0.007282069476406294
71186,SIDM00148,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7336994,0.045638513,-1.7219688617828364,-0.05110956229125205
37519,SIDM00872,Ribociclib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8522895,-0.021672012,0.25878444964583786,0.016047016650402982
74139,SIDM00776,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.76444525,-0.016880073,0.9575060080104896,0.03390806028521498
89902,SIDM00872,Nilotinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6269044,-0.121844426,0.30328918578962794,0.02940067707675713
93687,SIDM00928,PF-4708671,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.9552877,-0.1287304,-0.2997205724161126,0.024091274092306547
72912,SIDM00633,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.089197,0.039661124,3.3949646944101346,0.0924979837752354
32588,SIDM00633,SCH772984,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.2862055,-0.25893822,-1.998616117984127,-0.07880897930964216
66194,SIDM00877,RO-3306,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.36466506,-0.032863073,-0.2193026471349187,-0.009649022667802239
72121,SIDM00673,Luminespib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.4075536,-0.041833162,-0.5677607402798391,-0.007545803795829456
35870,SIDM01042,Olaparib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5933776,-0.14941683,-2.718883661213769,-0.08842111853030869
30066,SIDM00776,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.3338217,0.06119249,-0.4477998874656976,-0.023732545019300264
12585,SIDM01042,Doramapimod,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8714262,0.06939017,0.05206196873889912,0.025710354312591444
90860,SIDM00877,Paclitaxel,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.61734354,0.06540393,-1.6222017512040938,-0.0999258074430035
62720,SIDM00872,Temozolomide,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6195047,0.013901625,0.290018320741941,-0.004815225726965721
79585,SIDM00837,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.5525455,-0.052694783,-1.1897230860422612,-0.03440448552741245
28515,SIDM01042,Cisplatin,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7025485,0.07417978,2.3328893345915125,0.026668932675396915
53860,SIDM00776,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.70617455,-0.014940505,-1.0001619396099009,-0.04772964696190136
71537,SIDM00826,AZD8055,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-1.2039642,-0.033877343,-2.2893531354195042,-0.09434201960579533
94466,SIDM00837,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.90011233,-0.013549738,0.3234701863610682,0.02470527992496325
53444,SIDM00097,Crizotinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2300192,0.066526435,0.37470259235363,0.031939892974067796
55742,SIDM00042,SCH772984,LGK974,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.94606125,-0.099308304,-1.9541347884992974,-0.07300317316258834
75225,SIDM00833,SB505124,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,0.32595018,0.026191263,-1.0996159749196242,-0.09462665605882178
101457,SIDM00832,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2092527,-0.018480124,2.0128526316111715,0.06054097865349959
26668,SIDM00148,Tozasertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7750449,-0.054375622,-2.9493573338969292,-0.09784699405246984
80508,SIDM00832,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,1.1310803,0.054721303,0.7719599482200307,0.03608789489036251
105797,SIDM00042,Erlotinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,4.2537527,0.14655766,2.624800595366636,0.11735106274410267
33059,SIDM00148,AZD7762,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8063492,0.07875521,-0.9191365710931876,-0.029973582359912692
59179,SIDM00833,AZD7762,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,1.2617261,0.10497286,-0.3591336107424962,-0.015179610024753981
88715,SIDM00455,Sorafenib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.7288766,0.04594772,1.936555653539986,0.11398112381988923
18148,SIDM00455,Paclitaxel,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.6517754,-0.17228377,-1.9504862908003338,-0.16802109626787
57590,SIDM00928,AZD8055,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,0.8077422,0.0701705,1.0783138104755405,0.03786307621737461
81568,SIDM00359,Linsitinib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.116351,0.33767596,0.7957362027533236,0.056657051203571306
51223,SIDM00933,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.25153664,0.028621165,0.07175560356409179,0.024284852136968998
31819,SIDM00875,Linsitinib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1131017,0.04921119,1.8468431313485472,0.08946365466924043
58582,SIDM00950,Taselisib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6902083,-0.16464977,-1.6222552218418982,-0.07764052868656961
20188,SIDM00633,AZD7762,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0532098,-0.12805307,-2.0294708883448482,-0.10556651996113196
3546,SIDM00835,5-Fluorouracil,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-0.8349318,-0.03711375,-1.1446641329188267,-0.04418789929152488
22907,SIDM00875,Olaparib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9295158,0.08965266,-1.1822726957054472,-0.03721354612433058
20367,SIDM00216,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6177676,-0.020645319,-0.7502137256002205,-0.041513469331233975
53345,SIDM00835,AZD8055,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-1.5314391,-0.0722954,1.9279828148003106,0.06418928447751517
27725,SIDM00148,Temozolomide,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5748416,0.041384265,-0.37396887285168856,0.0051090505448468035
1302,SIDM00872,Palbociclib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.49477896,-0.017939849,-0.04300827393693006,-0.00407966306934229
23842,SIDM00933,Taselisib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.227335,-0.027119474,-1.687605993059011,-0.1123574880898281
2702,SIDM00216,AZD7762,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.0479122,0.081557535,0.10429342878430994,0.09904293918890739
3267,SIDM00097,JQ1,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.8475714,-0.12501864,-0.5983827854167971,-0.10391819070636886
78328,SIDM00359,AZD4547,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.0147448,-0.08557793,-1.8509427299708938,-0.07562331745936883
70469,SIDM00097,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6643963,0.027718445,-0.12608607543880793,-0.03387910549503252
78258,SIDM01197,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5435088,-0.07388825,-1.0588389510778433,-0.06428284450621458
36217,SIDM00872,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7389684,0.11128879,0.8358376186088542,0.03085498391805817
92276,SIDM00359,Taselisib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6279112,-0.11823595,-1.6819334759793085,-0.08822617089247518
88111,SIDM00933,Doramapimod,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.8300683,0.05678679,2.069957980723808,0.05926032042219171
61946,SIDM00950,LGK974,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4761311,0.09494453,0.2551573583614432,0.01671539860899981
55892,SIDM01042,Doramapimod,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.40634936,0.035621833,-0.7534014173641733,-0.028650743528516768
42764,SIDM00832,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.7799008,0.13575523,-0.07636447849905914,-0.0011455275265643539
41649,SIDM00826,Crizotinib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,1.1622549,0.07545239,-2.198888621609042,-0.07542950888428826
69332,SIDM00148,Docetaxel,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-4.7864656,-0.32489228,-2.986312480596855,-0.252740653391573
45134,SIDM00633,Luminespib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.1790304,-0.15096988,-0.2765976953422343,0.018324577804728317
60122,SIDM00933,Docetaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.8408705,0.077528335,-0.6951368010378752,0.01325049084951984
37533,SIDM00097,AZD7762,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.929985,-0.10025115,-0.12438295944814799,0.03858857411693055
50274,SIDM00673,Sorafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8260073,0.054785848,0.5392793020730685,0.08949264956251646
3684,SIDM00872,Nilotinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.614278,0.1617719,0.3430595225047049,0.046299747376571165
24394,SIDM00835,BMS-754807,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-1.0974286,-0.09530489,-1.0695465560115418,-0.09907633464920199
78116,SIDM00826,AZD7762,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.7538365,0.09767476,-0.8621884572033065,-0.014444909881068004
102018,SIDM00833,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,3.328493,0.22249736,-1.5056189014973143,-0.10173556963440362
50939,SIDM00826,AZD7762,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.7812605,-0.053733904,0.08958842022186879,-0.01962209521979334
18591,SIDM01042,Vorinostat,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.12883742,-0.015308428,-0.20397327671926108,0.012648050915004138
16418,SIDM00826,Afatinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.131219,0.075572304,2.5859641323522307,0.1521404711518719
60309,SIDM00146,Gemcitabine,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.9828537,-0.15617077,-1.9075814608096433,-0.17502408542036876
86013,SIDM00833,BMS-754807,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.941403,0.07505176,-0.7748772603804066,-0.04657177926533079
44606,SIDM00455,Lapatinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.0986738,0.05777623,2.4888164459316227,0.13630423246279774
60989,SIDM01042,RO-3306,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.99518144,-0.12175645,-1.240552349045276,-0.09416977034000083
50933,SIDM00359,Taselisib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.8901484,-0.078418516,-0.8551710899402291,-0.013751980270418261
78842,SIDM01187,PD173074,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.248313,0.080593616,-1.439752630426909,-0.07569764174577695
43224,SIDM00875,Bortezomib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46523714,0.04424608,-0.7251065343876885,-0.019200239471178923
95872,SIDM00146,5-Fluorouracil,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.6598496,-0.043693956,-0.3696654359349451,0.004770865754150606
95829,SIDM00146,Sorafenib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.26755428,-0.025291326,-0.5347823627333527,-0.017616850605817996
102794,SIDM00097,Venetoclax,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4064522,-0.039433062,-1.404901781277802,-0.016294766299681428
54129,SIDM00633,Linsitinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9808184,0.0884043,2.8873455470896707,0.08143485093074662
44179,SIDM00148,ZM447439,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.96457046,0.068232834,0.8230472699547577,0.08148559201945792
79669,SIDM00146,Sorafenib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,0.8176766,0.073554285,0.3639673803158155,-0.03652884421962208
52926,SIDM00146,PF-4708671,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,3.6636825,0.1746554,1.7881876651719453,0.08647450873997042
65601,SIDM01042,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.92418134,0.105404414,0.1629560259890322,0.01780300243966223
62784,SIDM00826,Trametinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-8.928542,-0.119516306,-5.877701101170011,-0.12116851598602069
68384,SIDM00097,Alisertib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.597077,-0.17236046,-2.952386759786115,-0.13457942729773137
48914,SIDM00359,SB505124,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6121696,-0.12115698,-1.56696999956168,-0.04379532060646116
79866,SIDM00835,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.63746727,-0.029297061,0.12491534839479684,0.03520380051864309
29554,SIDM00148,Ribociclib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.6768684,-0.13550125,-1.318029690670605,-0.04818442032535002
99478,SIDM00633,JQ1,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.2702196,-0.021916172,-2.0092018852208224,-0.08262896405158336
5180,SIDM00837,Trametinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,4.6156225,0.096692674,1.2668371576680604,0.011388103510590353
62113,SIDM00877,Doramapimod,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3557879,-0.09777327,0.7078434279977103,0.05308501343603489
2444,SIDM00042,Cisplatin,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.7428783,0.11925629,-0.2859900747161902,-0.017789335075921908
57089,SIDM00877,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.4340492,0.03643467,0.6462943457581267,0.05788152261732226
87556,SIDM00282,AZD7762,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.9083139,0.06702183,1.3809613433247108,0.07213343398543119
40238,SIDM00933,OSI-027,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.8393048,0.15346627,-1.1752691403337383,-0.05074562663510533
48467,SIDM01042,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0491717,-0.02012716,0.274971784502046,-0.017134826126701082
23145,SIDM00776,Nutlin-3a (-),SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.4546721,-0.025566926,0.21584570329207803,-0.001417436183970133
33493,SIDM00872,Docetaxel,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.353071,-0.1324141,-1.3859486978124658,-0.07482904849418842
69978,SIDM00933,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-2.173042,-0.058408756,0.2406480779373744,0.009766312472151439
72752,SIDM00877,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-4.913272,-0.4014407,-3.414748445450375,-0.1487269444104187
81862,SIDM00875,Axitinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8060765,0.052206572,0.3942739261636355,-0.040473914544450394
30414,SIDM00875,Gemcitabine,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3856054,-0.00057783717,-1.2961409987651562,-0.01449277660458109
73042,SIDM00146,Linsitinib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.74968845,0.020096602,1.2201546723160301,0.04127868358397139
6453,SIDM00776,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,0.6058257,0.051883228,-0.8130893381247529,0.02750862365908516
59921,SIDM00216,Oxaliplatin,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3060839,-0.013171143,-2.3161188534011834,-0.0940822989182467
26775,SIDM00928,PF-4708671,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.642438,-0.043134972,0.6539920174905591,0.059208920420915113
39307,SIDM00950,Linsitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7079256,0.18293774,0.7151682334195509,0.07430936554824838
21226,SIDM00633,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.1706743,-0.18139906,-1.7412786339672648,-0.05081747520836019
84962,SIDM00875,MK-2206,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.42460886,-0.032765303,-0.10176017553167677,0.021348953372271398
14766,SIDM00282,BMS-754807,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.1767023,-0.086816296,0.3788848085973842,0.049352954416576326
4177,SIDM00872,Uprosertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.76768833,0.08104388,1.0257961849117854,0.056452980289839305
99271,SIDM00875,Alpelisib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.37766358,0.035005134,1.565670044621235,0.12149389587559839
37250,SIDM00146,Venetoclax,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.9663064,0.04217463,1.8558054611771664,0.040508952687674765
23320,SIDM01187,MK-2206,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7429058,-0.066473246,0.21560012128302738,0.010718300129460923
97109,SIDM00928,AZD6482,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.27908,0.18238956,1.5519734895044162,0.09611884408746531
56383,SIDM00216,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.4295429,0.060511835,-0.09354026759971228,0.06678715173530284
65756,SIDM00933,Nilotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.2019484,0.06889057,-1.6155576863408454,-0.043187373890859325
446,SIDM01042,GSK269962A,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6111398,-0.19929473,-0.2896362518774785,-0.06959322818353093
79444,SIDM00833,BMS-754807,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-1.9349942,-0.10870407,-1.761741021932327,-0.08456440267303734
24003,SIDM00776,LGK974,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-3.0473726,-0.11159313,-2.558613541611229,-0.07722047845019372
59060,SIDM00148,GSK269962A,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9572942,0.16372655,-1.0304819179099083,-0.03700953063628136
81213,SIDM00950,SCH772984,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.6376762,0.17154418,3.38680500916121,0.17251146730144004
84731,SIDM00359,Vinorelbine,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.404958,0.29857513,0.2223036749827252,0.07688743276121641
53915,SIDM00950,Paclitaxel,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.636073,-0.22577937,-1.4502391418791767,-0.10856537501596221
44877,SIDM01042,PD173074,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.6639965,-0.12328808,-1.2120973667030517,-0.09027534390217681
89905,SIDM00097,Paclitaxel,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.1728907,-0.257123,-3.69428782443436,-0.2641402545237302
10826,SIDM00359,MK-1775,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.149702,0.15391076,0.28585556137149537,0.06901915481042026
3885,SIDM00826,Nutlin-3a (-),Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,0.83175796,0.019158011,0.7746709739988994,0.058897304029255325
61953,SIDM00837,MK-2206,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,2.3381665,0.15672341,0.5198863212452408,0.07554985732214187
32904,SIDM00832,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.6525406,-0.05733214,-1.3196379247126542,-0.043190706538237304
24036,SIDM00928,Alisertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.85176486,0.07254344,1.6656648973998702,0.1456660205120173
67532,SIDM00872,Trametinib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3723449,-0.10564376,-0.31071452233149915,0.016729124715917483
24555,SIDM00673,Linsitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8418513,0.0142682195,3.158204223310239,0.0777687564144141
51976,SIDM00877,Cisplatin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.3706489,-0.10477274,-0.16202054041204605,-0.007395150073015902
59555,SIDM01042,SCH772984,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,4.265325,0.36734724,2.386695818027476,0.019094511185982453
24989,SIDM00673,Ribociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8938956,-0.08674509,-2.083598956228883,-0.07031654169933223
75323,SIDM00673,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6081329,0.013026596,1.1815674179933926,0.02337607820687686
74246,SIDM00282,Dabrafenib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-2.3453245,-0.054773115,0.5120109935657499,0.0012036480594983022
52510,SIDM00835,SCH772984,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-0.6475106,-0.05305453,-0.9093264914713791,-0.0282249433240045
31200,SIDM00673,MK-1775,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0765384,-0.10273676,-0.4186931340167933,-0.02056735410565758
63549,SIDM00875,Venetoclax,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4882543,-0.011209528,0.7581205376502198,0.014705480854948792
25031,SIDM00148,Pictilisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8254346,-0.043866202,-0.3981091888230499,-0.013055588104644356
16110,SIDM00673,Nutlin-3a (-),PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.059396166,0.001346088,0.41493640846204577,0.005981964780075051
69429,SIDM00633,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.0170968,-0.14952064,-1.2102843553554627,-0.04189462851271263
3763,SIDM00832,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-2.55205,-0.133636,-3.0180296288108206,-0.09912166444200263
99653,SIDM00877,Crizotinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.88281304,-0.04097526,0.3986227242012084,0.015216623121449387
41743,SIDM00673,Afatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.8281134,0.14332986,0.6342623959588028,0.10290013024284049
60123,SIDM00097,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1155024,-0.0991707,-2.3139167850757767,-0.060761555938400186
55429,SIDM00872,Palbociclib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.35666725,-0.012765099,0.6525998032694459,0.017215283093154926
6956,SIDM00146,Alpelisib,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.3501511,0.07804705,0.9454098622637769,0.05946662433599132
62572,SIDM01197,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6731725,-0.038538914,-1.2373326739047648,-0.08287663252523915
66963,SIDM00148,Alisertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5045521,-0.08326021,-0.5614175388368374,0.015587658448137505
87505,SIDM00875,SCH772984,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6329037,-0.11184224,-0.5356764689444229,-0.05951469087398867
107403,SIDM00282,Dabrafenib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7287544,-0.040933643,1.0236568667134198,0.04585779042583358
2215,SIDM00877,BI-2536,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.6907287,0.0015536441,-3.778143199613288,-0.0878328875440053
56223,SIDM00875,Nutlin-3a (-),MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.43924665,-0.013990312,1.0388856908807063,0.032038162785229085
105786,SIDM00097,Nilotinib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6386598,-0.039325364,0.7152596669443037,-0.010577733104753266
40911,SIDM00933,SCH772984,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.0293546,0.17406723,1.4417175908867281,0.15970149671537637
9894,SIDM00097,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0705088,-0.07681698,-1.088495424937988,-0.07722972762546815
106796,SIDM00835,SCH772984,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.6840675,-0.062011044,0.6216025648326164,0.023140550920346642
11168,SIDM00928,Camptothecin,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2272887,0.19652307,2.512351545161091,0.16988636096575144
87149,SIDM00148,AZD6482,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.67436075,-0.070015684,-0.4754604777097204,-0.025823232262191558
38626,SIDM00833,Afatinib,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-0.26454955,-0.022397956,-0.999221577074817,-0.0685349550614958
50881,SIDM00950,Linsitinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1619432,-0.19705084,-0.8710736268959541,-0.0062564987882660055
35123,SIDM00097,Lapatinib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.350612,-0.14122914,-0.46992423326853583,-0.028974298166454453
39030,SIDM00933,Alpelisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-1.5694215,-0.10471214,-0.38371158244073683,-0.0034347685930922298
53062,SIDM00837,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,-1.055586,-0.069059186,-1.2893269936915073,-0.07374353347905355
1282,SIDM01197,Navitoclax,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,1.120021,0.08730476,2.304899939001549,0.12668805756426296
108155,SIDM00097,GSK269962A,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8079824,-0.07177922,-1.0658597162079704,-0.04050463474434272
104519,SIDM00928,Cisplatin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.95027894,-0.02493611,1.6935444752859048,0.06179554637802256
12742,SIDM00877,Nutlin-3a (-),Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.5346296,0.031801533,0.47147429253500417,0.039692606717261256
104235,SIDM00837,MK-2206,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,82.0,3.9699724,0.2167564,-0.1887256824930757,-0.026616700173154692
93971,SIDM01187,PD173074,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.7955296,0.24353158,-0.7313666040798836,-0.04106210441486352
41588,SIDM00673,Wee1 Inhibitor,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5679063,-0.033437587,-0.07544334959319561,0.006847618855465836
58716,SIDM01042,Doramapimod,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7427741,0.07663523,0.42566074523532177,0.04516881436211932
548,SIDM00928,GSK269962A,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.5818651,-0.11882216,0.09527538216772273,-0.006196808994143977
99866,SIDM00097,GSK269962A,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1445352,-0.03498753,0.7682679000178855,-0.0225855723607027
85994,SIDM01042,AZD6482,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.450921,0.04821372,2.5355642455652836,0.03587525225990651
104787,SIDM00928,Camptothecin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.7408063,0.06568758,-0.5954423389741023,-0.02257759772405405
20391,SIDM00146,Taselisib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.32548347,-0.026475474,-1.4100230485236311,-0.09657282211719097
75378,SIDM00148,JQ1,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4014783,0.02372483,1.5146226070320488,0.0979223977941769
55022,SIDM01042,AZD6482,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9190577,-0.055706482,-1.2366131683076538,-0.08646850299886778
57957,SIDM00875,Taselisib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7248466,-0.08507305,-0.9057747544927105,-0.0406828742800069
54966,SIDM01187,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,5.8876686,0.2409614,4.133847459965254,0.1456399838158935
14627,SIDM00875,Nutlin-3a (-),Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6112613,-0.017642505,0.8531538798428319,0.017707047931669658
15916,SIDM00776,MK-2206,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1670481,0.10218843,-0.4550172824707758,-0.07094637371582983
71742,SIDM00872,Gemcitabine,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8877394,0.029027816,1.7018999495229588,0.017705373535720145
4490,SIDM00097,Paclitaxel,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.380101,0.23567577,3.054318227802169,0.21168936557585527
107037,SIDM00833,AZD7762,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.31881505,0.022087574,-0.21341147092487422,-0.02336167773663667
11582,SIDM00359,LGK974,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.770268,-0.020742673,-0.44374210277490406,0.01008559810840044
43012,SIDM00673,Crizotinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6888392,-0.06371291,-0.421580446478958,-0.016184984748827264
104378,SIDM00933,Nilotinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,3.0865428,0.182291,-0.4908309548820204,-0.037868256183370794
14309,SIDM00633,MK-1775,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7324275,-0.062141936,-1.0193270158911354,-0.07302236070064048
52936,SIDM00633,Venetoclax,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.444379,0.035732307,0.5005041694655975,0.02383832367269463
74299,SIDM00455,AZD7762,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.37378,0.08228283,1.083349673374636,0.11267184201677756
58219,SIDM00957,SCH772984,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.847824,-0.11520558,-0.4499830160910094,-0.02043538117353126
45775,SIDM00146,MK-2206,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.1435308,0.07534916,1.854262663000339,0.11404008729903566
91866,SIDM00455,Crizotinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.59520876,0.03904183,1.312288630050348,0.12381275979873484
18260,SIDM00633,MK-2206,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3480964,0.07995111,0.6555976797510138,-0.035923959331834024
92448,SIDM00928,AZD6482,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.4670349,-0.07555439,-0.6657275945040023,-0.03652751223991976
34036,SIDM00950,Irinotecan,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2112457,-0.04111535,-1.1383543203730566,-0.007423532354249638
45397,SIDM00933,Nutlin-3a (-),5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.8273583,0.08070779,-1.364540108841232,-0.08727043852290672
34522,SIDM00872,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5127645,-0.029642627,-0.09913600729512519,-0.08056652680974999
76607,SIDM00216,Linsitinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.7284849,-0.1005821,0.9649477493499509,0.043758611664341224
35235,SIDM00950,OSI-027,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4520788,0.08794505,1.1303243858406915,-0.03835060898135276
73023,SIDM00146,JQ1,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6506268,-0.07844574,-1.1063639700411758,-0.03759023832168057
45759,SIDM00950,Linsitinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3999798,0.28308842,2.3097964291547135,0.2043807137602357
85265,SIDM00673,Afatinib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0371614,0.06714217,1.4180791831027308,0.16008342816045926
49249,SIDM00633,RO-3306,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.44613153,-0.043181974,-2.0338950682561943,-0.12432698444823856
63238,SIDM00148,Camptothecin,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.29009202,-0.028659625,-0.6192248326454222,-0.04557700941968875
20919,SIDM01042,MK-1775,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22146142,0.014064741,-1.3162916401075342,-0.02712589353115542
36853,SIDM00455,AZD7762,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.687776,0.078498416,1.2681115387669464,0.13169232395896022
98649,SIDM00877,Wee1 Inhibitor,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,0.3961573,0.027234491,0.5416197933589809,0.04081937960931072
16531,SIDM00875,Tozasertib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1387057,-0.028171265,-0.5333475652222662,0.005838338500026052
71021,SIDM00633,KU-55933,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.8696897,0.16368794,1.8586096396453047,0.04963588044096755
27647,SIDM00872,Camptothecin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2718767,0.031148545,3.1743627147749396,0.07742153965518873
103905,SIDM00148,NU7441,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.345312,-0.14097676,-1.305340941029999,-0.07723216512793157
39641,SIDM01187,5-Fluorouracil,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.1816828,-0.1790722,-1.6699938789615614,-0.11308640861117367
44997,SIDM00455,Linsitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.7932112,0.18884474,0.7511526811552679,0.06532669102070872
72925,SIDM00928,Navitoclax,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.5677792,-0.13365784,0.3788799075201769,-0.023908185822731576
61830,SIDM01042,BI-2536,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7627178,0.0058265743,1.7947474215713368,0.02187610663917476
7479,SIDM00146,Bortezomib,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.1445504,-0.0077965297,-0.9844482551361293,-0.03448060173882956
78215,SIDM00146,Linsitinib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.3262987,0.06500037,2.5453779713661873,0.0895292758812351
2194,SIDM00146,AZD8055,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2722142,-0.11890231,0.8072478799992795,0.06367560054999433
4162,SIDM00148,Paclitaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0794897,0.13606453,0.20837091550660528,0.03715012436136064
48259,SIDM01187,Olaparib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1523181,-0.034850482,-0.14359891090400306,0.01632407547730114
27346,SIDM00928,5-Fluorouracil,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,1.6295086,0.13041598,-1.4036909239050352,-0.03649110342398181
103030,SIDM01187,MK-2206,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.09380043,-0.006317826,0.6999244746300157,0.04440316737334502
30870,SIDM00957,Crizotinib,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.3470601,-0.039110642,0.11261196695780157,0.05476724048920426
75535,SIDM00950,Trametinib,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.129472,-0.15503384,-2.21394002914924,-0.06657908812153984
103182,SIDM00875,GSK269962A,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.29727745,-0.01735217,-0.2786295916085717,0.04333015902589996
4348,SIDM01042,Nilotinib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4562277,0.027327275,0.11734116342160501,-0.007491821690307789
55505,SIDM00359,MK-2206,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1563436,-0.046797942,1.0047634043822014,0.08258800720653595
66921,SIDM00826,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,70.0,-0.8548745,-0.06840809,-0.2741885941923699,-0.06526458438876297
12431,SIDM00216,LGK974,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.3469196,0.020286728,0.14155670436162615,0.00039721183000003557
42136,SIDM00875,Nutlin-3a (-),Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5479736,0.056342248,1.8227691515555202,0.08229347187562797
107405,SIDM00776,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.88579,-0.047104005,1.3945128140498086,0.07102345765696758
49209,SIDM00097,Crizotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0221856,-0.09936142,-1.0243776858793028,-0.08727128227721538
68575,SIDM00950,5-Fluorouracil,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.06967332,-0.006245271,-1.2117870681684513,-0.0642614870506614
52238,SIDM00833,BMS-754807,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.4002735,-0.033882607,-1.3286194567659304,-0.0628356387767228
107677,SIDM00148,JQ1,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7912904,-0.15924405,-0.07920171625119914,-0.030589310370232308
92339,SIDM00633,ZM447439,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2922646,0.12013223,0.5358232978792069,0.05449524444595298
38509,SIDM00877,OSI-027,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.3794417,0.12355463,0.9489761488806042,0.093010776245534
96834,SIDM00042,MK-1775,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.8157183,-0.10225639,-2.251057005012514,-0.05280569576900244
96794,SIDM00832,AZD4547,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-2.1006286,-0.12886077,-0.8551529281559094,-0.024360350640903392
64608,SIDM00877,Navitoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.858057,0.123230115,1.9148348818954515,0.08376188543939457
25994,SIDM00097,Tozasertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6404986,-0.034448396,0.6080230491430613,0.014525161468562994
20798,SIDM00146,PF-4708671,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,4.4725137,0.23567049,1.8903562251650603,0.07457831903074479
71383,SIDM00933,Paclitaxel,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.6720819,-0.059754122,-2.0933930716156643,-0.052777889436482726
82733,SIDM00282,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.4048898,-0.1713393,-1.7746181787838715,-0.09392944189101439
64537,SIDM00148,Nilotinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7806675,0.07034877,-0.6790484457600241,-0.06436443311920073
80565,SIDM00148,Vorinostat,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.28270873,0.022180902,-0.10919017213792799,-0.0696514888651417
46603,SIDM00837,Olaparib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.6743531,-0.11299162,-1.2841600984447141,-0.01215344515811888
76599,SIDM01042,Lapatinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8576627,0.100212745,-0.8554727830244486,-0.05302087084825707
28455,SIDM00875,PF-4708671,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.80086064,0.041373666,2.1165578480923584,0.09065708897142928
58192,SIDM00933,JQ1,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1379868,0.10880412,-0.74900388172077,0.038511829135729314
2685,SIDM00146,JQ1,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.9673725,-0.17658995,-0.9653912823196373,-0.07985476703978435
94326,SIDM00776,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,65.0,0.93590045,0.06201463,-1.9061594262391113,-0.05491400408460151
105120,SIDM00928,SCH772984,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.8572793,0.30772537,0.5436944554031539,0.039007059671390266
28355,SIDM00933,GSK269962A,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.6995531,0.07015253,0.1706645211830235,0.022553834873637636
32736,SIDM00146,Navitoclax,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.85710126,0.060627937,1.4925615357112512,0.007058649465206778
69176,SIDM00633,Luminespib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8553389,-0.059490167,-0.6260960889461397,-0.05380623980389392
61372,SIDM00455,Palbociclib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.6125014,-0.06547771,-0.5933294145415998,0.019467630783130258
11333,SIDM00875,ZM447439,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.3224243,0.035990544,-0.6788139451991394,-0.06803137579429896
45209,SIDM00933,Navitoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.285069,0.03229547,1.1359387487616337,0.05004819210340137
94379,SIDM01187,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.5350751,0.04735725,1.088733757644363,0.02544427789242452
65097,SIDM00826,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,0.61949843,0.015545858,1.6385366857817758,0.042977423779153826
53233,SIDM00148,Alisertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.23584639,-0.012726756,-0.7259315690712781,-0.02987890466032596
981,SIDM00148,Venetoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.94168633,-0.034271795,-0.9411555436938229,-0.051010521063562866
62775,SIDM00933,Crizotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.4386925,0.19687104,0.03553614999801894,0.04835088390246382
13394,SIDM01197,Vinorelbine,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5831137,-0.25936967,-3.430580349171358,-0.242059923767187
97179,SIDM00950,Crizotinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.57475144,-0.035479043,-1.4197784479139297,-0.1013748661942119
3401,SIDM00933,Camptothecin,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,4.046899,0.13333264,-0.26010494646162036,-0.07509257887031662
37100,SIDM00875,PF-4708671,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7112955,0.009518467,1.41233549704419,0.060614579569201424
101177,SIDM00146,BI-2536,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.41290066,0.014256519,0.1145363324718951,-0.005577557226582272
108079,SIDM00146,Gemcitabine,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.6581295,0.065486334,-1.2207107588506356,-0.11636190120514961
5367,SIDM01042,Lapatinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.47577813,-0.06010072,-0.6194758123842453,-0.02379505647458441
104533,SIDM00875,5-Fluorouracil,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.08480124,-0.009041401,-1.8011187222017122,-0.03160582120295187
58517,SIDM00933,ZM447439,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,5.226913,0.40210146,0.08538081528558464,0.0450613856769756
45470,SIDM00957,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,1.7772214,0.038367763,3.078840940036186,0.03937156646227352
42895,SIDM00146,Olaparib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.1064883,0.059627425,0.6497532691219505,0.05377359794947504
86260,SIDM00875,Alisertib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2699372,-0.09763331,1.436951330421081,0.08113839120956931
61634,SIDM00872,MK-2206,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.59915864,0.06349623,0.23252433472250852,-0.017124399364015868
68392,SIDM00633,AZD6482,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7613661,-0.13242504,-0.5822276084587094,-0.0467992035583216
15729,SIDM01042,MK-1775,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.58310336,0.041380763,-0.8844887930596684,-0.007513989584789238
10752,SIDM00633,PD173074,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1039875,0.1124655,1.3502057163306551,0.06726793957141473
25726,SIDM00097,Temozolomide,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.84499925,0.01650379,-0.7768956387183299,0.005225294152196907
88932,SIDM00148,Ribociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.756901,0.062029473,-1.1931135564564743,-0.038213297455509804
41399,SIDM00928,Lapatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.9955283,0.19450471,1.040405166857585,0.11596091098579288
106583,SIDM00872,Taselisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0768877,-0.062201343,-1.2939860935644292,-0.07765965030557083
9280,SIDM00877,Alpelisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,0.67222035,0.063779734,0.40549368753695675,-0.0007216375171467274
54836,SIDM00359,Vinorelbine,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2856632,-0.062450446,0.1775124192204182,0.07051339207972286
46183,SIDM00833,Navitoclax,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,1.3228624,0.03245254,2.4460164041022647,0.03578535713300905
98640,SIDM00875,OSI-027,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8022318,0.087643646,-0.37786107260621205,-0.0027741095332021607
100168,SIDM00872,Trametinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8306124,-0.13364848,0.6247831105777782,0.03821448518334519
8732,SIDM00877,Olaparib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.2969128,0.08399006,-0.36230589290521187,0.029009352356116274
104763,SIDM00957,Afatinib,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.0932708,-0.06821239,0.8012917338528529,0.007255293087445878
94931,SIDM00097,AZD6482,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.58415145,0.041090082,0.11794684737599442,0.0012702247449233818
89104,SIDM00282,Palbociclib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-0.5299463,-0.01890558,0.6062205054988005,0.03007306839233524
23351,SIDM01197,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.5005723,0.01551506,-1.0282761804729044,0.004752811283455453
23643,SIDM00933,Wee1 Inhibitor,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.39436823,-0.030404532,-0.5349778929252176,-0.023783111298065436
18908,SIDM00673,Ribociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.8740082,-0.085202135,-2.6651545084052075,-0.04522966669290867
96879,SIDM00673,Alpelisib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.45042777,-0.025405757,0.8482420185613745,0.031535739846470144
68141,SIDM00950,Ruxolitinib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.843791,0.0835291,0.9946642336244178,0.06476021388001527
31855,SIDM00148,Alisertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5472631,0.21526517,1.1507889955509751,0.06252557182741994
20584,SIDM00633,Venetoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.686894,0.07978697,2.762987942471548,0.08642764063857364
36988,SIDM00875,BI-2536,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.063834675,-0.0025219992,0.15643550371425388,-0.01426491169843771
21359,SIDM00146,SCH772984,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.0195935,0.14971715,2.9431926497600758,0.19431194176791663
40997,SIDM00042,Navitoclax,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2305804,0.042187434,1.902748231714494,0.05104043363587742
6000,SIDM00833,AZD8055,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.253944,0.1445618,2.743482413038101,0.15279605324701429
19139,SIDM00928,Crizotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.3958962,0.10774678,0.7760660566579608,0.05238705391345725
69754,SIDM00633,Linsitinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.9611404,0.14702918,2.0102298818203654,0.07195584284414261
3559,SIDM01042,GSK269962A,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35605934,-0.031111911,-0.4394238264880027,0.017800757241152272
47531,SIDM00837,AZD4547,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.0151641,0.056731615,-0.6051826038889555,0.0016271343798333793
36907,SIDM00673,Gemcitabine,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9167215,-0.11503307,-2.817947200736236,-0.09443187312276399
35263,SIDM00928,Venetoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.202027,0.059030257,0.036178251586201,-0.006683860342867095
49274,SIDM00950,Trametinib,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.008956,-0.32118827,-2.333175236909694,-0.13295132635826512
35582,SIDM00928,Temozolomide,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,1.2160797,0.03975051,0.5617935310196003,0.04066643165133507
73507,SIDM00933,BI-2536,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-5.4695544,-0.10171877,-6.896095526537726,-0.15587295357687753
51406,SIDM01042,ZM447439,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9268258,0.11844311,-0.04266569392428534,-0.013036699268939021
44192,SIDM00216,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.400453,0.021776319,-2.4143991669972453,-0.09819823076567522
8301,SIDM00872,SCH772984,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.6209123,-0.12473326,-1.0572905111186874,-0.03666565067368738
73352,SIDM00146,Alisertib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6785781,0.096049756,-1.552285235200905,-0.05309493200940454
26467,SIDM00776,Camptothecin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.75076467,-0.035156555,-0.3094102466537163,0.03707199860157399
106943,SIDM00216,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.0655605,-0.034401122,0.33709010226182967,0.03773020361706796
48291,SIDM00833,SCH772984,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.43695974,0.036127657,-0.4139835129389609,-0.015789254309099
105796,SIDM00872,Venetoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.481773,-0.0554309,0.2722212473785755,0.045925590669913426
83187,SIDM00835,MK-1775,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-1.1098852,-0.09372907,-1.9426561848558555,-0.09574613039222425
46091,SIDM00833,LGK974,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.4466463,-0.04826443,-0.4508197613652555,0.011781934405685143
99842,SIDM00455,Taselisib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1361076,0.076161094,-0.4915610437190336,-0.07745102640496163
101357,SIDM00042,Irinotecan,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.6557062,0.18808626,-0.17073468738020056,-0.01390897520537315
7670,SIDM00359,Oxaliplatin,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.9616424,0.06177313,-1.1959662588553222,-0.005904172908148535
59430,SIDM00877,Camptothecin,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.1053011,-0.09850616,0.04475297525434224,0.04037471554628257
19418,SIDM00146,Cisplatin,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.941338,0.03744128,2.398852615431463,0.12813779003379272
87881,SIDM00832,Navitoclax,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-2.5148165,-0.1237187,-1.298445871829155,-0.03831865116602721
10476,SIDM00146,BI-2536,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.3160439,0.054910097,-0.3622507168056702,-0.003268733697363905
42166,SIDM00833,Crizotinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.3339137,0.083273605,0.899379202867785,0.07448768260409791
37258,SIDM00633,AZD8055,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.8619683,0.23969595,1.3610835462468736,0.12175961496488036
25826,SIDM00957,MK-1775,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-4.4954257,-0.12281085,-1.328338502764899,-0.07126747366982172
34004,SIDM00146,MK-1775,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.396666,-0.03458945,-0.778036401742068,-0.03820198719334552
105140,SIDM00957,Navitoclax,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-1.1778548,-0.042662982,-0.31904526142251616,-0.07321154756941804
61371,SIDM00950,SCH772984,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.937439,0.27901736,3.4734704295736063,0.1738736621369851
103162,SIDM00097,Camptothecin,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7243916,-0.031535324,-0.6632836794245233,-0.03749500367068303
22705,SIDM00146,Bortezomib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.6353833,0.03921039,-0.21791326324419477,0.010168621544243191
10702,SIDM00872,NU7441,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6862181,0.13863218,1.7711362128319013,0.09611097946022452
52312,SIDM00875,Alisertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3615706,0.033058543,-1.059842622325625,-0.030056601222257617
9791,SIDM00957,Crizotinib,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-2.0420682,-0.058090072,0.07775581594175562,-0.02315362408558447
43352,SIDM00837,Trametinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-3.8872938,-0.15694405,-3.473251576239011,-0.1563261329342223
44676,SIDM00282,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.993862,-0.0968071,-2.2754750315510894,-0.18696627456899165
92099,SIDM00146,Luminespib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.87538844,-0.074915774,-0.09720235057453486,-0.07438470485844129
107424,SIDM00673,PF-4708671,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-3.267318,-0.1532828,-1.820795424077191,-0.09990460107627443
85486,SIDM00877,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8948381,0.09910476,0.37344954601347374,0.0003884866419000852
54070,SIDM00933,GSK269962A,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.44835207,-0.041685533,-0.9049274503458047,-0.03541727428260396
79087,SIDM00097,AZD8055,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2488511,-0.08624312,-0.5156611801040344,-0.0685816443038033
103691,SIDM00833,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,4.485888,0.19347283,1.4033483373447908,0.02086669966471446
107429,SIDM00359,BMS-754807,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.3177881,-0.1647151,-0.8400357825348375,-0.0804551215620476
47646,SIDM00950,Olaparib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.54293483,-0.019984568,-0.04395864372530233,0.052994713632586905
27960,SIDM00872,Vorinostat,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0368506,-0.06424016,0.41286215615858185,0.05804817842191372
47950,SIDM00833,Camptothecin,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.69671637,-0.04062053,-0.8867858889695139,-0.06292527092779436
40461,SIDM00877,Luminespib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,-0.7376937,-0.046326444,-1.23394529305457,-0.025961731339332283
61611,SIDM00832,Linsitinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,1.1651094,0.1037994,0.6376219855749461,-0.001522166238479725
96357,SIDM00633,Gemcitabine,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.457391,-0.13348939,-0.6717502404607226,-0.02441354718102005
106330,SIDM00455,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.9455373,-0.10715376,0.6136877169619266,0.05210703858705255
59085,SIDM00933,Docetaxel,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.88478976,-0.11851319,-1.0847785582298373,-0.047218649742234255
107056,SIDM00950,Sorafenib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.8225462,0.07528844,-0.3250713566881656,0.02447389458417758
22859,SIDM00673,Trametinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.1714902,0.05497094,-0.8852080360812826,-0.01267837368237089
102280,SIDM00673,JQ1,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.5416818,-0.09393608,0.6804556141798646,0.11179433521919924
76960,SIDM01042,MK-2206,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1410527,-0.050741363,-1.426592348563234,-0.0971460434718009
70592,SIDM00673,Entinostat,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1588724,-0.11805293,-0.4660919344718818,-0.03893863706480923
45090,SIDM00359,AZD8055,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7867929,-0.02721922,0.19124461061295578,0.05514397320345117
75964,SIDM01042,JQ1,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5794635,0.015956258,-0.5063405570165318,-0.028022682931838877
4216,SIDM00877,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,1.2906846,0.039291494,0.5618897955724005,0.04596775293115826
76334,SIDM00776,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-1.2024933,-0.09787124,-0.720775852456347,-0.05506558067628893
79359,SIDM00957,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-1.3087358,-0.018185131,1.0711681674303055,0.04531606364581688
92916,SIDM00673,Docetaxel,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.68197465,0.06311203,-0.5226757751987432,-0.028058075912047214
24633,SIDM00833,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,5.975177,0.32485145,0.5844062816877336,0.023289747992769207
61972,SIDM01042,AZD7762,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.24853435,-0.032508224,-1.5356334945055754,-0.11148315243557504
30782,SIDM00872,PF-4708671,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6811126,0.06698332,0.4329162945890213,0.028096221323601005
61832,SIDM00776,SB505124,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.745063,-0.057633135,-0.2151461071000537,-0.042947666578933834
15238,SIDM00282,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7951436,-0.04626471,0.11226339944757717,0.025108080399067253
83752,SIDM00097,SCH772984,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.076495,-0.11747881,-0.7128825951900214,-0.05511979946473514
80573,SIDM01187,Bortezomib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.46920857,-0.043858938,-0.7816334903208706,-0.06215360661042313
97262,SIDM00950,SCH772984,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8683033,0.031517997,0.12766479473749615,0.0003673898296228326
56281,SIDM00146,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.51239485,-0.015331232,0.3211964015646728,0.011637449576052582
85735,SIDM00837,Camptothecin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.22098115,-0.010791133,-0.4380416332965468,-0.005435665114543977
34371,SIDM00097,Paclitaxel,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2494295,0.08539585,-0.2019926559263906,-0.0004996473030450874
58436,SIDM00146,Wee1 Inhibitor,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.0607698,-0.16421214,-2.237944068879926,-0.1725028119004478
77038,SIDM00877,Cisplatin,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.6764002,0.07455495,-0.29337635630330966,0.020582625836497743
65002,SIDM00359,Palbociclib,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4033216,0.101721846,-1.5752407043173131,-0.07055832036856212
17018,SIDM00282,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,4.045541,0.12022815,2.3305830093771087,0.12071888871147572
46289,SIDM00832,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-0.33101067,-0.017471312,0.28041741910032203,0.01999761847447697
7625,SIDM00633,NU7441,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9021741,0.15200502,-0.04406278970002317,-0.02623723959690185
5738,SIDM00146,Navitoclax,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8345101,0.05968195,0.7907144489175006,0.035070036601190194
78497,SIDM00875,NU7441,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4980586,0.12977096,1.32009490172928,0.0789390435296023
98159,SIDM00282,SB505124,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.51172787,0.021282664,1.529034510997472,0.1194457637914395
80620,SIDM00148,Nilotinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4385333,0.12515673,-0.4776907364601925,-0.03166181243800553
2502,SIDM00216,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.126501,-0.076145135,-2.12558133216651,-0.12413159023357913
98573,SIDM00950,MK-2206,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.0864022,0.19888347,0.698784413406182,0.08139541364436724
5742,SIDM00146,AZD7762,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.7300503,0.06603769,-0.6019091732921564,0.0038171756947189333
36816,SIDM00282,Afatinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.8582166,0.077273734,1.7586207404610548,0.07056056405074586
51139,SIDM00633,Afatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3505905,-0.014525792,-3.012744972490743,-0.010043601742451218
52842,SIDM00359,BMS-754807,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.900489,-0.22211745,-0.924439806033338,0.02323504867712673
89271,SIDM00872,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5051765,0.13808937,1.394782090137945,0.09472777548781208
72855,SIDM00872,Palbociclib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.44521233,-0.015601702,0.9308949218670697,0.05555065398884392
5371,SIDM01197,AZD7762,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-5.1633863,-0.35669497,-2.7412014094893675,-0.23712516939362396
76977,SIDM00146,AZD6482,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.8047682,0.06530821,1.5230094180322225,0.181021167690481
27735,SIDM00833,Olaparib,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.9681705,0.09552045,0.8164395973814026,0.06619019929376742
32140,SIDM00097,Sorafenib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.91661763,-0.037713986,-0.293173649608275,-0.019377770823955538
97881,SIDM00875,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7139247,-0.021294568,0.6247914940626107,-0.008115637210751491
78788,SIDM00872,Alisertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7811117,0.0982992,1.6458131528827875,0.16193192162882317
60883,SIDM00216,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2287104,-0.108921,-1.118617798687252,-0.12009662207446066
1785,SIDM00633,PF-4708671,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5677322,-0.118174374,-1.9704549013424852,-0.07709432373300758
58563,SIDM00832,AZD8055,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.5296628,-0.12468893,-1.948069032772663,-0.11918550884661004
48515,SIDM00933,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,2.3035207,0.330535,-0.8477745548969706,0.014488884628152688
11195,SIDM00282,MK-1775,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6521818,-0.037983704,-0.3565280596317075,-0.060275484766908916
99009,SIDM00148,Linsitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9043949,0.18927555,0.990616328576277,0.02466265386720825
40667,SIDM00146,Palbociclib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.3310348,-0.06310153,-1.6334949530520844,-0.063037382405958
49602,SIDM00042,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.6629484,0.25529882,2.8701425772071145,0.21302694828282
3611,SIDM01197,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-6.8176885,-0.16299507,-5.541823066581612,-0.12483376097487986
8602,SIDM00216,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-0.8075159,-0.044852678,-3.0985429769415167,-0.15641872835354229
23437,SIDM01197,Oxaliplatin,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.4374117,-0.025923658,-1.0635128425637528,-0.036156376096982856
77174,SIDM00097,NU7441,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2011724,-0.09294119,1.1127314992620614,0.07616751029607464
91544,SIDM00097,Cisplatin,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.90629107,0.018475778,0.18768252917412417,0.014092156446748981
68254,SIDM00633,Lapatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.93589735,-0.014306281,-1.403896311261059,-0.011283141705881307
85085,SIDM00146,KU-55933,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-2.1272337,-0.075524524,-1.131027657195227,0.004754106675985349
30501,SIDM00633,ZM447439,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5784931,0.14533904,0.8790152465393403,0.07036141971082072
49270,SIDM00673,Venetoclax,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4851669,0.052499108,-0.7081282984631911,0.0382716485272655
18938,SIDM00633,Crizotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.491818,0.07672585,-0.10710493346445532,0.021906005018427276
85532,SIDM00832,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.2150164,-0.080673,-0.04058907278388715,-0.03849949050252692
105090,SIDM01197,AZD8055,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.158531,0.030931693,1.7900161801506431,0.1263035684332157
107646,SIDM00875,Venetoclax,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34975705,-0.0071774945,0.7110825700940826,-0.026910420719620534
27404,SIDM01042,Pictilisib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.55984485,0.023266377,-1.80259952877015,-0.045039677115205526
40780,SIDM00832,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.7832668,-0.15432483,-1.4012565173764742,-0.0651718308933501
28860,SIDM00146,Gemcitabine,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-4.331742,-0.29571274,-3.652751037837088,-0.29690104948200724
71708,SIDM00933,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.64374125,-0.039533153,-1.034448023635396,-0.07587595068046063
107347,SIDM00872,Bortezomib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.1846807,-0.013174938,-0.43024307669193124,-0.006525561274288629
89808,SIDM00633,MK-2206,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1030174,0.059301384,-2.58762800707751,-0.08089640943275789
83330,SIDM01187,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9968415,-0.072368786,-2.259402319626908,-0.08253973405591095
46635,SIDM00042,Sorafenib,Linsitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2215499,0.13548866,0.6205685153259023,0.05906058181333006
32035,SIDM00835,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.45494395,0.03496832,-0.3416105007088134,-0.04754307282753986
11373,SIDM00875,Axitinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.08638088,-0.004462828,1.8442387762213215,0.08647526802197354
1715,SIDM00673,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.7356567,0.08589465,-1.975720075344898,-0.0477833413045341
80879,SIDM00835,AZD8055,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,White,73.0,-1.8214997,-0.087144904,-0.3121026801557022,-0.05246461438984215
15490,SIDM00776,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.209037,-0.06888961,-0.29108303666329255,-0.007031764705537367
30506,SIDM00455,Navitoclax,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8997844,0.052697726,-0.29312649645950395,0.03219337074140849
75184,SIDM00148,Vorinostat,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.40323278,-0.040225536,0.09952102932291862,-0.033197069925705085
99541,SIDM00833,Olaparib,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-1.789115,-0.064033784,-0.8888926360686279,-0.040767674729150924
74142,SIDM00832,AZD4547,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.1647213,-0.068683915,0.9147868087720314,0.025335494668903263
9404,SIDM00877,Alpelisib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-1.8814741,-0.14560823,-0.3580270784574565,0.0025025146982708977
55392,SIDM00957,MK-2206,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,5.2562695,0.08998375,4.402964756503169,0.20236348851363237
62481,SIDM00872,MK-1775,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2921299,-0.031084199,-0.17391318094168742,0.0032623321828267335
50802,SIDM00146,Uprosertib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-2.0382614,-0.13165417,0.8124858165668059,0.173752687605977
99223,SIDM00216,Taselisib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.4870716,0.016266543,-0.7907795528708468,0.003204610659769796
9883,SIDM00872,Gemcitabine,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8889921,0.029056992,1.5951630868765911,0.03549138506777122
106399,SIDM00282,Oxaliplatin,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7845658,-0.0584596,-1.755438347185048,-0.15141579171839661
99751,SIDM00933,Palbociclib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.38892457,-0.037141055,0.39374139628357097,0.1219439413927035
33138,SIDM00872,Olaparib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5393481,-0.08190487,-0.8396082559864682,-0.030343745558477322
81450,SIDM00877,Nutlin-3a (-),PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6259475,-0.060909748,-0.19113787447254696,0.01186946793365193
89936,SIDM00833,Navitoclax,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.0925583,-0.0812627,-1.5207953227893218,-0.12087919715062058
86768,SIDM00148,SCH772984,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9336883,0.0386512,0.06978643610123726,0.0012355148702456185
36623,SIDM01197,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.7444511,-0.03509791,-0.11749135864794467,-0.000586129093074707
65124,SIDM00877,PD173074,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.270251,-0.107887805,-0.34538458880521494,0.011740964283097828
51603,SIDM00148,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4094864,-0.066994384,-0.6350794110887218,-0.0928728540664637
106891,SIDM00877,Entinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3569032,0.09949128,0.7025067576965135,0.050071374817673424
70271,SIDM00455,Oxaliplatin,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4684381,-0.10275209,-1.1627094813188021,-0.06661946492035431
56885,SIDM00146,Cisplatin,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9155462,0.03743842,1.5833284624163817,0.059589061362040174
17829,SIDM01042,AZD8055,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5003474,0.11856751,-0.6225497711624396,0.023670195147965475
59948,SIDM00872,Axitinib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.9573603,0.080785565,-0.5895370245386801,-0.009072474777715698
20427,SIDM00832,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.1651146,0.085814156,-1.4623012423259911,-0.08766988683678663
78496,SIDM00872,Docetaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.177383,-0.19289428,-1.852120617618773,-0.1301834929245796
39173,SIDM00928,Tozasertib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.8270782,0.028861638,0.8298800571994547,0.05302535739641014
2445,SIDM00097,Olaparib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2896205,0.028105391,0.6170558944182077,0.027391409130370206
53795,SIDM00875,Linsitinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8758558,0.06735647,0.3117996564730268,0.02684616236863749
42350,SIDM00872,Axitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8429097,-0.054682806,-1.507344989949397,-0.11495145768293925
46664,SIDM01042,Uprosertib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7591559,-0.034620482,-1.0578505249440961,-0.07160647446128376
51242,SIDM00877,ZM447439,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-1.6385957,-0.13609625,-0.40206603163979565,0.02073633363957687
58642,SIDM00633,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.125444,-0.117610596,-1.2289555166923118,-0.010621536535126937
64893,SIDM00837,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.92509776,0.0420706,-0.4108394999385795,-0.04145388432302034
7263,SIDM00957,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-4.1904593,-0.078445815,-0.282092796879989,-0.00623597845796697
72470,SIDM00957,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.632312,0.06910478,1.966167273099606,0.08412120683553197
28232,SIDM00875,Olaparib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0707735,-0.08473588,-0.47661162115679273,-0.012386269450102214
9286,SIDM00042,Linsitinib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.9981544,0.24191462,2.329684494282566,0.07119732490149792
103148,SIDM00042,Irinotecan,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-3.1190615,-0.16920528,-0.8536244134848978,-0.04094966027213643
83105,SIDM00872,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9192742,0.17796126,1.5369669862112671,0.06058278123115784
10255,SIDM00875,Doramapimod,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9662046,0.074038364,1.5992898259754682,0.0322010133929376
13332,SIDM00950,Taselisib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5181792,-0.12862673,-0.43922001380519593,-0.06023057113729766
43382,SIDM00933,Crizotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.60022604,-0.05530432,-1.8723025251433012,-0.10216938132218396
48786,SIDM00933,SCH772984,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.1342747,-0.07017941,0.5632012054544355,0.024842787919179876
74356,SIDM00837,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.5843709,0.018179966,-0.04576605629447396,0.027024593058017108
45352,SIDM00148,GSK269962A,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.78484213,-0.07549053,-1.5550544682476743,-0.07812032693755308
8888,SIDM00833,MK-1775,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,0.4585099,0.025117809,-0.5552118473895363,-0.014651646844038262
93421,SIDM00950,OSI-027,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.1384444,0.106816076,1.1708210766591152,0.07519729938345619
77684,SIDM00633,Palbociclib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2664697,0.07135568,-1.2483822087558434,-0.05891858379276771
69080,SIDM00832,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.63981867,0.022641648,-0.27008799914243614,0.026358371274985956
45262,SIDM00875,Entinostat,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4927254,0.041765545,-0.28744602278749415,0.021978966606855173
2103,SIDM01187,Taselisib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.42454916,0.030122336,-0.4175166442287768,-0.024271062417368913
59884,SIDM00146,PD173074,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.58695054,0.021641238,-0.20562210439655612,0.009875375413375766
68701,SIDM00877,AZD6482,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.5441526,0.046648886,1.726402390520285,0.05512081585773398
35306,SIDM00216,Afatinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.31542647,-0.02425507,-0.6111076426945622,-0.031735909600800936
60876,SIDM00933,5-Fluorouracil,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.4214936,0.04388184,0.2641542221046762,0.03480259599565612
51769,SIDM00776,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9104879,-0.059034087,-0.7348488714250991,-0.033759813017391664
40256,SIDM00957,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Carcinoma,Male,Unknown,69.0,-4.730207,-0.091289654,-1.290545792229848,-0.08198821679827223
33443,SIDM00146,AZD8055,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1922246,-0.10492217,-0.6774363491353131,-0.0383054259015458
78869,SIDM00928,Pictilisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.5305223,-0.2266727,-0.4837327269389425,-0.052190351312216124
63026,SIDM00933,Pictilisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.3691564,0.13850391,-1.1546347246270543,-0.028580658834495287
2988,SIDM00826,Afatinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-1.3872644,-0.11674143,-1.6250140257590706,-0.02556927354702418
38849,SIDM01187,Olaparib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.684274,0.19605856,-1.5406304151532133,-0.018538595295640347
27713,SIDM00875,Dabrafenib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0380874,0.05791918,-0.01110702444861673,0.020789502636695177
100437,SIDM00633,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.906391,0.106010154,-1.5617704206619658,-0.06765610995566623
74757,SIDM00097,AZD6482,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.76854473,-0.05481665,-1.3014362455084056,-0.10280997082892968
97436,SIDM00097,Luminespib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4480189,-0.030433716,-0.6759393485226046,-0.08186796588065515
23835,SIDM00957,Taselisib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.5304966,-0.08599659,-1.2245645806447507,-0.047165873841682485
53023,SIDM00455,Gemcitabine,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.8937874,-0.10756957,-2.285433266060536,-0.07468715287579109
73297,SIDM00633,KU-55933,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3980137,-0.040921148,-1.4606924688758474,-0.04872903637706622
7602,SIDM00673,Doramapimod,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.021569,0.022032874,2.4954202341486065,0.08757291312917387
103213,SIDM00146,Gemcitabine,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3470834,0.085987486,-1.0190661718264007,-0.041972598758813956
56146,SIDM00148,Bortezomib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6483193,0.049810857,-0.4753802013737168,-0.07495854020221195
27808,SIDM00872,PD173074,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5470476,-0.06056458,-0.2640561459612161,0.017526397638693816
65972,SIDM00826,Olaparib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.4038204,-0.056777906,-1.4844415904353487,-0.06547696817679373
40047,SIDM00148,Tozasertib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.599258,0.18992087,-0.18898336916471492,0.013385061990330065
54429,SIDM00933,Dabrafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.1258078,0.087601475,-1.0216713866692662,-0.016193671154086715
72048,SIDM00282,Vinorelbine,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.5485086,-0.10385997,-1.2889394809424708,-0.08882727603850586
50965,SIDM00950,Lapatinib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4996104,0.15393463,2.2954795438014015,0.126714780273221
63240,SIDM00673,Trametinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.592979,0.107911356,-0.27061860802796633,-0.0617427700993387
87392,SIDM00950,Ruxolitinib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.66189337,-0.020682467,1.1710645068325387,0.04847333604963444
93460,SIDM00359,Navitoclax,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.79086006,0.037122227,1.776549341634463,0.09427895452403645
102614,SIDM01042,Afatinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.58004814,-0.070324525,-0.1819045278221342,0.00734972965677401
93533,SIDM00835,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.1612952,0.10614909,1.6313832293424724,0.06894729698801587
94024,SIDM00633,KU-55933,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4554075,-0.044348422,-1.1144770047429446,-0.02162232774352537
38661,SIDM00872,MK-2206,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5492857,-0.057338245,-1.004887458963944,-0.10875481862239168
9983,SIDM00097,RO-3306,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.055893,0.037958365,0.9271626492042307,0.024615273358455567
81307,SIDM01042,NU7441,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.36797184,0.029491156,0.6942444767780397,0.024809452590678866
89358,SIDM00837,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.9532102,0.03162596,-0.6041638201651356,-0.05382345792592296
2740,SIDM00148,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.598028,0.19801183,2.09155675163271,0.11052297668818092
106502,SIDM00097,MK-2206,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8614571,-0.056729894,1.3372891303701941,0.0474582599267447
79049,SIDM00875,JQ1,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88768375,-0.094704665,2.6927360880290623,0.04805080183394
64834,SIDM00776,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.5853225,-0.019510055,-0.1732069875891406,0.004484826927330015
41898,SIDM00673,Camptothecin,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2283832,-0.03502139,0.49991140370026627,0.004317630670328073
53003,SIDM00928,ZM447439,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.4213396,0.14371572,0.8263609423441961,0.02707317373756506
14447,SIDM00146,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,1.0314695,0.07771228,-0.723859195281386,-0.028088616440643997
98755,SIDM00957,Crizotinib,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.1000723,0.032542657,1.321055500756932,0.12070812680328631
6715,SIDM00148,PD173074,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3941858,0.037848715,-0.03786551877669182,0.0033117859016304116
72813,SIDM01197,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8876163,0.119377956,0.5208473238328242,-0.015275578309444832
7159,SIDM00933,Alpelisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.8899319,0.18267699,0.5175927286216969,0.0563345440207435
25613,SIDM00872,OSI-027,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.090010986,-0.009232647,0.46236987003590496,0.0446713763758808
22247,SIDM00872,Tozasertib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6051191,0.023902517,1.6592160465355699,0.03661800704808842
75445,SIDM00872,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0612539,0.07614628,-0.3099612092555529,-0.031018958877520143
76408,SIDM00216,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.85479,0.226594,-1.7440458259163532,-0.11651284699596316
91707,SIDM00928,Alisertib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.8803079,0.07651806,-0.6956062622513685,-0.02528308990529564
46039,SIDM00146,Nutlin-3a (-),OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.36405218,0.011956752,1.4616719989391784,0.05363446831608118
62617,SIDM00826,Palbociclib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,-3.1176982,-0.11641566,-3.03438262984845,-0.12492042019935477
14604,SIDM00146,Wee1 Inhibitor,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.1583887,0.0750168,-0.6062763454740517,-0.01818092774636188
47043,SIDM00146,Uprosertib,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.2780001,-0.08954098,0.32092838356946596,0.09026677454138389
106209,SIDM00933,Docetaxel,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-1.258934,-0.1680892,-1.2555631235004214,-0.08285696510577353
46575,SIDM00933,MK-1775,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,3.6673286,0.09401807,1.7213457500725635,0.07837778231331104
65431,SIDM00928,Axitinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.4306602,-0.12262633,-1.2062940793018944,-0.05832199389197647
61404,SIDM00282,AZD7762,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,2.1950812,0.08023832,1.9296731319126421,0.08909902310977438
61585,SIDM00148,Olaparib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9337167,0.11103685,0.6533480417781433,0.0659831238606158
37353,SIDM00832,Olaparib,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,1.3310691,0.040703934,0.1606042166634799,0.0032243406523685693
49611,SIDM00148,Temozolomide,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.831688,0.031143514,-0.6461085425091064,-0.0041938356959783174
91327,SIDM00928,Alpelisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.52632433,0.063469276,0.9388816313054433,0.04022915174326878
96780,SIDM00877,Taselisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-3.4122972,-0.16625205,-0.1323071648305652,-0.05067858898119954
98366,SIDM00950,OSI-027,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.690064,0.1458234,0.8034761191281519,0.055491663541309154
53671,SIDM00148,Docetaxel,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1921397,-0.06980965,-0.14684223261902205,0.03834016947260618
11700,SIDM00928,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.6632237,0.16804837,0.4907980669352579,0.042841326177580394
105286,SIDM00359,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6220129,-0.04174702,-0.9270414511435794,-0.02042874604706278
56018,SIDM00673,Venetoclax,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.9910633,0.019594382,1.3856632136064129,0.05132580862222079
18851,SIDM01042,OSI-027,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.64303505,0.05972054,-0.6122385840808519,-0.05258663680268691
37346,SIDM00826,LGK974,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.50193405,-0.008819226,-1.1250975391209324,-0.014493501788384341
53588,SIDM00042,Cisplatin,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.4389685,-0.04241991,-0.2870021320351431,-0.04435402034160585
75278,SIDM00146,AZD7762,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.60050875,0.052597284,-0.8458852181368752,0.03734990672016345
44094,SIDM00933,PD173074,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.5455032,-0.05207897,-1.2396838859270891,-0.061239054165976296
51330,SIDM01042,Crizotinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.952256,-0.09717527,-1.2264225778925857,-0.0437459446713736
1627,SIDM01042,Luminespib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0744208,0.10906526,-0.47564954394361897,-0.013645065836397186
86556,SIDM00826,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,0.5575853,0.04161748,-1.4667189991235323,-0.027132985885426692
27185,SIDM00872,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5367384,-0.084405854,-0.08233212136263425,0.02135894929984103
8863,SIDM00673,AZD8055,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.1626849,0.07823073,2.059355047751979,0.10541457398045499
62690,SIDM00928,Gemcitabine,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.9928572,-0.09764498,-0.354148443442811,-0.04121753200453197
32596,SIDM00148,RO-3306,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9969218,-0.10198501,-0.07989969488076563,-0.01700205678394721
48373,SIDM00359,MK-2206,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.7237623,0.12698019,3.3571261393929515,0.23654725368536672
108316,SIDM00875,Entinostat,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4604058,-0.03585709,0.7893996318562042,0.04538559658797463
18788,SIDM00872,Afatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,0.38756546,0.04163569,0.4948800376245521,-0.0010325751203106388
20187,SIDM00833,Camptothecin,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.40600932,-0.028937213,-1.5109281103215848,-0.11034949366508817
38508,SIDM00950,Linsitinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.5605219,0.05034222,1.1918825957124501,0.05942740821995158
105048,SIDM00673,GSK269962A,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.62145376,0.038100854,-0.3579672265350827,-0.01946082317364251
45091,SIDM00146,Navitoclax,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.37388894,-0.029962152,0.8997576724874647,0.011036487791139957
103922,SIDM00633,AZD6482,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0678486,0.08546704,1.5453703460564485,0.05150242915354091
74072,SIDM01042,SCH772984,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8316149,0.052282795,2.424491309412073,0.1260484894547143
60955,SIDM00097,Linsitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5327449,-0.06343403,-0.9828362444336527,-0.017304910821782024
7632,SIDM00877,Afatinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.4869913,-0.15750013,-0.8242894166975373,-0.07655850788114935
16115,SIDM00826,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-7.224661,-0.06553452,-3.1010165014438535,-0.05372496508664111
5718,SIDM00148,RO-3306,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6101432,0.059339948,-1.1566717895444105,-0.0695175012170038
66145,SIDM00633,Pictilisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.535125,0.06215649,-1.9748661398078584,-0.06653120279895103
37031,SIDM00957,MK-2206,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.5633386,0.022988321,-0.021780045688146784,0.10353545383295978
103010,SIDM01042,Docetaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2429204,0.20939918,-2.4134813340716925,-0.026924064837077696
50532,SIDM00633,GSK269962A,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.58841324,0.05409423,0.12719974399144718,0.05685628020307603
106282,SIDM00872,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2007209,-0.11596756,0.14704746974689378,-0.03394532256159003
26892,SIDM00933,Gemcitabine,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.72801906,0.0021282155,-1.2671787120981517,0.007470713434963224
61469,SIDM00148,BI-2536,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.70412755,0.020800166,-2.1660515188197333,-0.06360334533432388
25350,SIDM00146,GSK269962A,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.5867953,0.14335763,0.2839449740636701,0.0735109490787923
44290,SIDM00673,Trametinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44407108,-0.035719715,-0.24206420014177404,-0.020161038015559015
37021,SIDM00950,Ruxolitinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8292245,0.08067651,0.5246568076224677,0.016074737791552083
71152,SIDM00148,Paclitaxel,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.7252038,-0.24956952,-3.1306294468980043,-0.24982031997462598
14288,SIDM01187,Axitinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.018189222,0.0015381391,-0.721105679330533,-0.0289233344369999
26288,SIDM00359,Camptothecin,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.3899696,-0.15871114,-1.5128646035122726,-0.059684566905240065
99390,SIDM00359,5-Fluorouracil,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8101735,-0.110652596,-1.5923915920357654,-0.057301019470055316
108418,SIDM00877,Paclitaxel,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.8550856,-0.08357816,-3.2907251823510655,-0.06011869746403414
55687,SIDM00872,Wee1 Inhibitor,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.57170886,0.060307454,0.17481334355088798,0.0016498154118174126
59334,SIDM01197,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.118195,0.07102793,0.6309112190223555,0.048166255756609454
55735,SIDM00933,AZD8055,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.5166515,-0.08691067,0.03897133782094526,-0.00836321145975076
106657,SIDM00148,Docetaxel,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.8108113,-0.22854094,-0.8844641450643855,-0.0686497024157505
17716,SIDM00826,SCH772984,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.29287556,-0.006912883,-0.7745557554493616,-0.058465463424956635
85579,SIDM00282,LGK974,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-2.938221,-0.09023016,-1.6448371453688282,-0.049471096302508226
19034,SIDM00875,5-Fluorouracil,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.2269278,-0.021911703,-1.878149718350625,-0.12423152066011729
26946,SIDM00216,LGK974,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.9369655,0.013840543,1.4536106458346012,0.07690212342180633
100257,SIDM00875,Trametinib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2836596,0.14738636,2.7204919853117038,0.1853582815419564
78477,SIDM00933,PD173074,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8144839,0.10681432,1.090240324339777,0.08809770277801802
72572,SIDM00673,Vorinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.761966,-0.079080604,0.1314200304230209,-0.03619323732643873
67951,SIDM00875,Venetoclax,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7207859,0.1216387,0.896976299635467,0.014963348606654665
64439,SIDM00933,PF-4708671,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.66093373,-0.040339947,-0.3561058620039659,0.02135672390138281
54976,SIDM00673,AZD8055,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.22355352,-0.017709533,-0.3048892951782723,-0.04235466801458971
28177,SIDM00872,Docetaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1407617,-0.10953435,-2.1205989155709024,-0.2000997616123734
25721,SIDM00359,MK-1775,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4334676,-0.18622468,-1.6216322151225455,-0.04327512554654045
3266,SIDM00872,Nutlin-3a (-),Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.50319237,-0.0124564385,1.7137857317453407,0.042849366281198537
9103,SIDM00875,Gemcitabine,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5106194,-0.0034019817,-4.719862056758263,-0.08451411798922508
22934,SIDM00933,Uprosertib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.075907,0.22120203,-0.7852061374612368,-0.06757258996075292
102555,SIDM00673,OSI-027,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.4209877,0.09880942,1.001478735263925,0.09488819285656379
41177,SIDM00097,GSK269962A,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.119350865,-0.0059108064,-0.8020966958623867,-0.04350578320402334
106410,SIDM00146,PF-4708671,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.0095572,0.07387817,1.529655804324034,0.046994236776684906
78548,SIDM00097,Venetoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.39445767,0.014567444,-0.8243567661273152,-0.019509327547247254
42883,SIDM00933,BI-2536,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.215476,0.005710874,-2.0469371071327607,0.007935955600034694
38844,SIDM00216,LGK974,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.16441035,-0.009190917,0.38151595943471306,-0.009599278968362228
63742,SIDM00216,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,0.55554897,0.036923237,1.4712755436210243,0.07331678027979874
21815,SIDM00042,Linsitinib,Crizotinib,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.418316,0.14299528,0.40082324416502935,0.01351167996692023
40562,SIDM00042,Sorafenib,Navitoclax,Pancreas,4.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.5520406,0.097283475,1.2243990633562136,0.07417437577172646
76103,SIDM00097,Afatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0846926,-0.054725356,0.7042823853654244,0.06360529954394838
32019,SIDM00146,Bortezomib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.43401167,-0.029268527,-0.6686346536238075,-0.030142767329907616
32865,SIDM00146,Doramapimod,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.8425269,0.04739604,1.1678395257337704,0.07351863791593007
37710,SIDM00928,BI-2536,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.7194613,-0.09636245,-0.8346061658951024,-0.05075290430946496
6951,SIDM00146,Sorafenib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.49929827,-0.042945087,0.13364992938853215,-0.011319209470396465
83210,SIDM00146,JQ1,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.85712916,-0.06742331,-1.7138602799959826,-0.10370493087500127
106912,SIDM00933,Venetoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-2.6073306,-0.088368155,-0.4522596558548515,-0.0026566873758241444
89679,SIDM00097,Luminespib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6228955,0.03909307,-0.513598720276978,-0.04385233948627643
33705,SIDM00042,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.1645789,0.10478841,2.7873264712165726,0.12850470761148916
70546,SIDM00633,Docetaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.7661223,-0.19506821,-3.539958576603142,-0.1632242480266566
43768,SIDM00097,NU7441,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64824146,0.03751529,0.551395225371134,0.04948805860331648
11353,SIDM00282,Olaparib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8773815,-0.016975598,1.4367986307275227,0.028601096938336117
70851,SIDM00216,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6334595,-0.035343293,-2.884609541500953,-0.13952871513253237
16914,SIDM01042,SCH772984,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.48346373,-0.02204937,-1.0864548918774626,-0.015309284196797258
74274,SIDM00146,MK-2206,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,1.7680926,0.130684,0.8698916509738863,0.12316007174386141
53086,SIDM00950,Palbociclib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5824935,0.05148323,0.5493724785165949,0.0572379842425652
8759,SIDM00282,MK-1775,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0926763,-0.073018104,-0.6251602111156559,-0.049694848755793886
58715,SIDM00877,Bortezomib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.6516314,0.047892075,-0.1793271641897977,0.022281484403194197
25932,SIDM01187,OSI-027,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.72692835,-0.058602635,-1.6095666269292734,-0.0462461958340041
89640,SIDM00359,Vinorelbine,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1672305,-0.04625177,-0.29689946385094307,0.05688797134499253
45764,SIDM00875,Temozolomide,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.667295,0.015079601,-0.031841977548121486,-0.007044220468802076
49351,SIDM00957,Crizotinib,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,0.5567754,0.018880317,-0.4309823504498014,0.010694685583191081
63560,SIDM00673,Cisplatin,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.46955216,0.01243072,1.0165665399044461,0.03406118283979742
6769,SIDM00097,Camptothecin,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5352946,0.027574886,-0.8666955228732539,-0.036898355106465316
45579,SIDM00148,SCH772984,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.4595194,0.2789745,2.3117807544124895,0.06377543501729487
187,SIDM00097,5-Fluorouracil,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6525872,-0.018378023,0.4183551491739621,0.012248314992504894
14426,SIDM00673,RO-3306,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.609832,0.20017335,2.173449523832057,0.10216170549924537
46881,SIDM00837,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.3829335,0.026090534,-1.6140222283357664,-0.026550737379629756
90738,SIDM00776,SB505124,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-0.25499755,-0.016557666,-0.5450975846811752,-0.024535806268297315
107143,SIDM00877,Dabrafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,1.4017761,0.04146905,1.042065920015769,0.07067757692704614
9105,SIDM00832,Camptothecin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-4.5769043,-0.24113417,-0.463391216754404,-0.04598192750708436
99053,SIDM00950,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.77862656,-0.07444264,-1.502476464950818,-0.10254619782224812
67431,SIDM00282,LGK974,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3628501,0.06892592,0.33348993408389643,0.02384506871287617
8038,SIDM00216,Crizotinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.98917824,-0.08540692,-0.6625299771793989,-0.05289034996857752
89949,SIDM01042,AZD7762,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4941282,-0.17217365,-1.6395978517574488,-0.1594340629830671
25475,SIDM00673,ZM447439,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.54939145,-0.046357658,-0.5712354826538704,-0.07242006629755024
79430,SIDM00957,Camptothecin,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,2.8359127,0.050863843,5.332311121160867,0.14555258099572063
71432,SIDM00148,Lapatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.71318483,-0.057056345,0.009222033346045003,-0.02272751812821867
71643,SIDM00359,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.640483,-0.18616165,-2.4311282595905825,-0.10263020566723356
15258,SIDM00832,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.0035123,-0.04010572,-0.9319651783461791,-0.03224842109000371
101731,SIDM00872,Uprosertib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2856485,0.030423196,-0.2248110641034025,-0.039112778430426764
92383,SIDM00832,Navitoclax,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,0.62955314,0.0157157,0.7482034164340486,0.02001877103277755
99374,SIDM00833,LGK974,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.1035323,0.072247915,-0.10558996646834573,-0.004762727816794017
93076,SIDM00877,Afatinib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,0.7107597,0.08781874,-0.165241058108733,0.005403581726382162
25703,SIDM00455,MK-2206,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.03749,0.20045184,1.37324381049018,0.0961838912174103
52278,SIDM00633,AZD8055,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7761851,0.08178687,-0.9391975788265106,-0.06418671094674512
96096,SIDM00633,Trametinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3074623,-0.08812739,-1.8871546147094425,-0.09285195916650438
90400,SIDM00097,Crizotinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6060982,0.112153746,0.16314813961513788,0.005869782356415654
58765,SIDM00776,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,65.0,-2.8946748,-0.088974416,-2.323535578721411,-0.06018796406143505
28341,SIDM00877,Tozasertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.9070146,-0.1899376,-1.7926219732996045,-0.11219073494144333
47216,SIDM00933,Nilotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.68064046,0.06014777,0.6878855304729162,0.05377540808507927
44204,SIDM01197,5-Fluorouracil,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-2.525671,-0.07678531,-1.584957524812721,-0.055523203909842854
91183,SIDM00359,Trametinib,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5568249,-0.0546866,-0.5659169251024397,-0.01853171165766959
69699,SIDM00776,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,0.3545329,0.02260227,0.7630540719782937,0.009864811701040808
43718,SIDM00933,Olaparib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.10521,0.2726614,-1.1204289165277679,-0.03192477046007065
73709,SIDM00097,Entinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2072712,-0.05913275,-0.2892994329640822,-0.0029275507183964163
46004,SIDM00097,Uprosertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8756896,0.061849616,-0.49342533575334974,-0.007170858261747677
17855,SIDM00826,5-Fluorouracil,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-3.2760203,-0.21499687,-2.4805827705836285,-0.16440339803373835
101296,SIDM00950,Olaparib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3127153,0.15357095,0.8685375031791541,0.11968852069093963
80132,SIDM00875,AZD7762,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26462972,-0.018459577,-2.2760047282158333,-0.22607916026351738
94372,SIDM00875,Docetaxel,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49056223,0.037811346,-0.6782718965475355,-0.012067694859509925
51293,SIDM00359,AZD7762,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4146602,0.07954169,-0.9370761942157457,-0.0019962583588658636
28113,SIDM01042,MK-1775,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.2242792,-0.01918563,-1.540984780500181,-0.0556349054720588
48871,SIDM00673,AZD6482,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.2943792,-0.1688092,-1.2103574382223685,-0.08432161431984522
19450,SIDM00832,MK-2206,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,81.0,-0.5402777,-0.04574928,-0.16170097238395115,-0.034460586108206
56067,SIDM00877,Paclitaxel,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.8688834,-0.12309916,-4.458471104506779,-0.30906024322587405
70886,SIDM00148,Olaparib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8483643,-0.0328938,-1.8373106033345723,-0.07506628540049344
82724,SIDM00877,Entinostat,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.81642354,0.057668027,1.3096795400139738,0.09740432716153954
58236,SIDM00872,Alisertib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5903211,-0.022812724,-0.19746837313044785,-0.047902906181415336
72308,SIDM00928,GSK269962A,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.5608944,-0.044203393,0.05325719910432447,0.028181361071286434
43920,SIDM00216,Taselisib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,-0.74153364,-0.007185422,0.08314980596953819,-0.02764308323007205
43610,SIDM00877,RO-3306,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.3717545,-0.029778352,0.1715054087886885,0.0743607909082727
51902,SIDM00148,Sorafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7436156,0.06465184,1.999460813947429,0.12006764643180978
39539,SIDM00633,Vorinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1096468,-0.079974644,-0.24941177920655178,0.04281255114754857
8955,SIDM00148,KU-55933,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.1906796,0.28950343,-0.6911090907747984,-0.023803865209777775
41695,SIDM00872,KU-55933,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.346961,-0.09697145,-1.5030108830039755,-0.09174485438186357
100830,SIDM00673,NU7441,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.7237706,0.21134116,0.7808876753860624,0.050632605283170935
76337,SIDM00872,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3055917,-0.050398283,-0.7952588520313524,0.038423861886070054
593,SIDM01187,Olaparib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.16038163,-0.006799045,-0.4062156982035386,0.007653421637958999
37656,SIDM00872,Uprosertib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4715124,0.1578867,0.772158535053742,0.06099905127926244
63935,SIDM00673,Dabrafenib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,2.2424018,0.033393078,1.7193605466159918,0.05975950659419062
70315,SIDM00877,Doramapimod,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.3476455,0.20845224,0.8879202465219269,0.02206626647077147
35704,SIDM01042,PD173074,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.5737944,-0.11958195,0.7358400535293478,0.007865756467034192
34997,SIDM00097,Alisertib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.522144,-0.12574293,0.14737625275961871,-0.02902730273098308
90439,SIDM00097,Entinostat,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4208527,-0.0703784,-1.8077799966631303,-0.03815724004415662
7148,SIDM00933,Taselisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.0496174,0.07600857,-0.9469005640415865,-0.03717167054170422
795,SIDM01042,NU7441,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.17898232,0.014389639,-0.6554877336741259,-0.051983684569630755
31772,SIDM00933,5-Fluorouracil,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-0.9449001,-0.12775148,-1.462508086953783,-0.08312959947176995
62243,SIDM00877,MK-1775,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.8534315,-0.06490035,-0.10927021276156093,-0.005338714237576004
64170,SIDM00216,BMS-754807,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.7792738,-0.019494968,0.5001416252200193,0.033538995355940265
52696,SIDM00950,Palbociclib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.2244222,0.19478767,0.7354565144669473,0.04723573661597611
71375,SIDM00877,Navitoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.17698626,0.022351284,-0.4873846945986783,-0.0006365675044087022
80959,SIDM00933,Nutlin-3a (-),Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.3389312,-0.04255084,-1.6618776998945568,-0.09730030803988271
80509,SIDM00928,MK-2206,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.088664,-0.068876,0.3764850783579575,-0.0010315041550328467
90988,SIDM00875,JQ1,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5520943,-0.058415867,0.3151311025836581,-0.010525994263764472
107844,SIDM00933,Ribociclib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.8028401,0.0052096965,1.6798734434990916,0.04884569748642078
44361,SIDM00872,Tozasertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.62183005,-0.01996208,-0.21571293281620807,-0.05133021583307939
75941,SIDM00928,Gemcitabine,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-3.1401494,-0.2601737,-1.6622544954716065,-0.11529261140453158
50399,SIDM00673,Wee1 Inhibitor,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.2970339,0.090220965,-0.14735429894526234,0.03128124293540853
36030,SIDM00097,JQ1,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.009292,-0.13748766,-2.1240465688051717,-0.06601523403154719
100778,SIDM00957,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,7.4194865,0.3234523,0.06694544227830858,0.04372801559559444
61636,SIDM00776,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,-2.230717,-0.17125213,-2.205642943847587,-0.11439632021266571
104245,SIDM00872,Alpelisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.9707249,-0.11731153,-0.28710659999677923,-0.09706431530626879
95292,SIDM00933,Tozasertib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.51461774,-0.050284866,0.2943687906027104,0.03248832536142135
59056,SIDM00146,Alpelisib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.6989514,-0.07191339,-1.5674498386627422,-0.04843022208554945
23003,SIDM00633,Ribociclib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.837163,0.08772604,-0.29955116933656606,-0.02064259722118083
36697,SIDM00097,Wee1 Inhibitor,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.59080386,-0.032487426,-1.6051211737624085,-0.10679643009359667
37229,SIDM00826,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.3866088,0.09170577,-1.2625101274408221,-0.04454156389552379
89485,SIDM01042,Tozasertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.020222,0.20493878,0.0518668294981016,0.03693809406883099
93378,SIDM00950,Cisplatin,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.3666782,0.06371935,2.4779291586409666,0.1110721980668869
67352,SIDM00933,RO-3306,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6092723,0.06359306,1.29899269796796,0.03904242247341557
59810,SIDM00455,Gemcitabine,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6157353,-0.028818885,-0.5140348602463742,0.036136042697883904
49621,SIDM00633,Bortezomib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.95182437,0.049893845,-1.3382855647991092,-0.06307432164061798
69651,SIDM00957,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,1.6118833,0.025334839,2.0636267592082236,0.06648219800419493
55339,SIDM00146,Axitinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6628081,-0.041902333,-0.020107738573455797,0.08122658071330127
77302,SIDM00933,Wee1 Inhibitor,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-1.0334315,-0.0906735,-0.9267184174262824,-0.04871512295244696
64101,SIDM00877,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.2222438,0.050838184,0.45077722218998856,0.012065421674928387
52325,SIDM01042,Paclitaxel,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6260865,-0.075211726,-2.1625848428149954,-0.10562276768165252
55270,SIDM00837,Palbociclib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-1.1564475,-0.019986976,-2.6823410744301412,-0.08754534094409915
484,SIDM00872,Palbociclib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.94587004,0.01930995,2.5015328405771395,0.06872283387987504
70196,SIDM00216,Navitoclax,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,6.8471055,0.25464794,1.0861880309059737,0.08688876318398757
81054,SIDM00282,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,0.20118444,0.01558325,-0.3604198397920384,-0.07191252706074189
102775,SIDM00835,SB505124,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,0.42289856,0.037688818,-0.08953093703795256,0.014810264326329025
9864,SIDM00928,Taselisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.8469234,-0.121071704,-0.9107367564069597,-0.11091766081752251
60548,SIDM00148,Ribociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.7255492,-0.160264,-2.8891052589902535,-0.11690662226935221
63251,SIDM01197,Palbociclib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-3.9567816,-0.13845691,-1.6456111541848533,-0.07835602877871446
57495,SIDM00833,AZD4547,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,-3.0391529,-0.123054475,-1.3228609462593794,-0.11704398388339626
77133,SIDM00875,GSK269962A,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.41482463,0.02840434,0.3642309014356781,0.0015608353295992721
43885,SIDM00933,GSK269962A,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.8741795,-0.06005263,0.08157609142592609,0.028267856597699
11906,SIDM00097,Afatinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5347062,-0.107197605,1.6705664718539586,0.09453534066905356
36625,SIDM00148,Pictilisib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.182291,-0.09155115,-0.45261859496590245,-0.016985918471622587
96714,SIDM00826,AZD8055,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.5109671,-0.048649237,0.27750344543104233,-0.05067176913260813
75518,SIDM01187,5-Fluorouracil,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3662256,-0.060336992,-1.2010285173378676,-0.04291761755971822
65935,SIDM00148,Camptothecin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3317783,-0.021867134,-0.2041415310145687,-0.04486709919477595
61239,SIDM00957,SCH772984,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-0.49832007,-0.020837579,-0.1297753399861527,0.05610126908849114
7281,SIDM00097,Nilotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0664487,0.06886263,0.14132701732625955,0.013689103667130746
41629,SIDM00877,Uprosertib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.41050196,-0.048060283,-0.6816991268122675,-0.03538573681476734
65843,SIDM00216,Crizotinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.10335981,-0.008784663,-0.1449768487409302,-0.025154453097990984
76159,SIDM00673,PF-4708671,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.0331173,-0.08076013,-0.5538812008271713,0.0032570214012702815
100322,SIDM00950,Lapatinib,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0858401,0.11117238,0.25915556517174904,0.021015393208733087
24363,SIDM00148,Vorinostat,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.981554,0.15291415,0.6247186197784205,-0.02967256877653347
87255,SIDM00673,Trametinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,3.5485408,0.3469476,2.277495179406927,0.07840822402197059
33033,SIDM00359,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5689997,-0.04894226,0.40715364402907733,0.03381221969952291
13200,SIDM00776,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.9328579,0.058968674,0.879839477452704,0.024846534652928926
97900,SIDM00097,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3666971,-0.06372906,0.2606885670714101,0.007134860967371923
77541,SIDM00673,PD173074,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.106407,-0.049083114,-1.2758500142156222,-0.02090875678394947
79577,SIDM00282,Oxaliplatin,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.602505,-0.106626555,-1.8432407213238402,-0.12153904525692596
6002,SIDM00282,Vinorelbine,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.2777169,-0.18021597,-1.8280597754384023,-0.13830608542669684
52691,SIDM00957,5-Fluorouracil,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.1747438,-0.015514694,1.9541126737170251,0.0342177933906758
23138,SIDM00933,Vorinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.3056523,0.11399168,0.4062094229427174,0.019682331638979336
3078,SIDM00933,Axitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.08717575,0.012653749,0.4733035661166645,0.01843825407140467
25511,SIDM01042,AZD6482,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.2604087,0.012182051,-0.5912963462187599,-0.029132899089445927
55389,SIDM00097,Sorafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.351294,0.1327032,1.1085636144091067,0.1482586041972286
56066,SIDM00097,Entinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1706588,-0.10234389,0.4553461117296017,0.027235589143866108
74037,SIDM00455,Cisplatin,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4779445,0.06183853,0.4533767954046792,0.0582027023960036
59843,SIDM00950,Trametinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.9748926,0.11984821,2.7029562732019445,0.08739715947742911
82958,SIDM01042,MK-2206,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45100018,-0.017891828,-1.3897810053543254,-0.06158347750640621
91648,SIDM00933,Luminespib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.2200916,-0.009035243,-0.6344659352450828,0.028349053139133547
21909,SIDM00826,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-0.7258373,-0.014388866,-1.6203635599050563,-0.039910924124757705
20124,SIDM00673,Paclitaxel,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.2349021,-0.22704618,-0.45098281446005367,-0.06969936982756883
59991,SIDM00776,Crizotinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,65.0,-1.1964391,-0.10646502,-0.41752482366775606,-0.08029672919650738
71881,SIDM00872,Temozolomide,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8958254,0.018371291,1.406861821260578,0.04011214475665112
27552,SIDM00933,Camptothecin,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,2.7112584,0.18174593,-0.5317264435262292,-0.07643260522104477
57166,SIDM00146,PF-4708671,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.8539203,0.07377713,1.5952128334395987,0.09867385985021043
75488,SIDM01187,Axitinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1983163,0.11077028,0.48059583067793826,0.01513347871315512
71270,SIDM00837,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.9480444,-0.039942123,-0.1394062933338319,-0.022193779922800035
101381,SIDM00455,Cisplatin,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.33939552,0.016709948,0.4560375814445443,0.06684916054929957
103683,SIDM00832,5-Fluorouracil,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.9345996,-0.2223824,-0.8740521635174041,-0.06250631100366524
104369,SIDM00837,Navitoclax,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,0.5594013,0.02023383,1.5909258943323747,0.012663043293908879
105874,SIDM00148,Doramapimod,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5311365,0.22087695,-0.7292951150360153,-0.007223422947481938
76597,SIDM00835,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.4922385,0.11017192,1.4751876729103974,0.017087211923312667
103136,SIDM00877,AZD8055,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.9334263,-0.18766949,-0.07302699635970115,0.016291624182609585
4979,SIDM00875,Vorinostat,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2369651,0.12985232,0.9864908645611367,-0.011310906696239508
94725,SIDM00928,Paclitaxel,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-0.8254814,-0.07597163,-0.8293903617435688,-0.08603200094462822
74279,SIDM00875,Lapatinib,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.280632,-0.11715976,-1.4304579468858765,-0.08577058126327722
49450,SIDM00877,AZD8055,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.4749303,0.050659597,0.03730577410246585,0.00031872381646315054
93114,SIDM00148,Temozolomide,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.99986285,0.034889158,-0.7407143436329278,0.005109657589114039
35788,SIDM00633,NU7441,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4840238,0.10868508,0.9839634231234697,0.07982324808002546
63586,SIDM00933,Crizotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.7102986,0.0748416,-0.7824851771423192,-0.012381501174514403
62367,SIDM01197,Navitoclax,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.9644294,-0.33385336,-1.3236501093378537,-0.05493272840912597
89458,SIDM00928,Alpelisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.923351,-0.1302338,-0.2810544817161817,0.03043906821526304
104320,SIDM01042,Axitinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9658157,0.10835335,-0.331116908768568,-0.019883995393826785
3840,SIDM00928,Docetaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-3.8191843,-0.19654112,-1.339282099809624,-0.026132527323749263
34678,SIDM01197,Camptothecin,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.44791088,-0.028162982,0.4013300474617228,0.07065329245292386
72928,SIDM00950,Sorafenib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8574321,-0.17109515,-2.19429742915199,-0.09983110964825119
21338,SIDM00673,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.4277227,0.19573298,1.2027481203819763,0.06393377613512533
42987,SIDM00148,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0097284,0.071084,0.8422642460404934,0.019083390969654866
67665,SIDM00042,LGK974,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.2571466,-0.039078113,-0.9764928827559409,-0.0012088557954900176
75835,SIDM01042,MK-2206,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.017116632,0.0005575535,-1.3209113937341501,-0.09633631806618978
71447,SIDM00872,Docetaxel,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6402867,0.121770985,0.33107335289248196,0.0023018232250590466
16544,SIDM01042,Olaparib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2602756,-0.07731171,-1.3944356602033734,-0.010211649358508166
55444,SIDM00359,Taselisib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.896784,-0.059327837,-1.8545895654009306,-0.00046768656959335006
52254,SIDM00673,Sorafenib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.41624078,0.024378086,0.656860788219922,0.05219373175820985
77546,SIDM00042,Cisplatin,MK-1775,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.1104057,0.20473057,0.9446661367284409,0.08422493707488707
45807,SIDM00673,Linsitinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.61709803,0.012041983,1.135851497459747,0.02191876443616925
2477,SIDM00835,Crizotinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.6340345,0.13009945,0.20831573836838554,0.06536926282339944
87158,SIDM00633,Navitoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,6.411764,0.21764345,0.9347441424466588,0.07207455482708798
79274,SIDM00673,Taselisib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,0.34602535,0.032084923,-1.2427444681095783,-0.06446990322587484
46213,SIDM00877,Dabrafenib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.5910935,0.043682933,2.635772089835838,0.07687831883126822
72041,SIDM01187,Docetaxel,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-3.3598266,-0.18898545,-1.5245737527407741,-0.042413120850576067
64585,SIDM00633,SCH772984,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6409083,-0.05918537,-0.45274106168289424,-0.030775476002547333
8873,SIDM00359,MK-2206,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.984504,0.12989399,-0.1706560624789846,0.07248775236639839
34930,SIDM00875,Uprosertib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1885895,-0.10406336,-0.2794175577162596,-0.0007153396328875879
41437,SIDM00146,Afatinib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.41744855,-0.036819153,0.8208904687431359,0.04405593866001328
105693,SIDM00097,RO-3306,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32257554,-0.017880049,-0.7436186154781754,-0.048059790515747304
40541,SIDM00455,MK-2206,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.7859209,0.13905573,0.8101115724928211,0.10380948230023983
1218,SIDM00950,AZD7762,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.09617328,-0.010415016,-0.6669190863459383,-0.031080763419506954
15537,SIDM00872,Vorinostat,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.42110795,-0.02947568,1.4029898348344991,0.08477356334322785
92453,SIDM00673,Olaparib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.80990887,-0.041712593,-1.3112369470300909,-0.05315541539799229
61195,SIDM00776,LGK974,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,0.60907775,0.030675689,-1.308243465621533,-0.01239684056202268
94666,SIDM00957,MK-2206,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,2.5207648,0.053811688,-0.6117508546995101,0.0211506996767941
91210,SIDM00097,Ribociclib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8900061,-0.062504165,-1.596708408730961,-0.023968640882272393
81107,SIDM00933,AZD7762,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.13965401,0.017803151,-0.4013571810797996,-0.0076193582882441
51864,SIDM00097,GSK269962A,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3460045,0.07065201,-0.4901312472716519,-0.027926170785547436
81127,SIDM00282,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.6410229,-0.108861506,-1.3898297774406314,-0.11513962891534554
21237,SIDM00826,Olaparib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.803177,0.17822541,-0.9857418439466573,-0.0678167065202485
31084,SIDM00097,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0999882,0.14016996,1.7627237807929574,0.10597418495120187
88119,SIDM00950,Linsitinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.500405,-0.17135267,-0.6855640215068018,-0.016570033346357763
53661,SIDM00833,Crizotinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.108954,-0.124131404,-0.2759303223030688,-0.0045915433603855
54458,SIDM00633,AZD7762,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1677622,0.093809195,-2.7160835148630236,-0.0999612532508183
95404,SIDM00933,Alpelisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.49000946,0.03843953,0.9112902034271462,0.05828473113111438
39056,SIDM00877,Ribociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.165841,0.031448323,0.9517924897140312,0.031896158393426986
90979,SIDM01042,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0920084,0.13351123,-0.15469649907290892,0.02028045865313609
55094,SIDM00928,MK-1775,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.7942193,-0.15943962,-0.4620435868859533,-0.039455126897960775
104574,SIDM00875,MK-2206,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3110355,0.11747549,1.0211777316440303,0.053837460848883516
92412,SIDM00933,Lapatinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.6587933,0.09312414,0.4159931284024505,0.10442973509482396
88418,SIDM00146,Luminespib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1228436,-0.07601124,-0.6627918160767997,-0.03754574248046556
60477,SIDM00877,Alisertib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-2.3840766,-0.14054321,-0.7022365136955897,-0.09776601976102688
36253,SIDM00957,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.6821859,-0.027294386,-0.5963952216890398,0.03772637760692442
93286,SIDM00455,5-Fluorouracil,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.532704,-0.09044046,-1.9360492599469887,-0.04814582323216814
33873,SIDM00673,PF-4708671,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.236143,-0.116451055,-1.4646338636506584,-0.10030641774297215
6255,SIDM00950,SCH772984,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.119857,0.16007867,1.754451921520097,0.11020810222337564
8375,SIDM01042,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.73582745,-0.07321283,-0.6940949111811106,-0.05720759779345394
105971,SIDM01197,Oxaliplatin,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.4478407,-0.069851905,-1.323410007376143,-0.0823404189670202
73038,SIDM00633,AZD8055,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6487465,0.2035374,0.6945487150249725,0.04284841956923668
17174,SIDM00097,AZD6482,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.75245863,-0.054661766,-0.45449035346778904,-0.0394708952200805
4116,SIDM00837,Crizotinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.86781025,-0.050046116,-0.2931400302655942,-0.0696589350247599
91454,SIDM00877,MK-1775,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.60309774,-0.03262624,-0.1667414123579433,-0.010059762954096602
73067,SIDM00832,Crizotinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,0.2953275,0.022375992,0.7311745585895667,0.036478427642345115
18086,SIDM00282,Palbociclib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.5939043,0.06648849,0.9584095405918603,0.09035522176127506
4840,SIDM00872,Gemcitabine,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3002464,0.043997437,3.3396445097698786,0.118705676524217
96385,SIDM00877,RO-3306,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.0554047,-0.04721591,1.0798528191051262,0.13606566559725683
105932,SIDM00146,MK-2206,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.0529697,0.14667419,1.8423581319160007,0.14217331195995375
45347,SIDM00872,BI-2536,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.7823542,0.18166189,-0.14143032798852806,0.007372645913173359
108364,SIDM00872,Bortezomib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.066611275,0.0038021593,0.013770372024554021,0.02210078687416705
92875,SIDM00833,Crizotinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.703831,0.27729526,2.1435708843361145,0.19076197011630155
10185,SIDM00877,Dabrafenib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.6568923,0.049196877,2.1461919061214756,0.06032594937930142
34538,SIDM00832,Navitoclax,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.0255198,0.03281878,1.7305164608619021,0.02139297323018728
2361,SIDM00933,SCH772984,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.82506394,-0.056443997,-1.0868074433196735,-0.03477102122858722
51159,SIDM00875,Entinostat,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.12950374,-0.013281104,-0.1863788409429206,-0.02514740014806058
66565,SIDM00148,KU-55933,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.093512,0.11275476,0.8909742285080812,0.044076257756486714
70660,SIDM00872,Trametinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.05046,0.10614512,0.6576827335802133,-0.04086940026224029
63534,SIDM00673,PD173074,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.0006113,-0.0866744,-0.7685029967185284,-0.011740875264394726
83316,SIDM00875,Uprosertib,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.336996,-0.1037099,-0.3278694090079548,0.050167242190087134
78728,SIDM00928,MK-2206,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.6619551,0.13813876,0.30627976589173933,0.013601350774536577
64351,SIDM00097,Wee1 Inhibitor,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1348393,0.0758383,1.3401111957421243,0.11373551334780066
86261,SIDM00146,Gemcitabine,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-1.8178487,-0.10540827,-1.306847461376231,-0.10622192180710985
93484,SIDM00835,MK-1775,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.2043107,-0.09754375,-0.5147339578307275,-0.039822907181626316
34577,SIDM00216,AZD7762,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5405897,-0.108065404,-0.1675128916276796,-0.002950256188430112
38562,SIDM00933,5-Fluorouracil,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.3060705,0.039567884,-1.5934297228482257,-0.09139063892380778
98273,SIDM00673,Linsitinib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2371187,0.015395518,3.2589619994832133,0.059248160033908204
3930,SIDM00950,Paclitaxel,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-5.1076055,-0.4612557,-2.994943619940678,-0.2911614802762738
83728,SIDM00872,Nilotinib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.856894,-0.13502637,-0.20176763379358437,-0.023885397804769958
22204,SIDM00837,SCH772984,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.6118256,0.010277094,0.5332424515956091,0.007577670749395754
14549,SIDM00872,RO-3306,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.45546806,-0.017708296,1.476646373758724,0.01221932852186608
89849,SIDM00282,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7548307,-0.04477621,-1.0883335500573117,-0.014170475219256259
99033,SIDM01187,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.4799099,0.1335227,-0.20123755190003315,-0.00533800130755607
74759,SIDM00826,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-3.4782736,-0.27719626,-1.5574034808324635,-0.10083923772371903
89671,SIDM00282,BMS-754807,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.9570911,0.08148828,3.160933907635918,0.16099519431870332
104182,SIDM00928,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.84666336,-0.083279334,0.12724493467666448,-0.06744954371429532
67408,SIDM00875,Camptothecin,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.54531825,-0.057930253,-0.21768560857663546,-0.055556461940207656
96054,SIDM00950,Sorafenib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.20211834,0.019279305,-1.0859833210612024,-0.011397071090138317
97995,SIDM00933,Dabrafenib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.0144718,-0.09207314,-1.7088683224843964,-0.0595728490889925
20638,SIDM00877,Gemcitabine,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.90915585,-0.013870836,-1.4199362154456587,-0.04625073763896745
16386,SIDM00877,Linsitinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.390504,-0.19464996,-0.5772326888250584,-0.1016633290686375
104800,SIDM00455,Linsitinib,Dactolisib,Pancreas,0.0125,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6783068,0.03703227,1.8009669425425323,0.11257845371970564
20690,SIDM00359,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6957009,0.040341124,3.1088296826524333,0.12354106121798986
18741,SIDM00832,Palbociclib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,1.5395526,0.069036,0.9785964490810397,0.06017349128413102
3229,SIDM00875,Docetaxel,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17044991,-0.013360933,-1.1403391876374465,-0.10069583210765974
81720,SIDM00148,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.99636626,-0.07026199,-2.5863445667014116,-0.15293901429796833
55289,SIDM01187,Olaparib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.30631,-0.07621112,-2.2648349578194646,-0.03411710322559904
63105,SIDM00957,Crizotinib,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.858058,0.056840695,1.1606073489243984,0.09520941971834306
8571,SIDM00832,Dabrafenib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-1.3743265,-0.06671962,-0.07722608548392883,-0.03282968111275775
45752,SIDM00837,SCH772984,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.7538886,-0.04790275,-1.454152347300321,-0.06544377828504563
7874,SIDM00633,Pictilisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6769706,-0.053880986,-1.4227973673677767,-0.09045816106476295
67113,SIDM01187,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.7811813,-0.13007082,-1.3401611653658294,-0.062402973386147816
96146,SIDM00928,Luminespib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.58798784,-0.0632415,0.347858406374017,-0.006904317309527759
60844,SIDM00837,Oxaliplatin,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.709068,-0.06589578,-2.175142055974995,-0.09154447190646764
31065,SIDM00950,Navitoclax,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.213216,0.10184152,0.8445581713677136,0.05250859284935209
66330,SIDM00673,Nutlin-3a (-),Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.971099,0.09865111,0.5870508522676244,0.027294897126259578
89736,SIDM00148,Uprosertib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1387038,-0.085469104,-1.168352841371528,-0.10153396670430653
68387,SIDM00875,Temozolomide,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8847977,0.018533295,0.14325303655827817,-0.025120313312520612
22990,SIDM00282,Navitoclax,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,2.4797533,0.1523483,1.2557165642158992,0.12608138321143866
91033,SIDM00877,5-Fluorouracil,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.73223525,0.024999809,1.249311387427323,0.06368797850464646
37538,SIDM00282,Trametinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.9003103,0.122295365,3.6313723062444807,0.29302874227204073
46346,SIDM01042,Docetaxel,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.742637,-0.17058215,-1.2607997997306415,-0.0562201072049089
31149,SIDM01042,Taselisib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.349382,0.08634469,-0.4639942945122079,-0.05238973508941078
85831,SIDM00148,Crizotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0394075,0.15695752,1.9035343602395332,0.04320538989958493
37596,SIDM01187,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,5.856139,0.33875155,1.6893229338031046,0.07840666524441633
60759,SIDM00148,AZD8055,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.19513,-0.10896143,0.8254966028292196,0.030006013364975083
50012,SIDM00776,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.332458,0.044854145,1.4792322868811572,0.06168364888437894
14764,SIDM00282,Dabrafenib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-2.4505906,-0.05486187,0.6002032872013033,0.05028871576486012
75819,SIDM01187,Navitoclax,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.0854204,0.16269703,3.052459865802727,0.11346925968395484
68648,SIDM00833,Olaparib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-1.7563617,-0.05264055,0.007957202557044747,0.018258035850635276
56573,SIDM00673,Entinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.7377933,0.10283443,-0.25822942821327227,-0.033955071596300436
4299,SIDM00832,Crizotinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-0.21001919,-0.016961506,0.5522114855377398,0.08023361573650528
62018,SIDM00146,PF-4708671,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.3505604,0.09616738,1.438311730990047,0.07717948785759272
56780,SIDM00875,AZD6482,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3461342,0.096874855,1.0233048589084242,0.04343158936277432
18999,SIDM00097,Luminespib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4793339,0.107446566,0.05768812003034453,-0.004754040349229843
79436,SIDM00097,NU7441,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.439259,-0.07041013,-1.865913455494571,-0.09487033959536186
68134,SIDM00933,5-Fluorouracil,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.9740847,0.114689276,0.16380229340194807,-0.007663500117283759
39792,SIDM00826,AZD4547,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,0.5067462,0.04443428,-1.2684240210323205,0.0453519498736322
22273,SIDM00833,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.3847414,-0.11183499,-2.081469566925076,-0.13435033470398056
51265,SIDM00872,MK-1775,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0462898,0.09424967,0.10096150377309665,-0.0036575674745400384
105112,SIDM00097,AZD6482,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8193025,0.05729334,-1.0350455432333692,-0.06263481542512177
61358,SIDM00833,BMS-754807,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.6238523,0.036848083,0.2694069243524221,0.010794987862487948
24196,SIDM00826,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,0.47580412,0.022263208,-2.0036097311509606,-0.10980149592525201
52343,SIDM00776,SB505124,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.38107485,0.022611804,-1.0126130819086636,-0.06900311145593213
99093,SIDM00455,Lapatinib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2941911,0.08465883,3.3525206733508064,0.18990198894220015
13966,SIDM00673,AZD6482,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.9368306,0.1057811,-0.8804366799027991,-0.023726970144768995
26278,SIDM00835,AZD4547,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.2405779,-0.0284427,1.4742521934335688,0.014711035636824334
81666,SIDM01187,Vorinostat,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.0069195,0.094291545,2.2560398902921697,0.14166903560250066
19574,SIDM00928,Alisertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,0.58400464,0.047143064,-0.20761972238610574,-0.0008344779619170407
103376,SIDM00097,Lapatinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.615945,-0.086722076,-0.16796092656083172,-0.04812044699413621
2889,SIDM00097,Linsitinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.169752,-0.10633032,-1.0279021652306488,-0.04533897409813859
20869,SIDM00826,Taselisib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.449089,-0.04051373,-0.9806059453278707,-0.06041505905343209
31852,SIDM00359,Taselisib,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.6803236,-0.17269945,-1.5338129422362903,-0.014615767022408266
95436,SIDM00875,MK-1775,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.0428033,-0.044232942,-2.8482689221020028,-0.05523455234940367
3028,SIDM00835,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.0575948,0.07433821,0.26992516158764035,0.033926038129715834
2993,SIDM00957,Linsitinib,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,1.1659974,0.027168157,-0.5705181992834798,-0.012058456876979306
95102,SIDM00455,Sorafenib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2956345,-0.06732824,-0.46232872871616904,-0.0403941907443101
9995,SIDM00633,Sorafenib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.05116109,-0.0048541203,-2.029976466832225,-0.06561238785914293
7426,SIDM01042,MK-1775,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7977425,-0.17895402,-2.306120682047949,-0.17482756317452805
37616,SIDM00833,AZD8055,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Male,White,53.0,1.6571213,0.06599218,0.846093244078804,0.07174648979387106
102895,SIDM00933,ZM447439,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.3835208,0.3085736,1.497897839280157,0.0803312731521123
66329,SIDM01187,Bortezomib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0638291,-0.09991288,-1.366793606310492,-0.05757780977003789
4268,SIDM00875,Palbociclib,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2311847,0.1803523,1.5669374624779588,0.06299514273161484
100747,SIDM00928,BI-2536,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.97744,-0.12508307,-0.533101641168059,-0.07177578239271476
25335,SIDM00833,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.40126467,-0.019188177,-0.413506113652077,-0.02058003601647536
65112,SIDM00826,AZD4547,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.2680128,0.103489116,-1.6316336420729947,-0.012503164980197361
83515,SIDM01187,OSI-027,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2259167,-0.088892914,-0.58393813101385,-0.05533903237398134
35812,SIDM00877,AZD7762,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.36945814,-0.033463817,-0.3263442824149616,-0.00866781148922512
84723,SIDM00097,5-Fluorouracil,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5287216,-0.11947709,-2.4264021140853584,-0.12574188946708648
105579,SIDM00673,Pictilisib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.46104473,-0.046517607,-1.4119067934700775,-0.05153667099675728
93868,SIDM00833,Trametinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-0.43830344,-0.020959973,-1.0804962948122043,-0.0585242221644568
53432,SIDM01197,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.9406357,0.19542705,-0.6018615569300442,0.02635898898427721
19260,SIDM00282,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.8553642,-0.08844776,-1.0195621726549962,-0.04347915724079101
95444,SIDM00928,Sorafenib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.2663594,-0.09709915,-0.6995995281866607,-0.06594758385585474
77104,SIDM00359,SCH772984,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7171067,-0.13003042,-0.17474468912532964,-0.037225606499589656
102828,SIDM00673,5-Fluorouracil,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9186362,0.12302503,-0.0541271136474963,0.05490177057408603
81777,SIDM00833,Afatinib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.048301,0.12491489,1.1491110761961765,0.07258661262687827
55366,SIDM00097,Olaparib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8211747,0.056520708,-0.7984236248257056,0.0015260983163960444
13255,SIDM00455,Oxaliplatin,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3084562,-0.09368095,-0.5208321073635618,-0.02285362246702625
75075,SIDM00832,AZD8055,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-2.4305394,-0.19361731,-0.9092454593137863,-0.02860268011684481
92278,SIDM00835,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-3.505604,-0.18080983,-2.6845415597099103,-0.07373100089373039
83031,SIDM01042,Crizotinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7739939,-0.0804841,-1.8353466110218404,-0.08802211933906895
6353,SIDM00832,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,3.42668,0.22894283,0.9178964855144364,0.03634757980559494
52256,SIDM00673,AZD7762,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.9206417,0.06398535,0.5702351145442947,0.055868691232848766
102077,SIDM00833,LGK974,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7986859,-0.023460839,-0.8664254831171643,-0.024988002271427542
80864,SIDM00826,Camptothecin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.2246458,-0.00916577,-1.38534174397647,0.03529141921465547
86841,SIDM00933,ZM447439,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,6.716125,0.58373344,3.08709404357587,0.22364156938923313
91453,SIDM00633,BI-2536,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2409302,0.12710902,0.45605598331317326,0.11002583909947014
91013,SIDM00633,Dabrafenib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5574096,0.040921267,2.5923359506466324,0.10912731839347203
84265,SIDM00877,ZM447439,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.77331394,0.04622164,0.24289973782967075,0.012980417638825001
40162,SIDM00148,MK-1775,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7164978,0.100752145,0.8652746146454959,0.07276956287944676
56588,SIDM00928,Linsitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.4538578,0.1240037,1.064270050650297,0.06601998104025122
84070,SIDM00282,SB505124,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2741383,-0.043470617,1.507979086962323,0.050883291042475215
36064,SIDM00928,Pictilisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,2.3937135,0.18939796,0.36359421483268284,0.042548981428834225
58388,SIDM00833,Navitoclax,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.9045268,0.08750393,1.644725490833989,0.06794922705819528
26335,SIDM00097,Cisplatin,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4303305,0.04205776,1.8427440336770617,0.03917864730196151
66021,SIDM01042,Linsitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9213668,0.04849922,1.9194379675313675,0.05903599287420023
92422,SIDM00875,Alisertib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5275919,0.047775313,1.0733906394161306,0.06925057946332185
87298,SIDM01197,Linsitinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-3.1616046,-0.13224697,-4.033665426442408,-0.11340757986256988
40585,SIDM00877,Ribociclib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.82717353,0.022351183,0.7336269559354,0.01396103852693115
97884,SIDM00148,Olaparib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.1957064,0.08820643,0.012504625941284018,0.014665453800850747
1079,SIDM00148,Lapatinib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.46536565,-0.044854328,0.44741266737671803,0.012045976610267937
21239,SIDM00455,AZD7762,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.982024,-0.13401046,-1.0659128865060432,0.004323379856951937
107437,SIDM00633,Cisplatin,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3656275,-0.058079753,-1.590591421319547,-0.015706163575119125
2916,SIDM00673,Sorafenib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,0.3079602,0.022009121,-0.5609891982442795,-0.012153888789072153
29077,SIDM00633,MK-1775,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.8827128,0.19558729,1.4358769315806688,0.06715657927804718
82493,SIDM00097,Crizotinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.42617583,-0.026909282,-0.47034264103901197,-0.03898794060709634
39585,SIDM00875,Doramapimod,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5858705,0.05665742,1.882253720159045,0.04026322578176587
94338,SIDM00872,Paclitaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.38988152,-0.03873233,-0.5320620888735896,-0.030297236273521065
86032,SIDM00928,Alpelisib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.8884065,0.057337217,0.12108946410227235,0.07030280563538015
105310,SIDM00875,NU7441,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.537134,0.019716578,0.7669086272695721,0.035582841772206546
2514,SIDM00633,KU-55933,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4826598,-0.045718204,-1.7537189326511156,-0.05498585134292655
66205,SIDM00837,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,0.9542127,0.019747648,0.5264869982722166,0.025602790178678135
1369,SIDM00835,MK-1775,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.0029117,0.08215202,-0.2785058194402176,-0.0009109160589987018
91898,SIDM00877,Temozolomide,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,1.6348464,0.052678812,-0.36197890094963486,0.03235601296934992
92646,SIDM00875,Venetoclax,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.40163264,-0.008875167,-0.22365217584570224,0.0068909571806178346
80960,SIDM00875,Sorafenib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3714554,0.13700484,0.735399628870482,0.077242025353386
107974,SIDM00146,Alpelisib,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,1.4285461,0.08882075,-0.4332056408241643,-0.006213697112205926
62823,SIDM00872,5-Fluorouracil,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3398511,-0.06219401,-0.3222936998853609,-0.008730063519211928
102403,SIDM00216,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.1726165,0.04007863,-1.597224360005937,-0.06695839481504476
23361,SIDM00776,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.79701596,0.06386291,0.41044815665879014,0.02092194773812422
13177,SIDM00933,Doramapimod,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,3.8597414,0.17468405,3.0696808823899415,0.07044338506139336
30328,SIDM00633,Trametinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.382771,0.09847821,-0.31365418407041734,0.07339237609401156
27332,SIDM00928,Pictilisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.010834,-0.096791424,0.6376889401235839,0.09935481417619324
22080,SIDM00633,SCH772984,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,7.128346,0.35850987,2.2670904327464423,0.1380774202851072
58135,SIDM00097,Trametinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.96697205,0.032349046,-1.05302365789962,-0.01278312183016502
106700,SIDM00359,Linsitinib,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.1896839,0.011012642,-1.032945049788656,-0.006477123221835357
12897,SIDM00832,Linsitinib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.79007304,-0.06875989,0.14593097859771065,-0.058959753372087594
69113,SIDM00359,Taselisib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2344186,0.15862131,1.5801207978839054,0.11149056338951945
26419,SIDM00877,Ribociclib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,4.18982,0.11004084,1.1565541645348754,0.03713616397173601
83130,SIDM01197,Palbociclib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8318503,-0.02756262,-0.14873913253681734,0.009356505195999582
97031,SIDM00359,Oxaliplatin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8413994,-0.111027196,-2.4466920621412886,-0.045086856487149274
10735,SIDM00282,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3134359,-0.08435976,-0.607926126114123,-0.08975446762033999
80568,SIDM00872,GSK269962A,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8237673,0.088899024,0.04176548116288089,-0.016800643633607316
77782,SIDM00875,Dabrafenib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.0535753,0.031384405,-0.25012568043154004,0.01357934800680922
32976,SIDM00633,Uprosertib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.43404886,0.030496083,-0.9616620492466966,-0.03550128509306005
28498,SIDM00928,Taselisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.1542115,0.09307741,-0.003708347908276708,-0.05065707756394668
89490,SIDM00097,Doramapimod,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.91087765,0.027558668,0.2711872310679808,0.01740338565477714
78525,SIDM01042,KU-55933,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.6095352,0.0655803,-1.2078414863617841,-0.05061994060778657
69505,SIDM00455,Ruxolitinib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4690654,0.07123384,0.6890008664518272,0.05135560617313502
63113,SIDM00933,GSK269962A,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,0.13085936,0.013527538,0.6332758688849139,0.044769870622735526
84932,SIDM00359,Olaparib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.11344881,0.002175388,1.785005988578748,0.04224865645176767
103817,SIDM00673,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-2.4911804,-0.116375096,1.7916776836416606,0.07138433451239734
18696,SIDM00673,AZD7762,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4352403,0.09612668,1.5305413011880196,0.08073144361390033
105668,SIDM00633,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1745625,-0.1484988,-1.5936234653511507,-0.11673510514942331
53371,SIDM00933,Entinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.384761,0.029012214,0.06301467783580177,0.050225578414516484
17069,SIDM00933,Camptothecin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.05786367,-0.0054902593,-0.8130404652690251,-0.0754614194195525
41587,SIDM00148,Bortezomib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0181916,0.0623414,0.49839776573170314,0.02368071285664094
37192,SIDM00877,Taselisib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.6546595,-0.1351257,-0.40324846400040765,-0.08706699972452478
82991,SIDM00872,OSI-027,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.56064636,-0.054171477,-0.3956554493552681,0.011839777669039426
301,SIDM00633,Ribociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0768325,-0.028682837,-0.6158680232058333,0.006983108716049492
7557,SIDM00928,AZD7762,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.538682,-0.14511772,-0.4314947953050126,0.04108619248015857
41191,SIDM00875,AZD7762,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.39087617,-0.027557455,-1.9912772220843593,-0.10172707856467282
72403,SIDM00097,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2328019,0.08711374,2.296827251487825,0.11600217085572045
92648,SIDM00673,PD173074,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-1.8583449,-0.08867903,-1.1226665546423344,-0.01625532405885534
35858,SIDM00872,Paclitaxel,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-4.4784513,-0.40743402,-4.736600202532081,-0.3479599631406751
68931,SIDM01187,Linsitinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.8636196,0.17828207,1.765451452080007,0.05800379115541969
63998,SIDM00877,Temozolomide,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.5487644,0.014603395,-0.7820714738615326,0.01560476116057386
493,SIDM00928,AZD6482,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,0.8223759,0.060847662,0.8904491837034019,0.04525673428624203
104257,SIDM00633,Entinostat,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.95464486,-0.058394354,-1.8559727596443374,-0.0724404805707441
39123,SIDM00872,Camptothecin,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.6542423,0.04991008,2.778972742085535,0.0923525834398114
54726,SIDM00148,Vorinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.38086253,0.036361266,0.9353360576778496,0.021237607478136432
75755,SIDM00673,Nutlin-3a (-),AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.3099875,0.023108866,1.7141765480251048,0.02879327748183982
21704,SIDM00832,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.2229688,0.21078996,-0.38497090400077916,-0.04319420635216027
89232,SIDM00673,SCH772984,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-3.6105509,-0.25694564,0.6346178017102692,-0.04326158215942778
97518,SIDM00673,Taselisib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.40853763,0.036168758,-0.338353539233103,-0.026816856126044487
35000,SIDM00148,BI-2536,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7673321,-0.076456495,-2.2405283154244593,-0.06512786757291132
35026,SIDM00875,PF-4708671,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2688112,0.008763462,0.4413660198026883,0.028078043393836623
4828,SIDM00455,Olaparib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9030368,0.097865395,1.8781413837293883,0.07409448104266135
82725,SIDM00097,Linsitinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.649084,0.15454553,1.3376500628026151,0.11425559985700003
38991,SIDM00146,Trametinib,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3113252,-0.051429696,2.6628644380126194,0.07164589011002671
57649,SIDM00359,MK-2206,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.63089865,0.040749654,0.43750980236156634,0.08673463591208998
53428,SIDM00877,Trametinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3133699,0.039349694,0.7471641135302305,0.05414455416069855
52234,SIDM00148,Sorafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9619964,-0.09832694,-0.31100358095289327,-0.03502555340075223
10144,SIDM01187,Luminespib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.7054858,-0.064914115,0.2778999923400491,0.004019467239706683
44643,SIDM00673,Bortezomib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.37462813,-0.019474737,-0.6648912531008062,-0.0374287858550633
939,SIDM00148,Linsitinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.5495331,-0.11295444,-0.07092723161665548,-0.06578232403424916
7491,SIDM00042,Cisplatin,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6855812,-0.1314665,-2.094867237620059,-0.07090901847284957
107831,SIDM00097,ZM447439,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5127664,-0.09190741,-0.8314268068550033,-0.04333273881544734
74986,SIDM00877,Vorinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.6925398,-0.033946745,0.8247244442477599,0.013576481837740646
86815,SIDM00148,PD173074,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.9652026,0.07659564,1.3594050432078018,0.011566579044404408
33095,SIDM00282,AZD7762,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.0190456,0.032896683,2.313280094368793,0.063019063229594
12923,SIDM00933,Ribociclib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.75158167,0.017380163,1.1374546061803636,-0.01867290670024808
46042,SIDM00933,Wee1 Inhibitor,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.880158,-0.06998253,-0.10407830178936843,0.006206064682432733
34136,SIDM00877,Alpelisib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.1250792,-0.07400382,-0.5330559637178882,-0.08999413328485201
30383,SIDM00957,LGK974,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.5422817,-0.021059059,1.1037182023825518,0.030218631932341606
44186,SIDM00832,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-1.5018489,-0.049634043,-2.425231137102201,-0.10194605953499983
66172,SIDM00833,BMS-754807,Camptothecin,Large Intestine,0.0025,Rectal Adenocarcinoma,Male,White,53.0,-1.4606173,-0.11680521,-1.9500196685626314,-0.1476032002598046
62545,SIDM00928,Nilotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,-2.3810012,-0.18379597,-0.8350245488002693,-0.1069903365367426
79867,SIDM00832,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,-2.6432745,-0.077610195,-0.1780553962707262,-0.012258983228474307
34684,SIDM00042,Erlotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.9232731,0.05340472,1.3361454163706064,0.07249761698448898
88539,SIDM01042,Crizotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3923681,0.037828695,-0.3513342999817,-0.028282363301727263
22590,SIDM00933,Temozolomide,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.51064444,-0.022356154,0.8756380005512211,0.10648106669032091
24727,SIDM01197,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.5889672,0.018981606,-0.09334151277813103,-7.604121858090923e-05
75493,SIDM00148,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.87727594,-0.042303465,-1.762210571168989,-0.05934263571873123
25193,SIDM00933,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.8447087,-0.12977833,-3.270612500873844,-0.1205996126668698
761,SIDM00146,BI-2536,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8998974,-0.036173277,-1.1638000275284688,-0.05494928229872662
13995,SIDM00282,Olaparib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7291238,-0.015701065,-0.10835050353138778,-0.020513322452116765
47642,SIDM00833,Taselisib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,3.4364064,0.23580444,2.520377184106271,0.12281304663807419
12889,SIDM00216,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,2.0798032,0.19344872,1.1094850913343504,0.017844880562096894
40787,SIDM00837,BMS-754807,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-2.4978976,-0.033345398,-0.9099120857493349,0.011688623436159926
76804,SIDM00957,SCH772984,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,1.4636604,0.061420538,0.3886031317993325,0.03276432231924005
39240,SIDM00097,AZD6482,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2572173,0.091183096,2.792247218954154,0.12932587294273973
90425,SIDM00877,Uprosertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6274425,0.14403561,0.9098887920252793,0.051493241007660416
27270,SIDM01197,Vinorelbine,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.4711471,0.040242724,1.2188006253218053,0.03146698478541156
21083,SIDM01042,Nilotinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.19450264,-0.009617647,-1.3046655642861404,-0.09495860672202387
46787,SIDM00148,AZD7762,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0304871,-0.07449189,0.5283977491929539,0.1068108695565445
79879,SIDM00875,MK-1775,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.092869,-0.033162594,-0.8205086826721035,-0.030460372778411376
9118,SIDM00148,Nilotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5098854,0.119020484,0.6563080756201105,0.023497263704010486
89683,SIDM00633,Entinostat,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.70772713,0.05196555,-0.8896797807614866,-0.04483642979293466
103033,SIDM00633,Alisertib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.365111,-0.16696048,-2.4305308810548727,-0.13374450184576442
60818,SIDM00957,AZD4547,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.5008512,-0.051440407,1.1737833748197049,0.05853798832833211
77744,SIDM01042,Doramapimod,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.30208474,-0.03515075,0.2046464427080529,0.04526829685363666
19142,SIDM00832,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.4316034,-0.101046704,0.820637452517351,0.012129644670170716
3462,SIDM00146,AZD6482,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.0396721,0.06565592,0.8736660102509852,0.11565610811276042
69438,SIDM00455,MK-1775,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.5261613,0.09255348,0.6368730756317164,0.06793897289483956
107633,SIDM01187,Luminespib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.697717,-0.13223653,-2.5657478912642624,-0.08096333030252564
61202,SIDM00826,Palbociclib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-4.6545315,-0.25154063,-3.3960841850320653,-0.14010823473577022
94962,SIDM00148,Docetaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7930914,0.07038893,0.008423389675014607,-0.019062174609983315
88105,SIDM00455,Linsitinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1864932,0.06542541,0.7863654210224467,0.09249176247403049
95479,SIDM00957,Palbociclib,Taselisib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,0.6681685,0.015933227,2.3385887294377885,0.11611105734988368
94517,SIDM00872,Tozasertib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5842779,0.1523479,2.777137400291886,0.2065660640166239
42749,SIDM00146,Nilotinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.35955465,0.032271758,0.4794141572092356,0.15486220460467517
76627,SIDM00957,AZD4547,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.3414721,-0.048399605,0.9063349534971301,0.062173245420092914
37516,SIDM00097,Olaparib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.872936,0.09085638,1.3258712193559092,0.06034375229967091
8677,SIDM00928,AZD8055,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.1236677,0.24272273,-0.31262058363460404,-0.031004188377869803
66163,SIDM00833,AZD4547,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,-0.4015152,-0.016100224,-0.0459442882386811,-0.010977963885613486
96194,SIDM00148,PD173074,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7886212,0.023425108,-0.12813865180501208,-0.0056864831172227905
36713,SIDM00957,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.1970396,-0.03316707,-0.052037264184782564,0.007939606768494133
81694,SIDM00933,Axitinib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.93917865,-0.12328953,-0.9182990042675604,-0.004864148065654855
57489,SIDM00097,Ribociclib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1872588,-0.04209124,-1.161898738125491,-0.017504751934627402
12352,SIDM00633,Linsitinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.935887,0.18085685,0.7856120599050088,0.01934807336922708
50544,SIDM00673,Doramapimod,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.785316,0.033865977,2.7990211433200187,0.09670208992639662
94864,SIDM00826,Taselisib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.534705,-0.051567778,-1.5065509017776928,-0.08762991316002632
59399,SIDM00146,Paclitaxel,Navitoclax,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,4.683388,0.20981513,3.5210684233625145,0.19952035305328905
5484,SIDM01042,Tozasertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.6549677,0.13890994,1.1414995665448233,0.04169995612874213
71388,SIDM00872,Luminespib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5503516,0.0682822,0.291059919350696,-0.006769664188297984
38160,SIDM00216,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.48682913,-0.027916081,1.4542193708512805,0.14526654756355628
69730,SIDM00950,5-Fluorouracil,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3912579,0.12881449,1.3028699165578275,0.07252815838589254
93840,SIDM00928,Ribociclib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.117733,0.087855875,-0.08497089928706669,-0.01443356878911513
23415,SIDM00875,Ribociclib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6230884,0.028566502,-1.162134531458956,-0.015048086908971296
23405,SIDM00282,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.502485,-0.14371882,-2.3789234849034484,-0.16339264773251225
27909,SIDM00146,PF-4708671,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,3.6294084,0.17707866,0.9445219416629154,0.08483006476637799
3962,SIDM00928,Ribociclib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,1.9217235,0.07274575,0.5620923216764563,-0.006914982491955431
104895,SIDM00933,Sorafenib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.7504573,-0.06930151,-0.5397720855537954,-0.05984050638774523
39423,SIDM00673,Sorafenib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3491193,-0.076727055,-0.3661165043741299,-0.03485835724439347
84197,SIDM00673,RO-3306,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9049702,-0.08167241,-1.3358296215640684,-0.0640004727547599
90359,SIDM00359,Nutlin-3a (-),Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2012781,0.03280184,1.6502728962188042,0.08458800452961988
61519,SIDM00877,Alpelisib,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-2.2313385,-0.16711447,-0.8154686397893302,-0.05261295446552902
47728,SIDM00933,OSI-027,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.4315988,0.06436108,0.5906823035510771,0.06411538381756154
12139,SIDM00833,Vinorelbine,Crizotinib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-2.4824667,-0.15958753,-0.4782310675095772,-0.10650732804065419
106340,SIDM00875,Camptothecin,Vorinostat,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2479776,0.1317737,0.002710174213708079,-0.085820406328276
19869,SIDM00875,Tozasertib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.72871,-0.06305664,-1.0212713719266338,-0.01815892709341517
26163,SIDM00148,AZD6482,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3754797,0.109561495,-0.2132054312869862,0.020765329160467725
100285,SIDM00673,Paclitaxel,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.6137261,0.049016498,0.060355105234183894,-0.04953707096488026
3134,SIDM00148,MK-1775,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2913054,-0.012692233,-0.6447507981477765,-0.032185138817133974
84386,SIDM00148,Crizotinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.58681166,-0.016824802,1.0025974647791493,0.011010290056702043
52523,SIDM00950,Trametinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.90864,0.20031777,3.8498605111737327,0.20115713413923642
36667,SIDM00950,AZD7762,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7037627,-0.14518555,-0.11599117161065295,-0.020595522214009912
39737,SIDM00282,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.0175328,-0.11590279,-1.5515827722991722,-0.0996737603710635
81722,SIDM00875,Dabrafenib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5335884,0.027739305,0.9365903052851048,0.010719752484543746
67292,SIDM00877,BI-2536,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.40145156,-0.0008094147,0.14181802499778925,0.030071008719246325
45563,SIDM00148,Dabrafenib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.58470553,-0.035896517,-0.7178882597885912,-0.04140048048543922
61008,SIDM00872,NU7441,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.2656683,0.01915097,1.1971030240838592,0.058789744944310385
34852,SIDM00216,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.9788349,-0.19795565,-0.35104737109739403,-0.006847774187515893
6364,SIDM00832,Crizotinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,0.002670046,0.000115775,-0.3653905840581083,-0.0006422321125645026
33168,SIDM00097,Nutlin-3a (-),Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8577,-0.0316569,-0.14274383974469443,0.010311725326469318
634,SIDM00776,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,3.4145434,0.20271005,1.4637348722995982,0.07918351147510029
87387,SIDM00877,OSI-027,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.48706183,-0.04102493,0.6105142200136716,0.04463078974646239
11771,SIDM00776,Navitoclax,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.26402497,-0.018621232,0.5255806778480677,0.011391619141305275
104438,SIDM00097,5-Fluorouracil,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.64269227,0.035739552,-0.5102162684391355,-0.020139637471411037
36992,SIDM01187,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.1076553,0.09141557,1.8745158847263002,0.11371080923221592
69839,SIDM00148,Vorinostat,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.40981513,0.03987612,0.07227736235618455,-0.016087345322059035
99086,SIDM00148,AZD7762,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7249377,-0.06380025,0.8615688436120704,0.0872520861433723
27504,SIDM00097,Uprosertib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93958265,-0.06043568,1.7515788854892185,0.13291308489983375
101377,SIDM00872,Afatinib,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.803634,-0.14521638,0.47012441896419477,0.04761760407323929
26508,SIDM00928,Alisertib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.6932003,-0.04931374,-0.7714080279220289,-0.032508500529513394
33788,SIDM00837,SB505124,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.7915897,-0.07605966,-0.9083601291432675,-0.03951772158918674
83802,SIDM00875,Venetoclax,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.054344963,0.0011077884,1.4441504290616192,0.02369808159437041
95752,SIDM01042,Sorafenib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5535665,-0.0634269,-1.559306095142449,-0.10236939710738648
25891,SIDM01187,OSI-027,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7576036,0.16355048,0.48683000200240756,0.03841518768442602
62426,SIDM00097,Tozasertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6038737,-0.046060987,-1.7019156714517902,-0.013501953098013384
23199,SIDM00146,NU7441,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3718317,-0.10724998,-0.5339512243377049,-0.04166081426943487
55398,SIDM00837,MK-1775,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.5066636,-0.016757445,-1.41332004525577,-0.08935295492887968
177,SIDM00877,Bortezomib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.5971842,-0.04163882,-0.2834887417303486,0.008138816853180218
34505,SIDM00673,PF-4708671,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5564279,-0.03517327,-0.4989401378734953,-0.03351564357697629
68664,SIDM00633,AZD8055,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,5.078229,0.3042868,0.4275857676118204,0.007071016216388007
30036,SIDM00826,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.45799574,-0.017093463,-1.662062948205425,-0.03794564850894806
81693,SIDM00146,Afatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.6802631,0.061789177,-0.19287552334069363,0.010374635853843598
91269,SIDM00042,OSI-027,Cisplatin,Pancreas,8.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.84751254,-0.06821848,-0.9465537417433422,-0.0528810852006293
12434,SIDM00455,Dactolisib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.843808,-0.117669545,-1.1341210990713566,-0.060365846759666435
105044,SIDM00146,Dabrafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.532773,0.09790448,1.1851564314635157,0.07979942382070503
11996,SIDM00872,KU-55933,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7222545,-0.07627769,0.927139216915856,0.0036515121902458638
3096,SIDM00148,Paclitaxel,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8330247,-0.13356864,-2.010913584443866,-0.0986398725080327
26174,SIDM00359,AZD8055,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0502083,-0.06279619,-0.9627263680920801,-0.026824475724583553
105545,SIDM00950,AZD7762,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.6664829,0.06231148,0.8143991142425419,0.022543304030649546
40794,SIDM00359,SCH772984,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.4360925,0.03039131,-1.560748649540374,-0.03862204913605254
104591,SIDM00776,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.8816412,-0.06681724,-0.7450783395579395,-0.07002408714750864
58833,SIDM00148,Nilotinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.136833,0.08822495,0.9455787794205276,0.049786864011871323
95412,SIDM00833,SB505124,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-0.6662621,-0.04096687,-0.25290761636971304,-0.02866594972506916
51692,SIDM00832,AZD7762,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.3552977,0.11950719,-1.1488163986939681,-0.07435809230741121
34137,SIDM00455,Lapatinib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9270635,0.09723663,4.584762342021129,0.2419074388066109
81484,SIDM00359,Camptothecin,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1400142,0.10206209,1.7973119948244662,0.1376833390918931
50876,SIDM00633,Crizotinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.13315842,0.003920098,0.06820379523496745,0.012110501184869855
40673,SIDM00633,RO-3306,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.050741,-0.09063315,-2.1264747030982485,-0.1170841798496126
7794,SIDM00835,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,2.0618834,0.0718784,2.130390355596129,0.05310936788862082
103350,SIDM00146,Olaparib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,1.3811995,0.09110692,0.9954227364953321,0.10040518881206809
26311,SIDM00097,Sorafenib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1807008,0.059472084,0.12110443863811336,0.02292441464203802
45773,SIDM00282,Crizotinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.30018714,0.017325602,2.1563828349614895,0.12257647867875371
28401,SIDM00148,AZD6482,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.5101805,-0.12510175,-0.5021190302785419,-0.020994235117818467
9198,SIDM00455,Dasatinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,4.735173,0.21873604,3.911742458573467,0.2688903544237241
91953,SIDM00875,KU-55933,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.583881,0.08605677,1.1643603959314872,0.045620158824957555
23347,SIDM01187,Pictilisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.42478976,-0.029127318,-0.667002903909991,-0.0318780851294837
70264,SIDM00826,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,3.7573638,0.053912215,1.3311875749810387,0.04322070609853144
106022,SIDM00928,OSI-027,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.1109499,0.11494475,0.805788291321187,0.02991870274481778
37209,SIDM00826,LGK974,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.6571851,-0.05730665,-2.457613819495855,-0.08119529972995726
104113,SIDM01197,AZD8055,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,East Asian,71.0,1.9048443,0.15389776,-1.096029226752275,-0.04961701273203513
30878,SIDM01197,Afatinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5321864,-0.042981014,2.117779667822688,0.11948586264318048
97961,SIDM00837,SB505124,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.9566554,0.13114737,-0.6670794701308471,-0.027630680512963832
39109,SIDM00216,BMS-754807,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.38528875,-0.011595075,-0.2452642792212135,-0.03516705531125243
99282,SIDM00877,Uprosertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8549586,-0.09334448,-1.0816908332166866,-0.06855541809874875
55822,SIDM00633,Alpelisib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.34782606,0.03301331,-1.0556528708027282,-0.05318301153048451
82916,SIDM00832,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,0.6853588,0.01937617,-1.7711515354127152,-0.025423210354763918
13865,SIDM01042,Trametinib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2344326,-0.019203871,1.5743612422616093,0.055427641458336945
33951,SIDM00837,Dabrafenib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.68093073,0.006606149,2.058606019050789,0.05336343904775325
72891,SIDM01197,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.46221936,0.028940752,-0.42478632216528944,-0.068092939780021
83975,SIDM00835,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.95326823,-0.02268026,0.5016466366336222,-0.01741611466891193
47673,SIDM00673,Lapatinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.3085902,0.16987336,0.5920680272729316,0.05102489860819496
35218,SIDM00146,AZD6482,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.9517429,-0.1051472,0.604012590765879,0.06998009617206004
37947,SIDM00633,Trametinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6002921,-0.03928872,-2.296446703524309,-0.11351017956347119
107533,SIDM00216,5-Fluorouracil,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-0.127715,-0.012225789,0.7356368000640516,0.042824276402124585
26780,SIDM00146,Dabrafenib,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-0.6391543,-0.023946704,-0.2597517065010668,-0.009528965658403447
26274,SIDM00826,Camptothecin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-2.531185,-0.100203104,-2.040796107691362,-0.059083332426230394
15471,SIDM00042,MK-1775,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.3704643,0.122314386,-0.6802548583539685,-0.03373567601002979
60076,SIDM00875,Camptothecin,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.591718,-0.04811673,-0.41088132094621316,-0.013817046194270571
34033,SIDM00832,Oxaliplatin,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-1.5859786,-0.08704506,-1.8131796966545477,-0.09524664701571907
45426,SIDM00148,Nutlin-3a (-),Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1062998,-0.10304005,-1.0683109239603468,-0.04625777243611769
72024,SIDM00835,BMS-754807,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,0.7403188,0.06598832,-0.8822543200700392,-0.035452394332232955
81553,SIDM00872,Luminespib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.14781764,0.012018317,0.30781616652208,0.06293212924962109
82665,SIDM00872,Doramapimod,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3358537,0.056647707,1.3348554082036526,0.07303859988273387
78771,SIDM00148,KU-55933,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.045518573,-0.001799111,-0.33161550488676966,-0.010670354269418722
85400,SIDM00776,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.7492816,-0.087257385,-1.1224090778928186,-0.024942369806444917
33470,SIDM00673,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.67705566,0.0445018,0.3098990763890023,0.040662455195673824
8662,SIDM00282,Oxaliplatin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.598303,-0.04362905,-1.3230979636857545,-0.08845850213342758
47444,SIDM00097,Palbociclib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3908463,-0.086143985,-1.7032205941853966,-0.06468361943710776
1856,SIDM00826,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.5813123,0.048777603,-1.413118461653175,-0.024796928890610404
30030,SIDM01042,KU-55933,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0825696,0.26590744,0.36099567964698276,-0.0517609236753775
65395,SIDM00148,Pictilisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6125462,-0.09620469,-0.9977388449823411,-0.07108590531848372
96172,SIDM00872,AZD6482,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.81040746,0.0786417,0.5605502221161066,0.06027540755211287
80943,SIDM00875,Pictilisib,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17877856,-0.018302348,-1.0354578265975056,-0.051088627555564044
101376,SIDM00933,Bortezomib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.28762233,0.028414205,0.30966219860874794,0.0216288521133185
33791,SIDM00875,Nilotinib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2745976,0.24177723,0.764161762479693,0.028637563266149878
10241,SIDM00933,Cisplatin,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.561984,-0.06779932,-1.7317384132765097,-0.07850393565540298
89672,SIDM00833,Camptothecin,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.662419,0.12999798,1.368842063360335,0.09777914822833703
23447,SIDM00872,OSI-027,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3388216,-0.123815425,-1.3993967352606893,-0.12609425943172486
76847,SIDM00633,JQ1,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2502663,0.20848708,-0.13370610086401774,-0.016002742762358444
93016,SIDM00633,Afatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.473405,0.009445278,-2.590222742470387,-0.0420102070170508
38590,SIDM00146,OSI-027,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2360673,0.097971156,-0.21040088702651985,-0.007996729304356492
81857,SIDM00282,Vinorelbine,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-2.222737,-0.120416254,0.10861489802689307,0.03733563772515195
54136,SIDM00950,Taselisib,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8612514,0.05538533,-1.1581251653610218,-0.037207507102781305
42676,SIDM00832,Taselisib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-3.1112077,-0.12232934,-0.5197490244386521,-0.0006532009275194355
34165,SIDM00933,Afatinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.4265665,0.14140701,1.1275762009877979,0.08135400196240326
60099,SIDM01187,Bortezomib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9049893,-0.07201444,-1.3650611349289328,-0.058125563039247805
101560,SIDM00097,KU-55933,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2451177,-0.046565037,-0.8029815635843963,-0.04017674577756872
81255,SIDM00950,Navitoclax,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.2218838,0.24738196,1.0262347161658574,0.1134416389261949
93581,SIDM00673,NU7441,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.20363216,-0.01244065,0.10747640697889047,-0.05080119780018434
6480,SIDM00633,Alisertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7776747,0.2684769,0.9091512390755428,0.031021081618112886
37771,SIDM00455,5-Fluorouracil,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.591849,-0.02468076,-0.6920443725299917,-0.018146774130577838
107710,SIDM00282,Trametinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2902739,-0.08995894,-1.3257609842560376,-0.08397851292161972
92351,SIDM00933,Alisertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.9209703,0.18868531,0.638969525601996,-0.0059382283289975
46088,SIDM00872,Wee1 Inhibitor,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.47552946,-0.043168955,-0.70767645574748,-0.030707184540070993
38754,SIDM00933,JQ1,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.2201176,0.17230786,2.168250040869829,0.1829180256212159
26171,SIDM00928,Pictilisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.3547126,-0.14632186,-0.03492296625213085,-0.016309768890108347
108053,SIDM00875,ZM447439,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.4272995,0.04153337,1.0761612974322998,0.02790633008191421
64211,SIDM00826,BMS-754807,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-5.1226754,-0.054443855,-2.3042557866630573,-0.062126433856348945
29322,SIDM00875,Sorafenib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.42807114,0.038486287,0.8188229486478344,0.03874366426560079
96792,SIDM00042,Erlotinib,SCH772984,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.5011559,0.11449734,2.2890181865333514,0.11387136198816399
14490,SIDM00776,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.1467615,0.04380693,1.3704801514376166,0.0080161666751776
28738,SIDM00633,OSI-027,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9104098,0.07203953,-1.061996423143245,-0.0409863568851364
41832,SIDM00216,Navitoclax,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.9472673,0.18330902,1.9389954969433725,0.11564363376027292
2914,SIDM00877,5-Fluorouracil,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,-0.5356349,-0.029584272,-0.2630230697468064,0.012461410219824635
63243,SIDM00928,ZM447439,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,1.157242,0.12857094,0.025613982299523275,-0.10402178721544343
73958,SIDM00928,RO-3306,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.9979689,-0.069018915,0.10323046180270996,-0.0120979793161785
51932,SIDM00933,Tozasertib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.572192,0.05659991,-1.0257279291957033,-0.05182229992700165
58020,SIDM00216,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.42723143,-0.034775075,-0.3880333816912489,-0.08737062488590842
35322,SIDM00097,Paclitaxel,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0574226,-0.07081187,-0.28435675025056556,-0.048888477984594586
102820,SIDM00455,Irinotecan,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8707215,-0.039953437,-0.10368592603841789,0.10693481928320704
97987,SIDM00633,Tozasertib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,9.296059,0.63687605,5.353819257549178,0.22132674874179012
48307,SIDM00933,Bortezomib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.1238813,0.062532045,-0.0991584953362652,-0.008981784126781042
51161,SIDM00875,KU-55933,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3497413,-0.05669677,-0.1153259881346231,0.01674635364893708
71486,SIDM01042,OSI-027,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7644258,-0.07200765,-1.3179333653817495,-0.06734609739641094
98393,SIDM00950,Paclitaxel,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.5252833,0.06761639,0.6953616197200523,-0.010951982651388222
74202,SIDM00837,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,4.0356917,0.17752212,0.9087472981147304,0.03593955766087844
61300,SIDM00097,Linsitinib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.2178764,0.11077617,-0.8296413822984825,0.0029035721376858468
31370,SIDM00875,Dabrafenib,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.4982493,0.0874389,0.17612131638702025,0.021160052452905503
69215,SIDM00877,Temozolomide,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.325496,0.024282033,0.4693097025587719,0.09720336502629638
47662,SIDM00875,Uprosertib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.40178555,0.04354124,-0.3190527723808285,-0.002735428752106745
17170,SIDM00837,Trametinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,3.3278534,0.05251325,2.4979608592162785,0.08254891080138771
51005,SIDM00097,Temozolomide,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4423496,-0.0074113943,-0.42575862535364023,0.0018633226798683753
32295,SIDM00875,Doramapimod,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,7.306861,0.15674664,2.4187416520086455,0.02682965973201538
89677,SIDM01197,Linsitinib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-0.5252372,-0.024461169,-0.50085120304674,0.05386098618711714
4605,SIDM00673,AZD6482,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6718518,-0.047430556,-0.9324406734127076,-0.09181014512107559
82627,SIDM00928,Temozolomide,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.4454439,0.105656154,1.001224016395345,0.038247317876203724
50854,SIDM00928,Venetoclax,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-0.92583674,-0.027241154,-0.5739970589506987,-0.030461986904072775
72419,SIDM00835,Nutlin-3a (-),Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.0772841,-0.029534284,0.7632988734575277,0.08823989824333452
3337,SIDM00877,Olaparib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,2.8230617,0.107648246,-1.2406815933780806,0.005527380015092384
100715,SIDM00877,Taselisib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.1666977,-0.15431692,0.20968526303026366,0.0237024594716598
50516,SIDM00146,Paclitaxel,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.7685546,0.06711518,0.9824579274421146,0.038521940782743104
82890,SIDM00837,SCH772984,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,2.29805,0.05495361,-2.6104126790108046,-0.16060061799641054
68814,SIDM00282,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.9308877,0.04853513,-0.29957834208496537,-0.016853526781841443
85200,SIDM00957,Trametinib,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.7201147,0.03339738,-0.5923630823759372,-0.02429017641551519
20889,SIDM00928,Temozolomide,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.75150037,0.012801819,1.2506389195219805,0.022967644482426313
16075,SIDM00146,GSK269962A,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.8140702,-0.14403367,0.3857886206399818,0.07881733653123787
11356,SIDM00633,Alpelisib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.6749855,0.121808,0.22527271437838728,0.021761814373395732
13154,SIDM00097,Venetoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0275562,-0.054512706,-1.497258155017357,-0.03708035606407715
76246,SIDM00097,Taselisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1184083,0.06689445,-1.2332989377711816,-0.0051952729464175935
58885,SIDM00633,Linsitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,10.144605,0.14700377,4.983250417829476,0.13074363574304532
79726,SIDM00950,Paclitaxel,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.8075817,-0.11626545,0.07907394119838691,0.026675384353753592
30769,SIDM00837,LGK974,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,0.97635984,0.020635735,0.19415545010348156,0.025202018937218452
77342,SIDM00928,PF-4708671,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-3.6238868,-0.18629584,-1.6049087755371454,-0.07037458674013705
15047,SIDM01042,SCH772984,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.31134894,0.010000589,0.7985832865826294,0.015322804812395816
7044,SIDM00877,BI-2536,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-7.183942,-0.08130382,-6.714480305111622,-0.13172345954414222
8766,SIDM00950,Erlotinib,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.62549216,-0.064993754,-1.0799599236564073,-0.035416691730475194
106832,SIDM01042,Paclitaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,4.4378166,0.2277515,1.8723870159849911,0.12121341934998597
39865,SIDM00875,Pictilisib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6087509,0.16266523,0.3515995261223953,0.028505494213424954
47066,SIDM00282,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9586254,-0.11965648,-1.8076486955413615,-0.16473483056620364
13020,SIDM00875,Pictilisib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6195559,0.06886478,0.3930663695256026,0.007361402675326898
19290,SIDM00097,Nutlin-3a (-),5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.885106,-0.09180762,-1.3923739692564219,-0.0384924725922059
28382,SIDM00875,Cisplatin,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.1765232,0.040297866,3.4439669473822208,0.11398191556568187
20877,SIDM00826,AZD4547,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.4081137,0.20739105,-0.4161296228023325,0.04461704393789384
100606,SIDM00097,ZM447439,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2343396,0.067041576,1.0925572078476056,0.06712845339341776
23917,SIDM00957,Dabrafenib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.6547382,-0.017967729,2.0089449886048727,0.043891222542119725
4610,SIDM00957,BMS-754807,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,0.53098214,0.023153031,-0.6586089320557703,-0.054583344018134666
26955,SIDM00673,Pictilisib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5823584,-0.05825679,-0.8599045270314665,-0.07363120706903067
31702,SIDM00216,Linsitinib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.814789,-0.10185364,1.9659284908022896,0.14336771724757577
48744,SIDM00673,RO-3306,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.76134753,-0.05398243,-0.661505840523098,-0.02799944486630442
57728,SIDM00455,Gemcitabine,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.7907689,0.11919515,1.9919985405284741,0.1804544915162529
12616,SIDM00282,AZD4547,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,1.1501869,0.017796263,1.6853451128737413,0.05454268803460641
44904,SIDM01187,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.365039,-0.11549533,-1.9615338135116325,-0.15826124181287438
75201,SIDM01197,Linsitinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.76228243,0.049230456,1.1691556067801656,0.04907422817211291
23655,SIDM00826,Afatinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.0242672,0.07112578,0.29404625128970785,0.005279310556040952
33260,SIDM00216,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.1701865,0.19238853,0.005900942561246983,-0.0031071365580633086
92868,SIDM00455,Palbociclib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.4968728,-0.046110585,-1.343102900552593,-0.007653513918499178
100052,SIDM00877,MK-1775,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.30789694,0.015292649,0.5338557107822405,0.024567668404000723
81670,SIDM00776,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.69977057,-0.020954428,0.7785328028853007,0.07594695226018908
21023,SIDM00877,Navitoclax,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,White,44.0,0.86776006,0.11066106,0.7137816645324702,0.01000189770488603
70772,SIDM00950,Dasatinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.3903728,0.39601487,3.0109288798646334,0.16631139435093092
74070,SIDM01187,MK-1775,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.613863,-0.056782544,-0.49518418952530724,-0.041038753289883094
82156,SIDM00146,Wee1 Inhibitor,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1821855,0.083714604,-0.9854306746267695,-0.03996265563619046
62952,SIDM00097,JQ1,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.0970263,-0.11874561,0.6792822426160986,0.053013422742217
90382,SIDM00872,Luminespib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.85919297,-0.06923377,-1.039751147746269,-0.04404907927327921
106418,SIDM00875,PD173074,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2311367,-0.024280487,-0.35008784365517387,-0.01718983054768244
96713,SIDM00776,5-Fluorouracil,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.2613908,0.007515261,1.2819965443211656,0.04153617918955457
65197,SIDM01187,Bortezomib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.22977298,0.021817153,-0.004900130431667502,0.009965124962597988
103170,SIDM00875,SCH772984,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7838799,0.19024524,2.804122159932449,0.19024678861655633
89001,SIDM01042,Venetoclax,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0928327,-0.049614403,-0.24338127530356204,0.02088372885703566
45635,SIDM00633,Docetaxel,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.6783357,-0.17352994,-4.741544592749008,-0.2788982008105605
58878,SIDM00148,Gemcitabine,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.78483427,0.035097186,-2.7149363048806574,-0.12635694652351573
65869,SIDM00833,Dabrafenib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,0.67599577,0.009028066,1.5900024815286569,0.02717465384533711
40674,SIDM01042,PF-4708671,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.39009097,0.036140773,0.04826765679615567,0.00459056162458426
2523,SIDM01197,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1841676,-0.09064853,-1.1052783149640502,-0.06260810387492663
15432,SIDM00282,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.808884,-0.0452673,-0.8541903227448598,-0.09930023000550833
39392,SIDM00877,Camptothecin,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.3945539,-0.027826846,0.08183512705750211,-0.013052882187285788
22949,SIDM01042,RO-3306,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.999795,0.07962114,0.18819265982092542,-0.009563936868841593
76927,SIDM00673,Entinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.3676599,-0.059331004,-0.5848260746885454,-0.037606648166973664
22563,SIDM00837,Nutlin-3a (-),MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.6740991,0.036133226,-2.516925442599521,-0.0627823863157866
1268,SIDM00957,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.6527796,-0.060669247,-1.1180891630930956,-0.08978758381743286
88380,SIDM00282,AZD8055,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.5996604,0.10480399,1.545390404682154,0.14695087213093938
18769,SIDM00835,5-Fluorouracil,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.44838986,-0.020610118,-1.5706634900339544,-0.06947920059490617
18666,SIDM00928,Paclitaxel,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.9387586,-0.09486043,-0.25927389623106406,-0.044770960541077924
30295,SIDM00776,Afatinib,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-2.2144916,-0.17530945,-1.1375838050812765,-0.08643534631724539
45656,SIDM00633,Paclitaxel,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8350656,-0.056042783,-1.9029189091209269,-0.07524406666003848
91260,SIDM00835,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,2.3520496,0.16663459,0.6073763783480981,0.07402683017789419
14032,SIDM01187,Luminespib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.0739292,-0.089606,-1.2278749003260812,-0.08052980125024152
95624,SIDM00097,Alpelisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.9554987,-0.068528935,0.02872369657514617,-0.04158332186283413
22940,SIDM00875,Palbociclib,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4135237,0.05418016,2.3485220758795946,0.1002578918950198
11865,SIDM00146,Vorinostat,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.3608207,0.11732651,-0.391941052027426,-0.016041849348604614
7000,SIDM00872,SCH772984,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.69070834,-0.036729522,1.3597153461218623,0.04440337806415008
98351,SIDM00875,Luminespib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46569267,-0.04225015,0.0871511673563469,-0.01109930590634792
10184,SIDM00633,Temozolomide,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.3023932,0.06171969,0.5715123428946375,0.013620892607307537
14594,SIDM00216,AZD8055,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.7945918,0.1398727,-0.07453786010731235,-0.010486019536396343
29730,SIDM00835,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-0.58077806,-0.021328662,0.04471446195902051,0.010120076977751915
61223,SIDM00146,OSI-027,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.77342767,0.070870124,-1.0269248896931626,-0.062002083258981176
71142,SIDM00216,Olaparib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.30235,-0.06854543,-0.118268423759789,0.021600578308002927
83805,SIDM00146,Navitoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,2.4935918,0.10554404,1.7281150539704762,0.11982569279186318
67503,SIDM00097,Palbociclib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2009866,0.054483764,-0.8666955671145692,-0.015035697587904202
59939,SIDM00146,ZM447439,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,2.1596453,0.12222508,-0.5501052596802044,-0.03897169452331508
93384,SIDM00933,AZD8055,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.34694535,-0.02331827,0.9904395567263115,0.03422580004651791
90237,SIDM00835,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.3685787,-0.032830138,0.9519800073572418,0.06159428095595323
3644,SIDM00148,Venetoclax,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.0070903,0.20141295,-0.27182909252438,-0.041730025982218755
74817,SIDM00359,Taselisib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.1945691,0.10857245,0.19071726415467777,0.04210389768134757
33308,SIDM00673,Gemcitabine,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.4846138,-0.09466104,-1.3107425476372419,-0.07054564368493534
82452,SIDM00950,Linsitinib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.0377178,0.17270233,0.6870133854091572,0.03255861908527868
90634,SIDM01042,Dabrafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.7472134,-0.12610818,-0.4222100347086153,-0.005562504671743565
6702,SIDM00875,5-Fluorouracil,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.96669173,0.091766715,0.5243560770320927,0.18412359295654307
108064,SIDM00928,Sorafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.61956084,0.062266473,0.32675072191129734,0.03260048243885132
50352,SIDM00928,Ribociclib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,4.8896694,0.21016294,0.7565052154769408,0.03296551275538999
24656,SIDM00877,Cisplatin,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,0.5365019,0.058835447,-0.7543943675848266,-0.003064561624049905
15934,SIDM00826,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.152809,0.066935234,0.6233223026935221,9.823751740411808e-06
16104,SIDM00633,AZD6482,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.69784325,-0.06664384,-0.5431922330317474,-0.01367300942611728
65169,SIDM01187,Olaparib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.7569485,-0.060835086,-1.3894549671267173,-0.01119669155054433
24675,SIDM00872,5-Fluorouracil,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3756992,-0.062684245,-0.9317288880295082,-0.014507550166038014
95060,SIDM00928,RO-3306,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.7063987,-0.09722804,-0.38713672162109747,-0.025448141194504087
47461,SIDM01187,Pictilisib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.43420336,-0.029420927,-0.8832510645532263,-0.06461831950536313
21335,SIDM00877,Luminespib,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.8006211,-0.07135853,-0.9237440634308909,-0.026978773949617726
78584,SIDM00633,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.197929,0.18025711,3.03830723957928,0.14110340899238744
9147,SIDM00146,Docetaxel,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.4115016,0.037406694,0.4549619381577741,0.06118153036442959
55900,SIDM00148,Gemcitabine,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8074102,-0.12933542,-3.969003008642894,-0.3356423730007515
16031,SIDM00950,MK-2206,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1075144,0.0407175,0.7980197631471756,0.010129134336883715
78379,SIDM00673,Entinostat,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.4456537,-0.082770325,-0.6012190448222957,-0.0849449220999634
24614,SIDM01042,Nutlin-3a (-),PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.76269984,-0.022052744,-0.03967652362833549,0.02411608791737157
79283,SIDM00359,SCH772984,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5513189,0.093926765,1.5280284477723745,0.08365239255044106
17130,SIDM00455,MK-2206,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.7710476,-0.08609837,-0.92498546412336,0.014297160264097837
60768,SIDM00832,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,4.140088,0.2849851,-0.7942809362697311,0.024808744281095405
82362,SIDM00837,Trametinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,0.5021836,0.010235107,-1.5441987405331024,-0.08857978685141248
60345,SIDM01042,Nutlin-3a (-),Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.89877546,-0.02575889,1.4226961145949182,0.03788921038477996
84186,SIDM00148,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2075987,-0.11514578,0.28324297183654024,0.03081921309748727
32250,SIDM00148,Alisertib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4130439,-0.04726444,0.5117013737361891,0.041756989264502616
99012,SIDM00832,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.466796,0.100269556,1.938188494207714,0.08218513470987254
39419,SIDM00835,AZD7762,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.969474,0.27143553,0.47692334673890374,0.07557726742529236
32348,SIDM00359,MK-2206,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.9802785,0.1131152,2.9954871046865965,0.15066087864116293
72157,SIDM00633,Crizotinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5628688,0.16841187,2.6545286435880917,0.0673201073530411
10384,SIDM00455,Dasatinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.9242366,-0.02316238,1.5940345610581321,0.09972732724126998
58709,SIDM00875,Uprosertib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.15973623,-0.016523657,-1.0225057906759685,-0.05156382798667174
48480,SIDM00832,Vinorelbine,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.30197,0.11625877,0.6354448480919164,0.048927769913735354
32742,SIDM00933,AZD7762,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.88229764,-0.08773498,-0.6964381537886029,-0.04696004753693774
84920,SIDM01197,Trametinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1995739,-0.033397544,-0.9758502681606239,-0.05676584160648052
56781,SIDM00776,AZD7762,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-0.953007,-0.07852179,-1.6273237545738752,-0.07791248066114606
24689,SIDM00776,Olaparib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.3463993,0.0726491,-0.6901755767923061,-0.0172923506526147
15906,SIDM00835,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,1.4372413,0.11231304,-0.35237176632785366,-0.03340947253827302
7407,SIDM00633,Taselisib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6804175,-0.04068451,-0.9268022234628328,-0.0997973824457143
8395,SIDM00833,Taselisib,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.1434677,-0.11475141,-0.9044747436523424,-0.027387208134629696
104592,SIDM01197,SCH772984,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.5990952,0.046540756,0.02321294025874331,0.036120024009250226
36709,SIDM00146,Sorafenib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.99708086,-0.09677231,-0.03419243927476223,-0.004783928343520478
59252,SIDM00673,Alpelisib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.69318455,0.037922658,-0.87500457052261,-0.012774448136086946
97904,SIDM01042,Alisertib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.82533956,-0.110213645,0.04371974119069581,-0.0629134720668148
38152,SIDM01042,Crizotinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.39070168,-0.043913104,-1.1821008627965137,-0.08198441027554226
3730,SIDM01042,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4863197,-0.016219677,-0.45081291321366285,-0.02071814450060612
28247,SIDM00633,Temozolomide,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8055578,0.053693954,0.6764288154285051,0.0023176766549019103
88289,SIDM00837,Taselisib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.1761391,0.048043188,-0.514149015421323,-0.06259894793117741
55948,SIDM00097,MK-2206,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7437066,-0.111590944,-0.36132376028112134,-0.029545052743849002
63172,SIDM00875,Crizotinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4432806,-0.14033224,-1.4467625795829513,-0.1010583175389193
6578,SIDM00633,JQ1,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6482718,0.2151161,2.630057170218378,0.12377643359126816
72848,SIDM00928,Entinostat,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.39172152,0.039937314,0.022375514796403064,-0.0007083470842584648
95786,SIDM00282,AZD7762,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.05909,0.070447445,4.284631482511266,0.16856739823865918
15254,SIDM00633,Docetaxel,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1281142,-0.06503779,-0.8251586512664056,0.006215237552110865
66700,SIDM00097,JQ1,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6200044,-0.07171583,0.220006190709255,0.009091473738166607
25712,SIDM00875,AZD6482,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.22771105,-0.017719101,-0.183491196839636,-0.015492128836923396
100432,SIDM00833,Linsitinib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.960594,0.2224092,0.009187024200679565,-0.011457899079443263
99080,SIDM01197,Camptothecin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6610553,-0.0509161,0.8413099933320108,0.04554212699056846
67332,SIDM00933,Alisertib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.1299772,0.113492824,-0.909824546305873,-0.022692347906400286
42732,SIDM00455,Palbociclib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5588372,-0.067503065,-0.6560845507268906,-0.026458929728794458
54546,SIDM00835,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.1629982,0.14492057,0.47021528060158624,0.037066086722586905
4159,SIDM01187,Linsitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.4266603,0.14046341,1.9160100778524496,0.04081461353588838
66015,SIDM00928,Camptothecin,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.8049262,0.23715559,0.7965803407342693,0.1409709855297555
67022,SIDM00928,Pictilisib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.9711765,-0.09203511,1.1214284126220602,0.054866934051778234
95561,SIDM00776,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.1363413,0.03356518,0.1618265667165927,0.03520371230593637
11255,SIDM00826,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.1993482,0.053066295,0.7431524494061486,0.039756040547632064
3503,SIDM00933,AZD6482,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.3019655,0.05232797,1.8215924460866935,0.1329835972822864
69708,SIDM00877,Dabrafenib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.9445755,0.047428954,1.9027081806580735,0.0955781931872008
100631,SIDM00957,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,0.31218883,0.005831184,0.8735983607913635,0.029169352910828786
72824,SIDM00359,Dabrafenib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7434962,0.089399524,-1.4029568042196148,-0.01098909175241873
31669,SIDM00950,Sorafenib,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4340401,-0.04749549,-0.34636948129009854,0.002980904278457831
90064,SIDM00833,Taselisib,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-1.5902905,-0.10303822,-0.38073546961623467,-0.048969832024896444
32646,SIDM00633,AZD6482,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8484964,-0.052277528,-0.35760079684567914,0.01686647055750704
63217,SIDM00148,KU-55933,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6295552,-0.024540905,0.6184774895368929,0.03553540334743251
74416,SIDM00673,Nilotinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.8029048,-0.08714513,-0.24540962545730044,0.017970069921601047
91588,SIDM00872,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-3.641882,-0.3619483,-1.626885668806003,-0.13307437757853757
82193,SIDM01042,Luminespib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.45685095,0.047157645,-1.4400720701745084,-0.03634387964263217
63808,SIDM00673,Entinostat,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.43424493,-0.033903554,-0.607619850275414,-0.04225958245601209
67801,SIDM00833,MK-2206,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,3.0598242,0.23568887,-0.12896004338487366,0.021950768348628788
23002,SIDM00148,Doramapimod,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.8846514,-0.11077438,-0.488667230835278,-0.02867286935280507
39793,SIDM00455,Olaparib,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.4617794,0.061877973,1.8139957296692626,0.066018585089511
52487,SIDM01197,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.80352265,0.017175447,2.058132449588969,0.05953648314831829
28033,SIDM00673,Axitinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-0.31053865,-0.03141451,-0.508092231236602,-0.07512539900300423
63950,SIDM00928,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.740212,-0.21906078,0.2552483973688319,0.02734536549595487
79685,SIDM00875,Afatinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6564642,-0.11983651,0.7612770951167227,-0.016609984236939483
44479,SIDM00776,Dabrafenib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-2.067213,-0.05968937,-0.9758300102608183,-0.016074239666228767
23786,SIDM00832,MK-2206,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,81.0,-1.2724537,-0.046858687,-0.7851236444973965,-0.002937968321050075
64974,SIDM00148,Taselisib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2054212,-0.16341507,-0.6203464233086452,-0.01608554949990503
51591,SIDM00633,Axitinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7784684,0.22679447,1.2264960982008368,0.033981720071388055
20266,SIDM00146,RO-3306,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0348572,0.08807954,1.0287617831365985,0.034404548709730316
9132,SIDM00146,OSI-027,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.4227409,-0.032802835,-1.2256465240694232,-0.06495442854189003
65092,SIDM00875,Palbociclib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.28227207,0.0084145935,0.7701075683759336,-0.0012374801007354456
26815,SIDM00872,Docetaxel,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.3638015,-0.2140521,-1.7022838869573191,-0.19402349848054462
65289,SIDM01042,Alisertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,5.6419234,0.2995267,-0.20378955855237613,-0.03456945130987041
48248,SIDM00673,Crizotinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.2688015,-0.088919334,-0.5725123770747143,0.0032843312656454272
48959,SIDM00282,SB505124,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-1.4512275,-0.04710644,0.47287510022840185,0.016912333450552302
84740,SIDM00148,SCH772984,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3544263,0.033152685,1.4132560885303351,0.027260017994780984
26250,SIDM00933,Uprosertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.1385018,0.12426031,0.9849766090351023,0.11687000240943123
25042,SIDM00933,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.35542196,0.043018453,-1.638642384358562,-0.03597844477627154
63983,SIDM00776,AZD7762,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-0.9299552,-0.08270375,-0.2897151114234019,-0.02280519725717798
70646,SIDM00928,Afatinib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.1862631,0.13771762,0.30430821274541436,0.04182676759416372
101050,SIDM00933,OSI-027,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.2043893,0.17022534,-0.12282738048922104,0.00525698671456026
74102,SIDM00216,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.631897,-0.091719605,-1.7108809373257547,-0.07029913189480774
105624,SIDM00872,Docetaxel,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8420472,-0.15049691,-0.9930337551414,-0.051274451248823794
70340,SIDM00875,SCH772984,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8146258,0.095139466,-0.3237605523492919,-0.021158887634413703
4082,SIDM00455,MK-1775,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.9350518,0.047519144,-0.10502333294352051,0.04102915132950311
74233,SIDM01187,PD173074,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3476081,0.10691993,-0.8692187061910651,-0.052074100982802324
69656,SIDM00673,GSK269962A,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3212272,-0.08914713,-0.9272430395529204,-0.07947018628916559
18624,SIDM00359,Crizotinib,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.002934533,-0.000263277,-0.6551148053969094,-0.025968517336243644
51797,SIDM00146,Entinostat,MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.2785927,0.10613519,1.310912699660671,0.11511651555831706
80137,SIDM00933,Doramapimod,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.5833908,0.052799873,2.3605016974988873,0.08575689925358135
71364,SIDM00148,RO-3306,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2593838,-0.09900848,-0.6433609290785045,-0.05302077118713212
91242,SIDM00148,GSK269962A,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1838853,-0.055552028,-0.46858327808890377,-0.047039470201697645
192,SIDM00872,BI-2536,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5978365,0.061299272,0.18612058455412867,-0.01913037205824942
72613,SIDM00673,OSI-027,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2504764,-0.11990273,-0.6649028975339647,-0.04163251323158795
41219,SIDM00146,5-Fluorouracil,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.8602039,-0.11088661,1.9792543440483568,0.11107892922758976
50064,SIDM00455,Dasatinib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,6.631567,0.34720218,3.2643262476459043,0.22249435485119298
29996,SIDM00633,Temozolomide,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.4805942,0.010602758,0.6506249012545016,0.01693236391863608
48961,SIDM00933,Trametinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.98946,0.12939677,1.392361241350304,0.10343546634070383
89668,SIDM00146,Venetoclax,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.62059456,0.016525995,1.8775948762124202,0.07372658973012347
906,SIDM00359,Navitoclax,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.38598615,0.018828651,0.9909817125208541,0.016320056854155742
3211,SIDM00875,MK-2206,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7872151,0.0634501,0.10052846499682941,0.036389509288148186
62206,SIDM00872,Trametinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.5372658,0.15354006,1.8908882153585254,0.09146123523913252
14496,SIDM00877,JQ1,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.8207903,0.17370093,2.0245114933951984,0.15154207783776816
45984,SIDM00097,JQ1,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.5210502,-0.107499085,-0.40351132084234215,-0.02100017810843852
68924,SIDM00146,AZD7762,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.062463,-0.11872695,-0.3841638309613891,-0.052579452756424123
31057,SIDM00148,RO-3306,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.0680637,0.30617592,0.816837595627424,0.014641171056250717
100166,SIDM00359,Trametinib,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.314585,-0.05234564,-1.4222955957827244,-0.04393819874172681
54475,SIDM00455,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.0980446,-0.117774755,-2.1529723708128063,-0.015657610962754028
37013,SIDM00148,Doramapimod,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0215989,-0.064735964,-0.31133902782676204,-0.022986938325385255
88460,SIDM00673,Dabrafenib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0857303,0.056792974,1.1885918597125174,0.0532390447324896
11986,SIDM00837,SB505124,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,-2.4568794,-0.07645857,-0.47002773756211563,-0.016105832591572184
23471,SIDM00832,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.1510626,-0.0999204,-0.7246061256024976,0.0013206412432599265
106798,SIDM01197,MK-1775,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1167426,-0.038898796,-1.1762896031947914,-0.02453164002556428
52743,SIDM00282,SCH772984,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.995888,-0.04253196,0.3193502439969266,0.11135877672413667
99695,SIDM00216,AZD4547,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.28591436,0.017877772,0.4352750270593571,0.05860346226840724
28067,SIDM00872,Pictilisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1478957,0.11034981,1.3034947794252245,0.12344454198847644
11570,SIDM00872,Nilotinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.045268,0.10175896,1.0397505411069092,0.05889616658128939
21077,SIDM00875,Luminespib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.74974585,0.07131409,-0.10594609923219628,-0.05810120793050782
53214,SIDM00826,BMS-754807,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-5.068295,-0.07143525,-5.647721868154698,-0.18426531939139398
54906,SIDM00837,Dabrafenib,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,-0.48519665,-0.009942002,2.4674023284949427,0.03168851729574339
49566,SIDM00837,AZD7762,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.8088421,-0.0682429,-1.2709067850519835,-0.07949473507338502
100725,SIDM00673,Afatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.3234943,-0.09523127,-0.9565427130728477,-0.008871846285801066
10389,SIDM00146,NU7441,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.35062134,-0.03246965,0.3742064341034072,-0.00516823556818853
29596,SIDM00633,Taselisib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.2233574,-0.07988574,0.16699412325615742,0.038327086913283535
56182,SIDM00875,ZM447439,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2153505,0.029741505,-0.27111801902117777,-0.009115939417275036
62925,SIDM00633,Trametinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.562074,0.09969987,0.6695009905844589,0.07108622342247527
42848,SIDM00673,Olaparib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.60270315,-0.03248133,-1.134488790527768,-0.04278940592398792
81996,SIDM00359,Crizotinib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1312315,-0.082254305,-1.8701289758311732,-0.12262480005490618
21460,SIDM00837,Crizotinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-2.7763186,-0.086922415,-0.3453539481042526,-0.08865650562481645
105154,SIDM00633,Cisplatin,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4089481,-0.046714373,-1.289682034272216,-0.02677161801402345
36848,SIDM00148,Gemcitabine,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.14282987,-0.010215162,-0.3344468209982373,-0.02657568145343668
85554,SIDM00875,GSK269962A,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5289273,0.030566154,1.2381725299029045,0.0484041865685556
42823,SIDM00877,Pictilisib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.86129826,-0.094548166,-0.02854449875666169,-0.05888560415644229
72493,SIDM00097,Taselisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.0823417,-0.30142495,-0.16973565931897577,-0.055067798627350034
25125,SIDM00673,Cisplatin,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.20287,0.06959341,1.6787731627842297,0.06558524886201604
45363,SIDM00875,Luminespib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.8392105,-0.12815104,-1.2137243697358335,-0.1203046359820135
4524,SIDM01042,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.77637047,-0.10333876,-1.5353242923075343,-0.10611801059203506
32399,SIDM00148,KU-55933,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.037885,-0.041167106,-1.3190901667107353,-0.05467763188423484
24568,SIDM00776,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.833937,-0.0574376,0.45774434647920736,0.004317869757112547
59874,SIDM00673,Pictilisib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.1786344,0.08061427,-0.9795564100302006,-0.0321743772248071
93344,SIDM00282,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,1.2037284,0.084194236,0.7112578248736497,0.09266420590421212
64305,SIDM00148,Temozolomide,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.77959293,-0.021607254,-0.7482725086819701,-0.0005318591782602501
105085,SIDM00928,Crizotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.082338,0.11241032,0.3849919436122838,0.051480255163493305
97075,SIDM00875,Olaparib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8053755,0.07573498,-0.9437519931923969,-0.026347545401734875
84549,SIDM00933,NU7441,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.79706043,0.070988715,0.5133200832219245,0.031850374490964915
78546,SIDM00097,Sorafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.8815356,0.104264066,-0.3224160929790006,0.017873950487865664
62788,SIDM00872,Ribociclib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2373602,-0.028871395,0.20243860269659353,-0.015819445369332344
99821,SIDM00146,Dabrafenib,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.9377465,0.054112036,-0.33625001335542876,0.005881955051028813
46204,SIDM00146,Gemcitabine,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,7.1593256,0.22026843,2.8396233282113337,0.14037263257156743
31605,SIDM00282,Taselisib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.1836099,-0.013288633,-2.0985853172241753,-0.12113397603940364
72530,SIDM00673,Alpelisib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.6748503,-0.040081445,-0.1582989278073626,-0.011203812963236099
55211,SIDM00455,Crizotinib,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.2801224,-0.040475246,-0.718652062251417,-0.045373973493409554
73219,SIDM01042,MK-1775,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5359694,-0.010898144,-2.1966553954205623,-0.08864282845544025
57568,SIDM00957,Afatinib,5-Fluorouracil,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-1.105431,-0.043802224,-1.193219464165189,-0.04249619938295609
67409,SIDM00455,Gemcitabine,Erlotinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.40874162,0.020657348,-0.3098748180788802,0.03535953444032985
40621,SIDM00148,Alisertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.7981141,-0.082632184,-1.0647313141496997,-0.038618417064918
78862,SIDM01042,PF-4708671,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3085849,0.029851014,-1.0251183021821093,-0.06307834622453415
49415,SIDM00837,AZD8055,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.9828334,-0.1552617,-1.9516380539505802,-0.13671427463054436
4530,SIDM00957,MK-2206,Oxaliplatin,Large Intestine,5.0,Colon Carcinoma,Male,Unknown,69.0,2.3712845,0.049301624,1.089297777105458,0.05564524323654205
99542,SIDM01187,Palbociclib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6618017,-0.09346059,-2.560282201213167,-0.060330306006864745
77894,SIDM00776,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.7079787,0.06601282,0.3539045230564455,0.052688997191867974
51471,SIDM00872,5-Fluorouracil,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.521429,-0.07367807,-1.5704337497359762,-0.04725692412992479
36057,SIDM01197,Vinorelbine,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-0.31506082,-0.023713993,0.7040523617232036,-0.002585106085627091
80786,SIDM00872,PF-4708671,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.454543,-0.09402523,0.7044453162535195,0.03385110919923879
61655,SIDM00673,Luminespib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.0391613,-0.09900941,-0.6609139871843767,-0.04533418387707354
73225,SIDM00216,Dabrafenib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.62730145,0.021123135,0.41137748457867607,0.05536389731963794
81406,SIDM00872,Gemcitabine,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,0.86159694,0.029812189,1.4877049480835252,0.039357062750114864
94143,SIDM00042,Oxaliplatin,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-2.007126,-0.11627007,-2.1098271134573303,-0.08356310249178255
34160,SIDM00933,Luminespib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.20177798,0.0074103805,-0.5425717496623416,-0.03972835443990919
100221,SIDM00950,Irinotecan,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0905559,-0.037585806,-1.4643070589361864,-0.03999681122539019
5869,SIDM00633,Tozasertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7807554,0.044897094,1.7344322938713366,0.049770851819972546
78959,SIDM00148,Sorafenib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2526422,0.09202032,0.4407175901639597,0.06379830197311336
99536,SIDM00097,Vorinostat,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.33738565,-0.018951735,-0.7365841156109868,-0.05324907210192174
75281,SIDM00146,AZD8055,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.3689283,0.10657545,-0.2074196256769114,-0.017402728099793412
21781,SIDM00837,5-Fluorouracil,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.47169852,0.014164049,-1.949644000908021,-0.05959300651985303
3359,SIDM00673,Cisplatin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.13498615,-0.0044204625,0.5587723904704865,0.005046539796897472
97359,SIDM00826,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.5146998,-0.031037724,-0.20538650233863662,-0.02222010010073084
49806,SIDM00148,JQ1,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.72054905,0.055496838,-0.7342145183380129,-0.054994655763139014
7631,SIDM00216,MK-1775,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.8961415,-0.071604766,-2.6018197638005955,-0.05906640106665056
32840,SIDM01042,RO-3306,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9741036,-0.113465965,-0.6858381184318585,-0.025039937405206762
45125,SIDM00872,Nutlin-3a (-),Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.41832662,-0.009818921,0.873075165498171,0.018032428324954344
2280,SIDM00455,Irinotecan,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.4634743,0.059496,1.3271377183238493,0.14504543877861734
10787,SIDM00833,Navitoclax,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,2.2271287,0.09939729,0.6095954984361742,0.04308204247307737
35985,SIDM00928,RO-3306,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-1.358266,-0.085100286,-0.6180707972444459,-0.03111834968535853
24020,SIDM00928,AZD7762,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.7639821,-0.06566796,-0.8066840432206265,-0.05770800919285348
9247,SIDM00950,AZD7762,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.0843571,0.099544324,0.5630063513568542,-0.03537908531922927
33167,SIDM00933,Linsitinib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.9162366,-0.097274475,0.1582792938647275,0.07652546759168175
108111,SIDM00835,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,3.3366096,0.12039776,-0.11160172291198656,-0.026542625183323048
15885,SIDM00216,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.47618538,0.02554631,0.24351203561167667,8.923797920135272e-05
81237,SIDM00673,Nutlin-3a (-),OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.36416665,0.0070672254,1.1689909335952418,0.04149300176706385
68023,SIDM00455,Dasatinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.7184577,0.18373224,2.9795484304296687,0.24853642436019893
78680,SIDM00148,Pictilisib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7587705,0.088396765,-0.5918209272140071,-0.05179432629612446
106546,SIDM00875,Gemcitabine,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.513656,-0.007773892,-5.583756071084989,-0.1830095661560966
50031,SIDM01042,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.39295068,-0.020804284,-0.16997916158027226,0.03800045746656298
100422,SIDM00673,NU7441,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.5105183,0.11703749,0.3537465928578583,0.011205007083082764
48252,SIDM00832,Palbociclib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,-2.5764956,-0.09771848,-0.8421216291319309,-0.030048650397164724
82463,SIDM00097,Wee1 Inhibitor,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.596897,0.10105661,-0.8121695856824749,-0.05555179900644396
43227,SIDM00928,Luminespib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.65010244,-0.06882023,-1.0256159388390231,-0.07093745642418914
84149,SIDM01042,Doramapimod,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8327526,-0.09344968,0.37082758921619985,0.024478995389424465
24042,SIDM00872,Linsitinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,3.897324,0.1224435,2.145799061303942,0.10667984191858805
10124,SIDM01042,Doramapimod,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.32175907,-0.032230973,0.15669210240955944,0.04349664407306829
28001,SIDM00097,Linsitinib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6057992,-0.083151944,-0.5961565842081842,0.010448484687801464
39382,SIDM01042,Axitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.42822593,-0.052205145,-0.12212533243632805,0.011088568740909903
74537,SIDM00633,Taselisib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.2093377,0.10112757,0.29695578258962285,0.01611686884951917
62128,SIDM00872,Bortezomib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.14549254,-0.0109746335,0.17314695012387366,-0.007637462987407927
10236,SIDM00673,Bortezomib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.34949458,-0.018145869,-0.12211826577549866,0.030406451229629677
24780,SIDM00633,Sorafenib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1939425,0.092905216,-0.23518187056620374,0.03728719271155601
49937,SIDM00359,5-Fluorouracil,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6416321,-0.084194146,0.4205249808475482,0.05655937429097982
32067,SIDM00835,Vinorelbine,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.0285894,-0.042720705,-1.2764395752191142,0.022552213945191833
15554,SIDM00216,Olaparib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.6612961,0.18936549,1.0892730847301868,0.10738834551717864
42399,SIDM00837,Linsitinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.6526103,0.031665146,-0.21279761504286862,-0.02804974806812527
84562,SIDM00826,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.3485259,0.12625057,-1.3297690506312316,-0.061453883353734806
56230,SIDM00148,Nilotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.4576525,0.043685462,0.9754163817750015,0.048557259283560965
23629,SIDM00835,Oxaliplatin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.5398517,-0.11342873,-2.1803658919931195,-0.12030562603851779
72914,SIDM00835,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-2.4755688,-0.09441918,-1.8836023676898423,-0.024803696029593394
64035,SIDM01187,Taselisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.98316413,0.06773504,0.43942298909155925,0.04069541674425599
38098,SIDM00148,Taselisib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0705335,-0.085134365,-0.8254378615253997,-0.017385854981940795
35220,SIDM00875,Luminespib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.2904081,-0.11893392,-2.515285090026948,-0.1401119268831118
17072,SIDM00146,Trametinib,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.987238,0.17391838,2.13218535754006,0.0268462930790791
104075,SIDM00835,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.67234814,0.0461566,1.042575731995658,0.005578457490363801
57217,SIDM01042,Temozolomide,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4720525,0.066561446,-0.27075135367737374,0.0030023571172917212
26953,SIDM00835,AZD7762,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.6094248,0.079817094,0.7001739431660156,0.04703711896965292
32442,SIDM00097,MK-1775,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.040535,0.1210069,-0.30170760158896276,-0.062240134543446825
77297,SIDM00957,BMS-754807,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-3.299249,-0.092984736,2.0692040242504484,0.09141823348261814
71905,SIDM00097,Nutlin-3a (-),MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1402643,-0.044216644,-0.40227864284451714,0.007719854842295329
43433,SIDM00872,Doramapimod,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.48477924,-0.016435007,0.42644882732718803,0.05008671377159113
42844,SIDM00875,Ribociclib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4752533,-0.043476213,-0.9902493509420184,-0.03069921273451227
36882,SIDM00673,Bortezomib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.45545214,-0.025780588,-0.7303805445325027,-0.0223706089340819
69250,SIDM01042,Vorinostat,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,1.5817581,0.1323061,-0.06715989144622743,0.020707261229676286
69230,SIDM00832,Palbociclib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,2.7142978,0.1439263,0.21534794622476536,0.05546651331786416
66956,SIDM00928,Sorafenib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,1.6439538,0.16094023,-0.18391017478896238,-0.003700017599051901
37256,SIDM00933,Uprosertib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.6905193,0.26762834,0.47788031141338055,0.05923259096479399
106755,SIDM00359,Dabrafenib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.39954352,-0.019132549,-1.1109787943888418,-0.027056961664571146
6772,SIDM00837,Afatinib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-3.9333708,-0.13726406,0.2048104195889924,-0.01237072440826128
52177,SIDM00933,Paclitaxel,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-1.48859,-0.11190931,-3.123797212228043,-0.1580368570825896
61552,SIDM00042,Crizotinib,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.2701081,-0.112009,-2.420202064999147,-0.11116141133662802
21205,SIDM00148,Tozasertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.92878854,-0.03784442,-1.0401405374146846,-0.04619674263137354
41820,SIDM00826,SCH772984,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.5627778,0.021747353,0.8125231998658808,0.033889469508773064
26236,SIDM00933,Gemcitabine,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.7296878,0.0020644187,-0.9821555261834555,-0.030607069942183845
68015,SIDM00872,JQ1,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0749981,0.07856011,2.4103439581714317,0.12844593621939873
64043,SIDM00950,Dactolisib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.60291874,0.035855696,0.7213949497185261,-0.0063309624147669845
75928,SIDM00933,Camptothecin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.39131677,-0.025524672,-1.1739152741545757,-0.04602698150366945
63441,SIDM00933,Alisertib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.9761667,0.103450865,-1.6114152852726735,-0.0946173946820751
36524,SIDM01042,Nilotinib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.41017607,-0.028419238,-1.8542760794129127,-0.08251473084963439
102153,SIDM00933,Vorinostat,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.560562,0.18945348,-0.2781019425731608,-0.0044867119466883015
61892,SIDM01042,Alisertib,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.603568,0.07546069,-0.24076324717027459,-0.02421397597095059
34908,SIDM00455,AZD7762,Olaparib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.77918,-0.12612127,-0.41483437252538363,0.05143528645474018
26133,SIDM00928,ZM447439,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.5126296,0.17626451,1.1985071923086388,0.06492941094341537
39591,SIDM00837,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.74099183,0.008314737,0.3353566132203202,-0.007055629936222165
42606,SIDM00633,Doramapimod,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.81153613,-0.0698993,0.09557874531147467,0.029134375160199552
13542,SIDM00877,Luminespib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.7518055,-0.07775308,-1.202145905758116,-0.0006328166966237646
4555,SIDM00832,Crizotinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.9978441,-0.081014246,0.1758175831116151,0.028801971958129502
67465,SIDM00826,Crizotinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.41649646,0.026974214,-1.2324548189438544,-0.0178583097693688
73006,SIDM00146,MK-2206,5-Fluorouracil,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.469218,0.095637485,-0.4553675275351924,0.007818258821190858
83482,SIDM00633,Tozasertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.63584775,0.018085303,0.8927516418426102,0.01990172608551356
60821,SIDM00673,Cisplatin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,2.7667835,0.156667,0.962028264839168,0.07358397112991608
14461,SIDM00837,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,6.202148,0.3345665,1.109581580246761,0.0416432225296042
103797,SIDM00148,Afatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.005406,0.08773071,2.7034785898134466,0.25346017777386715
2253,SIDM00875,5-Fluorouracil,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.130611,-0.17532721,-1.694169703045027,-0.10316853665375442
103372,SIDM00148,GSK269962A,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4455583,0.14393725,-1.2663247917100426,-0.08015965265009888
497,SIDM00837,Camptothecin,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.32856786,-0.015906831,-1.425331940225789,-0.03929673774734132
95092,SIDM00875,Venetoclax,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.47692347,-0.010694769,0.7415652989800207,0.018834482966672946
76432,SIDM00633,BI-2536,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.70748264,0.07171379,-1.3850200868952514,-0.05023628463360042
51568,SIDM00837,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.0614777,-0.06703368,-0.5298965309843086,-0.07159383771310791
38156,SIDM00875,Cisplatin,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7319331,-0.035433684,-0.3832819447925856,-0.026957845151306954
4716,SIDM00673,NU7441,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9273432,-0.07292427,-0.1476802174511734,-0.045694203926852965
102407,SIDM00928,SCH772984,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.9229078,0.30939865,2.920532333492376,0.18283532766585484
16810,SIDM01042,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.22769882,-0.018249083,-2.018658967989324,-0.11604301464460848
36672,SIDM00875,Trametinib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.96512645,-0.106326714,-0.7847196119436441,-0.06864047069366588
58280,SIDM00835,Trametinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,1.4713545,0.059080757,0.853460491316416,0.006594543911961155
58294,SIDM00928,MK-1775,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.75373495,-0.07926732,0.5001071628948711,-0.02514405154746901
79521,SIDM00957,Linsitinib,SB505124,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,2.4244971,0.06622909,1.4851049814130952,0.03901594647444903
28780,SIDM00146,Tozasertib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.33966434,-0.022122215,-0.9664105844031466,-0.01944584511169903
32878,SIDM00837,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.5414734,0.013063058,-2.073858251690113,-0.09326230394196887
70309,SIDM00826,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.2414103,0.082242325,0.34236397782278455,0.037198295926614
43758,SIDM00455,Sorafenib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.7344494,-0.10295638,-0.4337220268110053,0.004860241401970475
95017,SIDM00146,SCH772984,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-4.8956714,-0.28153753,-4.169292775247453,-0.14136911033381486
25440,SIDM00148,ZM447439,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6594992,0.21716629,-2.0100226027045225,-0.1062426731332423
16215,SIDM00933,Dabrafenib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,45.0,-1.1109706,-0.074734114,-1.123164207284084,-0.023428284601146744
73152,SIDM00832,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-2.3026779,-0.0689787,-1.7153188556015735,-0.03165328069692765
54766,SIDM01187,PD173074,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.251713,0.110786155,-1.3420210211904238,-0.07172484501256678
80706,SIDM00837,Camptothecin,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.6003064,-0.015563417,-1.9485353231711633,-0.0654613634209378
72566,SIDM00826,Afatinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-2.1599646,-0.15674274,-0.8080184255637534,-0.00982174849878172
89967,SIDM00673,OSI-027,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8833119,0.08513158,0.1349016558504022,0.08037156810671266
97398,SIDM00148,Entinostat,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2138581,-0.040988334,-0.3391540093622464,0.04385165046730155
7847,SIDM00933,MK-2206,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.47704577,-0.06406802,0.847216291787724,0.0911167834096003
21410,SIDM00872,AZD8055,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.66119957,0.06798902,0.08599765503256883,-0.03892444434511343
11097,SIDM00146,Entinostat,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.2310116,-0.016556025,-1.1981283349000114,-0.012372547941334867
32983,SIDM00835,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.419012,0.15234452,1.4263110930675544,0.08770606625435609
60057,SIDM00148,Paclitaxel,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.197048,0.101401284,-0.7894668784251957,-0.09702667837428773
3647,SIDM00633,Luminespib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.659863,-0.12068546,-1.1528920326812535,-0.07268197900563902
75912,SIDM00097,BI-2536,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.2329972,-0.015817776,0.9661677306983607,0.0174212219285573
81880,SIDM00216,AZD4547,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,0.60668504,0.05720428,-0.8234555761818747,-0.009091515421525831
83508,SIDM00877,AZD6482,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.66262877,-0.07516582,0.30549451046099885,0.025929937861322413
103625,SIDM00877,ZM447439,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-1.6970227,-0.12821335,0.4913742675140771,0.035122753011648085
42347,SIDM00146,ZM447439,5-Fluorouracil,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.7087708,-0.11286062,-1.6902521749513413,-0.07317623302193846
34969,SIDM00837,Vinorelbine,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.7995546,0.038642004,-0.4456110014041093,-0.02696207029297601
64575,SIDM00097,Taselisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.76950663,-0.0468269,0.8288944418033555,0.040287070978934594
106363,SIDM01042,5-Fluorouracil,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.033913624,0.0014798329,1.8550616476651431,0.0754686104253212
87469,SIDM01187,Axitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.2957397,0.11474768,-1.6308709918581392,-0.035578576522996
20162,SIDM00835,LGK974,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.780866,0.030067122,0.07730739259059005,0.03469844777790823
58016,SIDM00148,Linsitinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.68464154,0.052414317,0.9467407590778462,0.014323744918267935
62415,SIDM01042,PF-4708671,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7257582,0.20398371,-0.45605423216810875,-0.003952115185500202
105978,SIDM00148,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7706422,-0.07577179,-1.1367829497684028,-0.05998327712392669
107213,SIDM01042,NU7441,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22719145,0.018650679,-0.05168755488905617,-0.04119344635264871
49730,SIDM00359,Taselisib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.39455,-0.103532605,-0.1676169483430171,-0.022808066395440068
16012,SIDM00875,AZD7762,Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1128668,-0.029333986,-0.08932667366828512,-0.0256159467219628
95014,SIDM00957,Afatinib,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.6996956,-0.08528995,2.59375761161625,0.13939615055445642
77643,SIDM00877,AZD8055,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.23226425,-0.028187588,0.0674544493944036,0.010934981226761642
23302,SIDM00933,Docetaxel,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,0.45884123,0.0636613,-0.25072404237730395,0.0182615612127627
25019,SIDM00928,Navitoclax,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.8002828,0.16457553,0.821647256811651,-0.0007456302731450909
53151,SIDM00146,Palbociclib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.8002504,-0.106077574,-0.37747011753130644,-0.041163304193603666
76499,SIDM00359,AZD7762,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5820186,-0.16673031,-1.4625214513219944,-0.08652557371633322
2331,SIDM01042,Ribociclib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6935782,-0.07729479,-0.16457365538214758,-0.04506831116460933
91765,SIDM00837,Trametinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,0.58603305,0.008340967,0.19447300252700725,0.0276898503809129
105515,SIDM00832,Linsitinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.5814805,0.06558545,2.471302552949875,0.09664810940835092
69454,SIDM00877,Vorinostat,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,-0.4935757,-0.042233817,-0.3224223958507937,-0.03041914646089857
883,SIDM00835,AZD8055,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,1.6735392,0.11031031,0.0874841554497733,-0.052630088740048056
52476,SIDM00872,Dabrafenib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.20918454,-0.0042624422,2.237001860992178,0.04586453359775058
13460,SIDM00877,Dabrafenib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,2.3636973,0.08664239,2.192595864396712,0.04053438895484079
79027,SIDM00877,Taselisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.0881608,-0.07020151,0.23974843038584515,0.005859711549529592
60973,SIDM00359,Navitoclax,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.09073158,-0.006672188,1.2920474615895203,0.040360361975115944
80272,SIDM00837,Trametinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.9741056,0.07033874,-1.4337851421588694,-0.04125736326233366
54984,SIDM00282,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.9883594,0.07246151,0.7812606359740708,0.06876565690926048
101030,SIDM00875,Lapatinib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48125786,0.010838615,1.5317731639812162,0.08146270782848615
50646,SIDM00832,Dabrafenib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,81.0,-2.2224774,-0.07762405,0.4173463240030428,0.05193372586440465
42362,SIDM00148,Tozasertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.2127287,0.23160739,-0.4477608364679262,0.0046925176702302535
52572,SIDM00928,Bortezomib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.5444389,-0.042626526,0.4020263748027681,0.01102157118173141
82680,SIDM00950,Sorafenib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4728185,-0.0552641,-1.2970035766877117,-0.011855046013555403
108172,SIDM00933,Taselisib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.74370164,0.059637126,-0.7857203710288415,-0.011633304765936861
27528,SIDM00875,Palbociclib,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2146964,0.020076133,0.573752248762647,0.022054795913960482
92782,SIDM00928,Entinostat,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.0956178,-0.15024124,0.40084488691432196,0.05000323891789407
46252,SIDM00673,BI-2536,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.341543,-0.11054146,-0.650100563232782,-0.10169428019828831
66788,SIDM00928,GSK269962A,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,-0.9922296,-0.07558283,-0.017425135708851618,0.01581704195420306
20207,SIDM00282,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.5237683,0.038353223,-0.033633977637249395,-0.0016213646450082388
91168,SIDM00928,OSI-027,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5433984,0.10547189,1.6456686628863038,0.010514598487374046
46884,SIDM01197,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.0215868,0.020322705,1.8332955214306843,0.05731168868413099
79811,SIDM00877,SCH772984,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,1.6598216,0.046139278,1.4749235124164444,0.08130591834033364
67847,SIDM00146,Trametinib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.867396,-0.07371234,-0.623814224900627,-0.07220341062940315
64694,SIDM00097,Alisertib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2060435,-0.0683677,-0.47039843897946837,-0.011257142123143464
14773,SIDM00673,PF-4708671,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.5747146,-0.03153676,-1.146637933858774,-0.04620779961976495
98342,SIDM00282,Dabrafenib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.0122662,-0.037103757,0.0420308310804442,0.006749046866496605
13387,SIDM00146,BI-2536,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.5036024,-0.067285456,-3.4317477653632595,-0.11395197262379517
16610,SIDM00933,Temozolomide,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.6843606,-0.02805943,-0.4370302552755002,0.034147123460834594
49306,SIDM00928,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,1.2622787,0.074946985,-0.7845224160135505,0.019957001260710778
37864,SIDM00359,Palbociclib,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.1063266,-0.09591955,-2.9282916423592926,-0.04833067909392895
13713,SIDM00146,Pictilisib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1174313,0.090079196,-0.1092191633015524,0.03660615256518326
53964,SIDM00835,Linsitinib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.9600139,0.20563737,1.009167446514389,0.009711028259948047
78975,SIDM00146,Paclitaxel,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.0702062,-0.16886406,0.38839260564003636,-0.059621316410906657
54512,SIDM01042,KU-55933,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.194023,-0.020671867,-1.5570961742250815,-0.10119250035629367
51630,SIDM00359,5-Fluorouracil,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.918408,-0.13569751,-1.4960174193144042,-0.003982866879734495
64654,SIDM00833,Olaparib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.4638515,0.11923858,0.1477595687556243,0.07103516173846065
6860,SIDM00950,Erlotinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.4540491,0.022540858,0.36509305242731965,0.012120744099322437
106614,SIDM00455,Ruxolitinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8034388,0.01863772,1.357419022383911,0.05666434356359019
59518,SIDM00633,Dabrafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.951017,0.058253225,1.4303042100198564,0.056202386652203395
105987,SIDM00875,SCH772984,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5164695,-0.055638943,-0.902539335742765,-0.03809520134974565
79258,SIDM00875,Lapatinib,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.8560821,-0.092140876,-0.6104807784503983,-0.034938208520993254
54372,SIDM00673,Bortezomib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.21186908,-0.010707739,0.4800715992684378,0.052053536338452944
15681,SIDM00928,Taselisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,-0.95869446,-0.08181015,-0.0534727182220854,-0.04232374947896146
29505,SIDM00146,PD173074,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.29498398,0.022523083,0.8584029057619184,0.1202643213943808
93657,SIDM00146,Ribociclib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.3773077,0.07725224,-0.76212721370523,0.03532410557718933
104144,SIDM00097,NU7441,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.8927732,-0.07110396,-0.3477435323814364,-0.0257881544269698
39167,SIDM00875,Pictilisib,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.58473957,-0.065810494,-0.8454067362354845,-0.042714906746064554
13689,SIDM00282,Dabrafenib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7183026,-0.016872173,1.0766861032620143,0.0494505886766434
85648,SIDM00933,Sorafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.12924965,0.010984784,1.2684491410312422,0.04534934648246614
30550,SIDM00950,MK-2206,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4168148,-0.14189976,0.8977522691158555,-0.045803496763105155
87077,SIDM00633,Luminespib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.510328,-0.19657761,-2.5452803018197807,-0.08308729144040529
72592,SIDM00957,LGK974,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.3451138,-0.020780833,1.4571524613872973,0.059337266286479444
18011,SIDM00633,AZD6482,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.930295,-0.09257129,-1.0448351358447696,-0.06882879704513524
47039,SIDM00872,SCH772984,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.5049922,-0.10967486,-0.22530678518206504,-0.018485258878318644
66407,SIDM00097,Docetaxel,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5760574,-0.0367717,-0.7631622607235448,-0.077758078564115
90710,SIDM00957,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-4.084228,-0.12956421,-1.2549774695896545,-0.11127445100146927
40277,SIDM00673,Alpelisib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.4411584,0.0902938,0.388620285917038,0.07170231836657515
75298,SIDM01042,ZM447439,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.254044,-0.024615854,-1.4302859276129118,-0.13031949956831798
66299,SIDM00872,Linsitinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.011046,0.04311796,0.41788817272158424,0.029144258248140105
92149,SIDM00216,AZD8055,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,56.0,1.121629,0.08289692,0.2516430147295854,0.023065349128630418
62126,SIDM00933,Trametinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.087975174,-0.012488839,0.3149003352633115,0.08321652064503199
64533,SIDM01187,Axitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.58767164,-0.050197225,-1.4378446259594444,-0.007093868115219252
75795,SIDM00359,Taselisib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7809329,-0.14360136,-1.7327016703482183,-0.034809549001816466
71544,SIDM00872,Dabrafenib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9286675,0.06011301,1.613450459000628,0.030613045693578
63306,SIDM00957,Camptothecin,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,5.6404567,0.09085974,4.075020412600962,0.11948038049915749
9206,SIDM00633,Taselisib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.145792,0.053798974,-1.674198961204677,-0.053072944291494555
102744,SIDM00673,Crizotinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.8945634,0.18214633,2.548253835562715,0.10147746286940636
73,SIDM00950,MK-1775,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-5.408345,-0.45779535,-3.430519816640862,-0.29120466680171947
33031,SIDM00832,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.2004324,-0.09367472,-1.384150160367435,-0.09029382151592384
77177,SIDM00950,Dasatinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.627825,0.1690805,1.9472715290792908,0.11104434496021845
26637,SIDM00835,5-Fluorouracil,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,-1.9615432,-0.078086354,-0.8025062366743944,-0.0391061044340833
98440,SIDM00673,NU7441,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.516006,-0.100208655,-0.9722263204320166,-0.10220886767455277
84344,SIDM00875,ZM447439,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.30469018,0.035425052,-0.4973320191490496,-0.04241612224045572
14028,SIDM00933,AZD8055,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.6867453,0.04481804,0.5985513024523231,0.059055038692796526
54987,SIDM00877,Dabrafenib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.50986,0.05394829,2.5758119641498554,0.11611482003311911
32507,SIDM00633,Temozolomide,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2903155,0.01763683,0.5468338490716641,0.02484694207447102
67673,SIDM00282,Palbociclib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.0317993,0.03769334,-0.4846307852576358,0.018421715451055705
30128,SIDM00146,Navitoclax,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.254668,0.082458034,2.5912645526428273,0.09157088215748595
66378,SIDM00875,Cisplatin,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88532084,-0.042013563,0.03223590052559391,0.004948135159984249
97792,SIDM00633,JQ1,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.427432,0.079958856,2.923591985746044,0.07977781693477762
14063,SIDM00933,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.0774493,0.09876562,-1.2911787600843287,-0.07574989295643575
5615,SIDM00875,Paclitaxel,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.44798675,-0.02992398,-0.9884246387230653,-0.04187711047961646
71279,SIDM00776,Crizotinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.8523683,-0.07645293,-0.900904335502734,-0.14057462833083026
17182,SIDM00042,Navitoclax,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.326935,-0.024434624,-0.5714987709430845,-0.04355310281282031
3360,SIDM00875,Bortezomib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.10976122,0.009279766,-0.6522523481015632,-0.0350912602982888
73785,SIDM01042,Axitinib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.63868874,0.066169046,-1.7564940979876387,-0.07910231661392954
56509,SIDM00216,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4427323,-0.106096074,-0.49598127997816366,-0.0727455293204087
13528,SIDM00875,AZD7762,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.06614905,-0.0036123258,-0.5885902796410014,-0.046196570422782066
989,SIDM00933,Taselisib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,-0.55460304,-0.06466013,0.10807133118887757,-0.010200168154996907
3743,SIDM00872,AZD8055,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.56363946,0.05901018,-0.09094100076066218,-0.06375332378836773
27515,SIDM00928,Taselisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,4.646192,0.19035882,1.8757229731805003,0.07071181760424403
56630,SIDM00359,Nutlin-3a (-),MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.4993093,0.064988516,2.6020542765642696,0.08991987882624373
84890,SIDM00933,Gemcitabine,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.9060122,-0.012252158,-2.6742716393326953,-0.06357946026579578
86460,SIDM00673,Crizotinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.49685994,-0.045203753,-0.15300938234528347,-0.027716699217917157
11213,SIDM01042,Dabrafenib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.31598204,-0.026990218,0.5846026382418084,0.04783406496036464
19298,SIDM01042,GSK269962A,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.6488407,0.11567728,-0.04223144772098597,-0.03154194076084209
59480,SIDM00097,Entinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2349975,-0.09407154,-0.6737257984084621,-0.012274157101662679
59536,SIDM00928,Gemcitabine,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-3.2703855,-0.32020047,-3.0809493429311736,-0.3056202731944285
24349,SIDM00146,BI-2536,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.37166438,0.012308024,-0.27631827214131144,-0.0019793947087738246
99241,SIDM00835,Vinorelbine,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,3.2310245,0.23177359,0.6406932541178608,0.03136255465952187
56724,SIDM01042,ZM447439,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,3.0259926,0.35160187,3.2777362333321696,0.18956848207433902
81439,SIDM00673,JQ1,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.9432456,0.13263334,-0.5228981481108154,0.015846113544835696
28778,SIDM00042,Oxaliplatin,Lapatinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1474134,-0.114073075,-2.3731612970352653,-0.05949589666243041
95834,SIDM01042,Tozasertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3420581,0.14890063,-0.3260947264009524,-0.0852951573412802
74844,SIDM00933,NU7441,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.42745906,-0.04125323,0.8209532468229428,0.08909492667956341
36181,SIDM00928,Cisplatin,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-1.0090278,-0.027266927,1.6776353981117385,0.055370848926902826
69728,SIDM01187,Navitoclax,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6882498,0.15551844,2.0614569760927823,0.11573266392507521
33022,SIDM00282,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,4.211556,0.08850784,3.1691461241808567,0.07706330826707615
96307,SIDM00928,Pictilisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.2130091,0.12528822,-0.04026950253416589,0.05892207084705271
103069,SIDM00875,PD173074,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91933423,0.0608867,1.3386418780317808,0.1030932076321659
40714,SIDM00875,BI-2536,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4973196,-0.021162445,-2.267898861795036,-0.12786148434320313
5606,SIDM00933,JQ1,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,1.1980836,0.10627736,0.9795797510429759,0.050672452424528204
22387,SIDM00877,GSK269962A,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0050563,0.12748313,0.3437132228000237,0.014871758595981667
45046,SIDM00928,KU-55933,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.0699617,0.07784443,1.2722499578515782,0.04132119094048224
90027,SIDM00875,MK-2206,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8977411,0.15863484,0.952754443730796,0.09607174301560242
33215,SIDM01042,Docetaxel,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.568911,-0.15399313,-0.701782950810193,-0.0319677062191894
973,SIDM00146,Paclitaxel,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.9837908,-0.09639559,-2.8315196380986514,-0.11023281973860125
6019,SIDM00872,Trametinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1892703,-0.09027435,-0.14142010334147792,-0.02719506433760916
12724,SIDM00872,Venetoclax,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.999673,-0.06876978,-1.184212238694332,-0.005679558210688531
90937,SIDM00455,5-Fluorouracil,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.87783283,0.020455493,-1.1352304130038222,0.022296640434057314
50859,SIDM00877,Crizotinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.5347285,-0.032999318,-0.405841178467716,-0.053727258133900356
67024,SIDM00872,Nilotinib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7070952,0.06849139,0.9063239828785652,0.045867034312306716
33857,SIDM00673,Crizotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0064025,-0.09049575,0.4089403929946692,0.023958010551784682
72920,SIDM00872,5-Fluorouracil,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.31596443,0.019677715,0.07186913120385323,0.0207537652081454
7619,SIDM00837,AZD4547,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.55960214,0.033607014,-2.7031266072544873,-0.0909034369413167
11207,SIDM00833,Taselisib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,-1.25662,-0.085513346,-0.9749349379632705,-0.05008385601169264
26361,SIDM00148,Axitinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.41505864,-0.02876168,-1.4185994552768313,-0.04349353220674436
73442,SIDM00146,Temozolomide,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.1865122,0.03382413,0.999329079490449,0.03419105583441143
99613,SIDM00826,MK-1775,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,0.51723236,0.02210092,-3.7700879826662796,-0.1527522368671678
61809,SIDM01042,NU7441,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.27496582,0.023607811,-0.28920079850333436,-0.042934095914194705
83538,SIDM00216,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,3.4562,0.24306385,0.6478507831919534,0.07222903077622864
31401,SIDM00633,Temozolomide,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.1583316,0.02549757,1.2279503575568083,0.030807685984195896
17987,SIDM00877,Sorafenib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.30586144,-0.02915309,-0.6365711903584866,-0.015816152191773045
40946,SIDM01187,PD173074,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.81099194,0.06585422,-1.6825490762820021,-0.08935707859257856
86876,SIDM00933,Alisertib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.9711947,0.09311295,-0.685207829075844,-0.11150796606090962
41486,SIDM00776,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.5978878,0.113944516,0.8446437724719962,0.022375137068011315
98202,SIDM00282,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7860665,-0.04473869,0.26002704829107204,-0.0014954212631081488
6183,SIDM00633,Pictilisib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0159986,-0.046337616,-0.879683254852544,-0.07503727692840766
1738,SIDM01197,Olaparib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.8441091,0.009955336,2.530113839209759,0.08016583197309902
30874,SIDM00776,LGK974,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.3039248,-0.050854523,-1.7006081074489072,-0.034307571102236804
46453,SIDM00933,Ribociclib,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.5602575,0.012841164,1.3627953170839586,0.023039036341906197
15728,SIDM01042,PF-4708671,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7919837,0.083824195,-1.1517989217178854,-0.10081861473784497
3500,SIDM01042,Sorafenib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9592344,0.09747529,-0.8083926584997924,-0.04554760560291234
101741,SIDM00826,Dabrafenib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.8881442,-0.03340205,-2.1658628884635625,-0.13449859244469567
43737,SIDM00872,Luminespib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9439819,0.09810186,-1.2788679576893385,-0.03933992063750766
42630,SIDM00359,Vinorelbine,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9575901,-0.09626814,-3.476613405738213,-0.10535947642500552
77615,SIDM00826,AZD4547,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.3084843,0.13089871,0.12964805486470082,-0.0023231834695905318
54661,SIDM00673,JQ1,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.9863235,0.12783805,-0.03156997988342554,0.043927832933020175
104598,SIDM00042,MK-1775,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.32032657,0.029531473,-0.5858414122498957,0.0018439737010979198
86814,SIDM00097,AZD6482,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6416755,-0.08465167,-0.3755836777695562,-0.06047688534264855
53560,SIDM00146,AZD6482,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.6859759,0.10795626,1.6829773958448242,0.187609467587342
89320,SIDM00776,Dabrafenib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.1609926,-0.018580617,0.8421184110541126,0.026247977030919994
21973,SIDM00877,5-Fluorouracil,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7717558,-0.038082004,-0.16705972605619318,0.02048640553136279
76256,SIDM00282,Crizotinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,0.7175068,0.04081337,0.1688777000909222,0.06373929657517276
5193,SIDM00950,SCH772984,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.5576813,0.2392146,-0.23441582755050025,-0.02267020865098963
17189,SIDM00359,Camptothecin,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-4.498309,-0.26413962,-3.12034196837537,-0.15480316992453028
672,SIDM01197,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.9674213,-0.07292633,-0.8026698359752537,-0.03715648896377778
47826,SIDM00950,Ruxolitinib,Navitoclax,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6758784,0.08747809,3.1673320312450177,0.08702493700323759
86854,SIDM00872,MK-1775,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5301709,0.055715475,1.96687327299682,0.134325362811225
58537,SIDM00832,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.268478,-0.08488029,-0.5872195856349696,-0.025498740006510295
83514,SIDM01187,PD173074,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9527659,0.069842175,-0.04742179207949328,-0.028278827073954047
4300,SIDM00933,GSK269962A,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.9747046,-0.051520195,0.0396721261822928,-0.009802234533840166
7504,SIDM00928,Entinostat,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.468125,-0.09949899,0.5869314454392176,0.08953758419386865
77971,SIDM01187,Olaparib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4154273,-0.044449247,0.23969995180435574,0.02038104704829991
7543,SIDM00832,MK-2206,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.093004,-0.09277453,0.1636113378748824,1.7617546248716274e-05
32601,SIDM00833,Olaparib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.7364823,-0.029116312,-0.3642792620981411,-0.022710404256072618
65334,SIDM00148,5-Fluorouracil,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2259326,0.08065533,-1.2247535636366096,-0.06710743920790602
13893,SIDM00837,AZD4547,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,82.0,-0.58445996,-0.046993006,-1.9038051675380174,-0.06855498712917597
57136,SIDM00837,Trametinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.9510391,0.051649302,-2.226329830389045,-0.15037340333718432
7449,SIDM00877,Vorinostat,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.0371175,0.07637209,0.8203903990103278,-0.009177951303728553
22493,SIDM00826,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-2.267137,-0.05809354,-2.727902327900612,-0.0574090158300261
77902,SIDM00146,Ribociclib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.1723399,-0.044270378,-0.49604469177078675,0.04181716159492094
47572,SIDM00359,Afatinib,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.604258,0.11752552,0.43751539372998116,0.022605490914279276
50910,SIDM00835,AZD4547,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.38110211,0.011373676,1.6435330431544553,0.054998376058683345
34602,SIDM01187,5-Fluorouracil,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2772894,-0.115666516,-0.6514560469459747,-0.05886378883942598
91750,SIDM00216,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.41593453,0.007497843,1.751329862294931,0.0411958978154734
81162,SIDM00146,Nutlin-3a (-),MK-2206,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-0.42224059,-0.012752655,0.9793831506771666,0.06332349321604484
52040,SIDM00875,Dabrafenib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5928081,0.07985429,0.06694065872965632,0.03731154770216158
2261,SIDM00875,Afatinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20246144,0.014387831,0.2868876576506013,-0.010390598230325837
56439,SIDM00833,Palbociclib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.547392,0.11386178,1.8544809065511547,0.1118147983842664
13867,SIDM00097,Docetaxel,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.7090394,-0.17042042,-1.737352304620748,-0.126185221858431
33464,SIDM00833,LGK974,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.70143515,0.022043675,0.5352833785692903,0.051778591887618804
17140,SIDM00875,Linsitinib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0109793,0.07980266,1.1755163263466437,0.032764840945170244
61922,SIDM00146,PF-4708671,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.8008319,0.04513062,1.7189872174171972,0.10044497732179067
2323,SIDM00875,Pictilisib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.14900818,-0.016271703,-1.2674329288305668,-0.06933060835738865
80570,SIDM00933,AZD8055,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.5443213,0.23292898,-0.13326283545193862,0.014868777386360547
20879,SIDM00148,MK-1775,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.355198,-0.04730963,0.19426446069126635,-0.014515202765365574
66765,SIDM00148,Navitoclax,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5101179,0.046664294,0.4010162064952979,-0.02332169921095621
24244,SIDM00872,Ribociclib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.443394,-0.035395008,0.04196436908355049,-0.02439362260195321
5298,SIDM00826,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.1218289,-0.079450026,-1.6785652457401405,-0.08463830177526246
35358,SIDM00148,AZD7762,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6803011,-0.13077673,-1.1586315648938368,-0.09878020159703446
40032,SIDM00826,Vinorelbine,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,0.33403137,0.004870281,-2.8569184713345184,-0.10089992360653141
16440,SIDM00837,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.66804564,-0.008888233,-1.4017980396366074,-0.06799865627684896
97965,SIDM01197,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-2.877933,-0.16248263,-2.5079870889718934,-0.1318092081663633
94611,SIDM00837,AZD4547,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.438702,-0.051218398,0.0749648493975162,0.03307319928757434
89368,SIDM01187,MK-1775,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4225954,-0.11697071,-1.567154894194938,-0.12228767839525236
83412,SIDM00928,Venetoclax,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.8855314,-0.02708556,0.32690158003838876,-0.015600293177371837
23539,SIDM00359,Camptothecin,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.5071875,-0.09544311,-1.2005160737697336,-0.01514841867730649
16797,SIDM00957,LGK974,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-1.6469773,-0.023771763,-0.40898705904024496,0.09155444153831904
616,SIDM00146,Pictilisib,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.94457257,0.07998923,1.119991269374299,0.12859082574839156
71868,SIDM00633,Tozasertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2727745,0.08505424,1.21699555838432,0.07236426536223173
46290,SIDM00875,OSI-027,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46107396,-0.04624073,-0.6364476440644004,-0.008508158706191118
40681,SIDM00928,JQ1,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.580501,-0.16365245,-1.1189795993474485,-0.09783224766507277
42233,SIDM00776,SCH772984,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-1.7398853,-0.15278459,-0.6926017631429258,-0.0669992067531573
51885,SIDM00673,Temozolomide,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.8213618,0.012843899,0.30430727005945213,0.015730359409393487
81850,SIDM00832,Vinorelbine,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,0.47822666,0.030834826,-0.2672467305032977,0.000258818775834066
92115,SIDM00950,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.692623,-0.05662474,-1.634152777526271,-0.0610169937997951
25604,SIDM00875,Wee1 Inhibitor,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.7296773,0.04170514,-1.4800599734386817,-0.04890970592282564
56795,SIDM00826,Taselisib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,4.241332,0.18820192,2.9423643316965613,0.06432304698143841
62779,SIDM00928,Navitoclax,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-2.365413,-0.18644477,1.5898600550253752,0.05577444426884461
70467,SIDM00877,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.9574819,0.09383648,-0.45773799614060223,0.054597169362896956
40055,SIDM00673,Navitoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.34373337,-0.02859706,0.3404185388224868,0.010728983685655077
44037,SIDM00832,SCH772984,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.3856564,0.14209385,2.415743272858322,0.1131931028050237
31360,SIDM00933,AZD8055,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.685916,0.13713479,-0.39916787565845024,-0.02129032763768991
23626,SIDM01042,Alpelisib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9181306,-0.06984248,0.07197827651265497,-0.0070835230338298465
43306,SIDM00097,Temozolomide,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.5496714,-0.009768231,-0.5042464307140602,0.020230850649611942
4136,SIDM00872,PD173074,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.170327,-0.07724606,-0.6570828129584887,-0.012668095363443935
32700,SIDM00673,Vorinostat,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.420906,0.13427943,1.3810273581526686,0.06808034112393702
107658,SIDM00933,OSI-027,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.6652523,0.09608253,-0.14225896276477087,-0.030352054971428052
7582,SIDM00146,KU-55933,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.8866942,-0.054747846,0.31638116277917416,0.08457986790598376
90605,SIDM00957,Olaparib,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,1.4891125,0.026006615,1.1386710943280762,0.04254701679029863
51698,SIDM01187,Crizotinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.53201574,-0.03855088,-1.129866372195704,-0.05412487826418903
56910,SIDM01187,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.25063333,-0.011300975,-1.4011990566410362,-0.005046749868476942
29257,SIDM00928,Entinostat,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-0.622956,-0.04966951,0.11688560013806587,0.07497036585407539
101231,SIDM00877,Trametinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.46631902,-0.01319158,-0.42172407623322283,0.010586761182084296
63017,SIDM00928,Camptothecin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,3.4566474,0.36118582,1.7367093957020727,0.27401322607730055
59005,SIDM01187,Linsitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.3517168,0.035375576,0.9455983348240722,0.044562653535202904
22445,SIDM00673,Lapatinib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.24426633,-0.021621548,-0.7160636056844916,-0.1141660324896153
9371,SIDM00826,Crizotinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.32898352,0.020770632,-1.769079928892078,-0.09386266930043229
38745,SIDM00097,Dabrafenib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2561545,-0.11620847,-1.459153139977694,-0.0835128435509394
23974,SIDM00957,BMS-754807,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,0.47080693,0.018102512,1.2913475295869834,0.07679507551940892
100427,SIDM00877,Uprosertib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.5520742,-0.059336748,0.08039556744364823,-0.03789313291773164
104819,SIDM00933,NU7441,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.4442604,0.15271361,0.877096672463627,0.10895415293771608
56379,SIDM00633,Wee1 Inhibitor,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.745558,0.06739835,-0.4214429221648145,-0.04684453583293278
94054,SIDM00877,Crizotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-1.7088753,-0.04463406,-1.7950218897249273,-0.054766301928994864
107244,SIDM00928,Nutlin-3a (-),Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,2.2558253,0.052219667,2.056570679621069,0.06482764355642233
78708,SIDM00097,OSI-027,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.9586177,0.04388659,1.5708841293977573,0.10550460763251468
93082,SIDM00875,Olaparib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.9066322,-0.033214916,-0.3779421477277214,-0.03514010820700682
88946,SIDM00928,Navitoclax,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,35.0,0.89044297,0.09766793,-0.047514793272283654,-0.00591615818278141
101648,SIDM01197,AZD8055,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-0.2907957,-0.009556546,1.3818901499820562,0.07881473306901177
30410,SIDM00216,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.45185894,-0.034569774,0.3330978303058511,-0.0252300949520046
89070,SIDM01187,Nutlin-3a (-),PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.45275176,-0.045564406,-1.2786990942739815,-0.02717026074521857
69869,SIDM00359,Dabrafenib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.52243,-0.069644555,-0.9463131942976981,-0.00323160412315822
96048,SIDM00216,AZD7762,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.75302315,-0.06645242,-0.9935710700336078,-0.05333673219377817
33762,SIDM00146,Taselisib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.6015607,-0.11130653,-0.04175599135775173,0.10038557634331005
66953,SIDM00928,GSK269962A,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.3152182,0.23614678,-0.22602963254154568,-0.004987979699655789
107370,SIDM00633,Palbociclib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5871256,-0.018733326,-2.141617168496526,-0.07389620649193503
14509,SIDM00833,Camptothecin,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,3.2521527,0.22885922,2.138892839177926,0.19332482508696275
61333,SIDM00877,Bortezomib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.3563213,-0.035434928,-0.4826082933959059,0.010564388144279015
53995,SIDM00282,SCH772984,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6475122,-0.03750718,2.3867769910699126,0.1946687810024309
76317,SIDM00957,Linsitinib,Dabrafenib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.1246781,0.08520767,1.9389676726092102,0.08445959532399443
67957,SIDM00633,PD173074,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2113376,0.07849614,-0.07462050418531417,0.014978598958511823
107781,SIDM00875,NU7441,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.22423957,0.018374983,0.1807801094183828,0.008372820142668923
46336,SIDM00933,AZD8055,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,1.1198831,0.09399163,-1.0345757031931933,-0.06464293270267904
14348,SIDM01197,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,2.9064486,0.17509273,1.4213767872720984,0.10247102446490569
82855,SIDM00933,Nilotinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.9508592,-0.10354867,-0.9260119613608445,-0.037192713362810575
27976,SIDM00148,BI-2536,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4053344,-0.07413436,-2.8979217114560143,-0.14469859245788663
36989,SIDM00875,NU7441,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.2462168,0.23708116,1.2395509833597784,0.07910786769949918
103297,SIDM00148,Linsitinib,Crizotinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.98685825,0.09180872,-2.1796012506899247,-0.16319373045293442
38851,SIDM01042,Taselisib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.548248,0.028862111,-2.8572293244009175,-0.13516158607001452
7455,SIDM00633,Entinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1226466,0.0882461,-1.1692827331463502,-0.02286161000121698
62283,SIDM00042,Linsitinib,Irinotecan,Pancreas,5.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.7362046,0.2534698,0.4158407847119253,0.039170093460380924
56560,SIDM01042,Ribociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9448524,-0.048998136,-0.9806891598117887,0.040436992569708896
97250,SIDM00872,Nilotinib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.55245924,-0.050179992,-0.6760626725560471,-0.08000396617909993
78641,SIDM00633,Ribociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.46558788,-0.011703555,1.192611782863119,0.023645032174282776
45515,SIDM00097,Afatinib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.18440875,-0.013634356,-0.15278139521923476,-0.04088319368632143
43534,SIDM00776,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-1.4015108,-0.030973533,0.36385718329489164,0.04261662792184188
91948,SIDM00148,GSK269962A,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1819961,-0.076926954,-1.246902718934309,-0.07512166890688414
35154,SIDM00097,Trametinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.9777302,0.05942209,0.9056726294577205,0.06684022214394586
84441,SIDM00633,Crizotinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.533223,0.052877765,0.782236149125722,0.03913634350586761
47005,SIDM01042,Sorafenib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9540564,0.097989,-0.1712599154681995,-0.06586579776467819
84817,SIDM01042,Vorinostat,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5916792,-0.07270328,-0.4973044991498577,-0.034638689451677106
15134,SIDM00455,Dactolisib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7517825,-0.045044463,-0.04417591026753098,-0.006366298917335447
73146,SIDM00826,BMS-754807,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-1.8707002,-0.02651015,-3.491815956258841,-0.1207043984167195
6911,SIDM00776,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,5.6080103,0.35000384,3.6056646456497354,0.23647190616133545
34051,SIDM00633,Alpelisib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.0644634,0.09278779,-1.118653472479353,-0.04871373191041087
7612,SIDM00146,Tozasertib,AZD7762,Breast,0.0625,Breast Adenocarcinoma,Female,White,51.0,-1.1640048,-0.076492555,0.14986498587861952,0.00530232388464498
87482,SIDM00673,Afatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.56287974,0.04276629,-0.3614646844840201,-0.0006166651856655296
72326,SIDM00933,Navitoclax,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.1520019,0.15795398,1.3447893461975384,0.04068869562423451
72362,SIDM00928,Olaparib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.3459306,-0.11739948,-1.4480866292960837,-0.04452624175563128
52382,SIDM00673,Camptothecin,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-0.747216,-0.022102691,0.48065082701771833,0.05699882320193431
57231,SIDM00826,AZD8055,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.2313788,-0.01123574,-0.9685029253727132,-0.054141410459664495
96165,SIDM00835,BMS-754807,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.696138,-0.21723688,-1.7654061906508394,-0.1368920129971776
38125,SIDM00877,Ribociclib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,0.6003143,0.014583707,1.0710540869799365,0.09193806565085604
1217,SIDM00933,KU-55933,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,3.972894,0.21457623,0.8289716739842526,0.013915600346596535
1795,SIDM00832,Linsitinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,3.5595171,0.19453868,-0.36208428560348754,0.0291360540900649
99283,SIDM00833,AZD4547,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-1.4890426,-0.06234976,-0.2464908611690062,-0.004531827320978394
80425,SIDM00148,AZD6482,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6161507,0.13155176,0.575275835482356,0.0014545610751107245
91323,SIDM00928,Alpelisib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.3071275,-0.13563418,-0.5030483807293676,-0.030027531156210766
83308,SIDM00282,Palbociclib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.0449235,0.08893627,-0.12179796506437678,0.00632127722919266
75515,SIDM00875,Nutlin-3a (-),Gemcitabine,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1612012,0.044964384,1.6127872882829983,0.051493762120359186
50682,SIDM00877,Olaparib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,2.6308908,0.1712612,-0.8422783364960652,0.00396432332946878
15131,SIDM00097,Tozasertib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2796144,-0.06513789,-0.7759797331531987,-0.02193777287057225
99090,SIDM00933,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.8741875,0.29356965,1.0146724822181985,0.061304382741599106
94681,SIDM00148,Venetoclax,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.573481,0.058310393,0.7135699308396715,0.04537201058050034
61279,SIDM00835,Olaparib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.5302697,0.04770805,1.092980375417563,0.05864788126914441
90614,SIDM00148,Camptothecin,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6123122,-0.14618929,-1.8513958164804094,-0.18765218747064896
63800,SIDM00933,Paclitaxel,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.4178668,0.14154162,0.699620375389793,0.09839478472529117
18492,SIDM00835,Taselisib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,White,73.0,-0.5218286,-0.031539857,-0.8668235883442341,-0.0320815188379685
47647,SIDM00776,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.3390138,-0.08730583,-1.6747085877787717,-0.07586281102379065
77289,SIDM00776,AZD4547,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.206762,0.1621461,0.9831951102801575,0.07718333513843079
65855,SIDM01197,AZD4547,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.95560324,-0.07343587,-1.979846167073658,-0.11933337116223784
25081,SIDM00146,Crizotinib,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.735625,-0.056922156,0.05533564758971409,0.055114815713686205
30713,SIDM00148,GSK269962A,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7180662,0.15933819,2.873987816709564,0.2085982415498034
51011,SIDM00957,Vinorelbine,Afatinib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.954101,0.016242094,2.8834959556340425,0.06334878803402805
12822,SIDM00872,Trametinib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7897161,-0.06646311,0.3054525314435925,0.004130860857757428
38294,SIDM01197,SCH772984,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.54966044,0.018479696,-0.9253393515638612,-0.03223550623111823
85264,SIDM00832,Palbociclib,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,81.0,1.2504929,0.059026044,0.9764653506453694,0.03525775226627617
63721,SIDM01042,Alisertib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4400874,0.109896496,0.12250127481184457,-0.0012165306054519693
32046,SIDM00933,Gemcitabine,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.6021774,0.0028338702,-3.729780482736439,-0.06905981732495722
43923,SIDM00950,Erlotinib,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6058775,0.16336423,1.9294755140527704,0.06025300796252225
98144,SIDM00097,RO-3306,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.06366,0.05887361,0.46609401470620343,0.0065204877237287
85437,SIDM00928,Afatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.4381287,0.3710788,1.4832725847656982,0.11705807159243162
66409,SIDM00455,Trametinib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.4062254,-0.08269082,-1.8781757028155592,-0.05336642541055634
103880,SIDM00633,Docetaxel,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.921332,-0.24159299,-4.061049685967432,-0.24200550816202618
84288,SIDM00933,Nutlin-3a (-),Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,0.5660361,0.08606244,-0.25677254917578507,-0.02735063984591505
21913,SIDM00673,AZD7762,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7925263,0.056342598,0.2829020233227654,-0.018042761364389735
40421,SIDM00933,AZD8055,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,2.8298156,0.1524399,-0.40042806900118955,-0.01667310296767648
36573,SIDM00146,Lapatinib,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,0.32623407,0.029301984,0.22720252025653523,-0.006091428902282425
101597,SIDM00875,Docetaxel,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5959375,0.09821075,2.6511136213945017,0.1582512511516366
93047,SIDM01187,Trametinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6382551,-0.07304489,0.6398614503538604,0.0977653147978842
80358,SIDM00833,Trametinib,Crizotinib,Large Intestine,0.625,Rectal Adenocarcinoma,Male,White,53.0,-0.403931,-0.019892208,0.17456963163058795,0.002044607065366681
101856,SIDM00928,Camptothecin,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,-0.62180567,-0.05105508,0.1430348024041538,0.04852435298928228
78006,SIDM00282,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.24349086,-0.01815033,-0.7200073453857062,-0.07508219344612908
88590,SIDM00146,Gemcitabine,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.8718547,-0.0598745,-1.8619897976679651,-0.13878047346407818
40113,SIDM00933,RO-3306,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.15548907,-0.015810752,-0.4858403370558643,-0.04435069723085383
53741,SIDM00950,Dasatinib,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.5861135,0.5257276,3.0715348918725662,0.1988073007357617
20277,SIDM01042,Trametinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0841184,-0.13167018,0.3879527069594928,0.00986836134478314
33861,SIDM00148,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6171439,0.054010052,2.215574536623048,0.1766066758836659
73078,SIDM00455,Ruxolitinib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.555935,0.074153,3.058656702090893,0.09289684234246068
85079,SIDM00832,Nutlin-3a (-),Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,5.5999284,0.09666175,2.888590137201484,0.05569694621834664
32512,SIDM01042,Axitinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8654261,-0.10856549,-2.6542255262587315,-0.08396206845476595
66411,SIDM00833,AZD4547,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-2.501005,-0.095812425,-0.7525295632379718,-0.06375819940308465
9005,SIDM00146,OSI-027,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.0148892,0.0868388,1.0911564755912133,0.06386996740604058
4416,SIDM00776,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.5932627,-0.029616585,-1.4487088175750513,-0.05703618992535273
57319,SIDM00928,Paclitaxel,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.020638,-0.19733527,-2.286007195930919,-0.2839459719719024
48762,SIDM00097,PD173074,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2788361,-0.051566336,-1.1997092726081742,-0.04640650136847785
30955,SIDM00837,SCH772984,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-0.33382684,-0.01311409,-0.10423455624204045,0.02265006087124291
36414,SIDM00216,Navitoclax,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,7.75348,0.30261633,0.8916292843404592,0.06465338506307643
35243,SIDM00933,BI-2536,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,0.20950921,0.0012870732,-2.466133055807282,-0.08660532929567845
30865,SIDM01042,SCH772984,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.077386,0.14602537,-0.42775013736027007,0.016437038553110062
19772,SIDM00832,Camptothecin,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.88705,-0.22308497,-1.6028583346443768,-0.12922798446629802
107728,SIDM00097,Wee1 Inhibitor,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0994282,-0.050079003,-0.5690234505804891,-0.026172450500067522
47497,SIDM00872,Lapatinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2535958,-0.13034703,0.49247692638573975,-0.008854227584755054
29964,SIDM00148,Linsitinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7270514,0.17283069,0.5124855373173896,-0.03310571769267019
78061,SIDM00872,JQ1,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2863683,0.044696435,3.034684176462007,0.12432801379622965
78363,SIDM00097,Wee1 Inhibitor,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.3160539,0.09282098,-0.8617258611787625,-0.022734988542989717
25066,SIDM00776,Camptothecin,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.3319275,-0.15061611,-1.8559354721267332,-0.09815576778375086
36342,SIDM00877,Linsitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.7520006,0.14846672,1.3825950536050111,0.0803183295662254
77664,SIDM00928,5-Fluorouracil,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.11587,0.06994581,0.2554546479457782,0.05547653985268313
75906,SIDM00776,Dabrafenib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,2.47854,0.13306156,-1.029288475742066,-0.014507161423867385
811,SIDM00146,Lapatinib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.787432,0.07010524,0.2638868182495961,0.03901612925213079
35784,SIDM00957,Linsitinib,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-0.6855465,-0.015324856,1.6194079192990474,0.009868603540021547
15173,SIDM00097,Navitoclax,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.5716272,0.040523198,0.7087344949774659,0.02620595095384764
97023,SIDM00633,AZD8055,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4964266,0.13865449,0.25639625141194144,0.08169014494874405
87563,SIDM00148,Axitinib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9946703,-0.090499796,-0.7459781353786473,-0.049408358136849496
63289,SIDM00835,Dabrafenib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.70661414,0.016164565,0.7828231952383553,0.04750263949772835
15127,SIDM01187,Lapatinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.746645,0.052086473,-0.3479658676129484,-0.017073550918978577
56805,SIDM01197,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,4.661918,0.12757717,0.9964610596527115,0.07132363152733064
31539,SIDM00875,Luminespib,Bortezomib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.83974785,-0.087926224,-1.5246474674267958,-0.1076720862036261
104095,SIDM00097,Taselisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-5.5457273,-0.26143408,-2.0261680429333704,-0.19869497916483497
62302,SIDM00148,OSI-027,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.47073394,-0.04392645,0.09949052248334482,-0.0734694937285823
5394,SIDM00633,MK-2206,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.6625886,-0.16462408,-0.9713144547795938,-0.0461501349245471
43827,SIDM00875,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.098515,-0.10821324,-0.8779404233011594,-0.04511273488990886
87740,SIDM00875,RO-3306,Luminespib,Breast,0.0025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4157037,-0.045735564,-1.3211081921009704,-0.13098581239109686
57529,SIDM00835,LGK974,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-1.467147,-0.043771654,0.06757677768856805,-0.007994806169912744
11214,SIDM00950,Gemcitabine,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.9646354,-0.08223086,-1.4754361611426552,-0.08185887455956622
23448,SIDM00097,Gemcitabine,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,6.1237555,0.32346106,1.9144659008940657,0.12488716528150809
7816,SIDM00097,ZM447439,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1236615,0.057851773,0.911002200997532,0.025234863348323262
45596,SIDM00933,MK-2206,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.54951954,0.07014678,0.01307093755826038,-0.026228246331153577
57388,SIDM00146,Wee1 Inhibitor,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-3.4101868,-0.13379967,-4.283150427613204,-0.11908058557349896
95056,SIDM00933,Dabrafenib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,0.30544192,0.02594248,-0.8468291441831551,-0.02078149907747791
94150,SIDM00455,Oxaliplatin,Cisplatin,Pancreas,0.8,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.311309,-0.13231722,-0.43687727203821247,-0.03206848604627649
49141,SIDM00633,BI-2536,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9688114,0.09497635,-0.24965744436978693,0.016848056610725557
100070,SIDM00776,AZD4547,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.2426248,-0.030324647,0.23023302497686168,0.07232337691201995
102356,SIDM00633,Uprosertib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.910895,0.056741457,0.22244284917279225,0.006555690082747622
75240,SIDM00633,Bortezomib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.7038182,0.032250796,-1.3021637272843156,-0.004483152149873128
76789,SIDM00673,Cisplatin,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.2349137,0.05512198,1.0072706636097934,0.029950581775988677
5297,SIDM01042,Trametinib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2368523,-0.09261459,-0.9423136236129414,-0.012519465319904811
4532,SIDM00673,OSI-027,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,0.20302917,0.019762995,0.8437373981382754,0.06553914285036122
21268,SIDM00282,MK-1775,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.156029,-0.06823556,-0.384607795747454,-0.04721384372604329
20569,SIDM00097,Venetoclax,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5925411,-0.046041105,-0.9140295625387744,-0.026592890558182185
64995,SIDM00875,Docetaxel,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.34456775,-0.02393192,-0.892099881333755,-0.045728659613468725
9159,SIDM00097,MK-1775,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5597569,-0.06025792,-0.5636065483177695,-0.048380953320922196
65944,SIDM00837,Oxaliplatin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,1.4837226,0.10256927,-2.384987685406849,-0.07142283995590186
31123,SIDM00673,Trametinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,3.445384,0.18982655,-0.343900537385343,-0.018055054471432734
7105,SIDM00826,MK-1775,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.19042,0.06705739,0.3102625847361892,0.03452666584861622
15165,SIDM00146,Docetaxel,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.7839871,-0.071650945,-2.179355763178544,-0.1482093158500392
102335,SIDM00933,Lapatinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.30850402,-0.03740283,-0.46036663397361743,-0.01201911353805655
34479,SIDM00673,Crizotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.1714048,-0.1652861,-1.1524584641819893,-0.0811456155813204
25162,SIDM00950,Oxaliplatin,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.4042087,0.13387781,-0.8848889875611302,-0.03565448733990514
29141,SIDM00933,SCH772984,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.571495,-0.04257595,-1.1795587470786697,-0.026767676580899874
41765,SIDM00633,ZM447439,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0544276,-0.09071211,-1.412045710843711,-0.07450611356669394
22832,SIDM00928,GSK269962A,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.8089734,-0.122104034,0.38357453449075235,-0.011036685358676059
91261,SIDM00877,PF-4708671,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0835003,0.09275578,-0.22975593532913843,0.03254606957805967
99156,SIDM00673,Camptothecin,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-1.1748239,-0.030378776,0.7467566677430155,0.06780553287931804
46690,SIDM00097,AZD7762,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.0994303,0.109176256,0.4122310738269839,0.09436539755678133
45166,SIDM00933,Gemcitabine,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-6.6878653,-0.04027635,-1.6882596655734985,0.06228144349077861
66835,SIDM00833,Camptothecin,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,0.94812536,0.06837391,0.3505593633613108,0.02892264206004105
37963,SIDM00872,Ribociclib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3530785,-0.030697152,1.5115853754529944,0.04323546566396272
97699,SIDM00673,Docetaxel,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44551343,-0.044188008,-2.0451406340133618,-0.11252182622946601
79983,SIDM00872,KU-55933,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4448564,-0.09028596,-0.732125502579271,-0.025879136124111992
73824,SIDM00097,KU-55933,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2552924,-0.05652663,0.14953186065497975,0.05488199336492083
70683,SIDM00673,Ribociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.301113,-0.07628042,-1.2727433536023491,-0.025416199250647694
26954,SIDM00633,AZD7762,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.438933,-0.18295206,-2.0923343953502846,-0.1540765921665511
22775,SIDM00673,KU-55933,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-4.475246,-0.1675437,-2.1706318716772994,-0.09870769859244675
13040,SIDM00933,Sorafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.8032455,0.03466982,0.19051941911119122,-0.048710835988099374
17832,SIDM00359,LGK974,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.7053254,0.1362377,-0.5672709452012936,0.01179298100791611
100748,SIDM00832,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-0.28173998,-0.013518991,-0.081067957552746,-0.0033771012610409774
4775,SIDM00872,RO-3306,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2543015,-0.06744838,0.3911420391026541,-0.022445644021228443
979,SIDM00933,AZD7762,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,3.429683,0.22366042,0.7627819459681795,0.0773691819786002
62157,SIDM01042,AZD6482,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1533642,0.04723205,-0.3086715371703649,-0.04654375851940381
21448,SIDM00833,BMS-754807,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.9345263,0.12035178,1.5820725303201821,0.07524612274762378
2317,SIDM00455,OSI-027,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.9446874,-0.22301348,-1.7251165850574681,-0.11579174169776875
55615,SIDM00833,Trametinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.9444794,0.028903753,1.999177709216305,0.07062163706349678
4458,SIDM00097,Doramapimod,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.9227216,0.10769415,2.194689877625073,0.06541251445770259
13017,SIDM00216,SB505124,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,-0.25854313,-0.022272483,-1.542610415231856,-0.09303344117414283
87328,SIDM00832,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.1020354,0.035261575,2.8409091748565363,0.08028775177395742
83858,SIDM00928,Cisplatin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.2184587,0.15065902,1.9555840669124989,0.09005589146682895
17640,SIDM00837,Trametinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,1.4897084,0.043675367,2.342378917895689,0.08576369749652632
29551,SIDM00148,Alpelisib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3026011,0.11926125,2.0556114409394692,0.1255284508261206
11071,SIDM00633,Alpelisib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.6932548,-0.06882732,-1.1494067721270542,-0.08676151005322413
37829,SIDM00633,Sorafenib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.3041459,-0.028419333,-0.6980427924609612,-0.0048745048262063915
76207,SIDM00148,Navitoclax,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0798352,0.115625,1.4940579288454792,0.08604211219275269
27383,SIDM00146,SCH772984,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.40633824,-0.036123395,1.7660480590017367,0.12793005813453817
26374,SIDM00633,JQ1,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9251549,0.14062901,1.9068598215713404,0.10368643245918162
45429,SIDM01187,Lapatinib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.66168,0.051761374,-0.7088792478808815,-0.019341929768142675
50122,SIDM00146,Venetoclax,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,2.2550554,0.074657336,1.1135659011884131,0.06301478100003895
22395,SIDM01042,Cisplatin,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.8668801,0.04902924,0.9659907057670444,0.04894764036077458
1559,SIDM01042,NU7441,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.46115866,-0.041688286,-0.7578215612842779,-0.03987147524167476
71901,SIDM01197,AZD7762,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.30552587,-0.023887796,0.3111047527816528,-0.006708200654822655
17009,SIDM01042,Crizotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.10806763,-0.009818963,-2.0532949142010652,-0.08141930170637468
72347,SIDM00872,MK-2206,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4209982,-0.13506868,-1.0608402458902966,-0.11865104590572684
83465,SIDM00148,NU7441,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3564056,-0.1301907,-0.9316116798286967,-0.08133070701739983
81972,SIDM00097,Linsitinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.723337,-0.08300497,-1.3449242134438202,-0.03164097882810315
59296,SIDM00875,KU-55933,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5471987,-0.06400408,0.22081577444274897,0.03621955347902736
50156,SIDM00832,Camptothecin,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-3.2343931,-0.11106799,-1.0485493405526312,-0.029232104339189317
86085,SIDM01187,Palbociclib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1217785,-0.0651353,-0.5336569078693805,0.0006048728979118571
38139,SIDM00872,Venetoclax,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.9020646,0.1033218,0.13677931628631823,0.04088486086683303
26182,SIDM00148,GSK269962A,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7674863,0.15747795,0.2868670676804192,0.06694815166947014
44483,SIDM00148,Wee1 Inhibitor,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.24887758,-0.025966438,-0.3113652413421171,-0.07398832617588552
7215,SIDM01187,Nutlin-3a (-),OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.6845814,-0.06816478,-0.8016488771474821,-0.029139977709644452
35549,SIDM00673,KU-55933,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-3.6636736,-0.16138645,-1.4040958861655966,-0.046329829023955715
106568,SIDM00673,Axitinib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.2816792,-0.08933897,-0.06974874422487083,-0.03727544797913734
2251,SIDM00872,PD173074,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4862285,0.08223181,1.8295229983507089,0.15123521102402815
34567,SIDM01042,MK-2206,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.44836766,-0.017449759,-1.0306998688863485,-0.044440823697179964
70525,SIDM01042,Uprosertib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.60237885,-0.02611832,0.06201314167488526,0.006158060494247104
35467,SIDM00146,GSK269962A,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.8478084,-0.059111807,0.7937417640080319,0.05931343885502833
46708,SIDM01042,Alisertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,2.2036593,0.24309874,0.42521269646849436,-0.005712508279055427
91484,SIDM00875,Cisplatin,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4676046,-0.022557093,0.9390535515736385,0.03298307584579494
25363,SIDM00928,Alisertib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.3050554,-0.079863906,-0.9783005444180084,-0.045761417790009105
7552,SIDM00875,Nilotinib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.85793054,0.07086956,0.39784793103587623,0.01464053455642945
51399,SIDM00146,Docetaxel,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.8405515,-0.12292654,-1.1668979309212888,0.003473168775306511
42940,SIDM00835,AZD7762,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,3.2094913,0.18414488,2.6184884419592707,0.23187394866268668
63363,SIDM00146,OSI-027,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.37019226,-0.036181215,-0.949614743918255,-0.06302125092886562
31699,SIDM00146,BI-2536,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-2.4431925,-0.107954435,-1.7378306521463331,-0.09719244805989924
81350,SIDM01042,Pictilisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3657008,0.023740286,-1.5167046720538226,-0.09256857561586976
29006,SIDM00872,Camptothecin,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3468883,0.039348952,2.0440884500657712,0.06746857037491386
7911,SIDM00097,OSI-027,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2656343,-0.13891158,-2.3744873712254964,-0.11299366977115574
52355,SIDM00673,Doramapimod,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0431124,0.023257002,1.4480140905032655,0.04583787568504841
67065,SIDM00146,Doramapimod,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,3.30639,0.24769558,0.1981970031497576,-0.02605592231998809
39490,SIDM00097,AZD7762,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2942057,-0.10894578,-2.311160334120905,-0.05520020822665186
27780,SIDM00633,Palbociclib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3049597,-0.05470368,-2.123500628520367,-0.10206555136586079
18181,SIDM00875,Pictilisib,PD173074,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.2927593,0.034510393,0.19615783816566534,0.054618532579712845
66223,SIDM00875,Paclitaxel,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.1835089,-0.11708864,-0.8148243971583488,-0.05898801981660223
74196,SIDM00216,SB505124,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,-0.3697181,-0.022114312,-0.6661984428548346,-0.04184875108672459
42416,SIDM00837,Taselisib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-0.92259395,-0.048824176,-1.4445467495933124,-0.027245968110901398
66569,SIDM01042,KU-55933,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.86239517,-0.07705703,-0.7577061797026188,-0.060496243608315466
7239,SIDM00875,Venetoclax,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9279888,0.0075825527,1.782115079008386,0.001191293085467677
20587,SIDM00872,Dabrafenib,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.30705577,-0.0060134702,1.682573843364324,0.04933337173395515
33958,SIDM00282,Nutlin-3a (-),BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.4522249,0.098402426,0.4830369126789309,0.04370974199968828
32375,SIDM00216,MK-1775,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.61285514,-0.025858557,-0.7633056445388599,-0.021653090467586414
96807,SIDM01042,Nilotinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7885656,0.086535774,-0.15268748211888014,0.002573012155709561
82672,SIDM00146,Venetoclax,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.2307814,0.029465238,2.409998391375253,0.07821120515856822
29706,SIDM01042,OSI-027,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7633411,-0.08290546,-0.6543400207964893,-0.0022287285222747817
106926,SIDM00826,Olaparib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-0.11093918,-0.009197728,-1.7778312171427344,-0.07066529158893138
88691,SIDM00957,AZD7762,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.171683,0.043607604,0.7014151904886562,0.06017141591644354
96760,SIDM00872,Tozasertib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.8212641,0.0922117,0.7578414298914519,0.010156586132243047
72738,SIDM00957,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-2.508568,-0.03665261,0.006437933630845388,-0.005970355632939207
54514,SIDM00928,AZD6482,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.92336315,-0.059066,0.4661177916611777,0.02622170956772774
57359,SIDM00673,Luminespib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.2055473,-0.10843112,-0.334977717877839,-0.0590520386883685
60700,SIDM00933,AZD7762,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.6001842,-0.0838865,-0.6225545091525962,-0.027884571656350613
38889,SIDM00633,Taselisib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8719,0.027269566,-1.8304485988418158,-0.0762644008179847
17108,SIDM00835,SCH772984,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-0.15516278,-0.013066592,-1.136006306852982,-0.06015598985292154
40036,SIDM00216,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1414454,-0.058331694,-0.7336659439218036,-0.04132923614366481
25951,SIDM00776,Olaparib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-2.0331807,-0.073222876,-1.2263122336169774,-0.03770694291739548
36052,SIDM00877,Bortezomib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,-0.3096827,-0.027741263,0.15375396676822375,0.030484455597335577
107626,SIDM00872,Nutlin-3a (-),Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.37314638,-0.008905025,1.440727756308562,0.0343140328431553
94644,SIDM01197,AZD8055,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.358556,0.09747024,-0.6211711825505402,-0.059953919617389814
33844,SIDM00455,Olaparib,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.036025,0.06696757,2.070692132175748,0.05347502921826982
101735,SIDM00835,MK-1775,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,-1.0882636,-0.08064873,-0.7470858982067157,-0.05560470680330113
41991,SIDM00877,Wee1 Inhibitor,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.32568446,0.021728678,0.16233932797791192,0.03244737386984293
100517,SIDM00877,Navitoclax,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,2.2392714,0.2204643,-0.40869156031169684,0.015256930524160694
103810,SIDM00455,LGK974,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.1544294,0.08810312,-1.5314462637243171,-0.05487344768953288
9878,SIDM00928,Cisplatin,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.9367555,-0.025248697,0.5091470616795365,0.02073592552258475
39450,SIDM00673,PF-4708671,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.9209964,-0.110818535,-0.5151785078054326,-0.03426492076813958
34976,SIDM00148,Olaparib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7927359,-0.023792407,-0.8195900295668227,-0.01033483848163999
67335,SIDM00673,Entinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.1737107,0.09264572,1.8357289978077787,0.09256339003807308
87311,SIDM00673,OSI-027,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.308588,0.106161155,0.0238843006793563,-0.04571124692168459
39149,SIDM00826,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.1314902,-0.08285767,-0.8889072172799527,-0.05637602671831359
69386,SIDM00673,KU-55933,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2250637,0.08825983,-1.332964645834135,-0.04556573812744142
60830,SIDM00837,AZD4547,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.0056517,0.05192454,-1.2889502569816775,-0.010047304687730829
8913,SIDM00872,Axitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7882004,-0.048971586,-0.3363913904652588,-0.0024760953573545225
85425,SIDM00835,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-0.5492873,-0.012962977,0.3523007535645247,0.031159493735750107
97785,SIDM00455,Palbociclib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.374765,-0.11387732,-1.7673784290527008,0.0005196622570117995
41400,SIDM00872,Alisertib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0626924,0.11449427,2.570907767519797,0.0871911735895553
85564,SIDM00633,Linsitinib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.6803532,0.092236675,0.9592130982651476,0.02273000944742819
75028,SIDM00146,Venetoclax,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,1.36353,0.03672843,0.8967010334033774,0.04834788973849489
6609,SIDM01187,Palbociclib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.012917,0.038251787,-0.36545793049392167,0.03231530891447621
103752,SIDM00875,AZD6482,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1006931,0.08804414,0.0023702958832173106,0.02945914607397996
47148,SIDM00933,GSK269962A,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.44409427,-0.022124901,-0.23436586645136298,0.026491566840624228
27043,SIDM00042,MK-1775,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.36244413,-0.041104306,-1.252353417941959,-0.08132455350947412
66107,SIDM00875,Venetoclax,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46045625,-0.010168187,0.586183231992879,0.02919521762819691
44155,SIDM00148,Lapatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6002231,-0.056615405,0.6243518576955805,0.06679829226316494
81604,SIDM00875,JQ1,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8164541,0.069766,0.553681117332889,-0.014074502413219229
83140,SIDM00928,Palbociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,4.281703,0.4240393,-1.0107168129548862,-0.062431262887182884
13891,SIDM00673,Bortezomib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6431961,-0.0267361,-0.46740392648613505,-0.010576314621852632
92644,SIDM00148,Wee1 Inhibitor,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.84430146,0.0785421,-0.41965819458935677,-0.006394715996927915
53116,SIDM00833,AZD4547,Navitoclax,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-1.205252,-0.06758524,-0.061974121349828215,0.029168363464082487
93553,SIDM00097,Navitoclax,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.31969988,-0.02157811,2.149286660968971,0.09446212456977121
35806,SIDM00832,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-0.7360262,-0.008407419,-0.694776692394403,-0.045938524589119276
91950,SIDM00673,Cisplatin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.4592221,0.02695296,3.228169919417718,0.12656595402498202
103316,SIDM00097,Palbociclib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.414504,-0.08126733,-1.718902267964167,-0.04890264326790173
67911,SIDM00933,RO-3306,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.2955656,-0.029703246,-0.9254440132278954,-0.03420158990383144
23399,SIDM00877,Temozolomide,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.9072458,0.038832977,0.3035694431553068,0.056019031511295586
102953,SIDM00455,Crizotinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.6247699,0.044394318,-0.16074606267976224,0.005438976044812531
11396,SIDM00282,Camptothecin,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.6513307,-0.12906823,-0.8956704464872423,-0.06285284025087148
50638,SIDM00875,AZD6482,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4178382,0.13369487,0.6185644989054229,0.060152516533698956
31258,SIDM00835,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.8866759,0.06492997,-1.5928836389670087,-0.057553953300686266
72897,SIDM00933,Vorinostat,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.102001,0.10437579,0.08198492388145552,0.009542766063282991
103280,SIDM00877,5-Fluorouracil,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.5138888,0.017972669,1.5532490695581291,0.09647462794192585
45793,SIDM00097,Linsitinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.7087634,0.22425742,0.09699619492962318,0.03668436171062057
3805,SIDM00833,MK-2206,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.043443,0.15449375,0.6902162800591768,0.06008727535375826
8283,SIDM00832,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.453354,-0.038148254,-0.3752035644438895,-0.05708271672618346
43631,SIDM00097,KU-55933,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7157338,-0.056776997,-0.6858454295360479,-0.013036422677612288
98090,SIDM00826,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,1.009957,0.009359645,-1.9009702669840496,-0.13127477765231393
101480,SIDM00872,Temozolomide,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.16341063,-0.0033547746,0.6459125588933724,0.006100919009921533
23235,SIDM00673,AZD7762,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.92237586,0.06194278,-0.1732752191402254,-0.0393135454530169
93194,SIDM00826,LGK974,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,70.0,1.625425,0.10782536,-0.48322748288048945,-0.006435551546817954
46275,SIDM00826,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-0.5980393,-0.01140559,-0.7544777518994628,-0.03062930025942895
87970,SIDM00835,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,3.2404022,0.10789112,0.5528036941731437,0.00855082512357769
78282,SIDM00872,MK-2206,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9926146,0.18232256,-0.5128715840721803,-0.05283846671896468
70903,SIDM00146,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.3124999,-0.08350363,-0.7980389401252584,-0.027226800677188055
47224,SIDM00872,Nilotinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.4890635,0.047496896,1.453693603041447,0.08005126682833383
53859,SIDM00928,Paclitaxel,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-5.3752155,-0.4875328,-4.254127202831999,-0.3663358012488067
68912,SIDM00875,ZM447439,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.72216904,0.0656338,0.6521943445452056,0.0075896955160410515
56135,SIDM00673,JQ1,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.60968715,-0.041009467,-0.19596773873068593,0.02300197489757187
74556,SIDM00826,AZD8055,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.547761,-0.038545728,-0.7267866940181528,-0.07429528384024074
62207,SIDM00776,Trametinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,2.696446,0.18219456,2.2249385395279866,0.11184425772128158
83913,SIDM01197,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Male,East Asian,71.0,-1.1751865,-0.09623993,1.414384328908394,0.11420197929601796
21253,SIDM00872,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.60480535,-0.03726623,0.41294087928512174,0.02647328437545771
97551,SIDM01187,Trametinib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.3515471,-0.06319204,-0.9802010505630152,0.026196948663046987
65730,SIDM00928,Sorafenib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,0.9233183,0.09117266,0.22382000914993352,0.0376896131958874
23039,SIDM00359,Navitoclax,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.22842728,-0.016232548,0.9485729899770234,-0.004052135701836126
63300,SIDM00359,SCH772984,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.480455,0.039969917,-1.635656924595331,-0.08790229758153392
65850,SIDM00146,ZM447439,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,0.1809711,0.013025737,-0.957784399450335,-0.02797075053364098
54770,SIDM01042,Alisertib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1931472,-0.20318286,-2.3808248087995554,-0.14270353327497054
91171,SIDM01042,OSI-027,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.013436718,-0.0011786917,-0.9323331025377961,-0.05365251104072662
56298,SIDM01187,Palbociclib,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.056714,0.3392548,-0.015263603979199354,0.04069473243466496
53605,SIDM00148,Vorinostat,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.8011101,0.07917979,-0.11393597362134042,-0.048401585945901424
80944,SIDM00097,Trametinib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7773336,-0.046715934,-1.3385594447398983,-0.023438782372719433
101122,SIDM00933,BI-2536,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.239105,0.0049752914,-0.5176811235406119,0.039980245398682654
29127,SIDM00633,GSK269962A,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.9423624,-0.09920148,0.24134226878039522,0.04832121420588524
4891,SIDM01187,Gemcitabine,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6700253,0.06699771,-1.5060276988471673,-0.1047677069019801
4670,SIDM01042,Nilotinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.22664899,-0.005229381,0.6243269064065321,0.03209310305236344
93311,SIDM00835,Crizotinib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-1.661488,-0.12564814,2.2758793771184185,0.1229329407562895
76723,SIDM00826,MK-1775,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,2.7946253,0.10682833,-0.8728333221145613,-0.07309585086043154
86533,SIDM00042,Linsitinib,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.1094564,-0.047163315,1.4527642376651375,0.039936191272757035
41928,SIDM00928,Vorinostat,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-1.3617414,-0.11161088,-0.8063626591598898,-0.02296968641549526
86068,SIDM00633,Luminespib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.12513341,-0.0103978645,-0.5283362253648882,-0.04457299295273658
6590,SIDM00826,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.8694185,0.043526877,-0.966314054528798,-0.004716781636742034
2965,SIDM00146,Luminespib,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.39759853,-0.030178156,-0.4428330310473602,-0.06507089332776787
61676,SIDM01042,Nilotinib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.739124,-0.04598864,-3.1803145560330455,-0.14312838521465338
90673,SIDM00633,5-Fluorouracil,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1287123,-0.04078517,-2.3036938307803774,-0.07339079951151213
39532,SIDM01187,Vorinostat,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.3519134,-0.03695352,0.2180556724379517,0.0324428664336526
8534,SIDM00957,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.5263572,0.080121286,1.2668783479137358,0.0816670440845863
3859,SIDM00146,JQ1,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.1271582,0.060201697,1.4614370368597631,0.06781698155732109
77764,SIDM00957,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-3.3580153,-0.08041384,-0.6797799865723083,0.0021100774970796575
24444,SIDM00933,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.6844963,-0.060346715,-0.5356980738322662,-0.043607881584970004
62842,SIDM00633,Navitoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9948335,0.18173417,1.373153899066176,0.11868011562246653
19246,SIDM00673,KU-55933,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.1649147,-0.04842389,0.032588962363675374,0.07468418031214014
85372,SIDM00928,Nutlin-3a (-),Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.5778478,0.053359956,0.9944531426941916,0.025560139000308565
75294,SIDM00673,GSK269962A,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.97227,-0.071673505,0.13269787482562662,-0.029982963005131296
4131,SIDM00146,Alpelisib,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.7432917,-0.0720077,-0.13826828699014698,0.06352612934599323
48888,SIDM00776,SCH772984,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-1.4951291,-0.13221398,1.4843115314954152,0.13827560953601722
69835,SIDM00097,Alisertib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6220815,0.106080145,1.3093815192629341,0.08499186524837847
76676,SIDM00833,Vinorelbine,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.2963855,-0.17744477,-0.6939838214091538,-0.05667282520492914
26857,SIDM01042,AZD6482,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.3506784,-0.08574353,0.5389572350639188,-0.057264406081708706
59631,SIDM00950,Crizotinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.548585,-0.14141847,-2.6864392325179187,-0.0714960177101767
71066,SIDM00826,Nutlin-3a (-),Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.6099813,0.040198468,3.7081618540923276,0.09005444820058217
48456,SIDM00633,SCH772984,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3287566,-0.12054935,-1.479398575584899,-0.04697767125020733
29023,SIDM00928,PF-4708671,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,-3.6829338,-0.1783537,-0.1311846718503628,0.007600417918561979
58256,SIDM00042,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-4.2334943,-0.19168802,-4.1539264059861845,-0.15543506444932523
96745,SIDM00282,AZD4547,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,0.75393885,0.011620891,-0.1691048901553141,-0.012258329902048217
106138,SIDM00359,Palbociclib,SB505124,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6609182,-0.07496375,-1.4467699248414976,-0.05311219235016325
7443,SIDM00673,Vorinostat,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.16748528,-0.017634613,-0.4651845994907621,-0.033908119268664695
39536,SIDM00875,Taselisib,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9503598,0.09462853,-1.0153512458147833,-0.08820019311483998
86522,SIDM00359,Crizotinib,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0562325,0.07671151,0.09499736478089571,-0.006726972397567308
62763,SIDM00832,Afatinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-3.7604885,-0.12455468,-0.2971946715195834,-0.02476308130015965
2664,SIDM00835,Linsitinib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,1.8037993,0.055215932,3.1311641798779353,0.05733469467381214
57782,SIDM00837,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,82.0,-1.9984078,-0.08746914,-2.1640707832286914,-0.0646721030608183
24558,SIDM00872,KU-55933,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.057702,-0.08633522,-1.1642540702699804,-0.07614130912976481
5591,SIDM01187,Linsitinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.754669,0.06741896,1.128492820046739,0.042470468362236447
55388,SIDM00950,Linsitinib,Crizotinib,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.045788,0.14823052,-0.0750391820851742,-0.008169930308480792
95211,SIDM00875,Uprosertib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.631465,0.27413487,1.0043743755278156,0.07007914894291285
101431,SIDM00877,Venetoclax,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,2.1463103,0.09056398,-0.33657638907534904,0.06814291969930093
105607,SIDM00633,Olaparib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0376546,-0.055775892,-1.0528129100714225,-0.04033550607099279
98881,SIDM00776,AZD4547,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.2468274,-0.03065654,0.619974355809745,0.05829654793589546
39540,SIDM00673,Taselisib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,0.5164833,0.04689594,-1.2780313084787003,-0.10045005449890625
23997,SIDM00097,Crizotinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.27753717,0.011553296,-0.1954908286123059,0.005192536941240311
43890,SIDM00950,Gemcitabine,Taselisib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8238199,-0.08595887,-1.864249528594208,-0.08058404171157728
29987,SIDM00633,Lapatinib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3447582,-0.04942592,0.5702289776463038,-0.03274492485971646
108056,SIDM00875,Crizotinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3913896,-0.100928016,-0.48024493813297975,-0.06870588452542759
9068,SIDM00872,Wee1 Inhibitor,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.87361574,-0.083118245,-1.9481728556428572,-0.08849210926014832
93615,SIDM00097,JQ1,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.45002413,-0.02508067,-0.19718167102433562,-0.008173428189792317
101306,SIDM00146,RO-3306,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,0.11720649,0.008896694,0.10389370924915854,0.03976201232466895
67678,SIDM00928,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-2.4371634,-0.22931275,-1.2892291539391891,-0.09076592296548772
5440,SIDM00097,RO-3306,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7561892,-0.08090291,0.5284623838661718,0.012631226764586998
102003,SIDM00282,Olaparib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.8423734,0.07674294,1.236855288950736,0.0328048786957714
67580,SIDM00872,KU-55933,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8583437,-0.050301883,1.7903887684455853,0.019615913619881103
87724,SIDM00455,Linsitinib,5-Fluorouracil,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.46335652,-0.029786395,-0.9328713092257279,-0.029487081582336608
14102,SIDM00633,PD173074,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.147576,0.19042805,1.3515063199642035,0.05733977507760716
14887,SIDM01042,Sorafenib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.4546089,0.115707405,1.5270507838002152,0.07339631140387931
49526,SIDM00928,Trametinib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,1.2926941,0.12544906,-1.066516970859354,-0.08334295677942971
23474,SIDM00877,AZD6482,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-2.0527296,-0.118053354,-0.12404637565980989,-0.012840105905430499
6547,SIDM00097,Navitoclax,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.731874,0.041148506,2.0697979444190033,0.08018721738576531
17297,SIDM00148,5-Fluorouracil,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6528555,0.12782244,-0.4133868593160429,-0.018427701755619023
71194,SIDM00633,Cisplatin,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3612528,-0.036397345,-0.3064980523942781,0.007071442511697341
65483,SIDM00097,Pictilisib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0286391,0.053461973,0.9538716123443918,0.023066766093592046
10079,SIDM00097,Venetoclax,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.41357678,0.012633073,-0.39621678004768074,0.005692208261742474
15087,SIDM00673,Linsitinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7326151,0.015567697,2.586910254426343,0.06762752028806909
78125,SIDM00875,Sorafenib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.3000443,0.04535249,-1.2252554442796473,-0.02601160625390069
25212,SIDM00673,ZM447439,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.95390135,-0.07787169,-0.15810975281835687,-0.007679443113435196
79659,SIDM00282,Palbociclib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.1443573,0.047674585,-1.2375090634711967,-0.03123761229109134
72255,SIDM00097,Navitoclax,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.4107948,-0.02368702,1.5520503736842248,0.05674529215851385
38609,SIDM00146,Bortezomib,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.46521112,0.027620101,-0.5142506393302375,0.0012355555591206054
68556,SIDM00826,AZD8055,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-1.6109073,-0.10980379,-1.7247768054211448,-0.09959751754791506
74411,SIDM00097,BI-2536,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.36642757,0.02417846,-1.091491918764889,-0.0385615220125409
30747,SIDM01187,Luminespib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2489182,-0.12404335,-1.244120940259047,-0.08704512111053689
13575,SIDM00148,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1858318,0.073537245,0.08307672976059775,0.02210448690905357
91404,SIDM00833,Afatinib,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,2.9009042,0.1954542,2.673321886137964,0.13729856158486872
104234,SIDM00633,Alpelisib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.40741277,0.040304538,-0.7298683435802683,-0.028401704764731903
13843,SIDM00673,AZD7762,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.59811485,-0.05037539,-0.4438622115185494,-0.02766868995370277
14530,SIDM00146,Crizotinib,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.8293855,-0.063779294,-0.40680179112451853,0.013124549761578343
17428,SIDM00776,Camptothecin,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,-1.6848378,-0.07419493,-0.7195343314804871,0.001931764225716953
95736,SIDM01042,Docetaxel,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.8972158,-0.23979415,-2.3439644905501544,-0.15876736482403758
72083,SIDM01042,GSK269962A,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9572276,-0.106361866,-0.02751465780050216,-0.010629409115658838
8012,SIDM00633,Cisplatin,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.133929,-0.073630534,-1.7539424798966552,-0.053358513134713674
81221,SIDM00633,Sorafenib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.0638208,0.006070934,-0.897451769751738,-0.032568836738578306
39157,SIDM00928,Camptothecin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.2548707,-0.09331144,-0.680392392344548,0.02315332787405884
78773,SIDM00673,Luminespib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.7633013,0.07588062,-0.7454402424636802,-0.05245543430373409
55789,SIDM00633,AZD7762,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.6234157,-0.120821685,-2.8213495067613055,-0.11244239816216137
42409,SIDM00673,SCH772984,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.0528827,-0.1865848,-0.19915814871433218,-0.027822202972589142
50402,SIDM00877,Nilotinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.23610805,0.014917662,0.8349720653758892,0.1545171354298504
104573,SIDM00837,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-2.6137586,-0.10977298,-1.4052485221329016,-0.14052247873525
73293,SIDM00875,Vorinostat,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.1461715,0.016139098,-0.31507878261836153,-0.048408890979163795
13516,SIDM01197,MK-1775,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.6593063,-0.050741877,-0.49650749973756,-0.036114119010354155
9444,SIDM00875,Uprosertib,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7077749,0.22843924,1.9826958576654943,0.10167654294783667
63394,SIDM00042,Oxaliplatin,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.88607216,0.079063505,-1.7586607556801246,-0.08291468399231038
29836,SIDM00928,MK-1775,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.8115438,-0.17358735,-1.4941827371354088,-0.141178430855333
48100,SIDM00872,NU7441,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.7335857,-0.041390184,0.8739624663568537,0.05843802720062912
35837,SIDM00875,Linsitinib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4146887,0.11386705,0.5595097346617325,0.04701689818717616
83075,SIDM00216,Palbociclib,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3555337,-0.089538045,-1.0706203750331813,-0.06316272194612033
12694,SIDM00877,PD173074,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,1.0536431,0.08760444,0.6921898125314018,0.09571935354329023
65381,SIDM00282,MK-2206,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0213907,-0.032762654,1.0251772581200485,0.0583906025228696
64374,SIDM00877,Taselisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,White,44.0,1.2346851,0.07983892,0.4671813399545211,0.019174652826769032
103600,SIDM00673,Temozolomide,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.2892084,-0.006460049,0.8069384324390217,0.01761886947673085
28976,SIDM00872,AZD8055,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2378238,0.078187995,-0.9259614505701449,-0.07934289753136065
76293,SIDM00832,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,1.4500929,0.113281146,0.28053949827711566,-0.017539153453598456
86100,SIDM01187,Pictilisib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.8088498,0.16043565,-1.0546419312566644,-0.031192773345268716
78272,SIDM01187,Palbociclib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4290767,-0.07245437,-1.4258305721238445,-0.03421460810035092
1704,SIDM00673,RO-3306,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.84043914,0.06344739,-0.6765970640568928,-0.05842404973238207
29224,SIDM00673,Alpelisib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0547982,-0.06458228,-1.1373373585207731,-0.04347382321515823
85950,SIDM00872,Lapatinib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.97844523,-0.10702873,0.9705604127357124,0.09298485266291417
38833,SIDM00455,Erlotinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.7648536,0.04484565,3.813612155978248,0.15133528408552038
22396,SIDM00957,AZD7762,Palbociclib,Large Intestine,4.0,Colon Carcinoma,Male,Unknown,69.0,2.8266034,0.052682653,0.36832153035288373,0.015443842549131349
90354,SIDM00146,Alisertib,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.74488753,0.06599807,-0.9918243125317061,-0.06898408106002019
26390,SIDM00042,Linsitinib,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.730659,0.21315435,3.3756513632221417,0.15166587859280417
73360,SIDM00950,Dactolisib,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8031121,-0.084766634,-1.4399107989705997,-0.10751590695792904
33165,SIDM00216,LGK974,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.2074347,0.03193411,0.342828098590014,0.025931375511384674
29414,SIDM00933,KU-55933,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,0.42915675,0.015785938,0.37683984869029175,0.0385698033403766
100353,SIDM00776,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.66856915,0.024199814,0.27381283608824314,-0.005713260643349371
52136,SIDM00097,Entinostat,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0472544,-0.052164588,-0.8902810902300711,-0.045158597647385106
56012,SIDM00877,Luminespib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-2.0930083,-0.051053245,-2.1365412049245256,-0.018387517530459488
22789,SIDM00097,Lapatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.4093735,-0.17924902,-0.03778032268530136,-0.022465311670226414
87735,SIDM00148,Crizotinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.473837,0.016333895,1.2629748224763364,0.009679514714755177
15381,SIDM00875,Nilotinib,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2700344,0.14142494,1.3393808857847262,0.0739952427257679
25487,SIDM00950,Taselisib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.9762614,0.08038545,0.5960771853398066,-0.005939280134027842
67856,SIDM00875,Uprosertib,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9708659,-0.088000424,0.003915982276405913,-0.005710483024491057
14541,SIDM00928,Trametinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.3389032,0.099898994,-1.02032771743898,-0.06743435983310139
91318,SIDM00877,Bortezomib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.47038075,-0.041432552,-0.019530266108710226,-0.007156912328158882
107723,SIDM00957,Crizotinib,Taselisib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.8066518,-0.067674726,0.9227494160988751,0.03235331182547911
7898,SIDM00148,OSI-027,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.159162,0.16305743,-0.26606167138125975,-0.04025925069514971
48845,SIDM00875,Afatinib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.1659417,-0.16904286,-0.7591587476568142,-0.03401507977158174
29969,SIDM00097,Camptothecin,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8767664,0.045190632,0.12821677035119844,0.03686529407510997
73155,SIDM00950,Trametinib,LGK974,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3375876,0.11218917,-0.7902207617350494,-0.036919160695810076
64742,SIDM00673,Paclitaxel,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.3623247,-0.26436883,-1.7078498876446657,-0.16332441417964086
46437,SIDM00148,Afatinib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.8248823,0.30470365,1.5306681291958681,0.16607934068684765
96079,SIDM00957,Camptothecin,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.199071,0.049238767,2.6762891690445656,0.08535492367811989
73973,SIDM01042,Entinostat,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.2983673,-0.28008994,-0.4202930583574005,0.0036649777948443447
59945,SIDM00877,Gemcitabine,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0593089,0.013794616,0.6763071491740306,0.05754276991950932
42553,SIDM00673,MK-2206,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.6261371,0.08122,1.230556161658203,0.10703148819812672
43513,SIDM01197,AZD4547,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6079736,-0.07895014,-1.2743373810192529,-0.05485512552424396
52392,SIDM01042,Camptothecin,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.9922285,-0.1643519,-1.5480272149005394,-0.058372014239665086
68650,SIDM00875,Ribociclib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5011272,-0.044214603,-0.33440403394874907,0.0025456582727916293
88667,SIDM00148,Olaparib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.206914,-0.042804968,-0.7973189414894045,-0.016455495850742914
70475,SIDM01042,Olaparib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.4745525,-0.104173936,-0.6657758670465579,0.011850748729893527
79385,SIDM00835,AZD7762,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,0.42108306,0.019267809,0.4578378558176852,0.034343322294277764
93917,SIDM00097,Dabrafenib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.95766,-0.061563578,0.8656264881901709,0.025670045120236764
5890,SIDM00282,SB505124,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.3130658,0.13709402,2.4917403382350902,0.14952536691920157
1041,SIDM01042,NU7441,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.38352096,0.03201903,-0.05259944592147032,-0.0067873979549714115
85784,SIDM01042,Venetoclax,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5496964,-0.06259778,-0.870480686000743,0.013576583854901257
86674,SIDM00097,Vorinostat,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7272432,-0.042365476,1.2293273012611636,0.04476713366228709
75482,SIDM00928,Crizotinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.3025622,0.27327037,2.566223908955192,0.16838283542617027
7313,SIDM00673,Taselisib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5448616,-0.05311875,-0.30497070818777533,-0.024818101421909024
55401,SIDM00933,NU7441,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.20439357,-0.02068899,-0.09076728196770091,-0.02126395653933048
82389,SIDM00832,Vinorelbine,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-3.4222057,-0.21971843,-1.6688419149835192,-0.13715955746824754
87575,SIDM00148,JQ1,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9768504,-0.12361469,-0.41351135458419075,-0.10321051738322168
102930,SIDM00633,Sorafenib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.5280908,-0.039160956,-0.634745562102358,0.024828514660668363
50406,SIDM00148,Alpelisib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6390584,-0.06407011,-0.8644551641342765,-0.07840473602363505
71202,SIDM00633,AZD8055,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.695043,0.33408147,2.383068392637001,0.15070417366843877
87343,SIDM00875,Linsitinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1566792,0.1889608,0.43679513444010437,0.027678180073565734
105331,SIDM01042,PD173074,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.0551677,-0.11058622,-1.2590256059543514,-0.06868003577430443
19400,SIDM00872,GSK269962A,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7625083,0.07992417,-0.7732256862772624,-0.01276798866738833
19220,SIDM01187,Gemcitabine,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.6117599,0.15859337,0.4645463061675369,0.06843039600161704
61061,SIDM00359,Afatinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6163006,-0.12849873,-1.3584309376078592,-0.07291435038249995
13547,SIDM01197,Oxaliplatin,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7992337,-0.04062616,-0.669790195087581,-0.01837034838780896
6659,SIDM00875,Docetaxel,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-5.010687,-0.513077,-3.7028762412213547,-0.30726244332520924
81823,SIDM01042,Linsitinib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.24179052,0.021948889,-0.07299722271699041,0.005860492051634714
96302,SIDM00359,AZD7762,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.4533336,-0.20977114,-1.782807951705636,-0.09595605198696869
20041,SIDM00833,Taselisib,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.383514,0.1681129,-0.08774007724595617,0.004148509752716021
58285,SIDM00835,Crizotinib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-2.5768015,-0.18049741,-0.47849346211346827,-0.048853693944571015
495,SIDM00097,Alpelisib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93396294,-0.064624205,1.0019290053547643,0.04247415832591916
23056,SIDM00950,Trametinib,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,6.6354284,0.30624345,2.9803445492332394,0.1496971166008961
47131,SIDM01042,Ribociclib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8350836,-0.074710034,-1.0169006737452222,-0.03125479870049893
90089,SIDM00877,KU-55933,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.39148936,-0.009046018,0.18585853315364598,0.04177834957085442
90878,SIDM00633,Sorafenib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.0524093,-0.08420927,-2.015425753659645,-0.05713786449029933
1986,SIDM00875,OSI-027,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.2107031,0.13628088,1.240735471611927,0.11717877263002571
106519,SIDM00097,KU-55933,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.685896,-0.09727852,-0.47743719930253475,0.045385942352243594
23072,SIDM00872,OSI-027,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.2432383,-0.10763915,-0.7321212342819885,-0.01973835000539909
42092,SIDM00957,Palbociclib,Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-1.9699697,-0.04350226,-1.5727205935263355,-0.008594180444209737
44734,SIDM00146,AZD6482,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,2.743552,0.20918813,2.4132969570717324,0.15894063317954343
36821,SIDM00776,Vinorelbine,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,1.8967562,0.14897864,-0.15964141713296887,-0.028366257669206807
24891,SIDM00872,Vorinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1061347,-0.054271556,0.19832499206908938,0.05667639204654602
3145,SIDM00148,Pictilisib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.6051101,0.03898912,-0.8671323618970344,-0.002156940811618109
38262,SIDM00673,Docetaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.7742192,-0.10713972,-0.7774819573537085,0.01553988979422442
8859,SIDM00832,MK-2206,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-2.1338575,-0.19031148,1.5161979686026281,0.08628324342024361
16758,SIDM01187,OSI-027,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.036158,-0.080718055,-1.8059981712301842,-0.06394486380633749
54607,SIDM00216,Navitoclax,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,1.7529407,0.14685927,0.9480673645822946,0.06561248318072095
8516,SIDM00875,AZD8055,AZD7762,Breast,0.0625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0493991,-0.09038103,-0.7472831682864697,-0.029818071317125685
22740,SIDM00877,Dabrafenib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.0358891,0.055457722,1.7852212908051082,0.0839649417314446
65249,SIDM01187,Bortezomib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.44832823,0.03598459,1.4613789350633741,0.07780706789361883
5415,SIDM01187,5-Fluorouracil,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.32548863,0.03056521,1.4977106698511173,0.04335735825778341
99350,SIDM00146,AZD8055,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.71980315,-0.06497671,-0.41565599731157765,-0.11198812273280538
102519,SIDM00633,5-Fluorouracil,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5665432,0.109501995,1.3826504189133277,0.09447800644604429
11135,SIDM00928,Temozolomide,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,4.125008,0.114236765,1.8517370435474687,0.04691369844297442
24547,SIDM00950,Lapatinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.8045502,0.15993199,-0.9966499452474162,-0.08654489289056784
72239,SIDM00148,JQ1,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2037536,-0.094802506,1.9716247637107758,0.13688952406411975
686,SIDM00148,RO-3306,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6015737,0.16504987,0.525150251703747,0.011599094450587072
9233,SIDM00950,AZD7762,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9933576,0.07148497,-0.6469157441996352,-0.030281183692072066
104432,SIDM00673,Bortezomib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.5723569,-0.016859628,-1.7248178156623821,-0.044522150967951625
7889,SIDM00933,MK-1775,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.41853842,-0.021070102,-0.238915568015472,-0.019510699500650812
34604,SIDM00216,SCH772984,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-1.3229152,-0.06507837,-0.8689802972465268,-0.028850310747913145
38251,SIDM00455,OSI-027,Ruxolitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.0453334,-0.07415631,-0.5365282227138471,-0.06574375209082574
38137,SIDM00148,MK-1775,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.1445496,0.21894811,0.9949616825662101,0.060761480444029924
50037,SIDM00872,Crizotinib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,1.9102705,0.17942144,2.4119451759773596,0.16479609227233738
61875,SIDM00928,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,3.2732368,0.33308208,1.0995098156027376,0.04236292720005722
36289,SIDM01042,MK-2206,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.484804,0.0148038985,-1.8432621037894648,-0.1232569915324883
91692,SIDM00875,Linsitinib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.88298386,0.06251617,1.7766216608048568,0.13399539082668002
12003,SIDM00455,Crizotinib,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0619045,0.05614191,0.8026589896667685,0.10004018950040056
55265,SIDM00146,Doramapimod,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,1.1326526,0.059379343,0.6629501450651298,0.037858972654289676
27936,SIDM00673,Paclitaxel,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-3.0778863,-0.21858044,-2.691961685434635,-0.2049792155086112
23919,SIDM00928,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.7387328,0.06325895,0.4351494691753609,0.05049055807430459
85001,SIDM00877,PD173074,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.9500301,-0.055831704,-0.9346537457020742,0.0035077802557523553
71629,SIDM00872,MK-1775,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.19939834,0.01963028,0.39050056463677973,-0.0029258830367408315
93962,SIDM01042,Palbociclib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.28238,-0.014542035,-0.9542853873671902,-0.019652304389999632
46929,SIDM00933,Tozasertib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.7977909,-0.057550292,-3.188691893995168,-0.17741605726415044
36312,SIDM00837,Crizotinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.5044992,-0.032150682,-0.38685650061855636,-0.04299659379996051
65830,SIDM00933,Navitoclax,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.22124302,-0.026122753,0.7159240248966554,0.02483342753729324
18849,SIDM00833,Taselisib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.0480429,0.08190935,-0.5901264638263266,-0.03364680757413246
62797,SIDM00877,GSK269962A,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.1346113,-0.014976998,0.6805980046993167,-0.003212994452489013
91115,SIDM00776,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.4526159,-0.046848156,-0.6822699322886153,0.0030658152270129926
79920,SIDM00633,Paclitaxel,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.8325995,0.13224067,-0.3998217307745193,0.0022523836039825182
59367,SIDM00826,Afatinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,70.0,0.29550734,0.01316971,0.6127760563472721,0.08759904116499749
95911,SIDM00146,AZD7762,MK-1775,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,4.0776706,0.3110192,1.0510388487768227,0.17006776999741652
103864,SIDM00148,BI-2536,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4277374,-0.073023,-1.4816085148330096,-0.03980216339174105
33744,SIDM00776,MK-2206,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.571237,0.14128637,0.029402751276177443,-0.05001062957253905
5519,SIDM01042,Nutlin-3a (-),Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8339384,-0.02481234,0.6698229945248128,0.03239820224760792
16772,SIDM00146,Docetaxel,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-2.8424659,-0.19810821,-4.079242917731717,-0.29457711179096296
66167,SIDM00950,LGK974,Sorafenib,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9844728,-0.07051681,0.0330610263405872,0.04575058892988933
38942,SIDM00633,NU7441,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.0608482,0.16586624,0.12768939946634564,0.022574840872247523
51240,SIDM00148,Venetoclax,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,4.96981,0.33215928,1.3751699662448054,0.03936480455398797
39304,SIDM00928,Palbociclib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-1.8028016,-0.093798466,-0.24913972689604447,-0.04965381765675083
45137,SIDM00146,Bortezomib,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-0.09404093,-0.004779972,-0.9931241137289871,-0.024661736793102032
85482,SIDM00928,Cisplatin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.717818,0.08650033,1.9878500823916534,0.08632021657571054
23034,SIDM00776,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.0160886,-0.07635002,-0.150386109411239,-0.0708303962183332
17199,SIDM00928,Cisplatin,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,3.4183583,0.13298762,2.2989902799156363,0.104452480189826
68512,SIDM00673,Alpelisib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.0067047,0.07194124,1.640773266266084,0.08983574909442314
87185,SIDM00835,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.446644,0.093689494,1.9595189563255462,0.08127407588043672
34961,SIDM01187,Crizotinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.09821712,-0.007911947,-1.1323659685668193,-0.03113940403670783
40842,SIDM00950,Irinotecan,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.3579081,0.07369914,-0.7095394422579538,0.04319021232691326
13759,SIDM01187,Trametinib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.0521371,-0.06823734,1.7010290759028652,0.1272796965346809
55059,SIDM00826,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-1.1956396,-0.042862695,-1.9718744625899494,-0.037031159186536
58656,SIDM00455,Ruxolitinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8062055,0.090980254,1.9215186391902421,0.0865619483558799
37541,SIDM00877,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,1.3912108,0.14989728,0.3879733639737137,0.08895585710936058
21521,SIDM00146,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.80754834,0.043350298,-0.9494525622128653,-0.05707026079063899
80421,SIDM01187,Gemcitabine,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.4699731,-0.08410412,0.2978636483131364,0.02641403666451903
34135,SIDM00359,MK-2206,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.94240576,0.06572235,0.27008251699898755,0.0031106020815991433
59310,SIDM00216,AZD8055,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,2.0446675,0.1548903,-0.019125348847028566,-0.03817616731799495
25252,SIDM00776,Linsitinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.6427185,-0.03724816,1.013793466156106,0.043711969498643796
86499,SIDM00833,Nutlin-3a (-),5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.9871903,0.022041243,1.4625706035129087,0.004237652284659457
56071,SIDM00928,Nilotinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.5450011,0.15392621,0.8667343236472804,0.049770996847800876
18887,SIDM00957,Navitoclax,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-1.3355486,-0.033943705,2.080797927825347,0.0732055108365165
23816,SIDM00837,Crizotinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.305691,-0.062899105,-0.5037144719391048,-0.0962795454182454
97368,SIDM00933,Nilotinib,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.5216943,-0.049964994,-0.03098110990119927,-0.02130567032631788
38439,SIDM01187,Axitinib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.57642275,-0.02921643,-0.01905734588816017,0.022621518612183877
53652,SIDM00933,ZM447439,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,1.1928818,0.103711635,-0.7837313473480662,0.0042926492033332425
10795,SIDM00875,Vorinostat,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8526783,0.01397244,0.3666558349547924,0.0030947668443541978
79168,SIDM00933,Afatinib,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,1.2438768,0.049859185,-0.10770007393370366,0.025224873066518712
40649,SIDM00877,Luminespib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.39486614,-0.036230713,-0.9867881934161256,0.050213872564669575
104299,SIDM00933,NU7441,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,2.2224243,0.16784841,-0.34976407081724964,-0.08425310100192604
27403,SIDM00933,Luminespib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.2385908,0.008300789,-0.9610116586273005,-0.008137955563775228
35889,SIDM00776,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9715524,-0.11696375,-1.3772718308219059,-0.026299672315891462
36429,SIDM00148,AZD8055,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3707418,0.1460252,-0.3190334812300297,-0.02888566517916575
48311,SIDM01042,Doramapimod,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4428687,0.044662803,0.8041487553920185,0.037921934049628105
41992,SIDM00826,AZD4547,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,70.0,-0.47477558,-0.026774326,-2.383456875128651,-0.10705371411825663
93253,SIDM00875,AZD6482,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.64292777,-0.04604592,2.3858334667066545,0.14657634097348674
88903,SIDM00097,Temozolomide,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.30833367,0.0054079695,0.6014519381546036,0.0006315321123124526
53340,SIDM00148,Camptothecin,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6245631,-0.055260297,-1.3851654443599712,-0.08264668183052917
44914,SIDM00146,Paclitaxel,Axitinib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-2.7995934,-0.23420587,-3.3007165512646703,-0.28792641284860343
40284,SIDM01042,Camptothecin,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0547822,0.21089412,-0.3042746849224013,0.029439814397716084
25325,SIDM00359,BMS-754807,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3324608,0.11760735,-0.08710324562283044,0.0032314786946998322
75082,SIDM01042,Cisplatin,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1273606,0.058120154,1.24369125427957,0.04628469609413888
70613,SIDM00146,Nilotinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.6092312,0.05644934,0.9093738865888168,0.0926369762133354
1010,SIDM00826,SCH772984,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,1.525533,0.01627564,-0.40508573817245286,-0.015122727328546255
97362,SIDM00872,SCH772984,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1735529,-0.06370683,0.8963435497229434,0.05871319249941311
29522,SIDM00146,Temozolomide,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.9849093,0.060678504,2.3905797679085112,0.06792037362943916
69226,SIDM01197,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.179895,0.07761818,-0.23160145012493144,-0.029653856489281438
36222,SIDM00146,Paclitaxel,Docetaxel,Breast,0.001,Breast Adenocarcinoma,Female,White,51.0,-4.666021,-0.26757276,-1.1180194979771678,-0.06953972444884156
70878,SIDM00673,Linsitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.61790955,0.012052037,1.6923577881203757,-0.025306425041166754
100750,SIDM00957,Crizotinib,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,-0.32205978,-0.009990322,0.28304724735554787,0.02224236387658618
97691,SIDM00833,Camptothecin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.26781103,0.019192254,0.8307333077049833,0.07440690555615138
85756,SIDM00832,Nutlin-3a (-),LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,2.2240431,0.08268234,2.0460373846729536,0.02783403327300493
12678,SIDM00837,Dabrafenib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.0573297,0.025257079,2.509748319069108,0.06317460195386132
55559,SIDM00835,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,73.0,-2.2608573,-0.08900394,-0.9898615095696922,-0.05528944344848967
4160,SIDM00776,BMS-754807,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,1.947123,0.12176792,2.8581072744665117,0.14811422009200378
3242,SIDM00833,LGK974,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-1.4552587,-0.03810471,-0.46149682548922305,-0.02294289706756451
43942,SIDM00875,PF-4708671,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.814607,-0.026935637,0.04435654357879607,0.03148553543321204
48007,SIDM00146,Nutlin-3a (-),MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,3.618899,0.0915584,1.938978333718627,0.06705267372986091
42850,SIDM00837,Camptothecin,Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.2464963,-0.089940764,-1.050000251811194,-0.06983960558645852
2093,SIDM00872,Bortezomib,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.46220523,-0.03550933,-0.3929360425094753,-0.05018503320357241
21714,SIDM00877,Trametinib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,0.43253982,0.009828602,-0.31625474135351256,-0.024961708170330055
78051,SIDM00875,Axitinib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.8637633,0.066593915,-0.11992560789410785,-0.02088064349198625
80148,SIDM01042,Trametinib,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.1872303,-0.13631839,0.7345549408714335,0.019179706150388984
88934,SIDM00146,AZD7762,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.9738233,0.1884797,-0.7136507962620858,0.038011312731403256
88567,SIDM01197,Linsitinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.9508747,0.06640319,-0.26345843159802373,0.014226611507336298
93965,SIDM00875,Entinostat,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8788979,0.13781703,-0.7093455044281448,-0.01529420374262311
7500,SIDM01187,Luminespib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.19747357,-0.01857503,-0.7827397115867115,-0.0319324148963411
50564,SIDM01042,AZD7762,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,2.0072405,0.21386555,0.7013680568617343,0.000833076868821973
104566,SIDM01042,AZD8055,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.79777306,0.07411988,-0.860704282244863,-0.00834990354131142
43095,SIDM00872,Crizotinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6931833,0.06405279,1.0421869049804038,0.05165743304793422
72820,SIDM00633,AZD6482,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0800002,-0.14244822,-1.1200363039711327,-0.052944907632757804
76956,SIDM00877,Paclitaxel,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-0.3100424,-0.0371409,-0.23038168642790616,-0.045197186488369095
21636,SIDM00216,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,1.0235834,0.083087996,-0.48780658603814314,-0.036928388326565476
98693,SIDM00928,Entinostat,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.75459707,0.07723571,0.0032378525634100194,0.05304517690422054
93519,SIDM00633,Entinostat,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9090532,0.063669994,0.14718007910197556,0.010636169000664289
11892,SIDM00673,Lapatinib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5500474,0.053886436,1.0156247903901323,0.07414384201648515
16863,SIDM00148,Dabrafenib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.074470244,-0.004917016,-0.5113049229509596,-0.013443744855964824
81618,SIDM00673,Axitinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9242674,-0.13258246,-0.3585208113531299,-0.053410805254235985
47408,SIDM00042,Linsitinib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.26598927,0.009004228,2.021441125517232,0.07339253286847722
60064,SIDM00776,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.2302408,0.101074845,1.4730569323742573,0.07637954014088601
69430,SIDM00359,AZD7762,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.81968474,-0.065388694,-0.2968520504324812,0.025587046218913223
98781,SIDM01042,Camptothecin,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.26183435,-0.01438775,-0.009748438319916723,-0.023865635811558674
29712,SIDM00872,Lapatinib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.59098476,-0.0607969,0.2276915803520845,0.03292880337983289
79212,SIDM00957,SB505124,Navitoclax,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,-5.321298,-0.093831845,1.687366396529053,0.07813593308175149
1905,SIDM00633,Alisertib,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2566416,0.0996986,-1.6238598788234488,-0.05257392727153457
3132,SIDM00833,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,-3.4517653,-0.1486971,-2.8323596115495353,-0.1784453984273198
44255,SIDM00148,PF-4708671,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.1708338,0.091216944,-0.1481316373426711,0.0076634552626028175
16248,SIDM00673,Camptothecin,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-1.2522025,-0.034427058,1.3455133420049212,0.07825436087877151
38068,SIDM00872,Taselisib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,South Asian,61.0,1.5520375,0.06253708,0.1309656156478862,-0.03891075326924903
81899,SIDM00832,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,-1.3507357,-0.061009355,-1.4976977299849021,-0.10911281648149614
74828,SIDM00097,Ribociclib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.601034,-0.071231805,-2.325696059839924,-0.0797634709665665
104505,SIDM00455,SCH772984,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.205783,-0.12655857,0.967457377094047,0.03938681996894186
11049,SIDM00282,Olaparib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,3.3984058,0.109715566,2.004825200488637,0.042629933219577885
94986,SIDM00359,Nutlin-3a (-),Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.2007732,0.06426959,1.1333098396490773,0.035898023779119194
35710,SIDM00928,Navitoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-2.3440008,-0.1887822,-1.04900527889331,-0.08202168825251785
34565,SIDM00148,PD173074,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9793174,0.060863107,1.4449680300513403,0.06416572719849607
12465,SIDM00455,Navitoclax,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.8925998,0.058202438,0.32587157845372694,0.03238549558032747
35910,SIDM00146,MK-1775,Temozolomide,Breast,30.0,Breast Adenocarcinoma,Female,White,51.0,-0.6502152,-0.053430654,-0.19819577267445376,-0.013051339908591772
67685,SIDM00928,Linsitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,3.6184163,0.375968,1.6187074472089902,0.09862854351051215
21414,SIDM00875,Alpelisib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3064075,0.1382769,-0.4232671518626724,0.012506823526327612
24473,SIDM00928,PD173074,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.6591854,-0.049400583,-0.22532586138575733,-0.007265950604657801
49555,SIDM00928,Entinostat,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.8627451,-0.07743779,-0.8691308771436594,-0.015346643679817543
56703,SIDM00832,AZD4547,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-1.7751973,-0.10673203,-0.7161147939702851,-0.03547015665697306
49938,SIDM01187,Palbociclib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.7555467,0.056741092,-1.461029800391411,-0.06144337623856515
1681,SIDM00097,Entinostat,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.7261582,0.03394989,1.3402050280042042,0.10490413352653498
87078,SIDM00633,Venetoclax,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3176346,0.030703472,1.7412418443738031,0.026658929780954185
97705,SIDM00146,Doramapimod,PD173074,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.4783837,0.09378584,0.7769122448398899,0.05234628544378456
78949,SIDM00216,SB505124,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,0.36034086,0.028531343,-0.6675518865785084,-0.04209681247342941
50615,SIDM00097,MK-2206,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.9456944,-0.16576697,-2.065061589812208,-0.053402164521727115
80810,SIDM01187,Navitoclax,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.12949036,0.013148676,1.899052705014068,0.09244861912402935
66442,SIDM00097,Pictilisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.057982,-0.20696846,-0.8583967387641542,-0.07265097341908835
98088,SIDM00832,Palbociclib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.0316362,0.18016334,0.7835023081144591,0.0532744234960401
42786,SIDM00875,AZD8055,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.09512197,-0.010390628,-0.5394844372154192,-0.04252698046782825
60376,SIDM00097,Entinostat,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.32026553,-0.017285276,-0.47625081138687436,0.0008654951186717755
21616,SIDM00928,AZD8055,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.2189237,0.1494065,-0.402702819822283,-0.033824393516537495
68563,SIDM00877,Gemcitabine,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7785651,-0.011214228,-2.102069982239303,-0.07416794920368935
102531,SIDM00216,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.85387737,0.010001243,1.1310931895501364,0.03345746167114497
74263,SIDM00957,Camptothecin,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,4.6628833,0.08609261,1.936131937531762,0.06257498364989374
9174,SIDM00950,Sorafenib,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.75271666,-0.06242543,-1.4862498582731822,-0.08827137403000851
102393,SIDM00875,Camptothecin,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3040342,-0.25649416,-2.075545620821712,-0.23890213731730253
93601,SIDM00776,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,65.0,-2.103648,-0.06043042,0.6209529390509309,-0.00037456769963437156
67696,SIDM00837,Nutlin-3a (-),Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,1.6786803,0.073608205,-0.8548471083549296,-0.0165917353411056
101950,SIDM00835,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,-0.7127791,-0.028737258,-0.7266588032341437,-0.03537496140487794
84703,SIDM00875,Afatinib,Luminespib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.5075348,-0.04151608,-1.5194160831161017,-0.11329842990322231
79413,SIDM00957,Trametinib,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,1.412811,0.064574175,0.06408194125197007,0.00975031268208646
84295,SIDM00933,Palbociclib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-1.5029151,-0.077717826,-1.561770037677485,-0.08129675724366826
37218,SIDM00148,Wee1 Inhibitor,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.2911544,0.027855033,-0.7131265757300791,-0.08397041940850984
69289,SIDM00928,Tozasertib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.7667096,0.12686093,2.1181725942110914,0.10628218868305361
10183,SIDM00826,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.6111324,0.063098654,2.9800782212888026,0.09609854972931808
86324,SIDM01042,Temozolomide,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,0.06579228,0.0015216945,1.110181404489631,0.003925109997727092
11376,SIDM00776,AZD7762,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,3.7320855,0.30689356,0.7190370113858837,0.060519511253982604
92112,SIDM00875,Olaparib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.084971,-0.067705646,-1.859161402615616,-0.0807809246114823
82550,SIDM00097,Olaparib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.697009,-0.016161289,-0.44385061096864753,0.020452173944400992
50380,SIDM00673,NU7441,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,0.7717311,0.0601498,0.5907040322929605,0.04413715835402821
53919,SIDM00776,Oxaliplatin,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.5486572,-0.09320638,-1.7636971119879679,-0.06844752462818429
104851,SIDM00146,Linsitinib,Bortezomib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,3.9600706,0.17762564,3.499558452751361,0.06156324911102669
93196,SIDM00146,Entinostat,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-0.6817215,-0.040510796,1.051954190699298,0.0924989937428653
79489,SIDM00933,KU-55933,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,3.4567132,0.16633059,1.0105244050513114,0.021534587665879797
46670,SIDM00359,Linsitinib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7511482,0.13016278,1.3222585385374337,0.06669981694457894
56020,SIDM00933,GSK269962A,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.6299317,-0.04416787,-1.1497402388083762,-0.07277535911805254
53576,SIDM00837,AZD8055,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.3360115,-0.0535284,-0.7440887232874557,-0.02282344079848942
29912,SIDM01197,MK-2206,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.12272072,-0.009165325,-0.8979168009814497,-0.06768233451166265
28755,SIDM00933,Palbociclib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.72146213,0.08269397,-0.5810547736839999,-0.001660570215146678
46473,SIDM00833,Taselisib,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.503682,-0.11778801,-2.1943698326228227,-0.1153411147963325
105982,SIDM00957,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-2.4835432,-0.037088055,-0.25272434265443583,0.0038133632568818437
58084,SIDM00835,Olaparib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-0.65979946,-0.015453414,1.3524976108987197,0.02508067450508652
45666,SIDM00877,Alpelisib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.5944178,0.056106057,0.8770564284998709,0.017274539543897984
102411,SIDM00826,SCH772984,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-1.5736724,-0.030471735,-2.7343683802643435,-0.0988028607711164
21152,SIDM00835,AZD4547,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,-1.0193869,-0.020495456,0.911031187524198,0.026929169314731563
96915,SIDM00877,Docetaxel,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.60231197,-0.056862585,0.09109607094153635,-0.0014181514793864714
65670,SIDM00957,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,3.2621613,0.06719927,0.8681514742913397,0.16861873617799542
3003,SIDM00833,Camptothecin,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,2.1792316,0.14276202,0.40740715946898615,0.022909530113281677
31929,SIDM00216,Afatinib,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,1.1324124,0.08081193,-0.18565768215245795,-0.00848868508937452
3653,SIDM01042,PF-4708671,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.81498116,0.08508253,-0.1906810489925551,0.022291410476581862
33680,SIDM00359,Vinorelbine,Navitoclax,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.172999,0.26136494,3.478943638441948,0.18592229212446792
28735,SIDM00148,Afatinib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.38653708,0.035525095,-0.7613373197125259,-0.02801352520779963
61367,SIDM00877,Olaparib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.3438329,-0.017300224,-1.45142881537892,-0.010272598613188657
82032,SIDM00148,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.37093982,0.023490591,-0.23238176367530888,0.022698012093487867
66206,SIDM01197,Taselisib,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-3.0228033,-0.0963146,-2.750495546939026,-0.09252283878411004
67760,SIDM00282,Linsitinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0636004,-0.052957397,-0.16229733096487917,0.020977558054724572
82950,SIDM00148,MK-2206,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2642947,-0.026599966,0.1098611200421981,-0.00630820358471078
66219,SIDM00832,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,-1.5802246,-0.09045026,-1.1660196140574666,-0.054023311111931774
3556,SIDM00455,SCH772984,Trametinib,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.5801911,-0.1509671,-1.4515894996956427,-0.1327499978956869
23695,SIDM00148,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5808945,-0.053143345,0.11259488055811262,-0.04557291103618874
32064,SIDM00673,AZD6482,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-0.73016495,-0.059653148,-0.8015716281051698,-0.048529337399754076
65228,SIDM00146,Navitoclax,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-1.0761772,-0.0913858,0.802848640306011,0.02805444084687952
2158,SIDM00673,Olaparib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.1326725,-0.09002572,-0.7916046100186025,0.00744190118563418
92930,SIDM00455,Olaparib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.69856673,0.013998156,0.9301257363584648,0.08537046634181442
19471,SIDM00673,Alisertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-2.6046314,-0.12109757,-2.6698286414125563,-0.08340921436119822
74189,SIDM00633,AZD8055,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9659961,0.1899661,-0.03568801287026638,-0.004015448596352256
22792,SIDM00826,AZD4547,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-1.666809,-0.11514145,-2.7841933268466406,-0.14152141443296545
90628,SIDM00928,AZD7762,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,1.4309465,0.14543578,-0.5117533180992663,-0.044263524098344546
84918,SIDM00933,Venetoclax,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.2189112,-0.048841607,1.1606756222972197,0.025696828278472455
59009,SIDM01042,Docetaxel,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,3.9402442,0.36977074,1.9699074831293384,0.15586095550047677
21612,SIDM01187,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,3.9371824,0.10389257,0.6163576282880359,0.06120765150337387
49111,SIDM00097,KU-55933,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.2769747,-0.088540256,-1.293693765133648,-0.055786886439171186
81552,SIDM00148,ZM447439,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.9760562,-0.1112653,-0.09292702540837817,0.015352670669466691
58371,SIDM00928,AZD6482,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.9414685,0.058156643,0.6549481890641086,0.027072315803464343
33267,SIDM01187,Taselisib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5850052,-0.05117941,-0.7552706145651005,0.015120843017493535
73423,SIDM00148,Sorafenib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.49638215,-0.051241107,-0.6015000091540629,0.0016605276580748726
48481,SIDM00097,Gemcitabine,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1486658,0.038416732,0.7327868117749335,0.04700300275938359
86921,SIDM00877,GSK269962A,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,2.6825118,0.18776275,1.7137054977228923,0.15120240170203955
88585,SIDM00950,OSI-027,5-Fluorouracil,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4568207,-0.08132455,-1.3867431324483073,-0.0675944236700806
85328,SIDM00455,Ruxolitinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.8729253,0.08709034,2.5422171029268106,0.08110997109245138
51708,SIDM00633,Afatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1086137,0.0080351615,-1.3158172096877303,-0.04331094209251554
57564,SIDM00928,ZM447439,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,0.89684063,0.087578595,-0.06982973292184601,-0.03861288726517021
45350,SIDM00455,Crizotinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.4634478,-0.14223689,-1.889859857288247,-0.09255040278529723
81239,SIDM00097,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.7116292,-0.110429175,-0.3847364683846759,-0.0072828407953405856
2963,SIDM00633,Olaparib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0309544,-0.060129665,-0.43389825104991414,0.01123650986891708
46429,SIDM00957,AZD7762,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.180704,0.06098541,4.353643269296639,0.1474667250657386
37320,SIDM00282,Dabrafenib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2100236,-0.040284984,0.9784853052358432,0.03243447899071767
67986,SIDM00950,LGK974,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.217148,0.12837249,1.2580818559692264,0.03404449781989863
103637,SIDM00933,PF-4708671,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-0.75388265,-0.048730012,0.23185142684517182,-0.022690017999146047
81184,SIDM00042,Navitoclax,Lapatinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.4988918,0.085033916,2.3703831258124124,0.05251282559264605
33068,SIDM01042,Alisertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.2497182,-0.15528902,-0.030326905212191935,-0.01375781011116199
25255,SIDM01042,Venetoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3276427,0.069764875,-0.00835897188098145,0.00020873340164430777
86187,SIDM00875,Navitoclax,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3655155,-0.040442612,0.6813082539760619,0.00982737888835811
19593,SIDM00933,Gemcitabine,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.70655453,0.001791017,-0.921738614494784,-0.010481500083319354
53072,SIDM00148,Entinostat,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6185696,0.19971971,0.7710694792679164,0.06854149212566375
55662,SIDM01042,Trametinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4863796,0.1283588,1.1311735357007355,0.07458694867210458
98361,SIDM00282,Navitoclax,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.7580366,0.088240154,2.148857157780154,0.15191255802773973
35303,SIDM00097,AZD7762,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.1915658,-0.09931562,-1.7381991061842348,-0.03690852825304777
44170,SIDM00957,Taselisib,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.3530315,-0.037787642,4.187857332686394,0.18483887230431648
71145,SIDM00875,Wee1 Inhibitor,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07617872,-0.0048287935,-0.8694946961766744,-0.04863767142507043
78174,SIDM00875,GSK269962A,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.514046,-0.062491957,-0.8528493467707817,-0.010797363504207316
8258,SIDM00673,5-Fluorouracil,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.44872555,-0.017427642,0.00610643800982464,0.0027448195631359917
77774,SIDM00877,Trametinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-0.2709116,-0.007877091,-0.8109067018404968,0.036146987122968564
19397,SIDM00359,AZD4547,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,3.3540206,0.23268622,-1.890000307181546,-0.05360878027912561
76859,SIDM00282,BMS-754807,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.1384804,0.07786288,2.1130405835218355,0.19987283942833237
2262,SIDM00875,Nutlin-3a (-),Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.1756995,0.10215294,1.0546595356469242,0.03521092536773453
63109,SIDM00216,SCH772984,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.6572126,-0.044207856,-0.4447331720067135,-0.052411071895509004
76190,SIDM00673,AZD6482,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.9627596,0.14629042,1.5463763127038557,0.09632271190758221
84278,SIDM00216,Trametinib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.8381945,-0.11010286,-0.26628694740435527,-0.013903202195906203
34507,SIDM00928,Sorafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,0.7891211,0.07961786,0.5964952097299401,0.0133986961656672
74352,SIDM00957,Olaparib,MK-2206,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,0.10116669,0.001486165,0.7207733599167181,0.00561003156471446
50508,SIDM00633,GSK269962A,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.1559218,-0.097794645,-2.144793887441171,-0.09824408527567415
43424,SIDM00633,MK-1775,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5553671,-0.07602513,-1.549944762134706,-0.054140678091370784
24188,SIDM00097,Uprosertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-4.2820153,-0.21781974,-1.0846905945171479,-0.13022900927769268
21924,SIDM00673,AZD8055,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1006126,-0.17723309,-0.04135700939692773,-0.017674151899713275
46790,SIDM00633,Nutlin-3a (-),PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4324336,-0.10195389,-1.376960414286916,-0.10435451133871979
3495,SIDM00877,Nutlin-3a (-),Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.47358632,-0.025169678,0.5774282286733866,0.06510908918987267
90367,SIDM00633,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.907993,0.36006373,1.6186221989979481,0.08051123316211614
76115,SIDM00837,BMS-754807,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.557421,-0.022415927,-1.8173535252868076,-0.1139537137970407
78642,SIDM00928,5-Fluorouracil,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,2.9886854,0.19623362,-1.3712021136781367,-0.04763134147331769
50384,SIDM00872,Dabrafenib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.63024825,0.00891758,2.4018722618248614,0.0378536731406703
91249,SIDM00042,Cisplatin,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.5538771,0.05749177,-1.3043569516417979,-0.0718793578664133
51281,SIDM00673,Vorinostat,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.3607052,-0.035987813,-0.6510724048001405,-0.008393954512616913
100777,SIDM00832,Camptothecin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-3.1264594,-0.22488044,0.9110284066505139,0.060196906721998567
20052,SIDM00148,Camptothecin,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6440843,0.14428924,-0.5794285337807138,-0.011970557641600084
43591,SIDM00359,Taselisib,Dabrafenib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.5042545,0.11943656,-1.192595519749219,-0.0002824151522524446
60134,SIDM00877,Axitinib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.54299897,0.053939063,0.5348518799254732,0.14231428867624993
5608,SIDM00933,Cisplatin,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,2.0586267,0.25893694,2.2255674796489595,0.16453109583879022
27386,SIDM00835,Palbociclib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.1401958,-0.026567629,1.329907187448125,0.05094261416749002
40085,SIDM00148,5-Fluorouracil,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.4103302,0.124669954,-0.2465869323229593,-0.0063340024583478805
2705,SIDM00359,SB505124,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3513002,-0.09034876,-2.4153519549780613,-0.07982509427754404
13129,SIDM00928,MK-2206,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.0269175,0.2657994,0.6250542301722709,0.05380358335104187
62544,SIDM00146,Temozolomide,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.21692225,-0.0056693135,1.5189936398762403,0.10121188860932138
76005,SIDM00673,KU-55933,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-3.0706012,-0.14637804,-0.9513321724579988,-0.04820784147010719
107463,SIDM00097,BI-2536,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.6607308,0.16662809,0.6343368325835882,0.05404794732649909
139,SIDM00950,Ruxolitinib,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.9174601,0.026493976,2.16359850107858,0.04672062729797484
93073,SIDM00042,OSI-027,Trametinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.26977992,0.01255254,0.07000046812873822,0.03056297830850447
97576,SIDM00928,Venetoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.49084744,-0.010193038,1.3933516820613283,0.029878351168049697
45766,SIDM00877,Alisertib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,White,44.0,-1.6534169,-0.11584997,0.4359435133695307,0.04668804478695306
8689,SIDM00872,Wee1 Inhibitor,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,2.3182404,0.2229816,1.34917542175303,0.07267583613132121
72450,SIDM00928,PF-4708671,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.0219765,-0.077207245,-0.6575789264610683,-0.031738949594884776
48545,SIDM00673,Wee1 Inhibitor,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.32924554,-0.019619869,-0.8094004994409998,0.0801041409292202
83676,SIDM00875,Paclitaxel,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.53099525,0.03348516,-0.19237187316981244,-0.05299050562689466
71611,SIDM00282,Vinorelbine,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9722595,-0.08526141,0.09494828306125336,0.03474215447814495
42453,SIDM00877,NU7441,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6030265,0.1872239,0.6419087843255588,0.014308972734110225
102892,SIDM00928,Pictilisib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-1.4575318,-0.14288124,-1.0387928959370527,-0.03333384919198596
5383,SIDM00826,MK-1775,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.89943975,-0.022580259,-3.6436925151958586,-0.10531614058873462
66905,SIDM00837,AZD7762,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.2507859,0.012084802,-0.48965081675527466,0.005752497837208461
86538,SIDM00359,AZD4547,Taselisib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9579515,-0.05491063,-0.86018145107285,0.048278645384254776
85223,SIDM00097,MK-2206,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.66542435,-0.048232894,-1.306374603596018,-0.09046233397183054
72930,SIDM00216,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,1.9607393,0.09834645,-1.1501056358101551,-0.05947558533269944
71817,SIDM00928,Vorinostat,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.9812107,-0.07805387,0.16331736461231522,0.02556490130380208
102911,SIDM01042,AZD8055,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7057668,0.11701683,-0.016509406352946118,0.0020741843371855757
103554,SIDM01042,Palbociclib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.13129716,-0.006234047,0.6861029998620145,0.018151545107065896
21411,SIDM00933,Camptothecin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.8638463,-0.046213146,0.49247510194548344,0.012542009404259818
83138,SIDM00872,Alisertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6166275,-0.022281261,1.2554735209167458,0.08367370846660653
105161,SIDM00872,Olaparib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.291376,-0.06727021,-0.20814187472780646,0.010442686275240731
59971,SIDM01197,SB505124,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,-0.65531373,-0.049712367,-0.5943977758080625,-0.04901435543361448
24462,SIDM01042,Navitoclax,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.51792055,-0.06301023,0.13040892426400397,0.00013339204342935633
94747,SIDM00633,BI-2536,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3909252,0.1026051,1.80266820494124,0.10598404240956107
36196,SIDM00455,Palbociclib,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.1510382,-0.09145453,-1.3557532768018312,0.016397596697791696
67266,SIDM00928,MK-1775,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.68698424,0.072353974,0.2448898708316612,-0.01443300428716006
71794,SIDM00872,Gemcitabine,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1455784,0.042029027,1.9842619615382124,0.07908553846621323
82947,SIDM00097,Palbociclib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.1010076,0.041733637,0.6686093007241388,0.02875121063623959
41041,SIDM00833,Palbociclib,MK-1775,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,-0.6911868,-0.016621605,0.7106803103550999,0.00564112965355335
75420,SIDM01187,Lapatinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.9738674,0.16783921,2.648707096463072,0.11022399817420506
5713,SIDM00832,SCH772984,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,81.0,2.4641802,0.20565696,-0.6312729251930492,-0.06176616677375823
19753,SIDM00826,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.59751403,-0.01135402,-0.6895073901483814,-0.0488652483595456
46687,SIDM00877,Camptothecin,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.8363973,-0.050020594,-0.39146214079839015,-0.07037656234538654
52888,SIDM00837,Oxaliplatin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.4345099,-0.12531534,-1.8922743916917726,-0.10140112492110576
64334,SIDM00928,MK-2206,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,5.364633,0.43759605,0.3109130124468757,0.06075529178954463
98100,SIDM00097,RO-3306,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.4066296,0.15148167,-0.3234694712999253,-0.016999409059650097
93350,SIDM00877,Vorinostat,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,0.45510945,0.03594984,-0.1787396540499855,-0.04192185967951336
8799,SIDM00928,Ribociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.6643735,0.055886064,0.01615823527269121,0.003942767214526889
64386,SIDM00148,Ribociclib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.4205837,-0.13931337,-2.3854119682993233,-0.06807248990129074
10717,SIDM00146,Cisplatin,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.92021656,0.022131113,2.18228524808896,0.09264249790692514
30591,SIDM00872,Vorinostat,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.90247667,-0.06010699,0.11233926129569498,-0.008023198167668623
94501,SIDM00877,MK-1775,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.1077632,-0.06396074,-1.2251809781163001,-0.06947617839232219
56019,SIDM00673,AZD7762,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.49314052,-0.04117439,-0.7827579595132068,-0.04296037681470274
79926,SIDM00877,Luminespib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.6101702,-0.035102595,0.09945719378801712,0.09532639396703756
39604,SIDM00633,Uprosertib,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.82309705,-0.061910864,0.1515858645168976,-0.013382805569014819
41833,SIDM00832,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,White,81.0,-1.9298491,-0.14642023,-3.0304270627372163,-0.15857322899966922
30549,SIDM00835,AZD8055,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-1.9134698,-0.08627743,0.40368062440392105,-0.03929956187289316
12902,SIDM00146,MK-2206,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.0569607,0.072414026,0.7050706669964135,0.07251420932548111
53402,SIDM00837,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,1.0886518,0.04375933,-0.8531804000276431,-0.008626087355179725
31108,SIDM00673,Luminespib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.88133526,-0.09309531,-1.2593199199485936,-0.05614798000549372
80567,SIDM01042,Wee1 Inhibitor,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.33965752,-0.03336208,-0.9801920021191378,-0.03353485002779112
39459,SIDM00282,Camptothecin,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.0703027,-0.18199778,-3.0007871906789805,-0.24082135931436238
5234,SIDM01042,Alpelisib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,2.6906338,0.31967422,-0.615014663818799,-0.023250942541208526
97677,SIDM00933,Lapatinib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.0724924,0.074368104,0.055971148399454426,0.031164713359740557
81030,SIDM00957,MK-2206,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.5423224,0.050761912,-0.32006498372532555,0.052756990679648036
59994,SIDM00950,Lapatinib,Olaparib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.1484963,0.12012997,0.11360960611389667,0.0040810421980094274
39023,SIDM00875,AZD6482,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17111452,-0.013189939,0.17707455877013126,0.022098396384017168
68467,SIDM00216,Crizotinib,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,-1.4621159,-0.105782874,-2.411750992893744,-0.09750676575554905
18003,SIDM00042,SCH772984,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6472486,-0.14865287,-1.0748306754222305,-0.06828007037360519
57168,SIDM00826,AZD7762,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,5.4966583,0.4254585,-1.5819470506810271,-0.06825866297364208
29814,SIDM00826,Linsitinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-1.9802959,-0.053000633,-0.20440985228523897,-0.016255256416526555
7691,SIDM00957,Taselisib,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-1.4668099,-0.039840646,-0.03054061314027945,0.08875157242340136
12027,SIDM00872,Olaparib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8262331,-0.06591618,-1.2529098861120387,0.005523806427527376
1839,SIDM00933,Uprosertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,1.3160148,0.1161298,0.10982281204453113,0.06975271622389922
29480,SIDM00872,Linsitinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.428047,0.016444782,1.30038641094125,0.06784076937986436
82775,SIDM00837,AZD4547,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,0.38012263,0.023746833,-1.2380518838861831,-0.015929102909304382
60049,SIDM00673,NU7441,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.0911822,-0.0906359,-0.361779450261244,0.003099873489336403
49615,SIDM00933,Afatinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,2.1553614,0.21344163,1.509126775964064,0.1233372118222203
86121,SIDM00148,Sorafenib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5891174,0.05482018,0.25136733649657084,0.023471928536361892
73327,SIDM00146,Crizotinib,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.68957144,0.066640414,1.758830837463439,0.2491575459059271
102029,SIDM00359,SB505124,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.3566959,-0.08307372,0.13865079639338013,0.03712443070776188
108245,SIDM00673,Nutlin-3a (-),Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,1.9291208,0.05704553,0.8184800179856108,0.042360179424689164
5215,SIDM00146,MK-2206,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.5046143,0.030511346,1.0868362850786553,0.12438183351662177
45396,SIDM00928,Bortezomib,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.0699039,-0.09235048,-0.534405121700175,-0.07823344297845816
45715,SIDM00877,Taselisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.425322,-0.016994447,0.24134939768134026,0.04355620279463747
58835,SIDM00933,Alpelisib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.9538354,0.15281487,0.06402826098832681,0.046667114440254606
34727,SIDM00826,Dabrafenib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.18785107,-0.011294601,-2.5305957597550193,-0.08817162294625855
17187,SIDM00146,Palbociclib,MK-1775,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.3494124,-0.038646646,-1.4325589589479546,-0.057898403260717574
24023,SIDM00148,Taselisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.28004,-0.07837667,-0.9924142127612403,-0.06499427388349553
101830,SIDM00097,Alisertib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.4028643,-0.05379616,0.8998228365589572,0.05590088894028533
18397,SIDM00633,Axitinib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.9766436,-0.12918721,-1.969200670825243,-0.06004366953712405
63925,SIDM00673,Docetaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.30803964,-0.029826544,-0.4751551693478745,-0.03180375115838843
62365,SIDM00950,Erlotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4225897,-0.0997738,-0.6685816349818483,-0.06774823826341804
6195,SIDM00148,Crizotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.4759169,-0.014593493,1.6001316384176099,0.03521621466539605
66654,SIDM00877,Entinostat,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.089452,0.06875607,0.029122331172336195,0.022122898689251887
102418,SIDM00928,GSK269962A,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-2.3616133,-0.14288649,0.5426748881367209,0.015523112824440558
64520,SIDM00097,Trametinib,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7633893,-0.022786155,-0.24083449886032893,0.03241831842203417
104687,SIDM00146,Doramapimod,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,0.9196933,0.054062933,0.9358850558378141,0.03835197447757326
57561,SIDM00148,Vorinostat,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.40176514,0.0390534,-0.5775060224182084,-0.024727747296956655
44891,SIDM00633,Temozolomide,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1118991,0.028666835,0.877749601716176,0.008363797774076153
90373,SIDM00877,AZD8055,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-1.1512376,-0.125058,-1.26653069648303,-0.032307313895591674
95070,SIDM00877,JQ1,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.67255145,0.068506055,1.0456765223405888,0.08867500018065272
43462,SIDM01187,Temozolomide,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.62279344,-0.014132611,-0.8797398233089629,-0.013109528867684796
21632,SIDM00875,Luminespib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5308591,0.0549485,0.3292986910206545,-0.02494590503652477
64678,SIDM00933,Alpelisib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.37654984,-0.032673772,-0.3876726955094017,0.012727483245704725
82951,SIDM00633,MK-1775,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8254374,-0.12949759,-2.408111291585587,-0.08970040019594373
73369,SIDM00455,5-Fluorouracil,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.1512802,0.055762567,-1.1799058491507264,-0.002739102745242634
2227,SIDM00633,PD173074,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2158405,0.024979008,0.16580884700493084,-0.0073663786858689404
58463,SIDM00359,AZD4547,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2913514,-0.06991926,0.6312844845783615,0.04049012823487618
94652,SIDM00875,RO-3306,Pictilisib,Breast,0.125,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0094929,-0.104736805,-0.01611463175242846,0.0035340288288666396
76179,SIDM00097,PF-4708671,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6450537,-0.0539936,-0.6680703179673029,0.024083819066222936
70053,SIDM00872,Sorafenib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.24291031,-0.02615009,0.12113374851410698,-0.005561193333113394
81121,SIDM00933,NU7441,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.4914467,0.20718537,1.7324663421948445,0.14296603642424668
43516,SIDM01042,MK-2206,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45149633,-0.012735379,-0.6956245285392233,-0.050493803566118815
42000,SIDM00097,Linsitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.1488353,-0.045222204,1.0453460578902534,0.06410085331409855
54820,SIDM00216,Vinorelbine,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,56.0,0.5084704,0.010857381,-0.4316381421359592,-0.05911773761265215
70542,SIDM00097,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.53813,-0.06699293,-1.828663229420245,-0.05879111742079298
90124,SIDM00933,Navitoclax,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.3870476,0.03157724,1.5233872375306774,0.0686149584890479
71974,SIDM00673,Navitoclax,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,2.4777112,0.19822867,1.9557454558951057,0.10028164354960226
62044,SIDM00950,Oxaliplatin,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.4215078,-0.007788822,-0.5198273323577237,-0.06607040153683133
21065,SIDM01197,Afatinib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-0.48707938,-0.03114393,0.7531507129614485,0.06773123059246282
2708,SIDM00957,Afatinib,Dabrafenib,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-4.578473,-0.1556209,-1.0218592713441652,-0.049701584258013375
103258,SIDM00776,5-Fluorouracil,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-1.6480088,-0.041630093,0.3509648384614948,0.019663060965251146
41522,SIDM00928,Camptothecin,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.8370534,-0.119836636,0.24436831684247923,0.08414544231022134
80095,SIDM00673,Tozasertib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.3353727,-0.09615515,-0.8906343958678646,-0.05048892796227538
97336,SIDM00148,Uprosertib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8754768,-0.060308106,-1.6450612682946288,-0.08153745500651348
5683,SIDM00097,Palbociclib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7643886,-0.067129076,-1.1097053271788246,-0.035624035600616985
50303,SIDM00872,BI-2536,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.64773625,0.06830136,1.4760585544165574,0.11917817924353284
54692,SIDM00928,Taselisib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,2.4030154,0.18018909,0.4946014647860092,0.07620879409595059
81910,SIDM00148,Tozasertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3099421,0.110582255,-0.9376898286285297,-0.035455689407167264
18531,SIDM00875,Alpelisib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8183068,0.17440419,1.0157021872259562,0.08163903530303193
57938,SIDM00933,Docetaxel,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.3017752,-0.19881178,-2.729272444351334,-0.17480621296798782
30166,SIDM00877,RO-3306,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.7285223,-0.054503836,1.1480283325495408,0.13779429615649108
31292,SIDM00875,Linsitinib,OSI-027,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.256239,0.17579529,2.9169976324208533,0.1420115792041276
77822,SIDM00359,MK-1775,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2317812,-0.07122569,-1.0371276964568328,-0.054427948013177095
81851,SIDM00933,MK-1775,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.14891584,-0.011472492,-0.2967662737257782,-0.018478467526881384
55725,SIDM00148,Vorinostat,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3057308,0.0655987,0.28990800170616776,-0.040974543154121267
6477,SIDM00216,Palbociclib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,-1.5607954,-0.09512733,-0.8555652806549372,-0.040941663202169166
70696,SIDM00097,Sorafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,3.737099,0.19924608,0.8559708352539939,0.027120946167209427
45887,SIDM00148,Luminespib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.3889069,0.034523,-0.4284988232521966,-0.05749820739020834
59209,SIDM00146,GSK269962A,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.6057276,-0.042655062,0.9181443933000807,0.07813661582096408
23587,SIDM00933,AZD6482,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.7594392,0.075122684,4.218941019317322,0.1403575125501991
86298,SIDM00673,Pictilisib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6303662,-0.05848046,-1.0175184492040874,-0.10332551181711697
80209,SIDM01187,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2370415,-0.089946315,-0.7739239634123042,-0.028857076999062155
40451,SIDM00673,MK-1775,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.1908207,-0.11054696,-0.6697170994154382,-0.03843886740508697
40097,SIDM00833,Taselisib,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.0128236,-0.10404464,-0.32622773776063846,-0.03483542610935763
54743,SIDM00875,Paclitaxel,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4247183,-0.031939123,-0.5679011538308117,-0.03557194453540071
83863,SIDM00832,Afatinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.5755191,0.0567975,1.9788830499815873,0.09794477909280057
96635,SIDM00928,NU7441,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.1049607,0.10820589,0.8966982905908162,0.028647056842860206
72429,SIDM00146,Uprosertib,OSI-027,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,-2.2521775,-0.14028507,0.9025019599679992,0.18005117523357586
82773,SIDM01197,Oxaliplatin,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,1.2355679,0.07369863,-0.4756619224085917,-0.018670496567394893
6254,SIDM00216,Trametinib,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-0.82423055,-0.079938285,-1.241332607465191,-0.0796312542641906
29938,SIDM00673,Tozasertib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-4.276409,-0.205765,-0.4363534989571364,-0.013087761653875131
17259,SIDM00673,Doramapimod,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.9274159,0.019641185,1.99766328250114,0.06687164612941715
90212,SIDM00928,ZM447439,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.5920196,0.06533034,0.5978489530145754,0.011109554952795699
78620,SIDM00872,PD173074,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.2227051,-0.076647535,-1.103136592825552,-0.04247298878750033
63304,SIDM00776,AZD4547,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-1.4365021,-0.03813186,-0.2613206149823249,0.01120762882704367
2010,SIDM00146,GSK269962A,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.0086665,0.07061264,1.7453589134838057,0.09958199981558585
108150,SIDM00875,Alisertib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.49386224,0.037114255,-0.1415201071219772,0.04966179410472238
19599,SIDM00282,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,55.0,-3.9824224,-0.22044991,-3.33389150184752,-0.2521721032511209
55034,SIDM00282,Navitoclax,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.8724488,-0.055627014,-1.4389398384899397,-0.054928741600293304
44825,SIDM00097,Temozolomide,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.52807736,-0.009332577,-0.3222534798324051,-0.00011707482828425325
87398,SIDM01197,LGK974,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,3.1790252,0.108089164,0.34719880804582515,0.03205053895617479
101146,SIDM00832,Oxaliplatin,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-3.8216054,-0.20493938,-1.8085038836471807,-0.059852284551052
99606,SIDM00148,KU-55933,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.5068185,0.15211514,-0.3530926654324426,-0.01903462240472869
36345,SIDM00633,Alisertib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.97285676,-0.06732186,-0.2763716743481975,0.0023007982643821895
65886,SIDM00928,Dabrafenib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.5786641,0.094204895,-0.029489909949950103,0.023545200155392153
11576,SIDM00146,Sorafenib,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.7745347,-0.06975301,0.6285311110499098,0.09425565647208235
61234,SIDM00146,Navitoclax,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.2194239,0.07195799,2.908852559011694,0.06517781372379175
50467,SIDM00148,PF-4708671,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4618136,-0.048961047,-1.5759169553743941,-0.053992575555900355
97653,SIDM00872,Venetoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.003968,-0.040337645,-0.563102349977028,0.008551621476143243
26958,SIDM00633,MK-2206,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5152019,-0.05377836,-3.229394283688226,-0.09563236511091582
70919,SIDM00933,Navitoclax,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,2.067799,0.17026833,1.0830889769603134,0.05635613964119942
14018,SIDM00835,AZD4547,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-0.676776,-0.015673993,2.056510622919413,0.04334170318380914
39935,SIDM00933,Linsitinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.7952816,0.0721745,0.22899337301296058,0.08093670147741051
107331,SIDM00455,Oxaliplatin,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8533143,-0.07499953,-0.6973141703266117,-0.021496293686792546
19413,SIDM00835,LGK974,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,3.096371,0.16217394,0.22799840382231623,0.0302234940773562
34937,SIDM00933,Paclitaxel,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-2.9253263,-0.1834959,-0.2589276564211056,0.018869149364660366
55263,SIDM00933,Ribociclib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.4496108,0.03518714,0.9947778026276383,-0.011950710451480365
93004,SIDM00950,Cisplatin,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2177613,0.06565986,1.4280905359876632,0.11312646646427069
72373,SIDM00633,Palbociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4747505,0.05093552,-1.3039475012777137,-0.046104041337578984
63260,SIDM01042,Nilotinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.89803886,-0.068043925,-1.3930931483223534,-0.06693649240248523
2950,SIDM01197,Oxaliplatin,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.63677245,-0.044022076,-0.8936050857937052,-0.07378797721701828
44063,SIDM00042,Erlotinib,Taselisib,Pancreas,2.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.4324865,0.13974665,1.755935044564598,0.10592230653040208
19839,SIDM00282,Crizotinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.62514883,-0.031161044,-0.11620137480622907,-0.01252955350631643
43551,SIDM00877,PF-4708671,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,1.8899307,0.11573376,0.7546163368926838,0.055060186665888765
53809,SIDM00633,Paclitaxel,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4967809,0.09124359,-0.2769494155450779,-0.009570349524646643
85538,SIDM00148,Afatinib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.7271306,0.06643096,0.5376329505686323,0.028479668603845543
76065,SIDM00837,5-Fluorouracil,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,0.44998312,0.030176273,-1.5355711501253078,-0.057641776008002854
93008,SIDM00826,Olaparib,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.7006503,-0.05788725,-1.1576629196006176,-0.04371439790700308
42912,SIDM00832,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,2.7858188,0.13545774,-1.968231505347672,-0.0019337165731991171
20165,SIDM00146,Afatinib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.9154273,-0.07792722,1.4727265645790544,0.07147358911840095
11647,SIDM00872,Afatinib,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6158202,0.057389062,0.8400666459158215,0.06143038003532625
93238,SIDM01197,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7442257,-0.09139967,-1.0885586557924845,-0.028019580119415688
17468,SIDM00673,Paclitaxel,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,1.7450217,0.10130709,0.2206760876279468,0.03151757620673406
20328,SIDM00097,Taselisib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8449004,-0.048784018,0.05335902428107281,-0.008768442505420406
7938,SIDM01042,Docetaxel,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-3.0530517,-0.27478203,-4.437625482720309,-0.24615019776613323
96910,SIDM00832,Dabrafenib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.69847757,0.032237455,0.17441572757250023,0.030650226198237433
19587,SIDM00877,Luminespib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.4857365,0.1356838,0.16086451677641211,0.056313727354085207
83053,SIDM00673,AZD8055,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6508873,-0.048259452,-0.3193313945509711,-0.009849448883193964
95449,SIDM01042,JQ1,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.16010138,0.0043348474,0.406064233920685,-0.04342634733668497
47782,SIDM00282,Olaparib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.58095694,-0.010057175,1.4593732823881607,0.028476082862385326
27262,SIDM00148,5-Fluorouracil,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.8607957,-0.1759188,-1.5615733768207662,-0.09947715145341683
48028,SIDM00097,Palbociclib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.4722958,-0.084997475,-1.7139185167786235,-0.06819068704295518
27631,SIDM00875,Ribociclib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.58558226,-0.018640526,-0.07150784194523478,-0.0070835629139581096
10353,SIDM00835,Dabrafenib,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Male,White,73.0,-0.15661049,-0.003099326,0.8739071544242426,0.000937348414725076
24347,SIDM00928,Lapatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.2465441,0.115227655,1.0090884471687152,0.07646148783595189
82121,SIDM00146,SCH772984,Gemcitabine,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-3.6720078,-0.28998417,-1.400994975000191,-0.15755116962723584
53599,SIDM00673,Olaparib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.259288,-0.05023827,-1.2638727478943965,-0.017184135372643343
38539,SIDM00933,Navitoclax,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.61400366,0.04995567,0.7728150607869531,0.013622386442670798
64847,SIDM01197,AZD4547,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.2880542,-0.0771079,-1.0494058436112463,-0.0895384812283989
17425,SIDM00875,RO-3306,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.10634,-0.08906802,-0.8289625644622398,0.0017307367446314033
44422,SIDM00950,OSI-027,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,0.9999694,0.04707503,1.2564371101888607,0.07661711567861448
1658,SIDM00673,AZD6482,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.6258796,-0.05133181,0.12463442489366983,-0.001213891709021725
45234,SIDM00455,Crizotinib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3827226,-0.064977996,-0.9763615782159232,-0.05595973860545222
50800,SIDM00957,LGK974,Crizotinib,Large Intestine,0.625,Colon Carcinoma,Male,Unknown,69.0,-1.7625107,-0.02755229,0.5870894159969587,-0.004772466704837008
78433,SIDM00928,Cisplatin,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,4.159422,0.0824898,4.2731043466869085,0.1260573523343005
78715,SIDM00877,Paclitaxel,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-2.374809,-0.18978149,-2.4909184155853215,-0.21445454031221053
13645,SIDM00148,Paclitaxel,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.6148398,-0.23239498,-0.8948430027908063,-0.06638601959257417
19766,SIDM00835,5-Fluorouracil,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.5443352,-0.06281645,-1.3883110246868455,-0.05396442279029417
51649,SIDM00877,Cisplatin,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.33520013,-0.029919859,0.2582004081530591,0.006755078081101107
56005,SIDM00146,NU7441,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.8788176,-0.08740295,-0.139217412336523,0.06254250763756955
95,SIDM00148,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4537513,-0.049875926,-0.1002022292788618,0.03173354870384584
103617,SIDM00957,Linsitinib,MK-2206,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,1.5983652,0.04160329,1.5315164601770772,0.04595562488985323
103471,SIDM01042,Bortezomib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1826991,0.025872005,1.7007333768686757,0.020165353093673666
53687,SIDM00673,Bortezomib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.27063477,-0.014932103,-0.6097820607669935,-0.017852088638570417
78346,SIDM00673,Dabrafenib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,1.5076591,0.03285853,1.2088257577382038,0.062067215552920066
26375,SIDM01042,AZD7762,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5133448,-0.17347795,0.10959214330786936,-0.01676742952394619
8837,SIDM00097,OSI-027,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3294133,-0.064487875,0.7003814243404318,0.07965065543684459
19863,SIDM00872,Nilotinib,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-2.4266706,-0.16784781,0.740949993611001,0.039737505351022086
35031,SIDM00835,MK-2206,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,3.9436383,0.25204048,2.5797247402832073,0.12824657928872754
84833,SIDM00148,SCH772984,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2034441,0.03687946,1.766080114186642,0.03865441376665046
44731,SIDM00875,Sorafenib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.35630885,-0.03401012,-0.3250713810450771,-0.031293917328504735
6356,SIDM00872,BI-2536,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3662466,-0.1297296,-0.5108411031552899,-0.043127014389152174
37155,SIDM01187,AZD7762,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7296257,0.057741582,0.05525716905809474,0.02179148898051587
79492,SIDM00933,JQ1,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.74896014,-0.053115882,0.7888466304887635,0.07204680299494613
93304,SIDM00837,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-1.5935415,-0.039508782,0.6473439812118019,-0.023310062516052103
51088,SIDM00933,AZD6482,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,1.7931273,0.08787569,2.2538237072924168,0.15625620899280765
39932,SIDM00832,5-Fluorouracil,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-2.245617,-0.16360135,-0.4616608090965169,-0.01149736702463045
12579,SIDM00950,Trametinib,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.6938367,0.16197878,1.8023542503239705,0.07928683367729586
51898,SIDM00455,Sorafenib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.9763701,-0.10341702,-1.4048783231245643,-0.06306991877720244
37191,SIDM00673,Nilotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.2548861,0.014961443,0.6600648153118307,0.0630574472825831
103901,SIDM01197,Palbociclib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3197801,-0.0569732,-0.8529666705312658,-0.00940213911684204
3766,SIDM00148,JQ1,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.069891825,-0.0050814245,-0.05974184665778744,0.02741769443742996
94162,SIDM00776,Taselisib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,-3.7328246,-0.16621593,-1.0714077805893112,-0.03924739959696944
62804,SIDM01197,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3562677,-0.083853304,-1.3534296542650448,-0.08259712113389345
30441,SIDM00928,NU7441,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,0.96140444,0.118873484,0.8780284917671504,0.028476878464726144
54090,SIDM01187,Crizotinib,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.51770294,-0.03990308,-1.4099370176366361,-0.06748248086504238
68169,SIDM00148,Alisertib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,3.534918,0.27650732,-0.9558287038143615,-0.04133482014915071
26963,SIDM00837,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-2.5562985,-0.04448221,-0.726015349181217,-0.04533287726628338
80486,SIDM00455,Oxaliplatin,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8479419,-0.083731756,-0.7253390099561915,0.017058724984748287
103896,SIDM00673,Pictilisib,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.5727847,-0.03165154,-0.9987319722344677,-0.058898059069847034
6928,SIDM00148,Entinostat,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.9561397,0.08066445,0.26178667432760183,0.01378092456578511
1315,SIDM00826,5-Fluorouracil,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.3049082,-0.11001303,-0.8750161109176098,-0.08965106209246754
60629,SIDM00933,Trametinib,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.6717891,-0.08594149,0.23273918260575485,0.06420182456157927
25361,SIDM00872,PF-4708671,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7794297,-0.08216859,0.7998571520826039,0.00499591162252279
80460,SIDM00877,Venetoclax,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.0508012,-0.03411035,1.3668566193519456,0.05529339854187956
78465,SIDM00146,Temozolomide,Taselisib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,1.3772669,0.04482812,0.8172505462776015,0.062203107671683674
96334,SIDM01197,BMS-754807,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-0.2779867,-0.004079045,-1.4230874232678379,-0.026811753442186538
52070,SIDM00872,Pictilisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8664166,0.08425428,-0.14475795389828922,0.013573923017491288
105057,SIDM00933,Bortezomib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.18691927,-0.019625638,-0.3832810733428305,-0.025256867589867234
29641,SIDM00928,Luminespib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.48716554,0.051285718,-0.3573813240442351,-0.0731610421559553
61086,SIDM00872,NU7441,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3750823,-0.07791381,1.1212810422670643,0.033892703551259104
108253,SIDM01197,5-Fluorouracil,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.94685566,0.0769038,1.5131866316492641,0.09225380248450339
61570,SIDM01042,Uprosertib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3043173,-0.0066134934,-1.488334262790683,-0.12173880747505027
101795,SIDM00282,Oxaliplatin,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,-2.2628195,-0.08750009,-0.4452095757741711,0.0021004127741843823
79833,SIDM00872,Ribociclib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3969202,-0.032893732,-0.15114272003502086,-0.015658379531950806
21919,SIDM00833,MK-2206,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,0.12646222,0.005506905,-0.2453153271270299,-0.0072814609804060584
98963,SIDM00146,Luminespib,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,-1.1554943,-0.07654598,-1.4956430684005528,-0.07115608102326586
34338,SIDM00877,JQ1,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.8016617,-0.094682716,-0.28649491285738815,-0.05104238359698508
25459,SIDM00097,AZD8055,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5912216,0.09828679,1.1624332597043188,0.12150382634086285
1358,SIDM00875,Venetoclax,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.45492622,-0.010028301,0.4043454963292727,0.009923498465516996
40804,SIDM01042,Sorafenib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.19082868,0.021897193,-0.21762523723336155,-0.027966380873309004
86445,SIDM00146,Dabrafenib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.8677615,0.12323941,0.49245757926668,0.029910413238430956
47965,SIDM01042,Venetoclax,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.5698212,-0.060457353,-0.10681591175836544,0.023923049284520777
21881,SIDM00282,Crizotinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4563075,0.045132957,0.86603019432633,0.05135437132933086
107138,SIDM00673,5-Fluorouracil,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.9069899,0.026606783,3.6340732825145343,0.2771623332412358
31700,SIDM00933,OSI-027,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,2.6448474,0.25584707,1.1798735643016758,0.12463686597252191
108037,SIDM00950,SCH772984,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9854754,-0.08534838,-3.2328892610073785,-0.09571567289434874
35078,SIDM00957,AZD7762,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,2.778213,0.054531097,1.457640822834386,0.08374741942302516
101943,SIDM01187,Luminespib,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.77619356,-0.077983335,-1.6023083060233456,-0.09157326513930641
43198,SIDM00097,Temozolomide,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.614161,0.069412775,-0.06690306829201664,0.0016302422103112416
78627,SIDM00359,Olaparib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.2366574,0.030526025,1.8907829110485626,0.04336416045220513
66079,SIDM00872,Palbociclib,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.41172165,0.017800432,0.9765008752797645,0.02107112585897164
46798,SIDM00633,BI-2536,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.2783875,0.25599194,-1.3361581108542455,-0.022076134951362746
95628,SIDM00837,AZD7762,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.1396426,-0.038749006,-0.3177064678691911,-0.008892481174476087
33740,SIDM00097,Gemcitabine,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.8206401,-0.026914917,-1.6208322575458844,-0.05868446914622477
107187,SIDM01042,Linsitinib,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.71633977,-0.036299203,0.5603666446704074,-0.007040196197704451
14793,SIDM00633,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.6697943,-0.116520084,-1.0050880817618788,-0.05742773017314286
81384,SIDM00957,BMS-754807,5-Fluorouracil,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-1.3666843,-0.054981668,-1.7165845382457028,-0.07726002769793092
106254,SIDM00957,BMS-754807,AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-2.153347,-0.07081071,-1.0261248989110674,-0.0320217457093559
39118,SIDM00950,Lapatinib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.08965,0.20901236,0.5059868390796395,0.005952159879962469
28038,SIDM00872,MK-2206,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1879702,0.11373105,0.6306442676403067,0.07121443827977884
96569,SIDM00216,Vinorelbine,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,0.6047502,0.01648775,-0.5341655784642851,-0.034998018189104016
42870,SIDM00875,Temozolomide,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.9788257,0.024605019,0.30306550289909573,-0.0026072509354030803
107374,SIDM00148,Palbociclib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2327907,-0.05276796,-1.8589450232583382,-0.08210495238082728
104166,SIDM00933,PF-4708671,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.28498602,-0.026106322,-1.010349392715005,-0.037549934471618605
63366,SIDM00950,Ruxolitinib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.98762536,-0.034185406,0.24733156603334552,0.03409600705180405
8778,SIDM00835,Nutlin-3a (-),AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,73.0,-2.1006925,-0.054093212,-0.1420269401579264,0.0244721097568518
57908,SIDM00146,Luminespib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.2995231,-0.08247973,-1.6996461221817831,-0.12032743422846348
91809,SIDM00097,Cisplatin,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.6200968,0.03825586,1.5362950783272094,0.04388822653544634
75586,SIDM00835,Palbociclib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,2.2957373,0.08076433,1.5835894257386656,0.10167879631881685
57756,SIDM00957,MK-2206,MK-1775,Large Intestine,0.25,Colon Carcinoma,Male,Unknown,69.0,2.6324117,0.050681897,1.6295210105657736,0.10819239821767014
80928,SIDM00957,Afatinib,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-3.6872315,-0.092849575,2.652208687442246,0.15240106259872527
48898,SIDM00673,NU7441,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.72809136,-0.052440546,0.26056736919201595,-0.029089763722857067
64415,SIDM00146,Gemcitabine,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.7157753,-0.053223357,-1.5225900453878232,-0.18097205984092934
26601,SIDM00097,Entinostat,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.6583395,0.038227756,0.42698199129416964,0.014825148616782503
102261,SIDM00872,Paclitaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.43805486,-0.044254553,-0.8016676850675947,-0.018564886181415236
14972,SIDM00216,Taselisib,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.0767255,0.054528464,-1.8711935760505676,-0.10133896677196699
65438,SIDM00928,Bortezomib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-0.6031217,-0.046711355,-0.6575646000271179,-0.059741702974927334
88365,SIDM00928,Nilotinib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-1.2766083,-0.10172051,-0.26956386894467477,-0.05914025523298946
31521,SIDM00877,BI-2536,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.28729025,0.00067561836,0.006996241128657799,0.01533641719031341
55876,SIDM00146,Temozolomide,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.909157,0.028405989,0.7643378172664682,0.059687206485032035
27266,SIDM00875,Axitinib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.948602,0.05897906,-0.2773127356501154,-0.005212140957989939
5763,SIDM00633,Alisertib,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.007488,0.098158374,-0.8025098632648384,-0.012107610736478895
102596,SIDM00097,SCH772984,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.3960242,-0.0685405,1.465960193822447,0.057324868190688626
54779,SIDM00146,Palbociclib,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.0218068,-0.06746049,-1.0598465181646224,-0.05135409778248715
17634,SIDM00282,AZD8055,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,55.0,-2.7181318,-0.11450648,-1.7126878234129044,-0.08455788985097147
79619,SIDM00933,Taselisib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.1384449,0.103681974,-0.08986549562832019,0.05324976093220925
34279,SIDM00872,AZD8055,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6181211,-0.062471252,0.5035937513316556,-0.024375657631685546
20529,SIDM00833,AZD4547,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.51558965,0.02994548,1.0073207546489447,0.06778296877397234
30105,SIDM00826,SCH772984,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,2.9048343,0.018558346,-2.1280111192991518,-0.05382983245854301
46927,SIDM00673,Alpelisib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.261861,-0.07424534,-1.0409656220479808,-0.052034179760319876
25342,SIDM00837,Crizotinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.217696,-0.016605891,-1.8906807035024935,-0.11363796935026409
29065,SIDM00673,RO-3306,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,0.8933788,0.04304755,0.07665271135503691,0.06022752531485917
15890,SIDM00837,Olaparib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-1.4927303,-0.03911828,0.6910492169301178,0.018037446096338634
31471,SIDM00282,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.938304,0.12634234,2.236725868650318,0.12661874646839297
7642,SIDM00776,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9959745,-0.05185671,0.4094633779236603,0.02247143764022532
10696,SIDM00950,OSI-027,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-4.2424006,-0.20975207,-0.8453731239475027,-0.08675723464831751
88756,SIDM01187,OSI-027,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1145129,0.10210822,-0.7426478470373912,-0.03702400809950928
97138,SIDM00835,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,0.44961232,0.023411836,1.9023628106736241,0.059534993846300774
72656,SIDM00875,Pictilisib,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6946754,-0.09114416,-1.8328237436568589,-0.09110510227355145
86838,SIDM00875,AZD8055,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46917424,0.051537678,1.1841251762505425,0.1545039360191082
69949,SIDM00835,Nutlin-3a (-),Dabrafenib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-2.0813794,-0.05369334,-0.8619524264705348,0.010576236791711189
90661,SIDM00877,Pictilisib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7264997,-0.07699939,-0.030277036084801933,-0.0035120627094741338
101989,SIDM00875,GSK269962A,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.63428944,0.04415664,-0.14929671219625487,0.0009111890804254771
88468,SIDM00837,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,3.2982197,0.07615436,0.7483574721213698,0.041106640862792074
36822,SIDM00148,Bortezomib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.48392966,0.041182593,-0.5151014199541453,-0.004900467037384501
106391,SIDM00455,Paclitaxel,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.9543191,-0.08162677,-0.046181117421167026,-0.017781142994895586
81189,SIDM00146,Alisertib,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.81342894,0.06613113,1.7314248912798478,0.15890017755404173
49919,SIDM00148,AZD7762,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2518811,-0.17002827,-1.1835674603935242,-0.09895040118431346
108126,SIDM00933,MK-1775,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.35400203,-0.028543264,-0.8251830550104723,-0.015087907434659808
49205,SIDM00146,Dabrafenib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.9799975,0.042738795,0.7952174220735477,0.02542629666160289
30715,SIDM00776,Linsitinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,65.0,-2.112978,-0.10717286,-1.2727054830142572,-0.04078186544559194
88145,SIDM00359,AZD4547,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.333624,0.17518328,-2.511574385148886,-0.05269033592894003
107918,SIDM00877,Afatinib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,1.07071,0.128746,0.7587437061702584,0.015076167598714493
41107,SIDM00875,Venetoclax,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.47192985,0.013159815,-0.21518908394931976,-0.010496131065411016
101191,SIDM01042,PD173074,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.25242,0.19171011,0.27132429061388347,-0.013804225287640531
77999,SIDM00957,MK-2206,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,2.4310286,0.04506464,1.3223914257072107,0.12426693902689512
107343,SIDM00877,AZD8055,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-1.3107214,-0.14511678,0.42952974947354194,0.040187880497032494
21262,SIDM00826,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,-2.8273907,-0.19994853,-2.3629045022887816,-0.15921383052351462
17632,SIDM00872,Vorinostat,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.2365713,0.19755754,0.9238315249313422,0.11080837045755086
18399,SIDM00359,MK-1775,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.14932543,-0.012981429,-1.29516689663329,-0.06601977997657203
25590,SIDM00673,Palbociclib,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.34646523,0.016418543,0.6541733916839813,0.07095463122948495
97373,SIDM00282,LGK974,MK-2206,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.321109,0.11407536,0.5613455620189303,0.0239198283360616
17499,SIDM00933,Luminespib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.5579535,-0.023917131,-0.7502239774097315,-0.08240532132688375
38999,SIDM00826,BMS-754807,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.0490447,-0.004356417,-2.6051657967656157,-0.02787188318478287
50952,SIDM01187,OSI-027,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.5245081,-0.031015486,0.036046918029793,0.053714769794657016
93759,SIDM00146,KU-55933,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-1.4804286,-0.059208658,0.5026756516638058,0.04716419517003502
87208,SIDM00455,Gemcitabine,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.4216871,-0.12605077,-1.1821587847781632,-0.0001994831276117439
93607,SIDM00097,Vorinostat,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.5147614,0.05950335,1.1668091979452164,0.08054342141902088
21948,SIDM01042,Alpelisib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.0260535,-0.08637225,-0.25743351800133707,0.011992342854704104
41675,SIDM00826,BMS-754807,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-4.4307933,-0.044175453,-5.5358708589865415,-0.137946128181391
21939,SIDM00359,LGK974,5-Fluorouracil,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.5791586,-0.01909087,-1.1154728742939408,-0.015978843083923402
47411,SIDM00875,OSI-027,Navitoclax,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3612335,0.15063082,-0.30840396360612327,0.06535554711680629
20284,SIDM00835,Oxaliplatin,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,73.0,-2.3122284,-0.15245394,-1.9723564454064284,-0.08882937032322659
75970,SIDM01042,Uprosertib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0918351,0.030493336,0.7572699469312858,0.00034409643056186546
40723,SIDM00146,Axitinib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,1.4597402,0.09042931,0.535738116549419,0.0641231902393644
10958,SIDM00950,LGK974,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8651674,-0.063354075,-0.28425112194819857,0.009743527933061446
73302,SIDM00146,ZM447439,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8540033,0.07149102,1.1362848559006,0.06263053614600829
4451,SIDM00928,GSK269962A,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,-0.10919175,-0.009499286,0.44703410462205057,0.039365447944434764
31833,SIDM00872,AZD6482,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6378185,-0.062346328,0.6671784912958793,0.05303968460826973
79450,SIDM00776,Linsitinib,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-2.127494,-0.110520825,0.4450850730860879,0.009852071841852883
88957,SIDM00673,Axitinib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,0.89871156,0.093360595,-0.5365323043193231,-0.00778194885061476
102948,SIDM01042,Luminespib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.46682903,0.043633267,-0.5994638060289,0.004223454776737143
86405,SIDM00875,Navitoclax,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.09274877,-0.008211561,1.5633212311660245,0.05942519086033907
64282,SIDM00872,SCH772984,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,3.8723476,0.21224925,2.271036357345774,0.07029797212978113
70365,SIDM00216,5-Fluorouracil,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,East Asian,56.0,-3.2218823,-0.14066534,-2.578638075122676,-0.17049959920093932
74565,SIDM00148,MK-2206,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3023593,-0.16731976,-2.6631177822171175,-0.08815268570889227
7058,SIDM00928,Uprosertib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,2.7675679,0.23284376,1.9994146405047808,0.1319168010454994
46908,SIDM00148,Afatinib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6644672,-0.03635488,1.7059246222362618,0.11129837217964277
37612,SIDM00673,Alpelisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,0.82852954,0.049755994,0.2948266923493257,0.09412143336400611
79156,SIDM01197,MK-1775,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,0.35452342,0.00964013,-0.5061615722252706,-0.0004075240550951621
24849,SIDM00146,SCH772984,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,1.7883617,0.13858493,0.9025065228488465,-0.00756774209247185
11660,SIDM00875,Uprosertib,Docetaxel,Breast,0.00025,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.4472599,-0.042889453,0.5019631712152822,0.04589759181528097
77232,SIDM00872,ZM447439,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.1654297,0.12387662,-0.30268157071311586,0.02810800070915548
59088,SIDM00837,MK-1775,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,0.5022728,0.023846813,-0.8756152733546305,-0.02601589954786188
52420,SIDM00833,AZD7762,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Male,White,53.0,3.9890523,0.28677353,1.4681967234916684,0.06639490582964397
103563,SIDM00359,Camptothecin,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0127672,0.07534373,-1.8145844815039383,-0.02562715158632448
57924,SIDM00776,Nutlin-3a (-),MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,-1.9292276,-0.054792933,0.5081266016935752,0.02533035100583185
103287,SIDM00633,Doramapimod,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.1242487,-0.13918422,0.8823687240837005,0.023976571546733782
12463,SIDM01042,MK-1775,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.49057263,0.03735453,-0.9446906455651565,-0.05027222751483582
55601,SIDM00957,5-Fluorouracil,Nutlin-3a (-),Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.44843954,-0.005542103,1.7988744199623012,0.07416223433305287
54736,SIDM00835,Navitoclax,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.525582,0.029223047,1.9323656264954399,0.012772566212894382
2046,SIDM00146,NU7441,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-0.79014444,-0.07242625,-0.4362463163241371,0.0003925726890534381
64780,SIDM00928,GSK269962A,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,0.46604452,0.04257032,-0.1558081064366668,0.043207190070726854
106355,SIDM00950,Ruxolitinib,OSI-027,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.7407448,0.048239905,2.2223965023324146,0.02948481112414162
29238,SIDM00875,MK-2206,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.7685199,0.2305101,4.679372646954124,0.2391974488948654
58079,SIDM00359,Taselisib,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.8147211,0.10129457,1.2146340006299838,0.1039077425424895
18462,SIDM00776,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4634376,-0.07901477,-1.488631749037749,-0.0628853822365199
27648,SIDM01187,Cisplatin,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1689019,-0.0799991,-0.9940934568150216,0.003965056468164652
73105,SIDM00933,Sorafenib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,45.0,-0.49688286,-0.04602165,-0.08936213612423412,-0.019482253379231512
59912,SIDM01197,Oxaliplatin,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.5819288,-0.09822456,-0.8916228138044971,-0.04783686233178397
49079,SIDM00455,Navitoclax,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.2854302,0.08424541,2.1992355021002523,0.11687358072035593
6677,SIDM00148,Luminespib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8245856,-0.034661815,-0.37920611371173485,-0.049017324309321104
75026,SIDM00148,Linsitinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6559213,-0.10827819,-0.7479966869230571,-0.02592044234554377
88142,SIDM00633,PD173074,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.3742353,0.031991597,0.4908211167396087,0.016283492791730733
59603,SIDM00826,BMS-754807,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-2.1356363,-0.024069713,-4.5532739526755766,-0.1519235714880322
39106,SIDM00776,Oxaliplatin,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.4645,-0.1253374,-1.0891504860397472,-0.025456973698655436
20857,SIDM00776,BMS-754807,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.73360366,0.06786299,-0.4066972652472096,-0.08590926883925909
72138,SIDM00872,Bortezomib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2755813,-0.021281622,-0.5693193440410496,-0.03980271998606672
22230,SIDM00837,MK-2206,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.7100651,0.09575413,-1.484930413782742,-0.05159039851286489
61397,SIDM00875,GSK269962A,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.11407,0.3667395,2.226040565225938,0.13713453098777134
53769,SIDM00148,Entinostat,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3288282,0.06849181,-0.521307958671811,0.011467576978193394
107159,SIDM00837,SB505124,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-1.1768991,-0.04488418,-0.43869871452798476,0.0006154341502380016
95067,SIDM00833,Camptothecin,Linsitinib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.7616192,0.12026328,0.45195166346704774,0.04163768294709546
84622,SIDM00673,Palbociclib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,0.38670242,0.01818716,-0.12905349719514406,0.05699329968396036
17784,SIDM00928,GSK269962A,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-1.1966255,-0.09171414,-0.34898012008839324,-0.003397256934954685
8072,SIDM00673,AZD7762,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.12536386,-0.0074668527,-0.15552249608025726,-0.06953292052999849
70070,SIDM00146,NU7441,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-1.4541113,-0.13026614,-0.17416700109547698,0.011767785304295534
3542,SIDM00148,AZD6482,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2206436,0.12704943,1.0361536713277981,0.041164688072824134
20388,SIDM00877,PF-4708671,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.5360268,-0.027104665,0.7307593429242271,0.09072073401737897
80775,SIDM00837,SB505124,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.7025563,-0.0340021,-0.9818672346165922,-0.04223472367058857
89620,SIDM00673,Vorinostat,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.81493527,0.08697948,0.15289049030916393,-0.014769842582417418
47001,SIDM00957,Navitoclax,Olaparib,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.8628281,0.07460231,-0.9492852429796035,-0.06079994288983973
33256,SIDM00097,Navitoclax,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.6608781,-0.048661824,-0.2954124093618926,-0.03061078452603265
86363,SIDM00673,Uprosertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.5771369,-0.09597433,-1.5176544158629945,-0.06962935708678494
5123,SIDM00933,Doramapimod,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,3.6905265,0.1732794,1.7083952903258253,0.05723210341111153
2176,SIDM01197,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,1.0877861,0.087033644,-0.48003189591135076,-0.03899110871071277
10170,SIDM01187,Lapatinib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1252133,0.072234154,0.7494417348177562,0.03674728592382325
98137,SIDM00928,Crizotinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.8241379,-0.08174684,-0.5057599802062429,-0.02422114828393116
28863,SIDM00776,Navitoclax,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6696437,0.03622263,0.47192546167721416,-0.010947212075238775
99702,SIDM00872,Luminespib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,0.71589625,0.06760234,0.9288624826775,0.06922343387480978
6585,SIDM00826,Linsitinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.375078,-0.056259207,-0.7113839940989791,0.017734665794181495
11775,SIDM00097,Afatinib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5630655,-0.10572335,-0.26042074637444484,-0.049869607427411054
45911,SIDM00673,OSI-027,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-0.02554007,-0.0026493422,0.1940101542328783,-0.006141376495145847
103084,SIDM00872,Camptothecin,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.84916747,0.020240687,1.5263484493417785,0.04168979503549091
371,SIDM00282,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1117609,-0.08259327,-0.5083888742271596,-0.055196917387903735
104101,SIDM00216,5-Fluorouracil,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.0340121,0.06108784,-0.6914302453714629,-0.05080363305353048
25763,SIDM00928,Afatinib,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,0.85322225,0.099504665,0.03589780316915158,-0.012016536735714808
577,SIDM00633,Navitoclax,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.345196,0.17952149,2.3918614732627623,0.1383846428278363
107280,SIDM00097,Tozasertib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.1852381,-0.06699274,-1.234794240369761,-0.042080666688996494
87531,SIDM00933,RO-3306,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.7054209,0.16895093,0.3766119898393091,0.028781706715886767
8634,SIDM00928,Luminespib,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.5187004,0.11837046,-0.516676156521326,-0.08338151193873204
19840,SIDM01042,Paclitaxel,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.8651657,0.087756604,-0.6623602718680198,-0.03601663307264183
22957,SIDM00673,ZM447439,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.601322,-0.048248447,0.253696940632289,-0.01345096175484853
86736,SIDM00835,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,73.0,4.7873664,0.13637207,1.1645209012874143,0.0329296278402707
8620,SIDM00673,Axitinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.1237383,-0.16478823,-0.4229860786813304,-0.05884024120183228
48147,SIDM00148,Alpelisib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7537534,0.15445244,0.6216542094111912,0.03323514973599824
157,SIDM00826,Palbociclib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-4.552514,-0.14056066,-2.6577931273450512,-0.12942471285571183
73895,SIDM00826,LGK974,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-0.28392297,-0.007770851,-0.5511072609620955,-0.03189177217953573
77599,SIDM00776,Afatinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-2.2045753,-0.09520995,0.25639936264306834,0.029379377450925528
76447,SIDM00837,SB505124,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,-0.62410945,-0.044007972,-0.05448971744848577,-0.0511398046577938
32715,SIDM01042,Luminespib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,0.62489444,0.05618589,-1.035907092993037,0.04864999030555651
100796,SIDM00146,BI-2536,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-1.6173208,-0.070372656,0.49783472088960506,0.02781265542512935
29192,SIDM00928,BI-2536,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-1.1697717,-0.06587967,-0.6274100445414881,-0.05261742054909516
1676,SIDM00097,Bortezomib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2179427,-0.0481203,-0.9288536615087842,-0.0685827616727039
43894,SIDM00097,Cisplatin,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2334673,0.025306363,1.2910715879194647,0.02155675797509732
58031,SIDM00928,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,1.1518368,0.14018637,0.7772759417567064,0.019231040537876425
89886,SIDM00148,Lapatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8630137,-0.073505186,0.15847659084459376,-0.010865876275984506
17351,SIDM00042,Gemcitabine,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.68505293,0.07389022,0.15636940208169334,0.07740392818603449
41962,SIDM00633,Temozolomide,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.48789337,0.011178649,0.08968428185436654,0.012971293965266712
636,SIDM00216,Vinorelbine,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.689087,-0.06298,-2.4502736943669885,-0.095501099818473
64000,SIDM00877,Camptothecin,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.54091513,-0.055960987,-1.3762636835983681,-0.1357794201580961
65305,SIDM00957,Camptothecin,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.9379437,0.07560214,1.5220147001551505,0.05043784997978503
93796,SIDM00282,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,55.0,1.4546859,0.061846256,-0.45736572143882337,0.0013472187721298731
27020,SIDM01187,Temozolomide,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,4.5157967,0.24137436,-0.5262305742600997,0.00821126747843566
93725,SIDM00146,Ribociclib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,-0.9237034,-0.03967564,-1.1392025622129307,0.005920588744718936
12423,SIDM00673,Doramapimod,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2346535,0.0236064,2.274805659080769,0.09193983085036021
85947,SIDM01042,Camptothecin,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1373779,-0.11521679,-1.1927669697777525,-0.06436051859831
10751,SIDM00042,Navitoclax,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6145573,-0.0415193,-0.18007025503605814,-0.07235947440063611
2066,SIDM00872,Crizotinib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6837147,0.06169229,0.9127698380720806,0.048340188952449716
9944,SIDM01042,Taselisib,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,0.47600907,0.032870963,1.834219281183417,0.08094872388040306
101926,SIDM00933,JQ1,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,1.775701,0.13019554,1.0445899152370426,0.09067341145572282
42408,SIDM00875,JQ1,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1224071,0.097831026,-1.639267655299235,-0.09864371395931418
67177,SIDM00097,Afatinib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.22264887,-0.013597988,1.7309547172689206,0.07580184730593666
62490,SIDM00875,SCH772984,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.60253155,-0.0673112,0.4347194936630825,0.05203918246865343
59326,SIDM00877,Doramapimod,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.33479697,0.029806664,0.5229238804993869,0.06504445360870499
24514,SIDM00359,BMS-754807,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.9482335,0.14215554,1.2005651564229562,0.0726079814747858
15156,SIDM00877,ZM447439,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.287793,0.18172142,0.41937341436487335,0.08947588943295083
63512,SIDM01197,Trametinib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.7916334,-0.05494836,-0.7796028366926139,-0.04495099535076653
59432,SIDM00875,AZD7762,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.6226379,0.07137606,0.4079728872519453,0.05339872472101634
74630,SIDM00933,Entinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.8669656,-0.057283577,-0.9337612360698879,-0.04245036299955619
72148,SIDM00928,5-Fluorouracil,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,3.7578502,0.3609745,1.8614500948960113,0.1348376061367609
24699,SIDM00872,5-Fluorouracil,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.28868988,-0.014963776,-0.7961816703184437,0.011749279866313427
54629,SIDM00148,Pictilisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6706636,-0.11871836,-1.2659171696497626,-0.04757799149674247
78013,SIDM00359,BMS-754807,Dabrafenib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.0843456,0.16724464,-0.544639621019151,-0.011855115659421754
53238,SIDM00837,SB505124,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.9629564,0.05359425,-0.28990501141276004,0.04114045373499061
7925,SIDM00928,Olaparib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.2447538,-0.10351962,-0.9339858760210576,-0.06866189646666045
12317,SIDM00875,BI-2536,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.6022199,-0.081463195,-3.0456100947798155,-0.148957388456654
29541,SIDM00146,Lapatinib,Taselisib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.93662906,0.09025304,1.1551760492014158,0.040776545237572334
56555,SIDM00455,Trametinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.7825236,-0.034881726,0.6920378651834553,0.10513056399689621
61631,SIDM00633,Taselisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.5382924,-0.1513339,-2.2246707138306636,-0.09281114977803613
12677,SIDM00282,MK-2206,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.6857476,0.121215776,3.009194237380687,0.2616247317926845
65913,SIDM00957,Linsitinib,Trametinib,Large Intestine,0.1,Colon Carcinoma,Male,Unknown,69.0,1.5270622,0.0278789,2.754789898939565,0.13621712399419894
99573,SIDM00957,AZD4547,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-4.77408,-0.08332783,0.0854767083313842,0.0031755348314397025
70067,SIDM00950,Crizotinib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.6276749,-0.15875329,-1.6320961988146814,-0.12063198989961496
51638,SIDM00148,KU-55933,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.11792463,0.0042219437,-0.2542867403023949,-0.003683375016885563
56094,SIDM00359,Olaparib,BMS-754807,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,2.1144345,0.06028275,1.0580555303963457,0.053678236583131214
64730,SIDM00826,Dabrafenib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,1.1854706,0.039090674,-2.9578702541553836,-0.12646606886627054
28662,SIDM00148,SCH772984,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.9788932,0.092674926,0.4035609368938696,0.017250102230874902
51558,SIDM00877,Bortezomib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.53152835,-0.035992898,0.3627123303868066,0.04100229756643202
103082,SIDM00875,Sorafenib,Cisplatin,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.34568608,0.03343806,-1.1388689009973474,-0.03555766716562363
36772,SIDM00933,Nutlin-3a (-),Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.2638837,-0.038546346,-0.6615601496874673,0.00827431318323234
44557,SIDM00359,5-Fluorouracil,AZD8055,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.32938734,0.021474108,-1.5846312016849955,-0.05096179043095534
17584,SIDM00633,Axitinib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.94760203,-0.01162243,0.5018167625020652,0.023119291815178834
40285,SIDM00633,Linsitinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5327475,0.08485668,1.7808002455260403,0.05383938647015056
94760,SIDM00097,Alisertib,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6784838,-0.08152427,-0.08953331305480447,0.005460897136864777
52194,SIDM00872,Wee1 Inhibitor,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.26045078,0.026718237,0.497204243969118,-0.01958550966664207
101799,SIDM01042,Entinostat,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.6656492,-0.077067114,0.1355555559103315,0.02998994302889852
16735,SIDM00875,AZD7762,Nutlin-3a (-),Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.11863159,-0.008065349,-0.7689696807038092,-0.04026591820169468
86093,SIDM00359,Olaparib,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.7634184,0.04729651,0.8699578876545365,0.024173221374621887
8383,SIDM00872,Alisertib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.72279704,-0.02726811,-0.32366689500202184,-0.03481924247835694
80122,SIDM00216,Crizotinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-2.9719057,-0.15266189,-2.3400966245463595,-0.11083653363765344
27273,SIDM00933,Gemcitabine,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-0.35226434,-0.0010864497,-2.171337326355761,-0.049868255546492775
24701,SIDM00928,Paclitaxel,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,-1.9920235,-0.18443751,-1.4310142626373807,-0.1306315654811682
77381,SIDM00148,Nutlin-3a (-),Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8228597,-0.080531545,0.4228806542715926,-0.03409193765398088
70505,SIDM00673,Ribociclib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-0.94944596,-0.033324596,-0.8258912867100493,0.03123166645444564
50612,SIDM00833,Olaparib,MK-2206,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.9991261,0.042408872,-0.0521384227674638,0.02053020541515184
135,SIDM00148,Venetoclax,Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.95100224,-0.035146397,-0.4635419207970082,-0.025631088540380077
80543,SIDM00928,Alpelisib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.1571465,0.22502331,1.7627533942427207,0.09905510522262426
70590,SIDM00216,Navitoclax,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,East Asian,56.0,-2.5157077,-0.2091512,0.10337814717464287,0.04908441879138941
80489,SIDM00837,SB505124,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-2.1201265,-0.119490094,-0.7179715537906138,-0.08021588987653344
32514,SIDM01042,Paclitaxel,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.16987516,-0.019321555,-0.7714303096964074,-0.03308554264666379
7045,SIDM00933,Pictilisib,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,0.6242414,0.06828331,-0.6555601372341658,0.012614196931561244
81497,SIDM00877,KU-55933,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,White,44.0,-1.0199947,-0.048370745,-1.4416733316405526,-0.010473952027170396
55519,SIDM00933,SCH772984,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,45.0,-1.1095797,-0.072839916,0.42435464545817503,0.026168771114480984
16980,SIDM01042,ZM447439,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,0.88162583,0.11866656,-0.02119429016932966,0.03253621371638644
12205,SIDM00875,Entinostat,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.88654166,-0.03985237,-0.0784155846677232,-0.010946451123055435
2922,SIDM00148,Alpelisib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5735211,-0.041870646,0.46564110957736804,0.053806356025007385
16182,SIDM00359,Camptothecin,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6827137,-0.05045894,-0.6666350070236075,0.0324718959294311
63318,SIDM00875,Dabrafenib,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5677249,0.02778825,0.5614474884954828,0.04251351922565803
6766,SIDM00146,Linsitinib,PD173074,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.8680642,0.018153027,3.0419365524699136,0.10422616407792701
14167,SIDM00673,KU-55933,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,Black,49.0,-2.6772006,-0.14483432,-1.957054861459196,-0.07470841208544574
10107,SIDM00633,Gemcitabine,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8461943,-0.07289242,1.477119681061176,0.05466907177267673
8550,SIDM00933,Vorinostat,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.34989062,-0.0507708,-0.355039860219713,-0.011494351409545158
80833,SIDM00875,BI-2536,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-3.1471949,-0.19925866,-2.6391377121232904,-0.116482171056835
5696,SIDM00146,MK-2206,Pictilisib,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.35037744,-0.01917606,0.26332076932071674,0.07672116848834755
7879,SIDM00673,Uprosertib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.5848762,-0.043773066,0.131100947567236,-0.0019410505133205013
1963,SIDM00826,Crizotinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.63308245,-0.01764077,-2.2333969856247813,-0.04761436745284305
69601,SIDM00877,Linsitinib,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7982476,-0.04463351,-0.8602094914690831,-0.03856947500639117
101311,SIDM00673,GSK269962A,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-2.0950987,-0.14884569,-0.5501926721716406,0.021522166176572346
50196,SIDM00837,5-Fluorouracil,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,-0.159025,-0.011397486,-1.4695301404294092,-0.04630882092861421
48426,SIDM00633,Wee1 Inhibitor,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.2291205,0.09162309,-0.9496425789460287,-0.02731437352061808
95571,SIDM00673,Bortezomib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.20682357,0.010386048,-0.6564021668834404,-0.03790844609217968
87686,SIDM00872,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.5850741,0.06054656,-0.021868514998641658,0.03235772418236632
75360,SIDM00877,BI-2536,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.5393031,-0.0018433371,-3.236411647945459,-0.08491243415621955
39606,SIDM00042,Navitoclax,Oxaliplatin,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6370315,0.03492071,-0.07491986089191428,-0.016269400991910033
34335,SIDM00833,BMS-754807,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Male,White,53.0,3.2109847,0.20322481,0.12061887858961444,0.01818988297090624
9320,SIDM00216,Dabrafenib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.6326134,0.023338111,2.3300133593364114,0.0859386061245136
59956,SIDM00875,PF-4708671,MK-2206,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.46005362,0.021757957,1.8391916172836134,0.08765302011363955
53422,SIDM00042,Navitoclax,Irinotecan,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.8440087,0.09145262,2.4737049383596177,0.12820046404816393
21700,SIDM00148,Gemcitabine,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.53834105,0.035551645,-1.7720037048298078,-0.07091985931102424
64498,SIDM00877,AZD6482,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-2.30597,-0.18617646,-0.7674097846615002,-0.08683964309505945
102623,SIDM00282,Afatinib,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.897812,0.06918878,1.537335179180882,0.07738783382327125
79330,SIDM00872,Wee1 Inhibitor,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.86326706,0.08817478,-0.45718440392941123,-0.08674540579924955
24654,SIDM00950,Irinotecan,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,4.1442833,0.38558114,3.399620250758782,0.2305636230569502
69151,SIDM00282,Taselisib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6798147,-0.048909184,0.2848392200651886,0.024838624642104592
103271,SIDM00826,Camptothecin,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,2.351971,0.08215733,-2.0887564343779985,0.0030232993800561703
29929,SIDM00097,Cisplatin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4070508,0.033721395,1.7210108032677014,0.07625272841995483
15491,SIDM00928,PD173074,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.5540267,-0.040804937,0.9079601257929409,0.07404159229741206
22709,SIDM00950,Sorafenib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.671036,-0.07278275,-0.6059036630470672,-0.03672131411175658
26035,SIDM00833,Oxaliplatin,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6085222,-0.04987757,-0.7969612152305592,-0.08539521585925193
35371,SIDM00933,BI-2536,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.8287733,-0.028286092,-5.409960584249203,-0.13767748038427022
97434,SIDM00282,AZD4547,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,East Asian,55.0,4.6569366,0.1453825,2.3313184396285664,0.049661545555328326
55659,SIDM00826,Afatinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.4736086,0.095501915,-0.04796976901197646,0.09059349408604137
10576,SIDM00875,Uprosertib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.4128466,-0.08613999,-1.040160828860204,-0.014259032510410677
408,SIDM00875,Docetaxel,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6482099,-0.053261228,-3.027967540307539,-0.2213169754378026
83582,SIDM00826,Taselisib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-0.397903,-0.0299804,-0.705354568864609,-0.02422983393444204
34128,SIDM00872,Doramapimod,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,2.0781279,0.11453413,1.5138340689026208,0.12193754491729646
30052,SIDM00633,Tozasertib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.7350919,0.058785442,2.3963656527131416,0.05961831055280897
26562,SIDM00282,Navitoclax,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,2.9154925,0.21650913,1.8805407522043,0.11335200803833786
19436,SIDM00872,Alisertib,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6530894,-0.024023358,0.23404643493735755,-0.022969369135861603
96410,SIDM00148,JQ1,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2810533,0.087801255,1.676272400543143,0.08941944225699276
30638,SIDM00877,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9050593,0.05736952,0.29839481748236774,-0.005816893210765457
74252,SIDM00928,5-Fluorouracil,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-1.9331706,-0.07653832,0.24604422125338182,-0.010205215736846397
104482,SIDM00835,MK-2206,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,2.5606332,0.17703292,-0.12421457122870574,0.05135588425778721
43511,SIDM00928,ZM447439,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.120769665,0.012648416,1.4350248723739907,0.04463070084588068
73723,SIDM00359,SB505124,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8963684,-0.14714895,-1.3019052572265275,-0.05047537944998667
34958,SIDM00875,MK-2206,Crizotinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.9712063,0.17899935,0.1375336746890533,-0.017075479414058806
75017,SIDM00933,Bortezomib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.13850956,-0.0147958845,-0.8580518871511921,-0.048867380659732326
100223,SIDM00359,Nutlin-3a (-),Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.3500276,0.029948637,1.420556316191212,0.0358172241243724
94887,SIDM01042,Paclitaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7939292,0.13757415,-1.1414662159223699,-0.07977873841118524
50562,SIDM00950,Gemcitabine,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-3.4205122,-0.1764872,-1.1996579457344763,-0.028481163558050512
44451,SIDM00633,Crizotinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4676336,0.06620339,0.4523803326329175,0.0011624261716080238
64214,SIDM00877,Venetoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-0.7479434,-0.030150058,0.4403805447905831,0.05956375441870251
1826,SIDM00455,AZD7762,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.41892713,0.014713831,1.7214155736255725,0.0777065896609009
79546,SIDM00875,BI-2536,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-4.9915543,-0.1272802,-3.4968370036723817,-0.11829058134986141
5194,SIDM00872,Linsitinib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.5496726,0.14647399,0.49388154068512485,-0.004401827270211418
85665,SIDM01187,Axitinib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.8324098,-0.05860079,-1.4101821648649142,-0.041792566238208005
64393,SIDM01042,BI-2536,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.060202,-0.019437157,-4.2312483487392205,-0.15786761540823888
3144,SIDM00933,Ribociclib,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.66074246,0.015814336,2.378122019469897,0.0261075391866013
62487,SIDM00146,Palbociclib,Trametinib,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.7578043,0.038288534,-0.7588821562617026,-0.008181073487981992
4168,SIDM00148,SCH772984,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.3618894,0.10866353,2.7885766997265162,0.10767510822812644
83919,SIDM00950,Palbociclib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.4978038,-0.058328442,-1.4271976343032395,-0.04107475981460418
73750,SIDM00146,Vorinostat,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.1260054,0.07588487,0.10701032518094526,0.03203429608738396
29207,SIDM00833,Trametinib,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,1.9384967,0.05496502,1.8520934591143159,0.10245636711445523
102958,SIDM00042,Crizotinib,Ruxolitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.34379357,0.04015415,0.1882923201226445,0.012794785693836788
68870,SIDM00872,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.0109806,-0.09327206,-0.5210272726932924,-0.07857430502953781
55262,SIDM00835,LGK974,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,-1.714115,-0.043907948,0.783966712579647,0.051720931935167996
9210,SIDM00835,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,White,73.0,-4.1760144,-0.16144325,-3.3580444875984816,-0.10385174483371179
102300,SIDM00776,Trametinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-0.47627452,-0.04358304,0.0560419976088799,-0.004796569474400502
30012,SIDM00933,NU7441,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,1.7227445,0.15794931,0.8070718616800769,0.07655491762736902
28867,SIDM00148,AZD6482,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.3401557,-0.02500926,-1.5974786609642329,-0.06698590974886344
71326,SIDM00216,AZD8055,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,2.935561,0.23587821,1.1443127548680578,0.08835066540673449
32143,SIDM00833,Navitoclax,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,1.1017238,0.036320914,2.253371943466812,0.06751762738832538
93689,SIDM00146,AZD6482,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.3115919,0.10635942,1.5097592396779183,0.13146521922834728
107173,SIDM00097,Temozolomide,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.3373013,-0.00613795,-0.03049866221416398,0.020419171795349578
63531,SIDM00359,Linsitinib,Palbociclib,Large Intestine,4.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.0263852,-0.0580978,0.20754446578160832,0.004787743439034057
21741,SIDM00216,Trametinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.5892448,0.21671735,-0.7740385161592491,-0.0498444524876943
61482,SIDM00957,Nutlin-3a (-),AZD4547,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,3.0393515,0.091614366,0.5790757219268202,0.0584898024207454
73262,SIDM00872,Paclitaxel,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7008299,0.06326049,0.29082869305787046,0.0097802628661684
63668,SIDM01042,Docetaxel,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8362898,-0.0838484,-1.0772350876871568,-0.03387463310682473
107417,SIDM00832,AZD4547,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,-2.1916368,-0.115871534,0.22710004686119967,-0.00871147460275454
100243,SIDM00673,Olaparib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.2364228,-0.09045803,-0.6638265417517741,-0.0009019232115293568
91208,SIDM00832,Afatinib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,81.0,-1.317106,-0.12500715,0.12103426849845758,-0.037553825199093366
53665,SIDM01042,Vorinostat,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.49832177,0.05439831,-0.7777802081270786,-0.05632719025118692
62176,SIDM00933,Cisplatin,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-0.75023896,-0.06585922,-0.5361223985258283,-0.009858002335892138
27335,SIDM00877,AZD7762,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-0.56922716,-0.04192202,-0.8354809795896408,-0.02196132876173229
79902,SIDM00148,Camptothecin,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.6420189,-0.1309438,1.3491161355933947,0.1175790718090577
85345,SIDM00776,SB505124,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.2205806,-0.09050697,-0.11542991116353,-0.04280662526289661
9887,SIDM00875,Tozasertib,Lapatinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8237036,0.102831684,1.4346827435174856,0.09037851712098194
97276,SIDM00957,Vinorelbine,SCH772984,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,1.1938978,0.018946916,3.7645713819605024,0.08497485150301971
64132,SIDM00832,SB505124,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,81.0,-2.6973038,-0.18346268,0.5254667037264559,-0.01069910319793871
53812,SIDM00148,Afatinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.039807204,-0.0027458626,1.1571290084903998,0.09668980230686951
4237,SIDM00957,SCH772984,Trametinib,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-7.830111,-0.19792905,-0.6143353661981008,-0.06728914056042823
20369,SIDM01187,Nutlin-3a (-),Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.500128,0.035322636,-0.919270458392763,-0.02344176282204785
43876,SIDM00455,AZD7762,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.93146724,0.04668029,1.3599556721740726,0.09470785299676175
96940,SIDM00833,SCH772984,MK-1775,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.977149,-0.045832824,-0.9038805070156087,-0.034097966039811405
100965,SIDM00950,Paclitaxel,SCH772984,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.2049645,0.047364786,-0.04441547143648781,-0.01901683176685254
15452,SIDM01042,PF-4708671,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.20950802,-0.018505389,-0.8168715261303204,-0.07459437726060261
97999,SIDM01042,KU-55933,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.4708964,0.052867115,-1.1123687628060481,-0.056973388935014704
89581,SIDM00832,Trametinib,Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,81.0,1.7766197,0.03224982,-1.1235543437683622,0.05238367815254704
99968,SIDM01187,5-Fluorouracil,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.9531343,-0.059213288,-1.3189618831876009,-0.05800005668905819
55008,SIDM00776,AZD4547,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,65.0,-1.4083825,-0.037627436,0.1760203117783183,0.024761081359545082
13548,SIDM00148,Cisplatin,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.5139204,-0.026422158,-0.4041683909815415,-0.007435276425699992
2340,SIDM00872,PF-4708671,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9470693,-0.080481164,0.09253653560441336,-0.04812554092669606
3822,SIDM00776,Trametinib,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,1.6159179,0.13114624,-1.155239753741147,-0.0637277399996043
72698,SIDM00835,Olaparib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,2.099812,0.0631538,1.312025343372616,0.021096863750576355
80127,SIDM01197,BMS-754807,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Male,East Asian,71.0,1.705424,0.046359077,-0.4867303859615224,-0.016195520122259978
92929,SIDM00872,Navitoclax,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.9159479,-0.057331502,0.8190603455754792,0.10657946059993316
21958,SIDM00826,Nutlin-3a (-),Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,1.2706435,0.031087358,1.890552581223381,0.0688124493275052
14739,SIDM00950,Oxaliplatin,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.302766,-0.09016268,-1.8111046965239366,-0.0270286658149459
98329,SIDM00933,JQ1,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,3.1513844,0.23029676,1.6052037396063983,0.05859421563919487
94612,SIDM00146,RO-3306,Luminespib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,0.9780934,0.073147886,-0.3822477548850528,-0.05438524837965264
44038,SIDM00148,Linsitinib,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2690321,0.10609471,-0.06440762984527264,-0.032528668690646176
100966,SIDM00928,BI-2536,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,2.739284,0.08135958,0.8922785294809443,-0.025950758551360534
76296,SIDM00455,Taselisib,Lapatinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.07004377,-0.004749062,0.9233522118298119,0.08455566488595609
94794,SIDM00633,Alpelisib,PD173074,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6964138,0.06818751,-1.0101723289025115,-0.04450322356037711
8491,SIDM00148,Cisplatin,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.048124827,-0.002664393,-0.4283499297505696,0.04564355250774835
47529,SIDM00146,Taselisib,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,-0.141981,-0.0114416685,-0.27040039465191285,0.000801403213408848
75825,SIDM01197,LGK974,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.6353085,-0.07713132,-1.9447566148520707,-0.09294904795034523
24591,SIDM00826,Crizotinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,70.0,-3.2995338,-0.09506149,-2.286385527819504,-0.10794412994717281
70978,SIDM01187,Pictilisib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.4913118,-0.13541636,-1.1321684971532229,-0.03804488674627516
33637,SIDM00097,NU7441,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.93375003,-0.035553504,0.9403245751314605,0.06963142841585955
106019,SIDM00872,Alpelisib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.5297382,-0.056735117,0.2735300535533703,-0.027519849108684807
851,SIDM00950,Trametinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.2574792,-0.10547904,-1.1768985589086816,-0.017754063069750522
12930,SIDM00633,Taselisib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.9353893,-0.15943144,-3.2962701255653672,-0.1649141766165608
15417,SIDM00872,Trametinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.008642,-0.08931677,-0.7148738266829396,-0.07546399115863553
69212,SIDM00875,Taselisib,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5918382,-0.17064795,0.590378498830652,0.02633816051497984
52896,SIDM00875,KU-55933,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.1184101,-0.043266125,1.024536199414062,0.029906373181679147
2381,SIDM00933,Axitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,45.0,0.69703674,0.07440963,-0.499031408780951,-0.06922638729328352
78220,SIDM00875,PD173074,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0104371,-0.05181783,-0.7476426123240327,-0.038483289538245605
28573,SIDM01042,KU-55933,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9304913,0.11039415,-0.299730091030674,-0.03882659165799674
37456,SIDM00875,Alisertib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7677321,0.17798992,-0.7829814260827389,-0.01440596777056661
35443,SIDM01042,NU7441,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7390115,-0.06893688,-1.1011186165997473,-0.12798647568451152
2731,SIDM00633,Nutlin-3a (-),Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-4.0143833,-0.2110999,-2.383073540074312,-0.14787557198075862
6486,SIDM00146,Wee1 Inhibitor,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.6170319,0.045104485,-0.3343062823692804,0.014357082931600934
69358,SIDM00776,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,65.0,0.8845327,0.07026838,-1.7579698094309923,-0.12590735325453467
70570,SIDM00875,Alpelisib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.5209405,0.12684374,1.0970469015149926,0.0390841433465305
37882,SIDM00633,ZM447439,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2057118,-0.1743316,-1.0443052486950362,-0.025605506434730734
52468,SIDM01042,Alisertib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,1.161502,0.14679356,-0.10397728260420275,-0.05447047017090206
104032,SIDM00928,JQ1,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,0.19522567,0.021852251,0.7016453893412092,0.03624831728571119
77235,SIDM00148,AZD7762,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.252286,-0.074112855,-0.12429787668660211,0.052302486744711635
3839,SIDM00148,KU-55933,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2014376,-0.006929505,-1.1396183228479784,-0.0014795101708436674
83673,SIDM00146,Afatinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-0.5414533,-0.052033488,-0.2606398433611087,-0.009784765376905598
64853,SIDM00042,Irinotecan,MK-1775,Pancreas,0.2,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6935378,0.0739639,-1.9473591301885682,-0.037629581347891246
7882,SIDM00875,Bortezomib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.46608067,-0.034400135,-0.9288097217618441,-0.05609866628024864
19571,SIDM00455,Trametinib,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-3.064162,-0.15866041,-1.0824998909357408,0.004934152695974284
53678,SIDM00875,Pictilisib,Palbociclib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.20761706,0.022767179,-0.6509418709132972,-0.07724388648859863
93377,SIDM00673,Navitoclax,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.035187304,-0.0029764685,-0.5753816698373639,-0.033174955471367534
54219,SIDM00673,Cisplatin,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2476782,0.056376535,1.5331626648111707,0.09281283043277583
19416,SIDM00928,Axitinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.429092,0.12382918,0.5157171500229709,0.023529784112041756
60678,SIDM00957,Trametinib,Camptothecin,Large Intestine,0.025,Colon Carcinoma,Male,Unknown,69.0,-0.24719462,-0.01144489,-1.4473037434535188,-0.0727257157587599
2329,SIDM01042,Paclitaxel,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.5837324,-0.06380702,-0.45656321827709206,-0.003526201971881872
65472,SIDM01197,Dabrafenib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.7912211,-0.086748086,-1.513839361275923,-0.03366168824928388
90780,SIDM00633,Luminespib,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.7066085,-0.13371216,-0.4582202894336417,0.015443399431108744
41392,SIDM00826,MK-2206,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-0.16196959,-0.012134955,-0.5393397876190048,0.0022512513103459314
100007,SIDM00877,KU-55933,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5984632,-0.06722549,0.19916599533627757,0.042103080874907536
95083,SIDM00633,BI-2536,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4475629,0.12838188,1.134240685972676,0.14662206340429287
7975,SIDM00832,SB505124,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,3.566906,0.20662704,1.1057219821948119,0.057212942356548724
8924,SIDM00875,Dabrafenib,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.5064325,0.025021363,0.06908413633036545,0.002744313615130857
22263,SIDM01042,NU7441,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.35992444,-0.032441083,-0.07038400786195502,-0.005965334628925178
98285,SIDM00933,OSI-027,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,45.0,-0.4608613,-0.06487542,-0.320916835862697,0.01734256847228217
68952,SIDM00875,Bortezomib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.59827447,0.056208786,0.2694649887987897,0.016657133761505072
51016,SIDM01187,Navitoclax,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.7548907,0.09123297,2.383108050927997,0.06885183363363809
51978,SIDM00146,AZD7762,Lapatinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.5949667,0.052390754,-0.33095385409222233,0.06204701222120873
10845,SIDM00933,Luminespib,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,45.0,-0.49841058,-0.02546094,-1.037849739979134,-0.054574486256271426
64915,SIDM00833,SCH772984,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Male,White,53.0,-4.4105206,-0.18852496,-2.3208398417062193,-0.1203361520444514
34454,SIDM00359,SCH772984,Vinorelbine,Large Intestine,0.01,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.3007852,0.02211477,0.048876635329485385,0.014130226567680261
2944,SIDM00146,AZD8055,Trametinib,Breast,0.01,Breast Adenocarcinoma,Female,White,51.0,1.206356,0.09347267,0.32371565457536866,-0.0031351279650293795
79263,SIDM01197,Palbociclib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-3.5637352,-0.13227463,-0.6251995753791217,0.0008564120832150004
106083,SIDM00928,JQ1,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.2524421,0.21229081,1.1647537347272048,0.07301085428876777
81812,SIDM00837,Palbociclib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,1.7445807,0.14077693,-1.9739145929520554,-0.13028208460621019
103737,SIDM00673,Camptothecin,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.0174258,-0.030067557,1.5649729352962516,0.07919841497985823
19994,SIDM00877,Navitoclax,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.5418137,0.0638895,0.24859491757331,-0.015469929797675645
37950,SIDM00832,Trametinib,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.9656229,0.048842344,-0.5204743507269515,-0.025960381803190376
60811,SIDM00933,Axitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.7580257,0.10497871,-0.3221973560096168,-0.008721336718119714
7403,SIDM00148,Alisertib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.85691935,-0.047800124,1.1549518476001615,0.0650251291525709
48235,SIDM00928,Luminespib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,-0.82967424,-0.086396225,-0.28217070448696835,-0.07668890711030026
84668,SIDM00875,Wee1 Inhibitor,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.45024642,-0.02674142,-0.3536947489497216,-0.04354216766942849
9712,SIDM00097,MK-2206,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-3.780191,-0.22920062,-1.0328387608020566,-0.11302831406888214
31648,SIDM00148,Linsitinib,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.9369657,-0.24064596,-0.44925924732770645,-0.061259034772892504
85644,SIDM00633,PD173074,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.5627608,0.16293038,1.16061167811799,0.08032499300498742
16310,SIDM00928,Lapatinib,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,-1.5702428,-0.109896034,0.06274980964731701,0.016727077553463712
32929,SIDM00928,PF-4708671,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.69796,-0.11885735,-0.5593301219560073,-0.04842023916894091
47788,SIDM00933,PD173074,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,0.7492338,0.07791654,-0.11917170554228382,0.03133013046560686
86325,SIDM00282,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,2.8301015,0.19818084,0.7748670330030012,0.10266745124182587
50049,SIDM00633,Trametinib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9022043,0.09462865,-0.10717495047084033,0.0327638635267383
81286,SIDM01187,Nutlin-3a (-),Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.607241,-0.15495384,-1.4281287631528505,-0.14208087390841367
79271,SIDM01042,Alisertib,Cisplatin,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0074952,0.13023973,-2.5269726744969296,-0.18739358693128283
53892,SIDM00833,BMS-754807,Oxaliplatin,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-0.69922894,-0.049568687,-2.5807357986393256,-0.14588767328803443
74249,SIDM00950,Irinotecan,Paclitaxel,Pancreas,0.0025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.119093,-0.07117834,-2.3707423841565665,-0.01458604391781521
45154,SIDM00148,Wee1 Inhibitor,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.3619725,0.03479932,-0.12796590324081178,-0.03249144582192103
19295,SIDM00146,Vorinostat,Lapatinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,0.5244512,0.04971701,0.8841326101343775,0.05755356247052811
80564,SIDM00146,Taselisib,Palbociclib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.78813636,0.062027954,-0.3957341305517103,0.016146022670503756
103873,SIDM00950,5-Fluorouracil,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9295993,-0.05956496,-0.9826508552979701,-0.007593448276800104
66161,SIDM01042,5-Fluorouracil,Temozolomide,Breast,7.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.72430086,0.039301295,0.15963653808995473,0.026086491194617777
86313,SIDM00673,Bortezomib,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,0.22677237,0.011444507,-0.7400911927882835,-0.024018236577374598
66522,SIDM00776,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,65.0,-1.5419371,-0.051626828,-0.7379559594545534,-0.01106460618881722
52144,SIDM00359,BMS-754807,AZD8055,Large Intestine,0.125,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.4431067,0.115826376,0.1029584556137048,0.036387486996974056
63516,SIDM00950,Cisplatin,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6237354,0.09056872,0.44132483276616624,0.06930353258534803
92308,SIDM00673,5-Fluorouracil,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0512556,0.045088336,0.15360967202414155,0.02625238518121676
31235,SIDM00359,SB505124,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.32517213,-0.027917791,-0.9734717297547267,-0.006728108165073177
103894,SIDM00359,BMS-754807,SCH772984,Large Intestine,0.05,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.6076689,0.14013311,1.3289104016958997,0.13391751974482904
100483,SIDM00875,Linsitinib,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7496903,0.11800938,2.183934493514447,0.03675661805272912
95924,SIDM00359,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.6130946,0.052115217,0.12934069115430358,0.048147890386629144
88714,SIDM00835,MK-1775,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.57799953,0.04529944,-0.47152644948257566,-0.034907321579100446
90530,SIDM01042,Linsitinib,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1028343,-0.034531407,0.13294375489236523,0.015378199870775999
26724,SIDM00950,Paclitaxel,Linsitinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.8194127,-0.180129,-0.43315059114099624,-0.03670018760563159
5135,SIDM00633,RO-3306,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.92380035,-0.063780695,-0.6920136963160465,-0.03535661927233043
87549,SIDM00950,Dactolisib,MK-2206,Pancreas,1.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6289958,0.081615545,0.1970022732396225,0.027027504549075713
103365,SIDM00872,Afatinib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8663715,-0.08250782,0.1525474065761128,-0.022225430142153845
103290,SIDM00673,BI-2536,PD173074,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.46922234,-0.033223405,1.057583764904887,0.04749390294936086
61161,SIDM00633,GSK269962A,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.6258935,0.061190296,-0.8809839152691749,-0.0130048694576078
76321,SIDM00282,SCH772984,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.2834319,-0.047573507,-0.33507816665306067,0.025676128761153452
24438,SIDM00872,Axitinib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,0.79762787,0.06824227,0.4625771132278318,0.04880016559060156
106646,SIDM00933,Axitinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,-0.8784509,-0.12579961,-1.2165658564955342,-0.041560905613546514
43298,SIDM00933,Paclitaxel,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-0.9670013,-0.08043386,-2.199411487178689,-0.05881202911863382
53841,SIDM00875,OSI-027,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.90601444,0.08037888,0.10025244319046452,0.07852725243973899
35994,SIDM01042,Temozolomide,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9480402,0.02818563,-0.43840173319544,0.011823366858194384
87117,SIDM00148,Doramapimod,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.72832614,0.052780412,0.3007826686550483,0.06254721555712803
83589,SIDM00097,Trametinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6931486,-0.043732908,-0.9504762126059274,-0.01747827069978682
21138,SIDM00933,Dabrafenib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-0.44912,-0.030680144,-0.18860754018480635,0.03138178616328331
5041,SIDM00097,RO-3306,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3021375,-0.06350448,-0.7747860825090315,-0.04693080793026912
105689,SIDM00146,KU-55933,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,0.78332853,0.03876465,-1.305658814696666,-0.00929202009458039
62533,SIDM00877,PD173074,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.301451,0.19709003,0.17666666578226317,0.08437712113859425
105629,SIDM00835,Oxaliplatin,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-0.9440113,-0.074604034,-1.7656010492502396,-0.08053217887028173
94464,SIDM00835,5-Fluorouracil,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.4053005,0.08316089,0.05744411666523375,-0.024445085230322215
97786,SIDM01042,Bortezomib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.18850969,-0.010990521,-1.0119573175576615,-0.08443730923552045
4231,SIDM00928,SCH772984,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.2410715,-0.13541193,-0.516802627130836,-0.01876578354030417
40041,SIDM00282,5-Fluorouracil,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,55.0,-1.439797,-0.08026992,-0.5850065982937914,-0.03965302447330117
28649,SIDM00928,Linsitinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,3.9029033,0.3368197,1.6103856997418196,0.09494510307354567
47968,SIDM00097,Luminespib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0925742,-0.075934805,-1.4002133046797745,-0.08656226615759603
71735,SIDM00455,OSI-027,LGK974,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.1115634,-0.067204334,-0.708816639129725,-0.0616678668800092
71222,SIDM00933,Lapatinib,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,45.0,0.4357873,0.05590296,0.30819927404851033,0.09231531003602274
42273,SIDM00877,GSK269962A,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0629506,0.12939517,0.26074653975578327,0.0012278687521059164
56963,SIDM00928,Pictilisib,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-2.884253,-0.21052139,0.30014012186869554,-0.022720567307898037
8340,SIDM00872,Alisertib,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.68285793,0.03274027,1.7119716603965842,0.1337639955487431
61656,SIDM00633,Dabrafenib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.4939578,0.030822104,2.424730188275411,0.04223062247322569
10516,SIDM00282,Olaparib,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,East Asian,55.0,-1.3918229,-0.026762016,0.8061337201154939,0.01895531582731165
87194,SIDM00957,MK-2206,Navitoclax,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,3.407831,0.07407872,0.3635492492533991,0.03743329826069635
17825,SIDM00833,Palbociclib,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.97171724,0.030226404,0.34928669079332675,0.026584909532009027
21086,SIDM00673,PD173074,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.6611949,-0.038081538,-0.7740809960786124,-0.021530428116733176
17163,SIDM00282,5-Fluorouracil,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.9450852,-0.12914,-2.0518329554670824,-0.1484096338553332
79751,SIDM00148,NU7441,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9198801,-0.08426752,0.026785460538610677,0.01727050740416694
44446,SIDM00928,NU7441,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.2205511,0.14531706,-0.5681133794324713,-0.0005663479806747448
40828,SIDM00282,Taselisib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.6939708,-0.036962707,-1.3007861250873372,-0.04937327829062764
45354,SIDM00933,Alisertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,8.463504,0.50332874,4.207817700275875,0.19026242470336058
103447,SIDM00928,Trametinib,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,0.9551784,0.075804,-0.4062847378327215,-0.05710019184606382
36840,SIDM00875,Palbociclib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.7601279,0.057058375,3.009490817429655,0.1044726333671744
97214,SIDM00875,Cisplatin,Trametinib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.78160274,0.040298518,1.216372741355697,0.04861704984878451
65999,SIDM00928,Palbociclib,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-2.0724065,-0.08277557,-1.2566959290475108,-0.06136877987325107
15340,SIDM01042,Venetoclax,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.1359522,-0.042607363,1.418228956934766,0.038177134198986155
32783,SIDM00633,Alpelisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4087708,0.19290824,0.5535487875379133,0.059393734683970335
57295,SIDM00872,Dabrafenib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.38531482,-0.007539843,1.032332685428951,0.039144690402141386
15642,SIDM01197,LGK974,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.3200417,-0.06294423,-0.7957554428053955,-0.03862656400840601
20788,SIDM00950,Navitoclax,Crizotinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.6035624,0.3236045,2.9612500704560953,0.13854510320627603
59515,SIDM00872,Luminespib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.1989534,-0.08256743,-0.4018903783278075,0.0016989054905781444
103767,SIDM00837,Trametinib,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.58755356,0.013302761,0.8927002079628023,0.017715118735423807
75229,SIDM00826,Afatinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Male,White,70.0,-0.363268,-0.030110046,-1.861539747007495,-0.046766715548279915
58518,SIDM00097,Alisertib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.2698122,-0.07330595,-1.5756276330383,-0.0785774407361262
101887,SIDM01042,Pictilisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.52597064,-0.040288977,0.23129528815232425,-0.025236786344303642
84670,SIDM00148,Docetaxel,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.14485164,-0.011013154,-0.8439867805999949,-0.011848326461450424
16191,SIDM00148,Venetoclax,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.8075921,-0.027850907,-0.3747410237439866,-0.04182619818266661
90523,SIDM00877,Taselisib,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,3.3530807,0.10516847,1.5281849071120934,0.05962121140859309
74849,SIDM00776,MK-1775,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,-2.0950668,-0.13961321,-1.8284340691477836,-0.14173781664401464
48356,SIDM00673,Trametinib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-1.7881249,-0.1347678,0.0014149044110445663,0.01230162823830075
100759,SIDM00282,SCH772984,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,0.7422475,0.04035785,-0.14323876236451014,0.1493191152931697
74683,SIDM00633,Sorafenib,Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.4243554,-0.04117731,-0.7947310961479958,-0.04638102861410916
65470,SIDM00933,KU-55933,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.62084955,0.0060943654,0.26983436969874713,0.022856369776077617
48835,SIDM00633,AZD6482,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3096087,-0.1144679,-1.3351960247806587,-0.07500684606496075
102871,SIDM00148,Afatinib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.3176242,-0.097048014,-1.8224665722247508,-0.13002871195862828
75680,SIDM00833,Linsitinib,Palbociclib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.74346894,0.0506832,-0.15371394184061166,-0.0019470063248381313
72865,SIDM00826,5-Fluorouracil,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-1.7280397,-0.04115022,-3.1123998391162755,-0.10855190118126541
70351,SIDM00097,Afatinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2379521,0.08961156,1.0424985082912859,0.032413783763959085
90352,SIDM00877,JQ1,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,2.430893,0.19518088,1.6156794467150124,0.09794469474258737
59998,SIDM00837,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,2.302058,0.112872206,0.274923872184708,0.05101852427043111
73460,SIDM00837,MK-1775,Afatinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1108028,0.045634996,-0.5302728691103592,-0.03378095705467463
92310,SIDM00148,Paclitaxel,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.8140767,0.2020004,-0.028074112422004287,0.034013237578850046
93134,SIDM00148,Dabrafenib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.85333925,0.05539081,1.1416397980820363,0.042160128300039575
7269,SIDM01187,MK-1775,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.6854726,0.06949346,0.16281974971200136,-0.039124265151175903
47729,SIDM00146,PD173074,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-3.7405767,-0.19671845,-2.598327435892759,-0.1275403740979065
100058,SIDM00872,Uprosertib,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.17643411,-0.018314254,-0.2491288616447663,-0.02812717808229442
93812,SIDM00216,BMS-754807,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.6365405,-0.054738443,-1.5121641043593588,-0.0428036490289789
41621,SIDM00837,Nutlin-3a (-),Taselisib,Large Intestine,0.1,Colon Adenocarcinoma,Female,White,82.0,0.23242232,0.010203917,-0.7387852899682184,-0.003756500757551549
99060,SIDM00455,Ruxolitinib,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.72395295,0.016894527,3.269070717822148,0.12218602858891707
39749,SIDM00148,MK-1775,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.871366,0.106445655,0.6937489505518021,0.06473414209648996
29927,SIDM00950,Linsitinib,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-2.5851846,-0.09468887,-1.5617144395055678,-0.03673826579508873
26620,SIDM00933,Navitoclax,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.8118508,0.07505513,0.953765519333663,0.03441990702377578
91620,SIDM00042,OSI-027,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.6541681,-0.05791037,-1.562606486644105,-0.08734371085641213
8566,SIDM00877,Entinostat,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.571718,0.024922319,0.5970368955181313,0.028085784933674644
61628,SIDM00877,ZM447439,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,0.9000882,0.075690165,0.3148381794100101,0.06154369617808868
84990,SIDM00877,Temozolomide,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,3.2793195,0.15711446,-0.8996455525924446,0.00920349445556911
11346,SIDM00928,AZD6482,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,35.0,1.8374668,0.15999669,1.5596597092912075,0.13951787176411734
36837,SIDM00148,Tozasertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3982363,-0.13125184,-2.626508363728817,-0.16548296784610245
71453,SIDM00835,AZD4547,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,0.06427701,0.001791053,0.5531959478165516,0.020921765784929595
12614,SIDM00673,JQ1,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.5371097,0.039396234,-1.7249919677713197,-0.07761433189375795
105697,SIDM00833,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Male,White,53.0,1.0396645,0.015115121,1.735396520497888,0.048979528991966455
70532,SIDM00146,Wee1 Inhibitor,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-0.34635296,-0.029378619,-0.5052691643437008,-0.0004460566371880391
51145,SIDM01042,Linsitinib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,1.2607517,0.12531881,1.6009627968978166,0.09070887084621386
52979,SIDM00933,AZD6482,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,1.7237251,0.07970986,1.8570434906197906,0.06891441705223084
89122,SIDM00872,Nutlin-3a (-),Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.53854734,-0.013646001,1.2483934843260234,0.02592575778893531
15213,SIDM00633,Paclitaxel,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3044302,-0.10880037,-2.5466802136260123,-0.11826665889295501
59297,SIDM01042,Wee1 Inhibitor,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5103369,0.06271321,-1.1733238672902186,-0.02605642834188827
31997,SIDM00282,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,3.1228383,0.21131255,0.864774450691884,0.10752804192019799
50621,SIDM00933,MK-2206,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,-1.1644516,-0.10471578,-0.8065386946530982,-0.08283220874876522
35052,SIDM00928,Trametinib,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,3.7520297,0.33660397,0.07507974862236197,-0.024306380190382868
87406,SIDM00633,ZM447439,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5290432,-0.14342488,-1.7682111186789224,-0.046526515989472716
97618,SIDM00875,Venetoclax,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5502695,0.013155101,2.313153607052398,0.0378828119148979
57160,SIDM01197,Olaparib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.844312,0.03347111,2.296197748280814,0.06437675074239847
75474,SIDM00875,MK-1775,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.26741835,-0.017114658,-2.1409760018733217,-0.13373518067792775
18122,SIDM00633,Tozasertib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.5627601,0.049746085,1.7570850769566622,0.057908866137245295
84180,SIDM00933,Nilotinib,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.7821639,0.0603084,-0.0479643100094503,-0.024942926466023974
84898,SIDM00097,Afatinib,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8807762,0.061655145,0.24070458969116107,0.018558706949666156
62162,SIDM00826,Trametinib,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,White,70.0,-0.79557246,-0.005225733,-1.776213852669526,-0.06709281983541145
105632,SIDM01042,Nutlin-3a (-),MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.39410278,-0.010191161,1.60024918713228,0.02083772196460811
16926,SIDM00833,LGK974,Nutlin-3a (-),Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-0.025653707,-0.001044053,-0.9672651867388573,-0.02469744477777891
18276,SIDM00097,Axitinib,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0001936,-0.04711614,0.5040389261491074,0.005942002529545658
80287,SIDM00359,MK-2206,AZD4547,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,4.4557786,0.28173012,2.766847135299476,0.22554889630687308
75997,SIDM00146,Vorinostat,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.86822253,0.07801604,0.5515890723992417,-0.06249375526223437
94967,SIDM01197,BMS-754807,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.9295866,0.054815333,0.3522063518449571,-0.013604800885697172
31626,SIDM00835,AZD8055,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,-2.6140828,-0.11288129,-0.4331651664753418,-0.09323683474666147
23518,SIDM00097,AZD6482,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.0154201,-0.06902628,0.35201216478002717,0.03180103553364487
61822,SIDM00872,Linsitinib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7167811,0.029867454,0.8957650909787888,0.023318579059039626
1657,SIDM00872,SCH772984,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.39196664,-0.02563047,0.6851876951948104,0.06500998762073933
14750,SIDM00097,Taselisib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.3509026,0.12976891,1.6338128023269074,0.0347406682719472
74822,SIDM00097,Lapatinib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,4.1116776,0.2819818,-0.2917604241408305,-0.014445502957390164
107184,SIDM01197,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-2.5718486,-0.06806759,-0.9756755221629547,-0.07583897513272035
103056,SIDM00146,Afatinib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-1.136952,-0.11040032,0.12366783633546792,-0.04751031883817318
76173,SIDM00455,LGK974,Gemcitabine,Pancreas,0.01,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.7257313,-0.04905761,-1.846518515395148,-0.0669914803348022
49075,SIDM00148,AZD7762,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5167686,0.041735064,-0.9367646538504478,-0.029439247376552798
75111,SIDM01187,Bortezomib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.42931405,-0.036187228,0.31970738694579326,-0.004514434564946827
27723,SIDM00042,Trametinib,Sorafenib,Pancreas,1.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.33897638,-0.034022335,-1.3255849843023109,-0.08547514402606075
61475,SIDM00097,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.4194075,0.02950155,0.20959444857618698,0.0323485072302769
38450,SIDM00455,OSI-027,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8312432,-0.09778097,0.00026178265486415586,-0.020771307671790827
101812,SIDM00875,Ribociclib,Linsitinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.660313,0.02838608,-0.30370608546111066,0.028242272519260005
34026,SIDM00455,MK-1775,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3534658,0.14897138,1.1840441494947649,0.04727672987999046
106701,SIDM00633,Vorinostat,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.3323674,-0.15060133,-0.25654485654427106,-0.048418519962702404
21578,SIDM00216,Palbociclib,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.350917,-0.17470084,-1.351133027076478,-0.10456508421698721
73183,SIDM01187,Pictilisib,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.1129719,-0.08589627,-1.368660328433572,-0.08607287474519618
96554,SIDM00042,LGK974,Crizotinib,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.646586,-0.06855652,-1.475714653942864,-0.0011451395253128727
31958,SIDM00146,Sorafenib,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,0.3251261,0.021051103,-0.05612928734891873,0.005509159208362021
73312,SIDM00933,Nutlin-3a (-),Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,0.58195615,0.08224832,-0.2938536104537498,-0.025798749952071702
61615,SIDM00933,MK-1775,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-0.22213873,-0.017195879,-0.04996056654940411,0.011006429769201144
36117,SIDM00455,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.876474,0.03518346,2.7427798197891384,0.09280257650975941
56266,SIDM00146,Doramapimod,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.2983768,0.16115567,0.43421633814671307,0.028440220210786273
22601,SIDM00872,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,4.1651683,0.13662788,4.140103197119551,0.15876335394768748
88534,SIDM00148,JQ1,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.2186508,-0.19512299,-1.029694319835397,-0.06091405692135201
59251,SIDM00776,AZD4547,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,65.0,1.7357656,0.043906275,1.1673303212889339,0.07774147558519366
21844,SIDM00148,SCH772984,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3235291,0.06442819,2.195283430305762,0.06900945976877265
88737,SIDM00877,Lapatinib,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,-0.95988387,-0.08912716,0.5362402002843152,0.1291136384807164
77968,SIDM00928,Palbociclib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,35.0,-2.5655239,-0.10147806,-1.3396075970048489,-0.0592527616814385
60837,SIDM00875,BI-2536,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.649053,-0.07956372,-0.8177823164393311,-0.08259755414698833
7808,SIDM00776,BMS-754807,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,0.35714686,0.032600664,-1.469981858953735,-0.03516954419116051
96419,SIDM00673,Nilotinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,-3.3980942,-0.12131583,-1.4747092983085592,-0.056983178744452655
23258,SIDM00359,Linsitinib,Vinorelbine,Large Intestine,0.0025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.5871626,0.05032105,1.2829155344451928,0.07741398456651076
96571,SIDM00146,Nilotinib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.2503117,0.10058489,-0.4477512588934904,0.02811252365568762
64243,SIDM01042,JQ1,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8133636,-0.028866602,-0.4357121016305154,-0.04829489205701558
62828,SIDM00875,AZD7762,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.3450437,-0.024386264,-0.97461123247404,-0.058033488692878735
70776,SIDM00877,Taselisib,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,3.1980746,0.16189732,1.6257767804443048,0.08459705307084578
10475,SIDM00872,Luminespib,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.7379316,-0.1285319,-0.7816387876830236,-0.05748940538409986
36601,SIDM01197,Nutlin-3a (-),Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,4.8376713,0.1758277,4.210543166729836,0.21857248048511582
34554,SIDM00148,BI-2536,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.8089652,-0.10158162,-3.1248767979956553,-0.14147838303941845
57543,SIDM00928,JQ1,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,35.0,1.349886,0.1650395,1.418708290893598,0.11022302198555389
103635,SIDM00872,Camptothecin,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,South Asian,61.0,1.0824126,0.030430112,1.930826361563199,0.08704894206071889
47088,SIDM00216,Nutlin-3a (-),SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.6307337,0.09078641,-0.7897375640781714,-0.017358163031909714
45781,SIDM00455,LGK974,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.9130337,-0.064394385,-1.1637783335872742,-0.0033623423337831733
82402,SIDM00633,AZD7762,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.2231464,0.1785751,0.4359714425985496,0.033460183420844176
43578,SIDM00877,Pictilisib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,-0.9408761,-0.10164423,0.33187982116078246,0.024801336403283657
45605,SIDM00633,BI-2536,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.8405486,0.06850884,-0.20554474397674163,0.06113547749639813
37235,SIDM00673,Nutlin-3a (-),Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,1.5847236,0.038760636,2.083313476879211,0.06709151940791372
51588,SIDM01042,Nutlin-3a (-),Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0097117,0.044485006,0.13814737958494777,0.017091282573825358
10650,SIDM01197,AZD4547,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.8867314,0.036718644,0.8509562680636972,0.07713117227996145
67706,SIDM00877,PF-4708671,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,0.19756117,0.015991379,-0.0059071423439547325,0.01499834378222402
10587,SIDM00455,Sorafenib,Cisplatin,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.234627,-0.115932584,-1.4336622830302816,-0.06555986699205171
53495,SIDM00673,Venetoclax,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-1.3334929,-0.035116814,0.021558824137863225,0.011369246408582534
23095,SIDM00872,Alisertib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.14746004,-0.0057828436,0.4003669770350694,0.0116711166242813
48386,SIDM00455,SCH772984,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.9211475,0.12085745,1.2968144071054792,0.06769826340578702
81011,SIDM00633,Linsitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.9100506,0.17260458,1.7662195582635016,0.06762510770598425
38127,SIDM00826,Afatinib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,1.0768014,0.02934692,1.0291189131572036,0.08280487558893271
57267,SIDM00776,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,2.3844144,0.08902268,2.037468516952061,0.092082561884121
57476,SIDM01187,Palbociclib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.3275506,0.17273887,0.6790704771209126,0.02104949197020125
44811,SIDM00673,Navitoclax,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-2.0130997,-0.13246648,1.455513649905536,0.048478588276025476
33354,SIDM00455,LGK974,SCH772984,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.8762348,-0.06181855,-0.8103038318972609,0.02318257445834775
107365,SIDM00872,Venetoclax,Lapatinib,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3489031,-0.044559594,1.0677749481343697,0.08044740619657813
67658,SIDM00673,Paclitaxel,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8882697,-0.0730319,-0.6595059390446213,-0.0907406127395191
49478,SIDM00928,ZM447439,Crizotinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.3027673,0.1465995,-0.7578207515205055,-0.12498688149463767
27722,SIDM00146,RO-3306,Axitinib,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.3092763,-0.025558852,-0.2748676722757097,-0.012087327141931193
2964,SIDM00673,Docetaxel,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,Black,49.0,-3.0168211,-0.2400152,-1.9371788496323643,-0.12343968030155754
63650,SIDM00875,Dabrafenib,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3900217,0.0792233,1.3222358180592693,0.06169883822866444
41170,SIDM00826,AZD4547,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,70.0,-1.0359284,-0.07583873,-1.3029984105943984,-0.08077334301033373
18352,SIDM00673,Temozolomide,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.17114305,-0.0036487423,-0.11343093312151174,-0.02212853867152536
25352,SIDM01042,Navitoclax,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.7876668,0.15338573,0.7284211836221867,0.02374496461879896
44346,SIDM00097,RO-3306,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0476,-0.092513904,-1.4302995135082552,-0.0985986432102941
69914,SIDM00872,Uprosertib,Luminespib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.8323552,-0.081084296,-0.5689422544451342,-0.05925435325298109
107611,SIDM00455,Cisplatin,MK-2206,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.718618,0.14362024,1.6567450136174233,0.07572666677208513
74084,SIDM00633,PF-4708671,Vorinostat,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.75092655,0.06754164,-0.5856652720057018,-0.00824540641122478
79744,SIDM01042,Alpelisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.8891691,-0.14060843,0.7142427399902689,-0.009394313910324185
83338,SIDM00776,Oxaliplatin,AZD7762,Large Intestine,0.0625,Colon Adenocarcinoma,Female,White,65.0,-0.7598522,-0.046447556,-0.8446072680507161,-0.04110644353838329
77537,SIDM00097,Tozasertib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6823435,-0.07968283,-2.1335841227385584,-0.07443500525167904
66912,SIDM00875,SCH772984,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.17808628,-0.020505542,-0.3387124461507246,-0.024315729082642755
35871,SIDM01042,Vorinostat,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.57507014,-0.06604277,-0.3609459972609922,-0.017958095216204117
10605,SIDM00146,Docetaxel,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.6374773,0.0620804,-0.21750574186205457,0.02371399622759982
93231,SIDM01187,Crizotinib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5673823,-0.09472596,-1.0077721382024551,-0.04489453709066667
86386,SIDM00877,Docetaxel,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.6609951,0.107315525,-0.7833452319395168,0.03298526220936761
64683,SIDM01197,Dabrafenib,Olaparib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.8932972,-0.080528826,-0.3224097740576947,-2.709685788567784e-06
47006,SIDM00833,Olaparib,Oxaliplatin,Large Intestine,5.0,Rectal Adenocarcinoma,Male,White,53.0,0.42945674,0.013037723,0.7892670418972987,0.007786051760958937
87784,SIDM00875,Entinostat,Taselisib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.0840908,0.10265396,1.119902592439997,0.07092635139173437
7941,SIDM00872,Alpelisib,Axitinib,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.95288897,-0.09645376,-0.7504734520922791,-0.03565411531410276
2863,SIDM00832,Taselisib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,81.0,1.3771987,0.06918337,0.0002508877383621843,-0.01022608226511129
85082,SIDM00097,Doramapimod,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2321556,0.0399858,0.018804042159959365,0.02979839966035174
81310,SIDM00837,Crizotinib,Oxaliplatin,Large Intestine,5.0,Colon Adenocarcinoma,Female,White,82.0,-2.5182974,-0.076046295,-1.3100800468148175,-0.13416471416335252
35369,SIDM00826,Navitoclax,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,0.97007805,0.03914044,0.3086060189520841,-0.02636281984206877
96417,SIDM00872,Dabrafenib,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.26700416,-0.0050408323,1.779093637999747,0.0665478047820309
32357,SIDM00148,Navitoclax,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.7701052,-0.07402123,0.9195124584431988,0.01650729979852768
89213,SIDM00673,Vorinostat,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,0.26151532,0.024978146,-0.005569388904541763,-0.04490442550673309
98491,SIDM00146,Navitoclax,Olaparib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.8098346,0.106790505,0.3888751922657416,0.0025577535722379435
50609,SIDM00097,Gemcitabine,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.84523016,-0.02885183,0.05274773346629918,0.02782143506399143
105735,SIDM00633,Crizotinib,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.6002984,0.12785345,1.9049363747276096,0.022608145820379
94000,SIDM00872,MK-2206,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,1.2786878,0.12483407,1.2070056198771446,0.058544373020865736
21730,SIDM00872,MK-2206,Bortezomib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.17397447,-0.018661305,-0.08684806713432448,-0.0020239465367592356
64972,SIDM00146,MK-1775,AZD7762,Breast,0.25,Breast Adenocarcinoma,Female,White,51.0,1.9919193,0.1281849,1.5380538935158972,0.07833983984345112
83019,SIDM00877,Alisertib,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,-1.4058135,-0.09077124,-0.6333733684164733,-0.05764095457256805
35670,SIDM00950,Linsitinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1466079,0.0651416,2.0067452565422403,0.13388925264660287
53361,SIDM00633,Crizotinib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,4.276335,0.24167138,2.2313357808775627,0.09047090893502621
78310,SIDM00633,Tozasertib,OSI-027,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.9724784,0.023215257,1.356557071939367,0.029470042486053078
10651,SIDM00146,Docetaxel,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-1.279219,-0.12050381,-2.002922202343324,-0.0997231913126705
16728,SIDM00872,KU-55933,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5754651,-0.06964105,0.1938359464135168,-0.007663983215145811
107285,SIDM00872,Olaparib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.4946285,-0.059591502,-0.9146809953960082,-0.011282461414235584
95622,SIDM00216,Oxaliplatin,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.2187659,-0.06814413,-1.99767524035549,-0.11892302473340197
43677,SIDM00933,Paclitaxel,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-1.240643,-0.10313606,-0.670582202870214,0.022572528931349124
88335,SIDM00877,Ribociclib,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,White,44.0,1.4449582,0.045186486,0.18517003476239394,0.026019635880282638
67899,SIDM00928,Gemcitabine,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-2.2191265,-0.23058343,-2.118032053740543,-0.18437708280359605
8003,SIDM00673,Camptothecin,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,2.8299983,0.09953166,2.465407841899309,0.14840623256550467
66891,SIDM00837,LGK974,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,2.880934,0.07377638,0.5327327379293466,0.07199686110228957
17303,SIDM00776,Camptothecin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,65.0,0.21333681,0.007753943,-0.14977663616502201,0.004763358169383293
39097,SIDM00359,SB505124,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.8585562,-0.14860061,-1.657162313365177,-0.07262772753393786
22983,SIDM00146,SCH772984,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.36319512,-0.03480616,-0.37634887383098203,-0.0547529899600477
56882,SIDM00833,BMS-754807,Linsitinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,-2.9924834,-0.19047052,-1.3429025625461855,-0.06139887060446325
46280,SIDM00455,OSI-027,MK-1775,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.182537,-0.11291852,-1.3786826605937157,-0.07219443344897444
84700,SIDM00148,AZD8055,Vorinostat,Breast,2.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.2874135,0.07358619,1.1809149648815442,0.031816460472016875
27895,SIDM00146,ZM447439,Palbociclib,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.0408292,-0.06324986,-0.4406614408455625,0.007973862854604075
8282,SIDM00148,Bortezomib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.39587677,0.028953662,-0.04554937321353631,-0.022192813020369438
74539,SIDM00673,GSK269962A,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.3724424,0.09802562,-1.4199668824075142,-0.07192083418181398
53788,SIDM00673,AZD6482,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.2620835,0.12975128,-0.5810852658106271,-0.03943527912740664
25876,SIDM00148,AZD6482,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.7459724,0.15367815,1.4970752127060756,0.13438798233292856
59582,SIDM00359,Linsitinib,Taselisib,Large Intestine,1.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-2.440218,-0.1203443,-1.2827851198561113,-0.00966585796017114
59253,SIDM00146,Pictilisib,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-2.0772028,-0.15041415,-0.6357195578045594,0.02070785779496966
48072,SIDM00146,AZD8055,Docetaxel,Breast,0.00025,Breast Adenocarcinoma,Female,White,51.0,0.23651987,0.020914335,-0.365529850552136,-0.015069652911358169
39090,SIDM01187,Trametinib,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.5183784,-0.06924636,-0.1402513641269618,0.06508613809905434
80281,SIDM00875,MK-2206,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2283219,-0.09012596,0.14620615305011814,0.027897415018496872
44413,SIDM00872,RO-3306,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.4615647,0.100467965,0.9963012205047495,0.04448917692542173
56475,SIDM00673,Navitoclax,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.60636127,-0.048936695,-0.9684990035921179,-0.08688777471388251
53053,SIDM00875,Afatinib,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.59431034,-0.048855834,0.5187232713184234,-0.00996635333822183
75330,SIDM00872,PD173074,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.8738877,-0.070192985,0.02858649858519214,0.022744431859988225
24169,SIDM00359,Oxaliplatin,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,1.0098292,0.07477374,-0.9940147598158551,0.036596655625933824
88347,SIDM00875,Axitinib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1961217,0.0899724,0.5732654409621802,0.01910159629321557
16117,SIDM00633,Navitoclax,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4138116,-0.0916459,-0.9926320226994763,-0.029614701469125062
45071,SIDM01197,MK-1775,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.0248213,-0.037038125,-1.3932021156519523,-0.06013712885189022
4424,SIDM00928,OSI-027,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.2740333,0.21731985,1.33452295266463,0.11367571750734881
44327,SIDM00837,SB505124,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,White,82.0,-0.9505276,-0.016360475,-0.2561684681576157,0.04072336985621375
36399,SIDM00928,Temozolomide,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,-0.86646086,-0.023081992,0.392095347753953,0.03415698971047088
503,SIDM00835,Palbociclib,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,2.8731773,0.113696545,0.7663081660190791,0.037733583660867424
97702,SIDM00928,Paclitaxel,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,1.819511,0.12628946,3.006862430100757,0.08549641178487444
102106,SIDM00875,Afatinib,Vorinostat,Breast,2.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,2.8973053,0.13055786,1.259349879608845,0.028778541772476043
91893,SIDM00950,Palbociclib,Taselisib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.11462,0.12290671,2.147042282909713,0.07243462523294299
3912,SIDM00835,MK-2206,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,3.5489976,0.23233534,3.5010505892135817,0.18596700230237642
21739,SIDM00633,Olaparib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0151381,-0.041871794,-0.9303561516979019,-0.03975830028637235
22665,SIDM00877,Camptothecin,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.4913301,0.05405986,0.07552004352612378,0.0048628912757973635
46775,SIDM00877,Camptothecin,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.0975362,0.10230284,0.8119472734654335,0.042683288463184005
96156,SIDM00097,PD173074,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.620915,-0.06765049,-0.054965194106334124,0.010134622190352745
49066,SIDM00837,Dabrafenib,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.6784265,0.010570027,2.474541283951182,0.08090345409472384
37214,SIDM00455,Cisplatin,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.418755,0.10895771,0.9607987324137041,0.07906869000565005
21871,SIDM01042,Gemcitabine,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.9494668,-0.054925412,-1.415481477741005,-0.10902019704982813
27530,SIDM00933,MK-1775,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,-3.4646237,-0.120393835,-0.6533484094391282,-0.041246053910996276
33219,SIDM00877,PD173074,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.40076518,-0.026973879,-0.9043494949932149,-0.02198650037689587
83709,SIDM00875,Docetaxel,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07197827,-0.0052306964,0.4795454745374548,0.020644011687584722
87157,SIDM00146,ZM447439,Linsitinib,Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,1.5113211,0.12661594,1.6665133109607104,0.07231424284078411
23172,SIDM00148,BI-2536,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0167307,-0.05022774,-1.9520671321690184,-0.0928466611265099
27467,SIDM00826,AZD8055,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,3.516245,0.1767631,-2.8799367890077208,-0.06703415495572501
93247,SIDM00146,Dabrafenib,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,2.7582643,0.1767627,0.3979972971609132,0.02137193060166134
53598,SIDM00837,5-Fluorouracil,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,82.0,-2.886601,-0.10689091,-2.433984620326507,-0.0861061024707433
36444,SIDM00875,Ribociclib,Pictilisib,Breast,0.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.6661002,-0.02065849,0.24157143253474417,-0.0018468314958924178
76274,SIDM00776,Trametinib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.37248537,-0.032383062,0.8739414146262283,0.09358271767943738
51020,SIDM00216,Olaparib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,56.0,1.1952909,0.069656976,-0.6545816698755993,0.020345083574070295
81034,SIDM01042,Taselisib,Cisplatin,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.76055807,-0.061035097,-1.4432399420028976,-0.051504672955237994
84020,SIDM00282,AZD4547,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.2414916,0.051593453,0.9973570407598655,0.06091449661739722
67803,SIDM00097,Wee1 Inhibitor,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.66251886,0.044046175,-0.8991510752493328,-0.03958584531839796
26207,SIDM01042,Venetoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,3.2525108,0.15835506,0.33056708519215156,0.024970412765246138
31063,SIDM00148,Alpelisib,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.0515306,0.087184675,0.6883498129076634,0.0071705928017450245
85792,SIDM00933,Linsitinib,MK-2206,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,-1.4470396,-0.0871913,0.7308736847999613,0.07239508119475377
60623,SIDM00928,SCH772984,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,0.8884379,0.09244326,-1.484757380630936,-0.07816363134808085
36,SIDM00359,SB505124,Trametinib,Large Intestine,0.1,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6564782,-0.022822522,-1.766162640668602,-0.038586399985202316
87576,SIDM00216,MK-2206,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,East Asian,56.0,2.4618902,0.16374585,1.4342262626402187,0.030858283844244622
46111,SIDM00282,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-3.9864652,-0.21144061,-0.9597429289721425,-0.09997659595581351
7814,SIDM00216,Navitoclax,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,56.0,1.5760757,0.15014304,1.6279970916786923,0.12789974179403063
13652,SIDM00042,Ruxolitinib,Erlotinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.6312306,0.021463016,0.9866223963137022,0.013515839422707843
86693,SIDM01197,Oxaliplatin,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-1.9106928,-0.09792956,-2.5126352508043706,-0.07965828198592004
102779,SIDM01187,Bortezomib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.61842453,-0.062006094,0.20320391081662456,-0.029882313603075424
76263,SIDM00633,Nutlin-3a (-),Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.0367067,-0.08223458,-1.1153307899694522,-0.04219583791755223
46875,SIDM00148,Doramapimod,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.1126176,-0.050397202,-0.5613174853312447,0.0011812852665902317
15470,SIDM00146,Palbociclib,Cisplatin,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-1.1911047,-0.07613657,-2.0414315761961865,-0.10762562384930258
79614,SIDM00042,Taselisib,Trametinib,Pancreas,0.25,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.3732386,0.14860108,2.476968697958633,0.09725984365144676
16916,SIDM00097,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3254789,-0.071848914,-1.4952734274025188,-0.06560231873973048
57674,SIDM01187,Pictilisib,Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,6.2266273,0.21224123,1.7574737710720416,0.10017753942827826
40988,SIDM01187,PD173074,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,1.1096522,0.081115685,1.3660363101356088,0.056804325464257115
78520,SIDM00633,PD173074,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.9408149,0.04598475,1.8276939700491193,0.06384745035311683
82962,SIDM00216,Crizotinib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.6889555,0.049506184,1.1627257138860998,0.05659997899543322
81258,SIDM01042,JQ1,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.3697812,0.0105982395,-0.44777617023797683,-0.05283264152948702
58488,SIDM00872,AZD6482,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.8559186,0.07442466,0.7379755530066736,0.03408281593819513
74101,SIDM01187,Pictilisib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.6747856,-0.12395079,-1.512171143329608,-0.09773012842639915
85154,SIDM01042,ZM447439,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,0.39510033,0.051452022,-0.42223177110897975,-0.03875073975653407
11640,SIDM01042,AZD6482,5-Fluorouracil,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.18286043,0.008407021,-1.470839747972695,-0.10834339271060409
94154,SIDM00148,GSK269962A,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.6061563,0.25589317,-0.37524171337084294,-0.007436987379882856
65666,SIDM00957,SB505124,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-4.1327953,-0.07687168,0.9695900242599823,0.03145052027595641
90826,SIDM00148,Afatinib,Docetaxel,Breast,0.00025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.754827,0.06982406,0.4561243842654876,0.04963370102305408
77556,SIDM00928,Alisertib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,1.7283772,0.16887204,1.5530335554191264,0.10173822482588207
66353,SIDM00877,Pictilisib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-2.6023993,-0.07585805,-0.35646591693302776,-0.041448707046559154
25849,SIDM00146,AZD8055,Vorinostat,Breast,0.5,Breast Adenocarcinoma,Female,White,51.0,-0.87550306,-0.074615985,0.9105009857804357,0.04038249825344128
69286,SIDM00872,Lapatinib,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.40625548,-0.037877306,0.47713751775882807,0.061553455072454424
7694,SIDM00455,Oxaliplatin,Erlotinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.081482,-0.13284197,-2.9282542791271444,-0.07878447531660877
75712,SIDM00875,ZM447439,Temozolomide,Breast,30.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.48315287,0.05672961,0.041436707593672524,-0.008434235921812982
83530,SIDM01042,Temozolomide,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.7903152,0.08604536,0.6126112659618606,0.002350439483869497
84390,SIDM01042,Navitoclax,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,2.5690205,0.15169035,2.5818691264284768,0.08126554630289715
32935,SIDM00633,ZM447439,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5875825,0.05235233,0.11962265341227481,0.04963192878933602
37567,SIDM00875,Ribociclib,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5081375,-0.045783896,-1.4424693935078647,-0.019406200136615447
48985,SIDM00146,Doramapimod,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,2.4090579,0.12157042,2.0356434406382036,0.09465925021830929
28041,SIDM01042,Olaparib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.1735666,0.13354696,-1.1739670730279994,-0.01171874101839298
74962,SIDM00933,Vorinostat,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,0.7308605,0.100964405,-0.856017682342093,-0.031649821690411174
58540,SIDM00282,Crizotinib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.2852607,0.06693118,-0.04623257736792722,0.024782618651502858
83435,SIDM00146,KU-55933,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,2.372501,0.14574867,-0.7352740437651353,0.018843471777989403
47134,SIDM00146,Paclitaxel,Bortezomib,Breast,0.000625,Breast Adenocarcinoma,Female,White,51.0,-2.4622653,-0.21111472,-1.2776410071593465,-0.07691915301771937
35170,SIDM00872,Trametinib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.3345469,0.12594888,0.6350270532500083,0.02795019107540912
49989,SIDM01042,Bortezomib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.26636064,-0.016571155,-0.5432774520275848,-0.061982129811161475
71522,SIDM00146,Olaparib,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3115513,0.0829074,0.2685863447288049,0.05883281854333121
43549,SIDM00776,Dabrafenib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.6097795,-0.015867032,1.0127058485682248,0.02614434740805716
32350,SIDM00148,SCH772984,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.42796773,0.018123051,0.3332105783558568,-0.008001709920543646
85801,SIDM00877,Temozolomide,Crizotinib,Breast,0.625,Ductal Breast Carcinoma,Female,White,44.0,-0.4709429,-0.012742309,-0.713075950873184,0.05648941190577039
90497,SIDM00875,Ribociclib,Bortezomib,Breast,0.000625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.5062383,-0.04505524,-0.21060623277620966,-0.005344145896444746
17128,SIDM00837,Oxaliplatin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,0.9103314,0.06254486,-2.341601616603563,-0.05989164823850083
3278,SIDM00455,AZD7762,Dasatinib,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.8674182,-0.07332819,1.4738730946259675,0.11610876502114986
12606,SIDM00673,Alpelisib,MK-1775,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,-0.917884,-0.030586997,-0.16742023122186628,0.027081715140663824
85671,SIDM00673,Vorinostat,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.48163226,-0.051082157,-0.5436925386604717,-0.06184824795074043
63657,SIDM00146,Palbociclib,Linsitinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.21561068,0.015319871,0.2585727620267257,0.044046695078618296
27686,SIDM00097,Tozasertib,MK-2206,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.2951969,0.055332568,0.25817632046174716,0.013730919384934486
99338,SIDM01042,GSK269962A,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.7341679,-0.098203555,-0.7711721730908757,-0.027457616228128503
40196,SIDM00877,ZM447439,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.9786854,0.09782976,0.7018176908679065,0.07521484034984557
19408,SIDM00282,Olaparib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,1.6943303,0.044085804,1.5009548890913043,0.057118846930418174
44871,SIDM00776,Navitoclax,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.21512659,-0.01354136,-0.4706509171561262,-0.03730720584517057
53137,SIDM00872,Cisplatin,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.3423158,0.00974962,1.5813837073942936,0.07022798169078309
99218,SIDM00950,Linsitinib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.49394423,-0.041622028,-0.6201551805133063,-0.019126528972682702
92177,SIDM00875,Navitoclax,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.97115815,0.019663747,1.7312286947676874,0.058358416236391514
106672,SIDM01042,Palbociclib,MK-1775,Breast,0.625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.23001911,-0.011336467,0.6995633756032907,0.01657203917543177
88907,SIDM00673,Nutlin-3a (-),Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,0.6269815,0.012200839,1.1316446480245341,0.01698591893160465
39955,SIDM00673,Tozasertib,Axitinib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-4.083651,-0.16063115,-2.3743458053269726,-0.12079028609822627
55195,SIDM00282,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,2.4805696,0.13023141,1.9054758319517622,0.1360914019570317
101315,SIDM01187,Palbociclib,Crizotinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.1043322,-0.113305,-1.5595031220720479,-0.06177941136500071
33944,SIDM00875,OSI-027,5-Fluorouracil,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.91450536,0.09388961,-1.0375941484569802,-0.0014622641516880968
48153,SIDM00872,Tozasertib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,2.9593122,0.19026487,0.932068324596365,0.030246246657519862
44426,SIDM00872,Palbociclib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.4071669,-0.014740753,-0.01409986179006589,-0.011666886902847552
19740,SIDM00833,AZD8055,AZD7762,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,0.96407944,0.035251204,1.4265116917752516,0.015135548496494547
4404,SIDM01187,Docetaxel,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2719404,-0.0705725,0.1843003949192993,0.05441361672266731
86990,SIDM00875,Crizotinib,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8038362,0.15955618,2.970844680367735,0.15555995135973077
47295,SIDM00633,Paclitaxel,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7232158,-0.085248254,-3.914720596913499,-0.12874537943783546
84576,SIDM00216,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.1223999,-0.078601256,-1.075949897506513,-0.08121538919756509
7028,SIDM01187,Nutlin-3a (-),Cisplatin,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-2.2135007,-0.16342388,-1.037845506918783,-0.066035141368478
94434,SIDM00097,Luminespib,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9212217,-0.15629898,-1.64238191894605,-0.10297459444111112
31286,SIDM00950,Olaparib,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.9802018,-0.036786508,-0.5065259894486935,0.042141693508350064
57647,SIDM00835,Linsitinib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,White,73.0,3.8868988,0.2683297,0.9598235956392224,0.03108653912134015
5011,SIDM00776,Taselisib,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,65.0,-0.061753396,-0.005616871,-1.3649041799514956,-0.03783454198150729
48440,SIDM00872,Venetoclax,Taselisib,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5154389,-0.036240783,1.2398248020233054,0.0455431121037949
5689,SIDM00833,5-Fluorouracil,AZD4547,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,-1.3915333,-0.10167851,-1.589413577240118,-0.07583068979396913
55654,SIDM01042,AZD7762,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.45837787,-0.056566134,-1.2136430107084415,-0.11057868546747054
82246,SIDM00928,KU-55933,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.7414587,-0.083830155,-0.17994667667667308,-0.03705678069699105
42601,SIDM00928,Axitinib,Pictilisib,Breast,0.125,Breast Carcinoma,Female,Unknown,35.0,-2.3721986,-0.12627642,0.1046707792665433,-0.007323865094355199
22090,SIDM00833,BMS-754807,Trametinib,Large Intestine,0.01,Rectal Adenocarcinoma,Male,White,53.0,2.2519197,0.15109886,1.3270148892557356,0.025510633635536895
65627,SIDM00933,AZD6482,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.47716033,-0.015336231,1.2258277180947426,0.08475008664395789
19821,SIDM00833,Oxaliplatin,BMS-754807,Large Intestine,0.05,Rectal Adenocarcinoma,Male,White,53.0,-1.7392322,-0.10153164,-2.353681739623061,-0.14048273418755103
2672,SIDM00832,AZD7762,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.60260373,0.026379175,0.08251112269302889,0.006562868774860456
23424,SIDM00216,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.073922,0.04036968,0.1295206933554236,0.02843066116926524
15912,SIDM01197,BMS-754807,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,1.6355726,0.038172234,-0.19863845366667165,-0.03843018068234486
1752,SIDM00633,AZD7762,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.2287369,-0.14758536,-1.3729410337574668,-0.02120628356992441
49023,SIDM00673,PD173074,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8593423,-0.11615936,-0.43076323413872925,0.03751675741034084
25208,SIDM00633,Venetoclax,Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.4652903,0.1261988,1.3832503325130425,0.03080068360350158
26503,SIDM00148,Ribociclib,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.6610396,0.15359922,-1.1367921276601118,-0.04607738527160197
13358,SIDM00875,Bortezomib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.8279831,0.021429738,-2.3090207549866193,-0.09292781002915576
34314,SIDM00875,Afatinib,Docetaxel,Breast,0.001,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0140395,-0.03456104,0.7003985189699671,0.006087813637389848
62915,SIDM00872,Palbociclib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.33946133,0.012843407,0.41816774132602,-0.0015280578713569228
53395,SIDM00148,Cisplatin,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0083262,-0.040092964,-1.7274849047483642,-0.05621303203292103
98099,SIDM00877,Cisplatin,Luminespib,Breast,0.0025,Ductal Breast Carcinoma,Female,White,44.0,1.0101854,0.119168825,-0.45018383983470533,0.06216127296159749
93806,SIDM00875,JQ1,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.07751331,-0.006337657,0.6689055287329728,-0.013013159509990426
62602,SIDM00673,5-Fluorouracil,Docetaxel,Breast,0.00025,Ductal Breast Carcinoma,Female,Black,49.0,-0.36098656,-0.016098196,-0.19728402490491054,0.057473201593569334
89637,SIDM00148,AZD6482,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.86833614,0.06359127,0.7665396566549546,0.032201728491913544
46049,SIDM00877,Afatinib,Olaparib,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.7214135,0.075610176,-0.11893414944280681,-0.011243351428527837
58856,SIDM00673,Crizotinib,Palbociclib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.9562935,-0.16170278,-0.8813443595111996,-0.06720225455846172
86357,SIDM00673,Luminespib,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.8305716,-0.08722796,-1.232652130775389,-0.08439524809541199
83211,SIDM00877,Trametinib,Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,White,44.0,1.3581051,0.014228528,1.5507100972857926,0.028142226645242734
15084,SIDM00875,Doramapimod,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,5.025094,0.0735224,1.5669357972506381,0.01615965542073478
79905,SIDM00933,Taselisib,Trametinib,Breast,0.1,Breast Carcinoma,Female,Unknown,45.0,0.18815736,0.01617176,1.4236000520100924,0.07193364526749911
71590,SIDM01197,SB505124,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Male,East Asian,71.0,1.8435204,0.14944541,0.09248954039515289,0.024084823360611754
47522,SIDM01042,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.61542314,0.05645128,0.2713534652007249,0.05956945197673474
66471,SIDM01042,Trametinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,52.74992395704158,-2.501913,-0.1379058,0.38030283965314543,0.05145209537768257
82571,SIDM00097,Bortezomib,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.7678887,-0.046425592,-0.39908147580261816,-0.049655989662016314
16816,SIDM00097,Tozasertib,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.6777692,-0.079588346,-2.1653863828047393,-0.065166849219098
62265,SIDM00776,Navitoclax,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,0.6637984,0.026810994,0.651727992529815,0.008804336241205165
105056,SIDM00928,AZD6482,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.3727388,0.1811388,1.6877047696417835,0.11102221408752307
104982,SIDM00933,Taselisib,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.280072,-0.15910861,-1.6161980443435673,-0.08155146844438681
59622,SIDM00950,Dactolisib,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.47904915,-0.030649066,-2.0221125781625724,-0.11247339906271121
6503,SIDM00146,Crizotinib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.6941079,0.067379825,0.8256370042800608,0.09388372495709432
95821,SIDM00950,Ruxolitinib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.4724722,0.07332483,1.8761168018120566,0.03531706743779472
36037,SIDM00875,Taselisib,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.35336953,0.041629173,-0.4848882558237012,-0.0763878944289547
101036,SIDM00875,KU-55933,Axitinib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.714145,-0.06079179,-0.395779048126469,-0.013219217117049679
100172,SIDM00359,Vinorelbine,LGK974,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.1128993,-0.05454232,0.43158829004747484,0.024031553744367322
11500,SIDM00097,Uprosertib,Linsitinib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,2.1031547,0.13051516,0.5993216675433152,0.059305771880881694
54112,SIDM00673,MK-1775,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-0.7910656,-0.07186457,-0.6923923319736683,-0.03984261542955138
30853,SIDM00216,Palbociclib,Navitoclax,Large Intestine,0.1,Colon Adenocarcinoma,Female,East Asian,56.0,-1.7613075,-0.16372944,-1.3755631992670994,-0.09543115426394311
106788,SIDM00957,Taselisib,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,2.2509022,0.06952542,1.373646401988262,0.10213011985992118
35356,SIDM00933,Crizotinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.1879559,0.16098265,0.44964318647071866,0.07936010155360183
70109,SIDM00933,Camptothecin,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.3898829,-0.031786326,-1.9254639646814626,-0.13885526718633304
57463,SIDM00872,Ribociclib,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.3976991,-0.03389145,-0.10717320697840808,-0.0049968859481046716
92883,SIDM01042,Sorafenib,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.7735302,0.07129053,0.4260233884239419,0.005140250080178411
61463,SIDM00148,Palbociclib,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.6904513,-0.039147824,-0.3406404640859706,0.004612954038748833
38987,SIDM00282,AZD7762,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,1.2157532,0.03748743,0.9877605431295134,0.07463357027941406
88843,SIDM01042,Temozolomide,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.30645454,0.008239648,0.4445001230361523,-0.005313815888729939
38279,SIDM00673,Alisertib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,1.8667641,0.13318285,3.1261121574048785,0.19674384030736528
49762,SIDM01042,Crizotinib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.3681887,0.049945373,-0.2539847266047175,-0.01448482843672127
79201,SIDM00872,ZM447439,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.446545,0.044421088,-0.2552568545159245,-0.00464483369707821
44574,SIDM00837,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-1.9861354,-0.030253915,-3.3343313996334127,-0.1220019633780993
80380,SIDM00833,MK-1775,MK-2206,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,0.41526943,0.017790388,-0.42691938484093794,0.01751184396342487
81652,SIDM00833,Camptothecin,Afatinib,Large Intestine,0.25,Rectal Adenocarcinoma,Male,White,53.0,1.1401792,0.07949641,1.0248805470147693,0.006890332656681842
53448,SIDM00097,Dabrafenib,Axitinib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.5513508,-0.0583474,-0.20587724265095853,-0.01506998687821293
5548,SIDM00875,BI-2536,Axitinib,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.6937673,-0.16986929,-2.844916440564348,-0.14171017494370677
79178,SIDM00875,Crizotinib,Nutlin-3a (-),Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.15142825,0.016885167,0.4009239569744631,0.058306645102002966
70854,SIDM00835,SB505124,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,0.32421723,0.027894543,0.5449273890759625,0.014565886228783497
27411,SIDM00097,Palbociclib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.6573625,-0.061852876,-0.5331204802630444,-0.02100788508933764
106442,SIDM00950,SCH772984,Oxaliplatin,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.82297385,-0.08760013,-1.6180708378286788,-0.0803447334607934
104459,SIDM00877,Wee1 Inhibitor,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.2946868,-0.021103563,-0.4029505175119613,-0.03472745725387289
60445,SIDM00633,Trametinib,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.8983599,-0.0573637,-1.6621699347465522,-0.04991988069075015
75831,SIDM00875,Olaparib,Linsitinib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.0293304,-0.062021665,0.104896524153003,-0.003375392471469904
61411,SIDM00673,Wee1 Inhibitor,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.51256,-0.08660169,0.712419780516341,0.17276604395290276
81738,SIDM00673,Alisertib,Taselisib,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,2.0949745,0.12224807,1.4942382498151607,0.06636742216771918
101192,SIDM00148,Wee1 Inhibitor,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.3760884,0.107993364,-0.2914343290658922,-0.003379679060484108
60350,SIDM01187,Vorinostat,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.49243605,0.051056404,-0.5316355521525885,-0.05515907805473885
106769,SIDM00148,Tozasertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0343364,-0.060938153,-2.032363568587637,-0.10035609872657192
23528,SIDM00928,Pictilisib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-1.5590755,-0.146252,-1.2543453643668994,-0.08914875028009359
106717,SIDM00928,Trametinib,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-1.2054229,-0.12832877,-0.619889141198691,-0.025418117417367575
94487,SIDM00148,SCH772984,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5229772,0.0449101,1.7321358693146094,0.06658868175002236
15157,SIDM00872,Vorinostat,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.401967,-0.086770296,-0.7003986710204215,-0.09178860295877285
26720,SIDM00933,SCH772984,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,-1.0595033,-0.07886358,-1.2762624993988634,-0.07534306894930756
78754,SIDM00875,Camptothecin,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.7889623,-0.07272351,-0.42100445876205167,-0.07413015820928996
49778,SIDM00950,Sorafenib,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.924075,-0.082723044,-1.5449196543197221,-0.06846714692923934
35217,SIDM00835,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Male,White,73.0,-2.164262,-0.082717516,-2.030366085137364,-0.04794982114703664
28624,SIDM00928,Nilotinib,OSI-027,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.7848222,0.14410433,0.17658954790993206,-0.005217475308686717
33608,SIDM00928,GSK269962A,Trametinib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-0.5219068,-0.037928287,1.1970837237033245,0.06618887121554337
33124,SIDM00928,Axitinib,OSI-027,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,-2.1164868,-0.11979971,-0.31295298300511315,0.036723744785283
6270,SIDM01187,MK-1775,Gemcitabine,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-1.2751709,-0.11284655,-0.5383948076637293,-0.06927597466968055
92036,SIDM00875,Paclitaxel,AZD7762,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.2683003,-0.051054023,-1.7308392381164985,-0.040042738262468736
102839,SIDM00673,Camptothecin,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-0.29728222,-0.006659627,1.5127263084004714,0.10571024949843175
94056,SIDM00633,Nutlin-3a (-),Navitoclax,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.4644005,0.17949568,1.8128750566660472,0.08689971712132545
66273,SIDM00633,Venetoclax,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.0490284,0.054545477,2.0334441817035067,0.04294385906343596
74973,SIDM00872,Nutlin-3a (-),Gemcitabine,Breast,0.1,Ductal Breast Carcinoma,Female,South Asian,61.0,0.21055354,0.0060818777,0.8190073824604777,0.01157527105796444
2249,SIDM00877,PF-4708671,Cisplatin,Breast,4.0,Ductal Breast Carcinoma,Female,White,44.0,-1.5343761,-0.06947387,-1.1228526798961282,-0.04785016638849288
79237,SIDM00950,Taselisib,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,1.6997631,0.020455688,0.11619346207396558,-0.008358940034539589
42067,SIDM00776,Vinorelbine,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Female,White,65.0,1.2244604,0.062460545,-0.33714362436084816,0.05143985481317738
101342,SIDM00673,Ribociclib,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-2.3777087,-0.0704525,0.05570024479194323,0.01177936758412772
107262,SIDM00872,Docetaxel,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.54078704,0.05434585,0.4275395440630718,0.012313622975004674
50645,SIDM00837,MK-1775,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,1.1616356,0.044230185,0.8908922797909388,0.033205712324259166
42069,SIDM01042,Bortezomib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,0.22557245,0.0074802167,-0.8017765194844667,-0.05765559517233605
52104,SIDM00957,Nutlin-3a (-),Oxaliplatin,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,0.30340114,0.009030223,-0.08007473478353914,-0.016605631879207428
546,SIDM01197,MK-1775,Trametinib,Large Intestine,0.1,Colon Adenocarcinoma,Male,East Asian,71.0,-2.44743,-0.067162596,-2.5705945142348647,-0.08627948493614254
84715,SIDM00875,RO-3306,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.9885572,-0.083099894,0.248715473906668,0.015047296210385239
36320,SIDM00146,ZM447439,OSI-027,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,1.1935593,0.09417053,0.5539515996490642,0.050549492327810634
41272,SIDM00282,Vinorelbine,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.3401784,0.09839026,2.439980408212385,0.15334779821720082
60762,SIDM00832,Linsitinib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,81.0,-2.647532,-0.15495183,-1.0670822391835135,-0.089517753233951
18963,SIDM00877,Lapatinib,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,White,44.0,-0.6596028,-0.056069005,-0.6215522053958931,0.046597733837333365
28915,SIDM01042,MK-2206,PD173074,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.025893567,0.00083360897,-1.142983270817147,-0.054442627446979926
27058,SIDM00633,PF-4708671,5-Fluorouracil,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,1.1029906,0.10463462,-0.7136852339759931,0.0007758065946759983
25640,SIDM00928,Navitoclax,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,2.1661325,0.17242514,1.4500771401915489,0.08448618300261568
20472,SIDM00146,Temozolomide,MK-2206,Breast,1.0,Breast Adenocarcinoma,Female,White,51.0,-0.21225896,-0.0051001464,0.7191569265442048,0.049611010693339626
47489,SIDM00832,Navitoclax,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,0.7306666,0.014164973,0.03537642988839181,-0.009378449262797538
90280,SIDM00933,Docetaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,45.0,0.25286204,0.03555167,-1.6631338945262004,-0.005250569059589071
33569,SIDM00933,Cisplatin,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,0.21529303,0.028009284,-0.6551551984131931,-0.019254092045600506
61447,SIDM00928,Tozasertib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,6.7007766,0.4752034,4.753437855026175,0.2960446539051103
78830,SIDM00928,KU-55933,Crizotinib,Breast,0.625,Breast Carcinoma,Female,Unknown,35.0,-1.0643574,-0.055471506,-1.0895517284393328,-0.04417142074961637
73714,SIDM00455,Navitoclax,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,3.8326437,0.2118014,1.5684433269037235,0.13431459805937404
75761,SIDM00928,5-Fluorouracil,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,2.5605729,0.22503126,-0.2617983859022137,-0.020419208855313613
107442,SIDM00455,Cisplatin,Navitoclax,Pancreas,4.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.9258313,0.15765043,2.1306047083372093,0.17594058571226326
6906,SIDM00633,NU7441,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.7076135,0.21826117,0.8473887232455506,0.058068005239685014
58023,SIDM00146,Wee1 Inhibitor,Olaparib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.48725638,0.03791564,-0.4629937465924472,-0.03538421430074632
6861,SIDM00837,AZD8055,AZD4547,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,0.026414579,0.001020045,-1.3518824694535512,-0.08424029571046521
91018,SIDM00455,Palbociclib,AZD7762,Pancreas,0.0625,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-0.6244251,-0.030008001,-1.9358520471312572,-0.03492852585250293
106708,SIDM00146,Lapatinib,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,0.64370185,0.043603137,-0.20003757612661383,0.000996795323755854
22167,SIDM00950,Palbociclib,Irinotecan,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.6574246,-0.036700483,-1.217513615842207,-0.008059436855319619
14901,SIDM00148,Camptothecin,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.166475,-0.12873891,0.06576087075065343,0.016256272902416154
10736,SIDM00097,Entinostat,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.2421353,-0.08800391,-0.4443660361614577,-0.003508283776986649
65166,SIDM00877,Luminespib,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,-0.9068137,-0.05824961,-0.2412793925991067,0.03298301891751681
76620,SIDM00826,Olaparib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,2.2292287,0.22249332,-0.28319366274332647,-0.04539009558929152
35537,SIDM01197,SB505124,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.7550756,0.06842645,0.46062394416527735,0.027917044864464006
91294,SIDM00957,Navitoclax,BMS-754807,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,2.4765368,0.089107715,0.9219487657845199,0.06086898998682756
73142,SIDM00146,GSK269962A,Crizotinib,Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,0.717701,0.05449462,0.22809865350331857,-0.0036529674452388016
33105,SIDM00146,Palbociclib,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,-2.7186093,-0.14350826,-0.462113136040835,-0.04551814451885616
6346,SIDM00872,GSK269962A,Trametinib,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.6929261,0.06958613,0.4447300363303669,0.03929044361697065
98014,SIDM00928,Pictilisib,Lapatinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.3338182,0.20267437,1.2670762705875724,0.09404336897036339
105760,SIDM00097,Crizotinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.0411327,-0.10231885,-0.797531579948005,-0.06829351921912848
73027,SIDM00146,AZD8055,Crizotinib,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,-0.6136761,-0.059284307,0.18783473582152685,-0.02864290435278776
21060,SIDM00097,Trametinib,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-0.73067707,-0.020386204,-0.03446868535292573,0.031186752149808886
7805,SIDM00837,SB505124,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,White,82.0,-1.9095671,-0.0649744,-0.8925967918068335,-0.09217022646674601
91660,SIDM00148,Camptothecin,Nutlin-3a (-),Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.5677694,0.13917324,0.07763856034268321,-0.03899202878163033
76771,SIDM00282,Vinorelbine,5-Fluorouracil,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.1574998,-0.059113286,-1.278549473131893,-0.10167141175772408
86976,SIDM00282,SB505124,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,0.8058497,0.028123818,1.3844588552361947,0.09402741928306971
8858,SIDM00833,Crizotinib,AZD7762,Large Intestine,0.0625,Rectal Adenocarcinoma,Male,White,53.0,1.0463662,0.08133358,0.1323523757147198,-0.005209894349623256
91419,SIDM00673,JQ1,Vorinostat,Breast,0.5,Ductal Breast Carcinoma,Female,Black,49.0,6.4187226,0.4711494,1.9996339676084702,0.17698459116488438
86788,SIDM01042,Temozolomide,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.5317261,0.009188976,-0.4720267560205164,0.010970629047699316
84236,SIDM00957,Oxaliplatin,AZD8055,Large Intestine,0.5,Colon Carcinoma,Male,Unknown,69.0,-1.2638028,-0.02013107,-0.13653859919470773,0.012500540499140183
66280,SIDM00359,SB505124,Olaparib,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.66469735,-0.05473974,-1.1573176760560275,-0.07538295870884537
88633,SIDM00673,Uprosertib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,1.0284044,0.06399539,0.480634764822413,0.056578156155617475
36162,SIDM00933,Navitoclax,Palbociclib,Breast,1.0,Breast Carcinoma,Female,Unknown,45.0,-0.35113594,-0.042514306,-1.31330068789827,-0.052123206118365274
88178,SIDM00097,Afatinib,Linsitinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,0.8726402,0.058009084,1.0241533592376943,0.09859415079815541
73212,SIDM00928,MK-1775,Gemcitabine,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,-3.3526828,-0.16943729,-0.44772948732695184,-0.04790507896832711
107911,SIDM00673,BI-2536,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.07575,0.07957727,-0.9314076819604685,-0.0913184925712221
31562,SIDM00633,Palbociclib,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.174107,0.0899577,-0.9539808720367686,0.04467093202197871
54621,SIDM00957,Linsitinib,LGK974,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.5868941,-0.012235953,0.4877067517779228,0.043851401821986824
46158,SIDM00633,Doramapimod,Pictilisib,Breast,0.125,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.32768482,-0.02516543,0.4009933856989795,0.08745891923589567
107299,SIDM00833,AZD7762,Afatinib,Large Intestine,1.0,Rectal Adenocarcinoma,Male,White,53.0,0.72419035,0.050409287,0.393923303659998,0.021308219798761966
81821,SIDM00933,Entinostat,Olaparib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.2439742,0.0942092,-0.17834149844530278,0.018435273020759348
8647,SIDM01187,Nutlin-3a (-),Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,2.010746,0.19537166,-0.3614147795500513,-0.010704455987534183
73705,SIDM00282,Camptothecin,Oxaliplatin,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.5587609,-0.088795416,-1.8711873537384287,-0.11513111402781535
23390,SIDM00833,Palbociclib,Nutlin-3a (-),Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-0.6051701,-0.014298424,0.5625661076033529,-0.002434163223322658
7307,SIDM00875,Nilotinib,Cisplatin,Breast,4.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-2.3376656,-0.14710027,-1.8024292135199491,-0.053272920823932306
48139,SIDM00282,Oxaliplatin,SB505124,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-0.44096598,-0.031498488,-1.414301718115596,-0.1042955344481831
69566,SIDM00282,Trametinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,1.4960383,0.05028494,0.9690200937113315,0.0788606111496311
1467,SIDM00877,Olaparib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,-1.0363983,-0.039642353,-0.4572131002248604,0.048654466605691775
43131,SIDM00872,Bortezomib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.48538244,0.0336673,-0.013752517374560732,-0.01897980507580782
10828,SIDM00933,Nilotinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-2.0198405,-0.092428125,-2.4889583787136527,-0.14656663439822362
57135,SIDM00928,Bortezomib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,35.0,-0.7434514,-0.052705362,-0.36344290603808854,-0.047193628540694005
4778,SIDM00875,Olaparib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2455782,-0.08233865,-1.7183502110858173,-0.07980626762497385
83549,SIDM00835,LGK974,AZD8055,Large Intestine,0.125,Colon Adenocarcinoma,Male,White,73.0,-2.0501409,-0.05132796,-0.26388304526797235,-0.005600238624124187
57823,SIDM00837,Palbociclib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,82.0,-2.2321405,-0.16351248,-3.058174620896343,-0.12443588873977429
92397,SIDM00872,Pictilisib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.3087122,-0.033769805,-1.0578759683490324,-0.0743821703417852
43064,SIDM00673,ZM447439,Palbociclib,Breast,4.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.96628433,-0.07797235,-0.8398440035539491,-0.09480950101096083
105406,SIDM00877,PF-4708671,AZD7762,Breast,0.0625,Ductal Breast Carcinoma,Female,White,44.0,-1.7277439,-0.08463277,0.350846505712945,0.03403318180966009
104846,SIDM00633,Sorafenib,Palbociclib,Breast,4.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.35417145,-0.031057118,-1.539622449034039,-0.06129441837634801
69887,SIDM00957,MK-2206,Linsitinib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,2.7622786,0.050007697,2.7793650086746062,0.12526283322634943
18087,SIDM00877,Temozolomide,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,White,44.0,0.15449789,0.0029417367,-1.008604640694306,0.015580523968216931
13415,SIDM00455,Gemcitabine,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-2.3419163,-0.07633512,-0.7432073162014265,-0.027868444514756806
67712,SIDM00957,BMS-754807,Nutlin-3a (-),Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,1.7778989,0.06804243,-0.016525756005071113,0.042826052678359164
31484,SIDM00282,MK-2206,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.5803846,-0.030092493,-0.6773540429394396,-0.036687885174359745
42916,SIDM01197,AZD4547,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,0.541071,0.042727582,0.18115203587543216,0.015624807995581018
40080,SIDM00872,JQ1,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.6236681,-0.016076196,1.3551385128426878,0.06821288371673626
97606,SIDM00042,Ruxolitinib,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,1.2139047,0.045165144,1.5268662049429884,0.06242295927236147
79398,SIDM00633,AZD6482,Navitoclax,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.673815,0.2551874,2.8908518061394726,0.11719758482502626
5419,SIDM00282,Olaparib,5-Fluorouracil,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0273407,-0.015898429,2.5176796901069705,0.0671624721207543
102731,SIDM00633,KU-55933,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.3595895,-0.040108707,-0.13203403849888337,-0.014750089228539695
41265,SIDM00872,Docetaxel,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.168476,-0.107761756,-0.745533334545108,-0.0663358196906782
98312,SIDM00928,Temozolomide,Nutlin-3a (-),Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,1.9006631,0.0881861,0.1109688316106586,0.010337473305572185
30868,SIDM01187,5-Fluorouracil,Temozolomide,Breast,7.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.9629679,0.08934302,-0.09647645982006871,-0.050218907886453716
71673,SIDM00875,AZD7762,Lapatinib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.23055781,0.011988579,-0.8535887374853633,-0.027086651357493344
53327,SIDM00148,Sorafenib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.29775095,-0.029326916,-0.9389392011794437,-0.025370445317063492
12754,SIDM01042,Paclitaxel,Luminespib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,0.26121902,0.027537586,-0.98657521351328,-0.036570933975904364
5356,SIDM00875,GSK269962A,Temozolomide,Breast,7.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.3085649,0.10612282,-0.8547595619124325,-0.005104101428938854
105538,SIDM00877,Wee1 Inhibitor,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.5345541,0.034076806,0.5138452541381793,0.016722050165182606
77183,SIDM00148,Navitoclax,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.9480235,-0.09007972,1.7484765615695823,0.030982819897186098
53434,SIDM00933,PD173074,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,45.0,1.436938,0.030243525,-0.10120989311024926,0.02441092792910695
72596,SIDM00833,SB505124,LGK974,Large Intestine,10.0,Rectal Adenocarcinoma,Male,White,53.0,-2.2758803,-0.16586097,-1.0693968008134804,-0.08596523830585942
92679,SIDM00950,Crizotinib,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.6541123,0.18891211,0.4444669765399658,0.07649420842746787
27341,SIDM00633,KU-55933,Taselisib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,2.5792365,0.101418585,1.3572586247371186,0.03609106093840921
31476,SIDM00146,Venetoclax,Nutlin-3a (-),Breast,10.0,Breast Adenocarcinoma,Female,White,51.0,0.28183982,0.0069231736,-0.08879916015447771,0.03532802139343958
102457,SIDM01042,OSI-027,Olaparib,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.4597204,-0.04945253,-0.6347015009301288,-0.0656488285757151
47214,SIDM00282,Nutlin-3a (-),Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Female,East Asian,55.0,-0.23250341,-0.015687,0.7654166705787357,0.06864526351614217
86553,SIDM00042,MK-1775,Cisplatin,Pancreas,0.8,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-0.30191028,-0.02992502,-0.48128021180991176,-0.031793470622719824
92526,SIDM01187,Bortezomib,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.17732763,0.017471084,0.10081747281756266,-0.019959587794862583
17622,SIDM00673,AZD6482,OSI-027,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-1.6308465,-0.1103642,-0.965435445143806,-0.05470751053207405
3957,SIDM00957,Afatinib,AZD4547,Large Intestine,2.5,Colon Carcinoma,Male,Unknown,69.0,-0.8490311,-0.033522435,0.7633700963268459,0.07877050645372394
44224,SIDM00832,MK-2206,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.7401409,0.040587153,0.36150066065006187,0.049080728249601524
93754,SIDM00933,Trametinib,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,45.0,-0.28496382,-0.041239936,-1.0772995861927095,-0.023122194766667846
99177,SIDM00877,Afatinib,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,White,44.0,0.9745654,0.10550149,1.4867904930254865,0.03144109542516603
106721,SIDM00928,SCH772984,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.7104855,0.19521303,0.30651804719446807,0.00672163605429112
8648,SIDM00875,Dabrafenib,Taselisib,Breast,0.1,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.4089522,0.08059352,1.7447500799878255,0.05411062477216659
96819,SIDM00872,Dabrafenib,Nutlin-3a (-),Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.2622478,-0.0046447767,1.158388504772211,0.034572100975432694
107443,SIDM00875,NU7441,MK-2206,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.84958833,0.07753396,0.9971147396319248,0.06986958241517703
18521,SIDM00359,AZD8055,SB505124,Large Intestine,0.625,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7549296,-0.058878586,-0.301675344456832,-0.002561692628019418
40678,SIDM00826,Crizotinib,AZD8055,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,70.0,-1.1415021,-0.04260317,-2.150632653568114,-0.07847187230060373
69389,SIDM00875,Ribociclib,PD173074,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.5994947,0.078159854,-0.7356078978360705,-0.0028518549365998697
74271,SIDM00877,5-Fluorouracil,Vorinostat,Breast,2.0,Ductal Breast Carcinoma,Female,White,44.0,1.2694508,0.037193254,1.0283975111356918,0.0345426790278348
57087,SIDM01197,Camptothecin,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,-1.820311,-0.05105566,1.5300907151433303,0.07581518709574377
5436,SIDM00872,Axitinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,South Asian,61.0,2.8881423,0.2805303,2.3357013964334055,0.1643602172852392
21001,SIDM00875,GSK269962A,Navitoclax,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.3157468,0.30948934,2.7165544271929734,0.16957385798686334
108223,SIDM00673,Alisertib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,Black,49.0,1.2352272,0.08610451,-0.9931656624186378,-0.008885083909844422
39840,SIDM00877,KU-55933,Linsitinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,2.3519127,0.11792915,0.8814266254356462,0.13053069757505298
9391,SIDM00776,BMS-754807,AZD7762,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,65.0,0.7920428,0.071941555,-0.44128461262835206,-0.05124188526919023
45615,SIDM00950,LGK974,Dasatinib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.9119327,0.19742261,-0.6297842607778925,0.010127121382373708
68800,SIDM00148,RO-3306,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.0483732,0.11044448,-0.23525587025760372,0.020992503612410545
49643,SIDM00832,AZD4547,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Female,White,81.0,-0.8437392,-0.03160108,0.11567113038746278,0.011537268836781203
23014,SIDM00832,MK-2206,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-1.0489535,-0.08393428,1.0759563987666745,0.019402184462199334
88416,SIDM00872,AZD7762,OSI-027,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.28296405,0.026931087,-1.0574649568909438,-0.08378332233256654
1240,SIDM00928,Dabrafenib,MK-2206,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,2.7510173,0.20244403,0.6825213555915496,0.03520321067305525
108183,SIDM00148,Dabrafenib,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.0156012,-0.039694708,-1.3320005569032425,-0.06675304640756964
25543,SIDM00928,GSK269962A,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,35.0,1.1259392,0.106601134,0.09616787181332959,0.07083951251588952
27018,SIDM01042,MK-1775,Luminespib,Breast,0.01,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.52255696,-0.03337169,-1.0641791901274629,-0.07444049679004844
86987,SIDM00928,Lapatinib,Axitinib,Breast,1.0,Breast Carcinoma,Female,Unknown,35.0,1.3637502,0.12611236,1.0717296872157507,0.0985710160338368
88181,SIDM00832,Trametinib,Nutlin-3a (-),Large Intestine,2.5,Colon Adenocarcinoma,Female,White,81.0,-0.6585907,-0.026212309,-1.0730350767833974,-0.003850312002879336
88209,SIDM00928,Cisplatin,Temozolomide,Breast,30.0,Breast Carcinoma,Female,Unknown,35.0,2.1933088,0.11129927,0.9559615053857308,0.05495506093989512
28547,SIDM00832,Navitoclax,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,0.36925682,0.011831674,1.4707646700743693,0.01326724499050978
37761,SIDM00633,Nutlin-3a (-),Gemcitabine,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-3.8914397,-0.12524731,-1.658422320016728,-0.07078252649573408
88408,SIDM00673,BI-2536,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,Black,49.0,-0.11315247,-0.0084966,1.4313122336233823,0.068440723095464
10430,SIDM00633,Tozasertib,PD173074,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.59781975,0.016573329,0.8673920255288226,0.05296573025366649
62257,SIDM00633,OSI-027,Trametinib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.1319292,0.16196528,-0.1688095802207859,-0.016477529848958075
105767,SIDM00837,Oxaliplatin,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,82.0,-0.93257535,-0.07543131,-0.7422575782082796,-0.09723495424192229
33871,SIDM00148,MK-1775,MK-2206,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.4007227,0.1584403,0.5925453380296756,0.03265214043427871
84686,SIDM00455,MK-1775,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.8114722,0.11079594,0.7901729580335402,0.052932657841825395
19555,SIDM00282,Vinorelbine,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,East Asian,55.0,-2.1754081,-0.124950044,-0.9828584180467013,-0.041371343372466604
16882,SIDM01187,OSI-027,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,0.8859578,0.07392589,-0.5498315963032034,-0.049634887044392534
42333,SIDM00673,PD173074,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,Black,49.0,-2.6185951,-0.10951409,-1.9228084402511407,-0.0771721590972223
45758,SIDM00097,Bortezomib,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.3909501,-0.08910894,-0.9166568820277424,-0.06191532286438781
52456,SIDM00872,Axitinib,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,South Asian,61.0,0.97862,0.08382998,-0.5958578052718,-0.06311406823006215
41006,SIDM00957,SB505124,MK-1775,Large Intestine,1.0,Colon Carcinoma,Male,Unknown,69.0,-5.077507,-0.08367903,0.7857997465918432,0.010362699793306533
47758,SIDM00928,SCH772984,Docetaxel,Breast,0.001,Breast Carcinoma,Female,Unknown,35.0,0.876623,0.103600055,0.3115980967261138,-0.010487405668586651
46072,SIDM00957,LGK974,AZD7762,Large Intestine,0.0625,Colon Carcinoma,Male,Unknown,69.0,-1.3067039,-0.020296965,-0.7000213245557506,0.019536849115117532
4841,SIDM00928,ZM447439,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,35.0,-1.9471953,-0.1846352,-0.9019931290469115,-0.05870298552335653
94095,SIDM00633,PF-4708671,Nutlin-3a (-),Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.5369936,-0.07989685,-0.08683700111489909,0.01261686489052265
74796,SIDM00872,Navitoclax,MK-2206,Breast,0.25,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.68118954,-0.04338791,1.625938079895918,0.1326363147100362
16680,SIDM00148,Linsitinib,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,1.748779,0.16336186,-1.1078902350706623,-0.07758231441531606
46984,SIDM00875,Palbociclib,MK-1775,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,3.2508113,0.032608762,1.204586138891449,0.002487626835954569
19194,SIDM00826,AZD7762,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Male,White,70.0,8.548992,0.6036744,2.2122333970852757,0.16407584964191876
103424,SIDM00455,Paclitaxel,Gemcitabine,Pancreas,0.1,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-5.0508814,-0.21823889,-3.9150383048068176,-0.2488025184495944
75477,SIDM00148,Nutlin-3a (-),Bortezomib,Breast,0.000625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.39293158,-0.03959753,-0.10199923308194653,-0.012435969892162089
38606,SIDM00042,Linsitinib,Taselisib,Pancreas,0.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.9966937,0.04785867,-0.32937646114946834,0.024214420485563423
17451,SIDM00835,Taselisib,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,White,73.0,3.441092,0.22119872,3.8384657029956872,0.18782976701973086
88372,SIDM00146,Camptothecin,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,2.9149508,0.23433504,2.9220846416324884,0.2157733342216546
59357,SIDM00633,Doramapimod,Lapatinib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,3.9253085,0.09129023,1.8283728837981315,0.12727920669623197
17041,SIDM00950,AZD7762,MK-1775,Pancreas,0.2,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.5235388,0.20039095,1.2546684468696885,0.07436358877143194
98886,SIDM00933,Afatinib,Linsitinib,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,1.198158,0.11164191,1.812396693274127,0.1166042318184471
67722,SIDM01187,Temozolomide,Luminespib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,43.0,-0.62551016,-0.015076901,-0.21126062727379405,0.013499242872536616
73687,SIDM00877,Crizotinib,Pictilisib,Breast,0.125,Ductal Breast Carcinoma,Female,White,44.0,0.41532812,0.030806622,-0.09183569307466882,0.026651405098992283
31374,SIDM00633,Vorinostat,Olaparib,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.7951617,-0.14088371,-1.6393400031568925,-0.06168275235739188
56907,SIDM00633,Olaparib,5-Fluorouracil,Breast,10.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.4135644,-0.06497304,-0.5971259461145499,0.0024561707624079663
75799,SIDM00042,Irinotecan,Ruxolitinib,Pancreas,2.5,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,-1.6433848,-0.17035347,-1.5685250930336043,-0.0670220578966956
26870,SIDM00957,Linsitinib,BMS-754807,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-1.3595566,-0.026657265,0.6905219708635116,-0.03480737562984697
100067,SIDM00933,5-Fluorouracil,Vorinostat,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,-0.14386086,-0.019488031,-0.9609941051152148,-0.07031956496193653
58569,SIDM00148,AZD8055,MK-1775,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.560832,-0.08058261,-1.2118699046774828,-0.07363392628704411
74001,SIDM00950,Cisplatin,Irinotecan,Pancreas,0.5,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-1.7820004,-0.08228505,-0.7230585602779482,-0.005920744263447907
96984,SIDM00837,MK-2206,Crizotinib,Large Intestine,0.625,Colon Adenocarcinoma,Female,White,82.0,-1.2252221,-0.06776672,-1.043451784031778,0.026359139284147372
16058,SIDM00216,MK-1775,Palbociclib,Large Intestine,4.0,Colon Adenocarcinoma,Female,East Asian,56.0,-2.4428947,-0.08740947,-3.5268301208742145,-0.17610014060474008
20796,SIDM01042,Lapatinib,Navitoclax,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,0.9917975,0.09601961,1.8505894597928558,0.09847937817839553
11772,SIDM00933,Navitoclax,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,3.4261973,0.185168,1.8204724198827786,0.07224568518365723
12645,SIDM00875,PF-4708671,OSI-027,Breast,0.25,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.3055671,-0.04571309,0.166878911420119,0.046858652443925515
11317,SIDM00146,RO-3306,Navitoclax,Breast,0.625,Breast Adenocarcinoma,Female,White,51.0,1.2180998,0.09311357,2.844467324539077,0.22473755686912453
67825,SIDM00282,AZD7762,BMS-754807,Large Intestine,0.5,Colon Adenocarcinoma,Female,East Asian,55.0,2.1276119,0.06814998,1.08822952873598,0.08013211497186022
56897,SIDM00148,Nutlin-3a (-),Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.4020941,-0.102565594,-1.0827431873404978,-0.020223686944843968
77638,SIDM00097,AZD6482,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7645519,-0.10668609,-0.22608239057506505,-0.057574383015282456
6967,SIDM00455,LGK974,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.3547575,0.061751146,-0.3673278732233689,-0.03243203504369064
18670,SIDM00148,MK-1775,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,2.2903044,0.13327141,1.42884335592808,0.06907651619037046
2954,SIDM00146,KU-55933,Gemcitabine,Breast,0.1,Breast Adenocarcinoma,Female,White,51.0,-1.2979896,-0.03852335,-1.525611253156411,-0.008586936457218796
61996,SIDM00633,Sorafenib,Taselisib,Breast,0.1,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.7477453,-0.054023713,-1.3373555114028948,-0.03060872422905486
89528,SIDM00042,Cisplatin,Gemcitabine,Pancreas,0.1,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,2.3065503,0.21459123,-0.3115734418736539,0.009054183082371721
10218,SIDM00633,Wee1 Inhibitor,AZD7762,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.49434453,0.044751193,0.5446199201477627,0.03833649411207083
37016,SIDM00837,MK-1775,LGK974,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-0.33338758,-0.022348095,-0.5674217610978667,-0.04911256400393858
30809,SIDM00097,AZD6482,Lapatinib,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.9094795,-0.11172007,1.4168690186549127,0.03269647382428635
63503,SIDM01197,Crizotinib,AZD4547,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,0.6497426,0.047109924,0.2819870211673326,-0.03601487216895717
9009,SIDM00148,SCH772984,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.5587675,0.01585139,1.0381393916675985,0.015944767724631555
21405,SIDM00928,Taselisib,Vorinostat,Breast,2.0,Breast Carcinoma,Female,Unknown,35.0,1.5786666,0.105549216,0.6760155807334758,-0.05617662780509152
21646,SIDM00216,Linsitinib,Palbociclib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,-1.549896,-0.07414678,0.3696216313994889,0.03407534563327153
63329,SIDM00875,Docetaxel,5-Fluorouracil,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.7001711,-0.12632637,-2.829306005318563,-0.13329376682753943
63666,SIDM00633,Wee1 Inhibitor,Palbociclib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.28554353,-0.026418297,-1.1796150238576217,-0.15016705023096538
78685,SIDM00282,Camptothecin,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,East Asian,55.0,-0.7746345,-0.058106992,-1.8167946650729496,-0.09855247377908699
58269,SIDM00359,Linsitinib,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,0.7082048,0.03660043,1.813615196242061,0.1043436638094517
97230,SIDM00282,5-Fluorouracil,BMS-754807,Large Intestine,0.05,Colon Adenocarcinoma,Female,East Asian,55.0,-1.0436393,-0.071618795,-1.1050017672285588,-0.11452839595600067
33100,SIDM00146,SCH772984,Nutlin-3a (-),Breast,2.5,Breast Adenocarcinoma,Female,White,51.0,-1.0383043,-0.093205065,0.5863624029993469,0.04533031128820012
76559,SIDM00826,Palbociclib,MK-1775,Large Intestine,1.0,Colon Adenocarcinoma,Male,White,70.0,-4.9924955,-0.18707074,-4.9037639441200485,-0.1533301517855909
72420,SIDM00455,Oxaliplatin,Palbociclib,Pancreas,8.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.3570796,-0.059722103,-1.5913917799184865,-0.06476817489424712
11498,SIDM00673,OSI-027,Temozolomide,Breast,7.5,Ductal Breast Carcinoma,Female,Black,49.0,-0.6821263,-0.069575235,-0.48103247776827873,-0.02578673207885688
101019,SIDM00837,5-Fluorouracil,Vinorelbine,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,0.7301146,0.04019507,-2.8881150072624693,-0.08968113885768086
76181,SIDM00673,ZM447439,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,-1.373033,-0.11393042,-1.0176300537586875,-0.07964025034759464
41736,SIDM00097,Uprosertib,MK-1775,Breast,0.625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,1.0100825,0.0677705,-0.9906987895503245,-0.009618222479694849
38395,SIDM00877,AZD7762,Pictilisib,Breast,0.5,Ductal Breast Carcinoma,Female,White,44.0,-0.7039403,-0.043933876,0.3297455632887572,-0.008685475410583477
5896,SIDM00875,PD173074,Trametinib,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2741246,-0.053190146,0.7605450775271131,0.014692529208497836
40932,SIDM00928,Afatinib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,35.0,1.3130348,0.15376593,1.5353495852767722,0.069785249194298
7383,SIDM00872,Entinostat,Linsitinib,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.6273488,-0.0825253,0.5383363067450756,0.031158927314553997
84341,SIDM00875,Uprosertib,MK-1775,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,4.4577875,0.15183665,0.5936612609111483,0.05459083951410048
64148,SIDM00950,Navitoclax,Paclitaxel,Pancreas,0.025,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,7.260454,0.189769,5.733771364532358,0.1972919521134506
79802,SIDM00928,Alisertib,Docetaxel,Breast,0.00025,Breast Carcinoma,Female,Unknown,35.0,0.8651542,0.07469621,-1.455540254740271,-0.08232755866409805
57099,SIDM00872,Afatinib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,1.150404,0.12548669,0.01168009212902763,-0.009232130312864129
89879,SIDM00673,5-Fluorouracil,MK-2206,Breast,1.0,Ductal Breast Carcinoma,Female,Black,49.0,0.4267005,0.011735084,1.0047786641841916,0.07171443482934114
13208,SIDM01042,GSK269962A,Taselisib,Breast,1.0,Breast Carcinoma,Female,Unknown,52.74992395704158,1.0684994,0.09297173,-0.10443029296520534,-0.03261600638317754
99903,SIDM00146,SCH772984,Pictilisib,Breast,0.125,Breast Adenocarcinoma,Female,White,51.0,1.3369639,0.119522825,1.1873043732103283,0.0791105663298101
58295,SIDM01042,Bortezomib,Taselisib,Breast,0.1,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.3348809,-0.02021055,-1.4214313820296365,-0.0766526909801397
7832,SIDM00875,Sorafenib,Olaparib,Breast,2.5,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,0.6551273,0.065888636,-0.13850531918555237,0.00045177137042244175
84842,SIDM00933,MK-1775,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,45.0,-2.3265808,-0.23599876,-1.9062333872566553,-0.14028575238550106
71492,SIDM00875,Dabrafenib,Palbociclib,Breast,1.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,1.1349101,0.06591656,1.0131063408599754,0.02379234273460166
14522,SIDM01197,BMS-754807,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Male,East Asian,71.0,-4.694322,-0.0824361,-4.596694060126623,-0.14142560293151685
3888,SIDM00928,AZD6482,Palbociclib,Breast,4.0,Breast Carcinoma,Female,Unknown,35.0,-0.6257508,-0.03814703,-0.375928191311826,-0.023785606560997017
67102,SIDM00455,Olaparib,Linsitinib,Pancreas,2.5,Pancreatic Adenocarcinoma,Female,Unknown,44.0,2.3250542,0.070523225,2.1943175499373098,0.0860815933608675
1045,SIDM00148,Dabrafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-1.2653948,-0.0674781,-0.011517524874128063,0.01676917758956169
33270,SIDM00837,Taselisib,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Female,White,82.0,-3.8748267,-0.077950574,-1.3972516426730985,-0.060850449921941586
52189,SIDM00673,Crizotinib,Navitoclax,Breast,0.625,Ductal Breast Carcinoma,Female,Black,49.0,0.9711904,0.09188423,2.6043099318979333,0.14915754270189646
29653,SIDM00216,Palbociclib,Taselisib,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,56.0,0.9141553,0.067373,-0.3340720304653467,-0.009536481233786628
22104,SIDM00933,Alpelisib,AZD7762,Breast,0.25,Breast Carcinoma,Female,Unknown,45.0,1.4343538,0.1274453,-0.04838121031408122,0.014822335358166449
4382,SIDM00148,AZD8055,Pictilisib,Breast,0.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.8474476,-0.15123732,0.7113246824898498,0.03241142426279016
70383,SIDM00097,GSK269962A,OSI-027,Breast,0.25,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-1.7748188,-0.06805228,-1.223583835331276,-0.06587302927808741
25038,SIDM01197,MK-1775,SCH772984,Large Intestine,0.5,Colon Adenocarcinoma,Male,East Asian,71.0,-1.673269,-0.046594057,-1.3510822267816267,-0.08244387360226008
9543,SIDM00042,Lapatinib,OSI-027,Pancreas,1.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,3.603391,0.21765897,1.2097790818458622,0.027056482780431032
38465,SIDM00872,JQ1,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,South Asian,61.0,0.55130404,0.017423818,4.146749695232955,0.20879673159473125
92405,SIDM00875,KU-55933,Gemcitabine,Breast,0.01,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.75032794,-0.009150859,-0.9414065303365807,-0.008173573170072496
58062,SIDM00933,Trametinib,Gemcitabine,Breast,0.01,Breast Carcinoma,Female,Unknown,45.0,-0.30310604,-0.03639587,-2.322770636538967,-0.0755470083287895
106641,SIDM00872,Palbociclib,Temozolomide,Breast,30.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.36924765,0.016103227,-0.13529581571686902,-0.02810846490952608
72904,SIDM00673,Vorinostat,AZD7762,Breast,0.25,Ductal Breast Carcinoma,Female,Black,49.0,-2.9750447,-0.13056448,-0.0012082081981041144,0.01971736548063177
11687,SIDM01042,Alisertib,Axitinib,Breast,4.0,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6774337,-0.14314382,-1.5553956951030097,-0.11304983070404535
26317,SIDM00957,Dabrafenib,Olaparib,Large Intestine,10.0,Colon Carcinoma,Male,Unknown,69.0,-0.87330705,-0.011453119,1.1376439171056503,0.05256860589933015
20066,SIDM00835,Vinorelbine,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,73.0,1.1271875,0.060394593,-0.6936834853487518,0.05164454819021927
15751,SIDM00933,Cisplatin,Navitoclax,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,2.378769,0.3264822,1.4921655539182963,0.19350064658008606
103823,SIDM00957,Navitoclax,SCH772984,Large Intestine,0.05,Colon Carcinoma,Male,Unknown,69.0,-2.5030866,-0.07662175,2.5431297284917656,0.1600156078652656
76623,SIDM00359,Trametinib,Camptothecin,Large Intestine,0.025,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-1.9524177,-0.08238033,-2.894811936184769,-0.10800672681746513
77559,SIDM00837,Olaparib,Camptothecin,Large Intestine,0.0025,Colon Adenocarcinoma,Female,White,82.0,1.6859246,0.105895445,0.4249206495007818,0.05627108969253961
72081,SIDM00877,Vorinostat,Navitoclax,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.9914398,0.06706741,0.5874932038512964,0.059136767564618956
62897,SIDM00837,Camptothecin,SCH772984,Large Intestine,0.05,Colon Adenocarcinoma,Female,White,82.0,-0.31151897,-0.016333167,-1.9184925589394652,-0.05899032075502913
89732,SIDM00148,Axitinib,Docetaxel,Breast,0.001,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-3.2482228,-0.19196256,-0.842033999962031,-0.04169226798312987
23743,SIDM00282,Linsitinib,MK-2206,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,55.0,-1.7134862,-0.06500515,2.0637560986720755,0.13977240355202122
43507,SIDM01042,Camptothecin,Bortezomib,Breast,0.0025,Breast Carcinoma,Female,Unknown,52.74992395704158,2.4526608,0.08438668,-0.048711072739308935,0.02371153211163878
46495,SIDM00633,Olaparib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.4927195,-0.036295842,-0.16829498219026234,-0.010666661112669519
12851,SIDM00146,Temozolomide,Luminespib,Breast,0.0025,Breast Adenocarcinoma,Female,White,51.0,-0.33053985,-0.008352597,1.0623820558003705,0.03831410347136649
71670,SIDM00950,Navitoclax,Trametinib,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,3.3416564,0.2172038,1.349198303490988,0.12522157899245365
7630,SIDM00957,Afatinib,Vinorelbine,Large Intestine,0.01,Colon Carcinoma,Male,Unknown,69.0,-2.113548,-0.076379694,0.32132489199748937,0.07238510644299312
17143,SIDM00875,PF-4708671,Crizotinib,Breast,0.625,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-0.92807174,-0.03335964,1.2384164725204745,0.06604957221055847
100932,SIDM00826,MK-1775,SB505124,Large Intestine,0.625,Colon Adenocarcinoma,Male,White,70.0,-0.43730357,-0.03227611,-1.6118098308145066,-0.057967047583852675
62092,SIDM00359,Oxaliplatin,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.15956685,-0.010650256,-1.3344262054292861,-0.04915648117679504
32381,SIDM00877,ZM447439,Lapatinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,1.3293816,0.13994783,0.9690405783378189,0.11964932029890675
85720,SIDM00455,OSI-027,Oxaliplatin,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-4.5390983,-0.257147,-1.4166651753359645,-0.12788754122678056
48352,SIDM01042,Dabrafenib,MK-1775,Breast,2.5,Breast Carcinoma,Female,Unknown,52.74992395704158,-1.6415994,-0.106670596,-1.0067595583774036,-0.07961925129239655
91392,SIDM00776,5-Fluorouracil,Olaparib,Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-1.9848901,-0.059347995,-0.34227281703517887,0.019702988354869267
45175,SIDM00216,Palbociclib,Camptothecin,Large Intestine,0.025,Colon Adenocarcinoma,Female,East Asian,56.0,-3.9285035,-0.18335658,-2.2942406593309284,-0.1573251422614956
85134,SIDM00148,Linsitinib,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.31989443,0.03354792,-0.29068069882700576,-0.05729274857845436
83142,SIDM00146,Alisertib,Cisplatin,Breast,4.0,Breast Adenocarcinoma,Female,White,51.0,-1.8933653,-0.15689127,-2.3351769326329213,-0.15963440039754942
32318,SIDM00455,AZD7762,Sorafenib,Pancreas,5.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,0.53670245,0.02319113,1.3602506036709565,0.10410841618090894
61556,SIDM00950,Oxaliplatin,Palbociclib,Pancreas,2.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,-0.15323815,-0.009011922,-1.0709775012758502,-0.025206251635637236
79880,SIDM00835,Trametinib,Vinorelbine,Large Intestine,0.01,Colon Adenocarcinoma,Male,White,73.0,0.5922123,0.029686606,-0.06568357334020818,-0.013496617079808088
40514,SIDM00933,Entinostat,Lapatinib,Breast,0.625,Breast Carcinoma,Female,Unknown,45.0,-1.5912299,-0.097099565,1.4926687095428117,0.14160664979537474
79094,SIDM00933,Vorinostat,Pictilisib,Breast,0.5,Breast Carcinoma,Female,Unknown,45.0,1.095861,0.1410009,1.7354355800384305,0.10580353742670041
85064,SIDM00832,AZD8055,Afatinib,Large Intestine,0.25,Colon Adenocarcinoma,Female,White,81.0,-0.3756791,-0.029389033,-0.10354285511478978,-0.049074252884451
79374,SIDM00872,Crizotinib,Nutlin-3a (-),Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,0.87934685,0.08248634,0.3296493001077341,-0.008790682230537035
85557,SIDM00146,BI-2536,Vorinostat,Breast,2.0,Breast Adenocarcinoma,Female,White,51.0,3.6149452,0.052950736,-2.0531280895140083,-0.0648436368937812
76454,SIDM00455,Navitoclax,Dactolisib,Pancreas,0.05,Pancreatic Adenocarcinoma,Female,Unknown,44.0,1.0975513,0.037131432,0.7071568387636126,0.021755605235668316
55065,SIDM00875,PD173074,Olaparib,Breast,10.0,Squamous Cell Breast Carcinoma Acantholytic Variant,Female,Black,60.0,-1.2838564,-0.05648264,-0.035104028957576736,-0.008437041843277803
129,SIDM01197,Crizotinib,MK-1775,Large Intestine,0.25,Colon Adenocarcinoma,Male,East Asian,71.0,-0.74671113,-0.055898383,-1.590990074196117,-0.06869530586807322
22392,SIDM00872,ZM447439,Olaparib,Breast,2.5,Ductal Breast Carcinoma,Female,South Asian,61.0,-1.5206735,-0.12706368,-0.20474432445052482,-0.027517689473371774
21075,SIDM00673,NU7441,5-Fluorouracil,Breast,10.0,Ductal Breast Carcinoma,Female,Black,49.0,-0.39680576,-0.029780697,-0.4603388778599606,-0.053306337198284086
2818,SIDM00633,PF-4708671,Cisplatin,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-0.4680595,-0.040627304,-1.658452812143199,-0.09831015851532916
96128,SIDM00928,RO-3306,Linsitinib,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,2.1945193,0.22459874,1.100328274085589,0.11409070702801175
11945,SIDM00872,Navitoclax,PD173074,Breast,10.0,Ductal Breast Carcinoma,Female,South Asian,61.0,0.7385976,0.056296818,0.09447838904993885,0.027001098404173442
47856,SIDM00148,BI-2536,Axitinib,Breast,1.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-2.3482163,-0.12126042,-3.588812203354726,-0.15938199146313756
38029,SIDM00950,MK-2206,Lapatinib,Pancreas,10.0,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,5.9013033,0.15357134,3.3387000253575607,0.21626897031393055
63584,SIDM00148,Sorafenib,Trametinib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,0.47531196,0.044565234,0.25291164028963276,0.0346934711545223
66322,SIDM00097,PF-4708671,Temozolomide,Breast,30.0,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Unknown,54.0,-2.9823136,-0.09139057,-0.9078955150930943,-0.059622970170012855
69494,SIDM00832,Linsitinib,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,81.0,1.0930213,0.09866542,0.8381854542577074,0.04568658535469544
31708,SIDM01042,Tozasertib,AZD7762,Breast,0.0625,Breast Carcinoma,Female,Unknown,52.74992395704158,-0.8445676,-0.069309734,-0.21426882203815237,-0.04370378358003412
13024,SIDM00928,Tozasertib,Bortezomib,Breast,0.000625,Breast Carcinoma,Female,Unknown,35.0,3.9898279,0.24356814,0.9811061317778784,0.04794074707106565
50470,SIDM00455,Palbociclib,OSI-027,Pancreas,1.0,Pancreatic Adenocarcinoma,Female,Unknown,44.0,-1.5855465,-0.038411252,-0.09250415598104307,0.07656398900791525
44744,SIDM00042,Gemcitabine,Linsitinib,Pancreas,10.0,Pancreatic Ductal Adenocarcinoma,Unknown,Unknown,52.74992395704158,0.8014509,0.086799346,-1.465492293987664,-0.045253930562091274
80845,SIDM00877,Pictilisib,Crizotinib,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.5702734,-0.054653045,-0.5527365581526534,-0.07114717262922556
12688,SIDM00673,AZD8055,Trametinib,Breast,0.1,Ductal Breast Carcinoma,Female,Black,49.0,1.9616506,0.11008079,0.20965966330843966,0.02798496875906809
84936,SIDM00359,Crizotinib,5-Fluorouracil,Large Intestine,10.0,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-0.7059662,-0.048238557,-1.8218516870491746,-0.09325457086806004
74589,SIDM00359,Oxaliplatin,SCH772984,Large Intestine,0.5,Rectal Adenocarcinoma,Female,Unknown,52.74992395704158,-3.0953708,-0.0966933,-1.078477195269531,0.012098473027138408
38681,SIDM00837,Navitoclax,Linsitinib,Large Intestine,1.0,Colon Adenocarcinoma,Female,White,82.0,2.0869877,0.04866214,1.7531382691154667,0.008479524353819124
49448,SIDM00877,Trametinib,MK-1775,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,0.8154062,0.0034306087,1.8819572107781084,0.08524124555314219
39602,SIDM00877,Sorafenib,5-Fluorouracil,Breast,2.5,Ductal Breast Carcinoma,Female,White,44.0,-0.5922341,-0.06927918,-0.23303270382975838,-0.027877548042117825
53002,SIDM00633,AZD7762,Luminespib,Breast,0.01,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-2.966562,-0.12873252,-1.3170749352631594,-0.040236776118652014
103865,SIDM00776,Afatinib,Nutlin-3a (-),Large Intestine,10.0,Colon Adenocarcinoma,Female,White,65.0,-0.9248093,-0.08329284,-0.19164447532659892,-0.014951229399453855
5933,SIDM00933,AZD6482,PD173074,Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,0.48588943,0.01882075,1.7358630765190797,0.08596690775986694
79516,SIDM00673,PD173074,Bortezomib,Breast,0.000625,Ductal Breast Carcinoma,Female,Black,49.0,-2.8035855,-0.10994223,-1.0973815308465,-0.001844206332408955
42838,SIDM00928,Temozolomide,5-Fluorouracil,Breast,2.5,Breast Carcinoma,Female,Unknown,35.0,-0.9433531,-0.022301868,0.43247536520611624,-0.0009935539484350329
35624,SIDM00872,Bortezomib,Cisplatin,Breast,1.0,Ductal Breast Carcinoma,Female,South Asian,61.0,-0.3431002,-0.027256584,-0.7407826692889623,-0.0721617743621153
10444,SIDM00877,Venetoclax,Gemcitabine,Breast,0.01,Ductal Breast Carcinoma,Female,White,44.0,2.60303,0.081903934,0.8395123685205679,0.05320078407897861
13754,SIDM00216,LGK974,Linsitinib,Large Intestine,10.0,Colon Adenocarcinoma,Female,East Asian,56.0,1.9615469,0.07203485,1.6330437269961628,0.06308087011370786
5611,SIDM00833,Trametinib,Olaparib,Large Intestine,2.5,Rectal Adenocarcinoma,Male,White,53.0,0.6242375,0.026487151,-0.6845523963605394,-0.01339675218003744
31072,SIDM00933,Doramapimod,Nutlin-3a (-),Breast,10.0,Breast Carcinoma,Female,Unknown,45.0,3.4683306,0.118713215,2.9004481406493703,0.07542316576488156
4202,SIDM00282,Dabrafenib,Navitoclax,Large Intestine,1.0,Colon Adenocarcinoma,Female,East Asian,55.0,-0.18286096,-0.005794844,-0.19716280271287567,-0.018896297460029972
84850,SIDM00950,Ruxolitinib,AZD7762,Pancreas,0.25,Pancreatic Adenocarcinoma,Female,Unknown,52.74992395704158,2.1892388,0.11036353,1.5604593160229863,0.04162573314853875
29456,SIDM00633,ZM447439,Olaparib,Breast,2.5,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,0.5612404,0.052713692,-1.1987418141185913,-0.03273093473446019
93281,SIDM01197,SCH772984,Crizotinib,Large Intestine,2.5,Colon Adenocarcinoma,Male,East Asian,71.0,1.2153684,0.027235338,-1.4375263814651145,-0.0367985642025548
61490,SIDM00826,Trametinib,LGK974,Large Intestine,10.0,Colon Adenocarcinoma,Male,White,70.0,-5.5926523,-0.078391306,-2.172409563722416,-0.07219402727530533
33615,SIDM00957,Palbociclib,AZD8055,Large Intestine,0.125,Colon Carcinoma,Male,Unknown,69.0,-2.0596502,-0.045693148,0.8234005704920173,0.047832016827258614
50504,SIDM00148,AZD6482,AZD7762,Breast,0.0625,Invasive Ductal Carcinoma Not Otherwise Specified,Female,White,69.0,-0.2757642,-0.026161822,-0.3487488259609833,-0.019615672636696557
26459,SIDM00633,5-Fluorouracil,Bortezomib,Breast,0.0025,Invasive Ductal Carcinoma Not Otherwise Specified,Female,Black,56.0,-1.8883538,-0.08345804,-1.9020553608312827,-0.05900603155998562
30333,SIDM01197,LGK974,Dabrafenib,Large Intestine,1.0,Colon Adenocarcinoma,Male,East Asian,71.0,-0.57331055,-0.028601155,-0.5263183679492294,-0.035457289155281756
63593,SIDM00673,Crizotinib,Docetaxel,Breast,0.001,Ductal Breast Carcinoma,Female,Black,49.0,-1.1634542,-0.09042143,-0.5227628976335295,-0.04095647163923386
86138,SIDM01197,LGK974,Trametinib,Large Intestine,0.01,Colon Adenocarcinoma,Male,East Asian,71.0,0.91953826,0.0214119,-0.10167556573523777,-0.0016682309660493323
